PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shen, LJ; Chen, FY; Zhang, Y; Cao, LF; Kuang, Y; Zhong, M; Wang, T; Zhong, H				Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Cao, Lan-Fang; Kuang, Ying; Zhong, Min; Wang, Ting; Zhong, Hua			MYCN Transgenic Zebrafish Model with the Characterization of Acute Myeloid Leukemia and Altered Hematopoiesis	PLOS ONE			English	Article							GENE-EXPRESSION; DNA-DAMAGE; STEM-CELLS; TGF-BETA; C-MYC; DIFFERENTIATION; SCL; PROLIFERATION; ARREST; GROWTH	Background: Amplification of MYCN (N-Myc) oncogene has been reported as a frequent event and a poor prognostic marker in human acute myeloid leukemia (AML). The molecular mechanisms and transcriptional networks by which MYCN exerts its influence in AML are largely unknown. Methodology/Principal Findings: We introduced murine MYCN gene into embryonic zebrafish through a heat-shock promoter and established the stable germline Tg(MYCN: HSE:EGFP) zebrafish. N-Myc downstream regulated gene 1 (NDRG1), negatively controlled by MYCN in human and functionally involved in neutrophil maturation, was significantly under-expressed in this model. Using peripheral blood smear detection, histological section and flow cytometric analysis of single cell suspension from kidney and spleen, we found that MYCN overexpression promoted cell proliferation, enhanced the repopulating activity of myeloid cells and the accumulation of immature hematopoietic blast cells. MYCN enhanced primitive hematopoiesis by upregulating sc1 and Imo2 expression and promoted myelopoiesis by inhibiting gata1 expression and inducing pu.1, mpo expression. Microarray analysis identified that cell cycle, glycolysis/gluconeogenesis, MAPK/Ras, and p53-mediated apoptosis pathways were upregulated. In addition, mismatch repair, transforming and growth factor beta(TGF beta) were downregulated in MYCN-overexpressing blood cells (p<0.01). All of these signaling pathways are critical in the proliferation and malignant transformation of blood cells. Conclusion/Significance: The above results induced by overexpression of MYCN closely resemble the main aspects of human AML, suggesting that MYCN plays a role in the etiology of AML. MYCN reprograms hematopoietic cell fate by regulating NDRG1 and several lineage-specific hematopoietic transcription factors. Therefore, this MYCN transgenic zebrafish model facilitates dissection of MYCN-mediated signaling in vivo, and enables high-throughput scale screens to identify the potential therapeutic targets.	[Shen, Li-Jing; Chen, Fang-Yuan; Zhang, Yong; Zhong, Min; Wang, Ting; Zhong, Hua] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Cao, Lan-Fang] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat, Renji Hosp, Shanghai 200030, Peoples R China; [Kuang, Ying] Shanghai Res Ctr Biomodel Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, FY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	chenfangyuan62@163.com	; Rehman, Jalees/J-8258-2012	Marsboom, Glenn/0000-0001-6309-7557; Rehman, Jalees/0000-0002-2787-9292; Zhou, Yongqiang/0000-0003-1402-345X; Toth, Peter/0000-0003-2168-0124; Osburn, Christopher/0000-0002-9334-4202	National Natural Science Foundation of China [30900636]; Science and Technology Commission of Shanghai Municipality Grant [08JCI414900]; Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine [09XJ21066]; Science and Technology Commission of Shanghai Fund Project of TCM guide project [12401906700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Grant(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine; Science and Technology Commission of Shanghai Fund Project of TCM guide project	This work was supported in part by National Natural Science Foundation of China Grant (30900636), Science and Technology Commission of Shanghai Municipality Grant (08JCI414900), Science and Technology Fund Project of Shanghai Jiaotong University School of Medicine (09XJ21066), Science and Technology Commission of Shanghai Fund Project of TCM guide project (12401906700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BECKMANN RP, 1992, J CELL BIOL, V117, P1137, DOI 10.1083/jcb.117.6.1137; Bell E, 2007, CELL CYCLE, V6, P1249, DOI 10.4161/cc.6.10.4222; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Chen J, 2007, LEUKEMIA, V21, P462, DOI 10.1038/sj.leu.2404546; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; CUNNIFF NFA, 1993, J BIOL CHEM, V268, P8317; de Boer J, 2011, LEUKEMIA, V25, P321, DOI 10.1038/leu.2010.253; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dooley KA, 2005, DEV BIOL, V277, P522, DOI 10.1016/j.ydbio.2004.09.004; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Gupta Tripti, 2010, J Vis Exp, DOI 10.3791/1717; Halloran MC, 2000, DEVELOPMENT, V127, P1953; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kawagoe H, 2007, CANCER RES, V67, P10677, DOI 10.1158/0008-5472.CAN-07-1118; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Le HY, 2008, J BIOL CHEM, V283, P17652, DOI 10.1074/jbc.M710517200; Levantini E, 2011, EMBO J, V30, P4059, DOI 10.1038/emboj.2011.285; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007768; Milella M, 2001, J CLIN INVEST, V108, P851, DOI 10.1172/JCI200112807; Ng KP, 2011, LEUKEMIA, V25, P1739, DOI 10.1038/leu.2011.159; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rinaldi A, 2011, BRIT J HAEMATOL, V154, P590, DOI 10.1111/j.1365-2141.2011.08789.x; Rowley AF, 1997, THROMB HAEMOSTASIS, V77, P227; Scandurra M, 2010, HEMATOL ONCOL, V28, P62, DOI 10.1002/hon.932; Shafizadeh E, 2004, CURR OPIN HEMATOL, V11, P255, DOI 10.1097/01.moh.0000138686.15806.71; Sheppard RD, 1998, ONCOGENE, V17, P2073, DOI 10.1038/sj.onc.1202125; Sugihara E, 2006, CANCER RES, V66, P4020, DOI 10.1158/0008-5472.CAN-05-3250; Sun W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-22; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tschan MP, 2010, LEUKEMIA RES, V34, P393, DOI 10.1016/j.leukres.2009.08.037; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P11; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu H, 2012, ONCOL LETT, V3, P1119, DOI 10.3892/ol.2012.614; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904	47	209	220	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2013	8	3							e59070	10.1371/journal.pone.0059070	http://dx.doi.org/10.1371/journal.pone.0059070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109ZC	24204740	Green Published, gold, Green Submitted			2022-12-25	WOS:000316409800054
J	Yu, X; Wang, H; Zhong, WL; Bai, JJ; Liu, PL; He, YK				Yu, Xiang; Wang, Han; Zhong, Weili; Bai, Jinjuan; Liu, Pinglin; He, Yuke			QTL Mapping of Leafy Heads by Genome Resequencing in the RIL Population of Brassica rapa	PLOS ONE			English	Article							WIDE ASSOCIATION; LINKAGE MAP; GENE; PETIOLE	Leaf heads of cabbage (Brassica oleracea), Chinese cabbage (B. rapa), and lettuce (Lactuca sativa) are important vegetables that supply mineral nutrients, crude fiber and vitamins in the human diet. Head size, head shape, head weight, and heading time contribute to yield and quality. In an attempt to investigate genetic basis of leafy head in Chinese cabbage (B. rapa), we took advantage of recent technical advances of genome resequencing to perform quantitative trait locus (QTL) mapping using 150 recombinant inbred lines (RILs) derived from the cross between heading and non-heading Chinese cabbage. The resequenced genomes of the parents uncovered more than 1 million SNPs. Genotyping of RILs using the high-quality SNPs assisted by Hidden Markov Model (HMM) generated a recombination map. The raw genetic map revealed some physical assembly error and missing fragments in the reference genome that reduced the quality of SNP genotyping. By deletion of the genetic markers in which recombination rates higher than 20%, we have obtained a high-quality genetic map with 2209 markers and detected 18 QTLs for 6 head traits, from which 3 candidate genes were selected. These QTLs provide the foundation for study of genetic basis of leafy heads and the other complex traits.	[Yu, Xiang; Wang, Han; Zhong, Weili; Bai, Jinjuan; Liu, Pinglin; He, Yuke] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	He, YK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	ykhe@sibs.ac.cn	Yu, Xiang/H-9666-2019	Yu, Xiang/0000-0002-5730-8802	National Basic Research Program of China [2012CB113903]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Basic Research Program of China (Grant No. 2012CB113903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Hatakeyama K, 2010, GENOME, V53, P257, DOI [10.1139/G10-001, 10.1139/g10-001]; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Marian AJ, 2012, TRANSL RES, V159, P64, DOI 10.1016/j.trsl.2011.08.001; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nagata T, 1999, PLANT PHYSIOL, V120, P113, DOI 10.1104/pp.120.1.113; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-239; Ward JM, 2006, PLANT CELL, V18, P29, DOI 10.1105/tpc.105.036707; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Xiao L, 2012, THEOR APPL GENET, V124, P903, DOI 10.1007/s00122-011-1754-x; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; ZENG ZB, 1994, GENETICS, V136, P1457	26	39	40	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76059	10.1371/journal.pone.0076059	http://dx.doi.org/10.1371/journal.pone.0076059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204591	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200009
J	Dong, RL; Xu, XZ; Li, G; Feng, WJ; Zhao, G; Zhao, JJ; Wang, DW; Tu, L				Dong, Ruolan; Xu, Xizhen; Li, Geng; Feng, Wenjing; Zhao, Gang; Zhao, Junjie; Wang, Dao Wen; Tu, Ling			Bradykinin Inhibits Oxidative Stress-Induced Cardiomyocytes Senescence via Regulating Redox State	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CELLULAR SENESCENCE; TISSUE KALLIKREIN; DNA-DAMAGE; CELLS; APOPTOSIS; RECEPTORS; PATHWAYS; MICE	Background: Cell senescence is central to a large body of age related pathology, and accordingly, cardiomyocytes senescence is involved in many age related cardiovascular diseases. In consideration of that, delaying cardiomyocytes senescence is of great importance to control clinical cardiovascular diseases. Previous study indicated that bradykinin (BK) protected endothelial cells from senescence induced by oxidative stress. However, the effects of bradykinin on cardiomyocytes senescence remain to be elucidated. In this study, we investigated the effect of bradykinin on H2O2-induced H9C2 cells senescence. Methods and Results: Bradykinin pretreatment decreased the senescence induced by H2O2 in cultured H9C2 cells in a dose dependent manner. Interestingly, 1 nmol/L of BK almost completely inhibited the increase in senescent cell number and p21 expression induced by H2O2. Since H2O2 induces senescence through superoxide-induced DNA damage, we also observed the DNA damage by comet assay, and BK markedly reduced DNA damage induced by H2O2, and moreover, BK treatment significantly prevented reactive oxygen species (ROS) production in H9C2 cells treated with H2O2. Importantly, when co-incubated with bradykinin B2 receptor antagonist HOE-140 or eNOS inhibitor N-methyl-L-arginine acetate salt (L-NAME), the protective effects of bradykinin on H9C2 senescence were totally blocked. Furthermore, BK administration significantly prevented the increase in nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity characterized by increased ROS generation and gp91 expression and increased translocation of p47 and p67 to the membrane and the decrease in superoxide dismutase (SOD) activity and expression induced by H2O2 in H9C2 cells, which was dependent on BK B2 receptor mediated nitric oxide (NO) release. Conclusions: Bradykinin, acting through BK B2 receptor induced NO release, upregulated antioxidant Cu/Zn-SOD and Mn-SOD activity and expression while downregulating NADPH oxidase activity and subsequently inhibited ROS production, and finally protected against cardiomyocytes senescence induced by oxidative stress.	[Dong, Ruolan; Li, Geng; Feng, Wenjing; Zhao, Junjie; Tu, Ling] Huazhong Univ Sci & Technol, Dept Geriatr Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Xizhen; Zhao, Gang; Wang, Dao Wen] Huazhong Univ Sci & Technol, Inst Hypertens, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Xizhen; Zhao, Gang; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tu, L (corresponding author), Huazhong Univ Sci & Technol, Dept Geriatr Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	proftu@tom.com			National Nature Science Foundation Committee of China [303061511, 30971247, 81100085]	National Nature Science Foundation Committee of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Nature Science Foundation Committee of China (No. 303061511, No. 30971247 and No. 81100085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; Cyr M, 2001, TRANSFUSION, V41, P136, DOI 10.1046/j.1537-2995.2001.41010136.x; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Feng J, 2010, ARTERIOSCL THROM VAS, V30, P1703, DOI 10.1161/ATVBAHA.110.209726; Frank A, 2012, SEMIN CARDIOTHORAC V, V16, P123, DOI 10.1177/1089253211436350; Frantz S, 2006, BASIC RES CARDIOL, V101, P127, DOI 10.1007/s00395-005-0568-x; Freedman DA, 2005, EXP CELL RES, V307, P118, DOI 10.1016/j.yexcr.2005.03.025; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Iglesias-Ara A, 2010, ONCOGENE, V29, P5579, DOI 10.1038/onc.2010.296; Kakoki M, 2006, J CLIN INVEST, V116, P1302, DOI 10.1172/JCI26958; Kanai AJ, 1997, AM J PHYSIOL-CELL PH, V273, pC1371, DOI 10.1152/ajpcell.1997.273.4.C1371; Kintsurashvili E, 2005, AM J PHYSIOL-HEART C, V289, pH202, DOI 10.1152/ajpheart.01287.2004; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; Lou ZK, 2006, EXP CELL RES, V312, P2641, DOI 10.1016/j.yexcr.2006.06.009; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Oeseburg H, 2009, HYPERTENSION, V53, P417, DOI 10.1161/HYPERTENSIONAHA.108.123729; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Park SK, 2011, BMB REP, V44, P291, DOI 10.5483/BMBRep.2011.44.5.291; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Sayama K, 1999, J CELL PHYSIOL, V179, P40, DOI 10.1002/(SICI)1097-4652(199904)179:1<40::AID-JCP5>3.0.CO;2-Z; Tikellis C, 2011, CURR OPIN NEPHROL HY, V20, P62, DOI 10.1097/MNH.0b013e328341164a; Tu L, 2008, HUM GENE THER, V19, P318, DOI 10.1089/hum.2007.138; Unterluggauer H, 2003, EXP GERONTOL, V38, P1149, DOI 10.1016/j.exger.2003.08.007; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Vulliamy TJ, 2009, CELL MOL LIFE SCI, V66, P3091, DOI 10.1007/s00018-009-0091-6; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Xu XZ, 2012, INT J MOL MED, V29, P891, DOI 10.3892/ijmm.2012.922; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035836, 10.1371/journal.pone.0029652]; Yin H, 2008, LIFE SCI, V82, P156, DOI 10.1016/j.lfs.2007.10.021; Zhang MA, 2011, ARTERIOSCL THROM VAS, V31, P125, DOI 10.1161/ATVBAHA.110.207712; Zhang XL, 2005, J BIOL CHEM, V280, P19635, DOI 10.1074/jbc.M502262200; Zieman SJ, 2001, CIRC RES, V88, P97, DOI 10.1161/01.RES.88.1.97	39	34	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77034	10.1371/journal.pone.0077034	http://dx.doi.org/10.1371/journal.pone.0077034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204728	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400026
J	Taskinen, B; Zmurko, J; Ojanen, M; Kukkurainen, S; Parthiban, M; Maatta, JAE; Leppiniemi, J; Janis, J; Parikka, M; Turpeinen, H; Ramet, M; Pesu, M; Johnson, MS; Kulomaa, MS; Airenne, TT; Hytonen, VP				Taskinen, Barbara; Zmurko, Joanna; Ojanen, Markus; Kukkurainen, Sampo; Parthiban, Marimuthu; Maatta, Juha A. E.; Leppiniemi, Jenni; Janis, Janne; Parikka, Mataleena; Turpeinen, Hannu; Ramet, Mika; Pesu, Marko; Johnson, Mark S.; Kulomaa, Markku S.; Airenne, Tomi T.; Hytonen, Vesa P.			Zebavidin - An Avidin-Like Protein from Zebrafish	PLOS ONE			English	Article							BIOTIN-BINDING PROTEINS; THERMAL-STABILITY; SIGNAL PEPTIDES; LIGAND-BINDING; BRADAVIDIN-II; DANIO-RERIO; STREPTAVIDIN; MODEL; GENES; PREDICTION	The avidin protein family members are well known for their high affinity towards D-biotin and high structural stability. These properties make avidins valuable tools for a wide range of biotechnology applications. We have identified a new member of the avidin family in the zebrafish (Danio rerio) genome, hereafter called zebavidin. The protein is highly expressed in the gonads of both male and female zebrafish and in the gills of male fish, but our data suggest that zebavidin is not crucial for the developing embryo. Biophysical and structural characterisation of zebavidin revealed distinct properties not found in any previously characterised avidins. Gel filtration chromatography and native mass spectrometry suggest that the protein forms dimers in the absence of biotin at low ionic strength, but assembles into tetramers upon binding biotin. Ligand binding was analysed using radioactive and fluorescently labelled biotin and isothermal titration calorimetry. Moreover, the crystal structure of zebavidin in complex with biotin was solved at 2.4 angstrom resolution and unveiled unique ligand binding and subunit interface architectures; the atomic-level details support our physicochemical observations.	[Taskinen, Barbara; Zmurko, Joanna; Ojanen, Markus; Kukkurainen, Sampo; Maatta, Juha A. E.; Leppiniemi, Jenni; Parikka, Mataleena; Turpeinen, Hannu; Ramet, Mika; Pesu, Marko; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland; [Taskinen, Barbara; Kukkurainen, Sampo; Maatta, Juha A. E.; Pesu, Marko; Hytonen, Vesa P.] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Zmurko, Joanna] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Parthiban, Marimuthu; Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Dept Biosci, Turku, Finland; [Leppiniemi, Jenni; Ramet, Mika; Kulomaa, Markku S.] Tampere Univ Hosp, Tampere, Finland; [Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland; Tampere Univ Hosp, Dept Paediat, Tampere, Finland	Tampere University; Pirkanmaa Hospital District; University of Glasgow; Abo Akademi University; Tampere University; Tampere University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital	Hytonen, VP (corresponding author), Univ Tampere, Inst Biomed Technol, BioMediTech, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Leppiniemi, Jenni/S-6262-2019; Jänis, Janne/B-7326-2014; Ojanen, Markus/AAI-8316-2021; Määttä, Juha/A-6629-2016; Pesu, Marko/L-6344-2013; Marimuthu, Parthiban/AAU-6138-2021; Leppiniemi, Jenni/A-6641-2016; Kulomaa, Markku S/C-9063-2014; Hytonen, Vesa P./E-8855-2013; Parikka, Mataleena/D-4364-2014	Leppiniemi, Jenni/0000-0002-7225-1648; Ojanen, Markus/0000-0001-6623-844X; Määttä, Juha/0000-0003-3885-6149; Pesu, Marko/0000-0002-7541-3921; Marimuthu, Parthiban/0000-0003-4960-2160; Leppiniemi, Jenni/0000-0002-7225-1648; Hytonen, Vesa P./0000-0002-9357-1480; Parikka, Mataleena/0000-0001-5555-3815; Taskinen, Barbara/0000-0003-2989-7563; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [115976, 121236, 136288, 140978, 257814, 261285]; National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB); Foundation of Angstrombo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation; e, Pentti and Tor Borg Memorial Fund; European Community; Emil Aaltonen Foundation; Tampere Tuberculosis Foundation; Tampere University Hospital [9M019, 9M042, 9M080, 9N056]	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB); Foundation of Angstrombo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation(Sigrid Juselius Foundation); e, Pentti and Tor Borg Memorial Fund; European Community(European Commission); Emil Aaltonen Foundation; Tampere Tuberculosis Foundation; Tampere University Hospital	This work was funded by the Academy of Finland [projects 115976, 121236, 136288, 140978, 257814 and 261285], the National Doctoral Programme in Informational and Structural Biology (ISB), the Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB), the Foundation of angstrom bo Akademi (Centre of Excellence in Cell Stress and Aging), the Sigrid Juselius Foundation, the Joe, Pentti and Tor Borg Memorial Fund, a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme, Emil Aaltonen Foundation, and Tampere Tuberculosis Foundation. This study was financially supported by the Competitive Research Funding of the Tampere University Hospital [Grants 9M019, 9M042, 9M080 and 9N056]. The authors acknowledge the FIRI infrastructure support for structural biology from the Academy of Finland. Biocenter Finland is acknowledged for the infrastructure support and for the analysis of the zebavidin isolated from fish eggs. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIAMANDIS EP, 1991, CLIN CHEM, V37, P625; ELO HA, 1980, EXPERIENTIA, V36, P312, DOI 10.1007/BF01952296; ELO HA, 1980, J STEROID BIOCHEM, V12, P279, DOI 10.1016/0022-4731(80)90279-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GENTRYWEEKS CR, 1992, J BACTERIOL, V174, P7729, DOI 10.1128/JB.174.23.7729-7742.1992; Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Hayouka R, 2008, ACTA CRYSTALLOGR D, V64, P302, DOI 10.1107/S0907444907067844; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; Hytonen VP, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-8; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KEINANEN RA, 1994, EUR J BIOCHEM, V220, P615, DOI 10.1111/j.1432-1033.1994.tb18663.x; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; Laitinen OH, 1999, FEBS LETT, V461, P52, DOI 10.1016/S0014-5793(99)01423-4; Laitinen OH, 2001, J BIOL CHEM, V276, P8219, DOI 10.1074/jbc.M007930200; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leppiniemi J, 2013, PROTEIN SCI, V22, P980, DOI 10.1002/pro.2281; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Lohi O, 2013, ACTA PAEDIATR, V102, P104, DOI 10.1111/j.1651-2227.2012.02835.x; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; MAJUMDER K, 1992, GENE, V110, P89, DOI 10.1016/0378-1119(92)90448-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Niskanen EA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-41; NORDBACK I, 1982, COMP BIOCHEM PHYS A, V71, P389, DOI 10.1016/0300-9629(82)90423-6; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Nordlund HR, 2003, J BIOL CHEM, V278, P2479, DOI 10.1074/jbc.M210721200; OMALLEY BW, 1967, BIOCHEMISTRY-US, V6, P2546, DOI 10.1021/bi00860a036; Parikka M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002944; Pazy Y, 2003, J BIOL CHEM, V278, P7131, DOI 10.1074/jbc.M209983200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Qureshi MH, 2001, J BIOL CHEM, V276, P46422, DOI 10.1074/jbc.M107398200; Rounioja S, 2012, DEV COMP IMMUNOL, V36, P342, DOI 10.1016/j.dci.2011.05.008; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sano T, 1997, P NATL ACAD SCI USA, V94, P6153, DOI 10.1073/pnas.94.12.6153; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Takakura Y, 2009, FEBS J, V276, P1383, DOI 10.1111/j.1742-4658.2009.06879.x; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; TUOHIMAA P, 1989, International Journal of Developmental Biology, V33, P125; WHITE HB, 1987, BIOCHEM J, V241, P677, DOI 10.1042/bj2410677; WHITE HB, 1976, BIOCHEM J, V157, P395, DOI 10.1042/bj1570395; WHITE HB, 1985, ANN NY ACAD SCI, V447, P202, DOI 10.1111/j.1749-6632.1985.tb18438.x; Wixon J, 2000, YEAST, V17, P225, DOI 10.1002/1097-0061(20000930)17:3&lt;225::AID-YEA34&gt;3.0.CO;2-5	72	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77207	10.1371/journal.pone.0077207	http://dx.doi.org/10.1371/journal.pone.0077207			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204770	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300017
J	A'Bear, AD; Murray, W; Webb, R; Boddy, L; Jones, TH				A'Bear, A. Donald; Murray, William; Webb, Rachel; Boddy, Lynne; Jones, T. Hefin			Contrasting Effects of Elevated Temperature and Invertebrate Grazing Regulate Multispecies Interactions between Decomposer Fungi	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMUNITY STRUCTURE; WOODLAND SOIL; SITKA SPRUCE; BOTTOM-UP; TOP-DOWN; LITTER; BIODIVERSITY; IMPACTS; INOCULATION	Predicting the influence of biotic and abiotic factors on species interactions and ecosystem processes is among the primary aims of community ecologists. The composition of saprotrophic fungal communities is a consequence of competitive mycelial interactions, and a major determinant of woodland decomposition and nutrient cycling rates. Elevation of atmospheric temperature is predicted to drive changes in fungal community development. Top-down regulation of mycelial growth is an important determinant of, and moderator of temperature-driven changes to, two-species interaction outcomes. This study explores the interactive effects of a 4 degrees C temperature increase and soil invertebrate (collembola or woodlice) grazing on multispecies interactions between cord-forming basidiomycete fungi emerging from colonised beech (Fagus sylvatica) wood blocks. The fungal dominance hierarchy at ambient temperature (16 degrees C; Phanerochaete velutina > Resinicium bicolor > Hypholoma fasciculare) was altered by elevated temperature (20 degrees C; R. bicolor > P. velutina > H. fasciculare) in ungrazed systems. Warming promoted the competitive ability of the fungal species (R. bicolor) that was preferentially grazed by all invertebrate species. As a consequence, grazing prevented the effect of temperature on fungal community development and maintained a multispecies assemblage. Decomposition of fungal-colonised wood was stimulated by warming, with implications for increased CO2 efflux from woodland soil. Analogous to aboveground plant communities, increasing complexity of biotic and abiotic interactions appears to be important in buffering climate change effects on soil decomposers.	[A'Bear, A. Donald; Murray, William; Webb, Rachel; Boddy, Lynne; Jones, T. Hefin] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	A'Bear, AD (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	BoddyL@Cardiff.ac.uk	Boddy, Lynne/A-7250-2010	Jones, T Hefin/0000-0002-7874-3627; Boddy, Lynne/0000-0003-1845-6738	Natural Environment Research Council [NERC/I527861]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Natural Environment Research Council provided a studentship to ADA (NERC/I527861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A'Bear AD, 2013, FUNGAL ECOL, V6, P137, DOI 10.1016/j.funeco.2013.01.001; A'Bear AD, 2012, GLOBAL CHANGE BIOL, V18, P1823, DOI 10.1111/j.1365-2486.2012.02637.x; A'Bear AD, 2013, FUNGAL ECOL, DOI [10.1016/j.funeco.2013.01.009, DOI 10.1016/J.FUNEC0.2013.01.009]; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Boddy L, 1999, MYCOLOGIA, V91, P13, DOI 10.2307/3761190; BODDY L, 1983, SOIL BIOL BIOCHEM, V15, P149, DOI 10.1016/0038-0717(83)90096-2; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Crowther TW, 2012, ISME J, V6, P1992, DOI 10.1038/ismej.2012.53; Crowther TW, 2012, FEMS MICROBIOL ECOL, V81, P419, DOI 10.1111/j.1574-6941.2012.01364.x; Crowther TW, 2012, FUNGAL ECOL, V5, P277, DOI 10.1016/j.funeco.2011.07.006; Crowther TW, 2011, ECOL LETT, V14, P1134, DOI 10.1111/j.1461-0248.2011.01682.x; Crowther TW, 2011, SOIL BIOL BIOCHEM, V43, P2060, DOI 10.1016/j.soilbio.2011.06.003; Crowther TW, 2011, OECOLOGIA, V167, P535, DOI 10.1007/s00442-011-2005-1; Crowther TW, 2013, ECOLOGY IN PRESS; David JF, 2010, BIOL REV, V85, P881, DOI 10.1111/j.1469-185X.2010.00138.x; DOWSON CG, 1988, NEW PHYTOL, V109, P343, DOI 10.1111/j.1469-8137.1988.tb04204.x; DOWSON CG, 1988, NEW PHYTOL, V109, P335, DOI 10.1111/j.1469-8137.1988.tb04203.x; Eklof JS, 2012, ECOL LETT, V15, P864, DOI 10.1111/j.1461-0248.2012.01810.x; Fricker MD, 2008, BR MYCOL SY, V28, P3; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; HANLON RDG, 1979, OECOLOGIA, V38, P93, DOI 10.1007/BF00347827; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; Kaneko N, 1998, APPL SOIL ECOL, V9, P209, DOI 10.1016/S0929-1393(98)00077-8; Lawton JH, 1996, ECOLOGY, V77, P665, DOI 10.2307/2265488; LAWTON JH, 1995, SCIENCE, V269, P328, DOI 10.1126/science.269.5222.328; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; NEWELL K, 1984, SOIL BIOL BIOCHEM, V16, P235, DOI 10.1016/0038-0717(84)90007-5; NEWELL K, 1984, SOIL BIOL BIOCHEM, V16, P227, DOI 10.1016/0038-0717(84)90006-3; PETERSEN H, 1982, OIKOS, V39, P287, DOI 10.2307/3544689; Pollierer MM, 2009, SOIL BIOL BIOCH; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; R Core Team, 2021, R LANG ENV STAT COMP; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Topp W, 2006, SOIL BIOL BIOCHEM, V38, P43, DOI 10.1016/j.soilbio.2005.04.012; Tordoff GM, 2008, SOIL BIOL BIOCHEM, V40, P434, DOI 10.1016/j.soilbio.2007.09.006; Travleev AP, 1960, EURASIAN SOIL SCI, V10, P1108; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Veen GF, 2010, ECOLOGY, V91, P828, DOI 10.1890/09-0134.1; Voigt W, 2007, GLOBAL CHANGE BIOL, V13, P1710, DOI 10.1111/j.1365-2486.2007.01398.x; Walker M, 2001, OIKOS, V93, P177, DOI 10.1034/j.1600-0706.2001.930201.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P452, DOI 10.1111/j.1365-2486.2010.02253.x; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x	52	14	14	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77610	10.1371/journal.pone.0077610	http://dx.doi.org/10.1371/journal.pone.0077610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194892	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000071
J	Chiaverano, LM; Holland, BS; Crow, GL; Blair, L; Yanagihara, AA				Chiaverano, Luciano M.; Holland, Brenden S.; Crow, Gerald L.; Blair, Landy; Yanagihara, Angel A.			Long-Term Fluctuations in Circalunar Beach Aggregations of the Box Jellyfish Alatina moseri in Hawaii, with Links to Environmental Variability	PLOS ONE			English	Article							PACIFIC SUBTROPICAL GYRE; AURELIA-AURITA; GELATINOUS ZOOPLANKTON; TRIPEDALIA-CYSTOPHORA; PELAGIA-NOCTILUCA; CHIRONEX-FLECKERI; COMMON JELLYFISH; SOMATIC GROWTH; BLOOMS; CNIDARIA	The box jellyfish Alatina moseri forms monthly aggregations at Waikiki Beach 8-12 days after each full moon, posing a recurrent hazard to swimmers due to painful stings. We present an analysis of long-term (14 years: Jan 1998- Dec 2011) changes in box jellyfish abundance at Waikiki Beach. We tested the relationship of beach counts to climate and biogeochemical variables over time in the North Pacific Sub-tropical Gyre (NPSG). Generalized Additive Models (GAM), Change-Point Analysis (CPA), and General Regression Models (GRM) were used to characterize patterns in box jellyfish arrival at Waikiki Beach 8-12 days following 173 consecutive full moons. Variation in box jellyfish abundance lacked seasonality, but exhibited dramatic differences among months and among years, and followed an oscillating pattern with significant periods of increase (1998-2001; 2006-2011) and decrease (2001-2006). Of three climatic and 12 biogeochemical variables examined, box jellyfish showed a strong, positive relationship with primary production, >2 mm zooplankton biomass, and the North Pacific Gyre Oscillation (NPGO) index. It is clear that that the moon cycle plays a key role in synchronizing timing of the arrival of Alatina moseri medusae to shore. We propose that bottom-up processes, likely initiated by inter-annual regional climatic fluctuations influence primary production, secondary production, and ultimately regulate food availability, and are therefore important in controlling the inter-annual changes in box jellyfish abundance observed at Waikiki Beach.	[Chiaverano, Luciano M.] Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Holland, Brenden S.] Univ Hawaii Manoa, Ctr Conservat Res & Training, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Crow, Gerald L.] Univ Hawaii Manoa, Waikiki Aquarium, Honolulu, HI 96822 USA; [Blair, Landy] City & Cty Honolulu, Ocean Safety Serv, Honolulu, HI USA; [Blair, Landy] City & Cty Honolulu, Lifeguard Serv, Honolulu, HI USA; [Yanagihara, Angel A.] Univ Hawaii Manoa, Bekesy Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Yanagihara, Angel A.] Univ Hawaii Manoa, Dept Trop Med, John A Burns Sch Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Chiaverano, LM (corresponding author), Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	lchiave@hawaii.edu	holland, brenden/J-5630-2019; Yanagihara, Angel/O-5664-2016	holland, brenden/0000-0002-7832-8589; Yanagihara, Angel/0000-0001-6908-8176; Chiaverano, Luciano/0000-0002-3730-9744	National Institutes of Health [U54 NS039406, P20 RR016453, G12 RR003061, R21 DA024444]; Victoria S and Bradley L Geist Foundation of Hawaii Community Foundation [HCF 958935, 991879, 20001741, 20011908, 20061497, 20071368, 47031]; Oahu Army Natural Resources Program; Directorate For Geosciences [1260164] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS039406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024444] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victoria S and Bradley L Geist Foundation of Hawaii Community Foundation; Oahu Army Natural Resources Program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Field components of this project were partially supported by grants from the National Institutes of Health (U54 NS039406, P20 RR016453, G12 RR003061, P20 RR016453, R21 DA024444) and the Victoria S and Bradley L Geist Foundation of Hawaii Community Foundation (HCF 958935, 991879, 20001741, 20011908, 20061497, 20071368 and 47031) (AY). BSH and LMC were supported by the Oahu Army Natural Resources Program during preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP, P300; Arai MN, 2009, HYDROBIOLOGIA, V616, P241, DOI 10.1007/s10750-008-9588-5; Arneson AC, 1976, COELENTRATE ECOLOGY; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Bentlage B, 2010, P ROY SOC B-BIOL SCI, V277, P493, DOI 10.1098/rspb.2009.1707; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 1996, TRENDS ECOL EVOL, V11, P177, DOI 10.1016/0169-5347(96)20007-2; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Carrette T, 2002, TOXICON, V40, P1547, DOI 10.1016/S0041-0101(02)00168-X; Chiaverano L, 2004, HYDROBIOLOGIA, V530, P373, DOI 10.1007/s10750-004-2666-4; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Courtney R, 2012, THESIS; Daryanabard R, 2008, J MAR BIOL ASSOC UK, V88, P477, DOI 10.1017/S0025315408000945; Dave AC, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006507; Dawson MN, 2009, HYDROBIOLOGIA, V616, P193, DOI 10.1007/s10750-008-9591-x; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Doyle TK, 2007, HYDROBIOLOGIA, V579, P29, DOI 10.1007/s10750-006-0362-2; Eberhardt LL, 1999, MAR MAMMAL SCI, V15, P766, DOI 10.1111/j.1748-7692.1999.tb00842.x; Fenner PJ, 2010, J TRAVEL MED, V17, P133, DOI 10.1111/j.1708-8305.2009.00390.x; Fenner PJ, 2002, MED J AUSTRALIA, V177, P362, DOI 10.5694/j.1326-5377.2002.tb04838.x; Fenner PJ, 1996, MED J AUSTRALIA, V165, P658, DOI 10.5694/j.1326-5377.1996.tb138679.x; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; Fischer AB, 2004, HYDROBIOLOGIA, V530, P331, DOI 10.1007/s10750-004-2658-4; Garm A, 2012, BIOL BULL-US, V222, P35, DOI 10.1086/BBLv222n1p35; Gilhousen D. B., 1987, Journal of Atmospheric and Oceanic Technology, V4, P94, DOI 10.1175/1520-0426(1987)004<0094:AFEONM>2.0.CO;2; Gordon MR, 2009, HYDROBIOLOGIA, V616, P87, DOI 10.1007/s10750-008-9594-7; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; HAMNER WM, 1982, LIMNOL OCEANOGR, V27, P896, DOI 10.4319/lo.1982.27.5.0896; HAMNER WM, 1974, AM ZOOL, V14, P833; Han Chang-Hoon, 2010, Plankton & Benthos Research, V5, P98; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Hastie TJ., 1990, GEN ADDITIVE MODELS; Hoover RA, 2009, HYDROBIOLOGIA, V616, P259, DOI 10.1007/s10750-008-9595-6; Houghton JDR, 2007, HYDROBIOLOGIA, V589, P1, DOI 10.1007/s10750-007-0572-2; Huynh TT, 2003, MED J AUSTRALIA, V178, P38, DOI 10.5694/j.1326-5377.2003.tb05041.x; Ishii H, 1998, J PLANKTON RES, V20, P805, DOI 10.1093/plankt/20.5.805; Kahn AS, 2012, DEEP-SEA RES PT I, V70, P36, DOI 10.1016/j.dsr.2012.08.001; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 1999, ECOSYSTEMS, V2, P181, DOI 10.1007/s100219900068; Karl DM, 1996, DEEP-SEA RES PT II, V43, P129, DOI 10.1016/0967-0645(96)00005-7; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Lucas CH, 1996, J PLANKTON RES, V18, P987, DOI 10.1093/plankt/18.6.987; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Lucas CH, 1998, MAR BIOL, V131, P629, DOI 10.1007/s002270050355; Lynam CP, 2011, GLOBAL CHANGE BIOL, V17, P767, DOI 10.1111/j.1365-2486.2010.02352.x; Lynam CP, 2010, J MAR BIOL ASSOC UK, V90, P1153, DOI 10.1017/S0025315409990488; Ma XP, 2005, MAR BIOL, V147, P225, DOI 10.1007/s00227-004-1539-8; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Matsumoto George I., 2002, Bishop Museum Occasional Papers, V69, P44; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Molinero JC, 2005, LIMNOL OCEANOGR, V50, P1213, DOI 10.4319/lo.2005.50.4.1213; Molinero Juan Carlos, 2009, Annales Series Historia Naturalis, V19, P11; Nagata Renato M., 2009, Pan-American Journal of Aquatic Sciences, V4, P312; Nogueira M, 2008, BRAZ J OCEANOGR, V56, P157, DOI 10.1590/S1679-87592008000300001; Palomares MLD, 2009, HYDROBIOLOGIA, V616, P11, DOI 10.1007/s10750-008-9582-y; Pauly D., 2009, UN ENV PROGRAMME REG, P23; Perea-Blazquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029569; Pierce J, 2009, ZOO BIOL, V28, P163, DOI 10.1002/zoo.20218; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Robinson KL, 2013, LIMNOL OCEANOGR, V58, P235, DOI 10.4319/lo.2013.58.1.0235; Saba VS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003655; Schroth W, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-1; Sheridan C, 2004, ICES J MAR SCI, V61, P57; Stewart SE, 1996, MAR FRESHW BEHAV PHY, V27, P175, DOI 10.1080/10236249609378963; Suchman CL, 2012, HYDROBIOLOGIA, V690, P113, DOI 10.1007/s10750-012-1055-7; Taylor WA, 2003, CHANGE POINT ANAL VE; Thomas C S, 2001, Hawaii Med J, V60, P100; Underwood AH, 2007, TOXICON, V49, P1073, DOI 10.1016/j.toxicon.2007.01.014; Valiela I, 1995, MARINE ECOLOGICAL PR; Webster CN, 2012, J EXP MAR BIOL ECOL, V436, P50, DOI 10.1016/j.jembe.2012.08.014; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yoshimoto CM, 2002, T ROY SOC TROP MED H, V96, P300, DOI 10.1016/S0035-9203(02)90105-7	87	29	30	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77039	10.1371/journal.pone.0077039	http://dx.doi.org/10.1371/journal.pone.0077039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194856	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000035
J	Sanin, MJ; Anthelme, F; Pintaud, JC; Galeano, G; Bernal, R				Jose Sanin, Maria; Anthelme, Fabien; Pintaud, Jean-Christophe; Galeano, Gloria; Bernal, Rodrigo			Juvenile Resilience and Adult Longevity Explain Residual Populations of the Andean Wax Palm Ceroxylon quindiuense after Deforestation	PLOS ONE			English	Article							TREE; GROWTH; FOREST; PLANT; AVOIDANCE; DYNAMICS; PATTERNS; RISE	Wax palms are an important element of the cloud forests in the tropical Andes. Despite heavy deforestation, the density of adults seems to be similar in deforested pastures as in forests. We aimed to infer the mechanisms responsible for this apparent resilience in pastures and we tested two hypotheses to explain it: 1) adult palms survived in pastures because they were spared from logging, and 2) adults occurred in pastures through the resilience of large juvenile rosettes, which survived through subterranean meristems and later developed into adults. For this purpose, we characterized the demographic structure of C. quindiuense in a total of 122 plots of 400 m(2) in forests and pastures at two sites with contrasted land use histories in Colombia and Peru. Additionally, we implemented growth models that allowed us to estimate the age of individuals at four sites. These data were combined with information collected from local land managers in order to complete our knowledge on the land use history at each site. At two sites, the presence of old individuals up to 169 years and a wide age range evidenced that, at least, a portion of current adults in pastures were spared from logging at the time of deforestation. However, at the two other sites, the absence of older adults in pastures and the narrow age range of the populations indicated that individuals came exclusively from rosette resilience. These interpretations were consistent with the land use history of sites. In consequence, the combination of the two hypotheses (spared individuals and rosette resilience) explained patterns of C. quindiuense in pastures on a regional scale. Regeneration through subterranean meristems in palms is an important, yet overlooked mechanism of resilience, which occurs in a number of palm species and deserves being integrated in the conceptual framework of disturbance ecology.	[Jose Sanin, Maria; Galeano, Gloria; Bernal, Rodrigo] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Distrito Capita, Colombia; [Anthelme, Fabien; Pintaud, Jean-Christophe] Inst Rech Dev, Montpellier, Herault, France	Universidad Nacional de Colombia; Institut de Recherche pour le Developpement (IRD)	Sanin, MJ (corresponding author), Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Distrito Capita, Colombia.	mjsaninp@unal.edu.co		Anthelme, Fabien/0000-0001-6249-995X; Sanin, Maria Jose/0000-0001-7211-5913	FP7-PALMS program [FP7-ENV-2007-I]; Direccion Nacional de Investigacion (DIB), Universidad Nacional de Colombia sede Bogota [15154]	FP7-PALMS program; Direccion Nacional de Investigacion (DIB), Universidad Nacional de Colombia sede Bogota	This study was funded by the FP7-PALMS program FP7-ENV-2007-I (www.fp7-palms.org), and by the Direccion Nacional de Investigacion (DIB), Universidad Nacional de Colombia sede Bogota (http://www.dib.unal.edu.co, Project Code 15154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo CA, 2001, PALMA CERA BOSQUES, P127; Andre E, 1879, TOUR MONDE NOUVEAU J; [Anonymous], 2001, PLANT STRATEGIES VEG; [Anonymous], ESTRATEGIA REGIONAL; Anthelme F, 2007, J VEG SCI, V18, P355, DOI 10.1111/j.1654-1103.2007.tb02547.x; Anthelme F, 2011, BIOL CONSERV, V144, P1059, DOI 10.1016/j.biocon.2010.12.025; Armenteras D., 2007, EVALUACION ESTADO BO, P72; Barot S, 2005, EVOL ECOL RES, V7, P1051; Bernal M, 2007, THESIS U ANDES BOGOT; Boussingault M, 1849, VIAJES CIENTIFICOS A, P322; Callaway R. M., 2007, POSITIVE INTERACTION; Cayuela L, 2006, J APPL ECOL, V43, P1172, DOI 10.1111/j.1365-2664.2006.01217.x; Chapman CA, 2010, BIOL CONSERV, V143, P366, DOI 10.1016/j.biocon.2009.10.023; Charles-Dominique P, 2001, DISS BOT, V346, P153; CHRISTIE KH, 1978, HISPANIC AM HIST REV, V58, P260, DOI 10.2307/2513088; Corner E. J. H., 1966, NATURAL HIST PALMS; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; ENRIGHT NJ, 1985, AUST J ECOL, V10, P461, DOI 10.1111/j.1442-9993.1985.tb00907.x; Fernandez JF, 2005, J HERED, V96, P635, DOI 10.1093/jhered/esi104; Galeano G, 2005, SERIE LIBROS ROJOS E, V2, P224; Galeano G., 2010, PALMAS COLOMBIA GUIA; Galeano Gloria, 2008, Rev. peru biol., V15, P65; Giordano CV, 2009, NEW PHYTOL, V181, P880, DOI 10.1111/j.1469-8137.2008.02708.x; Goerner A, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2784111; Gonzalez ME, 2002, PLANT ECOL, V161, P59, DOI 10.1023/A:1020378822847; Gross N, 2010, FUNCT ECOL, V24, P1122, DOI 10.1111/j.1365-2435.2010.01713.x; Hansen MC, 2010, P NATL ACAD SCI USA, V107, P8650, DOI 10.1073/pnas.0912668107; Henderson A, 2002, ECOLOGY EVOLUTION PA; Holmgren M, 2012, OECOLOGIA, V169, P293, DOI 10.1007/s00442-011-2196-5; Sanin MJ, 2011, PHYTOTAXA, V34, P1; Kahn F, 2003, PEUPLEMENTS ANCIENS, P309; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lara E, 2011, THESIS U NACL COLOMB; Laurance WF, 2000, TRENDS ECOL EVOL, V15, P433, DOI 10.1016/S0169-5347(00)01962-5; Lopez-Gallego C, 2010, POPUL ECOL, V52, P191, DOI 10.1007/s10144-009-0171-3; Lyell C., 1833, PRINCIPLES GEOLOGY; Mandle L, 2012, J ECOL, V100, P997, DOI 10.1111/j.1365-2745.2012.01982.x; McPherson K, 1996, AM J BOT, V83, P1566, DOI 10.2307/2445830; Milchunas DG, 2002, OIKOS, V99, P113, DOI 10.1034/j.1600-0706.2002.990112.x; Montufar R, 2011, BOT REV, V77, P426, DOI 10.1007/s12229-011-9085-9; Mora J, 2004, THESIS U NACL COLOMB, P135; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Oleas NH, 2012, J HERED, V103, P557, DOI 10.1093/jhered/ess020; Orellana R., 1992, B I FR ETUDES ANDINE, V21, P651; PARSONS JJ, 1977, ANN ASSOC AM GEOGR, V67, P1, DOI 10.1111/j.1467-8306.1977.tb01116.x; Pintaud Jean-Christophe, 2008, Palms, V52, P96; Rasband W.S., 1997, IMAGE J; Svenning JC, 1998, BIODIVERS CONSERV, V7, P1529, DOI 10.1023/A:1008831600795; Tomlinson PB, 2012, AM J BOT, V99, P1891, DOI 10.3732/ajb.1200089; Tomlinson PB, 1990, STRUCTURAL BIOL PALM; Trenel P, 2008, MOL ECOL, V17, P3528, DOI 10.1111/j.1365-294X.2008.03853.x; Veldman JW, 2011, BIOL CONSERV, V144, P1419, DOI 10.1016/j.biocon.2011.01.011; Vergara-Chaparro L.K., 2002, THESIS U NACL COLOMB; Vesk PA, 2006, J ECOL, V94, P1027, DOI 10.1111/j.1365-2745.2006.01154.x; WATERHOUSE JT, 1978, BOT J LINN SOC, V77, P73, DOI 10.1111/j.1095-8339.1978.tb01374.x; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	56	12	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e74139	10.1371/journal.pone.0074139	http://dx.doi.org/10.1371/journal.pone.0074139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194823	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000002
J	McGowan, C; Harris, M; Rhodes, T				McGowan, Catherine; Harris, Magdalena; Rhodes, Tim			Hepatitis C Avoidance in Injection Drug Users: A Typology of Possible Protective Practices	PLOS ONE			English	Article							VIRUS-INFECTION; HARM REDUCTION; RISK FACTOR; NEEDLE; PREVALENCE; EQUIPMENT; PROGRAMS	Introduction: Hepatitis C virus (HCV) represents a serious public health concern. People who inject drugs (PWID) are at particular risk and nearly half (45%) of PWID in England may be infected. HCV prevention interventions have only had moderate impact on the prevalence of HCV in this population. Using qualitative methods, we sought to detail the protective practices potentially linked to HCV avoidance among PWID, and explore the motivations for these. Methods: The study used a life history approach allowing participants to detail their lived experience both before and during the course of their injecting careers. Thirty-seven participants were recruited from drug services in London, and from referrals within local injecting networks. A baseline and follow-up in-depth qualitative interview was carried out with each participant, and for half, a third interview was also undertaken. All underwent testing for HCV antibody. Analyses focused on developing a descriptive typology of protective practices potentially linked to HCV avoidance. Results: Practices were deemed to be protective against HCV if they could be expected a priori to reduce the number of overall injections and/or the number of injections using shared injecting equipment. Participants reported engaging in various protective practices which fell into three categories identified through thematic analysis: principles about injecting, preparedness, and flexibility. Conclusions: All participants engaged in protective practices irrespective of serostatus. It is important to consider the relative importance of different motivations framing protective practices in order to formulate harm reduction interventions which appeal to the situated concerns of PWID, especially given that these protective practices may also help protect against HIV and other blood borne infections.	[McGowan, Catherine; Harris, Magdalena; Rhodes, Tim] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Harris, M (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England.	Magdalena.Harris@lshtm.ac.uk	Rhodes, Tim/DNJ-9679-2022	Rhodes, Tim/0000-0003-2400-9838; McGowan, Catherine/0000-0001-6941-6539; Harris, Magdalena/0000-0001-8718-8226	Economic and Social Research Council (ESRC) [RES-062-23-1766]; Economic and Social Research Council [ES/G028753/1] Funding Source: researchfish; ESRC [ES/G028753/1] Funding Source: UKRI	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Staying Safe project was funded by the Economic and Social Research Council (ESRC) [Grant Number: RES-062-23-1766] (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NEV 1 ML FIX NEEDL S; Backmund M, 2003, EUR J EPIDEMIOL, V18, P563, DOI 10.1023/A:1024603517136; Blane DB, 1996, SOC SCI MED, V42, P751, DOI 10.1016/0277-9536(95)00340-1; Bryant J, 2010, DRUG ALCOHOL DEPEN, V107, P182, DOI 10.1016/j.drugalcdep.2009.10.007; Cao W, 2006, DRUG ALCOHOL REV, V25, P439, DOI 10.1080/09595230600891282; Carruthers SJ, 2005, DRUG ALCOHOL REV, V24, P193, DOI 10.1080/09595230500102673; Copeland L, 2012, SCOT MED J, V57, P38, DOI 10.1258/smj.2011.011289; Craine N, 2009, EPIDEMIOL INFECT, V137, P1255, DOI 10.1017/S095026880900212X; Daniulaityte R, 2007, SUBST USE MISUSE, V42, P129, DOI 10.1080/10826080601174678; Darke S., 2011, LIFE HEROIN USER TYP; De Angelis D, 2009, STAT METHODS MED RES, V18, P361, DOI 10.1177/0962280208094691; Deacon R, 2010, HEPATITIS C SEROCONV; Diaz T, 2001, AM J PUBLIC HEALTH, V91, P23, DOI 10.2105/AJPH.91.1.23; Firestone M, 2007, CAN J PUBLIC HEALTH, V98, P130, DOI 10.1007/BF03404324; Hagan H, 2001, AM J PUBLIC HEALTH, V91, P42, DOI 10.2105/AJPH.91.1.42; Harris M, 2012, ADDICTION, V107, P1090, DOI 10.1111/j.1360-0443.2011.03749.x; Harris M, 2012, QUAL HEALTH RES, V22, P31, DOI 10.1177/1049732311420579; Health Protection Agency, 2007, SHOOT INF INJ DRUG U; Health Protection Agency, 2012, HEP C UK 2012 REP; Jost JJ, 2010, DRUG-EDUC PREV POLIC, V17, P821, DOI 10.3109/09687630902858948; Kondili LA, 2002, GUT, V50, P693, DOI 10.1136/gut.50.5.693; Mateu-Gelabert P, 2007, Trastor Adict, V9, P260; Miller CL, 2002, J URBAN HEALTH, V79, P257, DOI 10.1093/jurban/79.2.257; National Treatment Agency for Substance Misuse, 2004, RED DRUG REL DEATHS; Rhodes T, 2002, SOC SCI MED, V55, P211, DOI 10.1016/S0277-9536(01)00162-9; Rhodes T, 2008, ADDICTION, V103, P1593, DOI 10.1111/j.1360-0443.2008.02306.x; Rhodes T, 2008, HEALTH RISK SOC, V10, P221, DOI 10.1080/13698570802160921; Rondy M, 2013, EPIDEMIOL INFECT, V141, P563, DOI 10.1017/S0950268812000921; Roy E, 2007, INT J DRUG POLICY, V18, P397, DOI 10.1016/j.drugpo.2007.02.005; SLAVNEY PR, 1985, AM J PSYCHOTHER, V39, P57, DOI 10.1176/appi.psychotherapy.1985.39.1.57; Stark K, 1996, AIDS, V10, P311, DOI 10.1097/00002030-199603000-00010; Stein JA, 2004, DRUG ALCOHOL DEPEN, V75, P89, DOI 10.1016/j.drugalcdep.2004.02.002; Stein MD, 2009, J ADDICT DIS, V28, P389, DOI 10.1080/10550880903183034; Sutton AJ, 2012, EPIDEMIOL INFECT, V140, P2190, DOI 10.1017/S0950268812000489; Thein H. H., 2003, INT J DRUG POLICY, V14, P425; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Thurairajah PH, 2008, J INFECT DIS, V198, P1749, DOI 10.1086/593337; Tilson H., 2006, PREVENTING HIV INFEC; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vickerman P, 2012, ADDICTION, V107, P1984, DOI 10.1111/j.1360-0443.2012.03932.x; Wilson S., 2007, QUALITATIVE RES, V7, P135, DOI [DOI 10.1177/1468794107071427, 10.1177/1468794107071427]; Wright Nat M J, 2006, Harm Reduct J, V3, P27, DOI 10.1186/1477-7517-3-27	42	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77038	10.1371/journal.pone.0077038	http://dx.doi.org/10.1371/journal.pone.0077038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194855	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000034
J	Momigliano, P; Sparrow, L; Blair, D; Heimann, K				Momigliano, Paolo; Sparrow, Leanne; Blair, David; Heimann, Kirsten			The Diversity of Coolia spp. (Dinophyceae Ostreopsidaceae) in the Central Great Barrier Reef Region	PLOS ONE			English	Article							SP. NOV. DINOPHYCEAE; BENTHIC DINOFLAGELLATE; PHYLOGENETIC ANALYSIS; MONOTIS DINOPHYCEAE; SPECIES BOUNDARIES; GAMBIERDISCUS; MORPHOLOGY; DNA; PROROCENTRUM; STRAIN	Background: Dinoflagellates are important primary producers, crucial in marine food webs. Toxic strains, however, are the main causative agents of non-bacterial seafood poisoning, a major concern for public health worldwide. Despite their importance, taxonomic uncertainty within many genera of dinoflagellates is still high. The genus Coolia includes potentially harmful species and the diversity within the genus is just starting to become apparent. Methodology/Principal Findings: In the current study, cultures were established from strains of Coolia spp. isolated from the central Great Barrier Reef (GBR). Cultures were identified based on thecal plate morphology and analyses of sequences (18S, ITS and 28S) from the nuclear rRNA operon. We report that the central GBR harbors a high diversity of Coolia species, including two species known to be capable of toxin production (C. tropicalis and C. malayensis), as well as the non-toxic C. canariensis. The strain of C. canariensis isolated from the GBR may in fact be a cryptic species, closely related but nevertheless phylogenetically distinct from the strain on which the holotype of C. canariensis was based. We also found evidence of the occurrence of a cryptic species morphologically very similar to both C. malayensis and C. monotis. The consequences of taxonomic confusion within the genus are discussed. Conclusion/Significance: The central GBR region harbors a previously unreported high diversity of Coolia spp., including two species known to potentially produce toxins. The presence of a cryptic species of unknown toxicity highlights the importance of cryptic diversity within dinoflagellates.	[Momigliano, Paolo; Sparrow, Leanne; Blair, David; Heimann, Kirsten] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Sparrow, Leanne; Heimann, Kirsten] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Sparrow, Leanne; Heimann, Kirsten] James Cook Univ, North Queensland Algal Identificat Culturing Faci, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University	Heimann, K (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	kirsten.heimann@jcu.edu.au	Momigliano, Paolo/H-7141-2019; Heimann, Kirsten/M-4814-2019; Heimann, Kirsten/N-1512-2013; Blair, David/O-2786-2019	Momigliano, Paolo/0000-0001-6390-6094; Heimann, Kirsten/0000-0003-2691-9659; Heimann, Kirsten/0000-0003-2691-9659; Blair, David/0000-0002-4658-3251	Marine and Tropical Science Research Facility	Marine and Tropical Science Research Facility	This work was funded by the Marine and Tropical Science Research Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; BAGNIS R, 1980, TOXICON, V18, P199, DOI 10.1016/0041-0101(80)90074-4; BESADA EG, 1982, B MAR SCI, V32, P723; Briggs JC, 2000, J BIOGEOGR, V27, P1183, DOI 10.1046/j.1365-2699.2000.00459.x; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Connolly SR, 2003, ECOLOGY, V84, P2178, DOI 10.1890/02-0254; Dolapsakis NP, 2006, SCI MAR, V70, P67, DOI 10.3989/scimar.2006.70n167; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; FAUST MA, 1992, J PHYCOL, V28, P94; FAUST MA, 2011, ATOLL RES B, V569; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Fraga S, 2008, J PHYCOL, V44, P1060, DOI 10.1111/j.1529-8817.2008.00555.x; FRITZ L, 1985, J PHYCOL, V21, P662, DOI 10.1111/j.0022-3646.1985.00662.x; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HANSEN PJ, 1991, MAR ECOL PROG SER, V73, P253, DOI 10.3354/meps073253; Haywood AJ, 2004, J PHYCOL, V40, P165, DOI 10.1111/j.0022-3646.2004.02-149.x; HEIMANN K, 2011, OCEAN SURFACE WARMIN; Holmes Michael J., 1995, Natural Toxins, V3, P355, DOI 10.1002/nt.2620030506; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; HOLMES MJ, 1991, TOXICON, V29, P761, DOI 10.1016/0041-0101(91)90068-3; Howard MDA, 2009, APPL ENVIRON MICROB, V75, P54, DOI 10.1128/AEM.00818-08; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ki JS, 2011, J PHYCOL, V47, P426, DOI 10.1111/j.1529-8817.2010.00950.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013102, 10.1371/journal.pone.0011875]; Lajeunesse TC, 2012, J PHYCOL, V48, P1380, DOI 10.1111/j.1529-8817.2012.01217.x; Laza-Martinez A, 2011, EUR J PHYCOL, V46, P45, DOI 10.1080/09670262.2010.550387; Leaw CP, 2010, J PHYCOL, V46, P162, DOI 10.1111/j.1529-8817.2009.00778.x; LEWIS RJ, 1993, COMP BIOCHEM PHYS C, V106, P615, DOI 10.1016/0742-8413(93)90217-9; Litaker RW, 2007, J PHYCOL, V43, P344, DOI 10.1111/j.1529-8817.2007.00320.x; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; MEUNIER A, 1919, MEMOIRES MUSEE ROYAL; Mohammad-Noor N, 2013, J PHYCOL, V49, P536, DOI 10.1111/jpy.12062; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2004, J PHYCOL, V40, P366, DOI 10.1046/j.1529-8817.2004.03132.x; Murray S, 2007, PHYCOL RES, V55, P176, DOI 10.1111/j.1440-1835.2007.00460.x; MUSCATINE L, 1977, J BIOSCIENCE, V7, P454; Nagahama Y, 2011, J PHYCOL, V47, P178, DOI 10.1111/j.1529-8817.2010.00939.x; Rhodes LL, 2010, TOXICON, V56, P751, DOI 10.1016/j.toxicon.2009.05.017; Rhodes LL, 1997, NEW ZEAL J MAR FRESH, V31, P139, DOI 10.1080/00288330.1997.9516751; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Stern RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013991; SWIFT AEB, 1993, NAT TOXINS, V31, P1, DOI DOI 10.3109/15563659309000371; Takano Y, 2006, J PHYCOL, V42, P251, DOI 10.1111/j.1529-8817.2006.00177.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR DL, 1969, J CELL SCI, V4, P751; Ten-Hage L, 2000, PHYCOLOGIA, V39, P377, DOI 10.2216/i0031-8884-39-5-377.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	56	26	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79278	10.1371/journal.pone.0079278	http://dx.doi.org/10.1371/journal.pone.0079278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194962	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000326037000141
J	Zhou, Y; Xia, H; Li, XJ; Hu, R; Chen, Y; Li, XB				Zhou, Ying; Xia, Hui; Li, Xiao-Jie; Hu, Rong; Chen, Yun; Li, Xue-Bao			Overexpression of a Cotton Gene That Encodes a Putative Transcription Factor of AP2/EREBP Family in Arabidopsis Affects Growth and Development of Transgenic Plants	PLOS ONE			English	Article							RESPONSIVE ELEMENT; ECTOPIC EXPRESSION; AUXIN BIOSYNTHESIS; INDUCIBLE GENE; ROOT-FORMATION; CROSS-TALK; ERF GENE; ETHYLENE; ELONGATION; TRANSPORT	In the study, a gene encoding a putative ethylene response factor of AP2/EREBP family was isolated from cotton (Gossypium hirsutum) and designated as GhERF12. Sequence alignment showed that GhERF12 protein contains a central AP2/ERF domain (58 amino acids) with two functional conserved amino acid residues (ala14 and asp19). Transactivation assay indicated that GhERF12 displayed strong transcription activation activity in yeast cells, suggesting that this protein may be a transcriptional activator in cotton. Quantitative RT-PCR analysis showed that GhERF12 expression in cotton was induced by ACC and IAA. Overexpression of GhERF12 in Arabidopsis affected seedling growth and development. The GhERF12 transgenic plants grew slowly, and displayed a dwarf phenotype. The mean bolting time of the transgenic plants was delayed for about 10 days, compared with that of wild type. Further study revealed that some ethylene-related and auxin-related genes were dramatically up-regulated in the transgenic plants, compared with those of wild type. Collectively, we speculated that GhERF12, as a transcription factor, may be involved in regulation of plant growth and development by activating the constitutive ethylene response likely related to auxin biosynthesis and/or signaling.	[Zhou, Ying; Xia, Hui; Li, Xiao-Jie; Hu, Rong; Chen, Yun; Li, Xue-Bao] Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Li, XB (corresponding author), Cent China Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	xbli@mail.ccnu.edu.cn			National Natural Sciences Foundation of China [31171174]; Ministry of Agriculture of China [2013ZX08009003-004]; Scientific Research Foundation of Hubei Province [2011CDA140, 2012FFA126]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Scientific Research Foundation of Hubei Province	This work was supported by National Natural Sciences Foundation of China (Grant No. 31171174), the project from the Ministry of Agriculture of China for transgenic research (Grant No. 2013ZX08009003-004), and the Scientific Research Foundation of Hubei Province (Grant No. 2011CDA140, 2012FFA126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno H, 2001, PLANT CELL, V13, P2609, DOI 10.1105/tpc.13.12.2609; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Collett CE, 2000, PLANT PHYSIOL, V124, P553, DOI 10.1104/pp.124.2.553; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hu YB, 2008, J PLANT PHYSIOL, V165, P1717, DOI 10.1016/j.jplph.2007.12.006; Hu YB, 2011, ACTA PHYSIOL PLANT, V33, P667, DOI 10.1007/s11738-010-0587-6; Imin N, 2007, J EXP BOT, V58, P439, DOI 10.1093/jxb/erl224; Jin LG, 2008, PLANT PHYSIOL BIOCH, V46, P46, DOI 10.1016/j.plaphy.2007.10.004; Jin LG, 2010, J INTEGR PLANT BIOL, V52, P485, DOI 10.1111/j.1744-7909.2010.00914.x; Kieber JJ, 1997, ANNU REV PLANT PHYS, V48, P277, DOI 10.1146/annurev.arplant.48.1.277; Kirch T, 2003, PLANT CELL, V15, P694, DOI 10.1105/tpc.009480; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Marsch-Martinez N, 2006, PLANT MOL BIOL, V62, P825, DOI 10.1007/s11103-006-9059-1; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Nagpal P, 2000, PLANT PHYSIOL, V123, P563, DOI 10.1104/pp.123.2.563; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Rahman A, 2001, PLANT CELL PHYSIOL, V42, P301, DOI 10.1093/pcp/pce035; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Swarup R, 2007, PLANT CELL, V19, P2186, DOI 10.1105/tpc.107.052100; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Thimann KV, 1977, HORMONE ACTION WHOLE, P448; Tian Q, 1999, DEVELOPMENT, V126, P711; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; Vandenbussche F, 2003, PLANT PHYSIOL, V131, P1228, DOI 10.1104/pp.010850; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207	46	6	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78635	10.1371/journal.pone.0078635	http://dx.doi.org/10.1371/journal.pone.0078635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194949	gold, Green Submitted, Green Published			2022-12-25	WOS:000326037000128
J	Dong, ZX; Ran, JH; Zhou, H; Chen, JH; Lei, TL; Wang, WL; Sun, Y; Lin, GT; Bankir, L; Yang, BX				Dong, Zixun; Ran, Jianhua; Zhou, Hong; Chen, Jihui; Lei, Tianluo; Wang, Weiling; Sun, Yi; Lin, Guiting; Bankir, Lise; Yang, Baoxue			Urea Transporter UT-B Deletion Induces DNA Damage and Apoptosis in Mouse Bladder Urothelium	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; GENOME-WIDE ASSOCIATION; ORNITHINE-DECARBOXYLASE; TERMINAL HYDROLASE-L1; CONCENTRATING ABILITY; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; SINGLET OXYGEN; IN-VIVO; ARGINASE	Background: Previous studies found that urea transporter UT-B is abundantly expressed in bladder urothelium. However, the dynamic role of UT-B in bladder urothelial cells remains unclear. The objective of this study is to evaluate the physiological roles of UT-B in bladder urothelium using UT-B knockout mouse model and T24 cell line. Methodology/Principal Findings: Urea and NO measurement, mRNA expression micro-array analysis, light and transmission electron microscopy, apoptosis assays, DNA damage and repair determination, and intracellular signaling examination were performed in UT-B null bladders vs wild-type bladders and in vitro T24 epithelial cells. UT-B was highly expressed in mouse bladder urothelium. The genes, Dcaf11, MCM2-4, Uch-L1, Bnip3 and 45 S pre rRNA, related to DNA damage and apoptosis were significantly regulated in UT-B null urothelium. DNA damage and apoptosis highly occurred in UT-B null urothelium. Urea and NO levels were significantly higher in UT-B null urothelium than that in wild-type, which may affect L-arginine metabolism and the intracellular signals related to DNA damage and apoptosis. These findings were consistent with the in vitro study in T24 cells that, after urea loading, exhibited cell cycle delay and apoptosis. Conclusions/Significance: UT-B may play an important role in protecting bladder urothelium by balancing intracellular urea concentration. Disruption of UT-B function induces DNA damage and apoptosis in bladder, which can result in bladder disorders.	[Dong, Zixun; Zhou, Hong; Chen, Jihui; Lei, Tianluo; Wang, Weiling; Sun, Yi; Yang, Baoxue] Peking Univ, State Key Lab Nat & Biomimet Drugs, Key Lab Mol Cardiovasc Sci, Minist Educ, Beijing 100871, Peoples R China; [Dong, Zixun; Zhou, Hong; Chen, Jihui; Lei, Tianluo; Wang, Weiling; Sun, Yi; Yang, Baoxue] Peking Univ, Dept Pharmacol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Ran, Jianhua] Chongqing Med Univ, Basic Med Coll, Neurosci Res Ctr, Dept Anat, Chongqing, Peoples R China; [Lin, Guiting] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA; [Bankir, Lise] Ctr Rech Cordeliers, INSERM, U872, Paris, France	Peking University; Peking University; Chongqing Medical University; University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Yang, BX (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Key Lab Mol Cardiovasc Sci, Minist Educ, Beijing 100871, Peoples R China.	baoxue@bjmu.edu.cn	BANKIR, Lise/AAK-2733-2020	BANKIR, Lise/0000-0002-3321-0819; Chen, Jihui/0000-0002-9819-9921	National Natural Science Foundation of China [30500171, 30870921, 31200869, 81261160507, 81170632]; Drug Discovery Program [2009ZX09301-010-30]; Research Fund for the Doctoral Program of Higher Education [20100001110047]; 111 project,; Beijing Natural Science Foundation [7102105]; International Science and Technology Cooperation Program of China;  [2012DFA11070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Drug Discovery Program; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); 111 project,(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation); International Science and Technology Cooperation Program of China; 	This work was supported by National Natural Science Foundation of China grants 30500171, 30870921, 31200869, 81261160507, and 81170632, Drug Discovery Program grant 2009ZX09301-010-30, the Research Fund for the Doctoral Program of Higher Education 20100001110047, the 111 project, International Science and Technology Cooperation Program of China 2012DFA11070, and Beijing Natural Science Foundation grant 7102105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankir L, 2004, AM J PHYSIOL-RENAL, V286, pF144, DOI 10.1152/ajprenal.00205.2003; Bauer PM, 2001, J BIOL CHEM, V276, P34458, DOI 10.1074/jbc.M105219200; Bheda A, 2010, CELL CYCLE, V9, P980, DOI 10.4161/cc.9.5.10934; Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006764; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; El-Bassossy HM, 2012, VASC PHARMACOL, V57, P194, DOI 10.1016/j.vph.2012.01.001; Feng ZH, 2012, P NATL ACAD SCI USA, V109, P7013, DOI 10.1073/pnas.1203930109; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Garcia-Closas M, 2011, HUM MOL GENET, V20, P4282, DOI 10.1093/hmg/ddr342; Giaginis C, 2009, DIGEST DIS SCI, V54, P282, DOI 10.1007/s10620-008-0305-z; Gonzalez MA, 2003, J CLIN ONCOL, V21, P4306, DOI 10.1200/JCO.2003.04.121; Guo LR, 2007, AM J PHYSIOL-CELL PH, V293, pC305, DOI 10.1152/ajpcell.00608.2006; Hussain S, 2010, LEUKEMIA, V24, P1641, DOI 10.1038/leu.2010.138; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Kawano K, 2006, J UROLOGY, V176, P387, DOI 10.1016/S0022-5347(06)00515-5; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11426, DOI 10.1073/pnas.89.23.11426; KHAN AU, 1992, P NATL ACAD SCI USA, V89, P11428, DOI 10.1073/pnas.89.23.11428; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Kunnev D, 2010, ONCOGENE, V29, P3630, DOI 10.1038/onc.2010.125; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Li X, 2012, J MOL NEUROSCI, V46, P362, DOI 10.1007/s12031-011-9594-3; Luperchio S, 1996, FREE RADICAL BIO MED, V21, P513, DOI 10.1016/0891-5849(96)00219-5; Lygerou Z, 2000, SCIENCE, V290, P2271; Meng Y, 2009, SCI CHINA SER C, V52, P474, DOI 10.1007/s11427-009-0047-y; Michea L, 2000, AM J PHYSIOL-RENAL, V278, pF209, DOI 10.1152/ajprenal.2000.278.2.F209; Nikolaeva S D, 2008, Zh Evol Biokhim Fiziol, V44, P234; Pahan K, 1999, J BIOL CHEM, V274, P7528, DOI 10.1074/jbc.274.11.7528; PRABHAKAR SS, 1997, AM J PHYSIOL-CELL PH, V273, pC1882; Rafnar T, 2011, HUM MOL GENET, V20, P4268, DOI 10.1093/hmg/ddr303; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; Singh R, 2008, BIOPHYS CHEM, V133, P81, DOI 10.1016/j.bpc.2007.12.006; Smith CP, 2006, J MEMBRANE BIOL, V212, P109, DOI 10.1007/s00232-006-0870-z; SNYDER RD, 1989, BIOCHEM J, V260, P697, DOI 10.1042/bj2600697; Spector DA, 2004, AM J PHYSIOL-RENAL, V287, pF102, DOI 10.1152/ajprenal.00442.2003; Spector DA, 2007, AM J PHYSIOL-RENAL, V292, pF467, DOI 10.1152/ajprenal.00181.2006; Stanley KP, 2006, AM J PHYSIOL-LUNG C, V290, pL298, DOI 10.1152/ajplung.00140.2005; Tan YY, 2008, MOL CELL BIOCHEM, V318, P109, DOI 10.1007/s11010-008-9862-x; Timmer RT, 2001, AM J PHYSIOL-CELL PH, V281, pC1318, DOI 10.1152/ajpcell.2001.281.4.C1318; Tratsiakovich Y, 2013, EUR J PHARM; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Yang B, 2002, J BIOL CHEM, V277, P10633, DOI 10.1074/jbc.M200207200; Yang BX, 2005, AM J PHYSIOL-RENAL, V288, pF881, DOI 10.1152/ajprenal.00367.2004; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101; Zhao D, 2007, BBA-BIOMEMBRANES, V1768, P1815, DOI 10.1016/j.bbamem.2007.04.010; Zou Q, 1998, PROTEINS, V31, P107, DOI 10.1002/(SICI)1097-0134(19980501)31:2<107::AID-PROT1>3.0.CO;2-J	50	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76952	10.1371/journal.pone.0076952	http://dx.doi.org/10.1371/journal.pone.0076952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204711	Green Published, gold			2022-12-25	WOS:000326032600017
J	Lu, MC; Yin, WY; Tsai, TY; Koo, M; Lai, NS				Lu, Ming-Chi; Yin, Wen-Yao; Tsai, Tzung-Yi; Koo, Malcolm; Lai, Ning-Sheng			Increased Risk of Primary Sjogren's Syndrome in Female Patients with Thyroid Disorders: A Longitudinal Population-Based Study in Taiwan	PLOS ONE			English	Article							DISEASE; PREVALENCE; GLAND; ASSOCIATION; ANTIBODIES; FEATURES	Background: A number of reports have indicated an association between thyroid diseases and primary Sjogren's syndrome (pSS). However, fewer studies have investigated whether the presence of thyroid diseases is associated with increased risk of developing pSS. Thus, the aim of our study was to use a nationwide health claims database to explore the prevalence and risk of pSS in female patients with thyroid diseases. Methods: From the Registry of Catastrophic Illness database in the National Health Insurance Research Database in Taiwan, we identified 389 female patients with a diagnosis of pSS from 2005 to 2010. We also obtained 1945 control subjects frequency-matched on sex, 10-year age interval, and year of index date from the Longitudinal Health Insurance Database (LHID2000). Both groups were retrospectively traced back to a period of eight years to obtain diagnosis of thyroid diseases prior to index date. Results: A significantly higher risk of pSS was associated with the presence of thyroid diseases (adjusted odds ratio (AOR) = 2.1, 95% confidence interval (CI) = 1.6-2.9). Among the sub-categories of thyroid diseases, patients with thyroiditis (AOR = 3.6, 95% CI = 1.7-7.5), thyrotoxicosis (AOR = 2.5, 95% CI = 1.6-3.8), and unspecified hypothyroidism (AOR = 2.4, 95% CI = 1.2-4.6), and simple and unspecified goiter (AOR = 2.0, 95% CI = 1.3-3.3) were significantly associated with increased risk of pSS. The associations were generally stronger in the mid-forties to mid-sixties age group, except in patients with unspecified hypothyroidism. Conclusions: The risk of pSS was significantly increased in female patients with thyroid diseases, particularly those in their mid-forties to mid-sixties. An increased awareness of the possibility of pSS in perimenopausal females with thyroid diseases is important to preserve their quality of life and to avoid comorbidity.	[Lu, Ming-Chi; Lai, Ning-Sheng] Buddhist Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Yin, Wen-Yao; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yin, Wen-Yao] Buddhist Dalin Tzu Chi Hosp, Div Gen Surg, Chiayi, Taiwan; [Tsai, Tzung-Yi; Koo, Malcolm] Buddhist Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Tsai, Tzung-Yi] Tzu Chi Coll Technol, Dept Nursing, Hualien, Taiwan; [Tsai, Tzung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University of Science & Technology; National Cheng Kung University; University of Toronto	Koo, M (corresponding author), Buddhist Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				ADAMSON TC, 1983, J IMMUNOL, V130, P203; Asmussen KH, 2001, RHEUMATOLOGY, V40, P1085, DOI 10.1093/rheumatology/40.10.1085; Biro E, 2006, CLIN RHEUMATOL, V25, P240, DOI 10.1007/s10067-005-1165-y; Bjoro T, 2000, EUR J ENDOCRINOL, V143, P639, DOI 10.1530/eje.0.1430639; Bureau of National Health Insurance, 2013, REG GOV EX NAT HLTH; Chen WS, 2007, FORMOSAN J RHEUMATOL, V21, P20; Coll J, 1997, J RHEUMATOL, V24, P1719; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; GUDBJORNSSON B, 1994, J RHEUMATOL, V21, P215; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Jara LJ, 2007, CLIN RHEUMATOL, V26, P1601, DOI 10.1007/s10067-007-0638-6; Kang JH, 2010, J RHEUMATOL, V37, P1188, DOI 10.3899/jrheum.090942; KROMER G, 1985, J IMMUNOL, V135, P2452; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Manji N, 2006, J CLIN ENDOCR METAB, V91, P4873, DOI 10.1210/jc.2006-1402; Robazzi TCMV, 2012, REV BRAS REUMATOL, V52, P417; Mavragani CP, 2012, J AUTOIMMUN, V39, P354, DOI 10.1016/j.jaut.2012.05.011; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Punzi L, 1996, REV RHUM, V63, P809; Tektonidou MG, 2004, ANN RHEUM DIS, V63, P1159, DOI 10.1136/ard.2004.022624; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WARFVINGE G, 1992, ORAL SURG ORAL MED O, V74, P288, DOI 10.1016/0030-4220(92)90061-T; Weng MY, 2011, J RHEUMATOL, V38, P706, DOI 10.3899/jrheum.100883	24	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77210	10.1371/journal.pone.0077210	http://dx.doi.org/10.1371/journal.pone.0077210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204772	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300089
J	Rajaram, N; Frees, AE; Fontanella, AN; Zhong, J; Hansen, K; Dewhirst, MW; Ramanujam, N				Rajaram, Narasimhan; Frees, Amy E.; Fontanella, Andrew N.; Zhong, Jim; Hansen, Katherine; Dewhirst, Mark W.; Ramanujam, Nirmala			Delivery Rate Affects Uptake of a Fluorescent Glucose Analog in Murine Metastatic Breast Cancer	PLOS ONE			English	Article							BLOOD-FLOW; NECK CANCER; TUMOR; METABOLISM; RADIOSENSITIVITY; THERAPY; GASES; HIF-1; PET	We demonstrate an optical strategy using intravital microscopy of dorsal skin flap window chamber models to image glucose uptake and vascular oxygenation in vivo. Glucose uptake was imaged using a fluorescent glucose analog, 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG). SO2 was imaged using the differential absorption properties of oxygenated [HbO(2)] and deoxygenated hemoglobin [dHb]. This study was carried out on two sibling murine mammary adenocarcinoma lines, 4T1 and 4T07. 2-NBDG uptake in the 4T1 tumors was lowest when rates of delivery and clearance were lowest, indicating perfusion-limited uptake in poorly oxygenated tumor regions. For increasing rates of delivery that were still lower than the glucose consumption rate (as measured in vitro), both 2-NBDG uptake and the clearance rate from the tumor increased. When the rate of delivery of 2-NBDG exceeded the glucose consumption rate, 2-NBDG uptake decreased with any further increase in rate of delivery, but the clearance rate continued to increase. This inflection point was not observed in the 4T07 tumors due to an absence of low delivery rates close to the glucose consumption rate. In the 4T07 tumors, 2-NBDG uptake increased with increasing rates of delivery at low rates of clearance. Our results demonstrate that 2-NBDG uptake in tumors is influenced by the rates of delivery and clearance of the tracer. The rates of delivery and clearance are, in turn, dependent on vascular oxygenation of the tumors. Knowledge of the kinetics of tracer uptake as well as vascular oxygenation is essential to make an informed assessment of glucose demand of a tumor.	[Rajaram, Narasimhan; Frees, Amy E.; Fontanella, Andrew N.; Dewhirst, Mark W.; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Zhong, Jim] Duke Univ, Sch Med, Durham, NC USA; [Hansen, Katherine; Dewhirst, Mark W.] Duke Univ, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University; Duke University	Rajaram, N (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	n.rajaram@duke.edu	Rajaram, Narasimhan/A-2249-2010; Dewhirst, Mark/Q-1302-2019; Ramanujam, Nimmi/AAA-7575-2021	Rajaram, Narasimhan/0000-0003-1224-8567; Dewhirst, Mark/0000-0003-3459-6546; Ramanujam, Nimmi/0000-0001-7319-8415; Martinez, Amy/0000-0002-8088-7398	Department of Defense Era of Hope Scholar Award [W81XWH-09-1-0410]	Department of Defense Era of Hope Scholar Award(United States Department of Defense)	Funding was provided by a Department of Defense Era of Hope Scholar Award (W81XWH-09-1-0410; PI: N. Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dunn TJ, 1999, BRIT J CANCER, V80, P117, DOI 10.1038/sj.bjc.6690330; Fokas E, 2012, CANCER RES, V72, P239, DOI 10.1158/0008-5472.CAN-11-2263; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Hermans R, 2003, INT J RADIAT ONCOL, V57, P1351, DOI 10.1016/S0360-3016(03)00764-8; KALLINOWSKI F, 1989, INT J CANCER, V44, P266, DOI 10.1002/ijc.2910440214; King LM, 1998, CARDIOVASC RES, V39, P381, DOI 10.1016/S0008-6363(98)00100-X; Komar G, 2009, CLIN CANCER RES, V15, P5511, DOI 10.1158/1078-0432.CCR-09-0414; KRUUV JA, 1967, CANCER, V20, P51, DOI 10.1002/1097-0142(1967)20:1<51::AID-CNCR2820200108>3.0.CO;2-D; Kunkel M, 2006, ORAL ONCOL, V42, P297, DOI 10.1016/j.oraloncology.2005.08.004; Kunkel M, 2003, ORAL ONCOL, V39, P170, DOI 10.1016/S1368-8375(02)00087-8; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mankoff DA, 2003, J NUCL MED, V44, P1806; Mankoff DA, 2002, J NUCL MED, V43, P500; Miller S, 2010, BOOK MIDWIVES CARE P, V2nd, P1; Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nitin N, 2009, INT J CANCER, V124, P2634, DOI 10.1002/ijc.24222; O'Neil RG, 2005, MOL IMAGING BIOL, V7, P388, DOI 10.1007/s11307-005-0011-6; Palmer GM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523363; Semple SIK, 2004, EUR RADIOL, V14, P2038, DOI 10.1007/s00330-004-2454-6; Shankar LK, 2006, J NUCL MED, V47, P1059; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Thorwarth D, 2006, RADIOTHER ONCOL, V80, P151, DOI 10.1016/j.radonc.2006.07.033; Tseng JC, 2012, MOL IMAGING BIOL, P1; Van den Abbeele AD, 2008, PET CLIN, V3, P77, DOI 10.1016/j.cpet.2008.08.001; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; Yamada K, 2007, NAT PROTOC, V2, P753, DOI 10.1038/nprot.2007.76; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Yoshioka K, 1996, APPL MICROBIOL BIOT, V46, P400; Zasadny KR, 2003, EUR J NUCL MED MOL I, V30, P274, DOI 10.1007/s00259-002-1022-z; Zhong J, 2013, RADIOTHER ONCOL, V106, P390, DOI 10.1016/j.radonc.2013.02.013	33	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76524	10.1371/journal.pone.0076524	http://dx.doi.org/10.1371/journal.pone.0076524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204635	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300033
J	Tanabe, AS; Toju, H				Tanabe, Akifumi S.; Toju, Hirokazu			Two New Computational Methods for Universal DNA Barcoding: A Benchmark Using Barcode Sequences of Bacteria, Archaea, Animals, Fungi, and Land Plants	PLOS ONE			English	Article							TAXONOMIC CLASSIFICATION; MAXIMUM-LIKELIHOOD; IDENTIFICATION; ASSIGNMENT; PLACEMENT; DIVERSITY; BLAST	Taxonomic identification of biological specimens based on DNA sequence information (a.k.a. DNA barcoding) is becoming increasingly common in biodiversity science. Although several methods have been proposed, many of them are not universally applicable due to the need for prerequisite phylogenetic/machine-learning analyses, the need for huge computational resources, or the lack of a firm theoretical background. Here, we propose two new computational methods of DNA barcoding and show a benchmark for bacterial/archeal 16S, animal COX1, fungal internal transcribed spacer, and three plant chloroplast (rbcL, matK, and trnH-psbA) barcode loci that can be used to compare the performance of existing and new methods. The benchmark was performed under two alternative situations: query sequences were available in the corresponding reference sequence databases in one, but were not available in the other. In the former situation, the commonly used "1-nearest-neighbor" (1-NN) method, which assigns the taxonomic information of the most similar sequences in a reference database (i.e., BLAST-top-hit reference sequence) to a query, displays the highest rate and highest precision of successful taxonomic identification. However, in the latter situation, the 1-NN method produced extremely high rates of misidentification for all the barcode loci examined. In contrast, one of our new methods, the query-centric auto-k-nearest-neighbor (QCauto) method, consistently produced low rates of misidentification for all the loci examined in both situations. These results indicate that the 1-NN method is most suitable if the reference sequences of all potentially observable species are available in databases; otherwise, the QCauto method returns the most reliable identification results. The benchmark results also indicated that the taxon coverage of reference sequences is far from complete for genus or species level identification in all the barcode loci examined. Therefore, we need to accelerate the registration of reference barcode sequences to apply high-throughput DNA barcoding to genus or species level identification in biodiversity research.	[Tanabe, Akifumi S.; Toju, Hirokazu] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan; [Toju, Hirokazu] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan	Kyoto University; Japan Fisheries Research & Education Agency (FRA); Kyoto University	Tanabe, AS (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	akifumi.tanabe@gmail.com	Toju, Hirokazu/S-7307-2017; Toju, Hirokazu/T-7355-2019; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers by the Japan Society for the Promotion of Science [GS014]	Funding Program for Next Generation World-Leading Researchers by the Japan Society for the Promotion of Science	This work was supported by grant-in-aid by Funding Program for Next Generation World-Leading Researchers (GS014) by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Primack R.B., 1993, ESSENTIALS CONSERVAT; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Stark M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-461; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x	47	133	144	5	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76910	10.1371/journal.pone.0076910	http://dx.doi.org/10.1371/journal.pone.0076910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204702	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300065
J	Wang, S; Cha, SW; Zorn, AM; Wylie, C				Wang, Sha; Cha, Sang-Wook; Zorn, Aaron M.; Wylie, Christopher			Par6b Regulates the Dynamics of Apicobasal Polarity during Development of the Stratified Xenopus Epidermis	PLOS ONE			English	Article							EPITHELIAL-CELL POLARITY; PROTEIN PAR6; JUNCTION FORMATION; GIANT-LARVAE; APKC; MORPHOGENESIS; LOCALIZATION; ECTODERM; CRUMBS; GENES	During early vertebrate development, epithelial cells establish and maintain apicobasal polarity, failure of which can cause developmental defects or cancer metastasis. This process has been mostly studied in simple epithelia that have only one layer of cells, but is poorly understood in stratified epithelia. In this paper we address the role of the polarity protein Partitioning defective-6 homolog beta (Par6b) in the developing stratified epidermis of Xenopus laevis. At the blastula stage, animal blastomeres divide perpendicularly to the apicobasal axis to generate partially polarized superficial cells and non-polarized deep cells. Both cell populations modify their apicobasal polarity during the gastrula stage, before differentiating into the superficial and deep layers of epidermis. Early differentiation of the epidermis is normal in Par6b-depleted embryos; however, epidermal cells dissociate and detach from embryos at the tailbud stage. Par6b-depleted epidermal cells exhibit a significant reduction in basolaterally localized E-cadherin. Examination of the apical marker Crumbs homolog 3 (Crb3) and the basolateral marker Lethal giant larvae 2 (Lgl2) after Par6b depletion reveals that Par6b cell-autonomously regulates the dynamics of apicobasal polarity in both superficial and deep epidermal layers. Par6b is required to maintain the "basolateral" state in both epidermal layers, which explains the reduction of basolateral adhesion complexes and epidermal cells shedding.	[Wang, Sha; Cha, Sang-Wook; Zorn, Aaron M.; Wylie, Christopher] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Wang, Sha] Cincinnati Childrens Res Fdn, Mol & Dev Biol Grad Program, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Wylie, C (corresponding author), Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA.	christopher.wylie@cchmc.org	Cha, Sang-Wook/D-3523-2016; Wang, Sha/J-7501-2019		National Institutes of Health [R01HD044764]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institutes of Health grant R01HD044764. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLETT FS, 1971, J ANAT, V108, P465; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Chalmers AD, 2003, DEVELOPMENT, V130, P2657, DOI 10.1242/dev.00490; Chalmers AD, 2002, DEV CELL, V2, P171, DOI 10.1016/S1534-5807(02)00113-2; Cline EG, 2007, MOL CELL BIOL, V27, P4431, DOI 10.1128/MCB.02235-06; Cunliffe HE, 2012, AM J CANCER RES, V2, P478; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Guo S, 1996, CURR OPIN GENET DEV, V6, P408, DOI 10.1016/S0959-437X(96)80061-X; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Helfrich I, 2007, J INVEST DERMATOL, V127, P782, DOI 10.1038/sj.jid.5700621; Hung TJ, 1999, DEVELOPMENT, V126, P127; Huynh JR, 2001, CURR BIOL, V11, P901, DOI 10.1016/S0960-9822(01)00244-5; JAMRICH M, 1987, GENE DEV, V1, P124, DOI 10.1101/gad.1.2.124; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; KELLER RE, 1980, J EMBRYOL EXP MORPH, V60, P201; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kishi M, 2000, DEVELOPMENT, V127, P791; Lee HS, 2008, NAT CELL BIOL, V10, P979, DOI 10.1038/ncb1758; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; LEVI G, 1991, DEVELOPMENT, V113, P1335; LEVI G, 1991, DEVELOPMENT, V111, P159; Longo D, 2004, DEV BIOL, V271, P210, DOI 10.1016/j.ydbio.2004.03.021; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mir A, 2007, DEVELOPMENT, V134, P779, DOI 10.1242/dev.02768; Mir Adnan, 2008, V469, P417, DOI 10.1007/978-1-60327-469-2_26; Muller HAJ, 2003, MECH DEVELOP, V120, P1231, DOI 10.1016/j.mod.2003.06.001; Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033; Muroyama A, 2012, SEMIN CELL DEV BIOL, V23, P890, DOI 10.1016/j.semcdb.2012.08.008; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nandadasa S, 2009, DEVELOPMENT, V136, P1327, DOI 10.1242/dev.031203; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Reischauer S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000720; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tadjuidje E, 2011, DEV DYNAM, V240, P1727, DOI 10.1002/dvdy.22671; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TORPEY NP, 1992, J CELL SCI, V101, P151; Totong R, 2007, DEVELOPMENT, V134, P1259, DOI 10.1242/dev.02833; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Watts JL, 1996, DEVELOPMENT, V122, P3133; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6	50	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76854	10.1371/journal.pone.0076854	http://dx.doi.org/10.1371/journal.pone.0076854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204686	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300055
J	Perez-Aso, M; Fernandez, P; Mediero, A; Chan, ES; Cronstein, BN				Perez-Aso, Miguel; Fernandez, Patricia; Mediero, Aranzazu; Chan, Edwin S.; Cronstein, Bruce N.			Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3	FASEB JOURNAL			English	Article						fibrosis; intracellular signaling	PROTEIN-KINASE-A; MATRIX METALLOPROTEINASE-1; PHARMACOLOGICAL BLOCKADE; DERMAL FIBROBLASTS; PROSTAGLANDIN E-2; DOWN-REGULATION; MURINE MODEL; TGF-BETA; ACTIVATION; EPAC	Activation of adenosine A2A receptor (A(2A)R) promotes fibrosis and collagen synthesis. However, the underlying mechanism is still unclear, not least because cAMP, its principal effector, has been found to inhibit TGF1-induced collagen synthesis. Here, we show that in primary normal human dermal fibroblasts, A(2A)R stimulation with CGS21680 elicits a modest cAMP increase (150 +/- 12% of control; EC50 54.8 nM), which stimulates collagen1 (Col1) and collagen3 (Col3), but maximal cAMP resulting from direct activation of adenylyl cyclase by forskolin (15,689 +/- 7038% of control; EC50 360.7 nM) inhibits Col1 and increases Col3. Similar to Col1 expression, fibroblast proliferation increased following physiological cAMP increases by CGS21680 but was inhibited by cAMP increases beyond the physiological range by forskolin. The A(2A)R-mediated increase of Col1 and Col3 was mediated by AKT, while Col3, but not Col1, expression was dependent on p38 and repressed by ERK. TGF1 induced phosphorylation of Smad2/3 and increased Col3 expression, which was prevented by Smad3 depletion. In contrast, CGS21680 did not activate Smad2/3, and Smad2/3 knockdown did not prevent CGS21680-induced Col1 or Col3 increases. Our results indicate that cAMP is a concentration-dependent switch for collagen production via noncanonical, AKT-dependent, Smad2/3-independent signaling. These observations explain the paradoxical effects of cAMP on collagen expression.Perez-Aso, M., Fernandez, P., Mediero, A., Chan, E. S., and Cronstein, B. N. Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3.	[Perez-Aso, Miguel; Mediero, Aranzazu; Chan, Edwin S.; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Fernandez, Patricia] NCI, NIH, Bethesda, MD 20892 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, 550 First Ave, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020	Pintor, Jesus/0000-0002-9191-7679; Perez-Aso, Miguel/0000-0002-4703-4182; Cronstein, Bruce/0000-0002-4295-7383; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health (NIH) [AR56672, AR54897]; New York University (NYU)-Health and Hospitals Corporation Clinical and Translational Science Institute [UL1RR029893]; NYU Cancer Institute (Center Support grant); NIH/National Cancer Institute [5 P30CA16087-31]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056672, R01AR054897, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University (NYU)-Health and Hospitals Corporation Clinical and Translational Science Institute; NYU Cancer Institute (Center Support grant); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the U.S. National Institutes of Health (NIH; AR56672 and AR54897), the New York University (NYU)-Health and Hospitals Corporation Clinical and Translational Science Institute (UL1RR029893), the NYU Cancer Institute (Center Support grant), and the NIH/National Cancer Institute (5 P30CA16087-31).	Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39; BUTKOWSKI RJ, 1982, METHOD ENZYMOL, V82, P410; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Cho HJ, 2007, CELL BIOL INT, V31, P1225, DOI 10.1016/j.cellbi.2007.04.006; D'Souza KM, 2011, J BIOL CHEM, V286, P15507, DOI 10.1074/jbc.M111.218263; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Fernandez P, 2008, AM J PATHOL, V172, P1675, DOI 10.2353/ajpath.2008.070952; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fredholm BB, 2000, N-S ARCH PHARMACOL, V362, P364, DOI 10.1007/s002100000313; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Goffin L, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2991; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hayashi T, 2006, J INVEST DERMATOL, V126, P990, DOI 10.1038/sj.jid.5700227; Huang SK, 2008, AM J RESP CELL MOL, V39, P482, DOI 10.1165/rcmb.2008-0080OC; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Jun JB, 2005, J INVEST DERMATOL, V124, P298, DOI 10.1111/j.0022-202X.2004.23559.x; Katebi M, 2008, INFLAMMATION, V31, P299, DOI 10.1007/s10753-008-9078-y; Lazarova T, 2004, BIOCHEMISTRY-US, V43, P12945, DOI 10.1021/bi0492051; Lazzerini PE, 2012, J MOL MED, V90, P331, DOI 10.1007/s00109-011-0824-5; Lipshtat A, 2010, P NATL ACAD SCI USA, V107, P1247, DOI 10.1073/pnas.0908647107; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Moore SW, 2006, J NEUROSCI, V26, P2419, DOI 10.1523/JNEUROSCI.5419-05.2006; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2009, J IMMUNOL, V183, P5487, DOI 10.4049/jimmunol.0901247; Okunishi K, 2011, J BIOL CHEM, V286, P32231, DOI 10.1074/jbc.M111.235606; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Park CH, 2010, J INVEST DERMATOL, V130, P2049, DOI 10.1038/jid.2010.62; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Perez-Aso M., 2013, PURINERG SIGNAL, DOI 10.1007/s11302-013-9368-1; Perez-Aso M, 2012, FASEB J, V26, P4254, DOI 10.1096/fj.12-209627; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Thevenin D, 2005, BIOCHEMISTRY-US, V44, P16239, DOI 10.1021/bi051422u; Victor-Vega C, 2002, INFLAMMATION, V26, P19, DOI 10.1023/A:1014417728325; Villarreal F, 2009, AM J PHYSIOL-CELL PH, V296, pC1178, DOI 10.1152/ajpcell.00291.2008; Wang SN, 2005, FASEB J, V19, P1, DOI 10.1096/fj.04-2370com; Yano N, 2007, J BIOL CHEM, V282, P18819, DOI 10.1074/jbc.M610537200; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	49	42	43	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					802	812		10.1096/fj.13-241646	http://dx.doi.org/10.1096/fj.13-241646			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24200882	Green Published			2022-12-25	WOS:000331072200027
J	Matsumura, R; Matsubara, C; Node, K; Takumi, T; Akashi, M				Matsumura, Ritsuko; Matsubara, Chiaki; Node, Koichi; Takumi, Toru; Akashi, Makoto			Nuclear Receptor-mediated Cell-autonomous Oscillatory Expression of the Circadian Transcription Factor, Neuronal PAS Domain Protein 2 (NPAS2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Circadian Clock; Circadian Rhythms; Clock Genes; Nuclear Receptors; Transcription; Transcription Factors	CLOCK; COMPONENT; MAMMALS; GENE; MICE	Background: NPAS2 is a circadian transcription factor responsive to a wide range of intra- and extracellular stimuli. Results: Deficiency of ROR caused a damped transcriptional oscillation of Npas2 and functional depletion of an RORE resulted in a complete loss of the oscillation. Conclusion: Nuclear receptors elicit cell-autonomous circadian transcription of Npas2. Significance: Synchronous transcriptional oscillation of Npas2 with Bmal1 provides the foundation for efficient circadian input and robust oscillation. NPAS2 (MOP4) is a heme-containing sensor transcription factor responsive to a wide range of intra- and extracellular stimuli, which also functions as a circadian transcription factor. This molecule forms a heterodimer with another circadian transcription factor, BMAL1, and activates transcription via E-box elements, indicating that circadian phase synchronization between NPAS2 and BMAL1 expression is important for the efficient transcriptional activation of target genes. However, details of the mechanism of cell-autonomous circadian transcription of Npas2 remain unclear. Here, we show that one of the ROREs (retinoid-related orphan receptor response elements) in the upstream region of the transcription start site is essential for circadian transcription of the Npas2 gene. Furthermore, we also show that endogenous ROR indeed plays an essential role in cell-autonomous circadian transcription of Npas2, because a damped transcriptional oscillation was observed not only by introduction of a dominant negative form or small interfering RNA but also in embryonic fibroblasts obtained from ROR-mutant (sg/sg) mice. These results indicate that circadian transcription of Npas2 is synchronized with that of Bmal1 in a cell-autonomous nuclear receptor-mediated fashion.	[Matsumura, Ritsuko; Akashi, Makoto] Yamaguchi Univ, Res Inst Time Studies, Yamaguchi 7538511, Japan; [Matsubara, Chiaki] Osaka City Univ, Grad Sch Med, Abeno Ku, Osaka 5450051, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 8498501, Japan; [Takumi, Toru] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Takumi, Toru] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan	Yamaguchi University; Osaka Metropolitan University; Saga University; RIKEN; Japan Science & Technology Agency (JST)	Takumi, T (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	toru.takumi@riken.jp; akashima@yamaguchi-u.ac.jp	Matsumura, Ritsuko/AAS-7122-2020		KAKENHI from Japan Society of Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Strategic International Cooperative Program (SICP) from Japan Science and Technology Agency (JST); Human Frontier Science Program (HFSP) [RPG 24/2012]; Uehara Memorial Foundation; Kanae Foundation; Takeda Science Foundation	KAKENHI from Japan Society of Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic International Cooperative Program (SICP) from Japan Science and Technology Agency (JST); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI from Japan Society of Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Strategic International Cooperative Program (SICP) from Japan Science and Technology Agency (JST), and Human Frontier Science Program (HFSP) Grant RPG 24/2012. This work was also supported by fellowships from the Uehara Memorial Foundation, the Kanae Foundation, and the Takeda Science Foundation.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akashi M, 2000, GENE DEV, V14, P645; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Partch CL, 2013, TRENDS CELL BIOL; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18	20	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36548	36553		10.1074/jbc.M113.517235	http://dx.doi.org/10.1074/jbc.M113.517235			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196956	Green Published, hybrid			2022-12-25	WOS:000328883400035
J	Mugisha, JO; Baisley, K; Asiki, G; Seeley, J; Kuper, H				Mugisha, Joseph O.; Baisley, Kathy; Asiki, Gershim; Seeley, Janet; Kuper, Hannah			Prevalence, Types, Risk Factors and Clinical Correlates of Anaemia in Older People in a Rural Ugandan Population	PLOS ONE			English	Article							IRON-DEFICIENCY; BLOOD HEMOGLOBIN; AGE 70; HEMATOPOIESIS; MORTALITY; AMERICANS; FOLATE; COHORT; ACID	Background: Studies conducted in high income countries have shown that anaemia is a common medical condition among older people, but such data are scarce in Africa. The objectives of this study were to estimate the prevalence, types, risk factors and clinical correlates of anaemia in older people. Methods: Participants were aged (>= 50) years recruited from a general population cohort from January 2012 to January 2013. Blood samples were collected for assessing hemoglobin, serum ferritin, serum vitamin B12, serum folate, C-reactive protein, malaria infection and stool samples for assessment of hookworm infection. HIV status was assessed using an algorithm for HIV rapid testing. Questionnaires were used to collect data on sociodemographic characteristics and other risk factors for anaemia. Results: In total, 1449 people participated (response rate 72.3%). The overall prevalence of anaemia was 20.3 % (95% CI 18.2-22.3%), and this was higher for males (24.1%, 95% CI=20.7-27.7%) than females (17.5%, 95% CI=15.0-20.1%). In males, the prevalence of anaemia increased rapidly with age almost doubling between 50 and 65 years (p-trend<0.001). Unexplained anaemia was responsible for more than half of all cases (59.7%). Anaemia was independently associated with infections including malaria (OR 3.49, 95% CI 1.78-6.82), HIV (OR 2.17, 1.32-3.57) heavy hookworm infection (OR 3.45, 1.73-6.91), low fruit consumption (OR 1.55, 1.05-2.29) and being unmarried (OR 1.37, 95% CI 1.01-1.89). However, the odds of anaemia were lower among older people with elevated blood pressure (OR 0.47, 95% CI 0.29-0.77). Conclusion: Anaemia control programmes in Uganda should target older people and should include interventions to treat and control hookworms and educational programs on diets that enhance iron absorption. Clinicians should consider screening older people with HIV or malaria for anaemia. Further studies should be done on unexplained anaemia and serum ferritin levels that predict iron deficiency anaemia in older people.	[Mugisha, Joseph O.; Asiki, Gershim; Seeley, Janet] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Mugisha, Joseph O.; Baisley, Kathy; Seeley, Janet; Kuper, Hannah] London Sch Hyg & Trop Med, London WC1, England; [Seeley, Janet] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England	University of London; London School of Hygiene & Tropical Medicine; University of East Anglia	Mugisha, JO (corresponding author), MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	Joseph.MugishaOkello@lshtm.ac.uk		Asiki, Gershim/0000-0002-9966-1153; Seeley, Janet/0000-0002-0583-5272	MRC UK (Medical Research Council); MRC; DFID (Department For International Development) [G0700837]; Medical Research Council [MC_U950097148, G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	MRC UK (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DFID (Department For International Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by MRC UK (Medical Research Council). Kathy Baisley receives support from the MRC and DFID (Department For International Development) (grant number G0700837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain T. J., 1997, Central African Journal of Medicine, V43, P325; [Anonymous], 1968, NUTR AN; Artz AS, 2004, J AM GERIATR SOC, V52, P423, DOI 10.1111/j.1532-5415.2004.52116.x; Asiki G, 2013, INT J EPIDEMIOL, V42, P129, DOI 10.1093/ije/dys234; Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Balducci L, 2005, CANC TREAT, P109; Balducci L, 2003, J AM GERIATR SOC, V51, pS2; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Bjorkegren K, 2001, J INTERN MED, V249, P423, DOI 10.1046/j.1365-2796.2001.00819.x; CHATTA GS, 1993, J GERONTOL, V48, pM207, DOI 10.1093/geronj/48.5.M207; De Benoist B, 2008, ORLDWIDE PREVALENCE; den Elzen WPJ, 2009, CAN MED ASSOC J, V181, P151, DOI 10.1503/cmaj.090040; Gaskell Helen, 2008, BMC Geriatr, V8, P1, DOI 10.1186/1471-2318-8-1; Gomez JML, 2002, KIDNEY INT, V61, pS39, DOI 10.1046/j.1523-1755.61.s80.8.x; Gross Rainer, 1997, Food and Nutrition Bulletin, V18, P267; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; HIROTA Y, 1988, EUR J HAEMATOL, V40, P83; Hurrell R, 2002, NUTR REV, V60, pS7, DOI 10.1301/002966402320285137; INELMEN EM, 1994, AGING-CLIN EXP RES, V6, P81, DOI 10.1007/BF03324220; JOHNSON MA, 1990, J NUTR, V120, P1486, DOI 10.1093/jn/120.suppl_11.1486; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Kikafunda JK, 2009, PUBLIC HEALTH NUTR, V12, P2302, DOI 10.1017/S1368980009005333; KIRKEBY O J, 1991, Scandinavian Journal of Primary Health Care, V9, P167, DOI 10.3109/02813439109018513; Kowal P, 2010, GLOBAL HEALTH ACTION, V3, P11, DOI 10.3402/gha.v3i0.5302; LETCHER RL, 1983, HYPERTENSION, V5, P757, DOI 10.1161/01.HYP.5.5.757; LIPSCHITZ DA, 1984, BLOOD, V63, P502; Mugisha JO, 2008, TROP MED INT HEALTH, V13, P788, DOI 10.1111/j.1365-3156.2008.02069.x; Mukhopadhyay D, 2002, AGE AGEING, V31, P87, DOI 10.1093/ageing/31.2.87; Nilsson-Ehle H, 2000, EUR J HAEMATOL, V65, P297, DOI 10.1034/j.1600-0609.2000.065005297.x; NILSSONEHLE H, 1989, BRIT J HAEMATOL, V71, P437; OLDEWAGETHERON W, 2009, J FAMILY ECOLOGY CON, V36; Patel KV, 2008, SEMIN HEMATOL, V45, P210, DOI 10.1053/j.seminhematol.2008.06.006; Patel KV, 2007, BLOOD, V109, P4663, DOI 10.1182/blood-2006-10-055384; PEARSON HA, 2008, ANAEMIAS OTHER RED C, P374; Sahadevan S., 1995, Singapore Medical Journal, V36, P375; Sasu BJ, 2010, BLOOD CELL MOL DIS, V45, P238, DOI 10.1016/j.bcmd.2010.07.013; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; United Nations Population Division, 2011, WORLD POP PROSP 2010; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; WHO, 2004, ASS IR STAT POP	41	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78394	10.1371/journal.pone.0078394	http://dx.doi.org/10.1371/journal.pone.0078394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194926	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000105
J	Thomassen, HA; Freedman, AH; Brown, DM; Buermann, W; Jacobs, DK				Thomassen, Henri A.; Freedman, Adam H.; Brown, David M.; Buermann, Wolfgang; Jacobs, David K.			Regional Differences in Seasonal Timing of Rainfall Discriminate between Genetically Distinct East African Giraffe Taxa	PLOS ONE			English	Article							GENE FLOW; POPULATION-STRUCTURE; VARIABLE IMPORTANCE; NATIONAL-PARK; SPECIATION; PHENOLOGY; CLIMATE; PHYLOGEOGRAPHY; CAMELOPARDALIS; SERENGETI	Masai (Giraffa tippelskirchi), Reticulated (G. reticulata) and Rothschild's (G. camelopardalis) giraffe lineages in East Africa are morphologically and genetically distinct, yet in Kenya their ranges abut. This raises the question of how divergence is maintained among populations of a large mammal capable of long-distance travel, and which readily hybridize in zoos. Here we test four hypotheses concerning the maintenance of the phylogeographic boundaries among the three taxa: 1) isolation-by-distance; 2) physical barriers to dispersal; 3) general habitat differences resulting in habitat segregation; or 4) regional differences in the seasonal timing of rainfall, and resultant timing of browse availability. We used satellite remotely sensed and climate data to characterize the environment at the locations of genotyped giraffes. Canonical variate analysis, random forest algorithms, and generalized dissimilarity modelling were employed in a landscape genetics framework to identify the predictor variables that best explained giraffes' genetic divergence. We found that regional differences in the timing of precipitation, and resulting green-up associated with the abundance of browse, effectively discriminate between taxa. Local habitat conditions, topographic and human-induced barriers, and geographic distance did not aid in discriminating among lineages. Our results suggest that selection associated with regional timing of events in the annual climatic cycle may help maintain genetic and phenotypic divergence in giraffes. We discuss potential mechanisms of maintaining divergence, and suggest that synchronization of reproduction with seasonal rainfall cycles that are geographically distinct may contribute to reproductive isolation. Coordination of weaning with green-up cycles could minimize the costs of lactation and predation on the young. Our findings are consistent with theory and empirical results demonstrating the efficacy of seasonal or phenologically dictated selection pressures in contributing to the reproductive isolation of parapatric populations.	[Thomassen, Henri A.; Freedman, Adam H.; Buermann, Wolfgang] Univ Calif Los Angeles, Ctr Trop Res, Los Angeles, CA 90095 USA; [Brown, David M.; Jacobs, David K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Buermann, Wolfgang] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Thomassen, HA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Los Angeles, CA 90095 USA.	hathomassen@ucla.edu		Freedman, Adam/0000-0003-4714-3925				Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Ansell W. F. H., 1971, P1; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Arctander P, 1999, MOL BIOL EVOL, V16, P1724, DOI 10.1093/oxfordjournals.molbev.a026085; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Bercovitch FB, 2004, J MAMMAL, V85, P428, DOI 10.1644/1545-1542(2004)085<0428:MIICG>2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; Brynard AM, 1960, KOEDOE, V3, P1; Caister LE, 2003, AFR J ECOL, V41, P201, DOI 10.1046/j.1365-2028.2003.00422.x; Chen C., 2004, USING RANDOM FOREST, V110, P24; Coyne JA, 2004, SPECIATION, V37; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; DAGG A I, 1971, Mammalian Species, V5, P1; Dagg A.I., 1976, GIRAFFE ITS BIOL BEH; Dagg AI, 1982, GIRAFFE ITS BIOL BEH; Dasmann R. F., 1962, Journal of Mammalogy, V43, P533, DOI 10.2307/1376916; del Castillo SM, 2005, GEN COMP ENDOCR, V141, P271, DOI 10.1016/j.ygcen.2005.01.011; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Doebeli M, 2005, EVOLUTION, V59, P691; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; FAIRALL N, 1968, Zoologica Africana, V3, P189; FEDER JL, 1993, ENTOMOL EXP APPL, V69, P117, DOI 10.1007/BF02380639; de Leon LF, 2010, PHILOS T R SOC B, V365, P1041, DOI 10.1098/rstb.2009.0314; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Field C.R., 1973, Journal Reprod Fert, V19, P287; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Foster J.B., 1972, East African Wildlife Journal, V10, P1; Frolking S, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006588; Gavrilets S, 2000, EVOLUTION, V54, P1126; Gavrilets S, 2000, P ROY SOC B-BIOL SCI, V267, P2483, DOI 10.1098/rspb.2000.1309; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Ginnett TF, 1999, AFR J ECOL, V37, P93, DOI 10.1046/j.1365-2028.1999.00163.x; Griffiths J.F., 1972, WORLD SURVEY CLIMATO, V10, P313; Groen TA, 2011, J ARID ENVIRON, V75, P724, DOI 10.1016/j.jaridenv.2011.03.010; Groves C., 2011, UNGULATE TAXONOMY; Hall-Martin AJ, 1975, E AFR WILDL J, V13, P237; HAMILTON AC, 1991, CLIMATIC CHANGE, V19, P65, DOI 10.1007/BF00142215; Hamilton AC, 1982, ENV HIST E AFRICAN S; Hansen MC, 2002, REMOTE SENS ENVIRON, V83, P303, DOI 10.1016/S0034-4257(02)00079-2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; Homewood K, 2001, P NATL ACAD SCI USA, V98, P12544, DOI 10.1073/pnas.221053998; JACOBS DK, 1993, NATURE, V361, P710, DOI 10.1038/361710a0; Kingdon J, 1997, KINGDON FIELD GUIDE; KINGDON J, 1979, E AFRICAN MAMMALS B, V3; Le Pendu Y, 1999, J TROP ECOL, V15, P341, DOI 10.1017/S0266467499000863; Leps J, 2003, MULTIVARIATE ANAL EC; Liu Z, 2004, CLIM DYNAM, V22, P157, DOI 10.1007/s00382-003-0372-y; LONG D. G., 2001, EOS T AM GEOPHYS UN, V82, P503, DOI DOI 10.1029/01EO00303; Lorenzen ED, 2008, CONSERV GENET, V9, P593, DOI 10.1007/s10592-007-9375-2; Lorenzen ED, 2006, MOL ECOL, V15, P3787, DOI 10.1111/j.1365-294X.2006.03059.x; Malpaux B, 2001, J BIOL RHYTHM, V16, P336, DOI 10.1177/074873001129002051; McKinnon JS, 2004, NATURE, V429, P294, DOI 10.1038/nature02556; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Murphy MA, 2010, ECOLOGY, V91, P252, DOI 10.1890/08-0879.1; Muwanika VB, 2003, HEREDITY, V91, P361, DOI 10.1038/sj.hdy.6800341; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Niemiller ML, 2008, MOL ECOL, V17, P2258, DOI 10.1111/j.1365-294X.2008.03750.x; Nix H., 1986, ATLAS ELAPID SNAKES; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pease KM, 2009, MOL ECOL, V18, P1848, DOI 10.1111/j.1365-294X.2009.04112.x; PELLEW RA, 1984, J ZOOL, V202, P57, DOI 10.1111/j.1469-7998.1984.tb04288.x; PELLEW RA, 1983, AFR J ECOL, V21, P269, DOI 10.1111/j.1365-2028.1983.tb00326.x; PELLEW RA, 1984, J APPL ECOL, V21, P141, DOI 10.2307/2403043; PRATT DM, 1979, Z TIERPSYCHOL, V51, P233; Prienaar U. de V., 1963, Koedoe, VNo. 6, P1; Pritchard JK, 2000, GENETICS, V155, P945; R East, 1998, ASG COCHAIR AFRICAN; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; Reason Roger, 2000, Animal Keepers' Forum, V27, P120; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ripley B. D., 1996, PATTERN RECOGNITION; Rossignol-Strick M, 1999, MAR GEOL, V153, P221, DOI 10.1016/S0025-3227(98)00080-2; Ryan SJ, 2007, BEHAV ECOL, V18, P635, DOI 10.1093/beheco/arm028; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Stevenson-Hamilton J., 1947, WILD LIFE S AFRICA; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Templeton Alan R., 1996, P398; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tuenter E, 2003, GLOBAL PLANET CHANGE, V36, P219, DOI 10.1016/S0921-8181(02)00196-0; van der Jeugd HP, 2000, J ZOOL, V251, P15, DOI 10.1017/S0952836900005033; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; White F., 1983, VEGETATION AFRICA DE, P356; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Yamamoto S, 2009, P R SOC B, V276, P2711, DOI 10.1098/rspb.2009.0349; Zhang XY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005263; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	97	19	19	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77191	10.1371/journal.pone.0077191	http://dx.doi.org/10.1371/journal.pone.0077191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194870	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000049
J	Cho, YB; Jones, SI; Vodkin, L				Cho, Young B.; Jones, Sarah I.; Vodkin, Lila			The Transition from Primary siRNAs to Amplified Secondary siRNAs That Regulate Chalcone Synthase During Development of Glycine max Seed Coats	PLOS ONE			English	Article							GENE FAMILY; RNA; SUPPRESSION; PETUNIA; MIRNAS; BIOGENESIS; EXPRESSION; CLUSTER	The / locus is a 27-kb inverted repeat cluster of chalcone synthase genes CHS1-3-4 that mediates siRNA down-regulation of CHS7 and CHS8 target mRNAs during seed development leading to yellow seed coats lacking anthocyanin pigments. Here, we report small RNA sequencing of ten stages of seed development from a few days post fertilization through maturity, revealing the amplification from primary to secondary short interfering RNAs (siRNAs) occurring during development. The young seed populations had a higher proportion of siRNAs representing the CHS1-3-4 gene family members, consistent with this region as the origin of the primary siRNAs. More intriguingly, the very young seed had a higher proportion of 22-nt CHS siRNAs than did the mid-maturation seed. We infer that the primary CHS siRNAs increase during development to levels sufficient to trigger amplification of secondary CHS siRNAs from the CHS7/8 target mRNAs, enabling the total levels of 21-nt CHS siRNAs to rise dramatically. Further, we demonstrate that the soybean system exhibits tissue-specific CHS siRNA production because primary CHS siRNA levels are not sufficient to trigger secondary amplification in tissues other than the seed coat.	[Cho, Young B.; Jones, Sarah I.; Vodkin, Lila] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Vodkin, L (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	l-vodkin@illinois.edu			United Soybean Board; Illinois Soybean Association; USDA-CSREES	United Soybean Board; Illinois Soybean Association; USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was supported by grants from the United Soybean Board, the Illinois Soybean Association, and the USDA-CSREES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Clough SJ, 2004, GENOME, V47, P819, DOI 10.1139/G04-049; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Dhaubhadel S, 2007, PLANT PHYSIOL, V143, P326, DOI 10.1104/pp.106.086306; Eckardt NA, 2009, PLANT CELL, V21, P1029, DOI 10.1105/tpc.109.210412; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Jones SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059270; Joshi T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S14; Kurauchi T, 2011, J PLANT PHYSIOL, V168, P1264, DOI 10.1016/j.jplph.2011.01.003; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pak J, 2012, CELL, V151, P885, DOI 10.1016/j.cell.2012.10.022; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Senda M, 2004, PLANT CELL, V16, P807, DOI 10.1105/tpc.019885; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tuteja JH, 2008, CROP SCI, V48, pS49, DOI 10.2135/cropsci2007.10.0542tpg; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wang C. S., 1994, Plant Molecular Biology Reporter, V12, P132, DOI 10.1007/BF02668374; WANG CS, 1994, PLANT PHYSIOL, V105, P739, DOI 10.1104/pp.105.2.739; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zabala G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-177; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	29	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76954	10.1371/journal.pone.0076954	http://dx.doi.org/10.1371/journal.pone.0076954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204712	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600018
J	Abrams, EW; Cheng, YL; Andrew, DJ				Abrams, Elliott W.; Cheng, Yim Ling; Andrew, Deborah J.			Drosophila KDEL Receptor Function in the Embryonic Salivary Gland and Epidermis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM RETENTION; PROTEIN DISULFIDE-ISOMERASE; LUMINAL ER PROTEINS; TRANSMEMBRANE PROTEINS; PROLYL 4-HYDROXYLASE; SECRETORY PATHWAY; FAMILY-MEMBERS; GOLGI; YEAST; IDENTIFICATION	Core components of the secretory pathway have largely been identified and studied in single cell systems such as the budding yeast S. cerevisiae or in mammalian tissue culture. These studies provide details on the molecular functions of the secretory machinery; they fail, however, to provide insight into the role of these proteins in the context of specialized organs of higher eukaryotes. Here, we identify and characterize the first loss-of-function mutations in a KDEL receptor gene from higher eukaryotes. Transcripts from the Drosophila KDEL receptor gene KdelR - formerly known as dmErd2 - are provided maternally and, at later stages, are at elevated levels in several embryonic cell types, including the salivary gland secretory cells, the fat body and the epidermis. We show that, unlike Saccharomyces cerevisiae Erd2 mutants, which are viable, KdelR mutations are early larval lethal, with homozygous mutant animals dying as first instar larvae. KdelR mutants have larval cuticle defects similar to those observed with loss-of-function mutations in other core secretory pathway genes and with mutations in CrebA, which encodes a bZip transcription factor that coordinately upregulates secretory pathway component genes in specialized secretory cell types. Using the salivary gland, we demonstrate a requirement for KdelR in maintaining the ER pool of a subset of soluble resident ER proteins. These studies underscore the utility of the Drosophila salivary gland as a unique system for studying the molecular machinery of the secretory pathway in vivo in a complex eukaryote.	[Abrams, Elliott W.; Cheng, Yim Ling; Andrew, Deborah J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Andrew, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21218 USA.	dandrew@jhmi.edu			NIH [RO1 DE013899]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE021285, R01DE013899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH RO1 DE013899 to D.J.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Abrams EW, 2002, MECH DEVELOP, V112, P165, DOI 10.1016/S0925-4773(01)00636-0; Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BEH CT, 1995, P NATL ACAD SCI USA, V92, P9820, DOI 10.1073/pnas.92.21.9820; Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194; CLEGG NJ, 1993, GENETICS, V134, P221; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Giannotta M, 2012, EMBO J, V31, P2869, DOI 10.1038/emboj.2012.134; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Konsolaki M, 1998, GENE DEV, V12, P120, DOI 10.1101/gad.12.1.120; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; LEWIS MJ, 1990, CELL, V61, P1359, DOI 10.1016/0092-8674(90)90699-F; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NAPIER RM, 1992, J CELL SCI, V102, P261; NISHIKAWA S, 1993, P NATL ACAD SCI USA, V90, P8179, DOI 10.1073/pnas.90.17.8179; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; REUTER R, 1990, DEVELOPMENT, V110, P1031; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Sen J, 2000, DEVELOPMENT, V127, P5541; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; Valcarcel R, 1999, J CELL SCI, V112, P4389; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; Wang P, 2011, NEUROSCIENCE, V190, P43, DOI 10.1016/j.neuroscience.2011.06.008; WILSON DW, 1993, J BIOL CHEM, V268, P7465	42	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77618	10.1371/journal.pone.0077618	http://dx.doi.org/10.1371/journal.pone.0077618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204897	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300107
J	Dobson, AJ; Purves, J; Kamysz, W; Rolff, J				Dobson, Adam J.; Purves, Joanne; Kamysz, Wojciech; Rolff, Jens			Comparing Selection on S. aureus between Antimicrobial Peptides and Common Antibiotics	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM LT2; GRAM-NEGATIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; RESISTANCE; EVOLUTION; MECHANISM; INFECTION; MELITTIN	With a diminishing number of effective antibiotics, there has been interest in developing antimicrobial peptides (AMPs) as drugs. However, any new drug faces potential bacterial resistance evolution. Here, we experimentally compare resistance evolution in Staphylococcus aureus selected by three AMPs (from mammals, amphibians and insects), a combination of two AMPs, and two antibiotics: the powerful last-resort vancomycin and the classic streptomycin. We find that resistance evolves readily against single AMPs and against streptomycin, with no detectable fitness cost. However the response to selection from our combination of AMPs led to extinction, in a fashion qualitatively similar to vancomycin. This is consistent with the hypothesis that simultaneous release of multiple AMPs during immune responses is a factor which constrains evolution of AMP resistant pathogens.	[Dobson, Adam J.; Purves, Joanne; Rolff, Jens] Univ Sheffield, Sheffield, S Yorkshire, England; [Dobson, Adam J.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Purves, Joanne] Univ Nottingham, Sch Mol Med Sci, Nottingham NG7 2RD, England; [Kamysz, Wojciech] Gdansk Univ Med, Fac Pharm, Gdansk, Poland; [Rolff, Jens] Free Univ Berlin, Inst Biol, Berlin, Germany	University of Sheffield; Cornell University; University of Nottingham; Fahrenheit Universities; Medical University Gdansk; Free University of Berlin	Rolff, J (corresponding author), Univ Sheffield, Western Bank, Sheffield, S Yorkshire, England.	jens.rolff@fu-berlin.de	Gutman, Gloria Margaret/H-8167-2014	Gutman, Gloria Margaret/0000-0001-8810-2287; Kamysz, Wojciech/0000-0001-5335-3043; Rolff, Jens/0000-0002-1529-5409; Dobson, Adam/0000-0003-1541-927X	ERCgrant Evoresin [260986]; Biotechnology and Biological Sciences Research Council studentship	ERCgrant Evoresin; Biotechnology and Biological Sciences Research Council studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by ERCgrant Evoresin (grant number: 260986). AD was supported by a Biotechnology and Biological Sciences Research Council studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres E, 2012, EUR J CLIN MICROBIOL, V31, P881, DOI 10.1007/s10096-011-1430-8; Bell G, 2003, MICROBIOL-SGM, V149, P1367, DOI 10.1099/mic.0.26265-0; Bolintineanu D, 2010, PEPTIDES, V31, P1, DOI 10.1016/j.peptides.2009.11.010; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chait R, 2007, NATURE; Chen J, 2000, BIOPOLYMERS, V55, P88, DOI 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.3.CO;2-B; Fischbach MA, 2011, CURR OPIN MICROBIOL; Giacometti A, 2003, GUT, V52, P874, DOI 10.1136/gut.52.6.874; Gottler LM, 2009, BBA-BIOMEMBRANES, V1788, P1680, DOI 10.1016/j.bbamem.2008.10.009; Gruenheid S, 2012, FEMS MICROBIOL LETT, V330, P81, DOI 10.1111/j.1574-6968.2012.02528.x; Habets MGJL, 2012, P ROY SOC B-BIOL SCI, V279, P3803, DOI 10.1098/rspb.2012.1118; Habets MGJL, 2012, BIOL LETTERS, V8, P416, DOI 10.1098/rsbl.2011.1203; Kahm M, 2010, J STAT SOFTW, V33, P1; Login FH, 2011, SCIENCE, V334, P362, DOI 10.1126/science.1209728; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301; Prajsnar TK, 2012, CELL MICROBIOL, V14, P1600, DOI 10.1111/j.1462-5822.2012.01826.x; Pranting M, 2008, ANTIMICROB AGENTS CH, V52, P2734, DOI 10.1128/AAC.00205-08; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P876, DOI 10.1093/jac/dkq059; Shaw LN, 2006, J BACTERIOL, V188, P6070, DOI 10.1128/JB.00551-06; Steinem C, 2000, PHYS CHEM CHEM PHYS, V2, P4580, DOI 10.1039/b003865m; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wiedman G, 2013, BBA-BIOMEMBRANES, V1828, P1357, DOI 10.1016/j.bbamem.2013.01.021; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zdybicka-Barabas A, 2012, BBA-BIOMEMBRANES, V1818, P2623, DOI 10.1016/j.bbamem.2012.06.008	28	43	46	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76521	10.1371/journal.pone.0076521	http://dx.doi.org/10.1371/journal.pone.0076521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204634	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300032
J	Skibinski, DAG; Hanson, BJ; Lin, YF; von Messling, V; Jegerlehner, A; Tee, JBS; Chye, D; Wong, SKK; Ng, AAP; Lee, HY; Au, BJ; Lee, BTK; Santoso, L; Poidinger, M; Fairhurst, AM; Matter, A; Bachmann, MF; Saudan, P; Connolly, JE				Skibinski, David A. G.; Hanson, Brendon J.; Lin, Yufang; von Messling, Veronika; Jegerlehner, Andrea; Tee, Jason Boon Sern; Chye, De Hoe; Wong, Steven K. K.; Ng, Amanda A. P.; Lee, Hui Yin; Au, Bijin; Lee, Bernett T. K.; Santoso, Lucia; Poidinger, Michael; Fairhurst, Anna-Marie; Matter, Alex; Bachmann, Martin F.; Saudan, Philippe; Connolly, John E.			Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; PHASE-I SAFETY; T-CELLS; AUTOIMMUNE ARTHRITIS; PRECLINICAL EFFICACY; ACTIVE IMMUNIZATION; PROTECTIVE IMMUNITY; DENDRITIC CELLS; DOUBLE-BLIND; A VIRUS	Influenza pandemics can spread quickly and cost millions of lives; the 2009 H1N1 pandemic highlighted the shortfall in the current vaccine strategy and the need for an improved global response in terms of shortening the time required to manufacture the vaccine and increasing production capacity. Here we describe the pre-clinical assessment of a novel 2009 H1N1 pandemic influenza vaccine based on the E. coli-produced HA globular head domain covalently linked to virus-like particles derived from the bacteriophage Q beta. When formulated with alum adjuvant and used to immunize mice, dose finding studies found that a 10 mu g dose of this vaccine (3.7 mu g globular HA content) induced antibody titers comparable to a 1.5 mu g dose (0.7 mu g globular HA content) of the licensed 2009 H1N1 pandemic vaccine Panvax, and significantly reduced viral titers in the lung following challenge with 2009 H1N1 pandemic influenza A/California/07/2009 virus. While Panvax failed to induce marked T cell responses, the novel vaccine stimulated substantial antigen-specific interferon-gamma production in splenocytes from immunized mice, alongside enhanced IgG2a antibody production. In ferrets the vaccine elicited neutralizing antibodies, and following challenge with influenza A/California/07/2009 virus reduced morbidity and lowered viral titers in nasal lavages.	[Skibinski, David A. G.; Ng, Amanda A. P.; Connolly, John E.] Agcy Sci Technol & Res, A STAR Program Translat Res Infect Dis, Singapore, Singapore; [Skibinski, David A. G.; Lin, Yufang; Ng, Amanda A. P.; Lee, Hui Yin; Au, Bijin; Lee, Bernett T. K.; Poidinger, Michael; Fairhurst, Anna-Marie; Connolly, John E.] Agcy Sci Technol & Res, Singapore Immunol Network SIgN, Singapore, Singapore; [Hanson, Brendon J.; Tee, Jason Boon Sern; Chye, De Hoe; Wong, Steven K. K.] Def Sci Org DSO Natl Labs, Singapore, Singapore; [von Messling, Veronika] Univ Quebec, Inst Armand Frappier, INRS, Quebec City, PQ, Canada; [Jegerlehner, Andrea; Bachmann, Martin F.; Saudan, Philippe] Cytos Biotechnol AG, Zurich, Switzerland; [Santoso, Lucia; Matter, Alex] Agcy Sci Technol & Res, ETC, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); University of Quebec; Institut national de la recherche scientifique (INRS); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre	Connolly, JE (corresponding author), ASTAR, IMCB, Singapore, Singapore.	jeconnolly@imcb.a-star.edu.sg		Fairhurst, Anna-Marie/0000-0002-8950-6192; Poidinger, Michael/0000-0002-1047-2277	A*Star Program in Translational Research on Infectious Disease Bio Medical Research Council [BMRC/EDB IAF311003]	A*Star Program in Translational Research on Infectious Disease Bio Medical Research Council	The study was supported by the A*Star Program in Translational Research on Infectious Disease Bio Medical Research Council (BMRC/EDB IAF311003; Connolly, J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; Arulanandam BP, 2000, J IMMUNOL, V164, P3698, DOI 10.4049/jimmunol.164.7.3698; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Baras B, 2011, VACCINE, V29, P2120, DOI 10.1016/j.vaccine.2010.12.125; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chackerian B, 2001, J CLIN INVEST, V108, P415, DOI 10.1172/JCI11849; Chujo D, 2012, CELL TRANSPLANT, V21, P2783, DOI 10.3727/096368912X654993; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; DAVENPORT FM, 1968, J IMMUNOL, V100, P1139; Gordon DL, 2012, VACCINE, V30, P5407, DOI 10.1016/j.vaccine.2012.06.009; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Guarnaccia T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003354; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Iyer V, 2012, HUM VACCIN IMMUNOTHE, V8; Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Keller SA, 2010, EUR J IMMUNOL, V40, P103, DOI 10.1002/eji.200939559; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312; Liu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020928; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Mozdzanowska K, 1997, J VIROL, V71, P4347, DOI 10.1128/JVI.71.6.4347-4355.1997; MURPHY BR, 1989, CURR TOP MICROBIOL, V146, P107; Palucka AK, 2006, J IMMUNOTHER, V29, P545, DOI 10.1097/01.cji.0000211309.90621.8b; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Pushko P, 2010, VACCINE, V28, P4771, DOI 10.1016/j.vaccine.2010.04.093; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Reed LJ, 1938, AM J EPIDEMIOLOGY; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Schmitz N, 2012, EUR J IMMUNOL, V42, P863, DOI 10.1002/eji.201041225; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Spohn G, 2007, J IMMUNOL, V178, P7450, DOI 10.4049/jimmunol.178.11.7450; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Svitek N, 2008, VIROLOGY, V376, P53, DOI 10.1016/j.virol.2008.02.035; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Treanor J, 2009, NEW GENERATION VACCI; Vela EM, 2012, INFLUENZA OTHER RESP, V6, P328, DOI 10.1111/j.1750-2659.2011.00321.x; Vence L, 2007, P NATL ACAD SCI USA, V104, P20884, DOI 10.1073/pnas.0710557105; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHO, 2012, REC COMP INFL VIR VA; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Winblad B, 2012, LANCET NEUROL, V11, P597, DOI 10.1016/S1474-4422(12)70140-0	55	19	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76571	10.1371/journal.pone.0076571	http://dx.doi.org/10.1371/journal.pone.0076571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204639	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326029300037
J	Feige, B; Biscaldi, M; Saville, CWN; Kluckert, C; Bender, S; Ebner-Priemer, U; Hennighausen, K; Rauh, R; Fleischhaker, C; Klein, C				Feige, Bernd; Biscaldi, Monica; Saville, Christopher W. N.; Kluckert, Christian; Bender, Stephan; Ebner-Priemer, Ulrich; Hennighausen, Klaus; Rauh, Reinhold; Fleischhaker, Christian; Klein, Christoph			On the Temporal Characteristics of Performance Variability in Attention Deficit Hyperactivity Disorder (ADHD)	PLOS ONE			English	Article							INTRA-SUBJECT VARIABILITY; DEFICIT/HYPERACTIVITY DISORDER; RESPONSE VARIABILITY; CHILDREN; FLUCTUATIONS; DISTRIBUTIONS; DISSOCIATION; IMPAIRMENTS; ADOLESCENTS; INSTABILITY	Increased intra-subject variability of reaction times (ISV-RT) is one of the most consistent findings in attention-deficit/hyperactivity disorder (ADHD). Although the nature of this phenomenon is still unclear, it has been hypothesised to reflect interference from the Default Mode Network (DMN). So far, ISV-RT has been operationally defined either as a frequency spectrum of the underlying RT time series, or as a measure of dispersion of the RT scores distribution. Here, we use a novel RT analysis framework to link these hitherto unconnected facets of ISV-RT by determining the sensitivity of different measures of RT dispersion to the frequency content of the underlying RT time series. N=27 patients with ADHD and N=26 healthy controls performed several visual N-back tasks. Different measures of RT dispersion were repeatedly modelled after individual frequency bands of the underlying RT time series had been either extracted or suppressed using frequency-domain filtering. We found that the intra-subject standard deviation of RT preserves the "1/f noise" characteristic typical of human RT data. Furthermore and most importantly, we found that the ex-Gaussian parameter T is rather exclusively sensitive to frequencies below 0.025 Hz in the underlying RT time series and that the particularly slow RTs, which nourish T, occur regularly as part of an quasi-periodic, ultra-slow RT fluctuation. Overall, our results are compatible with the idea that ISV-RT is modulated by an endogenous, slowly fluctuating process that may reflect DMN interference.	[Feige, Bernd] Univ Freiburg, Dept Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Biscaldi, Monica; Saville, Christopher W. N.; Kluckert, Christian; Hennighausen, Klaus; Rauh, Reinhold; Fleischhaker, Christian; Klein, Christoph] Univ Freiburg, Dept Child & Adolescent Psychiat & Psychotherapy, D-79106 Freiburg, Germany; [Saville, Christopher W. N.; Klein, Christoph] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Bender, Stephan] Univ Dresden, Dept Child & Adolescent Psychiat, Dresden, Germany; [Ebner-Priemer, Ulrich] Karlsruhe Inst Technol, Dept Appl Psychol, D-76021 Karlsruhe, Germany	University of Freiburg; University of Freiburg; Bangor University; Technische Universitat Dresden; Helmholtz Association; Karlsruhe Institute of Technology	Klein, C (corresponding author), Univ Freiburg, Dept Child & Adolescent Psychiat & Psychotherapy, Hugstetter Str 55, D-79106 Freiburg, Germany.	christoph.klein.kjp@uniklinik-freiburg.de	Rauh, Reinhold/S-6361-2019; Bender, Stephan/AAT-1266-2021; Feige, Bernd/C-6690-2012	Rauh, Reinhold/0000-0003-3053-1163; Feige, Bernd/0000-0002-9436-1258; Saville, Christopher W N/0000-0003-4870-7630				Bellgrove MA, 2005, NEUROPSYCHOLOGIA, V43, P1847, DOI 10.1016/j.neuropsychologia.2005.03.011; Buzy WM, 2009, CHILD NEUROPSYCHOL, V15, P441, DOI 10.1080/09297040802646991; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; DOPFNER M, 2008, CBCL 4 18 ELTERNFRAG; Douglas V.I., 1999, HDB DISRUPTIVE BEHAV, P105, DOI [10.1007/978-1-4615-4881-2_5, DOI 10.1007/978-1-4615-4881-2_5]; Ebner-Priemer UW, 2007, PSYCHOL MED, V37, P961, DOI 10.1017/S0033291706009706; Ebner-Priemer UW, 2009, J ABNORM PSYCHOL, V118, P195, DOI 10.1037/a0014868; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; FISKE DW, 1955, PSYCHOL BULL, V52, P217, DOI 10.1037/h0045276; Flehmig H. C., 2007, PSYCHOL SCI, V49, P132; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Gilden DL, 2001, PSYCHOL REV, V108, P33, DOI 10.1037/0033-295X.108.1.33; Halperin JM, 2008, J CHILD PSYCHOL PSYC, V49, P958, DOI 10.1111/j.1469-7610.2008.01926.x; Heathcote A, 2004, BEHAV RES METH INS C, V36, P277, DOI 10.3758/BF03195574; Heathcote A, 1996, BEHAV RES METH INSTR, V28, P427, DOI 10.3758/BF03200523; HELLER KA, 1998, STANDARD PROGR MATRI, V1; Helps SK, 2011, NEUROPSYCHOLOGY, V25, P711, DOI 10.1037/a0024479; HENDRICKSON A, 1982, MODEL INTELLIGENCE; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Johnson KA, 2008, NEUROPSYCHOLOGIA, V46, P1532, DOI 10.1016/j.neuropsychologia.2008.01.002; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P630, DOI 10.1016/j.neuropsychologia.2006.03.034; Kaufman J., 2001, KIDDIE SADS PRESENT; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Klein C., 2002, PERSON BIOL SOZIALEN, P29; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Ko AL, 2011, J NEUROSCI, V31, P11728, DOI 10.1523/JNEUROSCI.5730-10.2011; Kollins SH, 2009, DRUG ALCOHOL DEPEN, V100, P169, DOI 10.1016/j.drugalcdep.2008.09.019; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P211, DOI 10.1111/1469-7610.00712; KUNTSI J, 2012, CURRENT TOPICS BEHAV; Kuntsi J, 2010, ARCH GEN PSYCHIAT, V67, P1159, DOI 10.1001/archgenpsychiatry.2010.139; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Marsh R, 2006, HUM BRAIN MAPP, V27, P848, DOI 10.1002/hbm.20225; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Ram N, 2005, PSYCHOL AGING, V20, P623, DOI 10.1037/0882-7974.20.4.623; RATCLIFF R, 1979, PSYCHOL BULL, V86, P446, DOI 10.1037/0033-2909.86.3.446; Rommelse NNJ, 2008, BEHAV GENET, V38, P121, DOI 10.1007/s10519-007-9186-8; Rubia K, 2007, BIOL PSYCHIAT, V62, P999, DOI 10.1016/j.biopsych.2007.02.024; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; Russell Vivienne A, 2006, Behav Brain Funct, V2, P30, DOI 10.1186/1744-9081-2-30; Saville CWN, 2012, BIOL PSYCHOL, V91, P275, DOI 10.1016/j.biopsycho.2012.07.006; Saville CWN, 2011, PERS INDIV DIFFER, V51, P148, DOI 10.1016/j.paid.2011.03.034; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant J.A., 1999, HDB DISRUPTIVE BEHAV, P75, DOI DOI 10.1007/978-1-4615-4881-2_4; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Stasinopoulos DM, 2007, J STAT SOFTW, V23; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Toplak ME, 2006, J NEUROSCI METH, V151, P15, DOI 10.1016/j.jneumeth.2005.09.018; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Uebel H, 2010, J CHILD PSYCHOL PSYC, V51, P210, DOI 10.1111/j.1469-7610.2009.02139.x; Van Orden GC, 2003, J EXP PSYCHOL GEN, V132, P331, DOI 10.1037/0096-3445.132.3.331; Vaurio RG, 2009, NEUROPSYCHOLOGIA, V47, P2389, DOI 10.1016/j.neuropsychologia.2009.01.022; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wood AC, 2010, PSYCHOL MED, V40, P1027, DOI 10.1017/S003329170999119X	58	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2013	8	10							e69674	10.1371/journal.pone.0069674	http://dx.doi.org/10.1371/journal.pone.0069674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	231RG	24204553	gold, Green Published			2022-12-25	WOS:000325434500001
J	Vance, DJ; Tremblay, JM; Mantis, NJ; Shoemaker, CB				Vance, David J.; Tremblay, Jacqueline M.; Mantis, Nicholas J.; Shoemaker, Charles B.			Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Immunology; Immunotherapy; Mouse; Toxins; VHH	MONOCLONAL-ANTIBODIES; ENZYMATIC SUBUNIT; BINDING-AGENTS; B-SUBUNIT; CHAIN; FRAGMENTS; INHIBITORS; CHALLENGE; KINETICS; IMMUNITY	Background: We sought to engineer highly efficacious agents that neutralize ricin toxin. Results: We identified monomeric single-chain camelid V-H domains (V(H)Hs) capable of neutralizing ricin in vitro and engineered heterodimeric V(H)Hs that neutralized ricin in vivo. Conclusion: Stepwise engineering of V(H)Hs resulted in highly potent ricin toxin-neutralizing antibodies. Significance: This study highlights the potential use of a VHH platform as a strategy for therapeutics against diverse biological toxins. In an effort to engineer countermeasures for the category B toxin ricin, we produced and characterized a collection of epitopic tagged, heavy chain-only antibody V-H domains (V(H)Hs) specific for the ricin enzymatic (RTA) and binding (RTB) subunits. Among the 20 unique ricin-specific V(H)Hs we identified, six had toxin-neutralizing activity: five specific for RTA and one specific for RTB. Three neutralizing RTA-specific V(H)Hs were each linked via a short peptide spacer to the sole neutralizing anti-RTB VHH to create VHH heterodimers. As compared with equimolar concentrations of their respective monovalent monomers, all three VHH heterodimers had higher affinities for ricin and, in the case of heterodimer D10/B7, a 6-fold increase in in vitro toxin-neutralizing activity. When passively administered to mice at a 4:1 heterodimer:toxin ratio, D10/B7 conferred 100% survival in response to a 10 x LD50 ricin challenge, whereas a 2:1 heterodimer:toxin ratio conferred 20% survival. However, complete survival was achievable when the low dose of D10/B7 was combined with an IgG1 anti-epitopic tag monoclonal antibody, possibly because decorating the toxin with up to four IgGs promoted serum clearance. The two additional ricin-specific heterodimers, when tested in vivo, provided equal or greater passive protection than D10/B7, thereby warranting further investigation of all three heterodimers as possible therapeutics.	[Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, Albany, NY 12208 USA; [Tremblay, Jacqueline M.; Shoemaker, Charles B.] Tufts Univ, Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	State University of New York (SUNY) System; Wadsworth Center; Tufts University	Mantis, NJ (corresponding author), New York State Dept Hlth, Div Infect Dis, Wadsworth Ctr, 120 New Scotland Ave, Albany, NY 12208 USA.	nmantis@wadsworth.org; charles.shoemaker@tufts.edu	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health [AI097688, U54-AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R03AI097688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI097688 (to N. J. M.) and U54-AI057159 (to C. B. S.).	Anderson GP, 2010, ANAL CHEM, V82, P7202, DOI 10.1021/ac100961x; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; FRANZ DR, 2004, DEFENSE TOXIN WEAPON; Gibbs WW, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican0805-78; Jandhyala DM, 2012, CURR TOP MICROBIOL, V357, P41, DOI 10.1007/82_2011_181; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lebeda FJ, 1999, INT J BIOL MACROMOL, V24, P19, DOI 10.1016/S0141-8130(98)00059-2; LEMLEY PV, 1992, IMMUNOLOGY, V76, P511; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; Mukherjee J., 2012, PLOS ONE, V7; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; O'Hara JM, 2013, J IMMUNOL METHODS, V395, P71, DOI 10.1016/j.jim.2013.06.004; O'Hara JM, 2013, CLIN VACCINE IMMUNOL, V20, P789, DOI 10.1128/CVI.00098-13; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olsnes S, 1978, Methods Enzymol, V50, P330; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Reisler R. B., 2012, ADV PREV MED, V2012; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tremblay JM, 2010, TOXICON, V56, P990, DOI 10.1016/j.toxicon.2010.07.003; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Vance DJ, 2012, TOXICON, V60, P874, DOI 10.1016/j.toxicon.2012.06.014; Wahome P.G., 2013, CURR PROTOC TOXICOL, V23, DOI DOI 10.1002/0471140856.TX0223S55; Wolfe DN, 2013, HUM VACC IMMUNOTHER, V9, P1591, DOI 10.4161/hv.24063; Yermakova A., 2012, PLOS ONE, V7; Yermakova A, 2013, TOXICON, V72, P29, DOI 10.1016/j.toxicon.2013.04.005; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075	36	50	52	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36538	36547		10.1074/jbc.M113.519207	http://dx.doi.org/10.1074/jbc.M113.519207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24202178	Green Published, hybrid			2022-12-25	WOS:000328883400034
J	Wu, HA; Balsbaugh, JL; Chandler, H; Georgilis, A; Zullow, H; Shabanowitz, J; Hunt, DF; Gil, J; Peters, G; Bernstein, E				Wu, Hsan-au; Balsbaugh, Jeremy L.; Chandler, Hollie; Georgilis, Athena; Zullow, Hayley; Shabanowitz, Jeffrey; Hunt, Donald F.; Gil, Jesus; Peters, Gordon; Bernstein, Emily			Mitogen-activated Protein Kinase Signaling Mediates Phosphorylation of Polycomb Ortholog Cbx7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; MAP Kinases (MAPKs); Phosphorylation; Polycomb; Post translational Modification; Senescence; Cbx7; Polycomb Repressive Complex 1	HISTONE METHYLTRANSFERASE ACTIVITY; E3 LIGASE ACTIVITY; CHROMOBOX PROTEIN; CHROMATIN-ASSOCIATION; MASS-SPECTROMETRY; TUMOR-SUPPRESSOR; ONCOGENIC RAS; MOUSE; H3; DROSOPHILA	Background: Post-translational modification of Polycomb protein Cbx7 remains poorly understood. Results: Here we identify and characterize a novel phosphorylation site at threonine 118 of mouse Cbx7. Conclusion: MAPK signaling induces Cbx7 threonine 118 phosphorylation and enhances PRC1 association. Significance: Mitogen signaling to Cbx7 confers an additional layer of PRC1 regulation. Cbx7 is one of five mammalian orthologs of the Drosophila Polycomb. Cbx7 recognizes methylated lysine residues on the histone H3 tail and contributes to gene silencing in the context of the Polycomb repressive complex 1 (PRC1). However, our knowledge of Cbx7 post-translational modifications remains limited. Through combined biochemical and mass spectrometry approaches, we report a novel phosphorylation site on mouse Cbx7 at residue Thr-118 (Cbx7T118ph), near the highly conserved Polycomb box. The generation of a site-specific antibody to Cbx7T118ph demonstrates that Cbx7 is phosphorylated via MAPK signaling. Furthermore, we find Cbx7T118 phosphorylation in murine mammary carcinoma cells, which can be blocked by MEK inhibitors. Upon EGF stimulation, Cbx7 interacts robustly with other members of PRC1. To test the role of Cbx7T118 phosphorylation in gene silencing, we employed a RAS-induced senescence model system. We demonstrate that Cbx7T118 phosphorylation moderately enhances repression of its target gene p16. In summary, we have identified and characterized a novel MAPK-mediated phosphorylation site on Cbx7 and propose that mitogen signaling to the chromatin template regulates PRC1 function.	[Wu, Hsan-au; Zullow, Hayley; Bernstein, Emily] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Wu, Hsan-au; Bernstein, Emily] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Chandler, Hollie; Peters, Gordon] London Res Inst, Canc Res UK, London WC2A 3LY, England; [Georgilis, Athena; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Med Res Council Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Virginia; University of Virginia; Cancer Research UK; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Bernstein, E (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, Box 1130, New York, NY 10029 USA.	Emily.bernstein@mssm.edu	Gil, Jesus/C-7739-2012	Gil, Jesus/0000-0002-4303-6260; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health [GM037537]; Cancer Research UK; New York State Stem Cell Science Innovative, Developmental or Exploratory Activities Award [C024285]; MRC [MC_U120085810] Funding Source: UKRI; Medical Research Council [MC_U120085810, 1229061] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); New York State Stem Cell Science Innovative, Developmental or Exploratory Activities Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM037537 (to D. F. H.), Cancer Research UK via core funding to the London Research Institute (to G. P. and H. C.), core support from the Medical Research Council (to J. G. and A. G.), and New York State Stem Cell Science Innovative, Developmental or Exploratory Activities Award C024285 (to E. B.).	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Beuchle D, 2001, DEVELOPMENT, V128, P993; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen RQ, 2009, CANCER RES, V69, P2663, DOI 10.1158/0008-5472.CAN-08-3222; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; El Messaoudi-Aubert S, 2010, NAT STRUCT MOL BIOL, V17, P862, DOI 10.1038/nsmb.1824; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Ginjala V, 2011, MOL CELL BIOL, V31, P1972, DOI 10.1128/MCB.00981-10; Gumireddy K, 2007, P NATL ACAD SCI USA, V104, P6696, DOI 10.1073/pnas.0701145104; Hall EH, 2010, MOL CELL PROTEOMICS, V9, P2853, DOI 10.1074/mcp.M110.003665; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003199; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; O'Loghlen A, 2012, CELL STEM CELL, V10, P33, DOI 10.1016/j.stem.2011.12.004; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tie F, 2005, BIOCHEM BIOPH RES CO, V332, P622, DOI 10.1016/j.bbrc.2005.04.157; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36398	36408		10.1074/jbc.M113.486266	http://dx.doi.org/10.1074/jbc.M113.486266			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194518	hybrid, Green Published			2022-12-25	WOS:000328883400021
J	Shibata, N; Carlin, AF; Spann, NJ; Saijo, K; Morello, CS; McDonald, JG; Romanoski, CE; Maurya, MR; Kaikkonen, MU; Lam, MT; Crotti, A; Reichart, D; Fox, JN; Quehenberger, O; Raetz, CRH; Sullards, MC; Murphy, RC; Merrill, AH; Brown, HA; Dennis, EA; Fahy, E; Subramaniam, S; Cavener, DR; Spector, DH; Russell, DW; Glass, CK				Shibata, Norihito; Carlin, Aaron F.; Spann, Nathanael J.; Saijo, Kaoru; Morello, Christopher S.; McDonald, Jeffrey G.; Romanoski, Casey E.; Maurya, Mano R.; Kaikkonen, Minna U.; Lam, Michael T.; Crotti, Andrea; Reichart, Donna; Fox, Jesse N.; Quehenberger, Oswald; Raetz, Christian R. H.; Sullards, M. Cameron; Murphy, Robert C.; Merrill, Alfred H., Jr.; Brown, H. Alex; Dennis, Edward A.; Fahy, Eoin; Subramaniam, Shankar; Cavener, Douglas R.; Spector, Deborah H.; Russell, David W.; Glass, Christopher K.			25-Hydroxycholesterol Activates the Integrated Stress Response to Reprogram Transcription and Translation in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Lipids; Macrophages; Oxidative Stress; Stress Response; Translation; 25-Hydroxycholesterol; GCN2; MCMV; eIF2-	UNFOLDED PROTEIN RESPONSE; GCN2 EIF2-ALPHA KINASE; AMINO-ACID; ENDOPLASMIC-RETICULUM; CELL-DEATH; OXIDATIVE STRESS; GENE-EXPRESSION; INNATE IMMUNITY; CHOLESTEROL; DEPRIVATION	Background: Interferons and viral infections stimulate the production of 25-hydroxycholesterol. Results: 25-Hydroxycholesterol significantly alters cholesterol ester and sphingolipid levels and activates the integrated stress response. Conclusion: 25-Hydroxycholesterol activates the GCN2/eIF2/ATF4 integrated stress response likely by causing cysteine depletion and/or by generating oxidative stress. Significance: Altering important membrane lipids and activating the integrated stress response may contribute to the antiviral activity of 25-hydroxycholesterol. 25-Hydroxycholesterol (25OHC) is an enzymatically derived oxidation product of cholesterol that modulates lipid metabolism and immunity. 25OHC is synthesized in response to interferons and exerts broad antiviral activity by as yet poorly characterized mechanisms. To gain further insights into the basis for antiviral activity, we evaluated time-dependent responses of the macrophage lipidome and transcriptome to 25OHC treatment. In addition to altering specific aspects of cholesterol and sphingolipid metabolism, we found that 25OHC activates integrated stress response (ISR) genes and reprograms protein translation. Effects of 25OHC on ISR gene expression were independent of liver X receptors and sterol-response element-binding proteins and instead primarily resulted from activation of the GCN2/eIF2/ATF4 branch of the ISR pathway. These studies reveal that 25OHC activates the integrated stress response, which may contribute to its antiviral activity.	[Shibata, Norihito; Spann, Nathanael J.; Saijo, Kaoru; Morello, Christopher S.; Romanoski, Casey E.; Kaikkonen, Minna U.; Lam, Michael T.; Crotti, Andrea; Reichart, Donna; Fox, Jesse N.; Subramaniam, Shankar; Spector, Deborah H.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Maurya, Mano R.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Dennis, Edward A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Carlin, Aaron F.; Quehenberger, Oswald; Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [McDonald, Jeffrey G.; Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Dept Pharmacol, Nashville, TN 37232 USA; [Raetz, Christian R. H.] Duke Univ, Med Ctr, Sch Med, Dept Biochem, Durham, NC 27710 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Sullards, M. Cameron; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shibata, Norihito] Natl Inst Hlth Sci, Div Biochem & Mol Biol, Setagaya Ku, Tokyo 1588501, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Duke University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institute of Health Sciences - Japan	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Rooms 217 & 219,9500 Gilman Dr,MC 0651 CMM W, La Jolla, CA 92093 USA.	ckg@ucsd.edu	Dennis, Edward A./M-5554-2019; Kaikkonen, Minna U/AAK-3612-2020; Glass, Christopher/AAI-3933-2021; Morello, Christopher/GRS-1025-2022; Murphy, Robert/AAO-5349-2020; Carlin, Aaron/AAK-3806-2021	Dennis, Edward A./0000-0003-3738-3140; Kaikkonen, Minna U/0000-0001-6294-0979; Glass, Christopher/0000-0003-4344-3592; Morello, Christopher/0000-0001-8113-1173; Murphy, Robert/0000-0002-9430-6515; Spector, Deborah/0000-0002-7605-6348; Russell, David/0000-0002-0277-403X; Merrill, Alfred/0000-0002-6673-968X; SHIBATA, NORIHITO/0000-0001-5792-8510; Romanoski, Casey/0000-0002-0149-225X	National Institutes of Health Grant [GM U54 069338]; Clayton Foundation for Research; American Heart Association; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM107784, U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM U54 069338 (to the LIPID MAPS Consortium). This work was also supported by the Clayton Foundation for Research (to D. W. R.) and the American Heart Association (to N. S.).	Armas JCG, 1996, J VIROL, V70, P7921; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brune B, 2013, ANTIOXID REDOX SIGN, V19, P595, DOI 10.1089/ars.2012.4785; Budt M, 2009, J VIROL, V83, P1260, DOI 10.1128/JVI.01558-08; Chan RB, 2010, CHEM PHYS LIPIDS, V163, P449, DOI 10.1016/j.chemphyslip.2010.03.002; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Gupte AA, 2013, CURR DIABETES REP, V13, P362, DOI 10.1007/s11892-013-0372-1; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hullin-Matsuda F, 2012, J BIOL CHEM, V287, P24397, DOI [10.1074/jbc.M112.344432, 10.1074/jbc.M112.356733]; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; LANGE Y, 1994, J BIOL CHEM, V269, P29371; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lorizate M., 2011, COLD SPRING HARBOR P, V3; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002908; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Morello CS, 2007, J VIROL, V81, P7766, DOI 10.1128/JVI.00633-07; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8; RIDGWAY ND, 1995, J LIPID RES, V36, P1345; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Schenten D, 2011, ADV IMMUNOL, V109, P87, DOI 10.1016/B978-0-12-387664-5.00003-0; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; TABAS I, 1988, J BIOL CHEM, V263, P1266; Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wilkins C, 2013, IMMUNITY, V38, P3, DOI 10.1016/j.immuni.2013.01.002; Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yi TS, 2012, IMMUNITY, V37, P535, DOI 10.1016/j.immuni.2012.06.015; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	67	44	45	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35812	35823		10.1074/jbc.M113.519637	http://dx.doi.org/10.1074/jbc.M113.519637			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189069	Green Published, hybrid			2022-12-25	WOS:000329814700019
J	Peng, Y; Xie, ZX; Liu, JB; Pang, YS; Deng, XW; Xie, ZQ; Xie, LJ; Fan, Q; Luo, SS				Peng, Yi; Xie, Zhi-xun; Liu, Jia-bo; Pang, Yao-shan; Deng, Xian-wen; Xie, Zhi-qin; Xie, Li-ji; Fan, Qing; Luo, Si-si			Epidemiological Surveillance of Low Pathogenic Avian Influenza Virus (LPAIV) from Poultry in Guangxi Province, Southern China	PLOS ONE			English	Article							A VIRUSES; HUMAN INFECTION; HONG-KONG; ORIGIN; TRANSMISSION; EVOLUTION; CELLS; GENE	Low pathogenic avian influenza virus (LPAIV) usually causes mild disease or asymptomatic infection in poultry. However, some LPAIV strains can be transmitted to humans and cause severe infection. Genetic rearrangement and recombination of even low pathogenic influenza may generate a novel virus with increased virulence, posing a substantial risk to public health. Southern China is regarded as the world "influenza epicenter'', due to a rash of outbreaks of influenza in recent years. In this study, we conducted an epidemiological survey of LPAIV at different live bird markets (LBMs) in Guangxi province, Southern China. From January 2009 to December 2011, we collected 3,121 cotton swab samples of larynx, trachea and cloaca from the poultry at LBMs in Guangxi. Virus isolation, hemagglutination inhibition (HI) assay, and RT-PCR were used to detect and subtype LPAIV in the collected samples. Of the 3,121 samples, 336 samples (10.8%) were LPAIV positive, including 54 (1.7%) in chicken and 282 (9.1%) in duck. The identified LPAIV were H3N1, H3N2, H6N1, H6N2, H6N5, H6N6, H6N8, and H9N2, which are combinations of seven HA subtypes (H1, H3, H4, H6, H9, H10 and H11) and five NA subtypes (N1, N2, N5, N6 and N8). The H3 and H9 subtypes are predominant in the identified LPAIVs. Among the 336 cases, 29 types of mixed infection of different HA subtypes were identified in 87 of the cases (25.9%). The mixed infections may provide opportunities for genetic recombination. Our results suggest that the LPAIV epidemiology in poultry in the Guangxi province in southern China is complicated and highlights the need for further epidemiological and genetic studies of LPAIV in this area.	[Peng, Yi; Xie, Zhi-xun; Liu, Jia-bo; Pang, Yao-shan; Deng, Xian-wen; Xie, Zhi-qin; Xie, Li-ji; Fan, Qing; Luo, Si-si] Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & Diagnost, Nanning, Guangxi Provinc, Peoples R China	Guangxi Veterinary Research Institute	Xie, ZX (corresponding author), Guangxi Vet Res Inst, Guangxi Key Lab Anim Vaccines & Diagnost, Nanning, Guangxi Provinc, Peoples R China.	xiezhixun@126.com			Guangxi Science and Technology Bureau [1222003-2 4]; Guangxi Government Senior Scientist Foundation [2011B020]; Guangxi Natural Science Foundation [2011GXNSFA018088, 2013GXNSFDA09015]	Guangxi Science and Technology Bureau; Guangxi Government Senior Scientist Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study was supported by the Guangxi Science and Technology Bureau (1222003-2 4), Guangxi Government Senior Scientist Foundation (2011B020), Guangxi Natural Science Foundation (2011GXNSFA018088), and Guangxi Natural Science Foundation (2013GXNSFDA09015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Claas ECJ, 1998, VACCINE, V16, P977, DOI 10.1016/S0264-410X(98)00005-X; COCKBURN WC, 1969, B WORLD HEALTH ORGAN, V41, P345; Desnos-Ollivier M, 2010, MBIO, V1, DOI 10.1128/mBio.00091-10; Edwards S, 2006, DEV BIOLOGICALS, V124, P159; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Furuse Y, 2010, J CLIN MICROBIOL, V48, P369, DOI 10.1128/JCM.01795-09; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guo CT, 2007, GLYCOBIOLOGY, V17, P713, DOI 10.1093/glycob/cwm038; Hanashima S, 2007, CHEM-ASIAN J, V2, P1447, DOI 10.1002/asia.200600424; He CQ, 2009, MOL BIOL EVOL, V26, P177, DOI 10.1093/molbev/msn238; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Khiabanian H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007366; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Shortridge KF, 1997, CHINESE MED J-PEKING, V110, P637; SHORTRIDGE KF, 1982, LANCET, V2, P812; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; Walther T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003223; WEBSTER RG, 1987, J VIROL, V61, P2910, DOI 10.1128/JVI.61.9.2910-2916.1987; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu C, 2013, EMERG INFECT DIS, V19; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Zhao Chang-an, 2004, Zhonghua Er Ke Za Zhi, V42, P310	33	45	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77132	10.1371/journal.pone.0077132	http://dx.doi.org/10.1371/journal.pone.0077132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204754	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500018
J	Southan, C; Varkonyi, P; Boppana, K; Jagarlapudi, SARP; Muresan, S				Southan, Christopher; Varkonyi, Peter; Boppana, Kiran; Jagarlapudi, Sarma A. R. P.; Muresan, Sorel			Tracking 20 Years of Compound-to-Target Output from Literature and Patents	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-IV; IN-VITRO; DISCOVERY; BETA; PRODUCTIVITY; INHIBITION; QUALITY; BACE2	The statistics of drug development output and declining yield of approved medicines has been the subject of many recent reviews. However, assessing research productivity that feeds development is more difficult. Here we utilise an extensive database of structure-activity relationships extracted from papers and patents. We have used this database to analyse published compounds cumulatively linked to nearly 4000 protein target identifiers from multiple species over the last 20 years. The compound output increases up to 2005 followed by a decline that parallels a fall in pharmaceutical patenting. Counts of protein targets have plateaued but not fallen. We extended these results by exploring compounds and targets for one large pharmaceutical company. In addition, we examined collective time course data for six individual protease targets, including average molecular weight of the compounds. We also tracked the PubMed profile of these targets to detect signals related to changes in compound output. Our results show that research compound output had decreased 35% by 2012. The major causative factor is likely to be a contraction in the global research base due to mergers and acquisitions across the pharmaceutical industry. However, this does not rule out an increasing stringency of compound quality filtration and/or patenting cost control. The number of proteins mapped to compounds on a yearly basis shows less decline, indicating the cumulative published target capacity of global research is being sustained in the region of 300 proteins for large companies. The tracking of six individual targets shows uniquely detailed patterns not discernible from cumulative snapshots. These are interpretable in terms of events related to validation and de-risking of targets that produce detectable follow-on surges in patenting. Further analysis of the type we present here can provide unique insights into the process of drug discovery based on the data it actually generates.	[Southan, Christopher] TW2Informatics, Gothenburg, Sweden; [Varkonyi, Peter; Muresan, Sorel] AstraZeneca R&D, Chem Innovat Ctr, Discovery Sci, Molndal, Sweden; [Boppana, Kiran; Jagarlapudi, Sarma A. R. P.] GVK Biosci Pvt Ltd, Hyderabad, Andhra Pradesh, India; [Muresan, Sorel] Banats Univ Agr Sci & Vet Med, Food Control Dept, Timisoara, Romania	AstraZeneca; GVK Biosciences Private Limited; Banat University of Agricultural Sciences & Veterinary Medicine	Muresan, S (corresponding author), AstraZeneca R&D, Chem Innovat Ctr, Discovery Sci, Molndal, Sweden.	sorel.muresan@gmail.com	Southan, Christopher/B-1550-2010; Muresan, Sorel/C-1961-2009	Southan, Christopher/0000-0001-9580-0446; Muresan, Sorel/0000-0003-2386-0436				Agarwal P, 2009, NAT REV DRUG DISCOV, V8, P865, DOI 10.1038/nrd2973; Ahmed Shameer, 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry, V10, P116; Ahren B, 2002, DIABETES CARE, V25, P869, DOI 10.2337/diacare.25.5.869; Barnes MR, 2009, NAT REV DRUG DISCOV, V8, P701, DOI 10.1038/nrd2944; BODUSZEK B, 1994, J MED CHEM, V37, P3969, DOI 10.1021/jm00049a016; Bunnage ME, 2011, NAT CHEM BIOL, V7, P335, DOI 10.1038/nchembio.581; Clark RL, 2010, DRUG DISCOV TODAY, V15, P679, DOI 10.1016/j.drudis.2010.06.003; Esterhazy D, 2011, CELL METAB, V14, P365, DOI 10.1016/j.cmet.2011.06.018; Fisher NDL, 2001, EXPERT OPIN INV DRUG, V10, P417, DOI 10.1517/13543784.10.3.417; Frye S, 2011, NAT REV DRUG DISCOV, V10, P409, DOI 10.1038/nrd3462; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gustafsson D, 2004, NAT REV DRUG DISCOV, V3, P649, DOI 10.1038/nrd1466; Heifets A, 2012, NUCLEIC ACIDS RES, V40, pD428, DOI 10.1093/nar/gkr919; Holst JJ, 1998, DIABETES, V47, P1663, DOI 10.2337/diabetes.47.11.1663; Jeppsson F, 2012, J BIOL CHEM; Leeson PD, 2011, NAT REV DRUG DISCOV, V10, P749, DOI 10.1038/nrd3552; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Matthews S, 2012, NAT MED, V18, P1445, DOI 10.1038/nm1012-1445; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P91, DOI 10.1038/nrd3657; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Muresan S, 2011, DRUG DISCOV TODAY, V16, P1019, DOI 10.1016/j.drudis.2011.10.005; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Perzborn E, 2011, NAT REV DRUG DISCOV, V10, P61, DOI 10.1038/nrd3185; Phimister B, 2000, NAT BIOTECHNOL, V18, P16, DOI 10.1038/71846; Sanseau P, 2009, DRUG DISCOV TODAY, V14, P334, DOI 10.1016/j.drudis.2008.12.001; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Southan C, 2012, DRUG DISCOVERY TODAY; Southan C, 2013, EXPERT OPIN THER PAT, V23, P649, DOI 10.1517/13543776.2013.780032; Southan C, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-14; Southan C, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-10; van de Waterbeemd H, 2009, CHEM BIODIVERS, V6, P1760, DOI 10.1002/cbdv.200900056; Walters WP, 2011, J MED CHEM, V54, P6405, DOI 10.1021/jm200504p; Webber PM, 2003, NAT REV DRUG DISCOV, V2, P823, DOI 10.1038/nrd1200	35	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77142	10.1371/journal.pone.0077142	http://dx.doi.org/10.1371/journal.pone.0077142			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204758	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700019
J	Kong, XY; Zhang, YQ; Liu, CF; Guo, W; Li, XB; Su, XH; Wan, HY; Sun, YQ; Lin, N				Kong, Xiangying; Zhang, Yanqiong; Liu, Chunfang; Guo, Wei; Li, Xiangbin; Su, Xiaohui; Wan, Hongye; Sun, Yanqun; Lin, Na			Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; WILFORDII HOOK-F; TNF-ALPHA; DITERPENOID TRIEPOXIDE; SYNOVIAL FIBROBLASTS; CHRONIC INFLAMMATION; CELL PROLIFERATION; SUPPRESSES	Rheumatoid arthritis (RA) is characterized by a pre-vascular seriously inflammatory phase, followed by a vascular phase with high increase in vessel growth. Since angiogenesis has been considered as an essential event in perpetuating inflammatory and immune responses, as well as supporting pannus growth and development of RA, inhibition of angiogenesis has been proposed as a novel therapeutic strategy for RA. Triptolide, a diterpenoid triepoxide from Tripterygium wilfordii Hook F, has been extensively used in treatment of RA patients. It also acts as a small molecule inhibitor of tumor angiogenesis in several cancer types. However, it is unclear whether triptolide possesses an anti-angiogenic effect in RA. To address this problem, we constructed collagen-induced arthritis (CIA) model using DA rats by the injection of bovine type II collagen. Then, CIA rats were treated with triptolide (11-45 mu g/kg/day) starting on the day 1 after first immunization. The arthritis scores (P<0.05) and the arthritis incidence (P<0.05) of inflamed joints were both significantly decreased in triptolide-treated CIA rats compared to vehicle CIA rats. More interestingly, doses of 11 similar to 45 mu g/kg triptolide could markedly reduce the capillaries, small, medium and large vessel density in synovial membrane tissues of inflamed joints (all P<0.05). Moreover, triptolide inhibited matrigel-induced cell adhesion of HFLS-RA and HUVEC. It also disrupted tube formation of HUVEC on matrigel and suppressed the VEGF-induced chemotactic migration of HFLS-RA and HUVEC, respectively. Furthermore, triptolide significantly reduced the expression of angiogenic activators including TNF-alpha, IL-17, VEGF, VEGFR, Ang-1, Ang-2 and Tie2, as well as suppressed the IL1-beta-induced phosphorylated of ERK, p38 and JNK at protein levels. In conclusion, our data suggest for the first time that triptolide may possess anti-angiogenic effect in RA both in vivo and in vitro assay systems by downregulating the angiogenic activators and inhibiting the activation of mitogen-activated protein kinase downstream signal pathway.	[Kong, Xiangying; Zhang, Yanqiong; Liu, Chunfang; Guo, Wei; Li, Xiangbin; Su, Xiaohui; Wan, Hongye; Sun, Yanqun; Lin, Na] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS	Lin, N (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	linna888@163.com			national drug research and development projects [2009ZX09502-019, 2009ZX09301-005-007]; China Academy of Chinese Medical Sciences [ZZ20090105]; Beijing Natural Science Foundation [7062051]; National Natural Science Foundation of China [81274167, 30672647]	national drug research and development projects; China Academy of Chinese Medical Sciences(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the national drug research and development projects (2009ZX09502-019, 2009ZX09301-005-007), the project of China Academy of Chinese Medical Sciences (ZZ20090105), the Beijing Natural Science Foundation (7062051), and the National Natural Science Foundation of China (81274167, 30672647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottomley MJ, 1999, CLIN EXP IMMUNOL, V117, P171; Brenner M, 2005, ARTHRITIS RHEUM-US, V52, P322, DOI 10.1002/art.20782; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; Chen Zhan Kun, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P567; Ding Yi, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P778; Ding Yi, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P347; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fuchs Ota, 2010, Curr Mol Pharmacol, V3, P98; Goldbach-Mansky R, 2009, ANN INTERN MED, V151, P229, DOI 10.7326/0003-4819-151-4-200908180-00005; Gu WZ, 1998, INT J IMMUNOPHARMACO, V20, P389, DOI 10.1016/S0192-0561(98)00035-6; Guadagni F, 2007, IN VIVO, V21, P147; Hangai M, 2006, J NEUROIMMUNOL, V171, P45, DOI 10.1016/j.jneuroim.2005.09.018; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; HIRATA S, 1989, ARTHRITIS RHEUM, V32, P1065, DOI 10.1002/anr.1780320903; Karamysheva AF, 2008, BIOCHEMISTRY-MOSCOW+, V73, P751, DOI 10.1134/S0006297908070031; Kok T. W., 2005, Angiogenesis, V8, P3, DOI 10.1007/s10456-005-2892-z; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Li H, 2010, CANCER GENE THER, V17, P700, DOI 10.1038/cgt.2010.26; Lin N, 2001, ARTHRITIS RHEUM-US, V44, P2193, DOI 10.1002/1529-0131(200109)44:9&lt;2193::AID-ART373&gt;3.0.CO;2-5; Lin N, 2007, BIOCHEM PHARMACOL, V73, P136, DOI 10.1016/j.bcp.2006.08.027; Liu CF, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/626038; Lu Y, 2008, INFLAMM RES, V57, P260, DOI 10.1007/s00011-007-7128-9; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Marrelli A, 2011, AUTOIMMUN REV, V10, P595, DOI 10.1016/j.autrev.2011.04.020; Maruotti N, 2006, HISTOL HISTOPATHOL, V21, P557, DOI 10.14670/HH-21.557; Matta R, 2009, AM J TRANSL RES, V1, P267; Mould AW, 2003, ARTHRITIS RHEUM-US, V48, P2660, DOI 10.1002/art.11232; Nagashima M, 2000, RHEUMATOLOGY, V39, P1255, DOI 10.1093/rheumatology/39.11.1255; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Pan Xiao-dong, 2008, Yaoxue Xuebao, V43, P1179; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Remmers EF, 2002, ARTHRITIS RHEUM, V46, P2225, DOI 10.1002/art.10439; ROTHSCHILD BM, 1982, ARTHRITIS RHEUM, V25, P588, DOI 10.1002/art.1780250516; Saeki Y, 2012, EXPERT REV CLIN IMMU, V8, P455, DOI [10.1586/eci.12.35, 10.1586/ECI.12.35]; Sun LX, 2011, BIOCHEM BIOPH RES CO, V416, P99, DOI 10.1016/j.bbrc.2011.11.004; Thairu N, 2011, ANGIOGENESIS, V14, P223, DOI 10.1007/s10456-011-9208-2; Wang JX, 2012, ANAT REC, V295, P922, DOI 10.1002/ar.22479; Wang Y, 2008, SCAND J IMMUNOL, V68, P383, DOI 10.1111/j.1365-3083.2008.02147.x; Wang YF, 2007, PHARMACOL REP, V59, P795; Xiao Cheng, 2009, Chin Med, V4, P13, DOI 10.1186/1749-8546-4-13; Xiao C, 2009, NAT PROD RES, V23, P1699, DOI 10.1080/14786410802187783; Xue M, 2010, FITOTERAPIA, V81, P1109, DOI 10.1016/j.fitote.2010.07.007; Yang YL, 1998, IMMUNOPHARMACOLOGY, V40, P139, DOI 10.1016/S0162-3109(98)00036-8; Zhang Wan-Dong, 2007, Zhongguo Zhong Yao Za Zhi, V32, P414; Zhang WD, 2007, PLANTA MED, V73, P336, DOI 10.1055/s-2007-967136; Zhu WB, 2010, VASC PHARMACOL, V52, P46, DOI 10.1016/j.vph.2009.10.006; Zhu WB, 2009, MOL PHARMACOL, V75, P812, DOI 10.1124/mol.108.052605	47	55	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77513	10.1371/journal.pone.0077513	http://dx.doi.org/10.1371/journal.pone.0077513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204851	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200030
J	Acencio, ML; Bovolenta, LA; Camilo, E; Lemke, N				Acencio, Marcio Luis; Bovolenta, Luiz Augusto; Camilo, Esther; Lemke, Ney			Prediction of Oncogenic Interactions and Cancer-Related Signaling Networks Based on Network Topology	PLOS ONE			English	Article							BETA-CATENIN; CYCLIN D1; GENES; INTEGRATION; KEGG	Cancer has been increasingly recognized as a systems biology disease since many investigators have demonstrated that this malignant phenotype emerges from abnormal protein-protein, regulatory and metabolic interactions induced by simultaneous structural and regulatory changes in multiple genes and pathways. Therefore, the identification of oncogenic interactions and cancer-related signaling networks is crucial for better understanding cancer. As experimental techniques for determining such interactions and signaling networks are labor-intensive and time-consuming, the development of a computational approach capable to accomplish this task would be of great value. For this purpose, we present here a novel computational approach based on network topology and machine learning capable to predict oncogenic interactions and extract relevant cancer-related signaling subnetworks from an integrated network of human genes interactions (INHGI). This approach, called graph2sig, is twofold: first, it assigns oncogenic scores to all interactions in the INHGI and then these oncogenic scores are used as edge weights to extract oncogenic signaling subnetworks from INHGI. Regarding the prediction of oncogenic interactions, we showed that graph2sig is able to recover 89% of known oncogenic interactions with a precision of 77%. Moreover, the interactions that received high oncogenic scores are enriched in genes for which mutations have been causally implicated in cancer. We also demonstrated that graph2sig is potentially useful in extracting oncogenic signaling subnetworks: more than 80% of constructed subnetworks contain more than 50% of original interactions in their corresponding oncogenic linear pathways present in the KEGG PATHWAY database. In addition, the potential oncogenic signaling subnetworks discovered by graph2sig are supported by experimental evidence. Taken together, these results suggest that graph2sig can be a useful tool for investigators involved in cancer research interested in detecting signaling networks most prone to contribute with the emergence of malignant phenotype.	[Acencio, Marcio Luis; Bovolenta, Luiz Augusto; Camilo, Esther; Lemke, Ney] Univ Estadual Paulista, Dept Phys & Biophys, Botucatu Biosci Inst, Sao Paulo, Brazil	Universidade Estadual Paulista	Acencio, ML (corresponding author), Univ Estadual Paulista, Dept Phys & Biophys, Botucatu Biosci Inst, Sao Paulo, Brazil.	mlacencio@ibb.unesp.br	Lemke, Ney/L-6761-2019; Acencio, Marcio L/D-9264-2012; Lemke, Ney/A-8213-2008; Bovolenta, Luiz Augusto/AAQ-6356-2021; Acencio, Marcio Luis/ABH-1930-2020	Lemke, Ney/0000-0001-7463-4303; Acencio, Marcio L/0000-0002-8278-240X; Lemke, Ney/0000-0001-7463-4303; Bovolenta, Luiz Augusto/0000-0002-8116-8280; Acencio, Marcio Luis/0000-0002-8278-240X	Sao Paulo Research Foundation [2010/20684-3, 2012/13450-1, 2012/00741-8, 2013/02018-4]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work has been supported by grants #2010/20684-3, #2012/13450-1, #2012/00741-8 and #2013/02018-4 from the Sao Paulo Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acencio ML, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-290; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Costa PR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S9; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Demsar J, 2006, J MACH LEARN RES, V7, P1; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; FILMUS J, 1994, ONCOGENE, V9, P3627; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hagberg A, 2008, EXPLORING NETWORK ST, P11, DOI DOI 10.25080/ISSN.2575-9752; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jimenez VM, 1999, LECT NOTES COMPUT SC, V1668, P15; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; da Silva JPM, 2008, PHYSICA A, V387, P1049, DOI 10.1016/j.physa.2007.10.044; Quinlan J.R, 2014, C4 5 PROGRAMS MACHIN; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Syed ZA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-180; Wang E, 2007, CELL MOL LIFE SCI, V64, P1752, DOI 10.1007/s00018-007-7054-6; Wang E, 2010, CH CRC MATH COMP BIO, P1, DOI 10.1201/9781439811863-f; Wang E, 2012, CANC LETT; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; WILCOXON F, 1947, BIOMETRICS, V3, P119, DOI 10.2307/3001946; Witten I.H., 2000, DATA MINING PRACTICA	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77521	10.1371/journal.pone.0077521	http://dx.doi.org/10.1371/journal.pone.0077521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204854	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400041
J	Yuan, C; Sun, YN				Yuan, Cheng; Sun, Yanni			RNA-CODE: A Noncoding RNA Classification Tool for Short Reads in NGS Data Lacking Reference Genomes	PLOS ONE			English	Article							GENES; EXPRESSION; MICRORNAS; ALIGNMENT	The number of transcriptomic sequencing projects of various non-model organisms is still accumulating rapidly. As non-coding RNAs (ncRNAs) are highly abundant in living organism and play important roles in many biological processes, identifying fragmentary members of ncRNAs in small RNA-seq data is an important step in post-NGS analysis. However, the state-of-the-art ncRNA search tools are not optimized for next-generation sequencing (NGS) data, especially for very short reads. In this work, we propose and implement a comprehensive ncRNA classification tool (RNA-CODE) for very short reads. RNA-CODE is specifically designed for ncRNA identification in NGS data that lack quality reference genomes. Given a set of short reads, our tool classifies the reads into different types of ncRNA families. The classification results can be used to quantify the expression levels of different types of ncRNAs in RNA-seq data and ncRNA composition profiles in metagenomic data, respectively. The experimental results of applying RNA-CODE to RNA-seq of Arabidopsis and a metagenomic data set sampled from human guts demonstrate that RNA-CODE competes favorably in both sensitivity and specificity with other tools. The source codes of RNA-CODE can be downloaded at http://www.cse.msu.edu/similar to chengy/RNA_CODE.	[Yuan, Cheng; Sun, Yanni] Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University	Sun, YN (corresponding author), Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA.	yannisun@cse.msu.edu	Sun, Yanni/AAZ-7373-2021; SUN, Yanni/AHC-4163-2022	SUN, Yanni/0000-0003-1373-8023	NSF [DBI-0953738]	NSF(National Science Foundation (NSF))	NSF DBI-0953738 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fan L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039948; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kolbe DL, 2009, BIOINFORMATICS, V25, P1236, DOI 10.1093/bioinformatics/btp154; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu SF, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh170; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Peng X, 2011, MBIO, V2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sea Stricklin, 2005, C ELEGANS NONCODING; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Vilo C., 2012, METAGENOMICS, V1, P1, DOI DOI 10.4303/MG/235551; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029860; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	26	6	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77596	10.1371/journal.pone.0077596	http://dx.doi.org/10.1371/journal.pone.0077596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204885	Green Submitted, gold, Green Published			2022-12-25	WOS:000326155400047
J	Tsang, KM; Croen, LA; Torres, AR; Kharrazi, M; Delorenze, GN; Windham, GC; Yoshida, CK; Zerbo, O; Weiss, LA				Tsang, Kathryn M.; Croen, Lisa A.; Torres, Anthony R.; Kharrazi, Martin; Delorenze, Gerald N.; Windham, Gayle C.; Yoshida, Cathleen K.; Zerbo, Ousseny; Weiss, Lauren A.			A Genome-Wide Survey of Transgenerational Genetic Effects in Autism	PLOS ONE			English	Article							SPECTRUM DISORDERS; FETAL MICROCHIMERISM; EARLY MARKERS; RISK-FACTORS; TWIN PAIRS; BRAIN; ASSOCIATION; VARIANTS; PROGENITOR; PREGNANCY	Effects of parental genotype or parent-offspring genetic interaction are well established in model organisms for a variety of traits. However, these transgenerational genetic models are rarely studied in humans. We have utilized an autism case-control study with 735 mother-child pairs to perform genome-wide screening for maternal genetic effects and maternal-offspring genetic interaction. We used simple models of single locus parent-child interaction and identified suggestive results (P<10(-4)) that cannot be explained by main effects, but no genome-wide significant signals. Some of these maternal and maternal-child associations were in or adjacent to autism candidate genes including: PCDH9, FOXP1, GABRB3, NRXN1, RELN, MACROD2, FHIT, RORA, CNTN4, CNTNAP2, FAM135B, LAMA1, NFIA, NLGN4X, RAPGEF4, and SDK1. We attempted validation of potential autism association under maternal-specific models using maternal-paternal comparison in family-based GWAS datasets. Our results suggest that further study of parental genetic effects and parent-child interaction in autism is warranted.	[Tsang, Kathryn M.; Weiss, Lauren A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Tsang, Kathryn M.; Weiss, Lauren A.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Croen, Lisa A.; Delorenze, Gerald N.; Yoshida, Cathleen K.; Zerbo, Ousseny] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Torres, Anthony R.] Utah State Univ, Ctr Persons Disabil, Logan, UT 84322 USA; [Kharrazi, Martin] Calif Dept Hlth Serv, Genet Dis Screening Program, Richmond, CA USA; [Windham, Gayle C.] Calif Dept Hlth Serv, Div Environm & Occupat Dis Control, Richmond, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Utah System of Higher Education; Utah State University; California Department of Health Care Services; California Department of Health Care Services	Weiss, LA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	Lauren.Weiss@ucsf.edu		Croen, Lisa/0000-0001-7849-9428; Weiss, Lauren/0000-0002-5700-135X	National Institute of environmental Health Sciences [R01-ES016669]; National Institute of Health [MH52708, MH39437, MH00219, MH00980, MH64547]; National Health Medical Research Council [0034328]; Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders; Nancy Pritzker Laboratory (Stanford); Cure Autism Now Foundation; National Institute of Mental Health [1U24MH081810]; Medical Research Council [G0601030]; Wellcome Trust [075491/Z/04]; MRC [G0601030] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547, U24MH081810, K05MH000219, P01MH039437, R01MH052708] Funding Source: NIH RePORTER	National Institute of environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders(NARSAD); Nancy Pritzker Laboratory (Stanford); Cure Autism Now Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of environmental Health Sciences (http://www.niehs.nih.gov/- R01-ES016669). The collection of data and biomaterials that participated in the National Institute of Mental Health Autism Genetics Initiative has been supported by National Institute of Health grants MH52708, MH39437, MH00219 and MH00980; National Health Medical Research Council grant 0034328; and by grants from the Scottish Rite, the Spunk Fund, Inc., the Rebecca and Solomon Baker Fund, the APEX Foundation, the National Alliance for Research in Schizophrenia and Affective Disorders, the endowment fund of the Nancy Pritzker Laboratory (Stanford), by gifts from the Autism Society of America, the Janet M. Grace Pervasive Developmental Disorders Fund, and families and friends of individuals with autism. The collection data and biomaterials also come from the Autism Genetic Resource Exchange (AGRE) collection supported by a National Institute of Health grant MH64547 and the Cure Autism Now Foundation. AGRE is a program of Autism Speaks and is supported, in part, by grant 1U24MH081810 from the National Institute of Mental Health to Clara M. Lajonchere (PI). Collection and submission of the data to dbGaP were supported by a grant from the Medical Research Council (G0601030) and the Wellcome Trust (075491/Z/04), Anthony P. Monaco, P. I., University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Becker JAJ, 2008, NEUROSCIENCE, V156, P950, DOI 10.1016/j.neuroscience.2008.07.070; Braunschweig D, 2008, NEUROTOXICOLOGY, V29, P226, DOI 10.1016/j.neuro.2007.10.010; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chao CCK, 2005, J NEUROSCI RES, V81, P153, DOI 10.1002/jnr.20552; Connolly JJ, 2013, CHILD DEV, V84, P17, DOI 10.1111/j.1467-8624.2012.01838.x; Croen LA, 2008, BIOL PSYCHIAT, V64, P583, DOI 10.1016/j.biopsych.2008.05.006; Croen LA, 2008, AUTISM RES, V1, P130, DOI 10.1002/aur.14; Delahanty RJ, 2011, MOL PSYCHIATR, V16, P86, DOI 10.1038/mp.2009.118; Dunster K, 2005, CLIN EXP IMMUNOL, V140, P556, DOI 10.1111/j.1365-2249.2005.02774.x; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Glezer I, 2009, J COMP NEUROL, V517, P906, DOI 10.1002/cne.22185; Godbole K, 2011, BIRTH DEFECTS RES A, V91, P848, DOI 10.1002/bdra.20841; Groer MW, 2011, BIOL RES NURS, V13, P346, DOI 10.1177/1099800410385840; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Howey R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-149; Hsieh CL, 2011, NUCLEIC ACIDS RES, V39, P4048, DOI 10.1093/nar/gkq1338; Ichinose H, 2008, CHEM REC, V8, P378, DOI 10.1002/tcr.20166; Izaki T, 2006, BIOCHEM BIOPH RES CO, V341, P1001, DOI 10.1016/j.bbrc.2006.01.050; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Koch M, 2004, J BIOL CHEM, V279, P22514, DOI 10.1074/jbc.M400536200; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Kutzleb G, 2006, CELL BIOL, V127, P13; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin LA, 2008, BRAIN BEHAV IMMUN, V22, P806, DOI 10.1016/j.bbi.2007.12.007; MASONBROTHERS A, 1990, PEDIATRICS, V86, P514; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Mulatinho MV, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-30; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Narayanan G, 2012, STEM CELLS DEV, V21, P3351, DOI 10.1089/scd.2012.0232; Nelson JL, 1998, LANCET, V351, P559, DOI 10.1016/S0140-6736(97)08357-8; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ozgen HM, 2009, CLIN GENET, V76, P348, DOI 10.1111/j.1399-0004.2009.01254.x; Palmer CGS, 2002, AM J HUM GENET, V71, P1312, DOI 10.1086/344659; PARKHURST SM, 1991, GENE DEV, V5, P341, DOI 10.1101/gad.5.3.341; Passemard S, 2009, GENE REV; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RITVO ER, 1985, AM J PSYCHIAT, V142, P74; Rogenhofer N, 2012, FERTIL STERIL, V98, P383, DOI 10.1016/j.fertnstert.2012.04.026; Roohi J, 2009, J MED GENET, V46, P176, DOI 10.1136/jmg.2008.057505; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sinsheimer JS, 2003, GENET EPIDEMIOL, V24, P1, DOI 10.1002/gepi.10211; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Volcik KA, 2000, AM J MED GENET, V95, P21, DOI 10.1002/1096-8628(20001106)95:1<21::AID-AJMG6>3.0.CO;2-M; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wilcox CB, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-223; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49	65	41	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76978	10.1371/journal.pone.0076978	http://dx.doi.org/10.1371/journal.pone.0076978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204716	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300012
J	Hu, J; Ng, PC				Hu, Jing; Ng, Pauline C.			SIFT Indel: Predictions for the Functional Effects of Amino Acid Insertions/Deletions in Proteins	PLOS ONE			English	Article							MECHANISMS; DELETIONS; IMPACT	Indels in the coding regions of a gene can either cause frameshifts or amino acid insertions/deletions. Frameshifting indels are indels that have a length that is not divisible by 3 and subsequently cause frameshifts. Indels that have a length divisible by 3 cause amino acid insertions/deletions or block substitutions; we call these 3n indels. The new amino acid changes resulting from 3n indels could potentially affect protein function. Therefore, we construct a SIFT Indel prediction algorithm for 3n indels which achieves 82% accuracy, 81% sensitivity, 82% specificity, 82% precision, 0.63 MCC, and 0.87 AUC by 10-fold cross-validation. We have previously published a prediction algorithm for frameshifting indels. The rules for the prediction of 3n indels are different from the rules for the prediction of frameshifting indels and reflect the biological differences of these two different types of variations. SIFT Indel was applied to human 3n indels from the 1000 Genomes Project and the Exome Sequencing Project. We found that common variants are less likely to be deleterious than rare variants. The SIFT indel prediction algorithm for 3n indels is available at http://sift-dna.org/	[Hu, Jing] Franklin & Marshall Coll, Dept Math & Comp Sci, Lancaster, PA 17604 USA; [Ng, Pauline C.] Genome Inst Singapore, Dept Computat & Math Biol, Singapore, Singapore	Franklin & Marshall College; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Hu, J (corresponding author), Franklin & Marshall Coll, Dept Math & Comp Sci, Lancaster, PA 17604 USA.	jing.hu@fandm.edu; ngpc4@gis.a-star.edu.sg			A*STAR; Genome Institute of Singapore; Howard Hughes Medical Institute's Undergraduate Science Education Program	A*STAR(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore; Howard Hughes Medical Institute's Undergraduate Science Education Program	PCN is supported by A*STAR and Genome Institute of Singapore. JH is supported by an award to Franklin and Marshall College from the Howard Hughes Medical Institute's Undergraduate Science Education Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Brown C, 2002, EMBED SYST PROGRAM, V15, P55; Capriotti E, 2012, BRIEF BIOINFORM, V13, P495, DOI 10.1093/bib/bbr070; Castellana S, 2013, BRIEF BIOINFORM, V14, P448, DOI 10.1093/bib/bbt013; Chang MSS, 2004, J MOL BIOL, V341, P617, DOI 10.1016/j.jmb.2004.05.045; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Hu J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r9; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; LIXPLI XM, 2001, CHINESEJ CLIN PHARM, V3, P21502; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wang MJ, 2013, CURR BIOINFORM, V8, P161, DOI 10.2174/1574893611308020004; WITTEN IH, 2005, DATA MINING PRACTICA; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhao HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r23; 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534.PUBMED:20981092	28	71	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77940	10.1371/journal.pone.0077940	http://dx.doi.org/10.1371/journal.pone.0077940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194902	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000081
J	Kim, SK; Kim, H; Lee, DH; Kim, TS; Kim, T; Chung, C; Koh, GY; Kim, H; Lim, DS				Kim, Sang Kyum; Kim, Honsoul; Lee, Da-hye; Kim, Tae-shin; Kim, Tackhoon; Chung, Chaeuk; Koh, Gou Young; Kim, Hoguen; Lim, Dae-Sik			Reversing the Intractable Nature of Pancreatic Cancer by Selectively Targeting ALDH-High, Therapy-Resistant Cancer Cells	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; TWICE-WEEKLY GEMCITABINE; PHASE-II TRIAL; STEM-CELLS; KAPPA-B; DISULFIRAM; CHEMOTHERAPY; MARKER; CARCINOMA; RADIATION	Human pancreatic ductal adenocarcinoma (PDAC) is a cancer with a dismal prognosis. The efficacy of PDAC anticancer therapies is often short-lived; however, there is little information on how this disease entity so frequently gains resistance to treatment. We adopted the concept of cancer stem cells (CSCs) to explain the mechanism of resistance and evaluated the efficacy of a candidate anticancer drug to target these therapy-resistant CSCs. We identified a subpopulation of cells in PDAC with CSC features that were enriched for aldehyde dehydrogenase (ALDH), a marker expressed in certain stem/progenitor cells. These cells were also highly resistant to, and were further enriched by, treatment with gemcitabine. Similarly, surgical specimens from PDAC patients showed that those who had undergone preoperative chemo-radiation therapy more frequently displayed cancers with ALDH strongly positive subpopulations compared with untreated patients. Importantly, these ALDH-high cancer cells were sensitive to disulfiram, an ALDH inhibitor, when tested in vitro. Furthermore, in vivo xenograft studies showed that the effect of disulfiram was additive to that of low-dose gemcitabine when applied in combination. In conclusion, human PDAC-derived cells that express high levels of ALDH show CSC features and have a key role in the development of resistance to anticancer therapies. Disulfiram can be used to suppress this therapy-resistant subpopulation.	[Kim, Sang Kyum; Chung, Chaeuk; Koh, Gou Young] South Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn, Taejon, South Korea; [Kim, Honsoul] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Da-hye; Kim, Tae-shin; Kim, Tackhoon; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Hoguen] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Yonsei University; Yonsei University Health System	Kim, SK (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea.	nicekyumi@kaist.ac.kr; daesiklim@kaist.ac.kr	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555; Chung, Chaeuk/0000-0002-3978-0484; Kim, Tae-Shin/0000-0003-4736-0727; Kim, Sang Kyum/0000-0003-0768-9923	National Creative Research Initiatives Program [2010-001827]	National Creative Research Initiatives Program(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the National Creative Research Initiatives Program (2010-001827, http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKEVOLD KE, 1993, EUR J CANCER, V29A, P698, DOI 10.1016/S0959-8049(05)80349-1; Balber AE, 2011, STEM CELLS, V29, P570, DOI 10.1002/stem.613; Blackstock AW, 1999, J CLIN ONCOL, V17, P2208, DOI 10.1200/JCO.1999.17.7.2208; Brar SS, 2004, MOL CANCER THER, V3, P1049; Chen D, 2006, CANCER RES, V66, P10425, DOI 10.1158/0008-5472.CAN-06-2126; Cho HJ, 2007, J BIOCHEM MOL BIOL, V40, P1069; Cvek B, 2007, CURR PHARM DESIGN, V13, P3155, DOI 10.2174/138161207782110390; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dorado J, 2011, STEM CELLS BIOL REG, P79, DOI 10.1007/978-1-61779-246-5_5; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Edge SB, 2010, AJCC CANC STAGING MA; ENEANYA DI, 1981, ANNU REV PHARMACOL, V21, P575, DOI 10.1146/annurev.pa.21.040181.003043; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; GASSLANDER T, 1992, SCAND J GASTROENTERO, V27, P564, DOI 10.3109/00365529209000120; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Girard N, 2010, INT J RADIAT ONCOL, V77, P1426, DOI 10.1016/j.ijrobp.2009.06.053; GORDON MY, 1985, LEUKEMIA RES, V9, P1017, DOI 10.1016/0145-2126(85)90072-4; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; JOHANSSON B, 1992, ACTA PSYCHIAT SCAND, V86, P15, DOI 10.1111/j.1600-0447.1992.tb03310.x; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Klinkenbijl JH, 1999, ANN SURG, V230, P776, DOI 10.1097/00000658-199912000-00006; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Maeda S, 2007, BRIT J CANCER, V97, P405, DOI 10.1038/sj.bjc.6603879; Magnino A, 2005, ONCOLOGY-BASEL, V68, P493, DOI 10.1159/000086993; Mishra G, 2005, AM J CLIN ONCOL-CANC, V28, P345, DOI 10.1097/01.coc.0000159559.42311.c5; Moreb JS, 1995, LEUKEMIA LYMPHOMA, V20, P77, DOI 10.3109/10428199509054756; Nagasao J, 2003, ANN ANAT, V185, P211, DOI 10.1016/S0940-9602(03)80025-0; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Pozza ED, 2011, FREE RADICAL BIO MED, V50, P926, DOI 10.1016/j.freeradbiomed.2011.01.001; RAINEY JM, 1977, AM J PSYCHIAT, V134, P371; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; SAHOVIC EA, 1988, CANCER RES, V48, P1223; SAIF MW, 2011, JOP, V20, P12; Sauna ZE, 2004, MOL PHARMACOL, V65, P675, DOI 10.1124/mol.65.3.675; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Singh B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-82; Smeenk HG, 2007, ANN SURG, V246, P734, DOI 10.1097/SLA.0b013e318156eef3; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Takada T, 2002, CANCER, V95, P1685, DOI 10.1002/cncr.10831; Wang F, 2011, CANCER LETT, V300, P87, DOI 10.1016/j.canlet.2010.09.010; Wang WG, 2003, INT J CANCER, V104, P504, DOI 10.1002/ijc.10972; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774	49	38	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78130	10.1371/journal.pone.0078130	http://dx.doi.org/10.1371/journal.pone.0078130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194908	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000087
J	Shen, JJ; Xing, TJ; Yuan, HH; Liu, ZQ; Jin, ZP; Zhang, LP; Pei, YX				Shen, Jiejie; Xing, Tongji; Yuan, Huihong; Liu, Zhiqiang; Jin, Zhuping; Zhang, Liping; Pei, Yanxi			Hydrogen Sulfide Improves Drought Tolerance in Arabidopsis thaliana by MicroRNA Expressions	PLOS ONE			English	Article							NITRIC-OXIDE; ABSCISIC-ACID; STRESS; PROTEIN; GERMINATION; RESISTANCE; ALFALFA; ENZYMES; GROWTH	Hydrogen sulfide (H2S) is a gasotransmitter and plays an important role in many physiological processes in mammals. Studies of its functions in plants are attracting ever growing interest, for example, its ability to enhance drought resistance in Arabidopsis. A general role of microRNAs (miRNAs) in plant adaptive responses to drought stress has thereby increased our interest to delve into the possible interplay between H2S and miRNAs. Our results showed that treating wild type (WT) Arabidopsis seedlings with polyethylene glycol 8000 (PEG8000) to simulate drought stress caused an increase in production rate of endogenous H2S; and a significant transcriptional reformation of relevant miRNAs, which were also triggered by exogenous H2S in WT. When lcd mutants (with lower H2S production rate than WT) were treated with PEG8000, they showed lower levels of miRNA expression changes than WT. In addition, we detected significant changes in target gene expression of those miRNAs and the corresponding phenotypes in lcd, including less roots, retardation of leaf growth and development and greater superoxide dismutase (SOD) activity under drought stress. We thereby conclude that H2S can improve drought resistance through regulating drought associated miRNAs in Arabidopsis.	[Shen, Jiejie; Yuan, Huihong; Liu, Zhiqiang; Jin, Zhuping; Zhang, Liping; Pei, Yanxi] Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China; [Shen, Jiejie] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Tongji] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA; [Jin, Zhuping] North Univ China, Sch Chem Engn & Environm, Taiyuan, Shanxi, Peoples R China	Shanxi University; Zhejiang University; University of North Carolina; Appalachian State University; North University of China	Pei, YX (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Shanxi, Peoples R China.	peiyanxi@sxu.edu.cn	Zhang, Li/GWM-7501-2022; Pei, Yanxi/H-1501-2016	Pei, Yanxi/0000-0002-8428-3399	Natural Science Foundation of China [31372085]; National Natural Science Foundation of China [31300236]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31372085 to Yanxi Pei) and the National Natural Science Foundation of China (31300236 to Zhiqiang Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Alvarez C, 2010, PLANT PHYSIOL, V152, P656, DOI 10.1104/pp.109.147975; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Du JF, 2009, SCI CHINA SER C, V52, P771, DOI 10.1007/s11427-009-0099-z; Dugas DV, 2008, PLANT MOL BIOL, V67, P403, DOI 10.1007/s11103-008-9329-1; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jin ZP, 2013, PLANT PHYSIOL BIOCH, V62, P41, DOI 10.1016/j.plaphy.2012.10.017; Jin ZP, 2011, BIOCHEM BIOPH RES CO, V414, P481, DOI 10.1016/j.bbrc.2011.09.090; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li ZG, 2012, PLANT SCI, V185, P185, DOI 10.1016/j.plantsci.2011.10.006; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Liu ZQ, 2012, J EXP BOT, V63, P6371, DOI 10.1093/jxb/ers293; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Papenbrock J, 2007, PLANT BIOLOGY, V9, P582, DOI 10.1055/s-2007-965424; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Scaramagli S, 1999, J PLANT PHYSIOL, V155, P122, DOI 10.1016/S0176-1617(99)80151-5; Shen JJ, 2012, J APPL MICROBIOL, V113, P1130, DOI 10.1111/j.1365-2672.2012.05408.x; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Wang BL, 2010, PLANTA, V231, P1301, DOI 10.1007/s00425-010-1134-9; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wang YQ, 2012, PLANT SOIL, V351, P107, DOI 10.1007/s11104-011-0936-2; Xu J, 2010, PLANT PHYSIOL, V154, P1319, DOI 10.1104/pp.110.162982; Xu MJ, 2008, SCI CHINA SER C, V51, P676, DOI 10.1007/s11427-008-0095-8; Zeid IM, 2006, BIOL PLANTARUM, V50, P635, DOI 10.1007/s10535-006-0099-9; Zhang H, 2011, POSTHARVEST BIOL TEC, V60, P251, DOI 10.1016/j.postharvbio.2011.01.006; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhu JJ, 2006, J FOREST RES-JPN, V11, P319, DOI 10.1007/s10310-006-0214-y	37	96	110	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77047	10.1371/journal.pone.0077047	http://dx.doi.org/10.1371/journal.pone.0077047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194857	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000036
J	Sirinukunwattana, K; Savage, RS; Bari, MF; Snead, DRJ; Rajpoot, NM				Sirinukunwattana, Korsuk; Savage, Richard S.; Bari, Muhammad F.; Snead, David R. J.; Rajpoot, Nasir M.			Bayesian Hierarchical Clustering for Studying Cancer Gene Expression Data with Unknown Statistics	PLOS ONE			English	Article							MOLECULAR CLASSIFICATION; PREDICTION; RECURRENCE; SURVIVAL	Clustering analysis is an important tool in studying gene expression data. The Bayesian hierarchical clustering (BHC) algorithm can automatically infer the number of clusters and uses Bayesian model selection to improve clustering quality. In this paper, we present an extension of the BHC algorithm. Our Gaussian BHC (GBHC) algorithm represents data as a mixture of Gaussian distributions. It uses normal-gamma distribution as a conjugate prior on the mean and precision of each of the Gaussian components. We tested GBHC over 11 cancer and 3 synthetic datasets. The results on cancer datasets show that in sample clustering, GBHC on average produces a clustering partition that is more concordant with the ground truth than those obtained from other commonly used algorithms. Furthermore, GBHC frequently infers the number of clusters that is often close to the ground truth. In gene clustering, GBHC also produces a clustering partition that is more biologically plausible than several other state-of-the-art methods. This suggests GBHC as an alternative tool for studying gene expression data. The implementation of GBHC is available at https://sites.google.com/site/gaussianbhc/	[Sirinukunwattana, Korsuk; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Savage, Richard S.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Bari, Muhammad F.; Snead, David R. J.] Univ Hosp Coventry & Warwickshire, Dept Pathol, Coventry, W Midlands, England; [Bari, Muhammad F.; Snead, David R. J.] Warwick Med Sch, Div Reprod, Coventry, W Midlands, England; [Bari, Muhammad F.; Snead, David R. J.] Warwick Med Sch, Div Metab & Vasc Hlth, Coventry, W Midlands, England; [Rajpoot, Nasir M.] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar	University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick; Qatar University	Rajpoot, NM (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	N.M.Rajpoot@warwick.ac.uk		Rajpoot, Nasir/0000-0002-4706-1308; SNEAD, DAVID/0000-0002-0766-9650; Sirinukunwattana, Korsuk/0000-0002-3603-4435	Qatar National Research Fund [NPRP5-1345-1-228]; Department of Computer Science, University of Warwick; Medical Research Council [G0902104]; Higher Education Commission; Dow University of Health Science, Pakistan; West Midlands Lung Tissue Consortium; MRC [G0902104] Funding Source: UKRI	Qatar National Research Fund(Qatar National Research Fund (QNRF)); Department of Computer Science, University of Warwick; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Dow University of Health Science, Pakistan; West Midlands Lung Tissue Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Korsuk Sirinukunwattana is partly funded by Qatar National Research Fund grant no. NPRP5-1345-1-228 and partly by the Department of Computer Science, University of Warwick. RSS acknowledges the support of an Medical Research Council Biostatistics Fellowship (G0902104). MFB acknowledges the support of Higher Education Commission and Dow University of Health Science, Pakistan. Funding for the collection of lung tissue was from the West Midlands Lung Tissue Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango D, 2005, GASTROENTEROLOGY, V129, P874, DOI 10.1053/j.gastro.2005.06.066; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Cooke EJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-399; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Ghahramani Z., 2005, P 22 INT C MACH LEAR, P297, DOI DOI 10.1145/1102351.1102389; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Macnaughton-Smith PNM, 1965, SOME STAT OTHER NUME, V6; MacQueen J, 1967, P 5 BERKELEY S MATH, V1, DOI DOI 10.1007/S11665-016-2173-6; Matsui S, 2008, STAT MED, V27, P1106, DOI 10.1002/sim.2997; McLachlan G, 2000, FINITE MIXTURE MODEL, V299; MCQUITTY LL, 1960, EDUC PSYCHOL MEAS, V20, P55, DOI 10.1177/001316446002000106; Neal RM, 2000, J COMPUT GRAPH STAT, V9, P249, DOI 10.2307/1390653; Nutt CL, 2003, CANCER RES, V63, P1602; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rasmussen C, 2000, ADV NEURAL INFORM PR, V12, P2; Rasmussen CE, 2009, IEEE ACM T COMPUT BI, V6, P615, DOI 10.1109/TCBB.2007.70269; Salvador S, 2004, PROC INT C TOOLS ART, P576; Savage RS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-242; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sokal RR, 1963, PRINCIPLES NUMERICAL; Su AI, 2001, CANCER RES, V61, P7388; Van Der Maaten Laurens, 2009, ARTIF INTELL, P384; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045894; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977	43	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75748	10.1371/journal.pone.0075748	http://dx.doi.org/10.1371/journal.pone.0075748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194826	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000005
J	Lopez-Madrigal, S; Balmand, S; Latorre, A; Heddi, A; Moya, A; Gil, R				Lopez-Madrigal, Sergio; Balmand, Severine; Latorre, Amparo; Heddi, Abdelaziz; Moya, Andres; Gil, Rosario			How Does Tremblaya princeps Get Essential Proteins from Its Nested Partner Moranella endobia in the Mealybug Planoccocus citri?	PLOS ONE			English	Article							MECHANOSENSITIVE CHANNEL MSCL; ELONGATION-FACTOR TU; ESCHERICHIA-COLI; OSMOTIC-SHOCK; BETA-PROTEOBACTERIA; SIGNAL PEPTIDES; SECA ALLELES; ENDOSYMBIONTS; SYMBIONTS; EVOLUTION	Many insects maintain intracellular mutualistic symbiosis with a wide range of bacteria which are considered essential for their survival (primary or P-endosymbiont) and typically suffer drastic genome degradation. Progressive loss of P-endosymbiont metabolic capabilities could lead to the recruitment of co-existent facultative endosymbiont (secondary or S-endosymbiont), thus adding more complexity to the symbiotic system. Planococcus citri, among other mealybug species, harbors an unconventional nested endosymbiotic system where every Tremblaya princeps cell (beta-proteobacterium) harbors many Moranella endobia cells (gamma-proteobacterium). In this system, T. princeps possess one of the smallest prokaryote genome known so far. This extreme genome reduction suggests the supply of many metabolites and essential gene products by M. endobia. Although sporadic cell lysis is plausible, the bacterial participation on the regulation of the predicted molecular exchange (at least to some extent) cannot be excluded. Although the comprehensive analysis of the protein translocation ability of M. endobia PCVAL rules out the existence of specific mechanisms for the exportation of proteins from M. endobia to T. princeps, immunolocation of two M. endobia proteins points towards a non-massive but controlled protein provision. We propose a sporadic pattern for the predicted protein exportation events, which could be putatively controlled by the host and/or mediated by local osmotic stress.	[Lopez-Madrigal, Sergio; Latorre, Amparo; Moya, Andres; Gil, Rosario] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Paterna, Valencia, Spain; [Balmand, Severine; Heddi, Abdelaziz] INRA, INSA Lyon, UMR203 BF2I, Villeurbanne, France; [Latorre, Amparo; Moya, Andres] Fdn El Fomento Invest Sanitaria & Biomed Comunita, Area Genom & Salud, Valencia, Spain	University of Valencia; INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Gil, R (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Paterna, Valencia, Spain.	rosario.gil@uv.es	Gil, Rosario/R-6932-2018; Latorre, Amparo/E-4997-2015; Moya, Andrés/A-8190-2008	Gil, Rosario/0000-0002-9397-1003; Latorre, Amparo/0000-0002-9146-7284; Moya, Andrés/0000-0002-2867-1119	Ministerio de Economia y Competitividad, Spain [BFU2012-39816-C02-01]; Conselleria d'Educacio, Generalitat Valenciana, Spain [Prometeo/2009/092]; ImmunSymbArt [ANR-2010-BLAN-170101]; Ministerio de Educacion (Spain)	Ministerio de Economia y Competitividad, Spain; Conselleria d'Educacio, Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); ImmunSymbArt; Ministerio de Educacion (Spain)	Financial support was provided by grants BFU2012-39816-C02-01 (Ministerio de Economia y Competitividad, Spain; http://www.mineco.gob.es/) to A. Latorre, Prometeo/2009/092 (Conselleria d'Educacio, Generalitat Valenciana, Spain; http://www.cece.gva.es/es/) to A. Moya, and ANR-2010-BLAN-170101 (ImmunSymbArt; http://www.agence-nationale-recherche.fr/en/) to A. Heddi. S. Lopez-Madrigal is a recipient of a fellowship from the Ministerio de Educacion (Spain; http://www.mecd.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; BERRIER C, 1992, EUR J BIOCHEM, V206, P559, DOI 10.1111/j.1432-1033.1992.tb16960.x; BOST S, 1995, EMBO J, V14, P4412, DOI 10.1002/j.1460-2075.1995.tb00120.x; ELYAAGOUBI A, 1994, J BACTERIOL, V176, P7074, DOI 10.1128/JB.176.22.7074-7078.1994; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; FIKES JD, 1989, J BACTERIOL, V171, P402, DOI 10.1128/jb.171.1.402-409.1989; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatehouse LN, 2012, APPL ENVIRON MICROB, V78, P1187, DOI 10.1128/AEM.06340-11; Gil R, 2010, MICROBIOL MONOGR, V19, P207, DOI 10.1007/978-3-642-13615-3_11; Hantash FM, 1997, MICROBIOL-UK, V143, P147, DOI 10.1099/00221287-143-1-147; HARA E, 1990, INSECT BIOCHEM, V20, P429, DOI 10.1016/0020-1790(90)90064-2; HUIE JL, 1995, J BACTERIOL, V177, P3518, DOI 10.1128/jb.177.12.3518-3526.1995; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; JACOBSON GR, 1976, NATURE, V261, P23, DOI 10.1038/261023a0; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Khatib K, 2002, GENETICS, V162, P1031; Kono M, 2008, APPL ENVIRON MICROB, V74, P4175, DOI 10.1128/AEM.00250-08; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lopez-Madrigal S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-74; Lopez-Madrigal S, 2011, J BACTERIOL, V193, P5587, DOI 10.1128/JB.05749-11; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2011, CURR BIOL, V21, P1366, DOI 10.1016/j.cub.2011.06.051; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Oakley AJ, 1999, PROTEIN SCI, V8, P1915, DOI 10.1110/ps.8.10.1915; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005; Sukharev S, 1999, FASEB J, V13, pS55; Thao ML, 2002, APPL ENVIRON MICROB, V68, P3190, DOI 10.1128/AEM.68.7.3190-3197.2002; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Vasquez-Laslop N, 2001, J BACTERIOL, V183, P2399, DOI 10.1128/JB.183.8.2399-2404.2001; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	44	16	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77307	10.1371/journal.pone.0077307	http://dx.doi.org/10.1371/journal.pone.0077307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204799	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600030
J	Sagar, N; Pandey, AK; Gurbani, D; Khan, K; Singh, D; Chaudhari, BP; Soni, VP; Chattopadhyay, N; Dhawan, A; Bellare, JR				Sagar, Nitin; Pandey, Alok K.; Gurbani, Deepak; Khan, Kainat; Singh, Dhirendra; Chaudhari, Bhushan P.; Soni, Vivek P.; Chattopadhyay, Naibedya; Dhawan, Alok; Bellare, Jayesh R.			In-Vivo Efficacy of Compliant 3D Nano-Composite in Critical-Size Bone Defect Repair: a Six Month Preclinical Study in Rabbit	PLOS ONE			English	Article							CARBOXYMETHYL-CHITIN; INJECTABLE MATERIAL; FRACTURE HEMATOMA; TISSUE; SCAFFOLDS; CALCIFICATION; RECEPTOR; SURFACE	Bone defects above critical size do not heal completely by itself and thus represent major clinical challenge to reconstructive surgery. Numerous bone substitutes have already been used to promote bone regeneration, however their use, particularly for critical-sized bone defects along with their long term in vivo safety and efficacy remains a concern. The present study was designed to obtain a complete healing of critical-size defect made in the proximal tibia of New Zealand White rabbit, using nano-hydroxyapatite/gelatin and chemically carboxymethylated chitin (n-HA/gel/CMC) scaffold construct. The bone-implant interfaces and defect site healing was evaluated for a period up to 25 weeks using radiography, micro-computed tomography, fluorescence labeling, and histology and compared with respective SHAM (empty contra lateral control). The viscoelastic porous scaffold construct allows easy surgical insertion and post-operatively facilitate oxygenation and angiogenesis. Radiography of defect treated with scaffold construct suggested expedited healing at defect edges and within the defect site, unlike confined healing at edges of the SHAM sites. The architecture indices analyzed by micro-computed tomography showed a significant increase in percentage of bone volume fraction, resulted in reconciled cortico-trabecular bone formation at n-HA/gel/CMC constructs treated site (15.2% to 52.7%) when compared with respective SHAM (10.2% to 31.8%). Histological examination and fluorescence labeling revealed that the uniformly interconnected porous surface of scaffold construct enhanced osteoblasts' activity and mineralization. These preclinical data suggest that, n-HA/gel/CMC construct exhibit stimulation of bone's innate regenerative capacity, thus underscoring their use in guided bone regeneration.	[Sagar, Nitin; Soni, Vivek P.; Bellare, Jayesh R.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India; [Pandey, Alok K.; Gurbani, Deepak; Dhawan, Alok] Indian Inst Toxicol Res, Council Sci & Ind Res, Nanomat Toxicol Grp, Lucknow, Uttar Pradesh, India; [Singh, Dhirendra; Chaudhari, Bhushan P.] Indian Inst Toxicol Res, Regulatory Toxicol Grp, Council Sci & Ind Res, Lucknow, Uttar Pradesh, India; [Khan, Kainat; Chattopadhyay, Naibedya] Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res 12, Lucknow, Uttar Pradesh, India; [Dhawan, Alok] Ahmedabad Univ, Inst Life Sci, Ahmadabad, Gujarat, India; [Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Ahmedabad University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Bellare, JR (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	jb@iitb.ac.in	PANDEY, ALOK KUMAR/AAZ-7403-2021; Chattopadhyay, Naibedya/AAQ-3213-2021; Bellare, Jayesh/AAO-8713-2020; Dhawan, Alok/AAF-7376-2019; Chattopadhyay, Naibedya/AAF-2058-2019; Dhawan, Alok/A-6588-2010	PANDEY, ALOK KUMAR/0000-0001-9005-2477; Chattopadhyay, Naibedya/0000-0003-2473-0246; Bellare, Jayesh/0000-0002-6792-8327; Dhawan, Alok/0000-0002-4405-9608; GURBANI, DEEPAK/0000-0002-0982-7173	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology (DST); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This study was supported by the Council of Scientific and Industrial Research (CSIR), Department of Science and Technology (DST) and Department of Biotechnology (DBT), Government of India, for providing fellowship and equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A; Aviv-Gavriel M, 2013, LANGMUIR, V29, P683, DOI 10.1021/la303693d; Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037; BLEEK K, ACTA BIOMATERIALIA; BOLANDER ME, 1994, BONE FORMATION REPAI, P117; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022; Chirila TV, 2007, ACTA BIOMATER, V3, P95, DOI 10.1016/j.actbio.2006.07.011; Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019; Da H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054838; Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236; Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049; Deng M, 2011, ADV FUNCT MATER, V21, P2641, DOI 10.1002/adfm.201100275; Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2; He Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042525; Jayakumar R, 2011, INT J MOL SCI, V12, P1876, DOI 10.3390/ijms12031876; Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042; Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083; Lalwani G, 2013, BIOMACROMOLECULES, V14, P900, DOI 10.1021/bm301995s; Langstaff S, 2001, BIOMATERIALS, V22, P135, DOI 10.1016/S0142-9612(00)00139-3; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Li M, 2003, J BONE MINER RES, V18, P2033, DOI 10.1359/jbmr.2003.18.11.2033; Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022; Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982; Liu X, 2009, BIOMATERIALS, V30, P2252, DOI 10.1016/j.biomaterials.2008.12.068; Lu Chuanyong, 2006, Iowa Orthop J, V26, P17; Mahony O, 2010, ADV FUNCT MATER, V20, P3835, DOI 10.1002/adfm.201000838; Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; MAROTTI G, 1993, CALCIFIED TISSUE INT, V53, pS47, DOI 10.1007/BF01673402; Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760; MIZUNO K, 1990, J BONE JOINT SURG BR, V72, P822, DOI 10.1302/0301-620X.72B5.2211764; MUNTING E, 1993, J MATER SCI-MATER M, V4, P337, DOI 10.1007/BF00122290; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Perren S. M., 1980, CURRENT CONCEPTS INT, P63; Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813; Poon YF, 2007, ADV FUNCT MATER, V17, P2139, DOI 10.1002/adfm.200600420; Rahn BA, 2002, BONE CLIN ORTHOPEDIC, P287; Sagar N, 2012, J BIOMED MATER RES B, V100B, P624, DOI 10.1002/jbm.b.31983; SCHILLER AL, 1988, PATHOLOGY, P1304; Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040; Sharan K, 2011, J BONE MINER RES, V26, P2096, DOI 10.1002/jbmr.434; Sharma S, 2009, J TISSUE ENG REGEN M, V3, P501, DOI 10.1002/term.186; Street J, 2000, CLIN ORTHOP RELAT R, P224, DOI 10.1097/00003086-200009000-00033; Tanase CE, 2012, J BIOMED MATER RES B, V100B, P700, DOI 10.1002/jbm.b.32502; Tokura S, 2001, BIOMACROMOLECULES, V2, P417, DOI 10.1021/bm0001345; Uda H, 2006, J PLAST RECONSTR AES, V59, P188, DOI 10.1016/j.bjps.2004.11.022; Lluch AV, 2009, COLLOID SURFACE B, V70, P218, DOI 10.1016/j.colsurfb.2008.12.027; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C; Wan ACA, 1998, BIOMATERIALS, V19, P1309; Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X; Wang GC, 2011, ACS APPL MATER INTER, V3, P1692, DOI 10.1021/am2002185; Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9; WEINER S, 1992, FASEB J, V6, P879, DOI 10.1096/fasebj.6.3.1740237; Yu JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057564	56	11	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77578	10.1371/journal.pone.0077578	http://dx.doi.org/10.1371/journal.pone.0077578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204879	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300104
J	Walther, BD; Kingsford, MJ; McCulloch, MT				Walther, Benjamin D.; Kingsford, Michael J.; McCulloch, Malcolm T.			Environmental Records from Great Barrier Reef Corals: Inshore versus Offshore Drivers	PLOS ONE			English	Article							UPWELLING ACTIVITY; BURDEKIN RIVER; IN-SITU; PACIFIC; WATER; SEA; VARIABILITY; DYNAMICS; PROXIES; BARIUM	The biogenic structures of stationary organisms can be effective recorders of environmental fluctuations. These proxy records of environmental change are preserved as geochemical signals in the carbonate skeletons of scleractinian corals and are useful for reconstructions of temporal and spatial fluctuations in the physical and chemical environments of coral reef ecosystems, including The Great Barrier Reef (GBR). We compared multi-year monitoring of water temperature and dissolved elements with analyses of chemical proxies recorded in Porites coral skeletons to identify the divergent mechanisms driving environmental variation at inshore versus offshore reefs. At inshore reefs, water Ba/Ca increased with the onset of monsoonal rains each year, indicating a dominant control of flooding on inshore ambient chemistry. Inshore multi-decadal records of coral Ba/Ca were also highly periodic in response to flood-driven pulses of terrigenous material. In contrast, an offshore reef at the edge of the continental shelf was subject to annual upwelling of waters that were presumed to be richer in Ba during summer months. Regular pulses of deep cold water were delivered to the reef as indicated by in situ temperature loggers and coral Ba/Ca. Our results indicate that although much of the GBR is subject to periodic environmental fluctuations, the mechanisms driving variation depend on proximity to the coast. Inshore reefs are primarily influenced by variable freshwater delivery and terrigenous erosion of catchments, while offshore reefs are dominated by seasonal and inter-annual variations in oceanographic conditions that influence the propensity for upwelling. The careful choice of sites can help distinguish between the various factors that promote Ba uptake in corals and therefore increase the utility of corals as monitors of spatial and temporal variation in environmental conditions.	[Walther, Benjamin D.] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Walther, Benjamin D.; McCulloch, Malcolm T.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Kingsford, Michael J.] James Cook Univ, Sch Marine & Trop Biol, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [McCulloch, Malcolm T.] Univ Western Australia, Sch Earth & Environm, Australian Res Council, Ctr Excellence Coral Reef Studies, Crawley, WA, Australia	University of Texas System; University of Texas Austin; Australian National University; James Cook University; University of Western Australia	Walther, BD (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	bwalther@utexas.edu	Walther, Benjamin/W-2681-2019; Kingsford, Michael J/C-2015-2008; Walther, Benjamin D/A-7284-2009; McCulloch, Malcolm Thomas/C-3651-2009	Kingsford, Michael J/0000-0003-1704-6198; Walther, Benjamin D/0000-0002-2902-4001; McCulloch, Malcolm Thomas/0000-0003-1538-1558	ARC Centre of Excellence for Coral Reef Studies; Australian Research Council	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council)	BDW was supported by the ARC Centre of Excellence for Coral Reef Studies (http://www.coralcoe.org.au/) and Australian Research Council (http://www.arc.gov.au/) funds awarded to MJK and MTM, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2006JC003979; Alibert C, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004263; ANDREWS JC, 1986, CONT SHELF RES, V6, P491, DOI 10.1016/0278-4343(86)90020-8; ANDREWS JC, 1982, MAR ECOL PROG SER, V8, P257, DOI 10.3354/meps008257; Asami R, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002555; Ayliffe LK, 2004, CONT SHELF RES, V24, P2343, DOI 10.1016/j.csr.2004.07.013; Berkelmans R, 2010, LIMNOL OCEANOGR, V55, P2634, DOI 10.4319/lo.2010.55.6.2634; Brinkman R, 2002, ESTUAR COAST SHELF S, V54, P655, DOI 10.1006/ecss.2001.0850; Bruland K.W., 2004, TREATISE GEOM, V6, P23; Carricart-Ganivet JP, 2007, J EXP MAR BIOL ECOL, V344, P67, DOI 10.1016/j.jembe.2006.12.018; CHAN LH, 1976, EARTH PLANET SC LETT, V32, P258, DOI 10.1016/0012-821X(76)90066-2; Cherubin LM, 2008, CORAL REEFS, V27, P503, DOI 10.1007/s00338-007-0348-1; Darwin C., 1842, STRUCTURE DISTRIBUTI; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Fallon SJ, 1999, EARTH PLANET SC LETT, V172, P221, DOI 10.1016/S0012-821X(99)00200-9; Furnas M, 2011, CONT SHELF RES, V31, P1967, DOI 10.1016/j.csr.2011.09.007; Gaetani GA, 2006, GEOCHIM COSMOCHIM AC, V70, P4617, DOI 10.1016/j.gca.2006.07.008; Hanson CE, 2005, CONT SHELF RES, V25, P1561, DOI 10.1016/j.csr.2005.04.003; Hatcher BG, 1997, CORAL REEFS, V16, pS77, DOI 10.1007/s003380050244; Inoue M, 2010, MAR GEOL, V271, P303, DOI 10.1016/j.margeo.2010.02.016; Isdale PJ, 1998, HOLOCENE, V8, P1, DOI 10.1191/095968398670905088; Jupiter S, 2008, CORAL REEFS, V27, P887, DOI 10.1007/s00338-008-0422-3; KING B, 2002, 44 CRC REEF RES CTR; Lambrechts J, 2008, ESTUAR COAST SHELF S, V79, P143, DOI 10.1016/j.ecss.2008.03.016; LEA DW, 1989, NATURE, V340, P373, DOI 10.1038/340373a0; Llewellyn LE, 2012, GEOCHIM COSMOCHIM AC, V83, P263, DOI 10.1016/j.gca.2011.12.028; Luick JL, 2007, CONT SHELF RES, V27, P757, DOI 10.1016/j.csr.2006.11.020; Marshall JF, 2002, GEOCHIM COSMOCHIM AC, V66, P3263, DOI 10.1016/S0016-7037(02)00926-2; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Montaggioni LF, 2006, PALAEOGEOGR PALAEOCL, V237, P436, DOI 10.1016/j.palaeo.2005.12.018; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Orr JP, 1933, PHYS CHEM CONDITIONS, VII, P37; Ourbak T, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001064; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Pfeiffer M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000964; Reuer MK, 2003, EARTH PLANET SC LETT, V210, P437, DOI [10.1016/S0012-821X(03)00162-6, 10.1016/S0012-821X(03)-00162-6]; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Shen GT, 1992, PALEOCEANOGRAPHY, V7, P563, DOI 10.1029/92PA01825; Sinclair DJ, 2011, GEOCHIM COSMOCHIM AC, V75, P5101, DOI 10.1016/j.gca.2011.05.012; Sinclair DJ, 2004, PALAEOGEOGR PALAEOCL, V214, P155, DOI 10.1016/j.palaeo.2004.07.028; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SINCLAIR DJ, 1999, THESIS AUSTR NATL U; Steinberg C., 2007, CLIMATE CHANGE GREAT, P51; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tudhope AW, 1996, PALAIOS, V11, P347, DOI 10.2307/3515245; Walther BD, 2012, J FISH BIOL, V81, P796, DOI 10.1111/j.1095-8649.2012.03371.x; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P49; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P65; Wolanski E., 2001, OCEANOGRAPHIC PROCES; Wolter K., 1998, WEATHER, V53, P315, DOI DOI 10.1002/J.1477-8696.1998.TB06408.X; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Wyatt ASJ, 2010, MAR ECOL PROG SER, V405, P113, DOI 10.3354/meps08508; Wyndham T, 2004, GEOCHIM COSMOCHIM AC, V68, P2067, DOI 10.1016/j.gca.2003.11.004; Zhang ZL, 2011, ECOL MODEL, V222, P1456, DOI 10.1016/j.ecolmodel.2011.01.014	58	28	28	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77091	10.1371/journal.pone.0077091	http://dx.doi.org/10.1371/journal.pone.0077091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204743	Green Accepted, Green Published, gold			2022-12-25	WOS:000326029300082
J	Hoang, T; Smith, MD; Jelokhani-Niaraki, M				Hoang, Tuan; Smith, Matthew D.; Jelokhani-Niaraki, Masoud			Expression, Folding, and Proton Transport Activity of Human Uncoupling Protein-1 (UCP1) in Lipid Membranes EVIDENCE FOR ASSOCIATED FUNCTIONAL FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiolipin; Circular Dichroism (CD); Protein Folding; Protein Self-assembly; Proton Transport; Uncoupling Proteins; Mitochondrial Membrane Proteins; Protein Reconstitution; Proteoliposomes; Structure-Function Relationship	ESSENTIAL REQUIREMENT; OUTER-MEMBRANE; CARDIOLIPIN; CARRIER; TRANSMEMBRANE; CD; MITOCHONDRIA; CONFORMATION; TROPOMYOSIN; SURFACTANT	Background: UCP1 transports protons across the inner mitochondrial membrane and generates heat. Results: Oligomeric forms of UCP1 transported protons across phospholipid bilayers and the conformation and proton transport activity were affected by cardiolipin. Conclusion: UCP1 is functional in its monomeric and associated forms in membranes. Significance: Existence of functional associated forms of UCP1 provides insights into the mechanism of action of UCPs in mitochondria. Uncoupling protein-1 (UCP1) is abundantly expressed in the mitochondrial inner membrane of brown adipose tissues and has an important role in heat generation, mediated by its proton transport function. The structure and function of UCP1 are not fully understood, partially due to the difficulty in obtaining native-like folded proteins in vitro. In this study, using the auto-induction method, we have successfully expressed UCP1 in Escherichia coli membranes in high yield. Overexpressed UCP1 in bacterial membranes was extracted using mild detergents and reconstituted into phospholipid bilayers for biochemical studies. UCP1 was folded in octyl glucoside, as indicated by its high helical content and binding to ATP, a known UCP1 proton transport inhibitor. Reconstituted UCP1 in phospholipid vesicles also exhibited highly helical structures and proton transport that is activated by fatty acids and inhibited by purine nucleotides. Self-associated functional forms of UCP1 in lipid membranes were observed for the first time. The self-assembly of UCP1 into tetramers was unambiguously characterized by circular dichroism and fluorescence spectroscopy, analytical ultracentrifugation, and semi-native gel electrophoresis. In addition, the mitochondrial lipid cardiolipin stabilized the structure of associated UCP1 and enhanced the proton transport activity of the protein. The existence of the functional oligomeric states of UCP1 in the lipid membranes has important implications for understanding the structure and proton transport mechanism of this protein in brown adipose tissues as well as structure-function relationships of other mammalian UCPs in other tissues.	Wilfrid Laurier Univ, Dept Chem, Waterloo, ON N2L 3C5, Canada; [Smith, Matthew D.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada; [Hoang, Tuan; Smith, Matthew D.; Jelokhani-Niaraki, Masoud] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada	Wilfrid Laurier University; Wilfrid Laurier University; University of Guelph	Jelokhani-Niaraki, M (corresponding author), Wilfrid Laurier Univ, 75 Univ Ave West, Waterloo, ON N2L 3C5, Canada.	mjelokhani@wlu.ca	Smith, Matthew/M-4726-2014; Hoang, Tuan/E-7323-2015	Smith, Matthew/0000-0002-2855-5126; Hoang, Tuan/0000-0003-3204-0579	Canada Foundation for Innovation (CFI); Natural Sciences and Engineering Research Council of Canada (NSERC) [CFI 6786, NSERC 250119, CFI 11292, NSERC 312143]	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canada Foundation for Innovation (CFI) and the Natural Sciences and Engineering Research Council of Canada (NSERC) CFI 6786 and NSERC 250119 (to M. J. N.) and CFI 11292 and NSERC 312143 (to M. D. S.).	Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Blesneac I, 2012, BBA-BIOMEMBRANES, V1818, P798, DOI 10.1016/j.bbamem.2011.12.016; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703; DeLano W, 2002, PYMOL 0 99; Douette P, 2005, BIOCHEM BIOPH RES CO, V333, P686, DOI 10.1016/j.bbrc.2005.05.164; Douette P, 2004, BIOCHEM J, V380, P139, DOI 10.1042/BJ20031957; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5; Hoang T, 2012, BIOCHEMISTRY-US, V51, P4004, DOI 10.1021/bi3003378; Ivanova MV, 2010, BIOCHEMISTRY-US, V49, P512, DOI 10.1021/bi901742g; Jaburek M, 2003, J BIOL CHEM, V278, P25825, DOI 10.1074/jbc.M302126200; Jastroch M, 2012, METHODS MOL BIOL, V810, P153, DOI 10.1007/978-1-61779-382-0_10; Jelokhani-Niaraki M, 2008, BIOCHEM J, V411, P593, DOI 10.1042/bj20071326; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Knyght I., 2012, J BIOL RES HONG KONG, V1, P12; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Laue T.M., 1992, THEORY COMPUTER AIDE, P90; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; LIN CS, 1980, FEBS LETT, V113, P304, DOI 10.1016/0014-5793(80)80614-4; Nicholls D G, 1978, Experientia Suppl, V32, P89; NOEL H, 1986, EUR J BIOCHEM, V155, P99, DOI 10.1111/j.1432-1033.1986.tb09463.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rupprecht A, 2010, BIOPHYS J, V98, P1503, DOI 10.1016/j.bpj.2009.12.4301; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Zhou QJ, 2010, PROG BIOCHEM BIOPHYS, V37, P56, DOI 10.3724/SP.J.1206.2009.00531	46	32	36	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36244	36258		10.1074/jbc.M113.509935	http://dx.doi.org/10.1074/jbc.M113.509935			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196960	Green Published, hybrid			2022-12-25	WOS:000328883400007
J	Stein, KWH; Werner, J				Stein, Koen W. H.; Werner, Jan			Preliminary Analysis of Osteocyte Lacunar Density in Long Bones of Tetrapods: All Measures Are Bigger in Sauropod Dinosaurs	PLOS ONE			English	Article							GROWTH-PATTERNS; EARLY EVOLUTION; CORTICAL BONE; BODY-SIZE; HISTOLOGY; RATES; OSTEOBLASTS; PARAMETERS; AMPHIBIANS; STRATEGIES	Osteocytes harbour much potential for paleobiological studies. Synchrotron radiation and spectroscopic analyses are providing fascinating data on osteocyte density, size and orientation in fossil taxa. However, such studies may be costly and time consuming. Here we describe an uncomplicated and inexpensive method to measure osteocyte lacunar densities in bone thin sections. We report on cell lacunar densities in the long bones of various extant and extinct tetrapods, with a focus on sauropodomorph dinosaurs, and how lacunar densities can help us understand bone formation rates in the iconic sauropod dinosaurs. Ordinary least square and phylogenetic generalized least square regressions suggest that sauropodomorphs have lacunar densities higher than scaled up or comparably sized mammals. We also found normal mammalian-like osteocyte densities for the extinct bovid Myotragus, questioning its crocodilian-like physiology. When accounting for body mass effects and phylogeny, growth rates are a main factor determining the density of the lacunocanalicular network. However, functional aspects most likely play an important role as well. Observed differences in cell strategies between mammals and dinosaurs likely illustrate the convergent nature of fast growing bone tissues in these groups.	[Stein, Koen W. H.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Werner, Jan] Johannes Gutenberg Univ Mainz, Inst Zool, Abt Okol, Mainz, Germany	University of Bonn; Johannes Gutenberg University of Mainz	Stein, KWH (corresponding author), Leibniz Inst Res Evolut & Biodivers Berlin, Museum Nat Kunde, Berlin, Germany.	koen_stein@yahoo.co.uk	Stein, Koen HW/G-5731-2015	Stein, Koen/0000-0003-4246-3225	German Research Foundation (DFG) as part of the Research Unit FOR 533 "Biology of the Sauropod Dinosaurs''	German Research Foundation (DFG) as part of the Research Unit FOR 533 "Biology of the Sauropod Dinosaurs''	This work was supported by the German Research Foundation (DFG) as part of the third funding period of the Research Unit FOR 533 "Biology of the Sauropod Dinosaurs''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2008, GEODIVERSITAS, V30, P345; Amer SAM, 2008, GENES GENET SYST, V83, P275, DOI 10.1266/ggs.83.275; Beck RMD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-93; Bennett SC, 2013, HIST BIOL, V25, P545, DOI 10.1080/08912963.2012.725727; Benton Michael J., 2009, P35; Berman DS, 2003, J PALEONTOL, V77, P172, DOI 10.1666/0022-3360(2003)077<0172:HOTAAS>2.0.CO;2; Bromage TG, 2009, CALCIFIED TISSUE INT, V84, P388, DOI 10.1007/s00223-009-9221-2; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; CANE V, 1982, CALCIFIED TISSUE INT, V34, P558, DOI 10.1007/BF02411304; Cao L, 2011, J BONE MINER METAB, V29, P662, DOI 10.1007/s00774-011-0268-6; Carter Y, 2013, BONE, V52, P126, DOI 10.1016/j.bone.2012.09.010; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Castanet J, 2004, J ZOOL, V263, P31, DOI 10.1017/S0952836904004844; CASTANET J, 1990, ANN SCI NAT ZOOL, V11, P191; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Chinsamy-Turan A., 2012, FORERUNNERS MAMMALS; Clack, 2012, GAINING GROUND ORIGI; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Francillon-Vieillot H., 1990, P471; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Ganse Bergita, 2011, P105; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hernandez CJ, 2004, BONE, V35, P1095, DOI 10.1016/j.bone.2004.07.002; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Ishimoto T, 2013, J BONE MINER RES, V28, P1170, DOI 10.1002/jbmr.1825; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Kohler M, 2009, P NATL ACAD SCI USA, V106, P20354, DOI 10.1073/pnas.0813385106; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Ma YL, 2008, J BIOMECH, V41, P1324, DOI 10.1016/j.jbiomech.2008.01.017; Maddison WP, 2011, MESQUITE MODULAR SYS; Maddison WP., 2006, PAIRWISE COMP PACKAG; Marjanovic D, 2013, GEODIVERSITAS, V35, P207, DOI 10.5252/g2013n1a8; Marotti G., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P133; Marotti G, 1990, ITAL J MIN ELECTROL, V4, P93; Matsugaki A, 2012, BIOMATERIALS, V33, P7327, DOI 10.1016/j.biomaterials.2012.06.022; Mulcahy DG, 2010, MOL PHYLOGENET EVOL, V65, P974; Mullender MG, 1996, BONE, V18, P109, DOI 10.1016/8756-3282(95)00444-0; Mullender MG, 1996, J ORTHOPAED RES, V14, P972, DOI 10.1002/jor.1100140618; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Niven JE, 2007, TRENDS ECOL EVOL, V22, P57, DOI 10.1016/j.tree.2006.11.009; Noble BS, 2008, ARCH BIOCHEM BIOPHYS, V473, P106, DOI 10.1016/j.abb.2008.04.009; Padian K, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P1; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Parfitt A. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P499; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Petermann H, 2013, J ANAT, V222, P419, DOI 10.1111/joa.12028; Pisani D, 2002, P ROY SOC B-BIOL SCI, V269, P915, DOI 10.1098/rspb.2001.1942; Prondvai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031392; Qiu S, 2002, BONE, V31, P709, DOI 10.1016/S8756-3282(02)00907-9; R Development Core Team, 2012, R LANG ENV STAT COMP; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Remaggi Francesca, 1998, Italian Journal of Anatomy and Embryology, V103, P145; Remes K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006924; Rensberger JM, 2000, NATURE, V406, P619, DOI 10.1038/35020550; Sanchez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056992; Sander P. M., 2011, BIOL SAUROPOD DINOSA; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Sereno PC, 2007, SPEC PAP PALAEONTOL, P261; Shelton CD, T ROYAL SOC EDINBURG; Skedros JG, 2005, CELLS TISSUES ORGANS, V180, P215, DOI 10.1159/000088938; Skedros JG, 2003, ANAT REC PART A, V273A, P609, DOI 10.1002/ar.a.10073; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Stein K, 2013, BIOL REV, V89, P24, DOI [DOI 10.1111/BRV.12041, 10.1111/brv.12041]; Stein K., 2009, METHODS FOSSIL PREPA, P69; Stein K, 2010, P NATL ACAD SCI USA, V107, P9258, DOI 10.1073/pnas.1000781107; Stoinski Stefan, 2011, P94; Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017; Van der Geer A., 2010, EVOLUTION ISLAND MAM; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Werning S, 2011, J VERTEBR PALEONTOL, V31, P213; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; Woodward HN, 2011, J HERPETOL, V45, P339; Woodward HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023339; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9	99	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77109	10.1371/journal.pone.0077109	http://dx.doi.org/10.1371/journal.pone.0077109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204748	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500016
J	Garziera, M; Canzonieri, V; Cannizzaro, R; Geremia, S; Caggiari, L; De Zorzi, M; Maiero, S; Orzes, E; Perin, T; Zanussi, S; De Paoli, P; De Re, V				Garziera, Marica; Canzonieri, Vincenzo; Cannizzaro, Renato; Geremia, Silvano; Caggiari, Laura; De Zorzi, Mariangela; Maiero, Stefania; Orzes, Enrico; Perin, Tiziana; Zanussi, Stefania; De Paoli, Paolo; De Re, Valli			Identification and Characterization of CDH1 Germline Variants in Sporadic Gastric Cancer Patients and in Individuals at Risk of Gastric Cancer	PLOS ONE			English	Article							E-CADHERIN GENE; CELL-CELL ADHESION; EARLY-ONSET; CRYSTAL-STRUCTURES; MOLECULAR-BIOLOGY; MUTATIONS; PROTEIN; POLYMORPHISMS; EXPRESSION; FREQUENCY	Objective: To screen and characterize germline variants for E-cadherin (CDH1) in non-hereditary gastric cancer (GC) patients and in subjects at risk of GC. Methods: 59 GCs, 59 first degree relatives (FDRs) of GC, 20 autoimmune metaplastic atrophic gastritis (AMAGs) and 52 blood donors (BDs) were analyzed for CDH1 by direct sequencing, structural modelling and bioinformatics. Functional impact on splicing was assessed for intronic mutations. E-cadherin/beta-catenin immunohistochemical staining and E-cadherin mRNA quantification using RT-PCR were performed. Results: In GCs, 4 missense variants (p.G274S; p.A298T; p.T470I; p.A592T), 1 mutation in the 59UTR (-71C>G) and 1 mutation in the intronic IVS12 (c.1937-13T>C) region were found. First pathogenic effect of p.A298T mutation was predicted by protein 3D modelling. The novel p.G274S mutation showed a no clear functional significance. Moreover, first, intronic IVS12 (c.1937-13T>C) mutation was demonstrated to lead to an aberrant CDH1 transcript with exon 11 deletion. This mutation was found in 2 GCs and in 1 BD. In FDRs, we identified 4 variants: the polymorphic (p.A592T) and 3 mutations in untranslated regions with unidentified functional role except for the 59UTR (-54G>C) that had been found to decrease CDH1 transcription. In AMAGs, we detected 2 alterations: 1 missense (p.A592T) and 1 novel variant (IVS1 (c.48+7C>T)) without effect on CDH1 splicing. Several silent and polymorphic substitutions were found in all the groups studied. Conclusions: Overall our study improves upon the current characterization of CDH1 mutations and their functional role in GC and in individuals at risk of GC. Mutations found in untranslated regions and data on splicing effects deserve a particular attention like associated with a reduced E-cadherin amount. The utility of CDH1 screening, in addition to the identification of other risk factors, could be useful for the early detection of GC in subjects at risk (i.e. FDRs and AMAGs), and warrants further study.	[Garziera, Marica; Caggiari, Laura; De Zorzi, Mariangela; De Re, Valli] Natl Canc Inst, Dept Translat Res, CRO, Aviano, Pordenone, Italy; [Canzonieri, Vincenzo; Perin, Tiziana] Natl Canc Inst, Pathol Unit, CRO, Aviano, Pordenone, Italy; [Cannizzaro, Renato; Maiero, Stefania; Orzes, Enrico] Natl Canc Inst, Gastroenterol Unit, CRO, Aviano, Pordenone, Italy; [Geremia, Silvano] Univ Trieste, Dept Chem Sci, CEB, Trieste, Italy; [Zanussi, Stefania] Natl Canc Inst, Microbiol Immunol & Virol Unit, CRO, Aviano, Pordenone, Italy; [De Paoli, Paolo] Natl Canc Inst, CRO, Aviano, Pordenone, Italy	IRCCS Aviano (CRO); IRCCS Aviano (CRO); IRCCS Aviano (CRO); University of Trieste; IRCCS Aviano (CRO); IRCCS Aviano (CRO)	De Re, V (corresponding author), Natl Canc Inst, Dept Translat Res, CRO, Aviano, Pordenone, Italy.	vdere@cro.it	De Paoli, Paolo/AAG-2586-2021; Cannizzaro, Renato/V-3804-2018; CAGGIARI, LAURA/Q-6125-2019; De Zorzi, Mariangela/AAA-8832-2019; Maiero, Stefania/ABD-6092-2020; Geremia, Silvano/E-7324-2011; De Re, Valli/K-4121-2016; DE RE, VALLI/AAA-1374-2019; Perin, Tiziana/AAC-2403-2020; Canzonieri, Vincenzo/AAA-7951-2019; Canzonieri, Vincenzo/Z-5933-2019; Zanussi, Stefania/I-2558-2018; Garziera, Marica/S-8383-2019	Cannizzaro, Renato/0000-0002-2020-222X; CAGGIARI, LAURA/0000-0003-1651-6653; De Zorzi, Mariangela/0000-0002-3794-270X; Maiero, Stefania/0000-0001-5085-1549; Geremia, Silvano/0000-0002-0711-5113; De Re, Valli/0000-0001-6100-9373; DE RE, VALLI/0000-0001-6100-9373; Perin, Tiziana/0000-0002-9823-0167; Canzonieri, Vincenzo/0000-0001-6010-0976; Zanussi, Stefania/0000-0003-0608-9766; Garziera, Marica/0000-0001-6902-210X; De Paoli, Paolo/0000-0002-9502-1781	Associazione Italiana per la Ricerca sul Cancro (AIRC) [10266]; AIRC Cannizzaro Special Program Molecular Clinical Oncology [12214]; Direzione Centrale del Lavoro, Formazione, Universita e Ricerca Della Regione Autonoma Friuli Venezia Giulia, Codice Progetto [200502027001]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC Cannizzaro Special Program Molecular Clinical Oncology(Fondazione AIRC per la ricerca sul cancro); Direzione Centrale del Lavoro, Formazione, Universita e Ricerca Della Regione Autonoma Friuli Venezia Giulia, Codice Progetto	Associazione Italiana per la Ricerca sul Cancro (AIRC De Re N. 10266 and AIRC Cannizzaro Special Program Molecular Clinical Oncology 5x1000 N. 12214), and Direzione Centrale del Lavoro, Formazione, Universita e Ricerca Della Regione Autonoma Friuli Venezia Giulia, Codice Progetto 200502027001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 2001, J MED GENET, V38, P49, DOI 10.1136/jmg.38.1.49; Bacani JT, 2006, J MED GENET, V43, P867, DOI 10.1136/jmg.2006.043133; Barber M, 2006, BEST PRACT RES CL GA, V20, P721, DOI 10.1016/j.bpg.2006.03.014; Becker K F, 1999, Hum Mutat, V13, P171, DOI 10.1002/(SICI)1098-1004(1999)13:2<171::AID-HUMU14>3.0.CO;2-Z; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Carneiro F, 2010, INT J SURG PATHOL, V18, p33S, DOI 10.1177/1066896910366463; Chen QH, 2013, WORLD J GASTROENTERO, V19, P909, DOI 10.3748/wjg.v19.i6.909; Correia JS, 2012, PLOS ONE, V7; Corso G, 2013, J CLIN ONCOL, V31, P868, DOI 10.1200/JCO.2012.44.4612; Corso G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-8; Corso G, 2011, EUR J CANCER, V47, P631, DOI 10.1016/j.ejca.2010.10.011; De Re V, 2010, TUMOR BIOL, V31, P23, DOI 10.1007/s13277-009-0004-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fitzgerald RC, 2010, J MED GENET, V47, P436, DOI 10.1136/jmg.2009.074237; Garziera M, CLIN EXPT M IN PRESS; Graziano F, 2004, ANN ONCOL, V15, P489, DOI 10.1093/annonc/mdh108; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Guilford P, 2007, HERED CANCER CLIN PR, V5, P183, DOI 10.1186/1897-4287-5-4-183; Guilford P, 2010, GASTRIC CANCER, V13, P1, DOI 10.1007/s10120-009-0531-x; Hamilton SR, 2000, PATHOLOGY GENETICS T, P43; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Ikonen T, 2001, CLIN CANCER RES, V7, P3465; Inghelmann R, 2007, TUMORI J, V93, P367; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Jordaan G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-88; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAUREN P, 1991, SCAND J GASTROENTERO, V26, P160; Lee YT, 2005, GUT, V54, P1541, DOI 10.1136/gut.2004.055772; Lim L, 2005, J CLIN ONCOL, V23, P6220, DOI 10.1200/JCO.2005.11.593; Livingston RJ, 2005, ES15478 NIEHS DEP GE; Martorelli D, 2012, CLIN CANCER RES, V18, P4080, DOI 10.1158/1078-0432.CCR-12-0763; Masciari S, 2007, J MED GENET, V44, P726, DOI 10.1136/jmg.2007.051268; Mateus AR, 2009, EXP CELL RES, V315, P1393, DOI 10.1016/j.yexcr.2009.02.020; Milne AN, 2010, WORLD J GASTRO ONCOL, V2, P59, DOI 10.4251/wjgo.v2.i2.59; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Murakami M, 2013, J PHARMACOL SCI, V121, P305, DOI 10.1254/jphs.12191FP; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nakamura A, 2002, MUTAT RES-FUND MOL M, V502, P19, DOI 10.1016/S0027-5107(02)00024-6; Oliveira C, 2002, HUM MUTAT, V19, P510, DOI 10.1002/humu.10068; Oliveira C, 2009, BEST PRACT RES CL GA, V23, P147, DOI 10.1016/j.bpg.2009.02.003; Oliveira C, 2009, GASTROENTEROLOGY, V136, P2137, DOI 10.1053/j.gastro.2009.02.065; Paredes J, 2012, BBA-REV CANCER, V1826, P297, DOI 10.1016/j.bbcan.2012.05.002; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; Pedrazzani C, 2007, SURGERY, V142, P645, DOI 10.1016/j.surg.2007.06.006; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Perri F, 2007, AM J GASTROENTEROL, V102, P1361, DOI 10.1111/j.1572-0241.2007.01284.x; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Roviello F, 2007, EJSO-EUR J SURG ONC, V33, P448, DOI 10.1016/j.ejso.2006.10.028; Salahshor S, 2001, BREAST CANCER RES, V3, P199, DOI 10.1186/bcr295; Scartozzi M, 2004, CANCER TREAT REV, V30, P451, DOI 10.1016/j.ctrv.2004.01.001; Schrader KA, 2011, J MED GENET, V48, P64, DOI 10.1136/jmg.2010.079814; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sharma S, 2011, MOL CANCER THER, V10, P1751, DOI 10.1158/1535-7163.MCT-11-0248; Sharma S, 2009, BLOOD, V114, P4179, DOI 10.1182/blood-2009-03-206482; Shinmura K, 2005, CLIN GENET, V67, P81, DOI 10.1111/j.1399-0004.2005.00380.x; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Suriano G, 2003, ONCOGENE, V22, P5716, DOI 10.1038/sj.onc.1206672; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; Tepes B, 2009, J PHYSIOL PHARMACOL, V60, P71; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vauhkonen M, 2006, BEST PRACT RES CL GA, V20, P651, DOI 10.1016/j.bpg.2006.03.016; Windham TC, 2002, J SURG ONCOL, V81, P118, DOI 10.1002/jso.10157	66	29	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77035	10.1371/journal.pone.0077035	http://dx.doi.org/10.1371/journal.pone.0077035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204729	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700015
J	Mruwat, R; Yedgar, S; Lavon, I; Ariel, A; Krimsky, M; Shoseyov, D				Mruwat, Rufayda; Yedgar, Saul; Lavon, Iris; Ariel, Amiram; Krimsky, Miron; Shoseyov, David			Phospholipase A(2) in Experimental Allergic Bronchitis: A Lesson from Mouse and Rat Models	PLOS ONE			English	Article							ARACHIDONIC-ACID METABOLITES; INFLAMMATION; MEDIATORS; ASTHMA; RESOLUTION; INHIBITION; CHITINASES; MEMBRANE; DISEASES; ARGININE	Background: Phospholipases A(2) (PLA(2)) hydrolyzes phospholipids, initiating the production of inflammatory lipid mediators. We have previously shown that in rats, sPLA(2) and cPLA(2) play opposing roles in the pathophysiology of ovalbumin (OVA)induced experimental allergic bronchitis (OVA-EAB), an asthma model: Upon disease induction sPLA(2) expression and production of the broncho-constricting CysLTs are elevated, whereas cPLA(2) expression and the broncho-dilating PGE(2) production are suppressed. These were reversed upon disease amelioration by treatment with an sPLA(2) inhibitor. However, studies in mice reported the involvement of both sPLA(2) and cPLA(2) in EAB induction. Objectives: To examine the relevance of mouse and rat models to understanding asthma pathophysiology. Methods: OVA-EAB was induced in mice using the same methodology applied in rats. Disease and biochemical markers in mice were compared with those in rats. Results: As in rats, EAB in mice was associated with increased mRNA of sPLA(2), specifically sPLA(2)gX, in the lungs, and production of the broncho-constricting eicosanoids CysLTs, PGD(2) and TBX2 in bronchoalveolar lavage (BAL). In contrast, EAB in mice was associated also with elevated cPLA(2) mRNA and PGE(2) production. Yet, treatment with an sPLA(2) inhibitor ameliorated the EAB concomitantly with reverting the expression of both cPLA(2) and sPLA2, and eicosanoid production. Conclusions: In both mice and rats sPLA(2) is pivotal in OVA-induced EAB. Yet, amelioration of asthma markers in mouse models, and human tissues, was observed also upon cPLA(2) inhibition. It is plausible that airway conditions, involving multiple cell types and organs, require the combined action of more than one, essential, PLA(2)s.	[Mruwat, Rufayda; Yedgar, Saul] Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91010 Jerusalem, Israel; [Lavon, Iris; Krimsky, Miron] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel; [Ariel, Amiram] Univ Haifa, Fac Nat Sci, Dept Biol, IL-31999 Haifa, Israel; [Krimsky, Miron; Shoseyov, David] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Haifa; Hebrew University of Jerusalem	Yedgar, S (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Biochem, IL-91010 Jerusalem, Israel.	yedgar@md.huji.ac.il	Lavon, Iris/ABE-6651-2021		Flight Attendants Medical Research Institute (FAMRI), Miami, Florida; Hebrew University Research and Development authority	Flight Attendants Medical Research Institute (FAMRI), Miami, Florida; Hebrew University Research and Development authority	This study was supported by grants from the Flight Attendants Medical Research Institute (FAMRI), Miami, Florida, and the Hebrew University Research and Development authority. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Beck GC, 2003, CRIT CARE MED, V31, P2015, DOI 10.1097/01.CCM.0000074717.46748.64; Bickford JS, BIOCH J, V442, P127; Calabrese C, 2000, ALLERGY, V55, P27, DOI 10.1034/j.1398-9995.2000.00504.x; Capper EA, 2001, PROG LIPID RES, V40, P167, DOI 10.1016/S0163-7827(01)00002-9; Diaz BL, 2003, PROSTAG LEUKOTR ESS, V69, P87, DOI 10.1016/S0952-3278(03)00069-3; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Giannattasio G, 2010, J IMMUNOL, V185, P4430, DOI 10.4049/jimmunol.1001384; Giannattasio G, 2009, BBA-MOL CELL BIOL L, V1791, P92, DOI 10.1016/j.bbalip.2008.12.002; Granata F, 2003, INT ARCH ALLERGY IMM, V131, P153, DOI 10.1159/000071481; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2011, J BIOL CHEM, V286, P28049, DOI 10.1074/jbc.M111.235812; Horwitz RJ, 1998, AM J RESP CRIT CARE, V157, P1363, DOI 10.1164/ajrccm.157.5.9706059; Ingber A, 2007, INT J IMMUNOPATH PH, V20, P191, DOI 10.1177/039463200702000123; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; King NE, 2004, J NUTR, V134, p2830S, DOI 10.1093/jn/134.10.2830S; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Levy BD, PROSTAGLANDINS LEUKO, V82, P327; Miyahara T, 2008, J APPL PHYSIOL, V104, P354, DOI 10.1152/japplphysiol.00959.2006; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Murakami M, J BIOCH, V150, P233; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; Offer S, 2005, AM J PHYSIOL-LUNG C, V288, pL523, DOI 10.1152/ajplung.00199.2004; Patel S, J PHARM EXP THER, V340, P656; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shoseyov D, 2005, THORAX, V60, P747, DOI 10.1136/thx.2005.043695; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Wenzel SE, 1997, PHARMACOTHERAPY, V17, pS3; Wijewickrama GT, 2006, J BIOL CHEM, V281, P10935, DOI 10.1074/jbc.M512657200; Yedgar S, 2003, ADV EXP MED BIOL, V525, P97; Yedgar S, 2000, BBA-MOL CELL BIOL L, V1488, P182, DOI 10.1016/S1388-1981(00)00120-7; Yedgar S, 2007, TRENDS PHARMACOL SCI, V28, P459, DOI 10.1016/j.tips.2007.07.005; Zimmermann N, 2006, EUR J PHARMACOL, V533, P253, DOI 10.1016/j.ejphar.2005.12.047	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76641	10.1371/journal.pone.0076641	http://dx.doi.org/10.1371/journal.pone.0076641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204651	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700010
J	Pawa, D; Firestone, R; Ratchasi, S; Dowling, O; Jittakoat, Y; Duke, A; Mundy, G				Pawa, Duangta; Firestone, Rebecca; Ratchasi, Sindh; Dowling, Olivia; Jittakoat, Yaowalak; Duke, Alex; Mundy, Gary			Reducing HIV Risk among Transgender Women in Thailand: A Quasi-Experimental Evaluation of the Sisters Program	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; PREVALENCE; PREVENTION; HEALTH; MEN; INFECTION; BANGKOK; WORKERS; FOCUS	Transgender women are particularly at risk of HIV infection, but little evidence exists on effective HIV prevention strategies with this population. We evaluated whether Sisters, a peer-led program for transgender women, could reduce HIV risks in Pattaya, Thailand. The study used time-location sampling to recruit 308 transgender women in Pattaya into a behavioral survey in 2011. Coarsened exact matching was used to create statistically equivalent groups of program participants and non-participants, based on factors influencing likelihood of program participation. Using multivariable logistic regression, we estimated effects of any program participation and participation by delivery channel on: condom use at last sex; consistent condom and condom/water-based lubricant use in the past 3 months with commercial, casual, and regular partners; and receipt of HIV testing in the past 6 months. Program coverage reached 75% of the population. In a matched sub-sample (n = 238), participation in outreach was associated with consistent condom/water-based lubricant use with commercial partners (AOR 3.22, 95% CI 1.64-6.31). Attendance at the Sisters drop-in center was associated with receiving an HIV test (AOR 2.58, 95% CI 1.47-4.52). Dedicated transgender-friendly programs are effective at reducing HIV risks and require expansion to better serve this key population and improve HIV prevention strategies.	[Pawa, Duangta; Ratchasi, Sindh; Jittakoat, Yaowalak] Populat Serv Int Thailand, Strateg Informat Dept, Bangkok, Thailand; [Firestone, Rebecca] Populat Serv Int, Res & Metr Dept, Washington, DC USA; [Dowling, Olivia; Mundy, Gary] Populat Serv Int, Res & Metr Dept, Bangkok, Thailand; [Duke, Alex] Populat Serv Int Thailand, Program Dept, Bangkok, Thailand		Pawa, D (corresponding author), Populat Serv Int Thailand, Strateg Informat Dept, Bangkok, Thailand.	duangta@psithailand.org			United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study is funded by United States Agency for International Development (USAID) http://www.usaid.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MA, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-32; Amon J., 2000, BEHAV SURVEILLANCE S; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Berry S., 2012, AIDSTAR ONE CASE STU; Blackwell M, 2009, STATA J, V9, P524, DOI 10.1177/1536867X0900900402; Bockting W, 2005, INT J TRANSGENDERISM, V8, P123, DOI 10.1300/J485v08n02_11; Bockting WO, 2005, AIDS CARE, V17, P289, DOI 10.1080/09540120412331299825; Bockting WO, 1998, AIDS CARE, V10, P505, DOI 10.1080/09540129850124028; Clements-Nolle K, 2001, AM J PUBLIC HEALTH, V91, P915, DOI 10.2105/AJPH.91.6.915; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Craft EM, 2001, AM J PUBLIC HEALTH, V91, P889, DOI 10.2105/AJPH.91.6.889; De Santis JP, 2009, J ASSOC NURSE AIDS C, V20, P362, DOI 10.1016/j.jana.2009.06.005; Earth B., 2006, Gender and Development, V14, P259, DOI 10.1080/13552070600747297; Guadamuz TE, 2011, AIDS BEHAV, V15, P650, DOI 10.1007/s10461-010-9850-5; Haider AH, 2013, ANN SURG; Henkel R., 2006, Asia Pacific Journal of Tourism Research, V11, P269, DOI 10.1080/10941660600753299; Jackson PA, 1997, J HIST SEXUALITY, V8, P52; Jackson PA, 1999, TOLERANT UNACCEPTING; King G., 2011, COMP EFFECTIVE UNPUB; Longfield K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-872; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4; Mayer K. H., 2007, HLTH SEXUAL MINORITI, P693; National AIDS Committee, 2012, THAIL AIDS RESP PROG; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; Nemoto T, 2005, AM J PUBLIC HEALTH, V95, P382, DOI 10.2105/AJPH.2004.040501; Nemoto T, 2004, AM J PUBLIC HEALTH, V94, P1193, DOI 10.2105/AJPH.94.7.1193; Nemoto T, 2012, AIDS CARE, V24, P210, DOI 10.1080/09540121.2011.597709; Ocha W, 2012, CULT HEALTH SEX, V14, P563, DOI 10.1080/13691058.2012.672653; Operario D, 2011, ARCH SEX BEHAV, V40, P1255, DOI 10.1007/s10508-011-9781-x; Pawa D, 2011, FACTORS ASS SEXUAL R; Peletz MG, 2006, CURR ANTHROPOL, V47, P309, DOI 10.1086/498947; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; Population Service International, 2009, THAIL 2009 HIV AIDS; Prabawanti C, 2011, AIDS BEHAV, V15, P663, DOI 10.1007/s10461-010-9790-0; Sheridan S, 2009, AIDS, V23, P409, DOI 10.1097/QAD.0b013e32831ef510; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; ten Brummelhuis H., 1999, J GAY LESBIAN SOCIAL, V9, P121, DOI [https://doi.org/10.1300/J041v09n02_06, DOI 10.1300/J041V09N02_06]; Toole MJ, 2006, SEX TRANSM INFECT, V82, P135, DOI 10.1136/sti.2005.016923; UNAIDS, 2011, AIDSINFO DAT THAIL C; UNDP, 2011, UN ACC EX MUN HIV PR; van Griensven F, 2013, LANCET INFECT DIS, V13, P185, DOI 10.1016/S1473-3099(12)70326-2; Wells AR, 2013, POPUL HEALTH MANAG, V16, P35, DOI 10.1089/pop.2011.0104; Winter S, 2006, INT J TRANSGENDERISM, V9, P47, DOI 10.1300/J485v09n02_06; Winter S, 2006, INT J TRANSGENDERISM, V9, P15, DOI 10.1300/J485v09n01_03	45	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77113	10.1371/journal.pone.0077113	http://dx.doi.org/10.1371/journal.pone.0077113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204750	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700018
J	Wei, ZH; Xu, ZX; Li, B; Xu, FQ				Wei, Zehong; Xu, Zhixiang; Li, Bo; Xu, Fuqiang			Numerical Simulation of Airway Dimension Effects on Airflow Patterns and Odorant Deposition Patterns in the Rat Nasal Cavity	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; COMPUTER-SIMULATION; INHALED FORMALDEHYDE; ACOUSTIC RHINOMETRY; F344 RAT; TRANSPORT; DOSIMETRY; FIXATION; MODEL; PREDICTIONS	The sense of smell is largely dependent on the airflow and odorant transport in the nasal cavity, which in turn depends on the anatomical structure of the nose. In order to evaluate the effect of airway dimension on rat nasal airflow patterns and odorant deposition patterns, we constructed two 3-dimensional, anatomically accurate models of the left nasal cavity of a Sprague-Dawley rat: one was based on high-resolution MRI images with relatively narrow airways and the other was based on artificially-widening airways of the MRI images by referencing the section images with relatively wide airways. Airflow and odorant transport, in the two models, were determined using the method of computational fluid dynamics with finite volume method. The results demonstrated that an increase of 34 mm in nasal airway dimension significantly decreased the average velocity in the whole nasal cavity by about 10% and in the olfactory region by about 12% and increased the volumetric flow into the olfactory region by about 3%. Odorant deposition was affected to a larger extent, especially in the olfactory region, where the maximum odorant deposition difference reached one order of magnitude. The results suggest that a more accurate nasal cavity model is necessary in order to more precisely study the olfactory function of the nose when using the rat.	[Wei, Zehong; Xu, Fuqiang] Wuhan Natl Lab Optoelect, Div Biomed Photon, Wuhan, Peoples R China; [Wei, Zehong; Xu, Zhixiang; Li, Bo; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance Atom & Mol Phys, Wuhan, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Xu, FQ (corresponding author), Wuhan Natl Lab Optoelect, Div Biomed Photon, Wuhan, Peoples R China.	fuqiang.xu@wipm.ac.cn	xu, fuqiang/AAI-1571-2019	Xu, Zhixiang/0000-0002-0962-7702; xu, fu qiang/0000-0002-4382-9797	National Natural Science Foundation of China [91132307/H09, 31171061/C090208]; Chinese Academy of Sciences [XDB02050500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (91132307/H09 and 31171061/C090208) and the Chinese Academy of Sciences (XDB02050500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOONSTRA H, 1983, VIRCHOWS ARCH A, V402, P195, DOI 10.1007/BF00695061; Botsis T, 2004, CIN-COMPUT INFORM NU, V22, P162, DOI 10.1097/00024665-200405000-00011; Chen XB, 2011, AM J RHINOL ALLERGY, V25, pE39, DOI 10.2500/ajra.2011.25.3565; Chen XB, 2010, RHINOLOGY, V48, P163, DOI 10.4193/Rhin09.093; Churchill SE, 2004, AM J HUM BIOL, V16, P625, DOI 10.1002/ajhb.20074; Clement PAR, 2005, RHINOLOGY, V43, P169; Corley RA, 2009, INHAL TOXICOL, V21, P512, DOI 10.1080/08958370802598005; Craven BA, 2010, J R SOC INTERFACE, V7, P933, DOI 10.1098/rsif.2009.0490; GETCHELL TV, 1984, PROG NEUROBIOL, V23, P317, DOI 10.1016/0301-0082(84)90008-X; GROTBERG JB, 1990, J BIOMECH ENG-T ASME, V112, P168, DOI 10.1115/1.2891168; HAHN I, 1994, J THEOR BIOL, V167, P115, DOI 10.1006/jtbi.1994.1057; HAHN I, 1993, J APPL PHYSIOL, V75, P2273, DOI 10.1152/jappl.1993.75.5.2273; HORNUNG DE, 1987, ARCH OTOLARYNGOL, V113, P169; HORNUNG DE, 1987, BRAIN RES, V413, P147, DOI 10.1016/0006-8993(87)90163-6; Hornung DE, 1980, OLFACTION TASTE, P167; Kepler GM, 1998, TOXICOL APPL PHARM, V150, P1, DOI 10.1006/taap.1997.8350; Keyhani K, 1995, J BIOMECH ENG-T ASME, V117, P429, DOI 10.1115/1.2794204; Keyhani K, 1997, J THEOR BIOL, V186, P279, DOI 10.1006/jtbi.1996.0347; KIMBELL JS, 1993, TOXICOL APPL PHARM, V121, P253, DOI 10.1006/taap.1993.1152; Kimbell JS, 1997, TOXICOL APPL PHARM, V145, P388, DOI 10.1006/taap.1997.8206; Kimbell JS, 2001, TOXICOL SCI, V64, P100, DOI 10.1093/toxsci/64.1.100; Kimbell JS, 2001, TOXICOL SCI, V64, P111, DOI 10.1093/toxsci/64.1.111; Kimbell JS, 1990, TOXICOLOGIST, V10, P259; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; Lee CF, 2012, BIOMED ENG-APP BAS C, V24, P327, DOI 10.4015/S1016237212500251; Lee JH, 2010, RESP PHYSIOL NEUROBI, V172, P136, DOI 10.1016/j.resp.2010.05.010; Lindemann J, 2005, AM J OTOLARYNG, V26, P175, DOI 10.1016/j.amjoto.2005.02.010; Liu B, 2011, CHINESE PHYS B, V20, DOI 10.1088/1674-1056/20/12/128702; Liu B, 2011, COMMUN THEOR PHYS, V56, P913, DOI 10.1088/0253-6102/56/5/19; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022487; Liu B, 2011, J THEOR BIOL, V269, P104, DOI 10.1016/j.jtbi.2010.10.009; Liu B, 2011, MOL BIOSYST, V7, P457, DOI 10.1039/c0mb00133c; Mosges R, 2010, B-ENT, V6, P161; MORGAN KT, 1991, TOXICOL APPL PHARM, V110, P223, DOI 10.1016/S0041-008X(05)80005-5; Nebot A, 2003, SIMUL-T SOC MOD SIM, V79, P648, DOI 10.1177/0037549703038883; PATRA AL, 1986, J APPL PHYSIOL, V61, P1959, DOI 10.1152/jappl.1986.61.5.1959; Pedley TJ, 1977, LUNG BIOL HLTH DISEA, P163; Quester R, 1997, J NEUROSCI METH, V75, P81, DOI 10.1016/S0165-0270(97)00050-2; Reber M., 1998, Rhinology (Utrecht), V36, P184; Riazuddin VN, 2011, J MED BIOL ENG, V31, P201, DOI 10.5405/jmbe.781; ROITHMANN R, 1994, J OTOLARYNGOL, V23, P454; Segal RA, 2008, ANN BIOMED ENG, V36, P1870, DOI 10.1007/s10439-008-9556-2; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; Subramaniam RP, 1998, INHAL TOXICOL, V10, P91, DOI 10.1080/089583798197772; Tan J, 2012, EUR ARCH OTO-RHINO-L, V269, P881, DOI 10.1007/s00405-011-1771-z; Wang DY, 2012, CLIN EXP OTORHINOLAR, V5, P181, DOI 10.3342/ceo.2012.5.4.181; Wen J, 2008, RESP PHYSIOL NEUROBI, V161, P125, DOI 10.1016/j.resp.2008.01.012; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Wexler D, 2005, ARCH OTOLARYNGOL, V131, P1102, DOI 10.1001/archotol.131.12.1102; Whitaker S, 1992, INTRO FLUID MECH, P474; Xiong GX, 2008, MED BIOL ENG COMPUT, V46, P1161, DOI 10.1007/s11517-008-0384-1; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yang GC, 2007, CHEM SENSES, V32, P273, DOI 10.1093/chemse/bjl056; Yang GC, 2007, CHEM SENSES, V32, P215, DOI 10.1093/chemse/bjl047; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; Zannoli R, 2009, PHYS MEDICA, V25, P94, DOI 10.1016/j.ejmp.2008.02.007; Zhao K, 2006, CHEM SENSES, V31, P107, DOI 10.1093/chemse/bjj008; Zhao K, 2004, CHEM SENSES, V29, P365, DOI 10.1093/chemse/bjh033; Zhu JH, 2011, RESP PHYSIOL NEUROBI, V175, P62, DOI 10.1016/j.resp.2010.09.008; Zubair M, 2010, ASIAN BIOMED, V4, P657, DOI 10.2478/abm-2010-0085	62	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77570	10.1371/journal.pone.0077570	http://dx.doi.org/10.1371/journal.pone.0077570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204875	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200033
J	Andersen, V; Holst, R; Kopp, TI; Tjonneland, A; Vogel, U				Andersen, Vibeke; Holst, Rene; Kopp, Tine Iskov; Tjonneland, Anne; Vogel, Ulla			Interactions between Diet, Lifestyle and IL10, IL1B, and PTGS2/COX-2 Gene Polymorphisms in Relation to Risk of Colorectal Cancer in a Prospective Danish Case-Cohort Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; RESISTANCE 1 MDR1; NSAID USE; INFLAMMATORY RESPONSE; ULCERATIVE-COLITIS; COLON-CANCER; CYCLOOXYGENASE-2; ALCOHOL; COX-2; ASSOCIATION	Background & Aims: Diet contributes to colorectal cancer development and may be potentially modified. We wanted to identify the biological mechanisms underlying colorectal carcinogenesis by assessment of diet-gene interactions. Methods: The polymorphisms IL10 C-592A (rs1800872), C-rs3024505-T, IL1b C-3737T (rs4848306), G-1464C (rs1143623), T-31C (rs1143627) and PTGS2 (encoding COX-2) A-1195G (rs689466), G-765C (rs20417), and T8473C (rs5275) were assessed in relation to risk of colorectal cancer (CRC) and interaction with diet (red meat, fish, fibre, cereals, fruit and vegetables) and lifestyle (non-steroid-anti-inflammatory drug use and smoking status) was assessed in a nested case-cohort study of nine hundred and seventy CRC cases and 1789 randomly selected participants from a prospective study of 57,053 persons. Results: IL1b C-3737T, G-1464C and PTGS2 T8473C variant genotypes were associated with risk of CRC compared to the homozygous wildtype genotype (IRR=0.81, 95% CI: 0.68-0.97, p=0.02, and IRR=1.22, 95% CI: 1.04-1.44, p=0.02, IRR=0.75, 95% CI: 0.57-0.99, p=0.04, respectively). Interactions were found between diet and IL10 rs3024505 (P-value for interaction (P-int); meat=0.04, fish=0.007, fibre=0.0008, vegetables=0.0005), C-592A (P-int; fibre=0.025), IL1b C-3737T (P-int; vegetables=0.030, NSAID use=0.040) and PTGS2 genotypes G-765C (P-int; meat=0.006, fibre=0.0003, fruit 0.004), and T8473C (P-int; meat 0.049, fruit=0.03) and A-1195G (P-int; meat 0.038, fibre 0.040, fruit=0.059, vegetables=0.025, and current smoking=0.046). Conclusions: Genetically determined low COX-2 and high IL-1 beta activity were associated with increased risk of CRC in this northern Caucasian cohort. Furthermore, interactions were found between IL10, IL1b, and PTGS2 and diet and lifestyle factors in relation to CRC. The present study demonstrates that gene-environment interactions may identify genes and environmental factors involved in colorectal carcinogenesis.	[Andersen, Vibeke] Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark; [Andersen, Vibeke; Holst, Rene] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Andersen, Vibeke] Reg Hosp, Dept Med, Viborg, Viborg, Denmark; [Kopp, Tine Iskov] Natl Food Inst, Soborg, Denmark; [Kopp, Tine Iskov; Tjonneland, Anne] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark	University of Southern Denmark; Technical University of Denmark; Danish Cancer Society; National Research Centre for the Working Environment	Andersen, V (corresponding author), Hosp Southern Jutland, Organ Ctr, Aabenraa, Denmark.	vandersen@health.sdu.dk	Vogel, Ulla B/I-5048-2012; Andersen, Vibeke/I-7932-2012; Vogel, Ulla/ABC-2212-2020	Vogel, Ulla B/0000-0001-6807-1524; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla/0000-0001-6807-1524; Tjonneland, Anne/0000-0003-4385-2097; Kopp, Tine/0000-0003-3729-4420	Hospital of Southern Jutland	Hospital of Southern Jutland	This work was funded by the Hospital of Southern Jutland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo A, 2002, PUBLIC HEALTH NUTR, V5, P1179, DOI 10.1079/PHN2002398; Al-Ashy R, 2006, CYTOKINE, V36, P1, DOI 10.1016/j.cyto.2006.10.003; Al-Salihi MA, 2009, CANCER LETT, V273, P225, DOI 10.1016/j.canlet.2008.08.012; Andersen V, 2013, ALIMENT PHARM THER, V37, P383, DOI 10.1111/apt.12180; Andersen V, 2010, EUR J GASTROENTEROL; Andersen V, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-183; Andersen V, 2012, SCAND J GASTROENTERO, V47, P572, DOI 10.3109/00365521.2012.668933; Andersen V, 2011, INFLAMM BOWEL DIS, V17, P937, DOI 10.1002/ibd.21440; Andersen V, 2011, EUR J GASTROEN HEPAT, V23, P282, DOI 10.1097/MEG.0b013e3283417f76; Andersen V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-484; Andersen V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-407; Andersen V, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-18; [Anonymous], 2004, LANGUAGE A ENV STAT; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Chen HM, 2006, HUM MOL GENET, V15, P519, DOI 10.1093/hmg/ddi469; Erridge C, 2011, J FOOD SCI, V76, pH72, DOI 10.1111/j.1750-3841.2010.02018.x; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Friis S, 2009, CANCER CAUSE CONTROL, V20, P731, DOI 10.1007/s10552-008-9286-7; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; Hansen RD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-54; Hansen RD, 2007, MUTAT RES-FUND MOL M, V619, P68, DOI 10.1016/j.mrfmmm.2007.02.002; Hansen RD, 2009, MUTAT RES-FUND MOL M, V664, P13, DOI 10.1016/j.mrfmmm.2009.01.009; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Joensen AM, 2010, BRIT J NUTR, V103, P602, DOI 10.1017/S0007114509992170; Koh WP, 2004, BRIT J CANCER, V90, P1760, DOI 10.1038/sj.bjc.6601797; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moore AE, 2012, ONCOGENE, V31, P1592, DOI 10.1038/onc.2011.349; Paul G, 2012, EUR J CLIN INVEST, V42, P95, DOI 10.1111/j.1365-2362.2011.02552.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; PROSKY L, 1985, J ASSOC OFF ANA CHEM, V68, P677; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Sanak M, 2005, J ALLERGY CLIN IMMUN, V116, P221, DOI 10.1016/j.jaci.2005.03.010; Slimani N, 2007, EUR J CLIN NUTR, V61, P1037, DOI 10.1038/sj.ejcn.1602679; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1125, DOI 10.1079/PHN2002395; Stegger JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036829; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; TJONNELAND A, 1992, INT J EPIDEMIOL, V21, P770, DOI 10.1093/ije/21.4.770; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vangsted AJ, 2012, BRIT J HAEMATOL, V158, P515, DOI 10.1111/j.1365-2141.2012.09141.x; Vangsted AJ, 2011, ANN HEMATOL, V90, P1173, DOI 10.1007/s00277-011-1194-3; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Vogel U, 2008, MUTAT RES-FUND MOL M, V639, P89, DOI 10.1016/j.mrfmmm.2007.11.004; Vogel U, 2007, MUTAT RES-FUND MOL M, V624, P88, DOI 10.1016/j.mrfmmm.2007.04.006; Vogel U, 2007, MUTAT RES-FUND MOL M, V617, P138, DOI 10.1016/j.mrfmmm.2007.01.005; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	51	47	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78366	10.1371/journal.pone.0078366	http://dx.doi.org/10.1371/journal.pone.0078366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194923	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000102
J	Garcia, PL; Council, LN; Christein, JD; Arnoletti, JP; Heslin, MJ; Gamblin, TL; Richardson, JH; Bjornsti, MA; Yoon, KJ				Garcia, Patrick L.; Council, Leona N.; Christein, John D.; Arnoletti, J. Pablo; Heslin, Marty J.; Gamblin, Tracy L.; Richardson, Joseph H.; Bjornsti, Mary-Ann; Yoon, Karina J.			Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; XENOGRAFT MODELS; NUDE-MICE; KRAS; GEMCITABINE; INSTABILITY; RESISTANCE; SIGNATURES; COOPERATE; CARCINOMA	Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for patients with this disease is 3-5%. Thus, there is a compelling need for novel therapeutic strategies to improve the clinical outcome for patients with pancreatic cancer. Several groups have demonstrated for other types of solid tumors that early passage human tumor xenograft models can be used to define some genetic and molecular characteristics of specific human tumors. Published studies also suggest that murine tumorgraft models (early passage xenografts derived from direct implantation of primary tumor specimens) may be useful in identifying compounds with efficacy against specific tumor types. Because pancreatic cancer is a fatal disease and few well-characterized model systems are available for translational research, we developed and characterized a panel of pancreatic tumorgraft models for biological evaluation and therapeutic drug testing. Of the 41 primary tumor specimens implanted subcutaneously into mice, 35 produced viable tumorgraft models. We document the fidelity of histological and morphological characteristics and of KRAS mutation status among primary (F0), F1, and F2 tumors for the twenty models that have progressed to the F3 generation. Importantly, our procedures produced a take rate of 85%, higher than any reported in the literature. Primary tumor specimens that failed to produce tumorgrafts were those that either contained <10% tumor cells or that were obtained from significantly smaller primary tumors. In view of the fidelity of characteristics of primary tumor specimens through at least the F2 generation in mice, we propose that these tumorgraft models represent a useful tool for identifying critical characteristics of pancreatic tumors and for evaluating potential therapies.	[Garcia, Patrick L.; Gamblin, Tracy L.; Bjornsti, Mary-Ann; Yoon, Karina J.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Council, Leona N.] Univ Alabama Birmingham, Dept Pathol, Div Anat Pathol, Birmingham, AL 35294 USA; [Christein, John D.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Arnoletti, J. Pablo; Heslin, Marty J.; Richardson, Joseph H.] Univ Alabama Birmingham, Dept Surg, Div Gen Surg, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yoon, KJ (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA.	kyoon@uab.edu			UAB/UMN SPORE in pancreatic cancer [P50 CA101955]; UAB-Comprehensive Cancer Center; Department of Pharmacology and Toxicology, University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE [P50CA101955, P30CA013148] Funding Source: NIH RePORTER	UAB/UMN SPORE in pancreatic cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB-Comprehensive Cancer Center; Department of Pharmacology and Toxicology, University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by UAB/UMN SPORE in pancreatic cancer (P50 CA101955), UAB-Comprehensive Cancer Center, and Department of Pharmacology and Toxicology, University of Alabama at Birmingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, BIOCHEM PHARMACOL, V78, P1083, DOI 10.1016/j.bcp.2009.05.027; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Baumgarten Axel J., 2007, Cancer Genomics & Proteomics, V4, P223; BOVEN E, 1992, CANCER RES, V52, P5940; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Feldmann G, 2008, J MOL DIAGN, V10, P111, DOI 10.2353/jmoldx.2008.070115; Fiebig Heinz-Herbert, 2007, Cancer Genomics & Proteomics, V4, P197; Fiebig HH, 2004, EUR J CANCER, V40, P802, DOI 10.1016/j.ejca.2004.01.009; Garrido-Laguna I, 2010, BRIT J CANCER, V103, P649, DOI 10.1038/sj.bjc.6605819; Garrido-Laguna I, 2011, CLIN CANCER RES, V17, P5793, DOI 10.1158/1078-0432.CCR-11-0341; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; GIOVANELLA BC, 1973, JNCI-J NATL CANCER I, V50, P1051, DOI 10.1093/jnci/50.4.1051; HAHN SA, 1995, CANCER RES, V55, P4670; Hausser HJ, 2005, BIOCHEM BIOPH RES CO, V333, P216, DOI 10.1016/j.bbrc.2005.05.097; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hong SM, 2011, ARCH PATHOL LAB MED, V135, P716, DOI 10.1043/2010-0566-RA.1; Houghton PJ, 2007, PEDIATR BLOOD CANCER, V49, P928, DOI 10.1002/pbc.21078; Hruban RH, 2007, GASTROENTEROL CLIN N, V36, P831, DOI 10.1016/j.gtc.2007.08.012; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Huynh H, 2006, CLIN CANCER RES, V12, P4306, DOI 10.1158/1078-0432.CCR-05-2568; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P91, DOI 10.1016/S0002-9440(10)64353-2; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Monsma DJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-125; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Quesnelle KM, 2012, CANCER BIOL THER, V13, P935, DOI 10.4161/cbt.20846; Raimondi S, 2009, NAT REV GASTRO HEPAT, V6, P699, DOI 10.1038/nrgastro.2009.177; Rajeshkumar NV, 2011, CLIN CANCER RES, V17, P2799, DOI 10.1158/1078-0432.CCR-10-2580; Rubio-Viqueira B, 2009, CLIN PHARMACOL THER, V85, P217, DOI 10.1038/clpt.2008.200; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; RYGAARD J, 1969, Acta Pathologica et Microbiologica Scandinavica, V77, P758; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; Troiani T, 2008, CRIT REV ONCOL HEMAT, V65, P200, DOI 10.1016/j.critrevonc.2007.10.003; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; Venkatesha VA, 2012, NEOPLASIA, V14, P519, DOI 10.1593/neo.12538; Villarroel MC, 2011, MOL CANCER THER, V10, P3, DOI 10.1158/1535-7163.MCT-10-0893; Wong HH, 2009, NAT REV GASTRO HEPAT, V6, P412, DOI 10.1038/nrgastro.2009.89	49	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78183	10.1371/journal.pone.0078183	http://dx.doi.org/10.1371/journal.pone.0078183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194913	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000092
J	Hong, SH; Minai-Tehrani, A; Chang, SH; Jiang, HL; Lee, S; Lee, AY; Seo, HW; Chae, C; Beck, GR; Cho, MH				Hong, Seong-Ho; Minai-Tehrani, Arash; Chang, Seung-Hee; Jiang, Hu-Lin; Lee, Somin; Lee, Ah-Young; Seo, Hwi Won; Chae, Chanhee; Beck, George R., Jr.; Cho, Myung-Haing			Knockdown of the Sodium-Dependent Phosphate Co-Transporter 2b (NPT2b) Suppresses Lung Tumorigenesis	PLOS ONE			English	Article							SMALL INTERFERING RNA; TUMOR-GROWTH; TARGETING OSTEOPONTIN; GENE DELIVERY; CANCER; ANGIOGENESIS; LOCALIZATION; EXPRESSION; INHIBITION; THERAPY	The sodium-dependent phosphate co-transporter 2b (NPT2b) plays an important role in maintaining phosphate homeostasis. In previous studies, we have shown that high dietary inorganic phosphate (Pi) consumption in mice stimulated lung tumorigenesis and increased NPT2b expression. NPT2b has also been found to be highly expressed in human lung cancer tissues. The association of high expression of NPT2b in the lung with poor prognosis in oncogenic lung diseases prompted us to test whether knockdown of NPT2b may regulate lung cancer growth. To address this issue, aerosols that contained small interfering RNA (siRNA) directed against NPT2b (siNPT2b) were delivered into the lungs of K-ras(LA1) mice, which constitute a murine model reflecting human lung cancer. Our results clearly showed that repeated aerosol delivery of siNPT2b successfully suppressed lung cancer growth and decreased cancer cell proliferation and angiogenesis, while facilitating apoptosis. These results strongly suggest that NPT2b plays a role lung tumorigenesis and represents a novel target for lung cancer therapy.	[Hong, Seong-Ho; Minai-Tehrani, Arash; Chang, Seung-Hee; Lee, Somin; Lee, Ah-Young; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea; [Jiang, Hu-Lin] China Pharmaceut Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China; [Seo, Hwi Won; Chae, Chanhee] Seoul Natl Univ, Laboratrory Pathol, Coll Vet Med, Seoul, South Korea; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA USA; [Cho, Myung-Haing] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Suwon, South Korea; [Lee, Somin; Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, South Korea	Seoul National University (SNU); China Pharmaceutical University; Seoul National University (SNU); Emory University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Cho, MH (corresponding author), Seoul Natl Univ, Coll Vet Med, Toxicol Lab, Seoul, South Korea.	mchotox@snu.ac.kr	Beck, George/AAO-2117-2020; Cho, Myung-Haing/B-7362-2014	Cho, Myung-Haing/0000-0002-3993-2011; Chae, Chanhee/0000-0002-0190-1957	National Research Foundation [NRF-2012-0000102]; Ministry of Education, Science, and Technology (MEST) of Korea; Veterinary Research Institute of Seoul National University in Korea; NATIONAL CANCER INSTITUTE [R01CA136716, R03CA136059] Funding Source: NIH RePORTER	National Research Foundation; Ministry of Education, Science, and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Veterinary Research Institute of Seoul National University in Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Research Foundation (NRF-2012-0000102) and the Ministry of Education, Science, and Technology (MEST) of Korea. MHC also acknowledges the support of the Veterinary Research Institute of Seoul National University in Korea. The authors further thank the Korea Lung Tissue Bank (KLTB) of the Infrastructure Project for Basic Science of MEST for providing the human lung tissues. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chen DR, 2010, ANTICANCER RES, V30, P4135; Densmore CL, 2003, CURR CANCER DRUG TAR, V3, P275, DOI 10.2174/1568009033481886; Feild JA, 1999, BIOCHEM BIOPH RES CO, V258, P578, DOI 10.1006/bbrc.1999.0666; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Forster IC, 2006, KIDNEY INT, V70, P1548, DOI 10.1038/sj.ki.5001813; Gong MC, 2008, CANCER LETT, V272, P148, DOI 10.1016/j.canlet.2008.07.004; Gupta A, 2001, BONE, V29, P467, DOI 10.1016/S8756-3282(01)00601-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto M, 2000, AM J PATHOL, V157, P21, DOI 10.1016/S0002-9440(10)64512-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Jin H, 2007, TOXICOL SCI, V100, P215, DOI 10.1093/toxsci/kfm202; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Khuri FR, 2001, ANN ONCOL, V12, P739, DOI 10.1023/A:1011197500223; Kim Hyun Sook, 2010, Korean Journal of Internal Medicine, V25, P399, DOI 10.3904/kjim.2010.25.4.399; Kiyamova R., 2011, Experimental Oncology, V33, P157; Lederer E, 2012, CLIN J AM SOC NEPHRO, V7, P1179, DOI 10.2215/CJN.09090911; Lee HY, 2004, CLIN CANCER RES, V10, P1074, DOI 10.1158/1078-0432.CCR-0833-3; Lee HY, 2002, CLIN CANCER RES, V8, P2970; Liu H, 2010, CANCER LETT, V295, P27, DOI 10.1016/j.canlet.2010.02.012; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Minai-Tehrani A, 2012, INT J PHARMACEUT, V431, P197, DOI 10.1016/j.ijpharm.2012.04.028; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Oishi M, 2005, J AM CHEM SOC, V127, P1624, DOI 10.1021/ja044941d; Pirollo KF, 2008, CANCER RES, V68, P1247, DOI 10.1158/0008-5472.CAN-07-5810; Shyian M., 2011, Experimental Oncology, V33, P94; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Walter A, 2010, FASEB J, V24, P3360, DOI 10.1096/fj.09-149419; Xu H, 1999, GENOMICS, V62, P281, DOI 10.1006/geno.1999.6009	34	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77121	10.1371/journal.pone.0077121	http://dx.doi.org/10.1371/journal.pone.0077121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194864	Green Submitted, gold, Green Published			2022-12-25	WOS:000326037000043
J	Johansson, I; Ringner, M; Hedenfalk, I				Johansson, Ida; Ringner, Markus; Hedenfalk, Ingrid			The Landscape of Candidate Driver Genes Differs between Male and Female Breast Cancer	PLOS ONE			English	Article							COPY NUMBER; CLAUDIN-LOW; PATHWAYS; THY-1; IDENTIFICATION; ABERRATIONS; NETWORKS; ADHESION; CENSUS; CELL	The rapidly growing collection of diverse genome-scale data from multiple tumor types sheds light on various aspects of the underlying tumor biology. With the objective to identify genes of importance for breast tumorigenesis in men and to enable comparisons with genes important for breast cancer development in women, we applied the computational framework COpy Number and EXpression In Cancer (CONEXIC) to detect candidate driver genes among all altered passenger genes. Unique to this approach is that each driver gene is associated with several gene modules that are believed to be altered by the driver. Thirty candidate drivers were found in the male breast cancers and 67 in the female breast cancers. We identified many known drivers of breast cancer and other types of cancer, in the female dataset (e. g. GATA3, CCNE1, GRB7, CDK4). In contrast, only three known cancer genes were found among male breast cancers; MAP2K4, LHP, and ZNF217. Many of the candidate drivers identified are known to be involved in processes associated with tumorigenesis, including proliferation, invasion and differentiation. One of the modules identified in male breast cancer was regulated by THY1, a gene involved in invasion and related to epithelial-mesenchymal transition. Furthermore, men with THY1 positive breast cancers had significantly inferior survival. THY1 may thus be a promising novel prognostic marker for male breast cancer. Another module identified among male breast cancers, regulated by SPAG5, was closely associated with proliferation. Our data indicate that male and female breast cancers display highly different landscapes of candidate driver genes, as only a few genes were found in common between the two. Consequently, the pathobiology of male breast cancer may differ from that of female breast cancer and can be associated with differences in prognosis; men diagnosed with breast cancer may consequently require different management and treatment strategies than women.	[Johansson, Ida] Dept Clin Sci, Div Oncol, Lund, Sweden; Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University	Johansson, I (corresponding author), Dept Clin Sci, Div Oncol, Lund, Sweden.	Ida.Johansson@med.lu.se	Ringnér, Markus/G-3641-2011	Ringnér, Markus/0000-0001-5469-8940; Hedenfalk, Ingrid/0000-0002-6840-3397	Swedish Cancer Society; G Nilsson Cancer Foundation; Mrs. B Kamprad Foundation; King Gustaf V's Jubilee Foundation; Lund University Hospital Research Foundation; governmental funding of clinical research within the national health services (ALF)	Swedish Cancer Society(Swedish Cancer Society); G Nilsson Cancer Foundation; Mrs. B Kamprad Foundation; King Gustaf V's Jubilee Foundation; Lund University Hospital Research Foundation; governmental funding of clinical research within the national health services (ALF)	This study was supported by grants from the Swedish Cancer Society, the G Nilsson Cancer Foundation, the Mrs. B Kamprad Foundation, the King Gustaf V's Jubilee Foundation, the Lund University Hospital Research Foundation and governmental funding of clinical research within the national health services (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe HR, 2004, CANCER GENET CYTOGEN, V149, P1, DOI 10.1016/S0165-4608(03)00234-6; Agrawal A, 2007, BREAST CANCER RES TR, V103, P11, DOI 10.1007/s10549-006-9356-z; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Callari M, 2011, BREAST CANCER RES TR, V127, P601, DOI 10.1007/s10549-010-1015-8; Cheng BQ, 2012, ASIAN PAC J CANCER P, V13, P1349, DOI 10.7314/APJCP.2012.13.4.1349; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dutta B, 2012, BRIT J CANCER, V106, P1107, DOI 10.1038/bjc.2011.584; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Fredlund E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3236; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giordano SH, 2005, ONCOLOGIST, V10, P471, DOI 10.1634/theoncologist.10-7-471; Hawkins RD, 2010, NAT REV GENET, V11, P476, DOI 10.1038/nrg2795; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Johansson I, 2011, BREAST CANCER RES TR, V129, P747, DOI 10.1007/s10549-010-1262-8; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Kersten Ferry Fj, 2012, Cilia, V1, P2, DOI 10.1186/2046-2530-1-2; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korde LA, 2010, J CLIN ONCOL, V28, P2114, DOI 10.1200/JCO.2009.25.5729; Lehmann U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-109; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lung HL, 2010, INT J CANCER, V127, P304, DOI 10.1002/ijc.25047; Nilsson C, 2013, MODERN PATHOL, V26, P87, DOI 10.1038/modpathol.2012.145; Nilsson C, 2013, ACTA ONCOL, V52, P102, DOI 10.3109/0284186X.2012.711952; Nilsson C, 2011, ACTA ONCOL, V50, P1083, DOI 10.3109/0284186X.2011.602114; Orr N, 2012, NAT GENET, V44, P1182, DOI 10.1038/ng.2417; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Saalbach A, 2005, ONCOGENE, V24, P4710, DOI 10.1038/sj.onc.1208559; Salari K, 2010, BIOINFORMATICS, V26, P414, DOI 10.1093/bioinformatics/btp702; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Solvang HK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-197; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tommasi S, 2010, ANAL CELL PATHOL, V33, P113, DOI [10.1155/2010/468280, 10.3233/ACP-CLO-2010-0544]; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; [No title captured]; [No title captured], DOI DOI 10.1038/NATURE11017.PUBMED:22722201	50	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78299	10.1371/journal.pone.0078299	http://dx.doi.org/10.1371/journal.pone.0078299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194916	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000095
J	Koch, CT; Bruggmann, R; Tetens, J; Drogemuller, C				Koch, Caroline Tina; Bruggmann, Remy; Tetens, Jens; Droegemueller, Cord			A Non-Coding Genomic Duplication at the HMX1 Locus Is Associated with Crop Ears in Highland Cattle	PLOS ONE			English	Article							INHERITANCE	Highland cattle with congenital crop ears have notches of variable size on the tips of both ears. In some cases, cartilage deformation can be seen and occasionally the external ears are shortened. We collected 40 cases and 80 controls across Switzerland. Pedigree data analysis confirmed a monogenic autosomal dominant mode of inheritance with variable expressivity. All affected animals could be traced back to a single common ancestor. A genome-wide association study was performed and the causative mutation was mapped to a 4 Mb interval on bovine chromosome 6. The H6 family homeobox 1 (HMX1) gene was selected as a positional and functional candidate gene. By whole genome re-sequencing of an affected Highland cattle, we detected 6 non-synonymous coding sequence variants and two variants in an ultra-conserved element at the HMX1 locus with respect to the reference genome. Of these 8 variants, only a non-coding 76 bp genomic duplication (g.106720058_106720133dup) located in the conserved region was perfectly associated with crop ears. The identified copy number variation probably results in HMX1 misregulation and possible gain-of-function. Our findings confirm the role of HMX1 during the development of the external ear. As it is sometimes difficult to phenotypically diagnose Highland cattle with slight ear notches, genetic testing can now be used to improve selection against this undesired trait.	[Koch, Caroline Tina; Droegemueller, Cord] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Bruggmann, Remy] Univ Bern, Interfac Bioinformat Unit, Bern, Switzerland; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	University of Bern; University of Bern; University of Kiel	Drogemuller, C (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	cord.droegemueller@vetsuisse.unibe.ch		Bruggmann, Remy/0000-0001-5629-6363; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X				Alasti F, 2009, J MED GENET, V46, P361, DOI 10.1136/jmg.2008.062158; [Anonymous], 2013, DAIRY GOAT J; [Anonymous], 2013, WHO INT CLASS DIS; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Lacombe D, 1997, Rev Laryngol Otol Rhinol (Bord), V118, P5; Liu GE, 2012, FUNCT INTEGR GENOMIC, V12, P609, DOI 10.1007/s10142-012-0289-9; Lush JL, 1922, J HERED, V13, P8, DOI 10.1093/oxfordjournals.jhered.a102155; MacDONALD M. A., 1957, JOUR HEREDITY, V48, P244; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Quina LA, 2012, DIS MODEL MECH, V5, P812, DOI 10.1242/dmm.009910; SCHEIDER A, 1994, BERL MUNCH TIERARZTL, V107, P348; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Thomson RG, 2001, THOMSONS SPECIAL VET; Wriedt C, 1925, Z TIERZ ZUCHTUNGSBIO, V3, P235; Yamane J, 1915, J COL AGR TOHOKU IMP, V6, P166	17	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77841	10.1371/journal.pone.0077841	http://dx.doi.org/10.1371/journal.pone.0077841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194898	Green Submitted, gold, Green Published			2022-12-25	WOS:000326037000077
J	Bos, MEH; Taverne, FJ; van Geijlswijk, IM; Mouton, JW; Mevius, DJ; Heederik, DJJ				Bos, Marian E. H.; Taverne, Femke J.; van Geijlswijk, Ingeborg M.; Mouton, Johan W.; Mevius, Dik J.; Heederik, Dick J. J.		Netherlands Vet Med Authority SDa	Consumption of Antimicrobials in Pigs, Veal Calves, and Broilers in The Netherlands: Quantitative Results of Nationwide Collection of Data in 2011	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ANIMALS; FARMERS; HEALTH; COSTS; HERDS; USAGE; MEAT; FOOD	In 2011, Dutch animal production sectors started recording veterinary antimicrobial consumption. These data are used by the Netherlands Veterinary Medicines Authority to create transparency in and define benchmark indicators for veterinary consumption of antimicrobials. This paper presents the results of sector wide consumption of antimicrobials, in the form of prescriptions or deliveries, for all pig, veal calf, and broiler farms. Data were used to calculate animal defined daily dosages per year (ADDD/Y) per pig or veal calf farm. For broiler farms, number of animal treatment days per year was calculated. Furthermore, data were used to calculate the consumption of specific antimicrobial classes per administration route per pig or veal calf farm. The distribution of antimicrobial consumption per farm varied greatly within and between farm categories. All categories, except for rose starter farms, showed a highly right skewed distribution with a long tail. Median ADDD/Y values varied from 1.2 ADDD/Y for rose finisher farms to 83.2 ADDD/Y for rose starter farms, with 28.6 ADDD/Y for white veal calf farms. Median consumption in pig farms was 9.3 ADDD/Y for production pig farms and 3.0 ADDD/Y for slaughter pig farms. Median consumption in broiler farms was 20.9 ATD/Y. Regarding specific antimicrobial classes, fluoroquinolones were mainly used on veal calf farms, but in low quantities: P75 range was 0 - 0.99 ADDD/Y, and 0 - 0.04 ADDD/Y in pig farms. The P75 range for 3rd/4th - generation cephalosporins was 0 - 0.07 ADDD/Y for veal calf farms, and 0 - 0.1 ADDD/Y for pig farms. The insights obtained from these results, and the full transparency obtained by monitoring antimicrobial consumption per farm, will help reduce antimicrobial consumption and endorse antimicrobial stewardship. The wide and skewed distribution in consumption has important practical and methodological implications for benchmarking, surveillance and future analysis of trends.	[Bos, Marian E. H.; Heederik, Dick J. J.] Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands; [Taverne, Femke J.; van Geijlswijk, Ingeborg M.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Mouton, Johan W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Mevius, Dik J.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Mevius, Dik J.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands	Utrecht University; Utrecht University; Radboud University Nijmegen; Utrecht University; Wageningen University & Research	Bos, MEH (corresponding author), Univ Utrecht, Div Environm Epidemiol, Inst Risk Assessment Sci, Utrecht, Netherlands.	m.e.h.bos@uu.nl	mouton, johan w/C-5915-2014; van Geijlswijk, Ingeborg M./A-5022-2015	mouton, johan w/0000-0001-6736-4149; van Geijlswijk, Ingeborg M./0000-0003-1306-8605; Heederik, Dick/0000-0002-4550-1437				Alban L, 2013, PREV VET MED, V108, P334, DOI 10.1016/j.prevetmed.2012.11.010; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bondt N., 2012, TRENDS VET ANTIBIOTI; Bondt N, 2013, PREV VET MED, V108, P10, DOI 10.1016/j.prevetmed.2012.07.009; Bos MEH, 2012, PREV VET MED, V105, P155, DOI 10.1016/j.prevetmed.2012.01.002; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; European Center for disease prevention and control, 2012, ANN REP EUR ANT RES; European Centre for Disease Prevention and Control, 2012, SUMM LAT DAT ANT CON; European Medicines Agency, 2012, EMA887282012; European Surveillance of Veterinary Antimicrobial Consumption, 2012, EMA2864162012CONSULT; Graveland H, 2012, PREV VET MED, V107, P180, DOI 10.1016/j.prevetmed.2012.06.006; Health Council of the Netherlands, 2011, ANT FOOD AN PROD RES; Jensen VF, 2004, PREV VET MED, V64, P201, DOI 10.1016/j.prevetmed.2004.04.001; Jensen VF, 2006, J ANTIMICROB CHEMOTH, V58, P101, DOI 10.1093/jac/dkl201; Jensen VF, 2010, PREV VET MED, V95, P239, DOI 10.1016/j.prevetmed.2010.04.001; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Liebana E, 2013, CLIN INFECT DIS, V56, P1030, DOI 10.1093/cid/cis1043; Mevius D, 2012, MONITORING ANTIMICRO; Mevius D.J.K., 2009, MONITORING ANTIMICRO; Moulin G, 2008, J ANTIMICROB CHEMOTH, V62, P617, DOI 10.1093/jac/dkn213; Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P663, DOI 10.1289/ehp.9760; SCHOP WA, 2012, INFECTIEZIEKTEN B, V23, P77; The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, 2012, DANMAP 2011 US ANT A; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van der Zee A, 2013, AM J INFECT CONTROL, V41, P204, DOI 10.1016/j.ajic.2012.02.033; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; World Health Organisation, 2012, WHO FACT SHEET ANT R	31	75	74	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77525	10.1371/journal.pone.0077525	http://dx.doi.org/10.1371/journal.pone.0077525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204857	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600035
J	Das, R				Das, Rhiju			Atomic-Accuracy Prediction of Protein Loop Structures through an RNA-Inspired Ansatz	PLOS ONE			English	Article							MOLECULAR-STRUCTURE; CRYSTAL; REFINEMENT; DOCKING; DESIGN; MODEL; CRYSTALLOGRAPHY; CONFORMATIONS; OPTIMIZATION; CASP9	Consistently predicting biopolymer structure at atomic resolution from sequence alone remains a difficult problem, even for small sub-segments of large proteins. Such loop prediction challenges, which arise frequently in comparative modeling and protein design, can become intractable as loop lengths exceed 10 residues and if surrounding side-chain conformations are erased. Current approaches, such as the protein local optimization protocol or kinematic inversion closure (KIC) Monte Carlo, involve stages that coarse-grain proteins, simplifying modeling but precluding a systematic search of all-atom configurations. This article introduces an alternative modeling strategy based on a 'stepwise ansatz', recently developed for RNA modeling, which posits that any realistic all-atom molecular conformation can be built up by residue-by-residue stepwise enumeration. When harnessed to a dynamic-programming-like recursion in the Rosetta framework, the resulting stepwise assembly (SWA) protocol enables enumerative sampling of a 12 residue loop at a significant but achievable cost of thousands of CPU-hours. In a previously established benchmark, SWA recovers crystallographic conformations with sub-Angstrom accuracy for 19 of 20 loops, compared to 14 of 20 by KIC modeling with a comparable expenditure of computational power. Furthermore, SWA gives high accuracy results on an additional set of 15 loops highlighted in the biological literature for their irregularity or unusual length. Successes include cis-Pro touch turns, loops that pass through tunnels of other side-chains, and loops of lengths up to 24 residues. Remaining problem cases are traced to inaccuracies in the Rosetta all-atom energy function. In five additional blind tests, SWA achieves sub-Angstrom accuracy models, including the first such success in a protein/RNA binding interface, the YbxF/kink-turn interaction in the fourth 'RNA-puzzle' competition. These results establish all-atom enumeration as an unusually systematic approach to ab initio protein structure modeling that can leverage high performance computing and physically realistic energy functions to more consistently achieve atomic accuracy.	[Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Das, R (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	rhiju@stanford.edu		Das, Rhiju/0000-0001-7497-0972	Burroughs Wellcome Career Award at the Scientific Interface; NIH [R21 GM102716]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM102716] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support came from a Burroughs Wellcome Career Award at the Scientific Interface and NIH R21 GM102716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Baird NJ, 2012, RNA, V18, P759, DOI 10.1261/rna.031518.111; BUCKLE AM, 1993, J MOL BIOL, V234, P847, DOI 10.1006/jmbi.1993.1630; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chen SJ, 2000, P NATL ACAD SCI USA, V97, P646, DOI 10.1073/pnas.97.2.646; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Chu MH, 2011, PLANTA, V234, P243, DOI 10.1007/s00425-011-1398-8; Cruz JA, 2012, RNA, V18, P610, DOI 10.1261/rna.031054.111; Das R, 2011, PLOS ONE, V6; Das R, 2009, P NATL ACAD SCI USA, V106, P18978, DOI 10.1073/pnas.0904407106; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Eddy SR, 2004, NAT BIOTECHNOL, V22, P909, DOI 10.1038/nbt0704-909; Eswar N, 2003, PROTEIN ENG, V16, P331, DOI 10.1093/protein/gzg046; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; GIBSON KD, 1987, J COMPUT CHEM, V8, P826, DOI 10.1002/jcc.540080611; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grigg JC, 2013, P NATL ACAD SCI USA, V110, P7240, DOI 10.1073/pnas.1222214110; Hammond NB, 2010, BIOCHEMISTRY-US, V49, P5817, DOI 10.1021/bi100332r; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HARRIS GW, 1992, ACTA CRYSTALLOGR B, V48, P67, DOI 10.1107/S0108768191006663; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hockenmaier J, 2007, PROTEINS, V66, P1, DOI 10.1002/prot.21195; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kratzner R, 2005, ACTA CRYSTALLOGR D, V61, P1255, DOI 10.1107/S0907444905021207; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lyskov S, 2013, PLOS ONE IN PRESS; Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Martin ACR, 1995, PROTEIN ENG, V8, P1093; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MCPHALEN CA, 1985, P NATL ACAD SCI USA, V82, P7242, DOI 10.1073/pnas.82.21.7242; MCPHALEN CA, 1987, BIOCHEMISTRY-US, V26, P261, DOI 10.1021/bi00375a036; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Ollikainen N, 2013, METHOD ENZYMOL, V523, P61, DOI 10.1016/B978-0-12-394292-0.00004-7; Ozkan SB, 2007, P NATL ACAD SCI USA, V104, P11987, DOI 10.1073/pnas.0703700104; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Raval A, 2012, PROTEINS; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Sellers BD, 2008, PROTEINS, V72, P959, DOI 10.1002/prot.21990; Sontag D, 2008, TIGHTENING LP RELAXA, P503; Sripakdeevong P, 2011, P NATL ACAD IN PRESS; Sripakdeevong P, 2013, NAT METHODS IN PRESS; Sripakdeevong P, 2011, P NATL ACAD SCI USA, V108, P20573, DOI 10.1073/pnas.1106516108; Urakubo Y, 2008, PROTEIN SCI, V17, P1055, DOI 10.1110/ps.073322508; VAJDA S, 1990, BIOPOLYMERS, V29, P1755, DOI 10.1002/bip.360291408; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Vernon R, 2010, STRUCTURE PREDICTION; Videau LL, 2004, PROTEINS, V56, P298, DOI 10.1002/prot.20101; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Zhu K, 2006, PROTEINS, V65, P438, DOI 10.1002/prot.21040	65	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e74830	10.1371/journal.pone.0074830	http://dx.doi.org/10.1371/journal.pone.0074830			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204571	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600003
J	Jonas, JB; Nangia, V; Matin, A; Bhojwani, K; Sinha, A; Khare, A; Agarwal, S; Bhate, K				Jonas, Jost B.; Nangia, Vinay; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma			Pseudoexfoliation: Normative Data and Associations. The Central India Eye and Medical Study	PLOS ONE			English	Article							POPULATION-BASED SURVEY; ANGLE-CLOSURE GLAUCOMA; EXFOLIATION SYNDROME; INTRAOCULAR-PRESSURE; OCCLUDABLE ANGLES; THESSALONIKI EYE; CHINESE PEOPLE; SOUTHERN INDIA; PREVALENCE; CHAMBER	Purpose: To assess the prevalence of pseudoexfoliation (PEX) and its associations in a population-based setting. Design: Population-based, cross-sectional study. Methods: The Central India Eye and Medical Study included 4711 individuals. All study participants underwent a detailed ophthalmological examination. After medical pupil dilation, PEX was assessed by an experienced ophthalmologist using slit-lamp based biomicroscopy. Results: Slit lamp examination results were available for 4646 (98.6%) study participants with a mean age of 49.3 +/- 13.3 years (range: 30-100 years). PEX was detected in 87 eyes (prevalence: 0.95 +/- 0.10% (95% CI: 0.75, 1.15) of 69 subjects (prevalence: 1.49 +/- 0.18% (95% CI: 1.14, 1.83). PEX prevalence increased significantly (P<0.001) from 0% in the age group of 30-39 years, to 2.85 +/- 0.56% in the age group of 60-69 years, to 6.60 +/- 1.21% in the age group of 70-79 years, and to 12.3 +/- 4.11% in the age group of 80+ years. In multivariate analysis, PEX prevalence was associated with higher age (P<0.001; regression coefficient B:0.11; odds ratio (OR): 1.11 (95% CI: 1.09, 1.13)), lower body mass index (P = 0.001; B:-0.12; OR: 0.88 (95CI: 0.82, 0.95)) and higher diastolic blood pressure (P = 0.002; B: 0.02; OR: 1.03 (95% CI: 1.01, 1.04)). In the multivariate analysis, PEX was not associated with retinal nerve fiber layer cross section area (P = 0.76) and presence of open-angle glaucoma (P = 0.15). Conclusions: In a rural Central Indian population aged 30+ years, PEX prevalence (mean: 1.49 +/- 0.18%) was significantly associated with older age, lower body mass index and higher diastolic blood pressure. It was not significantly associated with optic nerve head measurements, refractive error, any ocular biometric parameter, nuclear cataract, early age-related macular degeneration and retinal vein occlusion, diabetes mellitus, smoking, and dyslipidemia.	[Jonas, Jost B.; Nangia, Vinay; Matin, Arshia; Bhojwani, Krishna; Sinha, Ajit; Khare, Anshu; Agarwal, Shubhra; Bhate, Karishma] Suraj Eye Inst, Nagpur, Maharashtra, India; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Suraj Eye Institute; Ruprecht Karls University Heidelberg	Jonas, JB (corresponding author), Suraj Eye Inst, Nagpur, Maharashtra, India.	Jost.Jonas@medma.uni-heidelberg.de; nagpursuraj@gmail.com	Bhate, Karishma/AAD-8609-2019		Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; Carl Zeiss Meditec Co., Jena, Germany	Supported by an unrestricted grant from Om Drishti Trust, Nagpur, India; Heidelberg Engineering Co., Heidelberg, Germany; Rotary Sight Saver Netherlands; ORBIS International; and Carl Zeiss Meditec Co., Jena, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman AM, 2008, BRIT J OPHTHALMOL, V92, P1325, DOI 10.1136/bjo.2008.141523; Anastasopoulos E, 2011, J GLAUCOMA, V20, P160, DOI 10.1097/IJG.0b013e3181d9d8bd; Arnarsson A, 2007, ACTA OPHTHALMOL SCAN, V85, P822, DOI 10.1111/j.1600-0420.2007.01051.x; Arvind H, 2003, BRIT J OPHTHALMOL, V87, P1321, DOI 10.1136/bjo.87.11.1321; Astrom S, 2007, ACTA OPHTHALMOL SCAN, V85, P828, DOI 10.1111/j.1600-0420.2007.00992.x; Belovay GW, 2010, CURR OPIN OPHTHALMOL, V21, P25, DOI 10.1097/ICU.0b013e328332f814; Forsman E, 2007, ACTA OPHTHALMOL SCAN, V85, P500, DOI 10.1111/j.1600-0420.2007.00978.x; Foster PJ, 2005, BRIT J OPHTHALMOL, V89, P239, DOI 10.1136/bjo.2004.047605; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2000, BRIT J OPHTHALMOL, V84, P186, DOI 10.1136/bjo.84.2.186; GROSS FJ, 1994, AM J OPHTHALMOL, V117, P333, DOI 10.1016/S0002-9394(14)73141-1; HILLER R, 1982, ARCH OPHTHALMOL-CHIC, V100, P1080; Kang JH, 2012, OPHTHALMOLOGY, V119, P27, DOI 10.1016/j.ophtha.2011.06.018; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Krishnadas R, 2003, AM J OPHTHALMOL, V135, P830, DOI 10.1016/S0002-9394(02)02271-7; Landers J, 2012, CLIN EXP OPHTHALMOL, V40, P454, DOI 10.1111/j.1442-9071.2011.02696.x; McCarty CA, 2000, AM J OPHTHALMOL, V129, P629, DOI 10.1016/S0002-9394(99)00466-3; Miyazaki M, 2005, J GLAUCOMA, V14, P482, DOI 10.1097/01.ijg.0000185436.15675.b3; Nangia V, 2010, OPHTHALMOLOGY, V117, P1360, DOI 10.1016/j.ophtha.2009.11.040; Naumann GOH, 1998, OPHTHALMOLOGY, V105, P951, DOI 10.1016/S0161-6420(98)96020-1; Nouri-Mahdavi K, 1999, ACTA OPHTHALMOL SCAN, V77, P581, DOI 10.1034/j.1600-0420.1999.770521.x; Ritch R, 1994, J Glaucoma, V3, P176; Ritch R, SURV OPHTHALMOL, V45, P265; Rotchford AP, 2003, ARCH OPHTHALMOL-CHIC, V121, P863, DOI 10.1001/archopht.121.6.863; Rudkin AK, 2008, BRIT J OPHTHALMOL, V92, P1595, DOI 10.1136/bjo.2008.146407; SCHLOTZERSCHREHARDT UM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1752, DOI 10.1001/archopht.1992.01080240092038; Stein JD, 2011, ARCH OPHTHALMOL-CHIC, V129, P1053, DOI 10.1001/archophthalmol.2011.191; STREETEN BW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1757, DOI 10.1001/archopht.1992.01080240097039; Thomas R, 2005, INVEST OPHTH VIS SCI, V46, P1170, DOI 10.1167/iovs.04-1062; Thomas R, 2012, INDIAN J OPHTHALMOL, V60, P446, DOI 10.4103/0301-4738.100546; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Topouzis F, 2011, AM J OPHTHALMOL, V152, P219, DOI 10.1016/j.ajo.2011.01.032; Topouzis F, 2009, AM J OPHTHALMOL, V148, P606, DOI 10.1016/j.ajo.2009.03.024; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; Viso E, 2010, OPHTHAL EPIDEMIOL, V17, P118, DOI 10.3109/09286581003624970; You QS, 2013, OPHTHALMOLOGY, V2013; Young AL, 2004, BRIT J OPHTHALMOL, V88, P193, DOI 10.1136/bjo.2003.021816	37	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76770	10.1371/journal.pone.0076770	http://dx.doi.org/10.1371/journal.pone.0076770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204672	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600010
J	Salemme, M; Sica, M; Iazzetti, G; Gaudio, L; Aceto, S				Salemme, Marinella; Sica, Maria; Iazzetti, Giovanni; Gaudio, Luciano; Aceto, Serena			The AP2-Like Gene OitaAP2 Is Alternatively Spliced and Differentially Expressed in Inflorescence and Vegetative Tissues of the Orchid Orchis italica	PLOS ONE			English	Article							FLORAL ORGAN IDENTITY; MERISTEM CELL FATE; MADS-BOX GENES; TRANSCRIPTION FACTOR; APETALA2-LIKE GENES; ARABIDOPSIS FLOWER; PICEA-ABIES; SEED MASS; DOMAIN; MICRORNA	The AP2/ERF proteins are plant-specific transcription factors involved in multiple regulatory pathways, from plant organ development to response to various environmental stresses. One of the mechanisms that regulates the AP2-like genes involves the microRNA miR172, which controls their activity at the post-transcriptional level. Extensive studies on AP2-like genes are available in many different species; however, in orchids, one of the largest plant families, studies are restricted to a few species, all belonging to the Epidendroideae subfamily. In the present study, we report the isolation of an AP2-like gene in the Mediterranean orchid Orchis italica (Orchidoideae). The OitaAP2 locus includes 10 exons and 9 introns, and its transcript is alternatively spliced, resulting in the long OitaAP2 and the short OitaAP2_ISO isoforms, with the latter skipping exon 9. Both isoforms contain the conserved target site for miR172, whose action is demonstrated by the presence of cleaved OitaAP2 mRNA. The OitaAP2 and OitaAP2_ISO mRNAs are present in the tepals and lip before and after anthesis at different expression levels. In addition, the OitaAP2_ISO isoform is expressed in the ovary before pollination and in the root and stem. The isoform-specific expression pattern suggests a functional differentiation of the OitaAP2 alternatively spliced transcripts. The expression profile of miR172 is complementary to that of the OitaAP2 isoforms in inflorescence tissues before anthesis, whereas after anthesis and in ovary tissue before and after pollination, this relationship disappears, suggesting the existence of OitaAP2 inhibitory mechanisms in these tissues that differ from that involving miR172.	[Salemme, Marinella; Sica, Maria; Iazzetti, Giovanni; Gaudio, Luciano; Aceto, Serena] Univ Naples Federico II, Dept Biol, Naples, Italy	University of Naples Federico II	Aceto, S (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	serena.aceto@unina.it	Gaudio, Luciano/AAF-4322-2020; Aceto, Serena/E-5350-2010	Gaudio, Luciano/0000-0002-0172-2190; Aceto, Serena/0000-0003-3906-4872	Regione Campania [L.R. N5/2002]	Regione Campania(Regione Campania)	This work was supported by the 2009 Regione Campania Grant L.R. N5/2002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2008, DEVELOPMENT, V135, P3013, DOI 10.1242/dev.024273; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Dinh TT, 2012, DEVELOPMENT, V139, P1978, DOI 10.1242/dev.077073; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Gil-Humanes J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-66; Guillaumot D, 2008, J PLANT PHYSIOL, V165, P1003, DOI 10.1016/j.jplph.2007.08.009; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Javelle M, 2011, JOVE-J VIS EXP, DOI 10.3791/3328; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; KUNST L, 1989, PLANT CELL, V1, P1195, DOI 10.1105/tpc.1.12.1195; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Lin CS, 2013, PLANT MOL BIOL, V82, P193, DOI 10.1007/s11103-013-0055-y; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mondragon-Palomino M, 2011, PLANT J, V66, P1008, DOI 10.1111/j.1365-313X.2011.04560.x; Nilsson L, 2007, PLANTA, V225, P589, DOI 10.1007/s00425-006-0374-1; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Rashid M, 2012, EVOL BIOINFORM, V8, P321, DOI 10.4137/EBO.S9369; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Riechmann JL, 1998, BIOL CHEM, V379, P633; Salemme M, 2013, MOL BIOL REP, V40, P3523, DOI 10.1007/s11033-012-2426-x; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Shi Rui, 2012, Methods Mol Biol, V822, P53, DOI 10.1007/978-1-61779-427-8_4; Shigyo M, 2004, DEV GENES EVOL, V214, P105, DOI 10.1007/s00427-004-0385-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vahala T, 2001, J EXP BOT, V52, P1111, DOI 10.1093/jexbot/52.358.1111; Varkonyi-Gasic E, 2012, PLANT MOL BIOL, V78, P417, DOI 10.1007/s11103-012-9877-2; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Wollmann H, 2010, DEVELOPMENT, V137, P3633, DOI 10.1242/dev.036673; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Xu YF, 2006, PLANT J, V46, P54, DOI 10.1111/j.1365-313X.2006.02669.x; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606; Zahn LM, 2005, J HERED, V96, P225, DOI 10.1093/jhered/esi033; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	56	9	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77454	10.1371/journal.pone.0077454	http://dx.doi.org/10.1371/journal.pone.0077454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204832	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600033
J	Pescador, N; Perez-Barba, M; Ibarra, JM; Corbaton, A; Martinez-Larrad, MT; Serrano-Rios, M				Pescador, Nuria; Perez-Barba, Milagros; Maria Ibarra, Jose; Corbaton, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel			Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; CELLS; CANCER	Background and Aim: MicroRNAs are small non-coding RNAs that play important regulatory roles in a variety of biological processes, including complex metabolic processes, such as energy and lipid metabolism, which have been studied in the context of diabetes and obesity. Some particular microRNAs have recently been demonstrated to abundantly and stably exist in serum and to be potentially disease-specific. The aim of this profiling study was to characterize the expression of miRNA in serum samples of obese, nonobese diabetic and obese diabetic individuals to determine whether miRNA expression was deregulated in these serum samples and to identify whether any observed deregulation was specific to either obesity or diabetes or obesity with diabetes. Patients and Methods: Thirteen patients with type 2 diabetes, 20 obese patients, 16 obese patients with type 2 diabetes and 20 healthy controls were selected for this study. MiRNA PCR panels were employed to screen serum levels of 739 miRNAs in pooled samples from these four groups. We compared the levels of circulating miRNAs between serum pools of each group. Individual validation of the twelve microRNAs selected as promising biomarkers was carried out using RT-qPCR. Results: Three serum microRNAs, miR-138, miR-15b and miR-376a, were found to have potential as predictive biomarkers in obesity. Use of miR-138 or miR-376a provides a powerful predictive tool for distinguishing obese patients from normal healthy controls, diabetic patients, and obese diabetic patients. In addition, the combination of miR-503 and miR-138 can distinguish diabetic from obese diabetic patients. Conclusion: This study is the first to show a panel of serum miRNAs for obesity, and compare them with miRNAs identified in serum for diabetes and obesity with diabetes. Our results support the use of some miRNAs extracted from serum samples as potential predictive tools for obesity and type 2 diabetes.	[Pescador, Nuria; Maria Ibarra, Jose; Corbaton, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain; [Pescador, Nuria; Perez-Barba, Milagros; Maria Ibarra, Jose; Corbaton, Arturo; Teresa Martinez-Larrad, Maria; Serrano-Rios, Manuel] Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Madrid, Spain		Serrano-Rios, M (corresponding author), Spanish Biomed Res Ctr Diabet & Associated Metab, Madrid, Spain.	mserrano.hcsc@salud.madrid.org	Corbatón-Anchuelo, Arturo/I-4390-2013; Serrano Ríos, Manuel/E-4625-2019; Pescador, Nuria/ABG-8337-2020	Corbatón-Anchuelo, Arturo/0000-0002-8775-4766; Serrano Ríos, Manuel/0000-0002-3214-1444; 	CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); Madrid Autonomous Community [MOIR S2010/BMD-2423]; Eli Lilly Lab, Spain	CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion); Madrid Autonomous Community; Eli Lilly Lab, Spain(Eli Lilly)	This work was funded by CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovacion) and Madrid Autonomous Community (MOIR S2010/BMD-2423). Partial support also came from Educational Grants from Eli Lilly Lab, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Aranceta Bartrina J, 2002, Nutr Hosp, V17 Suppl 1, P34; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Fayyad-Kazan H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-31; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Gong H, 2013, CLIN CANCER RES, V19, P1083, DOI 10.1158/1078-0432.CCR-12-3169; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Kussmann M, 2006, J BIOTECHNOL, V124, P758, DOI 10.1016/j.jbiotec.2006.02.014; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Macias-Gonzalez M, 2009, EUR J CLIN INVEST, V39, P972, DOI 10.1111/j.1365-2362.2009.02198.x; Mellitzer G, 2004, MOL ENDOCRINOL, V18, P2765, DOI 10.1210/me.2004-0243; Mueller Guenter, 2010, Archives of Physiology and Biochemistry, V116, P28, DOI 10.3109/13813450903508812; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Permana PA, 2004, NUTRITION, V20, P134, DOI 10.1016/j.nut.2003.09.023; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rocha PM, 2008, METABOLISM, V57, P1315, DOI 10.1016/j.metabol.2008.01.003; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schmid C, 2006, SWISS MED WKLY, V136, P254; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Youssef WI, 2002, BEST PRACT RES CL GA, V16, P733, DOI 10.1053/bega.2002.0334; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang YH, 2013, DIABETES RES CLIN PR, V99, P327, DOI 10.1016/j.diabres.2012.11.025; Zheng YX, 2012, FEBS LETT, V586, P2396, DOI 10.1016/j.febslet.2012.05.054	34	180	188	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77251	10.1371/journal.pone.0077251	http://dx.doi.org/10.1371/journal.pone.0077251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204780	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100052
J	Bause, AS; Matsui, MS; Haigis, MC				Bause, Alexandra S.; Matsui, Mary S.; Haigis, Marcia C.			The Protein Deacetylase SIRT3 Prevents Oxidative Stress-induced Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Keratinocytes; Mitochondria; Reactive Oxygen Species (ROS); Sirtuins; SIRT3	HUMAN EPIDERMAL-KERATINOCYTES; TERMINAL DIFFERENTIATION; SUPEROXIDE; MITOCHONDRIA; EXPRESSION	Background: SIRT3 plays a major role in protecting against mitochondrial oxidative stress. Results: Oxidative stress increases during keratinocyte differentiation, and SIRT3 can decrease differentiation by attenuating oxidative stress. Conclusion: SIRT3-induced down-regulation of mitochondrial oxidative stress attenuates keratinocyte differentiation. Significance: Understanding the regulation of keratinocyte differentiation is crucial for developing new therapies against dysregulated skin differentiation and aging. Keratinocyte differentiation is a key process in the formation and maintenance of the protective skin barrier. Dysregulation in the balance of reactive oxygen species homeostasis may play a role in keratinocyte differentiation. We have identified the mitochondrial deacetylase SIRT3 as a key regulator of mitochondrial reactive oxygen species in keratinocytes. Our studies demonstrate that SIRT3 expression is down-regulated during keratinocyte differentiation, consistent with an increase in mitochondrial superoxide levels. Importantly, loss of SIRT3 expression in keratinocytes increased superoxide levels and promoted the expression of differentiation markers, whereas overexpression decreased superoxide levels and reduced the expression of differentiation markers. These findings identify a new role for SIRT3 in the suppression of epidermal differentiation via lowering oxidative stress.	[Bause, Alexandra S.; Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Matsui, Mary S.] Estee Lauder Co Inc, Melville, NY 11747 USA	Harvard University; Harvard Medical School; Estee Lauder Companies	Haigis, MC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, SGM 329C,250 Longwood Ave, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu			Estee Lauder Companies Inc.; German Academic Exchange Service; Glenn Foundation for Medical Research	Estee Lauder Companies Inc.; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Glenn Foundation for Medical Research	This work was supported by The Estee Lauder Companies Inc. (to M. C. H.), the German Academic Exchange Service (to A. S. B.), and the Glenn Foundation for Medical Research (to the Haigis laboratory).	Allombert-Blaise C, 2003, CELL DEATH DIFFER, V10, P850, DOI 10.1038/sj.cdd.4401245; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008; Bellizzi D, 2009, MOL CELLS, V28, P87, DOI 10.1007/s10059-009-0110-3; Benrahmoune M, 2000, FREE RADICAL BIO MED, V29, P775, DOI 10.1016/S0891-5849(00)00380-4; Bose A., 2012, PLOS ONE, V7; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hornig-Do HT, 2007, J INVEST DERMATOL, V127, P1084, DOI 10.1038/sj.jid.5700666; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Kalinin A, 2001, J CELL SCI, V114, P3069; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rutberg SE, 1996, ONCOGENE, V13, P167; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; STEVEN AC, 1994, J CELL SCI, V107, P693; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tamiji S, 2005, J INVEST DERMATOL, V125, P647, DOI 10.1111/j.0022-202X.2005.23885.x; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Velarde MC, 2012, AGING-US, V4, P3, DOI 10.18632/aging.100423; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	26	26	27	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36484	36491		10.1074/jbc.M113.472324	http://dx.doi.org/10.1074/jbc.M113.472324			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194516	Green Published, hybrid			2022-12-25	WOS:000328883400029
J	Giorgini, F; Huang, SY; Sathyasaikumar, KV; Notarangelo, FM; Thomas, MAR; Tararina, M; Wu, HQ; Schwarcz, R; Muchowski, PJ				Giorgini, Flaviano; Huang, Shao-Yi; Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Thomas, Marian A. R.; Tararina, Margarita; Wu, Hui-Qiu; Schwarcz, Robert; Muchowski, Paul J.			Targeted Deletion of Kynurenine 3-Monooxygenase in Mice A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metabolism; Neurodegeneration; Neuroprotection; Schizophrenia; Tryptophan; Kynurenic Acid; Kynurenine; Kynurenine 3-Monooxygenase	ARYL-HYDROCARBON RECEPTOR; QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE; CONVERT L-TRYPTOPHAN; 3-HYDROXYANTHRANILIC ACID; INDOLEAMINE 2,3-DIOXYGENASE; INHIBITION; SCHIZOPHRENIA; INFLAMMATION; 3-HYDROXYKYNURENINE; HYDROXYLASE	Background: Kynurenine 3-monooxygenase (KMO) is hypothesized to play a pivotal role in regulating tryptophan metabolism in health and disease. Results: Mice that were generated lacking KMO have alterations in the levels of several tryptophan metabolites. Conclusion: KMO is a critical regulator of tryptophan metabolism. Significance: KMO knock-out mice will be a useful research tool to dissect the biological and pathophysiological roles of tryptophan metabolism. Kynurenine 3-monooxygenase (KMO), a pivotal enzyme in the kynurenine pathway (KP) of tryptophan degradation, has been suggested to play a major role in physiological and pathological events involving bioactive KP metabolites. To explore this role in greater detail, we generated mice with a targeted genetic disruption of Kmo and present here the first biochemical and neurochemical characterization of these mutant animals. Kmo(-/-) mice lacked KMO activity but showed no obvious abnormalities in the activity of four additional KP enzymes tested. As expected, Kmo(-/-) mice showed substantial reductions in the levels of its enzymatic product, 3-hydroxykynurenine, in liver, brain, and plasma. Compared with wild-type animals, the levels of the downstream metabolite quinolinic acid were also greatly decreased in liver and plasma of the mutant mice but surprisingly were only slightly reduced (by approximate to 20%) in the brain. The levels of three other KP metabolites: kynurenine, kynurenic acid, and anthranilic acid, were substantially, but differentially, elevated in the liver, brain, and plasma of Kmo(-/-) mice, whereas the liver and brain content of the major end product of the enzymatic cascade, NAD(+), did not differ between Kmo(-/-) and wild-type animals. When assessed by in vivo microdialysis, extracellular kynurenic acid levels were found to be significantly elevated in the brains of Kmo(-/-) mice. Taken together, these results provide further evidence that KMO plays a key regulatory role in the KP and indicate that Kmo(-/-) mice will be useful for studying tissue-specific functions of individual KP metabolites in health and disease.	[Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Huang, Shao-Yi; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Thomas, Marian A. R.; Tararina, Margarita; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA	University of Leicester; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore	Muchowski, PJ (corresponding author), Soteria Therapeut, 195 Beacon St, San Francisco, CA 94131 USA.	paulmuchowski@gmail.com	Schwarcz, Robert/P-3134-2018	Giorgini, Flaviano/0000-0001-7881-9508; Tararina, Margarita/0000-0003-4750-2289	National Institutes of Health from the United States Public Health Service [NS057715, AG022074]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS057715 and AG022074 from the United States Public Health Service.	AlberatiGiani D, 1996, ADV EXP MED BIOL, V398, P171; Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039; Amori L, 2009, J NEUROCHEM, V109, P316, DOI 10.1111/j.1471-4159.2009.05893.x; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BARAN H, 1990, J NEUROCHEM, V55, P738, DOI 10.1111/j.1471-4159.1990.tb04553.x; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Cannazza G, 2001, NEUROCHEM RES, V26, P511, DOI 10.1023/A:1010960812204; CARPENEDO R, 1994, NEUROSCIENCE, V61, P237, DOI 10.1016/0306-4522(94)90227-5; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; Chess AC, 2007, SCHIZOPHRENIA BULL, V33, P797, DOI 10.1093/schbul/sbl033; Chess AC, 2009, BEHAV BRAIN RES, V201, P325, DOI 10.1016/j.bbr.2009.03.013; CHIARUGI A, 1995, J NEUROCHEM, V65, P1176; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; Costantino G, 2009, EXPERT OPIN THER TAR, V13, P247, DOI [10.1517/14728220802665734, 10.1517/14728220802665734 ]; Cozzi A, 1999, J CEREBR BLOOD F MET, V19, P771, DOI 10.1097/00004647-199907000-00007; DECASTRO FT, 1957, J BIOL CHEM, V228, P777; DiNatale BC, 2010, TOXICOL SCI, V115, P89, DOI 10.1093/toxsci/kfq024; Erhardt S, 2004, BIOL PSYCHIAT, V56, P255, DOI 10.1016/j.biopsych.2004.06.006; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FOSTER AC, 1985, J NEUROCHEM, V44, P446, DOI 10.1111/j.1471-4159.1985.tb05435.x; FOSTER AC, 1986, J NEUROCHEM, V47, P23; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; HEYES MP, 1992, J NEUROIMMUNOL, V40, P71, DOI 10.1016/0165-5728(92)90214-6; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; HEYES MP, 1988, J CHROMATOGR-BIOMED, V428, P340, DOI 10.1016/S0378-4347(00)83925-0; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; HIRAKU Y, 1995, CARCINOGENESIS, V16, P349, DOI 10.1093/carcin/16.2.349; Holtze M, 2012, J PSYCHIATR NEUROSCI, V37, P53, DOI 10.1503/jpn.100175; ISHII T, 1992, ARCH BIOCHEM BIOPHYS, V294, P616, DOI 10.1016/0003-9861(92)90733-D; Kaszaki J, 2012, J NEURAL TRANSM, V119, P211, DOI 10.1007/s00702-011-0658-x; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; LEKLEM JE, 1971, AM J CLIN NUTR, V24, P659; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Mandi Y, 2012, J NEURAL TRANSM, V119, P197, DOI 10.1007/s00702-011-0681-y; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller CL, 2008, NEUROCHEM INT, V52, P1297, DOI 10.1016/j.neuint.2008.01.013; MOFFETT JR, 1994, CELL TISSUE RES, V278, P461; Morita T, 2001, ANN CLIN BIOCHEM, V38, P242, DOI 10.1258/0004563011900461; Moroni F, 2012, J NEURAL TRANSM, V119, P133, DOI 10.1007/s00702-011-0763-x; Muller N, 2006, NEUROTOX RES, V10, P131; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Notarangelo FM, 2012, ANAL BIOCHEM, V421, P573, DOI 10.1016/j.ab.2011.12.032; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Oxenkrug GF, 2011, J NEURAL TRANSM, V118, P75, DOI 10.1007/s00702-010-0475-7; Prendergast GC, 2011, CURR MED CHEM, V18, P2257, DOI 0929-8673/11 $58.00+.00; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; RIOS C, 1991, NEUROCHEM RES, V16, P1139, DOI 10.1007/BF00966592; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Sathyasaikumar KV, 2011, SCHIZOPHRENIA BULL, V37, P1147, DOI 10.1093/schbul/sbq112; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Shepard PD, 2003, NEUROPSYCHOPHARMACOL, V28, P1454, DOI 10.1038/sj.npp.1300188; Speciale C, 1996, EUR J PHARMACOL, V315, P263, DOI 10.1016/S0014-2999(96)00613-9; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; Stone TW, 2012, J NEURAL TRANSM, V119, P261, DOI 10.1007/s00702-011-0676-8; STONE TW, 1981, EUR J PHARMACOL, V72, P411, DOI 10.1016/0014-2999(81)90587-2; Terakata M, 2013, J NUTR, V143, P1046, DOI 10.3945/jn.113.176875; Terakata M, 2012, J NUTR, V142, P2148, DOI 10.3945/jn.112.167569; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Thomas M., 2012, SOC NEUR ABSTR, V37; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Wejksza K, 2009, PHARMACOL REP, V61, P751, DOI 10.1016/S1734-1140(09)70130-6; Wonodi I, 2011, ARCH GEN PSYCHIAT, V68, P665, DOI 10.1001/archgenpsychiatry.2011.71; Wonodi I, 2010, SCHIZOPHRENIA BULL, V36, P211, DOI 10.1093/schbul/sbq002; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	81	81	82	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36554	36566		10.1074/jbc.M113.503813	http://dx.doi.org/10.1074/jbc.M113.503813			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189070	hybrid, Green Published			2022-12-25	WOS:000328883400036
J	Fernandez-Murray, JP; Ngo, MH; McMaster, CR				Fernandez-Murray, J. Pedro; Ngo, Michael H.; McMaster, Christopher R.			Choline Transport Activity Regulates Phosphatidylcholine Synthesis through Choline Transporter Hnm1 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycerophospholipid; Membrane Transport; Phosphatidylcholine; Phospholipid Metabolism; Yeast Metabolism	YEAST SACCHAROMYCES-CEREVISIAE; UBIQUITIN-DEPENDENT TRAFFICKING; PHOSPHOLIPID-SYNTHESIS; TRANSFER PROTEIN; URACIL PERMEASE; ENDOCYTOSIS; GENE; BIOSYNTHESIS; PHOSPHORYLATION; PATHWAY	Background: Yeast cells grown in choline exhibit a reduction in the level of the choline transporter Hnm1. Results: Hnm1 transporter activity triggers its endocytosis by a mechanism dependent on the ubiquitin ligase Rsp5 and the casein kinases Yck1/2. Conclusion: Choline transport activity affects the stability of the Hnm1 choline transporter. Significance: Regulation of choline transporter activity constitutes an important regulatory node for phosphatidylcholine homeostasis. Choline is a precursor for the synthesis of phosphatidylcholine through the CDP-choline pathway. Saccharomyces cerevisiae expresses a single high affinity choline transporter at the plasma membrane, encoded by the HNM1 gene. We show that exposing cells to increasing levels of choline results in two different regulatory mechanisms impacting Hnm1 activity. Initial exposure to choline results in a rapid decrease in Hnm1-mediated transport at the level of transporter activity, whereas chronic exposure results in Hnm1 degradation through an endocytic mechanism that depends on the ubiquitin ligase Rsp5 and the casein kinase 1 redundant pair Yck1/Yck2. We present details of how the choline transporter is a major regulator of phosphatidylcholine synthesis.	[Fernandez-Murray, J. Pedro; Ngo, Michael H.; McMaster, Christopher R.] Dalhousie Univ, Fac Med, Dept Pharmacol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada	Dalhousie University	McMaster, CR (corresponding author), Dalhousie Univ, Fac Med, Dept Pharmacol, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada.	Christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a Canadian Institutes of Health Research grant (to C. R. M.).	Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; CLEVES AE, 1991, CELL, V64, P789, DOI 10.1016/0092-8674(91)90508-V; COTTRELL SF, 1981, J BIOL CHEM, V256, P973; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Fernandez-Murray JP, 2009, J BIOL CHEM, V284, P36034, DOI 10.1074/jbc.M109.063958; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HOSAKA K, 1980, J BACTERIOL, V143, P176, DOI 10.1128/JB.143.1.176-181.1980; Howe AG, 2002, J BIOL CHEM, V277, P44100, DOI 10.1074/jbc.M206643200; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; LEE KS, 1994, J BIOL CHEM, V269, P19725; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Litvak V, 2005, NAT CELL BIOL, V7, P225, DOI 10.1038/ncb1221; Lykidis A, 2001, PROG NUCLEIC ACID RE, V65, P361; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rudge SA, 2002, GENETICS, V160, P1353; Sarri E, 2011, J BIOL CHEM, V286, P28632, DOI 10.1074/jbc.M111.267534; SKINNER HB, 1995, P NATL ACAD SCI USA, V92, P112, DOI 10.1073/pnas.92.1.112; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; Xie ZG, 1998, P NATL ACAD SCI USA, V95, P12346, DOI 10.1073/pnas.95.21.12346	42	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36106	36115		10.1074/jbc.M113.499855	http://dx.doi.org/10.1074/jbc.M113.499855			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24187140	Green Published, hybrid			2022-12-25	WOS:000329814700045
J	Kurtenbach, S; Wewering, S; Hatt, H; Neuhaus, EM; Lubbert, H				Kurtenbach, Stefan; Wewering, Sonja; Hatt, Hanns; Neuhaus, Eva M.; Luebbert, Hermann			Olfaction in Three Genetic and Two MPTP-Induced Parkinson's Disease Mouse Models	PLOS ONE			English	Article							NEURONAL CHLORIDE ACCUMULATION; ALPHA-SYNUCLEIN; EXPRESSION PATTERN; MICE LACKING; SENSITIVITY; PATHOLOGY; AGE; DYSFUNCTION; IMPAIRMENT; EPITHELIUM	Various genetic or toxin-induced mouse models are frequently used for investigation of early PD pathology. Although olfactory impairment is known to precede motor symptoms by years, it is not known whether it is caused by impairments in the brain, the olfactory epithelium, or both. In this study, we investigated the olfactory function in three genetic Parkinson's disease (PD) mouse models and mice treated with MPTP intraperitoneally and intranasally. To investigate olfactory function, we performed electro-olfactogram recordings (EOGs) and an olfactory behavior test (cookie-finding test). We show that neither a parkin knockout mouse strain, nor intraperitoneal MPTP treated animals display any olfactory impairment in EOG recordings and the applied behavior test. We also found no difference in the responses of the olfactory epithelium to odorants in a mouse strain over-expressing doubly mutated alpha-synuclein, while this mouse strain was not suitable to test olfaction in a cookie-finding test as it displays a mobility impairment. A transgenic mouse expressing mutated alpha-synuclein in dopaminergic neurons performed equal to control animals in the cookie-finding test. Further we show that intranasal MPTP application can cause functional damage of the olfactory epithelium.	[Kurtenbach, Stefan; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Wewering, Sonja; Luebbert, Hermann] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany; [Neuhaus, Eva M.] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany; [Neuhaus, Eva M.] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany	Ruhr University Bochum; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kurtenbach, S (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	stefan.kurtenbach@rub.de	Kurtenbach, Stefan/H-3786-2019; Neuhaus, Eva M./L-1428-2015	Kurtenbach, Stefan/0000-0002-7445-596X; Neuhaus, Eva M./0000-0003-3363-1231; Luebbert, Herrmann/0000-0003-3429-5233	German National Academic Foundation; Research School of the Ruhr University Bochum; Deutsche Forschungsgemeinschaft [Exc257 NeuroCure, SFB642]; International Max Planck Research School (IMPRS)	German National Academic Foundation; Research School of the Ruhr University Bochum; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Max Planck Research School (IMPRS)	This work was supported by The German National Academic Foundation (SM), the Research School of the Ruhr University Bochum, the Deutsche Forschungsgemeinschaft (Exc257 NeuroCure and the SFB642) and the International Max Planck Research School (IMPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Braak H, 2004, NEUROBIOL AGING, V25, P19, DOI 10.1016/j.neurobiolaging.2003.04.001; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; DOTY RL, 1992, ANN NEUROL, V32, P97, DOI 10.1002/ana.410320116; Filipov NM, 2009, NEUROREPORT, V20, P713, DOI 10.1097/WNR.0b013e32832aa95b; Flagella M, 1999, J BIOL CHEM, V274, P26946, DOI 10.1074/jbc.274.38.26946; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; FULLER RW, 1990, TOXICOL LETT, V54, P253, DOI 10.1016/0378-4274(90)90192-O; Getchell TV, 2003, AGEING RES REV, V2, P211, DOI 10.1016/S1568-1637(02)00066-1; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Hawkes CH, 1997, J NEUROL NEUROSUR PS, V62, P436, DOI 10.1136/jnnp.62.5.436; Hawkes CH, 1999, QJM-MON J ASSOC PHYS, V92, P473, DOI 10.1093/qjmed/92.8.473; Kim YH, 2011, NEUROSCIENCE, V172, P379, DOI 10.1016/j.neuroscience.2010.10.072; Kuhn K, 2003, EUR J NEUROSCI, V17, P1, DOI 10.1046/j.1460-9568.2003.02408.x; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Maskri L, 2004, NEURODEGENER DIS, V1, P255, DOI 10.1159/000085064; Mendritzki S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/375462; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Muller A, 2002, J NEURAL TRANSM, V109, P805, DOI 10.1007/s007020200067; Nickell WT, 2007, J PHYSIOL-LONDON, V583, P1005, DOI 10.1113/jphysiol.2007.129601; Nickell WT, 2006, J NEUROPHYSIOL, V95, P2003, DOI 10.1152/jn.00962.2005; Nijjar RK, 2002, NEUROBIOL AGING, V23, P65, DOI 10.1016/S0197-4580(01)00263-9; Nordin S, 1995, J Int Neuropsychol Soc, V1, P281; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Orimo S, 2011, NEUROPATH APPL NEURO, V37, P791, DOI 10.1111/j.1365-2990.2011.01194.x; Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762; Periquet M, 2005, J NEUROCHEM, V95, P1259, DOI 10.1111/j.1471-4159.2005.03442.x; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Prediger RDS, 2006, EXP NEUROL, V202, P391, DOI 10.1016/j.expneurol.2006.07.001; Prediger RDS, 2010, NEUROTOX RES, V17, P114, DOI 10.1007/s12640-009-9087-0; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Razani J, 1996, PHYSIOL BEHAV, V59, P877, DOI 10.1016/0031-9384(95)02163-9; Rojo AI, 2006, EUR J NEUROSCI, V24, P1874, DOI 10.1111/j.1460-9568.2006.05060.x; Ross CA, 2007, PARKINSONISM RELAT D, V13, pS309, DOI 10.1016/S1353-8020(08)70022-1; Schapira AHV, 2006, NEUROLOGY, V66, pS10, DOI 10.1212/WNL.66.10_suppl_4.S10; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schmidt N, 2001, J NEURAL TRANSM, V108, P1263, DOI 10.1007/s007020100004; Schmidt S, 2011, HUM MOL GENET, V20, P1197, DOI 10.1093/hmg/ddq564; SONSALLA PK, 1986, EUR J PHARMACOL, V129, P339, DOI 10.1016/0014-2999(86)90444-9; STICHEL CC, 1990, EXP BRAIN RES, V82, P575; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Ubeda-Banon I, 2012, BRAIN STRUCT FUNCT, V217, P447, DOI 10.1007/s00429-011-0347-4; Vitalis T, 2003, J COMP NEUROL, V464, P392, DOI 10.1002/cne.10804; WARD CD, 1983, NEUROLOGY, V33, P943, DOI 10.1212/WNL.33.7.943; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	49	25	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77509	10.1371/journal.pone.0077509	http://dx.doi.org/10.1371/journal.pone.0077509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204848	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500031
J	Salek, M; McGowan, S; Trudgian, DC; Dushek, O; de Wet, B; Efstathiou, G; Acuto, O				Salek, Mogjiborahman; McGowan, Simon; Trudgian, David C.; Dushek, Omer; de Wet, Ben; Efstathiou, Georgios; Acuto, Oreste			Quantitative Phosphoproteome Analysis Unveils LAT as a Modulator of CD3 zeta and ZAP-70 Tyrosine Phosphorylation	PLOS ONE			English	Article							SCALE-FREE NETWORKS; SIGNALING NETWORKS; MASS-SPECTROMETRY; PROTEOMICS; PROTEIN; ACTIVATION; MUTATION; SITE	Signaling through the T cell receptor (TCR) initiates adaptive immunity and its perturbation may results in autoimmunity. The plasma membrane scaffolding protein LAT acts as a central organizer of the TCR signaling machinery to activate many functional pathways. LAT-deficient mice develop an autoimmune syndrome but the mechanism of this pathology is unknown. In this work we have compared global dynamics of TCR signaling by MS-based quantitative phosphoproteomics in LAT-sufficient and LAT-defective Jurkat T cells. Surprisingly, we found that many TCR-induced phosphorylation events persist in the absence of LAT, despite ERK and PLC gamma 1 phosphorylation being repressed. Most importantly, the absence of LAT resulted in augmented and persistent tyrosine phosphorylation of CD3 zeta and ZAP70. This indicates that LAT signaling hub is also implicated in negative feedback signals to modulate upstream phosphorylation events. Phosphorylation kinetics data resulting from this investigation is documented in a database (phosphoTCR) accessible online. The MS data have been deposited to the ProteomeXchange with identifier PXD000341.	[Salek, Mogjiborahman; de Wet, Ben; Efstathiou, Georgios; Acuto, Oreste] Univ Oxford, Sir William Dunn Sch Pathol, T Cell Signaling Lab, Oxford OX1 3RE, England; [Trudgian, David C.; de Wet, Ben] Univ Oxford, Sir William Dunn Sch Pathol, Cent Prote Facil, Oxford OX1 3RE, England; [Dushek, Omer] Univ Oxford, Sir William Dunn Sch Pathol, Mol Immunol Grp, Oxford OX1 3RE, England; [McGowan, Simon] Univ Oxford, Nuffield Dept Med, Computat Biol Res Grp, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Salek, M (corresponding author), Prote Consulting, Toulouse, France.	mogjibs@gmail.com; oreste.acuto@path.ox.ac.uk	Efstathiou, Georgios/E-2848-2013	McGowan, Simon/0000-0001-9720-1914; Salek, Mogjiborahman/0000-0002-6664-4752; Efstathiou, Georgios/0000-0002-8245-9549	Wellcome Trust [GR076558MA, WT094296MA, 098363]; EU-FP7 "Sybilla" Grant [201106]; Sir Henry Dale Fellowship; Royal Society [098363]	Wellcome Trust(Wellcome Trust); EU-FP7 "Sybilla" Grant; Sir Henry Dale Fellowship; Royal Society(Royal Society of London)	This work was supported by Wellcome Trust Grants GR076558MA, WT094296MA, and EU-FP7 "Sybilla" Grant 201106 to O.A. O.D. is supported by the Sir Henry Dale Fellowship, which is jointly funded by the Wellcome Trust and the Royal Society (098363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Brockmeyer C, 2011, J BIOL CHEM, V286, P7535, DOI 10.1074/jbc.M110.201236; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Nika K, 2006, MOL CELL BIOL, V26, P1806, DOI 10.1128/MCB.26.5.1806-1816.2006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommers CL, 2005, J EXP MED, V201, P1125, DOI 10.1084/jem.20041869; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943	26	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77423	10.1371/journal.pone.0077423	http://dx.doi.org/10.1371/journal.pone.0077423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204825	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500027
J	Reithmeier, L; Kernaghan, G				Reithmeier, Laura; Kernaghan, Gavin			Availability of Ectomycorrhizal Fungi to Black Spruce above the Present Treeline in Eastern Labrador	PLOS ONE			English	Article							DOUGLAS-FIR FOREST; MYCORRHIZAL FUNGI; GLACIER FOREFRONT; SPORE DISPERSAL; PINUS-CONTORTA; SUB-ALPINE; DIVERSITY; SEEDLINGS; COLONIZATION; INOCULUM	Ectomycorrhizal fungi (ECMF) are an important biotic factor in the survival of conifer seedlings under stressful conditions and therefore have the potential to facilitate conifer establishment into alpine and tundra habitats. In order to assess patterns of ectomycorrhizal availability and community structure above treeline, we conducted soil bioassays in which Picea mariana (black spruce) seedlings were grown in field-collected soils under controlled conditions. Soils were collected from distinct alpine habitats, each dominated by a different ectomycorrhizal host shrub: Betula glandulosa, Arctostaphylos alpina or Salix herbacaea. Within each habitat, half of the soils collected contained roots of ectomycorrhizal shrubs (host(+)) and the other half were free of host plants (host(-)). Forest and glacial moraine soils were also included for comparison. Fungi forming ectomycorrhizae during the bioassays were identified by DNA sequencing. Our results indicate that ECMF capable of colonizing black spruce are widespread above the current tree line in Eastern Labrador and that the level of available inoculum has a significant influence on the growth of seedlings under controlled conditions. Many of the host(-) soils possessed appreciable levels of ectomycorrhizal inoculum, likely in the form of spore banks. Inoculum levels in these soils may be influenced by spore production from neighboring soils where ectomycorrhizal shrubs are present. Under predicted temperature increases, ectomycorrhizal inoculum in soils with host shrubs as well as in nearby soils without host shrubs have the potential to facilitate conifer establishment above the present tree line.	[Reithmeier, Laura] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Kernaghan, Gavin] Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada	Dalhousie University; Mount Saint Vincent University	Kernaghan, G (corresponding author), Mt St Vincent Univ, Dept Biol, Halifax, NS B3M 2J6, Canada.	gavin.kernaghan@msvu.ca			Government of Canada Program for International Polar Year [2006-SR1-CC-027]	Government of Canada Program for International Polar Year	This research was supported by the Government of Canada Program for International Polar Year (http://www.api-ipy.gc.ca) grant number 2006-SR1-CC-027. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Agerer R., 2004, DEEMY INFORM SYSTEM; Agerer R, 1998, COLOUR ATLAS ECTOMYC; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; BA AM, 1991, CAN J BOT, V69, P2442, DOI 10.1139/b91-303; Baar J, 1999, NEW PHYTOL, V143, P409, DOI 10.1046/j.1469-8137.1999.00452.x; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; CAZARES E, 1994, MYCOLOGIA, V86, P507, DOI 10.2307/3760743; Colpaert JV, 1999, NEW PHYTOL, V143, P589, DOI 10.1046/j.1469-8137.1999.00471.x; Correa A, 2012, OIKOS, V121, P449, DOI 10.1111/j.1600-0706.2011.19406.x; Courty PE, 2005, NEW PHYTOL, V167, P309, DOI 10.1111/j.1469-8137.2005.01401.x; Cripps CL, 2005, ARCT ANTARCT ALP RES, V37, P177, DOI 10.1657/1523-0430(2005)037[0177:DOMTAA]2.0.CO;2; Danby RK, 2007, J ECOL, V95, P352, DOI 10.1111/j.1365-2745.2006.01200.x; DANIELSON RM, 1984, CAN J FOREST RES, V14, P33, DOI 10.1139/x84-007; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Dickie IA, 2005, J ECOL, V93, P244, DOI 10.1111/j.1365-2745.2005.00977.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egger KN., 1996, MANUAL CONCISE DESCR, DOI [DOI 10.1007/S005720050212, 10.1007/s005720050212]; Ferrier R. C., 1985, Ecological interactions in soil: plants, microbes and animals, P175; FINLAY RD, 1992, NEW PHYTOL, V120, P105, DOI 10.1111/j.1469-8137.1992.tb01063.x; FRIES N, 1980, EXPERIENTIA, V36, P1056, DOI 10.1007/BF01965965; Galante TE, 2011, MYCOLOGIA, V103, P1175, DOI 10.3852/10-388; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardes M, 1996, NEW PHYTOL, V133, P147, DOI 10.1111/j.1469-8137.1996.tb04350.x; Germino MJ, 2002, PLANT ECOL, V162, P157, DOI 10.1023/A:1020385320738; Hagerman SM, 2004, CAN J BOT, V82, P742, DOI [10.1139/b04-047, 10.1139/B04-047]; Hagerman SM, 1999, CAN J FOREST RES, V29, P124, DOI 10.1139/cjfr-29-1-124; Hagerman SM, 2001, CAN J FOREST RES, V31, P711, DOI 10.1139/cjfr-31-4-711; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Hasselquist N, 2005, NEW PHYTOL, V165, P867, DOI 10.1111/j.1469-8137.2005.01275.x; Hogberg P, 1999, P NATL ACAD SCI USA, V96, P8534, DOI 10.1073/pnas.96.15.8534; Ingleby K, 1990, IDENTIFICATON ECTOMY; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Jacobs JD, 2007, LABRADOR HIGHLANDS R; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jonsson L, 1999, NEW PHYTOL, V142, P151, DOI 10.1046/j.1469-8137.1999.00383.x; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Jumpponen A, 2003, NEW PHYTOL, V158, P569, DOI 10.1046/j.1469-8137.2003.00767.x; Jumpponen A, 2002, MYCORRHIZA, V12, P43, DOI 10.1007/s00572-001-0152-7; Kernaghan G, 2001, ECOGRAPHY, V24, P181, DOI 10.1034/j.1600-0587.2001.240208.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Korner C, 1999, ALPINE PLANT LIFE FU; Krpata D, 2007, FOREST ECOL MANAG, V250, P167, DOI 10.1016/j.foreco.2007.05.012; Kupfer JA, 1996, PROG PHYS GEOG, V20, P253, DOI 10.1177/030913339602000301; Lilleskov EA, 2005, MYCOLOGIA, V97, P762, DOI 10.3852/mycologia.97.4.762; Maher EL, 2005, CAN J FOREST RES, V35, P567, DOI 10.1139/X04-201; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; MASON PA, 1983, PLANT SOIL, V71, P247, DOI 10.1007/BF02182659; Muhlmann O, 2008, MYCORRHIZA, V18, P171, DOI 10.1007/s00572-008-0169-2; Muhsin TM, 2002, NEW PHYTOL, V153, P153, DOI 10.1046/j.0028-646X.2001.00297.x; Munier A, 2010, PLANT ECOL, V210, P19, DOI 10.1007/s11258-010-9724-y; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Nagy L, 2009, BIOL ALPINE HABITATS; Nara K, 2004, ECOLOGY, V85, P1700, DOI 10.1890/03-0373; Nara K, 2006, NEW PHYTOL, V171, P187, DOI 10.1111/j.1469-8137.2006.01744.x; NEWTON AC, 1991, NEW PHYTOL, V117, P53, DOI 10.1111/j.1469-8137.1991.tb00944.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Onguene NA, 2002, MYCORRHIZA, V12, P13, DOI 10.1007/s00572-001-0140-y; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Perez-Moreno J, 2000, NEW PHYTOL, V145, P301, DOI 10.1046/j.1469-8137.2000.00569.x; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Ryberg M, 2009, ARCT ANTARCT ALP RES, V41, P506, DOI 10.1657/1938-4246-41.4.506; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; STRIBLEY DP, 1980, NEW PHYTOL, V86, P261, DOI 10.1111/j.1469-8137.1980.tb00786.x; Teste FP, 2009, FUNGAL ECOL, V2, P21, DOI 10.1016/j.funeco.2008.11.003; THEODOROU C, 1987, NEW PHYTOL, V106, P217, DOI 10.1111/j.1469-8137.1987.tb00137.x; Thiet RK, 2007, MYCORRHIZA, V17, P507, DOI 10.1007/s00572-007-0123-8; THOMSON BD, 1994, NEW PHYTOL, V126, P517, DOI 10.1111/j.1469-8137.1994.tb04250.x; Tibbett M, 2002, ANN BOT-LONDON, V89, P783, DOI 10.1093/aob/mcf129; Tranquillini W., 1979, PHYSL ECOLOGY ALPINE; VISSER S, 1995, NEW PHYTOL, V129, P389, DOI 10.1111/j.1469-8137.1995.tb04309.x; Wheeler JA, 2011, OIKOS, V120, P1263, DOI 10.1111/j.1600-0706.2010.18966.x	79	16	16	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77527	10.1371/journal.pone.0077527	http://dx.doi.org/10.1371/journal.pone.0077527			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204858	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700034
J	Chen, KM; Shi, WM; Xin, ZH; Wang, HF; Zhu, XL; Wu, XP; Li, Z; Li, H; Liu, Y				Chen, Kangmei; Shi, Weimei; Xin, Zhenhui; Wang, Huifen; Zhu, Xilin; Wu, Xiaopan; Li, Zhuo; Li, Hui; Liu, Ying			Replication of Genome Wide Association Studies on Hepatocellular Carcinoma Susceptibility Loci in a Chinese Population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; RISK-FACTORS; C VIRUS; HCV; POLYMORPHISMS; INFECTIONS; GENE; HBV	Background: Genome-wide association studies (GWAS) have identified three loci (rs17401966 in KIF1B, rs7574865 in STAT4, rs9275319 in HLA-DQ) as being associated with hepatitis B virus-related hepatocellular carcinoma (HBV-related HCC) in a Chinese population, two loci (rs2596542 in MICA, rs9275572 located between HLA-DQA and HLA-DQB) with hepatitis C virus-related HCC (HCV-related HCC) in a Japanese population. In the present study, we sought to determine whether these SNPs are predictive for HBV-related HCC development in other Chinese population as well. Method and Findings: We genotyped 4 SNPs, rs2596542, rs9275572, rs17401966, rs7574865, in 506 HBV-related HCC patients and 772 chronic hepatitis B (CHB) patients in Han Chinese by TaqMan methods. Odds ratio(OR) and 95% confidence interval (CI) were calculated by logistic regression. In our case-control study, significant association between rs9275572 and HCC were observed (P = 0.02, OR = 0.73, 95% CI = 0.56-0.95). In the further haplotype analysis between rs2596542 at 6p21.33 and rs9275572 at 6p21.3, G-A showed a protective effect on HBV-related HCC occurrence (P<0.001, OR = 0.66, 95% CI = 0.52-0.84). Conclusion: These findings provided convincing evidence that rs9275572 significantly associated with HBV-related HCC.	[Chen, Kangmei; Shi, Weimei; Xin, Zhenhui; Zhu, Xilin; Wu, Xiaopan; Liu, Ying] Chinese Acad Med Sci, Natl Lab Med Mol Biol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China; [Wang, Huifen] Peoples Liberat Army, Hosp 302, Liver Failure Treatment & Res Ctr, Beijing, Peoples R China; [Li, Zhuo] Capital Univ Med Sci, Affiliated Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Li, Hui] Chinese Acad Med Sci, Dept Epidemiol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Fifth Medical Center of Chinese PLA General Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Li, H (corresponding author), Chinese Acad Med Sci, Dept Epidemiol, Inst Basic Med Sci, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	lihui99360@sohu.com; liuyingpumc@163.com			National Basic Research Program of China (973 Program) [2012CB519005]; Natural Sciences Foundation of China (NSFC) [81101543]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program) (No. 2012CB519005) and the Natural Sciences Foundation of China (NSFC, Grant No. 81101543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Clark A, 2013, INFECT GENET EVOL, V18, P257, DOI 10.1016/j.meegid.2013.05.025; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Gourraud PA, 2011, GENET EPIDEMIOL, V35, P568, DOI 10.1002/gepi.20592; Gurtsevitch VE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P504, DOI 10.1134/S0006297908050039; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lange CM, 2013, J HEPATOL; LIAW YF, 1995, HEPATOLOGY, V22, P1101, DOI 10.1016/0270-9139(95)90615-0; Long XD, 2010, HEPATOLOGY, V52, P1301, DOI 10.1002/hep.23807; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; Michalak TI, 2007, FUTURE VIROL, V2, P451, DOI 10.2217/17460794.2.5.451; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Sarma Manash Pratim, 2012, Cancer Biology Medicine, V9, P172, DOI 10.7497/j.issn.2095-3941.2012.03.004; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	24	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77315	10.1371/journal.pone.0077315	http://dx.doi.org/10.1371/journal.pone.0077315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204805	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200022
J	Cosentino, S; Larsen, MV; Aarestrup, FM; Lund, O				Cosentino, Salvatore; Larsen, Mette Voldby; Aarestrup, Frank Moller; Lund, Ole			PathogenFinder - Distinguishing Friend from Foe Using Bacterial Whole Genome Sequence Data	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; GENETIC ELEMENTS; VIRULENCE; PROTEIN; EVOLUTION; TOXIN; PATHOGENESIS; INSIGHTS; BIOINFORMATICS; ADAPTATION	Although the majority of bacteria are harmless or even beneficial to their host, others are highly virulent and can cause serious diseases, and even death. Due to the constantly decreasing cost of high-throughput sequencing there are now many completely sequenced genomes available from both human pathogenic and innocuous strains. The data can be used to identify gene families that correlate with pathogenicity and to develop tools to predict the pathogenicity of newly sequenced strains, investigations that previously were mainly done by means of more expensive and time consuming experimental approaches. We describe PathogenFinder (http://cge.cbs.dtu.dk/services/PathogenFinder/), a web-server for the prediction of bacterial pathogenicity by analysing the input proteome, genome, or raw reads provided by the user. The method relies on groups of proteins, created without regard to their annotated function or known involvement in pathogenicity. The method has been built to work with all taxonomic groups of bacteria and using the entire training-set, achieved an accuracy of 88.6% on an independent test-set, by correctly classifying 398 out of 449 completely sequenced bacteria. The approach here proposed is not biased on sets of genes known to be associated with pathogenicity, thus the approach could aid the discovery of novel pathogenicity factors. Furthermore the pathogenicity prediction web-server could be used to isolate the potential pathogenic features of both known and unknown strains.	[Cosentino, Salvatore; Larsen, Mette Voldby; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Aarestrup, Frank Moller] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Cosentino, S (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	salvocos@cbs.dtu.dk	Lund, Ole/F-4437-2014; Cosentino, Salvatore/V-9201-2019	Lund, Ole/0000-0003-1108-0491; Cosentino, Salvatore/0000-0002-1066-8659; Aarestrup, Frank/0000-0002-7116-2723	Center for Genomic Epidemiology at the Technical University of Denmark; Danish Council for Strategic Research [09-067103/DSF]	Center for Genomic Epidemiology at the Technical University of Denmark; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Center for Genomic Epidemiology (http://www.genomicepidemiology.org) at the Technical University of Denmark and was funded by grant 09-067103/DSF from the Danish Council for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup Frank M, 2012, Emerg Infect Dis, V18, pe1, DOI 10.3201/eid/1811.120453; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; Andreatta M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013680; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Day WA, 2001, INFECT IMMUN, V69, P7471, DOI 10.1128/IAI.69.12.7471-7480.2001; den Heijer CDJ, 2013, LANCET INFECT DIS, V13, P409, DOI 10.1016/S1473-3099(13)70036-7; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Falkow S, 1997, ASM NEWS, V63, P359; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iraola G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042144; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KROGFELT KA, 1991, REV INFECT DIS, V13, P721; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lina G, 1997, CLIN INFECT DIS, V25, P1369, DOI 10.1086/516129; Ma S, 1992, MOLEKULIARNAIA BIOL, V27, P1218; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maurelli AT, 2007, FEMS MICROBIOL LETT, V267, P1, DOI 10.1111/j.1574-6968.2006.00526.x; METZGER M, 1994, J BACTERIOL, V176, P450, DOI 10.1128/JB.176.2.450-459.1994; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MOURA I, 1994, METHOD ENZYMOL, V243, P216; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Paine K, 2002, J MOL MICROB BIOTECH, V4, P357; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Smits THM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-2; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Turner SM, 2005, BIOCHEM J, V388, P545, DOI 10.1042/BJ20041766; WALKER KE, 1994, INFECT IMMUN, V62, P3817, DOI 10.1128/IAI.62.9.3817-3828.1994; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; YOUNG RA, 1985, NATURE, V316, P450, DOI 10.1038/316450a0; Zhang XH, 2005, J APPL MICROBIOL, V98, P1011, DOI 10.1111/j.1365-2672.2005.02583.x	60	241	247	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77302	10.1371/journal.pone.0077302	http://dx.doi.org/10.1371/journal.pone.0077302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204795	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200021
J	Feehery, GR; Yigit, E; Oyola, SO; Langhorst, BW; Schmidt, VT; Stewart, FJ; Dimalanta, ET; Amaral-Zettler, LA; Davis, T; Quail, MA; Pradhan, S				Feehery, George R.; Yigit, Erbay; Oyola, Samuel O.; Langhorst, Bradley W.; Schmidt, Victor T.; Stewart, Fiona J.; Dimalanta, Eileen T.; Amaral-Zettler, Linda A.; Davis, Theodore; Quail, Michael A.; Pradhan, Sriharsa			A Method for Selectively Enriching Microbial DNA from Contaminating Vertebrate Host DNA	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; MITOCHONDRIAL-DNA; CPG METHYLATION; ORNAMENTAL FISH; GUT; BIODIVERSITY; BACTERIA; SEQUENCE; ABSENCE	DNA samples derived from vertebrate skin, bodily cavities and body fluids contain both host and microbial DNA; the latter often present as a minor component. Consequently, DNA sequencing of a microbiome sample frequently yields reads originating from the microbe(s) of interest, but with a vast excess of host genome-derived reads. In this study, we used a methyl-CpG binding domain (MBD) to separate methylated host DNA from microbial DNA based on differences in CpG methylation density. MBD fused to the Fc region of a human antibody (MBD-Fc) binds strongly to protein A paramagnetic beads, forming an effective one-step enrichment complex that was used to remove human or fish host DNA from bacterial and protistan DNA for subsequent sequencing and analysis. We report enrichment of DNA samples from human saliva, human blood, a mock malaria-infected blood sample and a black molly fish. When reads were mapped to reference genomes, sequence reads aligning to host genomes decreased 50-fold, while bacterial and Plasmodium DNA sequences reads increased 8-11.5-fold. The Shannon-Wiener diversity index was calculated for 149 bacterial species in saliva before and after enrichment. Unenriched saliva had an index of 4.72, while the enriched sample had an index of 4.80. The similarity of these indices demonstrates that bacterial species diversity and relative phylotype abundance remain conserved in enriched samples. Enrichment using the MBD-Fc method holds promise for targeted microbiome sequence analysis across a broad range of sample types.	[Feehery, George R.; Yigit, Erbay; Langhorst, Bradley W.; Stewart, Fiona J.; Dimalanta, Eileen T.; Davis, Theodore; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA USA; [Oyola, Samuel O.; Quail, Michael A.] Wellcome Trust Sanger Inst, Cambridge, England; [Schmidt, Victor T.; Amaral-Zettler, Linda A.] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Amaral-Zettler, Linda A.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Schmidt, Victor T.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	New England Biolabs; Wellcome Trust Sanger Institute; Marine Biological Laboratory - Woods Hole; Brown University; Brown University	Pradhan, S (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	Pradhan@neb.com	Quail, michael/ABE-6131-2020; Langhorst, Bradley/AAJ-5602-2020	Langhorst, Bradley/0000-0001-7390-1094; Oyola, Samuel O./0000-0002-6425-7345	Brown University Office of the Vice President of Research; Wellcome Trust Sanger Institute [098051, 079355/Z/06/Z]	Brown University Office of the Vice President of Research; Wellcome Trust Sanger Institute(Wellcome Trust)	LAZ and VS were funded by a Brown University Office of the Vice President of Research SEED grant (LAZ) entitled "Tracking disease spread through the wildlife trade: New techniques to identify infectious microbes in aquarium fishes." SOO and MQ were funded by Wellcome Trust Sanger Institute grant numbers 098051 and 079355/Z/06/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auburn S, 2011, PLOS ONE, V6; Austin B., 2012, BACTERIAL FISH PATHO, DOI DOI 10.1007/978-94-007-4884-2; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BOUDRAA M, 1987, NUCLEIC ACIDS RES, V15, P5729; Bright AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-262; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; CHAVES AL, 1995, PLANT MOL BIOL REP, V13, P18, DOI 10.1007/BF02668389; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DAWID IB, 1974, SCIENCE, V184, P80, DOI 10.1126/science.184.4132.80; Diaz PI, 2012, MOL ORAL MICROBIOL, V27, P182, DOI 10.1111/j.2041-1014.2012.00642.x; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Goecks J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-397; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hong EE, 2013, MOL CELL BIOL, V33, P2683, DOI 10.1128/MCB.00220-13; Horz HP, 2010, ANAEROBE, V16, P47, DOI 10.1016/j.anaerobe.2009.04.009; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lazarevic Vladimir, 2012, J Clin Bioinforma, V2, P4, DOI 10.1186/2043-9113-2-4; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037919; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; NIKOLSKA.II, 1968, BIOCHIM BIOPHYS ACTA, V155, P626, DOI 10.1016/0005-2787(68)90211-6; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Oyola SO, 2013, J CLIN MICROBIOL, V51, P745, DOI 10.1128/JCM.02507-12; Oyola SO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-1; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; REIS RJS, 1983, J BIOL CHEM, V258, P9078; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; RITCHOT N, 1990, GENE, V86, P103, DOI 10.1016/0378-1119(90)90120-G; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Verner-Jeffreys DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008388; Weir M, 2012, EPIDEMIOL INFECT, V140, P192, DOI 10.1017/S0950268811001798	46	101	115	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76096	10.1371/journal.pone.0076096	http://dx.doi.org/10.1371/journal.pone.0076096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204593	Green Published, gold			2022-12-25	WOS:000326241200010
J	Schluck, T; Nienhaus, U; Aegerter-Wilmsen, T; Aegerter, CM				Schluck, Thomas; Nienhaus, Ulrike; Aegerter-Wilmsen, Tinri; Aegerter, Christof M.			Mechanical Control of Organ Size in the Development of the Drosophila Wing Disc	PLOS ONE			English	Article							IMAGINAL DISC; GRADIENT FORMATION; GROWTH; CELLS; PROLIFERATION; CULTURE; PATTERN; MODEL; DPP	Control of cessation of growth in developing organs has recently been proposed to be influenced by mechanical forces acting on the tissue due to its growth. In particular, it was proposed that stretching of the tissue leads to an increase in cell proliferation. Using the model system of the Drosophila wing imaginal disc, we directly stretch the tissue finding a significant increase in cell proliferation, thus confirming this hypothesis. In addition, we characterize the growth over the entire growth period of the wing disc finding a correlation between the apical cell area and cell proliferation rate.	[Schluck, Thomas; Nienhaus, Ulrike; Aegerter, Christof M.] Univ Zurich, Inst Phys, Zurich, Switzerland; [Aegerter-Wilmsen, Tinri] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich	Aegerter, CM (corresponding author), Univ Zurich, Inst Phys, Zurich, Switzerland.	aegerter@physik.uzh.ch		Aegerter, Christof/0000-0002-7200-7987	Swiss National Science Foundation; Forschungskredit of UZH; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of UZH; SystemsX.ch	This work was supported by the Swiss National Science Foundation, the Forschungskredit of UZH as well as SystemsX.ch in the framework of the WingX RTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2012, DEVELOPMENT, V139, P3221, DOI 10.1242/dev.082800; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bittig T, 2009, EUR PHYS J E, V30, P93, DOI 10.1140/epje/i2009-10507-6; BRUNETTE DM, 1984, J CELL SCI, V69, P35; BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3; DAMBLYCHAUDIERE C, 1986, DEV BIOL, V113, P288, DOI 10.1016/0012-1606(86)90164-8; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; LEUNG DYM, 1976, SCIENCE, V191, P475; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Nienhaus U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047594; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oda H, 2001, J CELL SCI, V114, P493; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Schluck T, 2010, EUR PHYS J E, V33, P111, DOI 10.1140/epje/i2010-10580-8; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wolpert L, 2007, PRINCIPLES DEV, P350; Zartman J, 2013, DEVELOPMENT, V140, P667, DOI 10.1242/dev.088872; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	29	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76171	10.1371/journal.pone.0076171	http://dx.doi.org/10.1371/journal.pone.0076171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204600	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000326155400012
J	Klepeisz, P; Sagmeister, S; Haudek-Prinz, V; Pichlbauer, M; Grasl-Kraupp, B; Gerner, C				Klepeisz, Philip; Sagmeister, Sandra; Haudek-Prinz, Verena; Pichlbauer, Melanie; Grasl-Kraupp, Bettina; Gerner, Christopher			Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers	PLOS ONE			English	Article							CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; DISCRIMINATE RODENT CARCINOGENS; VITRO GENOTOXICITY TESTS; IN-VITRO; OXIDATIVE STRESS; CHEMICAL CARCINOGENS; KUPFFER CELLS; FOLLOW-UP; EXPRESSION; INDUCTION	Preceding studies on the mode of action of non-genotoxic hepatocarcinogens (NGCs) have concentrated on alterations induced in hepatocytes (HCs). A potential role of non-parenchymal liver cells (NPCs) in NGC-driven hepatocarcinogenesis has been largely neglected so far. The aim of this study is to characterize NGC-induced alterations in the proteome profiles of HCs as well as NPCs. We chose the prototypic NGC phenobarbital (PB) which was applied to male rats for a period of 14 days. The livers of PB-treated rats were perfused by collagenase and the cell suspensions obtained were subjected to density gradient centrifugation to separate HCs from NPCs. In addition, HCs and NPC isolated from untreated animals were treated with PB in vitro. Proteome profiling was done by CHIP-HPLC and ion trap mass spectrometry. Proteome analyses of the in vivo experiments showed many of the PB effects previously described in HCs by other methods, e. g. induction of phase I and phase II drug metabolising enzymes. In NPCs proteins related to inflammation and immune regulation such as PAI-1 and S100-A10, ADP-ribosyl cyclase 1 and to cell migration such as kinesin-1 heavy chain, myosin regulatory light chain RLC-A and dihydropyrimidinase-related protein 1 were found to be induced, indicating major PB effects on these cells. Remarkably, in vitro treatment of HCs and NPCs with PB hardly reproduced the proteome alterations observed in vivo, indicating differences of NGC induced responses of cells at culture conditions compared to the intact organism. To conclude, the present study clearly demonstrated that PB induces proteome alterations not only in HCs but also in NPCs. Thus, any profound molecular understanding on the mode of action of NGCs has to consider effects on cells of the hepatic mesenchyme.	[Klepeisz, Philip; Sagmeister, Sandra; Haudek-Prinz, Verena; Pichlbauer, Melanie; Grasl-Kraupp, Bettina; Gerner, Christopher] Med Univ Vienna, Inst Canc Res, Ctr Comprehens Canc, Dept Inner Med 1, Vienna, Austria; [Haudek-Prinz, Verena; Gerner, Christopher] Univ Vienna, Inst Analyt Chem, Fac Chem, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna	Gerner, C (corresponding author), Med Univ Vienna, Inst Canc Res, Ctr Comprehens Canc, Dept Inner Med 1, Vienna, Austria.	christopher.gerner@univie.ac.at		Gerner, Christopher/0000-0003-4964-0642	Innovative Medicine Initiative Joint Undertaking (IMI JU) [115001]	Innovative Medicine Initiative Joint Undertaking (IMI JU)	The research leading to these results has received funding from the Innovative Medicine Initiative Joint Undertaking (IMI JU) under grant agreement number 115001 (MARCAR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Cohen SM, 2004, TOXICOL SCI, V78, P181, DOI 10.1093/toxsci/kfh073; DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dudgeon C, 2012, ONCOGENE, V31, P4848, DOI 10.1038/onc.2011.644; Elrick MM, 2005, TOXICOL PATHOL, V33, P118, DOI 10.1080/01926230590888298; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Griss J, 2011, PROTEOMICS, V11, P1000, DOI 10.1002/pmic.201000507; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Haudek-Prinz VJ, 2012, J PROTEOMICS, V76, P150, DOI 10.1016/j.jprot.2012.07.012; Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002; HEWETT JA, 1993, PHARMACOL REV, V45, P381; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Holsapple MP, 2006, TOXICOL SCI, V89, P51, DOI 10.1093/toxsci/kfj001; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; JENKE HS, 1994, XENOBIOTICA, V24, P569, DOI 10.3109/00498259409043260; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V654, P114, DOI 10.1016/j.mrgentox.2008.05.002; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V653, P99, DOI 10.1016/j.mrgentox.2008.03.008; Kirkland D, 2006, MUTAT RES-GEN TOX EN, V608, P29, DOI 10.1016/j.mrgentox.2006.04.017; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Koj A, 1996, BBA-MOL BASIS DIS, V1317, P84, DOI 10.1016/S0925-4439(96)00048-8; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Kudlicki A, 2012, PLOS ONE, V6.5, DOI [10.1371/journal.pone.0032339, DOI 10.1371/J0URNAL.P0NE.0032339]; LASKIN DL, 1988, HEPATOLOGY, V8, P1051, DOI 10.1002/hep.1840080512; Lorenz O, 2009, PROTEOM CLIN APPL, V3, P947, DOI 10.1002/prca.200800173; Low-Baselli A, 2000, CARCINOGENESIS, V21, P79, DOI 10.1093/carcin/21.1.79; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Matsuda Y, 2011, MED MOL MORPHOL, V44, P183, DOI 10.1007/s00795-011-0558-z; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Partida-Sanchez S, 2004, IMMUNITY, V20, P279, DOI 10.1016/S1074-7613(04)00048-2; PARZEFALL W, 1989, ARCH TOXICOL, V63, P456, DOI 10.1007/BF00316448; Paulitschke V, 2009, J PROTEOME RES, V8, P2501, DOI 10.1021/pr8010827; Perks A, 2012, BRIT J ANAESTH, V108, P562, DOI 10.1093/bja/aes027; Phillips JM, 2009, TOXICOL SCI, V110, P319, DOI 10.1093/toxsci/kfp108; Phillips JM, 2009, TOXICOL SCI, V108, P273, DOI 10.1093/toxsci/kfp031; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Sagmeister S, 2008, J HEPATOL, V49, P955, DOI 10.1016/j.jhep.2008.06.031; Schaefer O, 2012, DRUG METAB DISPOS, V40, P93, DOI 10.1124/dmd.111.042275; SCHWARZ M, 1987, CARCINOGENESIS, V8, P1355, DOI 10.1093/carcin/8.9.1355; Slany A, 2009, ELECTROPHORESIS, V30, P1306, DOI 10.1002/elps.200800440; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; Teeguarden JG, 2000, J APPL TOXICOL, V20, P113, DOI 10.1002/(SICI)1099-1263(200003/04)20:2<113::AID-JAT641>3.0.CO;2-9; Teufelhofer O, 2005, CARCINOGENESIS, V26, P319, DOI 10.1093/carcin/bgh320; Teufelhofer O, 2006, ELECTROPHORESIS, V27, P4112, DOI 10.1002/elps.200600017; Toyokuni S, ANTIOXID REDOX S AUG, P1373, DOI [10.1089/ars.2006.8.1373, DOI 10.1089/ARS.2006.8.1373.PUBMED:16910784]; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Vasseur P, 2012, MUTAT RES-GEN TOX EN, V744, P8, DOI 10.1016/j.mrgentox.2011.11.007; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Woo RA, 2004, GENE DEV, V18, P1317, DOI 10.1101/gad.1165204; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yano Y, 2004, CANCER LETT, V207, P139, DOI 10.1016/j.canlet.2003.11.002	69	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76137	10.1371/journal.pone.0076137	http://dx.doi.org/10.1371/journal.pone.0076137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204595	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300002
J	Nording, ML; Yang, J; Georgi, K; Karbowski, CH; German, JB; Weiss, RH; Hogg, RJ; Trygg, J; Hammock, BD; Zivkovic, AM				Nording, Malin L.; Yang, Jun; Georgi, Katrin; Karbowski, Christine Hegedus; German, J. Bruce; Weiss, Robert H.; Hogg, Ronald J.; Trygg, Johan; Hammock, Bruce D.; Zivkovic, Angela M.			Individual Variation in Lipidomic Profiles of Healthy Subjects in Response to Omega-3 Fatty Acids	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; DIETARY SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; INFLAMMATORY MEDIATORS; PROSTAGLANDIN E-2; GENETIC-VARIANTS; N-3	Introduction: Conflicting findings in both interventional and observational studies have resulted in a lack of consensus on the benefits of omega 3 fatty acids in reducing disease risk. This may be due to individual variability in response. We used a multi-platform lipidomic approach to investigate both the consistent and inconsistent responses of individuals comprehensively to a defined omega 3 intervention. Methods: The lipidomic profile including fatty acids, lipid classes, lipoprotein distribution, and oxylipins was examined multi- and uni-variately in 12 healthy subjects pre vs. post six weeks of omega 3 fatty acids (1.9 g/d eicosapentaenoic acid [EPA] and 1.5 g/d docosahexaenoic acid [DHA]). Results: Total lipidomic and oxylipin profiles were significantly different pre vs. post treatment across all subjects (p=0.00007 and p=0.00002 respectively). There was a strong correlation between oxylipin profiles and EPA and DHA incorporated into different lipid classes (r(2)=0.93). However, strikingly divergent responses among individuals were also observed. Both omega 3 and omega 6 fatty acid metabolites displayed a large degree of variation among the subjects. For example, in half of the subjects, two arachidonic acid cyclooxygenase products, prostaglandin E-2 (PGE(2)) and thromboxane B2 (TXB2), and a lipoxygenase product, 12-hydroxyeicosatetraenoic acid (12-HETE) significantly decreased post intervention, whereas in the other half they either did not change or increased. The EPA lipoxygenase metabolite 12-hydroxyeicosapentaenoic acid (12-HEPE) varied among subjects from an 82% decrease to a 5,000% increase. Conclusions: Our results show that certain defined responses to omega 3 fatty acid intervention were consistent across all subjects. However, there was also a high degree of inter-individual variability in certain aspects of lipid metabolism. This lipidomic based phenotyping approach demonstrated that individual responsiveness to omega 3 fatty acids is highly variable and measurable, and could be used as a means to assess the effectiveness of omega 3 interventions in modifying disease risk and determining metabolic phenotype.	[Nording, Malin L.; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden; [Nording, Malin L.; Yang, Jun; Georgi, Katrin; Karbowski, Christine Hegedus; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Yang, Jun; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [German, J. Bruce; Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Dept Med, Div Nephrol, Davis, CA 95616 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA; [Hogg, Ronald J.] Scott & White Mem Hosp & Clin, Temple, TX USA; [Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA	Umea University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Scott & White Medical Center; University of California System; University of California Davis	Zivkovic, AM (corresponding author), Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA.	amzivkovic@ucdavis.edu	Yang, Jun/B-2262-2010	Yang, Jun/0000-0001-8126-1728; Nording, Malin/0000-0002-1732-8147; Zivkovic, Angela/0000-0002-2828-7862	Center for Health and Nutrition Research (CHNR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK49368]; University of California [05GEB01NHB]; National Institute of Environmental Health Sciences (NIEHS) [P42ES004699]; NIEHS [R01 ES002710, ES011269]; California Dairy Research Foundation; American Asthma Association [09-0269]; Cystic Fibrosis Research Inc.; Swedish Research Councils VR [2011-6044]; Formas [2010-303]; Vinnova [2010-02070]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049368, U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, R01ES002710, P42ES004699] Funding Source: NIH RePORTER	Center for Health and Nutrition Research (CHNR); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of California(University of California System); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Dairy Research Foundation; American Asthma Association; Cystic Fibrosis Research Inc.; Swedish Research Councils VR(Swedish Research Council); Formas(Swedish Research Council Formas); Vinnova(Vinnova); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided in part by The Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK49368; The University of California Discovery Program (05GEB01NHB); the National Institute of Environmental Health Sciences (NIEHS) P42ES004699, NIEHS R01 ES002710, and NIEHS Superfund Research Program P42 ES011269; the California Dairy Research Foundation; the American Asthma Association #09-0269; JY was supported by the Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc.; BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation; the Swedish Research Councils VR (#2011-6044), Formas (#2010-303), and Vinnova (#2010-02070); West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK U24 DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong P, 2012, J NUTR, V142, P1417, DOI 10.3945/jn.112.159814; BANG HO, 1971, LANCET, V1, P1143, DOI 10.1016/S0140-6736(71)91658-8; Baum SJ, 2012, J CLIN LIPIDOL, V6, P216, DOI 10.1016/j.jacl.2012.04.077; Bernstein AM, 2012, J NUTR, V142, P99, DOI 10.3945/jn.111.148973; BLONK MC, 1990, AM J CLIN NUTR, V52, P120, DOI 10.1093/ajcn/52.1.120; Bryan DL, 2006, LIPIDS, V41, P1101, DOI 10.1007/s11745-006-5059-9; Burillo E, 2012, CURR VASC PHARMACOL, V10, P432, DOI 10.2174/157016112800812845; Burr ML, 2007, P NUTR SOC, V66, P9, DOI 10.1017/S0029665107005241; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cansell MS, 2007, INT J PHARMACEUT, V343, P277, DOI 10.1016/j.ijpharm.2007.04.014; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; de Roos B, 2009, BRIT J PHARMACOL, V158, P413, DOI 10.1111/j.1476-5381.2009.00189.x; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gillingham LG, 2013, AM J CLIN NUTR, V97, P195, DOI 10.3945/ajcn.112.043117; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Harris WS, 1997, AM J CLIN NUTR, V65, P1645, DOI 10.1093/ajcn/65.5.1645S; Harslof LBS, 2013, AM J CLIN NUTR, V97, P1403, DOI 10.3945/ajcn.113.058685; Hartweg J, 2007, DIABETOLOGIA, V50, P1593, DOI 10.1007/s00125-007-0695-z; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Johnson JL, 2004, ATHEROSCLEROSIS, V176, P371, DOI 10.1016/j.atherosclerosis.2004.05.018; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Kelley DS, 2012, P NUTR SOC, V71, P322, DOI 10.1017/S0029665112000080; Kelley DS, 2012, METAB SYNDR RELAT D, V10, P32, DOI 10.1089/met.2011.0081; Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5; Koletzko B, 2011, AM J CLIN NUTR, V93, P211, DOI 10.3945/ajcn.110.006189; KROKAN HE, 1993, BIOCHIM BIOPHYS ACTA, V1168, P59, DOI 10.1016/0005-2760(93)90266-C; Langerhuus SN, 2012, BRIT J NUTR, V107, P735, DOI 10.1017/S0007114511003503; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; LeBlanc CJ, 2008, AM J VET RES, V69, P486, DOI 10.2460/ajvr.69.4.486; LEE TH, 1984, J CLIN INVEST, V74, P1922, DOI 10.1172/JCI111612; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; LEE TH, 1984, J BIOL CHEM, V259, P2383; Lopez-Huertas E, 2012, BRIT J NUTR, V107, pS185, DOI 10.1017/S0007114512001572; Lundstrom SL, 2013, MOL NUTR FOOD RES, V57, P1378, DOI 10.1002/mnfr.201200827; Minihane AM, 2000, ARTERIOSCL THROM VAS, V20, P1990, DOI 10.1161/01.ATV.20.8.1990; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; MUELLER BA, 1989, CLIN PHARMACY, V8, P328; Ottestad I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042550; Pei J, 2012, J RENAL NUTR, V22, P525, DOI 10.1053/j.jrn.2012.04.005; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Thifault E, 2013, J NUTRIGENET NUTRIGE, V6, P73, DOI 10.1159/000350744; Trygg J, 2002, J CHEMOMETR, V16, P283, DOI 10.1002/cem.724; VONSCHACKY C, 1993, BIOCHIM BIOPHYS ACTA, V1166, P20, DOI 10.1016/0005-2760(93)90278-H; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zivkovic AM, 2012, METABOLOMICS, V8, P1102, DOI 10.1007/s11306-012-0417-5; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2; Zulyniak MA, 2013, METABOLISM, V62, P1107, DOI 10.1016/j.metabol.2013.02.004	57	73	74	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76575	10.1371/journal.pone.0076575	http://dx.doi.org/10.1371/journal.pone.0076575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204640	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300007
J	Elshoff, L; Muthuraman, M; Anwar, AR; Deuschl, G; Stephani, U; Raethjen, J; Siniatchkin, M				Elshoff, Lydia; Muthuraman, Muthuraman; Anwar, Abdul Rauf; Deuschl, Guenther; Stephani, Ulrich; Raethjen, Jan; Siniatchkin, Michael			Dynamic Imaging of Coherent Sources Reveals Different Network Connectivity Underlying the Generation and Perpetuation of Epileptic Seizures	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SOURCE LOCALIZATION; EEG-FMRI; NEURONAL NETWORKS; FUNCTIONAL MRI; CLASSIFICATION; SEGMENTATION; CHILDREN; SPIKES; STATE	The concept of focal epilepsies includes a seizure origin in brain regions with hyper synchronous activity (epileptogenic zone and seizure onset zone) and a complex epileptic network of different brain areas involved in the generation, propagation, and modulation of seizures. The purpose of this work was to study functional and effective connectivity between regions involved in networks of epileptic seizures. The beginning and middle part of focal seizures from ictal surface EEG data were analyzed using dynamic imaging of coherent sources (DICS), an inverse solution in the frequency domain which describes neuronal networks and coherences of oscillatory brain activities. The information flow (effective connectivity) between coherent sources was investigated using the renormalized partial directed coherence (RPDC) method. In 8/11 patients, the first and second source of epileptic activity as found by DICS were concordant with the operative resection site; these patients became seizure free after epilepsy surgery. In the remaining 3 patients, the results of DICS/RPDC calculations and the resection site were discordant; these patients had a poorer post-operative outcome. The first sources as found by DICS were located predominantly in cortical structures; subsequent sources included some subcortical structures: thalamus, Nucl. Subthalamicus and cerebellum. DICS seems to be a powerful tool to define the seizure onset zone and the epileptic networks involved. Seizure generation seems to be related to the propagation of epileptic activity from the primary source in the seizure onset zone, and maintenance of seizures is attributed to the perpetuation of epileptic activity between nodes in the epileptic network. Despite of these promising results, this proof of principle study needs further confirmation prior to the use of the described methods in the clinical praxis.	[Elshoff, Lydia; Stephani, Ulrich; Siniatchkin, Michael] Univ Kiel, Dept Neuropediat, Kiel, Germany; [Muthuraman, Muthuraman; Anwar, Abdul Rauf; Deuschl, Guenther; Raethjen, Jan] Univ Kiel, Dept Neurol, Kiel, Germany; [Anwar, Abdul Rauf] Univ Kiel, Tech Fac, Kiel, Germany; [Siniatchkin, Michael] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-60054 Frankfurt, Germany	University of Kiel; University of Kiel; University of Kiel; Goethe University Frankfurt	Muthuraman, M (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.	m.muthuraman@neurologie.uni-kiel.de	Muthuraman, Muthuraman/ABD-2021-2020; Stephani, Ulrich/D-1004-2010; Deuschl, Gunther/A-7986-2010	Muthuraman, Muthuraman/0000-0001-6158-2663; Deuschl, Gunther/0000-0002-4176-9196	Deutsche Forschungsgemeinschaft [SI1419/2-1, SFB 855]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was financially supported by the Deutsche Forschungsgemeinschaft SI1419/2-1 as well as SFB 855, D2 and D3 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnold N, 2001, ESTIMATION PARAMETER, P27; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Ben-Ari Y, 2010, EPILEPSY CURR, V10, P118, DOI 10.1111/j.1535-7511.2010.01376.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blanke O, 2000, CLIN NEUROPHYSIOL, V111, P763, DOI 10.1016/S1388-2457(00)00251-0; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Boon P, 2002, J CLIN NEUROPHYSIOL, V19, P461, DOI 10.1097/00004691-200210000-00009; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; De Tiege X, 2007, EPILEPSIA, V48, P385, DOI 10.1111/j.1528-1167.2006.00951.x; Elshoff L, 2012, EPILEPSIA, V53, P1597, DOI 10.1111/j.1528-1167.2012.03587.x; Engel J, 1993, SURG TREATMENT EPILE, P609; Federico P, 2005, BRAIN, V128, P1811, DOI 10.1093/brain/awh533; Franaszczuk PJ, 1998, ELECTROEN CLIN NEURO, V106, P513, DOI 10.1016/S0013-4694(98)00024-8; GATH I, 1992, IEEE T BIO-MED ENG, V39, P952, DOI 10.1109/10.256429; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2006, J MAGN RESON IMAGING, V23, P906, DOI 10.1002/jmri.20577; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Japaridze N, 2013, BRAIN TOPOGR, V26, P157, DOI 10.1007/s10548-012-0245-y; Kahane P, 2010, CURR OPIN NEUROL, V23, P177, DOI 10.1097/WCO.0b013e3283374a39; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kobayashi E, 2006, NEUROLOGY, V66, P1049, DOI 10.1212/01.wnl.0000204232.37720.a4; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Kuzniecky R., 1995, MAGNETIC RESONANCE E; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Lantz G, 1999, CLIN NEUROPHYSIOL, V110, P176, DOI 10.1016/S0013-4694(98)00117-5; Lantz G, 2001, CLIN NEUROPHYSIOL, V112, P688, DOI 10.1016/S1388-2457(01)00479-5; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Laufs H, 2012, CURR OPIN NEUROL, V25, P194, DOI 10.1097/WCO.0b013e3283515db9; Levan P, 2010, NEUROIMAGE, V49, P366, DOI 10.1016/j.neuroimage.2009.07.064; Michels L, 2013, NEUROIMAGE, V81, P231, DOI 10.1016/j.neuroimage.2013.04.030; Moeller F, 2011, REPRESENTATION PROPA; Moeller F, 2013, HUM BRAIN MAPP, V34, P1896, DOI 10.1002/hbm.22026; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Muthuraman M, 2010, IEEE ENG MED BIO, P154, DOI 10.1109/IEMBS.2010.5627211; Muthuraman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033928; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Oostenveld R., 2011, COMPUTATIONAL INTELL; Paz JT, 2005, J NEUROSCI, V25, P2092, DOI 10.1523/JNEUROSCI.4689-04.2005; Rosenberg DS, 2006, EPILEPSIA, V47, P98, DOI 10.1111/j.1528-1167.2006.00375.x; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Schelter B, 2009, J NEUROSCI METH, V179, P121, DOI 10.1016/j.jneumeth.2009.01.006; Siniatchkin M, 2010, BRAIN, V133, P2798, DOI 10.1093/brain/awq183; SO N, 1989, ANN NEUROL, V25, P423, DOI 10.1002/ana.410250502; SO N, 1989, ANN NEUROL, V25, P432, DOI 10.1002/ana.410250503; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; Sudmeyer M, 2006, MOVEMENT DISORD, V21, P2134, DOI 10.1002/mds.21136; Tae WS, 2005, NEUROIMAGE, V24, P101, DOI 10.1016/j.neuroimage.2004.08.005; Tapio S, 2001, ALGORITHM 808 ARFIT, P58; Thornton R, 2010, J NEUROL NEUROSUR PS, V81, P922, DOI 10.1136/jnnp.2009.196253; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Timmermann L, 2003, NEUROLOGY, V61, P689, DOI 10.1212/01.WNL.0000078816.05164.B1; Tyvaert L, 2008, BRAIN, V131, P2042, DOI 10.1093/brain/awn145; Tyvaert L, 2009, HUM BRAIN MAPP, V30, P3993, DOI 10.1002/hbm.20824; Van Uitert R, 2004, IEEE T BIO-MED ENG, V51, P2129, DOI 10.1109/TBME.2004.836490; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vulliemoz S, 2010, NEUROIMAGE, V49, P3219, DOI 10.1016/j.neuroimage.2009.11.055; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wendling F, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00154; Wu L, 1998, ELECTROEN CLIN NEURO, V106, P344, DOI 10.1016/S0013-4694(97)00156-9; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	64	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78422	10.1371/journal.pone.0078422	http://dx.doi.org/10.1371/journal.pone.0078422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194931	gold, Green Published			2022-12-25	WOS:000326037000110
J	Garcia-Pravia, C; Galvan, JA; Gutierrez-Corral, N; Solar-Garcia, L; Garcia-Perez, E; Garcia-Ocana, M; Del Amo-Iribarren, J; Menendez-Rodriguez, P; Garcia-Garcia, J; de los Toyos, JR; Simon-Buela, L; Barneo, L				Garcia-Pravia, Carmen; Galvan, Jose A.; Gutierrez-Corral, Natalia; Solar-Garcia, Lorena; Garcia-Perez, Eva; Garcia-Ocana, Marcos; Del Amo-Iribarren, Jokin; Menendez-Rodriguez, Primitiva; Garcia-Garcia, Juan; de los Toyos, Juan R.; Simon-Buela, Laureano; Barneo, Luis			Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TUMOR-CELLS; ADENOCARCINOMA; IDENTIFICATION; CARCINOMA; COLLAGEN; DISCOVERY; MODEL; RISK	Background: The collagen11A1 (COL11A1) gene is overexpressed in pancreatic cancer. The expression of COL11A1 protein could be involved in desmoplastic events in pancreatic cancer, but an antibody that specifically stains the COL11A1 protein is not currently available. Methods and findings: A total of 54 pancreatic ductal adenocarcinomas (PDAC), 23 chronic pancreatitis (CP) samples, and cultured peritumoral stromal cells of PDAC (passages 3-6) were studied. Normal human pancreas tissue samples were obtained through a cadaveric organ donation program. 1) Validation of COL11A1 gene overexpression by q-RT-PCR. the expression of COL11A1 gene is significantly increased in PDAC samples vs. normal and CP samples. 2) Analysis of COL11A1 by immunohistochemistry using highly specific anti-proCOL11A1 antibodies. anti-proCOL11A1 stains stromal cells/cancer-associated fibroblasts (CAFs) of PDAC but it does not stain chronic benign condition (chronic pancreatitis) stromal cells, epithelial cells, or normal fibroblasts. 3) Evaluation of the discrimination ability of the antibody. anti-proCOL11A1 immunostaining accurately discriminates between PDAC and CP (AUC 0.936, 95% CI 0.851, 0.981). 4) Phenotypic characterization of proCOL11A1+ stromal cells co-staining with mesenchymal, epithelial and stellate cell markers on pancreatic tissue samples and cultured peritumoral pancreatic cancer stromal cells. ProCOL11A1+ cells present co-staining with mesenchymal, stellate and epithelial markers (EMT phenotype) in different proportions. Conclusions/Significance: Detection of proCOL11A1 through immunostaining with this newly-developed antibody allows for a highly accurate distinction between PDAC and CP. Unlike other available antibodies commonly used to detect CAFs, anti-proCOL11A1 is negative in stromal cells of the normal pancreas and almost absent in benign inflammation. These results strongly suggest that proCOL11A1 is a specific marker for CAFs, and thus, anti-proCOL11A1 is a powerful new tool for cancer research and clinical diagnostics.	[Garcia-Pravia, Carmen; Menendez-Rodriguez, Primitiva; Garcia-Garcia, Juan] HUCA, Serv Anat Pathol, Oviedo, Spain; [Garcia-Pravia, Carmen; Galvan, Jose A.; Garcia-Ocana, Marcos; de los Toyos, Juan R.; Barneo, Luis] IUOPA, Oviedo, Spain; [Galvan, Jose A.; Garcia-Perez, Eva; Barneo, Luis] Univ Oviedo, Dept Surg, Sch Med & Hlth Sci, Oviedo, Spain; [Gutierrez-Corral, Natalia; Solar-Garcia, Lorena; Barneo, Luis] HUCA, Gen Surg Serv, Oviedo, Spain; [Garcia-Ocana, Marcos] Tech Sci Serv, Biotechnol & Biomed Assays Unit, Oviedo, Spain; [Del Amo-Iribarren, Jokin] Progenika Biopharma SA, Derio, Spain; [de los Toyos, Juan R.] Univ Oviedo, Sch Med & Hlth Sci, Immunol Area, Oviedo, Spain; [Simon-Buela, Laureano] Oncomatrix SL, Derio, Spain	Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Central University Hospital Asturias; Grifols; University of Oviedo	Barneo, L (corresponding author), IUOPA, Oviedo, Spain.	lbarneo@uniovi.es	barneo, Luis/AAE-1634-2022; de los Toyos, Juan R./M-1681-2014; Galván, Jose A./C-7753-2013; Barneo, Luis/M-2712-2017	de los Toyos, Juan R./0000-0002-3880-6339; Galván, Jose A./0000-0003-3138-7642; Barneo, Luis/0000-0001-9410-4262	ERDF Funds from the EuropeanUnion; INNPACTO-ONCOPAN [IPT-010000-2010-31]; Ministry of Science and Innovation, Spain [FISS-09-PS09/01911]; FICYT [FC-11-PC10-23]; ERDF Operational Framework Programme of the Principality of Asturias, Spain; Progenika Biopharma, S. A.; Oncomatrix, S. L. Derio, Spain	ERDF Funds from the EuropeanUnion; INNPACTO-ONCOPAN; Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FICYT; ERDF Operational Framework Programme of the Principality of Asturias, Spain; Progenika Biopharma, S. A.; Oncomatrix, S. L. Derio, Spain	This research has been co-financed by ERDF Funds from the EuropeanUnion; by INNPACTO-ONCOPAN IPT-010000-2010-31 Project; by FISS-09-PS09/01911 Project, Ministry of Science and Innovation, Spain; by FC-11-PC10-23 Project, FICYT, Axe 1 of the 2007-2013 ERDF Operational Framework Programme of the Principality of Asturias, Spain; and by Progenika Biopharma, S. A. and Oncomatrix, S. L. Derio, Spain. The proCOL11A1 mAb has been patented by Oncomatrix, S. L. (PCT/ES2012/070616; WO 2013/021088 A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barneo L, 2006, PROCEEDINGS OF THE XLI CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, P27; Binkley CE, 2004, PANCREAS, V29, P254, DOI 10.1097/00006676-200411000-00003; Bowen KB, 2008, J HISTOCHEM CYTOCHEM, V56, P275, DOI 10.1369/jhc.7A7310.2007; Buchholz M, 2001, PANCREATOLOGY, V1, P581, DOI 10.1159/000055867; Chong IW, 2006, ONCOL REP, V16, P981; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Crnogorac-Jurcevic T, 2001, ONCOGENE, V20, P7437, DOI 10.1038/sj.onc.1204935; del Amo J, 2005, EJC SUPPL, V3, P54; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fischer H, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-17; Friess H, 2003, CELL MOL LIFE SCI, V60, P1180, DOI 10.1007/s00018-003-3036-5; Fuentes N, 2010, VIRCHOWS ARCH, V457, P230; Garcia Pravia C, 2009, BRIT J SURG, V96, P11; Garcia-Ocana M, 2012, INT J ONCOL, V40, P1447, DOI 10.3892/ijo.2012.1360; Garcia-Perez E, 2013, BRIT J SURG, V100, P6; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Han HY, 2002, CANCER RES, V62, P2890; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Howes N, 2002, GUT, V51, P765, DOI 10.1136/gut.51.6.765; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; IMAMURA T, 1995, PANCREAS, V11, P357, DOI 10.1097/00006676-199511000-00007; Jin G, 2005, WORLD J GASTROENTERO, V11, P6543, DOI 10.3748/wjg.v11.i41.6543; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kim HJ, 2010, J CERAM PROCESS RES, V11, P11; Kollmannsberger C, 1998, CANCER TREAT REV, V24, P133, DOI 10.1016/S0305-7372(98)90079-2; Kore M, 1997, AM J SURG, V194, pS84; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Linder S, 2001, HEPATO-GASTROENTEROL, V48, P1321; Logsdon CD, 2003, CANCER RES, V63, P2649; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Luciani MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020016; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Marjolin J-N, 1828, DICT MED, V21; Missiaglia E, 2004, INT J CANCER, V112, P100, DOI 10.1002/ijc.20376; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nelson Fuentes Martinez, 2009, THESIS U OVIEDO SPAI; Olumi AF, 1999, CANCER RES, V59, P5002; Otsuki M, 2003, J GASTROENTEROL, V38, P315, DOI 10.1007/s005350300058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Porrero-Guerrero B, 2013, BRIT J SURG, V100, P7; Raviraj V, 2012, CLIN EXP METASTAS, V29, P273, DOI 10.1007/s10585-011-9450-4; Sadlonova A, 2009, CANCER MICROENVIRON, V2, P9, DOI 10.1007/s12307-008-0017-0; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Schmalbach CE, 2004, ARCH OTOLARYNGOL, V130, P295, DOI 10.1001/archotol.130.3.295; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sok JC, 2003, ARCH OTOLARYNGOL, V129, P760, DOI 10.1001/archotol.129.7.760; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Tan ZJ, 2003, WORLD J GASTROENTERO, V9, P818, DOI 10.3748/wjg.v9.i4.818	56	50	51	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78327	10.1371/journal.pone.0078327	http://dx.doi.org/10.1371/journal.pone.0078327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194920	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000099
J	Hunt, CP; Fabb, SA; Pouton, CW; Haynes, JM				Hunt, Cameron P.; Fabb, Stewart A.; Pouton, Colin W.; Haynes, John M.			DNA-Dependent Protein Kinase Is a Context Dependent Regulator of Lmx1a and Midbrain Specification	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DOPAMINE NEURONS; NEURAL INDUCTION; GENE-EXPRESSION; SMALL MOLECULES; STEM-CELLS; DIFFERENTIATION; NOTCH; PHOSPHORYLATION; IDENTIFICATION	The identification of small molecules capable of directing pluripotent cell differentiation towards specific lineages is highly desirable to both reduce cost, and increase efficiency. Within neural progenitors, LIM homeobox transcription factor 1 alpha (Lmx1a) is required for proper development of roof plate and cortical hem structures of the forebrain, as well as the development of floor plate and midbrain dopaminergic neurons. In this study we generated homologous recombinant cell lines expressing either luciferase or beta-lactamase under the control of the Lmx1a promoter, and used these cell lines to investigate kinase-mediated regulation of Lmx1a activity during neuronal differentiation. A screen of 143 small molecule tyrosine kinase inhibitors yielded 16 compounds that positively or negatively modulated Lmx1a activity. Inhibition of EGF, VEGF and DNA-dependent protein kinase (DNA-PK) signaling significantly upregulated Lmx1a activity whereas MEK inhibition strongly downregulated its activity. Quantitative FACS analysis revealed that the DNA-PK inhibitor significantly increased the number of Lmx1a+ progenitors while subsequent qPCR showed an upregulation of Notch effectors, the basic helix-loop-helix genes, Hes5 and Hey1. FACS further revealed that DNA-PK-mediated regulation of Lmx1a+ cells is dependent on the rapamycin-sensitive complex, mTORC1. Interestingly, this DNA-PK inhibitor effect was preserved in a co-culture differentiation protocol. Terminal differentiation assays showed that DNA-PK inhibition shifted development of neurons from forebrain toward midbrain character as assessed by Pitx3/TH immunolabeling and corresponding upregulation of midbrain (En1), but not forebrain (FoxG1) transcripts. These studies show that Lmx1a signaling in mouse embryonic stem cells contributes to a molecular cascade establishing neuronal specification. The data presented here identifies a novel regulatory pathway where signaling from DNA-PK appears to suppress midbrain-specific Lmx1a expression.	[Hunt, Cameron P.; Fabb, Stewart A.; Pouton, Colin W.; Haynes, John M.] Monash Univ Parkville, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia	Monash University	Pouton, CW (corresponding author), Monash Univ Parkville, Monash Inst Pharmaceut Sci, Melbourne, Vic, Australia.	colin.pouton@monash.edu; john.haynes@monash.edu	Pouton, Colin W/M-2049-2016	Pouton, Colin W/0000-0003-0224-3308; , john/0000-0003-3075-1553; Fabb, Stewart/0000-0002-8887-7661; Hunt, Cameron/0000-0002-2295-5866	Monash University; Pfizer	Monash University(Monash University); Pfizer(Pfizer)	CPH was a recipient of a faculty scholarship from Monash University. Additional funding for was gratefully received from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Allsopp TE, 2010, MEDCHEMCOMM, V1, P16, DOI 10.1039/c0md00055h; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bailis W, 2012, BLOOD, V120, P1349, DOI 10.1182/blood-2012-06-435099; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Bergmans BA, 2008, STEM CELLS, V3, P183; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Burbach JPH, 2006, TRENDS NEUROSCI, V29, P601, DOI 10.1016/j.tins.2006.09.003; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Carpenter G, 1999, EXP CELL RES, V253, P15, DOI 10.1006/excr.1999.4671; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chen CW, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-33; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Ding S, 2005, CURR TOP MED CHEM, V5, P383, DOI 10.2174/1568026053828402; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Failli V, 2002, MECH DEVELOP, V118, P225, DOI 10.1016/S0925-4773(02)00254-X; Finlay MRV, 2012, BIOORG MED CHEM LETT, V22, P5352, DOI 10.1016/j.bmcl.2012.06.053; Friedmann BJ, 2006, MOL CANCER THER, V5, P209, DOI 10.1158/1535-7163.MCT-05-0239; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Gonzalez-Garcia S, 2009, J EXP MED, V206, P779, DOI 10.1084/jem.20081922; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Jonsson ME, 2009, EXP NEUROL, V219, P341, DOI 10.1016/j.expneurol.2009.06.006; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Mak SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/140427; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Nefzger CM, 2012, STEM CELLS, V30, P1349, DOI 10.1002/stem.1105; Panman L, 2011, CELL STEM CELL, V8, P663, DOI 10.1016/j.stem.2011.04.001; Schmole AC, 2010, BIOORGAN MED CHEM, V18, P6785, DOI 10.1016/j.bmc.2010.07.045; Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Smidt MP, 2012, PLOS ONE, V7, pe42641, DOI [10.1371/journal.pone.0042641, DOI 10.1371/J0URNAL.P0NE.0042641.PUBMED:22870339]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stavridis MP, 2010, DEVELOPMENT, V137, P881, DOI 10.1242/dev.043117; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Watmuff B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031999; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yoon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.188078; Zeng WR, 2011, NEUROCHEM INT, V59, P394, DOI 10.1016/j.neuint.2011.04.002; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	60	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78759	10.1371/journal.pone.0078759	http://dx.doi.org/10.1371/journal.pone.0078759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194952	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000131
J	Kershenbaum, A; Sayigh, LS; Janik, VM				Kershenbaum, Arik; Sayigh, Laela S.; Janik, Vincent M.			The Encoding of Individual Identity in Dolphin Signature Whistles: How Much Information Is Needed?	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; CATEGORIZATION; RECOGNITION; DISCRIMINATION; CLASSIFICATION; REPERTOIRES; EVOLUTION; PITFALLS; BEHAVIOR	Bottlenose dolphins (Tursiops truncatus) produce many vocalisations, including whistles that are unique to the individual producing them. Such "signature whistles" play a role in individual recognition and maintaining group integrity. Previous work has shown that humans can successfully group the spectrographic representations of signature whistles according to the individual dolphins that produced them. However, attempts at using mathematical algorithms to perform a similar task have been less successful. A greater understanding of the encoding of identity information in signature whistles is important for assessing similarity of whistles and thus social influences on the development of these learned calls. We re-examined 400 signature whistles from 20 individual dolphins used in a previous study, and tested the performance of new mathematical algorithms. We compared the measure used in the original study (correlation matrix of evenly sampled frequency measurements) to one used in several previous studies (similarity matrix of time-warped whistles), and to a new algorithm based on the Parsons code, used in music retrieval databases. The Parsons code records the direction of frequency change at each time step, and is effective at capturing human perception of music. We analysed similarity matrices from each of these three techniques, as well as a random control, by unsupervised clustering using three separate techniques: k-means clustering, hierarchical clustering, and an adaptive resonance theory neural network. For each of the three clustering techniques, a seven-level Parsons algorithm provided better clustering than the correlation and dynamic time warping algorithms, and was closer to the near-perfect visual categorisations of human judges. Thus, the Parsons code captures much of the individual identity information present in signature whistles, and may prove useful in studies requiring quantification of whistle similarity.	[Kershenbaum, Arik] Natl Inst Math & Biol Synth, Knoxville, TN USA; [Kershenbaum, Arik] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Sayigh, Laela S.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Janik, Vincent M.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of Tennessee System; University of Tennessee Knoxville; University of Haifa; Woods Hole Oceanographic Institution; University of St Andrews	Kershenbaum, A (corresponding author), Natl Inst Math & Biol Synth, Knoxville, TN USA.	arik@nimbios.org	Kershenbaum, Arik/C-3552-2012	Kershenbaum, Arik/0000-0003-0464-0243; Janik, Vincent/0000-0001-7894-0121	National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; University of Tennessee, Knoxville; University of Haifa; Dolphin Quest; Chicago Zoological Society; Natural Environment Research Council [smru10001] Funding Source: researchfish; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); University of Tennessee, Knoxville; University of Haifa; Dolphin Quest; Chicago Zoological Society; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Arik Kershenbaum is a Postdoctoral Fellow at the National Institute for Mathematical and Biological Synthesis, an Institute sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award #EF-0832858, with additional support from The University of Tennessee, Knoxville. Part of this work was conducted while Arik Kershenbaum was provided with a doctoral scholarship by the University of Haifa. Funding for access to the dolphins for recordings was provided by Dolphin Quest and the Chicago Zoological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Boughman JW, 2003, SPR HDB AUD, V16, P138; BUCK JR, 1993, J ACOUST SOC AM, V94, P2497, DOI 10.1121/1.407385; Caldwell M.C., 1990, P199; CARPENTER GA, 1987, APPL OPTICS, V26, P4919, DOI 10.1364/AO.26.004919; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; Cook MLH, 2004, P ROY SOC B-BIOL SCI, V271, P1043, DOI 10.1098/rspb.2003.2610; Cox T. F., 2000, MULTIDIMENSIONAL SCA; D'Errico J, 2012, SLM SHAPE LANGUAGE M; Datta S, 2002, SIGNAL PROCESS, V82, P251, DOI 10.1016/S0165-1684(01)00184-0; Deecke VB, 2006, J ACOUST SOC AM, V119, P645, DOI 10.1121/1.2139067; Deecke VB, 2011, AQUAT BIOL, V13, P79, DOI 10.3354/ab00353; Downie JS, 2003, ANNU REV INFORM SCI, V37, P295, DOI 10.1002/aris.1440370108; Everitt B. S., 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fripp D, 2005, ANIM COGN, V8, P17, DOI 10.1007/s10071-004-0225-z; Garrett A., 2003, FUZZY ART FUZZY ARTM; Harley HE, 2008, BEHAV PROCESS, V77, P243, DOI 10.1016/j.beproc.2007.11.002; Henry KS, 2011, J COMP PHYSIOL A, V197, P351, DOI 10.1007/s00359-010-0619-0; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Ji A, 2013, J ACOUST SOC AM, V133, P1762, DOI 10.1121/1.4789936; Kershenbaum A, 2012, P ROY SOC B-BIOL SCI, V279, P2974, DOI 10.1098/rspb.2012.0322; Koren L, 2011, BEHAV ECOL SOCIOBIOL, V65, P675, DOI 10.1007/s00265-010-1069-y; Krull CR, 2012, J ACOUST SOC AM, V132, P1189, DOI 10.1121/1.4734237; Lemstrom K., 2009, P 10 INT SOC MUSIC I, P591; Likic V, 2008, 7 MELB BIOINF COURS; Manning C.D., 2008, INTRO INFORM RETRIEV; MCCOWAN B, 1995, ETHOLOGY, V100, P194, DOI 10.1111/j.1439-0310.1995.tb00325.x; Mico P., 2008, CONTINUOUS DYNAMIC T; Mullensiefen D., 2003, COMPUTING MUSICOLOGY, V13, P147; Mullensiefen D, 2007, MUSIC SCI, P183; Nanayakkara S. C., 2007, OCEANS 2007 EUR, P1; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Parsons D., 1975, DIRECTORY TUNES MUSI; Pauws S., 2002, P 3 INT C MUS INF RE, P187; Quick NJ, 2012, P ROY SOC B-BIOL SCI, V279, P2539, DOI 10.1098/rspb.2011.2537; RALSTON JV, 1995, J COMP PSYCHOL, V109, P268, DOI 10.1037/0735-7036.109.3.268; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; Sayigh LS, 1999, ANIM BEHAV, V57, P41, DOI 10.1006/anbe.1998.0961; Thornton A, 2012, PHILOS T R SOC B, V367, P2670, DOI 10.1098/rstb.2012.0270; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; UKKONEN E, 1985, INFORM CONTROL, V64, P100, DOI 10.1016/S0019-9958(85)80046-2; Wells R.S., 2004, ECOHEALTH, V1, P246, DOI [10.1007/s10393-004-0094-6, DOI 10.1007/S10393-004-0094-6]; Zeng FG, 2005, P NATL ACAD SCI USA, V102, P2293, DOI 10.1073/pnas.0406460102; Zhong S, 2005, KNOWL INF SYST, V8, P374, DOI 10.1007/s10115-004-0194-1	47	36	36	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77671	10.1371/journal.pone.0077671	http://dx.doi.org/10.1371/journal.pone.0077671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194893	gold, Green Published			2022-12-25	WOS:000326037000072
J	Liu, HG; Ma, Y; Meng, DW; Yang, AC; Zhang, JG				Liu, Huan-Guang; Ma, Yu; Meng, Da-Wei; Yang, An-Chao; Zhang, Jian-guo			A Rat Model of Hemidystonia Induced by 3-Nitropropionic Acid	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; GLOBUS-PALLIDUS INTERNUS; TERM-FOLLOW-UP; BASAL GANGLIA; NEURONAL-ACTIVITY; POSTTRAUMATIC HEMIDYSTONIA; GENERALIZED DYSTONIA; EXCITOTOXIC LESIONS; PAROXYSMAL DYSTONIA; PARKINSONS-DISEASE	Objective: Secondary dystonia commonly presents as hemidystonia and is often refractory to current treatments. We aimed to establish an inducible rat model of hemidystonia utilizing 3-nitropropionic acid (3-NP) and to determine the pathophysiology of this model. Methods: Two different doses of 3-NP were stereotactically administered into the ipsilateral caudate putamen (CPu) of Wistar rats. Behavioral changes and alterations in the neurotransmitter levels in the basal ganglia were analyzed. We also performed an electromyogram, 7.0-T magnetic resonance imaging and transmission electron microscopy examination to determine the pathophysiology of the model. Results: In the CPu region, 3-NP produced mitochondrial cristae rupture, axonal degeneration, increased excitatory synaptic vesicles and necrosis. The extracellular concentrations of excitatory amino acids increased, whereas the inhibitory amino acids decreased in the CPu. Furthermore, an imbalance of neurotransmitters was found in other regions of the basal ganglia with the exception of the external globus pallidus. This study demonstrated that 3-NP administration results in CPu damage, and combined with a neurotransmitter imbalance in the basal ganglia, it produces specific neurobehavioral changes in rats. Right limb (contralateral side of CPu lesion) and trunk dystonic postures, shortened step length and ipsiversive dystonic posturing were observed in these rats. Furthermore, EMG recordings confirmed that co-contraction of the agonist and antagonist muscles could be seen for several seconds in right limbs. Conclusions: Stereotactic injection of 3-NP into the ipsilateral CPu of rats established an inducible model for hemidystonia. This effect might result from an imbalance of neurotransmitter levels, which induce dysfunctional activity of the basal ganglia mainly via the cortico-striato-GPi direct pathway. Symptoms in this model were present for 1 week. Activation of the cortico-striato-GPe indirect pathway and rebalance of neurotransmitters may lead to recovery. This rat model may be a suitable tool used to understand and further investigate the pathophysiology of dystonia.	[Liu, Huan-Guang; Meng, Da-Wei; Yang, An-Chao; Zhang, Jian-guo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Ma, Yu; Zhang, Jian-guo] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University	Zhang, JG (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	zjguo73@126.com		Meng, Dawei/0000-0002-3529-3873	National Natural Science Foundation of China [81171217]; Beijing Municipal Science and Technology New Star Program [2008-B-43]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology New Star Program	This work was supported by a Research Grant #81171217 from the National Natural Science Foundation of China and Research Grant #2008-B-43 from the Beijing Municipal Science and Technology New Star Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alkhani A, 2006, MOVEMENT DISORD, V21, P852, DOI 10.1002/mds.20838; Asanuma Kotaro, 2005, J Med Invest, V52 Suppl, P272, DOI 10.2152/jmi.52.272; BEAL MF, 1993, J NEUROSCI, V13, P4181; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; BURNS LH, 1995, NEUROSCIENCE, V64, P1007, DOI 10.1016/0306-4522(94)00431-4; Calderon DP, 2011, NAT NEUROSCI, V14, P357, DOI 10.1038/nn.2753; Cirillo G, 2010, NEUROCHEM INT, V56, P152, DOI 10.1016/j.neuint.2009.09.013; Cuny E, 2008, NEUROBIOL DIS, V30, P151, DOI 10.1016/j.nbd.2007.12.011; de Yebenes J G, 1988, Adv Neurol, V50, P167; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Drew KL, 2004, J NEUROSCI METH, V140, P127, DOI 10.1016/j.jneumeth.2004.04.039; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; FU YT, 1995, NEUROTOXICOL TERATOL, V17, P413, DOI 10.1016/0892-0362(94)00078-R; Ghorayeb I, 2002, NEUROSCI LETT, V335, P34, DOI 10.1016/S0304-3940(02)01137-0; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Hallett M, 2011, NEUROBIOL DIS, V42, P177, DOI 10.1016/j.nbd.2010.08.025; Hamann M, 2007, BRAIN RES, V1150, P190, DOI 10.1016/j.brainres.2007.02.074; Hamasaki T, 2008, MOVEMENT DISORD, V23, P1762, DOI 10.1002/mds.22183; He FS, 1995, NEUROLOGY, V45, P2178, DOI 10.1212/WNL.45.12.2178; Horie C, 2009, ACTA NEUROL SCAND, V119, P49, DOI 10.1111/j.1600-0404.2008.01053.x; Jankovic J, 2006, LANCET NEUROL, V5, P864, DOI 10.1016/S1474-4422(06)70574-9; Jinnah HA, 2005, MOVEMENT DISORD, V20, P283, DOI 10.1002/mds.20364; Kang DW, 2010, NEUROMODULATION, V13, P261, DOI 10.1111/j.1525-1403.2010.00306.x; Kim JP, 2012, ACTA NEUROCHIR, V154, P823, DOI 10.1007/s00701-012-1306-4; Kohling R, 2004, NEUROBIOL DIS, V16, P236, DOI 10.1016/j.nbd.2004.01.012; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kupsch A, 2006, NEW ENGL J MED, V355, P1978, DOI 10.1056/NEJMoa063618; Lee WT, 2000, NEUROSCIENCE, V95, P89; Levy LM, 2002, ANN NEUROL, V51, P93, DOI 10.1002/ana.10073; Liu HG, 2012, BRAIN RES, V1477, P37, DOI 10.1016/j.brainres.2012.08.007; Liu Y, 2000, CHINESE MED J-PEKING, V113, P948; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; Marti M, 2003, EUR J NEUROSCI, V18, P759, DOI 10.1046/j.1460-9568.2003.02806.x; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Meunier S, 2003, NEUROSCIENTIST, V9, P76, DOI 10.1177/1073858402239593; MING L, 1995, J TOXICOL-CLIN TOXIC, V33, P363, DOI 10.3109/15563659509028924; Montilla P, 2004, EUR J PHARMACOL, V488, P19, DOI 10.1016/j.ejphar.2004.02.004; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Nobrega JN, 2002, EXP NEUROL, V176, P371, DOI 10.1006/exnr.2002.7932; Obeso J A, 1988, Adv Neurol, V50, P113; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Palfi S, 2000, MOVEMENT DISORD, V15, P524, DOI 10.1002/1531-8257(200005)15:3<524::AID-MDS1016>3.0.CO;2-F; Parrot S, 2003, J NEUROSCI RES, V71, P445, DOI 10.1002/jnr.10489; Paxinos G, 2006, RAT BRAIN STEREOTAXI, P24; PERSCHAK H, 1990, NEUROSCIENCE, V35, P283, DOI 10.1016/0306-4522(90)90082-F; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; Presti MF, 2004, PHARMACOL BIOCHEM BE, V77, P501, DOI 10.1016/j.pbb.2003.12.004; Raike Robert S, 2005, NeuroRx, V2, P504; Richter A, 1998, PROG NEUROBIOL, V54, P633, DOI 10.1016/S0301-0082(97)00089-0; Richter Angelika, 2005, P459, DOI 10.1016/B978-012088382-0/50042-6; Starr PA, 2005, J NEUROPHYSIOL, V93, P3165, DOI 10.1152/jn.00971.2004; Storgaard J, 2000, EXP NEUROL, V164, P227, DOI 10.1006/exnr.2000.7428; Tang JKH, 2007, J NEUROPHYSIOL, V98, P720, DOI 10.1152/jn.01107.2006; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Vidailhet M, 2012, J NEUROL NEUROSURG P, DOI 10.1136/jnnp-2011-301714; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z; Volkmann J, 2012, LANCET NEUROL, V11, P1029, DOI 10.1016/S1474-4422(12)70257-0; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Wilson CJ, 2007, PROG BRAIN RES, V160, P91, DOI 10.1016/S0079-6123(06)60006-X; Zhuang P, 2004, CLIN NEUROPHYSIOL, V115, P2542, DOI 10.1016/j.clinph.2004.06.006	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79199	10.1371/journal.pone.0079199	http://dx.doi.org/10.1371/journal.pone.0079199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194961	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000140
J	Ma, X; Kelley, JL; Eilertson, K; Musharoff, S; Degenhardt, JD; Martins, AL; Vinar, T; Kosiol, C; Siepel, A; Gutenkunst, RN; Bustamante, CD				Ma, Xin; Kelley, Joanna L.; Eilertson, Kirsten; Musharoff, Shaila; Degenhardt, Jeremiah D.; Martins, Andre L.; Vinar, Tomas; Kosiol, Carolin; Siepel, Adam; Gutenkunst, Ryan N.; Bustamante, Carlos D.			Population Genomic Analysis Reveals a Rich Speciation and Demographic History of Orang-utans (Pongo pygmaeus and Pongo abelii)	PLOS ONE			English	Article							SOUTHEAST-ASIA; SUMATRAN ORANGUTANS; BORNEAN ORANGUTANS; NATURAL-SELECTION; DIVERGENCE DATES; ENZYME APOBEC3G; EVOLUTION; DNA; GLYCOPHORIN; PHYLOGENIES	To gain insights into evolutionary forces that have shaped the history of Bornean and Sumatran populations of orang-utans, we compare patterns of variation across more than 11 million single nucleotide polymorphisms found by previous mitochondrial and autosomal genome sequencing of 10 wild-caught orang-utans. Our analysis of the mitochondrial data yields a far more ancient split time between the two populations (similar to 3.4 million years ago) than estimates based on autosomal data (0.4 million years ago), suggesting a complex speciation process with moderate levels of primarily male migration. We find that the distribution of selection coefficients consistent with the observed frequency spectrum of autosomal non-synonymous polymorphisms in orang-utans is similar to the distribution in humans. Our analysis indicates that 35% of genes have evolved under detectable negative selection. Overall, our findings suggest that purifying natural selection, genetic drift, and a complex demographic history are the dominant drivers of genome evolution for the two orang-utan populations.	[Ma, Xin] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Kelley, Joanna L.; Musharoff, Shaila; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Eilertson, Kirsten] Gladstone Inst, Bioinformat Core, San Francisco, CA USA; [Degenhardt, Jeremiah D.; Martins, Andre L.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Vinar, Tomas] Comenius Univ, Dept Appl Informat, Bratislava, Slovakia; [Kosiol, Carolin] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria	Stanford University; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Cornell University; University of Arizona; Comenius University Bratislava; University of Veterinary Medicine Vienna	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu	Kelley, Joanna L/H-1693-2012; Vinar, Tomas/I-3695-2014	Kelley, Joanna L/0000-0002-7731-605X; Vinar, Tomas/0000-0003-3898-3447; Bustamante, Carlos D./0000-0002-4187-7920; Siepel, Adam/0000-0002-3557-7219	NSF [0606461, DEB-1146074, DBI-0644111]; NIH [P30-GM092391]; European Community [IRG-224885]; VEGA [VEGA 1/1085/12.]; NIH NRSA fellowship [GM087069]; Stanford Genome Training Grant Program (NIH/NHGRI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087069, P30GM092391] Funding Source: NIH RePORTER; Division Of Environmental Biology [1146074] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); NIH NRSA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Genome Training Grant Program (NIH/NHGRI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	X.M., K. E., J.D.D. and C. D. B. were supported by NSF 0606461 and R.N.G. was supported by NIH grant P30-GM092391 and NSF grant DEB-1146074. A. S. and A. L. M were supported by NSF grant DBI-0644111. T. V. was supported by European Community FP7 IRG-224885 from VEGA funding agency VEGA 1/1085/12. J.L.K. was supported by NIH NRSA fellowship GM087069. S. A. M. was supported by the Stanford Genome Training Grant Program (NIH/NHGRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bradley BJ, 2008, J ANAT, V212, P337, DOI 10.1111/j.1469-7580.2007.00840.x; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Bustamante CD, 2001, GENETICS, V159, P1779; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eilertson KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002806; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; GALDIKAS BMF, 1985, AM J PRIMATOL, V8, P87, DOI 10.1002/ajp.1350080202; GALDIKAS BMF, 1988, INT J PRIMATOL, V9, P1, DOI 10.1007/BF02740195; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Higham CFW, 2011, ANTIQUITY, V85, P529, DOI 10.1017/S0003598X00067922; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Mailund T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001319; Medway L, 1972, ASIAN PERSPECT, V20, P51; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; Nater A, 2011, MOL BIOL EVOL, V28, P2275, DOI 10.1093/molbev/msr042; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; OHYAMA K, 1993, BIOCHIM BIOPHYS ACTA, V1148, P133, DOI 10.1016/0005-2736(93)90170-5; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; PAUL RW, 1987, VIROLOGY, V159, P94, DOI 10.1016/0042-6822(87)90351-5; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Sanchez g, 2004, J VIROL, V78, P9807, DOI 10.1128/JVI.78.18.9807-9813.2004; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Singleton I, 2002, FOLIA PRIMATOL, V73, P1, DOI 10.1159/000060415; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Verstappen HT, 1997, J QUATERNARY SCI, V12, P413, DOI 10.1002/(SICI)1099-1417(199709/10)12:5<413::AID-JQS324>3.0.CO;2-P; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Warren KS, 2001, MOL BIOL EVOL, V18, P472, DOI 10.1093/oxfordjournals.molbev.a003826; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Wood B, 2011, NATURE, V470, P347, DOI 10.1038/nature09709; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhi L, 1996, CURR BIOL, V6, P1326, DOI 10.1016/S0960-9822(02)70719-7	63	8	8	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77175	10.1371/journal.pone.0077175	http://dx.doi.org/10.1371/journal.pone.0077175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194868	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000326037000047
J	Marini, MA; Frontoni, S; Succurro, E; Arturi, F; Fiorentino, TV; Sciacqua, A; Hribal, ML; Perticone, F; Sesti, G				Marini, Maria Adelaide; Frontoni, Simona; Succurro, Elena; Arturi, Franco; Fiorentino, Teresa Vanessa; Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio			Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELL FUNCTION; AFRICAN-AMERICANS; LIFE-STYLE; PREVENTION; RESISTANCE; TOLERANCE; RISK; SENSITIVITY; EXTRACTION	Reduced insulin clearance has been shown to predict the development of type 2 diabetes. Recently, it has been suggested that plasma glucose concentrations >8.6 mmol/l (155 mg/dl) at 1 h during an oral glucose tolerance test (OGTT) can identify individuals at high risk for type 2 diabetes among those who have normal glucose tolerance (NGT 1 h-high). The aim of this study was to examine whether NGT 1 h-high have a decrease in insulin clearance, as compared with NGT individuals with 1-h post-load glucose <8.6 mmol/l (l (155 mg/dl, NGT 1 h-low). To this end, 438 non-diabetic White individuals were subjected to OGTT and euglycemic-hyperinsulinemic clamp to evaluate insulin clearance and insulin sensitivity. As compared with NGT 1 h-low individuals, NGT 1 h-high had significantly higher 1-h and 2-h post-load plasma glucose and 2-h insulin levels as well as higher fasting glucose and insulin levels. NGT 1 h-high exhibited also a significant decrease in both insulin sensitivity (P<0.0001) and insulin clearance (P = 0.006) after adjusting for age, gender, adiposity measures, and insulin sensitivity. The differences in insulin clearance remained significant after adjustment for fasting glucose (P = 0.02) in addition to gender, age, and BMI. In univariate analyses adjusted for gender and age, insulin clearance was inversely correlated with body weight, body mass index, waist, fat mass, 1-h and 2-h post-load glucose levels, fasting, 1-h and 2-h post-load insulin levels, and insulin-stimulated glucose disposal. In conclusion, our data show that NGT 1 h-high have a reduction in insulin clearance as compared with NGT 1 h-low individuals; this suggests that impaired insulin clearance may contribute to sustained fasting and post-meal hyperinsulinemia.	[Marini, Maria Adelaide; Frontoni, Simona] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Succurro, Elena; Arturi, Franco; Fiorentino, Teresa Vanessa; Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Perticone, Francesco/I-4260-2017; FRONTONI, SIMONA/J-4893-2012; Sesti, Giorgio/B-1509-2012; Succurro, Elena/K-4138-2016; Fiorentino, Teresa Vanessa/AAP-1855-2020	FRONTONI, SIMONA/0000-0001-8241-7552; Succurro, Elena/0000-0003-2578-692X; ARTURI, Franco/0000-0002-1660-1228; Sesti, Giorgio/0000-0002-1618-7688	Italian Ministry of University [FIRB/MERIT RBNE08NKH7_002]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University grant FIRB/MERIT RBNE08NKH7_002 to G. Sesti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2008, DIABETES CARE, V31, P1650, DOI 10.2337/dc08-0225; Abdul-Ghani MA, 2009, DIABETES CARE, V32, P281, DOI 10.2337/dc08-1264; Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; BONORA E, 1983, METABOLISM, V32, P438, DOI 10.1016/0026-0495(83)90004-5; BONORA E, 1984, J CLIN ENDOCR METAB, V59, P1121, DOI 10.1210/jcem-59-6-1121; Castaldo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028312; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Duckworth WC, 1997, J INVEST MED, V45, P20; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fawcett J, 2010, BIOCHEM BIOPH RES CO, V402, P762, DOI 10.1016/j.bbrc.2010.10.104; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Hribal ML, 2001, MOL PHARMACOL, V59, P322, DOI 10.1124/mol.59.2.322; Jones CNO, 2000, AM J PHYSIOL-ENDOC M, V278, pE501, DOI 10.1152/ajpendo.2000.278.3.E501; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; Lee CC, 2013, DIABETES CARE, V36, P901, DOI 10.2337/dc12-1316; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; Marini MA, 2012, DIABETES CARE, V35, P868, DOI 10.2337/dc11-2181; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Osei K, 2007, METABOLISM, V56, P24, DOI 10.1016/j.metabol.2006.08.018; Perticone F, 2012, EUR J CLIN INVEST, V42, P1325, DOI 10.1111/eci.12005; Perticone F, 2012, DIABETES CARE, V35, P153, DOI 10.2337/dc11-1727; Sciacqua A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044470; Sciacqua A, 2011, DIABETES CARE, V34, P2291, DOI 10.2337/dc11-0879; Sciacqua A, 2011, DIABETES CARE, V34, P1406, DOI 10.2337/dc11-0155; Sesti G, 1996, DIABETOLOGIA, V39, P289; Succurro E, 2011, NUTR METAB CARDIOVAS, V21, P713, DOI 10.1016/j.numecd.2011.02.002; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Succurro E, 2010, CLIN J AM SOC NEPHRO, V5, P1922, DOI 10.2215/CJN.03240410; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x	36	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77440	10.1371/journal.pone.0077440	http://dx.doi.org/10.1371/journal.pone.0077440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194886	gold, Green Submitted, Green Published			2022-12-25	WOS:000326037000065
J	Steinbauer, MJ				Steinbauer, Martin J.			Shoot Feeding as a Nutrient Acquisition Strategy in Free-Living Psylloids	PLOS ONE			English	Article							JUMPING PLANT-LICE; PHLOEM-SAP; HOST-PLANT; AMINO-ACID; NUTRITIONAL QUALITY; LIFE-HISTORY; CTENARYTAINA-EUCALYPTI; INSECT VECTOR; ADULT LEAVES; HEMIPTERA	Shoot feeding by sucking insects is accepted as an adaptation to feeding where plant nutrients are most concentrated and/or of higher quality. Psylloids are an important hemipteran taxon, most of which are free-living and comprise many shoot feeding species, whose nutritional ecology has been largely ignored. I conducted a longitudinal study of Ctenarytaina eucalypti (Maskell) and C. bipartita Burckhardt et al. (Aphalaridae) feeding on eucalypts to document how within-plant (ontogenic) variation in nutritional quality, in particular of free amino acids, determines host suitability and hence the distribution and abundance of nymphs. Nymphs were most abundant within developing apical buds but were not more abundant on branchlets of greater vigour (indicated by rate of extension). Nymphs could be found up to two (C. bipartita) to three (C. eucalypti) alternate leaf pairs distant from apical buds but infrequently and in low numbers; they were never found on older, fully expanded leaves. The position of a leaf on a branchlet (indicative of age) determined its nutritional quality. Younger leaves had higher water contents, lower chlorophyll contents and differed in amino acid (essential and non-essential) composition compared to older leaves. The abundance of C. eucalypti nymphs on expanding leaves and in buds was positively correlated with the concentrations of methionine, valine and threonine in E. globulus leaves at the same or comparable position on a branchlet. The abundance of C. bipartita nymphs was positively correlated with foliar leucine concentrations. Shoot feeding by these two psyllids facilitates access to more concentrated, better quality plant nutrients but may not entirely explain the adaptive significance of their behaviour. The humid microclimate created by the architecture of the hosts' apical buds protects eggs and nymphs from desiccation and is suggested to have had a significant influence on the evolution of host utilisation strategies of psyllids within this genus.	La Trobe Univ, Dept Zool, Melbourne, Vic, Australia	La Trobe University	Steinbauer, MJ (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic, Australia.	M.Steinbauer@latrobe.edu.au	Steinbauer, Martin James/A-8612-2011	Steinbauer, Martin James/0000-0002-0345-2905	Australian Research Council [FT100100199]; Australia and Pacific Science Foundation [APSF 11-2]	Australian Research Council(Australian Research Council); Australia and Pacific Science Foundation	This work was funded by the Australian Research Council through a Future Fellowships award (FT100100199) granted to the author with additional financial support for research assistance provided by the Australia and Pacific Science Foundation (APSF 11-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON DH, 1975, AUST J BOT, V23, P239, DOI 10.1071/BT9750239; Ball MC, 1997, PLANT CELL ENVIRON, V20, P155, DOI 10.1046/j.1365-3040.1997.d01-61.x; Behmer ST, 2011, FUNCT ECOL, V25, P484, DOI 10.1111/j.1365-2435.2010.01810.x; Blackmer JL, 1999, ENTOMOL EXP APPL, V93, P29, DOI 10.1023/A:1003886107024; Boughton BA, 2011, ANAL CHEM, V83, P7523, DOI 10.1021/ac201610x; Brennan EB, 2001, ENVIRON ENTOMOL, V30, P1144, DOI 10.1603/0046-225X-30.6.1144; Brennan EB, 2001, ENTOMOL EXP APPL, V100, P179, DOI 10.1023/A:1019295104902; Brennan EB, 2001, ENTOMOL EXP APPL, V100, P355, DOI 10.1023/A:1019201412579; Burckhardt D, 2013, ZOOTAXA, V3613, P589, DOI 10.11646/zootaxa.3613.6.5; Chiyaka C, 2012, P NATL ACAD SCI USA, V109, P12213, DOI 10.1073/pnas.1208326109; Day KR, 2004, ECOL ENTOMOL, V29, P555, DOI 10.1111/j.0307-6946.2004.00631.x; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; Hollis D., 2004, AUSTR PSYLLOIDEA JUM; JOURNET ARP, 1980, ECOL ENTOMOL, V5, P249, DOI 10.1111/j.1365-2311.1980.tb01148.x; Karley AJ, 2003, B ENTOMOL RES, V93, P425, DOI 10.1079/BER2003252; Karley AJ, 2002, J EXP BIOL, V205, P3009; KIDD NAC, 1985, OIKOS, V44, P114, DOI 10.2307/3544051; Koyama Y, 2004, ENTOMOL EXP APPL, V113, P35, DOI 10.1111/j.0013-8703.2004.00207.x; Levy J, 2013, J ECON ENTOMOL, V106, P1440, DOI 10.1603/EC12419; Luft PA, 1997, ENTOMOL EXP APPL, V84, P293, DOI 10.1023/A:1003037029782; Luft PA, 2001, ECOL ENTOMOL, V26, P263, DOI 10.1046/j.1365-2311.2001.00322.x; MAELZER DA, 1977, AUST J ZOOL, V25, P269, DOI 10.1071/ZO9770269; Mayer CJ, 2008, J CHEM ECOL, V34, P1045, DOI 10.1007/s10886-008-9516-1; MENSAH RK, 1992, ENTOMOL EXP APPL, V62, P261, DOI 10.1007/BF00353445; Merchant A, 2006, PLANT CELL ENVIRON, V29, P2017, DOI 10.1111/j.1365-3040.2006.01577.x; Merchant A, 2010, J EXP BOT, V61, P1785, DOI 10.1093/jxb/erq045; Morgan F. D., 1984, Psylloidea of South Australia.; Oppong CK, 2010, AFR INVERTEBR, V51, P201, DOI 10.5733/afin.051.0105; Ouvrard D, 2010, SYST ENTOMOL, V35, P172, DOI 10.1111/j.1365-3113.2009.00499.x; Paine TD, 2011, ANNU REV ENTOMOL, V56, P181, DOI 10.1146/annurev-ento-120709-144817; PFEIFFER DG, 1984, ENVIRON ENTOMOL, V13, P1487, DOI 10.1093/ee/13.6.1487; Pinkard EA, 2006, FOREST ECOL MANAG, V223, P211, DOI 10.1016/j.foreco.2005.11.003; Price P.W., 2003, MACROEVOLUTIONARY TH; Purvis G, 2002, ANN APPL BIOL, V141, P283, DOI 10.1111/j.1744-7348.2002.tb00220.x; RIENS B, 1991, PLANT PHYSIOL, V97, P227, DOI 10.1104/pp.97.1.227; Salt DT, 1998, GLOB CHANGE BIOL, V4, P91, DOI 10.1046/j.1365-2486.1998.00108.x; Sandstrom J, 2000, CHEMOECOLOGY, V10, P17, DOI 10.1007/s000490050003; SCURFIELD G., 1961, AUSTRALIAN JOUR BOT, V9, P37, DOI 10.1071/BT9610037; Sequeira R, 1996, EUR J ENTOMOL, V93, P53; SHARMA A, 2013, ARTH STRUCT IN PRESS; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; Steinbauer MJ, 1998, B ENTOMOL RES, V88, P641, DOI 10.1017/S0007485300054316; Steinbauer MJ, 1999, ENTOMOL EXP APPL, V91, P175, DOI 10.1023/A:1003614516588; Stone C, 2010, AUST FORESTRY, V73, P98, DOI 10.1080/00049158.2010.10676315; SUTTON RD, 1984, J ANIM ECOL, V53, P37, DOI 10.2307/4340; Suzuki DK, 2009, ARTHROPOD-PLANT INTE, V3, P241, DOI 10.1007/s11829-009-9064-9; Taylor Gary S., 1997, P37; Turgeon R, 2009, ANNU REV PLANT BIOL, V60, P207, DOI 10.1146/annurev.arplant.043008.092045; ULLMAN DE, 1988, ENTOMOL EXP APPL, V47, P115, DOI 10.1007/BF00367477; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; WATMOUGH RH, 1968, J ANIM ECOL, V37, P283, DOI 10.2307/2949; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; White TCR, 2009, OIKOS, V118, P807, DOI 10.1111/j.1600-0706.2009.17495.x; WHITE T C R, 1970, Australian Journal of Zoology, V18, P105, DOI 10.1071/ZO9700105; WOODBURN T L, 1973, Journal of the Australian Entomological Society, V12, P134	58	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77990	10.1371/journal.pone.0077990	http://dx.doi.org/10.1371/journal.pone.0077990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194907	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000086
J	Vanura, K; Rieder, F; Kastner, MT; Biebl, J; Sandhofer, M; Le, T; Strassl, R; Puchhammer-Stockl, E; Perkmann, T; Steininger, CF; Stamatopoulos, K; Graninger, W; Jager, U; Steininger, C				Vanura, Katrina; Rieder, Franz; Kastner, Marie-Theres; Biebl, Julia; Sandhofer, Michael; Trang Le; Strassl, Robert; Puchhammer-Stoeckl, Elisabeth; Perkmann, Thomas; Steininger, Christoph F.; Stamatopoulos, Kostas; Graninger, Wolfgang; Jaeger, Ulrich; Steininger, Christoph			Chronic Lymphocytic Leukemia Patients Have a Preserved Cytomegalovirus-Specific Antibody Response despite Progressive Hypogammaglobulinemia	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; INFECTIOUS COMPLICATIONS; T-CELLS; B-CELLS; PROTEINS; BLOOD; PHOSPHOPROTEIN; PERSISTENCE; EXPRESSION; TEGUMENT	Chronic lymphocytic leukemia (CLL) is characterized by progressive hypogammaglobulinemia predisposing affected patients to a variety of infectious diseases but paradoxically not to cytomegalovirus (CMV) disease. Moreover, we found reactivity of a panel of CLL recombinant antibodies (CLL-rAbs) encoded by a germ-line allele with a single CMV protein, pUL32, despite differing antibody binding motifs. To put these findings into perspective, we studied prospectively relative frequency of viremia, kinetics of total and virus-specific IgG over time, and UL32 genetic variation in a cohort of therapy-naive patients (n=200). CMV-DNA was detected in 3% (6/200) of patients. The decay of total IgG was uniform (mean, 0.03; SD, 0.03) and correlated with that of IgG subclasses 1-4 in the paired samples available (n=64; p<0.001). Total CMV-specific IgG kinetics were more variable (mean, 0,02; SD, 0,06) and mean decay values differed significantly from those of total IgG (p=0.034). Boosts of CMV-specific antibody levels were observed in 49% (22/45) of CMV-seropositive patients. In contrast, VZV- and EBV-specific IgG levels decayed in parallel with total IgG levels (p=0.003 and p=0.001, respectively). VZV-specific IgG even became undetectable in 18% (9/50) of patients whereas CMV-specific ones remained detectable in all seropositive patients. The observed CMV-specific IgG kinetics were predicated upon the highly divergent kinetics of IgG specific for individual antigens - glycoprotein B-specific IgG were boosted in 51% and pUL32-specific IgG in 32% of patients. In conclusion, CLL patients have a preserved CMV-specific antibody response despite progressive decay of total IgG and IgG subclasses. CMV-specific IgG levels are frequently boosted in contrast to that of other herpesviruses indicative of a higher rate of CMV reactivation and antigen-presentation. In contrast to the reactivity of multiple different CLL-rAbs with pUL32, boosts of humoral immunity are triggered apparently by other CMV antigens than pUL32, like glycoprotein B.	[Vanura, Katrina; Trang Le; Jaeger, Ulrich] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostaseol, CCC, Vienna, Austria; [Rieder, Franz; Kastner, Marie-Theres; Biebl, Julia; Sandhofer, Michael; Steininger, Christoph F.; Graninger, Wolfgang; Steininger, Christoph] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Strassl, Robert; Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Dept Virol, Vienna, Austria; [Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Stamatopoulos, Kostas] G Papanicolaou Hosp, Dept Hematol, Thessaloniki, Greece; [Stamatopoulos, Kostas] G Papanicolaou Hosp, HCT Unit, Thessaloniki, Greece	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; George Papanikolaou General Hospital of Thessaloniki; George Papanikolaou General Hospital of Thessaloniki	Steininger, C (corresponding author), Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	christoph.steininger@meduniwien.ac.at	Vanura, Katrina/AAG-1236-2021; Perkmann, Thomas/F-3074-2012; Steininger, Christoph/U-8815-2019	Vanura, Katrina/0000-0002-2217-4998; Steininger, Christoph/0000-0003-3500-7205; Stamatopoulos, Kostas/0000-0001-8529-640X; Rieder, Franz/0000-0002-4839-9845; Perkmann, Thomas/0000-0002-7976-0285	European Society of Clinical Microbiology and Infectious Diseases; independent Karl-Landsteiner Society, Austria; Initiative Krebsforschung of the Medical University of Vienna, Austria	European Society of Clinical Microbiology and Infectious Diseases; independent Karl-Landsteiner Society, Austria; Initiative Krebsforschung of the Medical University of Vienna, Austria	This study was supported in part by a grant from the European Society of Clinical Microbiology and Infectious Diseases, the independent Karl-Landsteiner Society, Austria, and the Initiative Krebsforschung of the Medical University of Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan JM, 2010, LEUKEMIA, V24, P877, DOI 10.1038/leu.2009.298; Baxter MK, 2001, J VIROL, V75, P6865, DOI 10.1128/JVI.75.15.6865-6873.2001; Beghetto E, 2008, J VIROL METHODS, V151, P7, DOI 10.1016/j.jviromet.2008.04.005; Brinkhof MWG, 2013, VACCINE, V31, P1490, DOI 10.1016/j.vaccine.2013.01.011; Buhl AM, 2006, EUR J HAEMATOL, V76, P455, DOI 10.1111/j.0902-4441.2005.t01-1-EJH2530.x; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; CRNKOVIC I, 1994, J EXP MED, V179, P1713, DOI DOI 10.1084/JEM.179.5.1713.PUBMED:8163949; Daniels JA, 2007, AM J SURG PATHOL, V31, P1800, DOI 10.1097/PAS.0b013e3180cab60c; Dati F, 2001, CLIN CHEM LAB MED, V39, P1134, DOI 10.1515/CCLM.2001.179; Engelmann I, 2008, J MED VIROL, V80, P467, DOI 10.1002/jmv.21095; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; Greijer AE, 1999, J CLIN MICROBIOL, V37, P179, DOI 10.1128/JCM.37.1.179-188.1999; Hillmen P, 2007, J CLIN ONCOL, V25, P5616, DOI 10.1200/JCO.2007.12.9098; Kainulainen L, 1999, AM J RESP CRIT CARE, V159, P1199, DOI 10.1164/ajrccm.159.4.9807067; Kater AP, 2004, BRIT J HAEMATOL, V127, P404, DOI 10.1111/j.1365-2141.2004.05225.x; Keating MJ, 2002, BLOOD, V99, P3554, DOI 10.1182/blood.V99.10.3554; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Kostareli E, 2009, LEUKEMIA, V23, P919, DOI 10.1038/leu.2008.379; La Rosa C, 2005, HUM IMMUNOL, V66, P116, DOI 10.1016/j.humimm.2004.10.008; Lazzarotto T, 1997, J CLIN MICROBIOL, V35, P393, DOI 10.1128/JCM.35.2.393-397.1997; Leuridan E, 2012, EUR J PEDIATR, V171, P1167, DOI 10.1007/s00431-012-1691-y; Mackus WJM, 2003, BLOOD, V102, P1057, DOI 10.1182/blood-2003-01-0182; Malphettes M, 2009, CLIN INFECT DIS, V49, P1329, DOI 10.1086/606059; Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811; MOLICA S, 1993, HAEMATOLOGICA, V78, P374; Morrison VA, 2009, CLIN LYMPHOMA MYELOM, V9, P365, DOI 10.3816/CLM.2009.n.071; NOVAK J, 1991, J GEN VIROL, V72, P1409, DOI 10.1099/0022-1317-72-6-1409; Pourgheysari B, 2007, J VIROL, V81, P7759, DOI 10.1128/JVI.01262-06; Pourgheysari B, 2010, BLOOD, V116, P2968, DOI 10.1182/blood-2009-12-257147; Puchhammer-Stockl E, 2006, J CLIN VIROL, V36, P239, DOI 10.1016/j.jcv.2006.03.004; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Sanchez V, 2000, J VIROL, V74, P975, DOI 10.1128/JVI.74.2.975-986.2000; Schafer P, 1998, J CLIN MICROBIOL, V36, P1008; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Steininger C, 2005, AIDS, V19, P273; Steininger C, 2004, J INFECT DIS, V190, P1908, DOI 10.1086/424677; Steininger C, 2012, BLOOD, V119, P2293, DOI 10.1182/blood-2011-08-374058; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; Takahashi I, 2002, BIOSCI BIOTECH BIOCH, V66, P2402, DOI 10.1271/bbb.66.2402; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Tsiodras S, 2000, MAYO CLIN PROC, V75, P1039, DOI 10.4065/75.10.1039; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wadhwa PD, 2006, SEMIN ONCOL, V33, P240, DOI 10.1053/j.seminoncol.2005.12.013; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Widhopf GF, 2004, BLOOD, V104, P2499, DOI 10.1182/blood-2004-03-0818	49	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78925	10.1371/journal.pone.0078925	http://dx.doi.org/10.1371/journal.pone.0078925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194956	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000135
J	Vargas-Salinas, F; Amezquita, A				Vargas-Salinas, Fernando; Amezquita, Adolfo			Stream Noise, Hybridization, and Uncoupled Evolution of Call Traits in Two Lineages of Poison Frogs: Oophaga histrionica and Oophaga lehmanni	PLOS ONE			English	Article							ADVERTISEMENT CALL; PHYSALAEMUS-PUSTULOSUS; SEXUAL SELECTION; VISUAL-DISPLAYS; ACRIS-CREPITANS; SENSORY DRIVE; SPECIATION; ENVIRONMENT; PATTERNS; BIRD	According to the acoustic adaptation hypothesis, communication signals are evolutionary shaped in a way that minimizes its degradation and maximizes its contrast against the background noise. To compare the importance for call divergence of acoustic adaptation and hybridization, an evolutionary force allegedly promoting phenotypic variation, we compared the mate recognition signal of two species of poison frogs (Oophaga histrionica and O. lehmanni) at five localities: two (one per species) alongside noisy streams, two away from streams, and one interspecific hybrid. We recorded the calls of 47 males and characterized the microgeographic variation in their spectral and temporal features, measuring ambient noise level, body size, and body temperature as covariates. As predicted, frogs living in noisy habitats uttered high frequency calls and, in one species, were much smaller in size. These results support a previously unconsidered role of noise on streams as a selective force promoting an increase in call frequency and pleiotropic effects in body size. Regarding hybrid frogs, their calls overlapped in the signal space with the calls of one of the parental lineages. Our data support acoustic adaptation following two evolutionary routes but do not support the presumed role of hybridization in promoting phenotypic diversity.	[Vargas-Salinas, Fernando; Amezquita, Adolfo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia	Universidad de los Andes (Colombia)	Vargas-Salinas, F (corresponding author), Univ Quindi, Fac Ciencias Basicas & Tecnol, Programa Biol, Armenia, Colombia.	vargassalinasf@yahoo.com		Amezquita, Adolfo/0000-0001-7320-1143	COLCIENCIAS [1204-452-21096 CT 266-2008]; Faculty of Sciences at the Universidad de los Andes-Colombia (Proyecto Semilla a FVS convocatoria) [2009-2]; Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas''COLCIENCIAS	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Faculty of Sciences at the Universidad de los Andes-Colombia (Proyecto Semilla a FVS convocatoria); Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas''COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was supported by COLCIENCIAS (Project code 1204-452-21096 CT 266-2008) and the Faculty of Sciences at the Universidad de los Andes-Colombia (Proyecto Semilla a FVS convocatoria 2009-2). The Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia "Francisco Jose de Caldas''COLCIENCIAS provided economic support during the doctoral studies of FVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson E., 1949, INTROGRESSIVE HYBRID; [Anonymous], 1972, EVOLUTION GENUS BUFO; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; CASTROHERRERA F, 2004, SERIE LIBROS ROJOS E, P162; Center for Conservation Bioacoustics, 2011, RAV PROINT SOUND AN; CHAPUIS C, 1971, Terre et la Vie, V118, P183; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; Coyne JA, 2004, SPECIATION, V37; de Luna AG, 2010, ANIM BEHAV, V79, P739, DOI 10.1016/j.anbehav.2009.12.031; DUBOIS A, 1984, J ORNITHOL, V125, P455, DOI 10.1007/BF01640137; Duellman W. E., 2001, HYLID FROGS MIDDLE A; Duellman WE, 1986, BIOL AMPHIBIANS, P1; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; ENDLER JA, 1993, PHILOS T R SOC B, V340, P215, DOI 10.1098/rstb.1993.0060; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Fleishman Leo J., 2000, P209; FLEISHMAN LJ, 1992, AM NAT, V139, pS36, DOI 10.1086/285304; GERHARDT HC, 1980, COPEIA, P577; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gomez D, 2004, ECOL LETT, V7, P279, DOI 10.1111/j.1461-0248.2004.00584.x; Grafe TU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037965; Haven Wiley R., 1982, P131; Hoedl Walter, 2001, P121; Irwin DE, 2000, EVOLUTION, V54, P998; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lotters S., 2007, POISON FROGS BIOL SP; Lougheed SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-23; Maan ME, 2008, EVOLUTION, V62, P2334, DOI 10.1111/j.1558-5646.2008.00454.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MARCHETTI K, 1993, NATURE, V362, P149, DOI 10.1038/362149a0; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; McClelland BE, 1996, J EXP BIOL, V199, P1907; Medina I, 2013, ECOL EVOL, V3, P4388, DOI 10.1002/ece3.794; Meenderink SWF, 2010, BIOL LETTERS, V6, P278, DOI 10.1098/rsbl.2009.0763; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Narins PM, 2003, P NATL ACAD SCI USA, V100, P577, DOI 10.1073/pnas.0237165100; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Ord TJ, 2007, P R SOC B, V274, P1057, DOI 10.1098/rspb.2006.0263; Penna M, 1998, BEHAV ECOL SOCIOBIOL, V42, P371, DOI 10.1007/s002650050452; Price T, 2007, SPECIATION BIRDS; Roberts JL, 2007, J BIOGEOGR, V34, P417, DOI 10.1111/j.1365-2699.2006.01621.x; Rundle Howard D., 2010, P471; Ryan M. J., 1987, EVOLUTION AMPHIBIAN, P637; RYAN MJ, 1991, BIOL J LINN SOC, V44, P249, DOI 10.1111/j.1095-8312.1991.tb00619.x; Ryan MJ, 1996, EVOLUTION, V50, P2435, DOI 10.1111/j.1558-5646.1996.tb03630.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; RYAN MJ, 1990, BIOL J LINN SOC, V40, P37, DOI 10.1111/j.1095-8312.1990.tb00533.x; Saetre GP, 1997, NATURE, V387, P589; Schneider Hans, 2007, Amphibian Biology, V7, P2893; Seddon N, 2005, EVOLUTION, V59, P200; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; SILVERSTONE P A, 1973, Herpetologica, V29, P295; Silverstone PA., 1975, NAT HIST, V21, P1; Summers K, 2004, J HERPETOL, V38, P1, DOI 10.1670/51-03A; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; Velazquez EBE, 2009, EVALUACION ESTADO CO; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wiens JJ, 2004, AM NAT, V163, P914, DOI 10.1086/386552; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Wollenberg KC, 2008, BIOL J LINN SOC, V93, P433, DOI 10.1111/j.1095-8312.2007.00906.x; Ziegler L, 2011, BEHAV ECOL, V22, P520, DOI 10.1093/beheco/arr011; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	71	26	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77545	10.1371/journal.pone.0077545	http://dx.doi.org/10.1371/journal.pone.0077545			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194888	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000067
J	Yang, XB; Zhao, JJ; Huang, CY; Wang, QJ; Pan, K; Wang, DD; Pan, QZ; Jiang, SS; Lv, L; Gao, X; Chen, HW; Yao, JY; Zhi, M; Xia, JC				Yang, Xiao-bo; Zhao, Jing-jing; Huang, Chun-yu; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Gao, Xiang; Chen, Huang-wei; Yao, Jia-yin; Zhi, Min; Xia, Jian-chuan			Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PROMOTES TUMORIGENESIS; CANCER; SURVIVAL; IDENTIFICATION; CARCINOMA; PROFILE; CELLS	Background: FOXO3a, a member of the forkhead class 'O' (FOXO) transcription factor family, controls a wide spectrum of biological processes, such as DNA damage repair, apoptosis, and cell cycle regulation. FOXO3a has been shown to be a tumor suppressor in various cancers. This study investigated the expression of FOXO3a in primary gastric adenocarcinomas and its prognostic value for primary gastric adenocarcinoma patients. Methods: Real-time quantitative RT-PCR (qRT-PCR), western blotting, and immunohistochemical staining were used to detect FOXO3a expression in primary gastric cancerous surgical specimens and adjacent non-tumorous tissues. Results: Our data showed that the expression of FOXO3a mRNA (p = 0.03) and protein (p = 0.019) was lower in cancerous tissues compared with their adjacent non-tumorous tissues. In addition, the chi-square test revealed that low FOXO3a expression was significantly correlated with larger tumor size (p = 0.007), poor histopathological classification (p = 0.029), depth of invasion (p = 0.049), local lymph node metastasis (p = 0.013), distant metastasis (p = 0.013) and AJCC staging (p<0.001). Kaplan-Meier survival analysis demonstrated that low expression of FOXO3a was significantly correlated with a poor prognosis for gastric cancer patients (p<0.001). The multivariate analysis showed that FOXO3a expression was an independent prognostic factor of the overall survival rate of patients with primary gastric adenocarcinoma. Conclusion: Our study suggested that decreased FOXO3a expression may play an important role in the progression of gastric cancer. FOXO3a could be a valuable prognostic marker as well as a potential molecular therapy target for gastric cancer patients.	[Yang, Xiao-bo; Zhao, Jing-jing; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Xiao-bo; Zhao, Jing-jing; Wang, Qi-jing; Pan, Ke; Wang, Dan-dan; Pan, Qiu-zhong; Jiang, Shan-shan; Lv, Lin; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Xiao-bo; Gao, Xiang; Chen, Huang-wei; Yao, Jia-yin; Zhi, Min] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jing-jing; Wang, Qi-jing; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Chun-yu] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhi, M (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China.	merryzhi@163.com; xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Arden KC, 2006, EXP GERONTOL, V41, P709, DOI 10.1016/j.exger.2006.05.015; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Caruso RA, 2002, MODERN PATHOL, V15, P831, DOI 10.1097/01.MP.0000020391.98998.6B; Chen CN, 2005, J CLIN ONCOL, V23, P7286, DOI 10.1200/JCO.2004.00.2253; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Habashy HO, 2011, BREAST CANCER RES TR, V129, P11, DOI 10.1007/s10549-010-1161-z; Hippo Y, 2002, CANCER RES, V62, P233; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang Haojie, 2006, Future Oncol, V2, P83, DOI 10.2217/14796694.2.1.83; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karger S, 2009, ENDOCR-RELAT CANCER, V16, P189, DOI 10.1677/ERC-07-0283; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Ma HQ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-190; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Shukla S, 2009, INT J ONCOL, V34, P1613, DOI 10.3892/ijo_00000291; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024897; Yang JY, 2008, NAT CELL BIOL, V10, P370; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Yasui W, 2009, PATHOL INT, V59, P121, DOI 10.1111/j.1440-1827.2009.02329.x; Zhang B, 2008, BIOCHEM BIOPH RES CO, V374, P533, DOI 10.1016/j.bbrc.2008.07.060; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025; Zou YY, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1872	33	28	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78158	10.1371/journal.pone.0078158	http://dx.doi.org/10.1371/journal.pone.0078158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194912	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000091
J	Nitta, CF; Orlando, RA				Nitta, Carolina Franco; Orlando, Robert A.			Crosstalk between Immune Cells and Adipocytes Requires Both Paracrine Factors and Cell Contact to Modify Cytokine Secretion	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; FACTOR-KAPPA-B; INDUCED INFLAMMATORY CHANGES; LONG PENTRAXIN PTX3; FREE FATTY-ACIDS; KILLER T-CELLS; INSULIN-RESISTANCE; TNF-ALPHA	Increased adiposity results in a heightened infiltration of immune cells into fat depots, which in turn generates a pro-inflammatory phenotype in obese individuals. To better understand the causal factors that establish this pro-inflammatory profile, we examined events leading to crosstalk between adipocytes and immune cells. Using isolated spleen-derived immune cells, stimulated with LPS, together with cultured adipocytes, we differentiated the effects of paracrine factors and cell-cell contact on TNF alpha, IL-6 and MCP-1 secretion levels and secretion profiles. When splenocytes and adipocytes were co-cultured without direct contact, permitting only paracrine communication, secretion of IL-6 and MCP-1 were increased by 3- and 2.5-fold, respectively, over what was secreted by individual cultures, whereas TNF alpha secretion was reduced by 55%. When cells were co-cultured with direct cell-cell contact, IL-6 and MCP-1 secretion were increased by an additional 36% and 38%, respectively, over that measured from just paracrine stimulation alone, indicating that cell contact provides a synergistic signal that amplifies elevated cytokine secretion stimulated by paracrine signals. Using splenocytes from TNF alpha(-/-) mice showed that the absence of TNF alpha has little effect on paracrine stimulation of cytokine secretion, but attenuates cell contact-mediated enhancement of IL-6 and MCP-1 secretion. Furthermore, TNF alpha supports cell contact-mediated signaling in part, but not exclusively, through Nuclear Factor-kappa B activation. These findings indicate that engagement of cell contact between immune cells and adipocytes, in conjunction with locally secreted paracrine factors, activates a unique signaling pathway that mediates crosstalk between these cell types leading to marked effects on cytokine secretion and profile.	[Nitta, Carolina Franco; Orlando, Robert A.] Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA	University of New Mexico	Orlando, RA (corresponding author), Univ New Mexico, Sch Med, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	rorlando@salud.unm.edu			University of New Mexico, School of Medicine, Office of Research; New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE)	University of New Mexico, School of Medicine, Office of Research; New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE)	This work was support by a generous gift of Gap Funding to RAO from the University of New Mexico, School of Medicine, Office of Research. CFN was sponsored by a pre-doctoral scholarship from the New Mexico IDeA Networks of Biomedical Research Excellence (NM-INBRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Alberti L, 2009, ATHEROSCLEROSIS, V202, P455, DOI 10.1016/j.atherosclerosis.2008.05.015; Alexopoulou L, 1997, EUR J IMMUNOL, V27, P2588, DOI 10.1002/eji.1830271018; Avitsur R, 2002, J NEUROIMMUNOL, V132, P66, DOI 10.1016/S0165-5728(02)00310-7; Bays H, 2004, J CLIN ENDOCR METAB, V89, P463, DOI 10.1210/jc.2003-030723; Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Fain JN, 2003, BIOCHEM BIOPH RES CO, V300, P674, DOI 10.1016/S0006-291X(02)02864-4; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Garrow J. S., 1988, OBESITY RELATED DIS; Georgopoulos S, 1996, J INFLAMM, V46, P86; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Gotoh K, 2012, DIABETES, V61, P1994, DOI 10.2337/db11-1688; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Jensen MD, 2006, OBESITY, V14, p20S, DOI 10.1038/oby.2006.278; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kruisbeek Ada M, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0314s24; Lappas M, 2005, ENDOCRINOLOGY, V146, P1491, DOI 10.1210/en.2004-0809; Liu ZG, 2005, CELL RES, V15, P24, DOI 10.1038/sj.cr.7290259; Livak K, 1997, USER B BIOSYSTEMS PA, V2; McDonnell ME, 2012, OBESITY, V20, P1372, DOI 10.1038/oby.2012.54; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; Permana PA, 2006, BIOCHEM BIOPH RES CO, V341, P507, DOI 10.1016/j.bbrc.2006.01.012; Permana PA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1076, DOI 10.1152/ajpendo.91013.2008; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ruan H, 2003, J BIOL CHEM, V278, P47585, DOI 10.1074/jbc.M305257200; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Samuvel DJ, 2010, J BIOL CHEM, V285, P3916, DOI 10.1074/jbc.M109.033951; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Xie LL, 2010, CLIN VACCINE IMMUNOL, V17, P651, DOI 10.1128/CVI.00494-09; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	67	24	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77306	10.1371/journal.pone.0077306	http://dx.doi.org/10.1371/journal.pone.0077306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204798	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600029
J	Rastogi, A; Kumari, Y; Rani, S; Kumar, V				Rastogi, Ashutosh; Kumari, Yatinesh; Rani, Sangeeta; Kumar, Vinod			Neural Correlates of Migration: Activation of Hypothalamic Clock(s) in and out of Migratory State in the Blackheaded Bunting (Emberiza melanocephala)	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; NEUROPEPTIDE-Y; SUPRACHIASMATIC NUCLEUS; JAPANESE-QUAIL; C-FOS; MEDIOBASAL HYPOTHALAMUS; PHOTOPERIODIC RESPONSE; SEASONAL REPRODUCTION; LUTEINIZING-HORMONE; GONADAL DEVELOPMENT	Background: Many vertebrates distinguish between short and long day lengths using suprachiasmatic nuclei (SCN). In birds particular, the mediobasal hypothalamus (MBH) is suggested to be involved in the timing of seasonal reproduction. This study investigated the response of SCN and MBH to a single long day, and the role of MBH in induction of the migratory phenotype in night-migratory blackheaded buntings. Methodology/Principal Findings: Experiment 1 immunocytochemically measured c-fos in the SCN, and c-fos, vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY) in the MBH of buntings exposed to a 20 h light period. Long light period induced significantly stronger c-fos expression, measured as number of c-fos-like immunoreactive (c-fos-lir) cells, in MBH, but not in the SCN. Within the MBH, c-fos-lir cells were significantly denser in the inferior hypothalamic nucleus (IH) and infundibular nucleus (IN), but not in the dorsomedial hypothalamus (DMH). IH and IN also had significantly increased number of VIP and NPY labeled cells. DMH had significantly increased number of VIP labeled cells only. Experiment 2 assayed c-fos, VIP and NPY immunoreactivities in the middle of day and night in the MBH of buntings, after seven long days (day active, non-migratory state) and after seven days of Zugunruhe (night active, migratory state) in long days. In the migratory state, the number of c-fos-lir cells was significantly greater only in DMH; VIP-lir cells were denser in all three MBH regions suggesting enhanced light sensitivity at night. The denser NPY-lir cells only in IN in the non-migratory state were probably due to premigratory hyperphagia. Conclusions/Significance: In buntings, SCN may not be involved in the photoperiod-induced seasonal responses. MBH contains the seasonal clock sensitive to day length. VIP and NPY are parts of the neuroendocrine mechanism(s) involved, respectively, in sensing and translating the photoperiodic message in a seasonal response.	[Rastogi, Ashutosh; Kumari, Yatinesh; Rani, Sangeeta] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India; [Kumar, Vinod] Univ Delhi, Dept Zool, Delhi 110007, India	Lucknow University; University of Delhi	Kumar, V (corresponding author), Univ Delhi, Dept Zool, Delhi 110007, India.	drvkumar11@yahoo.com	Kumari, Yatinesh/F-9755-2018	Kumari, Yatinesh/0000-0001-6544-1243	Department of Science and Technology, New Delhi, India through Intensification of Research in High Priority Areas research funding [IR/SO/LU-02/2005]	Department of Science and Technology, New Delhi, India through Intensification of Research in High Priority Areas research funding	The study was funded by a generous research grant from the Department of Science and Technology, New Delhi, India, through Intensification of Research in High Priority Areas research funding (IR/SO/LU-02/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1974, HDB BIRDS INDIA PAKI; Aston-Jones G, 2001, NAT NEUROSCI, V4, P732, DOI 10.1038/89522; Bartell PA, 2005, J BIOL RHYTHM, V20, P538, DOI 10.1177/0748730405281826; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; Boswell Tim, 2005, Journal of Poultry Science, V42, P161, DOI 10.2141/jpsa.42.161; Brandstatter R, 2003, CHRONOBIOL INT, V20, P637, DOI 10.1081/CBI-120023343; Budki P, 2012, J EXP BIOL, V215, P3774, DOI 10.1242/jeb.065581; Cantwell EL, 2006, J COMP NEUROL, V496, P97, DOI 10.1002/cne.20935; Chou TC, 2003, J NEUROSCI, V23, P10691; CONTIJOCH AM, 1993, NEUROENDOCRINOLOGY, V57, P135, DOI 10.1159/000126353; D'Hondt E, 1999, J NEUROSCI METH, V91, P31, DOI 10.1016/S0165-0270(99)00067-9; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; ELHALAWANI ME, 1997, PERSPECTIVES AVIAN E, P403; FRALEY GS, 1993, LIFE SCI, V52, P1649, DOI 10.1016/0024-3205(93)90047-7; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Gupta NJ, 2013, ANIM BIOL IN PRESS; Gwinner E, 1996, J EXP BIOL, V199, P39; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Kawaguchi M, 2005, AM J PHYSIOL-REG I, V288, pR1800, DOI 10.1152/ajpregu.00805.2004; King VM, 1997, J COMP PHYSIOL A, V180, P541, DOI 10.1007/s003590050071; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kuenzel WJ, 2000, POULTRY SCI, V79, P1679, DOI 10.1093/ps/79.11.1679; KUENZEL WJ, 1987, PEPTIDES, V8, P823, DOI 10.1016/0196-9781(87)90066-0; KUMAR V, 1993, REPROD NUTR DEV, V33, P143, DOI 10.1051/rnd:19930207; Kumar V, 2004, BIOL RHYTHM RES, V35, P121, DOI 10.1080/09291010412331313287; Kumar V, 1997, MOL BRAIN RES, V52, P242, DOI 10.1016/S0169-328X(97)00260-X; KUMAR V, 1988, J ZOOL, V216, P253, DOI 10.1111/j.1469-7998.1988.tb02429.x; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Li HY, 2008, BRAIN RES BULL, V76, P586, DOI 10.1016/j.brainresbull.2008.04.007; MACNAMEE MC, 1986, GEN COMP ENDOCR, V62, P470, DOI 10.1016/0016-6480(86)90057-2; Malik S, 2004, CHRONOBIOL INT, V21, P367, DOI 10.1081/CBI-120038742; Meddle SL, 1997, J NEUROSCI, V17, P8909; MOLINERO P, 1993, NEUROSCI LETT, V151, P130, DOI 10.1016/0304-3940(93)90003-4; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; OHTA M, 1984, J COMP PHYSIOL, V154, P583, DOI 10.1007/BF00610171; OPEL H, 1988, P SOC EXP BIOL MED, V187, P455; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; PROUDMAN J, 1983, POULTRY SCI, V62, P1484; Ramakrishnan S, 2007, J NEUROENDOCRINOL, V19, P163, DOI 10.1111/j.1365-2826.2006.01520.x; Rani S, 2006, CURR SCI INDIA, V91, P1093; Rastogi A, 2011, EUR J NEUROSCI, V34, P99, DOI 10.1111/j.1460-9568.2011.07737.x; Rathinam T, 2005, BRAIN RES BULL, V64, P455, DOI 10.1016/j.brainresbull.2004.10.003; RICHARDSON RD, 1995, AM J PHYSIOL-REG I, V268, pR1418, DOI 10.1152/ajpregu.1995.268.6.R1418; Saab SS, 2010, J NEUROENDOCRINOL, V22, P196, DOI 10.1111/j.1365-2826.2010.01954.x; Sakharkar AJ, 2005, J COMP NEUROL, V489, P148, DOI 10.1002/cne.20614; Saldanha CJ, 2001, J BIOL RHYTHM, V16, P39, DOI 10.1177/074873040101600105; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; SHARP PJ, 1989, J ENDOCRINOL, V122, P5, DOI 10.1677/joe.0.1220005; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; Small TW, 2008, BRAIN BEHAV EVOLUT, V71, P127, DOI 10.1159/000111459; Stevenson TJ, 2012, EUR J NEUROSCI, V36, P2859, DOI 10.1111/j.1460-9568.2012.08209.x; Sumova A, 2002, PHYSL RES, V51; Teruyama R, 2001, CELL TISSUE RES, V303, P403, DOI 10.1007/s004410000313; TEWARY PD, 1984, CURR SCI INDIA, V53, P1307; TEWARY PD, 1981, INDIAN J EXP BIOL, V19, P469; Thayananuphat A, 2007, J NEUROENDOCRINOL, V19, P407, DOI 10.1111/j.1365-2826.2007.01544.x; WALLMAN J, 1994, J COMP PHYSIOL A, V174, P297; Wang G, 2011, GEN COMP ENDOCR, V170, P589, DOI 10.1016/j.ygcen.2010.11.014; WILSON FE, 1991, J EXP ZOOL, V259, P117, DOI 10.1002/jez.1402590114; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	65	45	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e70065	10.1371/journal.pone.0070065	http://dx.doi.org/10.1371/journal.pone.0070065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204554	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600001
J	Caramalho, R; Gusmao, L; Lackner, M; Amorim, A; Araujo, R				Caramalho, Rita; Gusmao, Leonor; Lackner, Michaela; Amorim, Antonio; Araujo, Ricardo			SNaPAfu: A Novel Single Nucleotide Polymorphism Multiplex Assay for Aspergillus fumigatus Direct Detection, Identification and Genotyping in Clinical Specimens	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; SECTION FUMIGATI; MOLECULAR-DETECTION; GENETIC DIVERSITY; FUNGAL DISEASE; DIAGNOSIS; PCR; RESISTANCE; EPIDEMIOLOGY; FREQUENCY	Objective: Early diagnosis of invasive aspergillosis is essential for positive patient outcome. Likewise genotyping of fungal isolates is desirable for outbreak control in clinical setting. We designed a molecular assay that combines detection, identification, and genotyping of Aspergillus fumigatus in a single reaction. Methods: To this aim we combined 20 markers in a multiplex reaction and the results were seen following mini-sequencing readings. Pure culture extracts were firstly tested. Thereafter, Aspergillus-DNA samples obtained from clinical specimens of patients with possible, probable, or proven aspergillosis according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria. Results: A new set of designed primers allowed multilocus sequence typing (MLST) gene amplification in a single multiplex reaction. The newly proposed SNaPAfu assay had a specificity of 100%, a sensitivity of 89% and detection limit of 1 ITS copy/mL (similar to 0.5 fg genomic Aspergillus-DNA/mL). The marker A49_F was detected in 89% of clinical samples. The SNaPAfu assay was accurately performed on clinical specimens using only 1% of DNA extract (total volume 50 mu L) from 1 mL of used bronchoalveolar lavage. Conclusions: The first highly sensitive and specific, time-and cost-economic multiplex assay was implemented that allows detection, identification, and genotyping of A. fumigatus strains in a single amplification followed by mini-sequencing reaction. The new test is suitable to clinical routine and will improve patient management.	[Caramalho, Rita; Gusmao, Leonor; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Caramalho, Rita; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Gusmao, Leonor] Univ Estado Rio De Janeiro, DNA Diagnost Lab, Rio De Janeiro, Brazil; [Lackner, Michaela] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria	Universidade do Porto; Universidade do Porto; Universidade do Estado do Rio de Janeiro; Medical University of Innsbruck	Araujo, R (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ricjparaujo@yahoo.com	Gusmao, Leonor/B-3122-2013; Amorim, Antonio/A-7938-2008; Gusmão, Leonor/L-8931-2019; Lackner, Michaela/Q-9471-2018; Araujo, Ricardo/H-2297-2018	Gusmao, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Gusmão, Leonor/0000-0003-0432-6481; Araujo, Ricardo/0000-0001-7382-4834	Fundacao Calouste Gulbenkian grant [35-9924-S/2009]; Pfizer Inc. [WS1948668]; Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund; FCT; Austrian Science Fund (FWF) [I 656] Funding Source: researchfish	Fundacao Calouste Gulbenkian grant; Pfizer Inc.(Pfizer); Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund(European Social Fund (ESF)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fundacao Calouste Gulbenkian grant no. 35-9924-S/2009 and partially resulted in the Master Thesis on Forensic Genetics of RC. The work was also partially supported by Pfizer Inc. (grant n. IIR#WS1948668). RA is supported by Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia 2007 and by the European Social Fund. Institute of Molecular Pathology and Immunology of the University of Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07; Almeida LA, 2013, INFECT GENET EVOL, V13, P67, DOI 10.1016/j.meegid.2012.08.011; Amorim A, 2010, INT J ANTIMICROB AG, V35, P396, DOI 10.1016/j.ijantimicag.2009.12.007; Araujo R, 2009, CLIN MICROBIOL INFEC, V15, P260, DOI 10.1111/j.1469-0691.2008.02661.x; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Badiee P, 2008, INFECTION, V36, P580, DOI 10.1007/s15010-008-7385-8; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Ben-Darif E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09; Caillot D, 2001, CLIN MICROBIOL INFEC, V7, P54, DOI 10.1111/j.1469-0691.2001.tb00010.x; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Debeaupuis JP, 1997, INFECT IMMUN, V65, P3080, DOI 10.1128/IAI.65.8.3080-3085.1997; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Eusebio N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066083; Ferri L, 2010, J MICROBIOL METH, V80, P251, DOI 10.1016/j.mimet.2010.01.008; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Guinea J, 2011, J CLIN MICROBIOL, V49, P3498, DOI 10.1128/JCM.01159-11; Herrera ML, 2009, J CLIN MICROBIOL, V47, P1325, DOI 10.1128/JCM.02073-08; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Klaassen CHW, 2009, J MICROBIOL METH, V77, P292, DOI 10.1016/j.mimet.2009.03.004; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Lass-Florl C, 2013, J CLIN MICROBIOL, V51, P863, DOI 10.1128/JCM.02965-12; Luong ML, 2011, CLIN INFECT DIS, V52, P1218, DOI 10.1093/cid/cir185; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; Mayr A, 2011, EUR J MED RES, V16, P153, DOI 10.1186/2047-783X-16-4-153; Ostrosky-Zeichner L, 2012, AM J MED, V125, pS14, DOI 10.1016/j.amjmed.2011.10.008; Pelaez T, 2012, CLIN INFECT DIS, V54, pE24, DOI 10.1093/cid/cir771; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Segal BH, 2006, AM J RESP CRIT CARE, V173, P707, DOI 10.1164/rccm.200505-727SO; Serrano R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-82; Stephens AJ, 2006, J MED MICROBIOL, V55, P43, DOI 10.1099/jmm.0.46157-0; Walsh TJ, 2011, J CLIN MICROBIOL, V49, P4150, DOI 10.1128/JCM.00570-11; White PL, 2010, J CLIN MICROBIOL, V48, P1231, DOI 10.1128/JCM.01767-09	38	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75968	10.1371/journal.pone.0075968	http://dx.doi.org/10.1371/journal.pone.0075968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204585	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300006
J	Dong, DY; Wang, B; Yin, W; Ding, XQ; Yu, JJ; Kang, YJ				Dong, Daoyin; Wang, Biao; Yin, Wen; Ding, Xueqing; Yu, Jingjing; Kang, Y. James			Disturbance of Copper Homeostasis Is a Mechanism for Homocysteine-Induced Vascular Endothelial Cell Injury	PLOS ONE			English	Article							PENICILLAMINE ADMINISTRATION REVERSES; PLASMA TOTAL HOMOCYSTEINE; DEPENDENT RELAXATION; HYPERHOMOCYSTEINAEMIA; BINDING	Elevation of serum homocysteine (Hcy) levels is a risk factor for cardiovascular diseases. Previous studies suggested that Hcy interferes with copper (Cu) metabolism in vascular endothelial cells. The present study was undertaken to test the hypothesis that Hcy-induced disturbance of Cu homeostasis leads to endothelial cell injury. Exposure of human umbilical vein endothelial cells (HUVECs) to concentrations of Hcy at 0.01, 0.1 or 1 mM resulted in a concentration-dependent decrease in cell viability and an increase in necrotic cell death. Pretreatment of the cells with a final concentration of 5 mu M Cu in cultures prevented the effects of Hcy. Hcy decreased intracellular Cu concentrations. HPLC-ICP-MS analysis revealed that Hcy caused alterations in the distribution of intracellular Cu; more Cu was redistributed to low molecular weight fractions. ESI-Q-TOF detected the formation of Cu-Hcy complexes. Hcy also decreased the protein levels of Cu chaperone COX17, which was accompanied by a decrease in the activity of cytochrome c oxidase (CCO) and a collapse of mitochondrial membrane potential. These effects of Hcy were all preventable by Cu pretreatment. The study thus demonstrated that Hcy disturbs Cu homeostasis and limits the availability of Cu to critical molecules such as COX17 and CCO, leading to mitochondrial dysfunction and endothelial cell injury.	[Dong, Daoyin; Wang, Biao; Yin, Wen; Ding, Xueqing; Kang, Y. James] Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Yu, Jingjing] Agilent Technol China Co Ltd, Beijing, Peoples R China	Sichuan University; Agilent Technologies	Kang, YJ (corresponding author), Sichuan Univ, Regenerat Med Res Ctr, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	yjkang01@louisville.edu	Dong, Daoyin/D-6014-2016; WANG, BIAO/AAN-7583-2020	Dong, Daoyin/0000-0003-0544-8341; WANG, BIAO/0000-0003-1049-8546	National Science Foundation of China [81230004]; Sichuan University West China Hospital	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan University West China Hospital	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the National Science Foundation of China (grant number:81230004 to Y. J. Kang) and Sichuan University West China Hospital.	Apostolova MD, 2003, J INORG BIOCHEM, V95, P321, DOI 10.1016/S0162-0134(03)00133-8; BABSON AL, 1973, CLIN CHEM, V19, P766; Carrasco-Pozo C, 2006, EXP BIOL MED, V231, P1569, DOI 10.1177/153537020623100918; Emsley AM, 1999, BRIT J PHARMACOL, V126, P1034, DOI 10.1038/sj.bjp.0702374; Exner M, 2002, FEBS LETT, V531, P402, DOI 10.1016/S0014-5793(02)03571-8; Garcia AJ, 2002, J CHROMATOGR B, V779, P359, DOI 10.1016/S1570-0232(02)00401-4; Getz J, 2011, BIOL TRACE ELEM RES, V143, P368, DOI 10.1007/s12011-010-8858-z; Jeremy JY, 2002, ANN THORAC SURG, V74, P1553, DOI 10.1016/S0003-4975(02)03807-9; Kang YJ, 2011, PHARMACOL THERAPEUT, V129, P321, DOI 10.1016/j.pharmthera.2010.11.004; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; KLAASSEN CD, 1994, ENVIRON HEALTH PERSP, V102, P141, DOI 10.2307/3431778; Koupparis AJ, 2006, BJU INT, V98, P440, DOI 10.1111/j.1464-410X.2006.06212.x; Linnebank M, 2006, NEUROBIOL DIS, V23, P725, DOI 10.1016/j.nbd.2006.06.010; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Mansoor MA, 2000, CLIN CHEM, V46, P385; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Selhub J, 2006, J NUTR, V136, p1726S, DOI 10.1093/jn/136.6.1726S; Shukla N, 2006, EUR J PHARMACOL, V531, P201, DOI 10.1016/j.ejphar.2005.12.003; Shukla N, 2007, ANN THORAC SURG, V84, P43, DOI 10.1016/j.athoracsur.2007.03.087	21	20	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76209	10.1371/journal.pone.0076209	http://dx.doi.org/10.1371/journal.pone.0076209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204604	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300014
J	Krieger, N; Waterman, PD; Kosheleva, A; Chen, JT; Smith, KW; Carney, DR; Bennett, GG; Williams, DR; Thornhill, G; Freeman, ER				Krieger, Nancy; Waterman, Pamela D.; Kosheleva, Anna; Chen, Jarvis T.; Smith, Kevin W.; Carney, Dana R.; Bennett, Gary G.; Williams, David R.; Thornhill, Gisele; Freeman, Elmer R.			Racial Discrimination & Cardiovascular Disease Risk: My Body My Story Study of 1005 US-Born Black and White Community Health Center Participants (US)	PLOS ONE			English	Article							AFRICAN-AMERICANS; IMPLICIT MEASURES; BLOOD-PRESSURE; PERCEIVED DISCRIMINATION; DISPARITIES; HYPERTENSION; EPIDEMIOLOGY	Objectives: To date, limited and inconsistent evidence exists regarding racial discrimination and risk of cardiovascular disease (CVD). Methods: Cross-sectional observational study of 1005 US-born non-Hispanic black (n = 504) and white (n = 501) participants age 35-64 randomly selected from community health centers in Boston, MA (2008-2010; 82.4% response rate), using 3 racial discrimination measures: explicit self-report; implicit association test (IAT, a time reaction test for self and group as target vs. perpetrator of discrimination); and structural (Jim Crow status of state of birth, i.e. legal racial discrimination prior 1964). Results: Black and white participants both had adverse cardiovascular and socioeconomic profiles, with black participants most highly exposed to racial discrimination. Positive crude associations among black participants occurred for Jim Crow birthplace and hypertension (odds ratio (OR) 1.92, 95% confidence interval (CI) 1.28, 2.89) and for explicit self-report and the Framingham 10 year CVD risk score (beta = 0.04; 95% CI 0.01, 0.07); among white participants, only negative crude associations existed (for IAT for self, for lower systolic blood pressure (SBP; beta = -4.86; 95% CI -9.08, -0.64) and lower Framingham CVD score (beta = -0.36, 95% CI -0.63, -0.08)). All of these associations were attenuated and all but the white IAT-Framingham risk score association were rendered null in analyses that controlled for lifetime socioeconomic position and additional covariates. Controlling for racial discrimination, socioeconomic position, and other covariates did not attenuate the crude black excess risk for SBP and hypertension and left unaffected the null excess risk for the Framingham CVD score. Conclusion: Despite worse exposures among the black participants, racial discrimination and socioeconomic position were not associated, in multivariable analyses, with risk of CVD. We interpret results in relation to constrained variability of exposures and outcomes and discuss implications for valid research on social determinants of health.	[Krieger, Nancy; Waterman, Pamela D.; Kosheleva, Anna; Chen, Jarvis T.; Williams, David R.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Smith, Kevin W.] RTI Int, Waltham, MA USA; [Carney, Dana R.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Bennett, Gary G.] Duke Univ, Durham, NC USA; [Bennett, Gary G.] Duke Univ, Duke Global Hlth Initiat, Durham, NC USA; [Williams, David R.] Harvard Univ, Dept Sociol, Cambridge, MA 02138 USA; [Thornhill, Gisele; Freeman, Elmer R.] Ctr Community Hlth Educ Res & Serv, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Research Triangle Institute; University of California System; University of California Berkeley; Duke University; Duke University; Harvard University	Krieger, N (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	nkrieger@hsph.harvard.edu			National Institutes of Health/National Institute on Aging [1 R01 AG027122-01, R01AG27122-3S1]; NATIONAL INSTITUTE ON AGING [R01AG027122] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the National Institutes of Health/National Institute on Aging (1 R01 AG027122-01 and R01AG27122-3S1); the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; Almond D, 2008, WORKING PAPER; Almond DV, 2006, 0704 MIT; American Diabetes Association, 2013, STAND MED CAR DIAB 2; [Anonymous], 2013, CHOLESTECH LDX SYSTE; Banaji MR., 2013, BLIND SPOT HIDDEN BI; Bastos JL, 2010, SOC SCI MED, V70, P1091, DOI 10.1016/j.socscimed.2009.12.020; Batsis JA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-29; Berry JD, 2012, NEW ENGL J MED, V366, P321, DOI 10.1056/NEJMoa1012848; Borrell LN, 2007, AM J EPIDEMIOL, V166, P1068, DOI 10.1093/aje/kwm180; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Boston Public Health Commission, 2013, HLTH BOST; Brondolo E, 2003, ANN BEHAV MED, V25, P55, DOI 10.1207/S15324796ABM2501_08; Brondolo E, 2011, AM J HYPERTENS, V24, P518, DOI 10.1038/ajh.2011.9; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Carney DR, 2010, SELF IDENTITY, V9, P162, DOI 10.1080/13594320902847927; Chay KY, 2000, AM ECON REV, V90, P326, DOI 10.1257/aer.90.2.326; Couto PF, 2012, ARQ BRAS CARDIOL, V99, P956, DOI 10.1590/S0066-782X2012005000090; Cuffee YL, 2012, ETHNIC DIS, V22, P422; D'Anna LH, 2010, ETHNIC HEALTH, V15, P121, DOI 10.1080/13557850903490298; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; Gee GC, 2012, AM J PUBLIC HEALTH, V102, P967, DOI 10.2105/AJPH.2012.300666; Gidron Y, 2001, J BEHAV MED, V24, P1, DOI 10.1023/A:1005631819744; Harper S, 2011, ANNU REV PUBL HEALTH, V32, P39, DOI 10.1146/annurev-publhealth-031210-101234; HAYS RD, 1989, EDUC PSYCHOL MEAS, V49, P629, DOI 10.1177/001316448904900315; Heerwig JA, 2009, SOCIOL SCI Q, V90, P675; Hernan MA, 2009, AM J EPIDEMIOL, V170, P959, DOI 10.1093/aje/kwp293; Kaplan G, 2008, MAKING AM HLTH SOCIA, P145; Karlamangla AS, 2010, ANN EPIDEMIOL, V20, P617, DOI 10.1016/j.annepidem.2010.05.003; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; KRIEGER N, 1990, SOC SCI MED, V30, P1273, DOI 10.1016/0277-9536(90)90307-E; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Krieger N, 1999, INT J HEALTH SERV, V29, P295, DOI 10.2190/M11W-VWXE-KQM9-G97Q; Krieger N, 2001, INT J EPIDEMIOL, V30, P668, DOI 10.1093/ije/30.4.668; Krieger N, AM J PUBLIC HLTH; Krieger N, SOCIAL EPID IN PRESS; Krieger N., 2011, EPIDEMIOLOGY PEOPLES, DOI [DOI 10.1093/ACPROF:OSO/9780195383874.001.0001, DOI 10.1007/s10803-010-0982-2]; Krieger N, 2007, EPIDEMIOLOGY, V18, P658, DOI 10.1097/EDE.0b013e318156bfcd; Krieger N, 2012, AM J PUBLIC HEALTH, V102, P936, DOI 10.2105/AJPH.2011.300544; Krieger N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027636; Krieger N, 2010, AM J PUBLIC HEALTH, V100, P1485, DOI 10.2105/AJPH.2009.159517; Krieger N, 2008, SOC SCI MED, V67, P1970, DOI 10.1016/j.socscimed.2008.09.039; LIEBERSON S, 1992, AM SOCIOL REV, V57, P1, DOI 10.2307/2096141; Link CL, 2009, ETHNIC DIS, V19, P288; Longino H. E., 2013, STUDYING HUMAN BEHAV; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Murray Pauli., 1950, STATES LAWS RACE COL; *NAT CTR HLTH STAT, 2000, 2000 NAT HLTH INT SU; National Association of Community Health Centers, 2011, AM HLTH CTR FACT SHE; National Center for Health Statistics, 2009, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; National Center for Health Statistics. Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; National Health Lung and Blood Institute National Institutes of Health, 2003, 7 JOINT NAT COMM PRE; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Nosek B.A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1037/0022-3514.89.3.277; Office of Applied Studies Substance Abuse and Mental Health Services Administration, 2001, DEV COMP ASS INT PRO; Ostchega Y, 2012, NATL HLTH STAT REPOR; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Pigeot I, 2007, HDB EPIDEMIOLOGY; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; SAS Institute, 2002, SAS 9 1 3 LANG REF D; Seedat S, 2009, SAMJ S AFR MED J, V99, P375; Sellers R M, 1998, Pers Soc Psychol Rev, V2, P18, DOI 10.1207/s15327957pspr0201_2; Shariff-Marco S, 2011, DU BOIS REV, V8, P159, DOI 10.1017/S1742058X11000129; Sims M, 2012, AM J PUBLIC HEALTH, V102, pS258, DOI 10.2105/AJPH.2011.300523; Sternthal MJ, 2011, DU BOIS REV, V8, P95, DOI 10.1017/S1742058X11000087; The Framingham Heart Study, 2013, RISK SCOR PROF; U.S. Census Bureau, 2013, AM COMM SURV; Walters KL, 2011, DU BOIS REV, V8, P179, DOI 10.1017/S1742058X1100018X; Weiss N, 2012, EXERCISES EPIDEMIOLO; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002	75	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77174	10.1371/journal.pone.0077174	http://dx.doi.org/10.1371/journal.pone.0077174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204765	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300087
J	Salgado-Salazar, C; Rossman, AY; Chaverri, P				Salgado-Salazar, Catalina; Rossman, Amy Y.; Chaverri, Priscila			Not as Ubiquitous as We Thought: Taxonomic Crypsis, Hidden Diversity and Cryptic Speciation in the Cosmopolitan Fungus Thelonectria discophora (Nectriaceae, Hypocreales, Ascomycota)	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; BAYESIAN-INFERENCE; GENETIC-VARIATION; TREES; CONCORDANCE; BIOGEOGRAPHY; DISPERSAL; ALIGNMENT; PATTERNS; COMPLEX	The distribution of microbial species, including fungi, has long been considered cosmopolitan. Recently, this perception has been challenged by molecular studies in historical biogeography, phylogeny and population genetics. Here we explore this issue using the fungal morphological species Thelonectria discophora, one of the most common species of fungi in the family Nectriaceae, encountered in almost all geographic regions and considered as a cosmopolitan taxon. In order to determine if T. discophora is a single cosmopolitan species or an assemblage of sibling species, we conducted various phylogenetic analyses, including standard gene concatenation, Bayesian concordance methods, and coalescent-based species tree reconstruction on isolates collected from a wide geographic range. Results show that diversity among isolates referred as T. discophora is greatly underestimated and that it represents a species complex. Within this complex, sixteen distinct highly supported lineages were recovered, each of which has a restricted geographic distribution and ecology. The taxonomic status of isolates regarded as T. discophora is reconsidered, and the assumed cosmopolitan distribution of this species is rejected. We discuss how assumptions about geographically widespread species have implications regarding their taxonomy, true diversity, biological diversity conservation, and ecological functions.	[Salgado-Salazar, Catalina; Chaverri, Priscila] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Rossman, Amy Y.] ARS, Systemat Mycol & Microbiol Lab, USDA, Beltsville, MD USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA)	Salgado-Salazar, C (corresponding author), Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA.	salgadoc@umd.edu		Salgado Salazar, Catalina/0000-0002-4156-692X; Chaverri, Priscila/0000-0002-8486-6033	United States National Science Foundation (PEET) [DEB-0925696]	United States National Science Foundation (PEET)	This study was funded by a grant from United States National Science Foundation (PEET program, grant number DEB-0925696: "Monographic Studies in the Nectriaceae, Hypocreales: Nectria, Cosmospora, and Neonectria" http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ane C, 2007, MOL BIOL EVOL, V24, P412; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Baum DA, 2007, TAXON, V56, P417, DOI 10.1002/tax.562013; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bleidorn C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-47; Booth C, 1966, MYCOL PAP; Brayford D, 2004, MYCOLOGIA, V96, P572, DOI 10.2307/3762176; Brayford D, 1991, COMPENDIUM RASPBERRY; Carriconde F, 2008, MICROB ECOL, V56, P513, DOI 10.1007/s00248-008-9370-2; Chaverri P, 2011, STUD MYCOL, P57, DOI 10.3114/sim.2011.68.03; Chaverri P, 2006, BIOTROPICA, V38, P531, DOI 10.1111/j.1744-7429.2006.00176.x; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Cranston KA, 2009, SYST BIOL, V58, P489, DOI 10.1093/sysbio/syp054; Dahlberg A, 2011, FUNGAL ECOL, V4, P147, DOI 10.1016/j.funeco.2010.11.001; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finlay BJ, 1996, NATURE, V383, P132, DOI 10.1038/383132a0; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foissner W, 2006, ACTA PROTOZOOL, V45, P111; Guu HR, 2007, BOT STUD, V48, P187; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hirooka Y, 2012, STUD MYCOL, P1, DOI 10.3114/sim0001; Hirooka Y, 2011, STUD MYCOL, P35, DOI [10.3114/sim.2011.68.02, 10.3114/sim.2011.68.03]; Hirooka Yuuri, 2007, Mycoscience, V48, P53, DOI 10.1007/s10267-006-0330-8; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; James TY, 1999, EVOLUTION, V53, P1665, DOI [10.1111/j.1558-5646.1999.tb04552.x, 10.2307/2640430]; Kalla SE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-31; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Klautau M, 1999, EVOLUTION, V53, P1414, DOI 10.1111/j.1558-5646.1999.tb05406.x; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V59, P587, DOI 10.1016/j.ympev.2011.03.020; Lee JY, 2012, SYST BIOL, V61, P253, DOI 10.1093/sysbio/syr101; Leigh JW, 2008, SYST BIOL, V57, P104, DOI 10.1080/10635150801910436; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lombard L, 2010, STUD MYCOL, P15, DOI 10.3114/sim.2010.66.02; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; McDonald MC, 2012, FUNGAL GENET BIOL, V49, P882, DOI 10.1016/j.fgb.2012.08.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Peay KG, 2010, NEW PHYTOL, V185, P878, DOI 10.1111/j.1469-8137.2009.03158.x; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Qu YH, 2012, MOL ECOL, V21, P6117, DOI 10.1111/mec.12080; Queloz V, 2011, GLOBAL ECOL BIOGEOGR, V20, P160, DOI 10.1111/j.1466-8238.2010.00589.x; Rambaut A, 2007, TRACER V 1 5; Rambaut A, 2005, FIGTREE V1 3 1; Roe AD, 2010, MOL ECOL RESOUR, V10, P946, DOI 10.1111/j.1755-0998.2010.02844.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roper M, 2010, P NATL ACAD SCI USA, V107, P17474, DOI 10.1073/pnas.1003577107; Roper M, 2008, P NATL ACAD SCI USA, V105, P20583, DOI 10.1073/pnas.0805017105; Rydholm C, 2006, EUKARYOT CELL, V5, P650, DOI 10.1128/EC.5.4.650-657.2006; Salgado-Salazar C, 2012, MYCOLOGIA, V104, P1325, DOI 10.3852/12-055; Samuels G.J., 1990, MEM N Y BOT GARD, V59, P6; Sato H, 2012, MOL ECOL, V21, P5599, DOI 10.1111/mec.12053; Seifert KA, 2010, IMA FUNGUS, V1, P109, DOI 10.5598/imafungus.2010.01.02.02; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015614; Suatoni E, 2006, MOL PHYLOGENET EVOL, V41, P86, DOI 10.1016/j.ympev.2006.04.025; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Wedin M, 2009, CLADISTICS, V25, P161, DOI 10.1111/j.1096-0031.2009.00240.x; Weisrock DW, 2012, MOL BIOL EVOL, V29, P1615, DOI 10.1093/molbev/mss008; Zufall RA, 2013, MOL ECOL, V22, P1081, DOI 10.1111/mec.12066	78	22	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76737	10.1371/journal.pone.0076737	http://dx.doi.org/10.1371/journal.pone.0076737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204665	Green Published, gold			2022-12-25	WOS:000326029300049
J	van Vonderen, JJ; Narayen, NE; Walther, FJ; Siew, ML; Davis, PG; Hooper, SB; te Pas, AB				van Vonderen, Jeroen J.; Narayen, Nadia E.; Walther, Frans J.; Siew, Melissa L.; Davis, Peter G.; Hooper, Stuart B.; te Pas, Arjan B.			The Administration of 100% Oxygen and Respiratory Drive in Very Preterm Infants at Birth	PLOS ONE			English	Article							ROOM-AIR; BREATHING PATTERNS; NEWBORN-INFANTS; RESUSCITATION; VENTILATION; VOLUME	Aim: To retrospectively investigate the changes of SpO(2) and respiratory drive in preterm infants at birth after administration of 100% oxygen. Methods: Respiratory parameters, FiO(2) and oximetry of infants <32 weeks gestation before and after receiving FiO(2) 1.0 were reviewed during continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV). Results: Results are given as median (IQR) or percentages where appropriate. Suitable recordings were made in 50 infants (GA 27 (26-29) weeks), 17 received CPAP and 33 PPV. SpO(2) increased rapidly in the first minute after FiO(2) 1.0 and remained stable. The duration of FiO(2) 1.0 tended to be shorter in the CPAP group than in the PPV group (CPAP vs. PPV: 65 (33-105) vs. 100 (40-280) s; p = 0.05), SpO(2) >95% occurred more often in PPV group (53% vs. 69%) and lasted longer (70(40-95) vs. 120(50-202) s). In CPAP group, minute volume increased from 134 (76-265) mL/kg/min 1 minute before to 240 (157-370) mL/kg/min (p<0.01) 1 minute after start FiO(2) 1.0 and remained stable at 2 minutes (252 (135-376) mL/kg/min; ns). The rate of rise to maximum tidal volume increased (from 13.8 (8.0-22.4) mL/kg/s to 18.2 (11.0-27.5) mL/kg/s; p<0.0001) to 18.8 (11.8-27.8) mL/kg/s; ns). In the PPV group respiratory rate increased from 0(0-4) to 9(0-20) at 1 minute (p<0.001) to 23 (0-34) breaths per minute at 2 minutes (p<0.01). Conclusion: In preterm infants at birth, a rapid increase in oxygenation, resulting from a transient increase to 100% oxygen might improve respiratory drive, but increases the risk for hyperoxia.	[van Vonderen, Jeroen J.; Narayen, Nadia E.; Walther, Frans J.; Siew, Melissa L.; te Pas, Arjan B.] Leiden Univ, Dept Pediat, Div Neonatol, Med Ctr, Leiden, Netherlands; [Siew, Melissa L.; Hooper, Stuart B.; te Pas, Arjan B.] Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Davis, Peter G.] Royal Womens Hosp, Dept Newborn Res, Melbourne, Vic, Australia	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Monash University	van Vonderen, JJ (corresponding author), Leiden Univ, Dept Pediat, Div Neonatol, Med Ctr, Leiden, Netherlands.	J.J.van_Vonderen@lumc.nl	pas, arjan te/AAA-9019-2020; van Vonderen, Jeroen J./L-4067-2019	pas, arjan te/0000-0001-7831-8797; van Vonderen, Jeroen J./0000-0002-1258-5224; Hooper, Stuart/0000-0003-1676-4825; Walther, Frans/0000-0003-1931-159X	Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici [91612027]; Willem-Alexander Children's Foundation scholarship	Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici; Willem-Alexander Children's Foundation scholarship	A.B. te Pas is the recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici, project number 91612027. J.J. van Vonderen is the recipient of a Willem-Alexander Children's Foundation scholarship www.willem-alexanderkinderfonds.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookatz GB, 2007, PEDIATR RES, V61, P698, DOI 10.1203/pdr.0b013e3180534171; Davey MG, 1996, RESP PHYSIOL, V105, P57, DOI 10.1016/0034-5687(96)00038-2; Dawson JA, 2010, PEDIATRICS, V125, pE1340, DOI 10.1542/peds.2009-1510; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Finer NN, 2009, PEDIATRICS, V123, P865, DOI 10.1542/peds.2008-0560; Fischer HS, 2008, PHYSIOL MEAS, V29, P95, DOI 10.1088/0967-3334/29/1/007; FOITZIK B, 1994, BIOMED TECH, V39, P85, DOI 10.1515/bmte.1994.39.4.85; Givan Deborah C, 2003, Semin Pediatr Neurol, V10, P271, DOI 10.1016/S1071-9091(03)00073-1; GLUCKMAN PD, 1987, J PHYSIOL-LONDON, V382, P373, DOI 10.1113/jphysiol.1987.sp016372; Hellstrom-Westas L, 2006, PEDIATRICS, V118, pE1798, DOI 10.1542/peds.2006-0102; Higgins RD, 2007, PEDIATRICS, V119, P790, DOI 10.1542/peds.2006-2200; Lakshminrusimha S, 2011, J APPL PHYSIOL, V111, P1441, DOI 10.1152/japplphysiol.00711.2011; O'Donnell CPF, 2010, J PEDIATR-US, V156, P846, DOI 10.1016/j.jpeds.2010.01.007; Pas ABT, 2008, PEDIATR RES, V64, P281, DOI 10.1203/PDR.0b013e31817d9c35; Perlman JM, 2010, CIRCULATION, V122, P8516, DOI 10.1161/CIRCULATIONAHA.110.971127; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Rabi Y, 2011, PEDIATRICS, V128, pE374, DOI 10.1542/peds.2010-3130; Roske K, 1998, J CLIN MONIT COMPUT, V14, P413, DOI 10.1023/A:1009993916980; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Schmolzer GM, 2011, ARCH DIS CHILD-FETAL, V96, pF254, DOI 10.1136/adc.2010.191171; Sobotka KS, 2011, PEDIATR RES, V70, P56, DOI 10.1203/PDR.0b013e31821d06a1; Tan A, 2005, COCHRANE DB SYST REV, V2; te Pas AB, 2009, J PEDIATR-US, V154, P369, DOI 10.1016/j.jpeds.2008.09.029; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; TEITEL DF, 1990, PEDIATR RES, V27, P372, DOI 10.1203/00006450-199004000-00010; Vento M, 2011, J PEDIAT S, V158, P5; Vento M, 2009, PEDIATRICS, V124, pE439, DOI 10.1542/peds.2009-0434; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; Wyllie J, 2010, RESUSCITATION, V81, pE260, DOI 10.1016/j.resuscitation.2010.08.029	31	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76898	10.1371/journal.pone.0076898	http://dx.doi.org/10.1371/journal.pone.0076898			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204698	Green Published, gold			2022-12-25	WOS:000326029300063
J	Yu, K; Wang, Y; Shen, KQ; Li, XP				Yu, Ke; Wang, Yue; Shen, Kaiquan; Li, Xiaoping			The Synergy between Complex Channel-Specific FIR Filter and Spatial Filter for Single-Trial EEG Classification	PLOS ONE			English	Article							MOTOR IMAGERY; PATTERNS	The common spatial pattern analysis (CSP), a frequently utilized feature extraction method in brain-computer-interface applications, is believed to be time-invariant and sensitive to noises, mainly due to an inherent shortcoming of purely relying on spatial filtering. Therefore, temporal/spectral filtering which can be very effective to counteract the unfavorable influence of noises is usually used as a supplement. This work integrates the CSP spatial filters with complex channel-specific finite impulse response (FIR) filters in a natural and intuitive manner. Each hybrid spatial-FIR filter is of high-order, data-driven and is unique to its corresponding channel. They are derived by introducing multiple time delays and regularization into conventional CSP. The general framework of the method follows that of CSP but performs better, as proven in single-trial classification tasks like event-related potential detection and motor imagery.	[Yu, Ke; Wang, Yue; Li, Xiaoping] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore; [Shen, Kaiquan] Natl Univ Singapore, Inst Neurotechnol, Ctr Life Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Li, XP (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.	mpelixp@nus.edu.sg						Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Falzon O, 2012, IEEE T BIO-MED ENG, V59, P2486, DOI 10.1109/TBME.2012.2205246; Falzon O, 2010, IEEE ENG MED BIO, P4707, DOI 10.1109/IEMBS.2010.5626381; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; Grosse-Wentrup M, 2009, IEEE T BIO-MED ENG, V56, P1209, DOI 10.1109/TBME.2008.2009768; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Naeem M, 2006, J NEURAL ENG, V3, P208, DOI 10.1088/1741-2560/3/3/003; Osuna BE, 1997, SUPPORT VECTOR MACHI; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Sajda P, 2010, P IEEE, V98, P462, DOI 10.1109/JPROC.2009.2038406; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Shao SY, 2009, IEEE T BIO-MED ENG, V56, P336, DOI 10.1109/TBME.2008.2005969; Tomioka R, 2006, SPECTRALLY WEIGHTED; Wang HX, 2012, IEEE T BIO-MED ENG, V59, P2496, DOI 10.1109/TBME.2012.2205383; Wu W, 2008, IEEE T BIO-MED ENG, V55, P1733, DOI 10.1109/TBME.2008.919125; Yu K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046013; Yu K, 2012, J NEUROSCI METH, V204, P288, DOI 10.1016/j.jneumeth.2011.11.023; Yu K, 2011, IEEE T BIO-MED ENG, V58, P2513, DOI 10.1109/TBME.2011.2158542; Yu Zhang, 2012, 2012 9th International Conference on Fuzzy Systems and Knowledge Discovery, P891, DOI 10.1109/FSKD.2012.6234268	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76923	10.1371/journal.pone.0076923	http://dx.doi.org/10.1371/journal.pone.0076923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204705	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300067
J	Zhang, SP; Suo, ML; Liu, SL; Liang, W				Zhang, Shuping; Suo, Mingli; Liu, Shenglin; Liang, Wei			Do Major Roads Reduce Gene Flow in Urban Bird Populations?	PLOS ONE			English	Article							LANDSCAPE; WILDLIFE; HABITAT; EXTINCTION; PROXIMITY; DIVERSITY; ABUNDANCE; WOODLAND; IMPACT	Background: Although the negative effects of roads on the genetics of animal populations have been extensively reported, the question of whether roads reduce gene flow in volant, urban bird populations has so far not been addressed. In this study, we assess whether highways decreased gene flow and genetic variation in a small passerine bird, the tree sparrow (Passer montanus). Methodology: We assessed genetic differences among tree sparrows (Passer montanus) sampled at 19 sites within Beijing Municipality, China, using 7 DNA microsatellites as genetic markers. Results: AMOVA showed that genetic variation between sites, between urban and rural populations, and between opposite sides of the same highway, were very weak. Mantel tests on all samples, and on urban samples only, indicated that the age and number of highways, and the number of ordinary roads, were uncorrelated with genetic differences (FST) among tree sparrows from different urban sites. Birds sampled at urban sites had similar levels of genetic diversity to those at rural sites. There was, however, evidence of some weak genetic structure between urban sites. Firstly, there were significant genetic differences (FST) between birds from opposite sides of the same highway, but no significant FST values between those from sites that were not separated by highways. Secondly, birds from eleven urban sites had loci that significantly deviated from the Hardy-Weinberg equilibrium but no such deviation was found in birds from rural sites. Conclusion: We cannot, therefore, conclusively reject the hypothesis that highways have no effect on the gene flow of tree sparrow populations. Furthermore, since the significance of these results may increase with time, we suggested that research on the influence of highways on gene flow in urban bird populations needs to be conducted over several decades.	[Zhang, Shuping; Suo, Mingli; Liu, Shenglin] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China; [Liang, Wei] Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Trop Anim & Plant Ecol, Haikou, Peoples R China	Minzu University of China; Hainan Normal University	Liang, W (corresponding author), Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Trop Anim & Plant Ecol, Haikou, Peoples R China.	liangwei@hainnu.edu.cn			National Natural Science Foundation of China [30900181, 31071938, 31272328, 31372225]; Program for New Century Excellent Talents in University [NCET-10-0111]; 985 Program in Minzu University of China [MUC98504-14, MUC98507- 08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 985 Program in Minzu University of China	This study was supported by the National Natural Science Foundation of China (Nos. 30900181, 31071938, 31272328 and 31372225), Program for New Century Excellent Talents in University (NCET-10-0111), and 985 Program in Minzu University of China (MUC98504-14, MUC98507- 08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS A, 1990, Australian Zoologist, V26, P130; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Brotons L, 2001, LANDSCAPE URBAN PLAN, V57, P77, DOI 10.1016/S0169-2046(01)00191-8; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Field RH, 2004, IBIS, V146, P60, DOI 10.1111/j.1474-919X.2004.00356.x; Forman R. T. T., 2003, ROAD ECOLOGY; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gagnon JW, 2007, J WILDLIFE MANAGE, V71, P2318, DOI 10.2193/2006-224; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Jaarsma CF, 2006, TRANSPORT RES D-TR E, V11, P264, DOI 10.1016/j.trd.2006.05.001; Johansson M, 2005, GLOBAL CHANGE BIOL, V11, P1664, DOI 10.1111/j.1365-2486.2005.1005.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keller I, 2003, P ROY SOC B-BIOL SCI, V270, P417, DOI 10.1098/rspb.2002.2247; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Murphy MA, 2008, ECOGRAPHY, V31, P685, DOI 10.1111/j.1600-0587.2008.05428.x; Pan Chao, 2003, Journal of Beijing Normal University (Natural Science), V39, P537; Partecke J, 2006, ECOLOGY, V87, P1945, DOI 10.1890/0012-9658(2006)87[1945:SATCUA]2.0.CO;2; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roedenbeck IA, 2008, EUR J WILDLIFE RES, V54, P425, DOI 10.1007/s10344-007-0166-3; Ruan X., 1991, P99; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Summers-Smith JD, 1995, TREE SPARROW; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; VANDERZANDE AN, 1980, BIOL CONSERV, V18, P299, DOI 10.1016/0006-3207(80)90006-3; Yang CC, 2013, J AVIAN BIOL, V44, P216, DOI 10.1111/j.1600-048X.2013.00123.x; Zhang S, 2008, FRONT BIOL CHINA, V3, P122; Zhang SN, 2010, SCI CHINA PHYS CHEM, V53, P1, DOI 10.1007/s11433-010-0065-6	41	7	7	4	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77026	10.1371/journal.pone.0077026	http://dx.doi.org/10.1371/journal.pone.0077026			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204724	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300075
J	Dicken, J; Mildner, A; Leshkowitz, D; Touw, IP; Hantisteanu, S; Jung, S; Groner, Y				Dicken, Joseph; Mildner, Alexander; Leshkowitz, Dena; Touw, Ivo P.; Hantisteanu, Shay; Jung, Steffen; Groner, Yoram			Transcriptional Reprogramming of CD11b(+)Esam(hi) Dendritic Cell Identity and Function by Loss of Runx3	PLOS ONE			English	Article							IN-VIVO; SIGNALING CONTROLS; HUMAN GENOME; FACTOR ZDC; EXPRESSION; HOMEOSTASIS; DIFFERENTIATION; MACROPHAGES; PROGENITORS; REGULATOR	Classical dendritic cells (cDC) are specialized antigen-presenting cells mediating immunity and tolerance. cDC cell-lineage decisions are largely controlled by transcriptional factor regulatory cascades. Using an in vivo cell-specific targeting of Runx3 at various stages of DC lineage development we show that Runx3 is required for cell-identity, homeostasis and function of splenic Esam(hi) DC. Ablation of Runx3 in DC progenitors led to a substantial decrease in splenic CD4(+)/CD11b(+) DC. Combined chromatin immunoprecipitation sequencing and gene expression analysis of purified DC-subsets revealed that Runx3 is a key gene expression regulator that facilitates specification and homeostasis of CD11b(+)Esam(hi) DC. Mechanistically, loss of Runx3 alters Esam(hi) DC gene expression to a signature characteristic of WT Esam(low) DC. This transcriptional reprogramming caused a cellular change that diminished phagocytosis and hampered Runx3(-/-) Esam(hi) DC capacity to prime CD4(+) T cells, attesting to the significant role of Runx3 in specifying Esam(hi) DC identity and function.	[Dicken, Joseph; Hantisteanu, Shay; Groner, Yoram] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Mildner, Alexander; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Leshkowitz, Dena] Weizmann Inst Sci, Bioinformat Unit, Israel Natl Ctr Personalized Med, IL-76100 Rehovot, Israel; [Touw, Ivo P.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Erasmus University Rotterdam; Erasmus MC	Groner, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yoram.groner@weizmann.ac.il	Mildner, Alexander/ABG-6122-2020; mildner, alexander/AFK-2161-2022; Jung, Steffen/K-1409-2012; mildner, alexander/AAF-9451-2022; mildner, alexander/GQA-3761-2022	mildner, alexander/0000-0002-2019-8427; Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This study was supported by grants from Israel Science Foundation individual grants to YG. URL: http://isf.org.il. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bar-On L, 2010, IMMUNOL REV, V234, P76, DOI 10.1111/j.0105-2896.2009.00875.x; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chen YW, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r11; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Fu YX, 2011, J BIOL CHEM, V286, P11803, DOI 10.1074/jbc.M111.222331; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Hacker C, 2003, NAT IMMUNOL, V4, P380, DOI 10.1038/ni903; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2011, EMBO MOL MED, V3, P593, DOI 10.1002/emmm.201100168; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meredith MM, 2012, J EXP MED, V209, P1583, DOI 10.1084/jem.20121003; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Strobl H, 1996, J IMMUNOL, V157, P1499; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tailor P, 2008, BLOOD, V111, P1942, DOI 10.1182/blood-2007-07-100750; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Wolfler A, 2010, BLOOD, V116, P4116, DOI 10.1182/blood-2010-03-275404; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	41	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77490	10.1371/journal.pone.0077490	http://dx.doi.org/10.1371/journal.pone.0077490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204843	gold, Green Published, Green Submitted			2022-12-25	WOS:000325894100075
J	Keuper, M; Jastroch, M; Yi, CX; Fischer-Posovszky, P; Wabitsch, M; Tschop, MH; Hofmann, SM				Keuper, Michaela; Jastroch, Martin; Yi, Chun-Xia; Fischer-Posovszky, Pamela; Wabitsch, Martin; Tschoep, Matthias H.; Hofmann, Susanna M.			Spare mitochondrial respiratory capacity permits human adipocytes to maintain ATP homeostasis under hypoglycemic conditions	FASEB JOURNAL			English	Article						glycolysis; lactate secretion; oxidative phosphorylation; hyperglycemic	INSULIN-RESISTANCE; ADIPOSE-TISSUE; LACTATE RELEASE; OBESITY; CELLS; DIFFERENTIATION; ROSIGLITAZONE; BIOLOGY; STRESS; MICE	Mitochondrial dysfunction in white adipose tissue plays a key role in the pathogenesis of type 2 diabetes. Emerging evidence specifically suggests that altered oxidative phosphorylation in adipocytes may have a relevant effect on systemic glucose homeostasis, requiring understanding of adipocyte bioenergetics. We analyzed energetic flux of an intact human adipocyte cell model by plate-based respirometry and extracellular acidification. During differentiation, we discovered that glycolytic ATP production was increasingly replaced by mitochondrial oxidative metabolism (from 20 to 60%). This observation was corroborated by simultaneous up-regulation of canonical mitochondrial gene programs, such as peroxisome proliferator-activated receptor coactivator (PGC1; 150-fold) and cytochrome c-1 (CytC; 3-fold). Mimicking diabetic phenotypes by exposure to various glucose levels (0, 5, and 25 mM) resulted in immediate adjustments of glycolytic and mitochondrial activity that aimed to maintain intracellular ATP. We conclude that ATP deficits by mitochondrial failure are compensated by glycolytic ATP production, resulting in inefficient conversion of glucose to cellular ATP. Metabolic inefficiency may enhance glucose uptake, therefore improving systemic glucose homeostasis. Notably, mature adipocytes developed a high spare respiratory capacity (increased by 6-fold) permitting rapid adaptation to metabolic changes. Spare respiratory capacity may also allow additional metabolic scope for energy dissipation, potentially offering new therapeutic targets for the treatment of metabolic disease.Keuper, M., Jastroch, M., Yi, C.-X., Fischer-Posovszky, P., Wabitsch, M., Tschop, M. H., Hofmann, S. M. Spare mitochondrial respiratory capacity permits human adipocytes to maintain ATP homeostasis under hypoglycemic conditions.	[Keuper, Michaela; Hofmann, Susanna M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, D-85764 Neuherberg, Germany; [Jastroch, Martin; Yi, Chun-Xia; Tschoep, Matthias H.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Diabet & Obes, D-85764 Neuherberg, Germany; [Jastroch, Martin; Yi, Chun-Xia; Tschoep, Matthias H.] Tech Univ Munich, D-80290 Munich, Germany; [Fischer-Posovszky, Pamela; Wabitsch, Martin] Univ Ulm, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Endocrinol & Diabet, D-89069 Ulm, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ulm University	Keuper, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	michaela.keuper@helmholtz-muenchen.de	Hofmann, Susanna/F-2654-2014; Tschoep, Matthias H/I-5443-2014; Jastroch, Martin/I-7494-2017; Yi, Chun-Xia/J-4068-2016	Hofmann, Susanna/0000-0001-7682-5840; Yi, Chun-Xia/0000-0003-1184-4615; Fischer-Posovszky, Pamela/0000-0003-3402-9840; Keuper, Michaela/0000-0003-0319-3509; Tschoep, Matthias/0000-0002-4744-371X	Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Network Fund of the Helmholtz Association	Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Network Fund of the Helmholtz Association	This work was funded (in part) by the Helmholtz Alliance ICEMED (Imaging and Curing Environmental Metabolic Diseases) through the Initiative and Network Fund of the Helmholtz Association. The authors declare no conflicts of interest.	Affourtit C, 2011, FREE RADICAL BIO MED, V50, P609, DOI 10.1016/j.freeradbiomed.2010.12.020; Bottcher H, 1996, INT J OBESITY, V20, P874; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Collins JM, 2011, J LIPID RES, V52, P1683, DOI 10.1194/jlr.M012195; Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126; de Heredia FP, 2010, PFLUG ARCH EUR J PHY, V459, P509, DOI 10.1007/s00424-009-0750-3; Ducluzeau PH, 2011, J PHYSIOL BIOCHEM, V67, P285, DOI 10.1007/s13105-011-0074-6; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Guo X, 2012, ACTA PHARM SIN B, V2, P358, DOI 10.1016/j.apsb.2012.06.002; Jastroch M, 2012, BBA-BIOENERGETICS, V1817, P1660, DOI 10.1016/j.bbabio.2012.05.014; Juraschek S. P., 2013, PLOS ONE, V8; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Keuper Michaela, 2011, Front Endocrinol (Lausanne), V2, P89, DOI 10.3389/fendo.2011.00089; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kita T, 2009, J BIOCHEM, V146, P787, DOI 10.1093/jb/mvp124; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Newton BW, 2011, J PROTEOME RES, V10, P4692, DOI 10.1021/pr200491h; Nicholls DG, 2009, BIOCHEM SOC T, V37, P1385, DOI 10.1042/BST0371385; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006; Si Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007000; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang T, 2010, OBESITY, V18, P1493, DOI 10.1038/oby.2009.456; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Yehuda-Shnaidman E, 2010, DIABETES, V59, P2474, DOI 10.2337/db10-0245; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	32	53	53	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					761	770		10.1096/fj.13-238725	http://dx.doi.org/10.1096/fj.13-238725			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24200885				2022-12-25	WOS:000331072200023
J	Zheng, LZ; Liu, Z; Lei, M; Peng, J; He, YX; Xie, XH; Man, CW; Huang, L; Wang, XL; Fong, DTP; Xiao, DM; Wang, DP; Chen, Y; Feng, JQ; Liu, Y; Zhang, G; Qin, L				Zheng, Li-Zhen; Liu, Zhong; Lei, Ming; Peng, Jiang; He, Yi-Xin; Xie, Xin-Hui; Man, Chi-Wai; Huang, Le; Wang, Xin-Luan; Fong, Daniel Tik-Pui; Xiao, De-Ming; Wang, Da-Ping; Chen, Yang; Feng, Jian Q.; Liu, Ying; Zhang, Ge; Qin, Ling			Steroid-Associated Hip Joint Collapse in Bipedal Emus	PLOS ONE			English	Article							FEMORAL-HEAD OSTEONECROSIS; ACUTE-RESPIRATORY-SYNDROME; BONE-MARROW EDEMA; CORTICOSTEROID-INDUCED OSTEONECROSIS; NONTRAUMATIC OSTEONECROSIS; PHYTOMOLECULE ICARITIN; AVASCULAR NECROSIS; SUBCHONDRAL BONE; NATURAL-HISTORY; ANIMAL-MODEL	In this study we established a bipedal animal model of steroid-associated hip joint collapse in emus for testing potential treatment protocols to be developed for prevention of steroid-associated joint collapse in preclinical settings. Five adult male emus were treated with a steroid-associated osteonecrosis (SAON) induction protocol using combination of pulsed lipopolysaccharide (LPS) and methylprednisolone (MPS). Additional three emus were used as normal control. Post-induction, emu gait was observed, magnetic resonance imaging (MRI) was performed, and blood was collected for routine examination, including testing blood coagulation and lipid metabolism. Emus were sacrificed at week 24 post-induction, bilateral femora were collected for micro-computed tomography (micro-CT) and histological analysis. Asymmetric limping gait and abnormal MRI signals were found in steroid-treated emus. SAON was found in all emus with a joint collapse incidence of 70%. The percentage of neutrophils (Neut %) and parameters on lipid metabolism significantly increased after induction. Micro-CT revealed structure deterioration of subchondral trabecular bone. Histomorphometry showed larger fat cell fraction and size, thinning of subchondral plate and cartilage layer, smaller osteoblast perimeter percentage and less blood vessels distributed at collapsed region in SAON group as compared with the normal controls. Scanning electron microscope (SEM) showed poor mineral matrix and more osteo-lacunae outline in the collapsed region in SAON group. The combination of pulsed LPS and MPS developed in the current study was safe and effective to induce SAON and deterioration of subchondral bone in bipedal emus with subsequent femoral head collapse, a typical clinical feature observed in patients under pulsed steroid treatment. In conclusion, bipedal emus could be used as an effective preclinical experimental model to evaluate potential treatment protocols to be developed for prevention of ON-induced hip joint collapse in patients.	[Zheng, Li-Zhen; Liu, Zhong; Peng, Jiang; He, Yi-Xin; Xie, Xin-Hui; Man, Chi-Wai; Huang, Le; Wang, Xin-Luan; Fong, Daniel Tik-Pui; Zhang, Ge; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Lei, Ming; Xiao, De-Ming; Wang, Da-Ping; Chen, Yang] Shenzhen Second Peoples Hosp, Dept Orthopaed & Traumatol, Shenzhen, Peoples R China; [Wang, Xin-Luan; Qin, Ling] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Translat Med R&D Ctr, Shenzhen, Peoples R China; [Peng, Jiang] Chinese Peoples Liberat Army, Gen Hosp, Orthoped Res Inst, Beijing, Peoples R China; [Feng, Jian Q.; Liu, Ying] Univ Missouri, Baylor Coll Dent, Kansas City, MO 64110 USA; [Lei, Ming; Xiao, De-Ming] Beijing Univ, Shenzhen Hosp, Dept Orthopead, Shenzhen, Peoples R China; [Xie, Xin-Hui] Southeast Univ, Zhongda Hosp, Dept Orthopaed, Nanjing, Jiangsu, Peoples R China; [Zhang, Ge] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Second People's Hospital of Shenzhen; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese People's Liberation Army General Hospital; University of Missouri System; University of Missouri Kansas City; Peking University; Southeast University - China; Hong Kong Baptist University	Zhang, G (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	zhangge@ort.cuhk.edu.hk; lingqin@cuhk.edu.hk	Zhang, Ge/K-9118-2019; Zhang, Ge/N-4150-2013; Fong, Daniel T.P./AAT-8659-2020; Zheng, Lizhen/C-6550-2014; Man, Gene Chi-Wai/AAH-4865-2019; Qin, Ling/J-9047-2018	Zhang, Ge/0000-0002-7807-7695; Zhang, Ge/0000-0002-7807-7695; Man, Gene Chi-Wai/0000-0002-8608-9688; Qin, Ling/0000-0001-6173-6167; Fong, Daniel Tik-Pui/0000-0001-7314-189X	Hong Kong ITC [GHP/001/08]; Hong Kong ITF [ITS/451/09FP]; Shenzhen Science & Technology Fund [SG200810200101A/02/A]; NIDCR/NIH [DE018486]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018486] Funding Source: NIH RePORTER	Hong Kong ITC; Hong Kong ITF; Shenzhen Science & Technology Fund; NIDCR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was funded by Hong Kong ITC (GHP/001/08 and ITF Tier 2 ITS/451/09FP): https://www.itf.gov.hk/; Shenzhen Science & Technology Fund (SG200810200101A/02/A): http://www.szsti.gov.cn/; and DE018486 from NIDCR/NIH: http://www.nidcr.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada T, 2008, RHEUMATOLOGY, V47, P591, DOI 10.1093/rheumatology/ken037; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Bitto A, 2009, J ENDOCRINOL, V201, P321, DOI 10.1677/JOE-08-0552; Bradway J K, 1993, J Arthroplasty, V8, P383, DOI 10.1016/S0883-5403(06)80036-7; Chan MHM, 2006, PATHOLOGY, V38, P229, DOI 10.1080/00313020600696231; Chen SH, 2013, ACTA BIOMATER, V9, P6711, DOI 10.1016/j.actbio.2013.01.024; Chen SH, 2012, ACTA BIOMATER, V8, P3128, DOI 10.1016/j.actbio.2012.04.030; Conzemius MG, 2002, J ORTHOP RES, V20, P303, DOI 10.1016/S0736-0266(01)00108-5; Cui QJ, 2000, CONNECT TISSUE RES, V41, P45; Cui QJ, 1997, CLIN ORTHOP RELAT R, P8; Davis ET, 2006, J BONE JOINT SURG AM, V88A, P110, DOI 10.2106/JBJS.F.00771; Drescher W, 2004, J ORTHOPAED RES, V22, P501, DOI 10.1016/j.orthres.2003.10.002; Drescher W, 2001, J BONE JOINT SURG BR, V83B, P274, DOI 10.1302/0301-620X.83B2.10323; Drescher W, 2006, J BONE JOINT SURG AM, V88A, P162, DOI 10.2106/JBJS.F.00452; Fan M, 2011, J INT MED RES, V39, P187, DOI 10.1177/147323001103900120; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FORDYCE MJF, 1993, J BONE JOINT SURG BR, V75, P365, DOI 10.1302/0301-620X.75B3.8496201; Fujioka M, 2001, MAGN RESON IMAGING, V19, P985, DOI 10.1016/S0730-725X(01)00424-6; Goetz JE, 2008, J BIOMECH, V41, P2197, DOI 10.1016/j.jbiomech.2008.04.032; Goetz JE, 2008, J BIOMECH, V41, P770, DOI 10.1016/j.jbiomech.2007.11.022; Griffith JF, 2005, RADIOLOGY, V235, P168, DOI 10.1148/radiol.2351040100; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hernigou P, 1999, J BONE JOINT SURG BR, V81B, P349, DOI 10.1302/0301-620X.81B2.8818; Irisa T, 2001, BONE, V28, P641, DOI 10.1016/S8756-3282(01)00460-4; Ito H, 2006, AM J ROENTGENOL, V186, P1761, DOI 10.2214/AJR.05.0086; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koo KH, 1999, RADIOLOGY, V213, P715, DOI 10.1148/radiology.213.3.r99dc06715; Kubo T, 1997, MAGN RESON IMAGING, V15, P1017, DOI 10.1016/S0730-725X(97)00159-8; LANE LB, 1977, J BONE JOINT SURG BR, V59, P272, DOI 10.1302/0301-620X.59B3.893504; Lau EMC, 2005, BONE, V37, P420, DOI 10.1016/j.bone.2005.04.018; Law RKY, 2008, WORK, V30, P17; Li Zi-rong, 2005, Zhonghua Wai Ke Za Zhi, V43, P1048; Lieberman Jay R, 2003, Instr Course Lect, V52, P337; Lv H, 2009, TROP MED INT HEALTH, V14, P79, DOI 10.1111/j.1365-3156.2008.02187.x; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; MILLER SC, 1985, J DENT RES, V64, P1062, DOI 10.1177/00220345850640080701; Mont MA, 2006, J BONE JOINT SURG AM, V88A, P1117, DOI 10.2106/JBJS.E.01041; Moskal J T, 1997, Am J Orthop (Belle Mead NJ), V26, P609; Nishii T, 2002, CLIN ORTHOP RELAT R, P149; Okazaki S, 2009, RHEUMATOLOGY, V48, P227, DOI 10.1093/rheumatology/ken462; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Plenk H, 2001, CLIN ORTHOP RELAT R, P42; Qin L, 2006, BONE, V39, P863, DOI 10.1016/j.bone.2006.04.018; Reed KL, 2003, J BIOMECH, V36, P1317, DOI 10.1016/S0021-9290(03)00154-4; Resources I. O. L. A., 1996, GUIDE CARE USED LAB; Shen Jun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P189; Sheng H, 2009, J ORTHOP RES, V27, P742, DOI 10.1002/jor.20765; Solomon DH, 2006, ARTHRIT RHEUM-ARTHR, V55, P873, DOI 10.1002/art.22350; Sun W, 2006, INT ORTHOP, V30, P143, DOI 10.1007/s00264-005-0067-6; Sun Y, 2009, JOINT BONE SPINE, V76, P685, DOI 10.1016/j.jbspin.2009.04.002; Takano-Murakami R, 2009, TOHOKU J EXP MED, V217, P51, DOI 10.1620/tjem.217.51; Troy KL, 2009, J BIOMECH, V42, P2495, DOI 10.1016/j.jbiomech.2009.07.017; TURNER DA, 1989, RADIOLOGY, V171, P135, DOI 10.1148/radiology.171.1.2928517; Wang SX, 2007, ARTHRITIS RHEUM-US, V56, P1537, DOI 10.1002/art.22574; Wang XL, 2013, J ORTHOP RES, V31, P164, DOI 10.1002/jor.22188; Xie XH, 2011, J BONE JOINT SURG BR, V93B, P558, DOI 10.1302/0301-620X.93B4.25442; Xie XH, 2012, ARTHRITIS RHEUM-US, V64, P1562, DOI 10.1002/art.34525; Yamamoto T, 1997, ARTHRITIS RHEUM, V40, P2055, DOI 10.1002/art.1780401119; YAMAMOTO T, 1995, CLIN ORTHOP RELAT R, P235; Yamamoto T, 2006, J RHEUMATOL, V33, P1701; Yang L, 2009, J ORTHOP RES, V27, P169, DOI 10.1002/jor.20733; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006419; Zhang G, 2009, BONE, V44, P345, DOI 10.1016/j.bone.2008.10.035	63	13	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76797	10.1371/journal.pone.0076797	http://dx.doi.org/10.1371/journal.pone.0076797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204675	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600011
J	Mayer, M; Rabindranath, R; Borner, J; Horner, E; Bentz, A; Salgado, J; Han, H; Bose, H; Probst, J; Shamonin, M; Monkman, GJ; Schlunck, G				Mayer, Matthias; Rabindranath, Raman; Boerner, Juliane; Hoerner, Eva; Bentz, Alexander; Salgado, Josefina; Han, Hong; Boese, Holger; Probst, Joern; Shamonin, Mikhail; Monkman, Gareth J.; Schlunck, Guenther			Ultra-Soft PDMS-Based Magnetoactive Elastomers as Dynamic Cell Culture Substrata	PLOS ONE			English	Article							ELASTIC MAGNETIC-MATERIALS; SMOOTH MUSCLE ACTIN; MECHANOTRANSDUCTION; STIFFNESS; TENSION; HYDROGELS; BEHAVIOR; DAMPERS; SEALS	Mechanical cues such as extracellular matrix stiffness and movement have a major impact on cell differentiation and function. To replicate these biological features in vitro, soft substrata with tunable elasticity and the possibility for controlled surface translocation are desirable. Here we report on the use of ultra-soft (Young's modulus <100 kPa) PDMS-based magnetoactive elastomers (MAE) as suitable cell culture substrata. Soft non-viscous PDMS (<18 kPa) is produced using a modified extended crosslinker. MAEs are generated by embedding magnetic microparticles into a soft PDMS matrix. Both substrata yield an elasticity-dependent (14 vs. 100 kPa) modulation of alpha-smooth muscle actin expression in primary human fibroblasts. To allow for static or dynamic control of MAE material properties, we devise low magnetic field (approximate to 40 mT) stimulation systems compatible with cell-culture environments. Magnetic field-instigated stiffening (14 to 200 kPa) of soft MAE enhances the spreading of primary human fibroblasts and decreases PAX-7 transcription in human mesenchymal stem cells. Pulsatile MAE movements are generated using oscillating magnetic fields and are well tolerated by adherent human fibroblasts. This MAE system provides spatial and temporal control of substratum material characteristics and permits novel designs when used as dynamic cell culture substrata or cell culture-coated actuator in tissue engineering applications or biomedical devices.	[Mayer, Matthias; Hoerner, Eva; Bentz, Alexander; Shamonin, Mikhail; Monkman, Gareth J.] Regensburg Univ Appl Sci, Dept Elect Engn & Informat Technol, Regensburg, Germany; [Rabindranath, Raman; Boese, Holger; Probst, Joern] Fraunhofer Inst Silicatforsch, Ctr Smart Mat, Wurzburg, Germany; [Boerner, Juliane; Salgado, Josefina; Han, Hong; Schlunck, Guenther] Wurzburg Univ Hosp, Dept Ophthalmol, Wurzburg, Germany; [Schlunck, Guenther] Univ Freiburg, Med Ctr, Dept Ophthalmol, Freiburg, Germany	University of Regensburg; Fraunhofer Gesellschaft; University of Wurzburg; University of Freiburg	Mayer, M (corresponding author), Regensburg Univ Appl Sci, Dept Elect Engn & Informat Technol, Regensburg, Germany.	matthias.mayer@hs-regensburg.de; guenther.schlunck@uniklinik-freiburg.de	Monkman, Gareth/D-9731-2015	Monkman, Gareth/0000-0003-4891-8745; Shamonin, Mikhail/0000-0001-5637-7526	German Federal Ministry of Education and Research [13N10575, 17PNT021]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This material is based upon work supported by the German Federal Ministry of Education and Research (grants 13N10575, 17PNT021), http://foerderportal.bund.de/foekat/jsp/SucheAction.do?actionMode = view&fkz = 13N10574; http://foerderportal.bund.de/foekat/jsp/SucheAction.do?actionMode = view&fkz = 17PNT021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramchuk S, 2007, POLYM ADVAN TECHNOL, V18, P883, DOI 10.1002/pat.924; Abramchuk S, 2007, POLYM ADVAN TECHNOL, V18, P513, DOI 10.1002/pat.923; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; Adrian RJ., 2010, PARTICLE IMAGE VELOC; [Anonymous], 2012, J ASTM INT; [Anonymous], 2003, 1457712002 DIN EN IS; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f; Bose H, 2007, INT J MOD PHYS B, V21, P4790, DOI 10.1142/S0217979207045670; Bose H, 2009, US Patent, Patent No. 7608197; Cesa CM, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2712870; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Fischer-Cripps AC, 2011, MECH ENG SER, P235, DOI 10.1007/978-1-4419-9872-9_13; Fuchs A, 2007, J APPL POLYM SCI, V105, P2497, DOI 10.1002/app.24348; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gordaninejad F, 2012, J INTEL MAT SYST STR, V23, P1033, DOI 10.1177/1045389X12448286; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Kuhn H., 2000, FRACTURE TOUGHNESS F, V8, DOI [10.31399/asm.hb.v08.a0003305, DOI 10.31399/ASM.HB.V08.A0003305]; Li YH, 2013, ADV FUNCT MATER, V23, P660, DOI 10.1002/adfm.201201708; Lin IK, 2009, J MICROELECTROMECH S, V18, P1087, DOI 10.1109/JMEMS.2009.2029166; Mezger T G, 2010, RHEOLOGIE HDB ANWEND; Mitsumata T, 2012, J PHYS CHEM B, V116, P12341, DOI 10.1021/jp3049372; Nendza M, 2007, MAR POLLUT BULL, V54, P1190, DOI 10.1016/j.marpolbul.2007.04.009; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Stepanov GV, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/204121; Stolbov OV, 2010, POLYM SCI SER A+, V52, P1344, DOI 10.1134/S0965545X10120138; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Varga Z, 2006, POLYMER, V47, P227, DOI 10.1016/j.polymer.2005.10.139; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wipff PJ, 2009, BIOMATERIALS, V30, P1781, DOI 10.1016/j.biomaterials.2008.12.022; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	43	44	45	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76196	10.1371/journal.pone.0076196	http://dx.doi.org/10.1371/journal.pone.0076196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204603	Green Published, gold			2022-12-25	WOS:000326029300013
J	Walker, JA; Alfaro, ME; Noble, MM; Fulton, CJ				Walker, Jeffrey A.; Alfaro, Michael E.; Noble, Mae M.; Fulton, Christopher J.			Body Fineness Ratio as a Predictor of Maximum Prolonged-Swimming Speed in Coral Reef Fishes	PLOS ONE			English	Article							PERFORMANCE TRADE-OFFS; THREESPINE STICKLEBACK; GENETIC-DIVERGENCE; FIN MUSCLE; MORPHOLOGY; SHAPE; FLOW; HYDRODYNAMICS; ENERGETICS; SELECTION	The ability to sustain high swimming speeds is believed to be an important factor affecting resource acquisition in fishes. While we have gained insights into how fin morphology and motion influences swimming performance in coral reef fishes, the role of other traits, such as body shape, remains poorly understood. We explore the ability of two mechanistic models of the causal relationship between body fineness ratio and endurance swimming-performance to predict maximum prolonged-swimming speed (U-max) among 84 fish species from the Great Barrier Reef, Australia. A drag model, based on semi-empirical data on the drag of rigid, submerged bodies of revolution, was applied to species that employ pectoral-fin propulsion with a rigid body at U-max. An alternative model, based on the results of computer simulations of optimal shape in self-propelled undulating bodies, was applied to the species that swim by body-caudal-fin propulsion at U-max. For pectoral-fin swimmers, U-max increased with fineness, and the rate of increase decreased with fineness, as predicted by the drag model. While the mechanistic and statistical models of the relationship between fineness and U-max were very similar, the mechanistic (and statistical) model explained only a small fraction of the variance in U-max. For body-caudal-fin swimmers, we found a non-linear relationship between fineness and U-max, which was largely negative over most of the range of fineness. This pattern fails to support either predictions from the computational models or standard functional interpretations of body shape variation in fishes. Our results suggest that the widespread hypothesis that a more optimal fineness increases endurance-swimming performance via reduced drag should be limited to fishes that swim with rigid bodies.	[Walker, Jeffrey A.] Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA; [Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Noble, Mae M.; Fulton, Christopher J.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Coral Reef Studies, Canberra, ACT, Australia	University of Maine System; University of Southern Maine; University of California System; University of California Los Angeles; Australian National University	Walker, JA (corresponding author), Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA.	walker@maine.edu	Fulton, Christopher/A-5971-2008; Alfaro, Michael/Q-2113-2017	Fulton, Christopher/0000-0002-1140-1999; Alfaro, Michael/0000-0002-8898-8230	National Science Foundation Division of Environmental Biology (NSF DEB) [0842397]; Australian Research Council	National Science Foundation Division of Environmental Biology (NSF DEB)(National Science Foundation (NSF)); Australian Research Council(Australian Research Council)	MEA was partially supported by National Science Foundation Division of Environmental Biology (NSF DEB) grant 0842397 (http://www.nsf.gov/div/index.jsp?div = DEB). CJF was partially supported by the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn BK, 2009, CAN J ZOOL, V87, P124, DOI 10.1139/Z08-144; Anderson EJ, 2001, J EXP BIOL, V204, P81; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Ashley-Ross MA, 2002, J EXP ZOOL, V293, P561, DOI 10.1002/jez.10183; BAINBRIDGE R, 1960, J EXP BIOL, V37, P129; Bellwood DR, 2002, FUNCT ECOL, V16, P557, DOI 10.1046/j.1365-2435.2002.00655.x; Biewener AA, 2012, J EXP BIOL, V215, P4051, DOI 10.1242/jeb.081794; Blake R.W., 1983, FISH LOCOMOTION; Blake RW, 2005, J FISH BIOL, V67, P834, DOI 10.1111/j.0022-1112.2005.00788.x; Blake RW, 2004, J FISH BIOL, V65, P1193, DOI 10.1111/j.0022-1112.2004.00568.x; Boily P, 2002, J EXP BIOL, V205, P1031; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Borazjani I, 2009, J EXP BIOL, V212, P576, DOI 10.1242/jeb.025007; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chung MH, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/3/036001; Collin H, 2011, MOL ECOL, V20, P4490, DOI 10.1111/j.1365-294X.2011.05284.x; Dalziel AC, 2012, J EXP BIOL, V215, P3587, DOI 10.1242/jeb.071951; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; Davison W., 1994, New Zealand Natural Sciences, V21, P11; Domenici P, 2003, EXPTL BIOL REV, P137; Ellerby DJ, 2011, EVOL BIOL, V38, P422, DOI 10.1007/s11692-011-9130-y; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fischer-Rousseau L, 2010, J EXP ZOOL PART B, V314B, P67, DOI 10.1002/jez.b.21311; Fisher R, 2007, J EXP BIOL, V210, P2436, DOI 10.1242/jeb.004275; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fulton CJ, 2007, CORAL REEFS, V26, P217, DOI 10.1007/s00338-007-0195-0; Fulton CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054033; Fulton CJ, 2005, P ROY SOC B-BIOL SCI, V272, P827, DOI 10.1098/rspb.2004.3029; Fulton CJ, 2004, MAR BIOL, V144, P429, DOI 10.1007/s00227-003-1216-3; Fulton CJ, 2001, MAR BIOL, V139, P25; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Gerstner CL, 1999, CAN J ZOOL, V77, P1102, DOI 10.1139/cjz-77-7-1102; Haas TC, 2010, BIOL LETTERS, V6, P803, DOI 10.1098/rsbl.2010.0401; HAMMER C, 1995, COMP BIOCHEM PHYS A, V112, P1, DOI 10.1016/0300-9629(95)00060-K; Heatwole SJ, 2013, MAR BIOL, V160, P677, DOI 10.1007/s00227-012-2123-2; Hendry AP, 2011, J EVOLUTION BIOL, V24, P23, DOI 10.1111/j.1420-9101.2010.02155.x; Hobson E. S., 1978, FISHERY B, V76; Hoerner S. F, 1965, FLUID DYNAMIC DRAG; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Jastrebski CJ, 2003, EVOL ECOL RES, V6, P1; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Jones EA, 2007, J EXP BIOL, V210, P3422, DOI 10.1242/jeb.005744; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Kunze S, 2011, EXP FLUIDS, V50, P747, DOI 10.1007/s00348-010-0981-2; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Li D, 2009, J FISH BIOL, V74, P186, DOI 10.1111/j.1095-8649.2008.02128.x; Lighthill J., 1975, MATH BIOFLUIDDYNAMIC; LIGHTHILL MJ, 1971, PROC R SOC SER B-BIO, V179, P125, DOI 10.1098/rspb.1971.0085; LUIKER EA, 1993, CAN J ZOOL, V71, P2185, DOI 10.1139/z93-307; McGuigan K, 2003, EVOLUTION, V57, P104; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI 10.1111/j.1558-5646.1987.tb02457.x; Nanami A, 2007, J EXP MAR BIOL ECOL, V348, P1, DOI 10.1016/j.jembe.2007.02.016; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Ojanguren AF, 2003, ECOL FRESHW FISH, V12, P241, DOI 10.1046/j.1600-0633.2003.00016.x; Orme D, 2012, CAPER COMP ANAL PHYL; Oufiero CE, 2011, ECOLOGY, V92, P170, DOI 10.1890/09-1912.1; Pakkasmaa S, 2000, EVOL ECOL, V14, P721, DOI 10.1023/A:1011691810801; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peres-Neto PR, 2004, OECOLOGIA, V140, P36, DOI 10.1007/s00442-004-1562-y; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Plaut I, 2001, COMP BIOCHEM PHYS A, V131, P41, DOI 10.1016/S1095-6433(01)00462-7; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramamurti R, 2002, J EXP BIOL, V205, P2997; Reid DAP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.021901; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; Sagnes P, 2009, AQUAT LIVING RESOUR, V22, P79, DOI 10.1051/alr/2009008; Sambilay V.C.J., 1990, FISHBYTE, V8, P16; Schaefer J, 2011, BIOL J LINN SOC, V103, P612, DOI 10.1111/j.1095-8312.2011.01660.x; Seiler SM, 2007, CAN J FISH AQUAT SCI, V64, P127, DOI 10.1139/F06-175; Shalizi C., 2013, ADV DATA ANAL ELEMEN; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Shen L, 2003, J FLUID MECH, V484, P197, DOI 10.1017/S0022112003004294; TANEDA S, 1974, J PHYS SOC JPN, V36, P1683, DOI 10.1143/JPSJ.36.1683; TAYLOR EB, 1986, CAN J ZOOL, V64, P416, DOI 10.1139/z86-064; Techet AH, 2003, FLOW TURBUL COMBUST, V71, P105, DOI 10.1023/B:APPL.0000014923.28324.87; Thorsen DH, 2004, J MORPHOL, V263, P133, DOI 10.1002/(ISSN)1097-4687.; Tokic G, 2012, P ROY SOC B-BIOL SCI, V279, P3065, DOI 10.1098/rspb.2012.0057; Triantafyllou MS, 2004, IEEE J OCEANIC ENG, V29, P585, DOI 10.1109/JOE.2004.833216; Tudorache C, 2007, J FISH BIOL, V71, P1448, DOI 10.1111/j.1095-8649.2007.01612.x; Tytell ED, 2010, INTEGR COMP BIOL, V50, P1140, DOI 10.1093/icb/icq057; Tytell ED, 2010, P NATL ACAD SCI USA, V107, P19832, DOI 10.1073/pnas.1011564107; Walker JA, 2000, P ROY SOC B-BIOL SCI, V267, P1875, DOI 10.1098/rspb.2000.1224; Walker JA, 2004, J EXP BIOL, V207, P1925, DOI 10.1242/jeb.00994; Walker JA, 2002, INTEGR COMP BIOL, V42, P232, DOI 10.1093/icb/42.2.232; Walker JA, 2002, J EXP BIOL, V205, P177; Walker JA, 2010, INTEGR COMP BIOL, V50, P1051, DOI 10.1093/icb/icq014; WARE DM, 1982, CAN J FISH AQUAT SCI, V39, P3, DOI 10.1139/f82-002; Webb PW, 2010, INTEGR COMP BIOL, V50, P1155, DOI 10.1093/icb/icq020	98	33	37	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75422	10.1371/journal.pone.0075422	http://dx.doi.org/10.1371/journal.pone.0075422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204575	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300003
J	Yang, Y; Li, RK; Li, WJ; Wang, M; Cao, Y; Wu, ZL; Xu, Q				Yang, Yang; Li, Runkui; Li, Wenjing; Wang, Meng; Cao, Yang; Wu, Zhenglai; Xu, Qun			The Association between Ambient Air Pollution and Daily Mortality in Beijing after the 2008 Olympics: A Time Series Study	PLOS ONE			English	Article							EXPOSURE-RESPONSE FUNCTIONS; PARTICULATE MATTER; CARBON-MONOXIDE; HEALTH OUTCOMES; PUBLIC-HEALTH; CHINA; CITIES; AGE; MODIFIERS; PARTICLES	In recent decades, ambient air pollution has been an important public health issue in Beijing, but little is known about air pollution and health effects after the 2008 Beijing Olympics. We conduct a time-series analysis to evaluate associations between daily mortality (nonaccidental, cardiovascular and respiratory mortality) and the major air pollutants (carbon monoxide, nitrogen dioxide and particulate matter less than 10 mm in aerodynamic diameter) in Beijing during the two years (2009 similar to 2010) after the 2008 Beijing Olympics. We used generalized additive model to analyze relationship between daily mortality and air pollution. In single air pollutant model with two-day moving average concentrations of the air pollutants, increase in their interquartile range (IQR) associated with percent increase in nonaccidental mortality, 2.55 percent [95% confidence interval (CI): 1.99, 3.11] for CO, 2.54 percent (95% CI: 2.00, 3.08) for NO2 and 1.80 percent (95% CI: 1.21, 2.40) for PM10, respectively; increases in the IQR of air pollutant concentrations associated with percent increase in cardiovascular mortality, 2.88 percent (95% CI: 2.10,3.65) for CO, 2.63 percent (95% CI: 1.87, 3.39) for NO2 and 1.72 percent (95% CI: 0.88, 2.55) for PM10, respectively; and increase in IQR of air pollutant concentrations associated with respiratory mortality, 2.39 percent (95% CI: 0.68, 4.09) for CO, 1.79 percent (95% CI: 0.11, 3.47) for NO2 and 2.07 percent (95% CI: 0.21, 3.92) for PM10, respectively. We used the principal component analysis to avoid collinearity of varied air pollutants. In addition, the association stratified by sex and age was also examined. Ambient air pollution remained a significant contributor to nonaccidental and cardiopulmonary mortalities in Beijing during 2009,2010.	[Yang, Yang; Li, Wenjing; Wang, Meng; Wu, Zhenglai; Xu, Qun] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China; [Yang, Yang; Li, Wenjing; Wang, Meng; Wu, Zhenglai; Xu, Qun] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Li, Runkui] Univ Chinese Acad Sci, Coll Resources & Environm, Beijing, Peoples R China; [Cao, Yang] Karolinska Inst, Inst Environm Med, Unit Biostat, S-10401 Stockholm, Sweden	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Karolinska Institutet	Xu, Q (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing 100730, Peoples R China.	qunxu@ibms.pumc.edu.cn	Li, Runkui/AAH-1534-2021; Cao, Yang/C-6185-2008; Cao, Yang/HGD-6463-2022	Cao, Yang/0000-0002-3552-9153; xu, qun/0000-0003-0141-4427	Gong-Yi Program of China Ministry of Environmental Protection [200909016, 201209046, 201309045]	Gong-Yi Program of China Ministry of Environmental Protection	This study was funded by Gong-Yi Program of China Ministry of Environmental Protection (200909016, 201209046, 201309045). URL:http://kjs.mep.gov.cn/gyxhykyzx/The funders had no role in study design, data collection and analysis, decision to publish, or preperation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2007, BEIJ STAT YB; Aunan K, 2004, SCI TOTAL ENVIRON, V329, P3, DOI 10.1016/j.scitotenv.2004.03.008; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Braga ALF, 2001, J OCCUP ENVIRON MED, V43, P927; Chen BH, 2004, TOXICOLOGY, V198, P291, DOI 10.1016/j.tox.2004.02.005; Chen RJ, 2011, SCI TOTAL ENVIRON, V409, P4923, DOI 10.1016/j.scitotenv.2011.08.029; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dong J W, 1996, Zhonghua Liu Xing Bing Xue Za Zhi, V17, P13; Gouveia N, 2000, J EPIDEMIOL COMMUN H, V54, P750, DOI 10.1136/jech.54.10.750; *HLTH EFF I, 2004, HLTH EFF OUTD AIR PO; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kan Haidong, 2010, Res Rep Health Eff Inst, P17; Kan HD, 2005, BIOMED ENVIRON SCI, V18, P159; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; McGrath JJ, 2000, INHAL TOXICOL, V12, P91, DOI 10.1080/089583700750019521; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Puett RC, 2008, AM J EPIDEMIOL, V168, P1161, DOI 10.1093/aje/kwn232; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Samoli E, 2008, ENVIRON HEALTH PERSP, V116, P1480, DOI 10.1289/ehp.11345; Samoli E, 2007, ENVIRON HEALTH PERSP, V115, P1578, DOI 10.1289/ehp.10375; Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794; Sun Ying, 2011, Huanjing Kexue, V32, P2732; Xu ZY, 2000, ARCH ENVIRON HEALTH, V55, P115, DOI 10.1080/00039890009603397; [杨敏娟 YANG Minjuan], 2008, [环境与健康杂志, Journal of Environment and Health], V25, P294; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517; Zeka A, 2006, AM J EPIDEMIOL, V163, P849, DOI 10.1093/aje/kwj116; Zhang FY, 2011, INT J ENV RES PUB HE, V8, P2109, DOI 10.3390/ijerph8062109; Zhao QG, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-2; [No title captured]; [No title captured]; [No title captured]	34	43	45	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76759	10.1371/journal.pone.0076759	http://dx.doi.org/10.1371/journal.pone.0076759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204670	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300051
J	Pussila, M; Sarantaus, L; Bebek, DD; Valo, S; Reyhani, N; Ollila, S; Paivarinta, E; Peltomaki, P; Mutanen, M; Nystrom, M				Pussila, Marjaana; Sarantaus, Laura; Bebek, Denis Dermadi; Valo, Satu; Reyhani, Nima; Ollila, Saara; Paivarinta, Essi; Peltomaki, Paivi; Mutanen, Marja; Nystrom, Minna			Cancer-Predicting Gene Expression Changes in Colonic Mucosa of Western Diet Fed Mlh1(+/-) Mice	PLOS ONE			English	Article							ANTAGONIST DICKKOPF-1 GENE; DNA METHYLATION; EPIGENETIC INACTIVATION; MOLECULAR-GENETICS; BETA-CATENIN/TCF; VITAMIN-D; HYPERMETHYLATION; TUMORIGENESIS; MICROARRAY; NUTRITION	Colorectal cancer (CRC) is the second most common cause of cancer-related deaths in the Western world and interactions between genetic and environmental factors, including diet, are suggested to play a critical role in its etiology. We conducted a long-term feeding experiment in the mouse to address gene expression and methylation changes arising in histologically normal colonic mucosa as putative cancer-predisposing events available for early detection. The expression of 94 growth-regulatory genes previously linked to human CRC was studied at two time points (5 weeks and 12 months of age) in the heterozygote Mlh1(+/-) mice, an animal model for human Lynch syndrome (LS), and wild type Mlh1(+/+) littermates, fed by either Western-style (WD) or AIN-93G control diet. In mice fed with WD, proximal colon mucosa, the predominant site of cancer formation in LS, exhibited a significant expression decrease in tumor suppressor genes, Dkk1, Hoxd1, Slc5a8, and Socs1, the latter two only in the Mlh1(+/-) mice. Reduced mRNA expression was accompanied by increased promoter methylation of the respective genes. The strongest expression decrease (7.3 fold) together with a significant increase in its promoter methylation was seen in Dkk1, an antagonist of the canonical Wnt signaling pathway. Furthermore, the inactivation of Dkk1 seems to predispose to neoplasias in the proximal colon. This and the fact that Mlh1 which showed only modest methylation was still expressed in both Mlh1(+/-) and Mlh1(+/+) mice indicate that the expression decreases and the inactivation of Dkk1 in particular is a prominent early marker for colon oncogenesis.	[Pussila, Marjaana; Sarantaus, Laura; Bebek, Denis Dermadi; Valo, Satu; Ollila, Saara; Nystrom, Minna] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Reyhani, Nima] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland; [Ollila, Saara] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Paivarinta, Essi; Mutanen, Marja] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Peltomaki, Paivi] Univ Helsinki, Dept Med Genet, Helsinki, Finland	University of Helsinki; Aalto University; University of Helsinki; University of Helsinki; University of Helsinki	Nystrom, M (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	minna.nystrom@helsinki.fi	Ollila, Saara/A-4336-2014	Ollila, Saara/0000-0002-8190-257X; Peltomaki, Paivi/0000-0001-8819-2980; Nystrom, Minna/0000-0003-0827-0243; Dermadi Bebek, Denis/0000-0001-6268-4178; Pussila, Marjaana/0000-0002-5494-0685; Paivarinta, Essi/0000-0002-0242-9682	European Research Council [2008-AdG-232635]; Sigrid Juselius Foundation; Finnish Cancer Organizations; Academy of Finland; Biocentrum Helsinki	European Research Council(European Research Council (ERC)European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Academy of Finland(Academy of Finland); Biocentrum Helsinki	This work was financially supported by the grants from European Research Council (2008-AdG-232635), The Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation), Finnish Cancer Organizations (http://www.cancer.fi/en/), The Academy of Finland (http://www.aka.fi/eng), and Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Ahuja N, 1998, CANCER RES, V58, P5489; Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Edelmann W, 1999, CANCER RES, V59, P1301; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Erdelyi I, 2009, J NUTR, V139, P2072, DOI 10.3945/jn.108.104125; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hitchler MJ, 2009, FREE RADICAL BIO MED, V47, P115, DOI 10.1016/j.freeradbiomed.2009.04.010; Issa JPJ, 2001, CANCER RES, V61, P3573; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Janssens S, 2010, INT J DEV BIOL, V54, P1435, DOI 10.1387/ijdb.092985sj; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Maehata T, 2008, WORLD J GASTROENTERO, V14, P2702, DOI 10.3748/wjg.14.2702; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871; Oyama T, 2008, CARCINOGENESIS, V29, P666, DOI 10.1093/carcin/bgn001; Pendas-Franco N, 2008, ANTICANCER RES, V28, P2613; Rawson JB, 2012, NUTR CANCER, V64, P919, DOI 10.1080/01635581.2012.711418; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Shiraishi M, 2002, ONCOGENE, V21, P3659, DOI 10.1038/sj.onc.1205453; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tammariello AE, 2010, J NUTR BIOCHEM, V21, P77, DOI 10.1016/j.jnutbio.2009.09.014; Taniguchi K, 2006, ONCOLOGY-BASEL, V71, P124, DOI 10.1159/000100522; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma M, 2012, ANTIOXID REDOX SIGN, V17, P355, DOI 10.1089/ars.2011.4388; Worthley DL, 2010, ONCOGENE, V29, P1653, DOI 10.1038/onc.2009.449; Yang K, 2005, J NUTR, V135, P2710, DOI 10.1093/jn/135.11.2710; Yang K, 2008, CANCER RES, V68, P7803, DOI 10.1158/0008-5472.CAN-08-1209	49	6	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2013	8	10							e76865	10.1371/journal.pone.0076865	http://dx.doi.org/10.1371/journal.pone.0076865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	233FK	24204690	Green Published, Green Submitted, gold			2022-12-25	WOS:000325552200080
J	Cole, DK; Miles, KM; Madura, F; Holland, CJ; Schauenburg, AJA; Godkin, AJ; Bulek, AM; Fuller, A; Akpovwa, HJE; Pymm, PG; Liddy, N; Sami, M; Li, Y; Rizkallah, PJ; Jakobsen, BK; Sewell, AK				Cole, David K.; Miles, Kim M.; Madura, Florian; Holland, Christopher J.; Schauenburg, Andrea J. A.; Godkin, Andrew J.; Bulek, Anna M.; Fuller, Anna; Akpovwa, Hephzibah J. E.; Pymm, Phillip G.; Liddy, Nathaniel; Sami, Malkit; Li, Yi; Rizkallah, Pierre J.; Jakobsen, Bent K.; Sewell, Andrew K.			T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COGNATE PEPTIDE-MHC; CROSS-REACTIVITY; CLASS-I; ANTIGEN RECOGNITION; DIRECTED EVOLUTION; CRYSTAL-STRUCTURES; DISTINCT KINETICS; PHAGE DISPLAY; STOP SIGNAL; AMINO-ACIDS	alpha beta T-cell receptors (TCRs) engage antigens using complementarity-determining region (CDR) loops that are either germ line-encoded (CDR1 and CDR2) or somatically rearranged (CDR3). TCR ligands compose a presentation platform (major histocompatibility complex (MHC)) and a variable antigenic component consisting of a short "foreign" peptide. The sequence of events when the TCR engages its peptide-MHC (pMHC) ligand remains unclear. Some studies suggest that the germ line elements of the TCR engage the MHC prior to peptide scanning, but this order of binding is difficult to reconcile with some TCR-pMHC structures. Here, we used TCRs that exhibited enhanced pMHC binding as a result of mutations in either CDR2 and/or CDR3 loops, that bound to the MHC or peptide, respectively, to dissect the roles of these loops in stabilizing TCR-pMHC interactions. Our data show that TCR-peptide interactions play a strongly dominant energetic role providing a binding mode that is both temporally and energetically complementary with a system requiring positive selection by self-pMHC in the thymus and rapid recognition of non-self-pMHC in the periphery.	[Cole, David K.; Miles, Kim M.; Madura, Florian; Holland, Christopher J.; Schauenburg, Andrea J. A.; Godkin, Andrew J.; Bulek, Anna M.; Fuller, Anna; Akpovwa, Hephzibah J. E.; Pymm, Phillip G.; Rizkallah, Pierre J.; Sewell, Andrew K.] Cardiff Univ Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Pymm, Phillip G.] Univ Oxford, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford 0X3 9DS, England; [Liddy, Nathaniel; Sami, Malkit; Li, Yi; Jakobsen, Bent K.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England	Cardiff University; University of Oxford	Cole, DK (corresponding author), Cardiff Univ Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk; sewellak@cf.ac.uk	Sewell, Andrew/GPT-4220-2022; Rizkallah, Pierre J/A-5367-2012	Sewell, Andrew/0000-0003-3194-3135; Rizkallah, Pierre J/0000-0002-9290-0369; Pymm, Phillip/0000-0003-2722-4621; Fuller, Anna/0000-0002-8655-6741; Godkin, Andrew/0000-0002-1910-7567; Cole, David/0000-0003-0028-9396	Royal Society Grant [RG080077]; Wellcome Trust Program Grant [WT086716MA]; Biotechnology and Biological Sciences Research Council Grant [BB/H001085/1]; Tenovus Ph.D. studentship;  [WT095767]; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; BBSRC [BB/H001085/1] Funding Source: UKRI	Royal Society Grant(Royal Society of London); Wellcome Trust Program Grant(Wellcome Trust); Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Ph.D. studentship; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Tenovus Cancer Care; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Royal Society Grant RG080077, Wellcome Trust Program Grant WT086716MA, and Biotechnology and Biological Sciences Research Council Grant BB/H001085/1.; Wellcome Trust Research Career Development Fellow supported by Grant WT095767.; Supported by a Tenovus Ph.D. studentship.	Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Archbold JK, 2006, J BIOL CHEM, V281, P34324, DOI 10.1074/jbc.M606755200; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00168; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cole DK, 2006, EUR J IMMUNOL, V36, P170, DOI 10.1002/eji.200535424; Colf LA, 2007, CELL, V129, P135, DOI 10.1016/j.cell.2007.01.048; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Dustin ML, 1997, P NATL ACAD SCI USA, V94, P3909, DOI 10.1073/pnas.94.8.3909; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia K C, 1999, Rev Immunogenet, V1, P75; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Gras S, 2010, J EXP MED, V207, P1555, DOI 10.1084/jem.20100603; Holland CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00629; Holland SJ, 2012, P NATL ACAD SCI USA, V109, pE3111, DOI 10.1073/pnas.1210882109; Housset D, 2003, TRENDS IMMUNOL, V24, P429, DOI 10.1016/S1471-4906(03)00180-7; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Laugel B, 2005, J BIOL CHEM, V280, P1882, DOI 10.1074/jbc.M409427200; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Madura F, 2013, J BIOL CHEM, V288, P18766, DOI 10.1074/jbc.M113.464560; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Persaud SP, 2010, MOL IMMUNOL, V47, P1793, DOI 10.1016/j.molimm.2010.02.013; Piepenbrink KH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2948; Purbhoo MA, 2007, MOL CANCER THER, V6, P2081, DOI 10.1158/1535-7163.MCT-07-0092; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	64	44	50	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					628	638		10.1074/jbc.M113.522110	http://dx.doi.org/10.1074/jbc.M113.522110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24196962	hybrid, Green Published			2022-12-25	WOS:000330541200004
J	Oliveira, IA; Goncalves, AS; Neves, JL; von Itzstein, M; Todeschini, AR				Oliveira, Isadora A.; Goncalves, Arlan S.; Neves, Jorge L.; von Itzstein, Mark; Todeschini, Adriane R.			Evidence of Ternary Complex Formation in Trypanosoma cruzi trans-Sialidase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Glycoconjugate; Enzyme Mechanisms; Enzyme Structure; Glycosidases; Molecular Dynamics; Sialic Acid; Nuclear Magnetic Resonance; Sialidase; Trypanosoma cruzi; trans-Sialidase	MOLECULAR-DYNAMICS SIMULATIONS; PING-PONG MECHANISM; SUBSTRATE-SPECIFICITY; RANGELI SIALIDASE; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; STRUCTURAL BASIS; INFLUENZA-VIRUS; ANIMAL LECTINS; FORCE-FIELD	Trypanosoma cruzi trans-sialidase (TcTS) is a key target protein for Chagas disease chemotherapy. In this study, we investigated the implications of active site flexibility on the biochemical mechanism of TcTS. Molecular dynamics studies revealed remarkable plasticity in the TcTS catalytic site, demonstrating, for the first time, how donor substrate engagement with the enzyme induces an acceptor binding site in the catalytic pocket that was not previously captured in crystal structures. Furthermore, NMR data showed cooperative binding between donor and acceptor substrates, supporting theoretical results. In summary, our data put forward a coherent dynamic framework to understand how a glycosidase evolved its highly efficient trans-glycosidase activity.	[Oliveira, Isadora A.; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil; [Goncalves, Arlan S.] Inst Fed Espirito Santo, BR-29106010 Vila Velha, ES, Brazil; [Neves, Jorge L.] Univ Fed Pernambuco, Dept Quim Fundamental, BR-50740560 Recife, PE, Brazil; [von Itzstein, Mark] Griffith Univ, Inst Glyc, Gold Coast, Qld 4222, Australia	Universidade Federal do Rio de Janeiro; Instituto Federal do Espirito Santo (IFES); Universidade Federal de Pernambuco; Griffith University	Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, Av Carlos Chagas Filho,373,Bloco D,Sala 3,Cidade, BR-21941902 Rio De Janeiro, RJ, Brazil.	adrianet@biof.ufrj.br	da Silva Goncalves, Arlan/J-4952-2017; von Itzstein, Mark/E-4823-2010; NEVES, JORGE LUIZ/AAK-7723-2021; Todeschini, Adriane/AAG-8128-2020; Neves, Jorge Luiz JL/F-8393-2010; Todeschini, Adriane Regina/ABC-9165-2020	Neves, Jorge Luiz JL/0000-0003-3853-4529; Todeschini, Adriane Regina/0000-0002-6049-2751; Oliveira, Isadora/0000-0003-0269-1450	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Instituto Nacional de Ciencia e Tecnologia de Vacinas	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Vacinas	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and Instituto Nacional de Ciencia e Tecnologia de Vacinas.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Blume A, 2007, CARBOHYD RES, V342, P1904, DOI 10.1016/j.carres.2007.05.037; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Buchini S, 2008, ANGEW CHEM INT EDIT, V47, P2700, DOI 10.1002/anie.200705435; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Buschiazzo A, 2002, MOL CELL, V10, P757, DOI 10.1016/S1097-2765(02)00680-9; Carvalho ST, 2010, GLYCOBIOLOGY, V20, P1034, DOI 10.1093/glycob/cwq065; Chappuis F, 2010, J CLIN MICROBIOL, V48, P2948, DOI 10.1128/JCM.00774-10; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Clayton J, 2010, NATURE, V465, pS12, DOI 10.1038/nature09224; Clayton J, 2010, NATURE, V465, pS4, DOI 10.1038/nature09220; CREMONA ML, 1995, GENE, V160, P123, DOI 10.1016/0378-1119(95)00175-6; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; Damager I, 2008, BIOCHEMISTRY-US, V47, P3507, DOI 10.1021/bi7024832; Damm W, 1997, J COMPUT CHEM, V18, P1955, DOI 10.1002/(SICI)1096-987X(199712)18:16<1955::AID-JCC1>3.0.CO;2-L; Demir O, 2009, BIOCHEMISTRY-US, V48, P3398, DOI 10.1021/bi802230y; Dias WB, 2008, CELL MICROBIOL, V10, P88, DOI 10.1111/j.1462-5822.2007.01017.x; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; Freire-De-Lima L, 2010, J BIOL CHEM, V285, P13388, DOI 10.1074/jbc.M109.096305; Goncalves AD, 2011, J BRAZIL CHEM SOC, V22, P155, DOI 10.1590/S0103-50532011000100021; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haselhorst T, 2004, GLYCOBIOLOGY, V14, P895, DOI 10.1093/glycob/cwh108; Hassinen T, 2001, J COMPUT CHEM, V22, P1229, DOI 10.1002/jcc.1080; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; IOBST ST, 1994, J BIOL CHEM, V269, P15512; Jones C, 2004, BIOCHEMISTRY-US, V43, P11889, DOI 10.1021/bi048942u; Kawashima M, 2011, INT J RADIAT ONCOL, V79, P1479, DOI 10.1016/j.ijrobp.2009.12.048; Kirmizialtin S, 2012, STRUCTURE, V20, P618, DOI 10.1016/j.str.2012.02.018; Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu S, 2009, BIOCHEMISTRY-US, V48, P11211, DOI 10.1021/bi9015154; Mendonca-Previato L, 2008, CURR ORG CHEM, V12, P926, DOI 10.2174/138527208784892187; Mitchell FL, 2013, BIOCHEMISTRY-US, V52, P3740, DOI 10.1021/bi301112p; Mitchell FL, 2010, BIOPHYS J, V98, pL38, DOI 10.1016/j.bpj.2010.01.006; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; Nesmelova IV, 2010, J MOL BIOL, V397, P1209, DOI 10.1016/j.jmb.2010.02.033; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Oppezzo P, 2011, BBA-PROTEINS PROTEOM, V1814, P1154, DOI 10.1016/j.bbapap.2011.04.012; Paris G, 2001, GLYCOBIOLOGY, V11, P305, DOI 10.1093/glycob/11.4.305; Pi NA, 2004, PROTEIN SCI, V13, P903, DOI 10.1110/ps.03581904; Pierdominici-Sottile G, 2011, BIOCHEMISTRY-US, V50, P836, DOI 10.1021/bi101648z; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; Ribeirao M, 1997, GLYCOBIOLOGY, V7, P1237, DOI 10.1093/glycob/7.8.1237; Ribeiro AAST, 2008, J BRAZIL CHEM SOC, V19, P1433, DOI 10.1590/S0103-50532008000700031; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Rizzo RC, 1999, J AM CHEM SOC, V121, P4827, DOI 10.1021/ja984106u; Rocha GB, 2006, J COMPUT CHEM, V27, P1101, DOI 10.1002/jcc.20425; Rogers MS, 2007, BIOCHEMISTRY-US, V46, P4606, DOI 10.1021/bi062139d; SCUDDER P, 1993, J BIOL CHEM, V268, P9886; Segel I. H., 1993, ENZYME KINETICS BEHA, p[273, 626, 660]; Smrcka AV, 2009, J PHYSIOL SCI, V59, P56; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Sujatha MS, 2005, BIOCHEMISTRY-US, V44, P8554, DOI 10.1021/bi050298b; Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200; Todeschini AR, 2002, GLYCOBIOLOGY, V12, P668; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; VANDEKERCKHOVE F, 1992, GLYCOBIOLOGY, V2, P541, DOI 10.1093/glycob/2.6.541; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Wilson JC, 1999, ORG LETT, V1, P443, DOI 10.1021/ol990652w; Winger M, 2012, J AM CHEM SOC, V134, P18447, DOI 10.1021/ja3084658; WITHERS SG, 1987, J AM CHEM SOC, V109, P7530, DOI 10.1021/ja00258a047; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	72	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					423	436		10.1074/jbc.M112.399303	http://dx.doi.org/10.1074/jbc.M112.399303			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24194520	hybrid, Green Published			2022-12-25	WOS:000329370900037
J	El Khatib, M; Bozko, P; Palagani, V; Malek, NP; Wilkens, L; Plentz, RR				El Khatib, Mona; Bozko, Przemyslaw; Palagani, Vindhya; Malek, Nisar P.; Wilkens, Ludwig; Plentz, Ruben R.			Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In Vivo (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							EPITHELIAL-MESENCHYMAL TRANSITION; EXTRAHEPATIC CHOLANGIOCARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; MUTATIONS; GALLBLADDER; EXPRESSION; LIVER; PROLIFERATION; CHEMOTHERAPY; CARCINOMA	Cholangiocacinoma (CC) is a cancer disease with rising incidence. Notch signaling has been shown to be deregulated in many cancers. However, the role of this signaling pathway in the carcinogenesis of CC is still not fully explored. In this study, we investigated the effects of Notch inhibition by gamma-secretase inhibitor IX (GSI IX) in cultured human CC cell lines and we established a transgenic mouse model with liver specific expression of the intracellular domain of Notch (Notch-ICD) and inactivation of tumor suppressor p53. GSI IX treatment effectively impaired cell proliferation, migration, invasion, epithelial to mesenchymal transition and growth of softagar colonies. In vivo overexpression of Notch-ICD together with an inactivation of p53 significantly increased tumor burden and showed CC characteristics. Conclusion: Our study highlights the importance of Notch signaling in the tumorigenesis of CC and demonstrates that additional inactivation of p53 in vivo.	[El Khatib, Mona; Bozko, Przemyslaw; Palagani, Vindhya; Malek, Nisar P.; Plentz, Ruben R.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Wilkens, Ludwig] Krankenhaus Nordstadt, Inst Pathol, Hannover, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Plentz, RR (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	Ruben.Plentz@med.uni-tuebingen.de	Udhane, Vindhya/Z-5947-2019		German Research Foundation [PL 468/4-1]	German Research Foundation(German Research Foundation (DFG))	Funding was provided by German Research Foundation (PL 468/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CARRIAGA MT, 1995, CANCER-AM CANCER SOC, V75, P171, DOI 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; Deshpande V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-60; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; FALKSON G, 1984, CANCER, V54, P965, DOI 10.1002/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Furubo S, 1999, HISTOPATHOLOGY, V35, P230; Gatto M, 2010, WORLD J GASTRO ONCOL, V2, P136, DOI 10.4251/wjgo.v2.i3.136; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Khan SA, 2005, LIVER INT, V25, P704, DOI 10.1111/j.1478-3231.2005.01106.x; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Kiesslich T, 2009, PHOTOCH PHOTOBIO SCI, V8, P23, DOI 10.1039/b813183j; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Lee QW, 2006, AM J CLIN ONCOL-CANC, V29, P127, DOI 10.1097/01.coc.0000203742.22828.bb; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Ryan MJ, 2008, HEPATOLOGY, V48, P1989, DOI 10.1002/hep.22538; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Tannapfel A, 2000, DIGEST DIS SCI, V45, P317, DOI 10.1023/A:1005412626515; Tannapfel A, 2000, GUT, V47, P721, DOI 10.1136/gut.47.5.721; Tannapfel A, 2003, GUT, V52, P706, DOI 10.1136/gut.52.5.706; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thongprasert S, 2005, ANN ONCOL, V16, P279, DOI 10.1093/annonc/mdi046; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; von Hahn T, 2011, SCAND J GASTROENTERO, V46, P1092, DOI 10.3109/00365521.2011.589472; Welzel TM, 2006, J NATL CANCER I, V98, P873, DOI 10.1093/jnci/djj234; Yoon HA, 2011, WORLD J GASTROENTERO, V17, P4023, DOI 10.3748/wjg.v17.i35.4023; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zhou Q, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-244; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	41	46	47	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77433	10.1371/journal.pone.0077433	http://dx.doi.org/10.1371/journal.pone.0077433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204826	gold, Green Published			2022-12-25	WOS:000326334500028
J	Ni, J; Reinhardt, JD; Zhang, X; Xiao, MY; Li, L; Jin, H; Zeng, XM; Li, JA				Ni, Jun; Reinhardt, Jan D.; Zhang, Xia; Xiao, Mingyue; Li, Ling; Jin, Hong; Zeng, Xianmin; Li, Jianan			Dysfunction and Post-Traumatic Stress Disorder in Fracture Victims 50 Months after the Sichuan Earthquake	PLOS ONE			English	Article							SPINAL-CORD-INJURY; QUALITY-OF-LIFE; MENTAL-HEALTH; PHYSICAL REHABILITATION; FUNCTIONAL OUTCOMES; ADULT SURVIVORS; FOLLOW-UP; EXERCISE; DISASTER; COMMUNITY	Background: This study aimed to evaluate the effectiveness of a rehabilitation intervention on physical dysfunction (PDF) and post-traumatic stress disorder (PTSD) in fracture victims 50 months after the Sichuan earthquake of 2008 and to identify risk factors for PTSD. Methods: This is a retrospective cohort study. Four hundred and fifty-nine earthquake-related fracture victims from Mianzhu city, Sichuan Province who did not qualify for disability pension participated. Two hundred and forty-five subjects received regular rehabilitation and 214 did not. Muscle strength, joint range of motion (ROM), sensory function, and sit-to-stand balance capacity were evaluated to assess PDF. The PTSD Checklist-Civilian Version (PCL-C) was administered to screen for PTSD. An ordinary least square regression was used to predict PTSD, and a logistic regression was used to predict PDF. In addition a Least Angle Regression (LARS) was carried out for PTSD to study the effects of rehabilitation and PDF at the same time. Results: Unadjusted and adjusted group differences in physical dysfunction (p<0.01) and PTSD prevalence (p<0.05) were significant in favor of the rehabilitation group. In addition, being female, average or above family income, having witnessed death and fearfulness were found risk factors for PTSD symptoms 50 months after the earthquake. Both PDF and rehabilitation were selected predictors by LARS demonstrating opposite effects. Conclusion: PDF and PTSD were significantly reduced by the rehabilitation intervention. Future medical intervention strategies should consider rehabilitation in order to assist survivors in dealing with both physical and psychological effects of natural disaster.	[Ni, Jun; Zhang, Xia; Xiao, Mingyue; Li, Ling; Li, Jianan] Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China; [Ni, Jun] Nantong Univ, Affiliated Hosp 1, Dept Rehabil Med, Nantong, Peoples R China; [Ni, Jun; Zhang, Xia; Xiao, Mingyue; Li, Ling] Caring Children Fdn, Hong Kong, Hong Kong, Peoples R China; [Reinhardt, Jan D.] Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu 610064, Peoples R China; [Reinhardt, Jan D.] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China; [Reinhardt, Jan D.; Zhang, Xia; Li, Jianan] Int Soc Phys & Rehabil Med, Comm Rehabil Disaster Relief, Geneva, Switzerland; [Reinhardt, Jan D.] Swiss Parapleg Res, Dept Human Functioning Sci, Nottwil, Switzerland; [Reinhardt, Jan D.] Univ Lucerne, Dept Hlth Sci & Hlth Policy, Luzern, Switzerland	Nanjing Medical University; Nantong University; Sichuan University; Hong Kong Polytechnic University; Swiss Paraplegic Research; University of Lucerne	Li, JA (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Rehabil Med, Nanjing, Jiangsu, Peoples R China.	lijianan@carm.org.cn			Hong Kong Caring for Children Foundation; Handicap International	Hong Kong Caring for Children Foundation; Handicap International	The study was supported by the Hong Kong Caring for Children Foundation and Handicap International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH J, 2005, PSYCHOSOC MED, V2; Blanchard EB, 1997, J TRAUMA STRESS, V10, P215, DOI 10.1023/A:1024826028483; Castillo RC, 2008, ARCH PHYS MED REHAB, V89, P1873, DOI 10.1016/j.apmr.2008.01.032; *CHIN SCIOO, 2008, UPD STAT REP WENCH E; Chou YJ, 2003, INT J EPIDEMIOL, V32, P1007, DOI 10.1093/ije/dyg296; Conybeare D, 2012, J CLIN PSYCHOL, V68, P699, DOI 10.1002/jclp.21845; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Gosney J, 2011, J REHABIL MED, V43, P965, DOI 10.2340/16501977-0890; Grubaugh AL, 2007, DEPRESS ANXIETY, V24, P124, DOI 10.1002/da.20226; Hu XR, 2012, J REHABIL MED, V44, P200, DOI 10.2340/16501977-0944; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Jia ZB, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-172; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Kun P, 2009, DEPRESS ANXIETY, V26, P1134, DOI 10.1002/da.20612; Li YQ, 2012, J REHABIL MED, V44, P534, DOI 10.2340/16501977-1005; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Pandya A, 2013, CAN J PSYCHIAT, V58, P128, DOI 10.1177/070674371305800302; Phillips MR, 2013, LANCET, V381, P1964, DOI 10.1016/S0140-6736(13)61177-0; PRICE M, 2013, J TELEMED TELECARE; Rosenbaum S, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-115; Salcioglu E, 2007, DISASTERS, V31, P115, DOI 10.1111/j.1467-7717.2007.01000.x; Samuelkamaleshkumar S, 2010, ARCH PHYS MED REHAB, V91, P1117, DOI 10.1016/j.apmr.2010.04.005; Schulz KH, 2012, BUNDESGESUNDHEITSBLA, V55, P55, DOI 10.1007/s00103-011-1387-x; Stratta P, 2012, ANN I SUPER SANITA, V48, P132, DOI 10.4415/ANN_12_02_05; Tordeurs D, 2011, ENCEPHALE, V37, P345, DOI 10.1016/j.encep.2011.02.003; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Xiao MY, 2011, J REHABIL MED, V43, P515, DOI 10.2340/16501977-0813; You CM, 2009, J PUBLIC HEALTH POL, V30, P379, DOI 10.1057/jphp.2009.30; Yzermans CJ, 2005, INT J EPIDEMIOL, V34, P820, DOI 10.1093/ije/dyi096; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053995; Zhang X, 2012, J REHABIL MED, V44, P206, DOI 10.2340/16501977-0945	35	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77535	10.1371/journal.pone.0077535	http://dx.doi.org/10.1371/journal.pone.0077535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	242VF	24204861	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700036
J	Offen, N; Kang, H; Meyer, A; Begemann, G				Offen, Nils; Kang, Hyoun; Meyer, Axel; Begemann, Gerrit			Retinoic Acid Is Involved in the Metamorphosis of the Anal Fin into an Intromittent Organ, the Gonopodium, in the Green Swordtail (Xiphophorus hellerii)	PLOS ONE			English	Article							GAMBUSIA-AFFINIS AFFINIS; SEXUALLY SELECTED TRAIT; PHYLOGENETIC ANALYSIS; MITOCHONDRIAL-DNA; LIMB DEVELOPMENT; SONIC-HEDGEHOG; CAUDAL FIN; ZEBRAFISH; GENES; EXPRESSION	In poeciliid fish the male anal fin has been transformed into a gonopodium, an intromittent organ required for internal fertilization. Elevated testosterone levels induce metamorphosis of a subset of anal fin rays to grow and form the specialized terminal structures of the gonopodium. The molecular mechanisms underlying these processes are largely unknown. Here, we investigated whether retinoic acid (RA) signaling is involved in gonopodium development in the swordtail Xiphophorus hellerii. We showed that aldh1a2, a RA synthesizing enzyme, and the RA receptors, rar-ga and rar-gb, are expressed in anal fins during metamorphosis. aldh1a2 expression is regulated by testosterone in a concentration-dependent manner and is up-regulated in both hormone-induced and naturally developing gonopodia. Androgen receptor (ar), a putative regulator of gonopodial development, is co-expressed with aldh1a2 and the RA receptors in gonopodial rays. Importantly, experimental increase of RA signaling promoted growth of the gonopodium and increased the number of new segments. Based on gene expression analyses and pharmacological manipulation of gonopodium development, we show that the RA signaling pathway is activated in response to androgen signaling and promotes fin ray growth and development during the metamorphosis of the anal fin into the gonopodium.	[Offen, Nils; Kang, Hyoun; Meyer, Axel; Begemann, Gerrit] Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Constance, Germany; [Offen, Nils] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, Dept Lab Med, Lund, Sweden; [Kang, Hyoun; Meyer, Axel] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Begemann, Gerrit] Univ Bayreuth, Bayreuth, Germany	University of Konstanz; Lund University; University of Konstanz; University of Bayreuth	Begemann, G (corresponding author), Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Constance, Germany.	gerrit.begemann@uni-bayreuth.de	Begemann, Gerrit/C-6223-2011; Meyer, Axel/C-9826-2009	Begemann, Gerrit/0000-0001-7822-7617; Meyer, Axel/0000-0002-0888-8193	Konstanz Research School Chemical Biology (KoRS-CB); University of Konstanz; Landesgraduiertenforrderung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft; German Research Foundation (DFG); University of Bayreuth	Konstanz Research School Chemical Biology (KoRS-CB); University of Konstanz; Landesgraduiertenforrderung Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	Support for this study came from the Konstanz Research School Chemical Biology (KoRS-CB) (JK, AM), the University of Konstanz (AM), Landesgraduiertenforrderung Baden-Wurttemberg (NO) and Deutsche Forschungsgemeinschaft (GB, AM). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKIMENKO MA, 1995, DEV BIOL, V170, P243, DOI 10.1006/dbio.1995.1211; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Begemann G, 2001, DEVELOPMENT, V128, P3081; Blum N, 2012, DEVELOPMENT, V139, P107, DOI 10.1242/dev.065391; Campo-Paysaa F, 2008, GENESIS, V46, P640, DOI 10.1002/dvg.20444; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Cohn MJ, 2011, DEV DYNAM, V240, P1108, DOI 10.1002/dvdy.22631; Duester Gregg, 2007, Birth Defects Research, V81, P84, DOI 10.1002/bdrc.20092; Dzwillo M., 1964, KOSSWIG FESTSCHRIFT, V8, P15; DZWILLO M, 1962, VERH DTSCH ZOOL GESE, P151; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GERAUDIE J, 1995, INT J DEV BIOL, V39, P373; GERAUDIE J, 1993, PROG CLIN BIOL RES, V383, P803; Ghedotti MJ, 2000, ZOOL J LINN SOC-LOND, V130, P1, DOI 10.1006/zjls.1999.0213; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Gordon M., 1951, B AM MUS NAT HIST, V95, P413; Grandel H, 2002, DEVELOPMENT, V129, P2851; Grandel H, 2011, DEV DYNAM, V240, P1116, DOI 10.1002/dvdy.22461; GROBSTEIN C, 1948, J EXP ZOOL, V109, P215, DOI 10.1002/jez.1401090205; GROBSTEIN C, 1947, ANAT REC, V99, P569; Grobstein C, 1942, J EXP ZOOL, V89, P305, DOI 10.1002/jez.1400890208; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hayashi Hitomi, 2007, Journal of Toxicological Sciences, V32, P91, DOI 10.2131/jts.32.91; Herfeld S, 1998, HORM BEHAV, V34, P303, DOI 10.1006/hbeh.1998.1486; Huang HFS, 1997, ENDOCRINOLOGY, V138, P553, DOI 10.1210/en.138.2.553; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Kang JH, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-25; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; Laforest L, 1998, DEVELOPMENT, V125, P4175; Langer W. F., 1913, Morphologisches Jahrbuch Leipzig, V47; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maden M, 2000, P NUTR SOC, V59, P65, DOI 10.1017/S0029665100000082; Maden M, 1996, DEV GENET, V19, P85; Mercader N, 2000, DEVELOPMENT, V127, P3961; Mercader N, 2005, DEVELOPMENT, V132, P4131, DOI 10.1242/dev.01976; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; MEYER A, 1993, P ROY SOC B-BIOL SCI, V254, P153, DOI 10.1098/rspb.1993.0140; Mic FA, 2004, J BIOL CHEM, V279, P26698, DOI 10.1074/jbc.M401920200; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; Offen N, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-98; Offen N, 2009, DEV DYNAM, V238, P1674, DOI 10.1002/dvdy.21983; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; PARENTI L.R., 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Pickford G.E., 1957, PHYSL PITUITARY GLAN; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; SANGSTER W, 1948, PHYSIOL ZOOL, V21, P134, DOI 10.1086/physzool.21.2.30151990; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Stange D, 2012, AQUAT TOXICOL, V106, P20, DOI 10.1016/j.aquatox.2011.10.010; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner CL, 1941, J MORPHOL, V69, P161, DOI 10.1002/jmor.1050690107; Turner CL, 1941, BIOL BULL-US, V80, P371, DOI 10.2307/1537723; TURNER CL, 1947, J EXP ZOOL, V106, P125, DOI 10.1002/jez.1401060202; TURNER CL, 1947, ANAT REC, V97, P375; WHITE JA, 1994, DEVELOPMENT, V120, P1861; WOURMS JP, 1981, AM ZOOL, V21, P473; Zauner H, 2003, EVOL DEV, V5, P466, DOI 10.1046/j.1525-142X.2003.03053.x	65	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77580	10.1371/journal.pone.0077580	http://dx.doi.org/10.1371/journal.pone.0077580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204880	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400045
J	Xiao, J; Gao, GJ; Li, YM; Zhang, W; Tian, YF; Huang, YX; Su, WJ; Han, N; Yang, D; Zhao, HX				Xiao, Jiang; Gao, Guiju; Li, Yanmei; Zhang, Wen; Tian, Yunfei; Huang, Yinxiu; Su, Wenjing; Han, Ning; Yang, Di; Zhao, Hongxin			Spectrums of Opportunistic Infections and Malignancies in HIV-Infected Patients in Tertiary Care Hospital, China	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; AIDS; INDIA; PNEUMONIA; DIAGNOSIS; PROGRAM; TRENDS	Background: HIV-related opportunistic infections (OIs) and malignancies continued to cause morbidity and mortality in Chinese HIV-infected individuals. The objective for this study is to elucidate the prevalence and spectrums of OIs and malignancies in HIV-infected patients in the Beijing Ditan Hospital. Methods: The evaluation of the prevalence and spectrums of OIs and malignancies was conducted by using the clinical data of 834 HIV-infected patients admitted in the Beijing Ditan hospital from January 1, 2009, to November 30, 2012. Results: The prevalence and spectrums of OIs and malignancies varied contingent on geographic region, transmission routes, and CD4 levels. We found that tuberculosis was most common OI and prevalence was 32.5%, followed by candidiasis(29.3%), Pneumocystis pneumonia(PCP)(22.4%), cytomegalovirus(CMV) infection(21.7%), other fungal infections(16.2%), mycobacterium avium complex(MAC)(11.3%), cryptococcosis(8.0%), progressive multifocal leukoencephalopathy(PML)(4.4%), Cerebral Toxoplasmosis(3.5%) and Penicillium marneffei infection(1.4%); while Lymphoma(2.9%), Kaposi's sarcoma(0.8%) and cervix carcinoma(0.3%) were emerged as common AIDS-defining malignancies. Pulmonary OI infections were the most prevalent morbidity and mortality in patients in the AIDS stage including pulmonary tuberculosis (26.6%) and PCP (22.4%). CMV infection(21.7%) was most common viral infection; Fungal OIs were one of most prevalent morbidity in patients in the AIDS stage, including oral candidiasis (29.3%), other fungal infection (16.2%), Cryptococcosis (8.0%) and Penicillium marneffei infection (1.4%). We found the low prevalence of AIDS-defining illnesses in central neural system in this study, including progressive multifocal leukoencephalopathy (4.4%), cerebral toxoplasmosis (3.5%), tuberculosis meningitis (3.2%), cryptococcal meningitis (2.4%) and CMV encephalitis (1.1%). In-hospital mortality rate was 4.3 per 100 person-years due to severe OIs, malignancies, and medical cost constraints. Conclusions: The prevalence and spectrums of OIs, malignancies and co-infections were discussed in this study. It would help increase the awareness for physicians to make a diagnosis and empirical treatment sooner and plan good management strategies, especially in resource limited regions.	[Xiao, Jiang; Gao, Guiju; Li, Yanmei; Zhang, Wen; Tian, Yunfei; Huang, Yinxiu; Su, Wenjing; Han, Ning; Yang, Di; Zhao, Hongxin] Capital Med Univ, Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University	Zhao, HX (corresponding author), Capital Med Univ, Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China.	13911022130@163.com			Twelve-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing [2012ZX10004-904]; Beijing Natural Science Fund [7112065]	Twelve-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing; Beijing Natural Science Fund(Beijing Natural Science Foundation)	Support for this work was provided by: (1) The Twelve-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing (2012ZX10004-904); (2) Beijing Natural Science Fund The evaluation of association between polymorphism of leptin or adiponectin and NAFLD complicated with AIDS(7112065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2012, J ACQ IMMUN DEF SYND; Armstrong AW, 2013, EPIDEMIOL INFECT, V141, P200, DOI 10.1017/S0950268812000325; Chaiwarith R, 2011, CURR HIV RES, V9, P334, DOI 10.2174/157016211797635991; Chaiwun B, 2011, INT J INFECT DIS, V15, pE236, DOI 10.1016/j.ijid.2010.12.001; Chakraborty N, 2008, JPN J INFECT DIS, V61, P49; Chou IH, 2004, NAT MED, V10, P4, DOI 10.1038/nm0104-4a; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Jabs DA, 2002, AM J OPHTHALMOL, V133, P48, DOI 10.1016/S0002-9394(01)01322-8; Jones JL, 1998, J INFECT DIS, V178, P114, DOI 10.1086/515593; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Mocroft A, 2000, LANCET, V356, P291, DOI 10.1016/S0140-6736(00)02504-6; Naba Mazen R, 2010, J Infect Public Health, V3, P130, DOI 10.1016/j.jiph.2010.07.005; Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2013, UID PREV TREATM OPP; Pisculli ML, 2008, CLIN INFECT DIS, V46, P1928, DOI 10.1086/588564; Saha K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-116; Sax PE, 2011, CLIN INFECT DIS, V53, P197, DOI 10.1093/cid/cir335; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; Srirangaraj S, 2011, INDIAN J MED MICROBI, V29, P395, DOI 10.4103/0255-0857.90175; UNAIDS/WHO Working Group on HIV Global/AIDS and STI Surveillance, 2012, CHIN EP RESP 2012 UP; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b	22	55	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e75915	10.1371/journal.pone.0075915	http://dx.doi.org/10.1371/journal.pone.0075915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204583	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400009
J	Field, KJ; George, R; Fearn, B; Quick, WP; Davey, MP				Field, Katie J.; George, Rachel; Fearn, Brian; Quick, W. Paul; Davey, Matthew P.			Best of Both Worlds: Simultaneous High-Light and Shade-Tolerance Adaptations within Individual Leaves of the Living Stone Lithops aucampiae	PLOS ONE			English	Article							CALCIUM-OXALATE CRYSTALS; LEAF WINDOWS; PHOTOPROTECTION; DIFFERENTIATION; ANTHOCYANINS; IDIOBLASTS; AIZOACEAE; RESPONSES; TISSUES; STRESS	"Living stones" (Lithops spp.) display some of the most extreme morphological and physiological adaptations in the plant kingdom to tolerate the xeric environments in which they grow. The physiological mechanisms that optimise the photosynthetic processes of Lithops spp. while minimising transpirational water loss in both above- and below-ground tissues remain unclear. Our experiments have shown unique simultaneous high-light and shade-tolerant adaptations within individual leaves of Lithops aucampiae. Leaf windows on the upper surfaces of the plant allow sunlight to penetrate to photosynthetic tissues within while sunlight-blocking flavonoid accumulation limits incoming solar radiation and aids screening of harmful UV radiation. Increased concentration of chlorophyll a and greater chlorophyll a:b in above- ground regions of leaves enable maximum photosynthetic use of incoming light, while inverted conical epidermal cells, increased chlorophyll b, and reduced chlorophyll a:b ensure maximum absorption and use of low light levels within the below-ground region of the leaf. High NPQ capacity affords physiological flexibility under variable natural light conditions. Our findings demonstrate unprecedented physiological flexibility in a xerophyte and further our understanding of plant responses and adaptations to extreme environments.	[Field, Katie J.; George, Rachel; Quick, W. Paul] Univ Sheffield, Western Bank, Sheffield, S Yorkshire, England; [Fearn, Brian] Abbey Brook Cactus Nursery, Matlock, Derbyshire, England; [Davey, Matthew P.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Sheffield; University of Cambridge	Davey, MP (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge, England.	mpd39@cam.ac.uk		Davey, Matthew/0000-0002-5220-4174; Field, Katie/0000-0002-5196-2360	Natural Environment Research Council [NE/C507837/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the Natural Environment Research Council - Post-Genomics and Proteomics programme (NE/C507837/1) who financed MPD and the chlorophyll fluorescence imager equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Cote GG, 2009, AM J BOT, V96, P1245, DOI 10.3732/ajb.0800276; Davey MP, 2008, NEW PHYTOL, V177, P380, DOI 10.1111/j.1469-8137.2007.02282.x; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Egbert KJ, 2002, PHOTOSYNTHETICA, V40, P35, DOI 10.1023/A:1020129820295; Ellis AG, 2006, J ECOL, V94, P322, DOI 10.1111/j.1365-2745.2005.01074.x; Fearn B., 1977, Cactus and Succulent Journal of Great Britain, V39, P68; FOSTER AS, 1956, PROTOPLASMA, V46, P184, DOI 10.1007/BF01248877; Gal A, 2012, ADV MATER, V24, pOP77, DOI 10.1002/adma.201104548; Gibson AC, 1998, BIOSCIENCE, V48, P911, DOI 10.2307/1313295; IHLENFELDT H-D, 1982, Mitteilungen aus dem Institut fuer Allgemeine Botanik Hamburg, V18, P103; Kellner A, 2011, PLANT BIOLOGY, V13, P368, DOI 10.1111/j.1438-8677.2010.00354.x; Kuo-Huang LL, 2007, BOT STUD, V48, P155; Martin CE, 2013, PLANT BIOLOGY, V15, P243, DOI 10.1111/j.1438-8677.2012.00672.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nesse W.D., 2000, INTRO MINERALOGY; Opel MR, 2005, HASELTONIA, P27; Raven P. H., 1999, BIOL PLANTS, V6th; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; TANNER V, 1986, J PLANT PHYSIOL, V125, P285, DOI 10.1016/S0176-1617(86)80151-1; Vogt T, 1999, PHYTOCHEMISTRY, V52, P583, DOI 10.1016/S0031-9422(99)00151-X; von Willert D.J., 1992, LIFE STRATEGIES SUCC; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Weryszko-Chmielewska Elzbieta, 2011, Acta Agrobotanica, V64, P11; Whitney HM, ANN BOT	25	9	9	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75671	10.1371/journal.pone.0075671	http://dx.doi.org/10.1371/journal.pone.0075671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194825	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000004
J	Valletti, A; Gigante, M; Palumbo, O; Carella, M; Divella, C; Sbisa, E; Tullo, A; Picardi, E; D'Erchia, AM; Battaglia, M; Gesualdo, L; Pesole, G; Ranieri, E				Valletti, Alessio; Gigante, Margherita; Palumbo, Orazio; Carella, Massimo; Divella, Chiara; Sbisa, Elisabetta; Tullo, Apollonia; Picardi, Ernesto; D'Erchia, Anna Maria; Battaglia, Michele; Gesualdo, Loreto; Pesole, Graziano; Ranieri, Elena			Genome-Wide Analysis of Differentially Expressed Genes and Splicing Isoforms in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; CANCER; HYPERMETHYLATION; TRANSCRIPT; BIOMARKERS; DATABASE; ASPICDB; TCF21; DAB2; EXON	Clear cell renal cell carcinoma (ccRCC) is the most common malignant renal epithelial tumor and also the most deadly. To identify molecular changes occurring in ccRCC, in the present study we performed a genome wide analysis of its entire complement of mRNAs. Gene and exon-level analyses were carried out by means of the Affymetrix Exon Array platform. To achieve a reliable detection of differentially expressed cassette exons we implemented a novel methodology that considered contiguous combinations of exon triplets and candidate differentially expressed cassette exons were identified when the expression level was significantly different only in the central exon of the triplet. More detailed analyses were performed for selected genes using quantitative RT-PCR and confocal laser scanning microscopy. Our analysis detected over 2,000 differentially expressed genes, and about 250 genes alternatively spliced and showed differential inclusion of specific cassette exons comparing tumor and non-tumoral tissues. We demonstrated the presence in ccRCC of an altered expression of the PTP4A3, LAMA4, KCNJ1 and TCF21 genes (at both transcript and protein level). Furthermore, we confirmed, at the mRNA level, the involvement of CAV2 and SFRP genes that have previously been identified. At exon level, among potential candidates we validated a differentially included cassette exon in DAB2 gene with a significant increase of DAB2 p96 splice variant as compared to the p67 isoform. Based on the results obtained, and their robustness according to both statistical analysis and literature surveys, we believe that a combination of gene/isoform expression signature may remarkably contribute, after suitable validation, to a more effective and reliable definition of molecular biomarkers for ccRCC early diagnosis, prognosis and prediction of therapeutic response.	[Valletti, Alessio; Picardi, Ernesto; D'Erchia, Anna Maria; Pesole, Graziano] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Gigante, Margherita; Ranieri, Elena] Univ Foggia, Dept Surg & Med Sci, Foggia, Italy; [Palumbo, Orazio; Carella, Massimo] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Divella, Chiara; Battaglia, Michele; Gesualdo, Loreto] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Bari, Italy; [Sbisa, Elisabetta; Tullo, Apollonia] CNR, Inst Biomed Technol UOS Bari, I-70126 Bari, Italy; [Picardi, Ernesto; D'Erchia, Anna Maria] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Foggia; IRCCS Casa Sollievo Della Sofferenza; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Universita degli Studi di Bari Aldo Moro	Pesole, G (corresponding author), CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.	g.pesole@ibbe.cnr.it	Pesole, Graziano/K-5283-2019; Sbisa', Elisabetta/AAW-9727-2020; Pesole, Graziano/E-9051-2014; Gesualdo, Loreto/K-7751-2016; Valletti, Alessio/P-1842-2018; Carella, Massimo/A-2804-2014; Tullo, Apollonia/AAX-1079-2020; Ranieri, Elena/AAD-8449-2019; PALUMBO, ORAZIO/C-1133-2014; Picardi, Ernesto/A-5863-2015; D'Erchia, Anna maria/K-9001-2016; Divella, Chiara/K-2783-2016	Pesole, Graziano/0000-0003-3663-0859; Gesualdo, Loreto/0000-0002-4861-0911; Valletti, Alessio/0000-0002-6772-1211; Carella, Massimo/0000-0002-6830-6829; Tullo, Apollonia/0000-0002-5081-4745; PALUMBO, ORAZIO/0000-0001-6583-3482; Picardi, Ernesto/0000-0002-6549-0114; Divella, Chiara/0000-0003-2717-3158; BATTAGLIA, Michele/0000-0002-2453-2349; D'ERCHIA, Anna Maria/0000-0002-4627-0626	MIUR [PON01_01297 - VIRTUALAB - RC]; Ministero dell'Istruzione, Universita e Ricerca, Italy; Consiglio Nazionale delle Ricerche, Italy; Apulia Region, Italy [PS_012]	MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Istruzione, Universita e Ricerca, Italy(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche, Italy(Consiglio Nazionale delle Ricerche (CNR)); Apulia Region, Italy(Regione Puglia)	This work was supported by MIUR (PON01_01297 - VIRTUALAB - R&C 2007-2013); PRIN projects 2009 and 2010 by Ministero dell'Istruzione, Universita e Ricerca, Italy; Progetto "Medicina Personalizzata" by Consiglio Nazionale delle Ricerche, Italy; Progetto Strategico PS_012 by Apulia Region, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000913; Allory Y, 2011, PATHOBIOLOGY, V78, P90, DOI 10.1159/000315543; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Arsanious A, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-20; Bonizzoni P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-244; Brannon AR, 2012, EUR UROL, V61, P258, DOI 10.1016/j.eururo.2011.10.007; Bratslavsky G, 2011, J CANCER, V2, P271, DOI 10.7150/jca.2.271; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Chidlow JH, 2010, CARDIOVASC RES, V86, P219, DOI 10.1093/cvr/cvq075; Costa VL, 2011, EPIGENETICS-US, V6, P1120, DOI 10.4161/epi.6.9.16376; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dubosq F, 2011, UROL ONCOL, V30, P833; Elsheikh SE, 2008, BRIT J CANCER, V99, P327, DOI 10.1038/sj.bjc.6604463; Epstein, 2004, PATHOLOGY GENETICS T, V7; Fisher R, 2013, SEMIN CANCER BIOL, V23, P38, DOI 10.1016/j.semcancer.2012.06.004; Gaidatzis D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp508; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hong SK, 2011, BJU INT, V107, P409, DOI 10.1111/j.1464-410X.2010.09561.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang XH, 2008, J CANCER RES CLIN, V134, P705, DOI 10.1007/s00432-007-0342-6; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kenne E, 2010, J LEUKOCYTE BIOL, V88, P523, DOI 10.1189/jlb.0110043; Kinoshita T, 2011, HEPATO-GASTROENTEROL, V58, P1051; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lugassy C, 2009, J CUTAN PATHOL, V36, P1237, DOI 10.1111/j.1600-0560.2009.01273.x; Martelli PL, 2011, NUCLEIC ACIDS RES, V39, pD80, DOI 10.1093/nar/gkq1073; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Marin AP, 2012, UROL ONCOL-SEMIN ORI, V30, P356, DOI 10.1016/j.urolonc.2009.11.008; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanjmyatav J, 2011, J UROLOGY, V186, P289, DOI 10.1016/j.juro.2011.03.033; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; Sobin L, 2009, TNM CLASSIFICATION M; Tang XR, 2010, J INNATE IMMUN, V2, P43, DOI 10.1159/000235685; Tong JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-253; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasudev NS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-112; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013; Zhao Q, 2013, CLIN CANCER RES, V19, P2460, DOI 10.1158/1078-0432.CCR-12-3708; Zimmerman MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058300	45	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78452	10.1371/journal.pone.0078452	http://dx.doi.org/10.1371/journal.pone.0078452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194935	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000114
J	Woitek, R; Kasprian, G; Lindner, C; Stuhr, F; Weber, M; Schopf, V; Brugger, PC; Asenbaum, U; Furtner, J; Bettelheim, D; Seidl, R; Prayer, D				Woitek, Ramona; Kasprian, Gregor; Lindner, Christian; Stuhr, Fritz; Weber, Michael; Schoepf, Veronika; Brugger, Peter C.; Asenbaum, Ulrika; Furtner, Julia; Bettelheim, Dieter; Seidl, Rainer; Prayer, Daniela			Fetal Eye Movements on Magnetic Resonance Imaging	PLOS ONE			English	Article							BEHAVIORAL STATES; SMOOTH-PURSUIT; MRI; MATURATION; SACCADES; FETUSES; INFANTS; SLEEP; TIME	Objectives: Eye movements are the physical expression of upper fetal brainstem function. Our aim was to identify and differentiate specific types of fetal eye movement patterns using dynamic MRI sequences. Their occurrence as well as the presence of conjugated eyeball motion and consistently parallel eyeball position was systematically analyzed. Methods: Dynamic SSFP sequences were acquired in 72 singleton fetuses (17-40 GW, three age groups [17-23 GW, 24-32 GW, 33-40 GW]). Fetal eye movements were evaluated according to a modified classification originally published by Birnholz (1981): Type 0: no eye movements; Type I: single transient deviations; Type Ia: fast deviation, slower reposition; Type Ib: fast deviation, fast reposition; Type II: single prolonged eye movements; Type III: complex sequences; and Type IV: nystagmoid. Results: In 95.8% of fetuses, the evaluation of eye movements was possible using MRI, with a mean acquisition time of 70 seconds. Due to head motion, 4.2% of the fetuses and 20.1% of all dynamic SSFP sequences were excluded. Eye movements were observed in 45 fetuses (65.2%). Significant differences between the age groups were found for Type I (p = 0.03), Type Ia (p = 0.031), and Type IV eye movements (p = 0.033). Consistently parallel bulbs were found in 27.3-45%. Conclusions: In human fetuses, different eye movement patterns can be identified and described by MRI in utero. In addition to the originally classified eye movement patterns, a novel subtype has been observed, which apparently characterizes an important step in fetal brainstem development. We evaluated, for the first time, eyeball position in fetuses. Ultimately, the assessment of fetal eye movements by MRI yields the potential to identify early signs of brainstem dysfunction, as encountered in brain malformations such as Chiari II or molar tooth malformations.	[Woitek, Ramona; Kasprian, Gregor; Lindner, Christian; Stuhr, Fritz; Weber, Michael; Schoepf, Veronika; Asenbaum, Ulrika; Furtner, Julia; Prayer, Daniela] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Brugger, Peter C.] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria; [Bettelheim, Dieter] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Seidl, Rainer] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Woitek, R (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	ramona.woitek@meduniwien.ac.at	Kasprian, Gregor/AAJ-5052-2020; Weber, Michael/L-9836-2016	Kasprian, Gregor/0000-0003-3858-3347; Weber, Michael/0000-0002-8507-2219; Woitek, Ramona/0000-0002-9146-9159; Schopf, Veronika/0000-0003-1937-4216; Furtner, Julia/0000-0001-8258-3681				BIRNHOLZ JC, 1981, SCIENCE, V213, P679, DOI 10.1126/science.7256272; BRIDGEMAN B, 1983, INVEST OPHTH VIS SCI, V24, P658; Brugger PC, 2006, EUR J RADIOL, V57, P172, DOI 10.1016/j.ejrad.2005.11.017; Brugger PC, 2012, EUR J RADIOL, V81, pE194, DOI 10.1016/j.ejrad.2011.01.115; Dan B, 2006, DEV MED CHILD NEUROL, V48, P773, DOI 10.1017/S0012162206001654; Garbutt S, 2006, DEV MED CHILD NEUROL, V48, P662, DOI 10.1017/S0012162206001393; HAINLINE L, 1984, VISION RES, V24, P1771, DOI 10.1016/0042-6989(84)90008-7; INOUE M, 1986, AM J OBSTET GYNECOL, V155, P170, DOI 10.1016/0002-9378(86)90105-5; Joseph R, 2000, DEV REV, V20, P81, DOI 10.1006/drev.1999.0486; KREMENITZER JP, 1979, CHILD DEV, V50, P442, DOI 10.1111/j.1467-8624.1979.tb04127.x; Li XB, 2010, PRENATAL DIAG, V30, P1064, DOI 10.1002/pd.2612; Mirmiran M, 2003, SLEEP MED REV, V7, P321, DOI 10.1053/smrv.2002.0243; Nijhuis JG, 1998, EARLY HUM DEV, V52, P125, DOI 10.1016/S0378-3782(98)00016-4; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; Pieh C, 2012, BRIT J OPHTHALMOL, V96, P73, DOI 10.1136/bjo.2010.191726; PILLAI M, 1990, ARCH DIS CHILD-FETAL, V65, P39, DOI 10.1136/adc.65.1_Spec_No.39; Prayer D, 2004, PEDIATR RADIOL, V34, P685, DOI 10.1007/s00247-004-1246-0; Qu J, 2006, EXP EYE RES, V82, P300, DOI 10.1016/j.exer.2005.07.002; Romanini C, 1995, EARLY HUM DEV, V43, P117, DOI 10.1016/0378-3782(95)01667-8; Stark RI, 1998, SLEEP, V21, P167; Thomke F, 2008, AUGENBEWEGUNGSSTORUN	21	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77439	10.1371/journal.pone.0077439	http://dx.doi.org/10.1371/journal.pone.0077439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194885	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000064
J	Han, LZ; Liu, YZ; Zhang, DD; Jin, Y; Luo, YJ				Han, Longzhu; Liu, Yunzhe; Zhang, Dandan; Jin, Yi; Luo, Yuejia			Low-Arousal Speech Noise Improves Performance in N-Back Task: An ERP Study	PLOS ONE			English	Article							WORKING-MEMORY; BACKGROUND-NOISE; ELECTROPHYSIOLOGICAL EVIDENCE; STIMULI; ATTENTION; P300; TIME; PARADIGM; CAPACITY; ADULTS	The relationship between noise and human performance is a crucial topic in ergonomic research. However, the brain dynamics of the emotional arousal effects of background noises are still unclear. The current study employed meaningless speech noises in the n-back working memory task to explore the changes of event-related potentials (ERPs) elicited by the noises with low arousal level vs. high arousal level. We found that the memory performance in low arousal condition were improved compared with the silent and the high arousal conditions; participants responded more quickly and had larger P2 and P3 amplitudes in low arousal condition while the performance and ERP components showed no significant difference between high arousal and silent conditions. These findings suggested that the emotional arousal dimension of background noises had a significant influence on human working memory performance, and that this effect was independent of the acoustic characteristics of noises (e. g., intensity) and the meaning of speech materials. The current findings improve our understanding of background noise effects on human performance and lay the ground for the investigation of patients with attention deficits.	[Han, Longzhu] Beihang Univ, Sch Biol Sci & Med Engn, Beijing, Peoples R China; [Liu, Yunzhe; Jin, Yi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Dandan; Luo, Yuejia] Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China	Beihang University; Beijing Normal University; Shenzhen University	Zhang, DD (corresponding author), Shenzhen Univ, Inst Affect & Social Neurosci, Shenzhen, Peoples R China.	zhangdd05@gmail.com			National Natural Science Foundation of China [31300867]; National Key Basic Research Program of China (973 Program) [2014CB744602]; Open project of Key Laboratory of Cryogenics, TIPC, Chinese Academy of Sciences [CYRO201224]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Open project of Key Laboratory of Cryogenics, TIPC, Chinese Academy of Sciences	This study was funded by the National Natural Science Foundation of China (31300867), National Key Basic Research Program of China (973 Program, 2014CB744602), and the Open project of Key Laboratory of Cryogenics, TIPC, Chinese Academy of Sciences (CYRO201224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2012, HEARING RES, V283, P126, DOI 10.1016/j.heares.2011.10.007; Alain C, 2009, EUR J NEUROSCI, V30, P132, DOI 10.1111/j.1460-9568.2009.06792.x; Amemiya S, 2010, PHYSIOL BEHAV, V99, P521, DOI 10.1016/j.physbeh.2010.01.001; Baddeley A, 1974, PSYCHOL LEARN MOTIV, P531; Botteldooren D, 2011, P 10 INT C NOIS PUBL, P341; BRITTON LA, 1989, PERCEPT MOTOR SKILL, V68, P875, DOI 10.2466/pms.1989.68.3.875; BROADBENT DE, 1978, PSYCHOL BULL, V85, P1052, DOI 10.1037/0033-2909.85.5.1052; Cabani Fernando Tolosa, 2005, Rev Enferm, V28, P26; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Cote KA, 2008, PHYSIOL BEHAV, V95, P353, DOI 10.1016/j.physbeh.2008.06.016; DELAY ER, 1985, PERCEPT MOTOR SKILL, V61, P415, DOI 10.2466/pms.1985.61.2.415; Frtusova JB, 2013, PSYCHOL AGING, V28, P481, DOI 10.1037/a0031243; Gevins A, 1996, ELECTROEN CLIN NEURO, V98, P327, DOI 10.1016/0013-4694(96)00288-X; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HOUSTON K, 1967, J EXP PSYCHOL, V74, P54, DOI 10.1037/h0024492; Jones DM, 1993, AAOS INSTR COURSE LE, P219; JONES DM, 1992, HDB HUMAN PERFORMANC, V1, P29; Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; KRAMER AF, 1991, PSYCHOPHYSIOLOGY, V28, P425, DOI 10.1111/j.1469-8986.1991.tb00726.x; Kryter KD, 1970, EFFECTS NOISE MAN, P129; Liu P, 2012, BEHAV RES METHODS, V44, P1042, DOI 10.3758/s13428-012-0203-3; McEvoy LK, 1998, CEREB CORTEX, V8, P563, DOI 10.1093/cercor/8.7.563; OLTMAN PK, 1964, PERCEPT MOTOR SKILL, V19, P441, DOI 10.2466/pms.1964.19.2.441; OMALLEY JJ, 1971, PERCEPT MOTOR SKILL, V33, P887, DOI 10.2466/pms.1971.33.3.887; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; POLICH J, 1985, BIOL PSYCHOL, V21, P309, DOI 10.1016/0301-0511(85)90185-1; SALAME P, 1982, J VERB LEARN VERB BE, V21, P150, DOI 10.1016/S0022-5371(82)90521-7; Salisbury DF, 2002, PSYCHOPHYSIOLOGY, V39, P111, DOI 10.1017/S0048577201020030; SanMiguel I, 2008, J COGNITIVE NEUROSCI, V20, P1131, DOI 10.1162/jocn.2008.20078; Savini N, 2012, INT J PSYCHOPHYSIOL, V86, P220, DOI 10.1016/j.ijpsycho.2012.09.007; Smith A, 2012, PSYCHOL BULL, V138, P1262, DOI 10.1037/a0028867; Smith A, 2010, NOISE HEALTH, V12, P235, DOI 10.4103/1463-1741.70502; SMITH AP, 1983, BRIT J PSYCHOL, V74, P83, DOI 10.1111/j.2044-8295.1983.tb01845.x; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Sorqvist P, 2010, APPL COGNITIVE PSYCH, V24, P67, DOI 10.1002/acp.1543; Spronk M, 2012, INT J PSYCHOPHYSIOL, V83, P24, DOI 10.1016/j.ijpsycho.2011.09.019; STRAYER DL, 1990, J EXP PSYCHOL LEARN, V16, P67, DOI 10.1037/0278-7393.16.1.67; Szalma JL, 2011, PSYCHOL BULL, V137, P682, DOI 10.1037/a0023987; Trimmel M, 2006, ERGONOMICS, V49, P202, DOI 10.1080/00140130500434986; Watter S, 2001, PSYCHOPHYSIOLOGY, V38, P998, DOI 10.1111/1469-8986.3860998; Xu JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014552	44	18	21	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76261	10.1371/journal.pone.0076261	http://dx.doi.org/10.1371/journal.pone.0076261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204607	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300016
J	Nanayakkara, M; Lania, G; Maglio, M; Kosova, R; Sarno, M; Gaito, A; Discepolo, V; Troncone, R; Auricchio, S; Auricchio, R; Barone, MV				Nanayakkara, Merlin; Lania, Giuliana; Maglio, Mariantonia; Kosova, Roberta; Sarno, Marco; Gaito, Alessandra; Discepolo, Valentina; Troncone, Riccardo; Auricchio, Salvatore; Auricchio, Renata; Barone, Maria Vittoria			Enterocyte Proliferation and Signaling Are Constitutively Altered in Celiac Disease	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN; ACTIVATION; RESPONSES; GLIADIN; SYSTEM; GENES; CELLS; ERK	Celiac disease (CD) occurs frequently, and is caused by ingestion of prolamins from cereals in subjects with a genetic predisposition. The small intestinal damage depends on an intestinal stress/innate immune response to certain gliadin peptides (e. g., A-gliadin P31-43) in association with an adaptive immune response to other gliadin peptides (e. g., A-gliadin P57-68). Gliadin and peptide P31-43 affect epithelial growth factor receptor (EGFR) signaling and CD enterocyte proliferation. The reason why the stress/innate immune and proliferative responses to certain gliadin peptides are present in CD and not in control intestine is so far unknown. The aim of this work is to investigate if, in CD, a constitutive alteration of enterocyte proliferation and signaling exists that may represent a predisposing condition to the damaging effects of gliadin. Immunofluorescence and immunohistochemistry were used to study signaling in CD fibroblasts and intestinal biopsies. Western blot (WB) analysis, immunoprecipitation, and quantitative PCR were also used. We found in CD enterocytes enhancement of both proliferation and Epidermal Growth Factor Receptor (EGFR)/ligand system. In CD enterocytes and fibroblasts we found increase of the phosphorylated downstream signaling molecule Extracellular Signal Regulated Kinase (ERK); block of the ERK activation normalizes enterocytes proliferation in CD mucosa. In conclusion the same pathway, which gliadin and gliadin peptide P31-43 can interfere with, is constitutively altered in CD cells. This observation potentially explains the specificity of the damaging effects of certain gliadin peptides on CD intestine.	[Nanayakkara, Merlin; Lania, Giuliana; Maglio, Mariantonia; Kosova, Roberta; Sarno, Marco; Gaito, Alessandra; Discepolo, Valentina; Troncone, Riccardo; Auricchio, Salvatore; Auricchio, Renata; Barone, Maria Vittoria] Univ Naples Federico II, Dept Traslat Med, Sect Pediat, Naples, Italy; [Nanayakkara, Merlin; Lania, Giuliana; Maglio, Mariantonia; Kosova, Roberta; Sarno, Marco; Gaito, Alessandra; Discepolo, Valentina; Troncone, Riccardo; Auricchio, Salvatore; Auricchio, Renata; Barone, Maria Vittoria] Univ Naples Federico II, ELFID European Lab Invest Food Induced Dis, Naples, Italy; [Discepolo, Valentina] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Naples Federico II; University of Naples Federico II; University of Chicago	Barone, MV (corresponding author), Univ Naples Federico II, Dept Traslat Med, Sect Pediat, Naples, Italy.	mv.barone@unina.it	AURICCHIO, RENATA/AAC-7718-2022; Discepolo, Valentina/AAC-7665-2022	NANAYAKKARA, MERLIN/0000-0002-2569-4606; Discepolo, Valentina/0000-0001-6158-0545; BARONE, Maria Vittoria/0000-0001-6190-4917	PRIN (Research Programs of National Interest) [CUP E61J11000300001]	PRIN (Research Programs of National Interest)(Ministry of Education, Universities and Research (MIUR))	PRIN 2009 (Research Programs of National Interest), code CUP E61J11000300001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barone MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017039; Barone MV, 2007, GASTROENTEROLOGY, V132, P1245, DOI 10.1053/j.gastro.2007.01.030; Barone MV, 2007, GUT, V56, P480, DOI 10.1136/gut.2005.086637; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Barone MV, 2001, ONCOGENE, V20, P6973, DOI 10.1038/sj.onc.1204886; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; DeWitt AE, 2001, J CELL SCI, V114, P2301; Diosdado B, 2004, GUT, V53, P944, DOI 10.1136/gut.2003.018374; FALCONE G, 1987, EXP CELL RES, V168, P273, DOI 10.1016/0014-4827(87)90435-6; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; Juuti-Uusitalo K, 2007, CLIN EXP IMMUNOL, V150, P294, DOI 10.1111/j.1365-2249.2007.03500.x; Kopp R, 2003, RECENT RESULTS CANC, V162, P115; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Lewkowicz P, 2005, IMMUNOL LETT, V96, P203, DOI 10.1016/j.imlet.2004.08.012; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; MARSH MN, 1992, EUR J GASTROEN HEPAT, V4, P667; MARSH MN, 1995, BAILLIERE CLIN GASTR, V9, P273, DOI 10.1016/0950-3528(95)90032-2; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MULDER CJJ, 1993, GUT, V34, P1740, DOI 10.1136/gut.34.12.1740; Nanayakkara M, 2013, AM J CLIN N IN PRESS; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76006	10.1371/journal.pone.0076006	http://dx.doi.org/10.1371/journal.pone.0076006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204586	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300007
J	Antonio, T; Childers, SR; Rothman, RB; Dersch, CM; King, C; Kuehne, M; Bornmann, WG; Eshleman, AJ; Janowsky, A; Simon, ER; Reith, MEA; Alper, K				Antonio, Tamara; Childers, Steven R.; Rothman, Richard B.; Dersch, Christina M.; King, Christine; Kuehne, Martin; Bornmann, William G.; Eshleman, Amy J.; Janowsky, Aaron; Simon, Eric R.; Reith, Maarten E. A.; Alper, Kenneth			Effect of Iboga Alkaloids on mu-Opioid Receptor-Coupled G Protein Activation	PLOS ONE			English	Article							NALOXONE-PRECIPITATED WITHDRAWAL; NICOTINIC ACETYLCHOLINE-RECEPTOR; INDUCED LOCOMOTOR-ACTIVITY; MORPHINE-WITHDRAWAL; ANTINOCICEPTIVE ACTION; TABERNANTHE-IBOGA; ADENYLYL-CYCLASE; ACUTE SIGNS; NORIBOGAINE; BINDING	Objective: The iboga alkaloids are a class of small molecules defined structurally on the basis of a common ibogamine skeleton, some of which modify opioid withdrawal and drug self-administration in humans and preclinical models. These compounds may represent an innovative approach to neurobiological investigation and development of addiction pharmacotherapy. In particular, the use of the prototypic iboga alkaloid ibogaine for opioid detoxification in humans raises the question of whether its effect is mediated by an opioid agonist action, or if it represents alternative and possibly novel mechanism of action. The aim of this study was to independently replicate and extend evidence regarding the activation of mu-opioid receptor (MOR)-related G proteins by iboga alkaloids. Methods: Ibogaine, its major metabolite noribogaine, and 18-methoxycoronaridine (18-MC), a synthetic congener, were evaluated by agonist-stimulated guanosine-5'-O-(gamma-thio)-triphosphate ([S-35]GTP gamma S) binding in cells overexpressing the recombinant MOR, in rat thalamic membranes, and autoradiography in rat brain slices. Results And Significance: In rat thalamic membranes ibogaine, noribogaine and 18-MC were MOR antagonists with functional Ke values ranging from 3 uM (ibogaine) to 13 uM (noribogaine and 18MC). Noribogaine and 18-MC did not stimulate [S-35]GTP gamma S binding in Chinese hamster ovary cells expressing human or rat MORs, and had only limited partial agonist effects in human embryonic kidney cells expressing mouse MORs. Ibogaine did not did not stimulate [S-35]GTP gamma S binding in any MOR expressing cells. Noribogaine did not stimulate [S-35]GTP gamma S binding in brain slices using autoradiography. An MOR agonist action does not appear to account for the effect of these iboga alkaloids on opioid withdrawal. Taken together with existing evidence that their mechanism of action also differs from that of other non-opioids with clinical effects on opioid tolerance and withdrawal, these findings suggest a novel mechanism of action, and further justify the search for alternative targets of iboga alkaloids.	[Antonio, Tamara; King, Christine; Simon, Eric R.; Reith, Maarten E. A.; Alper, Kenneth] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Antonio, Tamara; King, Christine; Simon, Eric R.; Reith, Maarten E. A.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Childers, Steven R.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC USA; [Rothman, Richard B.; Dersch, Christina M.] NIDA, Translat Pharmacol Res Sect, Intramural Res Program, Baltimore, MD USA; [Kuehne, Martin] Univ Vermont, Dept Chem, Burlington, VT 05405 USA; [Bornmann, William G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Eshleman, Amy J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Res Serv, VA Med Ctr, Portland, OR 97201 USA; [Eshleman, Amy J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Eshleman, Amy J.; Janowsky, Aaron] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Alper, Kenneth] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA	New York University; New York University; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Vermont; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; New York University	Alper, K (corresponding author), NYU, Sch Med, Dept Psychiat, New York, NY USA.	Kenneth.Alper@nyumc.org	Alper, Kenneth/AAH-9613-2020; Reith, Maarten E./AAD-2303-2019	Reith, Maarten E./0000-0002-1900-842X; Alper, Kenneth/0000-0002-7014-1445	New York University School of Medicine Addiction Center of Excellence; Methamphetamine Abuse Research Center [P50 DA018165]; NIDA-VA [ADA12013]; VA Research Career Scientist and Merit Review programs NIDA grant, Intramural Research Program, NIDA, National Institute of health, Baltimore, MD [DA-06634]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA018165, P50DA006634] Funding Source: NIH RePORTER	New York University School of Medicine Addiction Center of Excellence; Methamphetamine Abuse Research Center; NIDA-VA; VA Research Career Scientist and Merit Review programs NIDA grant, Intramural Research Program, NIDA, National Institute of health, Baltimore, MD; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by New York University School of Medicine Addiction Center of Excellence (MEAR, KA, TA), The Methamphetamine Abuse Research Center (P50 DA018165), NIDA-VA Interagency agreement ADA12013, and VA Research Career Scientist and Merit Review programs (AJ, AJE) NIDA grant DA-06634 (SRC) Intramural Research Program, NIDA, National Institute of health, Baltimore, MD (RBR, CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto M D, 1992, NIDA Res Monogr, V119, P513; Alper K R, 2001, Alkaloids Chem Biol, V56, P1, DOI 10.1016/S0099-9598(01)56005-8; Alper KR, 2008, J ETHNOPHARMACOL, V115, P9, DOI 10.1016/j.jep.2007.08.034; Alper KR, 2012, J FORENSIC SCI, V57, P398, DOI 10.1111/j.1556-4029.2011.02008.x; Alper KR, 1999, AM J ADDICTION, V8, P234; AMATO L, 2009, COCHRANE DB SYST REV; Arias HR, 2010, INT J BIOCHEM CELL B, V42, P1525, DOI 10.1016/j.biocel.2010.05.011; Bagal AA, 1996, BRAIN RES, V741, P258, DOI 10.1016/S0006-8993(96)00938-9; BARTLETT MF, 1958, J AM CHEM SOC, V80, P126, DOI 10.1021/ja01534a036; Baumann MH, 2001, J PHARMACOL EXP THER, V297, P531; Bhargava HN, 1997, BRAIN RES, V771, P343, DOI 10.1016/S0006-8993(97)00914-1; Bhargava HN, 1997, BRAIN RES, V752, P234, DOI 10.1016/S0006-8993(96)01461-8; Bie BH, 2005, J NEUROSCI, V25, P3824, DOI 10.1523/JNEUROSCI.5010-04.2005; Bisaga A, 2001, PSYCHOPHARMACOLOGY, V157, P1, DOI 10.1007/s002130100739; BUNZOW JR, 1995, J NEUROCHEM, V64, P14; Cao YJ, 1997, BRAIN RES, V752, P250, DOI 10.1016/S0006-8993(96)01470-9; CAPPENDIJK SLT, 1994, BEHAV BRAIN RES, V65, P117, DOI 10.1016/0166-4328(94)90080-9; Cheng KJ, 2011, J MED CHEM, V54, P957, DOI 10.1021/jm1011676; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Christoffers KH, 2002, REGUL PEPTIDES, V105, P9, DOI 10.1016/S0167-0115(01)00382-2; Corkery JM, 2004, HUM PSYCHOPHARM CLIN, V19, P565, DOI 10.1002/hup.630; DEECHER DC, 1992, BRAIN RES, V571, P242, DOI 10.1016/0006-8993(92)90661-R; DHAHIR HI, 1971, THESIS INDIANA U; DZOLJIC ED, 1988, ARCH INT PHARMACOD T, V294, P64; Fareed A, 2010, J ADDICT DIS, V29, P1, DOI 10.1080/10550880903436010; Fernandez James, 1982, BWITI ETHNOGRAPHY RE; Fichna J, 2006, BIOCHEM BIOPH RES CO, V345, P162, DOI 10.1016/j.bbrc.2006.04.079; FRANCES B, 1992, FUNDAM CLIN PHARM, V6, P327, DOI 10.1111/j.1472-8206.1992.tb00127.x; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; GALLAGHER CA, 1995, BIOCHEM PHARMACOL, V49, P73, DOI 10.1016/0006-2952(94)00441-N; Glick S D, 2001, Alkaloids Chem Biol, V56, P39, DOI 10.1016/S0099-9598(01)56006-X; Glick SD, 1996, BRAIN RES, V713, P294, DOI 10.1016/0006-8993(95)01563-9; GLICK SD, 1992, NEUROPHARMACOLOGY, V31, P497, DOI 10.1016/0028-3908(92)90089-8; Glick SD, 2002, EUR J PHARMACOL, V448, P185, DOI 10.1016/S0014-2999(02)01944-1; Glick SD, 2002, EUR J PHARMACOL, V438, P99, DOI 10.1016/S0014-2999(02)01284-0; Gowing L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002025.pub4; Gowing L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002024.pub3; Holstein SE, 2013, BEHAV BRAIN RES, V237, P49, DOI 10.1016/j.bbr.2012.09.006; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Jana GK, 2011, ORG PREP PROCED INT, V43, P541, DOI 10.1080/00304948.2011.629563; Ko MCH, 2003, J PHARMACOL EXP THER, V306, P179, DOI 10.1124/jpet.103.050625; Kontrimaviciute V, 2006, J ANAL TOXICOL, V30, P434, DOI 10.1093/jat/30.7.434; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Lamberts JT, 2011, NEUROPSYCHOPHARMACOL, V36, P2041, DOI 10.1038/npp.2011.91; Layer RT, 1996, EUR J PHARMACOL, V309, P159, DOI 10.1016/0014-2999(96)00304-4; Leal MB, 2003, PROG NEURO-PSYCHOPH, V27, P781, DOI 10.1016/S0278-5846(03)00109-X; Lester PA, 2006, BRAIN RES, V1073, P290, DOI 10.1016/j.brainres.2005.12.066; Levant B, 2004, BRAIN RES, V1003, P159, DOI 10.1016/j.brainres.2003.12.032; Maher CE, 2005, LIFE SCI, V77, P1140, DOI 10.1016/j.lfs.2005.03.004; MAISONNEUVE IM, 1992, BRAIN RES, V575, P69, DOI 10.1016/0006-8993(92)90424-8; MAISONNEUVE IM, 1991, EUR J PHARMACOL, V199, P35, DOI 10.1016/0014-2999(91)90634-3; Maisonneuve IM, 2003, PHARMACOL BIOCHEM BE, V75, P607, DOI 10.1016/S0091-3057(03)00119-9; Mash D C, 2001, Alkaloids Chem Biol, V56, P155, DOI 10.1016/S0099-9598(01)56012-5; *NAT I HLTH, 2013, ND EN STUD GMP SCAL; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; *NIDA, 1996, DET AC INT COMB IB M, V8, P1; Oka T, 1996, JPN J PHARMACOL, V71, P89, DOI 10.1254/jjp.71.89; Pablo JP, 1998, NEUROREPORT, V9, P109, DOI 10.1097/00001756-199801050-00022; Pace CJ, 2004, EUR J PHARMACOL, V492, P159, DOI 10.1016/j.ejphar.2004.03.062; Panchal V, 2005, EUR J PHARMACOL, V525, P98, DOI 10.1016/j.ejphar.2005.09.060; Parker LA, 2002, PROG NEURO-PSYCHOPH, V26, P293, DOI 10.1016/S0278-5846(01)00268-8; Pearl SM, 1996, NEUROPHARMACOLOGY, V35, P1779, DOI 10.1016/S0028-3908(96)00116-5; PEARL SM, 1995, PSYCHOPHARMACOLOGY, V121, P470, DOI 10.1007/BF02246495; Pearl SM, 1997, PHARMACOL BIOCHEM BE, V57, P809, DOI 10.1016/S0091-3057(96)00383-8; Peckham EM, 2005, BRAIN RES, V1058, P137, DOI 10.1016/j.brainres.2005.07.060; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; POPIK P, 1995, J PHARMACOL EXP THER, V275, P753; POPIK P, 1998, ALKALOIDS CHEM BIOL, V52, P197; Rabin RA, 1996, EUR J PHARMACOL, V316, P343, DOI 10.1016/S0014-2999(96)00690-5; *RES TRIANGL I, 1993, PHARM STUD TREATM DR, P1; Rho B, 1998, NEUROREPORT, V9, P1283, DOI 10.1097/00001756-199805110-00004; Romero DV, 1999, SYNAPSE, V34, P83, DOI 10.1002/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.3.CO;2-J; SCHNEIDER JA, 1956, EXPERIENTIA, V12, P323, DOI 10.1007/BF02159638; SCHNEIDER JA, 1957, TABERNANTHINE IBOGAI; Seifert R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003466; Selley DE, 1997, MOL PHARMACOL, V51, P87, DOI 10.1124/mol.51.1.87; Sershen H, 2001, Alkaloids Chem Biol, V56, P115; Shaqura MA, 2004, J PHARMACOL EXP THER, V308, P712, DOI 10.1124/jpet.103.057257; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sharma SS, 1998, PHARMACOLOGY, V57, P229, DOI 10.1159/000028246; Sharpe L G, 1990, Neuroreport, V1, P17, DOI 10.1097/00001756-199009000-00005; Sim L J, 1997, Methods Mol Biol, V83, P117; Sim-Selley LJ, 2007, BRIT J PHARMACOL, V151, P1324, DOI 10.1038/sj.bjp.0707328; Skolnick P, 2001, Alkaloids Chem Biol, V56, P55, DOI 10.1016/S0099-9598(01)56007-1; Staley JK, 1996, PSYCHOPHARMACOLOGY, V127, P10, DOI 10.1007/BF02805969; SWEETNAM PM, 1995, PSYCHOPHARMACOLOGY, V118, P369, DOI 10.1007/BF02245936; Taraschenko OD, 2005, EUR J PHARMACOL, V513, P207, DOI 10.1016/j.ejphar.2005.03.005; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Toll L, 1998, NIDA Res Monogr, V178, P440; TRUJILLO KA, 1994, BRAIN RES, V633, P178, DOI 10.1016/0006-8993(94)91538-5; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vigano D, 2003, NEUROSCIENCE, V117, P921, DOI 10.1016/S0306-4522(02)00825-4; Zhuo M, 2012, DRUG DISCOV TODAY, V17, P573, DOI 10.1016/j.drudis.2012.01.009	93	23	23	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77262	10.1371/journal.pone.0077262	http://dx.doi.org/10.1371/journal.pone.0077262			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24204784	Green Submitted, gold, Green Published			2022-12-25	WOS:000326019400097
J	Lin, CY; Huo, C; Kuo, LK; Hiipakka, RA; Jones, RB; Lin, HP; Hung, YW; Su, LC; Tseng, JC; Kuo, YY; Wang, YL; Fukui, Y; Kao, YH; Kokontis, JM; Yeh, CC; Chen, LY; Yang, SD; Fu, HH; Chen, YW; Tsai, KKC; Chang, JY; Chuu, CP				Lin, Ching-Yu; Huo, Chieh; Kuo, Li-Kuo; Hiipakka, Richard A.; Jones, Richard Baker; Lin, Hui-Ping; Hung, Yuwen; Su, Liang-Cheng; Tseng, Jen-Chih; Kuo, Ying-Yu; Wang, Yu-Ling; Fukui, Yasuhisa; Kao, Yung-Hsi; Kokontis, John M.; Yeh, Chien-Chih; Chen, Linyi; Yang, Shiaw-Der; Fu, Hsiao-Hui; Chen, Ya-Wen; Tsai, Kelvin K. C.; Chang, Jang-Yang; Chuu, Chih-Pin			Cholestane-3 beta, 5 alpha, 6 beta-triol Suppresses Proliferation, Migration, and Invasion of Human Prostate Cancer Cells	PLOS ONE			English	Article							ACID PHENETHYL ESTER; TO-MESENCHYMAL TRANSITION; 73/73 ENDOTHELIAL-CELLS; BOVINE ADRENAL-CORTEX; RICTOR-MTOR COMPLEX; X-RECEPTOR AGONIST; ANDROGEN RECEPTOR; CHOLESTEROL OXIDES; ATHYMIC MICE; C-MYC	Oxysterols are oxidation products of cholesterol. Cholestane-3 beta, 5 alpha, 6 beta-triol (abbreviated as triol) is one of the most abundant and active oxysterols. Here, we report that triol exhibits anti-cancer activity against human prostate cancer cells. Treatment of cells with triol dose-dependently suppressed proliferation of LNCaP CDXR-3, DU-145, and PC-3 human prostate cancer cells and reduced colony formation in soft agar. Oral administration of triol at 20 mg/kg daily for three weeks significantly retarded the growth of PC-3 xenografts in nude mice. Flow cytometric analysis revealed that triol treatment at 10-40 mu M caused G1 cell cycle arrest while the TUNEL assay indicated that triol treatment at 20-40 mu M induced apoptosis in all three cell lines. Micro-Western Arrays and traditional Western blotting methods indicated that triol treatment resulted in reduced expression of Akt1, phospho-Akt Ser473, phospho-Akt Thr308, PDK1, c-Myc, and Skp2 protein levels as well as accumulation of the cell cycle inhibitor p27(Kip). Triol treatment also resulted in reduced Akt1 protein expression in PC-3 xenografts. Overexpression of Skp2 in PC-3 cells partially rescued the growth inhibition caused by triol. Triol treatment suppressed migration and invasion of DU-145, PC-3, and CDXR-3 cells. The expression levels of proteins associated with epithelial-mesenchymal transition as well as focal adhesion kinase were affected by triol treatment in these cells. Triol treatment caused increased expression of E-cadherin protein levels but decreased expression of N-cadherin, vimentin, Slug, FAK, phospho-FAK Ser722, and phospho-FAK Tyr861 protein levels. Confocal laser microscopy revealed redistribution of beta-actin and alpha-tubulin at the periphery of the CDXR-3 and DU-145 cells. Our observations suggest that triol may represent a promising therapeutic agent for advanced metastatic prostate cancer.	[Lin, Ching-Yu; Huo, Chieh; Lin, Hui-Ping; Hung, Yuwen; Su, Liang-Cheng; Tseng, Jen-Chih; Kuo, Ying-Yu; Wang, Yu-Ling; Fukui, Yasuhisa; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Lin, Ching-Yu; Huo, Chieh; Lin, Hui-Ping; Su, Liang-Cheng; Kuo, Ying-Yu; Chen, Ya-Wen; Tsai, Kelvin K. C.; Chang, Jang-Yang; Chuu, Chih-Pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan; [Lin, Ching-Yu; Chen, Ya-Wen; Tsai, Kelvin K. C.; Chang, Jang-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Huo, Chieh; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Tao Yuan, Taiwan; [Kuo, Li-Kuo] Mackay Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taipei, Taiwan; [Hiipakka, Richard A.; Jones, Richard Baker; Kokontis, John M.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Jones, Richard Baker] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Hung, Yuwen; Tseng, Jen-Chih; Yang, Shiaw-Der; Fu, Hsiao-Hui] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Wang, Yu-Ling; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Yeh, Chien-Chih] Taoyuan Armed Forces Gen Hosp, Div Colon & Rectal Surg, Tao Yuan, Taiwan; [Yeh, Chien-Chih] Taoyuan Armed Forces Gen Hosp, Dept Surg, Tao Yuan, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan; [Chuu, Chih-Pin] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Central University; Mackay Memorial Hospital; University of Chicago; University of Chicago; National Tsing Hua University; National Tsing Hua University; China Medical University Taiwan; National Chung Hsing University	Chuu, CP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Tseng, Jen-Chih/AAK-3386-2020; Chen, Ya-Wen/AAG-7549-2019; Katanaev, Vladimir/F-9480-2014; Chuu, Chih-Pin/N-6697-2019; Fukui, Yasuhisa/E-8806-2010; Chen, Linyi/AAV-2632-2020; Lin, Ching Yu/AAN-9581-2020; Chen, Ya-Wen/B-1100-2010; Chang, Jang-Yang/D-2099-2010; Tsai, Kun-Chih/C-1371-2010	Chen, Ya-Wen/0000-0002-6080-8859; Katanaev, Vladimir/0000-0002-7909-5617; Chen, Linyi/0000-0001-7258-8817; Lin, Ching Yu/0000-0001-9041-5653; 	National Health Research Institutes [CS-101-PP-14]; (National Science Council) in Taiwan [NSC 99-2320-B-400-015-MY3, NSC 101-2325-B-400-014]; (Department of Health) in Taiwan [DOH101-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, Japan); (National Science Council) in Taiwan(Ministry of Science and Technology, Taiwan); (Department of Health) in Taiwan	This work was supported by CS-101-PP-14 (National Health Research Institutes), NSC 99-2320-B-400-015-MY3 and NSC 101-2325-B-400-014 (National Science Council) in Taiwan for CPC; DOH101-TD-C-111-004 (Department of Health) in Taiwan for JYC and CPC. CYL is supported by DOH101-TD-C-111-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ao MF, 2006, CANCER RES, V66, P8007, DOI 10.1158/0008-5472.CAN-05-4451; Ayala-Torres S, 1999, EXP CELL RES, V246, P193, DOI 10.1006/excr.1998.4308; Beach S, 2008, ONCOGENE, V27, P2243, DOI 10.1038/sj.onc.1210860; Biasi F, 2013, BIOCHIMIE, V95, P632, DOI 10.1016/j.biochi.2012.10.011; BOSISIO E, 1976, EUR J BIOCHEM, V63, P491, DOI 10.1111/j.1432-1033.1976.tb10252.x; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cantwell H, 1998, CELL BIOL TOXICOL, V14, P401, DOI 10.1023/A:1007595527176; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2011, MED HYPOTHESES, V76, P697, DOI 10.1016/j.mehy.2011.01.037; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Chuu CP, 2005, CANCER RES, V65, P2082, DOI 10.1158/0008-5472.CAN-04-3992; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dufour J, 2012, CURR OPIN PHARM; Edwards J, 2003, CLIN CANCER RES, V9, P5271; ELLEDGE SJ, 1994, CURR OPIN CELL BIOL, V6, P847, DOI 10.1016/0955-0674(94)90055-8; Franzen CA, 2009, CANCER PREV RES, V2, P830, DOI 10.1158/1940-6207.CAPR-09-0066; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Hause RJ, 2011, EXPERT REV PROTEOMIC, V8, P565, DOI [10.1586/EPR.11.49, 10.1586/epr.11.49]; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jusakul A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-44; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang KA, 2005, BIOL PHARM BULL, V28, P1377, DOI 10.1248/bpb.28.1377; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Lin HP, 2013, INT J MOL SCI, V14, P5264, DOI 10.3390/ijms14035264; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin HP, 2012, PHYTOTHER RES, V26, P122, DOI 10.1002/ptr.3523; Liu CC, 2013, MED HYPOTHESES, V80, P617, DOI 10.1016/j.mehy.2013.02.003; Liu J, 2011, HEAD NECK-J SCI SPEC, V33, P1774, DOI 10.1002/hed.21701; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Moriel P, 2002, BRAZ J MED BIOL RES, V35, P1301, DOI 10.1590/S0100-879X2002001100007; Nolasco S, 2005, FEBS LETT, V579, P3515, DOI 10.1016/j.febslet.2005.05.022; Palladini G, 1996, EXP CELL RES, V223, P83, DOI 10.1006/excr.1996.0060; Palladini G, 1996, EXP CELL RES, V223, P72, DOI 10.1006/excr.1996.0059; Panagiotou S, 1999, J CELL BIOCHEM, V73, P204, DOI 10.1002/(SICI)1097-4644(19990501)73:2<204::AID-JCB6>3.0.CO;2-V; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; WATABE T, 1979, J BIOL CHEM, V254, P3854; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Zheng DQ, 1999, CANCER RES, V59, P1655	66	4	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2013	8	6							e65734	10.1371/journal.pone.0065734	http://dx.doi.org/10.1371/journal.pone.0065734			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172XB	24204696	Green Published, Green Submitted, gold			2022-12-25	WOS:000321038800076
J	Su, JC; Gu, YC; Pruijn, FB; Smaill, JB; Patterson, AV; Guise, CP; Wilson, WR				Su, Jiechuang; Gu, Yongchuan; Pruijn, Frederik B.; Smaill, Jeff B.; Patterson, Adam V.; Guise, Christopher P.; Wilson, William R.			Zinc Finger Nuclease Knock-out of NADPH: Cytochrome P450 Oxidoreductase (POR) in Human Tumor Cell Lines Demonstrates That Hypoxia-activated Prodrugs Differ in POR Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Flavoproteins; Gene Knock-out; Hypoxia; Mass Spectrometry (MS); Molecular Cell Biology; Reductase; NADPH:Cytochrome P450 Oxidoreductase; Hypoxia-activated Prodrug; Proteotypic Peptides; Zinc Finger Nuclease	4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS; HAMSTER OVARY CELLS; C P450 REDUCTASE; MITOMYCIN-C; P-450 REDUCTASE; AEROBIC CONDITIONS; CANCER-THERAPY; GENE KNOCKOUT; TROG 02.02; CYTOTOXICITY	Hypoxia, a ubiquitous feature of tumors, can be exploited by hypoxia-activated prodrugs (HAP) that are substrates for one-electron reduction in the absence of oxygen. NADPH:cytochrome P450 oxidoreductase (POR) is considered one of the major enzymes responsible, based on studies using purified enzyme or forced overexpression in cell lines. To examine the role of POR in HAP activation at endogenous levels of expression, POR knock-outs were generated in HCT116 and SiHa cells by targeted mutation of exon 8 using zinc finger nucleases. Absolute quantitation by proteotypic peptide mass spectrometry of DNA sequence-confirmed multiallelic mutants demonstrated expression of proteins with residual one-electron reductase activity in some clones and identified two (Hko2 from HCT116 and S2ko1 from SiHa) that were functionally null by multiple criteria. Sensitivities of the clones to 11 HAP (six nitroaromatics, three benzotriazine N-oxides, and two quinones) were compared with wild-type and POR-overexpressing cells. All except the quinones were potentiated by POR overexpression. Knocking out POR had a marked effect on antiproliferative activity of the 5-nitroquinoline SN24349 in both genetic backgrounds after anoxic exposure but little or no effect on activity of most other HAP, including the clinical stage 2-nitroimidazole mustard TH-302, dinitrobenzamide mustard PR-104A, and benzotriazine N-oxide SN30000. Clonogenic cell killing and reductive metabolism of PR-104A and SN30000 under anoxia also showed little change in the POR knock-outs. Thus, although POR expression is a potential biomarker of sensitivity to some HAP, identification of other one-electron reductases responsible for HAP activation is needed for their rational clinical development.	[Su, Jiechuang; Gu, Yongchuan; Pruijn, Frederik B.; Smaill, Jeff B.; Patterson, Adam V.; Guise, Christopher P.; Wilson, William R.] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc Res Ctr, Auckland, New Zealand	University of Auckland	Wilson, WR (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc Res Ctr, Private Bag 92019, Auckland, New Zealand.	wr.wilson@auckland.ac.nz		Guise, Chris/0000-0001-8739-6682; Pruijn, Frederik/0000-0002-7354-5840; Gu, Yongchuan/0000-0001-5679-168X; Patterson, Adam/0000-0001-5138-1227	Health Research Council of New Zealand [11/1103]; University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Auckland	This work was supported by Grant 11/1103 from the Health Research Council of New Zealand and a doctoral scholarship from the University of Auckland (to J. S.).	Bailey SM, 2001, BIOCHEM PHARMACOL, V62, P461, DOI 10.1016/S0006-2952(01)00674-8; Baumann RP, 2001, CANCER RES, V61, P7770; Belcourt MF, 1996, P NATL ACAD SCI USA, V93, P456, DOI 10.1073/pnas.93.1.456; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Chen Y, 2009, MED RES REV, V29, P29, DOI 10.1002/med.20137; Cost GJ, 2010, BIOTECHNOL BIOENG, V105, P330, DOI 10.1002/bit.22541; Denny WA, 2010, FUTURE ONCOL, V6, P419, DOI [10.2217/fon.10.1, 10.2217/FON.10.1]; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Elwell JH, 1997, BIOCHEM PHARMACOL, V54, P249, DOI 10.1016/S0006-2952(97)00171-8; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Guise CP, 2007, BIOCHEM PHARMACOL, V74, P810, DOI 10.1016/j.bcp.2007.06.014; Guise CP, 2012, MOL PHARMACOL, V81, P31, DOI 10.1124/mol.111.073759; Guise CP, 2010, CANCER RES, V70, P1573, DOI 10.1158/0008-5472.CAN-09-3237; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Heine T, 2006, FREE RADICAL BIO MED, V40, P801, DOI 10.1016/j.freeradbiomed.2005.10.033; Henderson CJ, 2013, MOL PHARMACOL, V83, P1209, DOI 10.1124/mol.112.084616; Hendricksen K, 2012, J UROLOGY, V187, P1195, DOI 10.1016/j.juro.2011.11.101; HOBAN PR, 1990, CANCER RES, V50, P4692; Hunter FW, 2012, BIOCHEM PHARMACOL, V83, P574, DOI 10.1016/j.bcp.2011.12.005; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; KURZBAN GP, 1986, J BIOL CHEM, V261, P7824; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Liu PQ, 2010, BIOTECHNOL BIOENG, V106, P97, DOI 10.1002/bit.22654; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; MASON RP, 1975, BIOCHEM BIOPH RES CO, V67, P1267, DOI 10.1016/0006-291X(75)90163-1; McKeage MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-496; Meng FY, 2012, MOL CANCER THER, V11, P740, DOI 10.1158/1535-7163.MCT-11-0634; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Newton DC, 1998, ARCH BIOCHEM BIOPHYS, V359, P249, DOI 10.1006/abbi.1998.0917; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Olteanu H, 2001, J BIOL CHEM, V276, P35558, DOI 10.1074/jbc.M103707200; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; PATTERSON AV, 1995, BRIT J CANCER, V72, P1144, DOI 10.1038/bjc.1995.478; Patterson AV, 1997, BRIT J CANCER, V76, P1338, DOI 10.1038/bjc.1997.558; Peters LJ, 2010, J CLIN ONCOL, V28, P2996, DOI 10.1200/JCO.2009.27.4498; Richter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065267; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Rischin D, 2010, J CLIN ONCOL, V28, P2989, DOI 10.1200/JCO.2009.27.4449; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Saunders MP, 2000, BIOCHEM PHARMACOL, V59, P993, DOI 10.1016/S0006-2952(99)00405-0; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; SIIM BG, 1995, BIOCHEM PHARMACOL, V50, P75, DOI 10.1016/0006-2952(95)00112-D; SIIM BG, 1994, BRIT J CANCER, V70, P596, DOI 10.1038/bjc.1994.357; SIIM BG, 1994, BIOCHEM PHARMACOL, V48, P1593, DOI 10.1016/0006-2952(94)90204-6; SILVA JM, 1993, BRIT J CANCER, V68, P484, DOI 10.1038/bjc.1993.374; Singleton RS, 2009, CANCER RES, V69, P3884, DOI 10.1158/0008-5472.CAN-08-4023; Smaill J. B., 2010, U. S. Patent, Patent No. [2010/0173332 A1, 20100173332]; Su JC, 2013, BIOCHEM J, V452, P79, DOI 10.1042/BJ20121695; Tercel M, 2009, J MED CHEM, V52, P7258, DOI 10.1021/jm901202b; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Vaupel P, 2009, ADV EXP MED BIOL, V645, P241, DOI 10.1007/978-0-387-85998-9_36; WALTON MI, 1992, BIOCHEM PHARMACOL, V44, P251, DOI 10.1016/0006-2952(92)90007-6; Wang JL, 2012, CLIN CANCER RES, V18, P1684, DOI 10.1158/1078-0432.CCR-11-2296; Wang YL, 2010, MOL CANCER THER, V9, P410, DOI 10.1158/1535-7163.MCT-09-0555; WARDMAN P, 1976, BIOCHEM BIOPH RES CO, V69, P942, DOI 10.1016/0006-291X(76)90464-2; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	68	21	21	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37138	37153		10.1074/jbc.M113.505222	http://dx.doi.org/10.1074/jbc.M113.505222			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196959	Green Published, hybrid			2022-12-25	WOS:000329189700033
J	Forbes, LV; Sjogren, T; Auchere, F; Jenkins, DW; Thong, B; Laughton, D; Hemsley, P; Pairaudeau, G; Turner, R; Eriksson, H; Unitt, JF; Kettle, AJ				Forbes, Louisa V.; Sjogren, Tove; Auchere, Francoise; Jenkins, David W.; Thong, Bob; Laughton, David; Hemsley, Paul; Pairaudeau, Garry; Turner, Rufus; Eriksson, Hakan; Unitt, John F.; Kettle, Anthony J.			Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Inhibitors; Neutrophil; Oxidative Stress; Surface Plasmon Resonance (SPR); Hydroxamate; Myeloperoxidase; Reversible Inhibition	RAY CRYSTAL-STRUCTURE; CHLORINATING ACTIVITY; MOLECULAR-MECHANISMS; REDOX PROPERTIES; OXIDATION; ENZYME; PROTEINS; KINETICS; COMPLEX; HEALTH	Background: Myeloperoxidase causes oxidative damage in many inflammatory diseases. Results: New substituted aromatic hydroxamates are identified as potent, selective, and reversible inhibitors of MPO. Conclusion: Binding affinities of hydroxamates to the heme pocket determine the potency of inhibition. Significance: Compounds that bind tightly to the active site of myeloperoxidase have potential as therapeutically useful inhibitors of oxidative stress. The neutrophil enzyme myeloperoxidase (MPO) promotes oxidative stress in numerous inflammatory pathologies by producing hypohalous acids. Its inadvertent activity is a prime target for pharmacological control. Previously, salicylhydroxamic acid was reported to be a weak reversible inhibitor of MPO. We aimed to identify related hydroxamates that are good inhibitors of the enzyme. We report on three hydroxamates as the first potent reversible inhibitors of MPO. The chlorination activity of purified MPO was inhibited by 50% by a 5 nm concentration of a trifluoromethyl-substituted aromatic hydroxamate, HX1. The hydroxamates were specific for MPO in neutrophils and more potent toward MPO compared with a broad range of redox enzymes and alternative targets. Surface plasmon resonance measurements showed that the strength of binding of hydroxamates to MPO correlated with the degree of enzyme inhibition. The crystal structure of MPO-HX1 revealed that the inhibitor was bound within the active site cavity above the heme and blocked the substrate channel. HX1 was a mixed-type inhibitor of the halogenation activity of MPO with respect to both hydrogen peroxide and halide. Spectral analyses demonstrated that hydroxamates can act variably as substrates for MPO and convert the enzyme to a nitrosyl ferrous intermediate. This property was unrelated to their ability to inhibit MPO. We propose that aromatic hydroxamates bind tightly to the active site of MPO and prevent it from producing hypohalous acids. This mode of reversible inhibition has potential for blocking the activity of MPO and limiting oxidative stress during inflammation.	[Forbes, Louisa V.; Auchere, Francoise; Turner, Rufus; Kettle, Anthony J.] Univ Otago, Dept Pathol, Ctr Free Rad Res, Christchurch 8140, New Zealand; [Sjogren, Tove] AstraZeneca Res & Dev, Discovery Sci, S-43181 Molndal, Sweden; [Jenkins, David W.; Thong, Bob; Laughton, David; Hemsley, Paul; Pairaudeau, Garry; Unitt, John F.] AstraZeneca Res & Dev Charnwood, Biosci & Med Chem, Loughborough LE11 5RH, Leics, England; [Eriksson, Hakan] AstraZeneca Res & Dev Sodertalje, SE-15185 Sodertalje, Sweden	University of Otago; AstraZeneca; AstraZeneca; AstraZeneca	Forbes, LV (corresponding author), Univ Otago, Dept Pathol, Ctr Free Rad Res, POB 4345, Christchurch 8140, New Zealand.	louisa.forbes@otago.ac.nz	Ashby, Louisa/GRN-9388-2022	Ashby, Louisa/0000-0001-8247-096X; Kettle, Tony/0000-0002-8218-7766	AstraZeneca	AstraZeneca(AstraZeneca)	Received financial support from AstraZeneca to conduct this research.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; Arnhold J, 2001, EUR J BIOCHEM, V268, P5142, DOI 10.1046/j.0014-2956.2001.02449.x; Auchere F, 1999, BIOCHEM J, V343, P603, DOI 10.1042/0264-6021:3430603; AUERBACH BJ, 1992, ANAL BIOCHEM, V201, P375, DOI 10.1016/0003-2697(92)90354-A; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; BROOKS JL, 1983, BIOCHEM BIOPH RES CO, V116, P916, DOI 10.1016/S0006-291X(83)80229-0; Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970; Connolly S, 2004, J MED CHEM, V47, P3320, DOI 10.1021/jm031035n; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Davey CA, 1996, BIOCHEMISTRY-US, V35, P10967, DOI 10.1021/bi960577m; DAVIES B, 1989, BIOCHEM J, V258, P801, DOI 10.1042/bj2580801; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Dypbukt JM, 2005, FREE RADICAL BIO MED, V39, P1468, DOI 10.1016/j.freeradbiomed.2005.07.008; Farmer PJ, 2005, J INORG BIOCHEM, V99, P166, DOI 10.1016/j.jinorgbio.2004.11.005; Ferrari RP, 1997, J INORG BIOCHEM, V68, P61, DOI 10.1016/S0162-0134(97)81617-0; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Forbes LV, 2012, BIOCHEM PHARMACOL, V84, P949, DOI 10.1016/j.bcp.2012.07.020; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Halliwell B., 1999, FREE RADICALS BIOL M, P617; Hernandez-Mijares A, 2011, FREE RADICAL BIO MED, V50, P1215, DOI 10.1016/j.freeradbiomed.2011.01.019; Hope HR, 2000, PROTEIN EXPRES PURIF, V18, P269, DOI 10.1006/prep.1999.1197; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; IKEDASAITO M, 1991, J BIOL CHEM, V266, P3611; Jantschko W, 2005, BIOCHEM PHARMACOL, V69, P1149, DOI 10.1016/j.bcp.2005.02.006; JIANG XX, 1994, SCIENCE, V266, P810, DOI 10.1126/science.7973636; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; Kettle AJ, 1997, BIOCHEM J, V321, P503, DOI 10.1042/bj3210503; KETTLE AJ, 1991, BIOCHEM PHARMACOL, V41, P1485, DOI 10.1016/0006-2952(91)90565-M; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; Koelsch M, 2010, BIOCHEM PHARMACOL, V79, P1156, DOI 10.1016/j.bcp.2009.11.024; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; NOGUCHI M, 1994, EUR J BIOCHEM, V222, P285, DOI 10.1111/j.1432-1033.1994.tb18867.x; Ochs RS, 2000, J CHEM EDUC, V77, P1453, DOI 10.1021/ed077p1453; Prutz WA, 2000, ARCH BIOCHEM BIOPHYS, V380, P181, DOI 10.1006/abbi.2000.1914; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; Rees MD, 2009, BIOCHEM J, V421, P79, DOI 10.1042/BJ20090309; Reisz JA, 2010, DALTON T, V39, P5203, DOI 10.1039/c000980f; RICH PR, 1978, BIOCHIM BIOPHYS ACTA, V525, P325, DOI 10.1016/0005-2744(78)90227-9; Samuni Y, 2012, BBA-GEN SUBJECTS, V1820, P1560, DOI 10.1016/j.bbagen.2012.05.006; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; UETRECHT JP, 1992, DRUG METAB REV, V24, P299, DOI 10.3109/03602539208996297; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Weaver R, 2003, DRUG METAB DISPOS, V31, P955, DOI 10.1124/dmd.31.7.955; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182	52	76	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36636	36647		10.1074/jbc.M113.507756	http://dx.doi.org/10.1074/jbc.M113.507756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194519	Green Published, hybrid			2022-12-25	WOS:000328883400043
J	Pennesi, C; Totti, C; Beolchini, F				Pennesi, Chiara; Totti, Cecilia; Beolchini, Francesca			Removal of Vanadium(III) and Molybdenum(V) from Wastewater Using Posidonia oceanica (Tracheophyta) Biomass	PLOS ONE			English	Article							METAL CONTAMINATION; L. DELILE; BIOSORPTION; SEAGRASS; EQUILIBRIUM; RECOVERY; CHROMIUM; ADSORPTION; EXPRESSION; SEQUENCES	The use of dried and re-hydrated biomass of the seagrass Posidonia oceanica was investigated as an alternative and -low-cost biomaterial for removal of vanadium(III) and molybdenum(V) from wastewaters. Initial characterisation of this biomaterial identified carboxylic groups on the cuticle as potentially responsible for cation sorption, and confirmed the toxic-metal bioaccumulation. The combined effects on biosorption performance of equilibrium pH and metal concentrations were investigated in an ideal single-metal system and in more real-life multicomponent systems. There were either with one metal (vanadium or molybdenum) and sodium nitrate, as representative of high ionic strength systems, or with the two metals (vanadium and molybdenum). For the single-metal solutions, the optimum was at pH 3, where a significant proportion of vanadium was removed (ca. 70%) while there was ca. 40% adsorption of molybdenum. The data obtained from the more real-life multicomponent systems showed that biosorption of one metal was improved both by the presence of the other metal and by high ionic strength, suggesting a synergistic effect on biosorption rather than competition. There data ware used for the development of a simple multi-metal equilibrium model based on the noncompetitive Langmuir approach, which was successfully fitted to experimental data and represents a useful support tool for the prediction of biosorption performance in such real-life systems. Overall, the results suggest that biomass of P. oceanica can be used as an efficient biosorbent for removal of vanadium(III) and molybdenum(V) from aqueous solutions. This process thus offers an eco-compatible solution for the reuse of the waste material of leaves that accumulate on the beach due to both human activities and to storms at sea.	[Pennesi, Chiara; Totti, Cecilia; Beolchini, Francesca] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy	Marche Polytechnic University	Pennesi, C (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy.	c.pennesi@univpm.it	Totti, Cecilia Maria/A-9178-2016; Beolchini, Francesca/L-6205-2014; Pennesi, Chiara/B-7786-2013	Totti, Cecilia Maria/0000-0002-1532-6009; Beolchini, Francesca/0000-0002-6211-6354; Pennesi, Chiara/0000-0002-5774-2190	Polytechnic University of the Marche	Polytechnic University of the Marche	This study was funded by research funds of the Polytechnic University of the Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche FN, 2011, CHEM ENG J, V168, P1174, DOI 10.1016/j.cej.2011.02.005; [Anonymous], [No title captured]; Aydin M, 2012, J RADIOANAL NUCL CH, V293, P489, DOI 10.1007/s10967-012-1782-2; Benavente J, 1998, COLLOID SURFACE A, V140, P333, DOI 10.1016/S0927-7757(97)00290-2; Benedetto G, 2012, DOSSIER COSTE PROFIL; Beolchini F, 2006, ENVIRON SCI TECHNOL, V40, P2746, DOI 10.1021/es052114m; Beolchini F, 2005, HYDROMETALLURGY, V76, P73, DOI 10.1016/j.hydromet.2004.09.003; Beolchini F, 2010, J HAZARD MATER, V178, P529, DOI 10.1016/j.jhazmat.2010.01.114; Boudouresque C.F., 1982, CAH PARC NATION PORT, V4, P1; Boudouresque C.F., 2006, PRESERVATION CONSERV; Bulgariu D, 2012, BIORESOURCE TECHNOL, V103, P489, DOI 10.1016/j.biortech.2011.10.016; Cengiz S, 2012, CHEM ENG J, V189, P32, DOI 10.1016/j.cej.2012.02.015; Cozza R, 2006, AQUAT BOT, V85, P317, DOI 10.1016/j.aquabot.2006.06.010; Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Demirak A, 2011, MICROCHEM J, V99, P97, DOI 10.1016/j.microc.2011.04.002; Ferrat L, 2003, AQUAT TOXICOL, V65, P187, DOI 10.1016/S0166-445X(03)00133-4; Ferrat L, 2003, COMP BIOCHEM PHYS C, V134, P147, DOI 10.1016/S1532-0456(02)00220-X; Fourest E., 1996, TOXICOL ENVIRON CHEM, V54, P1, DOI DOI 10.1080/02772249609358291; Fourqurean JW, 2007, MAR BIOL, V151, P219, DOI 10.1007/s00227-006-0473-3; Francour P, 2006, MANAGEMENT GUIDE MAR; Gacia E, 2007, ESTUAR COAST SHELF S, V72, P579, DOI 10.1016/j.ecss.2006.11.021; GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011; Gerke TL, 2010, SCI TOTAL ENVIRON, V408, P5845, DOI 10.1016/j.scitotenv.2010.08.036; Giordani T, 2000, PLANT PHYSIOL, V123, P1571, DOI 10.1104/pp.123.4.1571; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Hoffman R.V., 2004, ORGANIC CHEM INTERME, Vsecond, DOI [10.1002/0471648736, DOI 10.1002/0471648736]; Izquierdo M, 2010, BIORESOURCE TECHNOL, V101, P510, DOI 10.1016/j.biortech.2009.08.018; Izqulerdo M, 2012, CLEAN-SOIL AIR WATER, V40, P428, DOI 10.1002/clen.201100303; Khiari R, 2010, BIORESOURCE TECHNOL, V101, P775, DOI 10.1016/j.biortech.2009.08.079; Krika F, 2012, INT J ENVIRON RES, V6, P719; Lafabrie C, 2008, MAR POLLUT BULL, V57, P155, DOI 10.1016/j.marpolbul.2007.10.007; Lafabrie C, 2008, ENVIRON POLLUT, V151, P262, DOI 10.1016/j.envpol.2007.01.047; Lafabrie C, 2007, CHEMOSPHERE, V68, P2033, DOI 10.1016/j.chemosphere.2007.02.039; Lafabrie C, 2007, ENVIRON POLLUT, V148, P688, DOI 10.1016/j.envpol.2006.11.015; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Liber K, 2011, ECOTOX ENVIRON SAFE, V74, P1171, DOI 10.1016/j.ecoenv.2011.02.014; Maserti BE, 2005, AQUAT TOXICOL, V75, P288, DOI 10.1016/j.aquatox.2005.08.008; Michalowski T, 2005, TALANTA, V65, P1241, DOI 10.1016/j.talanta.2004.08.053; Michalowski T, 2008, ANAL CHIM ACTA, V606, P172, DOI 10.1016/j.aca.2007.11.020; Montazer-Rahmati MM, 2011, J HAZARD MATER, V185, P401, DOI 10.1016/j.jhazmat.2010.09.047; Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015; Ncibi MC, 2009, DESALINATION, V243, P109, DOI 10.1016/j.desal.2008.04.018; Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029; Pennesi C, 2012, J APPL PHYCOL, V24, P1495, DOI 10.1007/s10811-012-9808-2; Pennesi C, 2012, WATER ENVIRON RES, V84, P9, DOI 10.2175/106143011X12989211841296; Piazzi L, 1999, AQUAT BOT, V63, P103, DOI 10.1016/S0304-3770(98)00115-6; Puigdomenech I, 2009, PROGRAM MEDUSA MAKE; Rocchetti L, 2013, WASTE MANAGE RES, V31, P568, DOI 10.1177/0734242X13476364; Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005; Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036; Shriver DF., 2010, INORG CHEM, V5, P851; Stasko R, 2006, MATER CHARACT, V56, P340, DOI 10.1016/j.matchar.2005.09.012; Tang ZH, 2008, MATER CHARACT, V59, P717, DOI 10.1016/j.matchar.2007.06.001; Veglio F, 1997, HYDROMETALLURGY, V44, P301, DOI 10.1016/S0304-386X(96)00059-X; Volesky B, 1990, BIOSORPTION HEAVY ME, P7; Wahab MA, 2011, J HAZARD MATER, V191, P333, DOI 10.1016/j.jhazmat.2011.04.085; Whittaker G, 2000, BIOS INSTANT NOTES P	58	28	29	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76870	10.1371/journal.pone.0076870	http://dx.doi.org/10.1371/journal.pone.0076870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204692	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400019
J	Rossignol, L; Pelat, C; Lambert, B; Flahault, A; Chartier-Kastler, E; Hanslik, T				Rossignol, Louise; Pelat, Camille; Lambert, Bruno; Flahault, Antoine; Chartier-Kastler, Emmanuel; Hanslik, Thomas			A Method to Assess Seasonality of Urinary Tract Infections Based on Medication Sales and Google Trends	PLOS ONE			English	Article							PUBLIC-HEALTH; PEAKS	Background: Despite the fact that urinary tract infection (UTI) is a very frequent disease, little is known about its seasonality in the community. Methods and Findings: To estimate seasonality of UTI using multiple time series constructed with available proxies of UTI. Eight time series based on two databases were used: sales of urinary antibacterial medications reported by a panel of pharmacy stores in France between 2000 and 2012, and search trends on the Google search engine for UTI-related terms between 2004 and 2012 in France, Germany, Italy, the USA, China, Australia and Brazil. Differences between summers and winters were statistically assessed with the Mann-Whitney test. We evaluated seasonality by applying the Harmonics Product Spectrum on Fast Fourier Transform. Seven time series out of eight displayed a significant increase in medication sales or web searches in the summer compared to the winter, ranging from 8% to 20%. The eight time series displayed a periodicity of one year. Annual increases were seen in the summer for UTI drug sales in France and Google searches in France, the USA, Germany, Italy, and China. Increases occurred in the austral summer for Google searches in Brazil and Australia. Conclusions: An annual seasonality of UTIs was evidenced in seven different countries, with peaks during the summer.	[Rossignol, Louise] Univ Paris 06, Dept Med Gen, Paris, France; [Rossignol, Louise] Univ Paris 06, UMRS 707, Paris, France; [Rossignol, Louise; Flahault, Antoine; Hanslik, Thomas] INSERM, U707, Paris, France; [Pelat, Camille] INSERM, U738, Paris, France; [Pelat, Camille] Univ Paris Diderot, UMRS 738, Paris, France; [Lambert, Bruno] IMS Hlth, La Defense, France; [Flahault, Antoine] Sorbonne Paris Cite, Descartes Sch Med, Paris, France; [Chartier-Kastler, Emmanuel] Urologist Hop Univ Pitie Salpetriere, AP HP, Fac Med Pierre & Marie Curie Paris 6, Paris, France; [Hanslik, Thomas] Univ Versailles St Quentin En Yvelines, Versailles, France	UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Rossignol, L (corresponding author), Univ Paris 06, Dept Med Gen, Paris, France.	rossignol@u707.jussieu.fr						Agence francaise de securite sanitaire des produits de sante, 2008, REC BONN PRAT DIAGN; Agence Nationale de Securite du Medicament, 2008, RES CAR PROD MON AD; Agence Nationale de Securite du Medicament, 2011, RES CAR PROD RUF; Al-Hasan MN, 2009, CLIN MICROBIOL INFEC, V15, P947, DOI 10.1111/j.1469-0691.2009.02877.x; Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; ANDERSON JE, 1983, J EPIDEMIOL COMMUN H, V37, P286, DOI 10.1136/jech.37.4.286; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chazan B, 2011, CLIN MICROBIOL INFEC, V17, P851, DOI 10.1111/j.1469-0691.2010.03327.x; Conseil de l'Ordre des pharmaciens, 2008, PHARM; Eber MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025298; EphMRA, 2012, AN CLASS; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; FoxNews.com, 2009, FOXNEWS; Freeman JT, 2009, CLIN MICROBIOL INFEC, V15, P951, DOI 10.1111/j.1469-0691.2009.02866.x; George DB, 2010, EPIDEMIOL INFECT, V138, P1679, DOI 10.1017/S0950268810001639; Google, 2012, UPD VERT TAX; Google, 2011, NOT IMPR OUR GEOGR A; Google, 2012, GOOGL INS SEARCH; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Keating Karen N, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P457, DOI 10.1586/14737167.5.4.457; Pelat C, 2010, PHARMACOEPIDEM DR S, V19, P1009, DOI 10.1002/pds.1965; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Richet H, 2012, CLIN MICROBIOL INFEC, V18, P934, DOI 10.1111/j.1469-0691.2012.03954.x; SCHROEDER MR, 1968, J ACOUST SOC AM, V43, P829, DOI 10.1121/1.1910902; Singleton R. C., 1979, MIXED RADIX FAST FOU; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; STANSFELD JM, 1966, BMJ-BRIT MED J, V1, P631, DOI 10.1136/bmj.1.5488.631; Valdivia A, 2010, EURO SURVEILL, V15, P19621; Valdivia A, 2010, EMERG INFECT DIS, V16, P168, DOI 10.3201/eid1601.091308; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yang AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013728; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517	34	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76020	10.1371/journal.pone.0076020	http://dx.doi.org/10.1371/journal.pone.0076020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204587	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400010
J	Tuval-Kochen, L; Paglin, S; Keshet, G; Lerenthal, Y; Nakar, C; Golani, T; Toren, A; Yahalom, J; Pfeffer, R; Lawrence, Y				Tuval-Kochen, Liron; Paglin, Shoshana; Keshet, Gilmor; Lerenthal, Yaniv; Nakar, Charles; Golani, Tamar; Toren, Amos; Yahalom, Joachim; Pfeffer, Raphael; Lawrence, Yaacov			Eukaryotic Initiation Factor 2 alpha - a Downstream Effector of Mammalian Target of Rapamycin - Modulates DNA Repair and Cancer Response to Treatment	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; BREAST-CANCER; EIF2-ALPHA DEPHOSPHORYLATION; INDUCED AUTOPHAGY; UNFOLDED PROTEIN; MTOR INHIBITOR; TRANSLATION; PHOSPHORYLATION; MECHANISM	In an effort to circumvent resistance to rapamycin - an mTOR inhibitor - we searched for novel rapamycin-downstream-targets that may be key players in the response of cancer cells to therapy. We found that rapamycin, at nM concentrations, increased phosphorylation of eukaryotic initiation factor (eIF) 2 alpha in rapamycin-sensitive and estrogen-dependent MCF-7 cells, but had only a minimal effect on eIF2 alpha phosphorylation in the rapamycin-insensitive triple-negative MDA-MB-231 cells. Addition of salubrinal - an inhibitor of eIF2 alpha dephosphorylation decreased expression of a surface marker associated with capacity for self renewal, increased senescence and induced clonogenic cell death, suggesting that excessive phosphorylation of eIF2 alpha is detrimental to the cells' survival. Treating cells with salubrinal enhanced radiation-induced increase in eIF2 alpha phosphorylation and clonogenic death and showed that irradiated cells are more sensitive to increased eIF2 alpha phosphorylation than non-irradiated ones. Similar to salubrinal - the phosphomimetic eIF2 alpha variant - S51D - increased sensitivity to radiation, and both abrogated radiation-induced increase in breast cancer type 1 susceptibility gene, thus implicating enhanced phosphorylation of eIF2 alpha in modulation of DNA repair. Indeed, salubrinal inhibited non-homologous end joining as well as homologous recombination repair of double strand breaks that were induced by I-SceI in green fluorescent protein reporter plasmids. In addition to its effect on radiation, salubrinal enhanced eIF2 alpha phosphorylation and clonogenic death in response to the histone deacetylase inhibitor - vorinostat. Finally, the catalytic competitive inhibitor of mTOR - Ku-0063794 - increased phosphorylation of eIF2 alpha demonstrating further the involvement of mTOR activity in modulating eIF2 alpha phosphorylation. These experiments suggest that excessive phosphorylation of eIF2 alpha decreases survival of cancer cells; making eIF2 alpha a worthy target for drug development, with the potential to enhance the cytotoxic effects of established anti-neoplastic therapies and circumvent resistance to rapalogues and possibly to other drugs that inhibit upstream components of the mTOR pathway.	[Tuval-Kochen, Liron; Paglin, Shoshana; Keshet, Gilmor; Lerenthal, Yaniv; Golani, Tamar; Pfeffer, Raphael; Lawrence, Yaacov] Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel; [Tuval-Kochen, Liron; Lerenthal, Yaniv] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Nakar, Charles; Yahalom, Joachim] Mem Sloan Kettering, Dept Oncol, New York, NY USA; [Toren, Amos] Safra Childrens Hosp, Dept Pediat Hematol Oncol, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Memorial Sloan Kettering Cancer Center	Paglin, S (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, Ramat Gan, Israel.	shoshana.paglin@sheba.health.gov.il	lawrence, yaacov richard/AFP-1121-2022	lawrence, yaacov richard/0000-0002-9959-2485; Keshet, Gilmor/0000-0002-1907-3029	Medical Research Infrastructure Development Fund - Sheba Medical Center	Medical Research Infrastructure Development Fund - Sheba Medical Center	The research was supported by a generous donation from the estate of Miss HARAN ESTER of blessed memory through Keren Izvonot, Israel, Ministry of health (S.P) and by the Medical Research Infrastructure Development Fund - Sheba Medical Center (Y.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gatei M, 2000, CANCER RES, V60, P3299; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Keshet GI, 2008, BIOCHEM BIOPH RES CO, V368, P930, DOI 10.1016/j.bbrc.2008.02.022; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Koren R, 2000, J STEROID BIOCHEM, V73, P105, DOI 10.1016/S0960-0760(00)00068-6; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mehilli J, 2008, EUR HEART J, V29, P1975, DOI 10.1093/eurheartj/ehn253; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nika J, 2001, J BIOL CHEM, V276, P1051, DOI 10.1074/jbc.M007398200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozpolat B, 2012, LEUKEMIA RES TREAT, V17; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Paglin S, 2001, CANCER RES, V61, P439; Peidis P, 2011, CELL DEATH DIFFER, V18, P145, DOI 10.1038/cdd.2010.76; Peidis P, 2010, AGING-US, V2, P669, DOI 10.18632/aging.100216; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Seluanov A., 2010, JOVE-J VIS EXP, V43, DOI [DOI 10.3791/2002, 10.3791/2002]; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu K, 2001, ENDOCR-RELAT CANCER, V8, P249, DOI 10.1677/erc.0.0080249; Yuan RR, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-45; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	47	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77260	10.1371/journal.pone.0077260	http://dx.doi.org/10.1371/journal.pone.0077260			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204783	Green Submitted, gold, Green Published			2022-12-25	WOS:000326155400032
J	Chiou, YW; Lin, HK; Tang, MJ; Lin, HH; Yeh, ML				Chiou, Yu-Wei; Lin, Hsiu-Kuan; Tang, Ming-Jer; Lin, Hsi-Hui; Yeh, Ming-Long			The Influence of Physical and Physiological Cues on Atomic Force Microscopy-Based Cell Stiffness Assessment	PLOS ONE			English	Article							LOW SUBSTRATUM RIGIDITY; STEM-CELLS; VISCOELASTIC PROPERTIES; MECHANICAL-PROPERTIES; ACTIN CYTOSKELETON; ACTOMYOSIN TENSION; EPITHELIAL-CELLS; ELASTICITY; FIBROBLASTS; PROTEINS	Atomic force microscopy provides a novel technique for differentiating the mechanical properties of various cell types. Cell elasticity is abundantly used to represent the structural strength of cells in different conditions. In this study, we are interested in whether physical or physiological cues affect cell elasticity in Atomic force microscopy (AFM)-based assessments. The physical cues include the geometry of the AFM tips, the indenting force and the operating temperature of the AFM. All of these cues show a significant influence on the cell elasticity assessment. Sharp AFM tips create a two-fold increase in the value of the effective Young's modulus (Eeff) relative to that of the blunt tips. Higher indenting force at the same loading rate generates higher estimated cell elasticity. Increasing the operation temperature of the AFM leads to decreases in the cell stiffness because the structure of actin filaments becomes disorganized. The physiological cues include the presence of fetal bovine serum or extracellular matrix-coated surfaces, the culture passage number, and the culture density. Both fetal bovine serum and the extracellular matrix are critical for cells to maintain the integrity of actin filaments and consequently exhibit higher elasticity. Unlike primary cells, mouse kidney progenitor cells can be passaged and maintain their morphology and elasticity for a very long period without a senescence phenotype. Finally, cell elasticity increases with increasing culture density only in MDCK epithelial cells. In summary, for researchers who use AFM to assess cell elasticity, our results provide basic and significant information about the suitable selection of physical and physiological cues.	[Chiou, Yu-Wei; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Hsiu-Kuan; Tang, Ming-Jer; Lin, Hsi-Hui] Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Lin, HH (corresponding author), Natl Cheng Kung Univ, Dept Physiol, Tainan 70101, Taiwan.	sophialin0113@hotmail.com; mlyeh@mail.ncku.edu.tw		Lin, Hsi-Hui/0000-0002-4880-3481; Tang, Ming-Jer/0000-0002-0883-4363	National Science Council of Taiwan [100-2627-B006-009-, 100-2627-B006-018-]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan (100-2627-B006-009- and 100-2627-B006-018-) (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6; Battista PJ, 1991, IN VITRO CELL DEV BI, V27; Berdyyeva TK, 2005, PHYS MED BIOL, V50, P81, DOI 10.1088/0031-9155/50/1/007; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Chancellor TJ, 2010, BIOPHYS J, V99, P115, DOI 10.1016/j.bpj.2010.04.011; Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040; CHRZANOWSKAWODNICKA M, 1994, J CELL SCI, V107, P3643; Clark EA, 1996, J BIOL CHEM, V271, P14814, DOI 10.1074/jbc.271.25.14814; Costa KD, 2006, J BIOMECH ENG-T ASME, V128, P176, DOI 10.1115/1.2165690; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Cuerrier CM, 2007, BIOCHEM BIOPH RES CO, V355, P632, DOI 10.1016/j.bbrc.2007.01.190; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FERRI A, 1982, BIOCHEM J, V205, P281, DOI 10.1042/bj2050281; Goncalves RP, 2006, NAT METHODS, V3, P1007, DOI 10.1038/nmeth965; Guck J, 2010, INTEGR BIOL-UK, V2, P575, DOI 10.1039/c0ib00050g; Hategan A, 2003, BIOPHYS J, V85, P2746, DOI 10.1016/S0006-3495(03)74697-9; Ketene AN, 2012, INTEGR BIOL-UK, V4, P540, DOI 10.1039/c2ib00168c; Ketene AN, 2012, NANOMED-NANOTECHNOL, V8, P93, DOI 10.1016/j.nano.2011.05.012; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Kidoaki S, 2007, J BIOMED MATER RES A, V81A, P803, DOI 10.1002/jbm.a.31114; Kim DH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00555; Koch CM, 2013, GENOME RES, V23, P248, DOI 10.1101/gr.141945.112; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lee PT, 2010, STEM CELLS, V28, P573, DOI 10.1002/stem.310; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Lim SM, 2010, EXP CELL RES, V316, P2833, DOI 10.1016/j.yexcr.2010.06.010; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lulevich V, 2006, LANGMUIR, V22, P8151, DOI 10.1021/la060561p; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Muller DJ, 2008, NAT NANOTECHNOL, V3, P261, DOI 10.1038/nnano.2008.100; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Niessen CM, 2007, J INVEST DERMATOL, V127, P2525, DOI 10.1038/sj.jid.5700865; Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pelling AE, 2007, NANOMED-NANOTECHNOL, V3, P43, DOI 10.1016/j.nano.2006.11.006; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Roduit C, 2009, BIOPHYS J, V97, P674, DOI 10.1016/j.bpj.2009.05.010; Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; SHYY TT, 1989, J CELL BIOL, V108, P997, DOI 10.1083/jcb.108.3.997; Sirghi L, 2008, EUR BIOPHYS J BIOPHY, V37, P935, DOI 10.1007/s00249-008-0311-2; Sokolov I, 2007, CANCER NANOTECHNOL, P1; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Sunyer R, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025009; Takai E, 2005, ANN BIOMED ENG, V33, P963, DOI 10.1007/s10439-005-3555-3; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Trickey WR, 2006, J BIOMECH, V39, P78, DOI 10.1016/j.jbiomech.2004.11.006; Wang YH, 2007, J BIOL CHEM, V282, P752, DOI 10.1074/jbc.M604801200; Wang YK, 2001, AM J PHYSIOL-CELL PH, V280, pC1440, DOI 10.1152/ajpcell.2001.280.6.C1440; Wei WC, 2008, AM J PHYSIOL-CELL PH, V295, pC1579, DOI 10.1152/ajpcell.00223.2008; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859	67	55	57	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77384	10.1371/journal.pone.0077384	http://dx.doi.org/10.1371/journal.pone.0077384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194882	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000061
J	Mills, JD; Kavanagh, T; Kim, WS; Chen, BJ; Kawahara, Y; Halliday, GM; Janitz, M				Mills, James D.; Kavanagh, Tomas; Kim, Woojin S.; Chen, Bei Jun; Kawahara, Yoshihiro; Halliday, Glenda M.; Janitz, Michael			Unique Transcriptome Patterns of the White and Grey Matter Corroborate Structural and Functional Heterogeneity in the Human Frontal Lobe	PLOS ONE			English	Article							RNA-SEQ; GENE; ALZHEIMERS; NEURONS; DISEASE; COMPLEX; TOPHAT; CORTEX; GALAXY; VOLUME	The human frontal lobe has undergone accelerated evolution, leading to the development of unique human features such as language and self-reflection. Cortical grey matter and underlying white matter reflect distinct cellular compositions in the frontal lobe. Surprisingly little is known about the transcriptomal landscape of these distinct regions. Here, for the first time, we report a detailed transcriptomal profile of the frontal grey (GM) and white matter (WM) with resolution to alternatively spliced isoforms obtained using the RNA-Seq approach. We observed more vigorous transcriptome activity in GM compared to WM, presumably because of the presence of cellular bodies of neurons in the GM and RNA associated with the nucleus and perinuclear space. Among the top differentially expressed genes, we also identified a number of long intergenic non-coding RNAs (lincRNAs), specifically expressed in white matter, such as LINC00162. Furthermore, along with confirmation of expression of known markers for neurons and oligodendrocytes, we identified a number of genes and splicing isoforms that are exclusively expressed in GM or WM with examples of GABRB2 and PAK2 transcripts, respectively. Pathway analysis identified distinct physiological and biochemical processes specific to grey and white matter samples with a prevalence of synaptic processes in GM and myelination regulation and axonogenesis in the WM. Our study also revealed that expression of many genes, for example, the GPR123, is characterized by isoform switching, depending in which structure the gene is expressed. Our report clearly shows that GM and WM have perhaps surprisingly divergent transcriptome profiles, reflecting distinct roles in brain physiology. Further, this study provides the first reference data set for a normal human frontal lobe, which will be useful in comparative transcriptome studies of cerebral disorders, in particular, neurodegenerative diseases.	[Mills, James D.; Kavanagh, Tomas; Chen, Bei Jun; Janitz, Michael] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kim, Woojin S.; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW, Australia; [Kim, Woojin S.; Halliday, Glenda M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Kawahara, Yoshihiro] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Bioinformat Res Unit, Tsukuba, Ibaraki, Japan	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney; National Institute of Agrobiological Sciences - Japan	Janitz, M (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	m.janitz@unsw.edu.au	Halliday, Glenda M/E-8555-2011; Janitz, Michael/E-9823-2015	Halliday, Glenda M/0000-0003-0422-8398; Janitz, Michael/0000-0002-4878-0259; Kavanagh, Tomas/0000-0003-2184-3552; Chen, Bei Jun/0000-0002-1910-9079	National Health and Medical Research Council of Australia (NHMRC) [1022325]; National Health and Medical Research Council of Australia (NHMRC); University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism [NIH (NIAAA) R24AA012725]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725, R24AA012725] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales; Neuroscience Research Australia; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a National Health and Medical Research Council of Australia (NHMRC) project grant (#1022325). GMH is a NHMRC Senior Principal Research Fellow (#630434). Tissues were received from the Sydney Brain Bank at Neuroscience Research Australia and the New South Wales Tissue Resource Centre at the University of Sydney which are supported by the National Health and Medical Research Council of Australia (NHMRC), University of New South Wales, Neuroscience Research Australia, Schizophrenia Research Institute and National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R24AA012725). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Borgwardt S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-138; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Costa V, 2013, EUR J HUM GENET, V21, P134, DOI 10.1038/ejhg.2012.129; Courtney E, 2010, J NEUROSCI METH, V193, P189, DOI 10.1016/j.jneumeth.2010.08.018; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Halliday GM, 2011, ACTA NEUROPATHOL, V122, P187, DOI 10.1007/s00401-011-0852-9; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Ho-Pun-Cheung A, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-31; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johns TG, 1999, J NEUROCHEM, V72, P1, DOI 10.1046/j.1471-4159.1999.0720001.x; Khodosevich K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-18; Kim MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009003; KIMBERG DY, 1993, J EXP PSYCHOL GEN, V122, P411, DOI 10.1037/0096-3445.122.4.411; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Mills JD, 2013, NEUROSCI LETT, V536, P90, DOI 10.1016/j.neulet.2012.12.042; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosell A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016750; Sachdev PS, 2013, CURR OPIN PSYCHIATR, V26, P244, DOI 10.1097/YCO.0b013e32835ed6e8; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Sibille E, 2008, J NEUROSCI METH, V167, P198, DOI 10.1016/j.jneumeth.2007.08.009; Smaers JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009123; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wakabayashi K, 1998, J NEUROL SCI, V156, P114, DOI 10.1016/S0022-510X(98)00018-5; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; ZILES K, 2011, HUMAN NERVOUS SYSTEM, P836	44	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78480	10.1371/journal.pone.0078480	http://dx.doi.org/10.1371/journal.pone.0078480			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194939	gold, Green Submitted, Green Published			2022-12-25	WOS:000326037000118
J	Veloso, A; Biewen, B; Paulsen, MT; Berg, N; Lima, LCD; Prasad, J; Bedi, K; Magnuson, B; Wilson, TE; Ljungman, M				Veloso, Artur; Biewen, Benjamin; Paulsen, Michelle T.; Berg, Nathan; de Andrade Lima, Leonardo Carmo; Prasad, Jayendra; Bedi, Karan; Magnuson, Brian; Wilson, Thomas E.; Ljungman, Mats			Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin	PLOS ONE			English	Article							DNA TOPOISOMERASE-I; RNA-POLYMERASE-II; DOUBLE-STRAND BREAKS; DRUG CAMPTOTHECIN; CLEAVABLE COMPLEXES; CELLS; ELONGATION; REPAIR; DAMAGE; INITIATION	The anti-cancer drug camptothecin inhibits replication and transcription by trapping DNA topoisomerase I (Top1) covalently to DNA in a "cleavable complex". To examine the effects of camptothecin on RNA synthesis genome-wide we used Bru-Seq and show that camptothecin treatment primarily affected transcription elongation. We also observed that camptothecin increased RNA reads past transcription termination sites as well as at enhancer elements. Following removal of camptothecin, transcription spread as a wave from the 5'-end of genes with no recovery of transcription apparent from RNA polymerases stalled in the body of genes. As a result, camptothecin preferentially inhibited the expression of large genes such as proto-oncogenes, and anti-apoptotic genes while smaller ribosomal protein genes, pro-apoptotic genes and p53 target genes showed relative higher expression. Cockayne syndrome group B fibroblasts (CS-B), which are defective in transcription-coupled repair (TCR), showed an RNA synthesis recovery profile similar to normal fibroblasts suggesting that TCR is not involved in the repair of or RNA synthesis recovery from transcription-blocking Top1 lesions. These findings of the effects of camptothecin on transcription have important implications for its anti-cancer activities and may aid in the design of improved combinatorial treatments involving Top1 poisons.	[Veloso, Artur; Biewen, Benjamin; Paulsen, Michelle T.; Berg, Nathan; de Andrade Lima, Leonardo Carmo; Prasad, Jayendra; Bedi, Karan; Magnuson, Brian; Ljungman, Mats] Univ Michigan, Dept Radiat Oncol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Veloso, Artur; Biewen, Benjamin; Paulsen, Michelle T.; Berg, Nathan; de Andrade Lima, Leonardo Carmo; Prasad, Jayendra; Bedi, Karan; Magnuson, Brian; Ljungman, Mats] Univ Michigan, Translat Oncol Program, Ann Arbor, MI 48109 USA; [Veloso, Artur] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA; [Veloso, Artur] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Biewen, Benjamin] Gustavus Adolphus Coll, St Peter, MN 56082 USA; [de Andrade Lima, Leonardo Carmo] Univ Sao Paulo, Sao Paulo, Brazil; [Bedi, Karan; Ljungman, Mats] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Wilson, Thomas E.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Wilson, Thomas E.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Gustavus Adolphus College; Universidade de Sao Paulo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ljungman, M (corresponding author), Univ Michigan, Dept Radiat Oncol, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	ljungman@umich.edu	Bedi, Karan/AAA-3331-2022	Bedi, Karan/0000-0002-7843-738X; Berg, Nathaniel/0000-0002-2568-2867; Veloso, Artur/0000-0003-1735-7711	National Institute of Environmental Sciences [1R21ES020946]; National Human Genome Research Institute [1R01HG006786]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES020946] Funding Source: NIH RePORTER	National Institute of Environmental Sciences; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by funds from National Institute of Environmental Sciences (1R21ES020946) and National Human Genome Research Institute (1R01HG006786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman KJ, 2001, BRIT J CANCER, V84, P106, DOI 10.1054/bjoc.2000.1555; Chen AY, 1999, ONCOLOGY-NY, V13, P39; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Durand-Dubief M, 2011, TRANSCR-AUSTIN, V2, P66, DOI 10.4161/trns.2.2.14411; Horibata K, 2011, GENES CELLS, V16, P101, DOI 10.1111/j.1365-2443.2010.01467.x; HSIANG YH, 1988, CANCER RES, V48, P1722; HSIANG YH, 1989, CANCER RES, V49, P5077; Lin RK, 2013, J BIOL CHEM, V288, P7182, DOI 10.1074/jbc.M112.415471; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Ljungman M, 2001, ONCOGENE, V20, P5964, DOI 10.1038/sj.onc.1204734; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 1996, CARCINOGENESIS, V17, P31, DOI 10.1093/carcin/17.1.31; McKay BC, 2004, P NATL ACAD SCI USA, V101, P6582, DOI 10.1073/pnas.0308181101; NITISS J, 1988, P NATL ACAD SCI USA, V85, P7501, DOI 10.1073/pnas.85.20.7501; Paulsen MT, 2013, P NATL ACAD SCI USA, V110, P2240, DOI 10.1073/pnas.1219192110; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Sakai A, 2012, GENES GENET SYST, V87, P265, DOI 10.1266/ggs.87.265; Sakasai R, 2010, J BIOL CHEM, V285, P15201, DOI 10.1074/jbc.M110.101808; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; SQUIRES S, 1993, CANCER RES, V53, P2012; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	28	35	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78190	10.1371/journal.pone.0078190	http://dx.doi.org/10.1371/journal.pone.0078190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194914	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000093
J	Sana, TG; Soscia, C; Tonglet, CM; Garvis, S; Bleves, S				Sana, Thibault G.; Soscia, Chantal; Tonglet, Celine M.; Garvis, Steve; Bleves, Sophie			Divergent Control of Two Type VI Secretion Systems by RpoN in Pseudomonas aeruginosa	PLOS ONE			English	Article							STRAIN PAO1; PROTEIN; IDENTIFICATION; EXPRESSION; REGULON; LOCUS; ACTIVATORS; TARGETS; GENES; PHASE	Three Type VI Secretion System (T6SS) loci called H1- to H3-T6SS coexist in Pseudomonas aeruginosa. H1-T6SS targets prokaryotic cells whereas H2-T6SS mediates interactions with both eukaryotic and prokaryotic host cells. Little is known about the third system, except that it may be connected to H2-T6SS during the host infection. Here we show that H3-T6SS is required for P. aeruginosa PAO1 virulence in the worm model. We demonstrate that the two putative H3-T6SS operons, called "left" and "right", are coregulated with H2-T6SS by the Las and Rhl Quorum Sensing systems. Interestingly, the RpoN sigma 54 factor has divergent effects on the three operons. As for many T6SSs, RpoN activates the expression of H3-T6SS left. However, RpoN unexpectedly represses the expression of H3-T6SS right and also H2-T6SS. Sfa2 and Sfa3 are putative enhancer binding proteins encoded on H2-T6SS and H3-T6SS left. In other T6SSs EBPs can act as s54 activators to promote T6SS transcription. Strikingly, we found that the RpoN effects of H3-T6SS are Sfa-independent while the RpoN mediated repression of H2-T6SS is Sfa2-dependent. This is the first example of RpoN repression of a T6SS being mediated by a T6SS-encoded EBP.	[Bleves, Sophie] CNRS, UMR7255, Lab Ingn Syst Macromol, Marseille, France; Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Bleves, S (corresponding author), CNRS, UMR7255, Lab Ingn Syst Macromol, Marseille, France.	bleves@imm.cnrs.fr	Bleves, SOPHIE/HII-4948-2022; Sana, Thibault G/B-1599-2013	garvis, steve/0000-0002-0547-0672; Sana, Thibault/0000-0003-0723-6924	French Research Ministry; "Teaching & Research" fellowship (ATER) from AMU; "Pathomics" ERA-net PATHO [ANR-08-PATH-004-01]	French Research Ministry(Ministry of Research, France); "Teaching & Research" fellowship (ATER) from AMU; "Pathomics" ERA-net PATHO	TGS was financed with a PhD fellowship from the French Research Ministry and with a "Teaching & Research" fellowship (ATER) from AMU. This work was supported by "Pathomics" ERA-net PATHO (ANR-08-PATH-004-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernard CS, 2011, J BACTERIOL, V193, P2158, DOI 10.1128/JB.00029-11; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; BORDI C, 2010, MOL MICROBIOL; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; BRINT JM, 1995, J BACTERIOL, V177, P7155, DOI 10.1128/jb.177.24.7155-7163.1995; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004; Chugani S, 2007, MICROB PATHOGENESIS, V42, P29, DOI 10.1016/j.micpath.2006.10.004; Dong TG, 2012, NUCLEIC ACIDS RES, V40, P7766, DOI 10.1093/nar/gks567; EspinosaUrgel M, 1996, MOL MICROBIOL, V21, P657; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hagins JM, 2010, MICROBIOL-SGM, V156, P1201, DOI 10.1099/mic.0.033381-0; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Heurlier K, 2003, J BACTERIOL, V185, P2227, DOI 10.1128/JB.185.7.2227-2235.2003; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Miller VL, 2002, CURR OPIN MICROBIOL, V5, P211, DOI 10.1016/S1369-5274(02)00303-X; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wilderman PJ, 2001, MOL MICROBIOL, V39, P291, DOI 10.1046/j.1365-2958.2001.02282.x; Zhang WP, 2011, ARCH MICROBIOL, V193, P351, DOI 10.1007/s00203-011-0680-2; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x	42	34	36	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76030	10.1371/journal.pone.0076030	http://dx.doi.org/10.1371/journal.pone.0076030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204589	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600004
J	Bennett, L; Kersaitis, C; Macaulay, SL; Munch, G; Niedermayer, G; Nigro, J; Payne, M; Sheean, P; Vallotton, P; Zabaras, D; Bird, M				Bennett, Louise; Kersaitis, Cindy; Macaulay, Stuart Lance; Muench, Gerald; Niedermayer, Garry; Nigro, Julie; Payne, Matthew; Sheean, Paul; Vallotton, Pascal; Zabaras, Dimitrios; Bird, Michael			Vitamin D-2-Enriched Button Mushroom (Agaricus bisporus) Improves Memory in Both Wild Type and APPswe/PS1dE9 Transgenic Mice	PLOS ONE			English	Article							PLASMA AMYLOID-BETA; MOUSE MODEL; D DEFICIENCY; COGNITIVE IMPAIRMENT; EXPLORATORY ACTIVITY; ELDERLY-WOMEN; DISEASE; ALZHEIMER; BRAIN; HEALTH	Vitamin D deficiency is widespread, affecting over 30% of adult Australians, and increasing up to 80% for at-risk groups including the elderly (age>65). The role for Vitamin D in development of the central nervous system is supported by the association between Vitamin D deficiency and incidence of neurological and psychiatric disorders including Alzheimer's disease (AD). A reported positive relationship between Vitamin D status and cognitive performance suggests that restoring Vitamin D status might provide a cognitive benefit to those with Vitamin D deficiency. Mushrooms are a rich source of ergosterol, which can be converted to Vitamin D-2 by treatment with UV light, presenting a new and convenient dietary source of Vitamin D-2. We hypothesised that Vitamin D-2-enriched mushrooms (VDM) could prevent the cognitive and pathological abnormalities associated with dementia. Two month old wild type (B6C3) and AD transgenic (APP(Swe)/PS1dE9) mice were fed a diet either deficient in Vitamin D-2 or a diet which was supplemented with VDM, containing 1 +/- 0.2 mu g/kg (similar to 54 IU/kg) vitamin D-2, for 7 months. Effects of the dietary intervention on memory were assessed pre- and post-feeding. Brain sections were evaluated for amyloid beta (A beta) plaque loads and inflammation biomarkers using immuno-histochemical methods. Plasma vitamin D metabolites, A beta 40, A beta 42, calcium, protein and cholesterol were measured using biochemical assays. Compared with mice on the control diet, VDM-fed wild type and AD transgenic mice displayed improved learning and memory, had significantly reduced amyloid plaque load and glial fibrillary acidic protein, and elevated interleukin-10 in the brain. The results suggest that VDM might provide a dietary source of Vitamin D-2 and other bioactives for preventing memory-impairment in dementia. This study supports the need for a randomised clinical trial to determine whether or not VDM consumption can benefit cognitive performance in the wider population.	[Bennett, Louise; Sheean, Paul] Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Anim Food & Hlth Sci, Werribee, Vic, Australia; [Kersaitis, Cindy; Muench, Gerald; Niedermayer, Garry; Bird, Michael] Univ Western Sydney, Sch Med, Campbelltown, NSW, Australia; [Macaulay, Stuart Lance; Nigro, Julie] Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Mat Sci & Engn, Parkville, Vic, Australia; [Payne, Matthew; Vallotton, Pascal] Commonwealth Sci & Ind Res Org Math & Informat Sc, N Ryde, NSW, Australia; [Zabaras, Dimitrios] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, N Ryde, NSW, Australia; [Muench, Gerald] Univ Western Sydney, Mol Med Res Grp, Campbelltown, NSW, Australia; [Muench, Gerald] Univ Western Sydney, Ctr Complementary Med Res, Campbelltown, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Western Sydney University; Western Sydney University	Bennett, L (corresponding author), Commonwealth Sci & Ind Res Org Preventat Hlth Fla, Anim Food & Hlth Sci, Werribee, Vic, Australia.	louise.bennett@csiro.au	Vallotton, Pascal/A-3633-2009; Bennett, Louise/AAA-8266-2020; Macaulay, Stuart Lance/A-6086-2008; Zabaras, Dimitrios/B-8538-2011	Vallotton, Pascal/0000-0002-0795-8719; Bennett, Louise/0000-0001-9421-4410; Macaulay, Stuart Lance/0000-0001-5069-9516; Zabaras, Dimitrios/0000-0002-3022-7965	Horticulture Australia Limited; Australian Mushroom Growers Association; Australian Government; CSIRO Preventative Health National Research Flagship	Horticulture Australia Limited(Horticulture Australia Limited); Australian Mushroom Growers Association; Australian Government(Australian GovernmentCGIAR); CSIRO Preventative Health National Research Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	This work was conducted with support from Horticulture Australia Limited, the Australian Mushroom Growers Association, the Australian Government and the CSIRO Preventative Health National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annweiler C, 2010, NEUROLOGY, V75, P1810, DOI 10.1212/WNL.0b013e3181fd6352; Annweiler C, 2010, NEUROLOGY, V74, P27, DOI 10.1212/WNL.0b013e3181beecd3; Annweiler C, 2012, J GERONTOLOGY A; Annweiler C, 2011, J AM GERIATR SOC, V59, P169, DOI 10.1111/j.1532-5415.2010.03166.x; Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; [Anonymous], 2006, FOOD AUST, V58, P298; AOAC, 2006, FAT MILK; Balion C, 2012, NEUROLOGY, V79, P1397, DOI 10.1212/WNL.0b013e31826c197f; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Beelman R, 2009, PENN STATE RES FOUND, V28; Bennett LE, INT J MED M IN PRESS; BINI F, 2009, N S ARCH PHARMACOL, V380, P361; Bischoff-Ferrari H, 2010, DERMATOL THER, V23, P23, DOI 10.1111/j.1529-8019.2009.01288.x; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bogh MKB, 2010, J INVEST DERMATOL, V130, P546, DOI 10.1038/jid.2009.323; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; Buell JS, 2010, NEUROLOGY, V74, P18, DOI 10.1212/WNL.0b013e3181beecb7; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen MP, 2009, CLIN EXP PHARMACOL P, V36, P1099, DOI 10.1111/j.1440-1681.2009.05201.x; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Du J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005530; Dubost NJ, 2007, FOOD CHEM, V105, P727, DOI 10.1016/j.foodchem.2007.01.030; Dursun E, 2011, J ALZHEIMERS DIS, V23, P207, DOI 10.3233/JAD-2010-101377; Durup D, 2012, J CLIN ENDOCRINOLOGY; Etgen T, 2012, DEMENT GERIATR COGN, V33, P297, DOI 10.1159/000339702; Eyles DW, VITAMIN D E IN PRESS; Eyles DW, 2012, FRONTIERS NEUROENDOC; Garcia-Alloza M, 2007, J NEUROCHEM, V102, P1095, DOI 10.1111/j.1471-4159.2007.04613.x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcion E, 1998, GLIA, V22, P282, DOI 10.1002/(SICI)1098-1136(199803)22:3<282::AID-GLIA7>3.0.CO;2-7; Gardener S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.91; Gezen-Ak D, 2012, NEUROLOGICAL SCI; Gezen-Ak D, 2007, TOHOKU J EXP MED, V212, P275, DOI 10.1620/tjem.212.275; Gezen-Ak D, 2012, TOHOKU J EXP MED, V228, P189, DOI 10.1620/tjem.228.189; GLOVER M, 1952, BIOCHEM J, V51, P1; Higashi T, 2001, BIOL PHARM BULL, V24, P738, DOI 10.1248/bpb.24.738; Holick MF, 2008, MOL ASPECTS MED, V29, P361, DOI 10.1016/j.mam.2008.08.008; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ito S, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-20; Japelt RB, 2011, FOOD CHEM, V129, P217, DOI 10.1016/j.foodchem.2011.04.029; Jasinghe VJ, 2006, J TOXICOL ENV HEAL A, V69, P1979, DOI 10.1080/15287390600751413; Kalaras MD, 2012, FOOD CHEM, V135, P396, DOI 10.1016/j.foodchem.2012.04.132; Kalueff AV, 2007, CURR OPIN CLIN NUTR, V10, P12, DOI 10.1097/MCO.0b013e328010ca18; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; Kiraly SJ, 2006, THESCIENTIFICWORLDJO, V6, P125, DOI 10.1100/tsw.2006.25; Koyyalamudi SR, 2009, J AGR FOOD CHEM, V57, P3351, DOI 10.1021/jf803908q; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lalonde R, 2004, NEUROSCI LETT, V369, P156, DOI 10.1016/j.neulet.2004.07.069; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lee DM, 2009, J NEUROL NEUROSUR PS, V80, P722, DOI 10.1136/jnnp.2008.165720; Lee GS, 2009, EUR J NUTR, V48, P75, DOI 10.1007/s00394-008-0763-2; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Liu LH, 2009, FOOD CHEM, V115, P495, DOI 10.1016/j.foodchem.2008.12.042; Llewellyn DJ, 2011, J GERONTOL A-BIOL, V66, P59, DOI 10.1093/gerona/glq185; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; MALEFYT RD, 1991, J EXP MED, V174, P1209; Mattila P, 2002, J AGR FOOD CHEM, V50, P6419, DOI 10.1021/jf020608m; McPherson CS, 2010, CEREB CORTEX, V20, P941, DOI 10.1093/cercor/bhp159; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Mizwicki MT, 2012, J ALZHEIMERS DIS, V29, P51, DOI 10.3233/JAD-2012-110560; Mori K, 2009, PHYTOTHER RES, V23, P367, DOI 10.1002/ptr.2634; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, COLD SPRING HARB SYM, V55, P161; Oh ES, 2008, NEUROMOL MED, V10, P195, DOI 10.1007/s12017-008-8035-0; Oudshoorn C, 2008, DEMENT GERIATR COGN, V25, P539, DOI 10.1159/000134382; Ozzard A, 2008, BRIT J GEN PRACT, V58, P644, DOI 10.3399/bjgp08X341959; Perez-Llamas F, 2008, NUTRITION, V24, P414, DOI 10.1016/j.nut.2008.01.006; Phan CW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-102; Przybelski RJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P202, DOI 10.1016/j.abb.2006.12.018; Rapuri PB, 2004, CALCIFIED TISSUE INT, V74, P150, DOI 10.1007/s00223-003-0083-8; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Sato Y, 1998, BONE, V23, P555, DOI 10.1016/S8756-3282(98)00134-3; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Scheltens P, 2012, J ALZHEIMERS DIS, V29, P37; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Serra-Majem L, 2009, BRIT J NUTR, V101, pS21, DOI 10.1017/S0007114509990559; Sheean P, 2012, FEBS J, V279, P1291, DOI 10.1111/j.1742-4658.2012.08524.x; Short JL, 2006, NEUROPSYCHOPHARMACOL, V31, P525, DOI 10.1038/sj.npp.1300852; Slinin Y, 2012, J GERONTOLOGY A; Slominski A, 2004, EUR J BIOCHEM, V271, P4178, DOI 10.1111/j.1432-1033.2004.04356.x; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; Stephensen CB, 2012, J NUTR; Stover KR, 2012, BEHAV BRAIN RES, V231, P75, DOI 10.1016/j.bbr.2012.02.044; SUTHERLAND MK, 1992, MOL BRAIN RES, V13, P239; Szelenyi J, 2001, BRAIN RES BULL, V54, P329, DOI 10.1016/S0361-9230(01)00428-2; Tammer AH, 2002, CLIN EXP IMMUNOL, V129, P453, DOI 10.1046/j.1365-2249.2002.01905.x; Tripkovic L, 2012, AM J CLIN NUTR, V95, P1357, DOI 10.3945/ajcn.111.031070; Tukaj C, 2008, POSTEP HIG MED DOSW, V62, P502; Vehmas AK, 2001, DNA CELL BIOL, V20, P713, DOI 10.1089/10445490152717578; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang L, 2012, NEUROBIOLOGY AGING; Wang SH, 2009, NUTR RES REV, V22, P188, DOI 10.1017/S0954422409990151; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Wimo A, 2010, WORLD ALZHEIMER REPO; Xiong HQ, 2011, NEUROSCI BULL, V27, P221, DOI 10.1007/s12264-011-1015-7; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yu J, 2011, J ALZHEIMERS DIS, V25, P295, DOI 10.3233/JAD-2011-101986	102	38	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76362	10.1371/journal.pone.0076362	http://dx.doi.org/10.1371/journal.pone.0076362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204618	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300024
J	Garrigan, E; Belkin, NS; Alexander, JJ; Han, Z; Seydel, F; Carter, J; Atkinson, M; Wasserfall, C; Clare-Salzler, MJ; Amick, MA; Litherland, SA				Garrigan, Erin; Belkin, Nicole S.; Alexander, John J.; Han, Zhao; Seydel, Federica; Carter, Jamal; Atkinson, Mark; Wasserfall, Clive; Clare-Salzler, Michael J.; Amick, Matthew A.; Litherland, Sally A.			Persistent STAT5 Phosphorylation and Epigenetic Dysregulation of GM-CSF and PGS2/COX2 Expression in Type 1 Diabetic Human Monocytes	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; MACROPHAGES; ACTIVATION; MELLITUS; SITES; SUSCEPTIBILITY; INTERLEUKIN-4; DYSFUNCTION; DEFECTS; DISPLAY	STAT5 proteins are adaptor proteins for histone acetylation enzymes. Histone acetylation at promoter and enhancer chromosomal regions opens the chromatin and allows access of transcription enzymes to specific genes in rapid response cell signals, such as in inflammation. Histone acetylation-mediated gene regulation is involved in expression of 2 key inflammatory response genes: CSF2, encoding granulocyte-macrophage colony stimulating factor (GM-CSF), and PTGS2, encoding prostaglandin synthase 2/cyclooxygenase 2 (PGS2/COX2). Prolonged CSF2 expression, high GM-CSF production, and GM-CSF activation of PTGS2 gene expression all are seen in type 1 diabetes (T1D) monocytes. Persistent phosphorylation activation of monocyte STAT5 (STAT5Ptyr) is also found in individuals with or at-risk for T1D. To examine whether elevated T1D monocyte STAT5Ptyr may be associated with aberrant inflammatory gene expression in T1D, blood monocytes from non-autoimmune controls and T1D patients were analyzed by flow cytometry for STAT5Ptyr activation, and by chromatin immuno-precipitation (ChIP) analyses for STAT5Ptyr's ability to bind at CSF2 and PTGS2 regulatory sites in association with histone acetylation. In unstimulated monocytes, STAT5Ptyr was elevated in 59.65% of T1D, but only 2.44% of control subjects (p<0.0001). Increased STAT5Ptyr correlated with T1D disease duration (p = 0.0030, r(2) = 0.0784). Unstimulated (p = 0.140) and GM-CSF-stimulated (p = 0.0485) T1D monocytes, had greater STAT5Ptyr binding to epigenetic regulatory sites upstream of CSF2 than control monocytes. Increased STAT5Ptyr binding in T1D monocytes was concurrent with binding at these sites of STAT6Ptyr (p = 0.0283), CBP/P300 histone acetylase, acetylated histones H3, SMRT/NCoR histone deacetylase (p = 0.0040), and RNA Polymerase II (p = 0.0040). Our study indicates that in T1D monocytes, STAT5Ptyr activation is significantly higher and that STAT5Ptyr is found bound to CSF2 promoter and PTGS2 enhancer regions coincident with histone acetylation and RNA polymerase II. These findings suggest that the persistent activation of STAT5 by GM-CSF may be involved in altering the epigenetic regulation of these inflammatory response genes in T1D monocytes.	[Garrigan, Erin; Belkin, Nicole S.; Alexander, John J.; Han, Zhao; Seydel, Federica; Carter, Jamal; Atkinson, Mark; Wasserfall, Clive; Clare-Salzler, Michael J.; Litherland, Sally A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Amick, Matthew A.; Litherland, Sally A.] Sanford Burnham Med Res Inst Orlando, Orlando, FL USA	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute	Litherland, SA (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.	Sally.Litherland@flhosp.org	wasserfall, clive/J-9078-2012; Alexander, John/GVS-7271-2022; Wasserfall, Clive/ABF-9385-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; carter, jamal/0000-0002-2436-0428	NIH/NIDDK [DK002947, DK08082]; JDRF [33-2008-407]; NIH/NIAID [PO1 AI42288]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI042288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002947, R21DK068082] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants to SAL from the NIH/NIDDK (DK002947 & DK08082) and the JDRF (33-2008-407)and to MA/MJCS from the NIH/NIAID (PO1 AI42288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman MA, 1996, J IMMUNOL, V157, P4690; CHASE HP, 1979, J PEDIATR-US, V94, P185, DOI 10.1016/S0022-3476(79)80819-7; Chen XX, 2005, MOL CELL BIOL, V25, P3209, DOI 10.1128/MCB.25.8.3209-3219.2005; Clare-Salzler MJ, 1998, NOD MICE RELATED STR, P101; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Dendrou CA, 2008, J CLIN IMMUNOL, V9; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Feili-Hariri M, 2001, CLIN IMMUNOL, V98, P133, DOI 10.1006/clim.2000.4959; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Hamilton TA, 1999, PATHOBIOLOGY, V67, P241, DOI 10.1159/000028101; Hashimoto S, 2001, J IMMUNOL, V167, P3619, DOI 10.4049/jimmunol.167.7.3619; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Litherland S A, 2003, Pediatr Diabetes, V4, P10, DOI 10.1034/j.1399-5448.2003.00042.x; Litherland SA, 1999, J CLIN INVEST, V104, P515, DOI 10.1172/JCI4852; Litherland SA, 2005, J IMMUNOL, V175, P4561, DOI 10.4049/jimmunol.175.7.4561; Litherland SA, 2005, J AUTOIMMUN, V24, P297, DOI 10.1016/j.jaut.2005.02.001; Litherland SA, 2004, J AUTOIMMUN, V22, P227, DOI 10.1016/j.jaut.2003.12.006; Litherland SA, 2008, DIABETES, V57, P3184, DOI 10.2337/db08-1275; Maio F, 2007, J BIOL CHEM, V282, P13854; Maio F, 2008, J IMMUNOL, V180, P2264; Mi QS, 2004, DIABETES, V53, P1303, DOI 10.2337/diabetes.53.5.1303; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Ohmori Y, 1998, J BIOL CHEM, V273, P29202, DOI 10.1074/jbc.273.44.29202; Rumore-Maton B, 2009, CLIN DEV IMMUNOL, P769; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SERREZE DV, 1993, FASEB J, V7, P1092, DOI 10.1096/fasebj.7.11.8370480; SERREZE DV, 1993, J IMMUNOL, V150, P2534; Seydel F, 2008, J AUTOIMMUN, V31, P377, DOI 10.1016/j.jaut.2008.08.010; Yamaoka K, 1998, J IMMUNOL, V160, P838	31	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76919	10.1371/journal.pone.0076919	http://dx.doi.org/10.1371/journal.pone.0076919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204704	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300066
J	Pandey, RB; Farmer, BL				Pandey, Ras B.; Farmer, Barry L.			Conformational Response to Solvent Interaction and Temperature of a Protein (Histone h3.1) by a Multi-Grained Monte Carlo Simulation	PLOS ONE			English	Article							DYNAMICS; POTENTIALS	Interaction with the solvent plays a critical role in modulating the structure and dynamics of a protein. Because of the heterogeneity of the interaction strength, it is difficult to identify multi-scale structural response. Using a coarse-grained Monte Carlo approach, we study the structure and dynamics of a protein (H3.1) in effective solvent media. The structural response is examined as a function of the solvent-residue interaction strength (based on hydropathy index) in a range of temperatures (spanning low to high) involving a knowledge-based (Miyazawa-Jernigan(MJ)) residue-residue interaction. The protein relaxes rapidly from an initial random configuration into a quasi-static structure at low temperatures while it continues to diffuse at high temperatures with fluctuating conformation. The radius of gyration (R-g) of the protein responds non-monotonically to solvent interaction, i.e., on increasing the residue-solvent interaction strength (f(s)), the increase in R-g (f(s)<= f(sc)) is followed by decay (f(s)>= f(sc)) with a maximum at a characteristic value (f(sc)) of the interaction. Raising the temperature leads to wider spread of the distribution of the radius of gyration with higher magnitude of f(sc). The effect of solvent on the multi-scale (lambda residue to R-g) structures of the protein is examined by analyzing the structure factor (S(q), vertical bar q vertical bar = 2 pi/lambda is the wave vector of wavelength, lambda) in detail. Random-coil to globular transition with temperature of unsolvated protein (H3.1) is dramatically altered by the solvent at low temperature while a systematic change in structure and scale is observed on increasing the temperature. The interaction energy profile of the residues is not sufficient to predict its mobility in the solvent. Fine-grain representation of protein with two-node and three-node residue enhances the structural resolution; results of the fine-grained simulations are consistent with the finding described above of the coarse-grained description with one-node residue.	[Pandey, Ras B.] Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA; [Farmer, Barry L.] Air Force Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH USA	University of Southern Mississippi; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Pandey, RB (corresponding author), Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA.	ras.pandey@usm.edu			Air Force Research Laboratory	Air Force Research Laboratory	This work is supported by the Air Force Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betancourt MR, 1999, PROTEIN SCI, V8, P361; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Binder K, 1995, MOL DYNAMICS SIMULAT; Doster W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.098101; Fritsche M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064507; Godzik A, 1996, STRUCTURE, V4, P363, DOI 10.1016/S0969-2126(96)00041-X; Hinsen K, 2008, PROTEINS, V70, P1235, DOI 10.1002/prot.21655; Hissam RS, 2011, PHYS CHEM CHEM PHYS, V13, P21262, DOI 10.1039/c1cp22361e; Hong L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028104; Huang SY, 2011, PROTEINS, V79, P2648, DOI 10.1002/prot.23086; Kurkal V, 2005, CHEM PHYS, V317, P267, DOI 10.1016/j.chemphys.2005.05.019; Liwo A, 2008, CURR OPIN STRUC BIOL, V18, P134, DOI 10.1016/j.sbi.2007.12.001; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Materese CK, 2008, P NATL ACAD SCI USA, V105, P10659, DOI 10.1073/pnas.0801850105; Miao YL, 2012, J AM CHEM SOC, V134, P19576, DOI 10.1021/ja3097898; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Pandey RB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3358340; Pandey RB, 2012, PLOS ONE, V7; Pandey RB, 2013, PLOS ONE, V8; Sakai VG, 2013, SOFT MATTER, V9, P5336, DOI 10.1039/c3sm50492a; Xu ZJ, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3698164	21	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76069	10.1371/journal.pone.0076069	http://dx.doi.org/10.1371/journal.pone.0076069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204592	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300009
J	Wang, YL; Li, TQ				Wang, Yanlu; Li, Tie-Qiang			Analysis of Whole-Brain Resting-State fMRI Data Using Hierarchical Clustering Approach	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EFFICIENT ALGORITHM	Background: Previous studies using hierarchical clustering approach to analyze resting-state fMRI data were limited to a few slices or regions-of-interest (ROIs) after substantial data reduction. Purpose: To develop a framework that can perform voxel-wise hierarchical clustering of whole-brain resting-state fMRI data from a group of subjects. Materials and Methods: Resting-state fMRI measurements were conducted for 86 adult subjects using a single-shot echoplanar imaging (EPI) technique. After pre-processing and co-registration to a standard template, pair-wise cross-correlation coefficients (CC) were calculated for all voxels inside the brain and translated into absolute Pearson's distances after imposing a threshold CC >= 0.3. The group averages of the Pearson's distances were then used to perform hierarchical clustering with the developed framework, which entails gray matter masking and an iterative scheme to analyze the dendrogram. Results: With the hierarchical clustering framework, we identified most of the functional connectivity networks reported previously in the literature, such as the motor, sensory, visual, memory, and the default-mode functional networks (DMN). Furthermore, the DMN and visual system were split into their corresponding hierarchical sub-networks. Conclusion: It is feasible to use the proposed hierarchical clustering scheme for voxel-wise analysis of whole-brain resting-state fMRI data. The hierarchical clustering result not only confirmed generally the finding in functional connectivity networks identified previously using other data processing techniques, such as ICA, but also revealed directly the hierarchical structure within the functional connectivity networks.	[Wang, Yanlu; Li, Tie-Qiang] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Wang, Yanlu; Li, Tie-Qiang] Karolinska Univ Hosp, Dept Med Phys, Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Wang, YL (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	yanlu.wang@ki.se		Li, Tie-Qiang/0000-0002-4866-5904	Swedish Research Console	Swedish Research Console	The authors would like to acknowledge that this study is partly supported by a research grant from the Swedish Research Console. No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Benjaminsson S, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00034; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Gomez-Laberge C, 2011, BIOMEDICAL ENG IEEE, P1; Johanna Ooberg TJ, 2011, AGING RELATED CHANGE; Liu X, 2012, J NEUROSCI METH, V211, P94, DOI 10.1016/j.jneumeth.2012.08.016; Marrelec G, 2008, MED IMAGE ANAL, V12, P484, DOI 10.1016/j.media.2008.02.002; Marrelec G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014788; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narasimhan M, 2005, AGING RELATED CHANGE; Pamilo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042000; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SIBSON R, 1973, COMPUT J, V16, P30, DOI 10.1093/comjnl/16.1.30; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	17	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76315	10.1371/journal.pone.0076315	http://dx.doi.org/10.1371/journal.pone.0076315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204612	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300020
J	Ma, X; Pietsch, J; Wehland, M; Schulz, H; Saar, K; Hubner, N; Bauer, J; Braun, M; Schwarzwalder, A; Segerer, J; Birlem, M; Horn, A; Hemmersbach, R; Wasser, K; Grosse, J; Infanger, M; Grimm, D				Ma, Xiao; Pietsch, Jessica; Wehland, Markus; Schulz, Herbert; Saar, Katrin; Huebner, Norbert; Bauer, Johann; Braun, Markus; Schwarzwaelder, Achim; Segerer, Juergen; Birlem, Maria; Horn, Astrid; Hemmersbach, Ruth; Wasser, Kai; Grosse, Jirka; Infanger, Manfred; Grimm, Daniela			Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space	FASEB JOURNAL			English	Article						growth factors; microgravity; protein kinases; extracellular matrix	ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; SIMULATED MICROGRAVITY; CARCINOMA CELLS; EXTRACELLULAR-MATRIX; ANTITUMOR-ACTIVITY; BIOLOGICAL FUNCTIONS; INCREASES APOPTOSIS; TISSUE INHIBITORS; HUMAN-LYMPHOCYTES	This study focuses on the effects of short-term [22 s, parabolic flight campaign (PFC)] and long-term (10 d, Shenzhou 8 space mission) real microgravity on changes in cytokine secretion and gene expression patterns in poorly differentiated thyroid cancer cells. FTC-133 cells were cultured in space and on a random positioning machine (RPM) for 10 d, to evaluate differences between real and simulated microgravity. Multianalyte profiling was used to evaluate 128 secreted cytokines. Microarray analysis revealed 63 significantly regulated transcripts after 22 s of microgravity during a PFC and 2881 after 10 d on the RPM or in space. Genes in several biological processes, including apoptosis (n=182), cytoskeleton (n=80), adhesion/extracellular matrix (n=98), proliferation (n=184), stress response (n=268), migration (n=63), angiogenesis (n=39), and signal transduction (n=429), were differentially expressed. Genes and proteins involved in the regulation of cancer cell proliferation and metastasis, such as IL6, IL8, IL15, OPN, VEGFA, VEGFD, FGF17, MMP2, MMP3, TIMP1, PRKAA, and PRKACA, were similarly regulated under RPM and spaceflight conditions. The resulting effect was mostly antiproliferative. Gene expression during the PFC was often regulated in the opposite direction. In summary, microgravity is an invaluable tool for exploring new targets in anticancer therapy and can be simulated in some aspects in ground-based facilities.Ma, X., Pietsch, J., Wehland, M., Schulz, H., Saar, K., Hubner, N., Bauer, J., Braun, M., Schwarzwalder, A., Segerer, J., Birlem, M., Horn, A., Hemmersbach, R., Wa ss er, K., Grosse, J., Infanger, M., Grimm, D. Differential gene expression profile and altered cytokine secretion of thyroid cancer cells in space.	[Ma, Xiao; Grosse, Jirka; Grimm, Daniela] Aarhus Univ, Inst Biomed, Dept Pharmacol, DK-8000 Aarhus C, Denmark; [Pietsch, Jessica; Wehland, Markus; Infanger, Manfred] Univ Magdeburg, Clin Plast Aesthet & Hand Surg, D-39106 Magdeburg, Germany; [Schulz, Herbert; Saar, Katrin; Huebner, Norbert] Max Delbruck Ctr Mol Med, Berlin, Germany; [Bauer, Johann] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Braun, Markus] Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Gravitat Biol Grp, Bonn, Germany; [Schwarzwaelder, Achim; Segerer, Juergen; Birlem, Maria; Horn, Astrid] Astrium European Aeronaut Def & Space EADS, Immenstaad, Germany; [Hemmersbach, Ruth; Wasser, Kai] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Aerosp Med, Cologne, Germany; [Grosse, Jirka] Univ Regensburg, Dept Nucl Med, D-93053 Regensburg, Germany	Aarhus University; Otto von Guericke University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; University of Bonn; Airbus; Helmholtz Association; German Aerospace Centre (DLR); University of Regensburg	Grimm, D (corresponding author), Aarhus Univ, Inst Biomed, Wilhelm Meyers Alle 4, DK-8000 Aarhus C, Denmark.	daniela.grimm@farm.au.dk		Wehland, Markus/0000-0002-8160-859X; Grimm, Daniela/0000-0002-4991-3105; Saar, Kathrin/0000-0002-4483-1557	DLR [Bundesministerium fur Wirtschaft und Technologie (BMWi)] [50WB0824, 50WB1124]; Aarhus University (Aarhus, Denmark)	DLR [Bundesministerium fur Wirtschaft und Technologie (BMWi)]; Aarhus University (Aarhus, Denmark)	The authors thank Heidi Skou Knudsen for excellent technical assistance and Associate Professor Chun Yang (Tsinghua University, Beijing, China) for providing laboratory facilities and help during preparation for the space mission. The authors especially thank the Chinese Manned Space Engineering Office (CMSEO) and Professor Gunter Ruyters and Dr. Peter Preu [Deutsches Zentrum fur Luft- und Raumfahrt (DLR) Administration, Bonn, Germany] for providing the opportunity to participate in the Shenzhou 8 mission. This study was supported by the DLR [Bundesministerium fur Wirtschaft und Technologie (BMWi) grants 50WB0824 and 50WB1124; D. G.] and Aarhus University (Aarhus, Denmark; D. G.). The authors thank the team of PRS & EJE (Letchworth Garden City, UK) for academic proofreading of the manuscript.	Agarwal M, 2013, PROSTATE, V73, P573, DOI 10.1002/pros.22597; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Antonelli A, 2009, ENDOCR-RELAT CANCER, V16, P1299, DOI 10.1677/ERC-08-0337; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Basak GW, 2008, ONCOL REP, V19, P1173; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Belbin TJ, 2005, ARCH OTOLARYNGOL, V131, P10, DOI 10.1001/archotol.131.1.10; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Borst AG, 2009, MICROGRAVITY SCI TEC, V21, P287, DOI 10.1007/s12217-008-9043-2; Briese J, 2010, ANTICANCER RES, V30, P1681; Castellone MD, 2004, ONCOGENE, V23, P2188, DOI 10.1038/sj.onc.1207322; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; COGOLI A, 1984, SCIENCE, V225, P228, DOI 10.1126/science.6729481; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Cui YZ, 2009, INT J CANCER, V124, P1614, DOI 10.1002/ijc.24163; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Grimm D, 2002, FASEB J, V16, P604, DOI 10.1096/fj.01-0673fje; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Grimm D, 2010, TISSUE ENG PT A, V16, P1559, DOI [10.1089/ten.tea.2009.0524, 10.1089/ten.TEA.2009.0524]; Grimm D, 2009, CURR VASC PHARMACOL, V7, P347, DOI 10.2174/157016109788340640; Grimm D, 2009, TISSUE ENG PT A, V15, P2267, DOI 10.1089/ten.tea.2008.0576; Grosse J, 2013, CELL PHYSIOL BIOCHEM, V32, P154, DOI 10.1159/000350132; Grosse J, 2012, FASEB J, V26, P5124, DOI 10.1096/fj.12-215749; Grosse J, 2012, FASEB J, V26, P639, DOI 10.1096/fj.11-194886; Guarino V, 2005, J CLIN ENDOCR METAB, V90, P5270, DOI 10.1210/jc.2005-0271; Heer R, 2004, J PATHOL, V204, P578, DOI 10.1002/path.1668; Hoelting T, 1997, CANCER LETT, V119, P1, DOI 10.1016/S0304-3835(97)00242-5; Hsueh C, 2011, J SURG ONCOL, V103, P395, DOI 10.1002/jso.21844; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Huigsloot M, 2011, AM J HUM GENET, V88, P488, DOI 10.1016/j.ajhg.2011.03.002; Infanger M, 2005, J VASC RES, V42, P202, DOI 10.1159/000085176; Infanger M, 2004, BURNS, V30, P305, DOI 10.1016/j.burns.2003.12.006; Infanger M, 2008, ANN VASC SURG, V22, P273, DOI 10.1016/j.avsg.2007.11.002; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kimura K, 2000, CANCER IMMUNOL IMMUN, V49, P71, DOI 10.1007/s002620050604; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; Kossmehl P, 2006, APOPTOSIS, V11, P347, DOI 10.1007/s10495-006-4350-9; Kossmehl P, 2003, ENDOCRINOLOGY, V144, P4172, DOI 10.1210/en.2002-0171; Kraiem Z, 2000, THYROID, V10, P1061, DOI 10.1089/thy.2000.10.1061; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; LaPorta CAM, 1997, CLIN EXP METASTAS, V15, P568, DOI 10.1023/A:1018447531813; Lee YY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.76; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Levina V, 2009, CLIN CANCER RES, V15, P2647, DOI 10.1158/1078-0432.CCR-08-2024; Lewis ML, 1998, FASEB J, V12, P1007, DOI 10.1096/fasebj.12.11.1007; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Maccarrone M, 2003, J LEUKOCYTE BIOL, V73, P472, DOI 10.1189/jlb.0602295; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; Mori M, 2006, J CLIN INVEST, V116, P395, DOI 10.1172/JCI20797; Murooka TT, 2005, CANC TREAT, V126, P15, DOI 10.1007/0-387-24361-5_2; Nersita R, 2012, CLIN ENDOCRINOL, V76, P142, DOI 10.1111/j.1365-2265.2011.04183.x; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Ornitz DM, 2001, GENOME BIOL, V2; Pemberton PA, 1997, J HISTOCHEM CYTOCHEM, V45, P1697, DOI 10.1177/002215549704501213; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Pietsch J, 2013, BIOMATERIALS, V34, P7694, DOI 10.1016/j.biomaterials.2013.06.054; Pietsch J, 2010, PROTEOMICS, V10, P904, DOI 10.1002/pmic.200900226; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Rothermund L, 2002, AM J HYPERTENS, V15, P644, DOI 10.1016/S0895-7061(02)02956-4; Sarrio D, 2006, BREAST CANCER RES TR, V98, P71, DOI 10.1007/s10549-005-9133-4; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Ulbrich C, 2008, J CELL BIOCHEM, V104, P1324, DOI 10.1002/jcb.21710; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Ulbrich C, 2010, CELL PHYSIOL BIOCHEM, V25, P551, DOI 10.1159/000303059; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; Villagra A, 2007, J BIOL CHEM, V282, P35457, DOI 10.1074/jbc.M701719200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Volpe V, 2013, J CLIN ENDOCR METAB, V98, P228, DOI 10.1210/jc.2012-2528; Wehland M, 2013, CELL PHYSIOL BIOCHEM, V31, P432, DOI 10.1159/000343380; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Xu JS, 2000, DEVELOPMENT, V127, P1833; Xu JS, 1999, MECH DEVELOP, V83, P165, DOI 10.1016/S0925-4773(99)00034-9; Yu P, 2010, CLIN CANCER RES, V16, P6019, DOI 10.1158/1078-0432.CCR-10-1966; Zeng J, 2012, COMB CHEM HIGH T SCR, V15, P276, DOI 10.2174/138620712799218608; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106; Zhu AX, 2009, J CLIN ONCOL, V27, P3027, DOI 10.1200/JCO.2008.20.9908; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	98	97	97	4	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					813	835		10.1096/fj.13-243287	http://dx.doi.org/10.1096/fj.13-243287			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24196587				2022-12-25	WOS:000331072200028
J	Spaethling, JM; Piel, D; Dueck, H; Buckley, PT; Morris, JF; Fisher, SA; Lee, J; Sul, JY; Kim, J; Bartfai, T; Beck, SG; Eberwine, JH				Spaethling, Jennifer M.; Piel, David; Dueck, Hannah; Buckley, Peter T.; Morris, Jacqueline F.; Fisher, Stephen A.; Lee, JaeHee; Sul, Jai-Yoon; Kim, Junhyong; Bartfai, Tamas; Beck, Sheryl G.; Eberwine, James H.			Serotonergic neuron regulation informed by in vivo single-cell transcriptomics	FASEB JOURNAL			English	Article						RNA-Seq; GPCR; electophysiology; histamine; dorsal raphe	HISTAMINE H-3 RECEPTOR; DORSAL RAPHE NEURONS; RAT-BRAIN; EXPRESSION; MICE; OXYTOCIN; LIGANDS; NUCLEUS; ANXIETY; GENES	Despite the recognized importance of the dorsal raphe (DR) serotonergic (5-HT) nuclei in the pathophysiology of depression and anxiety, the molecular components/putative drug targets expressed by these neurons are poorly characterized. Utilizing the promoter of an ETS domain transcription factor that is a stable marker of 5-HT neurons (Pet-1) to drive 5-HT neuronal expression of YFP, we identified 5-HT neurons in live acute slices. We isolated RNA from single 5-HT neurons in the ventromedial and lateral wings of the DR and performed single-cell RNA-Seq analysis identifying >500 G-protein coupled receptors (GPCRs) including receptors for classical transmitters, lipid signals, and peptides as well as dozens of orphan-GPCRs. Using these data to inform our selection of receptors to assess, we found that oxytocin and lysophosphatidic acid 1 receptors are translated and active in costimulating, with the (1)-adrenergic receptor, the firing of DR 5-HT neurons, while the effects of histamine are inhibitory and exerted at H3 histamine receptors. The inhibitory histamine response provides evidence for tonic in vivo histamine inhibition of 5-HT neurons. This study illustrates that unbiased single-cell transcriptomics coupled with functional analyses provides novel insights into how neurons and neuronal systems are regulated.Spaethling, J. M., Piel, D., Dueck, H., Buckley, P. T., Morris, J. F., Fisher, S. A., Lee, J., Sul, J.-Y., Kim, J., Bartfai, T., Beck, S. G., Eberwine, J. H. Serotonergic neuron regulation informed by in vivo single-cell transcriptomics.	[Spaethling, Jennifer M.; Buckley, Peter T.; Morris, Jacqueline F.; Lee, JaeHee; Sul, Jai-Yoon; Eberwine, James H.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Dueck, Hannah; Fisher, Stephen A.; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Piel, David; Beck, Sheryl G.] Childrens Hosp Philadelphia, Res Inst, Dept Anesthesiol, Philadelphia, PA 19104 USA; [Bartfai, Tamas] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Scripps Research Institute	Eberwine, JH (corresponding author), Univ Penn, 37 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	eberwine@upenn.edu			U.S. National Institutes of Health [MH075047, DP1OD004117]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075047] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD004117] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by U.S. National Institutes of Health grants MH075047 (to S.B.) and DP1OD004117 (to J.E).	Allen MC, 1998, EUR J PHARMACOL, V361, P261, DOI 10.1016/S0014-2999(98)00719-5; Aman TK, 2007, J PHARMACOL EXP THER, V320, P376, DOI 10.1124/jpet.106.111690; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Artigas F, 2001, TRENDS PHARMACOL SCI, V22, P224, DOI 10.1016/S0165-6147(00)01682-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Bartfai T, 2012, TRENDS PHARMACOL SCI, V33, P9, DOI 10.1016/j.tips.2011.09.006; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bosch OJ, 2011, HORM BEHAV, V59, P202, DOI 10.1016/j.yhbeh.2010.11.012; Boudaba C, 2006, AM J PHYSIOL-REG I, V291, pR102, DOI 10.1152/ajpregu.00795.2005; Buckley PT, 2011, NEURON, V69, P877, DOI 10.1016/j.neuron.2011.02.028; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Crawford LK, 2013, ACS CHEM NEUROSCI, V4, P200, DOI 10.1021/cn300238j; Crawford LK, 2010, J NEUROPHYSIOL, V103, P2652, DOI 10.1152/jn.01132.2009; Drutel G, 2001, MOL PHARMACOL, V59, P1; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eberwine J., 2001, CURR PROTOC NEUROSCI, V5; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Hardoy Maria Carolina, 2010, Clin Pract Epidemiol Ment Health, V6, P1, DOI 10.2174/1745017901006010001; Hendricks T, 1999, J NEUROSCI, V19, P10348; Im DS, 2000, MOL PHARMACOL, V57, P753, DOI 10.1124/mol.57.4.753; JANSEN FP, 1994, BRIT J PHARMACOL, V113, P355, DOI 10.1111/j.1476-5381.1994.tb16995.x; Johnson PL, 2004, ANN NY ACAD SCI, V1018, P58, DOI 10.1196/annals.1296.006; Kim MA, 2004, BRAIN RES, V1026, P56, DOI 10.1016/j.brainres.2004.08.022; LAKOSKI JM, 1984, EUR J PHARMACOL, V103, P153, DOI 10.1016/0014-2999(84)90202-4; Larsen PJ, 1996, NEUROSCIENCE, V70, P963, DOI 10.1016/0306-4522(95)00415-7; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Machado-Vieira R, 2010, PHARMACEUTICALS, V3, P19, DOI 10.3390/ph3010019; Perez-Garcia C, 1999, PSYCHOPHARMACOLOGY, V142, P215, DOI 10.1007/s002130050882; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; R Core Team, 2022, R LANG ENV STAT COMP; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Rizk A, 2004, EUR J NEUROSCI, V19, P1992, DOI 10.1111/j.1460-9568.2004.03251.x; Roberts C, 2005, NEUROCHEM RES, V30, P371, DOI 10.1007/s11064-005-2611-6; Sakai K, 2000, NEUROREPORT, V11, P3237, DOI 10.1097/00001756-200009280-00037; Sakai K, 2001, NEUROSCIENCE, V104, P1141, DOI 10.1016/S0306-4522(01)00103-8; Santin LJ, 2009, GENES BRAIN BEHAV, V8, P772, DOI 10.1111/j.1601-183X.2009.00524.x; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Sharman JL, 2011, NUCLEIC ACIDS RES, V39, pD534, DOI 10.1093/nar/gkq1062; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Souza RP, 2010, INT J NEUROPSYCHOPH, V13, P793, DOI 10.1017/S1461145710000167; SUGIURA T, 1994, ARCH BIOCHEM BIOPHYS, V311, P358, DOI 10.1006/abbi.1994.1249; Takei H, 2012, NEUROSCI LETT, V518, P55, DOI 10.1016/j.neulet.2012.04.056; Templin JS, 2012, BRAIN RES, V1457, P1, DOI 10.1016/j.brainres.2012.03.066; Terenzi MG, 2005, NEUROSCIENCE, V134, P345, DOI 10.1016/j.neuroscience.2005.04.004; Threlfell S, 2004, J NEUROSCI, V24, P8704, DOI 10.1523/JNEUROSCI.2690-04.2004; van der Goot H, 2000, EUR J MED CHEM, V35, P5, DOI 10.1016/S0223-5234(00)00101-X; Warnes GR, 2012, GPLOTS VARIOUS R PRO; Woclawek-Potocka I, 2009, EXP BIOL MED, V234, P986, DOI 10.3181/0901-RM-36; Yoshida M, 2009, J NEUROSCI, V29, P2259, DOI 10.1523/JNEUROSCI.5593-08.2009	52	43	46	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					771	780		10.1096/fj.13-240267	http://dx.doi.org/10.1096/fj.13-240267			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24192459	Green Published, Bronze			2022-12-25	WOS:000331072200024
J	Zapata-Morales, JR; Galicia-Cruz, OG; Franco, M; Morales, FMY				Zapata-Morales, Juan R.; Galicia-Cruz, Othir G.; Franco, Martha; Martinez y Morales, Flavio			Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) Protein Diminishes Sodium Glucose Transport 1 (SGLT1) and SGLT2 Protein Expression in Renal Epithelial Tubular Cells (LLC-PK1) under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucose Transport; Hypoxia; Hypoxia-inducible factor (HIF); Kidney Metabolism; Renal Physiology; GLUT1; Renal Glucose Transporters; SGLT1; SGLT2	NITRIC-OXIDE; OXYGEN-CONSUMPTION; GENE-EXPRESSION; FACTOR-ALPHA; FACTOR-I; COBALT; INJURY; ACTIVATION; KIDNEY; HIF-1	In this work, we demonstrated the regulation of glucose transporters by hypoxia inducible factor-1 (HIF-1) activation in renal epithelial cells. LLC-PK1 monolayers were incubated for 1, 3, 6, or 12 h with 0% or 5% O-2 or 300 m cobalt (CoCl2). We evaluated the effects of hypoxia on the mRNA and protein expression of HIF-1 and of the glucose transporters SGLT1, SGLT2, and GLUT1. The data showed an increase in HIF-1 mRNA and protein expression under the three evaluated conditions (p < 0.05 versus t = 0). An increase in GLUT1 mRNA (12 h) and protein expression (at 3, 6, and 12 h) was observed (p < 0.05 versus t = 0). SGLT1 and SGLT2 mRNA and protein expression decreased under the three evaluated conditions (p < 0.05 versus t = 0). In conclusion, our results suggest a clear decrease in the expression of the glucose transporters SGLT1 and SGLT2 under hypoxic conditions which implies a possible correlation with increased expression of HIF-1.	[Zapata-Morales, Juan R.; Galicia-Cruz, Othir G.; Martinez y Morales, Flavio] Univ San Luis Potosi, Sch Med, Dept Pharmacol, Los Filtros 78210, San Luis Potosi, Mexico; [Franco, Martha] Inst Nacl Cardiol Dr Ignacio Chavez, Dept Nephrol, Mexico City 14080, DF, Mexico	Universidad Autonoma de San Luis Potosi; National Institute of Cardiology - Mexico	Morales, FMY (corresponding author), Univ San Luis Potosi, Sch Med, Dept Pharmacol, 2405 V Carranza Ave, Los Filtros 78210, San Luis Potosi, Mexico.	martinej@uaslp.mx	Martinez, Flavio/E-9854-2011	Martinez, Flavio/0000-0003-0339-1089; Zapata-Morales, Juan Ramon/0000-0001-6523-5474; Franco, Martha/0000-0003-4073-524X	Programa para el Mejoramiento del Profesorado (PROMEP) [PROMEP/103.5/09/599]; Programa Integral de Fortalecimiento Institucional (PIFI) [2009-24MSU0011E-12]; CONACYT-Mx Fellowship [205614/200424]	Programa para el Mejoramiento del Profesorado (PROMEP); Programa Integral de Fortalecimiento Institucional (PIFI); CONACYT-Mx Fellowship	This work was supported by Programa para el Mejoramiento del Profesorado (PROMEP) Grant PROMEP/103.5/09/599 (to O. G. G.-C.) and Programa Integral de Fortalecimiento Institucional (PIFI) Grant 2009-24MSU0011E-12 (to F. M. M.).; Supported by CONACYT-Mx Fellowship 205614/200424.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; AUKLAND K, 1960, NATURE, V188, P671, DOI 10.1038/188671a0; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; BRUNDIN T, 1994, AM J PHYSIOL-ENDOC M, V267, pE648, DOI 10.1152/ajpendo.1994.267.5.E648; Chaudary N, 2004, CARDIOVASC RES, V61, P780, DOI 10.1016/j.cardiores.2003.11.031; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; De Boeck M, 2003, MUTAT RES-FUND MOL M, V533, P135, DOI 10.1016/j.mrfmmm.2003.07.012; Deng AH, 2005, KIDNEY INT, V68, P723, DOI 10.1111/j.1523-1755.2005.00450.x; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; El Awad B, 2000, KIDNEY INT, V58, P43, DOI 10.1046/j.1523-1755.2000.00139.x; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Evans RG, 2008, AM J PHYSIOL-RENAL, V295, pF1259, DOI 10.1152/ajprenal.90230.2008; Friederich M, 2009, CURR DIABETES REV, V5, P120, DOI 10.2174/157339909788166800; Graven KK, 1999, BBA-GENE STRUCT EXPR, V1447, P208, DOI 10.1016/S0167-4781(99)00118-9; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; JONES DP, 1982, AM J PHYSIOL, V243, pC247, DOI 10.1152/ajpcell.1982.243.5.C247; Kles KA, 2002, AM J PHYSIOL-GASTR L, V283, pG1336, DOI 10.1152/ajpgi.00055.2002; Lang Florian, 2005, Clin Exp Nephrol, V9, P91, DOI 10.1007/s10157-005-0355-x; Leonard MO, 2003, J BIOL CHEM, V278, P40296, DOI 10.1074/jbc.M302560200; Lison D, 2001, OCCUP ENVIRON MED, V58, P619, DOI 10.1136/oem.58.10.619; Lukiw WJ, 2003, INVEST OPHTH VIS SCI, V44, P4163, DOI 10.1167/iovs.02-0655; Maldonado-Cervantes MI, 2012, J PHYSIOL BIOCHEM, V68, P411, DOI 10.1007/s13105-012-0153-3; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Maxwell P, 2003, J AM SOC NEPHROL, V14, P2712, DOI 10.1097/01.ASN.0000092792.97122.E0; Nagy G, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-79; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; OHTA T, 1990, MOL CELL BIOL, V10, P6491, DOI 10.1128/MCB.10.12.6491; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Phillips AO, 1997, AM J PATHOL, V150, P1101; Pourgholami MH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-143; Rosenberger C, 2008, KIDNEY INT, V73, P34, DOI 10.1038/sj.ki.5002567; Sandau KB, 2001, J BIOL CHEM, V276, P39805, DOI 10.1074/jbc.M107689200; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; TAKANO T, 1985, J CLIN INVEST, V76, P2377, DOI 10.1172/JCI112250; Takiyama Y, 2011, DIABETES, V60, P981, DOI 10.2337/db10-0655; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 2001, CANCER RES, V61, P5215; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; YOU YD, 1992, J AM SOC NEPHROL, V3, P965; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	46	36	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					346	357		10.1074/jbc.M113.526814	http://dx.doi.org/10.1074/jbc.M113.526814			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24196951	Green Published, hybrid			2022-12-25	WOS:000329370900030
J	Okatsu, K; Uno, M; Koyano, F; Go, E; Kimura, M; Oka, T; Tanaka, K; Matsuda, N				Okatsu, Kei; Uno, Midori; Koyano, Fumika; Go, Etsu; Kimura, Mayumi; Oka, Toshihiko; Tanaka, Keiji; Matsuda, Noriyuki			A Dimeric PINK1-containing Complex on Depolarized Mitochondria Stimulates Parkin Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Parkin; Parkinson Disease; Phosphorylation; Pink1	PINK1/PARKIN-MEDIATED MITOPHAGY; NATIVE ELECTROPHORESIS; DAMAGED MITOCHONDRIA; KINASE DOMAIN; PINK1; MEMBRANE; DISEASE; TRANSLOCATION; MUTATIONS; NEURONS	Background: PINK1 functions on depolarized mitochondria. However, details regarding its mechanism remain limited. Results: We reveal the formation of a high molecular weight complex composed of two phosphorylated PINK1 molecules that stimulates Parkin recruitment. Conclusion: The dimeric PINK1-containing complex is important for mitochondrial quality control. Significance: The PINK1 molecular process is reminiscent of receptor kinase dimerization in signal transduction. Parkinsonism typified by sporadic Parkinson disease is a prevalent neurodegenerative disease. Mutations in PINK1 (PTEN-induced putative kinase 1), a mitochondrial Ser/Thr protein kinase, or PARKIN, a ubiquitin-protein ligase, cause familial parkinsonism. The accumulation and autophosphorylation of PINK1 on damaged mitochondria results in the recruitment of Parkin, which ultimately triggers quarantine and/or degradation of the damaged mitochondria by the proteasome and autophagy. However, the molecular mechanism of PINK1 in dissipation of the mitochondrial membrane potential (m) has not been fully elucidated. Here we show by fluorescence-based techniques that the PINK1 complex formed following a decrease in m is composed of two PINK1 molecules and is correlated with intermolecular phosphorylation of PINK1. Disruption of complex formation by the PINK1 S402A mutation weakened Parkin recruitment onto depolarized mitochondria. The most disease-relevant mutations of PINK1 inhibit the complex formation. Taken together, these results suggest that formation of the complex containing dyadic PINK1 is an important step for Parkin recruitment onto damaged mitochondria.	[Okatsu, Kei; Koyano, Fumika; Go, Etsu; Kimura, Mayumi; Tanaka, Keiji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Okatsu, Kei; Koyano, Fumika] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Uno, Midori; Oka, Toshihiko] Rikkyo Univ, Dept Life Sci, Coll Sci, Tokyo 1718501, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Rikkyo University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan.	tanaka-kj@igakuken.or.jp; matsuda-nr@igakuken.or.jp	Matsuda, Noriyuki/AAI-3156-2020	Matsuda, Noriyuki/0000-0001-8199-952X; Okatsu, Kei/0000-0001-8949-3750	Japan Society for the Promotion of Science (JSPS) KAKENHI [23687018]; MEXT KAKENHI [24111557, 25112522]; Takeda Science Foundation; Tomizawa Jun-ichi and Keiko Fund for Young Scientists; JSPS KAKENHI [23570232, 23'6061]; JST; KAKENHI [21000012]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tomizawa Jun-ichi and Keiko Fund for Young Scientists; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST(Japan Science & Technology Agency (JST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 23687018 and MEXT KAKENHI Grants 24111557 and 25112522, the Takeda Science Foundation, and the Tomizawa Jun-ichi and Keiko Fund for Young Scientists (to N. M.); by JSPS KAKENHI Grant 23570232 and the grant for CREST from JST (to T. O.); by JSPS KAKENHI Grant 23'6061 (to K. O.); and by KAKENHI Grant 21000012 and the Takeda Science Foundation (to K. T.).	Amo T, 2011, NEUROBIOL DIS, V41, P111, DOI 10.1016/j.nbd.2010.08.027; Becker D, 2012, J BIOL CHEM, V287, P22969, DOI 10.1074/jbc.M112.365700; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Cai Q, 2012, CURR BIOL, V22, P545, DOI 10.1016/j.cub.2012.02.005; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Deas E, 2011, HUM MOL GENET, V20, P867, DOI 10.1093/hmg/ddq526; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Geisler S, 2010, AUTOPHAGY, V6, P871, DOI 10.4161/auto.6.7.13286; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Iguchi M, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.467530; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2013, GENES CELLS, V18, P672, DOI 10.1111/gtc.12066; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Meissner C, 2011, J NEUROCHEM, V117, P856, DOI 10.1111/j.1471-4159.2011.07253.x; Narendra D, 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schapira AHV, 2008, LANCET NEUROL, V7, P97, DOI 10.1016/S1474-4422(07)70327-7; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shi G, 2011, HUM MOL GENET, V20, P1966, DOI 10.1093/hmg/ddr077; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Song S, 2013, J BIOL CHEM, V288, P5660, DOI 10.1074/jbc.M112.430801; Swamy M, 2007, J IMMUNOL METHODS, V324, P74, DOI 10.1016/j.jim.2007.05.003; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Van Laar VS, 2011, HUM MOL GENET, V20, P927, DOI 10.1093/hmg/ddq531; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang JY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3428; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	59	128	130	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36372	36384		10.1074/jbc.M113.509653	http://dx.doi.org/10.1074/jbc.M113.509653			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189060	hybrid, Green Published			2022-12-25	WOS:000328883400019
J	Berlina, AN; Taranova, NA; Zherdev, AV; Sankov, MN; Andreev, IV; Martynov, AI; Dzantiev, BB				Berlina, Anna N.; Taranova, Nadezhda A.; Zherdev, Anatoly V.; Sankov, Mikhail N.; Andreev, Igor V.; Martynov, Alexandr I.; Dzantiev, Boris B.			Quantum-Dot-Based Immunochromatographic Assay for Total IgE in Human Serum	PLOS ONE			English	Article							ALLERGEN-SPECIFIC IGE; CHLORAMPHENICOL; IMMUNOASSAYS; NANOCRYSTALS; ANTIBODIES; CLUSTERS; PROTEIN; MILK	To rapidly quantify total immunoglobulin E levels in human serum, we developed a novel quantum-dot-based immunochromatographic assay that employs digital recording of fluorescence. It can detect IgE levels of 5-1000 kU/L, with a coefficient of variation ranging from 2.0 to 9.5%. The assay can be processed in 10 min. The developed assay was tested on 95 serum samples. The correlation coefficient between the IgE values obtained by the proposed assay and those obtained by a commercial ELISA kit was 0.9884. Our assay thus shows promise as a new diagnostic tool for IgE detection.	[Berlina, Anna N.; Taranova, Nadezhda A.; Zherdev, Anatoly V.; Dzantiev, Boris B.] Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia; [Sankov, Mikhail N.; Andreev, Igor V.; Martynov, Alexandr I.] Russian Fed Medicobiol Agcy, Inst Immunol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; NRC Institute of Immunology FMBA of Russia	Dzantiev, BB (corresponding author), Russian Acad Sci, AN Bach Inst Biochem, Moscow, Russia.	dzantiev@inbi.ras.ru	Dzantiev, Boris B/C-6125-2014; Taranova, Nadezhda A./I-9872-2014; Berlina, Anna N./F-8900-2017; Zherdev, Anatoly V/G-2916-2013	Zherdev, Anatoly V/0000-0003-3008-2839; Berlina, Anna/0000-0002-3761-7472; Martynov, Alexandr/0000-0001-9761-8058	Ministry of Education and Science of the Russian Federation [8284]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by the Ministry of Education and Science of the Russian Federation (State Target Program "Research and scientific-pedagogical personnel of innovative Russia in 2009-2013, contract No. 8284). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algar WR, 2010, ANAL CHIM ACTA, V673, P1, DOI 10.1016/j.aca.2010.05.026; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; BAZARAL M, 1972, J ALLERGY CLIN IMMUN, V49, P189, DOI 10.1016/0091-6749(72)90113-3; Beloglazova NV, 2011, MICROCHIM ACTA, V175, P361, DOI 10.1007/s00604-011-0682-4; Berlina AN, 2013, MEAS TECH+, V55, P1434, DOI 10.1007/s11018-013-0145-x; Berlina AN, 2013, ANAL BIOANAL CHEM, V405, P4997, DOI 10.1007/s00216-013-6876-3; Biotec Milenia, 2009, LAT FLOW IMM QUANT M; Blank U, 2011, ADV EXP MED BIOL, V716, P107, DOI 10.1007/978-1-4419-9533-9_7; Byzova NA, 2010, TALANTA, V81, P843, DOI 10.1016/j.talanta.2010.01.025; Byzova NA, 2010, IMMUNOLOGY, P47; Doekes G, 1996, OCCUP ENVIRON MED, V53, P63, DOI 10.1136/oem.53.1.63; GLEICH GJ, 1975, SCIENCE, V190, P1106, DOI 10.1126/science.1188389; GLEICH GJ, 1971, J LAB CLIN MED, V77, P690; Glovsky M Michael, 2007, Methods Mol Biol, V378, P205, DOI 10.1007/978-1-59745-323-3_15; Goldman ER, 2006, ANAL BIOANAL CHEM, V384, P560, DOI 10.1007/s00216-005-0212-5; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; IgE, 2013, IGE HUMAN ELISA KIT; Johansson SGO, 2011, CURR ALLERGY ASTHM R, V11, P173, DOI 10.1007/s11882-010-0174-3; Liskova M, 2011, ANAL BIOANAL CHEM, V400, P369, DOI 10.1007/s00216-011-4700-5; Liu GD, 2007, ANAL CHEM, V79, P7644, DOI 10.1021/ac070691i; Liu JM, 2012, J FLUORESC, V22, P419, DOI 10.1007/s10895-011-0975-3; Lowe PJ, 2011, BRIT J CLIN PHARMACO, V72, P306, DOI 10.1111/j.1365-2125.2011.03962.x; Mahmoud W, 2011, ANAL BIOCHEM, V416, P180, DOI 10.1016/j.ab.2011.05.018; Oleinikov VA, 2011, RUSS J BIOORG CHEM+, V37, P151, DOI 10.1134/S1068162011020117; Pyo D, 2012, J IMMUNOASS IMMUNOCH, V33, P203, DOI 10.1080/15321819.2011.618863; Sinclair D, 2004, J CLIN PATHOL, V57, P956, DOI 10.1136/jcp.2004.017681; STANWORTH DR, 1993, ALLERGY, V48, P67, DOI 10.1111/j.1398-9995.1993.tb00687.x; Sun BQ, 2008, J NANJING MED U, V22, P273; Urusov AE, 2011, J ANAL CHEM+, V66, P770, DOI 10.1134/S1061934811080144; Wang Y, 2011, IET NANOBIOTECHNOL, V5, P14, DOI 10.1049/iet-nbt.2010.0001; WHO Expert Committee on Biological Standartization, 1973, 25 WHO EXP COMM BIOL; Wong RC, 2009, LATERAL FLOW IMMUNOASSAY, P1, DOI 10.1007/978-1-59745-240-3; Yang H, 2010, NANOSCALE RES LETT, V5, P875, DOI 10.1007/s11671-010-9578-1; Yao JJ, 2012, ANAL CHEM, V84, P1645, DOI 10.1021/ac202910y	34	19	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77485	10.1371/journal.pone.0077485	http://dx.doi.org/10.1371/journal.pone.0077485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204841	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500030
J	Lin, JR; Hu, JJ				Lin, Jhih-rong; Hu, Jianjun			SeqNLS: Nuclear Localization Signal Prediction Based on Frequent Pattern Mining and Linear Motif Scoring	PLOS ONE			English	Article							SEQUENCE; PROTEINS; BINDING; SERVER; IDENTIFICATION; RECOGNITION; DEFINITION; DISCOVERY; DATABASE; CONTEXT	Nuclear localization signals (NLSs) are stretches of residues in proteins mediating their importing into the nucleus. NLSs are known to have diverse patterns, of which only a limited number are covered by currently known NLS motifs. Here we propose a sequential pattern mining algorithm SeqNLS to effectively identify potential NLS patterns without being constrained by the limitation of current knowledge of NLSs. The extracted frequent sequential patterns are used to predict NLS candidates which are then filtered by a linear motif-scoring scheme based on predicted sequence disorder and by the relatively local conservation (IRLC) based masking. The experiment results on the newly curated Yeast and Hybrid datasets show that SeqNLS is effective in detecting potential NLSs. The performance comparison between SeqNLS with and without the linear motif scoring shows that linear motif features are highly complementary to sequence features in discerning NLSs. For the two independent datasets, our SeqNLS not only can consistently find over 50% of NLSs with prediction precision of at least 0.7, but also outperforms other state-of-the-art NLS prediction methods in terms of F1 score or prediction precision with similar or higher recall rates. The web server of the SeqNLS algorithm is available at http://mleg.cse.sc.edu/seqNLS.	[Lin, Jhih-rong; Hu, Jianjun] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hu, JJ (corresponding author), Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.	jianjunh@cse.sc.edu			National Science Foundation [BIO-DBI-0845381]; Div Of Biological Infrastructure [0845381] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation Career Award (Grant BIO-DBI-0845381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Davey NE, 2012, MOL BIOSYST, V8, P268, DOI 10.1039/c1mb05231d; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Davey NE, 2009, BIOINFORMATICS, V25, P443, DOI 10.1093/bioinformatics/btn664; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gutman R, 2005, NUCLEIC ACIDS RES, V33, pW255, DOI 10.1093/nar/gki496; Hahn S, 2008, J MOL BIOL, V379, P678, DOI 10.1016/j.jmb.2008.04.038; Haslam NJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-104; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lange A, 2010, TRAFFIC, V11, P311, DOI 10.1111/j.1600-0854.2009.01028.x; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mehdi AM, 2011, BIOINFORMATICS, V27, P1239, DOI 10.1093/bioinformatics/btr121; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Nair R, 2003, NUCLEIC ACIDS RES, V31, P397, DOI 10.1093/nar/gkg001; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Ramu C, 2003, NUCLEIC ACIDS RES, V31, P3771, DOI 10.1093/nar/gkg546; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Tan PN, 2006, INTRO DATA MINING, Vxxi; Tan SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-502; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Via A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-351	42	67	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76864	10.1371/journal.pone.0076864	http://dx.doi.org/10.1371/journal.pone.0076864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204689	gold, Green Published			2022-12-25	WOS:000326270700013
J	Yang, RR; Yang, L; Qiu, FM; Zhang, LS; Wang, H; Yang, XR; Deng, JQ; Fang, WX; Zhou, YF; Lu, JC				Yang, Rongrong; Yang, Lei; Qiu, Fuman; Zhang, Lisha; Wang, Hui; Yang, Xiaorong; Deng, Jieqiong; Fang, Wenxiang; Zhou, Yifeng; Lu, Jiachun			Functional Genetic Polymorphisms in PP2A Subunit Genes Confer Increased Risks of Lung Cancer in Southern and Eastern Chinese	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; TUMOR-SUPPRESSOR PP2A; COPY-NUMBER VARIATION; REGULATORY SUBUNIT; BREAST-CANCER; DNA-REPAIR; NBS1 GENE; PHOSPHORYLATION; HAPLOTYPES; PATHWAYS	Protein phosphatase-2A (PP2A) is one of the major cellular serine-threonine phosphatases and functions as a tumor suppressor that negatively regulates the activity of some oncogenic kinases. Recent studies have reported that PP2A expression was suppressed during lung carcinogenesis, we there hypothesized that the single nucleotide polymorphisms (SNPs) in PP2A subunit genes may affect PP2A function and thus contribute to lung cancer susceptibility. In a two-stage case-control study with a total of 1559 lung cancer patients and 1679 controls, we genotyped eight putative functional SNPs and one identified functional SNP (i.e., rs11453459) in seven major PP2A subunits (i.e., PPP2R1A, PPP2R1B, PPP2CA, PPP2R2A, PPP2R2B, PPP2R5C, PPP2R5E) in southern and eastern Chinese. We found that rs11453459G (-G/GG) variant genotypes of PPP2R1A and the rs1255722AA variant genotype of PPP2R5E conferred increased risks of lung cancer (rs11453459, -G/GG vs. -: OR = 1.31, 95% CI = 1.13-1.51; rs1255722, AA vs. AG/GG: OR = 1.27, 95% CI = 1.07-1.51). After combined the two variants, the number of the adverse genotypes was positively associated with lung cancer risk in a dose-response manner (P-trend = 5.63x10(-6)). Further functional assay showed that lung cancer tissues carrying rs1255722AA variant genotype had a significantly lower mRNA level of PPP2R5E compared with tissues carrying GG/GA genotypes. However, such effect was not observed for the other SNPs and other combinations. Our findings suggested that the two functional variants in PPP2R1A and PPP2R5E and their combination are associated with lung cancer risk in Chinese, which may be valuable biomarkers to predict risk of lung cancer.	[Yang, Rongrong; Yang, Lei; Qiu, Fuman; Zhang, Lisha; Wang, Hui; Yang, Xiaorong; Fang, Wenxiang; Lu, Jiachun] Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Deng, Jieqiong; Zhou, Yifeng] Soochow Univ, Lab Canc Mol Genet, Coll Med, Suzhou, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Soochow University - China	Lu, JC (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China.	jcLu@gzhmc.edu.cn			National Natural Scientific Foundation of China [30671813, 30872178, 81072366, 81273149, 81001278, 81171895]; Guangdong Provincial High Level Experts Grants [2010-79]; Changjiang Scholars and Innovative Research Team in University [IRT0961]; Guangdong natural science foundation [10351012003000000]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial High Level Experts Grants; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Guangdong natural science foundation(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Scientific Foundation of China grants 30671813, 30872178, 81072366, 81273149 (JL), and partly 81001278, 81171895 (YZ); Guangdong Provincial High Level Experts Grants 2010-79 (JL); Changjiang Scholars and Innovative Research Team in University grant IRT0961 (JW), Guangdong natural science foundation team grant 10351012003000000 (WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; [Anonymous], 1998, CURR OPIN ONCOL, V10, P88; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chen HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007019; Cheng Y, 2011, CANCER GENET-NY, V204, P375, DOI 10.1016/j.cancergen.2011.05.002; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Dupont WD, 2009, CANCER, V116, P8; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Ganesh B, 2011, ASIAN PAC J CANCER P, V12, P357; Grochola LF, 2009, CLIN CANCER RES, V15, P6301, DOI 10.1158/1078-0432.CCR-09-0797; Huang BF, 2012, INT J CANCER, V131, pE744, DOI 10.1002/ijc.27407; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kalev P, 2012, CANCER RES, V72, P6414, DOI 10.1158/0008-5472.CAN-12-1667; Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Li HH, 2007, EMBO J, V26, P402, DOI 10.1038/sj.emboj.7601519; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lifschitz-Mercer B, 2001, HISTOCHEM CELL BIOL, V116, P31; Lin YC, 2011, MUTAT RES-FUND MOL M, V716, P66, DOI 10.1016/j.mrfmmm.2011.08.004; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Lu JC, 2007, CARCINOGENESIS, V28, P988, DOI 10.1093/carcin/bgl225; Lu JC, 2006, CARCINOGENESIS, V27, P2209, DOI 10.1093/carcin/bgl077; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Soprano KJ, 2006, ONCOGENE, V25, P5315, DOI 10.1038/sj.onc.1209679; Takakura S, 2001, INT J ONCOL, V18, P817; Uh H.W., 2007, BMC P S1, V1, pS114; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Vazquez A, 2011, INT J CANCER, V128, P2335, DOI 10.1002/ijc.25582; Wade R, 2011, HAEMATOL-HEMATOL J, V96, P1496, DOI 10.3324/haematol.2011.043471; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Yang L, 2013, HUM MOL GENET, V22, P1886, DOI 10.1093/hmg/ddt019; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Zhang M, 2012, CANCER RES, V72, P4178, DOI 10.1158/0008-5472.CAN-11-3983	47	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77285	10.1371/journal.pone.0077285	http://dx.doi.org/10.1371/journal.pone.0077285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204789	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700023
J	Alon, M; Malka, O; Eakteiman, G; Elbaz, M; Ben Zvi, MM; Vainstein, A; Morin, S				Alon, Michal; Malka, Osnat; Eakteiman, Galit; Elbaz, Moshe; Ben Zvi, Michal Moyal; Vainstein, Alexander; Morin, Shai			Activation of the Phenylpropanoid Pathway in Nicotiana tabacum Improves the Performance of the Whitefly Bemisia tabaci via Reduced Jasmonate Signaling	PLOS ONE			English	Article							PLANT DEFENSE; TRANSCRIPTION FACTOR; SALICYLIC-ACID; INDUCED RESISTANCE; CROSS-TALK; ARABIDOPSIS; RESPONSES; EXPRESSION; TOBACCO; APHIDS	Background: Phloem-feeding insects can manipulate plant-induced resistance and are able to suppress effective jasmonic acid/ethylene (JA/ET) defenses by the induction of inefficient salicylic acid (SA) based responses. As a result, activation of the phenylpropanoid biosynthesis pathway in transgenic plants is anticipated to cause complex interactions between phloem-feeding insects and their host plants due to predicted contradiction between two defense forces: the toxicity of various phenylpropanoids and the accumulation of SA via a branch of the activated pathway. Methodology/Principal Findings: Here, we investigated the effect of activating the phenylpropanoids pathway in Nicotiana tabacum, by over-expression of the PAP1 transcription factor, on the whitefly Bemisia tabaci, a phloem-feeding insect model. Our performance assays indicated that the over-expression made the transgenic plants a more suitable host for B. tabaci than wild-type (WT) plants, although these plants accumulated significantly higher levels of flavonoids. Transcription analyses of indicator genes in the SA (PR1a) and JA/ET (ERF1, COI1 and AOC) pathways followed by quantification of the SA and JA hormone levels, indicated that B. tabaci infestation periods longer than 8 hours, caused higher levels of activity of SA signaling in transgenic plants and higher levels of JA/ET signaling in WT plants. Conclusions/Significance: Taken together, these results emphasize the important role JA/ET-induced defenses play in protecting plants from successful infestation by B. tabaci and likely other phloem-feeding insects. It also indicates the necessity of phloem feeders to suppress these defenses for efficient utilization of plant hosts. Our data also indicate that the defensive chemistry produced by the phenylpropanoids pathway has only a minor effect on the insect fitness.	[Alon, Michal; Malka, Osnat; Eakteiman, Galit; Elbaz, Moshe; Morin, Shai] Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel; [Ben Zvi, Michal Moyal; Vainstein, Alexander] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Morin, S (corresponding author), Hebrew Univ Jerusalem, Dept Entomol, IL-76100 Rehovot, Israel.	shai.morin@mail.huji.ac.il			Israel Science Foundation [971/04, 848/08]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (http://www.isf.org.il/) grants 971/04 and 848/08 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2012, INSECT BIOCHEM MOLEC, V42, P251, DOI 10.1016/j.ibmb.2011.12.007; Antico Christopher J, 2012, [Frontiers in Biology, 生物学前沿], V7, P48; Baldwin IT, 1999, J CHEM ECOL, V25, P3, DOI 10.1023/A:1020880931488; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Berner JM, 2010, CEREAL RES COMMUN, V38, P506, DOI 10.1556/CRC.38.2010.4.7; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; CALATAYUD PA, 1994, ENTOMOL EXP APPL, V72, P47, DOI 10.1007/BF02382414; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Cui H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-76; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Elsayed G., 2011, Archives of Phytopathology and Plant Protection, V44, P1534, DOI 10.1080/03235408.2010.507957; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Glazebrook J, 1999, CURR OPIN PLANT BIOL, V2, P280, DOI 10.1016/S1369-5266(99)80050-8; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Heil M, 2002, CURR OPIN PLANT BIOL, V5, P345, DOI 10.1016/S1369-5266(02)00267-4; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Johnson ET, 2004, J AGR FOOD CHEM, V52, P5135, DOI 10.1021/jf0308049; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kusnierczyk A, 2008, PLANT CELL ENVIRON, V31, P1097, DOI 10.1111/j.1365-3040.2008.01823.x; Lattanzio V, 2000, J AGR FOOD CHEM, V48, P5316, DOI 10.1021/jf000229y; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; MACLEOD NJ, 1966, PHYTOCHEMISTRY, V5, P777, DOI 10.1016/S0031-9422(00)83659-6; Malone LA, 2009, ENTOMOL EXP APPL, V133, P117, DOI 10.1111/j.1570-7458.2009.00910.x; Misra P, 2010, PLANT PHYSIOL, V152, P2258, DOI 10.1104/pp.109.150979; Niki T, 1998, PLANT CELL PHYSIOL, V39, P500, DOI 10.1093/oxfordjournals.pcp.a029397; O'Neill BF, 2010, J CHEM ECOL, V36, P35, DOI 10.1007/s10886-009-9727-0; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Pyati P, 2011, J INSECT PHYSIOL, V57, P881, DOI 10.1016/j.jinsphys.2011.03.024; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rojo E, 1999, PLANT J, V20, P135, DOI 10.1046/j.1365-313x.1999.00570.x; Salvucci ME, 1998, ARCH INSECT BIOCHEM, V39, P155, DOI 10.1002/(SICI)1520-6327(1998)39:4&lt;155::AID-ARCH3&gt;3.0.CO;2-#; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; TODD GW, 1971, ANN ENTOMOL SOC AM, V64, P718, DOI 10.1093/aesa/64.3.718; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Van Cutsem E, 2011, PROTEOMICS, V11, P440, DOI 10.1002/pmic.201000356; van Dam NM, 2008, PLANT SIGNAL BEHAV, V3, P91, DOI 10.4161/psb.3.2.5220; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; WALKER GP, 1994, ANN ENTOMOL SOC AM, V87, P363, DOI 10.1093/aesa/87.3.363; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Wuyts N, 2006, J EXP BOT, V57, P2825, DOI 10.1093/jxb/erl044; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	58	25	27	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76619	10.1371/journal.pone.0076619	http://dx.doi.org/10.1371/journal.pone.0076619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204646	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400015
J	Neumann, S; Fuchs, A; Hummel, B; Frishman, D				Neumann, Sindy; Fuchs, Angelika; Hummel, Barbara; Frishman, Dmitrij			Classification of alpha-Helical Membrane Proteins Using Predicted Helix Architectures	PLOS ONE			English	Article							SECONDARY TRANSPORT PROTEINS; TRANSMEMBRANE PROTEINS; DATA-BANK; ESCHERICHIA-COLI; STRUCTURAL CLASS; GENE ONTOLOGY; HUMAN GENOME; TOPOLOGY; FAMILIES; DATABASE	Despite significant methodological advances in protein structure determination high-resolution structures of membrane proteins are still rare, leaving sequence-based predictions as the only option for exploring the structural variability of membrane proteins at large scale. Here, a new structural classification approach for alpha-helical membrane proteins is introduced based on the similarity of predicted helix interaction patterns. Its application to proteins with known 3D structure showed that it is able to reliably detect structurally similar proteins even in the absence of any sequence similarity, reproducing the SCOP and CATH classifications with a sensitivity of 65% at a specificity of 90%. We applied the new approach to enhance our comprehensive structural classification of alpha-helical membrane proteins (CAMPS), which is primarily based on sequence and topology similarity, in order to find protein clusters that describe the same fold in the absence of sequence similarity. The total of 151 helix architectures were delineated for proteins with more than four transmembrane segments. Interestingly, we observed that proteins with 8 and more transmembrane helices correspond to fewer different architectures than proteins with up to 7 helices, suggesting that in large membrane proteins the evolutionary tendency to re-use already available folds is more pronounced.	[Neumann, Sindy; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany; [Fuchs, Angelika] Roche Diagnost GmbH, pRED, pRED Informat, Penzberg, Germany; [Hummel, Barbara] Univ Freiburg, Med Ctr, Dept Urol, Womens Hosp, Freiburg, Germany; [Hummel, Barbara] Univ Freiburg, Med Ctr, Clin Res Ctr, Freiburg, Germany; [Frishman, Dmitrij] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany	Technical University of Munich; Roche Holding; University of Freiburg; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissensch Zentrum Weihenstephan, Freising Weihenstephan, Germany.	d.frishman@wzw.tum.de	Frishman, Dmitrij/AAT-7815-2020	Hummel, Barbara/0000-0001-6563-3675	DFG [FR 1411/5-1]; DFG International Research Training Group 'Regulation and Evolution of Cellular Systems' [GRK 1563]	DFG(German Research Foundation (DFG)); DFG International Research Training Group 'Regulation and Evolution of Cellular Systems'	This work was supported by the DFG grant FR 1411/5-1 and the DFG International Research Training Group 'Regulation and Evolution of Cellular Systems' (GRK 1563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Arai M, 2003, GENE, V304, P77, DOI 10.1016/S0378-1119(02)01181-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Choi S, 2008, PROTEINS, V71, P68, DOI 10.1002/prot.21656; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fuchs A, 2010, PROTEINS, V78, P2587, DOI 10.1002/prot.22768; Fuchs A, 2009, PROTEINS, V74, P857, DOI 10.1002/prot.22194; Granseth E, 2005, J MOL BIOL, V346, P377, DOI 10.1016/j.jmb.2004.11.036; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hennerdal A, 2010, PROTEIN SCI, V19, P2305, DOI 10.1002/pro.510; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jones DT, 1998, FEBS LETT, V423, P281, DOI 10.1016/S0014-5793(98)00095-7; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lolkema JS, 2003, J MOL BIOL, V327, P901, DOI 10.1016/S0022-2836(03)00214-6; Lolkema JS, 1998, MOL MEMBR BIOL, V15, P33, DOI 10.3109/09687689809027516; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Martin-Galiano AJ, 2006, PROTEINS, V64, P906, DOI 10.1002/prot.21081; Neumann S, 2012, PROTEINS, V80, P839, DOI 10.1002/prot.23242; Neumann S, 2010, PROTEINS, V78, P1760, DOI 10.1002/prot.22692; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Remm M, 2000, GENOME RES, V10, P1679, DOI 10.1101/gr.GR-1491R; Saaf A, 2001, J BIOL CHEM, V276, P18905, DOI 10.1074/jbc.M101716200; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; SAIER MH, 1994, BIOESSAYS, V16, P23, DOI 10.1002/bies.950160104; SANSOM MSP, 1992, PROTEIN ENG, V5, P53, DOI 10.1093/protein/5.1.53; Shimizu T, 2004, J MOL BIOL, V339, P1, DOI 10.1016/j.jmb.2004.03.048; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; ter Horst R, 2012, BBA-BIOMEMBRANES, V1818, P72, DOI 10.1016/j.bbamem.2011.09.021; Theobald DL, 2010, NAT STRUCT MOL BIOL, V17, P2, DOI 10.1038/nsmb0110-2; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2010, CURR PROTEIN PEPT SC, V11, P550; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	54	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77491	10.1371/journal.pone.0077491	http://dx.doi.org/10.1371/journal.pone.0077491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204844	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400039
J	Radhakrishnan, P; Mohr, AM; Grandgenett, PM; Steele, MM; Batra, SK; Hollingsworth, MA				Radhakrishnan, Prakash; Mohr, Ashley M.; Grandgenett, Paul M.; Steele, Maria M.; Batra, Surinder K.; Hollingsworth, Michael A.			MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; E-CADHERIN; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; REDUCED EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; UP-REGULATION; LET-7; METASTASIS	Transmembrane mucins, MUC4 and MUC16 are associated with tumor progression and metastatic potential in human pancreatic adenocarcinoma. We discovered that miR-200c interacts with specific sequences within the coding sequence of MUC4 and MUC16 mRNAs, and evaluated the regulatory nature of this association. Pancreatic cancer cell lines S2.028 and T3M-4 transfected with miR-200c showed a 4.18 and 8.50 fold down regulation of MUC4 mRNA, and 4.68 and 4.82 fold down regulation of MUC16 mRNA compared to mock-transfected cells, respectively. A significant reduction of glycoprotein expression was also observed. These results indicate that miR-200c overexpression regulates MUC4 and MUC16 mucins in pancreatic cancer cells by directly targeting the mRNA coding sequence of each, resulting in reduced levels of MUC4 and MUC16 mRNA and protein. These data suggest that, in addition to regulating proteins that modulate EMT, miR-200c influences expression of cell surface mucins in pancreatic cancer.	[Radhakrishnan, Prakash; Mohr, Ashley M.; Grandgenett, Paul M.; Steele, Maria M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Hollingsworth, MA (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	mahollin@unmc.edu		Steele, Maria/0000-0003-0186-2633	National Cancer Institute: SPORE [1P50CA127297]; National Cancer Institute: Early Detection Research Network [5U01CA111294]; National Cancer Institute: Alliance of Glycobiologist for Detection of Cancer and Cancer Risk [5U01CA128437]; National Cancer Institute: Tumor Microenvironment Network [U54 CA163120]; National Cancer Institute [R01CA57362]; NATIONAL CANCER INSTITUTE [P50CA127297, U54CA163120, U01CA128437, R01CA057362, U01CA111294] Funding Source: NIH RePORTER	National Cancer Institute: SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute: Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute: Alliance of Glycobiologist for Detection of Cancer and Cancer Risk; National Cancer Institute: Tumor Microenvironment Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants from the National Cancer Institute: SPORE (1P50CA127297), Early Detection Research Network (5U01CA111294), the Alliance of Glycobiologist for Detection of Cancer and Cancer Risk (5U01CA128437), Tumor Microenvironment Network (U54 CA163120), and R01CA57362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Argueso P, 2003, INVEST OPHTH VIS SCI, V44, P2487, DOI 10.1167/iovs.02-0862; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Cittelly DM, 2012, MOL CANCER THER, V11, P2556, DOI 10.1158/1535-7163.MCT-12-0463; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gabriel M, 2005, CLIN ORAL INVEST, V9, P284, DOI 10.1007/s00784-005-0007-2; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Huang SL, 2010, NUCLEIC ACIDS RES, V38, P7211, DOI 10.1093/nar/gkq564; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Mohr AM, 2013, PLOS ONE IN PRESS; OLIVER MH, 1989, J CELL SCI, V92, P513; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Shimizu A, 2012, CANCER SCI, V103, P739, DOI 10.1111/j.1349-7006.2012.02214.x; Singh AP, 2004, CANCER RES, V64, P622, DOI 10.1158/0008-5472.CAN-03-2636; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Theriault C, 2011, GYNECOL ONCOL, V121, P434, DOI 10.1016/j.ygyno.2011.02.020; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169	37	30	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e73356	10.1371/journal.pone.0073356	http://dx.doi.org/10.1371/journal.pone.0073356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204560	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400003
J	Andersson, M; Karlsson, O; Bergstrom, U; Brittebo, EB; Brandt, I				Andersson, Marie; Karlsson, Oskar; Bergstrom, Ulrika; Brittebo, Eva B.; Brandt, Ingvar			Maternal Transfer of the Cyanobacterial Neurotoxin beta-N-Methylamino-L-Alanine (BMAA) via Milk to Suckling Offspring	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; AMINO-ACID TRANSPORTERS; BLOOD-BRAIN-BARRIER; RAT MAMMARY-GLAND; NEURODEGENERATIVE DISEASE; PROTEIN; EXPOSURE; CELLS; GUAM; INTESTINE	The cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) has been implicated in the etiology of neurodegenerative disease and proposed to be biomagnified in terrestrial and aquatic food chains. We have previously shown that the neonatal period in rats, which in humans corresponds to the last trimester of pregnancy and the first few years of age, is a particularly sensitive period for exposure to BMAA. The present study aimed to examine the secretion of C-14-labeled L-and D-BMAA into milk in lactating mice and the subsequent transfer of BMAA into the developing brain. The results suggest that secretion into milk is an important elimination pathway of BMAA in lactating mothers and an efficient exposure route predominantly for L-BMAA but also for D-BMAA in suckling mice. Following secretion of [C-14] L-BMAA into milk, the levels of [C-14] L-BMAA in the brains of the suckling neonatal mice significantly exceeded the levels in the maternal brains. In vitro studies using the mouse mammary epithelial HC11 cell line confirmed a more efficient influx and efflux of L-BMAA than of D-BMAA in cells, suggesting enantiomer-selective transport. Competition experiments with other amino acids and a low sodium dependency of the influx suggests that the amino acid transporters LAT1 and LAT2 are involved in the transport of L-BMAA into milk. Given the persistent neurodevelopmental toxicity following injection of L-BMAA to neonatal rodent pups, the current results highlight the need to determine whether BMAA is enriched mother's and cow's milk.	[Andersson, Marie; Karlsson, Oskar; Bergstrom, Ulrika; Brandt, Ingvar] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Karlsson, Oskar; Brittebo, Eva B.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden	Uppsala University; Uppsala University	Brandt, I (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.	Ingvar.Brandt@ebc.uu.se	Brittebo, Eva/F-5005-2016	Brittebo, Eva/0000-0002-7644-1967; Karlsson, Oskar/0000-0001-8009-0015; Brandt, Ingvar/0000-0002-5386-2400	Swedish Research Council Formas	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council Formas (http://www.formas.se/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman G, 2009, METABOLISM, V58, P594, DOI 10.1016/j.metabol.2008.12.003; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Bradley WG, 2013, AMYOTROPH LAT SCL FR, V14, P325, DOI 10.3109/21678421.2012.750364; Brand LE, 2010, HARMFUL ALGAE, V9, P620, DOI 10.1016/j.hal.2010.05.002; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DREJER J, 1983, NEUROCHEM RES, V8, P231, DOI 10.1007/BF00963923; DUNCAN MW, 1992, NEUROBIOL AGING, V13, P333, DOI 10.1016/0197-4580(92)90047-2; DUNCAN MW, 1991, J PHARMACOL EXP THER, V258, P27; Engskog MK, 2013, TOXICOLOGY; Eriksson P, 1997, NEUROTOXICOLOGY, V18, P719; Field NC, 2013, TOXICON, V70, P179, DOI 10.1016/j.toxicon.2013.04.010; Hasegawa H, 2004, AM J PHYSIOL-ENDOC M, V287, pE160, DOI 10.1152/ajpendo.00397.2003; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA110, DOI 10.1289/ehp.120-a110; Jager, 2008, BMC RES NOTES, V1; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; Karlsson O, 2013, J PROTEOME RES; Karlsson O, 2012, TOXICOL SCI, V130, P391, DOI 10.1093/toxsci/kfs241; Karlsson O, 2011, BEHAV BRAIN RES, V219, P310, DOI 10.1016/j.bbr.2011.01.056; Karlsson O, 2009, TOXICOL SCI, V112, P185, DOI 10.1093/toxsci/kfp196; Karlsson O, 2009, PIGM CELL MELANOMA R, V22, P120, DOI 10.1111/j.1755-148X.2008.00508.x; Karlsson O, 2009, TOXICOL SCI, V109, P286, DOI 10.1093/toxsci/kfp062; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; MALATHI P, 1973, BIOCHIM BIOPHYS ACTA, V307, P613, DOI 10.1016/0005-2736(73)90306-4; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Metcalf JS, 2013, CHEMOSPHERE, V90, P835, DOI 10.1016/j.chemosphere.2012.09.094; Metcalf JS, 2012, SCI TOTAL ENVIRON, V421, P118, DOI 10.1016/j.scitotenv.2012.01.053; Mondo K, 2012, MAR DRUGS, V10, P509, DOI 10.3390/md10020509; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; MYERS TG, 1990, J BIOL CHEM, V265, P10193; NUNN PB, 1989, FEBS LETT, V251, P31, DOI 10.1016/0014-5793(89)81423-1; Okle O, 2013, TOXICOL SCI, V131, P217, DOI 10.1093/toxsci/kfs291; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; PERRY TL, 1989, J NEUROL SCI, V94, P173, DOI 10.1016/0022-510X(89)90227-X; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Prasanna R, 2012, WORLD J MICROB BIOT, V28, P1223, DOI 10.1007/s11274-011-0926-9; Rajan DP, 2000, BBA-BIOMEMBRANES, V1463, P6, DOI 10.1016/S0005-2736(99)00224-2; ROSS SM, 1987, BRAIN RES, V425, P120, DOI 10.1016/0006-8993(87)90490-2; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Sarwar G, 1998, BRIT J NUTR, V79, P129, DOI 10.1079/BJN19980023; Shennan DB, 2002, BBA-BIOMEMBRANES, V1564, P133, DOI 10.1016/S0005-2736(02)00410-8; Shennan DB, 2000, PHYSIOL REV, V80, P925, DOI 10.1152/physrev.2000.80.3.925; SMITH QR, 1992, J NEUROCHEM, V58, P1330, DOI 10.1111/j.1471-4159.1992.tb11346.x; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; SPENCER PS, 1987, CIBA F SYMP, V126, P221; SVANBERG U, 1977, AM J CLIN NUTR, V30, P499, DOI 10.1093/ajcn/30.4.499; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Ullberg S., 1977, SCI TOOLS LKB INSTRU, P2; VERMA N, 1993, INDIAN J MED RES-B, V98, P297; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Xie XB, 2013, NEUROREPORT, V24, P779, DOI 10.1097/WNR.0b013e328363fd89; Zerangue N, 1996, J BIOL CHEM, V271, P27991, DOI 10.1074/jbc.271.45.27991	57	32	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78133	10.1371/journal.pone.0078133	http://dx.doi.org/10.1371/journal.pone.0078133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194910	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000089
J	Garcia-Alvarez, I; Garrido, L; Romero-Ramirez, L; Nieto-Sampedro, M; Fernandez-Mayoralas, A; Campos-Olivas, R				Garcia-Alvarez, Isabel; Garrido, Leoncio; Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel; Fernandez-Mayoralas, Alfonso; Campos-Olivas, Ramon			The Effect of Antitumor Glycosides on Glioma Cells and Tissues as Studied by Proton HR-MAS NMR Spectroscopy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN BRAIN; IN-VITRO; SCYLLO-INOSITOL; METABOLISM; APOPTOSIS; HYPOXIA; VIVO; SPHINGOLIPIDS; INHIBITION	The effect of the treatment with glycolipid derivatives on the metabolic profile of intact glioma cells and tumor tissues, investigated using proton high resolution magic angle spinning (H-1 HR-MAS) nuclear magnetic resonance (NMR) spectroscopy, is reported here. Two compounds were used, a glycoside and its thioglycoside analogue, both showing anti-proliferative activity on glioma C6 cell cultures; however, only the thioglycoside exhibited antitumor activity in vivo. At the drug concentrations showing anti-proliferative activity in cell culture (20 and 40 mu M), significant increases in choline containing metabolites were observed in the H-1 NMR spectra of the same intact cells. In vivo experiments in nude mice bearing tumors derived from implanted C6 glioma cells, showed that reduction of tumor volume was associated with significant changes in the metabolic profile of the same intact tumor tissues; and were similar to those observed in cell culture. Specifically, the activity of the compounds is mainly associated with an increase in choline and phosphocholine, in both the cell cultures and tumoral tissues. Taurine, a metabolite that has been considered a biomarker of apoptosis, correlated with the reduction of tumor volume. Thus, the results indicate that the mode of action of the glycoside involves, at least in part, alteration of phospholipid metabolism, resulting in cell death.	[Garcia-Alvarez, Isabel; Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel] Hosp Nacl Paraplej, Unidad Neurol Expt, Serv Salud Castilla La Mancha SESCAM, Toledo, Spain; [Garcia-Alvarez, Isabel; Fernandez-Mayoralas, Alfonso] CSIC, Inst Quim Organ Gen, Madrid, Spain; [Garrido, Leoncio] CSIC, Inst Ciencia & Tecnol Polimeros, Madrid, Spain; [Romero-Ramirez, Lorenzo; Nieto-Sampedro, Manuel] CSIC, Inst Cajal Neurobiol, Madrid, Spain; [Campos-Olivas, Ramon] Spanish Natl Canc Ctr CNIO, Spect & NMR Unit, Struct Biol & Biocomp Programme, Madrid, Spain	Hospital Nacional de Paraplejicos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Centro Nacional de Investigaciones Oncologicas (CNIO)	Garcia-Alvarez, I (corresponding author), Hosp Nacl Paraplej, Unidad Neurol Expt, Serv Salud Castilla La Mancha SESCAM, Toledo, Spain.	garcia.alvarez@iqog.csic.es; rcampos@cnio.es	García-Álvarez, Isabel/J-8022-2014; Alvarez, Isabel Garcia/J-7347-2017; Alvarez, Isabel Garcia/ABH-2430-2020; Garrido, Leoncio -/K-3092-2014; Fernández-Mayoralas, Alfonso/K-2929-2014; Campos-Olivas, Ramón/L-9173-2014	García-Álvarez, Isabel/0000-0002-2273-5046; Alvarez, Isabel Garcia/0000-0002-2273-5046; Garrido, Leoncio -/0000-0002-7587-1260; Fernández-Mayoralas, Alfonso/0000-0002-1241-7538; Campos-Olivas, Ramón/0000-0002-5743-2221	Servicio de Salud de Castilla-La Mancha Community (SESCAM), Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM) [PI-2008/18, PI-2008/19, PI-2009/51]; Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) [PI11/00592, PI11/01436]; Comunidad de Madrid [S2009/PPQ-1752]	Servicio de Salud de Castilla-La Mancha Community (SESCAM), Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM); Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS); Comunidad de Madrid(Comunidad de Madrid)	The financial support was provided by the Servicio de Salud de Castilla-La Mancha Community (SESCAM), Fundacion para la Investigacion Sanitaria de Castilla-La Mancha (FISCAM) (PI-2008/18, PI-2008/19 and PI-2009/51); Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS) (PI11/00592 and PI11/01436) and Comunidad de Madrid (Grant S2009/PPQ-1752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Andrieu-Abadie N, 2001, FREE RADICAL BIO MED, V31, P717, DOI 10.1016/S0891-5849(01)00655-4; Bello C, 2011, BIOORGAN MED CHEM, V19, P7720, DOI 10.1016/j.bmc.2011.07.053; Benedetti E, 2010, INT J IMMUNOPATH PH, V23, P235, DOI 10.1177/039463201002300121; Brindle KM, 2002, ADV ENZYME REGUL, V42, P101, DOI 10.1016/S0065-2571(01)00025-5; Brown B. W., 1977, STAT BIOMEDICAL INTR; Cao MD, 2012, NMR BIOMED, V25, P1033, DOI 10.1002/nbm.2766; Duarte IF, 2010, VIRCHOWS ARCH, V457, P715, DOI 10.1007/s00428-010-0993-6; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Gallinger A, 2011, ANGEW CHEM INT EDIT, V50, P11672, DOI 10.1002/anie.201104836; Garcia-Alvarez I, 2007, J MED CHEM, V50, P364, DOI 10.1021/jm0611556; Garcia-Alvarez I, 2011, J MED CHEM, V54, P6949, DOI 10.1021/jm200961q; Garcia-Alvarez I, 2011, CURR TOP MED CHEM, V11, P27, DOI 10.2174/156802611793611841; Garcia-Alvarez I, 2011, MOL BIOSYST, V7, P129, DOI 10.1039/c0mb00125b; Garcia-Alvarez I, 2009, J MED CHEM, V52, P1263, DOI 10.1021/jm8012807; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Gomez-Munoz A, 2004, J LIPID RES, V45, P99, DOI 10.1194/jlr.M300158-JLR200; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Griffin JL, 2002, NMR BIOMED, V15, P375, DOI 10.1002/nbm.792; Griffin JL, 2001, MAGNET RESON MED, V46, P249, DOI 10.1002/mrm.1185; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Imperiale A, 2011, PEDIATR BLOOD CANCER, V56, P24, DOI 10.1002/pbc.22668; Kaiser LG, 2005, NMR BIOMED, V18, P51, DOI 10.1002/nbm.927; Kinoshita Y, 1997, NMR BIOMED, V10, P2, DOI 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N; KUNZ M, 2003, MOL CANCER, V2, P1, DOI DOI 10.1186/1476-4598-2-1.PUBMED:12537587; Laurenti G, 2011, J CELL BIOCHEM, V112, P3891, DOI 10.1002/jcb.23323; Lindon JC, 2009, PROG NUCL MAG RES SP, V55, P79, DOI 10.1016/j.pnmrs.2008.11.004; Lutz NW, 2005, METABOLOMICS, V1, P251, DOI 10.1007/s11306-005-0005-z; Mazzio EA, 2010, CELL BIOL TOXICOL, V26, P177, DOI 10.1007/s10565-009-9138-6; MENDENHALL W, 1989, INTRO PROBABILITY ST; MICHAELIS T, 1993, NMR BIOMED, V6, P105, DOI 10.1002/nbm.1940060116; Milkevitch M, 2005, BBA-MOL CELL BIOL L, V1734, P1, DOI 10.1016/j.bbalip.2005.01.008; Mirbahai L, 2011, INT J BIOCHEM CELL B, V43, P990, DOI 10.1016/j.biocel.2010.07.002; Moestue S, 2011, CURR TOP MED CHEM, V11, P2, DOI 10.2174/156802611793611869; Moore D. S., 1989, INTRO PRACTICE STAT; Morales A, 2007, APOPTOSIS, V12, P923, DOI 10.1007/s10495-007-0721-0; Morse DL, 2007, MAGN RESON MED, V58, P270, DOI 10.1002/mrm.21333; Ohanian J, 2001, CELL MOL LIFE SCI, V58, P2053, DOI 10.1007/PL00000836; Opstad KS, 2009, BRIT J CANCER, V100, P789, DOI 10.1038/sj.bjc.6604933; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Quintero M, 2007, BBA-MOL CELL BIOL L, V1771, P31, DOI 10.1016/j.bbalip.2006.10.003; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Rodriguez-Gonzalez A, 2004, ONCOGENE, V23, P8247, DOI 10.1038/sj.onc.1208045; Rodriguez-Gonzalez Agustin, 2003, Prog Cell Cycle Res, V5, P191; Sitter B, 2009, PROG NUCL MAG RES SP, V54, P239, DOI 10.1016/j.pnmrs.2008.10.001; Somashekar BS, 2011, J PROTEOME RES, V10, P5232, DOI 10.1021/pr200800w; VEECH RL, 1991, NMR BIOMED, V4, P53, DOI 10.1002/nbm.1940040204; Venugopal N, 2012, MAGN RESON IMAGING, V30, P195, DOI 10.1016/j.mri.2011.09.020; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	51	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78391	10.1371/journal.pone.0078391	http://dx.doi.org/10.1371/journal.pone.0078391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194925	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000104
J	Fahlgren, N; Bollmann, SR; Kasschau, KD; Cuperus, JT; Press, CM; Sullivan, CM; Chapman, EJ; Hoyer, JS; Gilbert, KB; Grunwald, NJ; Carrington, JC				Fahlgren, Noah; Bollmann, Stephanie R.; Kasschau, Kristin D.; Cuperus, Josh T.; Press, Caroline M.; Sullivan, Christopher M.; Chapman, Elisabeth J.; Hoyer, J. Steen; Gilbert, Kerrigan B.; Gruenwald, Niklaus J.; Carrington, James C.			Phytophthora Have Distinct Endogenous Small RNA Populations That Include Short Interfering and microRNAs	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENOME SEQUENCE; PLANT; MECHANISMS; PATHOGEN; BIOGENESIS; EVOLUTION; INFESTANS; RECOGNITION	In eukaryotes, RNA silencing pathways utilize 20-30-nucleotide small RNAs to regulate gene expression, specify and maintain chromatin structure, and repress viruses and mobile genetic elements. RNA silencing was likely present in the common ancestor of modern eukaryotes, but most research has focused on plant and animal RNA silencing systems. Phytophthora species belong to a phylogenetically distinct group of economically important plant pathogens that cause billions of dollars in yield losses annually as well as ecologically devastating outbreaks. We analyzed the small RNA-generating components of the genomes of P. infestans, P. sojae and P. ramorum using bioinformatics, genetic, phylogenetic and high-throughput sequencing-based methods. Each species produces two distinct populations of small RNAs that are predominantly 21- or 25-nucleotides long. The 25-nucleotide small RNAs were primarily derived from loci encoding transposable elements and we propose that these small RNAs define a pathway of short-interfering RNAs that silence repetitive genetic elements. The 21-nucleotide small RNAs were primarily derived from inverted repeats, including a novel microRNA family that is conserved among the three species, and several gene families, including Crinkler effectors and type III fibronectins. The Phytophthora microRNA is predicted to target a family of amino acid/auxin permeases, and we propose that 21-nucleotide small RNAs function at the post-transcriptional level. The functional significance of microRNA-guided regulation of amino acid/auxin permeases and the association of 21-nucleotide small RNAs with Crinkler effectors remains unclear, but this work provides a framework for testing the role of small RNAs in Phytophthora biology and pathogenesis in future work.	[Fahlgren, Noah; Hoyer, J. Steen; Gilbert, Kerrigan B.; Carrington, James C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Fahlgren, Noah; Kasschau, Kristin D.; Cuperus, Josh T.; Sullivan, Christopher M.; Chapman, Elisabeth J.; Carrington, James C.] Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Bollmann, Stephanie R.; Press, Caroline M.; Gruenwald, Niklaus J.] USDA ARS, Hort Crops Res Lab, Corvallis, OR USA	Donald Danforth Plant Science Center; Oregon State University; United States Department of Agriculture (USDA)	Grunwald, NJ (corresponding author), USDA ARS, Hort Crops Res Lab, Corvallis, OR USA.	nik.grunwald@ars.usda.gov; JCarrington@danforthcenter.org	Grunwald, Niklaus` J/K-6041-2013; Carrington, James C/A-4656-2012; Fahlgren, Noah/D-4404-2011	Grunwald, Niklaus` J/0000-0003-1656-7602; Carrington, James C/0000-0003-3572-129X; Fahlgren, Noah/0000-0002-5597-4537; Hoyer, J. Steen/0000-0002-1338-8900; Gilbert, Kerrigan/0000-0002-7164-5821; Press, Caroline/0000-0003-4741-9776; Cuperus, Josh/0000-0002-8019-7733	National Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2008-35600-18780]; US Forest Service Pacific Southwest Research Station Sudden Oak Death research program; National Science Foundation [MCB-1231726]; National Institutes of Health [AI043288]; Direct For Biological Sciences [1231726] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI043288, R21AI043288, R01AI043288] Funding Source: NIH RePORTER	National Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; US Forest Service Pacific Southwest Research Station Sudden Oak Death research program(United States Department of Agriculture (USDA)United States Forest Service); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the National Research Initiative Competitive Grants Program grant 2008-35600-18780 from the USDA National Institute of Food and Agriculture to NJG and JCC, the US Forest Service Pacific Southwest Research Station Sudden Oak Death research program to NJG, and the National Science Foundation grant MCB-1231726 and the National Institutes of Health grant AI043288 to JCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439, DOI 10.1093/nar/gkl777; Arnaiz O, 2011, NUCLEIC ACIDS RES, V39, pD632, DOI 10.1093/nar/gkq918; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Brasier C, 2010, NATURE, V466, P824, DOI 10.1038/466824a; Braun L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000920; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012759; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cai PF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001256; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Dong SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020172; Dou DL, 2010, MOL PLANT MICROBE IN, V23, P425, DOI 10.1094/MPMI-23-4-0425; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Ester M., 1996, KDD, V96, P226; Fahlgren N, 2010, METHODS MOL BIOL, V592, P51, DOI 10.1007/978-1-60327-005-2_4; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Goss EM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000583; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Grunwald NJ, 2008, MOL PLANT PATHOL, V9, P729, DOI [10.1111/j.1364-3703.2008.00500.x, 10.1111/J.1364-3703.2008.00500.X]; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hennig C, 2013, FPC FLEXIBLE PROCEDU; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Judelson HS, 2007, EUKARYOT CELL, V6, P1200, DOI 10.1128/EC.00311-06; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCormick Kevin P, 2011, Silence, V2, P2, DOI 10.1186/1758-907X-2-2; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Poulsen C, 2013, PLANT CELL, V25, P22, DOI 10.1105/tpc.112.105643; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; R Core Team, 2012, R LANG ENV STAT COMP; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Raman V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-326; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stover NA, 2006, NUCLEIC ACIDS RES, V34, pD500, DOI 10.1093/nar/gkj054; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van West P, 1999, MOL CELL, V3, P339, DOI 10.1016/S1097-2765(00)80461-X; van West P, 2008, MICROBIOL-SGM, V154, P1482, DOI 10.1099/mic.0.2007/015545-0; Vetukuri RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051399; Vetukuri RR, 2011, MOL PLANT PATHOL, V12, P772, DOI [10.1111/J.1364-3703.2011.00710.X, 10.1111/j.1364-3703.2011.00710.x]; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Walker CA, 2008, FUNGAL GENET BIOL, V45, P954, DOI 10.1016/j.fgb.2008.03.004; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Whisson SC, 2005, MOL PLANT PATHOL, V6, P153, DOI 10.1111/J.1364-3703.2005.00272.X; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Zhao W, 2011, FUNGAL GENET BIOL, V48, P241, DOI 10.1016/j.fgb.2010.11.006	94	46	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77181	10.1371/journal.pone.0077181	http://dx.doi.org/10.1371/journal.pone.0077181			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204767	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600024
J	Deng, B; Liu, SG; Liu, S; Jansa, L; Li, ZW; Zhong, Y				Deng, Bin; Liu, Shugen; Liu, Sun; Jansa, Luba; Li, Zhiwu; Zhong, Yong			Progressive Indosinian N-S Deformation of the Jiaochang Structure in the Songpan-Ganzi Fold-Belt, Western China	PLOS ONE			English	Article							EASTERN TIBETAN PLATEAU; THRUST BELT; TECTONIC EVOLUTION; SICHUAN BASIN; OROGENIC BELT; SOUTH CHINA; STRAIN; CONSTRAINTS; GRANITE; SALIENT	Integrated field data, microstructural and three-dimensional strain analyses are used to document coaxial N-S shortening and southward increase in deformation intensity and metamorphism at the Jiaochang structure. Two episodes of deformation (D-1,D-2) with localized post-D-2 deformation have been identified in the area. The first deformation (D-1) episode is defined by a main axial-plane of parallel folds observable on a micro-to kilometer-scale, while the second episode of deformation (D-2) is defined by micro-scale metamorphic folds, associated with E-W oriented stretching lineation. These processes are the result of Indosinian tectonism (Late Triassic to Early Jurassic) characterized by nearly coaxial N-S compression and deformation. This is indicated by E-W trending, sub-parallel to parallel foliation (S-1, e. g. axial-plane of folds, and S-2, i.e. axial-plane of metamorphic folds, crenulation cleavage) and lineation (L-1, e. g. axis of folds, and L-2, i.e. stretching lineation, axis of metamorphic folds and B-axis of echelon lens). Most of the porphyroblasts and minerals (e. g. pyrite, biotite) show two growth phases with localized growth in the third phase (muscovite). The progressive D-1-D-2 structure is widespread in the south of the Jiaochang area, but only D-1 structure crops out at the north. The strain intensity (c), compression ratios (c%) and octahedral strain intensity (epsilon(s)) are similar across the Jiaochang structure (i.e., gamma approximate to 1.8, c approximate to 27%, epsilon(s) = 0.9), showing a broad range of Flinn values (K = 0.77 to 7.57). The long-axis orientations are roughly symmetric between two limbs of the structure. Therefore, we suggest that the architecture of the Jiaochang structure has been controlled by coaxial N-S shortening and deformation (D1-D2) during the Indosinian tectonic epoch, with insignificant post-D-2 deformation.	[Deng, Bin; Liu, Shugen; Liu, Sun; Li, Zhiwu] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Jansa, Luba] Dalhousie Univ, Halifax, NS, Canada; [Jansa, Luba] Geol Survey Canada Atlantic, Dartmouth, NS, Canada; [Zhong, Yong] CCDE Geophys Prospecting Co, Chengdu, Peoples R China	Chengdu University of Technology; Dalhousie University; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Liu, SG (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	lsg@cdut.edu.cn		Li, Zhiwu/0000-0002-4312-6768	National Natural Science Foundation of China [41230313]; College of Energy Resources of CDUT	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College of Energy Resources of CDUT	This study was supported by the National Natural Science Foundation of China (No. 41230313), and by a College of Energy Resources of CDUT graduate fellowship to B. Deng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruguier O, 1997, EARTH PLANET SC LETT, V152, P217, DOI 10.1016/S0012-821X(97)00138-6; Burchfiel B., 1995, INT GEOL REV, V37, P661, DOI [10.1080/00206819509465424, DOI 10.1080/00206819509465424]; CHEN SF, 1995, BASIN RES, V7, P235, DOI 10.1111/j.1365-2117.1995.tb00108.x; Deng B, 2012, J GEOL SOC INDIA, V80, P241, DOI 10.1007/s12594-012-0134-8; Deng B, 2012, J ASIAN EARTH SCI, V48, P43, DOI 10.1016/j.jseaes.2011.12.019; Dirks P H G M, 1994, J SE ASIAN EARTH SCI, V9, P181, DOI DOI 10.1016/0743-9547(94)90074-4; Flinn D., 1962, Q J GEOL SOC LOND, V118, P385, DOI DOI 10.1144/GSJGS.118.1.0385; FRY N, 1979, TECTONOPHYSICS, V60, P89, DOI 10.1016/0040-1951(79)90135-5; Harrowfield MJ, 2005, J STRUCT GEOL, V27, P101, DOI 10.1016/j.jsg.2004.06.010; HIRTH G, 1992, J STRUCT GEOL, V14, P145, DOI 10.1016/0191-8141(92)90053-Y; Huang M, 2003, J METAMORPH GEOL, V21, P223, DOI 10.1046/j.1525-1314.2003.00438.x; Kollmeier JM, 2000, EARTH PLANET SC LETT, V181, P203, DOI 10.1016/S0012-821X(00)00203-X; Li SZ, 2007, GONDWANA RES, V12, P121, DOI 10.1016/j.gr.2006.11.011; Lin SF, 2001, GEOLOGY, V29, P767, DOI 10.1130/0091-7613(2001)029<0767:UASVIS>2.0.CO;2; Liu SG, 2012, J ASIAN EARTH SCI, V47, P204, DOI 10.1016/j.jseaes.2011.10.012; Macedo J, 1999, GEOL SOC AM BULL, V111, P1808, DOI 10.1130/0016-7606(1999)111<1808:COTGOF>2.3.CO;2; Marshak S, 1996, J STRUCT GEOL, V18, P891, DOI 10.1016/0191-8141(96)00016-8; Marshak S., 2004, THRUST TECTONICS HYD, V82, P131, DOI DOI 10.1306/M82813C9; Passchier CW., 2005, MICROTECTONICS; Pullen A, 2008, GEOLOGY, V36, P351, DOI 10.1130/G24435A.1; Ramsay J. G., 1983, TECHNIQUES MODERN ST, V1; Reid AJ, 2005, J STRUCT GEOL, V27, P119, DOI 10.1016/j.jsg.2004.06.011; Reiter K, 2011, EARTH PLANET SC LETT, V302, P132, DOI 10.1016/j.epsl.2010.12.002; RIES AC, 1976, PHILOS T R SOC A, V283, P281, DOI 10.1098/rsta.1976.0085; Roger F, 2004, J ASIAN EARTH SCI, V22, P465, DOI 10.1016/S1367-9120(03)00089-0; Roger F, 2010, J ASIAN EARTH SCI, V39, P254, DOI 10.1016/j.jseaes.2010.03.008; Sussman A.J., 2004, 383 GEOL SOC AM; Tikoff B, 1997, J STRUCTURAL GEOLOGY, V19, P267; Wang Erqi, 2001, EARTH SCI FRONTIERS, V8, P375; Weil AB, 2010, GEOL SOC AM BULL, V122, P3, DOI 10.1130/B26483.1; Worley BA, 1996, J STRUCT GEOL, V18, P395, DOI 10.1016/0191-8141(95)00095-U; Xu Z. Q, 1992, OROGENIC PROCESSES S; Yan DP, 2003, J STRUCT GEOL, V25, P765, DOI 10.1016/S0191-8141(02)00059-7; Yuan C, 2010, EARTH PLANET SC LETT, V290, P481, DOI 10.1016/j.epsl.2010.01.005; Zhang HF, 2007, LITHOS, V97, P323, DOI 10.1016/j.lithos.2007.01.002; Zhang HF, 2006, J ASIAN EARTH SCI, V27, P751, DOI 10.1016/j.jseaes.2005.07.008	36	7	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76732	10.1371/journal.pone.0076732	http://dx.doi.org/10.1371/journal.pone.0076732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204663	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300048
J	Godiksen, S; Soendergaard, C; Friis, S; Jensen, JK; Bornholdt, J; Sales, KU; Huang, MD; Bugge, TH; Vogel, LK				Godiksen, Sine; Soendergaard, Christoffer; Friis, Stine; Jensen, Jan K.; Bornholdt, Jette; Sales, Katiuchia Uzzun; Huang, Mingdong; Bugge, Thomas H.; Vogel, Lotte K.			Detection of Active Matriptase Using a Biotinylated Chloromethyl Ketone Peptide	PLOS ONE			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; SERINE-PROTEASE MATRIPTASE; NEURAL-TUBE CLOSURE; ZYMOGEN ACTIVATION; PLACENTAL DEVELOPMENT; EPITHELIAL-CELLS; BARRIER FUNCTION; IN-VITRO; INHIBITOR; COMPLEX	Matriptase is a member of the family of type II transmembrane serine proteases that is essential for development and maintenance of several epithelial tissues. Matriptase is synthesized as a single-chain zymogen precursor that is processed into a two-chain disulfide-linked form dependent on its own catalytic activity leading to the hypothesis that matriptase functions at the pinnacle of several protease induced signal cascades. Matriptase is usually found in either its zymogen form or in a complex with its cognate inhibitor hepatocyte growth factor activator inhibitor 1 (HAI-1), whereas the active non-inhibited form has been difficult to detect. In this study, we have developed an assay to detect enzymatically active non-inhibitor-complexed matriptase by using a biotinylated peptide substrate-based chloromethyl ketone (CMK) inhibitor. Covalently CMK peptide-bound matriptase is detected by streptavidin pull-down and subsequent analysis by Western blotting. This study presents a novel assay for detection of enzymatically active matriptase in living human and murine cells. The assay can be applied to a variety of cell systems and species.	[Godiksen, Sine; Soendergaard, Christoffer; Friis, Stine; Bornholdt, Jette; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark; [Godiksen, Sine] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Godiksen, Sine; Friis, Stine; Sales, Katiuchia Uzzun; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Unit, Bethesda, MD USA; [Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Jensen, Jan K.; Huang, Mingdong] Danish Chinese Ctr Proteases & Canc, Fuzhou, Fujian, Peoples R China; [Huang, Mingdong] Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou, Fujian, Peoples R China	University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Aarhus University; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Vogel, LK (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark.	vogel@sund.ku.dk	Huang, Mingdong/J-4278-2017; sales, katiuchia u/J-4880-2012	Huang, Mingdong/0000-0003-0085-9141; sales, katiuchia/0000-0002-3768-5790; Soendergaard, Christoffer/0000-0002-2943-6911; Vogel, Lotte K./0000-0001-9920-0982	Faculty of Science, University of Copenhagen; Grocer Kristian Kjaer and wife's Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Master Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation; Wholesale Dealer Valdemar Foersom and wife Thyra Foersom's Foundation; Manufacturer Einar Willumsen's Foundation; Lundbeck Foundation; Architect Holger Hjortenberg and wife Dagmar Hjortenberg's Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	Faculty of Science, University of Copenhagen; Grocer Kristian Kjaer and wife's Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Master Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation; Wholesale Dealer Valdemar Foersom and wife Thyra Foersom's Foundation; Manufacturer Einar Willumsen's Foundation; Lundbeck Foundation(Lundbeckfonden); Architect Holger Hjortenberg and wife Dagmar Hjortenberg's Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Faculty of Science, University of Copenhagen, Architect Holger Hjortenberg and wife Dagmar Hjortenberg's Foundation; Grocer Kristian Kjaer and wife's Foundation, the Kjaer-Foundation; Dagmar Marshalls Foundation; Master Cabinetmaker Sophus Jacobsen and wife Astrid Jacobsen's Foundation; Wholesale Dealer Valdemar Foersom and wife Thyra Foersom's Foundation; Manufacturer Einar Willumsen's Foundation; and the Lundbeck Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PJ, 2001, ANAL BIOCHEM, V296, P254, DOI 10.1006/abio.2001.5302; Antalis TM, 2010, BIOCHEM J, V428, P325, DOI 10.1042/BJ20100046; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; BOOSE JA, 1989, BIOCHEMISTRY-US, V28, P635, DOI 10.1021/bi00428a033; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Buzza MS, 2010, P NATL ACAD SCI US; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Carney TJ, 2007, DEVELOPMENT, V134, P3461, DOI 10.1242/dev.004556; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Inouye K, 2013, J BIOCHEM, V153, P51, DOI 10.1093/jb/mvs118; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Larsen BR, 2013, EXP CELL RES, V319, P918, DOI 10.1016/j.yexcr.2013.01.008; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; RANBY M, 1982, THROMB RES, V27, P175, DOI 10.1016/0049-3848(82)90197-9; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tachias K, 1996, J BIOL CHEM, V271, P28749, DOI 10.1074/jbc.271.46.28749; TACHIAS K, 1995, J BIOL CHEM, V270, P18319, DOI 10.1074/jbc.270.31.18319; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; TATE KM, 1987, BIOCHEMISTRY-US, V26, P338, DOI 10.1021/bi00376a002; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; VOGEL LK, 1995, J BIOL CHEM, V270, P22933, DOI 10.1074/jbc.270.39.22933; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	53	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77146	10.1371/journal.pone.0077146	http://dx.doi.org/10.1371/journal.pone.0077146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204759	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300085
J	Shah, N; Martin-Antonio, B; Yang, H; Ku, S; Lee, DA; Cooper, LJN; Decker, WK; Li, SF; Robinson, SN; Sekine, T; Parmar, S; Gribben, J; Wang, M; Rezvani, K; Yvon, E; Najjar, A; Burks, J; Kaur, I; Champlin, RE; Bollard, CM; Shpall, EJ				Shah, Nina; Martin-Antonio, Beatriz; Yang, Hong; Ku, Stephanie; Lee, Dean A.; Cooper, Laurence J. N.; Decker, William K.; Li, Sufang; Robinson, Simon N.; Sekine, Takuya; Parmar, Simrit; Gribben, John; Wang, Michael; Rezvani, Katy; Yvon, Eric; Najjar, Amer; Burks, Jared; Kaur, Indreshpal; Champlin, Richard E.; Bollard, Catherine M.; Shpall, Elizabeth J.			Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE FORMATION; EX-VIVO EXPANSION; TERM-FOLLOW-UP; MULTIPLE-MYELOMA; BONE-MARROW; NK CELLS; UNRELATED DONOR; AUTOLOGOUS TRANSPLANTATION; ANTITUMOR-ACTIVITY; T-LYMPHOCYTES	Natural killer (NK) cells are important mediators of anti-tumor immunity and are active against several hematologic malignancies, including multiple myeloma (MM). Umbilical cord blood (CB) is a promising source of allogeneic NK cells but large scale ex vivo expansion is required for generation of clinically relevant CB-derived NK (CB-NK) cell doses. Here we describe a novel strategy for expanding NK cells from cryopreserved CB units using artificial antigen presenting feeder cells (aAPC) in a gas permeable culture system. After 14 days, mean fold expansion of CB-NK cells was 1848-fold from fresh and 2389-fold from cryopreserved CB with >95% purity for NK cells (CD56(+)/CD3(-)) and less than 1% CD3(+) cells. Though surface expression of some cytotoxicity receptors was decreased, aAPC-expanded CB-NK cells exhibited a phenotype similar to CB-NK cells expanded with IL-2 alone with respect to various inhibitory receptors, NKG2C and CD94 and maintained strong expression of transcription factors Eomesodermin and T-bet. Furthermore, CB-NK cells formed functional immune synapses with and demonstrated cytotoxicity against various MM targets. Finally, aAPC-expanded CB-NK cells showed significant in vivo activity against MM in a xenogenic mouse model. Our findings introduce a clinically applicable strategy for the generation of highly functional CB-NK cells which can be used to eradicate MM.	[Shah, Nina; Martin-Antonio, Beatriz; Yang, Hong; Li, Sufang; Robinson, Simon N.; Sekine, Takuya; Parmar, Simrit; Rezvani, Katy; Yvon, Eric; Kaur, Indreshpal; Champlin, Richard E.; Shpall, Elizabeth J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Ku, Stephanie; Decker, William K.; Bollard, Catherine M.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Lee, Dean A.; Cooper, Laurence J. N.] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Decker, William K.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Gribben, John] Queen Mary Univ London, Inst Canc, Barts & London Sch Med, Ctr Med Oncol, London, England; [Wang, Michael] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma, Houston, TX 77030 USA; [Najjar, Amer] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Burks, Jared] Univ Texas MD Anderson Canc Ctr, Dept Leukemia Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of London; Queen Mary University London; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shah, N (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	nshah@mdanderson.org	Lee, Dean Anthony/AAK-8443-2021; Martín-Antonio, Beatriz/D-4963-2014	Lee, Dean Anthony/0000-0001-6693-5392; Martín-Antonio, Beatriz/0000-0003-0612-2693; Bollard, Catherine M./0000-0001-5140-9090	National Institutes of Health [K12 CA088084]; Cancer Prevention and Research Institute of Texas RP [100430]; NATIONAL CANCER INSTITUTE [P01CA049639, P30CA016672, K12CA088084, P01CA081534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas RP; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health K12 CA088084 (Shah) and Cancer Prevention and Research Institute of Texas RP#100430 (Shpall). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alici E, 2007, EXP HEMATOL, V35, P1839, DOI 10.1016/j.exphem.2007.08.006; Alici E, 2008, BLOOD, V111, P3155, DOI 10.1182/blood-2007-09-110312; Anasetti C, 2012, BIOL BLOOD MARROW TR, V18, pS161, DOI 10.1016/j.bbmt.2011.11.004; Beck RC, 2009, BIOL BLOOD MARROW TR, V15, P1026, DOI 10.1016/j.bbmt.2009.06.002; Bjorkstrand B, 2011, J CLIN ONCOL, V29, P3016, DOI 10.1200/JCO.2010.32.7312; Brunstein CG, 2009, BLOOD, V113, P5628, DOI 10.1182/blood-2008-12-197467; Carbone E, 2005, BLOOD, V105, P251, DOI 10.1182/blood-2004-04-1422; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Denman CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030264; Fauriat C, 2006, LEUKEMIA, V20, P732, DOI 10.1038/sj.leu.2404096; Feinman R, 1999, BLOOD, V93, P3044; Garg TK, 2012, HAEMATOL-HEMATOL J, V97, P1348, DOI 10.3324/haematol.2011.056747; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; Giaccone L, 2011, BLOOD, V117, P6721, DOI 10.1182/blood-2011-03-339945; Gill S, 2012, BLOOD, V119, P5758, DOI 10.1182/blood-2012-03-415364; Gluckman E, 2011, BRIT J HAEMATOL, V154, P441, DOI 10.1111/j.1365-2141.2011.08598.x; Godfrey J, 2012, LEUKEMIA LYMPHOMA, V53, P1666, DOI 10.3109/10428194.2012.676175; Harousseau JL, 2009, NEW ENGL J MED, V360, P2645, DOI 10.1056/NEJMct0805626; Hoyos V, 2010, LEUKEMIA, V24, P1160, DOI 10.1038/leu.2010.75; Hsu KC, 2006, BIOL BLOOD MARROW TR, V12, P828, DOI 10.1016/j.bbmt.2006.04.008; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jurisic V, 2007, MED ONCOL, V24, P312, DOI 10.1007/s12032-007-0007-y; Kanga U, 2012, TRANSPL P, V44, P919, DOI 10.1016/j.transproceed.2012.03.036; Katodritou E, 2011, AM J HEMATOL, V86, P967, DOI 10.1002/ajh.22163; Krishnan A, 2011, LANCET ONCOL, V12, P1195, DOI 10.1016/S1470-2045(11)70243-1; Kroger N, 2011, LEUKEMIA, V25, P1657, DOI 10.1038/leu.2011.138; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lundqvist A, 2007, BLOOD, V109, P3603, DOI 10.1182/blood-2006-05-024315; Miller JS, 2007, BLOOD, V109, P5058, DOI 10.1182/blood-2007-01-065383; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Paley MA, 2012, J LEUKOC BIOL; Passweg JR, 2005, BONE MARROW TRANSPL, V35, P637, DOI 10.1038/sj.bmt.1704810; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Rosinol L, 2008, BLOOD, V112, P3591, DOI 10.1182/blood-2008-02-141598; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 2004, BLOOD CELL MOL DIS, V33, P216, DOI 10.1016/j.bcmd.2004.08.005; Savoldo B, 2007, BLOOD, V110, P2620, DOI 10.1182/blood-2006-11-059139; Sawanobori M, 1997, ACTA HAEMATOL-BASEL, V98, P150, DOI 10.1159/000203610; Shi J, 2008, BRIT J HAEMATOL, V143, P641, DOI 10.1111/j.1365-2141.2008.07340.x; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Spanholtz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009221; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; TANNER J, 1991, J CLIN INVEST, V88, P239, DOI 10.1172/JCI115283; Tinhofer I, 2000, BLOOD, V95, P610, DOI 10.1182/blood.V95.2.610; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Willemze R, 2010, BEST PRACT RES CL HA, V23, P283, DOI 10.1016/j.beha.2010.05.005; Xing DX, 2010, J IMMUNOTHER, V33, P684, DOI 10.1097/CJI.0b013e3181e475e9; Yang J, 2009, CLIN CANCER RES, V15, P951, DOI 10.1158/1078-0432.CCR-08-1823	52	123	128	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76781	10.1371/journal.pone.0076781	http://dx.doi.org/10.1371/journal.pone.0076781			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204673	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300052
J	Broniowska, KA; Mathews, CE; Corbett, JA				Broniowska, Katarzyna A.; Mathews, Clayton E.; Corbett, John A.			Do beta-Cells Generate Peroxynitrite in Response to Cytokine Treatment?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; Diabetes; Islet; Nitric Oxide; Reactive Oxygen Species (ROS); Nitric-oxide Synthase; Peroxynitrite	HUMAN PANCREATIC-ISLETS; NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; OXYGEN SPECIES PRODUCTION; REACTIVE OXYGEN; INSULIN-SECRETION; SUPEROXIDE-PRODUCTION; NADPH OXIDASE; DNA-DAMAGE; RAT ISLETS	Background: The species that mediates cytokine-induced -cell death, be it nitric oxide or peroxynitrite, is unknown. Results: Cytokines stimulate the formation of nitric oxide but fail to stimulate peroxynitrite production by -cells. Conclusion: Terminally differentiated -cells, unlike macrophages, do not produce peroxynitrite. Significance: Peroxynitrite does not contribute to cytokine-induced -cell damage. The purpose of this study was to determine the reactive species that is responsible for cytokine-mediated -cell death. Inhibitors of inducible nitric oxide synthase prevent this death, and addition of exogenous nitric oxide using donors induces -cell death. The reaction of nitric oxide with superoxide results in the generation of peroxynitrite, and this powerful oxidant has been suggested to be the mediator of -cell death in response to cytokine treatment. Recently, coumarin-7-boronate has been developed as a probe for the selective detection of peroxynitrite. Using this reagent, we show that addition of the NADPH oxidase activator phorbol 12-myristate 13-acetate to nitric oxide-producing macrophages results in peroxynitrite generation. Using a similar approach, we demonstrate that cytokines fail to stimulate peroxynitrite generation by rat islets and insulinoma cells, either with or without phorbol 12-myristate 13-acetate treatment. When forced to produce superoxide using redox cyclers, this generation is associated with protection from nitric oxide toxicity. These findings indicate that: (i) nitric oxide is the likely mediator of the toxic effects of cytokines, (ii) -cells do not produce peroxynitrite in response to cytokines, and (iii) when forced to produce superoxide, the scavenging of nitric oxide by superoxide is associated with protection of -cells from nitric oxide-mediated toxicity.	[Broniowska, Katarzyna A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Mathews, Clayton E.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA	Medical College of Wisconsin; State University System of Florida; University of Florida	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu		Broniowska, Katarzyna/0000-0002-8000-9093	National Institutes of Health [DK-052194, AI-44458, AI-056374, DK-074656]; American Heart Association [13POST16940076]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056374, R01AI044458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104194, R01DK074656, R01DK052194, R56DK074656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-052194 and AI-44458 (to J. A. C.) and AI-056374 and DK-074656 (to C. E. M.). This work was also supported by American Heart Association Postdoctoral Fellowship 13POST16940076 (to K. A. B.).	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; Broniowska KA, 2013, BIOCHEMISTRY-US, V52, P4364, DOI 10.1021/bi400342t; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; CADENAS E, 1995, BIOCHEM PHARMACOL, V49, P127, DOI 10.1016/S0006-2952(94)00333-5; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; COMBADIERE C, 1990, BIOCHEM BIOPH RES CO, V168, P65, DOI 10.1016/0006-291X(90)91675-I; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P8992, DOI 10.1073/pnas.90.19.8992; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; CORBETT JA, 1991, J BIOL CHEM, V266, P21351; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; CURNUTTE JT, 1994, J BIOL CHEM, V269, P10813; Delaney CA, 1997, ADV EXP MED BIOL, V426, P335; Delaney CA, 1997, MUTAT RES-FUND MOL M, V375, P137, DOI 10.1016/S0027-5107(97)00009-2; Delaney CA, 1996, FEBS LETT, V394, P300, DOI 10.1016/0014-5793(96)00977-5; DiMatteo MA, 1997, APOPTOSIS, V2, P164, DOI 10.1023/A:1026412414666; Eizirik DL, 1996, MOL CELL ENDOCRINOL, V118, P71, DOI 10.1016/0303-7207(96)03768-9; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; EIZIRIK DL, 1993, FEBS LETT, V317, P62, DOI 10.1016/0014-5793(93)81492-I; Graciano MFR, 2011, J CELL PHYSIOL, V226, P1110, DOI 10.1002/jcp.22432; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gunther MR, 2002, TOXICOLOGY, V177, P1, DOI 10.1016/S0300-483X(02)00191-9; Gurgul-Convey E, 2011, J MOL MED, V89, P785, DOI 10.1007/s00109-011-0747-1; Gusdon A.M., 2006, DRUG DISCOV TODAY DI, V3, P367, DOI [10.1016/j.ddmec.2006.09.010, DOI 10.1016/J.DDMEC.2006.09.010]; Gusdon AM, 2007, J BIOL CHEM, V282, P5171, DOI 10.1074/jbc.M609367200; Hadjivassiliou V, 1998, NITRIC OXIDE-BIOL CH, V2, P429, DOI 10.1006/niox.1998.0203; Halliwell B., 2007, FREE RADICALS BIOL M; Hughes KJ, 2011, J BIOL CHEM, V286, P8338, DOI 10.1074/jbc.M110.204768; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Koeck T, 2009, ARCH BIOCHEM BIOPHYS, V484, P221, DOI 10.1016/j.abb.2009.01.021; Kohl R, 2006, FREE RADICAL BIO MED, V40, P1430, DOI 10.1016/j.freeradbiomed.2005.12.012; Lakey JRT, 2001, LAB INVEST, V81, P1683, DOI 10.1038/labinvest.3780381; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Mathews CE, 2005, J IMMUNOL, V175, P1248, DOI 10.4049/jimmunol.175.2.1248; Mathews CE, 2002, FREE RADICAL BIO MED, V32, P744, DOI 10.1016/S0891-5849(02)00747-5; Meares GP, 2013, AM J PHYSIOL-ENDOC M, V304, pE614, DOI 10.1152/ajpendo.00424.2012; Meares GP, 2011, MOL CELL BIOL, V31, P4286, DOI 10.1128/MCB.05668-11; Miles AM, 1996, J BIOL CHEM, V271, P40, DOI 10.1074/jbc.271.1.40; Oliveira HR, 2003, DIABETES, V52, P1457, DOI 10.2337/diabetes.52.6.1457; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; Syed I, 2011, DIABETES, V60, P2843, DOI 10.2337/db11-0809; Syed I, 2011, AM J PHYSIOL-REG I, V300, pR756, DOI 10.1152/ajpregu.00786.2010; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Thayer TC, 2011, DIABETES, V60, P2144, DOI 10.2337/db10-1222; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Thomas DD, 2006, J BIOL CHEM, V281, P25984, DOI 10.1074/jbc.M602242200; Uchizono Y, 2006, LIFE SCI, V80, P133, DOI 10.1016/j.lfs.2006.08.031; Watanabe N, 2003, ARCH BIOCHEM BIOPHYS, V411, P145, DOI 10.1016/S0003-9861(02)00716-6; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	69	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36567	36578		10.1074/jbc.M113.522243	http://dx.doi.org/10.1074/jbc.M113.522243			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194521	Green Published, hybrid			2022-12-25	WOS:000328883400037
J	Troeger, A; Chae, HD; Senturk, M; Wood, J; Williams, DA				Troeger, Anja; Chae, Hee-Don; Senturk, Mumine; Wood, Jenna; Williams, David A.			A Unique Carboxyl-terminal Insert Domain in the Hematopoietic-specific, GTPase-deficient Rho GTPase RhoH Regulates Post-translational Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Protein Degradation; Protein Stability; Rho GTPases; T Cell; Atypical Rho GTPases; B-Cell Malignancies; RhoH; Carboxyl Terminus; Chaperone-mediated Autophagy	T-CELL-RECEPTOR; ABERRANT SOMATIC HYPERMUTATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; BINDING PROTEIN; GENE-TRANSFER; AUTOPHAGY; UBIQUITIN; DEGRADATION; INHIBITION; EXPRESSION	Background: RhoH is required for T cell development and non-coding RhoH mutations are found in B-cell lymphoma. Results: The C-terminal insert domain regulates RhoH protein stability via chaperone-mediated autophagy. Conclusion: Although the insert domain is required for lysosomal uptake, it is dispensable for T cell development. Significance: Targeting the insert domain may permit alteration of RhoH protein levels without impairing vital protein functions. RhoH is a hematopoietic-specific, GTPase-deficient member of the Rho GTPase family that was first identified as a hypermutable gene in human B lineage lymphomas. RhoH remains in a constitutively active state and thus its effects are regulated by expression levels or post-translational modifications. Similar to other small GTPases, intracellular localization of RhoH is dependent upon the conserved CAAX box and surrounding sequences within the carboxyl (C) terminus. However, RhoH also contains a unique C-terminal insert domain of yet undetermined function. RhoH serves as adaptor molecule in T cell receptor signaling and RhoH expression correlates with the unfavorable prognostic marker ZAP70 in human chronic lymphocytic leukemia. Disease progression is attenuated in a Rhoh(-/-) mouse model of chronic lymphocytic leukemia and treatment of primary human chronic lymphocytic leukemia cells with Lenalidomide results in reduced RhoH protein levels. Thus, RhoH is a potential therapeutic target in B cell malignancies. In the current studies, we demonstrate that deletion of the insert domain (LFSINE) results in significant cytoplasmic protein accumulation. Using inhibitors of degradation pathways, we show that LFSINE regulates lysosomal RhoH uptake and degradation via chaperone-mediated autophagy. Whereas the C-terminal prenylation site is critical for ZAP70 interaction, subcellular localization and rescue of the Rhoh(-/-) T cell defect in vivo, the insert domain appears dispensable for these functions. Taken together, our findings suggest that the insert domain regulates protein stability and activity without otherwise affecting RhoH function.	[Troeger, Anja; Wood, Jenna; Williams, David A.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Troeger, Anja; Wood, Jenna; Williams, David A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chae, Hee-Don] Stanford Univ, Sch Med, Div Hematol Oncol, Dept Pediat,CSCR 1210, Stanford, CA 94305 USA; [Senturk, Mumine] Baylor Coll Med, Dept Dev Biol, Houston, TX 77030 USA; [Troeger, Anja] Univ Dusseldorf, Clin Pediat Oncol Hematol & Clin Immunol, D-40225 Dusseldorf, Germany	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Stanford University; Baylor College of Medicine; Heinrich Heine University Dusseldorf	Williams, DA (corresponding author), Karp Family Res Labs 08125 3, 300 Longwood Ave, Boston, MA 02115 USA.	DAWilliams@childrens.harvard.edu	Chae, Hee-Don/D-2620-2011	Wood, Jenna/0000-0001-6715-0626	National Institutes of Health [CA113969]; Deutsche Forschungsgemeinschaft [TR 1005/1-1]; NATIONAL CANCER INSTITUTE [R01CA113969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113969 (to D. A. W.) and Deutsche Forschungsgemeinschaft Grant TR 1005/1-1 (to A. T.).	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Benbrook D. M., 2012, Experimental Oncology, V34, P286; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blagosklonny MV, 1999, ONCOGENE, V18, P6460, DOI 10.1038/sj.onc.1203068; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; Chae HD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013970; Chang Xiu-Bao, 2011, Int J Biochem Mol Biol, V2, P287; Crequer A, 2012, J CLIN INVEST, V122, P3239, DOI 10.1172/JCI62949; Crul M, 2001, ANTI-CANCER DRUG, V12, P163, DOI 10.1097/00001813-200103000-00001; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DalleryPrudhomme E, 1997, GENOMICS, V43, P89, DOI 10.1006/geno.1997.4788; Delestre L, 2011, BIOCHEM J, V437, P75, DOI 10.1042/BJ20100829; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fueller Florian, 2008, Cell Commun Signal, V6, P6, DOI 10.1186/1478-811X-6-6; Gaidano G, 2003, BLOOD, V102, P1833, DOI 10.1182/blood-2002-11-3606; Galiegue-Zouitina S, 2008, CANCER RES, V68, P4531, DOI 10.1158/0008-5472.CAN-07-5661; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; Gu Y, 2005, CELL CYCLE, V4, P201; Gu Y, 2005, BLOOD, V105, P1467, DOI 10.1182/blood-2004-04-1604; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hiraga J, 2007, LEUKEMIA, V21, P1846, DOI 10.1038/sj.leu.2404717; Iwasaki T, 2008, EUR J HAEMATOL, V81, P454, DOI 10.1111/j.1600-0609.2008.01132.x; Jadhav Trafina, 2009, J Proteomics Bioinform, V2, P316; Kleer CG, 2002, AM J PATHOL, V160, P579, DOI 10.1016/S0002-9440(10)64877-8; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lahousse S, 2004, GENE, V343, P55, DOI 10.1016/j.gene.2004.08.022; Li WM, 2011, CELL MOL LIFE SCI, V68, P749, DOI 10.1007/s00018-010-0565-6; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Montesinos-Rongen M, 2004, BLOOD, V103, P1869, DOI 10.1182/blood-2003-05-1465; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Ochel HJ, 2001, CELL STRESS CHAPERON, V6, P105, DOI 10.1379/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2; Orenstein SJ, 2010, SEMIN CELL DEV BIOL, V21, P719, DOI 10.1016/j.semcdb.2010.02.005; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Perez-Sala D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008117; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; Qiao LY, 2009, NEUROSCI LETT, V456, P15, DOI 10.1016/j.neulet.2009.03.085; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Sanchez-Aguilera A, 2010, LEUKEMIA, V24, P97, DOI 10.1038/leu.2009.217; Schmidt-Mende J, 2010, EUR J IMMUNOL, V40, P525, DOI 10.1002/eji.200939556; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Troeger A, 2012, BLOOD, V119, P4708, DOI 10.1182/blood-2011-12-395939; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Viana R, 2008, BIOCHEM BIOPH RES CO, V369, P964, DOI 10.1016/j.bbrc.2008.02.126; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426; Wang H, 2011, CELL SIGNAL, V23, P249, DOI 10.1016/j.cellsig.2010.09.009; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	57	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36451	36462		10.1074/jbc.M113.505727	http://dx.doi.org/10.1074/jbc.M113.505727			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189071	Green Published, hybrid			2022-12-25	WOS:000328883400026
J	Alvarado, S; Wyglinski, J; Suderman, M; Andrews, SA; Szyf, M				Alvarado, Sebastian; Wyglinski, Joanne; Suderman, Matthew; Andrews, Stephen A.; Szyf, Moshe			Methylated DNA Binding Domain Protein 2 (MBD2) Coordinately Silences Gene Expression through Activation of the MicroRNA hsa-mir-496 Promoter in Breast Cancer Cell Line	PLOS ONE			English	Article							IN-VITRO; DEMETHYLATION; GROWTH; METHYLTRANSFERASE; HYPOMETHYLATION; TUMORIGENESIS; TRANSITION; MECHANISM; FAMILY	Methylated DNA binding protein 2 (MBD2) binds methylated promoters and suppresses transcription in cis through recruitment of a chromatin modification repressor complex. We show here a new mechanism of action for MBD2: suppression of gene expression indirectly through activation of microRNA hsa-mir-496. Overexpression of MBD2 in breast epithelial cell line MCF-10A results in induced expression and demethylation of hsa-mir-496 while depletion of MBD2 in a human breast cancer cell lines MCF-7 and MDA-MB231 results in suppression of hsa-mir-496. Activation of hsa-mir-496 by MBD2 is associated with silencing of several of its target genes while depletion of MBD2 leads to induction of hsa-mir-496 target genes. Depletion of hsa-mir-496 by locked nucleic acid (LNA) antisense oligonucleotide leads to activation of these target genes in MBD2 overexpressing cells supporting that hsa-mir-496 is mediating in part the effects of MBD2 on gene expression. We demonstrate that MBD2 binds the promoter of hsa-mir-496 in MCF-10A, MCF-7 and MDA-MB-231 cells and that it activates an in vitro methylated hsa-mir-496 promoter driving a CG-less luciferase reporter in a transient transfection assay. The activation of hsa-mir-496 is associated with reduced methylation of the promoter. Taken together these results describe a novel cascade for gene regulation by DNA methylation whereby activation of a methylated microRNA by MBD2 that is associated with loss of methylation triggers repression of downstream targets.	[Alvarado, Sebastian; Wyglinski, Joanne; Suderman, Matthew; Andrews, Stephen A.; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada; [Suderman, Matthew] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Szyf, M (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	moshe.szyf@mcgill.ca	Alvarado, Sebastian/S-7607-2018	Alvarado, Sebastian/0000-0001-5866-4043; Suderman, Matthew/0000-0002-2715-9930	National Cancer Institute of Canada; Canadian Institute of Health Research [MOP-42411]; Canadian Institute for Advanced Research; Sackler program in Epigenetics and psychobiology	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Sackler program in Epigenetics and psychobiology	This study was supported by a grant from the National Cancer Institute of Canada and the Canadian Institute of Health Research (MOP-42411) (http://cancer.ca/Research.aspx). MS is supported by the Canadian Institute for Advanced Research and the Sackler program in Epigenetics and psychobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Aoki K, 2009, J IMMUNOL, V182, P7698, DOI 10.4049/jimmunol.0801643; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Billard LM, 2002, ONCOGENE, V21, P2704, DOI 10.1038/sj/onc/1205357; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broday L, 1999, MOL CELL BIOL, V19, P3198; Buurman R, 2012, GASTROENTEROLOGY, V143, P811, DOI 10.1053/j.gastro.2012.05.033; Campbell PM, 2004, CARCINOGENESIS, V25, P499, DOI 10.1093/carcin/bgh045; Chen C. C., 2013, J BIOL CHEM; Chen CC, 2012, J BIOL CHEM, V287, P33116, DOI 10.1074/jbc.C112.406975; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Ego T, 2005, ONCOGENE, V24, P1914, DOI 10.1038/sj.onc.1208394; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Goel A, 2003, J BIOL CHEM, V278, P15333, DOI 10.1074/jbc.M300608200; Han L, 2007, CANCER BIOL THER, V6, P1284; HE L, 2004, NAT REV GENET, V5, P522; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Ishibashi O, 1999, Cancer Biochem Biophys, V17, P69; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kirschke H, 1997, ADV EXP MED BIOL, V421, P253; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Mohr F, 2011, EXP HEMATOL, V39, P272, DOI 10.1016/j.exphem.2010.12.004; Munnes M, 1998, ONCOGENE, V17, P2573, DOI 10.1038/sj.onc.1202165; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Omura N, 2010, MOL CANCER RES, V8, P821, DOI 10.1158/1541-7786.MCR-09-0336; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Pakneshan P, 2004, CLIN CANCER RES, V10, P3035, DOI 10.1158/1078-0432.CCR-03-0545; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; ROULEAU J, 1992, J BIOL CHEM, V267, P7368; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Saito Yoshimasa, 2012, Frontiers in Genetics, V3, P186, DOI 10.3389/fgene.2012.00186; Sansom OJ, 2003, NAT GENET, V34, P145, DOI 10.1038/ng1155; Shukeir N, 2006, CANCER RES, V66, P9202, DOI 10.1158/0008-5472.CAN-06-1954; Slack A, 2002, J GENE MED, V4, P381, DOI 10.1002/jgm.288; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yu FY, 2012, J BIOL CHEM, V287, P465, DOI 10.1074/jbc.M111.280768; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Z, 2006, ONCOGENE, V25, P5436, DOI 10.1038/sj.onc.1209530; ZUCMAN J, 1992, GENOMICS, V13, P395, DOI 10.1016/0888-7543(92)90259-U	53	24	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e74009	10.1371/journal.pone.0074009	http://dx.doi.org/10.1371/journal.pone.0074009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204564	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700001
J	Mundra, V; Wu, H; Mahato, RI				Mundra, Vaibhav; Wu, Hao; Mahato, Ram I.			Genetically Modified Human Bone Marrow Derived Mesenchymal Stem Cells for Improving the Outcome of Human Islet Transplantation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; PANCREATIC-ISLETS; GENE-TRANSFER; BETA-CELLS; CYTOKINES ACTIVATE; EXPRESSION; APOPTOSIS; DIFFERENTIATION; PROLIFERATION	The objective of this study was to determine the potential of human bone marrow derived mesenchymal stem cells (hBMSCs) as gene carriers for improving the outcome of human islet transplantation. hBMSCs were characterized for the expression of phenotypic markers and transduced with Adv-hVEGF-hIL-1Ra to overexpress human vascular endothelial growth factor (hVEGF) and human interleukin-1 receptor antagonist (hIL-1Ra). Human islets were co-cultured with hBMSCs overexpressing hVEGF and hIL-1Ra. Islet viability was determined by membrane fluorescent method and glucose stimulation test. Transduced hBMSCs and human islets were co-transplanted under the kidney capsule of NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) diabetic mice and blood glucose levels were measured over time to demonstrate the efficacy of genetically modified hBMSCs. At the end of study, immunofluorescent staining of kidney section bearing islets was performed for insulin and von Willebrand Factor (vWF). hBMSCs were positive for the expression of CD73, CD90, CD105, CD146 and Stro-1 surface markers as determined by flow cytometry. Transduction of hBMSCs with adenovirus did not affect their stemness and differentiation potential as confirmed by mRNA levels of stem cell markers and adipogenic differentiation of transduced hBMSCs. hBMSCs were efficiently transduced with Adv-hVEGF-hIL-1Ra to overexpress hVEGF and hIL-1Ra. Live dead cell staining and glucose stimulation test have shown that transduced hBMSCs improved the viability of islets against cytokine cocktail. Co-transplantation of human islets with genetically modified hBMSCs improved the glycemic control of diabetic NSG mice as determined by mean blood glucose levels and intraperitoneal glucose tolerance test. Immunofluorescent staining of kidney sections was positive for human insulin and vWF. In conclusion, our results have demonstrated that hBMSCs may be used as gene carriers and nursing cells to improve the outcome of islet transplantation.	[Mundra, Vaibhav; Wu, Hao; Mahato, Ram I.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Mahato, RI (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	ram.mahato@unmc.edu			National Institutes of Health (NIH) [RO1 DK69968]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069968] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (NIH) for financial support (RO1 DK69968). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augstein P, 2004, J AUTOIMMUN, V23, P301, DOI 10.1016/j.jaut.2004.09.006; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Bertuzzi F, 2002, DIABETOLOGIA, V45, P77, DOI 10.1007/s125-002-8247-2; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Cai Q, 2012, DEV BIOL, V367, P40, DOI 10.1016/j.ydbio.2012.04.022; Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duprez IR, 2011, UPSALA J MED SCI, V116, P8, DOI 10.3109/03009734.2010.524320; Garcia-Ocana A, 2003, J BIOL CHEM, V278, P343, DOI 10.1074/jbc.M207848200; Giannoukakis N, 1999, DIABETES, V48, P1730, DOI 10.2337/diabetes.48.9.1730; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; GORES PF, 1993, ANN NY ACAD SCI, V696, P377; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Han JH, 2012, STEM CELLS, V30, P2746, DOI 10.1002/stem.1223; HENDERSON JR, 1985, Q J EXP PHYSIOL CMS, V70, P347, DOI 10.1113/expphysiol.1985.sp002920; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Kim NY, 2010, J GENE MED, V12, P779, DOI 10.1002/jgm.1497; KURODA M, 1995, J CLIN ENDOCR METAB, V80, P3196, DOI 10.1210/jc.80.11.3196; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Luo JZQ, 2011, BONE MARROW TRANSPL, V46, P1128, DOI 10.1038/bmt.2010.278; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Milanesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042177; Narang AS, 2006, PHARM RES, V23, P1970, DOI 10.1007/s11095-006-9065-7; Nyqvist D, 2011, DIABETES, V60, P2571, DOI 10.2337/db10-1711; Panakanti R, 2009, MOL PHARMACEUT, V6, P274, DOI 10.1021/mp800183b; Panakanti R, 2009, PHARM RES-DORDR, V26, P587, DOI 10.1007/s11095-008-9777-y; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Psaltis PJ, 2010, J CELL PHYSIOL, V223, P530, DOI 10.1002/jcp.22081; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Stiehler M, 2006, ADV EXP MED BIOL, V585, P31; Tondreau T, 2004, CYTOTHERAPY, V6, P372, DOI 10.1080/14653240410004943; Treacy O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042662; Wu H, 2011, J GENE MED, V13, P658, DOI 10.1002/jgm.1626; Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e; Zhang N, 2003, AM J TRANSPLANT, V3, P1230, DOI 10.1046/j.1600-6143.2003.00215.x; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963; Zheng YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041392	51	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77591	10.1371/journal.pone.0077591	http://dx.doi.org/10.1371/journal.pone.0077591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204883	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700041
J	Jin, SB; Fu, HT; Zhou, Q; Sun, SM; Jiang, SF; Xiong, YW; Gong, YS; Qiao, H; Zhang, WY				Jin, Shubo; Fu, Hongtuo; Zhou, Qiao; Sun, Shengming; Jiang, Sufei; Xiong, Yiwei; Gong, Yongsheng; Qiao, Hui; Zhang, Wenyi			Transcriptome Analysis of Androgenic Gland for Discovery of Novel Genes from the Oriental River Prawn, Macrobrachium nipponense, Using Illumina Hiseq 2000	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; FRESH-WATER PRAWNS; SEXUAL CHARACTERISTICS; EXPRESSION ANALYSIS; MOLECULAR-CLONING; RNA-SEQ; FTZ-F1; IDENTIFICATION; HOMOLOG; PROTEIN	Background: The oriental river prawn, Macrobrachium nipponense, is an important aquaculture species in China, even in whole of Asia. The androgenic gland produces hormones that play crucial roles in sexual differentiation to maleness. This study is the first de novo M. nipponense transcriptome analysis using cDNA prepared from mRNA isolated from the androgenic gland. Illumina/Solexa was used for sequencing. Methodology and Principal Finding: The total volume of RNA sample was more than 5 ug. We generated 70,853,361 high quality reads after eliminating adapter sequences and filtering out low-quality reads. A total of 78,408 isosequences were obtained by clustering and assembly of the clean reads, producing 57,619 non-redundant transcripts with an average length of 1244.19 bp. In total 70,702 isosequences were matched to the Nr database, additional analyses were performed by GO (33,203), KEGG (17,868), and COG analyses (13,817), identifying the potential genes and their functions. A total of 47 sex-determination related gene families were identified from the M. nipponense androgenic gland transcriptome based on the functional annotation of non-redundant transcripts and comparisons with the published literature. Furthermore, a total of 40 candidate novel genes were found, that may contribute to sex-determination based on their extremely high expression levels in the androgenic compared to other sex glands,. Further, 437 SSRs and 65,535 high-confidence SNPs were identified in this EST dataset from which 14 EST-SSR markers have been isolated. Conclusion: Our study provides new sequence information for M. nipponense, which will be the basis for further genetic studies on decapods crustaceans. More importantly, this study dramatically improves understanding of sex-determination mechanisms, and advances sex-determination research in all crustacean species. The huge number of potential SSR and SNP markers isolated from the transcriptome may shed the lights on research in many fields, including the evolution and molecular ecology of Macrobrachium species.	[Jin, Shubo; Fu, Hongtuo; Zhou, Qiao] Nanjing Agr Univ, Wuxi Fishery Coll, Wuxi, Peoples R China; [Jin, Shubo; Fu, Hongtuo; Sun, Shengming; Jiang, Sufei; Xiong, Yiwei; Gong, Yongsheng; Qiao, Hui; Zhang, Wenyi] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Fu, HT (corresponding author), Nanjing Agr Univ, Wuxi Fishery Coll, Wuxi, Peoples R China.	fuht@ffrc.cn		Jin, Shubo/0000-0002-6550-9268	National Natural Science Foundation of China [31272654]; National Science & Technology Supporting Program of the 12th Five-year Plan of China [2012BAD26B04]; Science & Technology Supporting Program of Jiangsu Province [BE2012334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Supporting Program of the 12th Five-year Plan of China; Science & Technology Supporting Program of Jiangsu Province	The project was supported by the National Natural Science Foundation of China (Grant No.31272654) (http://www.nsfc.gov.cn/Portal0/InfoModule_544/29249.htm), the National Science & Technology Supporting Program of the 12th Five-year Plan of China (Grant No. 2012BAD26B04) (http://www.most.gov.cn/kjbgz/201208/t20120821_96332.htm) and the Science & Technology Supporting Program of Jiangsu Province (Grant No. BE2012334)(http://www.jiangsu.gov.cn/xxgk/bmhsxwj/bmwj/201206/t20120626_740122.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BOND U, 1985, MOL CELL BIOL, V5, P949, DOI 10.1128/MCB.5.5.949; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bureau of Fishery Ministry of Agriculture and P.R.C., 2009, CHIN FISH YB, P236; Cai YX, 2006, RAFFLES B ZOOL, V54, P245; CARLSON N, 1987, J CELL BIOL, V104, P547, DOI 10.1083/jcb.104.3.547; Casas E, 1999, ZYGOTE, V7, P21, DOI 10.1017/S0967199499000350; Chini V, 2008, GENE, V410, P207, DOI 10.1016/j.gene.2007.12.012; Chung JS, 2011, GEN COMP ENDOCR, V173, P4, DOI 10.1016/j.ygcen.2011.04.017; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Feng Jian-bin, 2008, Shanghai Shuichan Daxue Xuebao, V17, P371; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Gross PS, 2001, DEV COMP IMMUNOL, V25, P565, DOI 10.1016/S0145-305X(01)00018-0; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hake L, 2008, NATURE ED, V1; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Ito M, 2000, PLANT MOL BIOL, V43, P677, DOI 10.1023/A:1006336005587; Jones DO, 2001, DNA SEQUENCE, V12, P147, DOI 10.3109/10425170109080769; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kawahara-Miki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026043; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li H, 1997, ENDOCRINOLOGY, V138, P1289, DOI 10.1210/en.138.3.1289; Li SH, 2012, GEN COMP ENDOCR, V177, P246, DOI 10.1016/j.ygcen.2012.04.010; Li WW, 2011, PEPTIDES, V32, P518, DOI 10.1016/j.peptides.2010.08.027; Ma KY, 2013, GEN COMP ENDOCR, V185, P90, DOI 10.1016/j.ygcen.2013.01.018; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Ma KY, 2011, GENE, V487, P160, DOI 10.1016/j.gene.2011.07.017; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mareddy VR, 2011, AQUACULTURE, V318, P364, DOI 10.1016/j.aquaculture.2011.05.027; MATSUMOTO M, 1993, BIOCHIM BIOPHYS ACTA, V1174, P274, DOI 10.1016/0167-4781(93)90196-K; Mirabdullaev IM, 2005, 2 INT S INVASION ALI, P113; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; NAGAMINE C, 1980, GEN COMP ENDOCR, V41, P423, DOI 10.1016/0016-6480(80)90048-9; Oba K, 1996, BIOCHEM BIOPH RES CO, V226, P261, DOI 10.1006/bbrc.1996.1343; Okuno A, 2002, PEPTIDES, V23, P567, DOI 10.1016/S0196-9781(01)00635-0; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Preechaphol R, 2007, J BIOCHEM MOL BIOL, V40, P501; Qiao H, 2012, COMP BIOCHEM PHYS D, V7, P268, DOI 10.1016/j.cbd.2012.04.003; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; RABOY B, 1991, ACTA BIOL HUNG, V42, P3; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; SAGI A, 1990, GEN COMP ENDOCR, V77, P15, DOI 10.1016/0016-6480(90)90201-V; SAGI A, 1986, AQUACULTURE, V51, P265, DOI 10.1016/0044-8486(86)90318-2; Sagi A., 1990, World Aquaculture, V21, P87; Salman Salman D., 2006, Aquatic Invasions, V1, P109, DOI 10.3391/ai.2006.1.3.2; Sambrook J., 2011, MOL CLONING LAB MANU, V3rd; Schwartz AL, 1999, ANNU REV MED, V50, P57; Shen BL, 2009, MOL BIOL REP, V36, P1149, DOI 10.1007/s11033-008-9291-7; Sroyraya M, 2010, TISSUE CELL, V42, P293, DOI 10.1016/j.tice.2010.07.003; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; UEDA H, 1990, NUCLEIC ACIDS RES, V18, P7229, DOI 10.1093/nar/18.24.7229; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Ventura T, 2012, BIOTECHNOL ADV, V30, P1543, DOI 10.1016/j.biotechadv.2012.04.008; Ventura Tomer, 2011, ISRN Endocrinol, V2011, P476283, DOI 10.5402/2011/476283; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; von Hofsten J, 2001, GEN COMP ENDOCR, V121, P146, DOI 10.1006/gcen.2000.7582; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wu P, 2002, WATER CONSERVANCY RE, V123, P21; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Yamaguchi K, 1998, EXP CELL RES, V242, P303, DOI 10.1006/excr.1997.4082; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu H-P, 1972, OHMU, V3, P45; Zeng S, 2002, GENE, V294, P45, DOI 10.1016/S0378-1119(02)00791-6; Zhang FY, 2010, COMP BIOCHEM PHYS B, V155, P288, DOI 10.1016/j.cbpb.2009.11.013; Zhang WM, 2007, MOL REPROD DEV, V74, P665, DOI 10.1002/mrd.20642; Zhang YP, 2013, J WORLD AQUACULT SOC, V44, P338, DOI 10.1111/jwas.12039; Zhang YP, 2013, GENETIC MOL IN PRESS; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7	88	53	57	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76840	10.1371/journal.pone.0076840	http://dx.doi.org/10.1371/journal.pone.0076840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204682	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200016
J	Martelli-Palomino, G; Pancotto, JA; Muniz, YC; Mendes, CT; Castelli, EC; Massaro, JD; Krawice-Radanne, I; Poras, I; Rebmann, V; Carosella, ED; Rouas-Freiss, N; Moreau, P; Donadi, EA				Martelli-Palomino, Gustavo; Pancotto, Joao A.; Muniz, Yara C.; Mendes-Junior, Celso T.; Castelli, Erick C.; Massaro, Juliana D.; Krawice-Radanne, Irene; Poras, Isabelle; Rebmann, Vera; Carosella, Edgardo D.; Rouas-Freiss, Nathalie; Moreau, Philippe; Donadi, Eduardo A.			Polymorphic Sites at the 3 ' Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; G MESSENGER-RNA; G 3'UTR POLYMORPHISMS; G GENOTYPE; HAPLOTYPE FREQUENCIES; SUSCEPTIBILITY; ALLELE; PREECLAMPSIA; RECEPTOR; CELLS	HLA-G molecule has well-recognized tolerogenic properties, and the encoding gene shows lower frequency of polymorphism at the coding region but higher variability at regulatory 5' and 3' untranslated (3' UTR) regions. At least three 3' UTR polymorphic sites have been associated with HLA-G mRNA regulation, including the 14 base pair (14bp) Insertion/Deletion, +3142C-G and +3187A-G. We studied the association of polymorphic sites at 3' UTR (sequencing analysis, encompassing the 14bp Ins-Del/+3003T-C/+3010C-G/+3027C-A/+3035C-T/+3142C-G/+3187A-G/+3196C-G polymorphic sites) with plasma soluble HLA-G levels (sHLA-G, detected by ELISA) in 187 French and 153 Brazilian healthy individuals. Allele and genotype frequencies were closely similar in both populations; however, Brazilians showed a higher HLA-G 3' UTR haplotype diversity. Considering sHLA-G levels in both populations altogether, individuals presenting 14bp Del/Del showed higher levels compared to 14bpIns/Ins genotype (P < 0.05); those presenting +3010C/G showed higher levels compared to the +3010C-C genotype (P<0.05); those presenting +3027C-C showed higher levels than the +3027A-A genotype (P<0.05); and those bearing +3035C-C showed higher levels compared to the +3035C-T (P < 0.01) and +3035T-T (P < 0.05) genotypes. The analyses of 3' UTR haplotypes showed that UTR-1 (DelTGCCCGC) was associated with higher expression of sHLA-G, whereas UTR-5 (InsTCCTGAC) and UTR-7 (InsTCATGAC) with lower expression and other UTRs (UTR-2/3/4/6) exhibited intermediate levels. Since the differential expression of HLA-G may be beneficial or harmful depending on the underlying condition, the identification of individuals genetically programmed to differentially express HLA-G may help on defining novel strategies to control the immune response against the underlying disorder.	[Martelli-Palomino, Gustavo; Donadi, Eduardo A.] Univ Sao Paulo, Fac Med Ribeirao Preto, Program Basic & Appl Immunol, Sao Paulo, Brazil; [Martelli-Palomino, Gustavo; Pancotto, Joao A.; Muniz, Yara C.; Krawice-Radanne, Irene; Poras, Isabelle; Carosella, Edgardo D.; Rouas-Freiss, Nathalie; Moreau, Philippe] Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, Paris, France; [Martelli-Palomino, Gustavo; Pancotto, Joao A.; Krawice-Radanne, Irene; Poras, Isabelle; Carosella, Edgardo D.; Rouas-Freiss, Nathalie; Moreau, Philippe] Univ Paris Diderot, Hop St Louis, Sorbonne Paris Cite, Inst Univ Hematol,Umr E5, Paris, France; [Pancotto, Joao A.] Univ Fed Espirito Santo, Sao Mateus, ES, Brazil; [Muniz, Yara C.] Univ Fed Santa Catarina, Program Cellular & Dev Biol, BR-88040900 Florianopolis, SC, Brazil; [Mendes-Junior, Celso T.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil; [Castelli, Erick C.] Univ State Sao Paulo UNESP, Sch Med Botucatu, Dept Pathol, Botucatu, SP, Brazil; [Massaro, Juliana D.; Donadi, Eduardo A.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, Div Clin Immunol, Sao Paulo, Brazil; [Rebmann, Vera] Univ Hosp Essen, Inst Transfus Med, Essen, Germany	Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universidade Federal do Espirito Santo; Universidade Federal de Santa Catarina (UFSC); Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; University of Duisburg Essen	Moreau, P (corresponding author), Hop St Louis, Commissariat Energie Atom & Energies Alternat, Inst Malad Emergentes & Therapies Innovantes, Serv Rech Hematoimmunol, Paris, France.	philippe.moreau@cea.fr	Massaro, Juliana/V-4894-2019; Mendes-Junior, Celso Teixeira/B-1994-2010; Castelli, Erick C./B-4250-2010; Pancoto, João Alexandre Trés/AAI-9743-2021; donadi, eduardo A/H-7080-2013	Mendes-Junior, Celso Teixeira/0000-0002-7337-1203; Castelli, Erick C./0000-0003-2142-7196; Pancoto, João Alexandre Trés/0000-0003-1986-1452; donadi, eduardo A/0000-0002-9457-9601; Moreau, Philippe/0000-0002-2868-7401; Muniz, Yara Costa Netto/0000-0001-9526-8306; Rebmann, Vera/0000-0003-4660-3870	Binational Research Cooperation Program (CAPES/Brazil-COFECUB/France) [653/09]; Commissariat a L'Energie Atomique (CEA), France; CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil); ANR Agence Nationale de la Recherche [2010 PRSP 012 003]; Deutsche Krebshilfe [109816]	Binational Research Cooperation Program (CAPES/Brazil-COFECUB/France); Commissariat a L'Energie Atomique (CEA), France(French Atomic Energy Commission); CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); ANR Agence Nationale de la Recherche(French National Research Agency (ANR)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This research was supported by grants from: (1) The Binational Research Cooperation Program (CAPES/Brazil-COFECUB/France project no. 653/09), (2) Commissariat a L'Energie Atomique (CEA), France, (3) CNPq Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil), (4) ANR Agence Nationale de la Recherche (2010 PRSP 012 003) (5) Deutsche Krebshilfe 109816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasood A, 2011, HUM IMMUNOL, V72, P1064, DOI 10.1016/j.humimm.2011.08.016; Alvarez M, 2009, INT J IMMUNOGENET, V36, P361, DOI 10.1111/j.1744-313X.2009.00875.x; Bahri R, 2006, J IMMUNOL, V176, P1331, DOI 10.4049/jimmunol.176.3.1331; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2010, GENES IMMUN, V11, P134, DOI 10.1038/gene.2009.74; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Castelli EC, 2009, HUM IMMUNOL, V70, P1020, DOI 10.1016/j.humimm.2009.07.028; Castro MJ, 2000, HUM IMMUNOL, V61, P1157, DOI 10.1016/S0198-8859(00)00188-9; Alves DCC, 2012, HUM IMMUNOL, V73, P52, DOI 10.1016/j.humimm.2011.10.007; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Consiglio CR, 2011, TISSUE ANTIGENS, V77, P540, DOI 10.1111/j.1399-0039.2011.01635.x; Di Cristofaro J, 2012, HUM IMMUNOL, V2; Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Garcia A, 2013, INFECT GENET EVOL, V16, P263, DOI 10.1016/j.meegid.2013.02.021; Glas J, 2007, INT IMMUNOL, V19, P621, DOI 10.1093/intimm/dxm027; Gonzalez A, 2012, CRIT REV CL LAB SCI, V49, P63, DOI 10.3109/10408363.2012.677947; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Hviid TVF, 2004, IMMUNOGENETICS, V56, P135, DOI 10.1007/s00251-004-0673-2; Hviid TVF, 2004, TISSUE ANTIGENS, V64, P66, DOI 10.1111/j.1399-0039.2004.00239.x; Jiang YT, 2011, DNA CELL BIOL, V30, P1027, DOI 10.1089/dna.2011.1238; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Lucena-Silva N, 2012, TISSUE ANTIGENS, V79, P272, DOI 10.1111/j.1399-0039.2012.01842.x; Lucena-Silva N, 2013, J RHEUMATOL; Manaster I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033395; Mendes CT, 2007, TISSUE ANTIGENS, V69, P255, DOI 10.1111/j.1399-0039.2006.00797.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moreau P, 2008, BIOL REPROD, V79, P459, DOI 10.1095/biolreprod.108.068874; Moreau P, 2010, J CELL MOL MED, V14, P2540, DOI 10.1111/j.1582-4934.2010.01198.x; Moreau P, 2009, J CELL MOL MED, V13, P2973, DOI 10.1111/j.1582-4934.2009.00800.x; Nuckel Holger, 2012, Methods Mol Biol, V882, P123, DOI 10.1007/978-1-61779-842-9_7; O'Brien M, 2001, CELL MOL LIFE SCI, V58, P1943, DOI 10.1007/PL00000828; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P5249, DOI 10.1073/pnas.94.10.5249; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Silva ID, 2013, HUM IMMUNOL, V74, P452, DOI 10.1016/j.humimm.2012.11.025; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Veit TD, 2009, LUPUS, V18, P424, DOI 10.1177/0961203308098187; Yie SM, 2008, MOL HUM REPROD, V14, P649, DOI 10.1093/molehr/gan059; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	53	102	105	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e71742	10.1371/journal.pone.0071742	http://dx.doi.org/10.1371/journal.pone.0071742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204558	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400002
J	Wang, W; Luo, J; Hou, PP; Yang, YM; Xiao, F; Ming, YC; Qu, AL; Wang, LY; Ding, JP				Wang, Wei; Luo, Jie; Hou, Panpan; Yang, Yimei; Xiao, Feng; Ming Yuchi; Qu, Anlian; Wang, Luyang; Ding, Jiuping			Native Gating Behavior of Ion Channels in Neurons with Null-Deviation Modeling	PLOS ONE			English	Article							KINETICS; CLAMP	Computational modeling has emerged as an indispensable approach to resolve and predict the intricate interplay among the many ion channels underlying neuronal excitability. However, simulation results using the classic formula-based Hodgkin-Huxley (H-H) model or the superior Markov kinetic model of ion channels often deviate significantly from native cellular signals despite using carefully measured parameters. Here we found that the filters of patch-clamp amplifier not only delayed the signals, but also introduced ringing, and that the residual series resistance in experiments altered the command voltages, which had never been fully eliminated by improving the amplifier itself. To remove all the above errors, a virtual device with the parameters exactly same to that of amplifier was introduced into Markov kinetic modeling so as to establish a null-deviation model. We demonstrate that our novel null-deviation approach fully restores the native gating-kinetics of ion-channels with the data recorded at any condition, and predicts spike waveform and firing patterns clearly distinctive from those without correction.	[Wang, Wei; Luo, Jie; Hou, Panpan; Qu, Anlian; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Luo, Jie] Sun Yat Sen Univ, Sch Engn, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yimei; Wang, Luyang] Univ Toronto, Program Neurosci & Mental Hlth, SickKids Res Inst, Toronto, ON, Canada; [Yang, Yimei; Wang, Luyang] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Xiao, Feng; Ming Yuchi] Huazhong Univ Sci & Technol, Key Lab Image Proc & Intelligent Control, Coll Life Sci & Technol, Minist Educ,Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Sun Yat Sen University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Huazhong University of Science & Technology	Wang, LY (corresponding author), Univ Toronto, Program Neurosci & Mental Hlth, SickKids Res Inst, Toronto, ON, Canada.	luyang.wang@utoronto.ca; jpding@mail.hust.edu.cn	Yuchi, Ming/AHB-9595-2022; Hou, Panpan/Q-2941-2019	Yuchi, Ming/0000-0003-1506-0631; Yang, Yi-Mei/0000-0003-1491-8106; Hou, Panpan/0000-0001-7694-2262	National Basic Research Program of China [2010CB529804]; National Science Foundation of China [30971179, 31170814, 31028006]; Canadian Institutes of Health Research; China-Canada Joint Health Research Initiative Grant; Canada Research Chair	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative Grant; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by grants from the National Basic Research Program of China (2010CB529804), the National Science Foundation of China (30971179, 31170814, 31028006) (to JPD), and by individual Operating Grants from the Canadian Institutes of Health Research, China-Canada Joint Health Research Initiative Grant and Canada Research Chair (to LYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brette R, 2008, NEURON, V59, P379, DOI 10.1016/j.neuron.2008.06.021; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Milescu LS, 2005, BIOPHYS J, V88, P2494, DOI 10.1529/biophysj.104.053256; Prinz AA, 2004, TRENDS NEUROSCI, V27, P218, DOI 10.1016/j.tins.2004.02.004; Qin F, 2000, BIOPHYS J, V79, P1928, DOI 10.1016/S0006-3495(00)76442-3; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035208	10	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77105	10.1371/journal.pone.0077105	http://dx.doi.org/10.1371/journal.pone.0077105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204745	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400028
J	Li, Z; Zhou, ZG; Huang, G; Hu, F; Xiang, YF; He, LN				Li, Zhen; Zhou, Zhiguang; Huang, Gan; Hu, Fang; Xiang, Yufei; He, Lining			Exendin-4 Protects Mitochondria from Reactive Oxygen Species Induced Apoptosis in Pancreatic Beta Cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; INDEPENDENT PHOSPHOLIPASE A(2); FREE FATTY-ACIDS; OXIDATIVE STRESS; EXENATIDE EXENDIN-4; GLYCEMIC CONTROL; CARDIOLIPIN; DEGRADATION; INHIBITION; METFORMIN	Objective: Mitochondrial oxidative stress is the basis for pancreatic beta-cell apoptosis and a common pathway for numerous types of damage, including glucotoxicity and lipotoxicity. We cultivated mice pancreatic beta-cell tumor Min6 cell lines in vitro and observed pancreatic beta-cell apoptosis and changes in mitochondrial function before and after the addition of Exendin-4. Based on these observations, we discuss the protective role of Exendin-4 against mitochondrial oxidative damage and its relationship with Ca2+-independent phospholipase A2. Methods: We established a pancreatic beta-cell oxidative stress damage model using Min6 cell lines cultured in vitro with tert-buty1 hydroperoxide and hydrogen peroxide. We then added Exendin-4 to observe changes in the rate of cell apoptosis (Annexin-V-FITC-PI staining flow cytometry and DNA ladder). We detected the activity of the caspase 3 and 8 apoptotic factors, measured the mitochondrial membrane potential losses and reactive oxygen species production levels, and detected the expression of cytochrome c and Smac/DLAMO in the cytosol and mitochondria, mitochondrial Ca-2-independent phospholipase A2 and Ca2+-independent phospholipase A2 mRNA. Results: The time-concentration curve showed that different percentages of apoptosis occurred at different time-concentrations in tert-buty1 hydroperoxide- and hydrogen peroxide-induced Min6 cells. Incubation with 100 mmol/l of Exendin-4 for 48 hours reduced the Min6 cell apoptosis rate (p<0.05). The mitochondrial membrane potential loss and total reactive oxygen species levels decreased (p<0.05), and the release of cytochrome c and Smac/DLAMO from the mitochondria was reduced. The study also showed that Ca2+-independent phospholipase A2 activity was positively related to Exendin-4 activity. Conclusion: Exendin-4 reduces Min6 cell oxidative damage and the cell apoptosis rate, which may be related to Ca-2-independent phospholipase A2.	[Zhou, Zhiguang] Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; Cent S Univ, Inst Metab & Endocrinol, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, ZG (corresponding author), Cent S Univ, Ctr Diabet, Xiangya Hosp 2, Changsha, Hunan, Peoples R China.	zhouzg@hotmail.com		Zhou, Zhiguang/0000-0002-0374-1838	National Natural Science Foundation of China [81170725, 81070672, 81000316, 30831160518]; Science and Technology Department of Hunan Province of China [2010SK2007]; Hunan Provincial Natural Science Foundation of China [11JJ7005]; National Department Public Benefit (Health) Research Foundation of China [201002002]; Jiangsu Hengrui Pharmaceutical Joint Stock Co.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province of China; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Department Public Benefit (Health) Research Foundation of China; Jiangsu Hengrui Pharmaceutical Joint Stock Co.	This study was financial supported by the National Natural Science Foundation of China (Grant No. 81170725, 81070672, 81000316). Web site: http://www.nsfc.gov.cn/; the International Cooperation and Exchange of the National Natural Science Foundation of China (Grant No. 30831160518). Web site: http://www.nsfc.gov.cn/; the Key Project of Science and Technology Department of Hunan Province of China (2010SK2007); Hunan Provincial Natural Science Foundation of China(11JJ7005); the National Department Public Benefit (Health) Research Foundation of China(Grant No. 201002002). Web site: http://www.hnst.gov.cn/. This work was also supported by Jiangsu Hengrui Pharmaceutical Joint Stock Co. grants the trial medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Diabetes Center, 2nd Xiangya Hospital specifically disclaims responsibility for any analyses, interpretations, or conclusions.	Bulotta A, 2002, J MOL ENDOCRINOL, V29, P347, DOI 10.1677/jme.0.0290347; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen JQ, 2006, BIOCHEM BIOPH RES CO, V346, P1067, DOI 10.1016/j.bbrc.2006.06.027; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Copley K, 2006, CURR DRUG METAB, V7, P367, DOI 10.2174/138920006776873490; Creutzfeldt WOC, 1996, DIABETES CARE, V19, P580, DOI 10.2337/diacare.19.6.580; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Li YH, 2005, DIABETES, V54, P482, DOI 10.2337/diabetes.54.2.482; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ma Z, 2001, J BIOL CHEM, V276; Mileykovskaya E, 2005, BIOCHEMISTRY-MOSCOW+, V70, P154, DOI 10.1007/s10541-005-0095-2; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Monami M, 2009, EUR J ENDOCRINOL, V160, P909, DOI 10.1530/EJE-09-0101; Orrenius S, 2004, TOXICOL LETT, V149, P19, DOI 10.1016/j.toxlet.2003.12.017; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Ritzel RA, 2006, DIABETES CARE, V29, P717, DOI 10.2337/diacare.29.03.06.dc05-1538; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Song K, 2005, MOL ENDOCRINOL, V19, P504, DOI 10.1210/me.2004-0169; WANG YH, 1995, ENDOCRINOLOGY, V136, P4910, DOI 10.1210/en.136.11.4910; Widlansky ME, 2010, TRANSL RES, V156, P15, DOI 10.1016/j.trsl.2010.04.001; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4; Wiswedel I, 2010, FREE RADICAL RES, V44, P135, DOI 10.3109/10715760903352841; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016	34	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76172	10.1371/journal.pone.0076172	http://dx.doi.org/10.1371/journal.pone.0076172			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204601	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300003
J	Sprayberry, JDH; Ritter, KA; Riffell, JA				Sprayberry, Jordanna D. H.; Ritter, Kaitlin A.; Riffell, Jeffrey A.			The Effect of Olfactory Exposure to Non-Insecticidal Agrochemicals on Bumblebee Foraging Behavior	PLOS ONE			English	Article							HONEY-BEE; CONSERVATION; GROWTH; FUNGICIDES; MECHANISM; EVOLUTION; COLONIES; DECLINE	Declines in bumblebee populations have led to investigations into potential causes - including agrochemical effects on bumblebee physiology. The indirect effects of agrochemicals (i.e. behavior modulation) have been postulated, but rarely directly tested. Olfactory information is critical in mediating bumblebee-floral interactions. As agrochemicals emit volatiles, they may indirectly modify foraging behavior. We tested the effects of olfactory contamination of floral odor by agrochemical scent on foraging activity of Bombus impatiens using two behavioral paradigms: localization of food within a maze and forced-choice preference. The presence of a fungicide decreased bumblebees' ability to locate food within a maze. Additionally, bumblebees preferred to forage in non-contaminated feeding chambers when offered a choice between control and either fertilizer- or fungicide-scented chambers.	[Sprayberry, Jordanna D. H.; Ritter, Kaitlin A.] Muhlenberg Coll, Dept Biol, Allentown, PA 18104 USA; [Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sprayberry, JDH (corresponding author), Muhlenberg Coll, Dept Biol, Allentown, PA 18104 USA.	jsprayberry@muhlenberg.edu	Sprayberry, Jordanna/AAY-2501-2021	Sprayberry, Jordanna/0000-0002-6974-5735	Muhlenberg College; University of Washington; National Science Foundation [IOS 1120200]	Muhlenberg College; University of Washington(University of Washington); National Science Foundation(National Science Foundation (NSF))	Funding for this project came from Muhlenberg College start-up funds (to JDHS), University of Washington's Royalty Research Fund, and National Science Foundation grants IOS 1120200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani L, 2004, PESTIC BIOCHEM PHYS, V80, P163, DOI 10.1016/j.pestbp.2004.07.004; Bhattacharya M, 2003, BIOL CONSERV, V109, P37, DOI 10.1016/S0006-3207(02)00130-1; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Farooqui T, 2013, NEUROCHEM INT, V62, P122, DOI 10.1016/j.neuint.2012.09.020; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goyret J, 2006, J EXP BIOL, V209, P1585, DOI 10.1242/jeb.02169; Hegland SJ, 2008, OIKOS, V117, P883, DOI [10.1111/j.0030-1299.2008.16561.x, 10.1111/j.2008.0030-1299.16561.x]; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johansen NS, 2007, COMP BIOCHEM PHYS C, V145, P473, DOI 10.1016/j.cbpc.2007.02.004; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; Lynn SK, 2005, EVOLUTION, V59, P1300, DOI 10.1111/j.0014-3820.2005.tb01780.x; McFrederick QS, 2008, ATMOS ENVIRON, V42, P2336, DOI 10.1016/j.atmosenv.2007.12.033; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; OWEN RE, 1980, BEHAV ECOL SOCIOBIOL, V7, P287, DOI 10.1007/BF00300669; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Shiotsuki T, 2004, J PESTIC SCI, V29, P121, DOI 10.1584/jpestics.29.121; SNYDER GK, 1995, J THEOR BIOL, V172, P199, DOI 10.1006/jtbi.1995.0016; Spaethe J, 2003, J EXP BIOL, V206, P3447, DOI 10.1242/jeb.00570; Spaethe J, 2006, VISUAL SEARCH DECISI; Spaethe J, 2007, NATURWISSENSCHAFTEN, V94, P733, DOI 10.1007/s00114-007-0251-1; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Suzuki K, 2007, PLANT SPEC BIOL, V22, P141, DOI 10.1111/j.1442-1984.2007.00187.x; Theis N, 2006, J CHEM ECOL, V32, P917, DOI 10.1007/s10886-006-9051-x; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wilson E.O., 1971, INSECT SOC; Yuan JS, 2009, TRENDS ECOL EVOL, V24, P323, DOI 10.1016/j.tree.2009.01.012	37	11	13	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76273	10.1371/journal.pone.0076273	http://dx.doi.org/10.1371/journal.pone.0076273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204608	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300004
J	Akk, G; Eaton, M; Li, P; Zheng, S; Lo, J; Steinbach, JH				Akk, Gustav; Eaton, Megan; Li, Ping; Zheng, Steven; Lo, Joshua; Steinbach, Joe Henry			Energetic Contributions to Channel Gating of Residues in the Muscle Nicotinic Receptor beta 1 Subunit	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN INTERFACE; CYS-LOOP RECEPTORS; ACETYLCHOLINE-RECEPTOR; AGONIST BINDING; GABA(A) RECEPTORS; EXTRACELLULAR DOMAIN; PHARMACOLOGY; SUPERFAMILY; SENSITIVITY; ACTIVATION	In the pentameric ligand-gated ion channel family, transmitter binds in the extracellular domain and conformational changes result in channel opening in the transmembrane domain. In the muscle nicotinic receptor and other heteromeric members of the family one subunit does not contribute to the canonical agonist binding site for transmitter. A fundamental question is whether conformational changes occur in this subunit. We used records of single channel activity and rate-equilibrium free energy relationships to examine the beta 1 (non-ACh-binding) subunit of the muscle nicotinic receptor. Mutations to residues in the extracellular domain have minimal effects on the gating equilibrium constant. Positions in the channel lining (M2 transmembrane) domain contribute strongly and relatively late during gating. Positions thought to be important in other subunits in coupling the transmitter-binding to the channel domains have minimal effects on gating. We conclude that the conformational changes involved in channel gating propagate from the binding-site to the channel in the ACh-binding subunits and subsequently spread to the non-binding subunit.	[Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Steinbach, JH (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	jhs@morpheus.wustl.edu	Akk, Gustav/CAG-1703-2022		National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS72770, R01NS22356]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356, R21NS072770] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers R21NS72770 and R01NS22356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2005, J NEUROSCI, V25, P1992, DOI 10.1523/JNEUROSCI.4985-04.2005; Akk G, 2004, J PHYSIOL-LONDON, V556, P387, DOI 10.1113/jphysiol.2003.058230; Akk G, 2002, J PHYSIOL-LONDON, V544, P695, DOI 10.1113/jphysiol.2002.029413; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Auerbach A, 2007, J GEN PHYSIOL, V130, P543, DOI 10.1085/jgp.200709898; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bondarenko V, 2012, BBA-BIOMEMBRANES, V1818, P1261, DOI 10.1016/j.bbamem.2012.02.008; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bruhova I, 2010, J BIOL CHEM, V285, P38898, DOI 10.1074/jbc.M110.169110; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Colquhoun D, 2005, BIOPHYS J, V89, P3673, DOI 10.1529/biophysj.105.071563; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; Dent JA, 2006, J MOL EVOL, V62, P523, DOI 10.1007/s00239-005-0018-2; Fisher JL, 1997, J PHYSIOL-LONDON, V505, P283, DOI 10.1111/j.1469-7793.1997.283bb.x; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hogg RC, 2003, J BIOL CHEM, V278, P26908, DOI 10.1074/jbc.M212628200; Jha A, 2012, J PHYSIOL-LONDON, V590, P119, DOI 10.1113/jphysiol.2011.213892; Jha A, 2009, BIOPHYS J, V96, P4075, DOI 10.1016/j.bpj.2009.02.030; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2009, J PHYSIOL-LONDON, V587, P5045, DOI 10.1113/jphysiol.2009.176305; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Mnatsakanyan N, 2013, J NEUROCHEM, DOI [10.1111/jnc.12260, DOI 10.1111/JNC.12260.PUBMED:23565737]; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Tasneem A, 2005, GENOME BIOL, V6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	45	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78539	10.1371/journal.pone.0078539	http://dx.doi.org/10.1371/journal.pone.0078539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194945	Green Published, gold			2022-12-25	WOS:000326037000124
J	Hedlund, G; Eriksson, H; Sundstedt, A; Forsberg, G; Jakobsen, BK; Pumphrey, N; Rodstrom, K; Lindkvist-Petersson, K; Bjork, P				Hedlund, Gunnar; Eriksson, Helena; Sundstedt, Anette; Forsberg, Goran; Jakobsen, Bent K.; Pumphrey, Nicholas; Rodstrom, Karin; Lindkvist-Petersson, Karin; Bjork, Per			The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; RECEPTOR BETA-CHAIN; CLASS-II; NAPTUMOMAB ESTAFENATOX; MONOCLONAL-ANTIBODY; ANTIGEN RECEPTOR; METASTATIC MELANOMA; ESCHERICHIA-COLI; CANCER-THERAPY; IN-VIVO	The T lymphocytes are the most important effector cells in immunotherapy of cancer. The conceptual objective for developing the tumor targeted superantigen (TTS) ABR-217620 (naptumomab estafenatox, 5T4Fab-SEA/E-120), now in phase 3 studies for advanced renal cell cancer, was to selectively coat tumor cells with cytotoxic T lymphocytes (CTL) target structures functionally similar to natural CTL pMHC target molecules. Here we present data showing that the molecular basis for the anti-tumor activity by ABR-217620 resides in the distinct interaction between the T cell receptor beta variable (TRBV) 7-9 and the engineered superantigen (Sag) SEA/E-120 in the fusion protein bound to the 5T4 antigen on tumor cells. Multimeric but not monomeric ABR-217620 selectively stains TRBV7-9 expressing T lymphocytes from human peripheral blood similar to antigen specific staining of T cells with pMHC tetramers. SEA/E-120 selectively activates TRBV7-9 expressing T lymphocytes resulting in expansion of the subset. ABR-217620 selectively triggers TRBV7-9 expressing cytotoxic T lymphocytes to kill 5T4 positive tumor cells. Furthermore, ABR-217620 activates TRBV7-9 expressing T cell line cells in the presence of cell-and bead-bound 5T4 tumor antigen. Surface plasmon resonance analysis revealed that ABR-217620 binds to 5T4 with high affinity, to TRBV7-9 with low affinity and to MHC class II with very low affinity. The T lymphocyte engagement by ABR-217620 is constituted by displaying high affinity binding to the tumor cells (K-D approximately 1 nM) and with the mimicry of natural productive immune TCR-pMHC contact using affinities of around 1 mu M. This difference in kinetics between the two components of the ABR-217620 fusion protein will bias the binding towards the 5T4 target antigen, efficiently activating T-cells via SEA/E-120 only when presented by the tumor cells.	[Hedlund, Gunnar; Eriksson, Helena; Sundstedt, Anette; Forsberg, Goran; Bjork, Per] Act Biotech AB, Lund, Sweden; [Rodstrom, Karin; Lindkvist-Petersson, Karin] Lund Univ, Lund, Sweden	Lund University	Hedlund, G (corresponding author), Act Biotech AB, Lund, Sweden.	gunnar.hedlund@activebiotech.com		Rodstrom, Karin/0000-0002-2952-0400; Lindkvist, Karin/0000-0002-5209-3160				Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Andersen PS, 2001, J BIOL CHEM, V276, P33452, DOI 10.1074/jbc.M103750200; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI [10.1107/S0907444994003112., DOI 10.1107/S0907444994003112.PUBMED:15299374]; Antonsson P, 1997, J IMMUNOL, V158, P4245; Arad G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001149; Arden Bernhard, 1995, Immunogenetics, V42, P455; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; BJORK P, 1993, J BIOL CHEM, V268, P24232; Borghaei H, 2009, J CLIN ONCOL, V27, P4116, DOI 10.1200/JCO.2008.20.2515; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Cavallin A, 2000, J BIOL CHEM, V275, P1665, DOI 10.1074/jbc.275.3.1665; Cheng JD, 2004, J CLIN ONCOL, V22, P602, DOI 10.1200/JCO.2004.12.034; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; DOHLSTEN M, 1991, IMMUNOL TODAY, V12, P147, DOI 10.1016/0167-5699(91)90078-8; DOHLSTEN M, 1995, P NATL ACAD SCI USA, V92, P9791, DOI 10.1073/pnas.92.21.9791; DOHLSTEN M, 1991, P NATL ACAD SCI USA, V88, P9287, DOI 10.1073/pnas.88.20.9287; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; DOHLSTEN M, 1990, IMMUNOLOGY, V71, P96; DOHLSTEN M, 1993, INT J CANCER, V54, P482, DOI 10.1002/ijc.2910540321; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dudley ME, 2010, CLIN CANCER RES, V16, P6122, DOI 10.1158/1078-0432.CCR-10-1297; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Erlandsson E, 2003, J MOL BIOL, V333, P893, DOI 10.1016/j.jmb.2003.09.009; Forsberg G, 1997, J BIOL CHEM, V272, P12430, DOI 10.1074/jbc.272.19.12430; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Frayser M, 1999, PROTEIN EXPRES PURIF, V15, P105, DOI 10.1006/prep.1998.0987; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Guillet M, 2002, J IMMUNOL, V168, P5088, DOI 10.4049/jimmunol.168.10.5088; HEDLUND G, 1990, CELL IMMUNOL, V129, P426, DOI 10.1016/0008-8749(90)90218-G; IRWIN MJ, 1992, NATURE, V359, P841, DOI 10.1038/359841a0; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; Kammertoens T, 2009, EUR J IMMUNOL, V39, P2345, DOI 10.1002/eji.200939612; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; LANDO PA, 1995, INT J CANCER, V62, P466, DOI 10.1002/ijc.2910620418; Leder L, 1998, J EXP MED, V187, P823, DOI 10.1084/jem.187.6.823; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Petersson K, 2002, STRUCTURE, V10, P1619, DOI 10.1016/S0969-2126(02)00895-X; Petersson K, 2004, SCAND J IMMUNOL, V59, P345, DOI 10.1111/j.0300-9475.2004.01404.x; Potter TA, 2001, P NATL ACAD SCI USA, V98, P12624, DOI 10.1073/pnas.221458898; Robinson MK, 2010, EXPERT OPIN BIOL TH, V10, P273, DOI 10.1517/14712590903575620; Rosendahl A, 2000, METH MOL B, V145, P241; Saline M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1117; Sarikonda G, 2008, J IMMUNOL, V181, P7738, DOI 10.4049/jimmunol.181.11.7738; Shaw DM, 2007, BRIT J CANCER, V96, P567, DOI 10.1038/sj.bjc.6603567; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; Wooldridge L, 2009, IMMUNOLOGY, V126, P147, DOI 10.1111/j.1365-2567.2008.02848.x; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	57	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e79082	10.1371/journal.pone.0079082	http://dx.doi.org/10.1371/journal.pone.0079082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194959	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000138
J	Liu, Y; He, XQ; Huang, X; Ding, L; Xu, L; Shen, YT; Zhang, F; Zhu, MB; Xu, BH; Qi, ZQ; Wang, HL				Liu, Yu; He, Xiao-Qin; Huang, Xin; Ding, Lu; Xu, Lin; Shen, Yu-Ting; Zhang, Fei; Zhu, Mao-Bi; Xu, Bai-Hui; Qi, Zhong-Quan; Wang, Hai-Long			Resveratrol Protects Mouse Oocytes from Methylglyoxal-Induced Oxidative Damage	PLOS ONE			English	Article							DNA-DAMAGE; PARTHENOGENETIC ACTIVATION; CHROMOSOME SEGREGATION; MAMMALIAN OOCYTES; INDUCED APOPTOSIS; CARBONYL STRESS; LDL OXIDATION; IN-VITRO; ANTIOXIDANT; CHECKPOINT	Methylglyoxal, a reactive dicarbonyl compound, is mainly formed from glycolysis. Methylglyoxal can lead to the dysfunction of mitochondria, the depletion of cellular anti-oxidation enzymes and the formation of advanced glycation ends. Previous studies showed that the accumulation of methylglyoxal and advanced glycation ends can impair the oocyte maturation and reduce the oocyte quality in aged and diabetic females. In this study, we showed that resveratrol, a kind of phytoalexin found in the skin of grapes, red wine and other botanical extracts, can alleviate the adverse effects caused by methylglyoxal, such as inhibition of oocyte maturation and disruption of spindle assembly. Besides, methylglyoxal-treated oocytes displayed more DNA double strands breaks and this can also be decreased by treatment of resveratrol. Further investigation of these processes revealed that methylglyoxal may affect the oocyte quality by resulting in excessive reactive oxygen species production, aberrant mitochondrial distribution and high level lipid peroxidation, and resveratrol can block these cytotoxic changes. Collectively, our results showed that resveratrol can protect the oocytes from methylglyoxal-induced cytotoxicity and this was mainly through the correction of the abnormity of cellular reactive oxygen species metabolism.	[Liu, Yu; Huang, Xin; Xu, Lin; Zhu, Mao-Bi; Xu, Bai-Hui; Qi, Zhong-Quan; Wang, Hai-Long] Xiamen Univ, Coll Med, Organ Transplantat Inst, Xiamen, Fujian Province, Peoples R China; [He, Xiao-Qin; Shen, Yu-Ting; Zhang, Fei] Xiamen Univ, Dept Obstet & Gynaecol, Zhongshan Hosp, Xiamen, Fujian Province, Peoples R China; [Ding, Lu] Xiamen Matern & Child Hlth Care Hosp, Ctr Reprod Med, Xiamen, Fujian Province, Peoples R China	Xiamen University; Xiamen University	Qi, ZQ (corresponding author), Xiamen Univ, Coll Med, Organ Transplantat Inst, Xiamen, Fujian Province, Peoples R China.	oti@xmu.edu.cn; hailongwang@xmu.edu.cn	Ding, Lu/ABF-8526-2020	Ding, Lu/0000-0001-8087-2738; Qi, Zhongquan/0000-0002-7210-4955	National Natural Science Foundation of China [31201695]; Major State Scientific Research Program of China [2012CBA01303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Scientific Research Program of China	This work was supported by grants from the National Natural Science Foundation of China (No. 31201695) and Major State Scientific Research Program of China (No. 2012CBA01303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, REPROD BIOMED ONLINE, V9, P338, DOI 10.1016/S1472-6483(10)62151-7; Baek SJ, 2002, CARCINOGENESIS, V23, P425, DOI 10.1093/carcin/23.3.425; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chang YJ, 2010, TOXICOL LETT, V193, P217, DOI 10.1016/j.toxlet.2010.01.007; Chun YJ, 1999, BIOCHEM BIOPH RES CO, V262, P20, DOI 10.1006/bbrc.1999.1152; De Salvia R, 2002, TOXICOL LETT, V135, P1, DOI 10.1016/S0378-4274(02)00151-0; Degen J, 2012, J AGR FOOD CHEM, V60, P7071, DOI 10.1021/jf301306g; Desai Kaushik, 2007, Recent Pat Cardiovasc Drug Discov, V2, P89; Ding L, 2012, THERIOGENOLOGY, V78, P784, DOI 10.1016/j.theriogenology.2012.03.026; Du J, 2001, FREE RADICAL BIO MED, V31, P469, DOI 10.1016/S0891-5849(01)00611-6; FRANKEL EN, 1993, LANCET, V341, P1103, DOI 10.1016/0140-6736(93)92472-6; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Fujii EY, 2010, FERTIL STERIL, V94, P694, DOI 10.1016/j.fertnstert.2009.03.029; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang F. J., 2011, ENV TOXICOL, DOI 10.1002/tox.20734; Huang X, 2011, MICROSC MICROANAL, V17, P197, DOI 10.1017/S1431927610094456; Huang X, 2013, HISTOCHEM CELL BIOL, V139, P525, DOI 10.1007/s00418-012-1051-z; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kang JH, 2003, TOXICOL LETT, V145, P181, DOI 10.1016/S0378-4274(03)00305-9; Kilhovd BK, 2003, METABOLISM, V52, P163, DOI 10.1053/meta.2003.50035; Kwak SS, 2012, THERIOGENOLOGY, V78, P86, DOI 10.1016/j.theriogenology.2012.01.024; Lankin V. Z., 2012, Biomeditsinskaya Khimiya, V58, P727; Lee K, 2010, J REPROD DEVELOP, V56, P330, DOI 10.1262/jrd.09-174K; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liu MY, 2013, HUM REPROD, V28, P707, DOI 10.1093/humrep/des437; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Nagai S, 2006, TOHOKU J EXP MED, V210, P137, DOI 10.1620/tjem.210.137; Nakayama K, 2009, J TOXICOL SCI, V34, P699, DOI 10.2131/jts.34.699; Okado A, 1996, BIOCHEM BIOPH RES CO, V225, P219, DOI 10.1006/bbrc.1996.1157; PHILLIPS SA, 1993, EUR J BIOCHEM, V212, P101, DOI 10.1111/j.1432-1033.1993.tb17638.x; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Schon E A, 2000, Hum Reprod, V15 Suppl 2, P160; Sobinoff AP, 2012, TOXICOL APPL PHARM, V260, P70, DOI 10.1016/j.taap.2012.01.028; Sobinoff AP, 2010, TOXICOL SCI, V118, P653, DOI 10.1093/toxsci/kfq272; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Tarin JJ, 2002, THERIOGENOLOGY, V57, P869, DOI 10.1016/S0093-691X(01)00687-2; Tarin JJ, 1996, MOL HUM REPROD, V2, P717, DOI 10.1093/molehr/2.10.717; Tatone C, 2011, HUM REPROD, V26, P1843, DOI 10.1093/humrep/der140; THORNALLEY P, 1984, BIOCHIM BIOPHYS ACTA, V797, P276, DOI 10.1016/0304-4165(84)90131-4; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; Wu HJ, 2007, TOXICOL IN VITRO, V21, P335, DOI 10.1016/j.tiv.2006.09.002	50	44	47	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77960	10.1371/journal.pone.0077960	http://dx.doi.org/10.1371/journal.pone.0077960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194906	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000085
J	Voura, EB; English, JL; Yu, HYE; Ho, AT; Subarsky, P; Hill, RP; Hojilla, CV; Khokha, R				Voura, Evelyn B.; English, Jane L.; Yu, Hoi-Ying E.; Ho, Andrew T.; Subarsky, Patrick; Hill, Richard P.; Hojilla, Carlo V.; Khokha, Rama			Proteolysis during Tumor Cell Extravasation In Vitro: Metalloproteinase Involvement across Tumor Cell Types	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; HUMAN GELATINASE-A; TRANSENDOTHELIAL MIGRATION; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; MELANOMA-CELLS; IV COLLAGENASE; ACTIVATION; MECHANISM; VESICLES	To test if proteolysis is involved in tumor cell extravasation, we developed an in vitro model where tumor cells cross an endothelial monolayer cultured on a basement membrane. Using this model we classified the ability of the cells to transmigrate through the endothelial cell barrier onto the underlying matrix, and scored this invasion according to the stage of passage through the endothelium. Metalloproteinase inhibitors reduced tumor cell extravasation by at least 35%. Visualization of protease and cell adhesion molecules by confocal microscopy demonstrated the cell surface localization of MMP-2, MMP-9, MT1-MMP, furin, CD44 and alpha(v)beta(3), during the process of transendothelial migration. By the addition of inhibitors and bio-modulators we assessed the functional requirement of the aforementioned molecules for efficient migration. Proteolytic digestion occurred at the cell-matrix interface and was most evident during the migratory stage. All of the inhibitors and biomodulators affected the transition of the tumor cells into the migratory stage, highlighting the most prevalent use of proteolysis at this particular step of tumor cell extravasation. These data suggest that a proteolytic interface operates at the tumor cell surface within the tumor-endothelial cell microenvironment.	[Voura, Evelyn B.; English, Jane L.; Yu, Hoi-Ying E.; Ho, Andrew T.; Subarsky, Patrick; Hill, Richard P.; Hojilla, Carlo V.; Khokha, Rama] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [Voura, Evelyn B.] Dominican Coll Blauvelt, Dept Biol, Orangeburg, NY 10962 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Khokha, R (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada.	rkhokha@uhnres.utoronto.ca	Ho, Andrew Tri Van/D-9681-2019	Ho, Andrew Tri Van/0000-0002-5501-6419; Khokha, Rama/0000-0002-6028-1524; Hill, Richard Peter/0000-0001-5331-8045	U.S. Army [DAMD17-01-1-0433]; NSERC	U.S. Army; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	U.S. Army: DAMD17-01-1-0433 (http://mrmc.amedd.army.mil/index.cfm) and NSERC Post Doctoral Fellowship: E.B. Voura (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, CANCER RES, V50, P6757; ANGLIKER H, 1993, BIOCHEM J, V293, P75, DOI 10.1042/bj2930075; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Casimiro S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063153; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Desai B, 2009, J CELL BIOCHEM, V108, P272, DOI 10.1002/jcb.22248; Desch A, 2012, AM J PATHOL, V181, P693, DOI 10.1016/j.ajpath.2012.04.012; Dolo V, 1998, CANCER RES, V58, P4468; DOLO V, 1994, J SUBMICR CYTOL PATH, V26, P173; Dolo V, 1999, CLIN EXP METASTAS, V17, P131, DOI 10.1023/A:1006500406240; DOLO V, 1995, CLIN EXP METASTAS, V13, P277, DOI 10.1007/BF00133483; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.3.CO;2-A; Fang XJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-290; Ginestra A, 1997, J BIOL CHEM, V272, P17216, DOI 10.1074/jbc.272.27.17216; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; Golubkov VS, 2011, J BIOL CHEM, V286, P34215, DOI 10.1074/jbc.M111.264036; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496; JIAO Y, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0041591; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kargozaran H, 2007, CLIN EXP METASTAS, V24, P495, DOI 10.1007/s10585-007-9086-6; Kasaoka T, 2008, CLIN EXP METASTAS, V25, P827, DOI 10.1007/s10585-008-9198-7; KOOP S, 1994, CANCER RES, V54, P4791; Kruger A, 1997, BLOOD, V90, P1993, DOI 10.1182/blood.V90.5.1993; Kruger A, 1998, ONCOGENE, V16, P2419, DOI 10.1038/sj.onc.1201774; Kurschat P, 1999, J BIOL CHEM, V274, P21056, DOI 10.1074/jbc.274.30.21056; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Leroy-Dudal J, 2005, INT J CANCER, V114, P531, DOI 10.1002/ijc.20778; Maquoi E, 1998, FEBS LETT, V424, P262, DOI 10.1016/S0014-5793(98)00187-2; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Overall CM, 1999, J BIOL CHEM, V274, P4421, DOI 10.1074/jbc.274.7.4421; Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200; PFAFF M, 1994, J BIOL CHEM, V269, P20233; POSTE G, 1980, P NATL ACAD SCI-BIOL, V77, P399, DOI 10.1073/pnas.77.1.399; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Rozanov DV, 2003, J BIOL CHEM, V278, P8257, DOI 10.1074/jbc.M213246200; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Rupp PA, 2008, MOL BIOL CELL, V19, P5529, DOI 10.1091/mbc.E07-05-0480; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sandig M, 1997, CELL MOTIL CYTOSKEL, V38, P351, DOI 10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.3.CO;2-Z; Sato T, 1999, J BIOL CHEM, V274, P37280, DOI 10.1074/jbc.274.52.37280; Steffensen B, 1998, J BIOL CHEM, V273, P20622, DOI 10.1074/jbc.273.32.20622; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Voura EB, 1998, MICROSC RES TECHNIQ, V43, P265, DOI 10.1002/(SICI)1097-0029(19981101)43:3<265::AID-JEMT9>3.0.CO;2-Z; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Voura EB, 2001, CLIN EXP METASTAS, V18, P527, DOI 10.1023/A:1011884807746; Voura EB, 1998, CELL TISSUE RES, V293, P375, DOI 10.1007/s004410051129; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu Q, 2000, GENE DEV, V14, P163	68	31	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78413	10.1371/journal.pone.0078413	http://dx.doi.org/10.1371/journal.pone.0078413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194929	gold, Green Submitted, Green Published			2022-12-25	WOS:000326037000108
J	Yamaguchi, M; Terao, Y; Mori-Yamaguchi, Y; Domon, H; Sakaue, Y; Yagi, T; Nishino, K; Yamaguchi, A; Nizet, V; Kawabata, S				Yamaguchi, Masaya; Terao, Yutaka; Mori-Yamaguchi, Yuka; Domon, Hisanori; Sakaue, Yuuki; Yagi, Tetsuya; Nishino, Kunihiko; Yamaguchi, Akihito; Nizet, Victor; Kawabata, Shigetada			Streptococcus pneumoniae Invades Erythrocytes and Utilizes Them to Evade Human Innate Immunity	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; STAPHYLOCOCCUS-AUREUS; CONJUGATE VACCINE; VIRULENCE FACTORS; OXIDATIVE STRESS; LIPID RAFTS; STRAIN R6; IRON; PNEUMOLYSIN	Streptococcus pneumoniae, a Gram-positive bacterium, is a major cause of invasive infection-related diseases such as pneumonia and sepsis. In blood, erythrocytes are considered to be an important factor for bacterial growth, as they contain abundant nutrients. However, the relationship between S. pneumoniae and erythrocytes remains unclear. We analyzed interactions between S. pneumoniae and erythrocytes, and found that iron ion present in human erythrocytes supported the growth of Staphylococcus aureus, another major Gram-positive sepsis pathogen, while it partially inhibited pneumococcal growth by generating free radicals. S. pneumoniae cells incubated with human erythrocytes or blood were subjected to scanning electron and confocal fluorescence microscopic analyses, which showed that the bacterial cells adhered to and invaded human erythrocytes. In addition, S. pneumoniae cells were found associated with human erythrocytes in cultures of blood from patients with an invasive pneumococcal infection. Erythrocyte invasion assays indicated that LPXTG motif-containing pneumococcal proteins, erythrocyte lipid rafts, and erythrocyte actin remodeling are all involved in the invasion mechanism. In a neutrophil killing assay, the viability of S. pneumoniae co-incubated with erythrocytes was higher than that without erythrocytes. Also, H2O2 killing of S. pneumoniae was nearly completely ineffective in the presence of erythrocytes. These results indicate that even when S. pneumoniae organisms are partially killed by iron ion-induced free radicals, they can still invade erythrocytes. Furthermore, in the presence of erythrocytes, S. pneumoniae can more effectively evade antibiotics, neutrophil phagocytosis, and H2O2 killing.	[Yamaguchi, Masaya; Nishino, Kunihiko; Yamaguchi, Akihito] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Osaka, Japan; [Yamaguchi, Masaya; Terao, Yutaka; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Yamaguchi, Masaya; Mori-Yamaguchi, Yuka; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Terao, Yutaka; Domon, Hisanori; Sakaue, Yuuki] Niigata Univ, Grad Sch Med & Dent Sci, Div Microbiol & Infect Dis, Chuo Ku, Niigata, Japan; [Yagi, Tetsuya] Nagoya Univ Hosp, Ctr Natl Univ Hosp Infect Control, Nagoya, Aichi, Japan	Osaka University; Osaka University; University of California System; University of California San Diego; Niigata University; Nagoya University	Terao, Y (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan.	terao@dent.niigata-u.ac.jp	Yamaguchi, Masaya/I-8156-2019; Yagi, Tetsuya/J-3303-2012; Domon, Hisa/ADQ-4045-2022; Nizet, Victor/AAF-3190-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Nizet, Victor/0000-0003-3847-0422; Terao, Yutaka/0000-0002-4450-5583	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); JSPS; Grants-in-Aid for Scientific Research [24659812, 23592700] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, as well as Grants-in-Aid for Scientific Research (B), Young Scientists (A), and Challenging Exploratory Research from the Japan Society for the Promotion of Science (JSPS) and a Fellowship from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; EGGLETON P, 1989, J IMMUNOL METHODS, V121, P105, DOI 10.1016/0022-1759(89)90425-0; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Farrell DJ, 2007, PEDIATR INFECT DIS J, V26, P123, DOI 10.1097/01.inf.0000253059.84602.c3; GARVEY EP, 1994, J BIOL CHEM, V269, P26669; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Groebel K, 2009, INFECT IMMUN, V77, P576, DOI 10.1128/IAI.00773-08; Hament JM, 2003, EUR J CLIN INVEST, V33, P169, DOI 10.1046/j.1365-2362.2002.01109.x; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Hirst RA, 2002, INFECT IMMUN, V70, P1017, DOI 10.1128/IAI.70.2.1017-1022.2002; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iliev AI, 2007, P NATL ACAD SCI USA, V104, P2897, DOI 10.1073/pnas.0608213104; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Li J, 2010, INFECT IMMUN, V78, P3129, DOI 10.1128/IAI.01263-09; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; Lopez R, 2004, FEMS MICROBIOL REV, V28, P553, DOI 10.1016/j.femsre.2004.05.002; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marriott HM, 2008, CURR MOL MED, V8, P497, DOI 10.2174/156652408785747924; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Mori Y, 2012, J BIOL CHEM, V287, P10472, DOI 10.1074/jbc.M111.280321; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Polizzotto MN, 2008, TRANSFUSION, V48, P1520, DOI 10.1111/j.1537-2995.2008.01764.x; Price KE, 2009, J BACTERIOL, V191, P2163, DOI 10.1128/JB.01489-08; Pucheu S, 1996, CARDIOVASC DRUG THER, V10, P331, DOI 10.1007/BF02627957; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; REITER RJ, 1995, J PINEAL RES, V18, P1, DOI 10.1111/j.1600-079X.1995.tb00133.x; Rohde M, 2003, CELL MICROBIOL, V5, P323, DOI 10.1046/j.1462-5822.2003.00279.x; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Tas SW, 1999, J IMMUNOL, V163, P5056; Terao Y, 2008, J BIOL CHEM, V283, P6253, DOI 10.1074/jbc.M704821200; Tseng HJ, 2002, INFECT IMMUN, V70, P1635, DOI 10.1128/IAI.70.3.1635-1639.2002; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Vogl G, 2008, INFECT IMMUN, V76, P71, DOI 10.1128/IAI.00871-07; Yamaguchi M, 2013, CELL MICROBIOL, V15, P503, DOI 10.1111/cmi.12083; Yamaguchi M, 2009, BIOCHEM BIOPH RES CO, V390, P155, DOI 10.1016/j.bbrc.2009.09.099; Yamaguchi M, 2008, J BIOL CHEM, V283, P36272, DOI 10.1074/jbc.M807087200; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102	51	22	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77282	10.1371/journal.pone.0077282	http://dx.doi.org/10.1371/journal.pone.0077282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194877	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000056
J	Jiang, FR; Tan, GL				Jiang, Fengrui; Tan, Guolong			Fabrication and Optical Properties of Water Soluble CdSeS Nanocrystals Using Glycerin as Stabilizing Agent	PLOS ONE			English	Article							LIGHT-EMITTING-DIODES; ONE-POT SYNTHESIS; HIGH-QUALITY CDS; QUANTUM DOTS; SEMICONDUCTOR NANOCRYSTALS; NONCOORDINATING SOLVENTS; ZNXCD1-XSE NANOCRYSTALS; LUMINESCENCE; SIZE; CDTE	Herein we present an unusual phosphine-free method to fabricate water soluble CdSeS nanocrystals in cubic structure. In this method, glycerin was used as a stabilizing agent replacing tri-n-octylphosphine oxide (TOPO). Water solution of Na2SeO3 in polyethylene glycol was utilized as Se source. 3-Mercaptopropionic acid (MPA) provides S source. The phosphine-free Se and S sources were found to be highly reactive and suitable for the synthesis of CdSeS nanocrystals. XRD and HRTEM images confirm the formation of CdSeS nanocrystals in zinc blende structure. The absorption peaks on UV-vis spectra of as-prepared CdSeS nanocrystals are tunable from 330 nm to 440 nm, which blue shifts to shorter wavelength side in comparison with that of pure CdSe nanocrystals. The cubic CdSeS nanocrystals demonstrate narrow PL emissions spectra between 464 and 615 nm. Transmission electron microscopy images show the uniformity for the size distribution of the ternary QDs. Series water soluble CdSe1-xSx (x = 0 similar to 1) nanocrystals have also been synthesized using Na2SeO3 and Na2S solution as the Se-S co-sources. Tunable band gap energies of CdSe1-xSx (x = 0 similar to 1) nanocrystals upon chemical composition x have been achieved, the gap ranges from 290 nm to 558 nm.	[Jiang, Fengrui; Tan, Guolong] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China	Wuhan University of Technology	Tan, GL (corresponding author), Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth & Proc, Wuhan 430070, Peoples R China.	gltan@whut.edu.cn	Tan, Guolong/A-1098-2013	Tan, Guolong/0000-0003-0961-5506	Natural Science Foundation of Hubei Province [2010CDA078]	Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The financial support is from the Natural Science Foundation of Hubei Province (2010CDA078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salim N, 2007, CHEM MATER, V19, P5185, DOI 10.1021/cm070818k; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Bailey RE, 2003, J AM CHEM SOC, V125, P7100, DOI 10.1021/ja035000o; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BRUS L, 1986, J PHYS CHEM-US, V90, P2555, DOI 10.1021/j100403a003; Cao YC, 2004, J AM CHEM SOC, V126, P14336, DOI 10.1021/ja0459678; Caruge JM, 2008, NAT PHOTONICS, V2, P247, DOI 10.1038/nphoton.2008.34; Chen XF, 2010, MATER SCI ENG B-ADV, V166, P14, DOI 10.1016/j.mseb.2009.09.021; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; HERRON N, 1993, SCIENCE, V259, P1426, DOI 10.1126/science.259.5100.1426; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Jang E, 2003, CHEM COMMUN, P2964, DOI 10.1039/b310853h; Jiang W, 2006, CHEM MATER, V18, P4845, DOI 10.1021/cm061311x; Kale RB, 2005, SEMICOND SCI TECH, V20, P1, DOI 10.1088/0268-1242/20/1/001; Kasuya A, 2004, NAT MATER, V3, P99, DOI 10.1038/nmat1056; Khanna PK, 2005, MATER CHEM PHYS, V94, P454, DOI 10.1016/j.matchemphys.2005.05.006; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; Li JJ, 2003, J AM CHEM SOC, V125, P12567, DOI 10.1021/ja0363563; Liu TY, 2009, J PHYS CHEM C, V113, P2301, DOI 10.1021/jp809171f; Ma XD, 2002, J MATER CHEM, V12, P663, DOI 10.1039/b107173b; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Ouyang JY, 2008, J PHYS CHEM C, V112, P4908, DOI 10.1021/jp710852q; Ouyang JY, 2007, J PHYS CHEM C, V111, P16261, DOI 10.1021/jp074416b; Ouyang JY, 2009, J PHYS CHEM C, V113, P5193, DOI 10.1021/jp8110138; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Ratcliffe CI, 2006, PHYS CHEM CHEM PHYS, V8, P3510, DOI 10.1039/b606507b; Riehle FS, 2009, NANO LETT, V9, P514, DOI 10.1021/nl080150o; Rizzo A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2426899; Sedaghat Z, 2006, NANOTECHNOLOGY, V17, P3812, DOI 10.1088/0957-4484/17/15/034; Stampfl APJ, 1997, PHYS REV B, V55, P9679, DOI 10.1103/PhysRevB.55.9679; Steckel JS, 2006, ANGEW CHEM INT EDIT, V45, P5796, DOI 10.1002/anie.200600317; Swafford LA, 2006, J AM CHEM SOC, V128, P12299, DOI 10.1021/ja063939e; Wei YF, 2010, CHEM MATER, V22, P5672, DOI 10.1021/cm101308f; Yang YA, 2005, ANGEW CHEM INT EDIT, V44, P6712, DOI 10.1002/anie.200502279; Yang YJ, 2005, APPL PHYS A-MATER, V81, P1351, DOI 10.1007/s00339-005-3292-3; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Yu WW, 2002, ANGEW CHEM INT EDIT, V41, P2368, DOI 10.1002/1521-3773(20020703)41:13<2368::AID-ANIE2368>3.0.CO;2-G; Zhong XH, 2004, J PHYS CHEM B, V108, P15552, DOI 10.1021/jp048071y; Zhong XH, 2004, J MATER CHEM, V14, P2790, DOI 10.1039/b407556k; Zhong XH, 2003, J AM CHEM SOC, V125, P13559, DOI 10.1021/ja036683a; Zhong XH, 2003, J AM CHEM SOC, V125, P8589, DOI 10.1021/ja035096m	43	0	0	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77253	10.1371/journal.pone.0077253	http://dx.doi.org/10.1371/journal.pone.0077253			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204781	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600025
J	Zhang, GH; Zhang, YQ; Chen, ZG				Zhang, Guanghua; Zhang, Yuqing; Chen, Zhenguo			Using Trust to Secure Geographic and Energy Aware Routing against Multiple Attacks	PLOS ONE			English	Article							SENSOR; PROTOCOLS	To address the vulnerability of geographic routing to multiple security threats such as false routing information, selective forwarding and the Sybil attack in wireless sensor networks, this paper proposes a trust-based defending model against above-mentioned multiple attacks. Considering the characteristics of resource-constrained sensor nodes, trust values of neighboring nodes on the routing path can be calculated through the Dirichlet distribution function, which is based on data packets' acknowledgements in a certain period instead of energy-consuming monitoring. Trust is combined with the cost of geographic and energy aware routing for selecting the next hop of routing. At the same time, the initial trust is dynamically determined, service requests are restricted for malicious nodes in accordance with trust values, and the impact of node mobility is weakened by the trust evolution. The simulation results and analysis show that the proposed model under multiple attacks has advantages in packet delivery ratio and network lifetime over the existing models.	[Zhang, Guanghua; Zhang, Yuqing] Xidian Univ, Minist Educ, Key Lab Comp Networks & Informat Secur, Xian, Shaanxi, Peoples R China; [Zhang, Guanghua] Hebei Univ Sci & Technol, Coll Informat Sci & Engn, Shijiazhuang, Hebei, Peoples R China; [Zhang, Yuqing] Natl Comp Network Intrus Protect Ctr, Beijing, Peoples R China; [Chen, Zhenguo] Northeastern Univ, Sch Informat Sci & Engn, Shenyang, Liaoning, Peoples R China; [Chen, Zhenguo] North China Inst Sci & Technol, Dept Comp Sci & Technol, Beijing, Peoples R China	Xidian University; Hebei University of Science & Technology; Northeastern University - China; North China Institute Science & Technology	Zhang, YQ (corresponding author), Xidian Univ, Minist Educ, Key Lab Comp Networks & Informat Secur, Xian, Shaanxi, Peoples R China.	zhangyq@nipc.org.cn; czhenguo@gmail.com	Chen, Zhi-Gang/D-1558-2010	Chen, Zhi-Gang/0000-0002-9309-7993	National Natural Science Foundation of China [61163050, 61272481, 61300120, 61301091]; Natural Science Foundation of Hebei Province of China [F2012208016]; Fundamental Research Funds for the Central Universities [3142013098, 3142013070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the National Natural Science Foundation of China (61163050, 61272481, 61300120, 61301091), the Natural Science Foundation of Hebei Province of China (F2012208016), and Fundamental Research Funds for the Central Universities (3142013098, 3142013070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Chen SS, 2010 INT C COMM MOB, P142; Cheng WF, 2006, LECT NOTES COMPUT SC, V4138, P478; Ganeriwal S, 2008, ACM T SENSOR NETWORK, V4, DOI 10.1145/1362542.1362546; Heinzelman WR., 2000, PROC 33 ANN HAWAII I, V1, P10, DOI [10.1109/HICSS.2000.926982, DOI 10.1109/HICSS.2000.926982]; Intanagonwiwat C, 2003, IEEE ACM T NETWORK, V11, P2, DOI 10.1109/TNET.2002.808417; Josang A, 2007, 15 BLED EL COMM C, P324; Josang A, 2007, ARES 2007: SECOND INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY AND SECURITY, PROCEEDINGS, P112; Karlof C., 2003, AD HOC NETW, V1, P293, DOI DOI 10.1016/S1570-8705(03)00008-8; Kulik J, 2002, WIREL NETW, V8, P169, DOI 10.1023/A:1013715909417; Kulkarni RV, 2011, IEEE COMMUN SURV TUT, V13, P68, DOI 10.1109/SURV.2011.040310.00002; LAMPORT L, 1982, ACM T PROGR LANG SYS, V4, P382, DOI 10.1145/357172.357176; Maarouf I, 2009, IET COMMUN, V3, P846, DOI 10.1049/iet-com.2008.0324; Maarouf I, 2009, EURASIP J WIREL COMM, V1, P1; Nasser N, 2007, COMPUT COMMUN, V30, P2401, DOI 10.1016/j.comcom.2007.04.014; Ozdemir S, 2008, COMPUT COMMUN, V31, P3941, DOI 10.1016/j.comcom.2008.07.017; Perrig A, 2002, WIREL NETW, V8, P521, DOI 10.1023/A:1016598314198; Saaty TL, 1980, ANAL HIERARCHY PROCE; Satsiou A, 2010, IEEE T PARALL DISTR, V21, P466, DOI 10.1109/TPDS.2009.80; Varga A., 2008, P 1 INT C SIM TOOLS, P1, DOI DOI 10.1109/ITSC.2002.1041322; Wang WC, 2010, I C DEPEND SYS NETWO, P21, DOI 10.1109/DSN.2010.5545011; Wenjia Li, 2010, Proceedings 11th International Conference on Mobile Data Management (MDM 2010), P85, DOI 10.1109/MDM.2010.57; Yu Y., 2001, UCLACSDTR010023; Zahariadis T., 2010, Proceedings of the Third International Conference on Developments in eSystems Engineering (DESE 2010), P47, DOI 10.1109/DeSE.2010.15; Zhan GX, 2010, LECT NOTES COMPUT SC, V5970, P65, DOI 10.1007/978-3-642-11917-0_5	25	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77488	10.1371/journal.pone.0077488	http://dx.doi.org/10.1371/journal.pone.0077488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204842	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600034
J	Egecioglu, E; Engel, JA; Jerlhag, E				Egecioglu, Emil; Engel, Jorgen A.; Jerlhag, Elisabet			The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice	PLOS ONE			English	Article							GLP-1 RECEPTOR; NUCLEUS-ACCUMBENS; FOOD-INTAKE; RAT; ETHANOL; BRAIN; AMIDE; AMPHETAMINE; ANTAGONIST; DECREASES	The gastrointestinal peptide glucagon-like peptide 1 (GLP-1) is known to regulate consummatory behavior and is released in response to nutrient ingestion. Analogues of this peptide recently emerged as novel pharmacotherapies for treatment of type II diabetes since they reduce gastric emptying, glucagon secretion as well as enhance glucose-dependent insulin secretion. The findings that GLP-1 targets reward related areas including mesolimbic dopamine areas indicate that the physiological role of GLP-1 extends beyond food intake and glucose homeostasis control to include reward regulation. The present series of experiments was therefore designed to investigate the effects of the GLP-1 receptor agonist, Exendin-4 (Ex4), on established nicotine-induced effects on the mesolimbic dopamine system in mice. Specifically, we show that treatment with Ex4, at a dose with no effect per se, attenuate nicotine-induced locomotor stimulation, accumbal dopamine release as well as the expression of conditioned place preference in mice. In accordance, Ex4 also blocks nicotine-induced expression of locomotor sensitization in mice. Given that development of nicotine addiction largely depends on the effects of nicotine on the mesolimbic dopamine system these findings indicate that the GLP-1 receptor may be a potential target for the development of novel treatment strategies for nicotine cessations in humans.	[Egecioglu, Emil; Engel, Jorgen A.; Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden	University of Gothenburg	Engel, JA (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Pharmacol, Gothenburg, Sweden.	jorgen.engel@pharm.gu.se			Swedish Research Council [K2006-21X-04247-33-3, 2009-2782, K2010-80X-21496-01-6]; Swedish brain foundation, LUA/ALF from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly [148251]; foundation of Adlerbertska; foundation of Fredrik; foundation of Ingrid Thuring; Tore Nilsson; Langmanska; Torsten; Ragnar Soderberg; Wilhelm and Martina Lundgren; NovoNordisk; Knut and Alice Wallenberg; Magnus Bergvall; Aners; Jeansons; Ake Wiberg; Swedish Society of Medicine; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish brain foundation, LUA/ALF from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly; foundation of Adlerbertska; foundation of Fredrik; foundation of Ingrid Thuring; Tore Nilsson; Langmanska; Torsten; Ragnar Soderberg; Wilhelm and Martina Lundgren; NovoNordisk(Novo Nordisk); Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Magnus Bergvall; Aners; Jeansons; Ake Wiberg; Swedish Society of Medicine; Swedish Society for Medical Research	The research was supported by grants from the Swedish Research Council (grant no. K2006-21X-04247-33-3, 2009-2782 and K2010-80X-21496-01-6), The Swedish brain foundation, LUA/ALF (grant no. 148251) from the Sahlgrenska University Hospital, Alcohol research council of the Swedish alcohol retailing monopoly and the foundations of Adlerbertska, Fredrik and Ingrid Thuring, Tore Nilsson, Langmanska, Torsten and Ragnar Soderberg, Wilhelm and Martina Lundgren, NovoNordisk, Knut and Alice Wallenberg, Magnus Bergvall, Aners, Jeansons, Ake Wiberg, the Swedish Society of Medicine, Swedish Society for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhadeff AL, 2012, ENDOCRINOLOGY, V153, P647, DOI 10.1210/en.2011-1443; Alvarez E, 1996, J NEUROCHEM, V66, P920; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Brubaker PL, 2003, CAN J PHYSIOL PHARM, V81, P1005, DOI 10.1139/Y03-107; Cagniard B, 2013, BEHAV BRAIN RES, V236, P289, DOI 10.1016/j.bbr.2012.08.021; Clifford PS, 2012, ADDICT BIOL, V17, P956, DOI 10.1111/j.1369-1600.2011.00339.x; Dickson SL, 2012, J NEUROSCI, V32, P4812, DOI 10.1523/JNEUROSCI.6326-11.2012; Dossat AM, 2011, J NEUROSCI, V31, P14453, DOI 10.1523/JNEUROSCI.3262-11.2011; Duaso Maria, 2012, Br J Community Nurs, V17, P356; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069010; Egecioglu E, 2013, PSYCHONEUROENDOCRINO, V38, P1259, DOI 10.1016/j.psyneuen.2012.11.009; ENGEL JA, 1988, J NEURAL TRANSM, V74, P181, DOI 10.1007/BF01244784; Erreger K, 2012, PHYSIOL BEHAV, V106, P574, DOI 10.1016/j.physbeh.2012.03.014; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; GOKE R, 1995, EUR J NEUROSCI, V7, P2294, DOI 10.1111/j.1460-9568.1995.tb00650.x; Graham DL, 2013, MOL PSYCHIATR, V18, P961, DOI 10.1038/mp.2012.141; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Hayes MR, 2009, ENDOCRINOLOGY, V150, P2654, DOI 10.1210/en.2008-1479; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Kastin AJ, 2003, INT J OBESITY, V27, P313, DOI 10.1038/sj.ijo.0802206; KREYMANN B, 1987, LANCET, V2, P1300; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Malendowicz LK, 2003, INT J MOL MED, V12, P237; MATSUYAMA T, 1988, DIABETES RES CLIN PR, V5, P281, DOI 10.1016/S0168-8227(88)80063-9; McMahon LR, 1998, AM J PHYSIOL-REG I, V274, pR23, DOI 10.1152/ajpregu.1998.274.1.R23; Merchenthaler I, 1999, J COMP NEUROL, V403, P261, DOI 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5; Morganstern Irene, 2011, Curr Drug Abuse Rev, V4, P163; Neugebauer NM, 2011, PHARMACOL BIOCHEM BE, V98, P87, DOI 10.1016/j.pbb.2010.12.015; NOVAK U, 1987, EUR J BIOCHEM, V164, P553, DOI 10.1111/j.1432-1033.1987.tb11162.x; Rasmussen K, 1996, NEUROREPORT, V7, P1050, DOI 10.1097/00001756-199604100-00019; Rinaman L, 2010, BRAIN RES, V1350, P18, DOI 10.1016/j.brainres.2010.03.059; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Ruttimann EB, 2009, ENDOCRINOLOGY, V150, P1174, DOI 10.1210/en.2008-1221; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schirra J, 1997, P ASSOC AM PHYSICIAN, V109, P84; SEGAL DS, 1974, PHARMACOL BIOCHEM BE, V2, P249, DOI 10.1016/0091-3057(74)90060-4; Shirazi R. H., 2013, PLOS ONE, V8, DOI [10.1371/joumal.pone.0061965, DOI 10.1371/JOUMAL.PONE.0061965]; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tupala E, 2004, PROG NEURO-PSYCHOPH, V28, P1221, DOI 10.1016/j.pnpbp.2004.06.022; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; von der Goltz C, 2010, PSYCHONEUROENDOCRINO, V35, P570, DOI 10.1016/j.psyneuen.2009.09.005	51	68	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77284	10.1371/journal.pone.0077284	http://dx.doi.org/10.1371/journal.pone.0077284			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204788	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300094
J	Tsai, PH; Lee, HS; Siow, TY; Chang, YC; Chou, MC; Lin, MH; Lin, CY; Chung, HW; Huang, GS				Tsai, Ping-Huei; Lee, Herng-Sheng; Siow, Tiing Yee; Chang, Yue-Cune; Chou, Ming-Chung; Lin, Ming-Huang; Lin, Chien-Yuan; Chung, Hsiao-Wen; Huang, Guo-Shu			Sequential Change in T2*Values of Cartilage, Meniscus, and Subchondral Bone Marrow in a Rat Model of Knee Osteoarthritis	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; HUMAN ARTICULAR-CARTILAGE; 3 T; MENISCECTOMIZED MODELS; RELAXATION-TIMES; WATER-CONTENT; VIVO; T-2; MRI; ASSOCIATION	Background: There is an emerging interest in using magnetic resonance imaging (MRI) T2* measurement for the evaluation of degenerative cartilage in osteoarthritis (OA). However, relatively few studies have addressed OA-related changes in adjacent knee structures. This study used MRI T2* measurement to investigate sequential changes in knee cartilage, meniscus, and subchondral bone marrow in a rat OA model induced by anterior cruciate ligament transection (ACLX). Materials and Methods: Eighteen male Sprague Dawley rats were randomly separated into three groups (n = 6 each group). Group 1 was the normal control group. Groups 2 and 3 received ACLX and sham-ACLX, respectively, of the right knee. T2* values were measured in the knee cartilage, the meniscus, and femoral subchondral bone marrow of all rats at 0, 4, 13, and 18 weeks after surgery. Results: Cartilage T2* values were significantly higher at 4, 13, and 18 weeks postoperatively in rats of the ACLX group than in rats of the control and sham groups (p < 0.001). In the ACLX group (compared to the sham and control groups), T2* values increased significantly first in the posterior horn of the medial meniscus at 4 weeks (p = 0.001), then in the anterior horn of the medial meniscus at 13 weeks (p < 0.001), and began to increase significantly in the femoral subchondral bone marrow at 13 weeks (p = 0.043). Conclusion: Quantitative MR T2* measurements of OA-related tissues are feasible. Sequential change in T2* over time in cartilage, meniscus, and subchondral bone marrow were documented. This information could be potentially useful for in vivo monitoring of disease progression.	[Tsai, Ping-Huei] Taipei Med Univ, Imaging Res Ctr, Taipei, Taiwan; [Tsai, Ping-Huei] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Lee, Herng-Sheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Pathol, Taipei, Taiwan; [Siow, Tiing Yee] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Tao Yuan, Taiwan; [Siow, Tiing Yee; Lin, Ming-Huang; Lin, Chien-Yuan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chang, Yue-Cune] Tamkang Univ, Dept Math, Taipei, Taiwan; [Chou, Ming-Chung] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Chung, Hsiao-Wen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Huang, Guo-Shu] Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Academia Sinica - Taiwan; Tamkang University; Kaohsiung Medical University; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital	Huang, GS (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan.	gsh5@seed.net.tw		Chung, Hsiao-Wen/0000-0001-7127-1244	National Science Council, Taiwan [NSC96-2628-B-016-008-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council (NSC96-2628-B-016-008-MY3), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binks DA, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120163; Cha JG, 2012, KOREAN J RADIOL, V13, P332, DOI 10.3348/kjr.2012.13.3.332; Chou MC, 2009, OSTEOARTHR CARTILAGE, V17, P441, DOI 10.1016/j.joca.2008.09.009; Crema MD, 2010, OSTEOARTHR CARTILAGE, V18, P336, DOI 10.1016/j.joca.2009.11.003; Englund M, 2009, ARTHRITIS RHEUM-US, V60, P831, DOI 10.1002/art.24383; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P2986, DOI 10.1002/art.22851; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; Fragonas E, 1998, OSTEOARTHR CARTILAGE, V6, P24, DOI 10.1053/joca.1997.0089; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Grunder W, 1998, MAGN RESON MED, V39, P376, DOI 10.1002/mrm.1910390307; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Huang GS, 2010, OSTEOARTHR CARTILAGE, V18, P54, DOI 10.1016/j.joca.2009.08.014; Jean YH, 2006, J ORTHOP RES, V24, P1052, DOI 10.1002/jor.20123; Jimenez P. A., 1995, Inflammation Research, V44, pS129, DOI 10.1007/BF01778296; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Libicher M, 2005, EUR RADIOL, V15, P390, DOI 10.1007/s00330-004-2486-y; Link TM, 2007, EUR RADIOL, V17, P1135, DOI 10.1007/s00330-006-0453-5; Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7; Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Mlynarik V, 2002, AM J ROENTGENOL, V178, P1287, DOI 10.2214/ajr.178.5.1781287; Mosher TJ, 2004, SEMIN MUSCULOSKEL R, V8, P355, DOI 10.1055/s-2004-861764; Mosher TJ, 2001, AM J ROENTGENOL, V177, P665, DOI 10.2214/ajr.177.3.1770665; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Naraoka T, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4181; Newbould RD, 2012, J MAGN RESON IMAGING, V35, P1422, DOI 10.1002/jmri.23598; Nieminen MT, 2001, MAGN RESON MED, V46, P487, DOI 10.1002/mrm.1218; Nieminen MT, 2000, MAGNET RESON MED, V43, P676, DOI 10.1002/(SICI)1522-2594(200005)43:5<676::AID-MRM9>3.0.CO;2-X; Nishioka H, 2012, J MAGN RESON IMAGING, V35, P147, DOI 10.1002/jmri.22811; Nissi MJ, 2004, J ORTHOP RES, V22, P557, DOI 10.1016/j.orthres.2003.09.008; Pelletier JP, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2272; Pickarski M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-197; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Qian YX, 2010, MAGN RESON MED, V64, P1427, DOI 10.1002/mrm.22450; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Roemer FW, 2010, OSTEOARTHR CARTILAGE, V18, P47, DOI 10.1016/j.joca.2009.08.018; Shiomi T, 2010, MAGN RESON MED, V64, P707, DOI 10.1002/mrm.22469; Smith GN, 2002, OSTEOARTHR CARTILAGE, V10, P321, DOI 10.1053/joca.2002.0520; Wang YY, 2010, RHEUMATOLOGY, V49, P997, DOI 10.1093/rheumatology/keq034; Wiener E, 2011, ROFO-FORTSCHR RONTG, V183, P226, DOI 10.1055/s-0029-1245739; Williams A, 2012, OSTEOARTHR CARTILAGE, V20, P486, DOI 10.1016/j.joca.2012.01.009; Williams A, 2011, OSTEOARTHR CARTILAGE, V19, P84, DOI 10.1016/j.joca.2010.10.018; Zanetti M, 2000, RADIOLOGY, V215, P835, DOI 10.1148/radiology.215.3.r00jn05835; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	45	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76658	10.1371/journal.pone.0076658	http://dx.doi.org/10.1371/journal.pone.0076658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204653	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300041
J	Blanchard, E; Zlock, L; Lao, A; Mika, D; Namkung, W; Xie, M; Scheitrum, C; Gruenert, DC; Verkman, AS; Finkbeiner, WE; Conti, M; Richter, W				Blanchard, Elise; Zlock, Lorna; Lao, Anna; Mika, Delphine; Namkung, Wan; Xie, Moses; Scheitrum, Colleen; Gruenert, Dieter C.; Verkman, Alan S.; Finkbeiner, Walter E.; Conti, Marco; Richter, Wito			Anchored PDE4 regulates chloride conductance in wild-type and Delta F508-CFTR human airway epithelia	FASEB JOURNAL			English	Article						cystic fibrosis; cyclic nucleotide phosphodiesterase; cAMP; corrector	CYSTIC-FIBROSIS; PULMONARY-DISEASE; PHOSPHODIESTERASE-4 INHIBITOR; CHANNEL ACTIVITY; CFTR EXPRESSION; IN-VITRO; CAMP; ROFLUMILAST; RESCUE; INFLAMMATION	Cystic fibrosis (CF) is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) that impair its expression and/or chloride channel function. Here, we provide evidence that type 4 cyclic nucleotide phosphodiesterases (PDE4s) are critical regulators of the cAMP/PKA-dependent activation of CFTR in primary human bronchial epithelial cells. In non-CF cells, PDE4 inhibition increased CFTR activity under basal conditions (I-SC 7.1 A/cm(2)) and after isoproterenol stimulation (increased I-SC from 13.9 to 21.0 A/cm(2)) and slowed the return of stimulated CFTR activity to basal levels by >3-fold. In cells homozygous for F508-CFTR, the most common mutation found in CF, PDE4 inhibition alone produced minimal channel activation. However, PDE4 inhibition strongly amplified the effects of CFTR correctors, drugs that increase expression and membrane localization of CFTR, and/or CFTR potentiators, drugs that increase channel gating, to reach approximate to 25% of the chloride conductance observed in non-CF cells. Biochemical studies indicate that PDE4s are anchored to CFTR and mediate a local regulation of channel function. Taken together, our results implicate PDE4 as an important determinant of CFTR activity in airway epithelia, and support the use of PDE4 inhibitors to potentiate the therapeutic benefits of CFTR correctors and potentiators.Blanchard, E., Zlock, L., Lao, A., Mika, D., Namkung, W., Xie, M., Scheitrum, C., Gruenert, D.C., Verkman, A.S., Finkbeiner, W.E., Conti, M., Richter, W. Anchored PDE4 regulates chloride conductance in wild type and F508-CFTR human airway epithelia.	[Blanchard, Elise; Mika, Delphine; Xie, Moses; Scheitrum, Colleen; Conti, Marco; Richter, Wito] Univ Calif San Francisco, Inst Human Genet, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Zlock, Lorna; Lao, Anna; Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Namkung, Wan; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Namkung, Wan; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Gruenert, Dieter C.] Univ Calif San Francisco, Inst Human Genet, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Namkung, Wan] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Inchon, South Korea	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yonsei University	Richter, W (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556, San Francisco, CA 94143 USA.	richterw@obgyn.ucsf.edu	Mika, Delphine/Q-2808-2018	Richter, Wito/0000-0001-5588-9060	Cystic Fibrosis Foundation [RDP R613-CR11]; U.S. National Institutes of Health [HL107960, HL0927088, DK072517]; Elizabeth Nash Postdoctoral Fellowship from Cystic Fibrosis Research Inc. (CFRI); Pennsylvania Cystic Fibrosis, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL107960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Nash Postdoctoral Fellowship from Cystic Fibrosis Research Inc. (CFRI); Pennsylvania Cystic Fibrosis, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Cystic Fibrosis Foundation (pilot grant to W. R.; RDP R613-CR11 to A. S. V. and W. E. F.) and grants from the U.S. National Institutes of Health (HL107960 to W. R.; HL0927088 to M. C.; DK072517 to A. S. V and W. E. F.). E. B. is supported by an Elizabeth Nash Postdoctoral Fellowship from Cystic Fibrosis Research Inc. (CFRI), and D. C. G. was supported, in part, by funds from Pennsylvania Cystic Fibrosis, Inc.	Amaral MD, 2011, CURR DRUG TARGETS, V12, P683; Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Barnes AP, 2005, J BIOL CHEM, V280, P7997, DOI 10.1074/jbc.M407521200; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Cheng J, 2010, MOL BIOL CELL, V21, P1178, DOI 10.1091/mbc.E09-03-0229; Chiaw PK, 2011, ESSAYS BIOCHEM, V50, P233, DOI [10.1042/BSE0500233, 10.1042/bse0500233]; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Farinha CM, 2013, CHEM BIOL, V20, P943, DOI 10.1016/j.chembiol.2013.06.004; Francis SH, 2011, HANDB EXP PHARMACOL, V204, P47, DOI [10.1007/978-3-642-17969-3_2, 10.1007/978-3-642-13443-2_4]; Giembycz MA, 2008, BRIT J PHARMACOL, V155, P288, DOI 10.1038/bjp.2008.297; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; GRUBB B, 1993, AM J RESP CELL MOL, V8, P454, DOI 10.1165/ajrcmb/8.4.454; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hatzelmann A, 2010, PULM PHARMACOL THER, V23, P235, DOI 10.1016/j.pupt.2010.03.011; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Huang P, 2000, AM J PHYSIOL-CELL PH, V278, pC417, DOI 10.1152/ajpcell.2000.278.2.C417; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Kelley TJ, 1996, J CLIN INVEST, V98, P513, DOI 10.1172/JCI118819; KELLEY TJ, 1995, AM J RESP CELL MOL, V13, P657, DOI 10.1165/ajrcmb.13.6.7576703; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; Liu SS, 2005, J PHARMACOL EXP THER, V314, P846, DOI 10.1124/jpet.105.083519; Loo TW, 2006, BIOCHEM J, V395, P537, DOI 10.1042/BJ20060013; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; McPhail GL, 2013, DRUG TODAY, V49, P253, DOI 10.1358/dot.2013.49.4.1940984; Monterisi S, 2012, J CELL SCI, V125, P1106, DOI 10.1242/jcs.089086; Nichols D, 2008, CLIN REV ALLERG IMMU, V34, P146, DOI 10.1007/s12016-007-8039-9; Nichols DP, 2008, CLIN REV ALLERG IMMU, V35, P135, DOI 10.1007/s12016-008-8081-2; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pettit RS, 2012, ANN PHARMACOTHER, V46, P1065, DOI 10.1345/aph.1R076; Powell K, 2002, ADV DRUG DELIVER REV, V54, P1395, DOI 10.1016/S0169-409X(02)00148-5; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Richter W, 2004, J BIOL CHEM, V279, P30338, DOI 10.1074/jbc.M312687200; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Richter W, 2013, EMBO REP, V14, P276, DOI 10.1038/embor.2013.4; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Shakur Y, 2002, CARDIOVASC DRUG THER, V16, P417, DOI 10.1023/A:1022186402442; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Srivani P, 2008, CURR PHARM DESIGN, V14, P3854, DOI 10.2174/138161208786898653; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Watson MJ, 2011, FASEB J, V25, P2996, DOI 10.1096/fj.11-186080; Xie M, 2011, MOL PHARMACOL, V80, P281, DOI 10.1124/mol.111.071134; Zhang KYJ, 2005, EXPERT OPIN THER TAR, V9, P1283, DOI 10.1517/14728222.9.6.1283; Zhang LL, 2013, AM J PATHOL, V182, P1986, DOI 10.1016/j.ajpath.2013.02.008	65	26	27	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					791	801		10.1096/fj.13-240861	http://dx.doi.org/10.1096/fj.13-240861			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24200884	Green Published			2022-12-25	WOS:000331072200026
J	Heo, DH; Yoo, I; Kong, J; Lidschreiber, M; Mayer, A; Choi, BY; Hahn, Y; Cramer, P; Buratowski, S; Kim, M				Heo, Dong-hyuk; Yoo, Inhea; Kong, Jiwon; Lidschreiber, Michael; Mayer, Andreas; Choi, Byung-Yi; Hahn, Yoonsoo; Cramer, Patrick; Buratowski, Stephen; Kim, Minkyu			The RNA Polymerase II C-terminal Domain-interacting Domain of Yeast Nrd1 Contributes to the Choice of Termination Pathway and Couples to RNA Processing by the Nuclear Exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; RNA Polymerase II; RNA Processing; Small Nucleolar RNA (snoRNA); Transcription Termination; C-terminal Domain; Nrd1	PROMOTES TRANSCRIPTION TERMINATION; DIFFERENT PHOSPHORYLATED FORMS; CTD; POLYADENYLATION; COMPLEX; PROTEIN; KINASE; THREONINE-4; DEGRADATION; TRANSITIONS	Background: Distinct termination pathways for yeast RNA polymerase II (RNApII) employ proteins (Nrd1 and Rtt103) recognizing different phospho-forms of the RNApII C-terminal domain (CTD). Results: Alteration of CTD-binding specificity of Nrd1 significantly affects RNApII termination. Conclusion: Differential interaction between RNApII CTD and termination factors is crucial in choosing a termination pathway. Significance: CTD-interacting domain of Nrd1 couples termination and RNA processing by the nuclear exosome. The RNA polymerase II (RNApII) C-terminal domain (CTD)-interacting domain (CID) proteins are involved in two distinct RNApII termination pathways and recognize different phosphorylated forms of CTD. To investigate the role of differential CTD-CID interactions in the choice of termination pathway, we altered the CTD-binding specificity of Nrd1 by domain swapping. Nrd1 with the CID from Rtt103 (Nrd1(CIDRtt103)) causes read-through transcription at many genes, but can also trigger termination where multiple Nrd1/Nab3-binding sites and the Ser(P)-2 CTD co-exist. Therefore, CTD-CID interactions target specific termination complexes to help choose an RNApII termination pathway. Interactions of Nrd1 with both CTD and nascent transcripts contribute to efficient termination by the Nrd1 complex. Surprisingly, replacing the Nrd1 CID with that from Rtt103 reduces binding to Rrp6/Trf4, and RNA transcripts terminated by Nrd1(CIDRtt103) are predominantly processed by core exosome. Thus, the Nrd1 CID couples Ser(P)-5 CTD not only to termination, but also to RNA processing by the nuclear exosome.	[Heo, Dong-hyuk; Choi, Byung-Yi; Kim, Minkyu] Seoul Natl Univ, Inst Basic Sci, Ctr RNA Res, Seoul 151742, South Korea; [Yoo, Inhea; Kong, Jiwon; Kim, Minkyu] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Lidschreiber, Michael; Mayer, Andreas; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lidschreiber, Michael; Mayer, Andreas; Cramer, Patrick] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Hahn, Yoonsoo] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Buratowski, Stephen] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); University of Munich; University of Munich; Chung Ang University; Harvard University; Harvard Medical School	Kim, M (corresponding author), Seoul Natl Univ, Inst Basic Sci, 1 Gwanak Ro, Seoul 151742, South Korea.	minkyu@snu.ac.kr	Kong, Jiwon/J-4912-2015; Kong, Jiwon/GXH-5761-2022; Mayer, Andreas/AAA-5173-2021	Kong, Jiwon/0000-0003-3990-5619; HAHN, YOONSOO/0000-0003-4273-9842; Mayer, Andreas/0000-0002-4532-9382	National Institutes of Health [GM56663]; Institute for Basic Science [EM1302]; National Research Foundation [NRF-2013R1A1A2A10013757]; Ministry of Education of Korea; Deutsche Forschungsgemeinschaft [SFB646, TR5, GraKo1721, SFB960]; CIPSM; NIM; European Research Council; LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Basic Science; National Research Foundation; Ministry of Education of Korea(Ministry of Education (MOE), Republic of Korea); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CIPSM; NIM; European Research Council(European Research Council (ERC)European Commission); LMUinnovativ project Bioimaging Network; Jung-Stiftung; Vallee Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM56663 (to S. B.), Research Center Program Grant EM1302 from the Institute for Basic Science and Basic Science Research Program Grant NRF-2013R1A1A2A10013757 (to M. K.) through the National Research Foundation funded by the Ministry of Education of Korea.; Supported by the Deutsche Forschungsgemeinschaft Grants SFB646, TR5, GraKo1721, SFB960, CIPSM, NIM, an Advanced Grant of the European Research Council, the LMUinnovativ project Bioimaging Network, the Jung-Stiftung, and the Vallee Foundation.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Bataille AR, 2012, MOL CELL, V45, P158, DOI 10.1016/j.molcel.2011.11.024; Becker R, 2008, J BIOL CHEM, V283, P22659, DOI 10.1074/jbc.M803540200; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Chinchilla K, 2012, EUKARYOT CELL, V11, P417, DOI 10.1128/EC.05320-11; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Gudipati RK, 2008, NAT STRUCT MOL BIOL, V15, P786, DOI 10.1038/nsmb.1460; HEIDMANN S, 1994, MOL CELL BIOL, V14, P4633, DOI 10.1128/MCB.14.7.4633; Hintermair C, 2012, EMBO J, V31, P2784, DOI 10.1038/emboj.2012.123; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Hsin JP, 2011, SCIENCE, V334, P683, DOI 10.1126/science.1206034; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kubicek K, 2012, GENE DEV, V26, P1891, DOI 10.1101/gad.192781.112; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; MANDART E, 1995, MOL CELL BIOL, V15, P6979; Marquardt S, 2011, TRANSCR-AUSTIN, V2, P145, DOI 10.4161/trns.2.3.16298; Mayer A, 2012, SCIENCE, V336, P1723, DOI 10.1126/science.1219651; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2004, NATURE, V430, P223, DOI 10.1038/nature02679; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Porrua O, 2012, EMBO J, V31, P3935, DOI 10.1038/emboj.2012.237; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Rondon AG, 2009, MOL CELL, V36, P88, DOI 10.1016/j.molcel.2009.07.028; Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sung MK, 2008, YEAST, V25, P301, DOI 10.1002/yea.1588; Thiebaut M, 2006, MOL CELL, V23, P853, DOI 10.1016/j.molcel.2006.07.029; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Vo LTA, 2001, MOL CELL BIOL, V21, P8346, DOI 10.1128/MCB.21.24.8346-8356.2001; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	56	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36676	36690		10.1074/jbc.M113.508267	http://dx.doi.org/10.1074/jbc.M113.508267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196955	Green Published, hybrid			2022-12-25	WOS:000328883400046
J	Wilson, BJ; Nicholas, FW; James, JW; Wade, CM; Thomson, PC				Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Thomson, Peter C.			Estimated Breeding Values for Canine Hip Dysplasia Radiographic Traits in a Cohort of Australian German Shepherd Dogs	PLOS ONE			English	Article							ESTRELA-MOUNTAIN-DOG; INHERITED DISORDERS; GENETIC-PARAMETERS; ELBOW DYSPLASIA; UNITED-KINGDOM; HERITABILITY; RETRIEVERS; SELECTION; SCORE; EPIDEMIOLOGY	Canine hip dysplasia (CHD) is a serious and common musculoskeletal disease of pedigree dogs and therefore represents both an important welfare concern and an imperative breeding priority. The typical heritability estimates for radiographic CHD traits suggest that the accuracy of breeding dog selection could be substantially improved by the use of estimated breeding values (EBVs) in place of selection based on phenotypes of individuals. The British Veterinary Association/Kennel Club scoring method is a complex measure composed of nine bilateral ordinal traits, intended to evaluate both early and late dysplastic changes. However, the ordinal nature of the traits may represent a technical challenge for calculation of EBVs using linear methods. The purpose of the current study was to calculate EBVs of British Veterinary Association/Kennel Club traits in the Australian population of German Shepherd Dogs, using linear (both as individual traits and a summed phenotype), binary and ordinal methods to determine the optimal method for EBV calculation. Ordinal EBVs correlated well with linear EBVs (r = 0.90-0.99) and somewhat well with EBVs for the sum of the individual traits (r = 0.58-0.92). Correlation of ordinal and binary EBVs varied widely (r = 0.24-0.99) depending on the trait and cut-point considered. The ordinal EBVs have increased accuracy (0.48-0.69) of selection compared with accuracies from individual phenotype-based selection (0.40-0.52). Despite the high correlations between linear and ordinal EBVs, the underlying relationship between EBVs calculated by the two methods was not always linear, leading us to suggest that ordinal models should be used wherever possible. As the population of German Shepherd Dogs which was studied was purportedly under selection for the traits studied, we examined the EBVs for evidence of a genetic trend in these traits and found substantial genetic improvement over time. This study suggests the use of ordinal EBVs could increase the rate of genetic improvement in this population.	[Wilson, Bethany J.; Nicholas, Frank W.; James, John W.; Wade, Claire M.; Thomson, Peter C.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Sydney	Wilson, BJ (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	bethany.wilson@sydney.edu.au	Nicholas, Frank William/AAE-5566-2022; Nicholas, Frank/AGY-8318-2022; Thomson, Peter/V-7290-2019	Nicholas, Frank William/0000-0002-9178-3965; Nicholas, Frank/0000-0002-9178-3965; Thomson, Peter/0000-0003-4428-444X; Wade, Claire/0000-0003-3413-4771				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; [Anonymous], 2010, R LANG ENV STAT COMP; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; Biery DN, 2006, BSAVA MANUAL CANINE, P119; Collins LM, 2011, VET J, V189, P147, DOI 10.1016/j.tvjl.2011.06.012; Demko J, 2005, VET CLIN N AM-SMALL, V35, P1111, DOI 10.1016/j.cvsm.2005.05.002; Dietschi E, 2003, J ANIM BREED GENET, V120, P150, DOI 10.1046/j.1439-0388.2003.00390.x; Everts RE, 2000, VET QUART, V22, P63, DOI 10.1080/01652176.2000.9695027; Falconer DS, 1996, INTRO QUANTITATIVE G, P160; Gibbs C, 1997, VET REC, V141, P275; Gilmour AR, 2009, ASREML USER GUIDE RE; Ginja MMD, 2008, ACTA VET HUNG, V56, P303, DOI 10.1556/AVet.56.2008.3.4; Janutta V, 2006, DEUT TIERARZTL WOCH, V113, P6; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Kapatkin AS, 2002, COMP CONT EDUC PRACT, V24, P681; Lawson DD, 2000, HEREDITARY BONE JOIN, P267; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013610; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Malm S, 2013, J ANIM BREED GENET, V130, P154, DOI 10.1111/j.1439-0388.2012.01013.x; Malm S, 2010, PREV VET MED, V93, P222, DOI 10.1016/j.prevetmed.2009.09.017; Paster ER, 2005, JAVMA-J AM VET MED A, V226, P387, DOI 10.2460/javma.2005.226.387; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Silvestre AM, 2007, J ANIM SCI, V85, P1880, DOI 10.2527/jas.2007-0166; Smith GK, 1997, J AM VET MED ASSOC, V210, P1451; Stock KF, 2011, J ANIM BREED GENET, V128, P219, DOI 10.1111/j.1439-0388.2010.00901.x; Stock KF, 2010, J ANIM BREED GENET, V127, P42, DOI 10.1111/j.1439-0388.2009.00809.x; Thomson PC, 2010, VET J, V183, P243, DOI 10.1016/j.tvjl.2009.12.002; Todhunter RJ, 2003, J HERED, V94, P39, DOI 10.1093/jhered/esg006; Wilson BJ, 2011, J ANIM BREED GENET, V128, P230, DOI 10.1111/j.1439-0388.2010.00903.x; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wood JLN, 2000, PREV VET MED, V46, P75, DOI 10.1016/S0167-5877(00)00140-9; Wood JLN, 2000, PREV VET MED, V46, P87, DOI 10.1016/S0167-5877(00)00141-0; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhu L, 2009, VET J, V181, P97, DOI 10.1016/j.tvjl.2009.02.008	38	11	11	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77470	10.1371/journal.pone.0077470	http://dx.doi.org/10.1371/journal.pone.0077470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204838	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700031
J	Jung, E; Perrone, EE; Brahmamdan, P; McDonough, JS; Leathersich, AM; Dominguez, JA; Clark, AT; Fox, AC; Dunne, WM; Hotchkiss, RS; Coopersmith, CM				Jung, Enjae; Perrone, Erin E.; Brahmamdan, Pavan; McDonough, Jacquelyn S.; Leathersich, Ann M.; Dominguez, Jessica A.; Clark, Andrew T.; Fox, Amy C.; Dunne, W. Michael; Hotchkiss, Richard S.; Coopersmith, Craig M.			Inhibition of Intestinal Epithelial Apoptosis Improves Survival in a Murine Model of Radiation Combined Injury	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MULTIPLE-ORGAN-FAILURE; METHICILLIN-RESISTANT; IONIZING-RADIATION; CECAL LIGATION; MORTALITY; GUT; EXPOSURE; SEPSIS; MICE	World conditions place large populations at risk from ionizing radiation (IR) from detonation of dirty bombs or nuclear devices. In a subgroup of patients, ionizing radiation exposure would be followed by a secondary infection. The effects of radiation combined injury are potentially more lethal than either insult in isolation. The purpose of this study was to determine mechanisms of mortality and possible therapeutic targets in radiation combined injury. Mice were exposed to IR with 2.5 Gray (Gy) followed four days later by intratracheal methicillin-resistant Staphylococcus aureus (MRSA). While either IR or MRSA alone yielded 100% survival, animals with radiation combined injury had 53% survival (p = 0.01). Compared to IR or MRSA alone, mice with radiation combined injury had increased gut apoptosis, local and systemic bacterial burden, decreased splenic CD4 T cells, CD8 T cells, B cells, NK cells, and dendritic cells, and increased BAL and systemic IL-6 and G-CSF. In contrast, radiation combined injury did not alter lymphocyte apoptosis, pulmonary injury, or intestinal proliferation compared to IR or MRSA alone. In light of the synergistic increase in gut apoptosis following radiation combined injury, transgenic mice that overexpress Bcl-2 in their intestine and wild type mice were subjected to IR followed by MRSA. Bcl-2 mice had decreased gut apoptosis and improved survival compared to WT mice (92% vs. 42%; p<0.01). These data demonstrate that radiation combined injury results in significantly higher mortality than could be predicted based upon either IR or MRSA infection alone, and that preventing gut apoptosis may be a potential therapeutic target.	[Jung, Enjae; Perrone, Erin E.; Clark, Andrew T.; Fox, Amy C.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Brahmamdan, Pavan; McDonough, Jacquelyn S.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Leathersich, Ann M.; Dunne, W. Michael] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Dominguez, Jessica A.] Bastyr Univ Calif, Dept Basic Sci, San Diego, CA USA; [Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA; [Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Emory University; Emory University	Coopersmith, CM (corresponding author), Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA 30322 USA.	cmcoop3@emory.edu		Dominguez Rieg, Jessica/0000-0001-6190-7464	National Institutes of Health [GM072808, GM66202, GM104323, GM008795, DK52574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM066202, R01GM104323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM072808, GM66202, GM104323, GM008795, DK52574). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brook I, 2004, MIL MED, V169, P194, DOI 10.7205/MILMED.169.3.194; BROOK I, 1986, CAN J MICROBIOL, V32, P719, DOI 10.1139/m86-130; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Clark JA, 2008, SHOCK, V30, P36, DOI 10.1097/SHK.0b013e31815D0820; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; DiCarlo AL, 2010, HEALTH PHYS, V98, P863, DOI 10.1097/HP.0b013e3181a6ee32; Dominguez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049159; Dominguez JA, 2011, SHOCK, V36, P381, DOI 10.1097/SHK.0b013e31822793c4; ERVIN FR, 1962, NEW ENGL J MED, V266, P1127, DOI 10.1056/NEJM196205312662204; Fox AC, 2012, SHOCK, V38, P508, DOI 10.1097/SHK.0b013e31826e47e8; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Jacob A, 2010, MOL MED, V16, P137, DOI 10.2119/molmed.2009.00154; Jung E, 2012, SHOCK, V37, P85, DOI 10.1097/SHK.0b013e3182360faf; KAPLAN HS, 1952, J LAB CLIN MED, V40, P682; Keller CE, 2003, COMPARATIVE MED, V53, P397; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Lee WJ, 2006, RADIAT RES, V165, P562, DOI 10.1667/RR3549.1; Manthous CA, 2007, CRIT CARE MED, V35, P716, DOI 10.1097/01.CCM.0000257328.31668.22; Mendoza AE, 2012, SHOCK, V38, P532, DOI 10.1097/SHK.0b013e31826c5b19; MERRITT AJ, 1994, CANCER RES, V54, P614; METTLER FA, 2001, MED MANAGEMENT RAD A, P53; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Osuchowski MF, 2012, J IMMUNOL, V189, P4648, DOI 10.4049/jimmunol.1201806; Park E, 2008, BIOCHEM BIOPH RES CO, V372, P792, DOI 10.1016/j.bbrc.2008.05.140; Perrone EE, 2012, SHOCK, V38, P68, DOI 10.1097/SHK.0b013e318259abdb; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Shah KG, 2009, MOL MED, V15, P407, DOI 10.2119/molmed.2009.00100; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; Shurland S, 2007, INFECT CONT HOSP EP, V28, P273, DOI 10.1086/512627; Stromberg PE, 2009, FASEB J, V23, P1817, DOI 10.1096/fj.08-119024; Tajima G, 2013, RADIAT RES, V179, P101, DOI 10.1667/RR3120.1; Tessner TG, 2004, J CLIN INVEST, V114, P1676, DOI 10.1172/JCI200422218; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Wells CL, 2004, SHOCK, V22, P562, DOI 10.1097/01.shk.0000145935.24344.2d; Williams Jacqueline P, 2012, Radiat Res, V177, pe0025; Zou ZM, 2008, RADIAT RES, V169, P722, DOI 10.1667/RR1284.1	45	10	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77203	10.1371/journal.pone.0077203	http://dx.doi.org/10.1371/journal.pone.0077203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204769	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200019
J	Jupelli, M; Shimada, K; Chiba, N; Slepenkin, A; Alsabeh, R; Jones, HD; Peterson, E; Chen, S; Arditi, M; Crother, TR				Jupelli, Madhulika; Shimada, Kenichi; Chiba, Norika; Slepenkin, Anatoly; Alsabeh, Randa; Jones, Heather D.; Peterson, Ellena; Chen, Shuang; Arditi, Moshe; Crother, Timothy R.			Chlamydia pneumoniae Infection in Mice Induces Chronic Lung Inflammation, iBALT Formation, and Fibrosis	PLOS ONE			English	Article							PULMONARY-FIBROSIS; STRAIN-TWAR; MACROPHAGE POLARIZATION; ALVEOLAR MACROPHAGES; BACTERIAL CLEARANCE; CURRENT KNOWLEDGE; MOUSE MODEL; ASSOCIATION; ASTHMA; REACTIVATION	Chlamydia pneumoniae (CP) lung infection can induce chronic lung inflammation and is associated with not only acute asthma but also COPD exacerbations. However, in mouse models of CP infection, most studies have investigated specifically the acute phase of the infection and not the longer-term chronic changes in the lungs. We infected C57BL/6 mice with 5x10(5) CP intratracheally and monitored inflammation, cellular infiltrates and cytokine levels over time to investigate the chronic inflammatory lung changes. While bacteria numbers declined by day 28, macrophage numbers remained high through day 35. Immune cell clusters were detected as early as day 14 and persisted through day 35, and stained positive for B, T, and follicular dendritic cells, indicating these clusters were inducible bronchus associated lymphoid tissues (iBALTs). Classically activated inflammatory M1 macrophages were the predominant subtype early on while alternatively activated M2 macrophages increased later during infection. Adoptive transfer of M1 but not M2 macrophages intratracheally 1 week after infection resulted in greater lung inflammation, severe fibrosis, and increased numbers of iBALTS 35 days after infection. In summary, we show that CP lung infection in mice induces chronic inflammatory changes including iBALT formations as well as fibrosis. These observations suggest that the M1 macrophages, which are part of the normal response to clear acute C. pneumoniae lung infection, result in an enhanced acute response when present in excess numbers, with greater inflammation, tissue injury, and severe fibrosis.	[Jupelli, Madhulika; Shimada, Kenichi; Chiba, Norika; Chen, Shuang; Arditi, Moshe; Crother, Timothy R.] Cedars Sinai Med Ctr, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90048 USA; [Slepenkin, Anatoly; Peterson, Ellena] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Alsabeh, Randa] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Jones, Heather D.] Cedars Sinai Med Ctr, Dept Med, Div Pulm & Crit Care Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Irvine; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Cedars Sinai Medical Center	Crother, TR (corresponding author), Cedars Sinai Med Ctr, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90048 USA.	timothy.crother@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health [HL-66436, AI-067995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI067995, R01AI067995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants HL-66436 and AI-067995 (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2004, TEX HEART I J, V31, P33; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Blasi F, 2002, THORAX, V57, P672, DOI 10.1136/thorax.57.8.672; Blasi F, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-83; Campbell Lee Ann, 2003, Semin Respir Infect, V18, P48, DOI 10.1053/srin.2003.50006; Crother TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048655; Duan M, 2012, J IMMUNOL, V189, P946, DOI 10.4049/jimmunol.1200660; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gerard HC, 2013, NANOMEDICINE, DOI [10.1016/j.nano.2013.04.004, DOI 10.1016/J.NAN0.2013.04.004, http://dx.doi.org/10.1016/j.nano.2013.04.004]; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; GRAYSTON JT, 1989, EUR J CLIN MICROBIOL, V8, P191, DOI 10.1007/BF01965260; HAHN DL, 1991, JAMA-J AM MED ASSOC, V266, P225, DOI 10.1001/jama.266.2.225; Hammerschlag Margaret R, 2002, Semin Pediatr Infect Dis, V13, P239, DOI 10.1053/spid.2002.127201; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kalayoglu MV, 2002, JAMA-J AM MED ASSOC, V288, P2724, DOI 10.1001/jama.288.21.2724; KAUKORANTATOLVANEN SSE, 1993, MICROB PATHOGENESIS, V15, P293, DOI 10.1006/mpat.1993.1079; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Laitinen K, 1996, INFECT IMMUN, V64, P1488, DOI 10.1128/IAI.64.4.1488-1490.1996; Laurila AL, 1997, SCAND J INFECT DIS, P34; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; MALINVERNI R, 1995, J INFECT DIS, V172, P593, DOI 10.1093/infdis/172.2.593; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Rahat MA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00045; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Schroeder NWJ, 2008, J ALLERGY CLIN IMMUN, V122, P595, DOI 10.1016/j.jaci.2008.06.038; Shah NR, 2005, SARCOIDOSIS VASC DIF, V22, P167; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Teh B, 2012, CLIN MICROBIOL INFEC, V18, pE71, DOI 10.1111/j.1469-0691.2011.03759.x; Tighe RM, 2011, AM J RESP CELL MOL, V45, P781, DOI 10.1165/rcmb.2010-0471OC; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; Webley WC, 2005, AM J RESP CRIT CARE, V171, P1083, DOI 10.1164/rccm.200407-917OC; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; YANG ZP, 1994, J INFECT DIS, V170, P464, DOI 10.1093/infdis/170.2.464; YANG ZP, 1993, INFECT IMMUN, V61, P2037, DOI 10.1128/IAI.61.5.2037-2040.1993	57	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77447	10.1371/journal.pone.0077447	http://dx.doi.org/10.1371/journal.pone.0077447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204830	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400037
J	Koskensalo, S; Louhimo, J; Hagstrom, J; Lundin, M; Stenman, UH; Haglund, C				Koskensalo, Selja; Louhimo, Johanna; Hagstrom, Jaana; Lundin, Mikael; Stenman, Ulf-Hakan; Haglund, Caj			Concomitant Tumor Expression of EGFR and TATI/SPINK1 Associates with Better Prognosis in Colorectal Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SECRETORY TRYPSIN-INHIBITOR; RECTAL-CANCER; 1ST-LINE TREATMENT; TISSUE MICROARRAY; PATIENT PROGNOSIS; COLON-CANCER; CETUXIMAB; SURVIVAL; KRAS	Background: Epidermal growth factor receptor (EGFR) activation plays a role in colorectal cancer (CRC) carcinogenesis, and anti-EGFR drugs are used in treatment of advanced CRC. One of the EGFR ligands is tumor-associated trypsinogen inhibitor TATI, also called serine protease inhibitor Kazal type1 (SPINK 1), which we recently showed to be an independent prognostic marker in CRC. Methods: We studied the prognostic value of immunohistochemical expression of EGFR and concomitant expression of EGFR and TATI/SPINK1 in a series of 619 colorectal cancer patients. Results: Of the samples, 92% were positive for EGFR. EGFR+/TATI+ was seen in 62.8%, EGFR+/TATI- in 29.5%, EGFR-/TATI+ in 4.9%, and EGFR-/TATI- in 2.7% of patients. EGFR expression correlated with WHO grade (p = 0.040). In univariate analysis, EGFR expression correlated with favourable survival (p = 0.006). EGFR+/TATI+ patients showed better survival than did those with other combinations (p<0.001). In multivariate analysis, EGFR+/TATI+ was an independent prognostic factor of favourable prognosis (p<0.001). Conclusion: Concomitant positivity of EGFR and TATI/SPINK1 predicts favourable prognosis in CRC.	[Koskensalo, Selja; Louhimo, Johanna; Haglund, Caj] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland; [Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland; [Lundin, Mikael] Univ Helsinki, Finnish Inst Mol Med Helsinki, Helsinki, Finland; [Stenman, Ulf-Hakan] Univ Helsinki, Cent Hosp, Dept Clin Chem, Helsinki, Finland; [Haglund, Caj] Univ Helsinki, Res Programs Unit, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Haglund, C (corresponding author), Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.	caj.haglund@hus.fi	Haglund, Caj/N-1240-2019; Hagström, Jaana/G-1468-2018	Hagström, Jaana/0000-0001-6079-7881; Louhimo, Johanna Marika/0000-0002-6208-978X; Stenman, Ulf-Hakan/0000-0002-2695-3454	Finska Lakaresallskapet; Medicinska Understosforeningen Liv och Halsa; Sigrid Juselius Foundation	Finska Lakaresallskapet; Medicinska Understosforeningen Liv och Halsa; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by Finska Lakaresallskapet, Medicinska Understosforeningen Liv och Halsa and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Bibeau F, 2006, VIRCHOWS ARCH, V449, P281, DOI 10.1007/s00428-006-0247-9; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Boyle P, 2008, WORLD CANC REPORT; Chang DZ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-18; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cunningham MP, 2006, INT J ONCOL, V28, P329; DAVIS NC, 1984, DIS COLON RECTUM, V27, P707, DOI 10.1007/BF02554593; Debucquoy A, 2009, INT J COLORECTAL DIS, V24, P129, DOI 10.1007/s00384-008-0608-8; Deng YH, 2009, AM J CLIN ONCOL-CANC, V32, P245, DOI 10.1097/COC.0b013e3181891326; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Eklof V, 2013, BRIT J CANCER, V108, P2153, DOI 10.1038/bjc.2013.212; Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137; Ferlay J., 2004, IARC CANCERBASE; Fernebro E, 2004, INT J CANCER, V111, P921, DOI 10.1002/ijc.20229; Galizia G, 2006, ANN SURG ONCOL, V13, P823, DOI 10.1245/ASO.2006.05.052; Giralt J, 2005, RADIOTHER ONCOL, V74, P101, DOI 10.1016/j.radonc.2004.12.021; Howlader N, 2011, SEER CANC STAT REV 1; Imamura Y, 2012, CLIN CANCER RES, V18, P4753, DOI 10.1158/1078-0432.CCR-11-3210; Koskensalo S, 2012, ONCOLOGY-BASEL, V82, P234, DOI 10.1159/000336080; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; McKay JA, 2002, EUR J CANCER, V38, P2258, DOI 10.1016/S0959-8049(02)00234-4; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Molaei M, 2009, EUR J GASTROEN HEPAT, V21, P289, DOI 10.1097/MEG.0b013e32830b82ba; Ozaki N, 2009, MOL CANCER RES, V7, P1572, DOI 10.1158/1541-7786.MCR-08-0567; Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852; Rego RL, 2010, BRIT J CANCER, V102, P165, DOI 10.1038/sj.bjc.6605473; Resnick MB, 2004, CLIN CANCER RES, V10, P3069, DOI 10.1158/1078-0432.CCR-03-0462; Saif MW, 2010, EXPERT OPIN INV DRUG, V19, P357, DOI 10.1517/13543781003593962; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SCHEVING LA, 1983, ARCH BIOCHEM BIOPHYS, V226, P411, DOI 10.1016/0003-9861(83)90309-0; Spano JP, 2005, ANN ONCOL, V16, P102, DOI 10.1093/annonc/mdi006; Stephen BE BD, 2010, CANC STAGING HDB 3, P173; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Wiksten JP, 2005, HISTOPATHOLOGY, V46, P380, DOI 10.1111/j.1365-2559.2005.02073.x; Yasuda H, 2009, ONCOL REP, V22, P709, DOI 10.3892/or_00000491	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76906	10.1371/journal.pone.0076906	http://dx.doi.org/10.1371/journal.pone.0076906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204699	Green Submitted, gold, Green Published			2022-12-25	WOS:000326155400020
J	Hobden, MR; Martin-Morales, A; Guerin-Deremaux, L; Wils, D; Costabile, A; Walton, GE; Rowland, I; Kennedy, OB; Gibson, GR				Hobden, Mark R.; Martin-Morales, Agustin; Guerin-Deremaux, Laetitia; Wils, Daniel; Costabile, Adele; Walton, Gemma E.; Rowland, Ian; Kennedy, Orla B.; Gibson, Glenn R.			In Vitro Fermentation of NUTRIOSE (R) FB06, a Wheat Dextrin Soluble Fibre, in a Continuous Culture Human Colonic Model System	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HUMAN GUT MICROBIOTA; DIET-INDUCED OBESITY; BACTERIAL-POPULATIONS; INSULIN-RESISTANCE; METABOLIC SYNDROME; WEIGHT-LOSS; OVERWEIGHT; SUPPLEMENTATION; ECOLOGY	Wheat dextrin soluble fibre may have metabolic and health benefits, potentially acting via mechanisms governed by the selective modulation of the human gut microbiota. Our aim was to examine the impact of wheat dextrin on the composition and metabolic activity of the gut microbiota. We used a validated in vitro three-stage continuous culture human colonic model (gut model) system comprised of vessels simulating anatomical regions of the human colon. To mimic human ingestion, 7 g of wheat dextrin (NUTRIOSE (R) FB06) was administered to three gut models, twice daily at 10.00 and 15.00, for a total of 18 days. Samples were collected and analysed for microbial composition and organic acid concentrations by 16S rRNA-based fluorescence in situ hybridisation and gas chromatography approaches, respectively. Wheat dextrin mediated a significant increase in total bacteria in vessels simulating the transverse and distal colon, and a significant increase in key butyrate-producing bacteria Clostridium cluster XIVa and Roseburia genus in all vessels of the gut model. The production of principal short-chain fatty acids, acetate, propionate and butyrate, which have been purported to have protective, trophic and metabolic host benefits, were increased. Specifically, wheat dextrin fermentation had a significant butyrogenic effect in all vessels of the gut model and significantly increased production of acetate (vessels 2 and 3) and propionate (vessel 3), simulating the transverse and distal regions of the human colon, respectively. In conclusion, wheat dextrin NUTRIOSE (R) FB06 is selectively fermented in vitro by Clostridium cluster XIVa and Roseburia genus and beneficially alters the metabolic profile of the human gut microbiota.	[Hobden, Mark R.; Martin-Morales, Agustin; Costabile, Adele; Walton, Gemma E.; Rowland, Ian; Kennedy, Orla B.; Gibson, Glenn R.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Guerin-Deremaux, Laetitia; Wils, Daniel] Roquette, Lestrem, France	University of Reading	Hobden, MR (corresponding author), Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England.	m.r.hobden@reading.ac.uk		Costabile, Adele/0000-0003-3185-030X; Rowland, Ian/0000-0001-8738-4550	Roquette, France	Roquette, France	The study was funded by Roquette, France. The funders were involved in study design, decision to publish and preparation of the manuscript, however they had no role in running the experiments, data collection or analysis.	[Anonymous], 2009, FIBER INGREDIENTS FO; [Anonymous], APPL ENVIRON MICROB, V66, P4523, DOI [10.1128/AEM.66.10.4523-4527.2000, DOI 10.1128/AEM.66.10.4523-4527.2000.PUBMED:11010909]; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Cats A, 1996, INT J ONCOL, V9, P1055; Correa P, 1978, Adv Cancer Res, V26, P1, DOI 10.1016/S0065-230X(08)60086-X; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Fu BQ, 2008, J AOAC INT, V91, P614; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; Guerin-Deremaux L, 2013, OBESITY SILVER SPRIN, V1; Guerin-Deremaux L, 2011, NUTR RES, V31, P665, DOI 10.1016/j.nutres.2011.09.004; Guerin-Deremaux L, 2011, INT J FOOD SCI NUTR, V62, P628, DOI 10.3109/09637486.2011.569492; Guerin-Deremaux L, 2010, NUTR RES PRACT, V4, P470, DOI 10.4162/nrp.2010.4.6.470; Haffner SM, 2006, OBESITY, V14, p121S, DOI 10.1038/oby.2006.291; Harmsen HJM, 1999, MICROB ECOL HEALTH D, V11, P3, DOI DOI 10.1080/089106099435862; Konstantinov S, 2005, HDB CLOSTRIDIA ECOLO, P986; Laitinen R, 2002, SYST APPL MICROBIOL, V25, P241, DOI 10.1078/0723-2020-00118; Lefranc-Millot C, 2012, J INT MED RES, V40, P211, DOI 10.1177/147323001204000122; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li SG, 2010, APPL PHYSIOL NUTR ME, V35, P773, DOI 10.1139/H10-074; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Macfarlane GT, 2008, J APPL MICROBIOL, V104, P305, DOI 10.1111/j.1365-2672.2007.03520.x; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Martin-Pelaez S, 2008, FEMS MICROBIOL ECOL, V66, P608, DOI 10.1111/j.1574-6941.2008.00610.x; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nazare JA, 2011, J AM COLL NUTR, V30, P63, DOI 10.1080/07315724.2011.10719945; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Norris JM, 2012, ARTERIOSCL THROM VAS, V32, P2091, DOI 10.1161/ATVBAHA.112.255463; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Pasman W, 2006, EUR J CLIN NUTR, V60, P1024, DOI 10.1038/sj.ejcn.1602418; Pereira DIA, 2002, APPL ENVIRON MICROB, V68, P4689, DOI 10.1128/AEM.68.9.4689-4693.2002; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RICHARDSON AJ, 1989, LETT APPL MICROBIOL, V9, P5, DOI 10.1111/j.1472-765X.1989.tb00278.x; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; SAKATA T, 1984, CAN J ANIM SCI, V64, P189, DOI 10.4141/cjas84-218; SAKATA T, 1987, BRIT J NUTR, V58, P95, DOI 10.1079/BJN19870073; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van den Heuvel EGHM, 2004, EUR J CLIN NUTR, V58, P1046, DOI 10.1038/sj.ejcn.1601930; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; Walton G, 2013, PROKARYOTES, P25; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Woods M, 2001, CRC HDB DIETARY FIBR, P257; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	59	29	30	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77128	10.1371/journal.pone.0077128	http://dx.doi.org/10.1371/journal.pone.0077128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204753	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000326152300016
J	Zang, K; Wang, JY; Dong, MF; Sun, RX; Wang, YX; Huang, YN; Liu, XX; Li, YM; Wang, FN; Yu, M				Zang, Kun; Wang, Jingyu; Dong, Miaofang; Sun, Ruixin; Wang, Yuxiong; Huang, Yinong; Liu, Xiaoxia; Li, Yimin; Wang, Fangnian; Yu, Min			Brd2 Inhibits Adipogenesis via the ERK1/2 Signaling Pathway in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-GAMMA; MEDIATED PHOSPHORYLATION; BIOLOGICAL FUNCTIONS; DIABETES EPIDEMIC; RECEPTOR-GAMMA; C-MYC; OBESITY; DIFFERENTIATION; RAF	Bromodomain-containing protein 2 (Brd2) is a nuclear serine/threonine kinase involved in transcriptional regulation. In 3T3-L1 adipocytes, Brd2 normally co-represses PPAR gamma (peroxisome proliferator-activated receptor gamma) and inhibits adipogenesis. Here, we show that Brd2 over-expression in preadipocytes inhibits their differentiation into adipocytes, while Brd2 knockdown promotes adipogenic differentiation in vitro and forces cells to undergo adipogenesis independent of the MDI (methyisobutylxanthane, dexamethasone and insulin) induction. In this study, the two key transcription factors for adipogenesis, PPAR gamma and C/EBPa (CCAAT/enhancer binding protein-alpha) were persistently expressed during the differentiation of preadipocytes to mature adipocytes in Brd2 knockdown 3T3-L1 cells, but their expression was inhibited in cells in which Brd2 was overexpressed. To investigate the role of Brd2 in signal transduction we examined the expression of several signaling molecules involved in the regulation of gene expression and cell differentiation by immunoblotting assay. Down-regulation of Brd2 expression in 3T3-L1 cells led to a decrease in extracellular signal-regulated kinase1/2 (ERK1/2) activity and, conversely, the up-regulation of Brd2 leads to increase in ERK1/2 phosphorylation. Nevertheless, changes in Brd2 expression do not affect the activities of JNK and p38 MAPK. In addition, the phosphorylation of Rafs is not affected by changes in Brd2 expression in 3T3-L1 cells. MEK inhibitor UO126 partly restores differentiation of 3T3-L1 cells that overexpress Brd2. In conclusion, these results indicate that Brd2 regulates ERK1/2 activity independently of Raf signaling in 3T3-L1 adipocytes.	[Zang, Kun; Wang, Jingyu; Dong, Miaofang; Sun, Ruixin; Wang, Yuxiong; Huang, Yinong; Wang, Fangnian; Yu, Min] Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China; [Zang, Kun; Wang, Jingyu; Dong, Miaofang; Sun, Ruixin; Wang, Yuxiong; Huang, Yinong; Wang, Fangnian; Yu, Min] Fudan Univ, Dept Biochem & Mol Biol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Liu, Xiaoxia; Li, Yimin] Fudan Univ, Dept Endocrinol, Hua Shan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, FN (corresponding author), Fudan Univ, Key Lab Mol Med, Minist Educ, Shanghai 200433, Peoples R China.	fangnianwang@hotmail.com; minyu@shmu.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022		National Natural Science Foundation of China [30870565, 81171912, 81200561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (numbers 30870565, 81171912 and 81200561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Beck S, 1992, DNA Seq, V2, P203, DOI 10.3109/10425179209020804; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Dalla Vecchia CF, 2005, J PERIODONTOL, V76, P1721, DOI 10.1902/jop.2005.76.10.1721; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2010, DISCOV MED, V10, P489; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DiBenedetto AJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-39; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Engelman JA, 1999, J BIOL CHEM, V274, P35630, DOI 10.1074/jbc.274.50.35630; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; Franssen R, 2011, MED CLIN N AM, V95, P893, DOI 10.1016/j.mcna.2011.06.003; Graves JD, 1995, ANN NY ACAD SCI, V766, P320, DOI 10.1111/j.1749-6632.1995.tb26684.x; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo N, 2000, J CELL SCI, V113, P3085; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Lloyd CM, 2013, NAT MED, V19, P976, DOI 10.1038/nm.3296; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pischon N, 2007, J DENT RES, V86, P400, DOI 10.1177/154405910708600503; Rauch J, 2011, CANCER RES, V71, P4664, DOI 10.1158/0008-5472.CAN-10-4447; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schlesinger Thomas K., 1998, Frontiers in Bioscience, V3, pD1181; Speliotes EK, 2009, GASTROENTEROLOGY, V136, P1492, DOI 10.1053/j.gastro.2009.03.020; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tzotzas T, 2011, OBES REV, V12, pe282, DOI 10.1111/j.1467-789X.2010.00807.x; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	52	26	28	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78536	10.1371/journal.pone.0078536	http://dx.doi.org/10.1371/journal.pone.0078536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194944	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000123
J	Kubitz, N; Mehra, M; Potluri, RC; Garg, N; Cossrow, N				Kubitz, Nicole; Mehra, Maneesha; Potluri, Ravi C.; Garg, Nitesh; Cossrow, Nicole			Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database	PLOS ONE			English	Article							EPIDEMIOLOGY; EMPLOYEES; DISORDER; BURDEN; COSTS	Context: Treatment Resistant Depression (TRD) is a significant and burdensome health concern. Objective: To characterize, compare and understand the difference between TRD and non-TRD patients and episodes in respect of their episode duration, treatment patterns and healthcare resource utilization. Design and Setting: Patients between 18 and 64 years with a new diagnosis of major depressive disorder (MDD) and without a previous or comorbid diagnosis of schizophrenia or bipolar disease were included from PharMetrics Integrated Database, a claims database of commercial insurers in the US. Episodes of these patients in which there were at least two distinct failed regimens involving antidepressants and antipsychotics were classified as TRD. Patients: 82,742 MDD patients were included in the analysis; of these patients, 125,172 episodes were identified (47,654 of these were drug-treated episodes). Main Outcome Measures: Comparison between TRD and non-TRD episodes in terms of their duration, number and duration of lines of treatment, comorbidities, and medical resource utilization. Results: Of the treated episodes, 6.6% (N = 3,134) met the criteria for TRD. The median time to an episode becoming TRD was approximately one year. The mean duration of a TRD episode was 1,004 days (vs. 452 days for a non-TRD episode). More than 75% of TRD episodes had at least four lines of therapy; half of the treatment regimens included a combination of drugs. Average hospitalization costs were higher for TRD than non-TRD episodes: $6,464 vs. $1,734, as were all other health care utilization costs. Conclusions: While this study was limited to relatively young and commercially covered patients, used a rigorous definition of TRD and did not analyze for cause or consequence, the results highlight high unmet medical need and burden of TRD on patients and health care resources.	[Kubitz, Nicole] Janssen Cilag GmbH, Neurosci, Global Commercial Strategy Org, Market Access, Neuss, Germany; [Mehra, Maneesha; Cossrow, Nicole] Janssen Global Serv LLC, Market Access Analyt, Global Market Access & Commercial Strategy Org, Raritan, NJ USA; [Potluri, Ravi C.; Garg, Nitesh] SmartAnalyst Inc, New York, NY USA	Johnson & Johnson; Johnson & Johnson; Janssen Pharmaceuticals	Kubitz, N (corresponding author), Janssen Cilag GmbH, Neurosci, Global Commercial Strategy Org, Market Access, Neuss, Germany.	nkubitz@its.jnj.com			Janssen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	SmartAnalyst Inc was commissioned by Janssen Global Services to carry out the data analysis required for this project, for which it received a fee. The authors affiliated to the funders, Janssen Global Services and Janssen-Cilag GmbH, were involved in study design, the decision to publish, and preparation of the manuscript, but not in data analysis. Mr. Potluri and Mr. Garg are employees of SmartAnalyst Inc, which was contracted by Janssen to carry out the data analysis as well as contribute to manuscript development. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, OECD EXP M MENT HLTH; [Anonymous], 2007, ANTIPRESSANT MEDICAT; [Anonymous], 2010, PRACTICE GUIDELINE T; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Corey-Lisle PK, 2002, J CLIN PSYCHIAT, V63, P717, DOI 10.4088/JCP.v63n0810; Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102; EMEA-CHMP, 2009, CONC PAP NEED REV NO; French L, TREATMENT COMORBID A; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Gibson TB, 2010, AM J MANAG CARE, V16, P370; Greenberg P, 2004, PHARMACOECONOMICS, V22, P363, DOI 10.2165/00019053-200422060-00003; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Hirschfeld RMA, 2002, NEUROPSYCHOPHARMACOL; Ivanova JI, 2010, CURR MED RES OPIN, V26, P2475, DOI 10.1185/03007995.2010.517716; Keller MB, 2005, J CLIN PSYCHIAT, V66, P5; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; Philip NS, 2010, EXPERT OPIN PHARMACO, V11, P709, DOI 10.1517/14656561003614781; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; The Global Burden of Disease, 2004, GLOB BURD DIS; Vieta E, 2011, ANN MED, V43, P512, DOI 10.3109/07853890.2011.583675	24	95	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76882	10.1371/journal.pone.0076882	http://dx.doi.org/10.1371/journal.pone.0076882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204694	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300060
J	Zhang, H; Taxipalati, M; Yu, LY; Que, F; Feng, FQ				Zhang, Hui; Taxipalati, Maierhaba; Yu, Liyi; Que, Fei; Feng, Fengqin			Structure-Activity Relationship of a U-Type Antimicrobial Microemulsion System	PLOS ONE			English	Article								The structure-activity relationship of a U-type antimicrobial microemulsion system containing glycerol monolaurate and ethanol at a 1: 1 mass ratio as oil phase and Tween 20 as surfactant were investigated along a water dilution line at a ratio of 80: 20 mass% surfactant/oil phase, based on a pseudo-ternary phase diagram. The differential scanning calorimetry results showed that in the region of up to 33% water, all water molecules are confined to the hydrophilic core of the reverse micelles, leading to the formation of w/o microemulsion. As the water content increases, the water gains mobility, and transforms into bicontinuous in the region of 33-39% water, and finally the microemulsion become o/w in the region of above 39% water. The microstructure characterization was confirmed by the dynamic light scattering measurements and freeze-fracture transmission electron microscope observation. The antimicrobial activity assay using kinetics of killing analysis demonstrated that the microemulsions in w/o regions exhibited relatively high antimicrobial activity against Escherichia coli and Staphylococcus aureus due to the antimicrobial oil phase as the continuous phase, while the antimicrobial activity started to decrease when the microemulsions entered the bicontinuous region, and decreased rapidly as the water content increased in the o/w region, as a result of the dilution of antimicrobial oil droplets in the aqueous continuous phase.	[Zhang, Hui; Taxipalati, Maierhaba; Yu, Liyi; Feng, Fengqin] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Hui; Taxipalati, Maierhaba; Yu, Liyi; Feng, Fengqin] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Que, Fei] Zhejiang Econ & Trade Polytech, Dept Appl Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Feng, FQ (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	fengfq@zju.edu.cn			National Natural Science Foundation of China [31000818]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31000818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Adham ISI, 2000, J APPL MICROBIOL, V89, P32, DOI 10.1046/j.1365-2672.2000.01078.x; Al-Adham ISI, 2003, LETT APPL MICROBIOL, V36, P97, DOI 10.1046/j.1472-765X.2003.01266.x; Schlievert PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040350; SENATRA D, 1991, PROG COLL POL SCI S, V84, P122; Spernath A, 2006, J COLLOID INTERF SCI, V299, P900, DOI 10.1016/j.jcis.2006.02.024; Teixeira PC, 2007, INT J FOOD MICROBIOL, V118, P15, DOI 10.1016/j.ijfoodmicro.2007.05.008; Thevenin MA, 1996, INT J PHARM, V137, P177, DOI 10.1016/0378-5173(96)04518-8; Weast R. C., 1982, HDB CHEM PHYS C; Zhang H, 2010, INT J PHARMACEUT, V395, P154, DOI 10.1016/j.ijpharm.2010.05.022	9	5	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76245	10.1371/journal.pone.0076245	http://dx.doi.org/10.1371/journal.pone.0076245			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204605	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300015
J	Hurtado, R; Bub, G; Herzlinger, D				Hurtado, Romulo; Bub, Gil; Herzlinger, Doris			A molecular signature of tissues with pacemaker activity in the heart and upper urinary tract involves coexpressed hyperpolarization-activated cation and T-type Ca2+ channels	FASEB JOURNAL			English	Article						smooth muscle; kidney; peristalsis; ion channels; optical mapping	SINOATRIAL NODE CELLS; SMOOTH-MUSCLE-CELLS; MOUSE RENAL PELVIS; INTERSTITIAL-CELLS; BIOLOGICAL PACEMAKER; ACTION-POTENTIALS; CALCIUM CURRENTS; EMBRYONIC HEART; EXPRESSION; CAJAL	Renal pacemakers set the origin and frequency of the smooth muscle contractions that propel wastes from the kidney to the bladder. Although congenital defects impairing this peristalsis are a leading cause of pediatric renal failure, the mechanisms underlying renal pacemaker activity remain unknown. Using ratiometric optical mapping and video microscopy, we discovered that hyperpolarization-activated cation (HCN) channel block with the specific anatagonist ZD7288 (30 m; IC50) abolished the pacemaker depolarizations that initiate murine upper urinary tract peristalsis. Optical mapping and immunohistochemistry indicate that pacemaker potentials are generated by cells expressing HCN isoform-3, and that HCN3(+) cells are coupled to definitive smooth muscle via gap junctions. Furthermore, we demonstrate that HCN3(+) cells coexpress T-type Ca2+ (TTC) channels and that TTC channel inhibition with R(-)efonidipine or NNC55-0396 decreased contractile frequency in a dose-dependent manner. Collectively, these data demonstrate that HCN3(+)/TTC+ cells are the pacemakers that set the origin and rate of upper urinary tract peristalsis. These results reveal a conserved mechanism controlling autorhythmicity in 2 distinct muscle types, as HCN and TTC channels also mediate cardiac pacemaker activity. Moreover, these findings have translational applications, including the development of novel diagnostics to detect fetal urinary tract motility defects prior to renal damage.Hurtado, R., Bub, G., Herzlinger, D. A molecular signature of tissues with pacemaker activity in the heart and upper urinary tract involves coexpressed hyperpolarization-activated cation and T-type Ca2+ channels.	[Hurtado, Romulo; Herzlinger, Doris] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Bub, Gil] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	Cornell University; University of Oxford	Herzlinger, D (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.	daherzli@physbio-tech.net		Hurtado, Romulo/0000-0003-0865-3383	U.S. National Institutes of Health [RO1 DK45218]; British Heart Foundation Centre of Research Excellence, University of Oxford [RE/08/004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK103072, R01DK045218] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation Centre of Research Excellence, University of Oxford; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health grant RO1 DK45218, awarded to D. H., and British Heart Foundation Centre of Research Excellence, University of Oxford, grant RE/08/004, awarded to G.B. The authors thank Dr. Norio Hashimoto (Nissan Chemical Industries, Minamisaitama, Japan) for the generous gift of R(-) efondipine. The authors thank Dr. Jeremy Graham and Mr. Mark Henson for providing expertise in construction of ratiometric optical mapping apparatuses; Dr. David Christini, Dr. Emre Aksay, and Dr. Willemijn Groenendaal for helpful suggestions on experimental techniques; and Dr. Harel Weinstein, Dr. Jeremy Dittman, Dr. Tom Schultheiss, Dr. Lauren Acinapura, Mr. Chad Kurylo, Ms. Lauretta Lacko, and Mr. James Mtui for helpful manuscript discussions.	Alberti C, 2012, EUR REV MED PHARMACO, V16, P213; Barbuti A, 2008, ANN NY ACAD SCI, V1123, P213, DOI 10.1196/annals.1420.024; Baruscotti M, 2010, PFLUG ARCH EUR J PHY, V460, P405, DOI 10.1007/s00424-010-0810-8; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Bohn G, 2000, FEBS LETT, V481, P73, DOI 10.1016/S0014-5793(00)01979-7; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Bozler E, 1942, AM J PHYSIOL, V136, P9; Bramich NJ, 1996, J PHYSIOL-LONDON, V492, P185, DOI 10.1113/jphysiol.1996.sp021300; Bub G, 2003, J CARDIOVASC ELECTR, V14, pS229, DOI 10.1046/j.1540.8167.90315.x; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Cho HC, 2007, CIRC RES, V100, P1112, DOI 10.1161/01.RES.0000265845.04439.78; Dickens EJ, 1999, J PHYSIOL-LONDON, V514, P515, DOI 10.1111/j.1469-7793.1999.515ae.x; DIXON JS, 1982, J ANAT, V135, P129; DOERR T, 1989, PFLUG ARCH EUR J PHY, V413, P599, DOI 10.1007/BF00581808; Dwyer TM, 2003, NEWS PHYSIOL SCI, V18, P1, DOI 10.1152/nips.1416.2002; ENGELMANN TW, 1969, PFLUGERS ARCH GES PH, V2, P243; Furukawa T, 2004, BRIT J PHARMACOL, V143, P1050, DOI 10.1038/sj.bjp.0705944; GOEL R, 2013, CLIN PERINATOL, V40, P43, DOI DOI 10.1016/j.pop.2012.11.002; GOSLING JA, 1970, EXPERIENTIA, V26, P769, DOI 10.1007/BF02232539; GROSS D, 1986, BIOPHYS J, V50, P339, DOI 10.1016/S0006-3495(86)83467-1; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hall CE, 2004, DEVELOPMENT, V131, P581, DOI 10.1242/dev.00947; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hashitani H, 1999, J PHYSIOL-LONDON, V514, P459, DOI 10.1111/j.1469-7793.1999.459ae.x; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Hirota Seiichi, 2000, Journal of Gastroenterology, V35, P75; Hirst GDS, 2003, J PHYSIOL-LONDON, V550, P337, DOI 10.1113/jphysiol.2003.043299; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Huizinga JD, 2009, AM J PHYSIOL-GASTR L, V296, pG1, DOI 10.1152/ajpgi.90380.2008; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Hurtado R, 2006, DEV DYNAM, V235, P2811, DOI 10.1002/dvdy.20909; Hurtado R, 2010, KIDNEY INT, V77, P500, DOI 10.1038/ki.2009.483; IRISAWA H, 1962, P JPN ACAD, V38, P171, DOI 10.2183/pjab1945.38.171; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Klemm MF, 1999, J PHYSIOL-LONDON, V519, P867, DOI 10.1111/j.1469-7793.1999.0867n.x; Knisley SB, 2000, AM J PHYSIOL-HEART C, V279, pH1421, DOI 10.1152/ajpheart.2000.279.3.H1421; Laish-Farkash A, 2010, J CARDIOVASC ELECTR, V21, P1365, DOI 10.1111/j.1540-8167.2010.01844.x; Lang RJ, 2007, J PHYSIOL-LONDON, V583, P1049, DOI 10.1113/jphysiol.2007.137034; Lang RJ, 2010, CLIN EXP PHARMACOL P, V37, P509, DOI 10.1111/j.1440-1681.2009.05226.x; Lee SE, 2009, KOREAN J PHYSIOL PHA, V13, P241, DOI 10.4196/kjpp.2009.13.3.241; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Liau J, 2004, ANN BIOMED ENG, V32, P1202, DOI 10.1114/B:ABME.0000039354.41647.1b; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Madle A, 2001, Med Sci Monit, V7, P74; MARSHALL PW, 1993, J CARDIOVASC PHARM, V21, P902, DOI 10.1097/00005344-199306000-00008; Masumiya H, 1998, EUR J PHARMACOL, V349, P351, DOI 10.1016/S0014-2999(98)00204-0; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Nakagawa Tadashi, 2005, Journal of Smooth Muscle Research, V41, P141, DOI 10.1540/jsmr.41.141; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Niwa N, 2004, AM J PHYSIOL-HEART C, V286, pH2257, DOI 10.1152/ajpheart.01043.2003; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Ono K, 2010, J MOL CELL CARDIOL, V48, P65, DOI 10.1016/j.yjmcc.2009.08.021; Orbelli L, 1910, PFLUGERS ARCH GESAMT, V133, P23; Plotnikov AN, 2004, CIRCULATION, V109, P506, DOI 10.1161/01.CIR.0000114527.10764.CC; Potapova I, 2004, CIRC RES, V94, P952, DOI 10.1161/01.RES.0000123827.60210.72; Qu JH, 2003, CIRCULATION, V107, P1106, DOI 10.1161/01.CIR.0000059939.97249.2C; Roubille F, 2013, CIRCULATION, V127, P1986, DOI 10.1161/CIRCULATIONAHA.112.000145; ROUSE W, 1994, BRIT J PHARMACOL, V113, P1071, DOI 10.1111/j.1476-5381.1994.tb17102.x; SCHMIDTNIELSEN B, 1987, KIDNEY INT, V31, P621, DOI 10.1038/ki.1987.43; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Silverstein DM, 2003, PEDIATR NEPHROL, V18, P216, DOI 10.1007/s00467-002-1065-1; Steriade M, 2003, NEURON, V37, P563, DOI 10.1016/S0896-6273(03)00065-5; Stieber J, 2003, P NATL ACAD SCI USA, V100, P15235, DOI 10.1073/pnas.2434235100; Tanaka H, 2004, J PHARMACOL SCI, V96, P499, DOI 10.1254/jphs.RCJ04001X; Weiss Robert M., 2006, Journal of Smooth Muscle Research, V42, P103, DOI 10.1540/jsmr.42.103; WEISS ROBERT M., 1967, INVEST UROL, V5, P42; Xiao Yong-Fu, 2007, Shengli Xuebao, V59, P562; Xu C, 2003, BIOPHYS J, V84, P2768, DOI 10.1016/S0006-3495(03)75081-4; Zhu MH, 2009, J PHYSIOL-LONDON, V587, P4905, DOI 10.1113/jphysiol.2009.176206	73	22	22	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					730	739		10.1096/fj.13-237289	http://dx.doi.org/10.1096/fj.13-237289			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24189942	Green Published			2022-12-25	WOS:000331072200020
J	Filisetti, D; Theobald-Dietrich, A; Mahmoudi, N; Rudinger-Thirion, J; Candolfi, E; Frugier, M				Filisetti, Denis; Theobald-Dietrich, Anne; Mahmoudi, Nassira; Rudinger-Thirion, Joelle; Candolfi, Ermanno; Frugier, Magali			Aminoacylation of Plasmodium falciparum tRNA(Asn) and Insights in the Synthesis of Asparagine Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl tRNA Synthesis; Plasmodium; Protein Folding; Transfer RNA (tRNA); Translation; Asparagine Repeats; Low Complexity Regions	TRANSFER-RNA-SYNTHETASE; LOW-COMPLEXITY REGIONS; N-TERMINAL EXTENSION; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; SEQUENCE; EVOLUTION; REVEALS; TRANSCRIPTS; EXPRESSION	Background: Proteins from the malaria parasite Plasmodium contain extensive asparagine repeats. Results:Plasmodium tRNA(Asn) concentration and in vitro asparaginylation catalytic parameters were analyzed to explain the frequency of asparagine repeats. Conclusion: The requirement for high levels of asparaginylated tRNAs hinders efficient protein translation. Significance: Limiting the availability of asparaginylated tRNAs represents a plausible regulatory mechanism for the production of properly folded proteins. Genome sequencing revealed an extreme AT-rich genome and a profusion of asparagine repeats associated with low complexity regions (LCRs) in proteins of the malarial parasite Plasmodium falciparum. Despite their abundance, the function of these LCRs remains unclear. Because they occur in almost all families of plasmodial proteins, the occurrence of LCRs cannot be associated with any specific metabolic pathway; yet their accumulation must have given selective advantages to the parasite. Translation of these asparagine-rich LCRs demands extraordinarily high amounts of asparaginylated tRNA(Asn). However, unlike other organisms, Plasmodium codon bias is not correlated to tRNA gene copy number. Here, we studied tRNA(Asn) accumulation as well as the catalytic capacities of the asparaginyl-tRNA synthetase of the parasite in vitro. We observed that asparaginylation in this parasite can be considered standard, which is expected to limit the availability of asparaginylated tRNA(Asn) in the cell and, in turn, slow down the ribosomal translation rate when decoding asparagine repeats. This observation strengthens our earlier hypothesis considering that asparagine rich sequences act as tRNA sponges and help cotranslational folding of parasite proteins. However, it also raises many questions about the mechanistic aspects of the synthesis of asparagine repeats and about their implications in the global control of protein expression throughout Plasmodium life cycle.	[Filisetti, Denis; Theobald-Dietrich, Anne; Mahmoudi, Nassira; Rudinger-Thirion, Joelle; Frugier, Magali] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, F-67084 Strasbourg, France; [Filisetti, Denis; Candolfi, Ermanno] Univ Strasbourg, Inst Parasitol & Pathol Trop, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Frugier, M (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	m.frugier@ibmc-cnrs.unistra.fr		Mahmoudi, Nassira/0000-0002-2351-8123; FILISETTI, Denis/0000-0001-9002-8151	European Community [223024]; Laboratoire d'Excellence NetRNA Grant [ANR-10-LABX-36]	European Community(European Commission); Laboratoire d'Excellence NetRNA Grant	This work was supported by the European Community's Seventh Framework Programme FP7/2007-2013 under Grant 223024 and the Laboratoire d'Excellence NetRNA Grant ANR-10-LABX-36.	Aguilo A, 2000, J NUTR BIOCHEM, V11, P81, DOI 10.1016/S0955-2863(99)00073-X; ANDRULIS IL, 1978, J BIOL CHEM, V253, P58; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bastien O, 2004, GENE, V336, P163, DOI 10.1016/j.gene.2004.04.029; Beaulande M, 1998, NUCLEIC ACIDS RES, V26, P521, DOI 10.1093/nar/26.2.521; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Campanacci V, 2004, J MOL BIOL, V337, P273, DOI 10.1016/j.jmb.2004.01.027; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Charneski CA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001508; Chayen N, 2004, ANN NY ACAD SCI, V1027, P20, DOI 10.1196/annals.1324.003; Cheong HK, 2003, INT J BIOCHEM CELL B, V35, P1548, DOI 10.1016/S1357-2725(03)00070-0; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; Crepin T, 2011, J MOL BIOL, V405, P1056, DOI 10.1016/j.jmb.2010.11.049; Dalby AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006231; DePristo MA, 2006, GENE, V378, P19, DOI 10.1016/j.gene.2006.03.023; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Ferreira MU, 2003, GENE, V304, P65, DOI 10.1016/S0378-1119(02)01180-0; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2005, EMBO REP, V6, P860, DOI 10.1038/sj.embor.7400481; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Frugier M, 2010, FEBS LETT, V584, P448, DOI 10.1016/j.febslet.2009.11.004; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; Huntley M, 2000, J MOL EVOL, V51, P131, DOI 10.1007/s002390010073; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kron MA, 2012, MOL BIOCHEM PARASIT, V185, P66, DOI 10.1016/j.molbiopara.2012.06.003; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lopez-Barragan MJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-587; MADERN D, 1992, FEBS LETT, V299, P85, DOI 10.1016/0014-5793(92)80106-Q; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Marczinke B, 2000, J MOL BIOL, V295, P179, DOI 10.1006/jmbi.1999.3361; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Payne SH, 2006, EUKARYOT CELL, V5, P272, DOI 10.1128/EC.5.2.272-276.2006; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; Pizzi E, 2001, GENOME RES, V11, P218, DOI 10.1101/gr.GR-1522R; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Ryckelynck M, 2005, BIOCHIMIE, V87, P835, DOI 10.1016/j.biochi.2005.02.014; Seignovert L, 1996, EUR J BIOCHEM, V239, P501, DOI 10.1111/j.1432-1033.1996.0501u.x; Senger B, 1997, BIOCHEMISTRY-US, V36, P8269, DOI 10.1021/bi970206l; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wang LJ, 2001, PLANT PHYSIOL, V125, P1380, DOI 10.1104/pp.125.3.1380; Wayne N, 2010, J MOL BIOL, V401, P931, DOI 10.1016/j.jmb.2010.06.066; Xue HY, 2003, MOL BIOCHEM PARASIT, V128, P21, DOI 10.1016/S0166-6851(03)00039-2; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	57	15	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36361	36371		10.1074/jbc.M113.522896	http://dx.doi.org/10.1074/jbc.M113.522896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196969	Green Published, hybrid			2022-12-25	WOS:000328883400018
J	Weiss, GJ; Liang, WS; Demeure, MJ; Kiefer, JA; Hostetter, G; Izatt, T; Sinari, S; Christoforides, A; Aldrich, J; Kurdoglu, A; Phillips, L; Benson, H; Reiman, R; Baker, A; Marsh, V; Von Hoff, DD; Carpten, JD; Craig, DW				Weiss, Glen J.; Liang, Winnie S.; Demeure, Michael J.; Kiefer, Jeff A.; Hostetter, Galen; Izatt, Tyler; Sinari, Shripad; Christoforides, Alexis; Aldrich, Jessica; Kurdoglu, Ahmet; Phillips, Lori; Benson, Hollie; Reiman, Rebecca; Baker, Angela; Marsh, Vickie; Von Hoff, Daniel D.; Carpten, John D.; Craig, David W.			A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges	PLOS ONE			English	Article							TRIALS; GENOME	Purpose: New anticancer agents that target a single cell surface receptor, up-regulated or amplified gene product, or mutated gene, have met with some success in treating advanced cancers. However, patients' tumors still eventually progress on these therapies. If it were possible to identify a larger number of targetable vulnerabilities in an individual's tumor, multiple targets could be exploited with the use of specific therapeutic agents, thus possibly giving the patient viable therapeutic alternatives. Experimental Design: In this exploratory study, we used next-generation sequencing technologies (NGS) including whole genome sequencing (WGS), and where feasible, whole transcriptome sequencing (WTS) to identify genomic events and associated expression changes in advanced cancer patients. Results: WGS on paired tumor and normal samples from nine advanced cancer patients and WTS on six of these patients' tumors was completed. One patient's treatment was based on targets and pathways identified by NGS and the patient had a short-lived PET/CT response with a significant reduction in his tumor-related pain. To design treatment plans based on information garnered from NGS, several challenges were encountered: NGS reporting delays, communication of results to out-of-state participants and their treating oncologists, and chain of custody handling for fresh biopsy samples for Clinical Laboratory Improvement Amendments (CLIA) target validation. Conclusion: While the initial effort was a slower process than anticipated due to a variety of issues, we demonstrate the feasibility of using NGS in advanced cancer patients so that treatments for patients with progressing tumors may be improved.	[Weiss, Glen J.; Demeure, Michael J.; Marsh, Vickie; Von Hoff, Daniel D.] Virginia G Piper Canc Ctr Clin Trials Scottsdale, Scottsdale, AZ USA; [Weiss, Glen J.; Liang, Winnie S.; Demeure, Michael J.; Kiefer, Jeff A.; Hostetter, Galen; Izatt, Tyler; Sinari, Shripad; Christoforides, Alexis; Aldrich, Jessica; Kurdoglu, Ahmet; Phillips, Lori; Benson, Hollie; Reiman, Rebecca; Baker, Angela; Von Hoff, Daniel D.; Carpten, John D.; Craig, David W.] Translat Genom Res Inst, Phoenix, AZ USA; [Hostetter, Galen] Van Andel Res Inst, Grand Rapids, MI USA	Translational Genomics Research Institute; Van Andel Institute	Weiss, GJ (corresponding author), Virginia G Piper Canc Ctr Clin Trials Scottsdale, Scottsdale, AZ USA.	glen.weiss@ctca-hope.com	Craig, David Wesley/K-6961-2019; Jeff/ABB-2636-2021	Craig, David Wesley/0000-0003-2040-1955; Jeff/0000-0002-1238-3120	National Foundation of Cancer Research; Lee T. Hanley Fund for Pancreatic Cancer Research	National Foundation of Cancer Research; Lee T. Hanley Fund for Pancreatic Cancer Research	Funding was provided by the National Foundation of Cancer Research (www.nfcr.org) and the Lee T. Hanley Fund for Pancreatic Cancer Research (http://www.tgenfoundation.org/netcommunity/page.aspx?pid = 1196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzeid WM, 2009, J CLIN INVEST, V119, P1974, DOI 10.1172/JCI33816; Arora S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045614; Cherni I, 2012, CANC RES, V72; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Dopeso H, 2010, CLIN CANCER RES, V16, P2375, DOI 10.1158/1078-0432.CCR-09-3275; ESTEY E, 1986, CANCER TREAT REP, V70, P1105; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Smith TL, 1996, J CLIN ONCOL, V14, P287, DOI 10.1200/JCO.1996.14.1.287; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Weiss GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037029; Weiss GJ, 2011, J THORAC ONCOL, V6, pS1302; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10	15	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76438	10.1371/journal.pone.0076438	http://dx.doi.org/10.1371/journal.pone.0076438			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204627	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500007
J	Gottlich, M; Munte, TF; Heldmann, M; Kasten, M; Hagenah, J; Kramer, UM				Goettlich, Martin; Muente, Thomas F.; Heldmann, Marcus; Kasten, Meike; Hagenah, Johann; Kraemer, Ulrike M.			Altered Resting State Brain Networks in Parkinson's Disease	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; SMALL-WORLD; VISUAL HALLUCINATIONS; ANATOMICAL NETWORKS; CORTICAL AREAS; ORGANIZATION; CORTEX; ACTIVATION; IMPAIRMENT; RECEPTORS	Parkinson's disease (PD) is a neurodegenerative disorder affecting dopaminergic neurons in the substantia nigra leading to dysfunctional cortico-striato-thalamic-cortical loops. In addition to the characteristic motor symptoms, PD patients often show cognitive impairments, affective changes and other non-motor symptoms, suggesting system-wide effects on brain function. Here, we used functional magnetic resonance imaging and graph-theory based analysis methods to investigate altered whole-brain intrinsic functional connectivity in PD patients (n = 37) compared to healthy controls (n = 20). Global network properties indicated less efficient processing in PD. Analysis of brain network modules pointed to increased connectivity within the sensorimotor network, but decreased interaction of the visual network with other brain modules. We found lower connectivity mainly between the cuneus and the ventral caudate, medial orbitofrontal cortex and the temporal lobe. To identify regions of altered connectivity, we mapped the degree of intrinsic functional connectivity both on ROI- and on voxel-level across the brain. Compared to healthy controls, PD patients showed lower connectedness in the medial and middle orbitofrontal cortex. The degree of connectivity was also decreased in the occipital lobe (cuneus and calcarine), but increased in the superior parietal cortex, posterior cingulate gyrus, supramarginal gyrus and supplementary motor area. Our results on global network and module properties indicated that PD manifests as a disconnection syndrome. This was most apparent in the visual network module. The higher connectedness within the sensorimotor module in PD patients may be related to compensation mechanism in order to overcome the functional deficit of the striato-cortical motor loops or to loss of mutual inhibition between brain networks. Abnormal connectivity in the visual network may be related to adaptation and compensation processes as a consequence of altered motor function. Our analysis approach proved sensitive for detecting disease-related localized effects as well as changes in network functions on intermediate and global scale.	[Goettlich, Martin; Muente, Thomas F.; Heldmann, Marcus; Hagenah, Johann; Kraemer, Ulrike M.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Kasten, Meike] Med Univ Lubeck, Dept Psychiat, D-23538 Lubeck, Germany; [Hagenah, Johann] Westkustenklinikum Heide, Dept Neurol, Heide, Germany	University of Lubeck; University of Lubeck	Gottlich, M (corresponding author), Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany.	martin.goettlich@neuro.uni-luebeck.de	Münte, Thomas/C-2077-2014; Krämer, Ulrike/AAF-2966-2020; Krämer, Ulrike M./A-8871-2019	Krämer, Ulrike M./0000-0002-3841-1812; Kasten, Meike/0000-0003-1910-6035; Gottlich, Martin/0000-0002-7668-0730	Deutsche Forschungsgemeinschaft [KA 3179/2-1]; Bundesministerium fur Bildung und Forschung; University of Lubeck	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); University of Lubeck	TFM has received support from the Deutsche Forschungsgemeinschaft and the Bundesministerium fur Bildung und Forschung. MK has received support from the Deutsche Forschungsgemeinschaft (KA 3179/2-1). This work was supported through intramural funding of the University of Lubeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bodis-Wollner I G, 1999, Adv Neurol, V80, P383; BODISWOLLNER I, 1993, ADV NEUROL, V60, P390; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cardoso EF, 2010, MOVEMENT DISORD, V25, P1590, DOI 10.1002/mds.23101; CHIODO LA, 1984, NEUROSCIENCE, V12, P1, DOI 10.1016/0306-4522(84)90133-7; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Chumbley JR, 2009, NEUROIMAGE, V44, P62, DOI 10.1016/j.neuroimage.2008.05.021; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cronin-Golomb A, 2010, NEUROPSYCHOL REV, V20, P191, DOI 10.1007/s11065-010-9128-8; DIOP L, 1988, SYNAPSE, V2, P395, DOI 10.1002/syn.890020406; Eckert T, 2006, J NEUROL, V253, P199, DOI 10.1007/s00415-005-0956-z; Emre M, 2004, CURR OPIN NEUROL, V17, P399, DOI 10.1097/01.wco.0000137529.30750.ab; FROST JJ, 1993, ANN NEUROL, V34, P423, DOI 10.1002/ana.410340331; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ginestet CE, 2011, NEUROIMAGE, V55, P688, DOI 10.1016/j.neuroimage.2010.11.030; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Gratton C, 2012, J COGNITIVE NEUROSCI, V24, P1275, DOI 10.1162/jocn_a_00222; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Helmich RC, 2010, CEREB CORTEX, V20, P1175, DOI 10.1093/cercor/bhp178; Helmich RC, 2009, J NEUROSCI, V29, P6105, DOI 10.1523/JNEUROSCI.0704-09.2009; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hirano S, 2012, J NEUROL NEUROSUR PS, V83, P963, DOI 10.1136/jnnp-2011-301818; Jahanshahi M, 2002, J COGNITIVE NEUROSCI, V14, P298, DOI 10.1162/089892902317236911; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Katschnig P, 2011, J NEURAL TRANSM, V118, P783, DOI 10.1007/s00702-011-0621-x; Khoo TK, 2013, NEUROLOGY, V80, P276, DOI 10.1212/WNL.0b013e31827deb74; Kinnison J, 2012, J NEUROSCI, V32, P8361, DOI 10.1523/JNEUROSCI.0821-12.2012; Ko JH, 2012, HUMAN BRAIN MAPPING; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; Laatu S, 2004, PARKINSONISM RELAT D, V10, P227, DOI 10.1016/j.parkreldis.2004.02.001; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lewis SJG, 2003, J NEUROSCI, V23, P6351, DOI 10.1523/jneurosci.23-15-06351.2003; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MEADORWOODRUFF JH, 1989, P NATL ACAD SCI USA, V86, P7625, DOI 10.1073/pnas.86.19.7625; Mindham RHS, 2001, J NEUROL NEUROSUR PS, V70, P719; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rowe J, 2002, BRAIN, V125, P276, DOI 10.1093/brain/awf036; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Skidmore F, 2011, NEUROSCI LETT, V499, P47, DOI 10.1016/j.neulet.2011.05.030; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Starkstein SE, 2012, AM J GERIAT PSYCHIAT, V20, P99, DOI 10.1097/JGP.0b013e318240f90a; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Svenningsson P, 2012, LANCET NEUROL, V11, P697, DOI 10.1016/S1474-4422(12)70152-7; TRICK GL, 1994, OPTOMETRY VISION SCI, V71, P242, DOI 10.1097/00006324-199404000-00002; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILLIAMS SM, 1993, CEREB CORTEX, V3, P199, DOI 10.1093/cercor/3.3.199; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Young DE, 2010, VISION RES, V50, P2495, DOI 10.1016/j.visres.2010.08.029; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027	74	161	162	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77336	10.1371/journal.pone.0077336	http://dx.doi.org/10.1371/journal.pone.0077336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204812	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200026
J	Liu, SR; Li, WY; Long, D; Hu, CG; Zhang, JZ				Liu, Sheng-Rui; Li, Wen-Yang; Long, Dang; Hu, Chun-Gen; Zhang, Jin-Zhi			Development and Characterization of Genomic and Expressed SSRs in Citrus by Genome-Wide Analysis	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; MICROSATELLITE MARKERS; IDENTIFICATION; GENES; TAGS; SELECTION; NUMBER; BARLEY; MAIZE; RICE	Microsatellites or simple sequence repeats (SSRs) are one of the most popular sources of genetic markers and play a significant role in plant genetics and breeding. In this study, we identified citrus SSRs in the genome of Clementine mandarin and analyzed their frequency and distribution in different genomic regions. A total of 80,708 SSRs were detected in the genome with an overall density of 268 SSRs/Mb. While di-nucleotide repeats were the most frequent microsatellites in genomic DNA sequence, tetra-nucleotides, which had more repeat units than any other SSR types, had the highest cumulative sequence length. We identified 6,834 transcripts as containing 8,989 SSRs in 33,929 Clementine mandarin transcripts, among which, tri-nucleotide motifs (36.0%) were the most common, followed by di-nucleotide (26.9%) and hexa-nucleotide motifs (15.1%). The motif AG (16.7%) was most abundant among these SSRs, while motifs AAG (6.6%), AAT (5.0%), and TAG (2.2%) were most common among tri-nucleotides. Functional categorization of transcripts containing SSRs revealed that 5,879 (86.0%) of such transcripts had homology with known proteins, GO and KEGG annotation revealed that transcripts containing SSRs were those implicated in diverse biological processes in plants, including binding, development, transcription, and protein degradation. When 27 genomic and 78 randomly selected SSRs were tested on Clementine mandarin, 95 SSRs revealed polymorphism. These 95 SSRs were further deployed on 18 genotypes of the three generas of Rutaceae for the genetic diversity assessment, genomic SSRs generally show low transferability in comparison to SSRs developed from expressed sequences. These transcript-markers identified in our study may provide a valuable genetic and genomic tool for further genetic research and varietal development in citrus, such as diversity study, QTL mapping, molecular breeding, comparative mapping and other genetic analyses.	[Liu, Sheng-Rui; Li, Wen-Yang; Long, Dang; Hu, Chun-Gen; Zhang, Jin-Zhi] Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, JZ (corresponding author), Huazhong Agr Univ, Coll Hort & Forestry Sci, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China.	jinzhizhang@mail.hzau.edu.cn		Zhang, Jin-Zhi/0000-0002-3820-889X	Fundamental Research Funds for the Central Universities [2013PY083]; National Natural Science Foundation of China [31071777, 31130046, 31101528]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported financially by the Fundamental Research Funds for the Central Universities (2013PY083) and the National Natural Science Foundation of China (grant nos. 31071777, 31130046, and 31101528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar MH, 2011, SCI HORTIC-AMSTERDAM, V128, P220, DOI 10.1016/j.scienta.2011.01.021; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Bao JS, 2002, THEOR APPL GENET, V105, P898, DOI 10.1007/s00122-002-1049-3; Cardle L, 2000, GENETICS, V156, P847; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Cheng YunJiang, 2003, Plant Molecular Biology Reporter, V21, p177a, DOI 10.1007/BF02774246; Collard B, 2013, DEV NEW FLOOD TOLERA, P42; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Deng XiuXin, 2005, Acta Horticulturae Sinica, V32, P1140; Dresselhaus T, 1999, MOL GEN GENET, V261, P416, DOI 10.1007/s004380050983; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Geuna F, 2003, PLANT BREEDING, V122, P526, DOI 10.1111/j.1439-0523.2003.00897.x; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Gupta HS, 2009, CURR SCI INDIA, V96, P230; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Holton TA, 2002, MOL BREEDING, V9, P63, DOI 10.1023/A:1026785207878; Johnson R., 2004, Plant Breeding Reviews, V24, P293; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; KIMURA M, 1964, GENETICS, V49, P725; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lewontin R.C., 1972, NATURE, V236, P181, DOI DOI 10.1038/236181A0; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Metzgar D, 2000, GENOME RES, V10, P72; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Mun JH, 2006, GENETICS, V172, P2541, DOI 10.1534/genetics.105.054791; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1983, GENETICS, V105, P207; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Palmieri DA, 2007, GENET MOL BIOL, V30, P1009, DOI 10.1590/S1415-47572007000500029; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Qureshi S. N., 2004, Journal of Cotton Science, V8, P112; Schmid R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-180; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trifonov EN, 2004, EVOLUTIONARY THEORY AND PROCESSES: MODERN HORIZONS, P115; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yeh F.C., 1999, POPGENE VERSION 1 32; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Zhao YL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-237	47	53	59	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75149	10.1371/journal.pone.0075149	http://dx.doi.org/10.1371/journal.pone.0075149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204572	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200003
J	Fuchs, F; Bruyere, M; Senat, MV; Purenne, E; Benhamou, D; Fernandez, H				Fuchs, Florent; Bruyere, Marie; Senat, Marie-Victoire; Purenne, Emilien; Benhamou, Dan; Fernandez, Herve			Are Standard Intra-Abdominal Pressure Values Different during Pregnancy?	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ABDOMINAL COMPARTMENT SYNDROME; HYPERTENSION; TERM	Background: Measurement of intra-abdominal pressure (IAP) is an important parameter in the surveillance of intensive care unit patients. Standard values of IAP during pregnancy have not been well defined. The aim of this study was to assess IAP values in pregnant women before and after cesarean delivery. Methods: This prospective study, carried out from January to December 2011 in a French tertiary care centre, included women with an uneventful pregnancy undergoing elective cesarean delivery at term. IAP was measured through a Foley catheter inserted in the bladder under spinal anaesthesia before cesarean delivery, and every 30 minutes during the first two hours in the immediate postoperative period. Results: The study included 70 women. Mean IAP before cesarean delivery was 14.2 mmHg (95% CI: 6.3-23). This value was significantly higher than in the postoperative period: 11.5 mmHg (95% CI: 5-19.7) for the first measurement (p = 0.002). IAP did not significantly change during the following two postoperative hours (p = 0.2). Obese patients (n = 25) had a preoperative IAP value significantly higher than non-obese patients: 15.7 vs. 12.4; p = 0.02. Conclusion: In term pregnancies, IAP values are significantly higher before delivery than in the post-partum period, where IAP values remain elevated for at least two hours at the level of postoperative classical abdominal surgery. The knowledge of these physiological changes in IAP values may help prevent organ dysfunction/failure when abdominal compartment syndrome occurs after cesarean delivery.	[Fuchs, Florent; Senat, Marie-Victoire; Fernandez, Herve] Hop Bicetre, Assistance Publ Hop Paris, Dept Obstet & Gynecol, Le Kremlin Bicetre, France; [Fuchs, Florent; Senat, Marie-Victoire; Fernandez, Herve] INSERM, Ctr Res Epidemiol & Populat Hlth, U1018, Villejuif, France; [Fuchs, Florent; Senat, Marie-Victoire; Fernandez, Herve] Univ Paris 11, Unit 1018, Villejuif, France; [Bruyere, Marie; Purenne, Emilien; Benhamou, Dan] Hop Bicetre, Assistance Publ Hop Paris, Dept Anesthesia, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay	Fuchs, F (corresponding author), Hop Bicetre, Assistance Publ Hop Paris, Dept Obstet & Gynecol, Le Kremlin Bicetre, France.	florent.fuchs@bct.aphp.fr	Benhamou, Dan/ABG-7935-2021; FUCHS, Florent/AAA-5460-2019	FUCHS, Florent/0000-0003-3530-6328; FERNANDEZ, Herve/0000-0002-6463-1018				Abdel-Razeq SS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.055; ACOG, 2009, OBSTET GYNECOL, V113, P443; Al-Khan A, 2011, J REPROD MED, V56, P53; Berghella V, 2005, AM J OBSTET GYNECOL, V193, P1607, DOI 10.1016/j.ajog.2005.03.063; Chun R, 2012, INT J OBSTET ANESTH, V21, P135, DOI 10.1016/j.ijoa.2011.10.010; Chun R, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S5; Cuppett C, 2008, AM J OBSTET GYNECOL, V199, pS151, DOI 10.1016/j.ajog.2008.09.544; De Keulenaer BL, 2009, INTENS CARE MED, V35, P969, DOI 10.1007/s00134-009-1445-0; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Malbrain MLNG, 2004, INTENS CARE MED, V30, P822, DOI 10.1007/s00134-004-2169-9; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Sugerman HJ, 2011, MED HYPOTHESES, V77, P841, DOI 10.1016/j.mehy.2011.07.051; Sugrue M, 1999, ARCH SURG-CHICAGO, V134, P1082, DOI 10.1001/archsurg.134.10.1082; Sugrue M, 2005, CURR OPIN CRIT CARE, V11, P333, DOI 10.1097/01.ccx.0000170505.53657.48; Vidal MG, 2008, CRIT CARE MED, V36, P1823, DOI 10.1097/CCM.0b013e31817c7a4d; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Wilkinson C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000120.pub2	18	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77324	10.1371/journal.pone.0077324	http://dx.doi.org/10.1371/journal.pone.0077324			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204808	gold, Green Submitted, Green Published			2022-12-25	WOS:000326155400034
J	Ratti, S; Knoll, AH; Giordano, M				Ratti, Simona; Knoll, Andrew H.; Giordano, Mario			Grazers and Phytoplankton Growth in the Oceans: an Experimental and Evolutionary Perspective	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; MARINE-PHYTOPLANKTON; MACROEVOLUTIONARY CHANGE; CAMBRIAN RADIATION; ORGANISMS; AVAILABILITY; BIODIVERSITY; PATTERNS; ECOLOGY; STATE	The taxonomic composition of phytoplankton responsible for primary production on continental shelves has changed episodically through Earth history. Geological correlations suggest that major changes in phytoplankton composition correspond in time to changes in grazing and seawater chemistry. Testing hypotheses that arise from these correlations requires experimentation, and so we carried out a series of experiments in which selected phytoplankton species were grown in treatments that differed with respect to the presence or absence of grazers as well as seawater chemistry. Both protistan (Euplotes sp.) and microarthropod (Acartia tonsa) grazers changed the growth dynamics and biochemical composition of the green alga Tetraselmis suecica, the diatom Thalassiosira weissflogii, and the cyanobacterium Synechococcus sp., increasing the specific growth rate and palatability of the eukaryotic algae, while decreasing or leaving unchanged both parameters in the cyanobacteria. Synechococcus (especially) and Thalassiosira produced toxins effective against the copepod, but ciliate growth was unaffected. Acartia induced a 4-6 fold increase of Si cell quota in the diatom, but Euplotes had no similar effect. The differential growth responses of the eukaryotic algae and cyanobacteria to ciliate grazing may help to explain the apparently coeval radiation of eukaryophagic protists and rise of eukaryotes to ecological prominence as primary producers in Neoproterozoic oceans. The experimental results suggest that phytoplankton responses to the later radiation of microarthropod grazers were clade-specific, and included changes in growth dynamics, toxin synthesis, encystment, and (in diatoms) enhanced Si uptake.	[Ratti, Simona; Giordano, Mario] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [Knoll, Andrew H.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Marche Polytechnic University; Harvard University	Giordano, M (corresponding author), Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy.	m.giordano@univpm.it	Giordano, Mario/A-8949-2008	Giordano, Mario/0000-0001-7754-0521	NASA Astrobiology Institute; Fondazione Cariverona; Ministero delle Politiche Agricole, Alimentari e Forestali; Assemble EU	NASA Astrobiology Institute; Fondazione Cariverona(Fondazione Cariverona); Ministero delle Politiche Agricole, Alimentari e Forestali; Assemble EU	This work was funded by NASA Astrobiology Institute (https://astrobiology.nasa.gov/nai/); Fondazione Cariverona (www.fondazionecariverona.org/); Ministero delle Politiche Agricole, Alimentari e Forestali (http://www.politicheagricole.it); and Assemble EU FP7 research infrastructure initiative (http://www.assemblemarine.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x; Berney C, 2006, P ROY SOC B-BIOL SCI, V273, P1867, DOI 10.1098/rspb.2006.3537; Bradford-Grieve JM, 2002, HYDROBIOLOGIA, V485, P223, DOI 10.1023/A:1021373412738; Caron DA, 2013, J PLANKTON RES, V35, P235, DOI 10.1093/plankt/fbs091; Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fanesi A, 2013, PLANT CELL ENVIRON, DOI [10.1111/pce. 12176., DOI 10.1111/PCE.12176.PUBMED:23927015]; Finkel ZV, 2007, P NATL ACAD SCI USA, V104, P20416, DOI 10.1073/pnas.0709381104; Finkel ZV, 2010, GEOBIOLOGY, V8, P433, DOI 10.1111/j.1472-4669.2010.00250.x; Finkel ZV, 2010, GEOMICROBIOL J, V27, P596, DOI 10.1080/01490451003702941; Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x; Giordano M, 2013, PLANT SCI, V211, P92, DOI 10.1016/j.plantsci.2013.07.008; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Harvey THP, 2012, P NATL ACAD SCI USA, V109, P1589, DOI 10.1073/pnas.1115244109; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Knoll AH, 2013, ORIGIN EVOL IN PRESS; Knoll Andrew H., 2007, P133; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Leandro LF, 2010, J EXP MAR BIOL ECOL, V382, P88, DOI 10.1016/j.jembe.2009.11.002; NEJSTGAARD JC, 1995, ICES J MAR SCI, V52, P347, DOI 10.1016/1054-3139(95)80050-6; Norici A, 2005, PHOTOSYNTH RES, V86, P409, DOI 10.1007/s11120-005-3250-0; Palmucci M, 2011, J PHYCOL, V47, P313, DOI 10.1111/j.1529-8817.2011.00963.x; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pondevan P, 2011, PROTIST, V158, P21; Porter S, 2011, GEOLOGY, V39, P607, DOI 10.1130/focus062011.1; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Ratti S, 2011, GEOBIOLOGY, V9, P301, DOI 10.1111/j.1472-4669.2011.00284.x; Raven JA, 2009, GEOBIOLOGY, V7, P140, DOI 10.1111/j.1472-4669.2008.00181.x; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Selden PA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1049; Smetacek V, 2012, J BIOSCIENCES, V37, P589, DOI 10.1007/s12038-012-9240-4; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; Trommer G, 2012, MAR ECOL PROG SER, V449, P83, DOI 10.3354/meps09508; Vardi A, 2002, CURR BIOL, V12, P1767, DOI 10.1016/S0960-9822(02)01217-4; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	40	34	35	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77349	10.1371/journal.pone.0077349	http://dx.doi.org/10.1371/journal.pone.0077349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204815	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300021
J	Wang, HJ; Ye, F; Wang, Y; Huntington, D				Wang, Haijun; Ye, Fang; Wang, Yan; Huntington, Dale		Study Grp Econ Impact Maternal	Economic Impact of Maternal Death on Households in Rural China: A Prospective Cohort Study	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; HEALTH-CARE; MORTALITY; INCOME	Objective: To assess the economic impact of maternal death on rural Chinese households during the year after maternal death. Methods: A prospective cohort study matched 183 households who had suffered a maternal death to 346 households that experienced childbirth without maternal death in rural areas of three provinces in China. Surveys were conducted at baseline (1-3 months after maternal death or childbirth) and one year after baseline using the quantitative questionnaire. We investigated household income, expenditure, accumulated debts, and self-reported household economic status. Difference-in-Difference (DID), linear regression, and logistic regression analyses were used to compare the economic status between households with and without maternal death. Findings: The households with maternal death had a higher risk of self-reported "household economy became worse'' during the follow-up period (adjusted OR = 6.04, p<0.001). During the follow-up period, at the household level, DID estimator of income and expenditure showed that households with maternal death had a significant relative reduction of US$ 869 and US$ 650, compared to those households that experienced childbirth with no adverse event (p<0.001). Converted to proportions of change, an average of 32.0% reduction of annual income and 24.9% reduction of annual expenditure were observed in households with a maternal death. The mean increase of accumulated debts in households with a maternal death was 3.2 times as high as that in households without maternal death (p=0.024). Expenditure pattern of households with maternal death changed, with lower consumption on food (p=0.037), clothes and commodity (p=0.003), traffic and communication (p=0.022) and higher consumption on cigarette or alcohol (p=0.014). Conclusion: Compared with childbirth, maternal death had adverse impact on household economy, including higher risk of self-reported "household economy became worse'', decreased income and expenditure, increased debts and changed expenditure pattern.	[Wang, Haijun; Ye, Fang; Wang, Yan] Peking Univ, Sch Publ Hlth, Div Maternal & Child Hlth, Beijing 100871, Peoples R China; [Huntington, Dale] World Hlth Org Western Pacific Reg Off, Asia Pacific Observ Hlth Syst & Policies, Manila, Philippines	Peking University; World Health Organization	Wang, Y (corresponding author), Peking Univ, Sch Publ Hlth, Div Maternal & Child Hlth, Beijing 100871, Peoples R China.	wangyan@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903	United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland;  [A65403]	United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland; 	The study was supported by a grant from the United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, Geneva, Switzerland (http://www.who.int/reproductivehealth/en/). The Grant number is A65403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M, 1998, IMPACT ADULT DEATHS; Arsenault C, 2013, B WORLD HEALTH ORGAN, V91, P207, DOI 10.2471/BLT.12.108969; Bachmann MO, 2004, AIDS CARE, V16, P817, DOI 10.1080/09540120412331290220; Basu A, 1998, WORKSH CONS PREGN MA; Borghi J, 2003, HEALTH POLICY PLANN, V18, P383, DOI 10.1093/heapol/czg046; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Feng XL, 2010, HEALTH ECON, V19, P69, DOI 10.1002/hec.1593; GERTLER P, 2003, LOSING PRESENCE PRES; Greene M.E., 2005, POVERTY REDUCTION DO; Islam MK, 2006, COSTS MATERNAL NEWBO; Justine H, 2012, LANCET, V380, P1157, DOI [10.1016/S0140-6736(12)61415-9, DOI 10.1016/S0140-6736(12)61415-9]; Liu XN, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-566; Long QA, 2010, TROP MED INT HEALTH, V15, P1210, DOI 10.1111/j.1365-3156.2010.02602.x; Morris SS, 2000, J EPIDEMIOL COMMUN H, V54, P381, DOI 10.1136/jech.54.5.381; Over M, 1997, IMPACT ADULT MORTALI; Prescott N, 1999, INT DEV BANK C SOC P; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; State Statistical Bureau, 2010, CHIN STAT YB; State Statistical Bureau, 2012, CHIN STAT YB; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Wagstaff A, 2009, J HEALTH ECON, V28, P1, DOI 10.1016/j.jhealeco.2008.10.007; Wooldridge JM, 2002, INTRO ECONOMETRICS M; WOOLLEY FR, 1994, REV INCOME WEALTH, P415; Ye F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038467	25	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76624	10.1371/journal.pone.0076624	http://dx.doi.org/10.1371/journal.pone.0076624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241FR	24204648	Green Published, gold			2022-12-25	WOS:000326152300008
J	Yang, W; Wu, JM; Bi, AD; Ou-Yang, YC; Shen, HH; Chirn, GW; Zhou, JH; Weiss, E; Holman, EP; Liao, DJ				Yang, Wei; Wu, Jian-min; Bi, An-ding; Ou-yang, Yong-chang; Shen, Hai-hong; Chirn, Gung-wei; Zhou, Jian-hua; Weiss, Emily; Holman, Emily Pauline; Liao, D. Joshua			Possible Formation of Mitochondrial-RNA Containing Chimeric or Trimeric RNA Implies a Post-Transcriptional and Post-Splicing Mechanism for RNA Fusion	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; COPY NUMBER; EXPRESSION; TRANSCRIPTOME; GENOME; CANCER; GENES; DISEASE; BREAST; TUMORS	Human cells are known to express many chimeric RNAs, i.e. RNAs containing two genes' sequences. Wondering whether there also is trimeric RNA, i.e. an RNA containing three genes' sequences, we wrote simple computer code to screen human expression sequence tags (ESTs) deposited in different public databases, and obtained hundreds of putative trimeric ESTs. We then used NCBI Blast and UCSC Blat browsers to further analyze their sequences, and identified 61 trimeric and two tetrameric ESTs (one EST containing four different sequences). We also identified 57 chimeric, trimeric or teterameric ESTs that contained both mitochondrial (mt) RNA and nuclear RNA (nRNA), i.e. were mtRNA-nRNA fusions. In some trimeric ESTs, the downstream partner was fused to the poly-A tail of the upstream partner, which, together with the mtRNA-nRNA fusions, suggests a possible new mechanism for RNA fusion that occurs after both transcription and splicing have been terminated, and possibly outside the nucleus, in contrast to the two current hypothetical mechanisms, trans-splicing and transcriptional-slippage, that occur in the nucleus. The mt-sequences in the mtRNA-nRNA fusions had pseudogenes in the nucleus but, surprisingly, localized mainly in chromosomes 1 and 5. In some mtRNA-nRNA fusions, as well as in some ESTs that were derived only from mtRNA, the mt-sequences might be cis- or trans-spliced. Actually, we cloned a new cis-spliced mtRNA, coined as 16SrRNA-s. Hence, mtDNA may not always be intron-less. Fusion of three or more RNAs to one, fusion of nRNA to mtRNA, and cis- or trans-splicing of mtRNA should all enlarge the cellular RNA repertoire, in turn enlarging the cellular functions. Therefore, future experimental verification of the existence of these novel classes of fusion RNAs and spliced mtRNAs in human cells should significantly advance our understanding of biology and medicine.	[Yang, Wei; Wu, Jian-min] Guangxi Vet Res Inst, Nanning, Guangxi, Peoples R China; [Bi, An-ding; Ou-yang, Yong-chang; Weiss, Emily; Holman, Emily Pauline; Liao, D. Joshua] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Shen, Hai-hong] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Chirn, Gung-wei] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Zhou, Jian-hua] Nantong Univ, Nantong, Jiangsu, Peoples R China	Guangxi Veterinary Research Institute; University of Minnesota System; Gwangju Institute of Science & Technology (GIST); Boston University; Nantong University	Yang, W (corresponding author), Guangxi Vet Res Inst, Nanning, Guangxi, Peoples R China.	gxyangwei@163.com; djliao@hi.umn.edu			Department of Defense of United States [W81XWH-11-1-0119]	Department of Defense of United States	This work was supported by a grant from the Department of Defense of United States (DOD Award W81XWH-11-1-0119) to DJL. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Aral C, 2010, GENET MOL BIOL, V33, P1, DOI 10.1590/S1415-47572009005000102; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Burzio VA, 2009, P NATL ACAD SCI USA, V106, P9430, DOI 10.1073/pnas.0903086106; Celestino R, 2012, GENE CHROMOSOME CANC, V51, P1154, DOI 10.1002/gcc.22003; Charlesworth A, 2013, WIRES RNA, V4, P437, DOI 10.1002/wrna.1171; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Farre JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052644; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Jackson CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056777; Landerer E, 2011, CELL ONCOL, V34, P297, DOI 10.1007/s13402-011-0018-8; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005; Pink JJ, 1997, BRIT J CANCER, V75, P17, DOI 10.1038/bjc.1997.4; Pink JJ, 1996, NUCLEIC ACIDS RES, V24, P962, DOI 10.1093/nar/24.5.962; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Ramos A, 2011, MITOCHONDRION, V11, P946, DOI 10.1016/j.mito.2011.08.009; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Seligmann H, 2013, J THEOR BIOL, V324, P1, DOI 10.1016/j.jtbi.2013.01.024; Seligmann H, 2012, J THEOR BIOL, V315, P38, DOI 10.1016/j.jtbi.2012.08.044; Sun Y, 2013, ONCOGENE, V32, P1794, DOI 10.1038/onc.2012.200; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0041659, DOI 10.1371/J0URNAL.-P0NE.0041659]; Sun Y, 2012, J CANCER, V3, P93, DOI 10.7150/jca.4163; Szczesny RJ, 2013, BBA-GENE REGUL MECH, V1829, P842, DOI 10.1016/j.bbagrm.2013.02.009; Tonska K, 2012, GENE, V506, P161, DOI 10.1016/j.gene.2012.06.081; Tsuji J, 2012, NUCLEIC ACIDS RES, V40, P9073, DOI 10.1093/nar/gks424; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Villegas J, 2000, DNA CELL BIOL, V19, P579, DOI 10.1089/104454900439809; Villegas J, 2007, NUCLEIC ACIDS RES, V35, P7336, DOI 10.1093/nar/gkm863; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Woischnik M, 2002, GENOME RES, V12, P885, DOI 10.1101/gr.227202; Yang M, 2012, MOL BIOL REP, V39, P9247, DOI 10.1007/s11033-012-1798-2; Yang M, 2011, J CANCER, V2, P386, DOI 10.7150/jca.2.386; Yuan CF, 2013, RNA BIOL, V10, P958, DOI 10.4161/rna.24570	39	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77016	10.1371/journal.pone.0077016	http://dx.doi.org/10.1371/journal.pone.0077016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204722	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300013
J	Braima, KA; Sum, JS; Ghazali, ARM; Muslimin, M; Jeffery, J; Lee, WC; Shaker, MR; Elamin, AEM; Jamaiah, I; Lau, YL; Rohela, M; Kamarulzaman, A; Sitam, F; Mohd-Noh, R; Abdul-Aziz, NM				Braima, Kamil A.; Sum, Jia-Siang; Ghazali, Amir-Ridhwan M.; Muslimin, Mustakiza; Jeffery, John; Lee, Wenn-Chyau; Shaker, Mohammed R.; Elamin, Alaa-Eldeen M.; Jamaiah, Ibrahim; Lau, Yee-Ling; Rohela, Mahmud; Kamarulzaman, Adeeba; Sitam, Frankie; Mohd-Noh, Rosnida; Abdul-Aziz, Noraishah M.			Is There a Risk of Suburban Transmission of Malaria in Selangor, Malaysia?	PLOS ONE			English	Article							PLASMODIUM-KNOWLESI; INFECTIONS	Background: The suburban transmission of malaria in Selangor, Malaysia's most developed and populous state still remains a concern for public health in this region. Despite much successful control efforts directed at its reduction, sporadic cases, mostly brought in by foreigners have continued to occur. In addition, cases of simian malaria caused by Plasmodium knowlesi, some with fatal outcome have caused grave concern to health workers. The aim of this study was to investigate the possibility of local malaria transmission in suburban regions of Selangor, which are adjacent to secondary rainforests. Findings: A malaria survey spanning 7 years (2006 - 2012) was conducted in Selangor. A total of 1623 laboratory confirmed malaria cases were reported from Selangor's nine districts. While 72.6% of these cases (1178/1623) were attributed to imported malaria (cases originating from other countries), 25.5% (414/1623) were local cases and 1.9% (31/1623) were considered as relapse and unclassified cases combined. In this study, the most prevalent infection was P. vivax (1239 cases, prevalence 76.3%) followed by P. falciparum (211, 13.0%), P. knowlesi (75, 4.6%), P. malariae (71, 4.4%) and P. ovale (1, 0.06%). Mixed infections comprising of P. vivax and P. falciparum were confirmed (26, 1.6%). Entomological surveys targeting the residences of malaria patients' showed that the most commonly trapped Anopheles species was An. maculatus. No oocysts or sporozoites were found in the An. maculatus collected. Nevertheless, the possibility of An. maculatus being the malaria vector in the investigated locations was high due to its persistent occurrence in these areas. Conclusions: Malaria cases reported in this study were mostly imported cases. However the co-existence of local cases and potential Plasmodium spp. vectors should be cause for concern. The results of this survey reflect the need of maintaining closely monitored malaria control programs and continuous extensive malaria surveillance in Peninsula Malaysia.	[Braima, Kamil A.; Sum, Jia-Siang; Ghazali, Amir-Ridhwan M.; Muslimin, Mustakiza; Jeffery, John; Lee, Wenn-Chyau; Shaker, Mohammed R.; Jamaiah, Ibrahim; Lau, Yee-Ling; Rohela, Mahmud; Abdul-Aziz, Noraishah M.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Elamin, Alaa-Eldeen M.] Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia; [Kamarulzaman, Adeeba] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Sitam, Frankie] Dept Wildlife & Natl Pk Peninsular Malaysia, Kuala Lumpur, Malaysia; [Mohd-Noh, Rosnida] Univ Teknol MARA UiTM, Fac Med, Sungai Buloh, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Abdul-Aziz, NM (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	noisha@ummc.edu.my	ABDUL-AZIZ, NORAISHAH MYDIN/B-9337-2010; Shaker, Mohammed/AAI-9852-2021; Sitam, Frankie Thomas/AAF-6279-2021; KAMARULZAMAN, ADEEBA/B-5216-2010; Sum, Jia Siang/ABA-1036-2020; Lau, Yee Ling/C-6996-2009; LEE, Wenn-Chyau/AAR-4072-2020	ABDUL-AZIZ, NORAISHAH MYDIN/0000-0002-2447-3211; Shaker, Mohammed/0000-0002-3675-4598; Sitam, Frankie Thomas/0000-0001-7160-6243; Sum, Jia Siang/0000-0003-3621-1021; Lau, Yee Ling/0000-0002-2037-2165; LEE, Wenn-Chyau/0000-0002-7324-5792; Mohd Ghazali, Amir Ridhwan/0000-0001-6885-3606; Braima, Kamil A./0000-0003-2529-2313	University Malaya Postgraduate Research Fund [PV052/2012A]; University Malaya High-Impact Research [UM.C/HIR/MOHE/MED/18]; University of Malaya FRGS [FP036/2010A, FP022/2010B]; Peruntukan Penyelidikan Jangka Pendek (PJP); Universiti Malaya [FS344/2008C]	University Malaya Postgraduate Research Fund; University Malaya High-Impact Research; University of Malaya FRGS(Universiti Malaya); Peruntukan Penyelidikan Jangka Pendek (PJP); Universiti Malaya(Universiti Malaya)	This work was supported by grants from the University Malaya Postgraduate Research Fund (PV052/2012A); and University Malaya High-Impact Research (UM.C/HIR/MOHE/MED/18); University of Malaya FRGS 2010 (FP036/2010A); University of Malaya FRGS 2010 (FP022/2010B); Peruntukan Penyelidikan Jangka Pendek 2008 (PJP); Universiti Malaya (FS344/2008C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, MALARIA J, V10, P1, DOI [10.1186/1475-2875-10-1, DOI 10.1186/1475-2875-10-1.PUBMED:21214892]; Census Malaysia, 2010, POP DISTR BAS DEM CH; CHIN W, 1965, SCIENCE, V149, P865, DOI 10.1126/science.149.3686.865; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Cox-Singh J, 2012, CURR OPIN INFECT DIS, V25, P530, DOI 10.1097/QCO.0b013e3283558780; ESRI, 2006, ARCGIS 9 2; Garske T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056487; Hafiz H, 2012, HLTH ENV, V3, P46; Hodgkin Ernest P, 1956, TRANSMISSION MALARIA; Jamaiah I, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P60; Jamaiah I, 2007, SE ASIAN J TROP MED, V38, P1; Jamaiah I, 2006, SE ASIAN J TROP MED; Jeffery J., 2012, ILLUSTRATED KEYS SOM; Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Kantele A, 2008, EMERG INFECT DIS, V14, P1434, DOI 10.3201/eid1409.080170; Kaur G, 2009, TROP BIOMED, V26, P57; Lee C E, 2010, Med J Malaysia, V65, P63; Lloyd O. L., 1994, Journal of the Hong Kong Medical Association, V46, P3; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Martens P, 2000, EMERG INFECT DIS, V6, P103, DOI 10.3201/eid0602.000202; Masitah M., 2008, J HLTH TRANSLATIONAL, V11, P53; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Norhayati M, 2001, Med J Malaysia, V56, P271; Pinedo-Cancino V, 2006, AM J TROP MED HYG, V75, P238, DOI 10.4269/ajtmh.2006.75.238; Rahman Wahab A., 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P599; REID JA, 1968, STUDIES I MED RES MA, V31; Sandosham AA., 1983, MALARIOLOGY SPECIAL; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh J., 1988, World Health Organization, WHO/VBC, V88, P1; Singh J., 1988, CASE HIST MALARIA VE; Sinton J, 1932, REC MAL SURV IND, P381; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhu Huai-min, 2006, Chinese Journal of Parasitology and Parasitic Diseases, V24, P70	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77924	10.1371/journal.pone.0077924	http://dx.doi.org/10.1371/journal.pone.0077924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194901	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000080
J	Stoppelenburg, AJ; Salimi, V; Hennus, M; Plantinga, M; in 't Veld, RH; Walk, J; Meerding, J; Coenjaerts, F; Bont, L; Boes, M				Stoppelenburg, Arie Jan; Salimi, Vahid; Hennus, Marije; Plantinga, Maud; in 't Veld, Ron Huis; Walk, Jona; Meerding, Jenny; Coenjaerts, Frank; Bont, Louis; Boes, Marianne			Local IL-17A Potentiates Early Neutrophil Recruitment to the Respiratory Tract during Severe RSV Infection	PLOS ONE			English	Article							SYNCYTIAL VIRUS BRONCHIOLITIS; COLONY-STIMULATING FACTOR; T-CELLS; VIRAL-INFECTION; GENE-EXPRESSION; MESSENGER-RNA; LUNG; INFLAMMATION; CHEMOKINE; INFANTS	Respiratory syncytial virus (RSV) bronchiolitis triggers a strong innate immune response characterized by excessive neutrophil infiltration which contributes to RSV induced pathology. The cytokine IL-17A enhances neutrophil infiltration into virus infected lungs. IL-17A is however best known as an effector of adaptive immune responses. The role of IL-17A in early immune modulation in RSV infection is unknown. We aimed to elucidate whether local IL-17A facilitates the innate neutrophil infiltration into RSV infected lungs prior to adaptive immunity. To this end, we studied IL-17A production in newborns that were hospitalized for severe RSV bronchiolitis. In tracheal aspirates we measured IL-17A concentration and neutrophil counts. We utilized cultured human epithelial cells to test if IL-17A regulates RSV infection-induced IL-8 release as mediator of neutrophil recruitment. In mice we investigated the cell types that are responsible for early innate IL-17A production during RSV infection. Using IL-17A neutralizing antibodies we tested if IL-17A is responsible for innate neutrophil infiltration in mice. Our data show that increased IL-17A production in newborn RSV patient lungs correlates with subsequent neutrophil counts recruited to the lungs. IL-17A potentiates RSV-induced production of the neutrophil-attracting chemokine IL-8 by airway epithelial cells in vitro. Various lung-resident lymphocytes produced IL-17A during early RSV infection in Balb/c mice, of which a local population of CD4 T cells stood out as the predominant RSV-induced cell type. By removing IL-17A during early RSV infection in mice we showed that IL-17A is responsible for enhanced innate neutrophil infiltration in vivo. Using patient material, in vitro studies, and an animal model of RSV infection, we thus show that early local IL-17A production in the airways during RSV bronchiolitis facilitates neutrophil recruitment with pathologic consequences to infant lungs.	[Stoppelenburg, Arie Jan; Salimi, Vahid; Plantinga, Maud; in 't Veld, Ron Huis; Walk, Jona; Meerding, Jenny; Boes, Marianne] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Salimi, Vahid] Univ Tehran Med Sci, Dept Virol, Tehran, Iran; [Hennus, Marije] Univ Med Ctr Utrecht, Dept Pediat Intens Care, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Coenjaerts, Frank] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands; [Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Bont, Louis] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Tehran University of Medical Sciences; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Boes, M (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands.	M.L.Boes@umcutrecht.nl	Stoppelenburg, Arie/AAR-4381-2020; Walk, Jona/G-2793-2016; Hennus, Marije/D-1643-2014	Stoppelenburg, Arie/0000-0002-1969-6146; Walk, Jona/0000-0002-9420-4578; Salimi, Vahid/0000-0002-8541-7846; Boes, Marianne/0000-0003-2590-1692; Hennus, Marije/0000-0003-1508-0456	WKZ [R1812]	WKZ	This study was funded by the WKZ research fund (grant number R1812). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bera MM, 2011, J IMMUNOL, V187, P4245, DOI 10.4049/jimmunol.1101789; Cheng P, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-38; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Pol ACV, 2010, J CLIN MICROBIOL, V48, P3569, DOI 10.1128/JCM.00097-10; Essilfie AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002244; Faber TE, 2012, J MED VIROL, V84, P1084, DOI 10.1002/jmv.23291; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fiedler MA, 1995, AM J PHYSIOL-LUNG C, V269, pL865, DOI 10.1152/ajplung.1995.269.6.L865; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Hashimoto K, 2004, AM J RESP CRIT CARE, V170, P306, DOI 10.1164/rccm.200301-030OC; Heidema J, 2007, J IMMUNOL, V179, P8410, DOI 10.4049/jimmunol.179.12.8410; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jones CE, 2002, AM J RESP CELL MOL, V26, P748, DOI 10.1165/ajrcmb.26.6.4757; Kallal LE, 2010, J IMMUNOL, V185, P4137, DOI 10.4049/jimmunol.1000677; Kim JS, 2011, J EXP MED, V208, P2201, DOI 10.1084/jem.20110680; Laan M, 1999, J IMMUNOL, V162, P2347; Larranaga CL, 2009, PEDIATR INFECT DIS J, V28, P867, DOI 10.1097/INF.0b013e3181a3ea71; Lukens MV, 2010, J VIROL, V84, P2374, DOI 10.1128/JVI.01807-09; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mukherjee S, 2012, SHOCK, V38, P515, DOI 10.1097/SHK.0b013e31826f862c; Mukherjee S, 2011, AM J PATHOL, V179, P248, DOI 10.1016/j.ajpath.2011.03.003; Newcomb DC, 2013, THORAX, V68, P717, DOI 10.1136/thoraxjnl-2012-202404; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Tanaka S, 2009, J IMMUNOL, V183, P7523, DOI 10.4049/jimmunol.0803828; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Vanden Eijnden S, 2006, EUR J IMMUNOL, V36, P21, DOI 10.1002/eji.200535467; Yasui K, 2005, PEDIATR INT, V47, P190, DOI 10.1111/j.1442-200x.2005.02039.x; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	41	59	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78461	10.1371/journal.pone.0078461	http://dx.doi.org/10.1371/journal.pone.0078461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194936	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000115
J	van 't Klooster, R; Patterson, AJ; Young, VE; Gillard, JH; Reiber, JHC; van der Geest, RJ				van 't Klooster, Ronald; Patterson, Andrew J.; Young, Victoria E.; Gillard, Jonathan H.; Reiber, Johan H. C.; van der Geest, Rob J.			An Objective Method to Optimize the MR Sequence Set for Plaque Classification in Carotid Vessel Wall Images Using Automated Image Segmentation	PLOS ONE			English	Article							IN-VIVO; COMPONENTS	A typical MR imaging protocol to study the status of atherosclerosis in the carotid artery consists of the application of multiple MR sequences. Since scanner time is limited, a balance has to be reached between the duration of the applied MR protocol and the quantity and quality of the resulting images which are needed to assess the disease. In this study an objective method to optimize the MR sequence set for classification of soft plaque in vessel wall images of the carotid artery using automated image segmentation was developed. The automated method employs statistical pattern recognition techniques and was developed based on an extensive set of MR contrast weightings and corresponding manual segmentations of the vessel wall and soft plaque components, which were validated by histological sections. Evaluation of the results from nine contrast weightings showed the tradeoff between scan duration and automated image segmentation performance. For our dataset the best segmentation performance was achieved by selecting five contrast weightings. Similar performance was achieved with a set of three contrast weightings, which resulted in a reduction of scan time by more than 60%. The presented approach can help others to optimize MR imaging protocols by investigating the tradeoff between scan duration and automated image segmentation performance possibly leading to shorter scanning times and better image interpretation. This approach can potentially also be applied to other research fields focusing on different diseases and anatomical regions.	[van 't Klooster, Ronald; Reiber, Johan H. C.; van der Geest, Rob J.] Leiden Univ, Div Image Proc, Dept Radiol, Med Ctr, Leiden, Netherlands; [Patterson, Andrew J.; Young, Victoria E.; Gillard, Jonathan H.] Cambridge Univ Hosp NHS Fdn Trust, Univ Dept Radiol, Cambridge, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Cambridge	van der Geest, RJ (corresponding author), Leiden Univ, Div Image Proc, Dept Radiol, Med Ctr, Leiden, Netherlands.	rvdgeest@lumc.nl	van der Geest, Rob J/J-8193-2015	van der Geest, Rob J/0000-0002-9084-5597; Patterson, Andrew/0000-0001-8338-5652	Dutch Technology Foundation STW, which is the applied science division of NWO; Technology Programme of the Ministry of Economic Affairs [LGT.6454]	Dutch Technology Foundation STW, which is the applied science division of NWO(Technologiestichting STW); Technology Programme of the Ministry of Economic Affairs	This study was funded by the Dutch Technology Foundation STW, which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. Project number LGT.6454. http://www.stw.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame IM, 2004, MAGN RESON MATER PHY, V16, P227, DOI 10.1007/s10334-003-0030-8; Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Cappendijk VC, 2005, RADIOLOGY, V234, P487, DOI 10.1148/radiol.2342032101; Duin R, 2007, PRTOOLS4 1 MATLAB TO; Hofman JMA, 2006, MAGN RESON MED, V55, P790, DOI 10.1002/mrm.20828; Karmonik C, 2009, IEEE T BIO-MED ENG, V56, P352, DOI 10.1109/TBME.2008.2003100; Liu F, 2006, MAGN RESON MED, V55, P659, DOI 10.1002/mrm.20814; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; PasterkampC FalkE, 2000, J CLIN BASIC CARDIOL, V3, P81; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Young VE, 2010, NEURORADIOLOGY, V52, P929, DOI 10.1007/s00234-010-0680-y; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Yuan C, 2008, J NUCL CARDIOL, V15, P266, DOI 10.1016/j.nuclcard.2008.02.001; Zhao XH, 2010, INVEST RADIOL, V45, P36, DOI 10.1097/RLI.0b013e3181beada7	14	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78492	10.1371/journal.pone.0078492	http://dx.doi.org/10.1371/journal.pone.0078492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194941	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000120
J	Ng, YL; Klopcic, B; Lloyd, F; Forrest, C; Greene, W; Lawrance, IC				Ng, Yoke-Leng; Klopcic, Borut; Lloyd, Frances; Forrest, Cynthia; Greene, Wayne; Lawrance, Ian C.			Secreted Protein Acidic and Rich in Cysteine (SPARC) Exacerbates Colonic Inflammatory Symptoms in Dextran Sodium Sulphate-Induced Murine Colitis	PLOS ONE			English	Article							NULL MICE EXHIBIT; INTESTINAL INFLAMMATION; MATRICELLULAR PROTEIN; ULCERATIVE-COLITIS; MEDIATED COLITIS; IMMUNE-RESPONSE; BOWEL-DISEASE; MOUSE MODELS; CELL-MATRIX; EXPRESSION	Background: Secreted Protein Acidic and Rich in Cysteine (SPARC) is expressed during tissue repair and regulates cellular proliferation, migration and cytokine expression. The aim was to determine if SPARC modifies intestinal inflammation. Methods: Wild-type (WT) and SPARC-null (KO) mice received 3% dextran sodium sulphate (DSS) for 7 days. Inflammation was assessed endoscopically, clinically and histologically. IL-1 beta, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17A, IL-12/IL23p40, TNF-alpha, IFN-gamma, RANTES, MCP-1, MIP-1 alpha, MIP-1 beta, MIG and TGF-beta 1 levels were measured by ELISA and cytometric bead array. Inflammatory cells were characterised by CD68, Ly6G, F4/80 and CD11b immunofluorescence staining and regulatory T cells from spleen and mesenteric lymph nodes were assessed by flow cytometry. Results: KO mice had less weight loss and diarrhoea with less endoscopic and histological inflammation than WT animals. By day 35, all (n = 13) KO animals completely resolved the inflammation compared to 7 of 14 WT mice (p < 0.01). Compared to WTs, KO animals at day 7 had less IL1 beta (p = 0.025) and MIG (p = 0.031) with higher TGF beta 1 (p = 0.017) expression and a greater percentage of FoxP3+ regulatory T cells in the spleen and draining lymph nodes of KO animals (p, 0.01). KO mice also had fewer CD68+ and F4/80+ macrophages, Ly6G+ neutrophils and CD11b+ cells infiltrating the inflamed colon. Conclusions: Compared to WT, SPARC KO mice had less inflammation with fewer inflammatory cells and more regulatory T cells. Together, with increased TGF-beta 1 levels, this could aid in the more rapid resolution of inflammation and restoration of the intestinal mucosa suggesting that the presence of SPARC increases intestinal inflammation.	[Ng, Yoke-Leng; Klopcic, Borut; Lloyd, Frances; Lawrance, Ian C.] Univ Western Australia, Sch Med & Pharmacol, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia; [Ng, Yoke-Leng; Greene, Wayne] Murdoch Univ, Sch Vet & Biomed Sci, Perth, WA, Australia; [Forrest, Cynthia] Univ Western Australia, Sch Pathol & Lab Med, Fremantle, WA, Australia	University of Western Australia; Murdoch University; University of Western Australia	Ng, YL (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Ctr Inflammatory Bowel Dis, Fremantle, WA, Australia.	yokeleng.ng@uwa.edu.au	Lawrance, Ian C/H-5252-2014	Greene, Wayne/0000-0002-5797-1356				Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Basu A, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-15; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Birgersdotter A, 2009, BRIT J CANCER, V101, P1393, DOI 10.1038/sj.bjc.6605238; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Fae KC, 2013, INFLAMMATION; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Guimbaud R, 1998, AM J GASTROENTEROL, V93, P2397, DOI 10.1016/S0002-9270(98)00575-9; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Jendraschak E, 1996, SEMIN CANCER BIOL, V7, P139, DOI 10.1006/scbi.1996.0019; Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9; Kwon KH, 2005, BIOCHEM BIOPH RES CO, V337, P647, DOI 10.1016/j.bbrc.2005.09.107; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Latvala T, 1996, EXP EYE RES, V63, P579, DOI 10.1006/exer.1996.0148; Ludwiczek O, 2004, CLIN EXP IMMUNOL, V138, P323, DOI 10.1111/j.1365-2249.2004.02599.x; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; McKaig BC, 1999, AM J PHYSIOL-GASTR L, V276, pG1087, DOI 10.1152/ajpgi.1999.276.5.G1087; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Norose K, 2000, EXP EYE RES, V71, P295, DOI 10.1006/exer.2000.0884; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rempel SA, 2007, GENES IMMUN, V8, P262, DOI 10.1038/sj.gene.6364388; Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743, DOI 10.1152/ajplung.2000.279.4.L743; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Siegmund B, 2002, GASTROENTEROLOGY, V122, P2011, DOI 10.1053/gast.2002.33631; Socha MJ, 2007, AM J PATHOL, V171, P1104, DOI 10.2353/ajpath.2007.061273; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; TREMBLE PM, 1993, J CELL BIOL, V121, P1433, DOI 10.1083/jcb.121.6.1433; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; YOUNGMAN KR, 1993, GASTROENTEROLOGY, V104, P749, DOI 10.1016/0016-5085(93)91010-F	41	61	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77575	10.1371/journal.pone.0077575	http://dx.doi.org/10.1371/journal.pone.0077575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204877	gold, Green Submitted, Green Published			2022-12-25	WOS:000326032600036
J	Seeliger, D				Seeliger, Daniel			Development of Scoring Functions for Antibody Sequence Assessment and Optimization	PLOS ONE			English	Article							BIOPHYSICAL PROPERTIES; AFFINITY MATURATION; MONOCLONAL-ANTIBODY; PROTEIN AGGREGATION; VARIABLE DOMAINS; PREDICTION; STABILITY; CHALLENGES; MUTATIONS; LIBRARIES	Antibody development is still associated with substantial risks and difficulties as single mutations can radically change molecule properties like thermodynamic stability, solubility or viscosity. Since antibody generation methodologies cannot select and optimize for molecule properties which are important for biotechnological applications, careful sequence analysis and optimization is necessary to develop antibodies that fulfil the ambitious requirements of future drugs. While efforts to grab the physical principles of undesired molecule properties from the very bottom are becoming increasingly powerful, the wealth of publically available antibody sequences provides an alternative way to develop early assessment strategies for antibodies using a statistical approach which is the objective of this paper. Here, publically available sequences were used to develop heuristic potentials for the framework regions of heavy and light chains of antibodies of human and murine origin. The potentials take into account position dependent probabilities of individual amino acids but also conditional probabilities which are inevitable for sequence assessment and optimization. It is shown that the potentials derived from human sequences clearly distinguish between human sequences and sequences from mice and, hence, can be used as a measure of humaness which compares a given sequence with the phenotypic pool of human sequences instead of comparing sequence identities to germline genes. Following this line, it is demonstrated that, using the developed potentials, humanization of an antibody can be described as a simple mathematical optimization problem and that the in-silico generated framework variants closely resemble native sequences in terms of predicted immunogenicity.	Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Identificat & Optimizat Support, Biberach, Germany	Boehringer Ingelheim	Seeliger, D (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept Lead Identificat & Optimizat Support, Biberach, Germany.	daniel.seeliger@boehringer-ingelheim.com						Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Chaudhri A, 2012, J PHYS CHEM B, V116, P8045, DOI 10.1021/jp301140u; Choulier L, 2000, PROTEINS, V41, P475, DOI 10.1002/1097-0134(20001201)41:4<475::AID-PROT50>3.0.CO;2-G; De Groot AS, 2009, CLIN IMMUNOL, V131, P189, DOI 10.1016/j.clim.2009.01.009; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hugo N, 2002, PROTEIN SCI, V11, P2697, DOI 10.1110/ps.0209302; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kabat EA, 1992, SEQUENCES PROTEINS I; Koren E, 2007, CLIN IMMUNOL, V124, P26, DOI 10.1016/j.clim.2007.03.544; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lauer TM, 2012, J PHARM SCI-US, V101, P102, DOI 10.1002/jps.22758; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; McConnell AD, 2013, PROTEIN ENG DES SEL, V26, P151, DOI 10.1093/protein/gzs090; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Perchiacca JM, 2012, PROTEIN ENG DES SEL, V25, P591, DOI 10.1093/protein/gzs042; Perchiacca JM, 2012, ANNU REV CHEM BIOMOL, V3, P263, DOI 10.1146/annurev-chembioeng-062011-081052; Philo JS, 2009, CURR PHARM BIOTECHNO, V10, P348, DOI 10.2174/138920109788488932; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schaefer JV, 2012, PROTEIN ENG DES SEL, V25, P485, DOI 10.1093/protein/gzs039; Schmidt AG, 2013, P NATL ACAD SCI USA, V110, P264, DOI 10.1073/pnas.1218256109; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tiller T, 2013, MABS-AUSTIN, V5, P445, DOI 10.4161/mabs.24218; Weiss WF, 2009, J PHARM SCI-US, V98, P1246, DOI 10.1002/jps.21521; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Wu SJ, 2010, PROTEIN ENG DES SEL, V23, P643, DOI 10.1093/protein/gzq037	41	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76909	10.1371/journal.pone.0076909	http://dx.doi.org/10.1371/journal.pone.0076909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204701	Green Submitted, gold, Green Published			2022-12-25	WOS:000326032600014
J	Gupta, S; Melnyk, SB; Kruger, WD				Gupta, Sapna; Melnyk, Stepan B.; Kruger, Warren D.			Cystathionine beta-synthase-deficient mice thrive on a low-methionine diet	FASEB JOURNAL			English	Article						osteoporosis; alopecia; homocysteine; metabolism; inborn errors	S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; NATURAL-HISTORY; MOUSE MODEL; HOMOCYSTINURIA; HYPERHOMOCYSTEINEMIA; HUMANS	Cystathionine -synthase (CBS) deficiency is a recessive inborn error of metabolism characterized by elevated serum total homocysteine (tHcy). Previously, our laboratory developed a mouse model of CBS deficiency, TgI278T Cbs(-)/(-) (abbreviated as Cbs(-/-)), characterized by low weight, low adiposity, decreased Scd-1 expression, facial alopecia, and osteoporosis. To determine the potential benefit of a methionine-restricted diet (MRD), we fed Cbs(-/-) and Cbs(+/-) control mice either an MRD or a regular diet (RD) from weaning till 240 d of age. Cbs(-/-) mice fed the MRD had a 77% decrease in tHcy, 28% increase in weight, 130% increase in fat mass, 82% increase in Scd-1 expression, and 10.6% increase in bone density and entirely lacked the alopecia phenotype observed in age-matched Cbs(-/-) mice fed the RD. At the end of the study, Cbs(-/-) mice fed the MRD were phenotypically indistinguishable from Cbs(+/-) mice fed the RD. Notably, whereas the MRD diet was highly beneficial to Cbs(-/-) mice, it had nearly opposite effect on Cbs(+/-) mice. These studies show that a low-methionine diet can correct the phenotypic consequences of loss of CBS and provide a striking example of how genotype and diet can interact to influence phenotype in mammals.Gupta, S., Melnyk, S.B., Kruger, W.D. Cystathionine -synthase-deficient mice thrive on a low-methionine diet.	[Gupta, Sapna; Kruger, Warren D.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Melnyk, Stepan B.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	Fox Chase Cancer Center; University of Arkansas System; University of Arkansas Medical Sciences	Kruger, WD (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	warren.kruger@fccc.edu	Kruger, Warren/Y-2541-2018; kruger, warren/A-6407-2008	kruger, warren/0000-0002-4990-3695	Monell Chemical Senses Center under a grant from the Pennsylvania Department of Health; Hempling Foundation for Homocystinuria Research, the U.S. National Institutes of Health [CA06927, R01GM098772]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098772] Funding Source: NIH RePORTER	Monell Chemical Senses Center under a grant from the Pennsylvania Department of Health; Hempling Foundation for Homocystinuria Research, the U.S. National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the staff of the genomics, laboratory animal, and biostatistics facilities of Fox Chase Cancer Center for their assistance. The authors specifically acknowledge Fang Zhu for statistical support. The authors also thank Dr. Michael Tordoff and his laboratory for help in use of the PIXimus II DEXA. This equipment was provided by funds awarded to the Monell Chemical Senses Center under a grant from the Pennsylvania Department of Health. The department specifically disclaims responsibility for any analyses, interpretations or conclusions of the study. This work was supported by grants from the Hempling Foundation for Homocystinuria Research, the U.S. National Institutes of Health (CA06927 and R01GM098772), and an appropriation from the Commonwealth of Pennsylvania.	Benight NM, 2011, AM J PHYSIOL-GASTR L, V301, pG249, DOI 10.1152/ajpgi.00076.2011; BRENTON D P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P277; Brosnan JT, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P176; CARSON NAJ, 1963, ARCH DIS CHILD, V38, P425, DOI 10.1136/adc.38.201.425; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Gupta S., 2011, PLOS ONE, V6; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; KOMROWER GM, 1966, ARCH DIS CHILD, V41, P666, DOI 10.1136/adc.41.220.666; Lu YH, 2012, MOL GENET METAB, V105, P590, DOI 10.1016/j.ymgme.2012.01.021; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Melnyk S, 2000, CLIN CHEM, V46, P265; MUDD SH, 1985, AM J HUM GENET, V37, P1; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Perrone CE, 2010, METABOLISM, V59, P1000, DOI 10.1016/j.metabol.2009.10.023; PERRY TL, 1966, PEDIATRICS, V37, P502; REISH O, 1995, AM J HUM GENET, V57, P127; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Robert K, 2004, ANAT REC PART A, V280A, P1072, DOI 10.1002/ar.a.20082; SARDHARW.IB, 1968, CAN MED ASSOC J, V99, P731; STORCH KJ, 1990, AM J PHYSIOL, V258, pE790, DOI 10.1152/ajpendo.1990.258.5.E790; STORCH KJ, 1988, AM J PHYSIOL, V255, pE322, DOI 10.1152/ajpendo.1988.255.3.E322; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wilcken DEL, 1997, J INHERIT METAB DIS, V20, P295, DOI 10.1023/A:1005373209964; Yap S, 2000, SEMIN THROMB HEMOST, V26, P335, DOI 10.1055/s-2000-8100; Yap S, 1998, J INHERIT METAB DIS, V21, P738, DOI 10.1023/A:1005445132327; Yap S, 2001, ARTERIOSCL THROM VAS, V21, P2080, DOI 10.1161/hq1201.100225; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	31	22	29	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					781	790		10.1096/fj.13-240770	http://dx.doi.org/10.1096/fj.13-240770			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24189943	Green Published			2022-12-25	WOS:000331072200025
J	Ormsby, AR; Ramdzan, YM; Mok, YF; Jovanoski, KD; Hatters, DM				Ormsby, Angelique R.; Ramdzan, Yasmin M.; Mok, Yee-Foong; Jovanoski, Kristijan D.; Hatters, Danny M.			A Platform to View Huntingtin Exon 1 Aggregation Flux in the Cell Reveals Divergent Influences from Chaperones hsp40 and hsp70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Analytical Ultracentrifugation; Chaperone Chaperonin; Flow Cytometry; Protein Aggregation; PulSA; huntingtin; Oligomers; Polyglutamine	MUTANT HUNTINGTIN; TRINUCLEOTIDE REPEAT; PROTEIN; OLIGOMERS; SUPPRESSION; LENGTH; CONFORMATION; PATHOGENESIS; SUFFICIENT; INCLUSIONS	Our capacity for tracking how misfolded proteins aggregate inside a cell and how different aggregation states impact cell biology remains enigmatic. To address this, we built a new toolkit that enabled the high throughput tracking of individual cells enriched with polyglutamine-expanded Htt exon 1 (Httex1) monomers, oligomers, and inclusions using biosensors of aggregation state and flow cytometry pulse shape analysis. Supplemented with gel filtration chromatography and fluorescence-adapted sedimentation velocity analysis of cell lysates, we collated a multidimensional view of Httex1 aggregation in cells with respect to time, polyglutamine length, expression levels, cell survival, and overexpression of protein quality control chaperones hsp40 (DNAJB1) and hsp70 (HSPA1A). Cell death rates trended higher for Neuro2a cells containing Httex1 in inclusions than with Httex1 dispersed through the cytosol at time points of expression over 2 days. hsp40 stabilized monomers and suppressed inclusion formation but did not otherwise change Httex1 toxicity. hsp70, however, had no major effect on aggregation of Httex1 but increased the survival rate of cells with inclusions. hsp40 and hsp70 also increased levels of a second bicistronic reporter of Httex1 expression, mKate2, and increased total numbers of cells in culture, suggesting these chaperones partly rectify Httex1-induced deficiencies in quality control and growth rates. Collectively, these data suggest that Httex1 overstretches the protein quality control resources and that the defects can be partly rescued by overexpression of hsp40 and hsp70. Importantly, these effects occurred in a pronounced manner for soluble Httex1, which points to Httex1 aggregation occurring subsequently to more acute impacts on the cell.	[Ormsby, Angelique R.; Ramdzan, Yasmin M.; Mok, Yee-Foong; Jovanoski, Kristijan D.; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	University of Melbourne	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.	dhatters@unimelb.edu.au		Hatters, Danny/0000-0002-9965-2847; , Angelique/0000-0002-2780-9550	National Health and Medical Research Council [566640, APP1049458, APP1049459]; Australian Research Council [DP120102763]; Hereditary Disease Foundation, New York; Miegunyah Trust	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Hereditary Disease Foundation, New York; Miegunyah Trust	This work was supported by National Health and Medical Research Council Project Grants 566640, APP1049458, and APP1049459 (to D. M. H.), Australian Research Council Discovery Grant DP120102763, and the Hereditary Disease Foundation, New York.; Grimwade Fellow supported by the Miegunyah Trust and is currently an Australian Research Council Future Fellow.	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Brignull HR, 2006, METHOD ENZYMOL, V412, P256, DOI 10.1016/S0076-6879(06)12016-9; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Coleman BM, 2009, BIOCHEM BIOPH RES CO, V380, P564, DOI 10.1016/j.bbrc.2009.01.120; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gong B, 2008, BRAIN RES BULL, V75, P146, DOI 10.1016/j.brainresbull.2007.08.005; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Harvey KJ, 2001, CYTOMETRY, V43, P273, DOI 10.1002/1097-0320(20010401)43:4<273::AID-CYTO1059>3.0.CO;2-3; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Lee CC, 2007, BIOCHEMISTRY-US, V46, P12810, DOI 10.1021/bi700806c; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; NOZAKI Y, 1982, SCIENCE, V217, P366, DOI 10.1126/science.7089571; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Pappu RV, 2008, ARCH BIOCHEM BIOPHYS, V469, P132, DOI 10.1016/j.abb.2007.08.033; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Peters-Libeu C, 2012, J MOL BIOL, V421, P587, DOI 10.1016/j.jmb.2012.01.034; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Rujano MA, 2007, EXP CELL RES, V313, P3568, DOI 10.1016/j.yexcr.2007.07.034; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Singh VR, 2008, J PHYS CHEM B, V112, P13172, DOI 10.1021/jp805636p; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Vitalis A, 2009, BIOPHYS J, V97, P303, DOI 10.1016/j.bpj.2009.05.003; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034; Wang XL, 2006, PROTEINS, V63, P297, DOI 10.1002/prot.20761; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhang QC, 2011, J BIOL CHEM, V286, P8188, DOI 10.1074/jbc.M110.192013; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200	61	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37192	37203		10.1074/jbc.M113.486944	http://dx.doi.org/10.1074/jbc.M113.486944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196953	hybrid, Green Published			2022-12-25	WOS:000329189700037
J	Baldwin, HM; Pallas, K; King, V; Jamieson, T; McKimmie, CS; Nibbs, RJB; Carballido, JM; Jaritz, M; Rot, A; Graham, GJ				Baldwin, Helen M.; Pallas, Kenneth; King, Vicky; Jamieson, Thomas; McKimmie, Clive S.; Nibbs, Robert J. B.; Carballido, Jose M.; Jaritz, Marcus; Rot, Antal; Graham, Gerard J.			Microarray Analyses Demonstrate the Involvement of Type I Interferons in Psoriasiform Pathology Development in D6-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Cytokines; Interferon; Inflammation; Mouse; Psoriasis	CHEMOKINE RECEPTOR D6; DECOY RECEPTOR; RHEUMATOID-ARTHRITIS; IMMUNE; INFLAMMATION; CYTOKINE; CELLS; SYSTEM; EXPRESSION; DELETION	Background: D6 regulates resolution of inflammatory responses. Its mode of action has not been molecularly defined. Results: Microarray analysis of inflamed D6-deficient mouse skin identifies dysregulated type I interferon responses as underpinning exaggerated inflammatory responses in D6-deficient mice. Conclusion: D6 is important for regulating type I interferon-based responses in inflammation. Significance: The study provides novel insights into roles for D6 in the resolution of inflammatory responses. The inflammatory response is normally limited by mechanisms regulating its resolution. In the absence of resolution, inflammatory pathologies can emerge, resulting in substantial morbidity and mortality. We have been studying the D6 chemokine scavenging receptor, which played an indispensable role in the resolution phase of inflammatory responses and does so by facilitating removal of inflammatory CC chemokines. In D6-deficient mice, otherwise innocuous cutaneous inflammatory stimuli induce a grossly exaggerated inflammatory response that bears many similarities to human psoriasis. In the present study, we have used transcriptomic approaches to define the molecular make up of this response. The data presented highlight potential roles for a number of cytokines in initiating and maintaining the psoriasis-like pathology. Most compellingly, we provide data indicating a key role for the type I interferon pathway in the emergence of this pathology. Neutralizing antibodies to type I interferons are able to ameliorate the psoriasis-like pathology, confirming a role in its development. Comparison of transcriptional data generated from this mouse model with equivalent data obtained from human psoriasis further demonstrates the strong similarities between the experimental and clinical systems. As such, the transcriptional data obtained in this preclinical model provide insights into the cytokine network active in exaggerated inflammatory responses and offer an excellent tool to evaluate the efficacy of compounds designed to therapeutically interfere with inflammatory processes.	[Baldwin, Helen M.; Pallas, Kenneth; King, Vicky; McKimmie, Clive S.; Nibbs, Robert J. B.; Graham, Gerard J.] Univ Glasgow, Chemokine Res Grp, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Jamieson, Thomas] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Carballido, Jose M.; Jaritz, Marcus; Rot, Antal] Novartis Inst Biomed Res, A-1235 Vienna, Austria; [Carballido, Jose M.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Rot, Antal] Univ Birmingham, Birmingham B15 2TT, W Midlands, England	University of Glasgow; Beatson Institute; Novartis; Novartis; University of Birmingham	Graham, GJ (corresponding author), Univ Glasgow, Chemokine Res Grp, Glasgow Biomed Res Ctr, Rm B3-27, Glasgow G12 8TA, Lanark, Scotland.	gerard.graham@glasgow.ac.uk	McKimmie, Clive/AAD-9509-2019	McKimmie, Clive/0000-0002-7694-9509; Rot, Antal/0000-0002-9730-6166; Nibbs, Robert/0000-0002-8150-0044; Graham, Gerard/0000-0002-7801-204X	Medical Research Council; Oliver Bird Ph.D. Programme; Arthritis Research UK Foundation Fellowship; MRC [G1001724, G0802838, G0901113] Funding Source: UKRI; Medical Research Council [G0901113, G0802838, G1001724] Funding Source: researchfish; Versus Arthritis [19656] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oliver Bird Ph.D. Programme; Arthritis Research UK Foundation Fellowship(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was supported by grants from the Medical Research Council and Oliver Bird Ph.D. Programme.; Recipient of an Arthritis Research UK Foundation Fellowship.	Albanesi C, 2010, AUTOIMMUNITY, V43, P215, DOI 10.3109/08916930903510906; Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; Bordon Y, 2009, J IMMUNOL, V182, P5032, DOI 10.4049/jimmunol.0802802; Ciocon DH, 2007, BRIT J DERMATOL, V157, P850, DOI 10.1111/j.1365-2133.2007.08148.x; Cochain C, 2012, ARTERIOSCL THROM VAS, V32, P2206, DOI 10.1161/ATVBAHA.112.254409; Codullo V, 2011, ANN RHEUM DIS, V70, P1115, DOI 10.1136/ard.2010.137349; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Graham GJ, 2013, J PATHOL, V229, P168, DOI 10.1002/path.4123; Graham GJ, 2009, EUR J IMMUNOL, V39, P342, DOI 10.1002/eji.200838858; Homey B, 2008, CLIN DERMATOL, V26, P539, DOI 10.1016/j.clindermatol.2007.11.003; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Lee KM, 2013, TRENDS IMMUNOL, V34, P7, DOI 10.1016/j.it.2012.08.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McInnes IB, 2005, NAT CLIN PRACT RHEUM, V1, P31, DOI 10.1038/ncprheum0020; McKimmie CS, 2013, BLOOD, V121, P3768, DOI 10.1182/blood-2012-04-425314; Molin S, 2011, J INVEST ALLERG CLIN, V21, P472; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; Nibbs RJB, 1997, J BIOL CHEM, V272, P32078, DOI 10.1074/jbc.272.51.32078; Nibbs RJB, 2001, AM J PATHOL, V158, P867, DOI 10.1016/S0002-9440(10)64035-7; Nibbs RJB, 2007, J CLIN INVEST, V117, P1884, DOI 10.1172/JCI30068; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nickoloff BJ, 2007, NAT MED, V13, P242, DOI 10.1038/nm0307-242; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Savino B, 2009, J BIOL CHEM, V284, P26207, DOI 10.1074/jbc.M109.029249; Singh MD, 2012, AM J PATHOL, V181, P1158, DOI 10.1016/j.ajpath.2012.06.042; Vetrano S, 2010, GUT, V59, P197, DOI 10.1136/gut.2009.183772; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Whitehead GS, 2007, AM J RESP CRIT CARE, V175, P243, DOI 10.1164/rccm.200606-839OC; Yao YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002737; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243	41	6	7	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36473	36483		10.1074/jbc.M113.491563	http://dx.doi.org/10.1074/jbc.M113.491563			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194523	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000328883400028
J	Pascual, F; Soto-Cardalda, A; Carman, GM				Pascual, Florencia; Soto-Cardalda, Anibal; Carman, George M.			PAH1-encoded Phosphatidate Phosphatase Plays a Role in the Growth Phase-and Inositol-mediated Regulation of Lipid Synthesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diacylglycerol; Lipids; Phosphatase; Phosphatidate; Phospholipid; Phospholipid Metabolism; Triacylglycerol; Yeast	DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; CYTIDINE DIPHOSPHATE CHOLINE; PHOSPHATIDYLSERINE SYNTHASE ACTIVITY; PROTEIN-INTERACTION NETWORKS; PHOSPHOLIPASE-D ACTIVITY; NUCLEAR-MEMBRANE GROWTH; ENZYMATIC-SYNTHESIS; ESCHERICHIA-COLI; BUDDING YEAST; TRANSCRIPTIONAL REGULATION	Background: Yeast Pah1p phosphatidate phosphatase produces diacylglycerol for triacylglycerol synthesis and controls phosphatidate content for phospholipid synthesis. Results:PAH1 expression was induced throughout growth, stimulated by inositol supplementation, and mediated by the Ino2p/Ino4p/Opi1p regulatory circuit and transcription factors Gis1p and Rph1p. Conclusion: Growth phase- and inositol-mediated expression of PAH1 regulates lipid synthesis. Significance: Pah1p phosphatidate phosphatase is regulated by a transcriptional mechanism throughout growth. In the yeast Saccharomyces cerevisiae, the synthesis of phospholipids in the exponential phase of growth occurs at the expense of the storage lipid triacylglycerol. As exponential phase cells progress into the stationary phase, the synthesis of triacylglycerol occurs at the expense of phospholipids. Early work indicates a role of the phosphatidate phosphatase (PAP) in this metabolism; the enzyme produces the diacylglycerol needed for the synthesis of triacylglycerol and simultaneously controls the level of phosphatidate for the synthesis of phospholipids. Four genes (APP1, DPP1, LPP1, and PAH1) encode PAP activity in yeast, and it has been unclear which gene is responsible for the synthesis of triacylglycerol throughout growth. An analysis of lipid synthesis and composition, as well as PAP activity in various PAP mutant strains, showed the essential role of PAH1 in triacylglycerol synthesis throughout growth. Pah1p is a phosphorylated enzyme whose in vivo function is dependent on its dephosphorylation by the Nem1p-Spo7p protein phosphatase complex. nem1 mutant cells exhibited defects in triacylglycerol synthesis and lipid metabolism that mirrored those imparted by the pah1 mutation, substantiating the importance of Pah1p dephosphorylation throughout growth. An analysis of cells bearing P-PAH1-lacZ and P-PAH1-DPP1 reporter genes showed that PAH1 expression was induced throughout growth and that the induction in the stationary phase was stimulated by inositol supplementation. A mutant analysis indicated that the Ino2p/Ino4p/Opi1p regulatory circuit and transcription factors Gis1p and Rph1p mediated this regulation.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health Grant from the USPHS [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health Grant from the USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 from the USPHS.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; Blackwood RA, 1997, AM J PHYSIOL-CELL PH, V272, pC1279, DOI 10.1152/ajpcell.1997.272.4.C1279; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bon E, 2000, YEAST, V16, P1229, DOI 10.1002/1097-0061(20000930)16:13<1229::AID-YEA618>3.0.CO;2-Q; BORKENHAGEN LF, 1957, J BIOL CHEM, V227, P951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Brindley DN, 1996, CHEM PHYS LIPIDS, V80, P45, DOI 10.1016/0009-3084(96)02545-5; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 1997, BBA-LIPID LIPID MET, V1348, P45, DOI 10.1016/S0005-2760(97)00095-7; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; CRAVEN GR, 1965, J BIOL CHEM, V240, P2468; CULBERTSON MR, 1975, GENETICS, V80, P23; DAVIDSON JB, 1971, BIOCHEM BIOPH RES CO, V42, P1191, DOI 10.1016/0006-291X(71)90032-5; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dillon DA, 1997, J BIOL CHEM, V272, P10361; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Goni FM, 1999, PROG LIPID RES, V38, P1, DOI 10.1016/S0163-7827(98)00021-6; Goodman JM, 2009, J LIPID RES, V50, P2148, DOI 10.1194/jlr.R001446; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; HOSHIZAKI DK, 1990, J BIOL CHEM, V265, P4736; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KENNEDY EP, 1956, J BIOL CHEM, V222, P185; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KENNEDY EP, 1961, FED PROC, V20, P934; KIYASU JY, 1963, J BIOL CHEM, V238, P2293; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; Kocsis MG, 1996, LIPIDS, V31, P785, DOI 10.1007/BF02522974; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; KOTER M, 1978, BIOCHIM BIOPHYS ACTA, V514, P255, DOI 10.1016/0005-2736(78)90296-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; LEHEL C, 1995, J BIOL CHEM, V270, P19651, DOI 10.1074/jbc.270.33.19651; LIAO MJ, 1979, BIOCHIM BIOPHYS ACTA, V550, P157, DOI 10.1016/0005-2736(79)90204-9; LIN YP, 1989, J BIOL CHEM, V264, P8641; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Maissel A, 2006, CELL SIGNAL, V18, P1127, DOI 10.1016/j.cellsig.2005.09.003; Michelot A, 2010, CURR BIOL, V20, P1890, DOI 10.1016/j.cub.2010.10.016; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Murray M, 1997, MOL MICROBIOL, V25, P541, DOI 10.1046/j.1365-2958.1997.4881840.x; Murray M, 2000, MOL MICROBIOL, V36, P651, DOI 10.1046/j.1365-2958.2000.01886.x; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oshiro J, 2003, BBA-MOL CELL BIOL L, V1635, P1, DOI 10.1016/j.bbalip.2003.10.002; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Oshiro J, 2000, J BIOL CHEM, V275, P40887, DOI 10.1074/jbc.M008144200; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Quinn J. E., 2001, THESIS RUTGERS U NEW; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P1499, DOI 10.1093/nar/28.7.1499; Robinson KA, 2000, NUCLEIC ACIDS RES, V28, P4460, DOI 10.1093/nar/28.22.4460; Rose MD., 1990, METHODS YEAST GENETI; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Stukey J, 1997, PROTEIN SCI, V6, P469; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; van Kuilenburg ABP, 2000, BBA-GENE STRUCT EXPR, V1492, P548, DOI 10.1016/S0167-4781(00)00141-X; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Weigert R, 1999, NATURE, V402, P429, DOI 10.1038/46587; WEISS SB, 1958, J BIOL CHEM, V231, P53; WEISS SB, 1960, J BIOL CHEM, V235, P40; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	142	44	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35781	35792		10.1074/jbc.M113.525766	http://dx.doi.org/10.1074/jbc.M113.525766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24196957	Green Published, hybrid			2022-12-25	WOS:000329814700016
J	Vilhena, DA; Smith, AB				Vilhena, Daril A.; Smith, Andrew B.			Spatial Bias in the Marine Fossil Record	PLOS ONE			English	Article							LARGE-SCALE; ROCK RECORD; DIVERSITY; BIODIVERSITY; TRENDS; SHELF; AREA; DISSOLUTION; BIVALVES; MOLLUSKS	Inference of past and present global biodiversity requires enough global data to distinguish biological pattern from sampling artifact. Pertinently, many studies have exposed correlated relationships between richness and sampling in the fossil record, and methods to circumvent these biases have been proposed. Yet, these studies often ignore paleobiogeography, which is undeniably a critical component of ancient global diversity. Alarmingly, our global analysis of 481,613 marine fossils spread throughout the Phanerozoic reveals that where localities are and how intensively they have been sampled almost completely determines empirical spatial patterns of richness, suggesting no separation of biological pattern from sampling pattern. To overcome this, we analyze diversity using occurrence records drawn from two discrete paleolatitudinal bands which cover the bulk of the fossil data. After correcting the data for sampling bias, we find that these two bands have similar patterns of richness despite markedly different spatial coverage. Our findings suggest that i) long-term diversity trends result from large-scale tectonic evolution of the planet, ii) short-term diversity trends are region-specific, and iii) paleodiversity studies must constrain their analyses to well-sampled regions to uncover patterns not driven by sampling.	[Vilhena, Daril A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Smith, Andrew B.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Washington; University of Washington Seattle; Natural History Museum London	Vilhena, DA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	daril@uw.edu	Smith, Andrew B/B-9849-2009					ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Alroy J, 2010, SCIENCE, V329, P1191, DOI 10.1126/science.1189910; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Ausich WI, 2005, PALEOBIOLOGY, V31, P538, DOI 10.1666/0094-8373(2005)031[0538:ARMHFO]2.0.CO;2; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; Benson RBJ, 2013, GEOLOGY, V41, P43, DOI 10.1130/G33543.1; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Cherns L, 2000, GEOLOGY, V28, P791, DOI 10.1130/0091-7613(2000)28<791:MMAEOL>2.0.CO;2; Cherns L, 2011, TOP GEOBIOL, V32, P79, DOI 10.1007/978-90-481-8643-3_3; Crampton JS, 2006, PALAIOS, V21, P86, DOI 10.2110/palo.2004.p04-90; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Harnik PG, 2010, P ROY SOC B-BIOL SCI, V277, P3427, DOI 10.1098/rspb.2010.0628; Holland SM, 2012, PALEOBIOLOGY, V38, P205, DOI 10.1666/11030.1; Jackson JBC, 2001, SCIENCE, V293, P2401, DOI 10.1126/science.1063789; Johnson KG, 2003, PALEOBIOLOGY, V29, P19, DOI 10.1666/0094-8373(2003)029<0019:NDFOQ>2.0.CO;2; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; Lagomarcino AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040472; Lloyd GT, 2012, BIOL LETTERS, V8, P123, DOI 10.1098/rsbl.2011.0210; McGowan AJ, 2008, PALEOBIOLOGY, V34, P80, DOI 10.1666/07019.1; Melott AL, 2011, PALEOBIOLOGY, V37, P383, DOI 10.1666/09055.1; Meyers SR, 2011, EARTH PLANET SC LETT, V303, P174, DOI 10.1016/j.epsl.2010.12.044; Miller AI, 1996, PALEOBIOLOGY, V31, P533; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Schmachtenberg WF, 2011, PALEOBIOLOGY, V37, P438, DOI 10.1666/09015.1; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Smith AB, 2013, GEOLOGY, V41, P171, DOI 10.1130/G33773.1; Smith AB, 2012, P ROY SOC B-BIOL SCI, V279, P4489, DOI 10.1098/rspb.2012.1793; Valentine JW, 2006, P NATL ACAD SCI USA, V103, P6599, DOI 10.1073/pnas.0601264103; Walker LJ, 2002, J GEOL, V110, P75, DOI 10.1086/324318	32	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e74470	10.1371/journal.pone.0074470	http://dx.doi.org/10.1371/journal.pone.0074470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204570	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500005
J	Lieberman, R; Wadwa, RP; Nguyen, N; Bishop, FK; Reinick, C; Snell-Bergeon, JK; Maahs, DM				Lieberman, Rachel; Wadwa, R. Paul; Nhung Nguyen; Bishop, Franziska K.; Reinick, Christina; Snell-Bergeon, Janet K.; Maahs, David M.			The Association between Vitamin D and Vascular Stiffness in Adolescents with and without Type 1 Diabetes	PLOS ONE			English	Article							25-HYDROXYVITAMIN D; ARTERIAL STIFFNESS; D DEFICIENCY; BLOOD-PRESSURE; E CONSUMPTION; RISK; SUPPLEMENTATION; CHILDREN; DISEASE; YOUTH	Objective: Vitamin D deficiency is common and associated with increased cardiovascular disease (CVD) risk. Pulse wave velocity (PWV) is a marker of vascular stiffness associated with CVD. We hypothesized that Vitamin D (25 (OH) D) levels would be inversely associated with PWV in youth with and without type 1 diabetes (T1D). Study Design: Comparisons were made between adolescents with T1D (n = 211; age = 17.5 +/- 2.3 years; diabetes duration = 10.9 +/- 3.2 years; A1c = 9.1 +/- 1.7%) and non-DM controls (n = 67; age = 16.9 +/- 1.9 years). PWV was measured in the carotid-femoral segment (Sphygmocor Vx, AtCor Medical, Lisle, IL). Results: Vitamin D levels were similar in adolescents with T1D and controls (27.7 +/- 0.7 v. 26.0 +/- 1.3 ng/ml; p = 0.26). Vitamin D was significantly inversely associated with PWV after adjusting for age, sex, quarter of the year, and race-ethnicity in adolescents with T1D (beta = -0.01 +/- 0.004, p = 0.02) but not in the non-DM adolescents (beta = -0.008 +/- 0.008, p = 0.32). Vitamin D remained significantly associated with PWV after additionally adjusting for hs-CRP in adolescents with T1D (-0.01 +/- 0.004, p = 0.01). After adjusting for BMI z-score, lipids, or blood pressure, the relationship of Vitamin D with PWV was not significant. Conclusions: Vitamin D levels were inversely associated with PWV in adolescents with T1D, but not independently of BMI, lipids, or blood pressure. Our data contrast with other reports and suggest further research is indicated to determine if Vitamin D supplementation would be beneficial to lower CVD risk in adolescents with T1D with vitamin D insufficiency or deficiency.	[Lieberman, Rachel] St Louis Univ, Sch Med, St Louis, MO USA; [Wadwa, R. Paul; Nhung Nguyen; Bishop, Franziska K.; Reinick, Christina; Snell-Bergeon, Janet K.; Maahs, David M.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Wadwa, R. Paul; Maahs, David M.] Childrens Hosp Colorado, Aurora, CO USA; [Snell-Bergeon, Janet K.; Maahs, David M.] Univ Colorado Denver, Dept Epidemiol, Colorado Sch Publ Hlth, Aurora, CO USA	Saint Louis University; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Nguyen, N (corresponding author), Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.	Nhung.Nguyen@ucdenver.edu		Maahs, David/0000-0002-4602-7909; Snell-Bergeon, Janet/0000-0002-9337-3740	NIDDK Medical Student Summer Research Program in Diabetes [3T32DK063687-10S1]; NIDDK [DK075360]; Juvenile Diabetes Research Foundation [11-2007-694]; American Diabetes Association [1-10-JF-50]; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075360, T32DK063687] Funding Source: NIH RePORTER	NIDDK Medical Student Summer Research Program in Diabetes; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); NIH/NCRR Colorado CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Ms. Lieberman and Ms. Reinick were supported by the NIDDK Medical Student Summer Research Program in Diabetes (3T32DK063687-10S1). Dr. Maahs was supported by a grant from NIDDK (DK075360); Dr. Wadwa by an early career award from the Juvenile Diabetes Research Foundation (11-2007-694); and Dr. Snell-Bergeon by a junior faculty career development award from the American Diabetes Association (1-10-JF-50). This project was supported by the Juvenile Diabetes Research Foundation (11-2007-694) and NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Bierschenk L, 2009, DIABETES CARE, V32, P1977, DOI 10.2337/dc09-1089; Borkar VV, 2010, PEDIATR DIABETES, V11, P345, DOI 10.1111/j.1399-5448.2009.00589.x; Dong YB, 2010, J CLIN ENDOCR METAB, V95, P4584, DOI 10.1210/jc.2010-0606; Ghandchi Z, 2012, J HUM NUTR DIET, V25, P365, DOI 10.1111/j.1365-277X.2012.01228.x; Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584; Janner M, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13091; Joergensen C, 2010, DIABETES CARE, V33, P2238, DOI 10.2337/dc10-0582; Jorde R, 2010, EUR J CLIN NUTR, V64, P1457, DOI 10.1038/ejcn.2010.176; Jorde R, 2011, PROG LIPID RES, V50, P303, DOI 10.1016/j.plipres.2011.05.001; Jorde R, 2010, HYPERTENSION, V55, P792, DOI 10.1161/HYPERTENSIONAHA.109.143990; Kumar J, 2009, PEDIATRICS, V124, pE362, DOI 10.1542/peds.2009-0051; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Looker Anne C, 2011, NCHS Data Brief, P1; Maahs DM, 2011, DIABETES CARE, V34, P2360, DOI 10.2337/dc11-0829; Mayer O, 2012, J HUM HYPERTENS, V26, P650, DOI 10.1038/jhh.2011.94; Mohr SB, 2008, DIABETOLOGIA, V51, P1391, DOI 10.1007/s00125-008-1061-5; Oh J, 2009, CIRCULATION, V120, P687, DOI 10.1161/CIRCULATIONAHA.109.856070; Palombo C, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-88; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Rodriguez-Rodriguez E, 2011, EUR J NUTR, V50, P373, DOI 10.1007/s00394-010-0145-4; Sachs MC, 2013, DIABETES CARE, V36, P2423, DOI 10.2337/dc12-2020; Schwalfenberg GK, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/619381; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Snell-Bergeon JK, 2010, J CLIN ENDOCR METAB, V95, P2868, DOI 10.1210/jc.2009-1993; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Svoren BM, 2009, J PEDIATR-US, V154, P132, DOI 10.1016/j.jpeds.2008.07.015; Urbina EM, 2010, J PEDIATR-US, V156, P731, DOI 10.1016/j.jpeds.2009.11.011; Urbina EM, 2009, HYPERTENSION, V54, P919, DOI 10.1161/HYPERTENSIONAHA.109.192639; Wang H, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-42; Young KA, 2011, DIABETES CARE, V34, P454, DOI 10.2337/dc10-0757; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	34	23	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77272	10.1371/journal.pone.0077272	http://dx.doi.org/10.1371/journal.pone.0077272			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204786	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700022
J	Sobarzo-Sanchez, E; Bilbao-Ramos, P; Dea-Ayuela, M; Gonzalez-Diaz, H; Yanez, M; Uriarte, E; Santana, L; Martinez-Sernandez, V; Bolas-Fernandez, F; Ubeira, FM				Sobarzo-Sanchez, Eduardo; Bilbao-Ramos, Pablo; Dea-Ayuela, Maria; Gonzalez-Diaz, Humberto; Yanez, Matilde; Uriarte, Eugenio; Santana, Lourdes; Martinez-Sernandez, Victoria; Bolas-Fernandez, Francisco; Ubeira, Florencio M.			Synthetic Oxoisoaporphine Alkaloids: In Vitro, In Vivo and In Silico Assessment of Antileishmanial Activities	PLOS ONE			English	Article							BETA-AMYLOID AGGREGATION; LEISHMANICIDAL ACTIVITY; TOPOISOMERASE-I; INHIBITORS; ACETYLCHOLINESTERASE; DERIVATIVES; COMPLEX; DRUGS	Leishmaniasis is a growing health problem worldwide. As there are certain drawbacks with the drugs currently used to treat human leishmaniasis and resistance to these drugs is emerging, there is a need to develop novel antileishmanial compounds, among which isoquinoline alkaloids are promising candidates. In this study, 18 novel oxoisoaporphine derivatives were synthesized and their possible antileishmanial activity was evaluated. The in vitro activity of these derivatives against Leishmania amazonensis axenic amastigotes was first evaluated, and the selected compounds were then tested in an inhibition assay with promastigotes of L. infantum, L. braziliensis, L. amazonensis and L. guyanensis, and with intracellular amastigotes of L. infantum and L. amazonensis. Finally, the most active compounds, OXO 1 (2,3-dihydro-7H-dibenzo[de,h]quinolin-7-one) and OXO 13 (2,3,8,9,10,11-hexahydro-7H-dibenzo[de,h]quinolin-7-one), were tested in BALB/c mice infected with L. infantum. Treatment of mice at a dose of 10 mg/kg with OXO 1 yielded significant reductions (p<0.05) in parasite burden in liver and spleen (99% and 78%, respectively) whereas with OXO 13 were not significant. Although previous reports suggest that this family of molecules displays inhibitory activity against monoamine oxidase A and acetylcholinesterase, these enzymes were not confirmed as targets for antileishmanial activity on the basis of the present results. However, after development of a new bioinformatics model to analyze the Leishmania proteome, we were able to identify other putative targets for these molecules. The most promising candidates were four proteins: two putative pteridine reductase 2 (1MXF and 1MXH), one N-myristoyltransferase (2WUU) and one type I topoisomerase (2B9S).	[Sobarzo-Sanchez, Eduardo] Univ Santiago de Compostela, Fac Farm, Dept Tecnol Farmaceut, Santiago De Compostela, Spain; [Sobarzo-Sanchez, Eduardo] Univ Autonoma Chile, Fac Ciencias Salud, Santiago, Chile; [Bilbao-Ramos, Pablo; Bolas-Fernandez, Francisco] Univ Complutense Madrid, Fac Farm, Dept Parasitol, Madrid, Spain; [Dea-Ayuela, Maria] Univ Cardenal Herrera, Dept Farm, Valencia, Spain; [Martinez-Sernandez, Victoria; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Dept Microbiol & Parasitol, Santiago De Compostela, Spain; [Yanez, Matilde] Univ Santiago de Compostela, Fac Farm, Dept Farmacol, Santiago De Compostela, Spain; [Uriarte, Eugenio; Santana, Lourdes] Univ Santiago de Compostela, Fac Farm, Dept Quim Organ, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidad Autonoma de Chile; Complutense University of Madrid; Universidad CEU Cardenal Herrera; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Fac Farm, Dept Microbiol & Parasitol, Santiago De Compostela, Spain.	fm.ubeira@usc.es	Santana, Lourdes/L-2981-2014; Uriarte, Eugenio EU/F-5691-2012; SOBARZO-SANCHEZ, EDUARDO/G-4126-2014; Sobarzo-Sánchez, Eduardo/B-1507-2012; Yañez, Matilde/ABC-5520-2020; Dea-Ayuela, M. Auxiliadora/AAA-7021-2019; Dea-Ayuela, M. Auxiliadora/ABG-5971-2020; , Humbert G. Díaz/A-6785-2012; Bolas Fernandez, Francisco/H-2514-2017	Santana, Lourdes/0000-0001-6056-8253; Uriarte, Eugenio EU/0000-0001-6218-2899; SOBARZO-SANCHEZ, EDUARDO/0000-0002-2790-2544; Sobarzo-Sánchez, Eduardo/0000-0002-2790-2544; Dea-Ayuela, M. Auxiliadora/0000-0002-5468-1863; , Humbert G. Díaz/0000-0002-9392-2797; Bolas Fernandez, Francisco/0000-0001-8062-2974; Ubeira, Florencio/0000-0001-7312-2752	Spanish Ministerio de Ciencia e Innovacion [AGL2011-30563-C03-01]; Spanish Agency for International Cooperation and Development (AECID) [A-024457/09]; Xunta de Galicia (Spain); MAEC-AECID	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Agency for International Cooperation and Development (AECID)(Spanish Government); Xunta de Galicia (Spain)(Xunta de Galicia); MAEC-AECID	This work was partially financed by grants AGL2011-30563-C03-01 from the Spanish Ministerio de Ciencia e Innovacion and A-024457/09 from the Spanish Agency for International Cooperation and Development (AECID). Eduardo Sobarzo-Sanchez is grateful to the Xunta de Galicia (Spain) for the "Isidro Parga Pondal" fellowship. Pablo Bilbao-Ramos is thankful to the MAEC-AECID for a PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dea-Ayuela MA, 2009, BIOORGAN MED CHEM, V17, P7449, DOI 10.1016/j.bmc.2009.09.030; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bilbao-Ramos P, 2012, PARASITOL INT, V61, P604, DOI 10.1016/j.parint.2012.05.015; Bilbao-Ramos P, 2012, J MICROBIOL METH, V89, P8, DOI 10.1016/j.mimet.2012.01.013; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; Camacho MD, 2000, PLANTA MED, V66, P478, DOI 10.1055/s-2000-8597; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Chan-Bacab MJ, 2001, NAT PROD REP, V18, P674, DOI 10.1039/b100455g; Chen ZF, 2012, J BIOL INORG CHEM, V17, P247, DOI 10.1007/s00775-011-0846-z; Costa EV, 2006, J NAT PROD, V69, P292, DOI 10.1021/np050422s; da Silva DB, 2009, PHYTOMEDICINE, V16, P1059, DOI 10.1016/j.phymed.2009.03.019; da Silva SM, 2012, ANTIMICROB AGENTS CH, V56, P2858, DOI 10.1128/AAC.00208-12; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Estevez Y, 2007, J ETHNOPHARMACOL, V114, P254, DOI 10.1016/j.jep.2007.08.007; Fabre JL, 1978, US patent, Patent No. [4128,650, 4128650, 4,128,650]; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; HILL JO, 1983, INFECT IMMUN, V39, P1087, DOI 10.1128/IAI.39.3.1087-1094.1983; Hill T., 2006, STAT METHODS APPL CO; Mijares A, 2011, PARASITOL RES, V108, P1, DOI 10.1007/s00436-010-2032-6; Pearson RD, 1996, CLIN INFECT DIS, V22, P1, DOI 10.1093/clinids/22.1.1; Prado-Prado F, 2011, EUR J MED CHEM, V46, P5838, DOI 10.1016/j.ejmech.2011.09.045; Schormann N, 2005, J STRUCT BIOL, V152, P64, DOI 10.1016/j.jsb.2005.07.008; Sereno D, 1997, PARASITOL RES, V83, P401, DOI 10.1007/s004360050272; Sobarzo-Sanchez E, 2005, MAGN RESON CHEM, V43, P1080, DOI 10.1002/mrc.1703; Sobarzo-Sanchez E, 2003, SYNLETT, P1647, DOI 10.1055/s-2003-41422; Tang H, 2012, BIOORG MED CHEM LETT, V22, P2257, DOI 10.1016/j.bmcl.2012.01.090; Tang H, 2011, EUR J MED CHEM, V46, P4970, DOI 10.1016/j.ejmech.2011.08.002; Tang H, 2009, EUR J MED CHEM, V44, P2523, DOI 10.1016/j.ejmech.2009.01.021; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Waechter AI, 1999, PHYTOTHER RES, V13, P175, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;175::AID-PTR395&gt;3.0.CO;2-N; Yanez M, 2006, BIOCHEM BIOPH RES CO, V344, P688, DOI 10.1016/j.bbrc.2006.03.190; Zhou BN, 2000, J NAT PROD, V63, P217, DOI 10.1021/np990442s	34	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77560	10.1371/journal.pone.0077560	http://dx.doi.org/10.1371/journal.pone.0077560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204870	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700038
J	Gritti, N; Caccia, M; Sironi, L; Collini, M; D'Alfonso, L; Granucci, F; Zanoni, I; Chirico, G				Gritti, Nicola; Caccia, Michele; Sironi, Laura; Collini, Maddalena; D'Alfonso, Laura; Granucci, Francesca; Zanoni, Ivan; Chirico, Giuseppe			Modeling Leukocyte-Leukocyte Non-Contact Interactions in a Lymph Node	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; T-CELLS; BROWNIAN DYNAMICS; IN-VIVO; DEPENDENT ACTIVATION; IMMUNE-RESPONSES; NK CELLS; CHEMOTAXIS; TRAFFICKING	The interaction among leukocytes is at the basis of the innate and adaptive immune-response and it is largely ascribed to direct cell-cell contacts. However, the exchange of a number of chemical stimuli (chemokines) allows also non-contact interaction during the immunological response. We want here to evaluate the extent of the effect of the non-contact interactions on the observed leukocyte-leukocyte kinematics and their interaction duration. To this aim we adopt a simplified mean field description inspired by the Keller-Segel chemotaxis model, of which we report an analytical solution suited for slowly varying sources of chemokines. Since our focus is on the non-contact interactions, leukocyte-leukocyte contact interactions are simulated only by means of a space dependent friction coefficient of the cells. The analytical solution of the Keller-Segel model is then taken as the basis of numerical simulations of interactions between leukocytes and their duration. The mean field interaction force that we derive has a time-space separable form and depends on the chemotaxis sensitivity parameter as well as on the chemokines diffusion coefficient and their degradation rate. All these parameters affect the distribution of the interaction durations. We draw a successful qualitative comparison between simulated data and sets of experimental data for DC-NK cells interaction duration and other kinematic parameters. Remarkably, the predicted percentage of the leukocyte-leukocyte interactions falls in the experimental range and depends (congruent to 25% increase) upon the chemotactic parameter indicating a non-negligible direct effect of the non-contact interaction on the leukocyte interactions.	[Gritti, Nicola; Caccia, Michele; Sironi, Laura; Collini, Maddalena; D'Alfonso, Laura; Chirico, Giuseppe] Univ Milano Bicocca, Dipartimento Fis, Milan, Italy; [Granucci, Francesca; Zanoni, Ivan] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Sironi, Laura] Ist Sci San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Chirico, G (corresponding author), Univ Milano Bicocca, Dipartimento Fis, Milan, Italy.	giuseppe.chirico@mib.infn.it	Caccia, Michele/Q-5623-2018; Gritti, Nicola/AAA-6604-2019; Sironi, Laura/AAA-5384-2022; Caccia, Michele/AAW-2808-2021; D'Alfonso, Laura/J-4193-2012; GRANUCCI, Francesca/K-6150-2019	Gritti, Nicola/0000-0002-7637-4258; Caccia, Michele/0000-0002-2968-5635; D'Alfonso, Laura/0000-0002-7378-4462; granucci, francesca/0000-0002-7046-4914; CHIRICO, Giuseppe/0000-0001-6578-6460; Zanoni, Ivan/0000-0002-3423-7474; SIRONI, LAURA/0000-0002-6638-7709	FP7 program ENCITE [201842]; Regional Project of Regione Lombardia, "Accordo Quadro"	FP7 program ENCITE; Regional Project of Regione Lombardia, "Accordo Quadro"	This work has been partially funded by the FP7 program ENCITE (grant agreement number 201842; http://www.encite.org) to FG and GC and by the Regional Project of Regione Lombardia, "Accordo Quadro" 2009, to GC (http://www.formalavoro.regione.lombardia.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoniou CE, 2005, NAT IMMUNOL, V6, P1011, DOI 10.1038/ni1244; Baldazzi V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-387; Beltman JB, 2007, IMMUNOL CELL BIOL, V85, P306, DOI 10.1038/sj.icb.7100054; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Bousso P, 2004, IMMUNITY, V21, P349, DOI 10.1016/j.immuni.2004.08.005; Bousso P, 2008, NAT REV IMMUNOL, V8, P675, DOI 10.1038/nri2379; Byrne HM, 1998, IMA J MATH APPL MED, V15, P235; Caccia M, 2008, EUR BIOPHYS J BIOPHY, V37, P979, DOI 10.1007/s00249-008-0323-y; Caccia M, 2010, PROC SPIE, V7565, DOI 10.1117/12.842214; Cahalan MD, 2003, CURR OPIN IMMUNOL, V15, P372, DOI 10.1016/S0952-7915(03)00079-7; Chavanis PH, 2010, COMMUN NONLINEAR SCI, V15, P60, DOI 10.1016/j.cnsns.2008.09.002; CHIRICO G, 1992, MACROMOLECULES, V25, P769, DOI 10.1021/ma00028a041; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Doi M, 1986, THEORY POLYM DYNAMIC, P52; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Keller EF, 2006, B MATH BIOL, V68, P1033, DOI 10.1007/s11538-006-9097-5; Frank T, 1996, FOKKER PLANCK EQUATI; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Harizi H, 2013, CELL MOL IMMUNOL, V10, P213, DOI 10.1038/cmi.2013.1; Janeway CA, 2007, IMMUNOBIOLOGY IMMUNE, P13; Jinquan Tan, 1995, Journal of Immunology, V154, P3742; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Klenin K, 1998, BIOPHYS J, V74, P780, DOI 10.1016/S0006-3495(98)74003-2; Kloeden PE, 1994, APPL MATH, V23, P305; Matzavinos A, 2004, MATH MED BIOL, V21, P1; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Millington OR, 2007, INFLAMM RES, V56, P391, DOI 10.1007/s00011-007-7017-2; Narang V, 2012, IMMUNOL RES, V53, P251, DOI 10.1007/s12026-012-8305-7; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Pearce IG, 2007, J MATH BIOL, V55, P365, DOI 10.1007/s00285-007-0088-4; Press WH, 2007, NUMERICAL RECIPES AR, P287; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Rapin N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009862; SHERRATT JA, 1994, B MATH BIOL, V56, P129, DOI 10.1016/S0092-8240(05)80208-3; Smyth MJ, 2002, NAT REV CANCER, V2, P850, DOI 10.1038/nrc928; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; Thakar J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-35; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; TRANQUILLO RT, 1988, CELL MOTIL CYTOSKEL, V11, P1, DOI 10.1002/cm.970110102; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Villa CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012216; Walzer T, 2005, EXPERT OPIN BIOL TH, V5, pS49, DOI 10.1517/14712598.5.1.S49; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286	53	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76756	10.1371/journal.pone.0076756	http://dx.doi.org/10.1371/journal.pone.0076756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204669	Green Submitted, gold, Green Published			2022-12-25	WOS:000326241200013
J	Shinozaki, S; Chiba, T; Kokame, K; Miyata, T; Kaneko, E; Shimokado, K				Shinozaki, Shohei; Chiba, Tsuyoshi; Kokame, Koichi; Miyata, Toshiyuki; Kaneko, Eiji; Shimokado, Kentaro			A Deficiency of Herp, an Endoplasmic Reticulum Stress Protein, Suppresses Atherosclerosis in ApoE Knockout Mice by Attenuating Inflammatory Responses	PLOS ONE			English	Article							C/EBP HOMOLOGOUS PROTEIN; ACCELERATED ATHEROSCLEROSIS; MACROPHAGE APOPTOSIS; CELL-LINE; EXPRESSION; RECEPTOR; PATHWAYS; DISEASE; ER; DEGRADATION	Herp was originally identified as an endoplasmic reticulum (ER) stress protein in vascular endothelial cells. ER stress is induced in atherosclerotic lesions, but it is not known whether Herp plays any role in the development of atherosclerosis. To address this question, we generated Herp-and apolipoprotein E (apoE)-deficient mice (Herp(-/-); apoE(-/-) mice) by crossbreeding Herp(-/-) mice and apoE(-/-) mice. Herp was expressed in the endothelial cells and medial smooth muscle cells of the aorta, as well as in a subset of macrophages in the atherosclerotic lesions in apoE(-/-) mice, while there was no expression of Herp in the Herp(-/-); apoE(-/-) mice. The doubly deficient mice developed significantly fewer atherosclerotic lesions than the apoE(-/-) mice at 36 and 72 weeks of age, whereas the plasma levels of cholesterol and triglycerides were not significantly different between the strains. The plasma levels of non-esterified fatty acids were significantly lower in the Herp(-/-); apoE(-/-) mice when they were eight and 16 weeks old. The gene expression levels of ER stress response proteins (GRP78 and CHOP) and inflammatory cytokines (IL-1 beta, IL-6, TNF-alpha and MCP-1) in the aorta were significantly lower in Herp(-/-); apoE(-/-) mice than in apoE(-/-) mice, suggesting that Herp mediated ER stress-induced inflammation. In fact, peritoneal macrophages isolated from Herp-deficient mice and RAW264.7 macrophages in which Herp was eliminated with a siRNA expressed lower levels of mRNA for inflammatory cytokines when they were treated with tunicamycin. Herp deficiency affected the major mediators of the unfolded protein response, including IRE1 and PERK, but not ATF6. These findings suggest that a deficiency of Herp suppressed the development of atherosclerosis by attenuating the ER stress-induced inflammatory reactions.	[Shinozaki, Shohei; Chiba, Tsuyoshi; Kaneko, Eiji; Shimokado, Kentaro] Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan; [Chiba, Tsuyoshi] Natl Inst Hlth & Nutr, Informat Ctr, Tokyo 162, Japan; [Kokame, Koichi; Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Osaka, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Health & Nutrition - Japan; National Cerebral & Cardiovascular Center - Japan	Shimokado, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Tokyo, Japan.	k.shimoka.vasc@tmd.ac.jp	Shinozaki, Shohei/AAT-3018-2021	Kokame, Koichi/0000-0002-9654-6299	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a grant to KS from Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EK, 2012, ARTERIOSCL THROM VAS, V32, P1687, DOI 10.1161/ATVBAHA.112.250142; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chiba T, 2007, ATHEROSCLEROSIS; Chiba T, 2006, J ATHEROSCLER THROMB, V13, P308, DOI 10.5551/jat.13.308; Chigurupati S, 2009, J BIOL CHEM; Deng JN, 2012, J BIOL CHEM, V287, P6240, DOI 10.1074/jbc.M111.299115; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; Eura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034298; Gao JH, 2011, CIRCULATION, V124, P830, DOI 10.1161/CIRCULATIONAHA.110.014050; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Hartley T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-59; Higaki M, 1999, ARTERIOSCL THROM VAS, V19, P2127, DOI 10.1161/01.ATV.19.9.2127; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Nogalska A, 2006, J NEUROCHEM, V96, P1491, DOI 10.1111/j.1471-4159.2006.03668.x; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Scull CM, 2011, ARTERIOSCL THROM VAS, V31, P2792, DOI 10.1161/ATVBAHA.111.224881; Shinozaki S, 2007, HORM METAB RES, V39, P192, DOI 10.1055/s-2007-970417; Slodzinski H, 2009, CLIN NEUROPATHOL, V28, P333, DOI 10.2379/NPX08162; Suyama K, 2008, BIOCHEM BIOPH RES CO, V367, P176, DOI 10.1016/j.bbrc.2007.12.132; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Wong KS, 1999, ONCOGENE, V18, P5525, DOI 10.1038/sj.onc.1202938; Yamazaki H, 2009, J IMMUNOL, V183, P1480, DOI 10.4049/jimmunol.0900017; Yan S, 2012, EXP DIABETES RES, DOI 10.1155/2012/743780; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhou AX, 2013, SEMIN IMMUNOPATHOL, V35, P321, DOI 10.1007/s00281-013-0372-x; Zhou J, 2005, CIRCULATION, V111, P1814, DOI 10.1161/01.CIR.0000160864.31351.C1; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	41	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75249	10.1371/journal.pone.0075249	http://dx.doi.org/10.1371/journal.pone.0075249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204574	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200004
J	Kung, WM; Chen, ST; Lin, CH; Lu, YM; Chen, TH; Lin, MS				Kung, Woon-Man; Chen, Shuo-Tsung; Lin, Chung-Hsiang; Lu, Yu-Mei; Chen, Tzu-Hsuan; Lin, Muh-Shi			Verifying Three-Dimensional Skull Model Reconstruction Using Cranial Index of Symmetry	PLOS ONE			English	Article							DECOMPRESSIVE CRANIECTOMY; TITANIUM MESH; CRANIOPLASTY; TECHNOLOGIES; IMPLANTS; DEFECT	Background: Difficulty exists in scalp adaptation for cranioplasty with customized computer-assisted design/manufacturing (CAD/CAM) implant in situations of excessive wound tension and sub-cranioplasty dead space. To solve this clinical problem, the CAD/CAM technique should include algorithms to reconstruct a depressed contour to cover the skull defect. Satisfactory CAM-derived alloplastic implants are based on highly accurate three-dimensional (3-D) CAD modeling. Thus, it is quite important to establish a symmetrically regular CAD/CAM reconstruction prior to depressing the contour. The purpose of this study is to verify the aesthetic outcomes of CAD models with regular contours using cranial index of symmetry (CIS). Materials and methods: From January 2011 to June 2012, decompressive craniectomy (DC) was performed for 15 consecutive patients in our institute. 3-D CAD models of skull defects were reconstructed using commercial software. These models were checked in terms of symmetry by CIS scores. Results: CIS scores of CAD reconstructions were 99.24+/-0.004% (range 98.47-99.84). CIS scores of these CAD models were statistically significantly greater than 95%, identical to 99.5%, but lower than 99.6% (p<0.001, p = 0.064, p = 0.021 respectively, Wilcoxon matched pairs signed rank test). These data evidenced the highly accurate symmetry of these CAD models with regular contours. Conclusions: CIS calculation is beneficial to assess aesthetic outcomes of CAD-reconstructed skulls in terms of cranial symmetry. This enables further accurate CAD models and CAM cranial implants with depressed contours, which are essential in patients with difficult scalp adaptation.	[Kung, Woon-Man] Chinese Culture Univ, Coll Educ, Dept Exercise & Hlth Promot, Taipei, Taiwan; [Kung, Woon-Man] Lotung Poh Ai Hosp, Lo Hsu Fdn, Dept Neurosurg, Luodong, Yilan, Taiwan; [Chen, Shuo-Tsung] Tunghai Univ, Dept Appl Math, Taichung 40704, Taiwan; [Lin, Chung-Hsiang] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Coll Elect Engn & Comp Sci, Taipei 10764, Taiwan; [Lu, Yu-Mei] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Chen, Tzu-Hsuan] Mackay Mem Hosp, Dept Phys Med & Rehabil, Hsinchu, Taiwan; [Lin, Muh-Shi] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan; [Lin, Muh-Shi] Taipei City Hosp, Dept Neurosurg, Zhong Xiao Branch, Taipei, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Kung, Woon-Man] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan	Chinese Culture University; Tunghai University; National Taiwan University; National Taiwan Normal University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taiwan University; National Taiwan University	Lin, MS (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan.	neurosurgery2005@yahoo.com.tw	Kung, Woon-Man/Q-3012-2019; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/U-7004-2019	Kung, Woon-Man/0000-0001-8311-2902; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/0000-0002-9798-8160				Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Galantucci L. M., 2006, Journal of Medical Engineering & Technology, V30, P102, DOI 10.1080/03091900500131714; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kasper EM, 2012, NEUROSURGERY, V71, P15, DOI 10.1227/NEU.0b013e318242cea2; Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009; Kung WM, 2012, BRAIN INJURY, V26, P1737, DOI 10.3109/02699052.2012.698361; Kung WM, 2012, J NEUROTRAUM, V29, P2030, DOI 10.1089/neu.2011.2220; Lin MS, 2013, J NEUROPSYCH CLIN N, V25, pE52, DOI 10.1176/appi.neuropsych.12080189; Lin Samuel J, 2008, Semin Plast Surg, V22, P281, DOI 10.1055/s-0028-1095887; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Miyazawa T, 2007, SURG NEUROL, V67, P291, DOI 10.1016/j.surneu.2006.04.019; Patel A, 2011, FACIAL PLAST SURG CL, V19, P683, DOI 10.1016/j.fsc.2011.07.010; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; Vanezis P, 2000, FORENSIC SCI INT, V108, P81, DOI 10.1016/S0379-0738(99)00026-2; Winder RJ, 2006, ST HEAL T, V119, P574; Zonenshayn M, 2004, J NEUROSURG, V100, P537, DOI 10.3171/ped.2004.100.5.0537	20	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e74267	10.1371/journal.pone.0074267	http://dx.doi.org/10.1371/journal.pone.0074267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204566	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400005
J	Rehan, SM; Leys, R; Schwarz, MP				Rehan, Sandra M.; Leys, Remko; Schwarz, Michael P.			First Evidence for a Massive Extinction Event Affecting Bees Close to the K-T Boundary	PLOS ONE			English	Article							CRETACEOUS TERTIARY BOUNDARY; EXONEURINE ALLODAPINE BEES; HISTORICAL BIOGEOGRAPHY; DIVERGENCE TIMES; SOUTH-AMERICA; NORTH-DAKOTA; EVOLUTION; DIVERSIFICATION; HYMENOPTERA; PHYLOGENY	Bees and eudicot plants both arose in the mid-late Cretaceous, and their co-evolutionary relationships have often been assumed as an important element in the rise of flowering plants. Given the near-complete dependence of bees on eudicots we would expect that major extinction events affecting the latter would have also impacted bees. However, given the very patchy distribution of bees in the fossil record, identifying any such extinctions using fossils is very problematic. Here we use molecular phylogenetic analyses to show that one bee group, the Xylocopinae, originated in the mid-Cretaceous, coinciding with the early radiation of the eudicots. Lineage through time analyses for this bee subfamily show very early diversification, followed by a long period of seemingly no radiation and then followed by rapid diversification in each of the four constituent tribes. These patterns are consistent with both a long-fuse model of radiation and a massive extinction event close to the K-T boundary. We argue that massive extinction is much more plausible than a long fuse, given the historical biogeography of these bees and the diversity of ecological niches that they occupy. Our results suggest that events near the K-T boundary would have disrupted many plant-bee relationships, with major consequences for the subsequent evolution of eudicots and their pollinators.	[Rehan, Sandra M.] Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA; [Leys, Remko; Schwarz, Michael P.] Flinders Univ South Australia, Sch Biol Sci, Adelaide, SA, Australia; [Leys, Remko] South Australia Museum, Evolutionary Biol Unit, Adelaide, SA, Australia; [Leys, Remko] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia	University System Of New Hampshire; University of New Hampshire; Flinders University South Australia; South Australian Museum; University of Adelaide	Rehan, SM (corresponding author), Univ New Hampshire, Dept Biol Sci, Durham, NH 03824 USA.	sandra.rehan@gmail.com		Leijs, Remko/0000-0001-6909-5659	Australian Endeavour fellowships; Australian Research Council	Australian Endeavour fellowships(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Research Council(Australian Research Council)	This research was supported by Australian Endeavour fellowships to SMR and an Australian Research Council grant to MPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 2010, AM J BOT, V97, P782, DOI 10.3732/ajb.0900182; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; Antonelli A, 2011, SYST BIOL, V60, P596, DOI 10.1093/sysbio/syr062; Barrera E, 1999, GEOL S AM S, P245; Bartomeus I, 2013, P NATL ACAD SCI USA, V110, P4656, DOI 10.1073/pnas.1218503110; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cardinal S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2686; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; Chaw SM, 2004, J MOL EVOL, V58, P424, DOI 10.1007/s00239-003-2564-9; Chenoweth LB, 2011, J BIOGEOGR, V38, P1471, DOI 10.1111/j.1365-2699.2011.02488.x; Crepet WL, 1998, AM J BOT, V85, P1122, DOI 10.2307/2446345; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Danforth BN, 2006, P NATL ACAD SCI USA, V103, P15118, DOI 10.1073/pnas.0604033103; Danforth BN, 2013, ANNU REV ENTOMOL, V58, P57, DOI 10.1146/annurev-ento-120811-153633; Dingle RV, 1998, PALAEOGEOGR PALAEOCL, V141, P215, DOI 10.1016/S0031-0182(98)00056-X; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Engel M.S., 2013, STINGLESS BEES PROCE, P1; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Engel MS, 2001, P NATL ACAD SCI USA, V98, P1661, DOI 10.1073/pnas.98.4.1661; Flores-Prado L, 2012, REV CHIL HIST NAT, V85, P245, DOI 10.4067/S0716-078X2012000300001; Gibbs J, 2012, MOL PHYLOGENET EVOL, V65, P926, DOI 10.1016/j.ympev.2012.08.013; Groom SVC, 2013, MOL PHYLOGENET EVOL, V68, P582, DOI 10.1016/j.ympev.2013.04.015; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hu SS, 2008, P NATL ACAD SCI USA, V105, P240, DOI 10.1073/pnas.0707989105; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iglesias A, 2011, BIOL J LINN SOC, V103, P409, DOI 10.1111/j.1095-8312.2011.01657.x; JOHNSON KR, 1992, CRETACEOUS RES, V13, P91, DOI 10.1016/0195-6671(92)90029-P; Judd WS, 2004, AM J BOT, V91, P1627, DOI 10.3732/ajb.91.10.1627; Kayaalp P, 2013, MOL PHYLOGENET EVOL, V66, P668, DOI 10.1016/j.ympev.2012.10.018; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Labandeira CC, 2002, P NATL ACAD SCI USA, V99, P2061, DOI 10.1073/pnas.042492999; Leys R, 2002, BIOL J LINN SOC, V77, P249, DOI 10.1046/j.1095-8312.2002.00108.x; Litman JR, 2011, P ROY SOC B-BIOL SCI, V278, P3593, DOI 10.1098/rspb.2011.0365; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Packer L, 2005, CONSERV BIOL, V19, P195, DOI 10.1111/j.1523-1739.2005.00601.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pike EM, 1995, AMBER TAPHONOMY GRAS; Pole M, 2009, CRETACEOUS RES, V30, P917, DOI 10.1016/j.cretres.2009.02.007; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rambaut A., 2007, TRACER V1 5; Rehan SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034690; Rehan SM, 2010, MOL PHYLOGENET EVOL, V55, P1042, DOI 10.1016/j.ympev.2010.01.011; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Schwarz MP, 2011, BIOL LETTERS, V7, P277, DOI 10.1098/rsbl.2010.0757; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Smith JA, 2013, BIOL J LINN SOC, V109, P320, DOI 10.1111/bij.12043; Smith SD, 2010, NEW PHYTOL, V188, P354, DOI 10.1111/j.1469-8137.2010.03292.x; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Stadler T., 2010, TREESIM R SIMULATING; Stadler T, 2011, SYST BIOL, V60, P676, DOI 10.1093/sysbio/syr029; TSCHUDY RH, 1986, GEOLOGY, V14, P667, DOI 10.1130/0091-7613(1986)14<667:EASOPL>2.0.CO;2; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilf P, 2004, PALEOBIOLOGY, V30, P347, DOI 10.1666/0094-8373(2004)030<0347:LPEATE>2.0.CO;2; Wing SL., 2004, EXTINCTIONS HIST LIF, P61; Zayed A, 2005, CONSERV GENET, V6, P1017, DOI 10.1007/s10592-005-9094-5	64	22	22	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76683	10.1371/journal.pone.0076683	http://dx.doi.org/10.1371/journal.pone.0076683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194843	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000022
J	Solinas, M; Massi, P; Cinquina, V; Valenti, M; Bolognini, D; Gariboldi, M; Monti, E; Rubino, T; Parolaro, D				Solinas, Marta; Massi, Paola; Cinquina, Valentina; Valenti, Marta; Bolognini, Daniele; Gariboldi, Marzia; Monti, Elena; Rubino, Tiziana; Parolaro, Daniela			Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	PLOS ONE			English	Article							STEM-LIKE CELLS; MATRIX METALLOPROTEINASES; CANCER; GLIOBLASTOMA; EXPRESSION; PATHWAY; GROWTH; ANGIOGENESIS; ACTIVATION; THERAPY	In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasiveness in vitro and caused a decrease in the expression of a set of proteins specifically involved in growth, invasion and angiogenesis. In addition, CBD treatment caused a dose-related down-regulation of ERK and Akt prosurvival signaling pathways in U87-MG and T98G cells and decreased hypoxia inducible factor HIF-1 alpha expression in U87-MG cells. Taken together, these results provide new insights into the antitumor action of CBD, showing that this cannabinoid affects multiple tumoral features and molecular pathways. As CBD is a non-psychoactive phytocannabinoid that appears to be devoid of side effects, our results support its exploitation as an effective anti-cancer drug in the management of gliomas.	[Solinas, Marta; Cinquina, Valentina; Valenti, Marta; Gariboldi, Marzia; Monti, Elena; Rubino, Tiziana; Parolaro, Daniela] Univ Insubria, Ctr Neurosci, Biomed Res Div, Dept Theoret & Appl Sci, Busto Arsizio, Varese, Italy; [Massi, Paola] Univ Milan, Dept Pharmacol Chemotherapy & Toxicol, Milan, Italy; [Bolognini, Daniele] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Insubria; University of Milan; University of Toronto	Parolaro, D (corresponding author), Univ Insubria, Ctr Neurosci, Biomed Res Div, Dept Theoret & Appl Sci, Busto Arsizio, Varese, Italy.	daniela.parolaro@uninsubria.it	Gariboldi, Marzia Bruna/U-1331-2019; Bolognini, Daniele/AAF-7892-2020; Rubino, Tiziana/AAC-8210-2020	Gariboldi, Marzia Bruna/0000-0002-5683-0885; RUBINO, Tiziana/0000-0002-3128-6377; Cinquina, Valentina/0000-0002-7365-1395	University of Milan-F.I.R.S.T; GW Pharmaceuticals	University of Milan-F.I.R.S.T; GW Pharmaceuticals	This work was supported by a grant from University of Milan-F.I.R.S.T 2008. GW Pharmaceuticals funded part of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andradas C, 2011, ONCOGENE, V30, P245, DOI 10.1038/onc.2010.402; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Di Cosimo S, 2008, EUR J CANCER, V44, P2781, DOI 10.1016/j.ejca.2008.09.026; Eberle K, 2000, ANTICANCER RES, V20, P1679; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Fillmore HL, 2001, J NEURO-ONCOL, V53, P187, DOI 10.1023/A:1012213604731; Franceschi E, 2009, EXPERT REV ANTICANC, V9, P613, DOI [10.1586/era.09.23, 10.1586/ERA.09.23]; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Groft LL, 2001, BRIT J CANCER, V85, P55, DOI 10.1054/bjoc.2001.1854; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Jones NA, 2012, SEIZURE-EUR J EPILEP, V21, P344, DOI 10.1016/j.seizure.2012.03.001; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Liang KC, 2007, J CELL PHYSIOL, V211, P759, DOI 10.1002/jcp.20992; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; Ludwig A, 2005, J NEUROCHEM, V93, P1293, DOI 10.1111/j.1471-4159.2005.03123.x; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massi P, 2008, J NEUROCHEM, V104, P1091, DOI 10.1111/j.1471-4159.2007.05073.x; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; Massi P, 2013, BRIT J CLIN PHARMACO, V75, P303, DOI 10.1111/j.1365-2125.2012.04298.x; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McPartland JM, 2007, BRIT J PHARMACOL, V152, P583, DOI 10.1038/sj.bjp.0707399; Mizutani K, 2009, NEOPLASIA, V11, P1235, DOI 10.1593/neo.09988; Ramer R, 2012, FASEB J, V26, P1535, DOI 10.1096/fj.11-198184; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Solinas M, 2012, BRIT J PHARMACOL, V167, P1218, DOI 10.1111/j.1476-5381.2012.02050.x; Soroceanu L, 2013, CANCER RES, V73, P1559, DOI 10.1158/0008-5472.CAN-12-1943; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Torres S, 2011, MOL CANCER THER, V10, P90, DOI 10.1158/1535-7163.MCT-10-0688; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Vaccani A, 2005, BRIT J PHARMACOL, V144, P1032, DOI 10.1038/sj.bjp.0706134; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248	45	85	87	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76918	10.1371/journal.pone.0076918	http://dx.doi.org/10.1371/journal.pone.0076918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204703	gold, Green Published			2022-12-25	WOS:000326032600015
J	Di Cristofaro, J; Pennarun, E; Mazieres, S; Myres, NM; Lin, AA; Temori, SA; Metspalu, M; Metspalu, E; Witzel, M; King, RJ; Underhill, PA; Villems, R; Chiaroni, J				Di Cristofaro, Julie; Pennarun, Erwan; Mazieres, Stephane; Myres, Natalie M.; Lin, Alice A.; Temori, Shah Aga; Metspalu, Mait; Metspalu, Ene; Witzel, Michael; King, Roy J.; Underhill, Peter A.; Villems, Richard; Chiaroni, Jacques			Afghan Hindu Kush: Where Eurasian Sub-Continent Gene Flows Converge	PLOS ONE			English	Article							CHROMOSOME HAPLOGROUP C; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; CONTRASTING PATTERNS; POSITIVE SELECTION; NATIVE-AMERICANS; MODERN HUMANS; ETHNIC-GROUPS; SILK ROAD; LANDSCAPE	Despite being located at the crossroads of Asia, genetics of the Afghanistan populations have been largely overlooked. It is currently inhabited by five major ethnic populations: Pashtun, Tajik, Hazara, Uzbek and Turkmen. Here we present autosomal from a subset of our samples, mitochondrial and Y- chromosome data from over 500 Afghan samples among these 5 ethnic groups. This Afghan data was supplemented with the same Y-chromosome analyses of samples from Iran, Kyrgyzstan, Mongolia and updated Pakistani samples (HGDP-CEPH). The data presented here was integrated into existing knowledge of pan-Eurasian genetic diversity. The pattern of genetic variation, revealed by structure-like and Principal Component analyses and Analysis of Molecular Variance indicates that the people of Afghanistan are made up of a mosaic of components representing various geographic regions of Eurasian ancestry. The absence of a major Central Asian-specific component indicates that the Hindu Kush, like the gene pool of Central Asian populations in general, is a confluence of gene flows rather than a source of distinctly autochthonous populations that have arisen in situ: a conclusion that is reinforced by the phylogeography of both haploid loci.	[Di Cristofaro, Julie; Mazieres, Stephane; Chiaroni, Jacques] Aix Marseille Univ, CNRS, ADES UMR7268, EFS AM, Marseille, France; [Pennarun, Erwan; Metspalu, Mait; Metspalu, Ene; Villems, Richard] Univ Tartu, Estonian Bioctr, EE-50090 Tartu, Estonia; [Pennarun, Erwan; Metspalu, Mait; Metspalu, Ene; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [Myres, Natalie M.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Lin, Alice A.; King, Roy J.] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Temori, Shah Aga] Kabul Med Univ, Dept Biochem, Kabul, Afghanistan; [Witzel, Michael] Harvard Univ, Dept South Asian Studies, Cambridge, MA 02138 USA; [Underhill, Peter A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Estonian Biocentre; University of Tartu; University of Tartu; Stanford University; Harvard University; Stanford University; Estonian Academy of Sciences	Chiaroni, J (corresponding author), Aix Marseille Univ, CNRS, ADES UMR7268, EFS AM, Marseille, France.	jacques.chiaroni@efs.sante.fr	Chiaroni, Jacques/ABA-2944-2021; Mazieres, Stephane/G-1702-2010; Pennarun, Erwan/AAW-7041-2020; Metspalu, Mait/G-8671-2015; Mazières, Stéphane/R-2061-2019	Chiaroni, Jacques/0000-0002-3133-8990; Mazieres, Stephane/0000-0003-1266-4659; Pennarun, Erwan/0000-0002-8267-883X; Metspalu, Mait/0000-0003-3099-9161; Di Cristofaro, Julie/0000-0001-7867-6455	Agence National de la Recherche [BLAN07-3_222301, CSD 9 - Sciences humaines et sociales]	Agence National de la Recherche(French National Research Agency (ANR))	Research was granted by the Agence National de la Recherche (Grant #BLAN07-3_222301, CSD 9 - Sciences humaines et sociales). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KM, 2012, BEIGNNINGS ANCIENT K; Alexander D.H., 2010, ADMIXTURE 1 04 SOFTW; Ali Ihsan, 2005, FRONTIER ARCHAEOLOGY, V3, P109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Bailey H. W., 2002, INDOIRANIAN LANGUAGE; Bashir E, 1998, TOPICS KALASHA SYNTA; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bengtson J, 2003, MOTHER TONGUE, V8, P131; Bengtson John D., 1997, GEORGICA, V20, P88; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Busby GBJ, 2012, P ROY SOC B-BIOL SCI, V279, P884, DOI 10.1098/rspb.2011.1044; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cann HM, 2002, SCIENCE, V296, P261; Carpelan CP, 2001, URALIC INDOEUROPEAN; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Comas D, 2000, AM J PHYS ANTHROPOL, V112, P5, DOI 10.1002/(SICI)1096-8644(200005)112:1<5::AID-AJPA2>3.0.CO;2-Z; Di Cristofaro J, 2012, FORENSIC SCI INT-GEN, V6, pE44, DOI 10.1016/j.fsigen.2011.03.004; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Elfenbein JH, 1987, PERIPLOUS BRAHUI PRO, V16, P215; Elisseeff V, 2001, SILK ROADS HIGHWAYS; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Findley C., 2005, TURKS WORLD HIST; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2009, ETHNOGENESIS S CENTR, P3; Genealogy ISoG, 2012, Y DNA HAPL TREE 2012; Geppert M, 2011, FORENSIC SCI INT-GEN, V5, P100, DOI 10.1016/j.fsigen.2010.08.016; Golden PB, 2011, CENTRAL ASIA WORLD H, P192; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Hegedus I, 2010, POSITION NURISTANI I; Hiebert F.T., 1994, ORIGINS BRONZE AGE O; Hintze A, 1996, INNSBRUCK, V22, P139; Hodoglugil U, 2012, ANN HUM GENET, V76, P128, DOI 10.1111/j.1469-1809.2011.00701.x; Holster CW, 1993, TURKS CENTRAL ASIA; Holt Frank L., 2006, LAND BONES ALEXANDER; Irwin JA, 2010, INT J LEGAL MED, V124, P195, DOI 10.1007/s00414-009-0406-z; Jackson P, 2005, MONGOLS W 1221 1410, P448; Katoh T, 2005, GENE, V346, P63, DOI 10.1016/j.gene.2004.10.023; Keyser-Tracqui C, 2003, AM J HUM GENET, V73, P247, DOI 10.1086/377005; Keyser-Tracqui C, 2006, AM J PHYS ANTHROPOL, V131, P272, DOI 10.1002/ajpa.20429; Kuz'mina EE, 2012, HELSINKI MEMOIRES SO, V242, P289; Kuzmina EE, 2008, ENCOUNTERS ASIA, P1; Lacau H, 2012, EUR J HUM GENET; Lacau H, 2011, LEGAL MED-TOKYO, V13, P103, DOI 10.1016/j.legalmed.2010.11.004; Lamberg-Karlovsky CC, 2002, CURR ANTHROPOL, V43, P63, DOI 10.1086/324130; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Li H, 2009, AM J HUM GENET, V85, P934, DOI 10.1016/j.ajhg.2009.10.024; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lubotsky A, 2001, SUOMALAIS UGRILAISEN; Malyarchuk B, 2011, J HUM GENET, V56, P583, DOI 10.1038/jhg.2011.64; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; Mazieres S, 2013, TRANSFUS MED; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Morgenstierne G., 1973, INDOIRANIAN FRONTIER, VIV; Oranskij IosifM., 1977, LANGUES IRANIENNES; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinault G-J, 2003, HIST SPRACHFORSCHUNG, V116, P175; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Redei K, SITZUNGSBERICHTE STE, Vvol 468; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Witzel M, 2003, PHILADELPHIA SINO PL, P129; Witzel M, 1999, MOTHER TONGUE; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yunusbayev B., 2011, MOL BIOL EVOL; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	93	74	77	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76748	10.1371/journal.pone.0076748	http://dx.doi.org/10.1371/journal.pone.0076748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204668	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300050
J	McBane, JE; Vulesevic, B; Padavan, DT; McEwan, KA; Korbutt, GS; Suuronen, EJ				McBane, Joanne E.; Vulesevic, Branka; Padavan, Donna T.; McEwan, Kimberly A.; Korbutt, Gregory S.; Suuronen, Erik J.			Evaluation of a Collagen-Chitosan Hydrogel for Potential Use as a Pro-Angiogenic Site for Islet Transplantation	PLOS ONE			English	Article							PROGENITOR-CELL MOBILIZATION; PANCREATIC-ISLETS; DIABETES-MELLITUS; DEVICE; MICE; NEOVASCULARIZATION; SURVIVAL; PREIMPLANTATION; VASCULARIZATION; STREPTOZOTOCIN	Islet transplantation to treat type 1 diabetes (T1D) has shown varied long-term success, due in part to insufficient blood supply to maintain the islets. In the current study, collagen and collagen: chitosan (10: 1) hydrogels, +/-circulating angiogenic cells (CACs), were compared for their ability to produce a pro-angiogenic environment in a streptozotocin-induced mouse model of T1D. Initial characterization showed that collagen-chitosan gels were mechanically stronger than the collagen gels (0.7kPa vs. 0.4kPa elastic modulus, respectively), had more cross-links (9.2 vs. 7.4/mu m(2)), and were degraded more slowly by collagenase. After gelation with CACs, live/dead staining showed greater CAC viability in the collagen-chitosan gels after 18h compared to collagen (79% vs. 69%). In vivo, collagen-chitosan gels, subcutaneously implanted for up to 6 weeks in a T1D mouse, showed increased levels of pro-angiogenic cytokines over time. By 6 weeks, anti-islet cytokine levels were decreased in all matrix formulations +/- CACs. The 6-week implants demonstrated increased expression of VCAM-1 in collagen-chitosan implants. Despite this, infiltrating vWF(+) and CXCR4(+) angiogenic cell numbers were not different between the implant types, which may be due to a delayed and reduced cytokine response in a T1D versus non-diabetic setting. The mechanical, degradation and cytokine data all suggest that the collagen-chitosan gel may be a suitable candidate for use as a pro-angiogenic ectopic islet transplant site.	[McBane, Joanne E.; Vulesevic, Branka; Padavan, Donna T.; McEwan, Kimberly A.; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Ottawa, ON, Canada; [McBane, Joanne E.; Vulesevic, Branka; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [McEwan, Kimberly A.] Univ Ottawa, Fac Engn, Ottawa, ON, Canada; [Korbutt, Gregory S.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; University of Ottawa; University of Alberta	Suuronen, EJ (corresponding author), Univ Ottawa, Inst Heart, Ottawa, ON, Canada.	esuuronen@ottawaheart.ca		McBane, Joanne/0000-0002-9053-4668; Vulesevic, Branka/0000-0003-2297-2209	JDRF [41-2009-771]; CIHR Doctoral Research Award; University of Ottawa Cardiovascular Research Endowment Fund Fellowship; Ontario Graduate Scholarship; Molecular Function & Imaging Program; HSF of Ontario Program Grant [PRG 6242]; JDRF postdoctoral fellowship; CDA postdoctoral fellowship incentive program award	JDRF(Juvenile Diabetes Research Foundation); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); University of Ottawa Cardiovascular Research Endowment Fund Fellowship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Molecular Function & Imaging Program; HSF of Ontario Program Grant; JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation); CDA postdoctoral fellowship incentive program award	This work was supported by operating grant number 41-2009-771 from JDRF (to GSK and EJS). BV was funded by a CIHR Doctoral Research Award, DTP was funded by a University of Ottawa Cardiovascular Research Endowment Fund Fellowship, KM was supported by an Ontario Graduate Scholarship, and JEM was supported first by a fellowship from the Molecular Function & Imaging Program, funded by a HSF of Ontario Program Grant (PRG 6242), and then by a JDRF postdoctoral fellowship and a CDA postdoctoral fellowship incentive program award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Albiero M, 2012, CURR VASC PHARMACOL, V10, P310, DOI 10.2174/157016112799959387; Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]; Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012; Bowers DT, 2011, TRANSPL P, V43, P3285, DOI 10.1016/j.transproceed.2011.09.008; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Carlsson PO, 2011, UPSALA J MED SCI, V116, P1, DOI 10.3109/03009734.2010.548609; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Deng C, 2011, J CONTROL RELEASE, V152, pE196, DOI 10.1016/j.jconrel.2011.09.005; Deng C, 2010, MACROMOL SYMP, V297, P138, DOI 10.1002/masy.200900149; Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504; Dong L, 2011, MICROVASC RES, V82, P227, DOI 10.1016/j.mvr.2011.09.006; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fadini GP, 2005, CURR DIABETES REV, V1, P41, DOI 10.2174/1573399052952640; Forster NA, 2011, ISLETS, V3, P271, DOI 10.4161/isl.3.5.15942; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Ishiyama K, 2011, TRANSPLANTATION, V91, P952, DOI 10.1097/TP.0b013e3182139dc1; Jacobs-Tulleneers-Thevissen D, 2010, DIABETOLOGIA, V53, P1690, DOI 10.1007/s00125-010-1721-0; Kakabadze Z, 2011, TRANSPL INT, V24, P175, DOI 10.1111/j.1432-2277.2010.01160.x; Kaufman-Francis K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040741; Kim JS, 2012, J CONTROL RELEASE, V162, P382, DOI 10.1016/j.jconrel.2012.07.018; Kriz J, 2010, TRANSPL P, V42, P2097, DOI 10.1016/j.transproceed.2010.05.088; Kriz J, 2012, AM J SURG, V203, P793, DOI 10.1016/j.amjsurg.2011.02.009; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; MANDRUPPOULSEN T, 1990, CURR TOP MICROBIOL, V164, P169; McEwan K, 2012, J BIOMAT SCI-POLYM E, V23, P1467, DOI 10.1163/092050611X584397; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Moore WV, 2002, CELL TRANSPLANT, V11, P707, DOI 10.3727/000000002783985369; Muthyala S, 2010, ISLETS, V2, P357, DOI 10.4161/isl.2.6.13765; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Pan SK, 2011, J ZHEJIANG UNIV-SC B, V12, P931, DOI 10.1631/jzus.B1100065; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Rafael E, 2003, CELL TRANSPLANT, V12, P407, DOI 10.3727/000000003108746957; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sorenby AK, 2008, TRANSPLANTATION, V86, P364, DOI 10.1097/TP.0b013e31817efc78; Stamenovic D, 2000, J APPL PHYSIOL, V89, P2085, DOI 10.1152/jappl.2000.89.5.2085; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134; Witkowski P, 2009, TRANSPLANTATION, V88, P1065, DOI 10.1097/TP.0b013e3181ba2e87; YAMADA K, 1993, BIOCHEM BIOPH RES CO, V197, P22, DOI 10.1006/bbrc.1993.2435; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189	46	40	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77538	10.1371/journal.pone.0077538	http://dx.doi.org/10.1371/journal.pone.0077538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204863	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300103
J	Walters, DM; Stokes, JB; Adair, SJ; Stelow, EB; Borgman, CA; Lowrey, BT; Xin, WJ; Blais, EM; Lee, JK; Papin, JA; Parsons, JT; Bauer, TW				Walters, Dustin M.; Stokes, Jayme B.; Adair, Sara J.; Stelow, Edward B.; Borgman, Cheryl A.; Lowrey, Bryce T.; Xin, Wenjun; Blais, Edik M.; Lee, Jae K.; Papin, Jason A.; Parsons, J. Thomas; Bauer, Todd W.			Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human Specimens	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; CELL-LINES; CURATIVE RESECTION; CANCER XENOGRAFTS; BRCA2 MUTATIONS; PROBE LEVEL; K-RAS; GROWTH; MICE; CARCINOMA	Background: Relevant preclinical models that recapitulate the key features of human pancreatic ductal adenocarcinoma (PDAC) are needed in order to provide biologically tractable models to probe disease progression and therapeutic responses and ultimately improve patient outcomes for this disease. Here, we describe the establishment and clinical, pathological, molecular and genetic validation of a murine, orthotopic xenograft model of PDAC. Methods: Human PDACs were resected and orthotopically implanted and propagated in immunocompromised mice. Patient survival was correlated with xenograft growth and metastatic rate in mice. Human and mouse tumor pathology were compared. Tumors were analyzed for genetic mutations, gene expression, receptor tyrosine kinase activation, and cytokine expression. Results: Fifteen human PDACs were propagated orthotopically in mice. Xenograft-bearing mice developed peritoneal and liver metastases. Time to tumor growth and metastatic efficiency in mice each correlated with patient survival. Tumor architecture, nuclear grade and stromal content were similar in patient and xenografted tumors. Propagated tumors closely exhibited the genetic and molecular features known to characterize pancreatic cancer (e.g. high rate of KRAS, P53, SMAD4 mutation and EGFR activation). The correlation coefficient of gene expression between patient tumors and xenografts propagated through multiple generations was 93 to 99%. Analysis of gene expression demonstrated distinct differences between xenografts from fresh patient tumors versus commercially available PDAC cell lines. Conclusions: The orthotopic xenograft model derived from fresh human PDACs closely recapitulates the clinical, pathologic, genetic and molecular aspects of human disease. This model has resulted in the identification of rational therapeutic strategies to be tested in clinical trials and will permit additional therapeutic approaches and identification of biomarkers of response to therapy.	[Walters, Dustin M.; Stokes, Jayme B.; Adair, Sara J.; Lowrey, Bryce T.; Bauer, Todd W.] Univ Virginia, Dept Surg, Charlottesville, VA 22903 USA; [Stelow, Edward B.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Xin, Wenjun; Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Blais, Edik M.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Borgman, Cheryl A.; Parsons, J. Thomas] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Bauer, TW (corresponding author), Univ Virginia, Dept Surg, Charlottesville, VA 22903 USA.	twb7f@virginia.edu	Adair, Sara J./AAD-5589-2019	Lowrey, Bryce/0000-0002-0656-8604; Papin, Jason/0000-0002-2769-5805	NIH [T32 HL007849, R03CA141245-01, T32 CA009109]; American Cancer Society [MRSG-0700201CCE]; University of Virginia Cancer Center; James and Rebecca Craig Research Scholars Award; NCI Cancer Center Support Grant [P30 CA44579]; NATIONAL CANCER INSTITUTE [P30CA044579, R03CA141245, T32CA009109] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Virginia Cancer Center; James and Rebecca Craig Research Scholars Award; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sources of funding that have supported the work: 1. NIH T32 HL007849 (JBS; http://www.nih.gov/), 2. American Cancer Society MRSG-0700201CCE (TWB; http://www.cancer.org/), 3. NIH R03CA141245-01 (TWB, JTP; http://www.nih.gov/), 4. NIH T32 CA009109 (EB; http://www.nih.gov/), and the 5. University of Virginia Cancer Center (http://www.medicine.virginia.edu/research/research-centers/cancer-center/home.html) through the Farrow Fellowship Fund, the James and Rebecca Craig Research Scholars Award, and the NCI Cancer Center Support Grant, P30 CA44579.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Arshad A., 2011, AM J CLIN ONCOL; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; CALDAS C, 1995, INT J PANCREATOL, V18, P1; Conlon KC, 1996, ANN SURG, V223, P273, DOI 10.1097/00000658-199603000-00007; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P342, DOI 10.1158/1055-9965.EPI-06-0783; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Eltawil KM, 2012, HPB, V14, P260, DOI 10.1111/j.1477-2574.2012.00441.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Herreros-Villanueva M, 2012, WORLD J GASTROENTERO, V18, P1286, DOI 10.3748/wjg.v18.i12.1286; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hughes P, 2007, BIOTECHNIQUES, V43, P575, DOI 10.2144/000112598; Huynh AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020330; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Kimura K, 2006, CLIN CANCER RES, V12, P4925, DOI 10.1158/1078-0432.CCR-06-0544; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Larbouret C, 2012, NEOPLASIA, V14, P121, DOI 10.1593/neo.111602; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; Merk J, 2009, EUR J CARDIO-THORAC, V36, P454, DOI 10.1016/j.ejcts.2009.03.054; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, Vxxv; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; REDSTON MS, 1994, CANCER RES, V54, P3025; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Shi CJ, 2009, MOL CANCER RES, V7, P230, DOI 10.1158/1541-7786.MCR-08-0206; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Sun CL, 2001, ONCOL REP, V8, P89; Tseng WW, 2010, CLIN CANCER RES, V16, P3684, DOI 10.1158/1078-0432.CCR-09-2384; Tuveson DA, 2006, CANCER RES, V66, P242, DOI 10.1158/0008-5472.CAN-05-2305; Wagner T, 1999, GENOMICS, V62, P369, DOI 10.1006/geno.1999.6026; Walters DM, 2013, NEOPLASIA, V15, P143, DOI 10.1593/neo.121712; Wang H, 2005, ARCH DERMATOL, V141, P177, DOI 10.1001/archderm.141.2.177	42	60	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77065	10.1371/journal.pone.0077065	http://dx.doi.org/10.1371/journal.pone.0077065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204737	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300078
J	Widhalm, G; Kiesel, B; Woehrer, A; Traub-Weidinger, T; Preusser, M; Marosi, C; Prayer, D; Hainfellner, JA; Knosp, E; Wolfsberger, S				Widhalm, Georg; Kiesel, Barbara; Woehrer, Adelheid; Traub-Weidinger, Tatjana; Preusser, Matthias; Marosi, Christine; Prayer, Daniela; Hainfellner, Johannes A.; Knosp, Engelbert; Wolfsberger, Stefan			5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN-IX; DIFFUSELY INFILTRATING GLIOMAS; GUIDED RESECTION; BRAIN-TUMORS; QUANTITATIVE FLUORESCENCE; MALIGNANT GLIOMA; ANAPLASTIC FOCI; IMAGE FUSION; SURGERY; MANAGEMENT	Background: Intraoperative identification of anaplastic foci in diffusely infiltrating gliomas (DIG) with non-significant contrast-enhancement on MRI is indispensible to avoid histopathological undergrading and subsequent treatment failure. Recently, we found that 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PpIX) fluorescence can visualize areas with increased proliferative and metabolic activity in such gliomas intraoperatively. As treatment of DIG is predominantely based on histopathological World Health Organisation (WHO) parameters, we analyzed whether PpIX fluorescence can detect anaplastic foci according to these criteria. Methods: We prospectively included DIG patients with non-significant contrast-enhancement that received 5-ALA prior to resection. Intraoperatively, multiple samples from PpIX positive and negative intratumoral areas were collected using a modified neurosurgical microscope. In all samples, histopathological WHO criteria and proliferation rate were assessed and correlated to the PpIX fluorescence status. Results: A total of 215 tumor specimens were collected in 59 patients. Of 26 WHO grade III gliomas, 23 cases (85%) showed focal PpIX fluorescence, whereas 29 (91%) of 33 WHO grade II gliomas were PpIX negative. In intratumoral areas with focal PpIX fluorescence, mitotic rate, cell density, nuclear pleomorphism, and proliferation rate were significantly higher than in non-fluorescing areas. The positive predictive value of focal PpIX fluorescence for WHO grade III histology was 85%. Conclusions: Our study indicates that 5-ALA induced PpIX fluorescence is a powerful marker for intraoperative identification of anaplastic foci according to the histopathological WHO criteria in DIG with non-significant contrast-enhancement. Therefore, application of 5-ALA optimizes tissue sampling for precise histopathological diagnosis independent of brain-shift.	[Widhalm, Georg; Kiesel, Barbara; Knosp, Engelbert; Wolfsberger, Stefan] Med Univ Vienna, Dept Neurosurg, Vienna, Austria; [Widhalm, Georg; Woehrer, Adelheid; Hainfellner, Johannes A.] Med Univ Vienna, Inst Neurol, Vienna, Austria; [Traub-Weidinger, Tatjana] Med Univ Vienna, Dept Nucl Med, Vienna, Austria; [Preusser, Matthias; Marosi, Christine] Med Univ Vienna, Dept Internal Med 1, Vienna, Austria; [Prayer, Daniela] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Widhalm, Georg; Kiesel, Barbara; Woehrer, Adelheid; Traub-Weidinger, Tatjana; Preusser, Matthias; Marosi, Christine; Prayer, Daniela; Hainfellner, Johannes A.; Knosp, Engelbert; Wolfsberger, Stefan] Med Univ Vienna, Ctr Comprehens Canc, Cent Nervous Syst Tumours Unit CCC CNS, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Widhalm, G (corresponding author), Med Univ Vienna, Dept Neurosurg, Vienna, Austria.	georg.widhalm@meduniwien.ac.at	Preusser, Matthias/C-8530-2011; Widhalm, Georg/AFK-1669-2022	Preusser, Matthias/0000-0003-3541-2315; Widhalm, Georg/0000-0001-6014-0273; Kiesel, Barbara/0000-0003-0939-9831; Woehrer, Adelheid/0000-0001-8435-8189; Traub-Weidinger, Tatjana/0000-0003-1118-926X				Arita H, 2012, CANCER-AM CANCER SOC, V118, P1619, DOI 10.1002/cncr.26445; Bekelis K, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1112; Coluccia D, 2010, ACTA NEUROCHIR, V152, P1711, DOI 10.1007/s00701-010-0708-4; Duffau H, 2009, CURR OPIN ONCOL, V21, P543, DOI 10.1097/CCO.0b013e3283305996; Eljamel M Sam, 2009, Clin Neurosurg, V56, P93; Ewelt C, 2011, CLIN NEUROL NEUROSUR, V113, P541, DOI 10.1016/j.clineuro.2011.03.008; Floeth FW, 2011, EUR J NUCL MED MOL I, V38, P731, DOI 10.1007/s00259-010-1690-z; Hefti M, 2008, SWISS MED WKLY, V138, P180, DOI 2008/11/smw-12077; Ishihara R, 2007, NEUROL MED-CHIR, V47, P53, DOI 10.2176/nmc.47.53; Kamp MA, 2012, ACTA NEUROCHIR, V154, P223, DOI 10.1007/s00701-011-1200-5; Kuhnt Daniela, 2012, Critical Reviews in Biomedical Engineering, V40, P175, DOI 10.1615/CritRevBiomedEng.v40.i3.20; Kunz M, 2011, NEURO-ONCOLOGY, V13, P307, DOI 10.1093/neuonc/noq196; Li Y, 2013, INTRAOPERATIVE FLUOR; Moriuchi S, 2011, J NEUROSURG, V115, P278, DOI 10.3171/2011.4.JNS102137; Murahari MS, 2013, CURR PHARM DESIGN, V19, P4622, DOI 10.2174/1381612811319250009; Nguyen QT, 2013, NAT REV CANC; Nimsky C, 2000, NEUROSURGERY, V47, P1070, DOI 10.1097/00006123-200011000-00008; Nimsky Christopher, 2009, Top Magn Reson Imaging, V19, P197, DOI 10.1097/RMR.0b013e31819574ad; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; PAULUS W, 1989, CANCER, V64, P442, DOI 10.1002/1097-0142(19890715)64:2<442::AID-CNCR2820640217>3.0.CO;2-S; Potzi C, 2007, J NEURO-ONCOL, V84, P305, DOI 10.1007/s11060-007-9375-6; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Roberts DW, 2011, J NEUROSURG, V114, P595, DOI 10.3171/2010.2.JNS091322; Roessler K, 2007, MINIM INVAS NEUROSUR, V50, P273, DOI 10.1055/s-2007-991143; Sanai N, 2011, J NEUROSURG, V115, P740, DOI 10.3171/2011.6.JNS11252; Scherer H., 1940, AM J CANC, VXL, P1; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 1998, J PHOTOCH PHOTOBIO B, V45, P160, DOI 10.1016/S1011-1344(98)00176-6; Stummer W, 1998, ACTA NEUROCHIR, V140, P995, DOI 10.1007/s007010050206; Stupp R, 2003, SEMIN ONCOL, V30, P23, DOI 10.1053/j.seminoncol.2003.11.029; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Su XH, 2013, WIRES NANOMED NANOBI, V5, P219, DOI 10.1002/wnan.1212; The WHO, 2020, CLASSIFICATION TUMOU; Tsugu A, 2011, WORLD NEUROSURG, V76, P120, DOI 10.1016/j.wneu.2011.02.005; Utsuki S, 2006, J NEUROSURG, V104, P618, DOI 10.3171/jns.2006.104.4.618; Utsuki S, 2007, BRAIN TUMOR PATHOL, V24, P53, DOI 10.1007/s10014-007-0223-3; Valdes PA, 2011, J NEUROSURG, V115, P11, DOI 10.3171/2011.2.JNS101451; Valdes PA, 2011, NEURO-ONCOLOGY, V13, P846, DOI 10.1093/neuonc/nor086; von Campe G, 2012, ACTA NEUROCHIR, V154, P585, DOI 10.1007/s00701-012-1290-8; Wester HJ, 1999, J NUCL MED, V40, P205; Widhalm G, 2012, NEUROSURG REV, V35, P381, DOI 10.1007/s10143-012-0374-5; Widhalm G, 2011, J NEUROL NEUROSUR PS, V82, P512, DOI 10.1136/jnnp.2010.205229; Widhalm G, 2010, CANCER-AM CANCER SOC, V116, P1545, DOI 10.1002/cncr.24903; Zhao SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063682	47	109	111	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76988	10.1371/journal.pone.0076988	http://dx.doi.org/10.1371/journal.pone.0076988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204718	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300072
J	Singh, H; Dai, YY; Outten, FW; Busenlehner, LS				Singh, Harsimran; Dai, Yuyuan; Outten, F. Wayne; Busenlehner, Laura S.			Escherichia coli SufE Sulfur Transfer Protein Modulates the SufS Cysteine Desulfurase through Allosteric Conformational Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Structure; Iron-Sulfur Protein; Mass Spectrometry (MS); Protein Complexes; Protein Conformation; Protein-Protein Interactions; Cysteine Desulfurase; Hydrogen; Deuterium Exchange	FE-S CLUSTER; CSDB; BIOGENESIS; IDENTIFICATION; COUNTERPART; MECHANISMS; HOMOLOG; SYSTEM; GENE	Background: SufS cysteine desulfurase mobilizes sulfur for stress-responsive iron-sulfur cluster biogenesis in bacteria. Results: Interaction with the sulfur transfer protein SufE triggers conformational changes in the SufS active site. Conclusion: SufE participates in allosteric regulation of SufS activity in addition to being a sulfur acceptor. Significance: New insight into sulfur mobilization and transfer during iron-sulfur cluster metallocofactor assembly is provided. Fe-S clusters are critical metallocofactors required for cell function. Fe-S cluster biogenesis is carried out by assembly machinery consisting of multiple proteins. Fe-S cluster biogenesis proteins work together to mobilize sulfide and iron, form the nascent cluster, traffic the cluster to target metalloproteins, and regulate the assembly machinery in response to cellular Fe-S cluster demand. A complex series of protein-protein interactions is required for the assembly machinery to function properly. Despite considerable progress in obtaining static three-dimensional structures of the assembly proteins, little is known about transient protein-protein interactions during cluster assembly or the role of protein dynamics in the cluster assembly process. The Escherichia coli cysteine desulfurase SufS (EC 2.8.1.7) and its accessory protein SufE work together to mobilize persulfide from l-cysteine, which is then donated to the SufB Fe-S cluster scaffold. Here we use amide hydrogen/deuterium exchange mass spectrometry (HDX-MS) to characterize SufS-SufE interactions and protein dynamics in solution. HDX-MS analysis shows that SufE binds near the SufS active site to accept persulfide from Cys-364. Furthermore, SufE binding initiates allosteric changes in other parts of the SufS structure that likely affect SufS catalysis and alter SufS monomer-monomer interactions. SufE enhances the initial l-cysteine substrate binding to SufS and formation of the external aldimine with pyridoxal phosphate required for early steps in SufS catalysis. Together, these results provide a new picture of the SufS-SufE sulfur transferase pathway and suggest a more active role for SufE in promoting the SufS cysteine desulfurase reaction for Fe-S cluster assembly.	[Singh, Harsimran; Busenlehner, Laura S.] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA; [Dai, Yuyuan; Outten, F. Wayne] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	University of Alabama System; University of Alabama Tuscaloosa; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Outten, FW (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29208 USA.	outtenf@mailbox.sc.edu; LSBusenlehner@bama.ua.edu	Dai, Yuyuan/D-6485-2016	Outten, Franklin/0000-0002-9095-0194	Chemistry Research Instrumentation and Facilities Program (CRIF) [CHE 0639003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081706] Funding Source: NIH RePORTER	Chemistry Research Instrumentation and Facilities Program (CRIF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Qiaoli Liang (The University of Alabama) for maintenance and help with the mass spectrometer and Dr. Leslie Lovelace and Dr. Lukasz Lebioda (The University of South Carolina) for assistance with use of their ITC instrument. The University of Alabama Mass Spectrometry Facility was supported by Chemistry Research Instrumentation and Facilities Program (CRIF) Grant CHE 0639003.	Behshad E, 2009, BIOCHEMISTRY-US, V48, P12014, DOI 10.1021/bi802161u; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Busenlehner LS, 2007, BIOCHEMISTRY-US, V46, P2812, DOI 10.1021/bi6023385; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; Dai YY, 2012, FEBS LETT, V586, P4016, DOI 10.1016/j.febslet.2012.10.001; Ehring H, 1999, ANAL BIOCHEM, V267, P252, DOI 10.1006/abio.1998.3000; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Engen JR, 1999, BIOCHEMISTRY-US, V38, P8926, DOI 10.1021/bi982611y; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Goldsmith-Fischman S, 2004, J MOL BIOL, V344, P549, DOI 10.1016/j.jmb.2004.08.074; Hidese R, 2011, APPL MICROBIOL BIOT, V91, P47, DOI 10.1007/s00253-011-3336-x; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Loiseau L, 2005, J BIOL CHEM, V280, P26760, DOI 10.1074/jbc.M504067200; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Mandell J. G., 2005, CURRENT PROTOCOLS PR, V40; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Mandell JG, 2001, J MOL BIOL, V306, P575, DOI 10.1006/jmbi.2000.4416; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Ollagnier-De-Choudens S, 2003, FEBS LETT, V555, P263, DOI 10.1016/S0014-5793(03)01244-4; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Selbach B, 2010, BIOCHEMISTRY-US, V49, P8794, DOI 10.1021/bi101358k; Selbach BP, 2013, BIOCHEMISTRY-US, V52, P4089, DOI 10.1021/bi4001479; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Singh H, 2014, METHODS MOL BIOL, V1084, P81, DOI 10.1007/978-1-62703-658-0_5; Tawfik D.S., 2002, PROTEIN PROTOCOLS HD, P483; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	35	28	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36189	36200		10.1074/jbc.M113.525709	http://dx.doi.org/10.1074/jbc.M113.525709			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196966	hybrid, Green Published			2022-12-25	WOS:000328883400002
J	Peres, S; Felicori, L; Molina, F				Peres, Sabine; Felicori, Liza; Molina, Franck			Elementary Flux Modes Analysis of Functional Domain Networks Allows a Better Metabolic Pathway Interpretation	PLOS ONE			English	Article							DEHYDROGENASE; COMPLEX; BRICKS; TOOL	Metabolic network analysis is an important step for the functional understanding of biological systems. In these networks, enzymes are made of one or more functional domains often involved in different catalytic activities. Elementary flux mode (EFM) analysis is a method of choice for the topological studies of these enzymatic networks. In this article, we propose to use an EFM approach on networks that encompass available knowledge on structure-function. We introduce a new method that allows to represent the metabolic networks as functional domain networks and provides an application of the algorithm for computing elementary flux modes to analyse them. Any EFM that can be represented using the classical representation can be represented using our functional domain network representation but the fine-grained feature of functional domain networks allows to highlight new connections in EFMs. This methodology is applied to the tricarboxylic acid cycle (TCA cycle) of Bacillus subtilis, and compared to the classical analyses. This new method of analysis of the functional domain network reveals that a specific inhibition on the second domain of the lipoamide dehydrogenase (pdhD) component of pyruvate dehydrogenase complex leads to the loss of all fluxes. Such conclusion was not predictable in the classical approach.	[Peres, Sabine] Univ Paris 11, CNRS, Lab Rech Informat, UMR 8623, F-91405 Orsay, France; [Peres, Sabine] INRIA Saclay, Orsay, France; [Felicori, Liza] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Peres, Sabine; Felicori, Liza; Molina, Franck] SysDiag UMR3145 CNRS Biorad Parc Euromed, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Universidade Federal de Minas Gerais; Centre National de la Recherche Scientifique (CNRS)	Peres, S (corresponding author), Univ Paris 11, CNRS, Lab Rech Informat, UMR 8623, F-91405 Orsay, France.	speres@lri.fr; franck.molina@sysdiag.cnrs.fr	Felicori, Liza F/I-6683-2013	Peres, Sabine/0000-0002-4467-9989	BaSysBio FP6 EU project [LSHG-CT-2006-037469]	BaSysBio FP6 EU project	The work has been supported by BaSysBio FP6 EU project (LSHG-CT-2006-037469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; ASALI TBA, 1993, J MOL BIOL, V234, P779; Betts MJ, 2009, NAT STRUCT MOL BIOL, V16, P1125, DOI 10.1038/nsmb1109-1125; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Cuff AL, 2011, NUCLEIC ACIDS RES, V39, pD420, DOI 10.1093/nar/gkq1001; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; HOCH JA, 1978, J BACTERIOL, V133, P265, DOI 10.1128/JB.133.1.265-269.1978; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Maziere P, 2004, J MOL BIOL, V339, P77, DOI 10.1016/j.jmb.2004.03.029; Pei XY, 2008, STRUCTURE, V16, P1860, DOI 10.1016/j.str.2008.10.009; Peres S, 2010, BIOINFORMATICS, V26, P1542, DOI 10.1093/bioinformatics/btq169; Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251; Rialle S, 2010, BIOINFORMATICS, V26, P2298, DOI 10.1093/bioinformatics/btq409; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Ruppin E, 2010, CURR OPIN BIOTECH, V21, P502, DOI 10.1016/j.copbio.2010.07.002; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6; SCHUSTER STEFAN, 1994, J BIOL SYST, V2, P165, DOI [DOI 10.1142/S0218339094000131, 10.1142/S0218339094000131]; SONENSHEIN AL, 2002, KREBS CRITIC ACID CY, P151; Tung CH, 2007, NUCLEIC ACIDS RES, V35, pW438, DOI 10.1093/nar/gkm288; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76143	10.1371/journal.pone.0076143	http://dx.doi.org/10.1371/journal.pone.0076143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204596	Green Published, gold			2022-12-25	WOS:000326270700003
J	Salma, M; Rousseaux, S; Sequeira-Le Grand, A; Divol, B; Alexandre, H				Salma, Mohammad; Rousseaux, Sandrine; Sequeira-Le Grand, Anabelle; Divol, Benoit; Alexandre, Herve			Characterization of the Viable but Nonculturable (VBNC) State in Saccharomyces cerevisiae	PLOS ONE			English	Article							BOTRYTIS-AFFECTED WINE; MICROBIAL-POPULATIONS; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; PLASMA-MEMBRANE; SULFUR-DIOXIDE; FLOW-CYTOMETRY; VIABILITY; SULFITE; RESUSCITATION	The Viable But Non Culturable (VBNC) state has been thoroughly studied in bacteria. In contrast, it has received much less attention in other microorganisms. However, it has been suggested that various yeast species occurring in wine may enter in VBNC following sulfite stress. In order to provide conclusive evidences for the existence of a VBNC state in yeast, the ability of Saccharomyces cerevisiae to enter into a VBNC state by applying sulfite stress was investigated. Viable populations were monitored by flow cytometry while culturable populations were followed by plating on culture medium. Twenty-four hours after the application of the stress, the comparison between the culturable population and the viable population demonstrated the presence of viable cells that were non culturable. In addition, removal of the stress by increasing the pH of the medium at different time intervals into the VBNC state allowed the VBNC S. cerevisiae cells to "resuscitate". The similarity between the cell cycle profiles of VBNC cells and cells exiting the VBNC state together with the generation rate of cells exiting VBNC state demonstrated the absence of cellular multiplication during the exit from the VBNC state. This provides evidence of a true VBNC state. To get further insight into the molecular mechanism pertaining to the VBNC state, we studied the involvement of the SSU1 gene, encoding a sulfite pump in S. cerevisiae. The physiological behavior of wild-type S. cerevisiae was compared to those of a recombinant strain overexpressing SSU1 and null Delta ssu1 mutant. Our results demonstrated that the SSU1 gene is only implicated in the first stages of sulfite resistance but not per se in the VBNC phenotype. Our study clearly demonstrated the existence of an SO2-induced VBNC state in S. cerevisiae and that the stress removal allows the "resuscitation" of VBNC cells during the VBNC state.	[Salma, Mohammad; Rousseaux, Sandrine; Alexandre, Herve] Univ Bourgogne, UMR PAM, AgroSup Dijon Lab, Inst Univ Vigne & Vin Jules Guyot, Dijon, France; [Divol, Benoit] Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, South Africa; [Sequeira-Le Grand, Anabelle] Univ Bourgogne, Dijon, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; Stellenbosch University; Universite de Bourgogne	Alexandre, H (corresponding author), Univ Bourgogne, UMR PAM, AgroSup Dijon Lab, Inst Univ Vigne & Vin Jules Guyot, Dijon, France.	rvalex@u-bourgogne.fr	Rousseaux, Sandrine/L-3465-2016; alexandre, hervé/T-2101-2017	alexandre, herve/0000-0002-1316-7016; Divol, Benoit/0000-0003-1506-3170				Agnolucci M, 2010, INT J FOOD MICROBIOL, V143, P76, DOI 10.1016/j.ijfoodmicro.2010.07.022; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Avram D, 1997, J BACTERIOL, V179, P5971, DOI 10.1128/jb.179.18.5971-5974.1997; Bleve G, 2003, APPL ENVIRON MICROB, V69, P4116, DOI 10.1128/AEM.69.7.4116-4122.2003; Bogosian G, 1998, APPL ENVIRON MICROB, V64, P1736; Bogosian G, 2001, EMBO REP, V2, P770, DOI 10.1093/embo-reports/kve182; Brachmann CB, 1998, YEAST, V14, P115; CASALONE E, 1992, CURR GENET, V22, P435, DOI 10.1007/BF00326407; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Dhiaf A, 2008, J WATER HEALTH, V6, P565, DOI 10.2166/wh.2008.131; Divol B, 2005, J APPL MICROBIOL, V99, P85, DOI 10.1111/j.1365-2672.2005.02578.x; du Toit WJ, 2005, J APPL MICROBIOL, V98, P862, DOI 10.1111/j.1365-2672.2004.02549.x; Gauthier MJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P87; Giraffa G, 2004, FEMS MICROBIOL REV, V28, P251, DOI 10.1016/j.femsre.2003.10.005; Guillou S, 2003, INT J FOOD MICROBIOL, V88, P85, DOI 10.1016/S0168-1605(03)00112-0; Gundllapalli SB, 2006, ANN MICROBIOL, V56, P143, DOI 10.1007/BF03174996; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Lleo MD, 2000, APPL ENVIRON MICROB, V66, P4564; McDougald D, 1998, FEMS MICROBIOL ECOL, V25, P1, DOI 10.1111/j.1574-6941.1998.tb00455.x; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Millet V, 2001, THESIS; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; Minois N, 2009, AGING CELL, V8, P36, DOI 10.1111/j.1474-9726.2008.00446.x; NILSSON L, 1991, J BACTERIOL, V173, P5054, DOI 10.1128/jb.173.16.5054-5059.1991; Nystrom T, 2003, BIOESSAYS, V25, P204, DOI 10.1002/bies.10233; Oliver JD, 2005, J MICROBIOL, V43, P93; Park H, 2000, YEAST, V16, P881, DOI 10.1002/1097-0061(200007)16:10<881::AID-YEA576>3.0.CO;2-3; Park H, 2008, J MICROBIOL, V46, P542, DOI 10.1007/s12275-008-0053-y; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; RAVEL J, 1995, MICROBIOL-UK, V141, P377, DOI 10.1099/13500872-141-2-377; ROLLINS DM, 1986, APPL ENVIRON MICROB, V52, P531, DOI 10.1128/AEM.52.3.531-538.1986; Romano P., 1993, WINE MICROBIOLOGY BI; ROSZAK DB, 1984, CAN J MICROBIOL, V30, P334, DOI 10.1139/m84-049; ROTH WG, 1988, APPL ENVIRON MICROB, V54, P3142, DOI 10.1128/AEM.54.12.3142-3146.1988; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIMZ KL, 1980, ARCH MICROBIOL, V125, P89, DOI 10.1007/BF00403203; Serpaggi V, 2012, FOOD MICROBIOL, V30, P438, DOI 10.1016/j.fm.2011.12.020; Singleton VL, 1998, PRINCIPLES PRACTICES; Teixeira H, 2002, MICROBIAL ECOL, V43, P146, DOI 10.1007/s00248-001-0036-6; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; Yamamoto H, 2000, J Infect Chemother, V6, P112, DOI 10.1007/PL00012149; Zhong L, 2009, LETT APPL MICROBIOL, V48, P247, DOI 10.1111/j.1472-765X.2008.02522.x	43	57	60	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77600	10.1371/journal.pone.0077600	http://dx.doi.org/10.1371/journal.pone.0077600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204887	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700042
J	Kopek, BG; Shtengel, G; Grimm, JB; Clayton, DA; Hess, HF				Kopek, Benjamin G.; Shtengel, Gleb; Grimm, Jonathan B.; Clayton, David A.; Hess, Harald F.			Correlative Photoactivated Localization and Scanning Electron Microscopy	PLOS ONE			English	Article							SUPERRESOLUTION FLUORESCENCE; MITOCHONDRIAL NUCLEOIDS; ULTRATHIN CRYOSECTIONS; PROTEIN; ACTIN; MOLECULES; REVEALS; LIGHT; TOOL; VISUALIZATION	The ability to localize proteins precisely within subcellular space is crucial to understanding the functioning of biological systems. Recently, we described a protocol that correlates a precise map of fluorescent fusion proteins localized using three-dimensional super-resolution optical microscopy with the fine ultrastructural context of three-dimensional electron micrographs. While it achieved the difficult simultaneous objectives of high photoactivated fluorophore preservation and ultrastructure preservation, it required a super-resolution optical and specialized electron microscope that is not available to many researchers. We present here a faster and more practical protocol with the advantage of a simpler two-dimensional optical (Photoactivated Localization Microscopy (PALM)) and scanning electron microscope (SEM) system that retains the often mutually exclusive attributes of fluorophore preservation and ultrastructure preservation. As before, cryosections were prepared using the Tokuyasu protocol, but the staining protocol was modified to be amenable for use in a standard SEM without the need for focused ion beam ablation. We show the versatility of this technique by labeling different cellular compartments and structures including mitochondrial nucleoids, peroxisomes, and the nuclear lamina. We also demonstrate simultaneous two-color PALM imaging with correlated electron micrographs. Lastly, this technique can be used with small-molecule dyes as demonstrated with actin labeling using phalloidin conjugated to a caged dye. By retaining the dense protein labeling expected for super-resolution microscopy combined with ultrastructural preservation, simplifying the tools required for correlative microscopy, and expanding the number of useful labels we expect this method to be accessible and valuable to a wide variety of researchers.	[Kopek, Benjamin G.; Shtengel, Gleb; Grimm, Jonathan B.; Clayton, David A.; Hess, Harald F.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Kopek, BG (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	kopekb@janelia.hhmi.org	Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Kopek, Benjamin/0000-0002-5288-3744	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatty KE, 2006, ANGEW CHEM, V118, P7524, DOI DOI 10.1002/ANGE.200602114; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bos E, 2011, J STRUCT BIOL, V175, P62, DOI 10.1016/j.jsb.2011.03.022; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Brown TA, 2010, METHODS, V51, P458, DOI 10.1016/j.ymeth.2010.01.001; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Green M. R., 2012, MOL CLONING LAB MANU, V4th; GRIFFITHS G, 1984, J ULTRA MOL STRUCT R, V89, P65, DOI 10.1016/S0022-5320(84)80024-6; Grimm JB, 2013, ACS CHEM BIOL, V8, P1303, DOI 10.1021/cb4000822; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Humbel BM, 1998, MICROSC RES TECHNIQ, V42, P43, DOI 10.1002/(SICI)1097-0029(19980701)42:1<43::AID-JEMT6>3.3.CO;2-4; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; LOW I, 1974, FEBS LETT, V44, P340, DOI 10.1016/0014-5793(74)81173-7; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Morphew MK, 2007, METHOD CELL BIOL, V79, P493, DOI 10.1016/S0091-679X(06)79019-7; Murphy GE, 2011, J STRUCT BIOL, V176, P268, DOI 10.1016/j.jsb.2011.08.013; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Puliti D, 2011, BIOORGAN MED CHEM, V19, P1023, DOI 10.1016/j.bmc.2010.07.011; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sjollema KA, 2012, METHOD CELL BIOL, V111, P157, DOI 10.1016/B978-0-12-416026-2.00009-1; Small JV, 1999, MICROSC RES TECHNIQ, V47, P3; Takizawa T, 2003, J HISTOCHEM CYTOCHEM, V51, P31, DOI 10.1177/002215540305100105; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Welch MD, 1998, METHOD ENZYMOL, V298, P52, DOI 10.1016/S0076-6879(98)98008-9; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Wysocki LM, 2011, ANGEW CHEM INT EDIT, V50, P11206, DOI 10.1002/anie.201104571; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/NMETH.1841, 10.1038/nmeth.1841]; Yao J, 2011, GENE DEV, V25, P569, DOI 10.1101/gad.2021411	51	52	52	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77209	10.1371/journal.pone.0077209	http://dx.doi.org/10.1371/journal.pone.0077209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204771	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400030
J	Moura, A; Savageau, MA; Alves, R				Moura, Alexandra; Savageau, Michael A.; Alves, Rui			Relative Amino Acid Composition Signatures of Organisms and Environments	PLOS ONE			English	Article							HIGHLY EXPRESSED GENES; CODON USAGE BIAS; ESCHERICHIA-COLI; METABOLIC FLUXES; GENOMES; STOICHIOMETRY; EVOLUTION; PROTEOMES; SELECTION; SEQUENCE	Background: Identifying organism-environment interactions at the molecular level is crucial to understanding how organisms adapt to and change the chemical and molecular landscape of their habitats. In this work we investigated whether relative amino acid compositions could be used as a molecular signature of an environment and whether such a signature could also be observed at the level of the cellular amino acid composition of the microorganisms that inhabit that environment. Methodologies/Principal Findings: To address these questions we collected and analyzed environmental amino acid determinations from the literature, and estimated from complete genomic sequences the global relative amino acid abundances of organisms that are cognate to the different types of environment. Environmental relative amino acid abundances clustered into broad groups (ocean waters, host-associated environments, grass land environments, sandy soils and sediments, and forest soils), indicating the presence of amino acid signatures specific for each environment. These signatures correlate to those found in organisms. Nevertheless, relative amino acid abundance of organisms was more influenced by GC content than habitat or phylogeny. Conclusions: Our results suggest that relative amino acid composition can be used as a signature of an environment. In addition, we observed that the relative amino acid composition of organisms is not highly determined by environment, reinforcing previous studies that find GC content to be the major factor correlating to amino acid composition in living organisms.	[Moura, Alexandra; Alves, Rui] Univ Lleida, Dept Basic Med Sci, Lleida, Spain; [Moura, Alexandra; Alves, Rui] Univ Lleida, Inst Biomed Res, Lleida, Spain; [Moura, Alexandra] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Moura, Alexandra] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Savageau, Michael A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Universitat de Lleida; Universitat de Lleida; Universidade de Aveiro; Universidade de Aveiro; University of California System; University of California Davis	Alves, R (corresponding author), Univ Lleida, Dept Basic Med Sci, Lleida, Spain.	ralves@cmb.udl.cat	Alves, Rui/C-5920-2009; Moura, Alexandra/C-8555-2009	Alves, Rui/0000-0002-8112-5184; Moura, Alexandra/0000-0003-0339-1230	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/72256/2010]; Ministerio de Ciencia e Innovacion (Spain) [BFU2010-17704]; Generalitat de Catalunya [2009SGR809]; US Public Health Service [RO1-GM30054]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030054] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AM was supported by Fundacao para a Ciencia e a Tecnologia, Portugal, through the postdoctoral grant SFRH/BPD/72256/2010. RA was partially supported by the Ministerio de Ciencia e Innovacion (Spain) through grant BFU2010-17704, and by the Generalitat de Catalunya through a grant for research group 2009SGR809. MAS was supported in part by a grant from the US Public Health Service (RO1-GM30054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, DOI 10.4135/9781412952644; Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alves R, 2005, MOL MICROBIOL, V56, P1017, DOI 10.1111/j.1365-2958.2005.04566.x; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Baudouin-Cornu P, 2001, SCIENCE, V293, P297, DOI 10.1126/science.1061052; Bernal A, 2012, NUCLEIC ACIDS RES, V29, P126; Botzman M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r109; Chowdhury AR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-236; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; CURRAN JF, 1989, J MOL BIOL, V209, P65, DOI 10.1016/0022-2836(89)90170-8; Foerstner KU, 2005, EMBO REP, V6, P1208, DOI 10.1038/sj.embor.7400538; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Jollivet D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031150; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; Karlin S, 2005, P NATL ACAD SCI USA, V102, P7303, DOI 10.1073/pnas.0502313102; Karlin S, 2003, P NATL ACAD SCI USA, V100, P7313, DOI 10.1073/pnas.1232298100; Karlin S, 1998, MOL MICROBIOL, V29, P1341, DOI 10.1046/j.1365-2958.1998.01008.x; Klumpp S, 2013, PLOS ONE, V7; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Okayasu T, 1997, AMINO ACIDS, V13, P379, DOI 10.1007/BF01372601; Pramanik J, 1998, BIOTECHNOL BIOENG, V60, P230, DOI 10.1002/(SICI)1097-0290(19981020)60:2<230::AID-BIT10>3.0.CO;2-Q; Priestley M. B., 1988, NONLINEAR NONSTATION; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Redfield A.C., 1934, J JOHNSTONE MEMORIAL, P177; REDFIELD AC, 1958, AM SCI, V46, P205; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Roth A, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P189; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Sauer U, 1996, APPL ENVIRON MICROB, V62, P3687, DOI 10.1128/AEM.62.10.3687-3696.1996; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tekaia F, 2002, GENE, V297, P51, DOI 10.1016/S0378-1119(02)00871-5; Tekaia F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-307; Weber T, 2012, NATURE, V489, P419, DOI 10.1038/nature11357; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	42	54	56	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77319	10.1371/journal.pone.0077319	http://dx.doi.org/10.1371/journal.pone.0077319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204807	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400033
J	Ng, CA; Ke, Y; Perry, MD; Tan, PS; Hill, AP; Vandenberg, JI				Ng, Chai Ann; Ke, Ying; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Vandenberg, Jamie I.			C-Terminal beta 9-Strand of the Cyclic Nucleotide-Binding Homology Domain Stabilizes Activated States of Kv11.1 Channels	PLOS ONE			English	Article							LONG-QT SYNDROME; PROTEIN-STRUCTURE PREDICTION; SWISS-MODEL WORKSPACE; MOLECULAR-DYNAMICS; K+ CHANNEL; POTASSIUM CHANNEL; FUNCTIONAL-CHARACTERIZATION; CARDIAC-ARRHYTHMIA; PITUITARY-CELLS; HERG MUTATIONS	Kv11.1 potassium channels are important for regulation of the normal rhythm of the heartbeat. Reduced activity of Kv11.1 channels causes long QT syndrome type 2, a disorder that increases the risk of cardiac arrhythmias and sudden cardiac arrest. Kv11.1 channels are members of the KCNH subfamily of voltage-gated K+ channels. However, they also share many similarities with the cyclic nucleotide gated ion channel family, including having a cyclic nucleotide-binding homology (cNBH) domain. Kv11.1 channels, however, are not directly regulated by cyclic nucleotides. Recently, crystal structures of the cNBH domain from mEAG and zELK channels, both members of the KCNH family of voltage-gated potassium channels, revealed that a C-terminal beta 9-strand in the cNBH domain occupied the putative cyclic nucleotide-binding site thereby precluding binding of cyclic nucleotides. Here we show that mutations to residues in the beta 9-strand affect the stability of the open state relative to the closed state of Kv11.1 channels. We also show that disrupting the structure of the beta 9-strand reduces the stability of the inactivated state relative to the open state. Clinical mutations located in this beta 9-strand result in reduced trafficking efficiency, which suggests that binding of the C-terminal beta 9-strand to the putative cyclic nucleotide-binding pocket is also important for assembly and trafficking of Kv11.1 channels.	[Ng, Chai Ann; Ke, Ying; Perry, Matthew D.; Tan, Peter S.; Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia; [Ng, Chai Ann; Ke, Ying; Perry, Matthew D.; Hill, Adam P.; Vandenberg, Jamie I.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Vandenberg, JI (corresponding author), Victor Chang Cardiac Res Inst, Mol Cardiol & Biophys Div, Darlinghurst, NSW, Australia.	j.vandenberg@victorchang.edu.au	Vandenberg, Jamie I/B-6608-2013	Vandenberg, Jamie I/0000-0002-3859-3716; Ng, Chai Ann/0000-0002-3120-5450	National Health and Medical Research Council of Australia [573715]; National Heart Foundation of Australia [G11S5829]; NHMRC Senior Research Fellowship [1019693]; Australian Research Council Future Fellowship [FT110100075]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (#573715) (www.nhmrc.gov.au) and the National Heart Foundation of Australia (#G11S5829) (www.heartfoundation.org.au). JIV is supported by an NHMRC Senior Research Fellowship (#1019693) (www.nhmrc.gov.au) and APH is supported by an Australian Research Council Future Fellowship (FT110100075) (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Al-Owais M, 2009, EUR BIOPHYS J BIOPHY, V38, P569, DOI 10.1007/s00249-009-0408-2; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barros F, 1997, PFLUG ARCH EUR J PHY, V435, P119; Bauer CK, 1998, RECEPTOR CHANNEL, V6, P19; Becchetti A, 2002, EUR J NEUROSCI, V16, P415, DOI 10.1046/j.1460-9568.2002.02079.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Brelidze TI, 2013, P NATL ACAD SCI USA, V110, P11648, DOI 10.1073/pnas.1306887110; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Carlson AE, 2013, J GEN PHYSIOL, V141, P347, DOI 10.1085/jgp.201210900; Case DA, 2012, AMBER 12; Cerutti DS, 2008, J CHEM THEORY COMPUT, V4, P1669, DOI 10.1021/ct8002173; Ng CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031640; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Engeland B, 1998, J PHYSIOL-LONDON, V513, P647, DOI 10.1111/j.1469-7793.1998.647ba.x; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greenwood IA, 2009, J PHYSIOL-LONDON, V587, P2313, DOI 10.1113/jphysiol.2009.171272; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gustina AS, 2013, J GEN PHYSIOL, V141, P229, DOI 10.1085/jgp.201210870; Harley CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032654; Heide J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045624; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ju PC, 2009, J BIOL CHEM, V284, P1000, DOI 10.1074/jbc.M806400200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ng CA, 2009, J CHEM THEORY COMPUT, V5, P2886, DOI 10.1021/ct900190n; Ohya S, 2002, AM J PHYSIOL-GASTR L, V282, pG277, DOI 10.1152/ajpgi.00200.2001; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI [10.1517/14728222.12.7.837, 10.1517/14728222.12.7.837 ]; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schafer R, 1999, J PHYSIOL-LONDON, V518, P401, DOI 10.1111/j.1469-7793.1999.0401p.x; Sindhikara DJ, 2009, J CHEM THEORY COMPUT, V5, P1624, DOI 10.1021/ct800573m; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Trudeau MC, 1999, J NEUROSCI, V19, P2906; Uberuaga BP, 2004, J CHEM PHYS, V120, P6363, DOI 10.1063/1.1667473; Vandenberg JI, 2006, AM J PHYSIOL-CELL PH, V291, pC165, DOI 10.1152/ajpcell.00596.2005; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang DT, 2011, NAT STRUCT MOL BIOL, V18, P35, DOI 10.1038/nsmb.1966; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhao JT, 2009, J CARDIOVASC ELECTR, V20, P923, DOI 10.1111/j.1540-8167.2009.01468.x	54	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77032	10.1371/journal.pone.0077032	http://dx.doi.org/10.1371/journal.pone.0077032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204727	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400025
J	Chen, XY; Lu, MJ; Yin, G; Zhao, T; Shao, XN; Zhao, RX; Tang, Y; An, J; Jiang, SL; Zhao, SH				Chen, Xiuyu; Lu, Minjie; Yin, Gang; Zhao, Tao; Shao, Xiaoning; Zhao, Ranxu; Tang, Yue; An, Jing; Jiang, Shiliang; Zhao, Shihua			Three-Dimensional Phase-Sensitive Inversion-Recovery Turbo FLASH Sequence for the Assessment of Left Ventricular Myocardial Scar in Swine	PLOS ONE			English	Article							DELAYED CONTRAST ENHANCEMENT; INFARCT SIZE; BLOOD-FLOW; VIABILITY; MRI; 3D; 2D; VOLUME	Objectives: We sought to evaluate the feasibility and accuracy of free-breathing three-dimensional (3D) phase-sensitive inversion-recovery (PSIR) Turbo FLASH sequence for noninvasive assessment of left ventricular myocardial scar in swine models. Materials and Methods: Nine Chinese minipigs with experimentally induced acute myocardial infarction were studied. At 1 week and the study endpoint 4 weeks after myocardial infarction surgery, the 3D and 2D contrasted cardiac magnetic resonance (CMR) imaging were performed randomly by using a 1.5T clinical MR imaging system. Comparisons of myocardial scar volume (in cubic centimeters), scar transmurality (on a 5 points scale) and image quality (on a 4 points Likert scale) were performed by using the Pearson correlation and Bland-Altman analysis (for myocardial scar volume) or. statistics (for transmurality) or Wilcoxon signed rank test (for image quality). Results: In 6 of the 9 pigs, all procedures were successfully completed. In these pigs, a total of 48 segments with myocardial scars were detected by both 3D and 2D sequences, and there was good agreement for classification of scar transmurality (kappa=0.930). The scar volume determined by triphenyltetrazolium chloride (TTC) staining (3.52 +/- 1.40cm(3)) showed a good correlation with both 3D (3.54 +/- 1.36cm(3), r=0.957, P=0.003) and 2D sequence (3.53 +/- 1.26cm(3), r=0.942, P=0.005) at 4 weeks. And there were good correlation between scar volumes obtained from 3D and 2D techniques (r=0.859, P<0.001) at both time points. Both 3D and 2D images detected a small reduction of scar volume from week 1 to week 4 by a factor of 1.179 and 1.176, respectively. Although slightly more artifacts were observed on 2D PSIR images, the overall image quality was not significantly different between the two sequences (3.17 +/- 0.83 for 2D vs. 3.25 +/- 0.75 for 3D, P=0.655). Conclusions: The free-breathing 3D PSIR Turbo FLASH sequence enables accurate assessment of left ventricular myocardial scar.	[Chen, Xiuyu; Lu, Minjie; Yin, Gang; Zhao, Tao; Jiang, Shiliang; Zhao, Shihua] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Chen, Xiuyu; Lu, Minjie; Yin, Gang; Zhao, Tao; Zhao, Ranxu; Tang, Yue; Jiang, Shiliang; Zhao, Shihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shao, Xiaoning] Zhengzhou Univ, Dapartment Magnet Resonance Imaging, Affiliated Hosp 1, Zhengzhou 450052, Henan Province, Peoples R China; [Zhao, Ranxu] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Pathol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Tang, Yue] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Anim Expt Ctr,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [An, Jing] Siemens Shenzhen Magnet Resonance Ltd, APPL Dept, Shenzhen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhengzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Siemens AG	Zhao, SH (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Radiol,State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	zhaoshihua0202@126.com	Zhao, Shihua/A-7553-2019; Lu, Minjie/AAF-5091-2020	Zhao, Shihua/0000-0003-1339-7476; Lu, Minjie/0000-0001-8696-318X	National Natural Science Foundation of China [81130029, 81000604]; Peking Union Medical College Research Fund for Youth [2009-xhj04#]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Research Fund for Youth	This study was supported by a research grant of National Natural Science Foundation of China (81130029 and 81000604) and Peking Union Medical College Research Fund for Youth (2009-xhj04#). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano Y, 2008, J MAGN RESON IMAGING, V28, P1361, DOI 10.1002/jmri.21595; Cheng HB, 2011, INT J CARDIOVAS IMAG, V27, P979, DOI 10.1007/s10554-010-9741-x; Cheng HB, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-15; Dewey M, 2006, RADIOLOGY, V239, P703, DOI 10.1148/radiol.2393050586; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Fieno DS, 2004, J AM COLL CARDIOL, V43, P2124, DOI 10.1016/j.jacc.2004.01.043; Flett AS, 2011, JACC-CARDIOVASC IMAG, V4, P150, DOI 10.1016/j.jcmg.2010.11.015; Foo TKF, 2004, RADIOLOGY, V230, P845, DOI 10.1148/radiol.2303021411; Goetti R, 2011, RADIOLOGY, V259, P704, DOI 10.1148/radiol.11102216; Goldfarb JW, 2005, MAGNET RESON MED, V53, P367, DOI 10.1002/mrm.20369; Huber AM, 2005, RADIOLOGY, V237, P854, DOI 10.1148/radiol.2373041483; Hundley WG, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-5; Ishida M, 2009, CIRC J, V73, P1577, DOI 10.1253/circj.CJ-09-0524; Kellman P, 2002, MAGNET RESON MED, V47, P372, DOI 10.1002/mrm.10051; Kim RJ, 2008, CIRCULATION, V117, P629, DOI 10.1161/CIRCULATIONAHA.107.723262; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kino A, 2011, INT J CARDIOVAS IMAG, V27, P527, DOI 10.1007/s10554-010-9640-1; Kino A, 2009, AM J ROENTGENOL, V193, pW381, DOI 10.2214/AJR.08.1952; Klein C, 2004, J MAGN RESON IMAGING, V20, P588, DOI 10.1002/jmri.20164; Kuhl HP, 2004, RADIOLOGY, V230, P576, DOI 10.1148/radiol.2302021120; Nguyen TD, 2008, J MAGN RESON IMAGING, V27, P802, DOI 10.1002/jmri.21296; Ordovas KG, 2011, RADIOLOGY, V261, P358, DOI 10.1148/radiol.11091882; Peters DC, 2009, J MAGN RESON IMAGING, V30, P794, DOI 10.1002/jmri.21897; REIMER KA, 1979, CIRCULATION, V60, P866, DOI 10.1161/01.CIR.60.4.866; Saeed M, 2006, J AM COLL CARDIOL, V48, P1961, DOI 10.1016/j.jacc.2006.03.071; Selvanayagam JB, 2004, CIRCULATION, V110, P1535, DOI 10.1161/01.CIR.0000142045.22628.74; Simonetti OP, 2001, RADIOLOGY, V218, P215, DOI 10.1148/radiology.218.1.r01ja50215; Viallon M, 2011, J MAGN RESON IMAGING, V34, P1374, DOI 10.1002/jmri.22783; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Yin G, 2013, J MAGN RESON IMAGING, V38, P72, DOI 10.1002/jmri.23962	31	1	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78305	10.1371/journal.pone.0078305	http://dx.doi.org/10.1371/journal.pone.0078305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194917	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000096
J	Iyer, S; Karig, DK; Norred, SE; Simpson, ML; Doktycz, MJ				Iyer, Sukanya; Karig, David K.; Norred, S. Elizabeth; Simpson, Michael L.; Doktycz, Mitchel J.			Multi-Input Regulation and Logic with T7 Promoters in Cells and Cell-Free Systems	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; RNA-POLYMERASE; ESCHERICHIA-COLI; TRANSCRIPTION; EXPRESSION; OPERATORS; NETWORK; INTEGRATION; INHIBITION; ACTIVATION	Engineered gene circuits offer an opportunity to harness biological systems for biotechnological and biomedical applications. However, reliance on native host promoters for the construction of circuit elements, such as logic gates, can make the implementation of predictable, independently functioning circuits difficult. In contrast, T7 promoters offer a simple orthogonal expression system for use in a variety of cellular backgrounds and even in cell-free systems. Here we develop a T7 promoter system that can be regulated by two different transcriptional repressors for the construction of a logic gate that functions in cells and in cell-free systems. We first present LacI repressible T7lacO promoters that are regulated from a distal lac operator site for repression. We next explore the positioning of a tet operator site within the T7lacO framework to create T7 promoters that respond to tet and lac repressors and realize an IMPLIES gate. Finally, we demonstrate that these dual input sensitive promoters function in an E. coli cell-free protein expression system. Our results expand the utility of T7 promoters in cell based as well as cell-free synthetic biology applications.	[Iyer, Sukanya; Doktycz, Mitchel J.] Univ Tennessee, Grad Program Genome Sci & Technol, Knoxville, TN USA; [Iyer, Sukanya; Doktycz, Mitchel J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Karig, David K.; Simpson, Michael L.; Doktycz, Mitchel J.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA; [Norred, S. Elizabeth; Simpson, Michael L.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Simpson, Michael L.] Univ Tennessee, Ctr Environm Biotechnol, Knoxville, TN 37932 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Doktycz, MJ (corresponding author), Univ Tennessee, Grad Program Genome Sci & Technol, Knoxville, TN USA.	doktyczmj@ornl.gov	Simpson, Michael/A-8410-2011; Karig, David/AAT-9108-2020; Iyer, Sukanya/I-8283-2019; Karig, David/G-5703-2011; Doktycz, Mitchel J/A-7499-2011	Simpson, Michael/0000-0002-3933-3457; Karig, David/0000-0002-9508-6411; Iyer, Sukanya/0000-0001-8409-235X; Karig, David/0000-0002-9508-6411; Doktycz, Mitchel J/0000-0003-4856-8343; Norred, Sarah/0000-0001-7827-4050	NIH [EB000657]; Center for Nanophase Materials Sciences; Oak Ridge National Laboratory by the Division of Scientific User Facilities, U.S. Department of Energy; U.S. DOE [DE-AC05- 00OR22725]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000657] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Nanophase Materials Sciences(United States Department of Energy (DOE)); Oak Ridge National Laboratory by the Division of Scientific User Facilities, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	work was supported by NIH Grant EB000657 and by the in-house research program of the Center for Nanophase Materials Sciences, which is sponsored at Oak Ridge National Laboratory by the Division of Scientific User Facilities, U.S. Department of Energy. This work was performed at the Oak Ridge National Laboratory, managed by UT-Battelle, LLC, for the U.S. DOE under Contract No. DE-AC05- 00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An WL, 2009, P NATL ACAD SCI USA, V106, P8477, DOI 10.1073/pnas.0900267106; Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bond LM, 2010, NUCLEIC ACIDS RES, V38, P8072, DOI 10.1093/nar/gkq755; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Borghetti J, 2010, NATURE, V464, P873, DOI 10.1038/nature08940; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; CARRA JH, 1993, EMBO J, V12, P35, DOI 10.1002/j.1460-2075.1993.tb05629.x; CHAPMAN KA, 1987, NUCLEIC ACIDS RES, V15, P5413, DOI 10.1093/nar/15.13.5413; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Collier CP, 2011, CURR OPIN BIOTECH, V22, P516, DOI 10.1016/j.copbio.2011.05.002; Doktycz MJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100165; Dragosits M, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-2; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fletcher BL, 2004, NANO LETT, V4, P1809, DOI 10.1021/nl0493702; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Heyman Y, 2012, NAT NANOTECHNOL, V7, P374, DOI [10.1038/nnano.2012.65, 10.1038/NNANO.2012.65]; Hockenberry AJ, 2012, CURR OPIN CHEM BIOL, V16, P253, DOI 10.1016/j.cbpa.2012.05.179; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Ishikawa K, 2004, FEBS LETT, V576, P387, DOI 10.1016/j.febslet.2004.09.046; Karig D, 2005, BIOTECHNOL BIOENG, V89, P709, DOI 10.1002/bit.20371; Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lopez PJ, 1998, J MOL BIOL, V276, P861, DOI 10.1006/jmbi.1997.1576; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MAHER LJ, 1992, BIOCHEMISTRY-US, V31, P7587, DOI 10.1021/bi00148a021; McAllister W., 1997, MECH TRANSCRIPTION, P15; Michener JK, 2012, METAB ENG, V14, P212, DOI 10.1016/j.ymben.2011.09.004; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Moon TS, 2012, NATURE, V491, P249, DOI 10.1038/nature11516; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Niederholtmeyer H, 2013, ACS SYNTH BIOL, V2, P411, DOI 10.1021/sb300104f; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rao CV, 2012, CURR OPIN BIOTECH, V23, P689, DOI 10.1016/j.copbio.2011.12.015; RASKIN CA, 1993, P NATL ACAD SCI USA, V90, P3147, DOI 10.1073/pnas.90.8.3147; Retterer ST, 2010, LAB CHIP, V10, P1174, DOI 10.1039/b921592a; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; Shis DL, 2013, P NATL ACAD SCI USA, V110, P5028, DOI 10.1073/pnas.1220157110; Simpson ML, 2001, TRENDS BIOTECHNOL, V19, P317, DOI 10.1016/S0167-7799(01)01691-2; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Siuti P, 2012, ANAL CHEM, V84, P1092, DOI 10.1021/ac202726n; Siuti P, 2011, LAB CHIP, V11, P3523, DOI 10.1039/c1lc20462a; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tabor S, 1992, Biotechnology, V24, P280; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Temme K, 2012, NUCLEIC ACIDS RES, V40, P8773, DOI 10.1093/nar/gks597; WEICKERT MJ, 1993, J BACTERIOL, V175, P251, DOI 10.1128/JB.175.1.251-258.1993; Xie Z, 2010, NUCLEIC ACIDS RES, V38, P2692, DOI 10.1093/nar/gkq117; Zhan JA, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.42	64	18	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78442	10.1371/journal.pone.0078442	http://dx.doi.org/10.1371/journal.pone.0078442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194933	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000112
J	Pilling, E; Campbell, P; Coulson, M; Ruddle, N; Tornier, I				Pilling, Edward; Campbell, Peter; Coulson, Mike; Ruddle, Natalie; Tornier, Ingo			A Four-Year Field Program Investigating Long-Term Effects of Repeated Exposure of Honey Bee Colonies to Flowering Crops Treated with Thiamethoxam	PLOS ONE			English	Article							HYMENOPTERA APIDAE; PESTICIDE-RESIDUES; DECLINES; LOSSES; IMPACT	Neonicotinoid residues in nectar and pollen from crop plants have been implicated as one of the potential factors causing the declines of honey bee populations. Median residues of thiamethoxam in pollen collected from honey bees after foraging on flowering seed treated maize were found to be between 1 and 7 mu g/kg, median residues of the metabolite CGA322704 (clothianidin) in the pollen were between 1 and 4 mu g/kg. In oilseed rape, median residues of thiamethoxam found in pollen collected from bees were between <1 and 3.5 mu g/kg and in nectar from foraging bees were between 0.65 and 2.4 mu g/kg. Median residues of CGA322704 in pollen and nectar in the oilseed rape trials were all below the limit of quantification (1 mu g/kg). Residues in the hive were even lower in both the maize and oilseed rape trials, being at or below the level of detection of 1 mu g/kg for bee bread in the hive and at or below the level of detection of 0.5 mu g/kg for hive nectar, honey and royal jelly samples. The long-term risk to honey bee colonies in the field was also investigated, including the sensitive overwintering stage, from four years consecutive single treatment crop exposures to flowering maize and oilseed rape grown from thiamethoxam treated seeds at rates recommended for insect control. Throughout the study, mortality, foraging behavior, colony strength, colony weight, brood development and food storage levels were similar between treatment and control colonies. Detailed examination of brood development throughout the year demonstrated that colonies exposed to the treated crop were able to successfully overwinter and had a similar health status to the control colonies in the following spring. We conclude that these data demonstrate there is a low risk to honey bees from systemic residues in nectar and pollen following the use of thiamethoxam as a seed treatment on oilseed rape and maize.	[Pilling, Edward] JSC Int Ltd, Harrogate, N Yorkshire, England; [Campbell, Peter; Coulson, Mike; Ruddle, Natalie] Syngenta Ltd, Jealotts Hill Res Stn, Bracknell, Berks, England; [Tornier, Ingo] EcoChem GmbH, Eurofins Agrosci Serv, Niefern Oschelbronn, Germany	Syngenta	Campbell, P (corresponding author), Syngenta Ltd, Jealotts Hill Res Stn, Bracknell, Berks, England.	peter.campbell@syngenta.com	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216				Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anonymous, 2010, Bulletin OEPP, V40, P313, DOI 10.1111/j.1365-2338.2010.02418.x; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2752; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Greatti M, 2002, B INSECTOL, V56, P69; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; IMDORF A, 1987, APIDOLOGIE, V18, P137, DOI 10.1051/apido:19870204; Kluser S., 2011, UNEP EMERGING ISSUES; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Winston M. L. L., 1991, BIOL HONEY BEE	29	151	156	4	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77193	10.1371/journal.pone.0077193	http://dx.doi.org/10.1371/journal.pone.0077193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194871	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000050
J	Saw, JHW; Schatz, M; Brown, MV; Kunkel, DD; Foster, JS; Shick, H; Christensen, S; Hou, SB; Wan, XH; Donachie, SP				Saw, Jimmy H. W.; Schatz, Michael; Brown, Mark V.; Kunkel, Dennis D.; Foster, Jamie S.; Shick, Harry; Christensen, Stephanie; Hou, Shaobin; Wan, Xuehua; Donachie, Stuart P.			Cultivation and Complete Genome Sequencing of Gloeobacter kilaueensis sp nov., from a Lava Cave in Kilauea Caldera, Hawai'i	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; CAROTENOID BIOSYNTHESIS; OXYGENIC PHOTOSYNTHESIS; VANCOMYCIN RESISTANCE; PHYLOGENETIC ANALYSES; PHYTOENE DESATURASE; VIOLACEUS PCC-7421; SPECIES DEFINITION; LACKS THYLAKOIDS; CYANOBACTERIUM	The ancestor of Gloeobacter violaceus PCC 7421(T) is believed to have diverged from that of all known cyanobacteria before the evolution of thylakoid membranes and plant plastids. The long and largely independent evolutionary history of G. violaceus presents an organism retaining ancestral features of early oxygenic photoautotrophs, and in whom cyanobacteria evolution can be investigated. No other Gloeobacter species has been described since the genus was established in 1974 (Rippka et al., Arch Microbiol 100:435). Gloeobacter affiliated ribosomal gene sequences have been reported in environmental DNA libraries, but only the type strain's genome has been sequenced. However, we report here the cultivation of a new Gloeobacter species, G. kilaueensis JS1(T), from an epilithic biofilm in a lava cave in Kilauea Caldera, Hawai'i. The strain's genome was sequenced from an enriched culture resembling a low-complexity metagenomic sample, using 9 kb paired-end 454 pyrosequences and 400 bp paired-end Illumina reads. The JS1(T) and G. violaceus PCC 7421(T) genomes have little gene synteny despite sharing 2842 orthologous genes; comparing the genomes shows they do not belong to the same species. Our results support establishing a new species to accommodate JS1(T), for which we propose the name Gloeobacter kilaueensis sp. nov. Strain JS1(T) has been deposited in the American Type Culture Collection (BAA-2537), the Scottish Marine Institute's Culture Collection of Algae and Protozoa (CCAP 1431/1), and the Belgian Coordinated Collections of Microorganisms (ULC0316). The G. kilaueensis holotype has been deposited in the Algal Collection of the US National Herbarium (US# 217948). The JS1(T) genome sequence has been deposited in GenBank under accession number CP003587. The G+C content of the genome is 60.54 mol%. The complete genome sequence of G. kilaueensis JS1(T) may further understanding of cyanobacteria evolution, and the shift from anoxygenic to oxygenic photosynthesis.	[Saw, Jimmy H. W.; Hou, Shaobin; Wan, Xuehua; Donachie, Stuart P.] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Schatz, Michael] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Brown, Mark V.] Univ Hawaii, NASA Astrobiol Inst, Honolulu, HI 96822 USA; [Brown, Mark V.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Kunkel, Dennis D.] Dennis Kunkel Microscopy Inc, Kailua, HI USA; [Foster, Jamie S.] Univ Florida, Space Life Sci Lab, Dept Microbiol & Cell Sci, Kennedy Space Ctr, Kennedy, FL USA; [Christensen, Stephanie] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; [Hou, Shaobin; Wan, Xuehua] Univ Hawaii Manoa, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; Cold Spring Harbor Laboratory; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of New South Wales Sydney; State University System of Florida; University of Florida; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Donachie, SP (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	donachie@hawaii.edu	Saw, Jimmy/J-1360-2019; Donachie, Stuart P/O-6220-2016; Wan, Xuehua/AAE-4237-2022; Saw, Jimmy HW/A-9972-2009; Schatz, Michael/L-2690-2019; Wan, Xuehua/D-5433-2016	Saw, Jimmy/0000-0001-8353-3854; Wan, Xuehua/0000-0002-6367-848X; Saw, Jimmy HW/0000-0001-8353-3854; Schatz, Michael/0000-0002-4118-4446; Wan, Xuehua/0000-0002-6367-848X; Donachie, Stuart/0000-0002-8322-6915; Hou, Shaobin/0000-0003-3467-8242; Foster, Jamie/0000-0001-8603-4006	College of Natural Sciences; EPSCoR REAP award through NSF [0554657]; Lewis and Clark Fund for Exploration and Field Research in Astrobiology	College of Natural Sciences; EPSCoR REAP award through NSF; Lewis and Clark Fund for Exploration and Field Research in Astrobiology	Early investigations of the epilithic biofilm were supported by start-up funds to SPD from the Dean of the College of Natural Sciences, and by an EPSCoR REAP award to SPD, MVB, Gernot Presting and John M. Berestecky through NSF #0554657 IMUA 2: NSF Hawaii EPSCoR to James Gaines (PI), Kenneth Kaneshiro (Co-PI), and Donald Price (co-PI). Fieldwork was supported by a grant from The Lewis and Clark Fund for Exploration and Field Research in Astrobiology to JHWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 2011, PHOTOSYNTH RES, V107, P59, DOI 10.1007/s11120-010-9552-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Bidigare R.R., 2005, ALGAL CULTURING TECH, P327; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Brady A, 2011, NAT METHODS, V8, P367, DOI 10.1038/nmeth0511-367; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cohen O, 2010, BIOINFORMATICS, V26, P2914, DOI 10.1093/bioinformatics/btq549; Cohen O, 2010, MOL BIOL EVOL, V27, P703, DOI 10.1093/molbev/msp240; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Couradeau E, 2012, SCIENCE, V336, P459, DOI 10.1126/science.1216171; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Cuzman OA, 2010, MICROB ECOL, V60, P81, DOI 10.1007/s00248-010-9672-z; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; Guler S, 1996, J BIOL CHEM, V271, P7501; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kroll D, 2001, P NATL ACAD SCI USA, V98, P4238, DOI 10.1073/pnas.061500998; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lapage SP, 1992, INT CODE NOMENCLATUR; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066323; Mathies G, 2011, J PHYS CHEM A, V115, P9552, DOI 10.1021/jp112413d; McNeill J, 2011, TAXON, V60, P1495, DOI 10.1002/tax.605030; Mimuro M, 2008, PHOTOSYNTH RES, V97, P167, DOI 10.1007/s11120-008-9311-4; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; NELISSEN B, 1995, MOL BIOL EVOL, V12, P1166; Rexroth S, 2011, PLANT CELL, V23, P2379, DOI 10.1105/tpc.111.085779; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; RosselloMora R., 2006, MOL IDENTIFICATION S, P23, DOI DOI 10.1007/978-3-540-31292-5_2; Rozen S, 2000, Methods Mol Biol, V132, P365; Saw JHW, 2012, STAND GENOMIC SCI, V6, P84, DOI 10.4056/sigs.2445005; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steiger S, 2005, ARCH MICROBIOL, V184, P207, DOI 10.1007/s00203-005-0004-5; Swingley Wesley D., 2008, P21; Tsuchiya T, 2005, FEBS LETT, V579, P2125, DOI 10.1016/j.febslet.2005.02.066; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Ulijasz AT, 2000, BIOCHEMISTRY-US, V39, P11417, DOI 10.1021/bi0012888; Westphal S, 2001, P NATL ACAD SCI USA, V98, P4243, DOI 10.1073/pnas.061501198; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032	56	49	52	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76376	10.1371/journal.pone.0076376	http://dx.doi.org/10.1371/journal.pone.0076376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194836	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326037000015
J	Wang, PW; Lai, WF; Li, MLJ; Xu, F; Yalamanchili, HK; Lovell-Badge, R; Wang, JW				Wang, Panwen; Lai, Wing-Fu; Li, Mulin Jun; Xu, Feng; Yalamanchili, Hari Krishna; Lovell-Badge, Robin; Wang, Junwen			Inference of Gene-Phenotype Associations via Protein-Protein Interaction and Orthology	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINURIA; JAPANESE CHILDREN; DISEASE; PRIORITIZATION; GENOME; DATABASE; NEPHROCALCINOSIS; PHENOMICDB; MUTATIONS; DISCOVERY	One of the fundamental goals of genetics is to understand gene functions and their associated phenotypes. To achieve this goal, in this study we developed a computational algorithm that uses orthology and protein-protein interaction information to infer gene-phenotype associations for multiple species. Furthermore, we developed a web server that provides genome-wide phenotype inference for six species: fly, human, mouse, worm, yeast, and zebrafish. We evaluated our inference method by comparing the inferred results with known gene-phenotype associations. The high Area Under the Curve values suggest a significant performance of our method. By applying our method to two human representative diseases, Type 2 Diabetes and Breast Cancer, we demonstrated that our method is able to identify related Gene Ontology terms and Kyoto Encyclopedia of Genes and Genomes pathways. The web server can be used to infer functions and putative phenotypes of a gene along with the candidate genes of a phenotype, and thus aids in disease candidate gene discovery. Our web server is available at http://jjwanglab.org/PhenoPPIOrth.	[Wang, Panwen; Lai, Wing-Fu; Li, Mulin Jun; Xu, Feng; Yalamanchili, Hari Krishna; Wang, Junwen] Univ Hong Kong, Dept Biochem, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wang, Panwen; Li, Mulin Jun; Xu, Feng; Yalamanchili, Hari Krishna; Wang, Junwen] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen, Peoples R China; [Lovell-Badge, Robin] MRC Natl Inst Med Res, Div Dev Genet, London, England; [Wang, Junwen] Univ Hong Kong, Ctr Genom Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; MRC National Institute for Medical Research; University of Hong Kong	Wang, JW (corresponding author), Univ Hong Kong, Dept Biochem, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	Junwen@hku.hk	Wang, Junwen/C-4432-2009; Wang, Junwen/D-3700-2011; Lai, Wing-Fu/J-3170-2015	Wang, Junwen/0000-0002-4432-4707; Lai, Wing-Fu/0000-0003-0585-6396; Lovell-Badge, Robin/0000-0001-9364-4179; Yalamanchili, Hari Krishna/0000-0001-9892-3054	Research Grants Council of Hong Kong [781511M, N_HKU752/10, AoE M-04/04]; Natural Science Foundation of China(NSFC) [91229105]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Natural Science Foundation of China(NSFC)(National Natural Science Foundation of China (NSFC))	Research Grants Council of Hong Kong (781511M, N_HKU752/10, AoE M-04/04) Natural Science Foundation of China(NSFC) (91229105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045; Adie EA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-55; Adie EA, 2006, BIOINFORMATICS, V22, P773, DOI 10.1093/bioinformatics/btk031; Akuta N, 1997, KIDNEY INT, V52, P911, DOI 10.1038/ki.1997.412; Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Cho SK, 2004, EUKARYOT CELL, V3, P302, DOI 10.1128/EC.3.2.302-310.2004; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Date Shailesh V., 2007, V408, P109, DOI 10.1007/978-1-59745-547-3_7; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; Giallourakis C, 2005, ANNU REV GENOM HUM G, V6, P381, DOI 10.1146/annurev.genom.6.080604.162234; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Groth P, 2007, NUCLEIC ACIDS RES, V35, pD696, DOI 10.1093/nar/gkl662; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Hwang T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks615; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Kahraman A, 2005, BIOINFORMATICS, V21, P418, DOI 10.1093/bioinformatics/bti010; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Li MLJ, 2013, NUCLEIC ACIDS RES, V41, pW150, DOI 10.1093/nar/gkt456; Li MJ, 2012, CELL RES, V22, P1505, DOI 10.1038/cr.2012.106; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lloyd SE, 1997, J CLIN INVEST, V99, P967, DOI 10.1172/JCI119262; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Nehrt NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002073; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Parshad R, 1996, BRIT J CANCER, V74, P1, DOI 10.1038/bjc.1996.307; Patti ME, 1998, J BASIC CLIN PHYSL P, V9, P89, DOI DOI 10.1515/JBCPP.1998.9.2-4.89; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; POOK MA, 1993, HUM MOL GENET, V2, P2129, DOI 10.1093/hmg/2.12.2129; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rantamaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068722; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; SCHEINMAN SJ, 1993, J CLIN INVEST, V91, P2351, DOI 10.1172/JCI116467; Sergeev IN, 2012, ANTICANCER RES, V32, P299; Singh S, 2009, REJUV RES, V12, P185, DOI 10.1089/rej.2009.0850; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Studer RA, 2009, TRENDS GENET, V25, P210, DOI 10.1016/j.tig.2009.03.004; Sypecka J, 2005, ACTA NEUROBIOL EXP, V65, P221; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thompson VC, 2012, INT J CANCER, V131, P662, DOI 10.1002/ijc.26414; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Washington NL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000247; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yalamanchili HK, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S19; Yalamanchili HK, 2011, NRPROF NEURAL RESPON, V2011, P33; Yang P, 2012, BIOINFORMATICS, V28, P2640, DOI 10.1093/bioinformatics/bts504; Yang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021502	61	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77478	10.1371/journal.pone.0077478	http://dx.doi.org/10.1371/journal.pone.0077478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194887	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000066
J	Xu, ZQ; Zhao, L; Zhu, LY; He, M; Zheng, LM; Wu, Y				Xu, Zhenqun; Zhao, Lan; Zhu, Ling-Yan; He, Min; Zheng, Limin; Wu, Yan			MicroRNA-17, 20a Regulates the Proangiogenic Function of Tumor-Associated Macrophages via Targeting Hypoxia-Inducible Factor 2 alpha	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; ACTIVATED MONOCYTES; TRANSCRIPTIONAL RESPONSE; PERITUMORAL STROMA; PROMOTE EXPANSION; CANCER; EXPRESSION; HIF-2-ALPHA; ANGIOGENESIS; INVASION	Tumor-associated macrophages (TAMs) constitute a major component of the leukocyte infiltrate of most solid tumors, and they usually exhibit a proangiogenic phenotype which facilitates tumor growth in most circumstances. However, the precise mechanisms regulating the proangiogenic properties of TAMs remain largely unclear. In the present study, we found that the expression of hypoxia-inducible factor 2 alpha (HIF-2 alpha) was significantly up-regulated in macrophages from tumor tissues of several solid tumors. Macrophages exposed to tumor cell line derived-culture supernatants (TSN) also expressed high levels of HIF-2 alpha in vitro, without a requirement for hypoxia. We identified miR-17 and miR-20a as the key regulators of HIF-2 alpha expression in TAMs, and autocrine IL-6 played an important role in mediating the expression of miR-17, miR-20a, and thereafter HIF-2 alpha in TAMs. Furthermore, the elevated HIF-2 alpha in TAMs stimulated transcription of a set of proangiogenic genes such as VEGFA and PDGFB, which might in turn contribute to the angiogenic process within tumors. Our data provide evidence in support of the critical role of HIF-2 alpha in the proangiogenic activity of TAMs and also reveal a novel mechanism by which miRNAs regulate TAM functions through modulation of HIF-2 alpha expression under non-hypoxic conditions.	[Xu, Zhenqun; Zhao, Lan; Zhu, Ling-Yan; Zheng, Limin; Wu, Yan] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [He, Min] Guangdong Prov Hosp Chinese Med, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou University of Chinese Medicine	Wu, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Key Lab Gene Engn,Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	wuyan32@mail.sysu.edu.cn	zheng, limin/HGB-2510-2022	He, Min/0000-0003-0361-8984; Zheng, Limin/0000-0002-8281-1450	National Natural Science Foundation of China [31200663]; Natural Science Foundation of Guangdong Province, China [S2012040008103]; Fundamental Research Funds for the Central Universities [13lgpy37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the project grants from the National Natural Science Foundation of China (31200663), the Natural Science Foundation of Guangdong Province, China (S2012040008103), and the Fundamental Research Funds for the Central Universities (13lgpy37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Ding T, 2009, HUM PATHOL, V40, P381, DOI 10.1016/j.humpath.2008.08.011; Duluc D, 2007, BLOOD, V110, P4319, DOI 10.1182/blood-2007-02-072587; Elbarghati L, 2008, IMMUNOBIOLOGY, V213, P899, DOI 10.1016/j.imbio.2008.07.016; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; Knowles H, 2004, NOVART FDN SYMP, V256, P259; Knowles H, 2004, NOVART FDN SYMP, V256, P200; Knowles Helen, 2004, Novartis Found Symp, V256, P189; Koga F, 2004, J UROLOGY, V171, P1080, DOI 10.1097/01.ju.0000110541.62972.08; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kuang DM, 2010, J IMMUNOL, V185, P1544, DOI 10.4049/jimmunol.0904094; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Leek RD, 2002, CANCER RES, V62, P1326; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Pan XQ, 2012, CHIN J CANCER, V31, P557, DOI 10.5732/cjc.012.10046; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rupaimoole Rajesha, 2011, Chin J Cancer, V30, P368; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Sowter HM, 2003, CANCER RES, V63, P6130; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; THOMASSEN MJ, 1991, CANCER RES, V51, P857; VIGNAUD JM, 1994, CANCER RES, V54, P5455; Wang B, 2011, ANN SURG ONCOL, V18, P2585, DOI 10.1245/s10434-011-1609-3; Wang R, 2011, LUNG CANCER, V74, P188, DOI 10.1016/j.lungcan.2011.04.009; White JR, 2004, GENOMICS, V83, P1, DOI 10.1016/S0888-7543(03)00215-5; Wilke CM, 2011, INT REV IMMUNOL, V30, P120, DOI 10.3109/08830185.2011.567362; Wu Y, 2012, CANCER MICROENVIRON, V5, P195, DOI 10.1007/s12307-012-0113-z; Wu Y, 2011, J PATHOL, V225, P438, DOI 10.1002/path.2947; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904; Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	56	22	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77890	10.1371/journal.pone.0077890	http://dx.doi.org/10.1371/journal.pone.0077890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194900	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000079
J	Alves, SP; Bessa, RJB; Quaresma, MAG; Kilminster, T; Scanlon, T; Oldham, C; Milton, J; Greeff, J; Almeida, AM				Alves, Susana P.; Bessa, Rui J. B.; Quaresma, Mario A. G.; Kilminster, Tanya; Scanlon, Tim; Oldham, Chris; Milton, John; Greeff, Johan; Almeida, Andre M.			Does the Fat Tailed Damara Ovine Breed Have a Distinct Lipid Metabolism Leading to a High Concentration of Branched Chain Fatty Acids in Tissues?	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; SHEEP; TRIACYLGLYCEROLS; ENERGY	Fat tailed sheep breeds are known for their adaptation to nutritional stress, among other harsh production conditions. Damara sheep, native to Southern Africa, have recently been exported to other areas of the world, particularly Australia, aiming to produce lamb in semi-arid regions. Damaras have a unique hanging fat tail, a fat depot able to be mobilized under nutritional stress. In this article we perform an in-depth characterization of the fatty acid profiles of the fat tail in underfed and control Damara rams. Profiles were very similar between experimental groups, with the exception of palmitic acid (16: 0) that was lower (P = 0.014) in underfed animals. However, the most striking result was the very high proportions of non-terminal branched chain fatty acids found in the fat tail adipose tissue, as well as the gastrocnemius muscle of Damara rams. The muscle of Dorper and Merino rams used in the same experiment did not present non-terminal branched chain fatty acids, suggesting that Damara rams have a unique lipid metabolism. Herein, we interpret this trait relating it to a higher ability of Damara sheep to digest fibrous fodder and to putative differences in the propionate metabolism by comparison to other sheep breeds.	[Alves, Susana P.; Bessa, Rui J. B.; Quaresma, Mario A. G.; Almeida, Andre M.] Univ Tecn Lisboa, Fac Med Vet, CIISA, Lisbon, Portugal; [Kilminster, Tanya; Scanlon, Tim; Oldham, Chris; Greeff, Johan] DAFWA, Perth, WA, Australia; [Milton, John] Univ Western Australia, Fac Nat & Agr Sci, Crawley, WA, Australia; [Almeida, Andre M.] IICT, Biotrop, Lisbon, Portugal; [Almeida, Andre M.] IBET, Oeiras, Portugal; [Almeida, Andre M.] UNL, ITQB, BCV, Oeiras, Portugal	Universidade de Lisboa; Government of Western Australia; Department of Agriculture & Food - Western Australia; University of Western Australia; Universidade Nova de Lisboa	Almeida, AM (corresponding author), Univ Tecn Lisboa, Fac Med Vet, CIISA, Lisbon, Portugal.	aalmeida@fmv.utl.pt	Bessa, Rui J. B./B-8006-2008; Alves, Susana/Q-3889-2019; Alves, Susana P/C-1447-2008; Almeida, Andre/I-4369-2013	Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana/0000-0002-3171-9566; Alves, Susana P/0000-0002-3171-9566; Almeida, Andre/0000-0002-7810-3988; Quaresma, Mario/0000-0002-6988-3935; Scanlon, Timothy/0000-0001-5706-5487	Department of Agriculture and Food WA (Perth, Western Australia); Fundacao para a Ciencia e a Tecnologia of the Ministerio da Ciencia, Tecnologia e do Ensino Superior (Lisbon, Portugal) [SFRH/BPD/76836/2011, SFRH/BPD/90916/2012]	Department of Agriculture and Food WA (Perth, Western Australia); Fundacao para a Ciencia e a Tecnologia of the Ministerio da Ciencia, Tecnologia e do Ensino Superior (Lisbon, Portugal)	Authors acknowledge financial support from the Department of Agriculture and Food WA (Perth, Western Australia). SP Alves was supported through the grant SFRH/BPD/76836/2011 and AM Almeida was financed by grant SFRH/BPD/90916/2012, and a Ciencia 2007 Research Contract, both from Fundacao para a Ciencia e a Tecnologia of the Ministerio da Ciencia, Tecnologia e do Ensino Superior (Lisbon, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipanah M, 2011, J FOOD AGRIC ENVIRON, V9, P416; Almeida AM, 2013, TROP ANIM H IN PRESS; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; ALSHABIBI MM, 1973, J AGR SCI-CAMBRIDGE, V80, P255, DOI 10.1017/S0021859600057725; Atti N, 2004, ANIM RES, V53, P165, DOI 10.1051/animres:2004012; Bas P, 2000, LIVEST PROD SCI, V64, P61, DOI 10.1016/S0301-6226(00)00176-7; Berthelot V, 2012, MEAT SCI, V90, P548, DOI 10.1016/j.meatsci.2011.09.014; Berthelot V, 2001, SMALL RUMINANT RES, V41, P29, DOI 10.1016/S0921-4488(01)00190-0; BUCKNER JS, 1978, ARCH BIOCHEM BIOPHYS, V186, P152, DOI 10.1016/0003-9861(78)90474-5; Cai QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056189; Ciftci M, 2010, REV MED VET-TOULOUSE, V161, P432; DUNCAN WRH, 1978, BRIT J NUTR, V40, P29, DOI 10.1079/BJN19780092; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARTON GA, 1972, BRIT J NUTR, V28, P409, DOI 10.1079/BJN19720050; Guler GO, 2011, AFR J BIOTECHNOL, V10, P7099; HORNING MG, 1961, J BIOL CHEM, V236, P669; KENNEDY DG, 1994, BRIT J NUTR, V71, P67, DOI 10.1079/BJN19940111; MARCHELLO JA, 1967, J ANIM SCI, V26, P294, DOI 10.2527/jas1967.262294x; Moharrery A, 2007, SMALL RUMINANT RES, V69, P208, DOI 10.1016/j.smallrumres.2005.12.021; Murphy R. C., 1993, MASS SPECTROMETRY LI; Pourlis AF, 2011, TROP ANIM HEALTH PRO, V43, P1267, DOI 10.1007/s11250-011-9853-x; Ran-Ressler RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029032; SCAIFE JR, 1978, BIOCHEM J, V176, P799, DOI 10.1042/bj1760799; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; SMITH A, 1979, LIPIDS, V14, P953, DOI 10.1007/BF02533430; SMITH A, 1979, LIPIDS, V14, P350, DOI 10.1007/BF02533418; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; Unsal M, 2003, MEAT SCI, V63, P235, DOI 10.1016/S0309-1740(02)00074-8; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Wilkes MJ, 2012, ANIM PROD SCI, V52, P30, DOI 10.1071/AN11033; Wongtangtintharn S, 2004, J NUTR SCI VITAMINOL, V50, P137, DOI 10.3177/jnsv.50.137; Yilmaz MT, 2010, J THERM ANAL CALORIM, V101, P403, DOI 10.1007/s10973-009-0529-y	32	35	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77313	10.1371/journal.pone.0077313	http://dx.doi.org/10.1371/journal.pone.0077313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204803	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300095
J	Detto, M; Muller-Landau, HC; Mascaro, J; Asner, GP				Detto, Matteo; Muller-Landau, Helene C.; Mascaro, Joseph; Asner, Gregory P.			Hydrological Networks and Associated Topographic Variation as Templates for the Spatial Organization of Tropical Forest Vegetation	PLOS ONE			English	Article							ABOVEGROUND BIOMASS; CARBON STOCKS; PATTERNS; DISTURBANCE; GRADIENTS; SOIL	An understanding of the spatial variability in tropical forest structure and biomass, and the mechanisms that underpin this variability, is critical for designing, interpreting, and upscaling field studies for regional carbon inventories. We investigated the spatial structure of tropical forest vegetation and its relationship to the hydrological network and associated topographic structure across spatial scales of 10-1000 m using high-resolution maps of LiDAR-derived mean canopy profile height (MCH) and elevation for 4930 ha of tropical forest in central Panama. MCH was strongly associated with the hydrological network: canopy height was highest in areas of positive convexity (valleys, depressions) close to channels draining 1 ha or more. Average MCH declined strongly with decreasing convexity (transition to ridges, hilltops) and increasing distance from the nearest channel. Spectral analysis, performed with wavelet decomposition, showed that the variance in MCH had fractal similarity at scales of similar to 30-600 m, and was strongly associated with variation in elevation, with peak correlations at scales of similar to 250 m. Whereas previous studies of topographic correlates of tropical forest structure conducted analyses at just one or a few spatial grains, our study found that correlations were strongly scale-dependent. Multi-scale analyses of correlations of MCH with slope, aspect, curvature, and Laplacian convexity found that MCH was most strongly related to convexity measured at scales of 20-300 m, a topographic variable that is a good proxy for position with respect to the hydrological network. Overall, our results support the idea that, even in these mesic forests, hydrological networks and associated topographical variation serve as templates upon which vegetation is organized over specific ranges of scales. These findings constitute an important step towards a mechanistic understanding of these patterns, and can guide upscaling and downscaling.	[Detto, Matteo; Muller-Landau, Helene C.] Smithsonian Trop Res Inst, Panama City, Panama; [Mascaro, Joseph; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Carnegie Institution for Science	Detto, M (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	dettom@si.edu	Asner, Gregory/G-9268-2013	Asner, Gregory/0000-0001-7893-6421; Muller-Landau, Helene C./0000-0002-3526-9021	Smithsonian Institution Global Earth Observatories; HSBC Climate Partnership; National Science Foundation [DEB 0614055]	Smithsonian Institution Global Earth Observatories; HSBC Climate Partnership; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Smithsonian Institution Global Earth Observatories and the HSBC Climate Partnership. The Carnegie Airborne Observatory is made possible by the Gordon and Betty Moore Foundation, the John D. and Catherine T. MacArthur Foundation, Avatar Alliance Foundation, W. M. Keck Foundation, the Margaret A. Cargill Foundation, Grantham Foundation for the Protection of the Environment, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. This material is based upon work supported by the National Science Foundation under Grant Number DEB 0614055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LF, 2010, FOREST ECOL MANAG, V260, P679, DOI 10.1016/j.foreco.2010.05.023; ASHTON PS, 1992, J ECOL, V80, P459, DOI 10.2307/2260691; Asner GP, 2012, BIOGEOSCIENCES, V9, P2683, DOI 10.5194/bg-9-2683-2012; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Asner GP, 2009, ECOSYSTEMS, V12, P261, DOI 10.1007/s10021-008-9221-5; BECKER P, 1988, J TROP ECOL, V4, P173, DOI 10.1017/S0266467400002674; Bhatt MP, 2007, WATER RESOUR RES, V43, P1; Caylor KK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020260; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Clark D, 2000, FOREST ECOLOGY MANAG, V137; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; de Toledo JJ, 2012, FOREST ECOL MANAG, V263, P253, DOI 10.1016/j.foreco.2011.09.017; Englund G, 2008, ECOL LETT, V11, P440, DOI 10.1111/j.1461-0248.2008.01159.x; Ferry B, 2010, J ECOL, V98, P106, DOI 10.1111/j.1365-2745.2009.01604.x; Gagnon JS, 2006, NONLINEAR PROC GEOPH, V13, P541, DOI 10.5194/npg-13-541-2006; Gale N, 2001, J VEGETATION SCI; Gibbon A, 2010, ECOSYSTEMS, V13, P1097, DOI 10.1007/s10021-010-9376-8; Hall CAS, 1995, J BIOGEOGR, V22, P753, DOI 10.2307/2845977; Heneghan C, 1996, PROCEEDINGS OF THE IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, P213, DOI 10.1109/IAI.1996.493755; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; KERSHAW KA, 1963, ECOLOGY, V44, P377, DOI 10.2307/1932185; KUMAR P, 1995, GEOPHYS RES LETT, V22, P2777, DOI 10.1029/95GL02934; Larsen MC, 1998, GEOMORPHOLOGY, V24, P309, DOI 10.1016/S0169-555X(98)00023-3; Lashermes B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031140; Laumonier Y, 2010, FOREST ECOL MANAG, V259, P505, DOI 10.1016/j.foreco.2009.11.007; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Lefsky MA, 2002, GLOBAL ECOL BIOGEOGR, V11, P393, DOI 10.1046/j.1466-822x.2002.00303.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li BL, 2000, ECOL MODEL, V132, P33, DOI 10.1016/S0304-3800(00)00303-3; LUGO AE, 1993, J BIOSCIENCE, V18, P475, DOI 10.1007/BF02703080; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; MARDIA KV, 1976, BIOMETRIKA, V63, P403, DOI 10.2307/2335637; Marshall AR, 2012, BIOL CONSERV, V154, P20, DOI 10.1016/j.biocon.2012.03.017; Mascaro J, 2011, BIOGEOSCIENCES, V8, P1615, DOI 10.5194/bg-8-1615-2011; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; MOORE ID, 1991, HYDROL PROCESS, V5, P3, DOI 10.1002/hyp.3360050103; Naiman RJ, 1998, RIPARIAN FORESTS RIV, P713; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI 10.1016/0734-189X(89)90053-4; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Rinaldo A., 1997, FRACTAL RIVER BASINS, P547; Rodriguez-Iturbe I., 2009, Water Resources Research, V45, pW01413, DOI 10.1029/2008WR007124; SCATENA FN, 1995, GEOMORPHOLOGY, V13, P199, DOI 10.1016/0169-555X(95)00021-V; Schreiber T, 2000, PHYSICA D, V142, P346, DOI 10.1016/S0167-2789(00)00043-9; Schumm S.A., 1977, FLUVIAL SYSTEM, P338; SILVER WL, 1994, PLANT SOIL, V164, P129, DOI 10.1007/BF00010118; Sole R.V., 2006, SELF ORG COMPLEX ECO, DOI [10.1515/9781400842933, DOI 10.1515/9781400842933]; Stoy PC, 2009, LANDSCAPE ECOL, V24, P971, DOI 10.1007/s10980-009-9367-3; Takyu M, 2003, OECOLOGIA, V134, P397, DOI 10.1007/s00442-002-1115-1; Valencia R, 2009, J TROP ECOL, V25, P473, DOI 10.1017/S0266467409990095; Venema V, 2006, TELLUS A, V58, P104, DOI 10.1111/j.1600-0870.2006.00160.x; Vitousek P, 2003, ECOSYSTEMS, V6, P762, DOI 10.1007/s10021-003-0199-8; Weishampel JF, 2000, INT J REMOTE SENS, V21, P409, DOI 10.1080/014311600210939	58	49	49	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76296	10.1371/journal.pone.0076296	http://dx.doi.org/10.1371/journal.pone.0076296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204610	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300018
J	Dorelien, AM; Ballesteros, S; Grenfell, BT				Dorelien, Audrey M.; Ballesteros, Sebastien; Grenfell, Bryan T.			Impact of Birth Seasonality on Dynamics of Acute Immunizing Infections in Sub-Saharan Africa	PLOS ONE			English	Article							MEASLES; RATES; TRANSMISSION; VACCINATION	We analyze the impact of birth seasonality (seasonal oscillations in the birth rate) on the dynamics of acute, immunizing childhood infectious diseases. Previous research has explored the effect of human birth seasonality on infectious disease dynamics using parameters appropriate for the developed world. We build on this work by including in our analysis an extended range of baseline birth rates and amplitudes, which correspond to developing world settings. Additionally, our analysis accounts for seasonal forcing both in births and contact rates. We focus in particular on the dynamics of measles. In the absence of seasonal transmission rates or stochastic forcing, for typical measles epidemiological parameters, birth seasonality induces either annual or biennial epidemics. Changes in the magnitude of the birth fluctuations (birth amplitude) can induce significant changes in the size of the epidemic peaks, but have little impact on timing of disease epidemics within the year. In contrast, changes to the birth seasonality phase (location of the peak in birth amplitude within the year) significantly influence the timing of the epidemics. In the presence of seasonality in contact rates, at relatively low birth rates (20 per 1000), birth amplitude has little impact on the dynamics but does have an impact on the magnitude and timing of the epidemics. However, as the mean birth rate increases, both birth amplitude and phase play an important role in driving the dynamics of the epidemic. There are stronger effects at higher birth rates.	[Dorelien, Audrey M.] Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA; [Ballesteros, Sebastien; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Princeton University; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Dorelien, AM (corresponding author), Univ Michigan, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA.	dorelien@umich.edu		Dorelien, Audrey/0000-0002-0618-4782	National Institute for Child Health and Human Development [R24HD047879]; National Science Foundation [EF-0742373]; Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate; Fogarty International Center, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Audrey M. Dorelien was supported by the National Institute for Child Health and Human Development, Grant No. R24HD047879, to the Office of Population Research at Princeton University. Bryan Grenfell was supported by the National Science Foundation grant EF-0742373 and the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Department of Homeland Security Science and Technology Directorate and the Fogarty International Center, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON R M, 1991; BAILEY RC, 1992, J BIOSOC SCI, V24, P393, DOI 10.1017/S0021932000019957; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Bauch CT, 2003, P ROY SOC B-BIOL SCI, V270, P1573, DOI 10.1098/rspb.2003.2410; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BOLKER BM, 1993, P ROY SOC B-BIOL SCI, V251, P75, DOI 10.1098/rspb.1993.0011; Cancho-Candela R, 2007, J EPIDEMIOL COMMUN H, V61, P713, DOI 10.1136/jech.2006.050211; COWGILL UM, 1966, MAN, V1, P232, DOI 10.2307/2796349; Dowell SF, 2001, EMERG INFECT DIS, V7, P369; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Grassly NC, 2006, P ROY SOC B-BIOL SCI, V273, P2541, DOI 10.1098/rspb.2006.3604; GUYER B, 1981, INT J EPIDEMIOL, V10, P263, DOI 10.1093/ije/10.3.263; He DH, 2007, THEOR POPUL BIOL, V72, P274, DOI 10.1016/j.tpb.2007.04.004; Hethcote H., 1984, LECT NOTES BIOMATHEM; ICF Macro, 2010, DEM HLTH SURV BIRTH; Ireland JM, 2004, J THEOR BIOL, V231, P229, DOI 10.1016/j.jtbi.2004.06.017; Kaler SG, 2008, ANN NY ACAD SCI, V1136, P28, DOI 10.1196/annals.1425.035; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Lam DA, 1996, DEMOGRAPHY, V33, P291, DOI 10.2307/2061762; Manfredini M, 2009, HUM ECOL, V37, P227, DOI 10.1007/s10745-009-9221-x; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; YORKE JA, 1973, AM J EPIDEMIOL, V98, P469, DOI 10.1093/oxfordjournals.aje.a121576	32	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e75806	10.1371/journal.pone.0075806	http://dx.doi.org/10.1371/journal.pone.0075806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204580	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300004
J	Soltesz, F; Szucs, D; Leong, V; White, S; Goswami, U				Soltesz, Fruzsina; Szucs, Denes; Leong, Victoria; White, Sonia; Goswami, Usha			Differential Entrainment of Neuroelectric Delta Oscillations in Developmental Dyslexia	PLOS ONE			English	Article							CONTINGENT NEGATIVE-VARIATION; NEURONAL OSCILLATIONS; SPEECH-PERCEPTION; LANGUAGE-ACQUISITION; NEURAL RESPONSES; PHASE-LOCKING; CHILDREN; RHYTHMS; ADULTS; ATTENTION	Oscillatory entrainment to the speech signal is important for language processing, but has not yet been studied in developmental disorders of language. Developmental dyslexia, a difficulty in acquiring efficient reading skills linked to difficulties with phonology (the sound structure of language), has been associated with behavioural entrainment deficits. It has been proposed that the phonological 'deficit' that characterises dyslexia across languages is related to impaired auditory entrainment to speech at lower frequencies via neuroelectric oscillations (<10 Hz, 'temporal sampling theory'). Impaired entrainment to temporal modulations at lower frequencies would affect the recovery of the prosodic and syllabic structure of speech. Here we investigated event-related oscillatory EEG activity and contingent negative variation (CNV) to auditory rhythmic tone streams delivered at frequencies within the delta band (2 Hz, 1.5 Hz), relevant to sampling stressed syllables in speech. Given prior behavioural entrainment findings at these rates, we predicted functionally atypical entrainment of delta oscillations in dyslexia. Participants performed a rhythmic expectancy task, detecting occasional white noise targets interspersed with tones occurring regularly at rates of 2 Hz or 1.5 Hz. Both groups showed significant entrainment of delta oscillations to the rhythmic stimulus stream, however the strength of inter-trial delta phase coherence (ITC, 'phase locking') and the CNV were both significantly weaker in dyslexics, suggestive of weaker entrainment and less preparatory brain activity. Both ITC strength and CNV amplitude were significantly related to individual differences in language processing and reading. Additionally, the instantaneous phase of prestimulus delta oscillation predicted behavioural responding (response time) for control participants only.	[Soltesz, Fruzsina; Szucs, Denes; Leong, Victoria; White, Sonia; Goswami, Usha] Univ Cambridge, Ctr Neurosci Educ, Cambridge, England	University of Cambridge	Goswami, U (corresponding author), Univ Cambridge, Ctr Neurosci Educ, Cambridge, England.	ucg10@cam.ac.uk	Leong, Victoria/G-5778-2013	Leong, Victoria/0000-0003-0666-9445; White, Sonia/0000-0001-5828-5852; Szucs, Denes/0000-0002-9477-0801; Goswami, Usha/0000-0001-7858-2336	ANALOGY project (NEST program) [29088]; EC	ANALOGY project (NEST program); EC(European CommissionEuropean Commission Joint Research Centre)	This research was financially supported by the ANALOGY project (NEST program, contract 29088) funded by the EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2009, J NEUROSCI, V29, P7686, DOI 10.1523/JNEUROSCI.5242-08.2009; Arnal LH, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00225; Arvaniti A, 2009, PHONETICA, V66, P46, DOI 10.1159/000208930; Benjamini Y, 2001, ANN STAT, V29, P1165; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; BORDA RP, 1970, ELECTROEN CLIN NEURO, V29, P173, DOI 10.1016/0013-4694(70)90120-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chapin HL, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00224; Facoetti A, 2010, J COGNITIVE NEUROSCI, V22, P1011, DOI 10.1162/jocn.2009.21232; Fisher NI, 1995, STAT ANAL CIRCULAR D; Frederickson N., 1997, PHONOLOGICAL ASSESSM; Fujioka T, 2012, ANN NY ACAD SCI, V1169, P89; Funderud I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048504; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghitza O, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00130; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Golumbic EMZ, 2012, BRAIN LANG, V122, P151, DOI 10.1016/j.bandl.2011.12.010; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Gomez-Ramirez M, 2011, J NEUROSCI, V31, P18556, DOI 10.1523/JNEUROSCI.2164-11.2011; Goswami U, 2013, LAB PHONOL, V4, P67, DOI 10.1515/lp-2013-0004; Goswami U, 2013, CORTEX, V49, P1363, DOI 10.1016/j.cortex.2012.05.005; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Goswami U, 2010, READ WRIT, V23, P995, DOI 10.1007/s11145-009-9186-6; Hamalainen JA, 2013, J LEARN DISABIL-US, V46, P413, DOI 10.1177/0022219411436213; Hamalainen JA, 2012, NEUROIMAGE, V59, P2952, DOI 10.1016/j.neuroimage.2011.09.075; Hurtado JM, 2004, J NEUROPHYSIOL, V91, P1883, DOI 10.1152/jn.00853.2003; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; KELSO JAS, 1986, J PHONETICS, V14, P29, DOI 10.1016/S0095-4470(19)30608-4; Kerlin JR, 2010, J NEUROSCI, V30, P620, DOI 10.1523/JNEUROSCI.3631-09.2010; Kitzen K. R., 2001, DISS ABSTR INT A, V62, P460; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Lalor EC, 2010, EUR J NEUROSCI, V31, P189, DOI 10.1111/j.1460-9568.2009.07055.x; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; Leong V, 2012, THESIS U CAMBRIDGE; Leong V, 2011, J MEM LANG, V64, P59, DOI 10.1016/j.jml.2010.09.003; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Power AJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00216; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Serniclaes WI, 2004, J EXP CHILD PSYCHOL, V87, P336, DOI 10.1016/j.jecp.2004.02.001; Smith AB, 2008, J SPEECH LANG HEAR R, V51, P1300, DOI 10.1044/1092-4388(2008/06-0193); Snowling M., 2000, DYSLEXIA; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Telkemeyer S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00062; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Thomson JM, 2006, J RES READ, V29, P334, DOI 10.1111/j.1467-9817.2006.00312.x; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wilkinson G.S, 1993, WIDE RANGE ACHIEVEME; Wimmer H, 1996, J EXP CHILD PSYCHOL, V61, P80, DOI 10.1006/jecp.1996.0004; Wood C, 1998, BRIT J DEV PSYCHOL, V16, P397, DOI 10.1111/j.2044-835X.1998.tb00760.x; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	67	35	35	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76608	10.1371/journal.pone.0076608	http://dx.doi.org/10.1371/journal.pone.0076608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204644	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326029300039
J	Hayes, ML; Giang, K; Berhane, B; Mulligan, RM				Hayes, Michael L.; Giang, Karolyn; Berhane, Beniam; Mulligan, R. Michael			Identification of Two Pentatricopeptide Repeat Genes Required for RNA Editing and Zinc Binding by C-terminal Cytidine Deaminase-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloroplast; Gene Expression; Mass Spectrometry (MS); Metalloenzymes; RNA Modification	CRYSTAL-STRUCTURE; PPR PROTEINS; MESSENGER-RNA; DYW PROTEIN; ARABIDOPSIS; SITE; MITOCHONDRIA; TRANSCRIPTS; MUTANTS; REVEALS	Background: Many pentatricopeptide repeat (PPR) proteins are RNA site specificity factors and include C-terminal DYW deaminase domains. Results: ELI1 and DOT4 are required for editing single sites. The DYW deaminase domain binds two zinc atoms. Conclusion: The C terminus of PLS-type PPR proteins shares molecular characteristics with cytidine deaminase. Significance: This study provides the first evidence that DYW deaminase domains bind zinc. Many transcripts expressed from plant organelle genomes are modified by C-to-U RNA editing. Nuclear encoded pentatricopeptide repeat (PPR) proteins are required as RNA binding specificity determinants in the RNA editing mechanism. Bioinformatic analysis has shown that most of the Arabidopsis PPR proteins necessary for RNA editing events include a C-terminal portion that shares structural characteristics with a superfamily of deaminases. The DYW deaminase domain includes a highly conserved zinc binding motif that shares characteristics with cytidine deaminases. The Arabidopsis PPR genes, ELI1 and DOT4, both have DYW deaminase domains and are required for single RNA editing events in chloroplasts. The ELI1 DYW deaminase domain was expressed as a recombinant protein in Escherichia coli and was shown to bind two zinc atoms per polypeptide. Thus, the DYW deaminase domain binds a zinc metal ion, as expected for a cytidine deaminase, and is potentially the catalytic component of an editing complex. Genetic complementation experiments demonstrate that large portions of the DYW deaminase domain of ELI1 may be eliminated, but the truncated genes retain the ability to restore editing site conversion in a mutant plant. These results suggest that the catalytic activity can be supplied in trans by uncharacterized protein(s) of the editosome.	[Hayes, Michael L.; Giang, Karolyn; Mulligan, R. Michael] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Berhane, Beniam] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Mulligan, RM (corresponding author), Univ Calif Irvine, 5219 McGaugh Hall, Irvine, CA 92697 USA.	rmmullig@uci.edu		Berhane, Beniam/0000-0002-1963-376X	National Science Foundation [MCB-0929423]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0929423 (to R. M. M.).	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Bentolila S, 2008, GENETICS, V178, P1693, DOI 10.1534/genetics.107.073585; Bentolila S, 2012, P NATL ACAD SCI USA, V109, pE1453, DOI 10.1073/pnas.1121465109; Bersoult A., 2010, 20 INT C AR RES ED U, P54; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Boussardon C, 2012, PLANT CELL, V24, P3684, DOI 10.1105/tpc.112.099507; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Chateigner-Boutin AL, 2013, PLANT J, V74, P935, DOI 10.1111/tpj.12180; Chaudhuri S, 1996, EMBO J, V15, P5958, DOI 10.1002/j.1460-2075.1996.tb00982.x; COVELLO PS, 1989, NATURE, V341, P662, DOI 10.1038/341662a0; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; FRALEY RT, 1985, BIO-TECHNOL, V3, P629, DOI 10.1038/nbt0785-629; GUALBERTO JM, 1989, NATURE, V341, P660, DOI 10.1038/341660a0; Hall JC, 2002, AM J BOT, V89, P1826, DOI 10.3732/ajb.89.11.1826; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Hayes ML, 2007, RNA, V13, P281, DOI 10.1261/rna.295607; Hayes ML, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-66; Iyer LM, 2011, NUCLEIC ACIDS RES, V39, P9473, DOI 10.1093/nar/gkr691; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Makarova KS, 2002, TRENDS BIOCHEM SCI, V27, P384, DOI 10.1016/S0968-0004(02)02140-0; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Namuswe F, 2012, J INORG BIOCHEM, V111, P146, DOI 10.1016/j.jinorgbio.2011.10.018; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Petricka JJ, 2008, PLANT J, V56, P251, DOI 10.1111/j.1365-313X.2008.03595.x; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2011, RNA, V17, P2058, DOI 10.1261/rna.02962911; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schallenberg-Rudinger M., 2013, RNA BIOL, V10, P1343; Serrano-Cartagena J, 1999, MOL GEN GENET, V261, P725, DOI 10.1007/s004380050016; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tseng CC, 2010, PLANT MOL BIOL, V73, P309, DOI 10.1007/s11103-010-9616-5; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Verbitskiy D, 2012, PLANT CELL PHYSIOL, V53, P358, DOI 10.1093/pcp/pcr182; Xie KF, 2004, P NATL ACAD SCI USA, V101, P8114, DOI 10.1073/pnas.0400493101; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	56	54	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36519	36529		10.1074/jbc.M113.485755	http://dx.doi.org/10.1074/jbc.M113.485755			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194514	hybrid, Green Published			2022-12-25	WOS:000328883400032
J	Mukund, S; Shang, YL; Clarke, HJ; Madjidi, A; Corn, JE; Kates, L; Kolumam, G; Chiang, V; Luis, E; Murray, J; Zhang, YN; Hotzel, I; Koth, CM; Allan, BB				Mukund, Susmith; Shang, Yonglei; Clarke, Holly J.; Madjidi, Azadeh; Corn, Jacob E.; Kates, Lance; Kolumam, Ganesh; Chiang, Vicky; Luis, Elizabeth; Murray, Jeremy; Zhang, Yingnan; Hoetzel, Isidro; Koth, Christopher M.; Allan, Bernard B.			Inhibitory Mechanism of an Allosteric Antibody Targeting the Glucagon Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Diabetes; G Protein-coupled Receptors (GPCR); Glucose Metabolism; Structural Biology	MOLECULAR RECOGNITION; GLY40SER MUTATION; PHAGE DISPLAY; BINDING-SITE; B GPCRS; GENE; HORMONE; DOMAIN; ANTAGONIST; MODULATORS	Elevated glucagon levels and increased hepatic glucagon receptor (GCGR) signaling contribute to hyperglycemia in type 2 diabetes. We have identified a monoclonal antibody that inhibits GCGR, a class B G-protein coupled receptor (GPCR), through a unique allosteric mechanism. Receptor inhibition is mediated by the binding of this antibody to two distinct sites that lie outside of the glucagon binding cleft. One site consists of a patch of residues that are surface-exposed on the face of the extracellular domain (ECD) opposite the ligand-binding cleft, whereas the second binding site consists of residues in the A helix of the ECD. A docking model suggests that the antibody does not occlude the ligand-binding cleft. We solved the crystal structure of GCGR ECD containing a naturally occurring G40S mutation and found a shift in the register of the A helix that prevents antibody binding. We also found that alterations in the A helix impact the normal function of GCGR. We present a model for the allosteric inhibition of GCGR by a monoclonal antibody that may form the basis for the development of allosteric modulators for the treatment of diabetes and other class B GPCR-related diseases.	[Mukund, Susmith; Murray, Jeremy; Koth, Christopher M.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Shang, Yonglei; Chiang, Vicky; Hoetzel, Isidro] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Clarke, Holly J.; Madjidi, Azadeh; Allan, Bernard B.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kates, Lance; Kolumam, Ganesh] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Luis, Elizabeth] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Corn, Jacob E.; Zhang, Yingnan] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Koth, CM (corresponding author), Genentech Inc, Dept Biol Struct, 1 DNA Way, San Francisco, CA 94080 USA.	kothc@gene.com; allanb2@gene.com		Koth, Christopher/0000-0003-3939-8856; Hotzel, Isidro/0000-0001-6910-7840	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE))	We are grateful to the Structural Biology Expression Group for the generation of critical reagents to support this work. Portions of this work were carried out at the Advanced Light Source, Lawrence Berkeley National Laboratory. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy (Contract Number DE-AC02-05CH11231).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barwell J, 2012, BRIT J PHARMACOL, V166, P51, DOI 10.1111/j.1476-5381.2011.01525.x; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Cascieri MA, 1999, J BIOL CHEM, V274, P8694, DOI 10.1074/jbc.274.13.8694; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conner AC, 2004, BIOCHEM SOC T, V32, P843, DOI 10.1042/BST0320843; Dallas-Yang Q, 2004, EUR J PHARMACOL, V501, P225, DOI 10.1016/j.ejphar.2004.08.023; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dennis MS, 2010, BIOTECHNOL PHARM ASP, V11, P9, DOI 10.1007/978-0-387-76643-0_2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GOUGH SCL, 1995, HUM MOL GENET, V4, P1609, DOI 10.1093/hmg/4.9.1609; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; HAGER J, 1995, NAT GENET, V9, P299, DOI 10.1038/ng0395-299; Hansen LH, 1996, DIABETES, V45, P725, DOI 10.2337/diabetes.45.6.725; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoare SRJ, 2007, CURR NEUROPHARMACOL, V5, P168, DOI 10.2174/157015907781695928; Ke JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033676; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Patterson JT, 2013, MOL METAB, V2, P86, DOI 10.1016/j.molmet.2013.01.003; Petersen KF, 2001, DIABETOLOGIA, V44, P2018, DOI 10.1007/s001250100006; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ravn P, 2013, J BIOL CHEM, V288, P19760, DOI 10.1074/jbc.M112.426288; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Strazzullo P, 2001, J MOL MED, V79, P574, DOI 10.1007/s001090100257; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Tonolo G, 1997, DIABETOLOGIA, V40, P89, DOI 10.1007/s001250050647; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Vajdos FF, 2002, J MOL BIOL, V320, P415, DOI 10.1016/S0022-2836(02)00264-4; Wan M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001464; Willard FS, 2012, MOL PHARMACOL, V82, P1066, DOI 10.1124/mol.112.080432; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	39	28	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36168	36178		10.1074/jbc.M113.496984	http://dx.doi.org/10.1074/jbc.M113.496984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189067	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000329814700051
J	Ranaghan, MJ; Kumar, RP; Chakrabarti, KS; Buosi, V; Kern, D; Oprian, DD				Ranaghan, Matthew J.; Kumar, Ramasamy P.; Chakrabarti, Kalyan S.; Buosi, Vanessa; Kern, Dorothee; Oprian, Daniel D.			A Highly Conserved Cysteine of Neuronal Calcium-sensing Proteins Controls Cooperative Binding of Ca2+ to Recoverin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Calcium-binding Proteins; Calcium Signaling; Cooperativity; Mutant; Protein Myristoylation; Cysteine; Neuronal Calcium Sensor; Sulfenic Acid	RHODOPSIN KINASE; TERMINAL MYRISTOYLATION; SENSOR; PHOSPHORYLATION; INHIBITION; MODULATION; TRANSITION; SYSTEM	Background: Recoverin contains a cysteine (Cys-39) that is highly conserved in neuronal calcium-sensing (NCS) proteins. Results: The C39A mutation shifts the conformational equilibrium from the R to T state, inducing cooperative calcium binding. Conclusion: Cys-39 controls the conformational equilibrium of calcium-free recoverin. Significance: This mutation assigns a previously unknown function to the conserved cysteine in recoverin and possibly all NCS proteins. Recoverin, a 23-kDa Ca2+-binding protein of the neuronal calcium sensing (NCS) family, inhibits rhodopsin kinase, a Ser/Thr kinase responsible for termination of photoactivated rhodopsin in rod photoreceptor cells. Recoverin has two functional EF hands and a myristoylated N terminus. The myristoyl chain imparts cooperativity to the Ca2+-binding sites through an allosteric mechanism involving a conformational equilibrium between R and T states of the protein. Ca2+ binds preferentially to the R state; the myristoyl chain binds preferentially to the T state. In the absence of myristoylation, the R state predominates, and consequently, binding of Ca2+ to the non-myristoylated protein is not cooperative. We show here that a mutation, C39A, of a highly conserved Cys residue among NCS proteins, increases the apparent cooperativity for binding of Ca2+ to non-myristoylated recoverin. The binding data can be explained by an effect on the T/R equilibrium to favor the T state without affecting the intrinsic binding constants for the two Ca2+ sites.	[Ranaghan, Matthew J.; Kumar, Ramasamy P.; Chakrabarti, Kalyan S.; Buosi, Vanessa; Kern, Dorothee; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Chakrabarti, Kalyan S.; Buosi, Vanessa; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	dkern@brandeis.edu; oprian@brandeis.edu	Ramasamy, Prem Kumar/I-6801-2019; chakrabarti, kalyan s/A-4583-2013	Ramasamy, Prem Kumar/0000-0002-6555-8289; Chakrabarti, Kalyan S/0000-0003-4864-9477	NIGMS, National Institutes of Health; Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY009514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Doug Theobald, Chris Miller, and Benjamin Nickle for insightful discussions and Adelajda Zorba for help with HPLC experiments. The Berkeley Center for Structural Biology is supported in part by the NIGMS, National Institutes of Health. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; AMES JB, 1994, BIOCHEMISTRY-US, V33, P10743, DOI 10.1021/bi00201a023; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Baldwin AN, 1998, BIOCHEMISTRY-US, V37, P17408, DOI 10.1021/bi980928s; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Desmeules P, 2006, ANAL BIOCHEM, V349, P25, DOI 10.1016/j.ab.2005.11.023; DIZHOOR AM, 1992, J BIOL CHEM, V267, P16033; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gensch T, 2007, PROTEINS, V66, P492, DOI 10.1002/prot.21231; Higgins MK, 2006, J BIOL CHEM, V281, P19426, DOI 10.1074/jbc.M602203200; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; Permyakov SE, 2007, J PROTEOME RES, V6, P1855, DOI 10.1021/pr070015x; Permyakov SE, 2012, AMINO ACIDS, V42, P1435, DOI 10.1007/s00726-011-0843-0; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RAY S, 1992, P NATL ACAD SCI USA, V89, P5705, DOI 10.1073/pnas.89.13.5705; Senin II, 2002, J BIOL CHEM, V277, P50365, DOI 10.1074/jbc.M204338200; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Weiergraber OH, 2003, J BIOL CHEM, V278, P22972, DOI 10.1074/jbc.M300447200; Weiergraber OH, 2006, J BIOL CHEM, V281, P37594, DOI 10.1074/jbc.M603700200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	35	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36160	36167		10.1074/jbc.M113.524355	http://dx.doi.org/10.1074/jbc.M113.524355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189072	Green Published, hybrid			2022-12-25	WOS:000329814700050
J	Boutellis, A; Drali, R; Rivera, MA; Mumcuoglu, KY; Raoult, D				Boutellis, Amina; Drali, Rezak; Rivera, Mario A.; Mumcuoglu, Kosta Y.; Raoult, Didier			Evidence of Sympatry of Clade A and Clade B Head Lice in a Pre-Columbian Chilean Mummy from Camarones	PLOS ONE			English	Article							BARTONELLA-QUINTANA; INFESTATION; CAPITIS	Three different lineages of head lice are known to parasitize humans. Clade A, which is currently worldwide in distribution, was previously demonstrated to be present in the Americas before the time of Columbus. The two other types of head lice are geographically restricted to America and Australia for clade B and to Africa and Asia for clade C. In this study, we tested two operculated nits from a 4,000-year-old Chilean mummy of Camarones for the presence of the partial Cytb mitochondrial gene (270 bp). Our finding shows that clade B head lice were present in America before the arrival of the European colonists.	[Boutellis, Amina; Drali, Rezak; Raoult, Didier] Aix Marseille Univ, UMR CNRS 7278, URMITE, INSERM Fac Med 1095,IRD 198, Marseille, France; [Rivera, Mario A.] Univ Magallanes Mineduc, Programa Identidad Fin Mundo, Punta Arenas, Chile; [Mumcuoglu, Kosta Y.] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Hebrew University of Jerusalem	Raoult, D (corresponding author), Aix Marseille Univ, UMR CNRS 7278, URMITE, INSERM Fac Med 1095,IRD 198, 27 Bd Jean Moulin, Marseille, France.	didier.raoult@gmail.com	Drali, Rezak/AAR-3040-2020; Drali, Rezak/AAZ-9532-2020; RAOULT, Didier/A-8434-2008; Mumcuoglu, Kosta/AAY-2122-2020	RAOULT, Didier/0000-0002-0633-5974; Mumcuoglu, Kosta/0000-0001-8125-6099				Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Araujo A, 2000, PARASITOL TODAY, V16, P269, DOI 10.1016/S0169-4758(00)01694-X; Arriaza B, 2012, J PARASITOL, V98, P433, DOI 10.1645/GE-2903.1; Boutellis A, 2013, AM J TROP MED HYG, V88, P1180, DOI 10.4269/ajtmh.12-0766; Boutellis A, 2012, VECTOR-BORNE ZOONOT, V12, P564, DOI 10.1089/vbz.2011.0845; Fornaciari G, 2009, MEM I OSWALDO CRUZ, V104, P671, DOI 10.1590/S0074-02762009000400026; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, J PARASITOL, V94, P1275, DOI 10.1645/GE-1618.1; Mumcuoglu Kosta Y., 2008, P215, DOI 10.1007/978-3-540-75855-6_13; Raoult D, 2008, J INFECT DIS, V197, P535, DOI 10.1086/526520; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Rick FM, 2002, J PARASITOL, V88, P1266, DOI 10.1645/0022-3395(2002)088[1266:CLIIPC]2.0.CO;2; Rivera MA, 2008, CHUNGARA, V40, P31, DOI 10.4067/S0717-73562008000100004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	14	21	21	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76818	10.1371/journal.pone.0076818	http://dx.doi.org/10.1371/journal.pone.0076818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204678	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500011
J	Clauss, M; Steuer, P; Muller, DWH; Codron, D; Hummel, J				Clauss, Marcus; Steuer, Patrick; Mueller, Dennis W. H.; Codron, Daryl; Hummel, Juergen			Herbivory and Body Size: Allometries of Diet Quality and Gastrointestinal Physiology, and Implications for Herbivore Ecology and Dinosaur Gigantism	PLOS ONE			English	Review							RABBITS ORYCTOLAGUS-CUNICULUS; PIGS CAVIA-PORCELLUS; HAY-ONLY DIET; MAMMALIAN HERBIVORES; SAUROPOD DINOSAURS; FOOD-INTAKE; FEEDING ECOLOGY; DIGESTIVE PHYSIOLOGY; RUMEN FERMENTATION; METHANE PRODUCTION	Digestive physiology has played a prominent role in explanations for terrestrial herbivore body size evolution and size-driven diversification and niche differentiation. This is based on the association of increasing body mass (BM) with diets of lower quality, and with putative mechanisms by which a higher BM could translate into a higher digestive efficiency. Such concepts, however, often do not match empirical data. Here, we review concepts and data on terrestrial herbivore BM, diet quality, digestive physiology and metabolism, and in doing so give examples for problems in using allometric analyses and extrapolations. A digestive advantage of larger BM is not corroborated by conceptual or empirical approaches. We suggest that explanatory models should shift from physiological to ecological scenarios based on the association of forage quality and biomass availability, and the association between BM and feeding selectivity. These associations mostly (but not exclusively) allow large herbivores to use low quality forage only, whereas they allow small herbivores the use of any forage they can physically manage. Examples of small herbivores able to subsist on lower quality diets are rare but exist. We speculate that this could be explained by evolutionary adaptations to the ecological opportunity of selective feeding in smaller animals, rather than by a physiologic or metabolic necessity linked to BM. For gigantic herbivores such as sauropod dinosaurs, other factors than digestive physiology appear more promising candidates to explain evolutionary drives towards extreme BM.	[Clauss, Marcus; Codron, Daryl] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Steuer, Patrick; Hummel, Juergen] Univ Bonn, Inst Anim Sci, Bonn, Germany; [Mueller, Dennis W. H.] Natl Pk Bavarian Forest, Grafenau, Germany; [Codron, Daryl] Florisbad Quaternary Res, Natl Museum, Bloemfontein, South Africa; [Hummel, Juergen] Univ Gottingen, Dept Anim Sci, D-37073 Gottingen, Germany	University of Zurich; University of Bonn; University of Gottingen	Clauss, M (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland.	mclauss@vetclinics.uzh.ch	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/A-4710-2008; Codron, Daryl/B-8867-2008; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Codron, Daryl/0000-0001-5223-9513; Clauss, Marcus/0000-0003-3841-6207; Hummel, Jurgen/0000-0002-8876-7745	German Science Foundation (DFG) [CL 182/3-1, CL 182/3-2, CL 182/5-1, CL 182/6-1, HU 1308/2-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was funded by the German Science Foundation (DFG, CL 182/3-1,3-2,5-1,6-1; HU 1308/2-1). It is publication no. 147 of the DFG Research Unit FOR 533 "The Biology of the Sauropod Dinosaurs: The Evolution of Gigantism''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault R, 2008, OIKOS, V117, P1711, DOI 10.1111/j.1600-0706.2008.16575.x; Ashworth US., 1934, U MO AGR EXP STA RES, V220, P1; Bakker RT., 1986, DINOSAUR HERESIES; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P250, DOI 10.1086/499984; BARNES RFW, 1982, AFR J ECOL, V20, P123, DOI 10.1111/j.1365-2028.1982.tb00282.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Bhola N, 2012, BIODIVERS CONSERV, V21, P1509, DOI 10.1007/s10531-012-0261-y; Bourliere F., 1975, SMALL MAMMALS THEIR, P1; Butler RJ, 2009, J EVOLUTION BIOL, V22, P446, DOI 10.1111/j.1420-9101.2008.01680.x; Calvo Jorge O., 1994, Gaia, V10, P183; Capellini I, 2010, ECOLOGY, V91, P2783, DOI 10.1890/09-0817.1; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Christian A, 2011, UNDERSTANDING LIFE G, P251; Christiansen Per, 1999, Historical Biology, V13, P269; Christiansen Per, 2000, Historical Biology, V14, P137; Clauss M, 2005, MAMMAL REV, V35, P174, DOI 10.1111/j.1365-2907.2005.00062.x; Clauss M, 2013, MAMMALIAN B IN PRESS, DOI [10.1016/j.mambio.2013.01.002., DOI 10.1016/J.MAMBI0.2013.01.002]; Clauss M, 2011, UNDERSTANDING LIFE G, P3; Clauss M, 2007, COMP BIOCHEM PHYS A, V148, P249, DOI 10.1016/j.cbpa.2007.05.024; Clauss M, 2007, OIKOS, V116, P209, DOI [10.1111/j.2006.0030-1299.15461.x, 10.1111/j.0030-1299.2007.15461.x]; Clauss M, 2009, COMP BIOCHEM PHYS A, V154, P376, DOI 10.1016/j.cbpa.2009.07.016; CLEMENS ET, 1983, COMP BIOCHEM PHYS A, V76, P319, DOI 10.1016/0300-9629(83)90333-X; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; Cork S.J., 1991, P133; Cromsigt JPGM, 2006, ECOLOGY, V87, P1532, DOI 10.1890/0012-9658(2006)87[1532:RPASGM]2.0.CO;2; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; DEMMENT MW, 1983, AFR J ECOL, V21, P219, DOI 10.1111/j.1365-2028.1983.tb00323.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DUNCAN P, 1990, OECOLOGIA, V84, P411, DOI 10.1007/BF00329768; DUTOIT JT, 1989, AM NAT, V133, P736, DOI 10.1086/284949; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; Farlow JO, 2010, HIST BIOL, V22, P403, DOI 10.1080/08912961003787598; FARLOW JO, 1987, PALEOBIOLOGY, V13, P60; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; FIELD C R, 1970, Zoologica Africana, V5, P71; Fiorillo Anthony R., 1998, Historical Biology, V13, P1; FOLEY WJ, 1992, TRENDS ECOL EVOL, V7, P159, DOI 10.1016/0169-5347(92)90210-3; Foose T.J., 1982, TROPHIC STRATEGIES R; Fortelius M., 2008, ZOOLOGICAL J LINNEAN, V108, P85, DOI [DOI 10.1111/J.1096-3642.1993.TB02560.X, 10.1111/j.1096-3642.1993.tb02560.x.]; Franz R, 2011, J ANIM PHYSIOL AN N, V95, P564, DOI 10.1111/j.1439-0396.2010.01084.x; Franz R, 2010, EVOL ECOL RES, V12, P727; Franz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017628; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P94, DOI 10.1016/j.cbpa.2010.09.007; Franz R, 2011, COMP BIOCHEM PHYS A, V158, P177, DOI 10.1016/j.cbpa.2010.10.019; Franz R, 2009, P ROY SOC B-BIOL SCI, V276, P1731, DOI 10.1098/rspb.2008.1735; Freeland W.J., 1991, P61; Fritz J, 2012, COMP BIOCHEM PHYS A, V163, P56, DOI 10.1016/j.cbpa.2012.05.184; Fritz J, 2011, PALEOBIOLOGY, V37, P577, DOI 10.1666/10031.1; Fritz J, 2010, J EXP ZOOL PART A, V313A, P579, DOI 10.1002/jez.629; Fritz J, 2009, OIKOS, V118, P1623, DOI 10.1111/j.1600-0706.2009.17807.x; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P324; FURSTENBURG D, 1994, COMP BIOCHEM PHYS A, V107, P425, DOI 10.1016/0300-9629(94)90402-2; Galton P.M., 1986, P203; Gee CT, 2011, UNDERSTANDING LIFE G, P34; GEIST V, 1974, AM ZOOL, V14, P205, DOI 10.1093/icb/14.1.205; Gordon IJ, 1988, FUNCT ECOL, V2, P15, DOI 10.2307/2389455; GORDON IJ, 1994, OECOLOGIA, V98, P167, DOI 10.1007/BF00341469; Guthrie R.D., 1984, P259; Hackmann TJ, 2010, J DAIRY SCI, V93, P1320, DOI 10.3168/jds.2009-2071; HALL-MARTIN A J, 1974, Journal of the Southern African Wildlife Management Association, V4, P191; Hiiemae Karen M., 2000, P411, DOI 10.1016/B978-012632590-4/50014-9; HILLMAN JC, 1987, MAMMALIA, V51, P53, DOI 10.1515/mamm.1987.51.1.53; Hofmann R R, 1973, Bull Epizoot Dis Afr, V21, P385; HOLLEMAN DF, 1989, CAN J ZOOL, V67, P488, DOI 10.1139/z89-071; Hopcraft JGC, 2012, J ANIM ECOL, V81, P201, DOI 10.1111/j.1365-2656.2011.01885.x; Hoppe P.P., 1977, 13TH P INT C GAM BIO, P141; HOPPE PP, 1977, J ZOOL, V181, P1, DOI 10.1111/j.1469-7998.1977.tb04566.x; HOPPE PP, 1983, COMP BIOCHEM PHYS A, V75, P517, DOI 10.1016/0300-9629(83)90414-0; HOPPE PP, 1977, J AGR SCI, V89, P129, DOI 10.1017/S0021859600027283; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hummel J, 2006, FUNCT ECOL, V20, P989, DOI 10.1111/j.1365-2435.2006.01206.x; Hummel J, 2011, UNDERSTANDING LIFE G, P11; Hummel J, 2008, P ROY SOC B-BIOL SCI, V275, P1015, DOI 10.1098/rspb.2007.1728; Illius A.W., 1999, P71; IRBY LR, 1977, E AFR WILDL J, V15, P289; IRWIN LL, 1993, J WILDLIFE MANAGE, V57, P413, DOI 10.2307/3809442; Jarman P.J., 1979, SERENGETI DYNAMICS E, P130, DOI DOI 10.1086/284321; Jhala YV, 1997, J APPL ECOL, V34, P1348, DOI 10.2307/2405252; JUSTICE KE, 1992, AM NAT, V139, P398, DOI 10.1086/285333; KARASOV WH, 1986, J COMP PHYSIOL B, V156, P599, DOI 10.1007/BF00691047; Karasov William, 2012, P212; Klaassen M, 2008, ECOL LETT, V11, P785, DOI 10.1111/j.1461-0248.2008.01180.x; Kleynhans EJ, 2011, OIKOS, V120, P591, DOI 10.1111/j.1600-0706.2010.18712.x; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; LOEB SC, 1989, CAN J ZOOL, V67, P96, DOI 10.1139/z89-015; Lukas M, 2005, J ANIM SCI, V83, P1332; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; McNab BK, 1999, PHYSIOL BIOCHEM ZOOL, V72, P642, DOI 10.1086/316701; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mesochina P, 1998, GRASS FORAGE SCI, V53, P189, DOI 10.1046/j.1365-2494.1998.5320189.x; Meyer K, 2010, MAMMAL REV, V40, P221, DOI 10.1111/j.1365-2907.2010.00161.x; Midgley JJ, 2005, NEW PHYTOL, V168, P271, DOI 10.1111/j.1469-8137.2005.01564.x; Midgley JJ, 2002, EVOL ECOL RES, V4, P1093; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; MORRIS JG, 1986, ARCH TIERERNAHR, V36, P234, DOI 10.1080/17450398609425268; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; Muller DWH, 2012, OIKOS, V121, P102, DOI 10.1111/j.1600-0706.2011.19505.x; Muller DWH, 2011, COMP BIOCHEM PHYS A, V160, P207, DOI 10.1016/j.cbpa.2011.06.004; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Olivier R. C. D., 1974, AFRICAN J ECOLOGY, V12, P249; Osborn RG, 2001, WILDLIFE SOC B, V29, P1131; Owen-Smith N.R., 1988, MEGAHERBIVORES INFLU; Owen-Smith N, 2012, J MAMMAL, V93, P698, DOI 10.1644/11-MAMM-A-350.1; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; Perez-Barberia FJ, 2004, P ROY SOC B-BIOL SCI, V271, P1081, DOI 10.1098/rspb.2004.2714; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Robbins C. T., 1993, WILDLIFE FEEDING NUT; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schwarm A, 2006, J ANIM PHYSIOL AN N, V90, P300, DOI 10.1111/j.1439-0396.2005.00599.x; Schwarm A, 2009, J ANIM PHYSIOL AN N, V93, P596, DOI 10.1111/j.1439-0396.2008.00842.x; Schwarm A, 2009, COMP BIOCHEM PHYS A, V152, P504, DOI 10.1016/j.cbpa.2008.12.006; SCOTCHER JSB, 1978, S AFR J WILDL RES, V8, P1; Sensenig RL, 2010, ECOLOGY, V91, P2898, DOI 10.1890/09-1673.1; Shrader AM, 2006, FUNCT ECOL, V20, P376, DOI 10.1111/j.1365-2435.2006.01107.x; Sibly R. M., 2012, METABOLIC ECOLOGY SC; SMITH AP, 1987, PHYSIOL ZOOL, V60, P82, DOI 10.1086/physzool.60.1.30158630; Sorensen JS, 2004, INT CONGR SER, V1275, P313, DOI 10.1016/j.ics.2004.08.070; Sorensen JS, 2003, OECOLOGIA, V134, P88, DOI 10.1007/s00442-002-1085-3; Steuer P, LARGE HERBIVORE BODY; Steuer P, 2013, COMP BIOCHEM PHYS A, V164, P319, DOI 10.1016/j.cbpa.2012.10.026; Steuer P, 2011, COMP BIOCHEM PHYS A, V160, P355, DOI 10.1016/j.cbpa.2011.07.005; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Stevens KA, 2005, LIFE O PAST, P212; Taylor St C.S., 1987, P487; Tutken T, 2011, UNDERSTANDING LIFE G, P57; UDEN P, 1982, BRIT J NUTR, V47, P267, DOI 10.1079/BJN19820035; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; VanSoest PJ, 1996, ZOO BIOL, V15, P455, DOI 10.1002/(SICI)1098-2361(1996)15:5<455::AID-ZOO3>3.0.CO;2-A; Wang CJ, 2009, ANIM FEED SCI TECH, V149, P199, DOI 10.1016/j.anifeedsci.2008.06.005; WEHAUSEN JD, 1995, J WILDLIFE MANAGE, V59, P816, DOI 10.2307/3801962; Wenninger PS, 2000, OECOLOGIA, V123, P466, DOI 10.1007/s004420000338; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; Wilkinson DM, 2013, FUNCT ECOL, V27, P131, DOI 10.1111/1365-2435.12033; Wilkinson DM, 2012, CURR BIOL, V22, pR292, DOI 10.1016/j.cub.2012.03.042; Wings O, 2007, P ROY SOC B-BIOL SCI, V274, P635, DOI 10.1098/rspb.2006.3763; WOODALL PF, 1992, AFR J ECOL, V30, P181, DOI 10.1111/j.1365-2028.1992.tb00492.x; Wrench J. M., 1997, Koedoe, V40, P125; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526	143	122	123	4	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e68714	10.1371/journal.pone.0068714	http://dx.doi.org/10.1371/journal.pone.0068714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204552	Green Published, Green Accepted, gold			2022-12-25	WOS:000326334500001
J	Mazumdar, V; Amar, S; Segre, D				Mazumdar, Varun; Amar, Salomon; Segre, Daniel			Metabolic Proximity in the Order of Colonization of a Microbial Community	PLOS ONE			English	Article							GENOME-SCALE RECONSTRUCTION; KYOTO ENCYCLOPEDIA; BIOFILMS; NETWORK; MODEL; KEGG; RESISTANCE; EVOLUTION; BUTYRATE; BACTERIA	Microbial biofilms are often composed of multiple bacterial species that accumulate by adhering to a surface and to each other. Biofilms can be resistant to antibiotics and physical stresses, posing unresolved challenges in the fight against infectious diseases. It has been suggested that early colonizers of certain biofilms could cause local environmental changes, favoring the aggregation of subsequent organisms. Here we ask whether the enzyme content of different microbes in a well-characterized dental biofilm can be used to predict their order of colonization. We define a metabolic distance between different species, based on the overlap in their enzyme content. We next use this metric to quantify the average metabolic distance between neighboring organisms in the biofilm. We find that this distance is significantly smaller than the one observed for a random choice of prokaryotes, probably reflecting the environmental constraints on metabolic function of the community. More surprisingly, this metabolic metric is able to discriminate between observed and randomized orders of colonization of the biofilm, with the observed orders displaying smaller metabolic distance than randomized ones. By complementing these results with the analysis of individual vs. joint metabolic networks, we find that the tendency towards minimal metabolic distance may be counter-balanced by a propensity to pair organisms with maximal joint potential for synergistic interactions. The trade-off between these two tendencies may create a "sweet spot" of optimal inter-organism distance, with possible broad implications for our understanding of microbial community organization.	[Mazumdar, Varun; Amar, Salomon; Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Boston University; Boston University; Boston University; Boston University	Segre, D (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	dsegre@bu.edu	Segre, Daniel/A-1993-2009	Segre, Daniel/0000-0003-4859-1914	United States Department of Energy [DE-SC0004962]; NIH [R01DE15345, R01HL6801, R0115989]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015345] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was partially funded by the United States Department of Energy, grant DE-SC0004962, and by NIH grants R01DE15345, R01HL6801 and R0115989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1998, J BIOCHEM, V123, P305; [Anonymous], [No title captured]; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Belda-Ferre P, 2011, ISME J, P1; Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diaz-Torres ML, 2006, FEMS MICROBIOL LETT, V258, P257, DOI 10.1111/j.1574-6968.2006.00221.x; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HAWSER SP, 1994, INFECT IMMUN, V62, P915, DOI 10.1128/IAI.62.3.915-921.1994; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1986, J BACTERIOL, V168, P851, DOI 10.1128/jb.168.2.851-859.1986; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Lendenmann U, 2000, Adv Dent Res, V14, P22; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li LN, 2010, INT J ORAL SCI, V2, P66, DOI 10.4248/IJOS10024; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08; NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Palmer RJ, 2001, METHOD ENZYMOL, V337, P393, DOI 10.1016/S0076-6879(01)37028-3; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Senger RS, 2008, BIOTECHNOL BIOENG, V101, P1036, DOI 10.1002/bit.22010; SINGER RE, 1981, INFECT IMMUN, V32, P458, DOI 10.1128/IAI.32.2.458-463.1981; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2010, METAGENOMIC ANAL HUM, V1, P1; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Webb E. C., 1992, ENZYME NOMENCLATURE; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	52	24	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77617	10.1371/journal.pone.0077617	http://dx.doi.org/10.1371/journal.pone.0077617			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204896	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500037
J	Khuong, A; Lecheval, V; Fournier, R; Blanco, S; Weitz, S; Bezian, JJ; Gautrais, J				Khuong, Anais; Lecheval, Valentin; Fournier, Richard; Blanco, Stephane; Weitz, Sebastian; Bezian, Jean-Jacques; Gautrais, Jacques			How Do Ants Make Sense of Gravity? A Boltzmann Walker Analysis of Lasius niger Trajectories on Various Inclines	PLOS ONE			English	Article							SPATIAL-PATTERNS; ANIMAL MOVEMENTS; DESERT ANTS; WALKING; BEHAVIOR; INSECTS; DISPLACEMENTS; ORIENTATION; HYMENOPTERA; LOCOMOTION	The goal of this study is to describe accurately how the directional information given by support inclinations affects the ant Lasius niger motion in terms of a behavioral decision. To this end, we have tracked the spontaneous motion of 345 ants walking on a 0.5x0.5 m plane canvas, which was tilted with 5 various inclinations by (0, pi/9, pi/6, pi/4, pi/3) rad (>845000 data points). At the population scale, support inclination favors dispersal along uphill and downhill directions. An ant's decision making process is modeled using a version of the Boltzmann Walker model, which describes an ant's random walk as a series of straight segments separated by reorientation events, and was extended to take directional influence into account. From the data segmented accordingly (>73000 segments), this extension allows us to test separately how average speed, segments lengths and reorientation decisions are affected by support inclination and current walking direction of the ant. We found that support inclination had a major effect on average speed, which appeared approximately three times slower on the pi/3 incline. However, we found no effect of the walking direction on speed. Contrastingly, we found that ants tend to walk longer in the same direction when they move uphill or downhill, and also that they preferentially adopt new uphill or downhill headings at turning points. We conclude that ants continuously adapt their decision making about where to go, and how long to persist in the same direction, depending on how they are aligned with the line of maximum declivity gradient. Hence, their behavioral decision process appears to combine klinokinesis with geomenotaxis. The extended Boltzmann Walker model parameterized by these effects gives a fair account of the directional dispersal of ants on inclines.	[Khuong, Anais; Lecheval, Valentin; Gautrais, Jacques] UPS, Univ Toulouse, Ctr Rech Cognit Anim, Toulouse, France; [Khuong, Anais; Lecheval, Valentin; Gautrais, Jacques] CRCA, French Natl Ctr Sci Res, Toulouse, France; [Fournier, Richard; Blanco, Stephane; Weitz, Sebastian] UPS, Univ Toulouse, Lab Plasma & Convers Energie, Toulouse, France; [Fournier, Richard; Blanco, Stephane; Weitz, Sebastian] French Natl Ctr Sci Res, Lab Plasma & Convers Energie, Toulouse, France; [Bezian, Jean-Jacques] Univ Toulouse, Ctr Rech Albi Genie Proc Solides Divses Energie &, Mines Albi, France; [Bezian, Jean-Jacques] French Natl Ctr Sci Res, Ctr Rech Albi Genie Proc Solides Divses Energie &, Albi, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; IMT - Institut Mines-Telecom; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; IMT Mines Albi	Khuong, A (corresponding author), UPS, Univ Toulouse, Ctr Rech Cognit Anim, Toulouse, France.	anais.khuong@univ-tlse3.fr; jacques.gautrais@univ-tlse3.fr	Lecheval, Valentin/ABG-9070-2020; Gautrais, Jacques/B-4523-2008	Lecheval, Valentin/0000-0001-6041-2718; Gautrais, Jacques/0000-0002-7002-9920; BEZIAN, Jean Jacques/0000-0001-5667-2488	PRES University of Toulouse/Region Midi-Pyrenees [APR 2010]	PRES University of Toulouse/Region Midi-Pyrenees(Region Occitanie)	This study was supported by a PhD grant from the PRES University of Toulouse/Region Midi-Pyrenees (APR 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2011, R PACKAGE CIRCULAR C; AJNE B, 1968, BIOMETRIKA, V55, P343, DOI 10.1093/biomet/55.2.343; ALT W, 1995, BIOSYSTEMS, V34, P11, DOI 10.1016/0303-2647(94)01449-H; [Anonymous], 1959, INSECTES SOCIAUX; Apple, 2008, CICOLOR TRACK PROGR; Batschelet E, 1981, CIRCULAR STAT BIOL; BELL WJ, 1990, ANNU REV ENTOMOL, V35, P447, DOI 10.1146/annurev.en.35.010190.002311; Berens P., 2009, CIRCSTAT MATLAB TOOL; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Bernadou A, 2008, J INSECT PHYSIOL, V54, P534, DOI 10.1016/j.jinsphys.2007.12.001; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Brillinger DR, 2004, J STAT PLAN INFER, V122, P43, DOI 10.1016/j.jspi.2003.06.016; Case K., 1967, ADDISON WESLEY SERIE; Casellas E, 2008, J THEOR BIOL, V250, P424, DOI 10.1016/j.jtbi.2007.10.011; Challet M, 2005, INSECT SOC, V52, P309, DOI 10.1007/s00040-005-0821-1; Challet M, 2005, NATURWISSENSCHAFTEN, V92, P367, DOI 10.1007/s00114-005-0001-1; Challet M, 2005, THESIS U P SABATIER; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Devigne C, 2002, INSECT SOC, V49, P357, DOI 10.1007/PL00012659; Dussutour A, 2005, P ROY SOC B-BIOL SCI, V272, P705, DOI 10.1098/rspb.2004.2990; FULL RJ, 1990, J EXP BIOL, V149, P307; Galtier M, 2013, J QUANTITATIVE SPECT; Hillen T, 2000, SIAM J APPL MATH, V61, P751, DOI 10.1137/S0036139999358167; Himberg J, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P203, DOI 10.1109/ICDM.2001.989520; Holt NC, 2012, J EXP BIOL, V215, P2545, DOI 10.1242/jeb.057695; JANDER R, 1974, INSECT SOC, V21, P45, DOI 10.1007/BF02222979; Keogh E, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P289, DOI 10.1109/ICDM.2001.989531; Keogh E, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P115, DOI 10.1109/ICDM.2003.1250910; Keogh E. J., 1998, Proceedings Fourth International Conference on Knowledge Discovery and Data Mining, P239; Khuong A., 2011, ADV ARTIFICIAL LIFE, P404; Le Breton J, 2004, BEHAV ECOL SOCIOBIOL, V55, P242, DOI 10.1007/s00265-003-0704-2; Lenke R, 2000, SCATTERING IN POLYMERIC AND COLLOIDAL SYSTEMS, P1; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Lewis OT, 2008, BEHAV ECOL, V19, P805, DOI 10.1093/beheco/arn032; Lipp A, 2005, J EXP BIOL, V208, P707, DOI 10.1242/jeb.01434; Morales JM, 2002, ECOLOGY, V83, P2240; Othmer HG, 2002, SIAM J APPL MATH, V62, P1222, DOI 10.1137/S0036139900382772; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P431, DOI 10.1007/BF02476435; Pearce-Duvet JMC, 2011, BEHAV ECOL, V22, P501, DOI 10.1093/beheco/arr001; Pelletier Y, 2001, BIOL CYBERN, V84, P269, DOI 10.1007/s004220000214; Preisler HK, 2004, ENVIRONMETRICS, V15, P643, DOI 10.1002/env.636; Punskaya E, 2002, IEEE T SIGNAL PROCES, V50; R Development Core Team, 2010, R LANG ENV STAT COMP; Riveros AJ, 2008, ANIM BEHAV, V75, P1273, DOI 10.1016/j.anbehav.2007.09.030; Robinson EJH, 2008, ANIM BEHAV, V75, P1389, DOI 10.1016/j.anbehav.2007.09.013; Sandoval EL, 2012, J INSECT BEHAV, V25, P612, DOI 10.1007/s10905-012-9327-7; Saupe D, 1998, SPIE VISUAL COMMUNIC; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Schultheiss P, 2013, BEHAV ECOL, V24, P128, DOI 10.1093/beheco/ars143; Seidl T, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-8; Shimatani IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050309; Theraulaz G, 2003, PHILOS T R SOC A, V361, P1263, DOI 10.1098/rsta.2003.1198; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Theraulaz Guy, 1998, Complexity, V3, P15, DOI 10.1002/(SICI)1099-0526(199807/08)3:6<15::AID-CPLX3>3.0.CO;2-V; Vasko KT, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P466, DOI 10.1109/ICDM.2002.1183990; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; Weihmann T, 2009, J COMP PHYSIOL A, V195, P1011, DOI 10.1007/s00359-009-0475-y; Weitz S., 2012, THESIS U TOULOUSE 3; Weitz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038588; Winkler G, 2005, ST CLASS DAT ANAL, P295, DOI 10.1007/3-540-26981-9_34; Wintergerst S, 2012, J COMP PHYSIOL A, V198, P363, DOI 10.1007/s00359-012-0714-5; Wittlinger M, 2007, J EXP BIOL, V210, P375, DOI 10.1242/jeb.02674; Wohlgemuth S, 2001, NATURE, V411, P795, DOI 10.1038/35081069	65	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76531	10.1371/journal.pone.0076531	http://dx.doi.org/10.1371/journal.pone.0076531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204636	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700006
J	Rafajlovic, M; Eriksson, A; Rimark, A; Hintz-Saltin, S; Charrier, G; Panova, M; Andre, C; Johannesson, K; Mehlig, B				Rafajlovic, Marina; Eriksson, Anders; Rimark, Anna; Hintz-Saltin, Sara; Charrier, Gregory; Panova, Marina; Andre, Carl; Johannesson, Kerstin; Mehlig, Bernhard			The Effect of Multiple Paternity on Genetic Diversity of Small Populations during and after Colonisation	PLOS ONE			English	Article							EVOLUTION; PATTERNS; NUMBER	Genetic variation within and among populations is influenced by the genetic content of the founders and the migrants following establishment. This is particularly true if populations are small, migration rate low and habitats arranged in a stepping-stone fashion. Under these circumstances the level of multiple paternity is critical since multiply mated females bring more genetic variation into founder groups than single mated females. One such example is the marine snail Littorina saxatilis that during postglacial times has invaded mainland refuge areas and thereafter small islands emerging due to isostatic uplift by occasional rafting of multiply mated females. We modelled effects of varying degrees of multiple paternity on the genetic variation of island populations colonised by the founders spreading from the mainland, by quantifying the population heterozygosity during both the transient colonisation process, and after a steady state (with migration) has been reached. During colonisation, multiple mating by 2 10 males increased the heterozygosity by 10 300% in comparison with single paternity, while in the steady state the increase was 10-50% compared with single paternity. In the steady state the increase of heterozygosity due to multiple paternity is determined by a corresponding increase in effective population size. During colonisation, by contrast, the increase in heterozygosity is larger and it cannot be explained in terms of the effective population size alone. During the steady-state phase bursts of high genetic variation spread through the system, and far from the mainland this led to short periods of high diversity separated by long periods of low diversity. The size of these fluctuations was boosted by multiple paternity. We conclude that following glacial periods of extirpation, recolonization of isolated habitats by this species has been supported by its high level of multiple paternity.	[Rafajlovic, Marina; Rimark, Anna; Mehlig, Bernhard] Univ Gothenburg, Dept Phys, Gothenburg, Sweden; [Eriksson, Anders] Univ Cambridge, Dept Zool, Cambridge, England; [Eriksson, Anders] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal, Saudi Arabia; [Hintz-Saltin, Sara; Charrier, Gregory; Panova, Marina; Andre, Carl; Johannesson, Kerstin] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Gothenburg; University of Cambridge; King Abdullah University of Science & Technology; University of Gothenburg	Mehlig, B (corresponding author), Univ Gothenburg, Dept Phys, Gothenburg, Sweden.	Bernhard.Mehlig@physics.gu.se	Panova, Marina/D-2633-2015; Johannesson, Kerstin/X-7994-2019; Panova, Marina/V-3533-2019; Eriksson, Anders/C-9767-2010; Rafajlovic, Marina/ABB-8142-2021; Mehlig, Bernhard/N-6491-2013; Andre, Carl/B-4237-2010	Panova, Marina/0000-0002-4147-6473; Johannesson, Kerstin/0000-0003-0176-7986; Panova, Marina/0000-0002-4147-6473; Eriksson, Anders/0000-0003-3436-3726; Rafajlovic, Marina/0000-0003-2177-4622; Andre, Carl/0000-0003-4404-7292; Mehlig, Bernhard/0000-0002-3672-6538	Vetenskapsr\aa det; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; platform "Centre for Theoretical Biology" at the University of Gothenburg; Linnaeus Centre for Marine Evolutionary Biology (CeMEB)	Vetenskapsr\aa det; Goran Gustafsson Foundation for Research in Natural Sciences and Medicine; platform "Centre for Theoretical Biology" at the University of Gothenburg; Linnaeus Centre for Marine Evolutionary Biology (CeMEB)	The authors gratefully acknowledge financial support by Vetenskapsr\aa det, by the Goran Gustafsson Foundation for Research in Natural Sciences and Medicine, and by the platform "Centre for Theoretical Biology" at the University of Gothenburg. Further support was given from the Linnaeus Centre for Marine Evolutionary Biology (CeMEB, www.cemeb.science.gu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austerlitz F, 1997, THEOR POPUL BIOL, V51, P148, DOI 10.1006/tpbi.1997.1302; Avise JC, 2011, P NATL ACAD SCI USA, V108, P11512, DOI 10.1073/pnas.1109216108; Balloux F, 2003, GENETICS, V165, P2313; Bensch S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000072; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Brante A, 2011, J EXP MAR BIOL ECOL, V396, P83, DOI 10.1016/j.jembe.2010.10.001; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Coleman SW, 2011, BIOL J LINN SOC, V103, P735, DOI 10.1111/j.1095-8312.2011.01673.x; Eriksson A, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.040901; EWENS WJ, 1982, THEOR POPUL BIOL, V21, P373, DOI 10.1016/0040-5809(82)90024-7; Fisher RA, 1958, GENETICAL THEORY NAT; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; JANSON K, 1987, HEREDITY, V58, P31, DOI 10.1038/hdy.1987.5; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; JOHANNESSON K, 1990, HYDROBIOLOGIA, V193, P99, DOI 10.1007/BF00028069; JOHANNESSON K, 1995, HYDROBIOLOGIA, V309, P173, DOI 10.1007/BF00014485; Johannesson K, 2010, PHILOS T R SOC B, V365, P1735, DOI 10.1098/rstb.2009.0256; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1964, GENETICS, V49, P561; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Panova M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009640; Paterson IG, 2001, BIOL BULL-US, V200, P261, DOI 10.2307/1543508; Pearse DE, 2009, MOL ECOL, V18, P3124, DOI 10.1111/j.1365-294X.2009.04268.x; Reid D. G., 1996, SYSTEMATICS EVOLUTIO; Schaper E, 2012, GENETICS, V190, P217, DOI 10.1534/genetics.111.134437; Trontti K, 2007, BEHAV ECOL, V18, P298, DOI 10.1093/beheco/arl083; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wright S, 1931, GENETICS, V16, P0097	32	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e75587	10.1371/journal.pone.0075587	http://dx.doi.org/10.1371/journal.pone.0075587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204577	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200005
J	Crost, EH; Tailford, LE; Le Gall, G; Fons, M; Henrissat, B; Juge, N				Crost, Emmanuelle H.; Tailford, Louise E.; Le Gall, Gwenaelle; Fons, Michel; Henrissat, Bernard; Juge, Nathalie			Utilisation of Mucin Glycans by the Human Gut Symbiont Ruminococcus gnavus Is Strain-Dependent	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; MUCOSA-ASSOCIATED MICROBIOTA; BIFIDOBACTERIUM-BIFIDUM; HUMAN-COLON; FAECALIBACTERIUM-PRAUSNITZII; GASTROINTESTINAL-TRACT; ULCERATIVE-COLITIS; O-GLYCOSYLATION; IN-VITRO; BACTERIA	Commensal bacteria often have an especially rich source of glycan-degrading enzymes which allow them to utilize undigested carbohydrates from the food or the host. The species Ruminococcus gnavus is present in the digestive tract of $ 90% of humans and has been implicated in gut-related diseases such as inflammatory bowel diseases (IBD). Here we analysed the ability of two R. gnavus human strains, E1 and ATCC 29149, to utilize host glycans. We showed that although both strains could assimilate mucin monosaccharides, only R. gnavus ATCC 29149 was able to grow on mucin as a sole carbon source. Comparative genomic analysis of the two R. gnavus strains highlighted potential clusters and glycoside hydrolases (GHs) responsible for the breakdown and utilization of mucin-derived glycans. Transcriptomic and functional activity assays confirmed the importance of specific GH33 sialidase, and GH29 and GH95 fucosidases in the mucin utilisation pathway. Notably, we uncovered a novel pathway by which R. gnavus ATCC 29149 utilises sialic acid from sialylated substrates. Our results also demonstrated the ability of R. gnavus ATCC 29149 to produce propanol and propionate as the end products of metabolism when grown on mucin and fucosylated glycans. These new findings provide molecular insights into the strain-specificity of R. gnavus adaptation to the gut environment advancing our understanding of the role of gut commensals in health and disease.	[Crost, Emmanuelle H.; Tailford, Louise E.; Le Gall, Gwenaelle; Juge, Nathalie] Inst Food Res, Gut Hlth & Food Safety Inst Strateg Programme, Norwich NR4 7UA, Norfolk, England; [Fons, Michel] CNRS, Inst Microbiol Mediterranee, Lab Chim Bacterienne, Marseille, France; [Fons, Michel; Henrissat, Bernard] Aix Marseille Univ, Marseille, France; [Henrissat, Bernard] CNRS, Marseille, France; [Henrissat, Bernard] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen	Juge, N (corresponding author), Inst Food Res, Gut Hlth & Food Safety Inst Strateg Programme, Norwich NR4 7UA, Norfolk, England.	nathalie.juge@ifr.ac.uk	Henrissat, Bernard/J-2475-2012; Le+Gall, Gwenaelle/AAC-6938-2019	Henrissat, Bernard/0000-0002-3434-8588; Le+Gall, Gwenaelle/0000-0002-1379-2196; Fons, Michel/0000-0001-8263-3669; Juge, Nathalie/0000-0001-8515-1315	Biotechnology and Biological Sciences Research Council (BBSRC); Newton International Fellowships; Royal Society; BBSRC Institute Strategic Programme [BB/J004529/1]; BBSRC [BBS/E/F/00044452] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044452] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton International Fellowships; Royal Society(Royal Society of London); BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC). EC was a recipient of a Newton International Fellowships-2009. This research was partly funded by the Royal Society and the BBSRC Institute Strategic Programme BB/J004529/1: The Gut Health and Food Safety ISP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Baranyi J, 2000, MICROBIOLOGICAL SAFE, P342; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cervera-Tison M, 2012, APPL ENVIRON MICROB, V78, P7720, DOI 10.1128/AEM.01350-12; Chou MY, 1996, J BIOL CHEM, V271, P19219, DOI 10.1074/jbc.271.32.19219; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Ficko-Blean E, 2012, CURR OPIN STRUC BIOL, V22, P570, DOI 10.1016/j.sbi.2012.07.009; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; FURUHATA K, 1991, CHEM PHARM BULL, V39, P817; Gunning AP, 2013, FASEB J, V27, P2342, DOI 10.1096/fj.12-221416; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HOSKINS LC, 1985, J CLIN INVEST, V75, P944, DOI 10.1172/JCI111795; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; LI YT, 1990, J BIOL CHEM, V265, P21629; Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Ludwig W, 2009, BERGEYS MANUAL SYSTE, V3, P1, DOI DOI 10.1007/978-0-387-68489-5_; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; Martinez C, 2008, AM J GASTROENTEROL, V103, P643, DOI 10.1111/j.1572-0241.2007.01592.x; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; MOORE WEC, 1974, AM J CLIN NUTR, V27, P1450, DOI 10.1093/ajcn/27.12.1450; Nielsen DS, 2003, APPL ENVIRON MICROB, V69, P7545, DOI 10.1128/AEM.69.12.7545-7548.2003; Nishikawa J, 2009, SCAND J GASTROENTERO, V44, P180, DOI 10.1080/00365520802433231; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Prindiville T, 2004, INFLAMM BOWEL DIS, V10, P824, DOI 10.1097/00054725-200411000-00017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAMARE F, 1993, APPL ENVIRON MICROB, V59, P2876, DOI 10.1128/AEM.59.9.2876-2883.1993; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tannock GW, 2013, APPL ENVIRON MICROB, V79, P3040, DOI 10.1128/AEM.03910-12; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wada J, 2008, APPL ENVIRON MICROB, V74, P3996, DOI 10.1128/AEM.00149-08; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	69	167	177	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76341	10.1371/journal.pone.0076341	http://dx.doi.org/10.1371/journal.pone.0076341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204617	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000326155400013
J	Shi, W; Wei, S; Hu, XX; Hu, GJ; Chen, CL; Wang, XR; Giesy, JP; Yu, HX				Shi, Wei; Wei, Si; Hu, Xin-xin; Hu, Guan-jiu; Chen, Cu-lan; Wang, Xin-ru; Giesy, John P.; Yu, Hong-xia			Identification of Thyroid Receptor Ant/Agonists in Water Sources Using Mass Balance Analysis and Monte Carlo Simulation	PLOS ONE			English	Article							INDIVIDUAL POLYCHLORINATED NAPHTHALENES; ECOLOGICAL RISK-ASSESSMENT; PHTHALATE-ESTERS; DRINKING-WATER; RELATIVE POTENCIES; SUBTROPICAL CITY; MEILIANG BAY; WASTE-WATER; DIOXIN-LIKE; TAIHU LAKE	Some synthetic chemicals, which have been shown to disrupt thyroid hormone (TH) function, have been detected in surface waters and people have the potential to be exposed through water-drinking. Here, the presence of thyroid-active chemicals and their toxic potential in drinking water sources in Yangtze River Delta were investigated by use of instrumental analysis combined with cell-based reporter gene assay. A novel approach was developed to use Monte Carlo simulation, for evaluation of the potential risks of measured concentrations of TH agonists and antagonists and to determine the major contributors to observed thyroid receptor (TR) antagonist potency. None of the extracts exhibited TR agonist potency, while 12 of 14 water samples exhibited TR antagonistic potency. The most probable observed antagonist equivalents ranged from 1.4 to 5.6 mu g di-n-butyl phthalate (DNBP)/L, which posed potential risk in water sources. Based on Monte Carlo simulation related mass balance analysis, DNBP accounted for 64.4% for the entire observed antagonist toxic unit in water sources, while diisobutyl phthalate (DIBP), di-n-octyl phthalate (DNOP) and di-2-ethylhexyl phthalate (DEHP) also contributed. The most probable observed equivalent and most probable relative potency (REP) derived from Monte Carlo simulation is useful for potency comparison and responsible chemicals screening.	[Shi, Wei; Wei, Si; Hu, Xin-xin; Giesy, John P.; Yu, Hong-xia] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China; [Hu, Guan-jiu; Chen, Cu-lan] Jiangsu Prov Environm Monitoring Ctr, State Environm Protect Key Lab Monitoring & Anal, Nanjing, Jiangsu, Peoples R China; [Wang, Xin-ru] Nanjing Med Univ, Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Wang, Xin-ru] Nanjing Med Univ, Inst Toxicol, Nanjing, Jiangsu, Peoples R China; [Giesy, John P.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Giesy, John P.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Giesy, John P.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Giesy, John P.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Giesy, John P.] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] City Univ Hong Kong, State Key Lab Marine Pollut, Kowloon, Hong Kong, Peoples R China; [Giesy, John P.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Nanjing University; Nanjing Medical University; Nanjing Medical University; University of Saskatchewan; University of Saskatchewan; Michigan State University; Michigan State University; City University of Hong Kong; City University of Hong Kong; University of Hong Kong	Yu, HX (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210008, Jiangsu, Peoples R China.	yuhx@nju.edu.cn	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Giesy, John/0000-0003-1931-9962; Shi, Wei/0000-0002-6263-5664	National Natural Science Foundation of China [21307054]; Science Foundation in Jiangsu Province [BK20130551, BK2011032]; National High-tech R&D Program of China [2013AA062709]; Major Science and Technology Program for Water Pollution Control and Treatment [2012ZX07506-004-004]; Program for Environmental Monitoring in Jiangsu Province [1212]; program of 2012 "High Level Foreign Experts" [GDW20123200120]; State Administration of Foreign Experts Affairs, the P.R. China; Einstein Professor Program of the Chinese Academy of Sciences; Canada Research Chair program; Department of Biology and Chemistry, City University of Hong Kong; State Key Laboratory in Marine Pollution, City University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation in Jiangsu Province; National High-tech R&D Program of China(National High Technology Research and Development Program of China); Major Science and Technology Program for Water Pollution Control and Treatment; Program for Environmental Monitoring in Jiangsu Province; program of 2012 "High Level Foreign Experts"; State Administration of Foreign Experts Affairs, the P.R. China; Einstein Professor Program of the Chinese Academy of Sciences; Canada Research Chair program(Canada Research Chairs); Department of Biology and Chemistry, City University of Hong Kong; State Key Laboratory in Marine Pollution, City University of Hong Kong(City University of Hong Kong)	This work was supported by the National Natural Science Foundation of China (21307054), the Science Foundation in Jiangsu Province (BK20130551), the National High-tech R&D Program of China (2013AA062709), the Science Foundation in Jiangsu Province (BK2011032), the Major Science and Technology Program for Water Pollution Control and Treatment (2012ZX07506-004-004) and the Program for Environmental Monitoring in Jiangsu Province (1212). Prof. Giesy was supported by the program of 2012 "High Level Foreign Experts" (#GDW20123200120) funded by the State Administration of Foreign Experts Affairs, the P.R. China to Nanjing University and the Einstein Professor Program of the Chinese Academy of Sciences. He was also supported by the Canada Research Chair program, and a large Chair Professorship at the Department of Biology and Chemistry and State Key Laboratory in Marine Pollution, City University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhoum N, 2004, SEP PURIF TECHNOL, V38, P233, DOI 10.1016/j.seppur.2003.11.011; Blankenship AL, 2000, ENVIRON SCI TECHNOL, V34, P3153, DOI 10.1021/es9914339; Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Darnerud PO, 2010, ENVIRON INT, V36, P180, DOI 10.1016/j.envint.2009.11.001; Davis PJ, 2000, J BIOL CHEM, V275, P38032, DOI 10.1074/jbc.M002560200; Du GZ, 2010, TOXICOL SCI, V116, P58, DOI 10.1093/toxsci/kfq120; FINNEY D. J., 1978, STAT METHOD BIOL ASS; Ghisari M, 2005, MOL CELL ENDOCRINOL, V244, P31, DOI 10.1016/j.mce.2005.01.013; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106; Hladik ML, 2009, J AGR FOOD CHEM, V57, P9079, DOI 10.1021/jf9020448; Hoefling M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019791; Howdeshell KL, 2002, ENVIRON HEALTH PERSP, V110, P337, DOI 10.1289/ehp.02110s3337; Jang CS, 2006, ENVIRON SCI TECHNOL, V40, P1707, DOI 10.1021/es051875m; Jugan ML, 2009, SCI TOTAL ENVIRON, V407, P3579, DOI 10.1016/j.scitotenv.2009.01.027; Koh CH, 2005, ECOTOX ENVIRON SAFE, V61, P366, DOI 10.1016/j.ecoenv.2005.03.005; Li N, 2010, ENVIRON SCI TECHNOL, V44, P6863, DOI 10.1021/es101254c; Luo JP, 2011, WATER RES, V45, P3908, DOI 10.1016/j.watres.2011.04.045; Ma FJ, 2012, ENVIRON SCI TECHNOL, V46, P3236, DOI 10.1021/es204520b; Machala M, 2001, ENVIRON TOXICOL CHEM, V20, P2736, DOI 10.1002/etc.5620201212; National Research Council, 1994, NRC SCI JUDGM RISK A; Putzrath RM, 1997, REGUL TOXICOL PHARM, V25, P68, DOI 10.1006/rtph.1996.1063; Qiao M, 2006, ENVIRON SCI TECHNOL, V40, P1415, DOI 10.1021/es051456p; Qu CS, 2011, ECOL MODEL, V222, P287, DOI 10.1016/j.ecolmodel.2010.07.014; Qu CS, 2012, HUM ECOL RISK ASSESS, V18, P733, DOI 10.1080/10807039.2012.688697; Shen M, 2006, MAR POLLUT BULL, V52, P1299, DOI 10.1016/j.marpolbul.2006.05.023; Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019; Shi W, 2012, ENVIRON SCI TECHNOL, V46, P1811, DOI 10.1021/es202625r; Song LR, 2007, WATER RES, V41, P2853, DOI 10.1016/j.watres.2007.02.013; Sun C, 2002, ENVIRON POLLUT, V117, P9, DOI 10.1016/S0269-7491(01)00169-5; Sun H, 2009, TOXICOL IN VITRO, V23, P950, DOI 10.1016/j.tiv.2009.05.004; Suzuki G, 2008, ENVIRON SCI TECHNOL, V42, P1794, DOI 10.1021/es7021895; USEPA, 1997, GUID PRINC MONT CARL; VIJAYAN MM, 1988, GEN COMP ENDOCR, V70, P312, DOI 10.1016/0016-6480(88)90151-7; Villeneuve DL, 2000, ARCH ENVIRON CON TOX, V39, P273; Villeneuve DL, 2000, ENVIRON TOXICOL CHEM, V19, P2835, DOI 10.1002/etc.5620191131; Wang B, 2009, ENVIRON MONIT ASSESS, V157, P29, DOI 10.1007/s10661-008-0512-2; Wu B, 2009, ECOTOXICOLOGY, V18, P707, DOI 10.1007/s10646-009-0331-4; Xu ZW, 2010, ENVIRON SCI TECHNOL, V44, P3130, DOI 10.1021/es100058j; Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002; Zeng F, 2008, ENVIRON POLLUT, V156, P425, DOI 10.1016/j.envpol.2008.01.045; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029	42	10	11	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e73883	10.1371/journal.pone.0073883	http://dx.doi.org/10.1371/journal.pone.0073883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204563	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400004
J	Zhou, JH; Zhang, J; Sun, DJ; Ma, Q; Chen, HT; Ma, LN; Ding, YZ; Liu, YS				Zhou, Jian-hua; Zhang, Jie; Sun, Dong-jie; Ma, Qi; Chen, Hao-tai; Ma, Li-na; Ding, Yao-zhong; Liu, Yong-sheng			The Distribution of Synonymous Codon Choice in the Translation Initiation Region of Dengue Virus	PLOS ONE			English	Article							USAGE BIAS; HETEROLOGOUS EXPRESSION; MOLECULAR EVOLUTION; PREFERENTIAL USAGE; GENETIC-VARIATION; PESTIVIRUS GENUS; MINOR CODONS; TYPE-1 VIRUS; RNA VIRUSES; SEQUENCE	Dengue is the most common arthropod-borne viral (Arboviral) illness in humans. The genetic features concerning the codon usage of dengue virus (DENV) were analyzed by the relative synonymous codon usage, the effective number of codons and the codon adaptation index. The evolutionary distance between DENV and the natural hosts (Homo sapiens, Pan troglodytes, Aedes albopictus and Aedes aegypti) was estimated by a novel formula. Finally, the synonymous codon usage preference for the translation initiation region of this virus was also analyzed. The result indicates that the general trend of the 59 synonymous codon usage of the four genotypes of DENV are similar to each other, and this pattern has no link with the geographic distribution of the virus. The effect of codon usage pattern of Aedes albopictus and Aedes aegypti on the formation of codon usage of DENV is stronger than that of the two primates. Turning to the codon usage preference of the translation initiation region of this virus, some codons pairing to low tRNA copy numbers in the two primates have a stronger tendency to exist in the translation initiation region than those in the open reading frame of DENV. Although DENV, like other RNA viruses, has a high mutation to adapt its hosts, the regulatory features about the synonymous codon usage have been 'branded' on the translation initiation region of this virus in order to hijack the translational mechanisms of the hosts.	[Zhou, Jian-hua; Zhang, Jie; Sun, Dong-jie; Ma, Qi; Chen, Hao-tai; Ma, Li-na; Ding, Yao-zhong; Liu, Yong-sheng] Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Liu, YS (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Etiol Biol, Lanzhou Vet Res Inst, Lanzhou, Gansu, Peoples R China.	liuyongshengvip8@163.com			International Science & Technology Cooperation Program of China [2010DFA32640, 2012DFG31890]; Gansu Provincial Funds for Distinguished Young Scientists [1111RJDA005]; National Natural Science foundation of China [31172335, 31072143]	International Science & Technology Cooperation Program of China; Gansu Provincial Funds for Distinguished Young Scientists; National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in parts by grants International Science & Technology Cooperation Program of China (No. 2010DFA32640 and No. 2012DFG31890) and Gansu Provincial Funds for Distinguished Young Scientists (1111RJDA005). This study was also supported by National Natural Science foundation of China (No. 31172335 and No. 31072143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Behura SK, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00933.x; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Clarke TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003412; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; FU JL, 1992, VIROLOGY, V188, P953, DOI 10.1016/0042-6822(92)90560-C; Gilchrist MA, 2009, GENETICS, V183, P1493, DOI 10.1534/genetics.109.108209; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Kim S, 2006, PROTEIN EXPRES PURIF, V50, P49, DOI 10.1016/j.pep.2006.07.014; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lee KS, 2012, INFECT GENET EVOL, V12, P77, DOI 10.1016/j.meegid.2011.10.012; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Ma MR, 2012, J ANIM VET ADV, V11, P3999; MONATH TP, 1986, VIROLOGY, V154, P313, DOI 10.1016/0042-6822(86)90457-5; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Ohno H, 2001, GENE, V276, P107, DOI 10.1016/S0378-1119(01)00670-9; Parmley JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000548; Patil JA, 2011, INFECT GENET EVOL, V11, P1443, DOI 10.1016/j.meegid.2011.05.011; Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STANSSENS P, 1986, CELL, V44, P711, DOI 10.1016/0092-8674(86)90837-8; TRENT DW, 1983, VIROLOGY, V128, P271, DOI 10.1016/0042-6822(83)90255-6; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Weaver SC, 2006, CURR TOP MICROBIOL, V299, P285; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhou JH, 2013, INFECT GENET EVOL; Zhou JH, 2012, VIRUS GENES, V44, P475, DOI 10.1007/s11262-012-0731-z; Zhou JH, 2011, INFECT GENET EVOL, V11, P1815, DOI 10.1016/j.meegid.2011.07.014	53	61	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77239	10.1371/journal.pone.0077239	http://dx.doi.org/10.1371/journal.pone.0077239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204777	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400031
J	Mossbridge, JA; Grabowecky, M; Suzuki, S				Mossbridge, Julia A.; Grabowecky, Marcia; Suzuki, Satoru			Seeing the Song: Left Auditory Structures May Track Auditory-Visual Dynamic Alignment	PLOS ONE			English	Article							STEADY-STATE RESPONSES; MULTISENSORY INTEGRATION; 40 HZ; AUDIOVISUAL INTEGRATION; SUPERIOR COLLICULUS; DIVIDED ATTENTION; EVOKED-POTENTIALS; TEMPORAL FACTORS; CORTEX; SPEECH	Auditory and visual signals generated by a single source tend to be temporally correlated, such as the synchronous sounds of footsteps and the limb movements of a walker. Continuous tracking and comparison of the dynamics of auditory-visual streams is thus useful for the perceptual binding of information arising from a common source. Although language-related mechanisms have been implicated in the tracking of speech-related auditory-visual signals (e.g., speech sounds and lip movements), it is not well known what sensory mechanisms generally track ongoing auditory-visual synchrony for non-speech signals in a complex auditory-visual environment. To begin to address this question, we used music and visual displays that varied in the dynamics of multiple features (e.g., auditory loudness and pitch; visual luminance, color, size, motion, and organization) across multiple time scales. Auditory activity (monitored using auditory steady-state responses, ASSR) was selectively reduced in the left hemisphere when the music and dynamic visual displays were temporally misaligned. Importantly, ASSR was not affected when attentional engagement with the music was reduced, or when visual displays presented dynamics clearly dissimilar to the music. These results appear to suggest that left-lateralized auditory mechanisms are sensitive to auditory-visual temporal alignment, but perhaps only when the dynamics of auditory and visual streams are similar. These mechanisms may contribute to correct auditory-visual binding in a busy sensory environment.	[Mossbridge, Julia A.; Grabowecky, Marcia; Suzuki, Satoru] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Grabowecky, Marcia; Suzuki, Satoru] Northwestern Univ, Interdept Neurosci Program, Evanston, IL USA	Northwestern University; Northwestern University	Mossbridge, JA (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.	jmossbridge@gmail.com			NSF [BCS0643191]; NIH [R01 EY018197, 5T32NS047987-05]; NATIONAL EYE INSTITUTE [R01EY021184, R01EY018197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS047987] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	JM, MG, and SS were supported through NSF BCS0643191 (NSF.gov) and NIH R01 EY018197 (NIH.gov); JM was also supported through NIH 5T32NS047987-05 (NIH.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bernier PM, 2009, NEUROIMAGE, V47, P1767, DOI 10.1016/j.neuroimage.2009.05.028; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Carbonnell L, 2004, CLIN NEUROPHYSIOL, V115, P2164, DOI 10.1016/j.clinph.2004.04.012; de Jong R, 2010, INT J PSYCHOPHYSIOL, V75, P3, DOI 10.1016/j.ijpsycho.2009.09.013; Driver J, 1998, TRENDS COGN SCI, V2, P254, DOI 10.1016/S1364-6613(98)01188-7; Driver J, 1996, NATURE, V381, P66, DOI 10.1038/381066a0; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; Herrmann C. S., 2005, EVENT RELATED POTENT, P229; HUGHES HC, 1994, J EXP PSYCHOL HUMAN, V20, P131, DOI 10.1037/0096-1523.20.1.131; Iordanescu L, 2011, ACTA PSYCHOL, V137, P252, DOI 10.1016/j.actpsy.2010.07.017; Iordanescu L, 2010, ATTEN PERCEPT PSYCHO, V72, P1736, DOI 10.3758/APP.72.7.1736; Jenkins J, 2011, BRAIN TOPOGR, V24, P134, DOI 10.1007/s10548-011-0174-1; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser J, 2006, PSYCHOPHYSIOLOGY, V43, P237, DOI 10.1111/j.1469-8986.2006.00398.x; LINDEN RD, 1987, ELECTROEN CLIN NEURO, V66, P145, DOI 10.1016/0013-4694(87)90184-2; Lordanescu L, 2008, PSYCHON B REV, V15, P548, DOI 10.3758/PBR.15.3.548; Luo H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000445; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Miller LM, 2005, J NEUROSCI, V25, P5884, DOI 10.1523/JNEUROSCI.0896-05.2005; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Nozaradan S, 2012, NEUROIMAGE, V60, P21, DOI 10.1016/j.neuroimage.2011.11.065; Pastor MA, 2002, J NEUROSCI, V22, P10501; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; RADEAU M, 1977, PERCEPT PSYCHOPHYS, V22, P137, DOI 10.3758/BF03198746; ROBIN DA, 1990, BRAIN LANG, V39, P539, DOI 10.1016/0093-934X(90)90161-9; Ross B, 2005, CEREB CORTEX, V15, P2029, DOI 10.1093/cercor/bhi078; Ross B, 2004, Neurol Clin Neurophysiol, V2004, P22; Ross B, 2008, J NEUROPHYSIOL, V100, P1265, DOI 10.1152/jn.00048.2008; Samson S, 2001, ANN NY ACAD SCI, V930, P166, DOI 10.1111/j.1749-6632.2001.tb05732.x; Saupe K, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.058.2009; Saupe K, 2009, PSYCHOPHYSIOLOGY, V46, P321, DOI 10.1111/j.1469-8986.2008.00765.x; Schall S, 2009, EXP BRAIN RES, V198, P137, DOI 10.1007/s00221-009-1867-5; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Tenke CE, 2005, CLIN NEUROPHYSIOL, V116, P2826, DOI 10.1016/j.clinph.2005.08.007; Tenke CE, 2012, CLIN NEUROPHYSIOLOGY; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	51	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77201	10.1371/journal.pone.0077201	http://dx.doi.org/10.1371/journal.pone.0077201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194873	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000052
J	Nie, Y; Yan, W; Xu, Y; Chen, WB; Mu, XQ; Wang, XY; Xiao, R				Nie, Yao; Yan, Wei; Xu, Yan; Chen, Wen Bo; Mu, Xiao Qing; Wang, Xinye; Xiao, Rong			High-Level Expression of Bacillus naganoensis Pullulanase from Recombinant Escherichia coli with Auto-Induction: Effect of lac Operator	PLOS ONE			English	Article							T7 RNA-POLYMERASE; I-PULLULANASE; THERMOLEOVORANS US105; PROTEIN-PRODUCTION; GENE-EXPRESSION; CLONED GENES; E.-COLI; CLONING; STABILITY; SECRETION	Pullulanase plays an important role in specific hydrolysis of branch points in amylopectin and is generally employed as an important enzyme in starch-processing industry. So far, however, the production level of pullulanase is still somewhat low from wide-type strains and even heterologous expression systems. Here the gene encoding Bacillus naganoensis pullulanase was amplified and cloned. For expression of the protein, two recombinant systems, Escherichia coli BL21(DE3)/pET-20b(+)-pul and E. coli BL21(DE3)/pET-22b(+)-pul, were constructed, both bearing T7 promoter and signal peptide sequence, but different in the existance of lac operator and lacI gene encoding lac repressor. Recombinant pullulanase was initially expressed with the activity of up to 14 U/mL by E. coli BL21(DE3)/pET-20b(+)-pul with IPTG induction in LB medium, but its expression level reduced continually with the extension of cryopreservation time and basal expression was observed. However, E. coli BL21(DE3)/pET-22b(+)-pul, involving lac operator downstream of T7 promoter to regulate foreign gene transcription, exhibited pullulanase activity consistently without detected basal expression. By investigating the effect of lac operator, basal expression of foreign protein was found to cause expression instability and negative effect on production of target protein. Thus double-repression strategy was proposed that lac operators in both chromosome and plasmid were bound with lac repressor to repress T7 RNA polymerase synthesis and target protein expression before induction. Consequently, the total activity of pullulanase was remarkably increased to 580 U/mL with auto-induction by lac operator-involved E. coli BL21(DE3)/pET-22b(+)-pul. When adding 0.6% glycine in culture, the extracellular production of pullulanase was significantly improved with the extracellular activity of 502 U/mL, which is a relatively higher level achieved to date for extracellular production of pullulanase. The successful expression of pullulanase with lac operator regulation provides an efficient way for enhancement of expression stability and hence high-level production of target protein in recombinant E. coli.	[Nie, Yao; Yan, Wei; Xu, Yan; Chen, Wen Bo; Mu, Xiao Qing; Wang, Xinye] Jiangnan Univ, Sch Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Nie, Yao; Yan, Wei; Xu, Yan; Chen, Wen Bo; Mu, Xiao Qing; Wang, Xinye] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Xu, Yan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Xiao, Rong] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Jiangnan University; Jiangnan University; Jiangnan University; Rutgers State University New Brunswick	Xu, Y (corresponding author), Jiangnan Univ, Sch Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.	yxu@jiangnan.edu.cn	mu, xiaoqing/GRE-6842-2022		Hi-Tech Research and Development Program of China (863 Program) [2012AA022207]; National Key Basic Research and Development Program of China (973 Program) [2011CB710800, 2009CB724706]; Program of Introducing Talents of Discipline to Universities (111 Project) [111-2-06]; High-end Foreign Experts Recruitment Program [GDW20123200113]	Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); Program of Introducing Talents of Discipline to Universities (111 Project); High-end Foreign Experts Recruitment Program	This work was supported by the grants from Hi-Tech Research and Development Program of China (863 Program) (2012AA022207), the National Key Basic Research and Development Program of China (973 Program) (2011CB710800 and 2009CB724706), the Program of Introducing Talents of Discipline to Universities (111 Project) (111-2-06), and the High-end Foreign Experts Recruitment Program (GDW20123200113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi DZ, 2008, APPL MICROBIOL BIOT, V78, P473, DOI 10.1007/s00253-007-1318-9; Ben Messaoud E, 2002, ENZYME MICROB TECH, V31, P827, DOI 10.1016/S0141-0229(02)00185-0; Bertoldo C, 2004, APPL ENVIRON MICROB, V70, P3407, DOI 10.1128/AEM.70.6.3407-3416.2004; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Chen WB, 2013, APPL BIOCHEM BIOTECH, V169, P41, DOI 10.1007/s12010-012-9948-5; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Correa A, 2011, BIOTECHNOL J, V6, P715, DOI 10.1002/biot.201100025; Ding RR, 2010, PROCESS BIOCHEM, V45, P880, DOI 10.1016/j.procbio.2010.02.009; Doman-Pytka M, 2004, CRIT REV MICROBIOL, V30, P107, DOI 10.1080/10408410490435115; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Gomes I, 2003, BIORESOURCE TECHNOL, V90, P207, DOI 10.1016/S0960-8524(03)00110-X; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; Hii LS, 2012, FOOD BIOPROCESS TECH, V5, P729, DOI 10.1007/s11947-010-0368-7; Hii S.L., 2009, OPEN BIOTECHNOL J, V3, P1, DOI [DOI 10.2174/1874070700903010001, 10.2174/1874070700903010001]; Hii Siew Ling, 2012, Enzyme Res, V2012, P921362; Jana S, 2005, APPL MICROBIOL BIOT, V67, P289, DOI 10.1007/s00253-004-1814-0; Jiao YL, 2011, CURR MICROBIOL, V62, P222, DOI 10.1007/s00284-010-9690-6; Kang J, 2011, ENZYME MICROB TECH, V48, P260, DOI 10.1016/j.enzmictec.2010.11.006; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; Klosowski G, 2010, J BIOSCI BIOENG, V109, P466, DOI 10.1016/j.jbiosc.2009.10.024; Kunamneni A, 2006, ENZYME MICROB TECH, V39, P1399, DOI 10.1016/j.enzmictec.2006.03.023; Lee SY, 1996, TRENDS BIOTECHNOL, V14, P98, DOI 10.1016/0167-7799(96)80930-9; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Li ZF, 2009, J AGR FOOD CHEM, V57, P6231, DOI 10.1021/jf901239k; Mertens N, 1995, NAT BIOTECHNOL, V13, P175, DOI [10.1038/nbt0295-175, DOI 10.1038/NBT0295-175.PUBMED:9634760]; Nair SU, 2006, FOOD TECHNOL BIOTECH, V44, P275; NIGAM P, 1995, ENZYME MICROB TECH, V17, P770, DOI 10.1016/0141-0229(94)00003-A; NOVY R, 2001, BIOTECHNIQUES, V12, P1, DOI DOI 10.1002/9783527620937.CH; Ramesh B, 2001, BIORESOURCE TECHNOL, V76, P169, DOI 10.1016/S0960-8524(00)00082-1; Santi I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003787; Singh RS, 2011, CARBOHYD POLYM, V83, P672, DOI 10.1016/j.carbpol.2010.08.037; Singh RS, 2010, CARBOHYD POLYM, V80, P401, DOI 10.1016/j.carbpol.2009.11.040; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Vethanayagam JGG, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-3; Walia R, 2008, J CHEM TECHNOL BIOT, V83, P1120, DOI 10.1002/jctb.1885; Wong MT, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-38; Xu B, 2006, J MICROBIOL BIOTECHN, V16, P1185	43	25	37	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78416	10.1371/journal.pone.0078416	http://dx.doi.org/10.1371/journal.pone.0078416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194930	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000109
J	Xu, SY; Gao, B; Xing, Y; Ming, J; Bao, JX; Zhang, Q; Wan, Y; Ji, QH				Xu, Shaoyong; Gao, Bin; Xing, Ying; Ming, Jie; Bao, Junxiang; Zhang, Qiang; Wan, Yi; Ji, Qiuhe		China Natl Diabet Metab Disorders	Gender Differences in the Prevalence and Development of Metabolic Syndrome in Chinese Population with Abdominal Obesity	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ELEVATED SERUM-CHOLESTEROL; RISK-FACTOR; MEN; DEFINITION; ASSOCIATION; WOMEN; AGE; COMPONENTS; STROKE	Background: Not all the people with metabolic syndrome (MS) have abdominal obesity (AO). The study aimed to investigate gender differences in the prevalence and development of MS in Chinese population with abdominal obesity, which has rarely been reported. Methods: Data were obtained from the 2007-08 China National Diabetes and Metabolic Disorders Study, and participants were divided into two samples for analysis. Sample 1 consisted of 19,046 people with abdominal obesity, while sample 2 included 2,124 people meeting pre-specified requirements. Survival analysis was used to analyze the development of MS. Results: The age-standardized prevalence of MS in Chinese population with AO was 49.5%. The prevalence in males (73.7%) was significantly higher than that in females (36.9%). Males had significantly higher proportions of combinations of three or four MS components than females (36.4% vs. 30.2% and 18.4% vs. 5%, respectively). MS developed quick at first and became slow down later. Half of the participants with AO developed to MS after 3.9 years (95% CI: 3.7-4.1) from the initial metabolic abnormal component, whereas 75% developed to MS after 7.7 years (95% CI: 7.5-7.9). Conclusion: Compared with females, Chinese males with AO should receive more attention because of their higher prevalence of MS and its components, more complex and risky combinations of abnormal components, and faster development of MS.	[Xu, Shaoyong; Gao, Bin; Xing, Ying; Ming, Jie; Ji, Qiuhe] Fourth Mil Med Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710032, Peoples R China; [Bao, Junxiang] Fourth Mil Med Univ, Dept Aerosp Physiol, Xian 710032, Peoples R China; [Zhang, Qiang] Chinese Peoples Liberat Army Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Wan, Yi] Fourth Mil Med Univ, Sch Publ Hlth, Dept Hlth Stat, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Chinese People's Liberation Army General Hospital; Air Force Military Medical University	Wan, Y (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Hlth Stat, Xian 710032, Peoples R China.	wanyi@fmmu.edu.cn; jqiuhe@fmmu.edu.cn	Wan, Yi/G-3173-2010	Wan, Yi/0000-0002-4125-8396	Chinese Medical Association Foundation; Chinese Diabetes Society; National Natural Science Foundation of China [81101387]	Chinese Medical Association Foundation; Chinese Diabetes Society; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese Medical Association Foundation and the Chinese Diabetes Society. QZ received funding from the National Natural Science Foundation of China (grant 81101387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alexander CM, 2008, DIABETES OBES METAB, V10, P246, DOI 10.1111/j.1463-1326.2006.00695.x; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; BENFANTE R, 1994, STROKE, V25, P814, DOI 10.1161/01.STR.25.4.814; BENFANTE R, 1990, JAMA-J AM MED ASSOC, V263, P393, DOI 10.1001/jama.263.3.393; Carr DB, 2004, DIABETES, V53, P2087, DOI 10.2337/diabetes.53.8.2087; Correia Flora, 2006, Acta Med Port, V19, P289; Cui RZ, 2012, ATHEROSCLEROSIS, V221, P565, DOI 10.1016/j.atherosclerosis.2012.01.013; ERVIN RB, 2009, NATL HLTH STAT REPOR, V13, P1; Fan JG, 2005, J GASTROEN HEPATOL, V20, P1825, DOI 10.1111/j.1440-1746.2005.04058.x; Feng Y, 2006, OBESITY, V14, P2089, DOI 10.1038/oby.2006.244; Franco OH, 2009, CIRCULATION, V120, P1943, DOI 10.1161/CIRCULATIONAHA.109.855817; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gause-Nilsson I, 2006, ACTA DIABETOL, V43, P120, DOI 10.1007/s00592-006-0226-2; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hu FB, 2011, OBES REV, V12, P552, DOI 10.1111/j.1467-789X.2011.00863.x; Hwang LC, 2007, EUR J EPIDEMIOL, V22, P899, DOI 10.1007/s10654-007-9183-5; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Ko GTC, 2005, DIABETES RES CLIN PR, V69, P160, DOI 10.1016/j.diabres.2004.11.015; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Lafortuna CL, 2012, OBESITY FACTS, V5, P127, DOI 10.1159/000336700; Lao XQ, 2006, J ENDOCRINOL INVEST, V29, P989, DOI 10.1007/BF03349212; Li ZY, 2006, ATHEROSCLEROSIS, V184, P188, DOI 10.1016/j.atherosclerosis.2005.03.033; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Lu B, 2006, METABOLISM, V55, P1088, DOI 10.1016/j.metabol.2006.04.003; Martelli V, 2012, J SEX MED, V9, P434, DOI 10.1111/j.1743-6109.2011.02517.x; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; NATIONAL B, 2006, STATISTICS, V26, P2010; Pei WD, 2007, INT J CARDIOL, V116, P194, DOI 10.1016/j.ijcard.2006.03.045; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Safar ME, 2011, HYPERTENS RES, V34, P91, DOI 10.1038/hr.2010.180; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Saukkonen T, 2012, SCAND J PRIM HEALTH, V30, P29, DOI 10.3109/02813432.2012.654192; Shakir YA, 2007, FERTIL STERIL, V88, P163, DOI 10.1016/j.fertnstert.2006.11.111; Shen J, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/178675; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205	46	27	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78270	10.1371/journal.pone.0078270	http://dx.doi.org/10.1371/journal.pone.0078270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194915	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000094
J	Alarcon, GJC; Venegas, YR; Narvaez, LB; Martinez, OEP; Casanova, LG; Gallegos, SS; Vargas, AN; Ramirez, AMO; Suazo, FM				Canto Alarcon, Germinal J.; Rubio Venegas, Yezenia; Bojorquez Narvaez, Luis; Pizano Martinez, Oscar E.; Garcia Casanova, Leticia; Sosa Gallegos, Susana; Nava Vargas, Alejandro; Olvera Ramirez, Andrea M.; Milian Suazo, Feliciano			Efficacy of a Vaccine Formula against Tuberculosis in Cattle	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; BACILLE CALMETTE-GUERIN; POSSUM TRICHOSURUS-VULPECULA; IMMUNE-RESPONSES; NEONATAL CALVES; ENVIRONMENTAL MYCOBACTERIA; INDUCED PROTECTION; PRIME; BOOST; INFECTION	"Test-and-slaughter" has been successful in industrialized countries to control and eradicate tuberculosis from cattle; however, this strategy is too expensive for developing nations, where the prevalence is especially high. Vaccination with the Calmette-Guerin (BCG) strain has been shown to protect against the development of lesions in vaccinated animals: mouse, cattle and wildlife species. In this study, the immune response and the pathology of vaccinated (BCG-prime and BCG prime-CFP-boosted) and unvaccinated (controls) calves were evaluated under experimental settings. A 10(6) CFU dose of the BCG strain was inoculated subcutaneously on the neck to two groups of ten animas each. Thirty days after vaccination, one of the vaccinated groups was boosted with an M. bovis culture filtrate protein (CFP). Three months after vaccination, the three groups of animals were challenged with 5 x 10(5) CFU via intranasal by aerosol with a field strain of M. bovis. The immune response was monitored throughout the study. Protection was assessed based on immune response (IFN-g release) prechallenge, presence of visible lesions in lymph nodes and lungs at slaughter, and presence of bacilli in lymph nodes and lung samples in histological analysis. Vaccinated cattle, either with the BCG alone or with BCG and boosted with CFP showed higher IFN-g response, fewer lesions, and fewer bacilli per lesion than unvaccinated controls after challenge. Animals with low levels of IFN-g postvaccine-prechallenge showed more lesions than animals with high levels. Results from this study support the argument that vaccination could be incorporated into control programs to reduce the incidence of TB in cattle in countries with high prevalence.	[Canto Alarcon, Germinal J.; Rubio Venegas, Yezenia; Sosa Gallegos, Susana; Olvera Ramirez, Andrea M.; Milian Suazo, Feliciano] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico; [Bojorquez Narvaez, Luis] Prod Nacl Biol Vet PRONABIVE, Mexico City, DF, Mexico; [Pizano Martinez, Oscar E.; Garcia Casanova, Leticia; Nava Vargas, Alejandro] INIFAP, Ctr Nacl Invest Disciplinaria Fisiol & Mejoramien, Ajuchitlan, Qro, Mexico	Universidad Autonoma de Queretaro	Alarcon, GJC (corresponding author), Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Qro, Mexico.	gcanto07@uaq.mx		PIZANO, OSCAR/0000-0003-3635-7071				Ameni G, 2002, J IMMUNOASS IMMUNOCH, V23, P245, DOI 10.1081/IAS-120003664; Ameni G, 2010, CLIN VACCINE IMMUNOL, V17, P1533, DOI 10.1128/CVI.00222-10; Bawinec F, 1996, ASSESSMENT SOCIOECON; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Buddle BM, 1999, CLIN DIAGN LAB IMMUN, V6, P1; BUDDLE BM, 1995, VACCINE, V13, P1123, DOI 10.1016/0264-410X(94)00055-R; Buddle BM, 2006, VET MICROBIOL, V112, P191, DOI 10.1016/j.vetmic.2005.11.027; Buddle BM, 2005, VET IMMUNOL IMMUNOP, V108, P45, DOI 10.1016/j.vetimm.2005.08.002; Buddle BM, 2003, INT J PARASITOL, V33, P555, DOI 10.1016/S0020-7519(03)00060-2; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; Buddle BM, 2007, CAB REV, V73, P1; Cai H, 2006, DNA CELL BIOL, V25, P438, DOI 10.1089/dna.2006.25.438; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; Corner LAL, 2002, VET MICROBIOL, V84, P327, DOI 10.1016/S0378-1135(01)00461-8; Corner LAL, 2001, VET MICROBIOL, V81, P181, DOI 10.1016/S0378-1135(01)00344-3; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; ELLWOOD DC, 1972, BRIT VET J, V128, P619, DOI 10.1016/S0007-1935(17)36634-4; Ferraz JC, 2004, INFECT IMMUN, V72, P6945, DOI 10.1128/IAI.72.12.6945-6950.2004; FINE PEM, 2001, TUBERCULOSIS COMPREH, P503; FRANCIS J, 1950, LANCET, V258, P34; Hope JC, 2011, CLIN VACCINE IMMUNOL, V18, P373, DOI 10.1128/CVI.00543-10; Hope JC, 2008, COMP IMMUNOL MICROB, V31, P77, DOI 10.1016/j.cimid.2007.07.003; Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2005.02668.x; Kaneene JB, 2006, VET MICROBIOL, V112, P273, DOI 10.1016/j.vetmic.2005.11.018; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Logan KE, 2005, VACCINE, V23, P5526, DOI 10.1016/j.vaccine.2005.07.037; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; Milian-Suazo F, 2011, RES VET SCI, V90, P419, DOI 10.1016/j.rvsc.2010.07.018; Milian-Suazo F, 2000, AM J VET RES, V61, P86, DOI 10.2460/ajvr.2000.61.86; Nader A, 1988, REV MED VET, V68, P46; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Pollock JM, 2006, VET MICROBIOL, V112, P141, DOI 10.1016/j.vetmic.2005.11.032; Skinner MA, 2003, INFECT IMMUN, V71, P4901, DOI 10.1128/IAI.71.9.4901-4907.2003; Skinner MA, 2001, REV SCI TECH OIE, V20, P112, DOI 10.20506/rst.20.1.1276; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2004, IMMUNOLOGY, V112, P461, DOI 10.1111/j.1365-2567.2004.01903.x; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier HM, 2006, VET J, V171, P229, DOI 10.1016/j.tvjl.2004.11.001; Vordermeier HM, 2006, INFECT IMMUN, V74, P1416, DOI 10.1128/IAI.74.2.1416-1418.2006; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Vordermeier M, 2011, VET MICROBIOL, V151, P8, DOI 10.1016/j.vetmic.2011.02.020; WADDINGTON FG, 1972, BRIT VET J, V128, P541, DOI 10.1016/S0007-1935(17)36683-6; Waters WR, 2010, CLIN VACCINE IMMUNOL, V17, P247, DOI 10.1128/CVI.00442-09; Wedlock DN, 2007, VET IMMUNOL IMMUNOP, V118, P50, DOI 10.1016/j.vetimm.2007.04.005; Wedlock DN, 2005, INFECT IMMUN, V73, P3540, DOI 10.1128/IAI.73.6.3540-3546.2005; Wedlock DN, 2003, TUBERCULOSIS, V83, P339, DOI 10.1016/S1472-9792(03)00055-6	49	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76418	10.1371/journal.pone.0076418	http://dx.doi.org/10.1371/journal.pone.0076418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204624	Green Published, gold			2022-12-25	WOS:000326029300027
J	Halder, S; Ruf, CA; Furdea, A; Pasqualotto, E; De Massari, D; van der Heiden, L; Bogdan, M; Rosenstiel, W; Birbaumer, N; Kubler, A; Matuz, T				Halder, Sebastian; Ruf, Carolin Anne; Furdea, Adrian; Pasqualotto, Emanuele; De Massari, Daniele; van der Heiden, Linda; Bogdan, Martin; Rosenstiel, Wolfgang; Birbaumer, Niels; Kuebler, Andrea; Matuz, Tamara			Prediction of P300 BCI Aptitude in Severe Motor Impairment	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; AMYOTROPHIC-LATERAL-SCLEROSIS; EVENT-RELATED POTENTIALS; SELECTIVE ATTENTION; COMMUNICATION; CLASSIFICATION; PERFORMANCE; COMPONENT; ALS; TOPOGRAPHY	Brain-computer interfaces (BCIs) provide a non-muscular communication channel for persons with severe motor impairments. Previous studies have shown that the aptitude with which a BCI can be controlled varies from person to person. A reliable predictor of performance could facilitate selection of a suitable BCI paradigm. Eleven severely motor impaired participants performed three sessions of a P300 BCI web browsing task. Before each session auditory oddball data were collected to predict the BCI aptitude of the participants exhibited in the current session. We found a strong relationship of early positive and negative potentials around 200 ms (elicited with the auditory oddball task) with performance. The amplitude of the P2 (r = -0.77) and of the N2 (r = -0.86) had the strongest correlations. Aptitude prediction using an auditory oddball was successful. The finding that the N2 amplitude is a stronger predictor of performance than P3 amplitude was reproduced after initially showing this effect with a healthy sample of BCI users. This will reduce strain on the end-users by minimizing the time needed to find suitable paradigms and inspire new approaches to improve performance.	[Halder, Sebastian; Kuebler, Andrea] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Halder, Sebastian; Ruf, Carolin Anne; Furdea, Adrian; De Massari, Daniele; van der Heiden, Linda; Birbaumer, Niels; Matuz, Tamara] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Halder, Sebastian; Bogdan, Martin; Rosenstiel, Wolfgang] Univ Tubingen, Dept Comp Engn, Tubingen, Germany; Catholic Univ Louvain, Psychol Sci Res Inst, B-1348 Louvain, Belgium; [De Massari, Daniele; Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci Fdn, Venice, Italy; [Bogdan, Martin] Univ Leipzig, D-04109 Leipzig, Germany; [De Massari, Daniele] Int Max Planck Res Sch, Grad Training Ctr Neurosci, Tubingen, Germany; [van der Heiden, Linda] Univ Finance & Management, Dept Cognit Psychol, Warsaw, Poland	University of Wurzburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Universite Catholique Louvain; Fondazione IRCCS Istituto Nazionale Tumori Milan; Leipzig University; Max Planck Society; University of Finance & Management Warsaw	Halder, S (corresponding author), Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany.	sebastian.halder@uni-wuerzburg.de	Halder, Sebastian/G-3745-2012; Halder, Sebastian/J-6144-2019	Halder, Sebastian/0000-0003-1017-3696; Birbaumer, Niels/0000-0002-6786-5127; Kubler, Andrea/0000-0003-4876-0415	European ICT Programme Project FP7 [224631, SFB 550/B5, C6]; BMBF (Bundesministerium fuer Bildung und Forschung) Bernstein Center for Neurocomputation [Nr 01GQ0831]; European Research Council [ERC 227632-BCCI]; Deutsche Forschungsgemeinschaft [DFG Bi 195/58-1]; Centre for Integrative Neuroscience (CIN) Pool-project [2010-05]; European Community [288566]; German Research Foundation (DFG); University of Wuerzburg	European ICT Programme Project FP7; BMBF (Bundesministerium fuer Bildung und Forschung) Bernstein Center for Neurocomputation(Federal Ministry of Education & Research (BMBF)); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Integrative Neuroscience (CIN) Pool-project; European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work is supported by the European ICT Programme Project FP7-224631, SFB 550/B5 and C6, BMBF (Bundesministerium fuer Bildung und Forschung) Bernstein Center for Neurocomputation (Nr 01GQ0831), the European Research Council Grant (ERC 227632-BCCI), Deutsche Forschungsgemeinschaft (DFG Bi 195/58-1) and Centre for Integrative Neuroscience (CIN) Pool-project 2010-05. The research leading to these results has also received funding from the European Community's Seventh Framework Programme FP7/2007-2013, BackHome project grant agreement number 288566. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1997, J NEUROL SCI, V148, P95, DOI 10.1016/S0022-510X(96)05338-5; [Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Brouwer AM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00019; Burde W, 2006, P 3 INT BRAIN COMP I, P76; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Choularton S, 2004, P SST, V4; Cichocki A, 2005, CLIN NEUROPHYSIOL, V116, P729, DOI 10.1016/j.clinph.2004.09.017; Cipresso P, 2012, BRAIN BEHAV, V2, P479, DOI 10.1002/brb3.57; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; De Massari D, 2013, BIOL PSYCHOL, V92, P267, DOI 10.1016/j.biopsycho.2012.10.015; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Furdea A, 2012, J NEUROSCI METH, V203, P233, DOI 10.1016/j.jneumeth.2011.09.013; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Halder S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00105; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; HALDER S, 2013, PLOS ONE, V7, DOI DOI 10.3389/FNHUM.2013.00105; Halder S, 2011, P 5 INT BRAIN COMP I, P144; Halder S, 2008, P 4 INT BRAIN COMP I, P8; Halder Sebastian, 2007, Comput Intell Neurosci, P82069, DOI 10.1155/2007/82069; Hammer EM, 2012, BIOL PSYCHOL, V89, P80, DOI 10.1016/j.biopsycho.2011.09.006; Hanagasi HA, 2002, COGNITIVE BRAIN RES, V14, P234, DOI 10.1016/S0926-6410(02)00110-6; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Hopkins RO, 2005, CURR OPIN CRIT CARE, V11, P369, DOI 10.1097/01.ccx.0000166399.88635.a5; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Katayama J, 1999, CLIN NEUROPHYSIOL, V110, P463, DOI 10.1016/S1388-2457(98)00035-2; Kaufmann T, 2013, FRONTIERS NEUROSCIEN; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kaufmann T, 2012, INT J PSYCHOPHYSIOL, V83, P336, DOI 10.1016/j.ijpsycho.2011.11.018; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kotchoubey B, 2003, EUR J NEUROL, V10, P551, DOI 10.1046/j.1468-1331.2003.00647.x; Kotchoubey B, 2001, NEUROSCI LETT, V301, P37, DOI 10.1016/S0304-3940(01)01600-7; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kubler A., 2011, P 5 INT BRAIN COMPUT, P100; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; LANG T, 1991, IEEE T CIRCUITS SYST, V38, P499, DOI 10.1109/31.76486; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Mak JN, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026014; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; MICHIE PT, 1993, PSYCHOPHYSIOLOGY, V30, P205, DOI 10.1111/j.1469-8986.1993.tb01733.x; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Mugler EM, 2010, IEEE T NEUR SYS REH, V18, P599, DOI 10.1109/TNSRE.2010.2068059; Murguialday AR, 2011, CLIN NEUROPHYSIOL, V122, P925, DOI 10.1016/j.clinph.2010.08.019; Neumann N, 2003, J NEUROL NEUROSUR PS, V74, P1117, DOI 10.1136/jnnp.74.8.1117; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Ogawa T, 2009, CLIN NEUROPHYSIOL, V120, P659, DOI 10.1016/j.clinph.2009.01.013; Paulus KS, 2002, CLIN NEUROPHYSIOL, V113, P853, DOI 10.1016/S1388-2457(02)00082-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Pinkhardt EH, 2008, J NEUROL, V255, P532, DOI 10.1007/s00415-008-0734-9; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Polich J, 1997, BRAIN TOPOGR, V9, P275, DOI 10.1007/BF01464482; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Raaphorst J, 2010, AMYOTROPH LATERAL SC, V11, P27, DOI 10.3109/17482960802645008; Raggi A, 2008, CLIN NEUROPHYSIOL, V119, P342, DOI 10.1016/j.clinph.2007.10.010; RIF J, 1991, ELECTROEN CLIN NEURO, V79, P464, DOI 10.1016/0013-4694(91)90166-2; Ruf CA, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00023; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Silvoni S, 2013, AMYOTROPH LATERAL SC; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Sorger B, 2009, PROG BRAIN RES, V177, P275, DOI 10.1016/S0079-6123(09)17719-1; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; SQUIRES NK, 1977, J EXP PSYCHOL HUMAN, V3, P299, DOI 10.1037/0096-1523.3.2.299; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Vieregge P, 1999, COGNITIVE BRAIN RES, V8, P27, DOI 10.1016/S0926-6410(99)00004-X; Volpato C, 2010, J CLIN NEUROPHYSIOL, V27, P198, DOI 10.1097/WNP.0b013e3181e0aa14; Vuckovic A, 2013, CLIN NEUROPHYSIOL, V124, P1586, DOI 10.1016/j.clinph.2013.02.016; Wriessnegger SC, 2008, INT J PSYCHOPHYSIOL, V67, P54, DOI 10.1016/j.ijpsycho.2007.10.004; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	87	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76148	10.1371/journal.pone.0076148	http://dx.doi.org/10.1371/journal.pone.0076148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239MM	24204597	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300010
J	Ranger, M; Chau, CMY; Garg, A; Woodward, TS; Beg, MF; Bjornson, B; Poskitt, K; Fitzpatrick, K; Synnes, AR; Miller, SP; Grunau, RE				Ranger, Manon; Chau, Cecil M. Y.; Garg, Amanmeet; Woodward, Todd S.; Beg, Mirza Faisal; Bjornson, Bruce; Poskitt, Kenneth; Fitzpatrick, Kevin; Synnes, Anne R.; Miller, Steven P.; Grunau, Ruth E.			Neonatal Pain-Related Stress Predicts Cortical Thickness at Age 7 Years in Children Born Very Preterm	PLOS ONE			English	Article							PREEMPTIVE MORPHINE ANALGESIA; REGIONAL CEREBRAL DEVELOPMENT; PRINCIPAL COMPONENT ANALYSIS; LONG-TERM CONSEQUENCES; SURFACE-BASED ANALYSIS; INFLAMMATORY PAIN; PREMATURE-INFANTS; BRAIN-DEVELOPMENT; PROCEDURAL PAIN; MATERNAL-CARE	Background: Altered brain development is evident in children born very preterm (24-32 weeks gestational age), including reduction in gray and white matter volumes, and thinner cortex, from infancy to adolescence compared to term-born peers. However, many questions remain regarding the etiology. Infants born very preterm are exposed to repeated procedural pain-related stress during a period of very rapid brain development. In this vulnerable population, we have previously found that neonatal pain-related stress is associated with atypical brain development from birth to term-equivalent age. Our present aim was to evaluate whether neonatal pain-related stress (adjusted for clinical confounders of prematurity) is associated with altered cortical thickness in very preterm children at school age. Methods: 42 right-handed children born very preterm (24-32 weeks gestational age) followed longitudinally from birth underwent 3-D T1 MRI neuroimaging at mean age 7.9 yrs. Children with severe brain injury and major motor/sensory/cognitive impairment were excluded. Regional cortical thickness was calculated using custom developed software utilizing FreeSurfer segmentation data. The association between neonatal pain-related stress (defined as the number of skin-breaking procedures) accounting for clinical confounders (gestational age, illness severity, infection, mechanical ventilation, surgeries, and morphine exposure), was examined in relation to cortical thickness using constrained principal component analysis followed by generalized linear modeling. Results: After correcting for multiple comparisons and adjusting for neonatal clinical factors, greater neonatal pain-related stress was associated with significantly thinner cortex in 21/66 cerebral regions (p-values ranged from 0.00001 to 0.014), predominately in the frontal and parietal lobes. Conclusions: In very preterm children without major sensory, motor or cognitive impairments, neonatal pain-related stress appears to be associated with thinner cortex in multiple regions at school age, independent of other neonatal risk factors.	[Ranger, Manon; Woodward, Todd S.; Bjornson, Bruce; Poskitt, Kenneth; Synnes, Anne R.; Miller, Steven P.; Grunau, Ruth E.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Ranger, Manon; Chau, Cecil M. Y.; Bjornson, Bruce; Poskitt, Kenneth; Fitzpatrick, Kevin; Synnes, Anne R.; Miller, Steven P.; Grunau, Ruth E.] Child & Family Res Inst, Vancouver, BC, Canada; [Chau, Cecil M. Y.; Woodward, Todd S.] BC Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Garg, Amanmeet; Beg, Mirza Faisal] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Synnes, Anne R.; Grunau, Ruth E.] BC Childrens & Womens Hosp, Vancouver, BC, Canada; [Miller, Steven P.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Miller, Steven P.] Univ Toronto, Toronto, ON, Canada	University of British Columbia; Child & Family Research Institute; Simon Fraser University; University of British Columbia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Grunau, RE (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	rgrunau@cw.bc.ca	Bjornson, Bruce Hal/A-8616-2010; Ranger, Manon/AAN-6753-2021	Bjornson, Bruce Hal/0000-0002-1465-6196; Ranger, Manon/0000-0001-8253-0686; Beg, Mirza Faisal/0000-0001-6706-8630; Miller, Steven/0000-0001-9102-9105; Woodward, Todd/0000-0001-8083-0079; Grunau, Ruth/0000-0002-5428-9212	Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD/NIH) [RO1 HD039783]; Canadian Institutes for Health Research (CIHR) [MOP86489, MOP79262]; Child & Family Research Institute; Bloorview Children's Hospital Chair in Paediatric Neuroscience; CIHR; Pain In Child Health CIHR Strategic Training Initiative in Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD039783] Funding Source: NIH RePORTER	Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD/NIH); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute; Bloorview Children's Hospital Chair in Paediatric Neuroscience; CIHR(Canadian Institutes of Health Research (CIHR)); Pain In Child Health CIHR Strategic Training Initiative in Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD/NIH) grant RO1 HD039783 [R.E.G], the Canadian Institutes for Health Research (CIHR) grants MOP86489 [R.E.G.] and MOP79262 [R.E.G., S.P.M.]. Salary support includes a Senior Scientist award, Child & Family Research Institute [R.E.G]; Bloorview Children's Hospital Chair in Paediatric Neuroscience [S. P. M]; Post-doctoral Fellowships, CIHR and Pain In Child Health CIHR Strategic Training Initiative in Health Research [M.R.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand KJS, 2007, PEDIATR RES, V62, P283, DOI 10.1203/PDR.0b013e3180986d2f; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Anand KJS, 2004, LANCET, V363, P1673, DOI 10.1016/S0140-6736(04)16251-X; Anand KJS, 2000, PROG BRAIN RES, V122, P117; [Anonymous], 2008, PAIN, DOI DOI 10.1016/B978-012370880-9.00188-2; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bellu R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004212.pub3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Bramen JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033850; Brummelte S, 2006, HORM BEHAV, V50, P370, DOI 10.1016/j.yhbeh.2006.04.008; Brummelte S, 2012, ANN NEUROL, V71, P385, DOI 10.1002/ana.22267; Casey KL, 2000, J NEUROPHYSIOL, V84, P525, DOI 10.1152/jn.2000.84.1.525; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Clarkson MJ, 2011, NEUROIMAGE, V57, P856, DOI 10.1016/j.neuroimage.2011.05.053; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Graaf J, 2013, PAIN, V154, P449, DOI 10.1016/j.pain.2012.12.006; de Graaf J, 2011, PAIN, V152, P1391, DOI 10.1016/j.pain.2011.02.017; de Medeiros CB, 2009, PEDIATR RES, V66, P272, DOI 10.1203/PDR.0b013e3181b1be06; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Derbyshire SWG, 2007, NEUROIMAG CLIN N AM, V17, P485, DOI 10.1016/j.nic.2007.09.004; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doesburg SM, 2013, PAIN, V154, P1946, DOI 10.1016/j.pain.2013.04.009; Doesburg SM, 2010, IFMBE PROC, V28, P250; Doesburg SM, 2011, PEDIATR RES, V70, P171, DOI 10.1203/PDR.0b013e3182225a9e; Duhrsen L, 2013, NEONATOLOGY, V103, P35, DOI 10.1159/000341769; Efron B., 1994, INTRO BOOTSTRAP; Ferguson SA, 2012, NEUROTOXICOL TERATOL, V34, P47, DOI 10.1016/j.ntt.2011.10.008; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gibson E, 2009, ORG HUM BRAIN MAPP 1; Grunau RE, 2005, PAIN, V113, P293, DOI 10.1016/j.pain.2004.10.020; Grunau RE, 2007, J PEDIATR-US, V150, P151, DOI 10.1016/j.jpeds.2006.10.053; Grunau RE, 2006, SEMIN FETAL NEONAT M, V11, P268, DOI 10.1016/j.siny.2006.02.007; Grunau RE, 2009, PAIN, V143, P138, DOI 10.1016/j.pain.2009.02.014; Hamilton LS, 2007, NEUROREPORT, V18, P1427, DOI 10.1097/WNR.0b013e3282e9a5a2; Hatfield T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.027; HODGE CJ, 1990, CRIT REV NEUROBIOL, V5, P363; Hohmeister J, 2010, PAIN, V150, P257, DOI 10.1016/j.pain.2010.04.004; Hunter M, 2002, J EDUC BEHAV STAT, V27, P41; Johnston CC, 1997, CLIN J PAIN, V13, P308, DOI 10.1097/00002508-199712000-00008; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Juul SE, 2011, PEDIATR RES, V69, P285, DOI 10.1203/PDR.0b013e31820bd165; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; Lax I, 2012, BRAIN STRUCT FUNCT, P1; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Low LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034316; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Miller SP, 2005, J PEDIATR-US, V147, P609, DOI 10.1016/j.jpeds.2005.06.033; Miller SP, 2002, J MAGN RESON IMAGING, V16, P621, DOI 10.1002/jmri.10205; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nosarti C, 2011, HUM BRAIN MAPP, V32, P1615, DOI 10.1002/hbm.21133; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Phillips JP, 2011, PEDIATR NEUROL, V45, P215, DOI 10.1016/j.pediatrneurol.2011.06.001; Pryce CR, 2001, BEHAV NEUROSCI, V115, P71, DOI 10.1037//0735-7044.115.1.71; Richardosn DK, 2001, J PEDIATR-US, V138, P92, DOI 10.1067/mpd.2001.109608; Rogers CE, 2012, J AM ACAD CHILD PSY, V51, P181, DOI 10.1016/j.jaac.2011.11.009; Roze JC, 2008, ARCH PEDIAT ADOL MED, V162, P728, DOI 10.1001/archpedi.162.8.728; Schlaepfer TE, 1998, AM J PSYCHIAT, V155, P470, DOI 10.1176/ajp.155.4.470; SHAO J, 1995, JACKNIFE BOOTSTRAP; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Simons SHP, 2003, JAMA-J AM MED ASSOC, V290, P2419, DOI 10.1001/jama.290.18.2419; Skranes J, 2012, EARLY HUM DEV, V88, P103, DOI 10.1016/j.earlhumdev.2011.07.017; Slater R, 2010, NEUROIMAGE, V52, P583, DOI 10.1016/j.neuroimage.2010.04.253; Smith GC, 2011, ANN NEUROL, V70, P541, DOI 10.1002/ana.22545; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; TAKANE Y, 1991, PSYCHOMETRIKA, V56, P97, DOI 10.1007/BF02294589; Takane Y, 2001, APPL ALGEBR ENG COMM, V12, P391, DOI 10.1007/s002000100081; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tukey JW, 1977, EXPLORATORY DATA ANA; Vinall J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004666; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Walker CD, 2008, PAIN, V140, P167, DOI 10.1016/j.pain.2008.08.004; Wechsler D, 1974, WECHSLER INTELLIGENC; Yezzi AJ, 2003, IEEE T MED IMAGING, V22, P1332, DOI 10.1109/TMI.2003.817775; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148; Zwicker JG, 2013, PEDIATR NEUROL, V48, P123, DOI 10.1016/j.pediatrneurol.2012.10.016	84	140	145	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76702	10.1371/journal.pone.0076702	http://dx.doi.org/10.1371/journal.pone.0076702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204657	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300044
J	Willeboordse, M; van den Bersselaar, DLCM; van de Kant, KDG; Muris, JWM; van Schayck, OCP; Dompeling, E				Willeboordse, Maartje; van den Bersselaar, Donna L. C. M.; van de Kant, Kim D. G.; Muris, Jean W. M.; van Schayck, Onno C. P.; Dompeling, Edward			Sex Differences in the Relationship between Asthma and Overweight in Dutch Children: a Survey Study	PLOS ONE			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION; INCIDENT ASTHMA; NATIONAL-HEALTH; OBESITY; CHILDHOOD; RISK; METAANALYSIS; PREVALENCE; ADOLESCENCE	Objective: Obesity has been identified as a risk factor for asthma in children. However, in the Netherlands, the obesity prevalence is rising while the asthma prevalence in children is stabilising. The aim of this study is to clarify the association between asthma and Body Mass Index (BMI) in children and whether this association is influenced by sex. Study Design: Parents of 39,316 children (6-16 years) in the south of the Netherlands were invited to complete an online questionnaire on respiratory symptoms, anthropometric variables and several potential confounding factors for asthma and obesity (including sex, birth weight and breastfeeding). Data was analysed by multivariable logistic regression models and an ordinal regression model. Results: The response rate was 24% (n boys=4,743, n girls=4,529). The prevalence of asthma, overweight and obesity was 8%, 15% and 2% respectively. Body mass index -standard deviation Score (BMI-SDS) was related to current asthma (adjusted OR: 1.29; 95% CI: 1.14-1.45, p=0.001). When stratified for sex, asthma and BMI-SDS were only related in girls (Girls: adjusted OR: 1.31; 95% CI: 1.13-1.51, p=0.001. Boys: adjusted OR: 1.01; 95% CI: 0.91-1.14, p=0.72). Conclusions: The positive association between BMI-SDS and asthma is only present in girls, not boys. Future studies into obesity and asthma should correct for sex in their analyses.	[Willeboordse, Maartje; van den Bersselaar, Donna L. C. M.; van de Kant, Kim D. G.; Dompeling, Edward] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Pediat Resp Med, Maastricht, Netherlands; [Muris, Jean W. M.; van Schayck, Onno C. P.] MUMC, CAPHRI, Dept Family Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Willeboordse, M (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Pediat Resp Med, Maastricht, Netherlands.	m.willeboordse@mumc.nl		Muris, Jean/0000-0002-8780-476X; Willeboordse, Maartje/0000-0002-9695-9755	Dutch Lung Foundation [DLF 3.4.09.002]	Dutch Lung Foundation	The Dutch Lung Foundation (grant DLF 3.4.09.002) sponsored this study (https://www.longfonds.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2003, THORAX, V58, P846, DOI 10.1136/thorax.58.10.846; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Anto JM, 2012, CURR ALLERGY ASTHM R, V12, P192, DOI 10.1007/s11882-012-0254-7; Arriba-Mendez S, 2008, ALLERGOL IMMUNOPATH, V36, P259, DOI 10.1016/S0301-0546(08)75220-0; Assad NA, 2012, BIOCHIMIE, V94, P2180, DOI 10.1016/j.biochi.2012.03.006; Axinn WG, 2011, DEMOGRAPHY, V48, P1127, DOI 10.1007/s13524-011-0044-1; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; Castro-Rodriguez LA, 2001, AM J RESP CRIT CARE, V163, P1344, DOI 10.1164/ajrccm.163.6.2006140; Chen YC, 2013, OBES REV, V14, P222, DOI 10.1111/j.1467-789X.2012.01055.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flaherman V, 2006, ARCH DIS CHILD, V91, P334, DOI 10.1136/adc.2005.080390; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Jensen ME, 2011, PAEDIATR RESPIR REV, V12, P152, DOI 10.1016/j.prrv.2011.01.009; Keizer-Schrama SMPFD, 2001, HUM REPROD UPDATE, V7, P287; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Lamberts P, 2010, GEZONDE KIJK ZUID LI; Mahut B, 2012, EUR RESPIR J, V39, P1120, DOI 10.1183/09031936.00103311; Matricardi PM, 2007, CLIN EXP ALLERGY, V37, P476, DOI 10.1111/j.1365-2222.2007.02664.x; Noal RB, 2011, OBES REV, V12, P93, DOI 10.1111/j.1467-789X.2010.00741.x; Peroni DG, 2010, INT J OBESITY, V34, P599, DOI 10.1038/ijo.2009.273; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Santillan AA, 2003, INT J OBESITY, V27, P1430, DOI 10.1038/sj.ijo.0802395; Schonbeck Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027608; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sood A, 2011, EXERC SPORT SCI REV, V39, P48, DOI 10.1097/JES.0b013e318201f0c4; Su MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030694; van Merode T, 2007, PEDIATR ALLERGY IMMU, V18, P196, DOI 10.1111/j.1399-3038.2006.00513.x; van Schayck CP, 2005, EUR RESPIR J, V26, P647, DOI 10.1183/09031936.05.00019805; Varraso R, 2005, AM J RESP CRIT CARE, V171, P334, DOI 10.1164/rccm.200405-674OC; von Mutius E, 2001, THORAX, V56, P835, DOI 10.1136/thorax.56.11.835	33	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77574	10.1371/journal.pone.0077574	http://dx.doi.org/10.1371/journal.pone.0077574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24204876	Green Submitted, gold, Green Published			2022-12-25	WOS:000326022200047
J	Buonvicino, D; Formentini, L; Cipriani, G; Chiarugi, A				Buonvicino, Daniela; Formentini, Laura; Cipriani, Giulia; Chiarugi, Alberto			Glucose Deprivation Converts Poly(ADP-ribose) Polymerase-1 Hyperactivation into a Transient Energy-producing Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP; AMP; ATP; Glucose; Mitochondria; Adenine Nucleotides; Adenylate Kinases; Poly(ADP-ribose) Polymerase-1	CELL-DEATH; NAD(+) DEPLETION; ADENYLATE KINASE; PAR POLYMER; MITOCHONDRIAL; IDENTIFICATION; TRANSPORTER; CATABOLISM; EXPRESSION; REPAIR	Background: Excessive activation of enzyme poly(ADP-ribose) polymerase-1 (PARP-1) causes ATP depletion and kills cells. Results: We found that in the absence of glucose PARP-1 triggers an adenylate kinase-dependent increase of ATP. Conclusion: PARP-1 hyperactivation is not invariantly related to ATP loss. Significance: This study adds to the complexity of PARP-1 hyperactivity and energy derangement. Massive poly(ADP-ribose) formation by poly(ADP-ribose) polymerase-1 (PARP-1) triggers NAD depletion and cell death. These events have been invariantly related to cellular energy failure due to ATP shortage. The latter occurs because of both ATP consumption for NAD resynthesis and impairment of mitochondrial ATP formation caused by an increase of the AMP/ADP ratio. ATP depletion is therefore thought to be an inevitable consequence of NAD loss and a hallmark of PARP-1 activation. Here, we challenge this scenario by showing that PARP-1 hyperactivation in cells cultured in the absence of glucose (Glu(-) cells) is followed by NAD depletion and an unexpected PARP-1 activity-dependent ATP increase. We found increased ADP content in resting Glu(-) cells, a condition that counteracts the increase of the AMP/ADP ratio during hyperpoly(ADP-ribosyl)ation and preserves mitochondrial coupling. We also show that the increase of ATP in Glu(-) cells is due to adenylate kinase activity, transforming AMP into ADP which, in turn, is converted into ATP by coupled mitochondria. Interestingly, PARP-1-dependent mitochondrial release of apoptosis-inducing factor (AIF) and cytochrome complex (Cyt c) is reduced in Glu(-) cells, even though cell death eventually occurs. Overall, the present study identifies basal ADP content and adenylate kinase as key determinants of bioenergetics during PARP-1 hyperactivation and unequivocally demonstrates that ATP loss is not metabolically related to NAD depletion.	[Buonvicino, Daniela; Cipriani, Giulia; Chiarugi, Alberto] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, I-50139 Florence, Italy; [Formentini, Laura] Hosp 12 Octubre, Ctr Invest Biomed Red Enfermedades Raras, Dept Biol Mol, Ctr Biol Mol Severo Ochoa,Ctr Invest, E-28041 Madrid, Spain	University of Florence; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario 12 de Octubre	Buonvicino, D (corresponding author), Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Viale Pieraccini 6, I-50139 Florence, Italy.	daniela.buonvicino@unifi.it	Buonvicino, Daniela/AAC-4978-2022	buonvicino, daniela/0000-0003-0435-8475; Formentini, Laura/0000-0001-5641-821X	Associazione Ricerca Sclerosi Laterale Amiotrofica (ARISLA); Regione Toscana "Progetto Salute"; Associazione Italiana Sclerosi Multipla; Ente Cassa di Risparmio di Firenze	Associazione Ricerca Sclerosi Laterale Amiotrofica (ARISLA); Regione Toscana "Progetto Salute"(Regione Toscana); Associazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the Associazione Ricerca Sclerosi Laterale Amiotrofica (ARISLA), Regione Toscana "Progetto Salute 2009," Associazione Italiana Sclerosi Multipla, and Ente Cassa di Risparmio di Firenze.	Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; BROWNSON C, 1972, BIOCHEM J, V130, P797, DOI 10.1042/bj1300797; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Cohausz O, 2008, CELL MOL LIFE SCI, V65, P644, DOI 10.1007/s00018-008-7516-5; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dzeja P, 2009, INT J MOL SCI, V10, P1729, DOI 10.3390/ijms10041729; Ethier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047978; Formentini L, 2009, J BIOL CHEM, V284, P17668, DOI 10.1074/jbc.M109.002931; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Maruta H, 1997, BIOCHEM BIOPH RES CO, V236, P265, DOI 10.1006/bbrc.1997.6910; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Oei SL, 2000, J BIOL CHEM, V275, P23234, DOI 10.1074/jbc.M002429200; Palmieri L, 2008, PLANT PHYSIOL, V148, P1797, DOI 10.1104/pp.108.130310; Panayiotou C, 2011, BIOCHEM J, V433, P527, DOI 10.1042/BJ20101443; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; Rapizzi E, 2004, MOL PHARMACOL, V66, P890, DOI 10.1124/mol.104.000968; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; ROSE IA, 1968, P NATL ACAD SCI USA, V61, P1079, DOI 10.1073/pnas.61.3.1079; Rossi L, 2002, BIOCHIMIE, V84, P1229; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	38	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36530	36537		10.1074/jbc.M113.506378	http://dx.doi.org/10.1074/jbc.M113.506378			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194524	hybrid, Green Published			2022-12-25	WOS:000328883400033
J	Leung, YY; McGrath, C; Cheung, LK				Leung, Yiu Yan; McGrath, Colman; Cheung, Lim Kwong			Trigeminal Neurosensory Deficit and Patient Reported Outcome Measures: The Effect on Quality of Life	PLOS ONE			English	Article							SURGERY	Objectives: To investigate the effect of persistent neurosensory disturbance of the lingual nerve (LN) or inferior alveolar nerve (IAN) on general health and oral health-related quality of life (QoL). Methods: The study design was a case-control study. Patients with persistent neurosensory deficit of LN or IAN after lower third molar surgery (for 12 months or more) were the study group. The control group was an age and gender matched sample of patients who had dental extractions or lower third molar surgeries without trigeminal neurosensory deficit. The outcome variables were the general health and oral health-related QoL. General health-related QoL was assessed using the 36-item Short Form Health Survey (SF-36) and oral health-related QoL using the 14-item Short Form Oral Health Impact Profile (OHIP-14). Differences in SF-36 scores and OHIP-14 scores between the groups were compared. Results: Forty-eight subjects (24 cases and 24 controls) were recruited. When compared to the control group, patients with neurosensory deficits had poorer Mental-Health Component Scores (MCS) (p = 0.005), General Health (p = 0.023), Vitality (p = 0.048), Social Functioning (p = 0.003), Role-emotion (p = 0.008) and Mental Health (p = 0.022). The OHIP-14 scores were also significantly worse in this patients with neurosensory deficits compared with the control group (p = 0.002). When compared within the study group, older patient with neurosensory deficit was found to correlate with worse Physical Health Component Scores (PCS) (p = 0.02) and OHIP-14 scores (p = 0.02), while more severe visualized analog scaling rating of numbness was correlated with a worse PCS (p = 0.034). Conclusions: Patients with persistent LN or IAN deficit after lower third molar surgery have poorer health-related QoL and poorer oral health-related QoL than those without such deficits.	[Leung, Yiu Yan; McGrath, Colman; Cheung, Lim Kwong] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk		Cheung, Lim Kwong/0000-0002-2248-286X; McGrath, Colman Patrick Joseph/0000-0001-9379-0889; /0000-0001-7038-3279				Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cheung LK, 2009, INT J ORAL MAXILLOF, V108, P821; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Hupp James R, 2007, Oral Maxillofac Surg Clin North Am, V19, P129, DOI 10.1016/j.coms.2006.11.008; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Leung YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072891; Locker D, 2007, COMMUNITY DENT ORAL, V35, P401, DOI 10.1111/j.1600-0528.2007.00418.x; McGrath C, 2001, Community Dent Health, V18, P138; McGrath C, 2003, BRIT J ORAL MAX SURG, V41, P43, DOI 10.1016/S0266-4356(02)00289-9; McGrath C, 1999, Prim Dent Care, V6, P53; Pogrel MA, 2011, J ORAL MAXIL SURG, V69, P2284, DOI 10.1016/j.joms.2011.02.023; Reisine S, 2012, INT J ORAL MAX SURG, V41, P1558, DOI 10.1016/j.ijom.2012.04.019; Rustemeyer J, 2012, J CRANIO MAXILL SURG, V40, P400, DOI 10.1016/j.jcms.2011.07.009; SANDSTEDT P, 1995, J ORAL MAXIL SURG, V53, P498, DOI 10.1016/0278-2391(95)90055-1; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Wong W, 2012, QUAL LIFE RES, V21, P873, DOI 10.1007/s11136-011-9987-3	16	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77391	10.1371/journal.pone.0077391	http://dx.doi.org/10.1371/journal.pone.0077391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204820	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700028
J	Gowda, NM; Wu, XZ; Kumar, S; Febbraio, M; Gowda, DC				Gowda, Nagaraj M.; Wu, Xianzhu; Kumar, Sanjeev; Febbraio, Maria; Gowda, D. Channe			CD36 Contributes to Malaria Parasite-Induced Pro-Inflammatory Cytokine Production and NK and T Cell Activation by Dendritic Cells	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; PROTECTIVE IMMUNITY; MEMBRANE PROTEIN-1; RECEPTOR; ADHESION; INNATE; ADHERENCE; RESPONSES	The scavenger receptor CD36 plays important roles in malaria, including the sequestration of parasite-infected erythrocytes in microvascular capillaries, control of parasitemia through phagocytic clearance by macrophages, and immunity. Although the role of CD36 in the parasite sequestration and clearance has been extensively studied, how and to what extent CD36 contributes to malaria immunity remains poorly understood. In this study, to determine the role of CD36 in malaria immunity, we assessed the internalization of CD36-adherent and CD36-nonadherent Plasmodium falciparum-infected red blood cells (IRBCs) and production of pro-inflammatory cytokines by DCs, and the ability of DCs to activate NK, and T cells. Human DCs treated with anti-CD36 antibody and CD36 deficient murine DCs internalized lower levels of CD36-adherent IRBCs and produced significantly decreased levels of pro-inflammatory cytokines compared to untreated human DCs and wild type mouse DCs, respectively. Consistent with these results, wild type murine DCs internalized lower levels of CD36-nonadherent IRBCs and produced decreased levels of pro-inflammatory cytokines than wild type DCs treated with CD36-adherent IRBCs. Further, the cytokine production by NK and T cells activated by IRBC-internalized DCs was significantly dependent on CD36. Thus, our results demonstrate that CD36 contributes significantly to the uptake of IRBCs and pro-inflammatory cytokine responses by DCs, and the ability of DCs to activate NK and T cells to produce IFN-gamma. Given that DCs respond to malaria parasites very early during infection and influence development of immunity, and that CD36 contributes substantially to the cytokine production by DCs, NK and T cells, our results suggest that CD36 plays an important role in immunity to malaria. Furthermore, since the contribution of CD36 is particularly evident at low doses of infected erythrocytes, the results imply that the effect of CD36 on malaria immunity is imprinted early during infection when parasite load is low.	[Gowda, Nagaraj M.; Wu, Xianzhu; Kumar, Sanjeev; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Febbraio, Maria] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Cleveland Clinic Foundation	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	gowda@psu.edu		Gowda, Channe/0000-0002-6860-5108	National Institute of Infectious Diseases and Allergy, National Institutes of Health [AI41139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	National Institute of Infectious Diseases and Allergy, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by grant AI41139 from the National Institute of Infectious Diseases and Allergy, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; Beeson JG, 2002, CELL MOL LIFE SCI, V59, P258, DOI 10.1007/s00018-002-8421-y; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Brasel Kenneth, 2000, Blood, V96, P3029; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Davis SP, 2012, FASEB J, V26, P1119, DOI 10.1096/fj.11-196923; Deitsch KW, 2004, TRENDS PARASITOL, V20, P562, DOI 10.1016/j.pt.2004.09.002; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; Elliott SR, 2007, INFECT IMMUN, V75, P3621, DOI 10.1128/IAI.00095-07; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fesel C, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-5; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Langhorne J, 2004, IMMUNOL REV, V201, P35, DOI 10.1111/j.0105-2896.2004.00182.x; Leitner WW, 1997, PARASITE IMMUNOL, V19, P103, DOI 10.1046/j.1365-3024.1997.d01-188.x; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Mach N, 2000, CANCER RES, V60, P3239; Muthusamy A, 2007, AM J PATHOL, V170, P1989, DOI 10.2353/ajpath.2007.061238; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; Newman KC, 2006, PLOS PATHOG, V2, P1120, DOI 10.1371/journal.ppat.0020118; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; Omi Kazuya, 2002, Southeast Asian J Trop Med Public Health, V33 Suppl 3, P1; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; Seixas E, 2001, EUR J IMMUNOL, V31, P2970, DOI 10.1002/1521-4141(2001010)31:10&lt;2970::AID-IMMU2970&gt;3.0.CO;2-S; Senczuk AM, 2001, BLOOD, V98, P3132, DOI 10.1182/blood.V98.10.3132; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Su Z, 2005, INFECT IMMUN, V73, P3531, DOI 10.1128/IAI.73.6.3531-3539.2005; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Wagner H, 2004, TRENDS IMMUNOL, V25, P381, DOI 10.1016/j.it.2004.04.011; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	62	20	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77604	10.1371/journal.pone.0077604	http://dx.doi.org/10.1371/journal.pone.0077604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204889	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200034
J	Wang, KY; Chau, TT				Wang, Kuo-Ying; Chau, Tang-Tat			An Association between Air Pollution and Daily Outpatient Visits for Respiratory Disease in a Heavy Industry Area	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; ALLERGIC RHINITIS; SUBTROPICAL CITY; ASTHMA; TAIPEI; CONSULTATIONS; QUALITY; MORTALITY; LONDON	In this work we used daily outpatient data from the Landseed Hospital in a heavily industrial area in northern Taiwan to study the associations between daily outpatient visits and air pollution in the context of a heavily polluted atmospheric environment in Chung-Li area during the period 2007-2011. We test the normality of each data set, control for the confounding factors, and calculate correlation coefficient between the outpatient visits and air pollution and meteorology, and use multiple linear regression analysis to seek significance of these associations. Our results show that temperature and relative humidity tend to be negatively associated with respiratory diseases. NO and NO2 are two main air pollutants that are positively associated with respiratory diseases, followed by PM10, PM2.5, O-3, CO, and SO2. Young outpatients (age 0-15 years) are most sensitive to changing air pollution and meteorology factors, followed by the eldest (age >= 66 years) and age 16-65 years of outpatients. Outpatients for COPD diseases are most sensitive to air pollution and meteorology factors, followed by allergic rhinitis, asthma, and pneumonia diseases. In the context of sex difference to air pollution and meteorological factors, male outpatients are more sensitive than female outpatients in the 16-65 age groups, while female outpatients are more sensitive than male outpatients in the young 0-15 age groups and in the eldest age groups. In total, female outpatients are more sensitive to air pollution and meteorological factors than male outpatients.	[Wang, Kuo-Ying] Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan; [Chau, Tang-Tat] Taiwan Landseed Hosp, Dept Community Med, Ping Jen, Taiwan	National Central University	Wang, KY (corresponding author), Natl Cent Univ, Dept Atmospher Sci, Chungli 32054, Taiwan.	kuoying@mail.atm.ncu.edu.tw			National Central University-Landseed Hospital [100-A-004, 101-A-006]	National Central University-Landseed Hospital	This work was supported by National Central University-Landseed Hospital-100-A-004 and National Central University-Landseed Hospital-101-A-006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens C.D., 2021, METEOROLOGY TODAY IN; Braga LHP, 2012, CAN J SURG, V55, P132, DOI 10.1503/cjs.036311; Brookhart MA, 2010, MED CARE, V48, pS114, DOI 10.1097/MLR.0b013e3181dbebe3; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Chang CC, 2005, ENVIRON RES, V98, P114, DOI 10.1016/j.envres.2004.07.005; Chang SC, 2008, J ENVIRON MANAGE, V86, P627, DOI 10.1016/j.jenvman.2006.12.029; Cheng MF, 2007, J TOXICOL ENV HEAL A, V70, P2021, DOI 10.1080/15287390701601020; Department of Health, 2011, 2010 STAT GEN HLTH; Department of Health, 2012, 2011 TAIW HLTH REP; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Enia G, 2007, NEPHROL DIAL TRANSPL, V22, P538, DOI 10.1093/ndt/gfl605; Executive Yuan, 2011, MONTHL B STAT REP CH; Fang SH, 1996, ATMOS ENVIRON, V30, P735; Hajat S, 2002, OCCUP ENVIRON MED, V59, P294, DOI 10.1136/oem.59.5.294; Hajat S, 2001, AM J EPIDEMIOL, V153, P704, DOI 10.1093/aje/153.7.704; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Hwang JS, 2002, AM J EPIDEMIOL, V155, P1, DOI 10.1093/aje/155.1.1; Jager KJ, 2008, KIDNEY INT, V73, P256, DOI 10.1038/sj.ki.5002650; Bin J, 2006, J EXPO SCI ENV EPID, V16, P225, DOI 10.1038/sj.jea.7500451; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Krzyzanowski M, 2008, AIR QUAL ATMOS HLTH, V1, P7, DOI 10.1007/s11869-008-0008-9; Loomis D, 1999, EPIDEMIOLOGY, V10, P118, DOI 10.1097/00001648-199903000-00006; McConnell R, 1999, ENVIRON HEALTH PERSP, V107, P757, DOI 10.2307/3434662; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; More DS, 2000, STAT CONCEPTS CONTRO; Penna M L, 1991, Bull Pan Am Health Organ, V25, P47; Press W.H., 2007, NUMERICAL RECIPES, V3rd ed.; SCHWARTZ J, 1993, AM REV RESPIR DIS, V147, P826, DOI 10.1164/ajrccm/147.4.826; SCHWARTZ J, 1994, ENVIRON RES, V64, P26, DOI 10.1006/enrs.1994.1004; Sheppard L, 1999, EPIDEMIOLOGY, V10, P23, DOI 10.1097/00001648-199901000-00006; Stone R, 2002, SCIENCE, V298, P2106; Sunyer J, 1997, THORAX, V52, P760, DOI 10.1136/thx.52.9.760; Taiwan Landseed Hospital, 2010, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2011, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2009, STAT ANN REP MED SER; Taiwan Landseed Hospital, 2008, STAT ANN REP MED SER; Tripepi G, 2008, KIDNEY INT, V73, P806, DOI 10.1038/sj.ki.5002787; Villeneuve PJ, 2006, ALLERGY, V61, P750, DOI 10.1111/j.1398-9995.2006.01070.x; Wang KY, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005326; Wang KY, 2004, WATER AIR SOIL POLL, V156, P29, DOI 10.1023/B:WATE.0000036788.41409.5b; WHITTEMORE AS, 1980, AM J PUBLIC HEALTH, V70, P687, DOI 10.2105/AJPH.70.7.687; Wong TW, 2006, THORAX, V61, P585, DOI 10.1136/thx.2005.051730; World Bank, 2007, COST POLL CHIN; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; XU XP, 1995, ARCH ENVIRON HEALTH, V50, P214, DOI 10.1080/00039896.1995.9940390; XU XP, 1995, ENVIRON HEALTH PERSP, V103, P286, DOI 10.2307/3432550; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P1214, DOI 10.1080/15287390701380880; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P111, DOI 10.1080/15287390600755059	50	50	54	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e75220	10.1371/journal.pone.0075220	http://dx.doi.org/10.1371/journal.pone.0075220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204573	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400007
J	Wang, W; Zhang, M; Sun, WM; Yang, SM; Su, Y; Zhang, HS; Liu, CM; Li, XF; Lin, L; Kim, S; Okunieff, P; Zhang, ZH; Zhang, LR				Wang, Wei; Zhang, Mei; Sun, Weimin; Yang, Shanmin; Su, Ying; Zhang, Hengshan; Liu, Chaomei; Li, Xinfeng; Lin, Ling; Kim, Sunghee; Okunieff, Paul; Zhang, Zhenhuan; Zhang, Lurong			Reduction of Decoy Receptor 3 Enhances TRAIL-Mediated Apoptosis in Pancreatic Cancer	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; X-LINKED INHIBITOR; FAS LIGAND; CELL-LINES; T-CELL; ADENOCARCINOMA; EXPRESSION; RESISTANCE; DEATH; OVEREXPRESSION	Most human pancreatic cancer cells are resistant to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)mediated apoptosis. However, the mechanisms by which pancreatic cancer cells utilize their extracellular molecules to counteract the proapoptotic signaling mediated by the TNF family are largely unknown. In this study, we demonstrate for the first time that DcR3, a secreted decoy receptor that malignant pancreatic cancer cells express at a high level, acts as an extracellular antiapoptotic molecule by binding to TRAIL and counteracting its death-promoting function. The reduction of DcR3 with siRNA unmasked TRAIL and greatly enhanced TRAIL-induced apoptosis. Gemcitabine, a first-line drug for pancreatic cancer, also reduced the level of DcR3. The addition of DcR3 siRNA further enhanced gemcitabine-induced apoptosis. Notably, our in vivo study demonstrated that the therapeutic effect of gemcitabine could be enhanced via further reduction of DcR3, suggesting that downregulation of DcR3 in tumor cells could tip the balance of pancreatic cells towards apoptosis and potentially serve as a new strategy for pancreatic cancer therapy.	[Zhang, Mei; Sun, Weimin; Yang, Shanmin; Liu, Chaomei; Okunieff, Paul; Zhang, Zhenhuan; Zhang, Lurong] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA; [Wang, Wei; Su, Ying; Li, Xinfeng; Lin, Ling] Fujian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Quanzhou, Fujian, Peoples R China; [Sun, Weimin] Second Mil Med Coll, Dept Immunol, Shanghai, Peoples R China; [Kim, Sunghee] BioPowerTech, Tuscaloosa, AL USA; [Zhang, Hengshan; Zhang, Lurong] Fujian Med Univ, Affiliated Hosp 1, Cent Lab, Fuzhou, Fujian, Peoples R China	State University System of Florida; University of Florida; Fujian Medical University; Naval Medical University; Fujian Medical University	Wang, W (corresponding author), Fujian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Quanzhou, Fujian, Peoples R China.	gianty2005@yahoo.com; lz8506@gmail.com		Zhang, Hengshan/0000-0002-2226-4774	National Natural Science Fund of China [81071968]; Key Program of Scientific Research of Fujian Medical University [09ZD014]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Program of Scientific Research of Fujian Medical University	This work was supported in part by the National Natural Science Fund of China Grants (81071968) to WW and the Key Program of Scientific Research of Fujian Medical University (09ZD014) to WW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, PANCR CANC OV; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bai C, 2000, P NATL ACAD SCI USA, V97, P1230, DOI 10.1073/pnas.97.3.1230; Boehrer S, 2006, CURR MED CHEM, V13, P2091, DOI 10.2174/092986706777935294; Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Catz SD, 2003, APOPTOSIS, V8, P29, DOI 10.1023/A:1021692801278; Chang YC, 2008, BLOOD, V111, P5054, DOI 10.1182/blood-2007-12-130609; Chen JG, 2004, J IMMUNOL METHODS, V285, P63, DOI 10.1016/j.jim.2003.11.004; Chen PH, 2008, J IMMUNOL, V181, P8441, DOI 10.4049/jimmunol.181.12.8441; Connolly K, 2001, J PHARMACOL EXP THER, V298, P25; COSMAN D, 1994, STEM CELLS, V12, P440, DOI 10.1002/stem.5530120501; Farrelly N, 1999, J CELL BIOL, V144, P1337, DOI 10.1083/jcb.144.6.1337; Finnberg N, 2006, CLIN CANCER RES, V12, P4132, DOI 10.1158/1078-0432.CCR-06-0567; Flaherty KT, 2001, CURR OPIN ONCOL, V13, P499, DOI 10.1097/00001622-200111000-00013; Hall MA, 2007, CANCER CELL, V12, P4, DOI 10.1016/j.ccr.2007.06.011; Hylander BL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-22; Ibrahim SM, 2001, PANCREAS, V23, P72, DOI 10.1097/00006676-200107000-00011; Jacob D, 2005, CANCER GENE THER, V12, P109, DOI 10.1038/sj.cgt.7700773; Karikari CA, 2007, MOL CANCER THER, V6, P957, DOI 10.1158/1535-7163.MCT-06-0634; Li HX, 2005, AM J CLIN PATHOL, V124, P282, DOI 10.1309/XK594E4B5WU82QR6; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Mori T, 2005, SURGERY, V138, P71, DOI 10.1016/j.surg.2005.03.001; Mori T, 2007, J SURG RES, V142, P281, DOI 10.1016/j.jss.2007.03.068; Okamoto K, 2007, J CELL MOL MED, V11, P349, DOI 10.1111/j.1582-4934.2007.00013.x; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; She QB, 2001, CANCER RES, V61, P1604; Shi GX, 2005, J IMMUNOL, V174, P4727, DOI 10.4049/jimmunol.174.8.4727; Shrader M, 2007, CANCER RES, V67, P1430, DOI 10.1158/0008-5472.CAN-06-1224; Song JJ, 2007, J BIOL CHEM, V282, P319, DOI 10.1074/jbc.M608065200; Stauffer SR, 2007, CURR TOP MED CHEM, V7, P961, DOI 10.2174/156802607780906843; Tsuji S, 2003, INT J CANCER, V106, P17, DOI 10.1002/ijc.11170; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Xu ZW, 2003, ANTICANCER RES, V23, P251; Yu KY, 1999, J BIOL CHEM, V274, P13733, DOI 10.1074/jbc.274.20.13733; Zhan CY, 2011, STRUCTURE, V19, P162, DOI 10.1016/j.str.2010.12.004; Zhang J, 2001, J CLIN INVEST, V107, P1459, DOI 10.1172/JCI12159	39	17	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e74272	10.1371/journal.pone.0074272	http://dx.doi.org/10.1371/journal.pone.0074272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204567	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400006
J	Sato, T; Neschadim, A; Lavie, A; Yanagisawa, T; Medin, JA				Sato, Takeya; Neschadim, Anton; Lavie, Arnon; Yanagisawa, Teruyuki; Medin, Jeffrey A.			The Engineered Thymidylate Kinase (TMPK)/AZT Enzyme-Prodrug Axis Offers Efficient Bystander Cell Killing for Suicide Gene Therapy of Cancer	PLOS ONE			English	Article							VIRUS THYMIDINE KINASE; PROSTATE-CANCER; GAP-JUNCTIONS; DEOXYCYTIDINE KINASE; COMMUNICATION; GANCICLOVIR; PANNEXIN-1	We previously described a novel suicide (or 'cell fate control') gene therapy enzyme/prodrug system based on an engineered variant of human thymidylate kinase (TMPK) that potentiates azidothymidine (AZT) activation. Delivery of a suicide gene sequence into tumors by lentiviral transduction embodies a cancer gene therapy that could employ bystander cell killing as a mechanism driving significant tumor regression in vivo. Here we present evidence of a significant bystander cell killing in vitro and in vivo mediated by the TMPK/AZT suicide gene axis that is reliant on the formation of functional gap-junctional intercellular communications (GJICs). Potentiation of AZT activation by the engineered TMPK expressed in the human prostate cancer cell line, PC-3, resulted in effective bystander killing of PC-3 cells lacking TMPK expression - an effect that could be blocked by the GJIC inhibitor, carbenoxolone. Although GJICs are mainly formed by connexins, a new family of GJIC molecules designated pannexins has been recently identified. PC-3 cells expressed both connexin43 (Cx43) and Pannexin1 (Panx1), but Panx1 expression predominated at the plasma membrane, whereas Cx43 expression was primarily localized to the cytosol. The contribution of bystander effects to the reduction of solid tumor xenografts established by the PC-3 cell line was evaluated in an animal model. We demonstrate the contribution of bystander cell killing to tumor regression in a xenograft model relying on the delivery of expression of the TMPK suicide gene into tumors via direct intratumoral injection of recombinant therapeutic lentivirus. Taken together, our data underscore that the TMPK/AZT enzyme-prodrug axis can be effectively utilized in suicide gene therapy of solid tumors, wherein significant tumor regression can be achieved via bystander effects mediated by GJICs.	[Sato, Takeya; Yanagisawa, Teruyuki] Tohoku Univ, Sendai, Miyagi 980, Japan; [Neschadim, Anton] Canadian Blood Serv, Toronto, ON, Canada; [Lavie, Arnon] Univ Illinois, Chicago, IL USA; [Medin, Jeffrey A.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Medin, Jeffrey A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Medin, Jeffrey A.] Univ Hlth Network, Toronto, ON, Canada	Tohoku University; Canadian Blood Services; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Sato, T (corresponding author), Tohoku Univ, Sendai, Miyagi 980, Japan.	tksato@med.tohoku.ac.jp	Neschadim, Anton/G-3041-2011	Neschadim, Anton/0000-0003-1750-9703; Sato, Takeya/0000-0003-2409-1819; Lavie, Arnon/0000-0001-5591-8722	Japan Society for the Promotion of Science (JSPS) [20590533]; Saito Gratitude Foundation; Canadian Institutes of Health Research (CIHR)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Saito Gratitude Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was funded in part by Grant-in aid for Scientific Research (C) (20590533) to T. S. from the Japan Society for the Promotion of Science (JSPS) and by the research grant from the Saito Gratitude Foundation to T.S.. A.N. was funded by the Canadian Institutes of Health Research (CIHR) Training Program in Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Ardiani A, 2010, CANCER GENE THER, V17, P86, DOI 10.1038/cgt.2009.60; Beck C, 1995, HUM GENE THER, V6, P1525, DOI 10.1089/hum.1995.6.12-1525; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; Colombo F, 2005, CANCER GENE THER, V12, P835, DOI 10.1038/sj.cgt.7700851; Czyz J, 2012, NAT REV UROL, V9, P274, DOI 10.1038/nrurol.2012.14; Dachs GU, 2009, MOLECULES, V14, P4517, DOI 10.3390/molecules14114517; Denning C, 1997, HUM GENE THER, V8, P1825, DOI 10.1089/hum.1997.8.15-1825; Denny WA, 2003, J BIOMED BIOTECHNOL, P48; Dilber MS, 1997, CANCER RES, V57, P1523; FICK J, 1995, P NATL ACAD SCI USA, V92, P11071, DOI 10.1073/pnas.92.24.11071; GIAI M, 1991, European Journal of Gynaecological Oncology, V12, P359; Hodish I, 2009, CANCER BIOL THER, V8, P435, DOI 10.4161/cbt.8.5.7589; Hool LC, 2005, CARDIOVASC RES, V67, P624, DOI 10.1016/j.cardiores.2005.04.025; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Leinonen HM, 2012, CANCER RES, V72, P6227, DOI 10.1158/0008-5472.CAN-12-1166; Loimas S, 2001, CANCER GENE THER, V8, P137, DOI 10.1038/sj.cgt.7700286; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Neschadim A, 2012, CANCER GENE THER, V19, P320, DOI 10.1038/cgt.2012.4; Neschadim A, 2012, MOL THER, V20, P1002, DOI 10.1038/mt.2011.298; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Romanov RA, 2012, J CELL SCI, V125, P5514, DOI 10.1242/jcs.111062; Sato T, 2007, MOL THER, V15, P962, DOI 10.1038/mt.sj.6300122; Sato T, 2009, J CARDIOL, V54, P245, DOI 10.1016/j.jjcc.2009.05.010; Satoh T, 2005, CURR GENE THER, V5, P111; Silvertown JD, 2007, FASEB J, V21, P754, DOI 10.1096/fj.06-6847com; Van Dillen Ingrid J., 2002, Current Gene Therapy, V2, P307, DOI 10.2174/1566523023347733; Wei SJ, 1998, EXP CELL RES, V241, P66, DOI 10.1006/excr.1998.4005; Xing YF, 2007, J HUAZHONG U SCI-MED, V27, P291, DOI 10.1007/s11596-007-0319-3	29	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78711	10.1371/journal.pone.0078711	http://dx.doi.org/10.1371/journal.pone.0078711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194950	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000129
J	Cheung, YF; Yu, W; Cheuk, DKL; Cheng, FWT; Yang, JYK; Yau, JPW; Ho, KKH; Li, CK; Li, RCH; Yuen, HL; Ling, ASC; Li, VWY; Wong, WK; Tsang, KC; Chan, GCF				Cheung, Yiu-fai; Yu, Wei; Cheuk, Daniel Ka-leung; Cheng, Frankie Wai-tsoi; Yang, Janet Yee-kwan; Yau, Jeffrey Ping-wa; Ho, Karin Ka-huen; Li, Chi-kong; Li, Rever Chak-ho; Yuen, Hui-leung; Ling, Alvin Siu-cheung; Li, Vivian Wing-yi; Wong, Wai-keung; Tsang, Kwong-cheong; Chan, Godfrey Chi-fung			Plasma High Sensitivity Troponin T Levels in Adult Survivors of Childhood Leukaemias: Determinants and Associations with Cardiac Function	PLOS ONE			English	Article							PEDIATRIC-PATIENTS; ISOVOLUMIC ACCELERATION; MYOCARDIAL INJURY; NAD(P)H OXIDASE; HEART-FAILURE; MORTALITY; RISK; CANCER; FORCE; CARDIOTOXICITY	Background: We sought to quantify plasma high sensitivity cardiac troponin (hs-cTnT) levels, their determinants, and their associations with left ventricular (LV) myocardial deformation in adult survivors of childhood acute leukaemias. Methods and Results: One hundred adult survivors (57 males) of childhood acute leukaemias, aged 24.1 +/- 4.2 years, and 42 age-matched controls (26 males) were studied. Plasma cTnT was determined using a highly sensitive assay. Genotyping of NAD(P)H oxidase and multidrug resistance protein polymorphisms was performed. Left ventricular function was assessed by conventional, three-dimensional, and speckle tracking echocardiography. The medians (interquartile range) of hs-cTnT in male and female survivors were 4.9 (4.2 to 7.2) ng/L and 1.0 (1.0 to 3.5) ng/L, respectively. Nineteen survivors (13 males, 6 females) (19%) had elevated hs-cTnT (>95th centile of controls). Compared to those without elevated hs-TnT levels, these subjects had received larger cumulative anthracycline dose and were more likely to have leukaemic relapse, stem cell transplant, and cardiac irradiation. Their LV systolic and early diastolic myocardial velocities, isovolumic acceleration, and systolic longitudinal strain rate were significantly lower. Survivors having CT/TT at CYBA rs4673 had higher hs-cTnT levels than those with CC genotype. Functionally, increased hs-cTnT levels were associated with worse LV longitudinal systolic strain and systolic and diastolic strain rates. Conclusions: Increased hs-cTnT levels occur in a significant proportion of adult survivors of childhood acute leukaemias and are associated with larger cumulative anthracycline dose received, history of leukaemic relapse, stem cell transplant, and cardiac irradiation, genetic variants in free radical metabolism, and worse LV myocardial deformation.	[Cheung, Yiu-fai; Yu, Wei; Cheuk, Daniel Ka-leung; Li, Vivian Wing-yi; Chan, Godfrey Chi-fung] Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Cheng, Frankie Wai-tsoi; Li, Chi-kong] Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Yang, Janet Yee-kwan; Li, Rever Chak-ho] Tuen Mun Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Jeffrey Ping-wa; Yuen, Hui-leung] Queen Elizabeth Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Ho, Karin Ka-huen; Ling, Alvin Siu-cheung] Princess Margaret Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Wai-keung; Tsang, Kwong-cheong] Queen Mary Hosp, Dept Pathol & Clin Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Tuen Mun Hospital; University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	Li, Chi-kong/J-8456-2013; Cheung, Yiu Fai/C-4240-2009	Li, Chi-kong/0000-0002-2810-5758; Cheung, Yiu Fai/0000-0002-7279-4992; Cheuk, Daniel/0000-0001-9553-3528	Children's Cancer Foundation (Hong Kong)	Children's Cancer Foundation (Hong Kong)	Children's Cancer Foundation (Hong Kong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Cheung YF, 2010, HEART, V96, P1137, DOI 10.1136/hrt.2010.194118; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Filusch A, 2010, CLIN SCI, V119, P207, DOI 10.1042/CS20100014; Gatta G, 2002, CANCER-AM CANCER SOC, V95, P1767, DOI 10.1002/cncr.10833; Goethals I, 2002, ANN ONCOL, V13, P1331, DOI 10.1093/annonc/mdf318; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Kawahara C, 2011, AM HEART J, V162, P639, DOI 10.1016/j.ahj.2011.07.007; Kawahara C, 2011, CIRC J, V75, P656, DOI 10.1253/circj.CJ-10-0837; Kremer LCM, 2002, EUR J CANCER, V38, P686, DOI 10.1016/S0959-8049(01)00431-2; Lipshultz SE, 1997, CIRCULATION, V96, P2641, DOI 10.1161/01.CIR.96.8.2641; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; Lipshultz SE, 2012, J CLIN ONCOL, V30, P1042, DOI 10.1200/JCO.2010.30.3404; Masson S, 2012, CIRCULATION, V125, P280, DOI 10.1161/CIRCULATIONAHA.111.044149; Mathew P, 2001, CANCER INVEST, V19, P352, DOI 10.1081/CNV-100103130; Otsuka T, 2010, AM HEART J, V159, P972, DOI 10.1016/j.ahj.2010.02.036; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Roche SL, 2011, J AM COLL CARDIOL, V57, P1100, DOI 10.1016/j.jacc.2010.09.063; Saenger AK, 2011, CLIN CHIM ACTA, V412, P748, DOI 10.1016/j.cca.2010.12.034; Shankar SM, 2008, PEDIATRICS, V121, pE387, DOI 10.1542/peds.2007-0575; Shimo-Nakanishi Y, 2004, ATHEROSCLEROSIS, V175, P109, DOI 10.1016/j.atherosclerosis.2004.01.043; Sobel BE, 2000, J AM COLL CARDIOL, V35, P1355, DOI 10.1016/S0735-1097(00)00516-7; Thorburn A, 2006, MOL CANCER THER, V5, P197, DOI 10.1158/1535-7163.MCT-06-CO1; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Visscher H, 2012, J CLIN ONCOL, V30, P1422, DOI 10.1200/JCO.2010.34.3467; Vogel M, 2003, CIRCULATION, V107, P1647, DOI 10.1161/01.CIR.0000058171.62847.90; Wallace TW, 2006, CIRCULATION, V113, P1958, DOI 10.1161/CIRCULATIONAHA.105.609974; Wang TJ, 2007, CIRCULATION, V116, P1217, DOI 10.1161/CIRCULATIONAHA.107.721845; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Wyche KE, 2004, HYPERTENSION, V43, P1246, DOI 10.1161/01.HYP.0000126579.50711.62; Xue Y, 2011, EUR J HEART FAIL, V13, P37, DOI 10.1093/eurjhf/hfq210	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77063	10.1371/journal.pone.0077063	http://dx.doi.org/10.1371/journal.pone.0077063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204736	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600019
J	de Almeida, RS; Hammoumi, S; Gil, P; Briand, FX; Molia, S; Gaidet, N; Cappelle, J; Chevalier, V; Balanca, G; Traore, A; Grillet, C; Maminiaina, OF; Guendouz, S; Dakouo, M; Samake, K; Bezeid, OE; Diarra, A; Chaka, H; Goutard, F; Thompson, P; Martinez, D; Jestin, V; Albina, E				de Almeida, Renata Servan; Hammoumi, Saliha; Gil, Patricia; Briand, Francois-Xavier; Molia, Sophie; Gaidet, Nicolas; Cappelle, Julien; Chevalier, Veronique; Balanca, Gilles; Traore, Abdallah; Grillet, Colette; Maminiaina, Olivier Fridolin; Guendouz, Samia; Dakouo, Marthin; Samake, Kassim; Bezeid, Ould El Mamy; Diarra, Abbas; Chaka, Hassen; Goutard, Flavie; Thompson, Peter; Martinez, Dominique; Jestin, Veronique; Albina, Emmanuel			New Avian Paramyxoviruses Type I Strains Identified in Africa Provide New Outcomes for Phylogeny Reconstruction and Genotype Classification	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; VIRULENT-STRAINS; FUSION PROTEIN; BRANCH LENGTH; OUTBREAKS; SEQUENCE; PPMV-1; SITE; TIME; RECOMBINATION	Newcastle disease (ND) is one of the most lethal diseases of poultry worldwide. It is caused by an avian paramyxovirus 1 that has high genomic diversity. In the framework of an international surveillance program launched in 2007, several thousand samples from domestic and wild birds in Africa were collected and analyzed. ND viruses (NDV) were detected and isolated in apparently healthy fowls and wild birds. However, two thirds of the isolates collected in this study were classified as virulent strains of NDV based on the molecular analysis of the fusion protein and experimental in vivo challenges with two representative isolates. Phylogenetic analysis based on the F and HN genes showed that isolates recovered from poultry in Mali and Ethiopia form new groups, herein proposed as genotypes XIV and sub-genotype VIf with reference to the new nomenclature described by Diel's group. In Madagascar, the circulation of NDV strains of genotype XI, originally reported elsewhere, is also confirmed. Full genome sequencing of five African isolates was generated and an extensive phylogeny reconstruction was carried out based on the nucleotide sequences. The evolutionary distances between groups and the specific amino acid signatures of each cluster allowed us to refine the genotype nomenclature.	[de Almeida, Renata Servan; Hammoumi, Saliha; Gil, Patricia; Grillet, Colette; Guendouz, Samia; Martinez, Dominique] CIRAD, UMR CMAEE, Montpellier, France; [de Almeida, Renata Servan; Hammoumi, Saliha; Gil, Patricia; Grillet, Colette; Guendouz, Samia; Martinez, Dominique; Albina, Emmanuel] INRA, CMAEE UMR1309, F-34060 Montpellier, France; [Briand, Francois-Xavier; Jestin, Veronique] Anses Ploufragan Plouzane, VIPAC, French Reference Lab Avian Influenza & Newcastle, Ploufragan, France; [Molia, Sophie; Gaidet, Nicolas; Cappelle, Julien; Chevalier, Veronique; Balanca, Gilles; Goutard, Flavie] CIRAD, UPR AGIRS, Montpellier, France; [Traore, Abdallah; Dakouo, Marthin; Samake, Kassim; Diarra, Abbas] Cent Vet Lab, Bamako, Mali; [Maminiaina, Olivier Fridolin] FOFIFA DRZV, Antananarivo, Madagascar; [Bezeid, Ould El Mamy] CNERV, Nouakchott, Mauritania; [Chaka, Hassen] NAHDIC, Sebeta, Ethiopia; [Thompson, Peter] Univ Pretoria, Fac Vet Sci, ZA-0002 Pretoria, South Africa; [Albina, Emmanuel] CIRAD, UMR CMAEE, Petit Bourg, Guadeloupe, France	CIRAD; INRAE; CIRAD; University of Pretoria; CIRAD	de Almeida, RS (corresponding author), CIRAD, UMR CMAEE, Montpellier, France.	renata.almeida@cirad.fr	Thompson, Peter N/J-2534-2013	Thompson, Peter/0000-0002-2268-9748; BRIAND, Francois-Xavier/0000-0002-8094-9368; goutard, flavie luce/0000-0002-8618-4132; Cappelle, Julien/0000-0001-7668-1971; Molia, Sophie/0000-0002-5695-7464; Albina, Emmanuel/0000-0002-6613-3047	French Ministry of Foreign Affairs (MAE) [GRIPAVI 2006-26]; EU network of excellence [EPIZONE (016236)]; French Ministry of Foreign Affairs (MAE) [GRIPAVI 2006-26]; EU network of excellence [EPIZONE (016236)]	French Ministry of Foreign Affairs (MAE); EU network of excellence(European Commission); French Ministry of Foreign Affairs (MAE); EU network of excellence(European Commission)	This study was mainly funded by the French Ministry of Foreign Affairs (MAE) via the Fonds de Solidarite Prioritaire project [GRIPAVI 2006-26] and partly by the EU network of excellence project [EPIZONE (016236, 01/06/2006-31/05/2011)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2008, ONDERSTEPOORT J VET, V75, P147; Abolnik C, 2004, ONDERSTEPOORT J VET, V71, P157; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; BallagiPordany A, 1996, ARCH VIROL, V141, P243, DOI 10.1007/BF01718397; Cattoli G, 2010, VET MICROBIOL, V142, P168, DOI 10.1016/j.vetmic.2009.09.063; Chong YL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000872; Courtney SC, 2012, J CLIN MICROBIOL; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Almeida RS, 2009, VACCINE, V27, P3127, DOI 10.1016/j.vaccine.2009.03.076; de Leeuw OS, 2005, J GEN VIROL, V86, P1759, DOI 10.1099/vir.0.80822-0; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dortmans JCFM, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-122; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fuller CM, 2007, ARCH VIROL, V152, P1575, DOI 10.1007/s00705-007-0963-8; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; HANNAN EJ, 1979, J ROY STAT SOC B MET, V41, P190; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Khan TA, 2010, J CLIN MICROBIOL, V48, P1892, DOI 10.1128/JCM.00148-10; Kwon HJ, 2003, VET MICROBIOL, V95, P39, DOI 10.1016/S0378-1135(03)00130-5; Lien YY, 2007, VET MICROBIOL, V123, P194, DOI 10.1016/j.vetmic.2007.03.006; Liu HL, 2007, J VIROL METHODS, V140, P206, DOI 10.1016/j.jviromet.2006.10.012; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Maminiaina OF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013987; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Mohamed MHA, 2009, VIRUS GENES, V39, P234, DOI 10.1007/s11262-009-0385-7; Office International des Epizooties, 2008, MANUAL DIAGNOSTIC TE; Otim MO, 2004, J CLIN MICROBIOL, V42, P2802, DOI 10.1128/JCM.42.6.2802-2805.2004; Pchelkina IP, 2013, AVIAN DIS, V57, P2, DOI 10.1637/10246-051112-Reg.1; Pham HM, 2005, ARCH VIROL, V150, P2429, DOI 10.1007/s00705-005-0603-0; Qin ZM, 2008, VIRUS RES, V131, P299, DOI 10.1016/j.virusres.2007.10.001; Rannala B, 2012, MOL BIOL EVOL, V29, P325, DOI 10.1093/molbev/msr210; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Snoeck CJ, 2009, ARCH VIROL, V154, P47, DOI 10.1007/s00705-008-0269-5; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarnagda Z, 2011, J INFECT DEV COUNTR, V5, P565, DOI 10.3855/jidc.1441; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; Wang ZL, 2006, ANN NY ACAD SCI, V1081, P228, DOI 10.1196/annals.1373.027; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; Zhang C, 2012, SYST BIOL, V61, P779, DOI 10.1093/sysbio/sys030; Zou J, 2005, VIRUS GENES, V30, P13, DOI 10.1007/s11262-004-4577-x	51	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76413	10.1371/journal.pone.0076413	http://dx.doi.org/10.1371/journal.pone.0076413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204623	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300026
J	Forrester, HB; Ivashkevich, A; McKay, MJ; Leong, T; de Kretser, DM; Sprung, CN				Forrester, Helen B.; Ivashkevich, Alesia; McKay, Michael J.; Leong, Trevor; de Kretser, David M.; Sprung, Carl N.			Follistatin Is Induced by Ionizing Radiation and Potentially Predictive of Radiosensitivity in Radiation-Induced Fibrosis Patient Derived Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IDIOPATHIC PULMONARY-FIBROSIS; ACTIVIN-BINDING PROTEIN; CANCER-PATIENTS; TISSUE-REPAIR; TIME-LAPSE; CELLS; PIRFENIDONE; HALOFUGINONE; INHIBITION	Follistatin is a potent regulator of the inflammatory response and binds to and inhibits activin A action. Activin A is a member of the TGF beta protein superfamily which has regulatory roles in the inflammatory response and in the fibrotic process. Fibrosis can occur following cell injury and cell death induced by agents such as ionizing radiation (IR). IR is used to treat cancer and marked fibrotic response is a normal tissue (non-tumour) consequence in a fraction of patients under the current dose regimes. The discovery and development of a therapeutic to abate fibrosis in these radiosensitive patients would be a major advance for cancer radiotherapy. Likewise, prediction of which patients are susceptible to fibrosis would enable individualization of treatment and provide an opportunity for pre-emptive fibrosis control and better tumour treatment outcomes. The levels of activin A and follistatin were measured in fibroblasts derived from patients who developed severe radiation-induced fibrosis following radiotherapy and compared to fibroblasts from patients who did not. Both follistatin and activin A gene expression levels were increased following IR and the follistatin gene expression level was lower in the fibroblasts from fibrosis patients compared to controls at both basal levels and after IR. The major follistatin transcript variants were found to have a similar response to IR and both were reduced in fibrosis patients. Levels of follistatin and activin A secreted in the fibroblast culture medium also increased in response to IR and the relative follistatin protein levels were significantly lower in the samples derived from fibrosis patients. The decrease in the follistatin levels can lead to an increased bioactivity of activin A and hence may provide a useful measurement to identify patients at risk of a severe fibrotic response to IR. Additionally, follistatin, by its ability to neutralise the actions of activin A may be of value as an anti-fibrotic for radiation induced fibrosis.	[Forrester, Helen B.; Ivashkevich, Alesia; Sprung, Carl N.] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia; [McKay, Michael J.] North Coast Canc Inst, Lismore, NSW, Australia; [Leong, Trevor] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, East Melbourne, Vic, Australia; [de Kretser, David M.] Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [de Kretser, David M.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	Monash University; Peter Maccallum Cancer Center; Monash University; Monash University	Sprung, CN (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia.	carl.sprung@monash.edu	McKay, Michael/ABA-9029-2021		National Institute of Health [5U19AI067773-07]; 2010 round of the priority-driven Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Australian National Health and Medical Research Council; Australian National Breast Cancer Foundation [PG-08-06]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2010 round of the priority-driven Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported through National Institute of Health [grant 5U19AI067773-07] and the 2010 round of the priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Also, this work was supported by the Australian National Health and Medical Research Council; and the Australian National Breast Cancer Foundation [grant PG-08-06; http://www.nbcf.org.au/]. Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsbeih G, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-125; Alsner J, 2008, SEMIN RADIAT ONCOL, V18, P126, DOI 10.1016/j.semradonc.2007.10.004; Andreassen CN, 2010, RADIOTHER ONCOL, V97, P1, DOI 10.1016/j.radonc.2010.07.018; Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Anscher MS, 2006, INT J RADIAT ONCOL, V65, P876, DOI 10.1016/j.ijrobp.2006.02.051; Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bian YS, 2009, CANCER RES, V69, P5918, DOI 10.1158/0008-5472.CAN-08-4623; de Jonge MJA, 2006, EUR J CANCER, V42, P1768, DOI 10.1016/j.ejca.2005.12.027; de Kretser David M, 2013, Methods Mol Biol, V927, P531; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; DEKRETSER DM, 1989, BIOL REPROD, V40, P33, DOI 10.1095/biolreprod40.1.33; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Distel LVR, 2006, RADIOTHER ONCOL, V81, P257, DOI 10.1016/j.radonc.2006.10.012; Fields SZ, 2013, EXPERT OPIN INV DRUG, V22, P87, DOI 10.1517/13543784.2013.738666; Forrester HB, 1999, CANCER RES, V59, P931; Forrester HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053358; GRANOT I, 1993, BIOCHIM BIOPHYS ACTA, V1156, P107, DOI 10.1016/0304-4165(93)90123-P; Hedger MP, 2011, VITAM HORM, V85, P255, DOI 10.1016/B978-0-12-385961-7.00013-5; HEDGER MP, 1989, MOL CELL ENDOCRINOL, V61, P133, DOI 10.1016/0303-7207(89)90198-6; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; HURWITZ C, 1969, BIOPHYS J, V9, P607, DOI 10.1016/S0006-3495(69)86407-6; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Ishii H, 2009, INT J ONCOL, V35, P315, DOI 10.3892/ijo_00000342; Ismail SM, 2004, RADIOTHER ONCOL, V72, P325, DOI 10.1016/j.radonc.2004.07.003; Knight PG, 1996, J ENDOCRINOL, V148, P267, DOI 10.1677/joe.0.1480267; Lepparanta O, 2013, AM J RESP CELL MOL, V48, P448, DOI 10.1165/rcmb.2012-0201OC; Li ZB, 2012, J CELL SCI, V125, P3957, DOI 10.1242/jcs.090365; Lin SY, 2003, REPRODUCTION, V126, P133, DOI 10.1530/rep.0.1260133; Maher TM, 2010, DRUG TODAY, V46, P473, DOI 10.1358/dot.2010.46.7.1488336; MICHEL U, 1990, BIOCHEM BIOPH RES CO, V173, P401, DOI 10.1016/S0006-291X(05)81072-1; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Nagai S, 2002, INTERNAL MED, V41, P1118, DOI 10.2169/internalmedicine.41.1118; Nagashio Y, 2004, LAB INVEST, V84, P1610, DOI 10.1038/labinvest.3700191; NAKAMURA T, 1991, J BIOL CHEM, V266, P19432; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nishioka A, 2004, INT J RADIAT ONCOL, V58, P1235, DOI 10.1016/j.ijrobp.2003.11.006; O'Connor AE, 1999, HUM REPROD, V14, P827, DOI 10.1093/humrep/14.3.827; Ohga E, 1996, BIOCHEM BIOPH RES CO, V228, P391, DOI 10.1006/bbrc.1996.1672; Ohga E, 2000, LIFE SCI, V66, P1603, DOI 10.1016/S0024-3205(00)00480-X; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Parliament MB, 2012, LANCET ONCOL, V13, P7, DOI 10.1016/S1470-2045(11)70331-X; Patella S, 2006, AM J PHYSIOL-GASTR L, V290, pG137, DOI 10.1152/ajpgi.00080.2005; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Rabbani ZN, 2003, INT J RADIAT ONCOL, V57, P563, DOI 10.1016/S0360-3016(03)00639-4; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Schultze-Mosgau S, 2004, RADIOTHER ONCOL, V70, P249, DOI 10.1016/j.radonc.2004.01.010; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; Simone NL, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-19; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; Sprung CN, 2008, CANC BIOL THER, V7; Sugino Hiromu, 1997, Journal of Medical Investigation, V44, P1; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; Vasireddy RS, 2010, BRIT J CANCER, V102, P1511, DOI 10.1038/sj.bjc.6605666; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; West CML, 1998, INT J RADIAT BIOL, V73, P409, DOI 10.1080/095530098142248; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Yarnold J, 2010, RADIOTHER ONCOL, V97, P149, DOI 10.1016/j.radonc.2010.09.002; Zhou PK, 1998, RADIOTHER ONCOL, V47, P271, DOI 10.1016/S0167-8140(97)00200-4; Zion O, 2009, PANCREAS, V38, P427, DOI 10.1097/MPA.0b013e3181967670	67	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77119	10.1371/journal.pone.0077119	http://dx.doi.org/10.1371/journal.pone.0077119			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204752	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300083
J	Fujimoto, S; Itsumura, N; Tsuji, T; Anan, Y; Tsuji, N; Ogra, Y; Kimura, T; Miyamae, Y; Masuda, S; Nagao, M; Kambe, T				Fujimoto, Shigeyuki; Itsumura, Naoya; Tsuji, Tokuji; Anan, Yasumi; Tsuji, Natsuko; Ogra, Yasumitsu; Kimura, Tomoki; Miyamae, Yusaku; Masuda, Seiji; Nagao, Masaya; Kambe, Taiho			Cooperative Functions of ZnT1, Metallothionein and ZnT4 in the Cytoplasm Are Required for Full Activation of TNAP in the Early Secretory Pathway	PLOS ONE			English	Article							ZINC TRANSPORT COMPLEXES; ALKALINE-PHOSPHATASES; CONFERS RESISTANCE; SIGNALING PATHWAYS; VERTEBRATE CELLS; COPPER; EXPRESSION; PROTEINS; ACCUMULATION; PATHOGENESIS	The activation process of secretory or membrane-bound zinc enzymes is thought to be a highly coordinated process involving zinc transport, trafficking, transfer and coordination. We have previously shown that secretory and membrane-bound zinc enzymes are activated in the early secretory pathway (ESP) via zinc-loading by the zinc transporter 5 (ZnT5)-ZnT6 hetero-complex and ZnT7 homo-complex (zinc transport complexes). However, how other proteins conducting zinc metabolism affect the activation of these enzymes remains unknown. Here, we investigated this issue by disruption and re-expression of genes known to be involved in cytoplasmic zinc metabolism, using a zinc enzyme, tissue non-specific alkaline phosphatase (TNAP), as a reporter. We found that TNAP activity was significantly reduced in cells deficient in ZnT1, Metallothionein (MT) and ZnT4 genes (ZnT1(-/-) MT-/- ZnT4(-/-) cells), in spite of increased cytosolic zinc levels. The reduced TNAP activity in ZnT1(-/-) MT-/- ZnT4(-/-) cells was not restored when cytosolic zinc levels were normalized to levels comparable with those of wild-type cells, but was reversely restored by extreme zinc supplementation via zinc-loading by the zinc transport complexes. Moreover, the reduced TNAP activity was adequately restored by re-expression of mammalian counterparts of ZnT1, MT and ZnT4, but not by zinc transport-incompetent mutants of ZnT1 and ZnT4. In ZnT1(-/-) MT-/- ZnT4(-/-) cells, the secretory pathway normally operates. These findings suggest that cooperative zinc handling of ZnT1, MT and ZnT4 in the cytoplasm is required for full activation of TNAP in the ESP, and present clear evidence that the activation process of zinc enzymes is elaborately controlled.	[Fujimoto, Shigeyuki; Itsumura, Naoya; Tsuji, Tokuji; Tsuji, Natsuko; Miyamae, Yusaku; Masuda, Seiji; Nagao, Masaya; Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan; [Anan, Yasumi; Ogra, Yasumitsu] Showa Pharmaceut Univ, Lab Chem Toxicol & Environm Hlth, Machida, Tokyo, Japan; [Ogra, Yasumitsu] Showa Pharmaceut Univ, High Technol Res Ctr, Machida, Tokyo, Japan; [Kimura, Tomoki] Setsunan Univ, Fac Pharmaceut Sci, Dept Toxicol, Hirakata, Osaka 57301, Japan	Kyoto University; Showa Pharmaceutical University; Showa Pharmaceutical University; Setsunan University	Kambe, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto, Japan.	kambe1@kais.kyoto-u.ac.jp	Miyamae, Yusaku/F-3543-2018; Miyamae, Yusaku/S-3665-2019; Kimura, Tomoki/B-4363-2010; Ogra, Yasumitsu/A-2747-2017	Miyamae, Yusaku/0000-0002-8102-4391; Kimura, Tomoki/0000-0002-5138-5882; Ogra, Yasumitsu/0000-0002-8268-1828; Kambe, Taiho/0000-0001-9757-063X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Takeda Science Foundation; Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research [23380059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Suzuken Memorial Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Suzuken Memorial Foundation, the Takeda Science Foundation and the Japan Foundation for Applied Enzymology (to T. Kambe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; Costello LC, 2011, J INORG BIOCHEM, V105, P589, DOI 10.1016/j.jinorgbio.2011.02.002; Dutta A, 2011, NUTR RES, V31, P404, DOI 10.1016/j.nutres.2011.05.001; Eichelsdoerfer JL, 2010, J BIOL CHEM, V285, P34304, DOI 10.1074/jbc.C110.165480; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gao SY, 2002, BRIT J PHARMACOL, V137, P749, DOI 10.1038/sj.bjp.0704939; Hamza I, 2001, P NATL ACAD SCI USA, V98, P6848, DOI 10.1073/pnas.111058498; Hirooka T, 2010, TOXICOL IN VITRO, V24, P835, DOI 10.1016/j.tiv.2009.12.009; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jeney V, 2005, CIRC RES, V96, P723, DOI 10.1161/01.RES.0000162001.57896.66; Jeong J, 2012, P NATL ACAD SCI USA, V109, pE3530, DOI 10.1073/pnas.1211775110; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kambe T, 2011, BIOSCI BIOTECH BIOCH, V75, P1036, DOI 10.1271/bbb.110056; Kimura T, 2008, BIOCHEM J, V415, P477, DOI 10.1042/BJ20081025; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maret W, 2012, J INORG BIOCHEM, V111, P110, DOI 10.1016/j.jinorgbio.2011.11.018; Maret W, 2011, J BIOL INORG CHEM, V16, P1079, DOI 10.1007/s00775-011-0800-0; Maret W, 2011, BIOMETALS, V24, P411, DOI 10.1007/s10534-010-9406-1; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MILLAN JL, 1995, CRIT REV CL LAB SCI, V32, P1, DOI 10.3109/10408369509084680; Miyayama T, 2010, BIOCHEM J, V429, P53, DOI 10.1042/BJ20100223; Miyayama T, 2009, TOXICOL APPL PHARM, V237, P205, DOI 10.1016/j.taap.2009.03.024; Nam DH, 2007, COMP BIOCHEM PHYS C, V145, P295, DOI 10.1016/j.cbpc.2006.10.012; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taniguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058022; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yamasaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039654	51	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77445	10.1371/journal.pone.0077445	http://dx.doi.org/10.1371/journal.pone.0077445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204829	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300096
J	Hanaoka, Y; Takebe, F; Nodasaka, Y; Hara, I; Matsuyama, H; Yumoto, I				Hanaoka, Yoshiko; Takebe, Fumihiko; Nodasaka, Yoshinobu; Hara, Isao; Matsuyama, Hidetoshi; Yumoto, Isao			Growth-Dependent Catalase Localization in Exiguobacterium oxidotolerans T-2-2(T) Reflected by Catalase Activity of Cells	PLOS ONE			English	Article							FACULTATIVELY PSYCHROPHILIC BACTERIUM; VIBRIO-RUMOIENSIS S-1(T); HYDROGEN-PEROXIDE; SUPEROXIDE-PRODUCTION; PROTEIN SECRETION; OXIDATIVE STRESS; DNA DAMAGE; PSYCHROBACTER; MECHANISM; H2O2	A psychrotolerant and H2O2-resistant bacterium, Exiguobacterium oxidotolerans T-2-2(T), exhibits extraordinary H2O2 resistance and produces catalase not only intracellularly but also extracellularly. The intracellular and extracellular catalases exhibited the same enzymatic characteristics, that is, they exhibited the temperature-dependent activity characteristic of a cold-adapted enzyme, their heat stabilities were similar to those of mesophilic enzymes and very high catalytic intensity. In addition, catalase gene analysis indicated that the bacterium possessed the sole clade 1 catalase gene corresponding to intracellular catalase. Hence, intracellular catalase is secreted into the extracellular space. In addition to intracellular and extracellular catalases, the inner circumference of the cells showed the localization of catalase in the mid-stationary growth phase, which was observed by immunoelectron microscopy using an antibody against the intracellular catalase of the strain. The cells demonstrated higher catalase activity in the mid-stationary growth phase than in the exponential growth phase. The catalase localized in the inner circumference can be dissociated by treatment with Tween 60. Thus, the localized catalase is not tightly bound to the inner circumference of the cells and may play a role in the oxidative defense of the cells under low metabolic state.	[Hanaoka, Yoshiko; Yumoto, Isao] Hokkaido Univ, Lab Environm Microbiol, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido, Japan; [Hanaoka, Yoshiko; Takebe, Fumihiko; Hara, Isao; Yumoto, Isao] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido, Japan; [Takebe, Fumihiko; Matsuyama, Hidetoshi] Tokai Univ, Sch Biol Sci & Engn, Minami Ku, Sapporo, Hokkaido, Japan; [Nodasaka, Yoshinobu] Hokkaido Univ, Grad Sch Dent, Lab Electron Microscopy, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Tokai University; Hokkaido University	Yumoto, I (corresponding author), Hokkaido Univ, Lab Environm Microbiol, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido, Japan.	i.yumoto@aist.go.jp	Yumoto, Isao/N-2053-2018	Yumoto, Isao/0000-0001-9525-3155	National Institute of Advanced Industrial Science and Technology	National Institute of Advanced Industrial Science and Technology	Financial support was obtained from National Institute of Advanced Industrial Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; Edman P, 1975, PROTEIN SEQUENCE DET, P232; EGELSEER E, 1995, J BACTERIOL, V177, P1444, DOI 10.1128/jb.177.6.1444-1451.1995; Halliwell B., 1999, FREE RADICAL BIOL ME; Hara I, 2007, BIOCHEMISTRY-US, V46, P11, DOI 10.1021/bi061519w; Harris AG, 2003, FEMS MICROBIOL LETT, V229, P283, DOI 10.1016/S0378-1097(03)00850-4; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; Hoyoux A, 2004, J BIOSCI BIOENG, V98, P317; Ichise N, 1999, APPL ENVIRON MICROB, V65, P73; Ichise N, 2000, J BIOSCI BIOENG, V90, P530, DOI 10.1263/jbb.90.530; Ichise N, 2008, J BIOSCI BIOENG, V106, P39, DOI 10.1263/jbb.106.39; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; KATSUWON J, 1992, CAN J MICROBIOL, V38, P1026, DOI 10.1139/m92-169; Kimoto H, 2008, PROTEIN EXPRES PURIF, V59, P357, DOI 10.1016/j.pep.2008.03.016; Kimoto H, 2012, INT J MOL SCI, V13, P1733, DOI 10.3390/ijms13021733; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; Lorentzen MS, 2006, EXTREMOPHILES, V10, P427, DOI 10.1007/s00792-006-0518-z; Natale P, 2008, BBA-BIOMEMBRANES, V1778, P1735, DOI 10.1016/j.bbamem.2007.07.015; Orikasa Y, 2010, J BIOSCI BIOENG, V110, P397, DOI 10.1016/j.jbiosc.2010.04.007; POBINER H, 1961, ANAL CHEM, V33, P1423, DOI 10.1021/ac60178a045; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Raynaud C, 1998, MICROBIOL-SGM, V144, P577, DOI 10.1099/00221287-144-2-577; Rieske JS, 1967, METHOD ENZYMOL, V10, P488, DOI DOI 10.1016/0076-6879(67)10081-5; Rocha ER, 1996, J BACTERIOL, V178, P6895, DOI 10.1128/jb.178.23.6895-6903.1996; Rodrigues DF, 2009, ISME J, V3, P658, DOI 10.1038/ismej.2009.25; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3; SATO T, 1973, STAIN TECHNOL, V48, P223, DOI 10.3109/10520297309116628; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; SEEL WE, 1992, J EXP BOT, V43, P1031, DOI 10.1093/jxb/43.8.1031; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takebe F, 2007, J BIOSCI BIOENG, V104, P464, DOI 10.1263/jbb.104.464; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; TSUJI S, 1990, J JPN SOC FOOD SCI, V37, P111; Vishnivetskaya TA, 2011, J BACTERIOL, V193, P2880, DOI 10.1128/JB.00303-11; Visick KL, 1998, J BACTERIOL, V180, P2087, DOI 10.1128/JB.180.8.2087-2092.1998; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; Yumoto I, 2000, J BACTERIOL, V182, P1903, DOI 10.1128/JB.182.7.1903-1909.2000; Yumoto I, 1998, J FERMENT BIOENG, V85, P113, DOI 10.1016/S0922-338X(97)80364-9; Yumoto I, 2004, INT J SYST EVOL MICR, V54, P2013, DOI 10.1099/ijs.0.63129-0; Yumoto I, 1999, APPL ENVIRON MICROB, V65, P67; Yumoto I, 2010, INT J SYST EVOL MICR, V60, P205, DOI 10.1099/ijs.0.010959-0	47	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76862	10.1371/journal.pone.0076862	http://dx.doi.org/10.1371/journal.pone.0076862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204687	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300056
J	Tsang, WP; Shu, YL; Kwok, PL; Zhang, FJ; Lee, KKH; Tang, MK; Li, G; Chan, KM; Chan, WY; Wan, C				Tsang, Wing Pui; Shu, Yinglan; Kwok, Po Lam; Zhang, Fengjie; Lee, Kenneth Ka Ho; Tang, Mei Kuen; Li, Gang; Chan, Kai Ming; Chan, Wai-Yee; Wan, Chao			CD146(+) Human Umbilical Cord Perivascular Cells Maintain Stemness under Hypoxia and as a Cell Source for Skeletal Regeneration	PLOS ONE			English	Article							MARROW STROMAL CELLS; IN-VITRO; ULTRASTRUCTURAL-CHANGES; GENE-EXPRESSION; BONE-MARROW; PROLIFERATION; DIFFERENTIATION; HIF-2-ALPHA; PRECURSORS; OXYGEN	The human umbilical cord perivascular cells (HUCPVCs) have been considered as an alternative source of mesenchymal progenitors for cell based regenerative medicine. However, the biological properties of these cells remain to be well characterized. In the present study, HUCPVCs were isolated and sorted by CD146(+) pericyte marker. The purified CD146(+) HUCPVCs were induced to differentiate efficiently into osteoblast, chondrocyte and adipocyte lineages in vitro. Six weeks following subcutaneous transplantation of CD146(+) HUCPVCs-Gelfoam-alginate 3D complexes in severe combined immunodeficiency (SCID) mice, newly formed bone matrix with embedded osteocytes of donor origin was observed. The functional engraftment of CD146(+) HUCPVCs in the new bone regenerates was further confirmed in a critical-sized bone defect model in SCID mice. Hypoxic conditions suppressed osteogenic differentiation while increased cell proliferation and colony-forming efficiency of CD146(+) HUCPVCs as compared to that under normoxic conditions. Re-oxygenation restored the multi-differentiation potential of the CD146(+) HUCPVCs. Western blot analysis revealed an upregulation of HIF-1 alpha, HIF-2 alpha, and OCT-4 protein expression in CD146(+) HUCPVCs under hypoxia, while there was no remarkable change in SOX2 and NANOG expression. The gene expression profiles of stem cell transcription factors between cells treated by normoxia and hypoxic conditions were compared by PCR array analysis. Intriguingly, PPAR-gamma was dramatically downregulated (20-fold) in mRNA expression under hypoxia, and was revealed to possess a putative binding site in the Hif-2 alpha gene promoter region. Chromatin immunoprecipitation assays confirmed the binding of PPAR-gamma protein to the Hif-2 alpha promoter and the binding was suppressed by hypoxia treatment. Luciferase reporter assay showed that the Hif-2 alpha promoter activity was suppressed by PPAR expression. Thus, PPAR-gamma may involve in the regulation of HIF-2 alpha for stemness maintenance and promoting the expansion of CD146(+) HUCPVCs in response to hypoxia. CD146(+) HUCPVCs may serve as a potential autologous cell source for bone regeneration.	[Tsang, Wing Pui; Shu, Yinglan; Kwok, Po Lam; Zhang, Fengjie; Lee, Kenneth Ka Ho; Tang, Mei Kuen; Li, Gang; Chan, Wai-Yee; Wan, Chao] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China; [Tsang, Wing Pui; Zhang, Fengjie; Lee, Kenneth Ka Ho; Chan, Wai-Yee; Wan, Chao] Chinese Univ Hong Kong Shenzhen Res Inst, Sch Biomed Sci Core Lab, Shenzhen, Peoples R China; [Li, Gang; Chan, Kai Ming] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong	Wan, C (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Key Lab Regenerat Med,Minist Educ, Hong Kong, Hong Kong, Peoples R China.	cwan@cuhk.edu.hk	Wan, Chao/J-9277-2013; Li, Gang/J-7830-2018; Lee, Kenneth Ka Ho/H-6698-2013; Tang, Florence/AAW-4103-2021; Chan, Wai Yee/R-7442-2018	Wan, Chao/0000-0001-6780-2006; Li, Gang/0000-0002-3981-2239; Lee, Kenneth Ka Ho/0000-0002-6520-304X; Chan, Wai Yee/0000-0002-9714-0936	Hong Kong Research Grant Council General Research Fund [CUHK 475910]; NSFC-RGC Joint Research Scheme [CUHK445/10]; Chinese University of Hong Kong School of Biomedical Sciences Start-up Fund	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council); NSFC-RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); Chinese University of Hong Kong School of Biomedical Sciences Start-up Fund	The study was partly supported by Hong Kong Research Grant Council General Research Fund (CUHK 475910), NSFC-RGC Joint Research Scheme (CUHK445/10), and The Chinese University of Hong Kong School of Biomedical Sciences Start-up Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P832, DOI 10.2106/00004623-199173060-00006; Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Ennis J, 2008, CYTOTHERAPY, V10, P174, DOI 10.1080/14653240801891667; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hamm JK, 1999, ANN NY ACAD SCI, V892, P134, DOI 10.1111/j.1749-6632.1999.tb07792.x; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Michiels C, 2001, IUBMB LIFE, V52, P49, DOI 10.1080/15216540252774766; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Solchaga LA, 2002, TISSUE ENG, V8, P333, DOI 10.1089/107632702753725085; Studer L, 2000, J NEUROSCI, V20, P7377; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023965; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zebardast N, 2010, ORGANOGENESIS, V6, P197, DOI 10.4161/org.6.4.12393	33	50	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76153	10.1371/journal.pone.0076153	http://dx.doi.org/10.1371/journal.pone.0076153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204598	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300011
J	Kannenberg, F; Gorzelniak, K; Jager, K; Fobker, M; Rust, S; Repa, J; Roth, M; Bjorkhem, I; Walter, M				Kannenberg, Frank; Gorzelniak, Kerstin; Jaeger, Kathrin; Fobker, Manfred; Rust, Stephan; Repa, Joyce; Roth, Mike; Bjorkhem, Ingemar; Walter, Michael			Characterization of Cholesterol Homeostasis in Telomerase-immortalized Tangier Disease Fibroblasts Reveals Marked Phenotype Variability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cholesterol; Cholesterol Metabolism; High Density Lipoprotein (HDL); Telomerase; Oxysterols	APOLIPOPROTEIN-A-I; PERFORMANCE LIQUID-CHROMATOGRAPHY; DENSITY-LIPOPROTEIN DEFICIENCY; BINDING PROTEIN-1C GENE; CASSETTE TRANSPORTER 1; CELLULAR CHOLESTEROL; LXR-ALPHA; INTRACELLULAR CHOLESTEROL; EFFLUX; ATHEROSCLEROSIS	We compared the consequences of an ABCA1 mutation that produced an apparent lack of atherosclerosis (Tangier family 1, N935S) with an ABCA1 mutation with functional ABCA1 knockout that was associated with severe atherosclerosis (Tangier family 2, Leu(548):Leu(575)-End), using primary and telomerase-immortalized fibroblasts. Telomerase-immortalized Tangier fibroblasts of family 1 (TT1) showed 30% residual cholesterol efflux capacity in response to apolipoprotein A-I, whereas telomerase-immortalized Tangier fibroblasts of family 2 (TT2) showed only 20%. However, there were a number of secondary differences that were often stronger and may help to explain the more rapid development of atherosclerosis in family 2. First, the total cellular cholesterol content increase was 2-3-fold and 3-5-fold in TT1 and TT2 cells, respectively. The corresponding increase in esterified cholesterol concentration was 10- and 40-fold, respectively. Second, 24-, 25-, and 27-hydroxycholesterol concentrations were moderately increased in TT1 cells, but were increased as much as 200-fold in TT2 cells. Third, cholesterol biosynthesis was moderately decreased in TT1 cells, but was markedly decreased in TT2 cells. Fourth, potentially atheroprotective LXR-dependent SREBP1c signaling was normal in TT1, but was rather suppressed in TT2 cells. Cultivated primary Tangier fibroblasts were characterized by premature aging in culture and were associated with less obvious biochemical differences. In summary, these results may help to understand the differential atherosclerotic susceptibility in Tangier disease and further demonstrate the usefulness of telomerase-immortalized cells in studying this cellular phenotype. The data support the contention that side chain-oxidized oxysterols are strong suppressors of cholesterol biosynthesis under specific pathological conditions in humans.	[Kannenberg, Frank; Fobker, Manfred] Univ Munster, Ctr Lab Med, D-48149 Munster, Germany; [Gorzelniak, Kerstin] Unfallkrankenhaus, D-12683 Berlin, Germany; [Jaeger, Kathrin; Walter, Michael] Charite, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; [Rust, Stephan] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Repa, Joyce] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Roth, Mike] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bjorkhem, Ingemar] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, S-14186 Stockholm, Sweden; [Walter, Michael] Lab Berlin Charite Vivantes Serv GmbH, D-13353 Berlin, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet; Karolinska University Hospital; Labor Berlin - Charite Vivantes GmbH	Walter, M (corresponding author), Campus Virchow Klinikum, Inst Lab Med Clin Chem & Pathobiochem, Augustenburger Pl 1, D-13353 Berlin, Germany.	m.walter@charite.de		Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425; Repa, Joyce/0000-0001-5740-1954; Roth, Michael/0000-0002-9056-332X	Landesversicherungsanstalt Rheinprovinz (LVA); Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL; Bonn, Germany); Swedish Research Council	Landesversicherungsanstalt Rheinprovinz (LVA); Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL; Bonn, Germany); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was supported by grants from the "Landesversicherungsanstalt Rheinprovinz (LVA)" (to M. W.), the Foundation for Pathobiochemistry and Molecular Diagnostics, German Society for Clinical Chemistry and Laboratory Medicine e.V. (DGKL; Bonn, Germany) (to M. W.), and a grant from the Swedish Research Council (to I. B.).	Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; ASSMANN G, 1995, METABOLIC MOL BASES, P2053; AXELSON M, 1995, J BIOL CHEM, V270, P15102, DOI 10.1074/jbc.270.25.15102; Bjorkhem I, 2002, J CLIN INVEST, V110, P725, DOI 10.1172/JCI200216388; Bjorkhem I, 1999, CURR OPIN LIPIDOL, V10, P161, DOI 10.1097/00041433-199904000-00010; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown AJ, 1999, ATHEROSCLEROSIS, V142, P1, DOI 10.1016/S0021-9150(98)00196-8; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Cullen P, 1997, J LIPID RES, V38, P401; Cullen P, 1997, ANAL BIOCHEM, V251, P39, DOI 10.1006/abio.1997.2227; Drobnik W, 1999, ARTERIOSCL THROM VAS, V19, P28, DOI 10.1161/01.ATV.19.1.28; Engel T, 2007, FEBS LETT, V581, P1673, DOI 10.1016/j.febslet.2007.03.038; ESTERMAN AL, 1983, J LIPID RES, V24, P1304; Forsyth NR, 2003, AGING CELL, V2, P235, DOI 10.1046/j.1474-9728.2003.00057.x; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; KANDUTSCH AA, 1975, J CELL PHYSIOL, V85, P415, DOI 10.1002/jcp.1040850408; KLANSEK JJ, 1995, J LIPID RES, V36, P2261; Landau JM, 1997, BBA-LIPID LIPID MET, V1345, P349, DOI 10.1016/S0005-2760(97)00010-6; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lund E, 1996, ARTERIOSCL THROM VAS, V16, P208, DOI 10.1161/01.ATV.16.2.208; LUND E, 1993, BIOCHIM BIOPHYS ACTA, V1166, P177, DOI 10.1016/0005-2760(93)90094-P; Millard EE, 2000, J BIOL CHEM, V275, P38445, DOI 10.1074/jbc.M003180200; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Oram JF, 1999, J LIPID RES, V40, P1769; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; RADER DJ, 1993, LANCET, V342, P1455, DOI 10.1016/0140-6736(93)92933-K; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; ROGLER G, 1995, ARTERIOSCL THROM VAS, V15, P683, DOI 10.1161/01.ATV.15.5.683; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Rust S, 1998, NAT GENET, V20, P96, DOI 10.1038/1770; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Utech M, 2001, BIOCHEM BIOPH RES CO, V280, P229, DOI 10.1006/bbrc.2000.4061; WALTER M, 1995, ARTERIOSCL THROM VAS, V15, P1975, DOI 10.1161/01.ATV.15.11.1975; Walter M, 1996, J CLIN INVEST, V98, P2315, DOI 10.1172/JCI119043; Walter M, 2004, J BIOL CHEM, V279, P20866, DOI 10.1074/jbc.M401714200; WALTER M, 1994, ATHEROSCLEROSIS, V110, P203, DOI 10.1016/0021-9150(94)90205-4; WALTER M, 1994, BIOCHEM BIOPH RES CO, V205, P850, DOI 10.1006/bbrc.1994.2742; Walter M, 2009, ARTERIOSCL THROM VAS, V29, P1244, DOI 10.1161/ATVBAHA.108.181438; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200	51	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36936	36947		10.1074/jbc.M113.500256	http://dx.doi.org/10.1074/jbc.M113.500256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196952	Green Published, hybrid			2022-12-25	WOS:000329189700016
J	Colvin, SC; Maier, B; Morris, DL; Tersey, SA; Mirmira, RG				Colvin, Stephanie C.; Maier, Bernhard; Morris, David L.; Tersey, Sarah A.; Mirmira, Raghavendra G.			Deoxyhypusine Synthase Promotes Differentiation and Proliferation of T Helper Type 1 (Th1) Cells in Autoimmune Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Immunology; Islet; Mouse; T Cell	ENDOPLASMIC-RETICULUM STRESS; NITRIC-OXIDE SYNTHASE; NOD MOUSE; EIF5A; INHIBITION; TRANSLATION; ACTIVATION; EXPRESSION; ONSET; INTERLEUKIN-2	Background: Deoxyhypusine synthase promotes mRNA translation by catalyzing the hypusine modification of eIF5A. Results: Inhibition of deoxyhypusine synthase reduced accumulation and proliferation of Th1 cells in type 1 diabetic mice and in vitro by reducing CD25 expression in T cells. Conclusion: Deoxyhypusine synthase promotes Th1 cell proliferation and differentiation. Significance: Inhibition of deoxyhypusine synthase may provide a novel strategy for reducing diabetogenic Th1 cells in type 1 diabetes. In type 1 diabetes, cytokines arising from immune cells cause islet cell dysfunction even before overt hyperglycemia. Deoxyhypusine synthase catalyzes the crucial hypusine modification of the factor eIF5A, which promotes the translation of a subset of mRNAs involved in cytokine responses. Here, we tested the hypothesis that deoxyhypusine synthase and, secondarily, hypusinated eIF5A contribute to the pathogenesis of type 1 diabetes using the non-obese diabetic (NOD) mouse model. Pre-diabetic NOD mice that received injections of the deoxyhypusine inhibitor N1-guanyl-1,7-diaminoheptane (GC7) demonstrated significantly improved glucose tolerance, more robust insulin secretion, and reduced insulitis compared with control animals. Analysis of tissues from treated mice revealed selective reductions in diabetogenic T helper type 1 (Th1) cells in the pancreatic lymph nodes, a primary site of antigen presentation. Isolated mouse CD90.2(+) splenocytes stimulated in vitro with anti-CD3/anti-CD28 and IL-2 to mimic autoimmune T cell activation exhibited proliferation and differentiation of CD4(+) T cell subsets (Th1, Th17, and Treg), but those treated with the deoxyhypusine synthase inhibitor GC7 showed a dose-dependent block in T cell proliferation with selective reduction in Th1 cells, similar to that observed in NOD mice. Inhibition of deoxyhypusine synthase blocked post-transcriptional expression of CD25, the high affinity IL-2 receptor chain. Our results suggest a previously unrecognized role for deoxyhypusine synthase in promoting T cell proliferation and differentiation via regulation of CD25. Inhibition of deoxyhypusine synthase may provide a strategy for reducing diabetogenic Th1 cells and preserving cell function in type 1 diabetes.	[Colvin, Stephanie C.; Maier, Bernhard; Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Colvin, Stephanie C.; Maier, Bernhard; Tersey, Sarah A.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Morris, David L.; Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Mirmira, RG (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	rmirmira@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361	National Institutes of Health [R01 DK60581, F32 DK094489, F32 DK091976]; Juvenile Diabetes Research Foundation; institutional Clinical and Translational Sciences Institute KL2 award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060581, F32DK091976, F32DK094489] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); institutional Clinical and Translational Sciences Institute KL2 award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK60581 (to R. G. M.), F32 DK094489 (to S. C. C.), and F32 DK091976 (to D. L. M.). This work was also supported by a grant from the Juvenile Diabetes Research Foundation (to R. G. M.), an institutional Clinical and Translational Sciences Institute KL2 award (to S. A. T.), and gifts from the George and Frances Ball Foundation and the Ball Brothers Foundation (to R. G. M.).	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Balabanov S, 2007, BLOOD, V109, P1701, DOI 10.1182/blood-2005-03-037648; Berchtold S, 1999, FEBS LETT, V461, P211, DOI 10.1016/S0014-5793(99)01465-9; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Cabrera SM, 2012, CURR MOL MED, V12, P1261, DOI 10.2174/156652412803833634; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dias CAO, 2012, AMINO ACIDS, V42, P697, DOI 10.1007/s00726-011-0985-0; Evans-Molina C, 2007, DIABETES, V56, P827, DOI 10.2337/db06-1440; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Guo ZY, 2013, J IMMUNOL, V190, P3153, DOI 10.4049/jimmunol.1200751; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Keskinen P, 2002, DIABETOLOGIA, V45, P1639, DOI 10.1007/s00125-002-0981-8; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; LEITER EH, 1987, AM J PATHOL, V128, P380; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Maier B, 2010, DISCOV MED, V10, P18; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Nishiki Y, 2013, MOL ENDOCRINOL, V27, P336, DOI 10.1210/me.2012-1230; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; O'Sullivan-Murphy B, 2012, DIABETES, V61, P780, DOI 10.2337/db12-0091; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; PARK MH, 1994, J BIOL CHEM, V269, P27827; Robbins RD, 2010, J BIOL CHEM, V285, P39943, DOI 10.1074/jbc.M110.170142; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schlee M, 2004, J VIROL, V78, P3941, DOI 10.1128/JVI.78.8.3941-3952.2004; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; STRANDELL E, 1990, J CLIN INVEST, V85, P1944, DOI 10.1172/JCI114657; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494	48	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36226	36235		10.1074/jbc.M113.473942	http://dx.doi.org/10.1074/jbc.M113.473942			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196968	Green Published, hybrid			2022-12-25	WOS:000328883400005
J	Hartmann, T; Zhang, B; Baronian, G; Schulthess, B; Homerova, D; Grubmuller, S; Kutzner, E; Gaupp, R; Bertram, R; Powers, R; Eisenreich, W; Kormanec, J; Herrmann, M; Molle, V; Somerville, GA; Bischoff, M				Hartmann, Torsten; Zhang, Bo; Baronian, Gregory; Schulthess, Bettina; Homerova, Dagmar; Grubmueller, Stephanie; Kutzner, Erika; Gaupp, Rosmarie; Bertram, Ralph; Powers, Robert; Eisenreich, Wolfgang; Kormanec, Jan; Herrmann, Mathias; Molle, Virginie; Somerville, Greg A.; Bischoff, Markus			Catabolite Control Protein E (CcpE) Is a LysR-type Transcriptional Regulator of Tricarboxylic Acid Cycle Activity in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Metabolic Regulation; Staphylococcus aureus; Transcription Regulation; Tricarboxylic Acid (TCA) Cycle	GRAM-POSITIVE BACTERIA; BACILLUS-SUBTILIS; VIRULENCE GENES; REPRESSION; ACONITASE; IDENTIFICATION; GROWTH; INACTIVATION; METABOLISM; ACTIVATION	Background: The TCA cycle is a central metabolic pathway that facilitates the adaption of bacteria to a nutrient-limited environment. Results: Inactivation of CcpE in Staphylococcus aureus resulted in a decreased transcription of the aconitase encoding gene citB, and reduced TCA cycle activity. Conclusion: CcpE affects the TCA cycle via direct transcriptional control of citB.Significance: This is the first positive regulator of TCA cycle activity identified in this pathogen. The tricarboxylic acid cycle (TCA cycle) is a central metabolic pathway that provides energy, reducing potential, and biosynthetic intermediates. In Staphylococcus aureus, TCA cycle activity is controlled by several regulators (e.g. CcpA, CodY, and RpiRc) in response to the availability of sugars, amino acids, and environmental stress. Developing a bioinformatic search for additional carbon catabolite-responsive regulators in S. aureus, we identified a LysR-type regulator, catabolite control protein E (CcpE), with homology to the Bacillus subtilis CcpC regulator. Inactivation of ccpE in S. aureus strain Newman revealed that CcpE is a positive transcriptional effector of the first two enzymes of the TCA cycle, aconitase (citB) and to a lesser extent citrate synthase (citZ). Consistent with the transcriptional data, aconitase activity dramatically decreased in the ccpE mutant relative to the wild-type strain. The effect of ccpE inactivation on citB transcription and the lesser effect on citZ transcription were also reflected in electrophoretic mobility shift assays where CcpE bound to the citB promoter but not the citZ promoter. Metabolomic studies showed that inactivation of ccpE resulted in increased intracellular concentrations of acetate, citrate, lactate, and alanine, consistent with a redirection of carbon away from the TCA cycle. Taken together, our data suggest that CcpE is a major direct positive regulator of the TCA cycle gene citB.	[Hartmann, Torsten; Herrmann, Mathias; Bischoff, Markus] Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany; [Zhang, Bo; Powers, Robert] Univ Nebraska, Dept Chem, Lincoln, NE 68583 USA; [Gaupp, Rosmarie; Somerville, Greg A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68583 USA; [Baronian, Gregory; Molle, Virginie] Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, F-34090 Montpellier, France; [Schulthess, Bettina] Univ Zurich, Inst Med Microbiol, CH-8006 Zurich, Switzerland; [Homerova, Dagmar; Kormanec, Jan] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia; [Grubmueller, Stephanie; Kutzner, Erika; Eisenreich, Wolfgang] Tech Univ Munich, Dept Biochem, D-85748 Garching, Germany; [Bertram, Ralph] Univ Tubingen, Dept Microbial Genet, D-72076 Tubingen, Germany	Universitatsklinikum des Saarlandes; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Zurich; Slovak Academy of Sciences; Technical University of Munich; Eberhard Karls University of Tubingen	Bischoff, M (corresponding author), Univ Saarland Hosp, Inst Med Microbiol & Hyg, D-66421 Homburg, Germany.	markus.bischoff@uniklinikum-saarland.de	Eisenreich, Wolfgang/A-1258-2013; Schulthess, Bettina/ABA-8795-2021; Bischoff, Markus/D-2130-2014; MOLLE, Virginie/D-4050-2019; Somerville, Greg A/B-1326-2013; Powers, Robert/AAK-3431-2020; Kormanec, Jan/AAA-7446-2019; Herrmann, Mathias/B-6475-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Schulthess, Bettina/0000-0002-1562-4583; Bischoff, Markus/0000-0001-6734-2732; MOLLE, Virginie/0000-0002-6573-3411; Somerville, Greg A/0000-0002-0991-8737; Powers, Robert/0000-0001-9948-6837; Herrmann, Mathias/0000-0003-2638-2257; Kormanec, Jan/0000-0003-0377-6413; Zhang, Bo/0000-0001-8858-1425	National Institutes of Health [AI087668]; Deutsche Forschungsgemeinschaft (DFG) [BI 1350/1-1, BI 1350/1-2, BE 4038/1, BE 4038/2, EI-384/5-1, EI-384/5-2]; region Languedoc-Roussillon-Chercheur d'Avenir grant; Swiss National Science Foundation [31-117707]; Slovak Academy of Sciences [2/0028/12]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087668] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); region Languedoc-Roussillon-Chercheur d'Avenir grant(Region Occitanie); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Slovak Academy of Sciences(Slovak Academy of Sciences); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI087668 (to G. A. S. and R. P.) and Grants BI 1350/1-1 and BI 1350/1-2 from the Deutsche Forschungsgemeinschaft (DFG).; Supported by the region Languedoc-Roussillon-Chercheur d'Avenir grant.; Supported by Swiss National Science Foundation Grant 31-117707.; Supported by Grant 2/0028/12 from the Slovak Academy of Sciences.; Supported by DFG Grants BE 4038/1 and BE 4038/2.; Supported by the DFG Grants EI-384/5-1 and EI-384/5-2.	Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Baughn AD, 2002, P NATL ACAD SCI USA, V99, P4662, DOI 10.1073/pnas.052710199; Begun J, 2005, INFECT IMMUN, V73, P872, DOI 10.1128/IAI.73.2.872-877.2005; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Chaffin DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041329; Chatterjee I, 2005, J BACTERIOL, V187, P4488, DOI 10.1128/JB.187.13.4488-4496.2005; CHEUNG AL, 1994, ANAL BIOCHEM, V222, P511, DOI 10.1006/abio.1994.1528; Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deora R, 1996, J BIOL CHEM, V271, P21828, DOI 10.1074/jbc.271.36.21828; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DUTHIE ES, 1952, J GEN MICROBIOL, V7, P320, DOI 10.1099/00221287-7-3-4-320; Fiegler H, 1999, J BACTERIOL, V181, P4929, DOI 10.1128/JB.181.16.4929-4936.1999; FOUET A, 1990, J BACTERIOL, V172, P835, DOI 10.1128/jb.172.2.835-844.1990; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Halouska S, 2006, J MAGN RESON, V178, P88, DOI 10.1016/j.jmr.2005.08.016; Halouska S., 2013, J INTEGR OMICS, DOI 10.5584/jiomics.v2013i2013.139; Hu KF, 2011, J AM CHEM SOC, V133, P1662, DOI 10.1021/ja1095304; JIN SF, 1994, J BACTERIOL, V176, P4680, DOI 10.1128/JB.176.15.4680-4690.1994; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jourlin-Castelli C, 2000, J MOL BIOL, V295, P865, DOI 10.1006/jmbi.1999.3420; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Killcoyne S, 2009, METHODS MOL BIOL, V563, P219, DOI 10.1007/978-1-60761-175-2_12; Kim HJ, 2003, J BACTERIOL, V185, P1672, DOI 10.1128/JB.185.5.1672-1680.2003; Kovacs M, 2006, J BACTERIOL, V188, P5797, DOI 10.1128/JB.00336-06; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Leibig M, 2008, APPL ENVIRON MICROB, V74, P1316, DOI 10.1128/AEM.02424-07; Lorca GL, 2005, J BACTERIOL, V187, P7826, DOI 10.1128/JB.187.22.7826-7839.2005; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Nguyen BD, 2007, J MAGN RESON, V184, P263, DOI 10.1016/j.jmr.2006.10.014; RAO L, 1995, J BACTERIOL, V177, P2609, DOI 10.1128/jb.177.10.2609-2614.1995; Rossi J, 2003, ANTIMICROB AGENTS CH, V47, P2558, DOI 10.1128/AAC.47.8.2558-2564.2003; Sadykov MR, 2010, J BACTERIOL, V192, P1459, DOI 10.1128/JB.01377-09; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Seidl K, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-95; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Shivers RP, 2006, MOL MICROBIOL, V62, P811, DOI 10.1111/j.1365-2958.2006.05410.x; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Somerville G. A., 2009, STAPHYLOCOCCI HUMAN, V3-18; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; STRASTERS KC, 1963, J GEN MICROBIOL, V33, P213, DOI 10.1099/00221287-33-2-213; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Valihrach L, 2012, J MICROBIOL METH, V90, P214, DOI 10.1016/j.mimet.2012.05.008; Werth MT, 2010, ANAL BIOCHEM, V399, P58, DOI 10.1016/j.ab.2009.12.022; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011; Zhang B, 2011, J PROTEOME RES, V10, P3743, DOI 10.1021/pr200360w; Zhu YF, 2009, INFECT IMMUN, V77, P4256, DOI 10.1128/IAI.00195-09	59	28	29	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36116	36128		10.1074/jbc.M113.516302	http://dx.doi.org/10.1074/jbc.M113.516302			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24194525	hybrid, Green Published			2022-12-25	WOS:000329814700046
J	Naharudin, MN; Yusof, A				Naharudin, Mohamed Nashrudin; Yusof, Ashril			Fatigue Index and Fatigue Rate during an Anaerobic Performance under Hypohydrations	PLOS ONE			English	Article							RESISTANCE EXERCISE; MUSCULAR STRENGTH; HYDRATION STATE; MOTOR UNITS; WEIGHT-LOSS; MUSCLE; POWER; HYPERTHERMIA; DEHYDRATION	Background: Since hypohydration commonly occurs in sports, studies on anaerobic exercise performance under this condition have been extensively carried out. When describing anaerobic performance, authors usually refer to a drop in anaerobic performance as fatigue index (FI) which is conventionally calculated using peak and low power data points. Meanwhile, another possible method in explaining anaerobic fatigue is using the rate constant which is derived from the exponential decline of power output known as fatigue rate (FR). Few studies have demonstrated that there was no change in anaerobic performance under mild hypohydrations. Purpose: This study aimed to compare the kinetics of power output using FI and FR of an anaerobic performance (Wingate test) under 2, 3 and 4% state of hypohydrations. Method: Thirty two collegiate cyclists (age = 22 +/- 2 years; body weight = 71.45 +/- 3.43 kg; height = 173.23 +/- 0.04 cm) were matched using their baseline anaerobic peak power (APP) then randomly divided into 4 groups of EU (euhydrated), 2H, 3H and 4H respectively. Results: As expected the, FI, APP, anaerobic lower power (ALP) and rating of perceived exertion (RPE) did not show significant differences between and within the groups. However, the FR in 3H (0.018 +/- 0.005s(-1)) and 4H (0.019 +/- 0.010s(-1)) were significantly lower than EU (0.033 +/- 0.012s(-1)). Post-test FR also showed significant reduction in 3H and 4H compared to their pre-test values (p<0.05). Conclusion: Despite the lack of changes in APP and RPE, subjects in 3H and 4H showed evidence of lower reduction of power output over time. The findings support earlier reports which showed no change in anaerobic performance under mild hypohydrations. The relatively lower FR suggests higher drive in maintaining power output under hypohydrations of 3 and 4% body weight.	[Naharudin, Mohamed Nashrudin; Yusof, Ashril] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia	Universiti Malaya	Naharudin, MN (corresponding author), Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia.	nashrudin@um.edu.my	Naharudin, Mohamed Nashrudin/ABD-1540-2020; YUSOF, ASHRIL/B-8252-2010	Naharudin, Mohamed Nashrudin/0000-0002-1408-7966; YUSOF, ASHRIL/0000-0002-8117-6440	University of Malaya's Institute of Research Management and Monitoring research fund [RG367/11HTM]	University of Malaya's Institute of Research Management and Monitoring research fund	The work is supported by University of Malaya's Institute of Research Management and Monitoring research fund (RG367/11HTM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; Adam GM, 2002, EXERCISE PHYSL LAB M, P107; Ball D, 1999, EUR J APPL PHYSIOL, V79, P360, DOI 10.1007/s004210050521; BAROR O, 1977, ISRAEL J MED SCI, V13, P326; Carpentier A, 2001, J PHYSIOL-LONDON, V534, P903, DOI 10.1111/j.1469-7793.2001.00903.x; Cheuvront SN, 2006, MED SCI SPORT EXER, V38, P1093, DOI 10.1249/01.mss.0000222838.74015.15; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; Dotan R, 2006, EUR J APPL PHYSIOL, V98, P113, DOI 10.1007/s00421-006-0251-4; Drust B, 2005, ACTA PHYSIOL SCAND, V183, P181, DOI 10.1111/j.1365-201X.2004.01390.x; ENOKA RM, 1989, J NEUROPHYSIOL, V62, P1344, DOI 10.1152/jn.1989.62.6.1344; FOGELHOLM GM, 1993, MED SCI SPORT EXER, V25, P371, DOI 10.1249/00005768-199303000-00012; Gonzalez-Alonso J, 1999, J PHYSIOL-LONDON, V520, P577, DOI 10.1111/j.1469-7793.1999.00577.x; Greiwe JS, 1998, MED SCI SPORT EXER, V30, P284, DOI 10.1097/00005768-199802000-00017; Hedley AM, 2002, J STRENGTH COND RES, V16, P353; Houston M E, 1981, Phys Sportsmed, V9, P73, DOI 10.1080/00913847.1981.11711208; Inbar O, 1996, WINGATE ANAEROBIC TE, P1; JACOBS I, 1982, MED SCI SPORT EXER, V14, P457, DOI 10.1249/00005768-198206000-00009; Jones LC, 2008, J STRENGTH COND RES, V22, P455, DOI 10.1519/JSC.0b013e3181635ba5; Judelson DA, 2007, SPORTS MED, V37, P907, DOI 10.2165/00007256-200737100-00006; Judelson DA, 2007, MED SCI SPORT EXER, V39, P1817, DOI 10.1249/mss.0b013e3180de5f22; King RFGJ, 2008, J SPORT SCI, V26, P1361, DOI 10.1080/02640410802192768; Kraemer WJ, 2001, MED SCI SPORT EXER, V33, P1367, DOI 10.1097/00005768-200108000-00019; Kraft JA, 2011, J STRENGTH COND RES, V25, P778, DOI 10.1519/JSC.0b013e3181c1f79d; Laurent CM, 2007, EUR J APPL PHYSIOL, V100, P645, DOI 10.1007/s00421-007-0454-3; Marquardt JA., 1993, RES Q EXERCISE SPORT, V64, pA33; Montain SJ, 1998, J APPL PHYSIOL, V84, P1889, DOI 10.1152/jappl.1998.84.6.1889; Morrison S, 2004, EUR J APPL PHYSIOL, V91, P729, DOI 10.1007/s00421-004-1063-z; Nielsen B., 1981, SCAND J MED SCI SPOR, V3, P2; VIITASALO JT, 1987, INT J SPORTS MED, V8, P281, DOI 10.1055/s-2008-1025670; WEBSTER S, 1990, MED SCI SPORT EXER, V22, P229; Yamamoto LM, 2008, J STRENGTH COND RES, V22, P1387, DOI 10.1519/JSC.0b013e3181739403	31	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77290	10.1371/journal.pone.0077290	http://dx.doi.org/10.1371/journal.pone.0077290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204790	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500022
J	Arevalo, O; Bornschlegl, MA; Eberhardt, S; Ernst, U; Pawelzik, K; Fahle, M				Arevalo, Orlando; Bornschlegl, Mona A.; Eberhardt, Sven; Ernst, Udo; Pawelzik, Klaus; Fahle, Manfred			Dynamics of Dual Prism Adaptation: Relating Novel Experimental Results to a Minimalistic Neural Model	PLOS ONE			English	Article							1ST-TRIAL ADAPTATION; CALIBRATION; EXPOSURE	In everyday life, humans interact with a dynamic environment often requiring rapid adaptation of visual perception and motor control. In particular, new visuo-motor mappings must be learned while old skills have to be kept, such that after adaptation, subjects may be able to quickly change between two different modes of generating movements ('dual-adaptation'). A fundamental question is how the adaptation schedule determines the acquisition speed of new skills. Given a fixed number of movements in two different environments, will dual-adaptation be faster if switches ('phase changes') between the environments occur more frequently? We investigated the dynamics of dual-adaptation under different training schedules in a virtual pointing experiment. Surprisingly, we found that acquisition speed of dual visuo-motor mappings in a pointing task is largely independent of the number of phase changes. Next, we studied the neuronal mechanisms underlying this result and other key phenomena of dual-adaptation by relating model simulations to experimental data. We propose a simple and yet biologically plausible neural model consisting of a spatial mapping from an input layer to a pointing angle which is subjected to a global gain modulation. Adaptation is performed by reinforcement learning on the model parameters. Despite its simplicity, the model provides a unifying account for a broad range of experimental data: It quantitatively reproduced the learning rates in dual-adaptation experiments for both direct effect, i.e. adaptation to prisms, and aftereffect, i.e. behavior after removal of prisms, and their independence on the number of phase changes. Several other phenomena, e.g. initial pointing errors that are far smaller than the induced optical shift, were also captured. Moreover, the underlying mechanisms, a local adaptation of a spatial mapping and a global adaptation of a gain factor, explained asymmetric spatial transfer and generalization of prism adaptation, as observed in other experiments.	[Arevalo, Orlando; Ernst, Udo; Pawelzik, Klaus] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany; [Bornschlegl, Mona A.; Eberhardt, Sven; Fahle, Manfred] Univ Bremen, Inst Human Neurobiol, D-28359 Bremen, Germany; [Fahle, Manfred] City Univ London, Henry Wellcome Labs Vis Sci, London, England	University of Bremen; University of Bremen; City University London	Ernst, U (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	udo@neuro.uni-bremen.de			BMBF [01GQ0705]	BMBF(Federal Ministry of Education & Research (BMBF))	This work has been supported by the BMBF (Grant 01GQ0705, Bernstein Group for Computational Neuroscience Bremen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Baddeley RJ, 2003, J NEUROSCI, V23, P3066; BEDFORD FL, 1989, J EXP PSYCHOL HUMAN, V15, P232, DOI 10.1037/0096-1523.15.2.232; Bornschlegl MA, 2011, THESIS U BREMEN; Braun D, 2011, FRONTIERS COMPUTATIO, V5, p[27, 1]; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; COHEN MM, 1973, PERCEPT MOTOR SKILL, V37, P599, DOI 10.2466/pms.1973.37.2.599; Donchin O, 2004, P ANN INT IEEE EMBS, V26, P4495; Donchin O, 2003, J NEUROSCI, V23, P9032; Fernandez-Ruiz J, 2004, COGNITIVE BRAIN RES, V20, P92, DOI 10.1016/j.cogbrainres.2004.01.007; Fernandez-Ruiz J, 1999, LEARN MEMORY, V6, P47; Fiete IR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048104; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Ghahramani Z, 1997, SCIENCE, V269, P1880; Guigon E, 2002, J COGNITIVE NEUROSCI, V14, P538, DOI 10.1162/08989290260045792; HARRIS CS, 1965, PSYCHOL REV, V72, P419, DOI 10.1037/h0022616; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; JANSEN JKS, 1962, ACTA PHYSIOL SCAND, V55, P376, DOI 10.1111/j.1748-1716.1962.tb02451.x; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; Martin TA, 1996, BRAIN, V119, P1199, DOI 10.1093/brain/119.4.1199; Mattar AAG, 2007, J NEUROPHYSIOL, V98, P3321, DOI 10.1152/jn.00576.2007; Michel C, 2008, EXP BRAIN RES, V185, P259, DOI 10.1007/s00221-007-1152-4; Redding GM, 2004, J MOTOR BEHAV, V36, P291, DOI 10.3200/JMBR.36.3.291-304; Redding GM, 2005, NEUROSCI BIOBEHAV R, V29, P431, DOI 10.1016/j.neubiorev.2004.12.004; Redding GM, 2003, J MOTOR BEHAV, V35, P399, DOI 10.1080/00222890309603159; Redding GM, 2003, J MOTOR BEHAV, V35, P229, DOI 10.1080/00222890309602137; Redding GM, 2002, J MOTOR BEHAV, V34, P126, DOI 10.1080/00222890209601935; Redding GM, 2006, J EXP PSYCHOL HUMAN, V32, P1006, DOI 10.1037/0096-1523.32.4.1006; ROCK I, 1966, PERCEPT PSYCHOPHYS, V1, P351, DOI 10.3758/BF03215803; ROSSETTI Y, 1993, PERCEPT PSYCHOPHYS, V54, P355, DOI 10.3758/BF03205270; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Southall J. P. C., 1866, HELMHOLTZS TREATISE, VIII; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Welch R. B., 1978, PERCEPTUAL MODIFICAT; WELCH RB, 1993, PERCEPT PSYCHOPHYS, V54, P195, DOI 10.3758/BF03211756; Werfel J, 2005, NEURAL COMPUT, V17, P2699, DOI 10.1162/089976605774320539; Wischhusen S, 2008, THESIS U BREMEN; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005	43	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76601	10.1371/journal.pone.0076601	http://dx.doi.org/10.1371/journal.pone.0076601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204643	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700007
J	Leardini, A; Berti, L; Begon, M; Allard, P				Leardini, Alberto; Berti, Lisa; Begon, Mickael; Allard, Paul			Effect of Trunk Sagittal Attitude on Shoulder, Thorax and Pelvis Three-Dimensional Kinematics in Able-Bodied Subjects during Gait	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; LUMBAR SPINE; WALKING; MOVEMENTS; CLASSIFICATION; DEFORMITY; STANCE; SWAY; MEN	It has been shown that an original attitude in forward or backward inclination of the trunk is maintained at gait initiation and during locomotion, and that this affects lower limb loading patterns. However, no studies have shown the extent to which shoulder, thorax and pelvis three-dimensional kinematics are modified during gait due to this sagittal inclination attitude. Thirty young healthy volunteers were analyzed during level walking with video-based motion analysis. Reflecting markers were mounted on anatomical landmarks to form a two-marker shoulder line segment, and a four-marker thorax and pelvis segments. Absolute and relative spatial rotations were calculated, for a total of 11 degrees of freedom. The subjects were divided into two groups of 15 according to the median of mean thorax inclination angle over the gait cycle. Preliminary MANOVA analysis assessed whether gender was an independent variable. Then two-factor nested ANOVA was used to test the possible effect of thorax inclination on body segments, planes of motion and gait periods, separately. There was no significant difference in all anthropometric and spatio-temporal parameters between the two groups, except for subject mass. The three-dimensional kinematics of the thorax and pelvis were not affected by gender. Nested ANOVA revealed group effect in all segment rotations apart those at the pelvis, in the sagittal and frontal planes, and at the push-off. Attitudes in sagittal thorax inclination altered trunk segments kinematics during gait. Subjects with a backward thorax showed less thorax-to-pelvis motion, but more shoulder-to-thorax and thorax-to-laboratory motion, less motion in flexion/extension and in lateral bending, and also less motion during push-off. This contributes to the understanding of forward propulsion and sideways load transfer mechanisms, fundamental for the maintenance of balance and the risk of falling.	[Leardini, Alberto; Berti, Lisa] Ist Ortoped Rizzoli, MovementAnal Lab, Bologna, Italy; [Begon, Mickael] Univ Montreal, Dept Kinesiol, Lab Ingn Mouvement, Montreal, PQ, Canada; [Allard, Paul] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Allard, Paul] St Justine Hosp, Res Ctr, Human Movement Lab, Montreal, PQ, Canada	IRCCS Istituto Ortopedico Rizzoli; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine	Leardini, A (corresponding author), Ist Ortoped Rizzoli, MovementAnal Lab, Bologna, Italy.	leardini@ior.it	Allard, Paul/ABA-3257-2021; Leardini, Alberto/C-8189-2019; BEGON, Mickael/M-9574-2013; Begon, Mickaël/AAH-9887-2019	Leardini, Alberto/0000-0003-3547-7370; BEGON, Mickael/0000-0002-4107-9160; Begon, Mickaël/0000-0002-4107-9160; BERTI, LISA/0000-0002-0840-6617	NSERC; Regione Emilia-Romagna	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regione Emilia-Romagna(Regione Emilia Romagna)	NSERC and Regione Emilia-Romagna for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2005, GAIT POSTURE, V22, P240, DOI 10.1016/j.gaitpost.2004.09.009; Bruyneel AV, 2008, NEUROSCI LETT, V447, P158, DOI 10.1016/j.neulet.2008.10.007; CHRISTIE HJ, 1995, ARCH PHYS MED REHAB, V76, P218, DOI 10.1016/S0003-9993(95)80604-0; Chung CY, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-9; Crosbie J, 1997, GAIT POSTURE, V5, P6, DOI 10.1016/S0966-6362(96)01066-1; Dalleau G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036755; ENG JJ, 1995, J BIOMECH, V28, P753, DOI 10.1016/0021-9290(94)00124-M; Engsberg JR, 2001, SPINE, V26, P2020, DOI 10.1097/00007632-200109150-00016; Evcik D, 2003, RHEUMATOL INT, V23, P163, DOI 10.1007/s00296-002-0268-x; Goh JH, 1998, CLIN BIOMECH, V13, pS26, DOI 10.1016/S0268-0033(97)00071-5; Grood E, 1983, J BIOMECHANICAL ENG, V105, P2; Heyrman L, 2013, GAIT POSTURE; Hurt CP, 2010, GAIT POSTURE, V31, P461, DOI 10.1016/j.gaitpost.2010.02.001; Leardini A, 2011, CLIN BIOMECH, V26, P562, DOI 10.1016/j.clinbiomech.2011.01.015; Leardini A, 2009, CLIN BIOMECH, V24, P542, DOI 10.1016/j.clinbiomech.2009.05.005; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Leteneur S, 2009, CLIN BIOMECH, V24, P190, DOI 10.1016/j.clinbiomech.2008.10.005; Leteneur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055256; Linley HS, 2010, CLIN BIOMECH, V25, P1003, DOI 10.1016/j.clinbiomech.2010.07.012; Mansfield A, 2010, PHYS THER, V90, P476, DOI 10.2522/ptj.20090070; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; Mundermann A, 2008, J BIOMECH, V41, P165, DOI 10.1016/j.jbiomech.2007.07.001; Saha D, 2008, GAIT POSTURE, V27, P653, DOI 10.1016/j.gaitpost.2007.08.009; Stylianides GA, 2012, EUR SPINE J, V21, P725, DOI 10.1007/s00586-011-2070-5; Takahashi T, 2005, OSTEOPOROSIS INT, V16, P273, DOI 10.1007/s00198-004-1669-3; Taylor NF, 1999, GAIT POSTURE, V9, P88, DOI 10.1016/S0966-6362(99)00004-1; THORSTENSSON A, 1984, ACTA PHYSIOL SCAND, V121, P9, DOI 10.1111/j.1748-1716.1984.tb10452.x; Vardaxis VG, 1998, HUM MOVEMENT SCI, V17, P121, DOI 10.1016/S0167-9457(97)00024-9; Vogt L, 2002, CLIN BIOMECH, V17, P162, DOI 10.1016/S0268-0033(01)00111-5; Watelain E, 2000, ARCH PHYS MED REHAB, V81, P579, DOI 10.1053/mr.2000.4415; Whittle MW, 1999, HUM MOVEMENT SCI, V18, P681, DOI 10.1016/S0167-9457(99)00032-9; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7	33	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77168	10.1371/journal.pone.0077168	http://dx.doi.org/10.1371/journal.pone.0077168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204763	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700021
J	Nunes, MP; Fortes, B; Silva, JL; Terra-Granado, E; Santos, L; Conde, L; Oliveira, ID; Freire-de-Lima, L; Martins, MV; Pinheiro, AAS; Takyia, CM; Freire-de-Lima, CG; Todeschini, AR; DosReis, GA; Morrot, A				Nunes, Marise Pinheiro; Fortes, Barbara; Silva-Filho, Joao Luiz; Terra-Granado, Eugenia; Santos, Leonardo; Conde, Luciana; Oliveira, Isadora de Araujo; Freire-de-Lima, Leonardo; Martins, Marina Vieira; Sa Pinheiro, Ana Acacia; Takyia, Christina Maeda; Freire-de-Lima, Celio Geraldo; Todeschini, Adriane Regina; DosReis, George Alexandre; Morrot, Alexandre			Inhibitory Effects of Trypanosoma cruzi Sialoglycoproteins on CD4(+) T Cells Are Associated with Increased Susceptibility to Infection	PLOS ONE			English	Article							MEMBRANE GLYCOPROTEIN AGC10; TRANS-SIALIDASE; CHAGAS-DISEASE; INDUCED IMMUNOSUPPRESSION; DENDRITIC CELLS; MSIGLEC-E; ACTIVATION; IL-2; TRANSCRIPTION; PERSISTENCE	Background: The Trypanosoma cruzi infection is associated with severe T cell unresponsiveness to antigens and mitogens characterized by decreased IL-2 synthesis. Trypanosoma cruzi mucin (Tc Muc) has been implicated in this phenomenom. These molecules contain a unique type of glycosylation consisting of several sialylated O-glycans linked to the protein backbone via N-acetylglucosamine residues. Methodology/Principal Findings: In this study, we evaluated the ability of Tc Muc to modulate the activation of CD4(+) T cells. Our data show that cross-linking of CD3 on naive CD4(+) T cells in the presence of Tc Muc resulted in the inhibition of both cytokine secretion and proliferation. We further show that the sialylated O-Linked Glycan residues from tc mucin potentiate the suppression of T cell response by inducing G1-phase cell cycle arrest associated with upregulation of mitogen inhibitor p27(kip1). These inhibitory effects cannot be reversed by the addition of exogenous IL-2, rendering CD4(+) T cells anergic when activated by TCR triggering. Additionally, in vivo administration of Tc Muc during T. cruzi infection enhanced parasitemia and aggravated heart damage. Analysis of recall responses during infection showed lower frequencies of IFN-gamma producing CD4(+) T cells in the spleen of Tc Muc treated mice, compared to untreated controls. Conclusions/Significance: Our results indicate that Tc Muc mediates inhibitory efects on CD4(+) T expansion and cytokine production, by blocking cell cycle progression in the G1 phase. We propose that the sialyl motif of Tc Muc is able to interact with sialic acid-binding Ig-like lectins (Siglecs) on CD4(+) T cells, which may allow the parasite to modulate the immune system.	[Nunes, Marise Pinheiro; Santos, Leonardo; Conde, Luciana; Martins, Marina Vieira] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil; [Fortes, Barbara; Morrot, Alexandre] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil; [Silva-Filho, Joao Luiz; Oliveira, Isadora de Araujo; Freire-de-Lima, Leonardo; Sa Pinheiro, Ana Acacia; Takyia, Christina Maeda; Freire-de-Lima, Celio Geraldo; Todeschini, Adriane Regina; DosReis, George Alexandre] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Rio De Janeiro, Brazil; [Terra-Granado, Eugenia] Natl Canc Inst, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Nunes, MP (corresponding author), Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.	mnunes@ioc.fiocruz.br; morrot@micro.ufrj.br	de Lima, Celio Geraldo Freire/A-9057-2012; Todeschini, Adriane Regina/ABC-9165-2020; Todeschini, Adriane/AAG-8128-2020; Silva-Filho, João Luiz/I-5704-2016; Freire-de-Lima, Leonardo/I-1894-2012	Todeschini, Adriane Regina/0000-0002-6049-2751; Silva-Filho, João Luiz/0000-0003-4762-2205; Freire-de-Lima, Leonardo/0000-0003-3013-3173; Oliveira, Isadora/0000-0003-0269-1450; DosReis, George/0000-0002-8924-4727; Pinheiro, Ana Acacia/0000-0002-3894-1645; Terra-Granado, Eugenia/0000-0002-3616-140X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTv/CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Oswaldo Cruz	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTv/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil (CNPq), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTv/CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN IA, 1995, J IMMUNOL, V155, P3955; Alcaide P, 2004, INT IMMUNOL, V16, P1365, DOI 10.1093/intimm/dxh138; Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Anandkumar A, 2013, SCAND J IMMUNOL; Barry MA, 2013, PEDIATR CLIN N AM, V60, P471, DOI 10.1016/j.pcl.2012.12.011; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Camargo MM, 1997, J IMMUNOL, V159, P6131; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Charvet C, 2006, J IMMUNOL, V177, P5024, DOI 10.4049/jimmunol.177.8.5024; CHUENKOVA M, 1995, J EXP MED, V181, P1693, DOI 10.1084/jem.181.5.1693; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; DINOIA JM, 1995, J BIOL CHEM, V270, P24146, DOI 10.1074/jbc.270.41.24146; DosReis GA, 2005, TRENDS PARASITOL, V21, P237, DOI 10.1016/j.pt.2005.03.008; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Fernandes MC, 2012, FEMS MICROBIOL REV, V36, P734, DOI 10.1111/j.1574-6976.2012.00333.x; Fiuza JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000512; Freire T, 2011, J BIOL CHEM, V286, P7797, DOI 10.1074/jbc.M110.209742; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GAZZINELLI RT, 1991, PARASITE IMMUNOL, V13, P345, DOI 10.1111/j.1365-3024.1991.tb00288.x; Giorgi ME, 2011, CARBOHYD RES, V346, P1389, DOI 10.1016/j.carres.2011.04.006; Gutierrez FRS, 2009, PARASITE IMMUNOL, V31, P673, DOI 10.1111/j.1365-3024.2009.01108.x; Jacobs T, 2010, EUR J CELL BIOL, V89, P113, DOI 10.1016/j.ejcb.2009.10.006; Jatzek A, 2012, J IMMUNOL, V189, P5119, DOI 10.4049/jimmunol.1201482; JOINER K, 1986, P NATL ACAD SCI USA, V83, P6593, DOI 10.1073/pnas.83.17.6593; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Kierszenbaum F, 1999, EUR J IMMUNOL, V29, P1684, DOI 10.1002/(SICI)1521-4141(199905)29:05&lt;1684::AID-IMMU1684&gt;3.0.CO;2-7; Kierszenbaum F, 2002, MOL BIOCHEM PARASIT, V125, P91, DOI 10.1016/S0166-6851(02)00217-7; Kipnis TL, 1991, P NATL ACAD SCI USA, V78, P602; LIEW FY, 1987, J IMMUNOL, V139, P2452; Lopes MF, 1996, INFECT IMMUN, V64, P1559, DOI 10.1128/IAI.64.5.1559-1564.1996; Majumder S, 1996, J IMMUNOL, V156, P3866; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; Mendonca-Previato L, 2013, GLYCOCONJ J; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; Muia RP, 2010, GLYCOBIOLOGY, V20, P833, DOI 10.1093/glycob/cwq037; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nardy AFFR, 2013, MICROBES INFECT, V15, P365, DOI 10.1016/j.micinf.2013.02.003; Ohta M, 2010, BIOCHEM BIOPH RES CO, V402, P663, DOI 10.1016/j.bbrc.2010.10.079; Padilla AM, 2009, J IMMUNOL, V183, P1245, DOI 10.4049/jimmunol.0901178; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Pillai S, 2012, ANNU REV IMMUNOL, V30, P357, DOI 10.1146/annurev-immunol-020711-075018; Pinazo MJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001965; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; PREVIATO JO, 1995, J BIOL CHEM, V270, P7241, DOI 10.1074/jbc.270.13.7241; Ribeiro AL, 2012, NAT REV CARDIOL, V9, P576, DOI 10.1038/nrcardio.2012.109; Rosenberg CS, 2010, J IMMUNOL, V185, P560, DOI 10.4049/jimmunol.1000432; Sawai CM, 2012, CANCER CELL, V22, P452, DOI 10.1016/j.ccr.2012.09.016; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; SOONG L, 1992, J IMMUNOL, V149, P2095; Soto CDA, 2003, INFECT IMMUN, V71, P1194, DOI 10.1128/IAI.71.3.1194-1199.2003; Talvani A, 2009, PARASITOL RES, V104, P1141, DOI 10.1007/s00436-008-1300-1; Tarleton RL, 2003, TRENDS PARASITOL, V19, P447, DOI 10.1016/j.pt.2003.08.008; Tarleton RL, 1999, PARASITOL TODAY, V15, P94, DOI 10.1016/S0169-4758(99)01398-8; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Tinder TL, 2008, J IMMUNOL, V181, P3116, DOI 10.4049/jimmunol.181.5.3116; Van Overtvelt L, 2002, INT IMMUNOL, V14, P1135, DOI 10.1093/intimm/dxf077; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Yu ZB, 2001, BIOCHEM J, V353, P483, DOI 10.1042/0264-6021:3530483; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	65	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77568	10.1371/journal.pone.0077568	http://dx.doi.org/10.1371/journal.pone.0077568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204874	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326241200032
J	Tian, QY; Wang, XQ; Li, CF; Lu, WX; Yang, L; Jiang, YZ; Luo, KM				Tian, Qiaoyan; Wang, Xianqiang; Li, Chaofeng; Lu, Wanxiang; Yang, Li; Jiang, Yuanzhong; Luo, Keming			Functional Characterization of the Poplar R2R3-MYB Transcription Factor PtoMYB216 Involved in the Regulation of Lignin Biosynthesis during Wood Formation	PLOS ONE			English	Article							ACID O-METHYLTRANSFERASE; CELL-WALL BIOSYNTHESIS; PHENYLPROPANOID METABOLISM; GENE-EXPRESSION; DIRECT TARGET; LIGNIFICATION; MYB; DEPOSITION; PATHWAY; LOCALIZATION	Because of the importance of wood in many industrial applications, tremendous studies have been performed on wood formation, especially in lignin biosynthesis. MYB transcription factors (TFs), which consist of a large family of plant TFs, have been reported to directly regulate lignin biosynthetic genes in a number of plants. In this study, we describe the cloning and functional characterization of PtoMYB216, a cDNA isolated from Chinese white poplar (Populus tomentosa Carr.). PtoMYB216 encodes a protein belonging to the R2R3-MYB family and displays significant similarity with other MYB factors shown to regulate lignin synthesis in Arabidopsis. Gene expression profiling studies showed that PtoMYB216 mRNA is specifically expressed during secondary wall formation in wood. The 1.8-kb promoter sequence of PtoMYB216 was fused to the GUS coding sequence and introduced into wild-type A. thaliana. GUS expression was shown to be restricted to tissues undergoing secondary cell wall formation. Overexpression of PtoMYB216 specifically activated the expression of the upstream genes in the lignin biosynthetic pathway and resulted in ectopic deposition of lignin in cells that are normally unligninified. These results suggest that PtoMYB216 is specific transcriptional activators of lignin biosynthesis and involved in the regulation of wood formation in poplar.	[Tian, Qiaoyan; Wang, Xianqiang; Li, Chaofeng; Lu, Wanxiang; Yang, Li; Jiang, Yuanzhong; Luo, Keming] Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot,Sch Life Sci, Chongqing, Peoples R China; [Lu, Wanxiang] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Luo, Keming] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China	Southwest University - China; Southwest University - China; Chinese Academy of Sciences	Luo, KM (corresponding author), Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot,Sch Life Sci, Chongqing, Peoples R China.	kemingl@swu.edu.cn		Li, Chaofeng/0000-0002-0237-0350	National Natural Science Foundation of China [31171620]; program for New Century Excellent Talents in University [NCET-11-0700]; National Key Project for Research on Transgenic Plant [2011ZX08010-003]; Research Fund for the Dectoral Program of Higher Education [20110182110004]; 100 Talents Program of Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Key Project for Research on Transgenic Plant; Research Fund for the Dectoral Program of Higher Education; 100 Talents Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (31171620), the program for New Century Excellent Talents in University (NCET-11-0700), the National Key Project for Research on Transgenic Plant (2011ZX08010-003), The Research Fund for the Dectoral Program of Higher Education (20110182110004) and 100 Talents Program of Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum S, 2008, COLD SPRING HARB PRO, V10, P1101; Bedon F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-17; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bucciarelli B, 1998, CAN J BOT, V76, P1282, DOI 10.1139/cjb-76-7-1282; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dence C.W., 1992, METHODS LIGNIN CHEM, P33, DOI [DOI 10.1007/978-3-642-74065-7_3, 10.1007/978-3-642-74065-7_3]; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Goicoechea M, 2005, PLANT J, V43, P553, DOI 10.1111/j.1365-313X.2005.02480.x; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Hawkins S, 2003, PLANT SCI, V164, P165, DOI 10.1016/S0168-9452(02)00361-8; Kao YY, 2002, PLANT PHYSIOL, V130, P796, DOI 10.1104/pp.006262; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Li XX, 2010, BIOTECHNOL LETT, V32, P1333, DOI [10.1007/s10529-010-0297-6, 10.1007/s10529-010-0281-1]; Liang YK, 2005, CURR BIOL, V15, P1201, DOI 10.1016/j.cub.2005.06.041; Lloyd GB, 1980, COMB P INT PLANT PRO, V30, P421; McCarthy RL, 2010, PLANT CELL PHYSIOL, V51, P1084, DOI 10.1093/pcp/pcq064; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Meyer K, 1998, P NATL ACAD SCI USA, V95, P6619, DOI 10.1073/pnas.95.12.6619; Newman LJ, 2004, PLANT J, V37, P239, DOI 10.1046/j.1365-313X.2003.01953.x; Patzlaff A, 2003, PLANT J, V36, P743, DOI 10.1046/j.1365-313X.2003.01916.x; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Raes J, 2003, PLANT PHYSIOL, V133, P1051, DOI 10.1104/pp.103.026484; Rahantamalala A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-130; Ro DK, 2001, PLANT PHYSIOL, V126, P317, DOI 10.1104/pp.126.1.317; Rogers LA, 2004, NEW PHYTOL, V164, P17, DOI 10.1111/j.1469-8137.2004.01143.x; Romano JM, 2012, NEW PHYTOL, V195, P774, DOI 10.1111/j.1469-8137.2012.04201.x; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Wang HZ, 2010, P NATL ACAD SCI USA, V107, P22338, DOI 10.1073/pnas.1016436107; Wang Yuan, 2007, Plant Protection, V33, P50; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Zaragoza MV, 2004, GENE, V330, P9, DOI 10.1016/j.gene.2004.01.017; Zhao Q, 2011, TRENDS PLANT SCI, V16, P227, DOI 10.1016/j.tplants.2010.12.005; Zhong RQ, 2005, PLANT CELL, V17, P3390, DOI 10.1105/tpc.105.035501; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhou JL, 2009, PLANT CELL, V21, P248, DOI 10.1105/tpc.108.063321	52	62	69	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76369	10.1371/journal.pone.0076369	http://dx.doi.org/10.1371/journal.pone.0076369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204619	Green Submitted, gold, Green Published			2022-12-25	WOS:000326241200011
J	Kang, CS; Ban, M; Choi, EJ; Moon, HG; Jeon, JS; Kim, DK; Park, SK; Jeon, SG; Roh, TY; Myung, SJ; Gho, YS; Kim, JG; Kim, YK				Kang, Chil-sung; Ban, Mingi; Choi, Eun-Jeong; Moon, Hyung-Geun; Jeon, Jun-Sung; Kim, Dae-Kyum; Park, Soo-Kyung; Jeon, Seong Gyu; Roh, Tae-Young; Myung, Seung-Jae; Gho, Yong Song; Kim, Jae Gyu; Kim, Yoon-Keun			Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; OUTER-MEMBRANE VESICLES; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; BACTERIA; MICE; TM7; PREVALENCE; MICROFLORA; RESPONSES	Gut microbiota play an important part in the pathogenesis of mucosal inflammation, such as inflammatory bowel disease (IBD). However, owing to the complexity of the gut microbiota, our understanding of the roles of commensal and pathogenic bacteria in the maintenance of immune homeostasis in the gut is evolving only slowly. Here, we evaluated the role of gut microbiota and their secreting extracellular vesicles (EV) in the development of mucosal inflammation in the gut. Experimental IBD model was established by oral application of dextran sulfate sodium (DSS) to C57BL/6 mice. The composition of gut microbiota and bacteria-derived EV in stools was evaluated by metagenome sequencing using bacterial common primer of 16S rDNA. Metagenomics in the IBD mouse model showed that the change in stool EV composition was more drastic, compared to the change of bacterial composition. Oral DSS application decreased the composition of EV from Akkermansia muciniphila and Bacteroides acidifaciens in stools, whereas increased EV from TM7 phylum, especially from species DQ777900_s and AJ400239_s. In vitro pretreatment of A. muciniphila-derived EV ameliorated the production of a pro-inflammatory cytokine IL-6 from colon epithelial cells induced by Escherichia coli EV. Additionally, oral application of A. muciniphila EV also protected DSS-induced IBD phenotypes, such as body weight loss, colon length, and inflammatory cell infiltration of colon wall. Our data provides insight into the role of gut microbiota-derived EV in regulation of intestinal immunity and homeostasis, and A. muciniphila-derived EV have protective effects in the development of DSS-induced colitis.	[Kang, Chil-sung; Ban, Mingi; Choi, Eun-Jeong; Moon, Hyung-Geun; Jeon, Jun-Sung; Kim, Dae-Kyum; Jeon, Seong Gyu; Roh, Tae-Young; Gho, Yong Song; Kim, Yoon-Keun] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea; [Park, Soo-Kyung; Myung, Seung-Jae] Univ Ulsan, Coll Med, Dept Gastroenterol, Asan Med Ctr, Seoul, South Korea; [Kim, Jae Gyu] Chung Ang Univ, Coll Med, Dept Med, Seoul 156756, South Korea	Pohang University of Science & Technology (POSTECH); University of Ulsan; Chung Ang University; Chung Ang University Hospital	Gho, YS (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, South Korea.	ysgho@postech.ac.kr; jgkimd@cau.ac.kr; juinea@postech.ac.kr		Roh, Tae-Young/0000-0001-5833-0844; Jeon, Jinseong/0000-0003-1829-7319; Kim, Dae-Kyum/0000-0003-4568-8278; Myung, Seung-Jae/0000-0003-0585-4016	National Research Foundation of Korea [2011-0000879, 2012-0005634]; KRIBB Research Initiative Program	National Research Foundation of Korea(National Research Foundation of Korea); KRIBB Research Initiative Program	This study was supported by grants from the National Research Foundation of Korea Grant funded by the Korean Government (No. 2011-0000879 and No. 2012-0005634) and by a grant from KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elmi A, 2012, INFECT IMMUN, V80, P4089, DOI 10.1128/IAI.00161-12; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Greenhill Claire, 2010, Nat Rev Gastroenterol Hepatol, V7, P590, DOI 10.1038/nrgastro.2010.160; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kim MR, 2012, ALLERGY, V67, P1271, DOI 10.1111/all.12001; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Mangin I, 2004, FEMS MICROBIOL ECOL, V50, P25, DOI 10.1016/j.femsec.2004.05.005; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Nam YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022109; Neish AS, 2002, MICROBES INFECT, V4, P309, DOI 10.1016/S1286-4579(02)01543-5; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Samanta AK, 2012, J MICROBIOL, V50, P218, DOI 10.1007/s12275-012-1362-8; Sanders ME, 2011, J CLIN GASTROENTEROL, V45, pS115, DOI 10.1097/MCG.0b013e318227414a; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	36	299	312	20	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76520	10.1371/journal.pone.0076520	http://dx.doi.org/10.1371/journal.pone.0076520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204633	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300006
J	Aho, V; Ollila, HM; Rantanen, V; Kronholm, E; Surakka, I; van Leeuwen, WMA; Lehto, M; Matikainen, S; Ripatti, S; Harma, M; Sallinen, M; Salomaa, V; Jauhiainen, M; Alenius, H; Paunio, T; Porkka-Heiskanen, T				Aho, Vilma; Ollila, Hanna M.; Rantanen, Ville; Kronholm, Erkki; Surakka, Ida; van Leeuwen, Wessel M. A.; Lehto, Maili; Matikainen, Sampsa; Ripatti, Samuli; Harma, Mikko; Sallinen, Mikael; Salomaa, Veikko; Jauhiainen, Matti; Alenius, Harri; Paunio, Tiina; Porkka-Heiskanen, Tarja			Partial Sleep Restriction Activates Immune Response-Related Gene Expression Pathways: Experimental and Epidemiological Studies in Humans	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NF-KAPPA-B; TOLL-LIKE RECEPTORS; ENDOPLASMIC-RETICULUM; INSUFFICIENT SLEEP; NATURAL-KILLER; METABOLIC CONSEQUENCES; CARDIOMETABOLIC RISK; MACROPHAGE APOPTOSIS; TRANSCRIPTION FACTOR	Epidemiological studies have shown that short or insufficient sleep is associated with increased risk for metabolic diseases and mortality. To elucidate mechanisms behind this connection, we aimed to identify genes and pathways affected by experimentally induced, partial sleep restriction and to verify their connection to insufficient sleep at population level. The experimental design simulated sleep restriction during a working week: sleep of healthy men (N = 9) was restricted to 4 h/night for five nights. The control subjects (N = 4) spent 8 h/night in bed. Leukocyte RNA expression was analyzed at baseline, after sleep restriction, and after recovery using whole genome microarrays complemented with pathway and transcription factor analysis. Expression levels of the ten most up-regulated and ten most down-regulated transcripts were correlated with subjective assessment of insufficient sleep in a population cohort (N = 472). Experimental sleep restriction altered the expression of 117 genes. Eight of the 25 most up-regulated transcripts were related to immune function. Accordingly, fifteen of the 25 most up-regulated Gene Ontology pathways were also related to immune function, including those for B cell activation, interleukin 8 production, and NF-kappa B signaling (P<0.005). Of the ten most up-regulated genes, expression of STX16 correlated negatively with self-reported insufficient sleep in a population sample, while three other genes showed tendency for positive correlation. Of the ten most down-regulated genes, TBX21 and LGR6 correlated negatively and TGFBR3 positively with insufficient sleep. Partial sleep restriction affects the regulation of signaling pathways related to the immune system. Some of these changes appear to be long-lasting and may at least partly explain how prolonged sleep restriction can contribute to inflammation-associated pathological states, such as cardiometabolic diseases.	[Aho, Vilma; Ollila, Hanna M.; van Leeuwen, Wessel M. A.; Porkka-Heiskanen, Tarja] Univ Helsinki, Dept Physiol, Inst Biomed, Helsinki, Finland; [Ollila, Hanna M.; Surakka, Ida; Ripatti, Samuli; Jauhiainen, Matti; Paunio, Tiina] Natl Inst Hlth & Welf, Dept Mol Med, Helsinki, Finland; [Ollila, Hanna M.; Surakka, Ida; Ripatti, Samuli; Jauhiainen, Matti; Paunio, Tiina] Finnish Inst Mol Med, Helsinki, Finland; [Ollila, Hanna M.; Paunio, Tiina] HUCH, Dept Psychiat, Helsinki, Finland; [Rantanen, Ville] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Rantanen, Ville] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Kronholm, Erkki; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [van Leeuwen, Wessel M. A.; Harma, Mikko; Sallinen, Mikael] Finnish Inst Occupat Hlth, Ctr Expertise Human Factors Work, Helsinki, Finland; [van Leeuwen, Wessel M. A.] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Lehto, Maili; Matikainen, Sampsa; Alenius, Harri] Finnish Inst Occupat Hlth, Unit Syst Toxicol, Ctr Expertise Hlth & Work Abil, Helsinki, Finland; [Ripatti, Samuli] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Sallinen, Mikael] Univ Jyvaskyla, Agora Ctr, Jyvaskyla, Finland	University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finnish Institute of Occupational Health; Stockholm University; Finnish Institute of Occupational Health; Karolinska Institutet; Wellcome Trust Sanger Institute; University of Jyvaskyla	Porkka-Heiskanen, T (corresponding author), Univ Helsinki, Dept Physiol, Inst Biomed, Helsinki, Finland.	tarja.stenberg@helsinki.fi	van Leeuwen, Wessel M.A./A-5812-2019; Ripatti, Samuli/H-9446-2014; Ollila, Hanna M/I-8552-2017; Matikainen, Sampsa/AAH-8654-2021; Ollila, Hanna M/GQA-6308-2022	van Leeuwen, Wessel M.A./0000-0003-0834-0811; Ripatti, Samuli/0000-0002-0504-1202; Ollila, Hanna M/0000-0002-5302-6429; Ollila, Hanna M/0000-0002-5302-6429; Rantanen, Ville/0000-0002-0105-7071; Stenberg, Tarja/0000-0003-1843-7625; Lammi, Vilma/0000-0002-3256-5239; Sallinen, Mikael/0000-0001-6507-3807; Alenius, Harri/0000-0003-0106-8923; Surakka, Ida/0000-0002-6669-5541	EU [LSHM-CT-2005-518189, QLK6-CT-2000-00499]; Finska Lakaresallskapet; Finnish Work Environment Fund; Instrumentarium Foundation; Jalmari and Rauha Ahokas Foundation; Biomedicum Helsinki Foundation; Emil Aaltonen Foundation; Finnish foundation for Cardiovascular research; Paavo Nurmi Foundation; Finnish Brain Foundation; GPBM graduate school; Marie Curie ESRS project [046036]; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Sigrid Juselius Foundation; Academy of Finland [251217, 129494, 139635, 137575]	EU(European Commission); Finska Lakaresallskapet; Finnish Work Environment Fund; Instrumentarium Foundation; Jalmari and Rauha Ahokas Foundation; Biomedicum Helsinki Foundation; Emil Aaltonen Foundation; Finnish foundation for Cardiovascular research; Paavo Nurmi Foundation; Finnish Brain Foundation; GPBM graduate school; Marie Curie ESRS project; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	The authors gratefully acknowledge support for this work from the EU (LSHM-CT-2005-518189 and QLK6-CT-2000-00499), Finska Lakaresallskapet, and the Finnish Work Environment Fund (to VA), the Instrumentarium Foundation, the Jalmari and Rauha Ahokas Foundation, the Biomedicum Helsinki Foundation, the Emil Aaltonen Foundation, Finnish foundation for Cardiovascular research, the Paavo Nurmi Foundation, the Finnish Brain Foundation, and the GPBM graduate school (to HMO), the Marie Curie ESRS project (046036) (to WvL), the Academy of Finland Center of Excellence in Complex Disease Genetics (213506 and 129680) (to SR), the Sigrid Juselius Foundation (to SR and TP), and the Academy of Finland (251217 to SR, 129494 and 139635 to VS, and 137575 to TPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Basheer R, 2001, NEUROSCIENCE, V104, P731, DOI 10.1016/S0306-4522(01)00111-7; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Chae M, 2008, BIOCHEM BIOPH RES CO, V370, P519, DOI 10.1016/j.bbrc.2008.03.136; Cuesta N, 2007, J IMMUNOL, V178, P3602, DOI 10.4049/jimmunol.178.6.3602; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; EVERSON CA, 1993, AM J PHYSIOL, V265, pR1148, DOI 10.1152/ajpregu.1993.265.5.R1148; Everson CA, 2005, AM J PHYSIOL-REG I, V289, pR1054, DOI 10.1152/ajpregu.00021.2005; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Gottlieb DJ, 2005, ARCH INTERN MED, V165, P863, DOI 10.1001/archinte.165.8.863; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hui L, 2007, BRAIN BEHAV IMMUN, V21, P308, DOI 10.1016/j.bbi.2006.09.005; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; Irwin MR, 2008, BIOL PSYCHIAT, V64, P538, DOI 10.1016/j.biopsych.2008.05.004; Irwin MR, 2006, ARCH INTERN MED, V166, P1756, DOI 10.1001/archinte.166.16.1756; Jialal I, 2012, DIABETES CARE, V35, P900, DOI 10.2337/dc11-2375; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kronholm E, 2011, SLEEP MED, V12, P215, DOI 10.1016/j.sleep.2010.07.021; Li N, 2010, J IMMUNOL, V185, P3041, DOI 10.4049/jimmunol.1000993; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lim WS, 2008, CIRCULATION, V117, P940, DOI 10.1161/CIRCULATIONAHA.107.711275; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liukkonen T, 2007, PSYCHOSOM MED, V69, P756, DOI 10.1097/PSY.0b013e318157cb96; Lusardi P, 1999, AM J HYPERTENS, V12, P63, DOI 10.1016/S0895-7061(98)00200-3; Martinez-Gomez D, 2011, SLEEP MED, V12, P997, DOI 10.1016/j.sleep.2011.05.009; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Miller MA, 2009, SLEEP, V32, P857; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Naidoo N, 2005, J NEUROCHEM, V92, P1150, DOI 10.1111/j.1471-4159.2004.02952.x; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; Okun ML, 2009, BRAIN BEHAV IMMUN, V23, P351, DOI 10.1016/j.bbi.2008.10.008; Pannitteri G, 1997, AM J CARDIOL, V80, P622, DOI 10.1016/S0002-9149(97)00434-7; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Rietzschel E, 2012, BIOMARK MED, V6, P19, DOI [10.2217/BMM.11.108, 10.2217/bmm.11.108]; Robinson DS, 2002, CURR BIOL, V12, pR322, DOI 10.1016/S0960-9822(02)00830-8; Sikorski K, 2011, AM J PHYSIOL-CELL PH, V300, pC1337, DOI 10.1152/ajpcell.00276.2010; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tochikubo O, 1996, HYPERTENSION, V27, P1318, DOI 10.1161/01.HYP.27.6.1318; TRAPANI JA, 1993, IMMUNOL CELL BIOL, V71, P201, DOI 10.1038/icb.1993.22; Tsujimura T, 2009, DIABETES RES CLIN PR, V85, P286, DOI 10.1016/j.diabres.2009.07.001; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Leeuwen WMA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/108641; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720, DOI 10.1152/ajpendo.1997.273.4.E720; Wisor JP, 2011, SLEEP, V34, P1335, DOI 10.5665/SLEEP.1274; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zager A, 2007, AM J PHYSIOL-REG I, V293, pR504, DOI 10.1152/ajpregu.00105.2007	68	52	53	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77184	10.1371/journal.pone.0077184	http://dx.doi.org/10.1371/journal.pone.0077184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194869	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000048
J	Kuang, ZC; Yao, YW; Shi, Y; Gu, Z; Sun, ZG; Tso, JK				Kuang, Zhichao; Yao, Yuwei; Shi, Yan; Gu, Zheng; Sun, Zhaogui; Tso, Jiake			Winter Hibernation and UCHL1-p34(cdc2) Association in Toad Oocyte Maturation Competence	PLOS ONE			English	Article							CARBOXYL-TERMINAL HYDROLASE; GENE-PRODUCT 9.5; MOUSE OVA; UBIQUITIN; SPERMATOGENESIS; PHOSPHORYLATION; IDENTIFICATION; POLYSPERMY; EXPRESSION; PGP9.5	Currently, it is believed that toad oocyte maturation is dependent on the physiological conditions of winter hibernation. Previous antibody-blocking experiments have demonstrated that toad ubiquitin carboxyl-terminal hydrolase L1 (tUCHL1) is necessary for germinal vesicle breakdown during toad oocyte maturation. In this paper, we first supply evidence that tUCHL1 is highly evolutionarily conserved. Then, we exclude protein availability and ubiquitin carboxyl-terminal hydrolase enzyme activity as factors in the response of oocytes to winter hibernation. In the context of MPF (maturation promoting factor) controlling oocyte maturation and to further understand the role of UCHL1 in oocyte maturation, we performed adsorption and co-immunoprecipitation experiments using toad oocyte protein extracts and determined that tUCHL1 is associated with MPF in toad oocytes. Recombinant tUCHL1 absorbed p34(cdc2), a component of MPF, in obviously larger quantities from mature oocytes than from immature oocytes, and p13(suc1) was isolated from tUCHL1 with a dependence on the ATP regeneration system, suggesting that still other functions may be involved in their association that require phosphorylation. In oocytes from hibernation-interrupted toads, the p34(cdc2) protein level was significantly lower than in oocytes from toads in artificial hibernation, providing an explanation for the different quantities isolated by recombinant tUCHL1 pull-down and, more importantly, identifying a mechanism involved in the toad oocyte's dependence on a low environmental temperature during winter hibernation. Therefore, in toads, tUCHL1 binds p34(cdc2) and plays a role in oocyte maturation. However, neither tUCHL1 nor cyclin B1 respond to low temperatures to facilitate oocyte maturation competence during winter hibernation.	[Kuang, Zhichao; Yao, Yuwei; Sun, Zhaogui] Fudan Univ, Inst Reprod & Dev, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Shi, Yan; Gu, Zheng; Sun, Zhaogui; Tso, Jiake] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Commiss China, Key Lab Contracept Drugs & Devices, Shanghai, Peoples R China	Fudan University	Sun, ZG (corresponding author), Fudan Univ, Inst Reprod & Dev, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sunzgbio@126.com			National Natural Science Foundation of China [30370717, 81170569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project No. 30370717 and 81170569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN PA, 1993, J EXP ZOOL, V266, P603, DOI 10.1002/jez.1402660610; Benedit P, 2001, ONCOGENE, V20, P1455, DOI 10.1038/sj.onc.1204233; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; De Smedt V, 2002, J BIOL CHEM, V277, P28592, DOI 10.1074/jbc.M202742200; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; Holzenspies JJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-8; Ihara J, 1998, MOL REPROD DEV, V50, P499, DOI 10.1002/(SICI)1098-2795(199808)50:4<499::AID-MRD14>3.0.CO;2-Y; JACKSON P, 1985, J NEUROCHEM, V45, P185, DOI 10.1111/j.1471-4159.1985.tb05491.x; Jessus C, 2004, BIOL CELL, V96, P187, DOI 10.1016/j.biolcel.2003.12.007; Kong WH, 2000, CELL RES, V10, P289, DOI 10.1038/sj.cr.7290056; Kotani T, 2001, MOL REPROD DEV, P59; Koyanagi S, 2012, REPRODUCTION, V143, P271, DOI 10.1530/REP-11-0128; Kwon J, 2004, BIOL REPROD, V71, P515, DOI 10.1095/biolreprod.104.027565; Lu JN, 1996, CELL RES, V6, P115, DOI [10.1038/cr.1996.13, DOI 10.1038/CR.1996.13]; Mtango NR, 2012, J CELL PHYSIOL, V227, P2022, DOI 10.1002/jcp.22931; Piccinini M, 1996, BIOCHEM J, V318, P711, DOI 10.1042/bj3180711; REYNHOUT JK, 1974, DEV BIOL, V38, P394, DOI 10.1016/0012-1606(74)90016-5; Sekiguchi S, 2003, EXP ANIM TOKYO, V52, P365, DOI 10.1538/expanim.52.365; Sekiguchi S, 2006, AM J PATHOL, V169, P1722, DOI 10.2353/ajpath.2006.060301; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Sun ZG, 2002, CELL RES, V12, P199, DOI 10.1038/sj.cr.7290125; Sun Zhao Gui, 2003, Shi Yan Sheng Wu Xue Bao, V36, P105; Susor A, 2010, BIOL REPROD, V82, P1151, DOI 10.1095/biolreprod.109.081547; TCHOU S, 1963, SCI SINICA, V12, P1165; TCHOU S, 1963, SCI SINICA, V12, P1161; WILKINSON KD, 1986, BIOCHEMISTRY-US, V25, P6644, DOI 10.1021/bi00369a047; Yao YW, 2011, HISTOCHEM CELL BIOL, V136, P205, DOI 10.1007/s00418-011-0825-z; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Zhu G, 1993, Shi Yan Sheng Wu Xue Bao, V26, P469	30	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78785	10.1371/journal.pone.0078785	http://dx.doi.org/10.1371/journal.pone.0078785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194953	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000132
J	Lu, S; Peng, HY; Zhang, H; Zhang, L; Cao, QC; Li, R; Zhang, Y; Yan, LY; Duan, EK; Qiao, J				Lu, Shan; Peng, Hongying; Zhang, He; Zhang, Li; Cao, Qichen; Li, Rong; Zhang, Ying; Yan, Liying; Duan, Enkui; Qiao, Jie			Excessive Intrauterine Fluid Cause Aberrant Implantation and Pregnancy Outcome in Mice	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; UTERINE LUMINAL FLUID; EMBRYO IMPLANTATION; HYDROSALPINX; SALPINGECTOMY; IVF; EXPRESSION; WOMEN; RATES; PROGESTERONE	The normal intrauterine fluid environment is essential for embryo implantation. In hydrosalpinx patients, the implantation and pregnancy rates are markedly decreased after IVF-embryo transfer, while salpingectomy could significantly improve the pregnancy rates. The leakage of hydrosalpinx fluid into the endometrial cavity was supposed to be the major cause for impaired fertility. However, the underlying mechanisms of hydrosalpinx fluids on implantation and ongoing pregnancy were not fully understood and remain controversial regarding its toxicity. In present study, by infusing different volume of non-toxic fluid (0.9% saline) into uterine lumen before embryo implantation in mice (Day4 08: 30), we found that while the embryos were not "flushed out" from the uteri, the timing of implantation was deferred and normal intrauterine distribution (embryo spacing) was disrupted. The abnormal implantation at early pregnancy further lead to embryo growth retardation, miscarriage and increased pregnancy loss, which is similar to the adverse effects observed in hydrosalpinx patients undergoing IVF-ET. We further examined uterine receptivity related gene expression reported to be involved in human hydrosalpinx (Lif, Hoxa10, Integrin a(v) and beta(3)). The results showed that expression of integrin alpha(v) and beta(3) were increased in the fluid infused mouse uteri, implicating a compensatory effect to cope with the excessive fluid environment. Our data suggested that the adverse effects of excessive non-toxic luminal fluid on pregnancy are primarily due to the mechanical interference for normal timing and location of embryo apposition, which might be the major cause of decreased implantation rate in IVF-ET patients with hydrosalpinx.	[Lu, Shan; Li, Rong; Yan, Liying; Qiao, Jie] Peking Univ, Dept Obstet & Gynecol, Hosp 3, Beijing 100871, Peoples R China; [Peng, Hongying; Zhang, He; Zhang, Li; Cao, Qichen; Zhang, Ying; Duan, Enkui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Li, Rong; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China; [Li, Rong; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	zhangying@ioz.ac.cn; yanliyingkind@aliyun.com		Zhang, Ying/0000-0003-4082-5026	National Natural Science Foundation of China [81000275, 31300957, 31300960]; National Basic Research Program of China [2011CB944503, 2011CB944401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (81000275, 31300957, 31300960) and National Basic Research Program of China (2011CB944503, 2011CB944401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajonuma LC, 2008, J OBSTET GYNAECOL RE, V34, P923, DOI 10.1111/j.1447-0756.2008.00826.x; Baba K, 2000, FERTIL STERIL, V73, P123, DOI 10.1016/S0015-0282(99)00454-9; Bildirici I, 2001, HUM REPROD, V16, P2422, DOI 10.1093/humrep/16.11.2422; Camus E, 1999, HUM REPROD, V14, P1243, DOI 10.1093/humrep/14.5.1243; Carson DD, 1998, HUM REPROD UPDATE, V4, P459, DOI 10.1093/humupd/4.5.459; Chen Q, 2013, MOL ASPECTS MED, V34, P1024, DOI 10.1016/j.mam.2012.07.017; Chen Q, 2011, J BIOL CHEM, V286, P4349, DOI 10.1074/jbc.M110.197202; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Chien LW, 2002, HUM REPROD, V17, P351, DOI 10.1093/humrep/17.2.351; CLEMETSO.CA, 1970, J ENDOCRINOL, V47, P309, DOI 10.1677/joe.0.0470309; CLEMETSON CAB, 1977, J REPROD FERTIL, V49, P183; Daftary GS, 2007, FERTIL STERIL, V87, P367, DOI 10.1016/j.fertnstert.2006.06.041; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Diao HL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110106; Eytan O, 2001, HUM REPROD, V16, P2662, DOI 10.1093/humrep/16.12.2662; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hinckley MD, 2003, FERTIL STERIL, V80, P1268, DOI 10.1016/S0015-0282(03)01179-8; Johnson N, 2010, COCHRANE DB SYST REV, pD2125; Kontoravdis A, 2006, FERTIL STERIL, V86, P1642, DOI 10.1016/j.fertnstert.2006.05.032; Lu S, 2009, CHIN J CLIN OBSTET G, V10, P423; Magli MC, 2008, HUM REPROD, V23, P1253, DOI 10.1093/humrep/den068; Meyer WR, 1997, HUM REPROD, V12, P1393, DOI 10.1093/humrep/12.7.1393; Naftalin RJ, 2002, REPRODUCTION, V123, P633, DOI 10.1530/rep.0.1230633; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Pinborg A, 2006, BRIT J HOSP MED, V67, P417, DOI 10.12968/hmed.2006.67.8.21976; Soares SR, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.07.1353; RESTALL BJ, 1971, J REPROD FERTIL, V24, P423, DOI 10.1530/jrf.0.0240423; Salleh N, 2005, J MEMBRANE BIOL, V206, P17, DOI 10.1007/s00232-005-0770-7; Savaris RF, 2007, SEMIN REPROD MED, V25, P476, DOI 10.1055/s-2007-991045; Seli E, 2005, HUM REPROD, V20, P3012, DOI 10.1093/humrep/dei188; Sharara FI, 1999, HUM REPROD, V14, P577, DOI 10.1093/humrep/14.3.577; Song H, 2002, DEVELOPMENT, V129, P2879; Strandell A, 2002, HUM REPROD, V17, P1141, DOI 10.1093/humrep/17.5.1141; Strandell A, 2001, HUM REPROD, V16, P2403, DOI 10.1093/humrep/16.11.2403; Strandell A, 2007, CURR OPIN OBSTET GYN, V19, P360, DOI 10.1097/GCO.0b013e32821642b9; Wang H, 2005, CHIN J MIN INV SURG, V5, P792; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Zeyneloglu HB, 1998, FERTIL STERIL, V70, P492, DOI 10.1016/S0015-0282(98)00200-3; Zhang D, 2012, MOL ASPECTS MED, V33, P676, DOI 10.1016/j.mam.2012.02.002; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011	41	23	29	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78446	10.1371/journal.pone.0078446	http://dx.doi.org/10.1371/journal.pone.0078446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194934	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000113
J	McCarty, DR; Latshaw, S; Wu, S; Suzuki, M; Hunter, CT; Avigne, WT; Koch, KE				McCarty, Donald R.; Latshaw, Sue; Wu, Shan; Suzuki, Masaharu; Hunter, Charles T.; Avigne, Wayne T.; Koch, Karen E.			Mu-seq: Sequence-Based Mapping and Identification of Transposon Induced Mutations	PLOS ONE			English	Article							MAIZE; GENOME; MUTAGENESIS; GENE; INSERTION; ELEMENTS; SYSTEM; TOOL	Mutations tagged by transposon insertions can be readily mapped and identified in organisms with sequenced genomes. Collections of such mutants allow a systematic analysis of gene function, and can be sequence-indexed to build invaluable resources. Here we present Mu-seq (Mutant-seq), a high-throughput NextGen sequencing method for harnessing high-copy transposons. We illustrate the efficacy of Mu-seq by applying it to the Robertson's Mutator system in a large population of maize plants. A single Mu-seq library, for example, constructed from 576 different families (2304 plants), enabled 4, 723 novel, germinal, transposon insertions to be detected, identified, and mapped with single base-pair resolution. In addition to the specificity, efficiency, and reproducibility of Mu-seq, a key feature of this method is its adjustable scale that can accomodate simultaneous profiling of transposons in thousands of individuals. We also describe a Mu-seq bioinformatics framework tailored to high-throughput, genome-wide, and population-wide analysis of transposon insertions.	[McCarty, Donald R.; Latshaw, Sue; Wu, Shan; Suzuki, Masaharu; Hunter, Charles T.; Avigne, Wayne T.; Koch, Karen E.] Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	McCarty, DR (corresponding author), Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Genet Inst, Gainesville, FL 32610 USA.	drm@ufl.edu	Latshaw, Sue/GZB-1381-2022		US National Science Foundation [0703273, 1116561]; Direct For Biological Sciences [1116561] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	US National Science Foundation Grants: 0703273,1116561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; CHANDLER VL, 1992, ADV GENET, V30, P77, DOI 10.1016/S0065-2660(08)60319-3; CRESSE AD, 1995, GENETICS, V140, P315; Das L, 1995, PLANT CELL, V3, P287; Fernandes J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r82; Hirochika H, 2004, PLANT MOL BIOL, V54, P325, DOI 10.1023/B:PLAN.0000036368.74758.66; Hunter CT, 2010, MU TRANSPOSONS ZEA M; LISCH D, 1995, GENETICS, V139, P1777; Liu SZ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000733; May BP, 2003, P NATL ACAD SCI USA, V100, P11541, DOI 10.1073/pnas.1831119100; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; Miyao A, 2003, PLANT CELL, V15, P1771, DOI 10.1105/tpc.012559; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Qu S, 2008, PLANT PHYSIOL, V146, P189, DOI 10.1104/pp.107.111427; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Settles AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-116; Settles AM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh052; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Suzuki M, 2006, PLANT J, V45, P264, DOI 10.1111/j.1365-313X.2005.02620.x; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x	24	33	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77172	10.1371/journal.pone.0077172	http://dx.doi.org/10.1371/journal.pone.0077172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194867	Green Submitted, gold, Green Published			2022-12-25	WOS:000326037000046
J	Yang, SZ; Dai, P; Liu, X; Kang, DY; Zhang, X; Yang, WY; Zhou, CY; Yang, SM; Yuan, HJ				Yang, Shuzhi; Dai, Pu; Liu, Xin; Kang, Dongyang; Zhang, Xin; Yang, Weiyan; Zhou, Chengyong; Yang, Shiming; Yuan, Huijun			Genetic and Phenotypic Heterogeneity in Chinese Patients with Waardenburg Syndrome Type II	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; MITF GENE; MUTATIONS; MICROPHTHALMIA; DELETIONS; LOCUS; CELLS	Waardenburg Syndrome (WS) is an autosomal-dominant disorder characterized by sensorineural hearing loss and pigmentary abnormalities of the eyes, hair, and skin. Microphthalmia-associated transcription factor (MITF) gene mutations account for about 15% of WS type II (WS2) cases. To date, fewer than 40 different MITF gene mutations have been identified in human WS2 patients, and few of these were of Chinese descent. In this study, we report clinical findings and mutation identification in the MITF gene of 20 Chinese WS2 patients from 14 families. A high level of clinical variability was identified. Sensorineural hearing loss (17/20, 85.0%) and heterochromia iridum (20/20, 100.0%) were the most commonly observed clinical features in Chinese WS2 patients. Five affected individuals (5/20, 25.0%) had numerous brown freckles on the face, trunk, and limb extremities. Mutation screening of the MITF gene identified five mutations: c.20A>G, c.332C>T, c.647_649delGAA, c.649A>G, and c.763C>T. The total mutational frequency of the MITF gene was 21.4% (3/14), which is significantly higher than the 15.0% observed in the fair-skinned WS2 population. Our results indicate that MITF mutations are relatively common among Chinese WS2 patients.	[Yang, Shuzhi; Zhou, Chengyong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Otolaryngol, Beijing, Peoples R China; [Dai, Pu; Kang, Dongyang; Zhang, Xin; Yang, Weiyan; Yang, Shiming; Yuan, Huijun] Chinese Peoples Liberat Army Gen Hosp, Inst Otolaryngol, Beijing, Peoples R China; [Liu, Xin] 16 Hosp Chinese PLA, Dept Otolaryngol, Alatai, Xinjiang Autono, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Zhou, CY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Otolaryngol, Beijing, Peoples R China.	zhcyong@163bj.com; yangsm301@263.net; yuanhj301@yahoo.com.cn	yang, shuzhi/AAH-1933-2021		National Natural Science Foundation of China [81030017, 81200752]; National Natural Science Foundation [81125008]; National Basic Research Program of China (973 Program) [2013CB945402, 2012CB967900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	These investigations were supported by grants from the Key Project of National Natural Science Foundation of China (81030017), National Natural Science Foundation for Distinguished Young Scholars (81125008) and The National Basic Research Program of China (973 Program) (2013CB945402) to HY, a grant from The National Basic Research Program of China (973 Program) (2012CB967900) to Shiming Yang, and a grant from the National Natural Science Foundation of China (81200752) to Shuzhi Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Chen HS, 2010, BIOCHEM BIOPH RES CO, V397, P70, DOI 10.1016/j.bbrc.2010.05.066; Chen Jing, 2008, Yi Chuan, V30, P433, DOI 10.3724/SP.J.1005.2008.00433; Chiang PW, 2009, AM J MED GENET A, V149A, P2739, DOI 10.1002/ajmg.a.33128; FARRER LA, 1992, AM J HUM GENET, V50, P902; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Izumi K, 2008, CLIN GENET, V74, P93, DOI 10.1111/j.1399-0004.2008.01010.x; Lalwani A. K., 1994, American Journal of Human Genetics, V55, pA14; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Newton VE, 1995, AM J MED GENET, V55, P95; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Sanchez-Martin M, 2002, HUM MOL GENET, V11, P3231, DOI 10.1093/hmg/11.25.3231; Selicorni A, 2002, HUM GENET, V110, P64, DOI 10.1007/s00439-001-0643-9; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; Takebayashi K, 1996, MOL CELL BIOL, V16, P1203; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	26	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77149	10.1371/journal.pone.0077149	http://dx.doi.org/10.1371/journal.pone.0077149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194866	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000045
J	Agoni, L; Lenz, J; Guha, C				Agoni, Lorenzo; Lenz, Jack; Guha, Chandan			Variant Splicing and Influence of Ionizing Radiation on Human Endogenous Retrovirus K (HERV-K) Transcripts in Cancer Cell Lines	PLOS ONE			English	Article							HUMAN PAPILLOMAVIRUS-16; GAMMA-IRRADIATION; PERIPHERAL-BLOOD; T-LYMPHOCYTES; TUMOR-CELLS; EXPRESSION; MELANOMA; PROTEIN; SEQUENCES; PROVIRUS	Human endogenous retrovirus K (HERV-K) is the most intact retrovirus in the human genome. There are multiple full-length or near full-length HERV-K proviruses in it. To analyze which HERV-K proviruses give rise to viral transcripts in cancer cell lines and to test whether ionizing radiation can alter the levels of HERV-K transcripts, RT-PCR studies were undertaken using multiple human cancer cell lines. Primers from several positions in the viral genome were used and included pairs designed to cross splice junctions in viral RNAs. In the absence of ionizing radiation, transcripts were detected from multiple HERV-K proviruses in cell lines from human prostate, cervical, head and neck, or breast cancers, and the proviruses from which the transcripts originated varied among the different lines. Only one of 13 cell lines tested (cervical cancer line C33A) failed to show HERV-K transcripts. Spliced RNAs detected included viral RNAs spliced as expected at the conventional viral splice sites, plus several alternatively spliced RNAs. Alternatively spliced transcripts arose from specific proviruses, and were detected in most of the cell lines used. Quantitative RT-PCR was performed to assess the effects of ionizing radiation. These analyses showed that HERV-K transcripts were elevated in four of twelve lines tested, specifically all three prostate cancer lines used and one breast cancer line. The increases were transient, peaking at 24 hours following a single dose of gamma-irradiation that ranged from 2.5 to 20 Gy, and returning to baseline levels by 72 hours. In summary, these studies showed that ionizing radiation can affect the levels of HERV-K transcripts in cells, and these effects vary among different cells. The changes in HERV-K transcript levels might affect multiple biological processes in cells, and future studies of the effects of ionizing radiation on HERV-K are worth pursuing.	[Agoni, Lorenzo; Guha, Chandan] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Lenz, Jack] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Guha, C (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	cguha@montefiore.org		Agoni, Lorenzo/0000-0003-0270-248X	NIBIB [1 R01 EB009040]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009040] Funding Source: NIH RePORTER	NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported by NIBIB 1 R01 EB009040 (to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoni L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00180; Agoni L, 2012, CURR BIOL, V22, pR437, DOI 10.1016/j.cub.2012.04.049; Armbruester V, 2002, CLIN CANCER RES, V8, P1800; ASTIER T, 1982, J GEN VIROL, V61, P55, DOI 10.1099/0022-1317-61-1-55; Barbulescu M, 1999, CURR BIOL, V9, P861, DOI 10.1016/S0960-9822(99)80390-X; Barbulescu M, 2001, CURR BIOL, V11, P779, DOI 10.1016/S0960-9822(01)00227-5; Belshaw R, 2005, J VIROL, V79, P12507, DOI 10.1128/JVI.79.19.12507-12514.2005; Blikstad V, 2008, CELL MOL LIFE SCI, V65, P3348, DOI 10.1007/s00018-008-8495-2; Bogerd HP, 2000, J VIROL, V74, P9353, DOI 10.1128/JVI.74.20.9353-9361.2000; BOLLER K, 1993, VIROLOGY, V196, P349, DOI 10.1006/viro.1993.1487; Brudek T, 2007, J NEUROIMMUNOL, V187, P147, DOI 10.1016/j.jneuroim.2007.04.003; Buscher K, 2005, CANCER RES, V65, P4172, DOI 10.1158/0008-5472.CAN-04-2983; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Chakraborty M, 2003, J IMMUNOL, V170, P6338, DOI 10.4049/jimmunol.170.12.6338; Contreras-Galindo R, 2006, AIDS RES HUM RETROV, V22, P979, DOI 10.1089/aid.2006.22.979; Contreras-Galindo R, 2012, J VIROL, V86, P262, DOI 10.1128/JVI.00602-11; de Parseval N, 2005, CYTOGENET GENOME RES, V110, P318, DOI 10.1159/000084964; Delgado FG, 2009, IMMUNOLOGY, V126, P523, DOI 10.1111/j.1365-2567.2008.02912.x; Demaria S, 2007, INT J RADIAT BIOL, V83, P819, DOI 10.1080/09553000701481816; Demaria S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00128; Demaria S, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00095; Denne M, 2007, J VIROL, V81, P5607, DOI 10.1128/JVI.02771-06; Dewannieux M, 2006, GENOME RES, V16, P1548, DOI 10.1101/gr.5565706; Etkind PR, 1997, VIROLOGY, V234, P304, DOI 10.1006/viro.1997.8670; Feng WJN, 2007, INT J CANCER, V120, P81, DOI 10.1002/ijc.22256; Flockerzi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-354; Florl AR, 1999, BRIT J CANCER, V80, P1312, DOI 10.1038/sj.bjc.6690524; Formenti SC, 2009, LANCET ONCOL, V10, P718, DOI 10.1016/S1470-2045(09)70082-8; Frank O, 2008, J VIROL, V82, P1808, DOI 10.1128/JVI.02115-07; Freimanis G, 2010, CLIN EXP IMMUNOL, V160, P340, DOI 10.1111/j.1365-2249.2010.04110.x; Garrison KE, 2007, PLOS PATHOG, V3, P1617, DOI 10.1371/journal.ppat.0030165; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Hahn S, 2008, AIDS RES HUM RETROV, V24, P717, DOI 10.1089/aid.2007.0286; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; HEO DS, 1989, CANCER RES, V49, P5167; Herbst H, 1998, APMIS, V106, P216, DOI 10.1111/j.1699-0463.1998.tb01338.x; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Heslin DJ, 2009, J VIROL, V83, P1105, DOI 10.1128/JVI.01439-08; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Ishida Toshiaki, 2008, Cancer Immun, V8, P15; Jha AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020234; JOLICOEUR P, 1986, LEUKEMIA RES, V10, P843, DOI 10.1016/0145-2126(86)90305-X; Kaufmann S, 2010, J GEN VIROL, V91, P1494, DOI 10.1099/vir.0.014241-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim JH, 2007, INT J RADIAT ONCOL, V69, P813, DOI 10.1016/j.ijrobp.2007.04.005; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; LIEBERMAN M, 1959, SCIENCE, V130, P387, DOI 10.1126/science.130.3372.387; LIEBERMAN MIRIAM, 1966, NAT CANCER INST MONOGR, V22, P549; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Magin C, 1999, J VIROL, V73, P9496, DOI 10.1128/JVI.73.11.9496-9507.1999; Mamedov I, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf071; Mayer J, 1999, NAT GENET, V21, P257, DOI 10.1038/6766; Medstrand P, 1998, J VIROL, V72, P9782, DOI 10.1128/JVI.72.12.9782-9787.1998; Muster T, 2003, CANCER RES, V63, P8735; NOKTA M, 1992, P SOC EXP BIOL MED, V200, P402, DOI 10.3181/00379727-200-43448; Ohagen A, 2004, VOX SANG, V87, P1, DOI 10.1111/j.1423-0410.2004.00532.x; ONO M, 1986, J VIROL, V58, P937, DOI 10.1128/JVI.58.3.937-944.1986; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Rakoff-Nahoum S, 2006, AIDS RES HUM RETROV, V22, P52, DOI 10.1089/aid.2006.22.52; Reiche J, 2010, MELANOMA RES, V20, P435, DOI 10.1097/CMR.0b013e32833c1b5d; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Santin AD, 1998, CANCER-AM CANCER SOC, V83, P2346, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2346::AID-CNCR14>3.0.CO;2-G; SAUTER M, 1995, J VIROL, V69, P414, DOI 10.1128/JVI.69.1.414-421.1995; Schiavetti F, 2002, CANCER RES, V62, P5510; Stevens RW, 1999, CLIN DIAGN LAB IMMUN, V6, P783, DOI 10.1128/CDLI.6.6.783-786.1999; Subramanian RP, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-90; Turner G, 2001, CURR BIOL, V11, P1531, DOI 10.1016/S0960-9822(01)00455-9; Vereecque R, 2003, GENE THER, V10, P227, DOI 10.1038/sj.gt.3301870; Wang-Johanning F, 2001, CLIN CANCER RES, V7, P1553; Wang-Johanning F, 2008, CANCER RES, V68, P5869, DOI 10.1158/0008-5472.CAN-07-6838; Wang-Johanning F, 2012, JNCI-J NATL CANCER I, V104, P189, DOI 10.1093/jnci/djr540; Xu Y, 1996, PHOTOCHEM PHOTOBIOL, V64, P238, DOI 10.1111/j.1751-1097.1996.tb02451.x	73	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76472	10.1371/journal.pone.0076472	http://dx.doi.org/10.1371/journal.pone.0076472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204631	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300030
J	Bowden, DA; Rowden, AA; Thurber, AR; Baco, AR; Levin, LA; Smith, CR				Bowden, David A.; Rowden, Ashley A.; Thurber, Andrew R.; Baco, Amy R.; Levin, Lisa A.; Smith, Craig R.			Cold Seep Epifaunal Communities on the Hikurangi Margin, New Zealand: Composition, Succession, and Vulnerability to Human Activities	PLOS ONE			English	Article							GULF-OF-MEXICO; TUBEWORM LAMELLIBRACHIA-LUYMESI; DEEP-SEA; FLUID-FLOW; VESICOMYID CLAMS; METHANE SEEPAGE; MONTEREY BAY; GROWTH; DIVERSITY; PATTERNS	Cold seep communities with distinctive chemoautotrophic fauna occur where hydrocarbon-rich fluids escape from the seabed. We describe community composition, population densities, spatial extent, and within-region variability of epifaunal communities at methane-rich cold seep sites on the Hikurangi Margin, New Zealand. Using data from towed camera transects, we match observations to information about the probable life-history characteristics of the principal fauna to develop a hypothetical succession sequence for the Hikurangi seep communities, from the onset of fluid flux to senescence. New Zealand seep communities exhibit taxa characteristic of seeps in other regions, including predominance of large siboglinid tubeworms, vesicomyid clams, and bathymodiolin mussels. Some aspects appear to be novel; however, particularly the association of dense populations of ampharetid polychaetes with high-sulphide, high-methane flux, soft-sediment microhabitats. The common occurrence of these ampharetids suggests they play a role in conditioning sulphide-rich sediments at the sediment-water interface, thus facilitating settlement of clam and tubeworm taxa which dominate space during later successional stages. The seep sites are subject to disturbance from bottom trawling at present and potentially from gas hydrate extraction in future. The likely life-history characteristics of the dominant megafauna suggest that while ampharetids, clams, and mussels exploit ephemeral resources through rapid growth and reproduction, lamellibrachid tubeworm populations may persist potentially for centuries. The potential consequences of gas hydrate extraction cannot be fully assessed until extraction methods and target localities are defined but any long-term modification of fluid flow to seep sites would have consequences for all chemoautotrophic fauna.	[Bowden, David A.; Rowden, Ashley A.] Natl Inst Water & Atmospher Res, Coasts & Oceans Ctr, Wellington, New Zealand; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Baco, Amy R.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Levin, Lisa A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Smith, Craig R.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI USA	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Oregon State University; State University System of Florida; Florida State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; University of Hawaii Manoa	Bowden, DA (corresponding author), Natl Inst Water & Atmospher Res, Coasts & Oceans Ctr, Wellington, New Zealand.	david.bowden@niwa.co.nz	Rowden, Ashley/ABG-6010-2020; Rowden, Ashley/O-9358-2019	Rowden, Ashley/0000-0003-2975-2524; Levin, Lisa/0000-0002-2858-8622	National Oceanic and Atmospheric Administration [NA05OAR4171076, NA17RJ1231/58]; National Institute of Water and Atmospheric Research (NIWA) Capability Fund project [CRFH073]; NIWA Capability Fund [CPDU073]; NIWA [GNS11304]; GNS [CO5X0908]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Institute of Water and Atmospheric Research (NIWA) Capability Fund project; NIWA Capability Fund; NIWA; GNS	Data and samples were collected during R/V Tangaroa voyage TAN0616 "New Zeeps" and R/V Sonne voyages SO191 "New Vents" and SO214 "NEMESYS." TAN0616 was funded by National Oceanic and Atmospheric Administration Ocean Exploration Grants NA05OAR4171076 and NA17RJ1231/58, and National Institute of Water and Atmospheric Research (NIWA) Capability Fund project CRFH073. DAB was funded on TAN0616 and SO191 by NIWA Capability Fund project CPDU073 and on SO214 by NIWA project GNS11304 under subcontract to GNS project CO5X0908 'Gas Hydrate Resources'. Support during analysis for DAB and AAR came from NIWA projects GNS11304 and DSCA113 Vulnerable Deep-Sea Communities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Baco AR, 2010, MAR GEOL, V272, P251, DOI 10.1016/j.margeo.2009.06.015; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Baird SJ, 2011, 73 NZ AQ ENV BIOD; Barnes PM, 2010, MAR GEOL, V272, P26, DOI 10.1016/j.margeo.2009.03.012; Barry JP, 2007, MAR ECOL-EVOL PERSP, V28, P169, DOI 10.1111/j.1439-0485.2007.00119.x; Barry JP, 1996, DEEP-SEA RES PT I, V43, P1739, DOI 10.1016/S0967-0637(96)00075-1; Barry JP, 2002, INVERTEBR BIOL, V121, P47; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; Bergquist DC, 2002, MAR ECOL PROG SER, V241, P89, DOI 10.3354/meps241089; Bernardino AF, 2010, MAR ECOL-EVOL PERSP, V31, P608, DOI 10.1111/j.1439-0485.2010.00389.x; Bertics VJ, 2007, AM GEOPH UN FALL M 2; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boswell R, 2012, MAR PETROL GEOL, V34, P4, DOI 10.1016/j.marpetgeo.2011.10.003; Campbell KA, 2010, MAR GEOL, V272, P285, DOI 10.1016/j.margeo.2010.01.002; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Cordes EE, 2005, PLOS BIOL, V3, P497, DOI 10.1371/journal.pbio.0030077; Cordes EE, 2003, ECOL LETT, V6, P212, DOI 10.1046/j.1461-0248.2003.00415.x; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; Cordes EE, 2007, MAR ECOL-EVOL PERSP, V28, P160, DOI 10.1111/j.1439-0485.2006.00112.x; Cordes EE, 2006, J EXP MAR BIOL ECOL, V339, P159, DOI 10.1016/j.jembe.2006.07.017; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; Crutchley GJ, 2011, MAR PETROL GEOL, V28, P1915, DOI 10.1016/j.marpetgeo.2010.12.005; Dale AW, 2010, GEOCHIM COSMOCHIM AC, V74, P5763, DOI 10.1016/j.gca.2010.06.038; Dattagupta S, 2008, GEOCHIM COSMOCHIM AC, V72, P2298, DOI 10.1016/j.gca.2008.02.016; Dattagupta S, 2006, J EXP BIOL, V209, P3795, DOI 10.1242/jeb.02413; Domack E, 2005, T AM GEOPHYS UNION, V86, P269; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Fischer D, 2012, BIOGEOSCIENCES, V9, P2013, DOI 10.5194/bg-9-2013-2012; Fisher CR, 1997, MAR ECOL-P S Z N I, V18, P83, DOI 10.1111/j.1439-0485.1997.tb00428.x; Fohrmann M, 2012, MAR PETROL GEOL, V38, P19, DOI 10.1016/j.marpetgeo.2012.08.001; Freytag JK, 2001, P NATL ACAD SCI USA, V98, P13408, DOI 10.1073/pnas.231589498; Fujikura K, 2007, MAR ECOL PROG SER, V333, P185, DOI 10.3354/meps333185; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; Govenar B, 2010, TOP GEOBIOL, V33, P403, DOI 10.1007/978-90-481-9572-5_13; Greinert J, 2010, MAR GEOL, V272, P6, DOI 10.1016/j.margeo.2010.01.017; Henrys SA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015772; Hill P, 2009, SEA TECHNOL, V50, P49; Jones AT, 2010, MAR GEOL, V272, P154, DOI 10.1016/j.margeo.2009.03.008; Klaucke I, 2010, MAR GEOL, V272, P49, DOI 10.1016/j.margeo.2009.02.009; Krabbenhoeft A, 2013, MAR PETROL GEOL, V39, P59, DOI 10.1016/j.marpetgeo.2012.09.008; Leon R, 2006, DEEP-SEA RES PT II, V53, P1464, DOI 10.1016/j.dsr2.2006.04.009; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2012, P ROY SOC B-BIOL SCI, V279, P2580, DOI 10.1098/rspb.2012.0205; Levin LA, 2010, MAR ECOL-EVOL PERSP, V31, P94, DOI 10.1111/j.1439-0485.2009.00335.x; Lewis KB, 1996, NEW ZEAL J GEOL GEOP, V39, P181, DOI 10.1080/00288306.1996.9514704; Liebetrau V, 2010, MAR GEOL, V272, P307, DOI 10.1016/j.margeo.2010.01.003; Lisin SE, 1997, INVERTEBR REPROD DEV, V31, P307, DOI 10.1080/07924259.1997.9672590; Luff R, 2005, CHEM GEOL, V216, P157, DOI 10.1016/j.chemgeo.2004.11.002; Naudts L, 2010, MAR GEOL, V272, P233, DOI 10.1016/j.margeo.2009.08.002; Navalpakam RS, 2012, J PETROL SCI ENG, V88-89, P29, DOI 10.1016/j.petrol.2012.01.008; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Pecher IA, 2003, POTENTIAL GAS RESERV; Pecher IA, 2010, MAR GEOL, V272, P99, DOI 10.1016/j.margeo.2009.10.006; Plaza-Faverola A, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004228; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Roy KOL, 2007, MAR ECOL-EVOL PERSP, V28, P115, DOI 10.1111/j.1439-0485.2006.00145.x; Sellanes J, 2008, ICES J MAR SCI, V65, P1102, DOI 10.1093/icesjms/fsn099; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sommer S, 2007, GEOCHIM COSMOCHIM AC, V71, pA955; Sommer S, 2010, MAR GEOL, V272, P223, DOI 10.1016/j.margeo.2009.06.003; SOUTHWARD EC, 1991, J NAT HIST, V25, P859, DOI 10.1080/00222939100770571; Thurber AR, 2010, MAR GEOL, V272, P260, DOI 10.1016/j.margeo.2009.06.001; Thurber AR, LIMNOLOGY O IN PRESS; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; TYLER PA, 1992, INVERTEBR REPROD DEV, V22, P185, DOI 10.1080/07924259.1992.9672271; Van Dover CL, 2012, MAR POLICY, V36, P378, DOI 10.1016/j.marpol.2011.07.002; Wallmann K, 1997, GEOCHIM COSMOCHIM AC, V61, P5209, DOI 10.1016/S0016-7037(97)00306-2	69	44	46	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76869	10.1371/journal.pone.0076869	http://dx.doi.org/10.1371/journal.pone.0076869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204691	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300058
J	Kim, JH; Kim, GE; Cho, GS; Kwon, HJ; Joo, CH; Kim, HS; Jang, YJ				Kim, Ji Heui; Kim, Gye Eun; Cho, Gye Song; Kwon, Hyung-Joon; Joo, Chul Hyun; Kim, Hun Sik; Jang, Yong Ju			Natural Killer Cells from Patients with Chronic Rhinosinusitis Have Impaired Effector Functions	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INNATE IMMUNITY; RECALCITRANT RHINOSINUSITIS; CHRONIC SINUSITIS; NK CELLS; EXPRESSION; ACTIVATION; ASTHMA; POLARIZATION; PATHOGENESIS	Natural killer (NK) cells are multicompetent lymphocytes of the innate immune system that play a central role in host defense and immune regulation. Although increasing evidence suggests that innate immunity plays a key role in the pathogenesis of chronic rhinosinusitis (CRS), the role of NK cells in CRS has been poorly studied. This study aimed to characterize the peripheral blood NK cells from patients with CRS, and to compare the functions of these cells with those from non-CRS controls. The correlation between NK cell functional activity and prognosis was also assessed. Eighteen CRS patients and 19 healthy non-CRS controls were included. The patients with CRS were classified into two subgroups, namely a treatment-responsive group and recalcitrant group. NK cell degranulation was determined by measuring the cell surface expression of CD107a against 721.221 and K562 cells. Intracytoplasmic cytokine production was determined by flow cytometry. Compared to the controls, the NK cells of CRS group had an impaired ability to degranulate and to produce cytokines such as IFN-gamma and TNF-alpha. The recalcitrant subgroup showed the most severe defects in NK cell effector functions. Moreover, the decreased NK cell functions in patients with CRS were associated with poor prognostic factors such as concomitant asthma and peripheral blood eosinophilia. NK cells, which were originally named for their ability to mediate spontaneous cytotoxicity towards diseased cells including infected cells, may play an important role in regulating the inflammatory process in CRS pathogenesis.	[Kim, Ji Heui; Cho, Gye Song; Jang, Yong Ju] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol, Seoul, South Korea; [Kim, Gye Eun; Kwon, Hyung-Joon; Kim, Hun Sik] Univ Ulsan, Coll Med, Grad Sch, Dept Med, Seoul, South Korea; [Joo, Chul Hyun; Kim, Hun Sik] Univ Ulsan, Coll Med, Dept Microbiol, Seoul, South Korea; [Kim, Hun Sik] Univ Ulsan, Coll Med, Cellular Dysfunct Res Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; University of Ulsan	Kim, HS (corresponding author), Univ Ulsan, Coll Med, Grad Sch, Dept Med, Seoul, South Korea.	hunkim@amc.seoul.kr; jangyj@amc.seoul.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A110893]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A110893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Bresciani M, 2001, J ALLERGY CLIN IMMUN, V107, P73, DOI 10.1067/mai.2001.111593; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Dupuy S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002486; El-Shazly AE, 2013, CLIN EXP ALLERGY, V43, P322, DOI 10.1111/cea.12022; El-Shazly AE, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/373589; Fairclough L, 2008, CLIN SCI, V114, P533, DOI 10.1042/CS20070356; Fokkens WJ, 2010, RHINOLOGY, V48, P257, DOI 10.4193/Rhin10.300; Hamilos DL, 2011, J ALLERGY CLIN IMMUN, V128, P693, DOI 10.1016/j.jaci.2011.08.004; HAMILOS DL, 1995, J ALLERGY CLIN IMMUN, V96, P537, DOI 10.1016/S0091-6749(95)70298-9; Hsu J, 2011, AM J RHINOL ALLERGY, V25, P285, DOI 10.2500/ajra.2011.25.3680; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Jyonouchi H, 2001, ARCH OTOLARYNGOL, V127, P1488, DOI 10.1001/archotol.127.12.1488; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kim HS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002754; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Lane AP, 2009, CURR ALLERGY ASTHM R, V9, P205, DOI 10.1007/s11882-009-0030-5; Lane AP, 2006, AM J RHINOL, V20, P138, DOI 10.1177/194589240602000203; Lee Stella, 2011, Curr Infect Dis Rep, V13, P159, DOI 10.1007/s11908-011-0166-z; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Matsubara S, 2007, AM J RESP CELL MOL, V36, P324, DOI 10.1165/rcmb.2006-0231OC; Matsuwaki Y, 2008, INT ARCH ALLERGY IMM, V146, P77, DOI 10.1159/000126066; Mesdaghi M, 2010, INT ARCH ALLERGY IMM, V153, P234, DOI 10.1159/000314363; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Ozdemir O, 2005, J ALLERGY CLIN IMMUN, V116, P1165, DOI 10.1016/j.jaci.2005.08.007; Papakosta D, 2009, RESPIRATION, V78, P177, DOI 10.1159/000203989; Parolini S, 2000, J EXP MED, V192, P337, DOI 10.1084/jem.192.3.337; Payne SC, 2011, J ALLERGY CLIN IMMUN, V128, P710, DOI 10.1016/j.jaci.2011.05.022; Prieto A, 2001, AM J RESP CRIT CARE, V163, P1578, DOI 10.1164/ajrccm.163.7.2002015; Ramanathan M, 2007, OTOLARYNG HEAD NECK, V136, P348, DOI 10.1016/j.otohns.2006.11.011; Rosenfeld RM, 2007, OTOLARYNG HEAD NECK, V137, pS1, DOI 10.1016/j.otohns.2007.06.726; Schierloh P, 2005, IMMUNOLOGY, V116, P541, DOI 10.1111/j.1365-2567.2005.02259.x; Strieter RM, 2004, J CLIN INVEST, V114, P165, DOI 10.1172/JCI200422398; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; Vankayalapati R, 2002, J IMMUNOL, V168, P3451, DOI 10.4049/jimmunol.168.7.3451; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wei HM, 2005, J ALLERGY CLIN IMMUN, V115, P841, DOI 10.1016/j.jaci.2004.11.026; Wesselkamper SC, 2008, J IMMUNOL, V181, P5481, DOI 10.4049/jimmunol.181.8.5481	41	19	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77177	10.1371/journal.pone.0077177	http://dx.doi.org/10.1371/journal.pone.0077177			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204766	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300088
J	King, AJF; Guo, YJ; Cai, DS; Hollister-Lock, J; Morris, B; Salvatori, A; Corbett, JA; Bonner-Weir, S; Shoelson, SE; Weir, GC				King, Aileen J. F.; Guo, Yongjing; Cai, Dongsheng; Hollister-Lock, Jennifer; Morris, Brooke; Salvatori, Alison; Corbett, John A.; Bonner-Weir, Susan; Shoelson, Steven E.; Weir, Gordon C.			Sustained NF-kappa B Activation and Inhibition in beta-Cells Have Minimal Effects on Function and Islet Transplant Outcomes	PLOS ONE			English	Article							OXIDE SYNTHASE EXPRESSION; STIMULATED-INSULIN-SECRETION; TRANSCRIPTION FACTOR; PANCREATIC-ISLETS; IKK-BETA; CHRONIC HYPERGLYCEMIA; SODIUM-SALICYLATE; DIABETES-MELLITUS; RANDOMIZED-TRIAL; APOPTOSIS	The activation of the transcription factor NF-kappa B leads to changes in expression of many genes in pancreatic beta-cells. However, the role of NF-kappa B activation in islet transplantation has not been fully elucidated. The aim of the present study was to investigate whether the state of NF-kappa B activation would influence the outcome of islet transplantation. Transgenic mice expressing a dominant active IKK beta (constitutively active) or a non-degradable form of I kappa B alpha (constitutive inhibition) under control of the rat insulin promoter were generated. Islets from these mice were transplanted into streptozotocin diabetic mice in suboptimal numbers. Further, the effects of salicylate (an inhibitor of NF-kappa B) treatment of normal islets prior to transplantation, and the effects of salicylate administration to mice prior to and after islet implantation were evaluated. Transplantation outcomes were not affected using islets expressing a non-degradable form of I kappa B alpha when compared to wild type controls. However, the transplantation outcomes using islets isolated from mice expressing a constitutively active mutant of NF-kappa B were marginally worse, although no aberrations of islet function in vitro could be detected. Salicylate treatment of normal islets or mice had no effect on transplantation outcome. The current study draws attention to the complexities of NF-kappa B in pancreatic beta cells by suggesting that they can adapt with normal or near normal function to both chronic activation and inhibition of this important transcription factor.	[King, Aileen J. F.] Kings Coll London, Diabet Res Grp, London, England; [King, Aileen J. F.; Hollister-Lock, Jennifer; Morris, Brooke; Bonner-Weir, Susan; Shoelson, Steven E.; Weir, Gordon C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02115 USA; [Guo, Yongjing; Cai, Dongsheng] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Pathophysiol & Mol Pharmacol, Boston, MA 02115 USA; [Salvatori, Alison] St Louis Univ, Dept Physiol & Pharmacol, St Louis, MO 63103 USA; [Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of London; King's College London; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Saint Louis University; Medical College of Wisconsin	Weir, GC (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02115 USA.	gordon.weir@joslin.harvard.edu	King, Aileen/I-5935-2013	King, Aileen/0000-0001-5759-7985; Bonner-Weir, Susan/0000-0003-4682-0656	Juvenile Diabetes Research Foundation; National Institutes of Health [R01 DK 66056, DK 93909, R01 DK 45943, DK 51729]; Joslin Diabetes Research Center (DRC) Advanced Microscopy Core [P30 DK36836]; Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051729, R01DK066056, P30DK036836, R01DK045943, R01DK051729, R01DK093909] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joslin Diabetes Research Center (DRC) Advanced Microscopy Core; Diabetes Research and Wellness Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Juvenile Diabetes Research Foundation (GCW), grants from the National Institutes of Health: R01 DK 66056 and DK 93909 (SBW) and R01 DK 45943 and DK 51729 (SES), P30 DK36836 Joslin Diabetes Research Center (DRC) Advanced Microscopy Core, as well as the Diabetes Research and Wellness Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; ANDERSSON A, 1983, CRYOBIOLOGY, V20, P161, DOI 10.1016/0011-2240(83)90005-6; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Borthwick GM, 2006, FASEB J, V20, P2009, DOI 10.1096/fj.06-5987com; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Chen C, 2011, AM J TRANSPLANT, V11, P215, DOI 10.1111/j.1600-6143.2010.03390.x; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Ding XM, 2012, ARTIF ORGANS, V36, pE21, DOI 10.1111/j.1525-1594.2011.01395.x; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Eldor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056924; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Giannoukakis N, 2000, J BIOL CHEM, V275, P36509, DOI 10.1074/jbc.M005943200; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; Hawley SA, 2012, SCIENCE; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Heitmeier MR, 1999, J BIOL CHEM, V274, P29266, DOI 10.1074/jbc.274.41.29266; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; KWON G, 1995, ENDOCRINOLOGY, V136, P4790, DOI 10.1210/en.136.11.4790; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Mabley JG, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730457; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; McCall MD, 2011, ISLETS, V3; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; Rink JS, 2012, SURGERY, V151, P330, DOI 10.1016/j.surg.2011.07.011; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SoRelle JA, 2013, DIABETOLOGIA, V56, P814, DOI 10.1007/s00125-012-2813-9; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Takahashi T, 2010, J SURG RES, V163, pE23, DOI 10.1016/j.jss.2010.04.044; Tillmar L, 2002, J BIOL CHEM, V277, P1099, DOI 10.1074/jbc.M108340200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zeender E, 2004, J CLIN ENDOCR METAB, V89, P5059, DOI 10.1210/jc.2004-0446	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77452	10.1371/journal.pone.0077452	http://dx.doi.org/10.1371/journal.pone.0077452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204831	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300097
J	Assmy, P; Ehn, JK; Fernandez-Mendez, M; Hop, H; Katlein, C; Sundfjord, A; Bluhm, K; Daase, M; Engel, A; Fransson, A; Granskog, MA; Hudson, SR; Kristiansen, S; Nicolaus, M; Peeken, I; Renner, AHH; Spreen, G; Tatarek, A; Wiktor, J				Assmy, Philipp; Ehn, Jens K.; Fernandez-Mendez, Mar; Hop, Haakon; Katlein, Christian; Sundfjord, Arild; Bluhm, Katrin; Daase, Malin; Engel, Anja; Fransson, Agneta; Granskog, Mats A.; Hudson, Stephen R.; Kristiansen, Svein; Nicolaus, Marcel; Peeken, Ilka; Renner, Angelika H. H.; Spreen, Gunnar; Tatarek, Agnieszka; Wiktor, Jozef			Floating Ice-Algal Aggregates below Melting Arctic Sea Ice	PLOS ONE			English	Article							TRANSPARENT EXOPOLYMER PARTICLES; POLYMERIC SUBSTANCES EPS; ATLANTIC-OCEAN; NATURAL-WATERS; CHLOROPHYLL-A; BARENTS SEA; PHYTOPLANKTON; CARBON; TEP; TRANSFORMATION	During two consecutive cruises to the Eastern Central Arctic in late summer 2012, we observed floating algal aggregates in the melt-water layer below and between melting ice floes of first-year pack ice. The macroscopic (1-15 cm in diameter) aggregates had a mucous consistency and were dominated by typical ice-associated pennate diatoms embedded within the mucous matrix. Aggregates maintained buoyancy and accumulated just above a strong pycnocline that separated meltwater and seawater layers. We were able, for the first time, to obtain quantitative abundance and biomass estimates of these aggregates. Although their biomass and production on a square metre basis was small compared to ice-algal blooms, the floating ice-algal aggregates supported high levels of biological activity on the scale of the individual aggregate. In addition they constituted a food source for the ice-associated fauna as revealed by pigments indicative of zooplankton grazing, high abundance of naked ciliates, and ice amphipods associated with them. During the Arctic melt season, these floating aggregates likely play an important ecological role in an otherwise impoverished near-surface sea ice environment. Our findings provide important observations and measurements of a unique aggregate-based habitat during the 2012 record sea ice minimum year.	[Assmy, Philipp; Hop, Haakon; Sundfjord, Arild; Daase, Malin; Fransson, Agneta; Granskog, Mats A.; Hudson, Stephen R.; Renner, Angelika H. H.; Spreen, Gunnar] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Ehn, Jens K.] Univ Manitoba, Ctr Earth Observat Sci, Winnipeg, MB, Canada; [Fernandez-Mendez, Mar; Katlein, Christian; Nicolaus, Marcel; Peeken, Ilka] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Bremerhaven, Germany; [Fernandez-Mendez, Mar] Max Planck Inst Marine Microbiol, Bremen, Germany; [Bluhm, Katrin] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Engel, Anja] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Kristiansen, Svein] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Peeken, Ilka] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Tatarek, Agnieszka; Wiktor, Jozef] Polish Acad Sci, Inst Oceanol, Sopot, Poland	Norwegian Polar Institute; University of Manitoba; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Max Planck Society; Akvaplan-niva; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; UiT The Arctic University of Tromso; University of Bremen; Polish Academy of Sciences; Institute of Oceanology of the Polish Academy of Sciences	Assmy, P (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	Philipp.Assmy@npolar.no	Nicolaus, Marcel/A-3658-2013; Spreen, Gunnar/A-4533-2010; Hudson, Stephen/ABD-9923-2020; Katlein, Christian/AAY-8731-2020	Nicolaus, Marcel/0000-0003-0903-1746; Spreen, Gunnar/0000-0003-0165-8448; Hudson, Stephen/0000-0002-6498-9167; Peeken, Ilka/0000-0003-1531-1664; Fernandez-Mendez, Mar/0000-0002-4968-1156; Daase, Malin/0000-0001-8413-3924; Sundfjord, Arild/0000-0002-6913-3368; Tatarek, Agnieszka/0000-0003-1467-6362; Granskog, Mats/0000-0002-5035-4347; Renner, Angelika/0000-0002-9997-6366; Katlein, Christian/0000-0003-2422-0414; Engel, Anja/0000-0002-1042-1955	Centre for Ice, Climate and Ecosystems (ICE) at the Norwegian Polar Institute; Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung	Centre for Ice, Climate and Ecosystems (ICE) at the Norwegian Polar Institute; Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung	This work was supported by the Centre for Ice, Climate and Ecosystems (ICE) at the Norwegian Polar Institute and the Alfred-Wegener-Institut Helmholtz-Zentrum fur Polar- und Meeresforschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge AL, 1998, J PLANKTON RES, V20, P393, DOI 10.1093/plankt/20.3.393; ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; Ambrose WG, 2005, POLAR BIOL, V28, P784, DOI 10.1007/s00300-005-0002-8; Arndt CE, 2005, J CRUSTACEAN BIOL, V25, P401, DOI 10.1651/C-2544; Arrigo KR., 2010, SEA ICE, P283, DOI DOI 10.1002/9781444317145.CH8; Aslam SN, 2012, J PHYCOL, V48, P1494, DOI 10.1111/jpy.12004; Bluhm K, 2010, AQUAT BIOL, V11, P1, DOI 10.3354/ab00284; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; Campos MLAM, 1997, MAR CHEM, V57, P107, DOI 10.1016/S0304-4203(96)00093-X; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Deal C, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006409; Ehn JK, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006908; Eicken H, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000583; Engel A, 2004, DEEP-SEA RES PT I, V51, P83, DOI 10.1016/j.dsr.2003.09.001; Engel A., 2009, PRACTICAL GUIDELINES, P125, DOI DOI 10.1201/9781420073072.CH7; Gran H.H., 1904, SCI RES NORW N POLAR, VIV, P1; GUTT J, 1995, POLAR BIOL, V15, P247; Haas C, 2006, ANN GLACIOL-SER, V44, P247, DOI 10.3189/172756406781811781; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; HEAD EJH, 1992, MAR ECOL PROG SER, V86, P229, DOI 10.3354/meps086229; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Hop H, 2006, PROG OCEANOGR, V71, P182, DOI 10.1016/j.pocean.2006.09.007; Hop H, 2011, POLAR BIOL, V34, P1947, DOI 10.1007/s00300-011-0991-4; HORNER RA, 1988, POLAR BIOL, V8, P249, DOI 10.1007/BF00263173; Hudson SR, 2013, GEOPHYS RES LETT, V40, P2679, DOI 10.1002/grl.50517; Ji RB, 2013, GLOBAL CHANGE BIOL, V19, P734, DOI 10.1111/gcb.12074; Juhl AR, 2011, MAR ECOL PROG SER, V436, P1, DOI 10.3354/meps09277; Krembs C, 2002, DEEP-SEA RES PT I, V49, P2163, DOI 10.1016/S0967-0637(02)00122-X; Krembs C, 2001, MAR BIOL, V138, P173, DOI 10.1007/s002270000396; Lee SH, 2011, OCEANOGRAPHY, V24, P302, DOI 10.5670/oceanog.2011.81; Lovejoy C, 2002, DEEP-SEA RES PT II, V49, P5027, DOI 10.1016/S0967-0645(02)00176-5; LUTHER GW, 1988, ANAL CHEM, V60, P1721, DOI 10.1021/ac00168a017; Meiners K, 2008, AQUAT MICROB ECOL, V52, P195, DOI 10.3354/ame01214; Melnikov I., 1997, ARCTIC SEA ICE ECOSY; Melnikov IA, 2002, DEEP-SEA RES PT I, V49, P1623, DOI 10.1016/S0967-0637(02)00042-0; Michel C, 2002, AQUAT MICROB ECOL, V30, P57, DOI 10.3354/ame030057; Mikkelsen DM, 2010, POLAR RES, V29, P451, DOI 10.1111/j.1751-8369.2010.00162.x; Mundy CJ, 2011, POLAR BIOL, V34, P1869, DOI 10.1007/s00300-011-0998-x; Nansen F., 1906, NORWEGIAN N POLAR EX, V1893-1896, P1; Nicolaus M, 2013, CRYOSPHERE, V7, P763, DOI 10.5194/tc-7-763-2013; Nicolaus M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053738; Nicolaus M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006074; OWENS TG, 1982, PHYTOCHEMISTRY, V21, P979, DOI 10.1016/S0031-9422(00)82401-2; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Perovich DK., 1996, MONOGRAPH COLD REGIO; PLATT T, 1980, J MAR RES, V38, P687; Poltermann M, 2001, POLAR BIOL, V24, P89, DOI 10.1007/s003000000177; Renaud PE, 2007, J MARINE SYST, V67, P1, DOI 10.1016/j.jmarsys.2006.07.006; RIEBESELL U, 1991, POLAR BIOL, V11, P239; Riedel A, 2006, AQUAT MICROB ECOL, V45, P195, DOI 10.3354/ame045195; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Soreide JE, 2006, PROG OCEANOGR, V71, P59, DOI 10.1016/j.pocean.2006.06.001; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; Steemann-Nielsen E, 1952, J CONS CONS PERM INT, V18, P117, DOI DOI 10.1093/ICESJMS/18.2.117; SYVERTSEN EE, 1991, POLAR RES, V10, P277, DOI 10.1111/j.1751-8369.1991.tb00653.x; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tamelander T, 2009, POLAR BIOL, V32, P1261, DOI 10.1007/s00300-009-0622-5; Taylor BB, 2011, BIOGEOSCIENCES, V8, P3609, DOI 10.5194/bg-8-3609-2011; Throndsen J., 1995, MANUAL HARMFUL MARIN, P63; TSUJI T, 1981, MAR BIOL, V64, P207, DOI 10.1007/BF00397110; Underwood GJC, 2010, MAR ECOL PROG SER, V404, P1, DOI 10.3354/meps08557; von Karman T, 1930, AHNLICHKEIT TURBULEN, V1, P58; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Werner I, 2005, MAR ECOL PROG SER, V292, P251, DOI 10.3354/meps292251	66	60	65	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76599	10.1371/journal.pone.0076599	http://dx.doi.org/10.1371/journal.pone.0076599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24204642	Green Published, Green Accepted, gold			2022-12-25	WOS:000326019400075
J	Hao, W; Collier, SM; Moffett, P; Chai, JJ				Hao, Wei; Collier, Sarah M.; Moffett, Peter; Chai, Jijie			Structural Basis for the Interaction between the Potato Virus X Resistance Protein (Rx) and Its Cofactor Ran GTPase-activating Protein 2 (RanGAP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Plant Molecular Biology; Protein Structure; Protein; Protein Interactions; Structural Biology; X-ray Crystallography; RanGAP; Rx; Coiled-coil Domain; Plant Resistance Protein	RICH REPEAT PROTEIN; DISEASE RESISTANCE; CRYSTAL-STRUCTURE; COILED-COIL; LRR PROTEIN; BINDING; DOMAIN; UNIQUE; GENE; ASSOCIATION	Background: The interaction of the potato disease resistance protein Rx with RanGAP2 is important for virus resistance. Results: The crystal structure of the complex of the Rx and RanGAP2 N-terminal domains was determined. Conclusion: The two proteins bind primarily through hydrophobic interactions. Significance: This work reveals the distinct surfaces of the Rx coiled-coil domain involved in intra- and intermolecular interactions. The potato (Solanum tuberosum) disease resistance protein Rx has a modular arrangement that contains coiled-coil (CC), nucleotide-binding (NB), and leucine-rich repeat (LRR) domains and mediates resistance to potato virus X. The Rx N-terminal CC domain undergoes an intramolecular interaction with the Rx NB-LRR region and an intermolecular interaction with the Rx cofactor RanGAP2 (Ran GTPase-activating protein 2). Here, we report the crystal structure of the Rx CC domain in complex with the Trp-Pro-Pro (WPP) domain of RanGAP2. The structure reveals that the Rx CC domain forms a heterodimer with RanGAP2, in striking contrast to the homodimeric structure of the CC domain of the barley disease resistance protein MLA10. Structure-based mutagenesis identified residues from both the Rx CC domain and the RanGAP2 WPP domain that are crucial for their interaction and function in vitro and in vivo. Our results reveal the molecular mechanism underlying the interaction of Rx with RanGAP2 and identify the distinct surfaces of the Rx CC domain that are involved in intramolecular and intermolecular interactions.	[Hao, Wei] China Agr Univ, Coll Biol Sci, Beijing 100193, Peoples R China; [Hao, Wei] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Collier, Sarah M.; Moffett, Peter] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Collier, Sarah M.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA; [Moffett, Peter] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Sherbrooke; Tsinghua University; Tsinghua University	Moffett, P (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	peter.moffett@usherbrooke.ca; chaijj@mail.tsinghua.edu.cn		Moffett, Peter/0000-0003-0678-4531; Collier, Sarah/0000-0002-8834-5075; Chai, Jijie/0000-0001-7591-3873	National Outstanding Young Scholar Science Foundation of China Grant [20101331722]; National Science Foundation Grant [IOB-0343327]; National Science Foundation graduate research fellowship	National Outstanding Young Scholar Science Foundation of China Grant; National Science Foundation Grant(National Science Foundation (NSF)); National Science Foundation graduate research fellowship(National Science Foundation (NSF))	This work was supported by National Outstanding Young Scholar Science Foundation of China Grant 20101331722 (to J. C.), National Science Foundation Grant IOB-0343327 (to P. M.), and a National Science Foundation graduate research fellowship (to S. M. C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Collier SM, 2011, MOL PLANT MICROBE IN, V24, P918, DOI 10.1094/MPMI-03-11-0050; Collier SM, 2009, TRENDS PLANT SCI, V14, P521, DOI 10.1016/j.tplants.2009.08.001; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frost D, 2004, MOL PLANT MICROBE IN, V17, P224, DOI 10.1094/MPMI.2004.17.2.224; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KOHM BA, 1993, PLANT CELL, V5, P913, DOI 10.1105/tpc.5.8.913; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Lewis J. D., 2013, P NATL ACAD IN PRESS; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Meier I, 2008, J MICROSC-OXFORD, V231, P225, DOI 10.1111/j.1365-2818.2008.02038.x; Meier I, 2010, BIOCHEM SOC T, V38, P733, DOI 10.1042/BST0380733; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Rose A, 2001, P NATL ACAD SCI USA, V98, P15377, DOI 10.1073/pnas.261459698; Sacco MA, 2007, PLANT J, V52, P82, DOI 10.1111/j.1365-313X.2007.03213.x; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Tameling WIL, 2007, PLANT CELL, V19, P1682, DOI 10.1105/tpc.107.050880; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461	34	77	83	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35868	35876		10.1074/jbc.M113.517417	http://dx.doi.org/10.1074/jbc.M113.517417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24194517	Green Published, hybrid			2022-12-25	WOS:000329814700023
J	Gardener, EKT; Carr, AR; MacGregor, A; Felmingham, KL				Gardener, Elyse K. T.; Carr, Andrea R.; MacGregor, Amy; Felmingham, Kim L.			Sex Differences and Emotion Regulation: An Event-Related Potential Study	PLOS ONE			English	Article							GENDER-DIFFERENCES; NEGATIVE EMOTIONS; RESPONSES; VALENCE; AROUSAL; MEMORY; TASK	Difficulties in emotion regulation have been implicated as a potential mechanism underlying anxiety and mood disorders. It is possible that sex differences in emotion regulation may contribute towards the heightened female prevalence for these disorders. Previous fMRI studies of sex differences in emotion regulation have shown mixed results, possibly due to difficulties in discriminating the component processes of early emotional reactivity and emotion regulation. The present study used event-related potentials (ERPs) to examine sex differences in N1 and N2 components (reflecting early emotional reactivity) and P3 and LPP components (reflecting emotion regulation). N1, N2, P3, and LPP were recorded from 20 men and 23 women who were instructed to "increase,'' "decrease,'' and "maintain'' their emotional response during passive viewing of negative images. Results indicated that women had significantly greater N1 and N2 amplitudes (reflecting early emotional reactivity) to negative stimuli than men, supporting a female negativity bias. LPP amplitudes increased to the "increase'' instruction, and women displayed greater LPP amplitudes than men to the "increase'' instruction. There were no differences to the "decrease'' instruction in women or men. These findings confirm predictions of the female negativity bias hypothesis and suggest that women have greater up-regulation of emotional responses to negative stimuli. This finding is highly significant in light of the female vulnerability for developing anxiety disorders.	[Gardener, Elyse K. T.; Carr, Andrea R.; MacGregor, Amy; Felmingham, Kim L.] Univ Tasmania, Sch Psychol, Hobart, Tas, Australia	University of Tasmania	Felmingham, KL (corresponding author), Univ Tasmania, Sch Psychol, Hobart, Tas, Australia.	Kim.Felmingham@utas.edu.au		Carr, Andrea/0000-0001-8201-7890				Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Campanella S, 2004, NEUROSCI LETT, V367, P14, DOI 10.1016/j.neulet.2004.05.097; Campanella S, 2012, PSYCHIAT RES, V197, P145, DOI 10.1016/j.psychres.2011.12.026; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; Domes G, 2010, HUM BRAIN MAPP, V31, P758, DOI 10.1002/hbm.20903; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Gasbarri A, 2006, BEHAV BRAIN RES, V168, P177, DOI 10.1016/j.bbr.2005.07.034; Gross J.J., 2007, HDB EMOTION REGULATI, P3; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Han SH, 2008, BRAIN RES, V1196, P85, DOI 10.1016/j.brainres.2007.12.062; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lang P.J., 2008, A8 U FLOR; Li H, 2008, NEUROIMAGE, V40, P1921, DOI 10.1016/j.neuroimage.2008.01.033; Lithari C, 2012, BIOMED SIGNAL PROCES, V7, P228, DOI 10.1016/j.bspc.2011.05.004; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mennin DS, 2007, BEHAV THER, V38, P284, DOI 10.1016/j.beth.2006.09.001; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moser JS, 2010, COGN AFFECT BEHAV NE, V10, P195, DOI 10.3758/CABN.10.2.195; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P17, DOI 10.1111/j.1469-8986.2008.00721.x; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; Proverbio AM, 2009, NEUROPSYCHOLOGIA, V47, P2374, DOI 10.1016/j.neuropsychologia.2008.10.030; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003; Williams Leanne M., 2008, Journal of Integrative Neuroscience, V7, P367, DOI 10.1142/S0219635208001939; Williams LM, 2005, NEUROIMAGE, V28, P618, DOI 10.1016/j.neuroimage.2005.06.035	36	67	70	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e73475	10.1371/journal.pone.0073475	http://dx.doi.org/10.1371/journal.pone.0073475			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	243RL	24204562	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500003
J	Huang, SG; Zhang, LL; Niu, Q; Xiang, GM; Liu, LL; Jiang, DN; Liu, F; Li, Y; Pu, XY				Huang, Shao-guang; Zhang, Le-le; Niu, Qin; Xiang, Gui-ming; Liu, Lin-lin; Jiang, Dong-neng; Liu, Fei; Li, Yi; Pu, Xiaoyun			Hypoxia Promotes Epithelial - Mesenchymal Transition of Hepatocellular Carcinoma Cells via Inducing GLIPR-2 Expression	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; PROGRESSION; METASTASIS; PATHWAYS; INVASION	Glioma pathogenesis related-2 (GLIPR-2) belongs to pathogenesis related-1 (PR-1) family whose function remains unknown. In our previous studies, GLIPR-2 was found to be a novel potent stimulator of epithelial-to-mesenchymal transition (EMT) in renal fibrosis which has been classified as type 2 EMT. However, whether GLIPR-2 could induce type 3 EMT in carcinogenesis needs further investigation. In this study, we showed that GLIPR-2 was expressed in hepatocellular carcinoma (HCC) tissues, hypoxia could upregulate the expression of GLIPR-2 in HepG2 and PLC/PRF/5 cells in vitro, overexpression of this protein promoted migration and invasion via EMT, knockdown of GLIPR-2 attenuated migration and invasion of HepG2 and PLC/PRF/5 cells in hypoxia. Moreover, extracellular signal-regulated kinases 1 and 2 (ERK1/2) are positively regulated by GLIPR-2. Taken together, we provide evidence for a hypoxia/GLIPR-2/EMT/migration and invasion axis in HCC cells and it provides novel insights into the mechanism of migration and invasion of hepatocellular carcinoma cells in hypoxia condition.	[Huang, Shao-guang; Zhang, Le-le; Xiang, Gui-ming; Liu, Lin-lin; Jiang, Dong-neng; Liu, Fei; Li, Yi; Pu, Xiaoyun] Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Niu, Qin] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Pu, XY (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China.	puxiaoyong@yahoo.com			National Natural Science Foundation of China [2009ZX10601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by contract grant sponsor National Natural Science Foundation of China, contract grant no. 2009ZX10601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter RM, 2007, MATRIX BIOL, V26, P20, DOI 10.1016/j.matbio.2006.09.005; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenberg I, 2002, GENE, V293, P141, DOI 10.1016/S0378-1119(02)00703-5; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Harrison L, 2004, ONCOLOGIST, V9, P31, DOI 10.1634/theoncologist.9-90005-31; Huang SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058574; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li X, 2012, EXP PHYSIOL, V97, P257, DOI 10.1113/expphysiol.2011.061382; Lin SC, 2012, J CLIN ENDOCRINOL ME; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sphyris N, 2011, JNCI-J NATL CANCER I, V103, P1644, DOI 10.1093/jnci/djr421; Subarsky P, 2003, CLIN EXP METASTAS, V20, P237, DOI 10.1023/A:1022939318102; Szyperski T, 1998, P NATL ACAD SCI USA, V95, P2262, DOI 10.1073/pnas.95.5.2262; Tafani M, 2011, CARCINOGENESIS, V32, P1167, DOI 10.1093/carcin/bgr101; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	26	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77497	10.1371/journal.pone.0077497	http://dx.doi.org/10.1371/journal.pone.0077497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204846	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700032
J	Kwak, N; Choi, SM; Lee, J; Park, YS; Lee, CH; Lee, SM; Yoo, CG; Kim, YW; Han, SK; Yim, JJ				Kwak, Nakwon; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon			Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; RAPID DETECTION; MICROSCOPY; SPUTUM	The Xpert MTB/RIF assay was introduced for timely and accurate detection of tuberculosis (TB). The aim of this study was to determine the diagnostic accuracy and turnaround time (TAT) of Xpert MTB/RIF assay in clinical practice in South Korea. We retrospectively reviewed the medical records of patients in whom Xpert MTB/RIF assay using sputum were requested. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the diagnosis of pulmonary tuberculosis (PTB) and detection of rifampicin resistance were calculated. In addition, TAT of Xpert MTB/RIF assay was compared with those of other tests. Total 681 patients in whom Xpert MTB/RIF assay was requested were included in the analysis. The sensitivity, specificity, PPV and NPV of Xpert MTB/RIF assay for diagnosis of PTB were 79.5% (124/156), 100.0% (505/505), 100.0% (124/124) and 94.0% (505/537), respectively. Those for the detection of rifampicin resistance were 57.1% (8/14), 100.0% (113/113), 100.0% (8/8) and 94.9% (113/119), respectively. The median TAT of Xpert MTB/RIF assay to the report of results and results confirmed by physicians in outpatient settings were 0 (0-1) and 6 (3-7) days, respectively. Median time to treatment after initial evaluation was 7 (4-9) days in patients with Xpert MTB/RIF assay, but was 21 (7-33.5) days in patients without Xpert MTB/RIF assay. Xpert MTB/RIF assay showed acceptable sensitivity and excellent specificity for the diagnosis of PTB and detection of rifampicin resistance in areas with intermediate TB burden. Additionally, the assay decreased time to the initiation of anti-TB drugs through shorter TAT.	[Kwak, Nakwon; Choi, Sun Mi; Lee, Jinwoo; Park, Young Sik; Lee, Chang-Hoon; Lee, Sang-Min; Yoo, Chul-Gyu; Kim, Young Whan; Han, Sung Koo; Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea	Seoul National University (SNU)	Yim, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 151, South Korea.	yimjj@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021; Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984; Yim, Jae-Joon/0000-0002-9605-0074	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0844]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann JS, 1999, J CLIN MICROBIOL, V37, P1419, DOI 10.1128/JCM.37.5.1419-1425.1999; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Joh JS, 2007, J KOREAN MED SCI, V22, P26, DOI 10.3346/jkms.2007.22.1.26; Koh WJ, 2006, INT J TUBERC LUNG D, V10, P1001; LIPSKY BA, 1984, REV INFECT DIS, V6, P214; Organization WH, 2011, RAP IMPL XPERT MTB R, V978, P4; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Park YS, 2012, TUBERC RESPIR DIS, V73, P48, DOI 10.4046/trd.2012.73.1.48; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Steingart KR, 2007, EXPERT REV ANTI-INFE, V5, P327, DOI 10.1586/14787210.5.3.327; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	19	49	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77456	10.1371/journal.pone.0077456	http://dx.doi.org/10.1371/journal.pone.0077456			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204834	Green Published, gold, Green Submitted			2022-12-25	WOS:000326270700030
J	Zheng, JS; Arnett, DK; Lee, YC; Shen, J; Parnell, LD; Smith, CE; Richardson, K; Li, D; Borecki, IB; Ordovas, JM; Lai, CQ				Zheng, Ju-Sheng; Arnett, Donna K.; Lee, Yu-Chi; Shen, Jian; Parnell, Laurence D.; Smith, Caren E.; Richardson, Kris; Li, Duo; Borecki, Ingrid B.; Ordovas, Jose M.; Lai, Chao-Qiang			Genome-Wide Contribution of Genotype by Environment Interaction to Variation of Diabetes-Related Traits	PLOS ONE			English	Article							COMMON SNPS EXPLAIN; INSULIN-RESISTANCE; FATTY-ACIDS; LARGE PROPORTION; BREAST-CANCER; LIFE-STYLE; ASSOCIATION; RISK; LOCI; HERITABILITY	While genome-wide association studies (GWAS) and candidate gene approaches have identified many genetic variants that contribute to disease risk as main effects, the impact of genotype by environment (GxE) interactions remains rather under-surveyed. To explore the importance of GxE interactions for diabetes-related traits, a tool for Genome-wide Complex Trait Analysis (GCTA) was used to examine GxE variance contribution of 15 macronutrients and lifestyle to the total phenotypic variance of diabetes-related traits at the genome-wide level in a European American population. GCTA identified two key environmental factors making significant contributions to the GxE variance for diabetes-related traits: carbohydrate for fasting insulin (25.1% of total variance, P-nominal = 0.032) and homeostasis model assessment of insulin resistance (HOMA-IR) (24.2% of total variance, P-nominal = 0.035), n-6 polyunsaturated fatty acid (PUFA) for HOMA-beta-cell-function (39.0% of total variance, P-nominal = 0.005). To demonstrate and support the results from GCTA, a GxE GWAS was conducted with each of the significant dietary factors and a control E factor (dietary protein), which contributed a non-significant GxE variance. We observed that GxE GWAS for the environmental factor contributing a significant GxE variance yielded more significant SNPs than the control factor. For each trait, we selected all significant SNPs produced from GxE GWAS, and conducted anew the GCTA to estimate the variance they contributed. We noted the variance contributed by these SNPs is higher than that of the control. In conclusion, we utilized a novel method that demonstrates the importance of genome-wide GxE interactions in explaining the variance of diabetes-related traits.	[Zheng, Ju-Sheng; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310027, Zhejiang, Peoples R China; [Zheng, Ju-Sheng; Lee, Yu-Chi; Shen, Jian; Parnell, Laurence D.; Smith, Caren E.; Richardson, Kris; Ordovas, Jose M.; Lai, Chao-Qiang] Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr, Boston, MA 02111 USA; [Arnett, Donna K.] Univ Alabama, Dept Epidemiol, Birmingham, MA USA; [Shen, Jian] Oregon Hlth & Sci Univ, Div Endocrinol, Bone & Mineral Unit, Portland, OR 97201 USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Zhejiang University; Tufts University; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham; Oregon Health & Science University; Washington University (WUSTL)	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310027, Zhejiang, Peoples R China.	duoli@zju.edu.cn; chaoqiang.lai@ars.usda.gov	; Li, Duo/N-3682-2013; Ordovas, Jose/B-8727-2013; Zheng, Ju-Sheng/J-3970-2015	Lai, Chao-Qiang/0000-0003-1107-8375; Li, Duo/0000-0001-5227-5565; Ordovas, Jose/0000-0002-7581-5680; Zheng, Ju-Sheng/0000-0001-6560-4890	National Natural Science Foundation of China [81273054]; Ph.D. Programs Foundation of Ministry of Education of China [20120101110107]; National Program on Key Basic Research Project of China (973 Program) [2011CB504002]; NHLBI [HL54776, HL078885]; US Department of Agriculture, Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072524, K08HL112845, R01HL091357] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Natural Science Foundation of China (81273054); by the Ph.D. Programs Foundation of Ministry of Education of China (20120101110107); by the National Program on Key Basic Research Project of China (973 Program: 2011CB504002); by NHLBI grant number HL54776 and HL078885; by contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture, Agriculture Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016; Akinkuolie AO, 2011, CLIN NUTR; Aslibekyan S, 2012, PHARMACOGENET GENOM, V22, P191, DOI 10.1097/FPC.0b013e32834fdd41; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen R, 2012, PLOS GENET, V8, P100, DOI 10.1371/journal.pgen.1002621; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Corella D, 2006, DIABETES CARE, V29, P1313, DOI 10.2337/dc06-0045; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; He K, 2009, PROG CARDIOVASC DIS, V52, P95, DOI 10.1016/j.pcad.2009.06.003; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Kim EHJ, 2006, AM J EPIDEMIOL, V164, P990, DOI 10.1093/aje/kwj309; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Lai CQ, 2012, PROG MOL BIOL TRANSL, V108, P461, DOI 10.1016/B978-0-12-398397-8.00018-6; Lee YC, 2011, J DATA MINING GENOMI, V2; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Manco M, 2004, DIABETES OBES METAB, V6, P402, DOI 10.1111/j.1462-8902.2004.00356.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Nettleton JA, 2010, DIABETES CARE, V33, P2684, DOI 10.2337/dc10-1150; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; Pala V, 2001, J NATL CANCER I, V93, P1088, DOI 10.1093/jnci/93.14.1088; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qi L, 2009, AM J CLIN NUTR, V89, P1453, DOI 10.3945/ajcn.2008.27249; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith CE, 2012, NUTR METAB CARDIOVAS, V22, P449, DOI 10.1016/j.numecd.2010.09.003; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Xun PC, 2012, DIABETES CARE, V35, P930, DOI 10.2337/dc11-1869; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044525; Zheng JS, 2012, PUBLIC HEALTH NUTR, V15, P725, DOI 10.1017/S1368980011002254	45	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77442	10.1371/journal.pone.0077442	http://dx.doi.org/10.1371/journal.pone.0077442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204828	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200028
J	Cao, MF; Zhang, H; Park, J; Daniels, NM; Crovella, ME; Cowen, LJ; Hescott, B				Cao, Mengfei; Zhang, Hao; Park, Jisoo; Daniels, Noah M.; Crovella, Mark E.; Cowen, Lenore J.; Hescott, Benjamin			Going the Distance for Protein Function Prediction: A New Distance Metric for Protein Interaction Networks	PLOS ONE			English	Article							GENE ONTOLOGY; SCALE-FREE; MODULARITY	In protein-protein interaction (PPI) networks, functional similarity is often inferred based on the function of directly interacting proteins, or more generally, some notion of interaction network proximity among proteins in a local neighborhood. Prior methods typically measure proximity as the shortest-path distance in the network, but this has only a limited ability to capture fine-grained neighborhood distinctions, because most proteins are close to each other, and there are many ties in proximity. We introduce diffusion state distance (DSD), a new metric based on a graph diffusion property, designed to capture finer-grained distinctions in proximity for transfer of functional annotation in PPI networks. We present a tool that, when input a PPI network, will output the DSD distances between every pair of proteins. We show that replacing the shortest-path metric by DSD improves the performance of classical function prediction methods across the board.	[Cao, Mengfei; Zhang, Hao; Park, Jisoo; Daniels, Noah M.; Cowen, Lenore J.; Hescott, Benjamin] Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA; [Crovella, Mark E.] Boston Univ, Dept Comp Sci, Boston, MA 02215 USA	Tufts University; Boston University	Cowen, LJ (corresponding author), Tufts Univ, Dept Comp Sci, Medford, MA 02155 USA.	lenore.cowen@tufts.edu; benjamin.hescott@tufts.edu	Cao, Mengfei/V-6685-2018; Crovella, Mark/N-5423-2014; Crovella, Mark/AIB-6289-2022	Cao, Mengfei/0000-0002-1101-338X; Crovella, Mark/0000-0002-5005-7019; Crovella, Mark/0000-0002-5005-7019; Daniels, Noah/0000-0002-9538-825X	National Institutes of Health (NIH) [GM080330, R01 HD058880]; National Science Foundation [CNS-0905565, CNS-1018266, CNS-1012910, CNS-1117039]; Army Research Office [W911NF-11-1-0227]; Division Of Computer and Network Systems [1117039, 0905565] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080330] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Army Research Office; Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MC, HZ, NMD and LJC were supported in part by National Institutes of Health (NIH) R01 grant GM080330. JP was supported in part by NIH grant R01 HD058880. This material is based upon work supported by the National Science Foundation under grant numbers CNS-0905565, CNS-1018266, CNS-1012910, and CNS-1117039, and supported by the Army Research Office under grant W911NF-11-1-0227 (to MEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Chiang T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r186; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; Deng MH, 2004, BIOINFORMATICS, V20, P895, DOI 10.1093/bioinformatics/btg500; Deng Minghua, 2003, Pac Symp Biocomput, P140; Erten S, 2011, J COMPUT BIOL, V18, P1561, DOI 10.1089/cmb.2011.0154; Friedel CC, 2006, NAT BIOTECHNOL, V24, P614, DOI 10.1038/nbt0606-614; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; He XL, 2006, GENETICS, V173, P1885, DOI 10.1534/genetics.106.060269; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Huang H, 2009, BIOINFORMATICS, V25, P372, DOI 10.1093/bioinformatics/btn640; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Song JM, 2009, BIOINFORMATICS, V25, P3143, DOI 10.1093/bioinformatics/btp551; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489	29	29	32	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76339	10.1371/journal.pone.0076339	http://dx.doi.org/10.1371/journal.pone.0076339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194834	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000013
J	Hu, ZP; Wang, ZW; Wu, HB; Yang, ZM; Jiang, WL; Li, LC; Hu, XP				Hu, Zhipeng; Wang, Zhiwei; Wu, Hongbing; Yang, Zhimin; Jiang, Wanli; Li, Luocheng; Hu, Xiaoping			Ang II Enhances Noradrenaline Release from Sympathetic Nerve Endings Thus Contributing to the Up-Regulation of Metalloprotease-2 in Aortic Dissection Patients' Aorta Wall	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; NOREPINEPHRINE; EXPRESSION; ANEURYSMS; LOSARTAN; PROGRESSION; DILATION; PRESSURE; BLOCKADE; RECEPTOR	Object: To test the hypothesis that angiotensin II (Ang II) could enhance noradrenaline (NA) release from sympathetic nerve endings of the aorta thus contributing to the up-regulation of matrix metalloproteinase 2 (MMP-2) during the formation of aortic dissection (AD). Methods: Ang II, NA, MMP-2, MMP-9 of the aorta sample obtained during operation from aortic dissection patients were detected by High Performance Liquid Chromatography and ELISA and compared with controls. Isotope labelling method was used to test the impact of exogenous Ang II and noradrenaline on the NA release and MMP-2, MMP-9 expression on Sprague Dawley (SD) rat aorta rings in vitro. Two kidneys, one clip, models were replicated for further check of that impact in SD rats in vivo. Results: The concentration of Ang II, MMP-2, 9 was increased and NA concentration was decreased in aorta samples from AD patients. Exogenous Ang II enhanced while exogenous NA restrained NA release from aortic sympathetic endings. The Ang II stimulated NA release and the following MMP-2 up-regulation could be weakened by Losartan and chemical sympathectomy. Beta blocker did not influence NA release but down-regulated MMP-2. Long term in vivo experiments confirmed that Ang II could enhance NA release and up-regulate MMP-2. Conclusions: AD is initiated by MMP-2 overexpression as a result of increased NA release from sympathetic nervous endings in response to Ang II. This indicates an interaction of RAS and SAS during the formation of AD.	[Hu, Zhipeng; Wang, Zhiwei; Wu, Hongbing; Jiang, Wanli; Li, Luocheng; Hu, Xiaoping] Wuhan Univ, Renmin Hosp, Dept Cardiothorac Surg, Wuhan 430072, Hubei Province, Peoples R China; [Hu, Zhipeng; Yang, Zhimin] Xiangyang Cent Hosp, Dept Cardiothorac Surg, Xiangyang, Hubei Province, Peoples R China	Wuhan University	Wang, ZW (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiothorac Surg, Wuhan 430072, Hubei Province, Peoples R China.	wangzhiwp@gmail.com		Hu, Zhipeng/0000-0002-6384-0037				Bealer SL, 2000, BRAIN RES, V864, P291, DOI 10.1016/S0006-8993(00)02197-1; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Cabassi A, 2005, J CLIN ENDOCR METAB, V90, P2888, DOI 10.1210/jc.2004-1995; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Dab H, 2012, J RENIN-ANGIO-ALDO S, V13, P36, DOI 10.1177/1470320311428344; Dab H, 2011, GEN PHYSIOL BIOPHYS, V30, P271, DOI 10.4149/gpb_2011_03_271; Dab H, 2009, AUTON NEUROSCI-BASIC, V150, P27, DOI 10.1016/j.autneu.2009.04.002; DiBona GF, 2000, HYPERTENSION, V36, P1083, DOI 10.1161/01.HYP.36.6.1083; ELLIS JL, 1989, BRIT J PHARMACOL, V97, P1157, DOI 10.1111/j.1476-5381.1989.tb12574.x; Fabiani ME, 2001, J ENDOCRINOL, V171, P97, DOI 10.1677/joe.0.1710097; Falkay G, 2007, NEUROCHEM INT, V51, P306, DOI 10.1016/j.neuint.2007.06.012; Faugeroux J, 2013, HYPERTENSION; Forteza A, 2011, REV ESP CARDIOL, V64, P492, DOI [10.1016/j.rec.2011.02.013, 10.1016/j.recesp.2011.02.009]; Gersony DR, 2007, INT J CARDIOL, V114, P303, DOI 10.1016/j.ijcard.2005.11.116; Gironacci MM, 2004, REGUL PEPTIDES, V118, P45, DOI 10.1016/j.regpep.2003.10.026; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Head GA, 2004, HYPERTENSION, V43, P636, DOI 10.1161/01.HYP.0000116301.02975.aa; HEATH JW, 1977, J NEUROCYTOL, V6, P397, DOI 10.1007/BF01178225; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; LIU FY, 1988, J CLIN INVEST, V82, P601, DOI 10.1172/JCI113638; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Moller MN, 2010, LARYNGOSCOPE, V120, P657, DOI 10.1002/lary.20834; Rathore H. A., 2009, Autonomic & Autacoid Pharmacology, V29, P171, DOI 10.1111/j.1474-8665.2009.00445.x; Rodrigues DR, 2010, PLOS ONE, V5; Salman IM, 2010, INDIAN J MED RES, V131, P786; Scholze P, 2007, BRIT J PHARMACOL, V151, P414, DOI 10.1038/sj.bjp.0707236; Schulte K, 2011, PHARMACOL REP, V63, P102, DOI 10.1016/S1734-1140(11)70404-2; Segura AM, 1998, CIRCULATION, V98, pII331; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; Tavares P, 2003, PHARMACOL RES, V47, P27, DOI 10.1016/S1043-6618(02)00257-8; Teisman ACH, 2000, J AUTONOM NERV SYST, V78, P117, DOI 10.1016/S0165-1838(99)00066-1; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Trivedi DB, 2013, CIRC RES, V112, P1219, DOI 10.1161/CIRCRESAHA.112.280399; Tulppo MP, 2005, AM J PHYSIOL-HEART C, V288, pH710, DOI 10.1152/ajpheart.00540.2004; Uresin Y, 2004, J RENIN-ANGIO-ALDO S, V5, P93, DOI 10.3317/jraas.2004.017; von Kodolitsch Y, 2003, CIRCULATION, V107, P1158, DOI 10.1161/01.CIR.0000052628.77047.EA; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724	41	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76922	10.1371/journal.pone.0076922	http://dx.doi.org/10.1371/journal.pone.0076922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194850	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000029
J	Shahar, OD; Gabizon, R; Feine, O; Alhadeff, R; Ganoth, A; Argaman, L; Shimshoni, E; Friedler, A; Goldberg, M				Shahar, Or David; Gabizon, Ronen; Feine, Oren; Alhadeff, Raphael; Ganoth, Assaf; Argaman, Liron; Shimshoni, Elee; Friedler, Assaf; Goldberg, Michal			Acetylation of Lysine 382 and Phosphorylation of Serine 392 in p53 Modulate the Interaction between p53 and MDC1 In Vitro	PLOS ONE			English	Article							DNA-BINDING FUNCTION; TERMINAL DOMAIN; DAMAGE RESPONSE; C-TERMINUS; PROTEIN; ACTIVATION; COMPLEX; RAD51; REPAIR; 53BP1	Occurrence of DNA damage in a cell activates the DNA damage response, a survival mechanism that ensures genomics stability. Two key members of the DNA damage response are the tumor suppressor p53, which is the most frequently mutated gene in cancers, and MDC1, which is a central adaptor that recruits many proteins to sites of DNA damage. Here we characterize the in vitro interaction between p53 and MDC1 and demonstrate that p53 and MDC1 directly interact. The p53-MDC1 interaction is mediated by the tandem BRCT domain of MDC1 and the C-terminal domain of p53. We further show that both acetylation of lysine 382 and phosphorylation of serine 392 in p53 enhance the interaction between p53 and MDC1. Additionally, we demonstrate that the p53-MDC1 interaction is augmented upon the induction of DNA damage in human cells. Our data suggests a new role for acetylation of lysine 382 and phosphorylation of serine 392 in p53 in the cellular stress response and offers the first evidence for an interaction involving MDC1 that is modulated by acetylation.	[Shahar, Or David; Feine, Oren; Argaman, Liron; Shimshoni, Elee; Goldberg, Michal] Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Gabizon, Ronen; Friedler, Assaf] Hebrew Univ Jerusalem, Dept Organ Chem, Jerusalem, Israel; [Alhadeff, Raphael] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Ganoth, Assaf] Interdisciplinary Ctr IDC, Herzliyya, Israel; [Ganoth, Assaf] Univ Haifa, Dept Biol & Environm, Fac Nat Sci, Tivon, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Reichman University; University of Haifa	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	goldbergm@mail.huji.ac.il	Shahar, Or/ABG-9168-2020	Goldberg, Michal/0000-0001-9397-2383; Shahar, Or/0000-0002-5039-8307; Gabizon, Ronen/0000-0002-3626-5073	Lejwa foundation; Rudin Fellowship Trust; European Research Council under the European Community [203413]; Israel Academy of Sciences and Humanities	Lejwa foundation; Rudin Fellowship Trust; European Research Council under the European Community(European Research Council (ERC)); Israel Academy of Sciences and Humanities	MG was supported by the Lejwa foundation. RA is supported by the Rudin Fellowship Trust and AF. is supported by a starting grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 203413. RG is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Ahn J, 2001, NAT STRUCT BIOL, V8, P730, DOI 10.1038/nsb0901-730; Allen WJ, 2010, J PHYS CHEM B, V114, P13201, DOI 10.1021/jp1011445; Anderson ME, 1997, MOL CELL BIOL, V17, P6255, DOI 10.1128/MCB.17.11.6255; Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; BAYLE JH, 1995, P NATL ACAD SCI USA, V92, P5729, DOI 10.1073/pnas.92.12.5729; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger M, 2001, J BIOL CHEM, V276, P3785, DOI 10.1074/jbc.M008879200; Bradbury JM, 2003, BIOCHEM SOC T, V31, P40, DOI 10.1042/bst0310040; Canman CE, 2003, CURR BIOL, V13, pR488, DOI 10.1016/S0960-9822(03)00410-X; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Friedler A, 2005, J BIOL CHEM, V280, P8051, DOI 10.1074/jbc.M411176200; Gabizon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038060; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HORIKOSHI N, 1995, MOL CELL BIOL, V15, P227, DOI 10.1128/MCB.15.1.227; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; HUPP TR, 1994, CURR BIOL, V4, P865, DOI 10.1016/S0960-9822(00)00195-0; HUPP TR, 1993, NUCLEIC ACIDS RES, V21, P3167, DOI 10.1093/nar/21.14.3167; Iwabuchi K, 2003, J BIOL CHEM, V278, P36487, DOI 10.1074/jbc.M304066200; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Jenkins LMM, 2012, CARCINOGENESIS, V33, P1441, DOI 10.1093/carcin/bgs145; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kapoor M, 1998, P NATL ACAD SCI USA, V95, P2834, DOI 10.1073/pnas.95.6.2834; Lazaro-Trueba I, 2006, CELL CYCLE, V5, P1062, DOI 10.4161/cc.5.10.2764; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Linke SP, 2003, CANCER RES, V63, P2596; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lou ZK, 2004, J BIOL CHEM, V279, P46359, DOI 10.1074/jbc.C400375200; Lou ZK, 2003, J BIOL CHEM, V278, P13599, DOI 10.1074/jbc.C300060200; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Nakanishi M, 2007, J BIOL CHEM, V282, P22993, DOI 10.1074/jbc.M611412200; OLINER JD, 1993, BIOESSAYS, V15, P703, DOI 10.1002/bies.950151102; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Rodriguez M, 2003, J BIOL CHEM, V278, P52914, DOI 10.1074/jbc.C300407200; Romanova LY, 2004, ONCOGENE, V23, P9025, DOI 10.1038/sj.onc.1207982; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Sakaguchi K, 1997, J PROTEIN CHEM, V16, P553, DOI 10.1023/A:1026334116189; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; STURZBECHER HW, 1992, ONCOGENE, V7, P1513; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verma S, 2013, J BIOCHEM, V154, P237, DOI 10.1093/jb/mvt040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Weber PJA, 1998, BIOORG MED CHEM LETT, V8, P597, DOI 10.1016/S0960-894X(98)00084-5; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang JR, 2005, NAT STRUCT MOL BIOL, V12, P902, DOI 10.1038/nsmb991	83	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78472	10.1371/journal.pone.0078472	http://dx.doi.org/10.1371/journal.pone.0078472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194938	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000117
J	Wu, XJ; Bolger, WE; Anders, JJ				Wu, Xingjia; Bolger, William E.; Anders, Juanita J.			Fibroblasts Isolated from Human Middle Turbinate Mucosa Cause Neural Progenitor Cells to Differentiate into Glial Lineage Cells	PLOS ONE			English	Article							OLFACTORY ENSHEATHING CELLS; SPINAL-CORD-INJURY; CHONDROITIN SULFATE PROTEOGLYCANS; PROMOTE LOCOMOTOR RECOVERY; TRANSPLANT-MEDIATED REPAIR; AXONAL REGENERATION; SUPERIOR TURBINATE; SCHWANN-CELLS; ADULT RATS; IN-VITRO	Transplantation of olfactory ensheathing cells (OECs) is a potential therapy for repair of spinal cord injury (SCI). Autologous transplantation of OECs has been reported in clinical trials. However, it is still controversial whether purified OECs or olfactory mucosa containing OECs, fibroblasts and other cells should be used for transplantation. OECs and fibroblasts were isolated from olfactory mucosa of the middle turbinate from seven patients. The percentage of OECs with p75(NTR+) and GFAP(+) ranged from 9.2% to 73.2%. Fibroblasts were purified and co-cultured with normal human neural progenitors (NHNPs). Based on immunocytochemical labeling, NHNPs were induced into glial lineage cells when they were co-cultured with the mucosal fibroblasts. These results demonstrate that OECs can be isolated from the mucosa of the middle turbinate bone as well as from the dorsal nasal septum and superior turbinates, which are the typical sites for harvesting OECs. Transplantation of olfactory mucosa containing fibroblasts into the central nervous system (CNS) needs to be further investigated before translation to clinical application.	[Wu, Xingjia; Anders, Juanita J.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Bolger, William E.] Mayo Clin, Sch Med, Dept Otorhinolaryngol, Jacksonville, FL 32224 USA	Uniformed Services University of the Health Sciences - USA; Mayo Clinic	Anders, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	juanita.anders@usuhs.edu	Anders, Juanita/U-8404-2019		Maryland State Board of Spinal Cord Injury Research, Department of Health and Mental Hygiene; USU [G170OA]	Maryland State Board of Spinal Cord Injury Research, Department of Health and Mental Hygiene; USU	This work was funded by Maryland State Board of Spinal Cord Injury Research, Department of Health and Mental Hygiene (http://dhmh.maryland.gov/SitePages/Home.aspx), USU grant number G170OA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011; Bartus K, 2012, EXP NEUROL, V235, P5, DOI 10.1016/j.expneurol.2011.08.008; Bianco JI, 2004, GLIA, V45, P111, DOI 10.1002/glia.10298; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chhabra HS, 2009, SPINAL CORD, V47, P887, DOI 10.1038/sc.2009.54; Choi D, 2008, NEUROSURGERY, V62, P1140, DOI 10.1227/01.neu.0000325876.90623.df; DAVID G, 1989, J CELL BIOL, V108, P1165, DOI 10.1083/jcb.108.3.1165; DOUCETTE JR, 1984, ANAT REC, V210, P385, DOI 10.1002/ar.1092100214; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Garcia-Escudero V, 2012, NEUROSCI LETT, V509, P27, DOI 10.1016/j.neulet.2011.12.037; Gorrie CA, 2010, BRAIN RES, V1337, P8, DOI 10.1016/j.brainres.2010.04.019; Harrop JS, 2012, J NEUROSURG-SPINE, V17, P230, DOI 10.3171/2012.5.AOSPINE12115; Hashimoto-Uoshima M, 2002, J PERIODONTAL RES, V37, P42, DOI 10.1034/j.1600-0765.2002.00642.x; Higginson JR, 2011, EXP NEUROL, V229, P2, DOI 10.1016/j.expneurol.2010.08.020; Huang ZH, 2008, CELL RES, V18, P479, DOI 10.1038/cr.2008.38; Inoue H, 2011, J ARTIF ORGANS, V14, P375, DOI 10.1007/s10047-011-0598-0; JOHANSSON S, 1985, BIOCHEM J, V232, P161, DOI 10.1042/bj2320161; Kachramanoglou C, 2013, NEUROSURGERY, V72, P170, DOI 10.1227/NEU.0b013e31827b99be; Krudewig C, 2006, CELL TISSUE RES, V326, P687, DOI 10.1007/s00441-006-0238-9; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Lane AP, 2002, LARYNGOSCOPE, V112, P1183, DOI 10.1097/00005537-200207000-00007; LARJAVA H, 1992, BIOCHEM J, V284, P267, DOI 10.1042/bj2840267; Li BC, 2012, J MOL NEUROSCI, V48, P35, DOI 10.1007/s12031-012-9740-6; Li Y, 2005, GLIA, V52, P245, DOI 10.1002/glia.20241; Li Y, 2003, J NEUROSCI, V23, P727; Lima C, 2006, J SPINAL CORD MED, V29, P191, DOI 10.1080/10790268.2006.11753874; Lima C, 2010, NEUROREHAB NEURAL RE, V24, P10, DOI 10.1177/1545968309347685; Lindsay SL, 2010, GLIA, V58, P125, DOI 10.1002/glia.20917; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Nash HH, 2002, J NEUROSCI, V22, P7111; Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; Pfeifer K, 2004, EUR J NEUROSCI, V20, P1695, DOI 10.1111/j.1460-9568.2004.03657.x; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Savchenko EA, 2005, B EXP BIOL MED+, V139, P510, DOI 10.1007/s10517-005-0332-0; Say P, 2004, AM J RHINOL, V18, P157, DOI 10.1177/194589240401800305; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Toft A, 2013, GLIA, V61, P513, DOI 10.1002/glia.22452; Van den Pol AN, 2003, J COMP NEUROL, V458, P175, DOI 10.1002/cne.10577; Vincent AJ, 2005, J NEUROCYTOL, V34, P65, DOI 10.1007/s11068-005-5048-6; Vroemen M, 2007, CELL TISSUE RES, V327, P1, DOI 10.1007/s00441-006-0252-y	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76926	10.1371/journal.pone.0076926	http://dx.doi.org/10.1371/journal.pone.0076926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204706	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600016
J	Nightingale, CM; Rudnicka, AR; Owen, CG; Donin, AS; Newton, SL; Furness, CA; Howard, EL; Gillings, RD; Wells, JCK; Cook, DG; Whincup, PH				Nightingale, Claire M.; Rudnicka, Alicja R.; Owen, Christopher G.; Donin, Angela S.; Newton, Sian L.; Furness, Cheryl A.; Howard, Emma L.; Gillings, Rachel D.; Wells, Jonathan C. K.; Cook, Derek G.; Whincup, Peter H.			Are Ethnic and Gender Specific Equations Needed to Derive Fat Free Mass from Bioelectrical Impedance in Children of South Asian, Black African-Caribbean and White European Origin? Results of the Assessment of Body Composition in Children Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; UK CHILDREN; AGE; ENGLAND; OBESITY; MODEL; INDEX; PREDICTION; MORTALITY; HYDRATION	Background: Bioelectrical impedance analysis (BIA) is a potentially valuable method for assessing lean mass and body fat levels in children from different ethnic groups. We examined the need for ethnic-and gender-specific equations for estimating fat free mass (FFM) from BIA in children from different ethnic groups and examined their effects on the assessment of ethnic differences in body fat. Methods: Cross-sectional study of children aged 8-10 years in London Primary schools including 325 South Asians, 250 black African-Caribbeans and 289 white Europeans with measurements of height, weight and arm-leg impedance (Z; Bodystat 1500). Total body water was estimated from deuterium dilution and converted to FFM. Multilevel models were used to derive three types of equation {A: FFM = linear combination(height+weight+Z); B: FFM = linear combination(height(2)/Z); C: FFM = linear combination(height(2)/Z+weight)}. Results: Ethnicity and gender were important predictors of FFM and improved model fit in all equations. The models of best fit were ethnicity and gender specific versions of equation A, followed by equation C; these provided accurate assessments of ethnic differences in FFM and FM. In contrast, the use of generic equations led to underestimation of both the negative South Asian-white European FFM difference and the positive black African-Caribbean-white European FFM difference (by 0.53 kg and by 0.73 kg respectively for equation A). The use of generic equations underestimated the positive South Asian-white European difference in fat mass (FM) and overestimated the positive black African-Caribbean-white European difference in FM (by 4.7% and 10.1% respectively for equation A). Consistent results were observed when the equations were applied to a large external data set. Conclusions: Ethnic-and gender-specific equations for predicting FFM from BIA provide better estimates of ethnic differences in FFM and FM in children, while generic equations can misrepresent these ethnic differences.	[Nightingale, Claire M.; Rudnicka, Alicja R.; Owen, Christopher G.; Donin, Angela S.; Newton, Sian L.; Furness, Cheryl A.; Howard, Emma L.; Gillings, Rachel D.; Cook, Derek G.; Whincup, Peter H.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of London; University of London; University College London	Nightingale, CM (corresponding author), Univ London, Div Populat Hlth Sci & Educ, London, England.	c.nightingale@sgul.ac.uk	Cook, Derek G/C-3271-2008; Wells, Jonathan/A-4604-2009	Wells, Jonathan/0000-0003-0411-8025; Donin, Angela/0000-0002-8238-9923; Nightingale, Claire/0000-0003-2408-757X; Nightingale, Claire/0000-0002-4803-7617; Cook, Derek/0000-0002-9723-5759; Owen, Christopher/0000-0003-1135-5977; Rudnicka, Alicja R/0000-0003-0369-8574; Whincup, Peter/0000-0002-5589-4107	National Institute for Health Research (NIHR) [DRF-2010-02-101]; NIHR; BUPA Foundation [TBF-S09-019]; British Heart Foundation [PG/11/42/28895]; Wellcome Trust [068362/Z/02/Z]; National Prevention Research Initiative (NPRI) [G0501295]; MRC [G0501295] Funding Source: UKRI; Medical Research Council [G0501295] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-101] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); BUPA Foundation; British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Prevention Research Initiative (NPRI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Claire Nightingale was supported by a National Institute for Health Research (NIHR) fellowship (grant reference DRF-2010-02-101). Data collection in the ABCC Study was supported by the NIHR fellowship grant and the BUPA Foundation (grant reference TBF-S09-019). Deuterium analyses were funded by a project grant from the British Heart Foundation (grant reference PG/11/42/28895). Data collection in CHASE was supported by grants from the Wellcome Trust (grant reference 068362/Z/02/Z) and the National Prevention Research Initiative (NPRI) (grant reference G0501295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1991, MULTIPLE REGRESSION; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aksglaede L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002728; [Anonymous], 2001, LANCET, V357, P1989; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Clasey JL, 2011, OBESITY, V19, P1813, DOI 10.1038/oby.2011.158; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; DEURENBERG P, 1991, INT J OBESITY, V15, P17; Deurenberg P, 2002, EUR J CLIN NUTR, V56, P214, DOI 10.1038/sj.ejcn.1601303; DEURENBERG P, 1990, EUR J CLIN NUTR, V44, P261; Deurenberg-Yap M, 2001, BRIT J NUTR, V85, P491, DOI 10.1079/BJN2000276; Donin AS, 2010, AM J CLIN NUTR, V92, P776, DOI 10.3945/ajcn.2010.29533; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Haroun D, 2010, OBESITY, V18, P1252, DOI 10.1038/oby.2009.344; Health Survey for England, 2011, HLTH SURV ENGL 2010; Health Survey for England, 2006, HLTH SURV ENGL 2004; Jakicic JM, 1998, INT J OBESITY, V22, P243, DOI 10.1038/sj.ijo.0800576; KUSHNER RF, 1992, AM J CLIN NUTR, V56, P835, DOI 10.1093/ajcn/56.5.835; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Lear SA, 2009, J CLIN ENDOCR METAB, V94, P4696, DOI 10.1210/jc.2009-1030; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Nightingale CM, 2013, DIABETES CARE, V36, P1712, DOI 10.2337/dc12-1726; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Unni US, 2009, EUR J CLIN NUTR, V63, P1206, DOI 10.1038/ejcn.2009.32; Wells JCK, 1999, AM J CLIN NUTR, V69, P904; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2010, AM J CLIN NUTR, V91, P610, DOI 10.3945/ajcn.2009.28428; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010; Xu RH, 2003, STAT MED, V22, P3527, DOI 10.1002/sim.1572; Zhu SK, 2005, AM J CLIN NUTR, V81, P409	39	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76426	10.1371/journal.pone.0076426	http://dx.doi.org/10.1371/journal.pone.0076426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204625	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300028
J	Ruyra, A; Cano-Sarabia, M; MacKenzie, SA; Maspoch, D; Roher, N				Ruyra, Angels; Cano-Sarabia, Mary; MacKenzie, Simon A.; Maspoch, Daniel; Roher, Nerea			A Novel Liposome-Based Nanocarrier Loaded with an LPS-dsRNA Cocktail for Fish Innate Immune System Stimulation	PLOS ONE			English	Article							AEROMONAS-SALMONICIDA; ORAL IMMUNIZATION; VACCINE ADJUVANTS; DELIVERY-SYSTEMS; CATIONIC LIPIDS; EXPRESSION; RESPONSES; LIPOPOLYSACCHARIDE; RECOGNITION; MICROPARTICLES	Development of novel systems of vaccine delivery is a growing demand of the aquaculture industry. Nano- and microencapsulation systems are promising tools to achieve efficient vaccines against orphan vaccine fish diseases. In this context, the use of liposomal based-nanocarriers has been poorly explored in fish; although liposomal nanocarriers have successfully been used in other species. Here, we report a new similar to 125 nm-in-diameter unilamellar liposome-encapsulated immunostimulant cocktail containing crude lipopolysaccharide (LPS) from E. coli and polyinosinic: polycytidylic acid [ poly (I: C)], a synthetic analog of dsRNA virus, aiming to be used as a non-specific vaccine nanocarrier in different fish species. This liposomal carrier showed high encapsulation efficiencies and low toxicity not only in vitro using three different cellular models but also in vivo using zebrafish embryos and larvae. We showed that such liposomal LPS-dsRNA cocktail is able to enter into contact with zebrafish hepatocytes (ZFL cell line) and trout macrophage plasma membranes, being preferentially internalized through caveolae-dependent endocytosis, although clathrin-mediated endocytosis in ZFL cells and macropinocytocis in macrophages also contribute to liposome uptake. Importantly, we also demonstrated that this liposomal LPS-dsRNA cocktail elicits a specific pro-inflammatory and anti-viral response in both zebrafish hepatocytes and trout macrophages. The design of a unique delivery system with the ability to stimulate two potent innate immunity pathways virtually present in all fish species represents a completely new approach in fish health.	[Ruyra, Angels; MacKenzie, Simon A.; Roher, Nerea] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Parc Recerca UAB, E-08193 Barcelona, Spain; [Cano-Sarabia, Mary; Maspoch, Daniel] Inst Catala Nanociencia & Nanotecnol, ICN2, Barcelona, Spain; [Maspoch, Daniel] ICREA, Barcelona, Spain	Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); ICREA	Maspoch, D (corresponding author), Inst Catala Nanociencia & Nanotecnol, ICN2, Campus UAB, Barcelona, Spain.	daniel.maspoch@icn.cat; nerea.roher@uab.cat	MacKenzie, Simon/Q-2362-2019; Maspoch, Daniel/AFI-3557-2022; Cano-Sarabia, Mary/A-1648-2015; Maspoch, Daniel/AAF-3727-2022; Roher, Nerea/F-3216-2016; Maspoch, Daniel/O-9266-2015	MacKenzie, Simon/0000-0003-1845-6826; Cano-Sarabia, Mary/0000-0003-4254-8157; Roher, Nerea/0000-0002-6659-4038; Maspoch, Daniel/0000-0003-1325-9161	Fundacion Ramon Areces; Fundacio Amics de la Universitat Autonoma de Barcelona-Programa Aposta; Ministry of Industry and Competitiveness (Spain); ICREA Funding Source: Custom	Fundacion Ramon Areces; Fundacio Amics de la Universitat Autonoma de Barcelona-Programa Aposta; Ministry of Industry and Competitiveness (Spain); ICREA(ICREA)	This work was supported by the Fundacion Ramon Areces (2010) and the Fundacio Amics de la Universitat Autonoma de Barcelona-Programa Aposta (2011). NR wishes to thank the Ministry of Industry and Competitiveness (Spain) for the Ramon y Cajal grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; Balazs DA, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/326497; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Bennett-Guerrero E, 2000, INFECT IMMUN, V68, P6202, DOI 10.1128/IAI.68.11.6202-6208.2000; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Donate C, 2007, FISH SHELLFISH IMMUN, V23, P877, DOI 10.1016/j.fsi.2007.03.016; Dow SW, 2008, EXPERT OPIN DRUG DEL, V5, P11, DOI 10.1517/17425247.5.1.11; Evensen O., 2009, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P177; Fent K, 2010, AQUAT TOXICOL, V100, P218, DOI 10.1016/j.aquatox.2010.02.019; Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0; Fredriksen BN, 2012, VACCINE, V30, P656, DOI 10.1016/j.vaccine.2011.10.105; Galindo-Villegas J, 2012, P NATL ACAD SCI USA, V109, pE2605, DOI 10.1073/pnas.1209920109; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Goetz FW, 2004, DEV COMP IMMUNOL, V28, P487, DOI 10.1016/j.dci.2003.09.008; Harper SL, 2011, ACS NANO, V5, P4688, DOI 10.1021/nn200546k; Iliev DB, 2005, FEBS LETT, V579, P6519, DOI 10.1016/j.febslet.2005.10.061; Irie T, 2005, FISH SHELLFISH IMMUN, V18, P235, DOI 10.1016/j.fsi.2004.07.006; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jess TJ, 1996, CELL SIGNAL, V8, P297, DOI 10.1016/0898-6568(96)00054-X; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Khan M. A., 2011, Biology and Medicine, V3, P291; KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H; Lee KJ, 2007, ACS NANO, V1, P133, DOI 10.1021/nn700048y; Lieschke GJ, 2009, CURR BIOL, V19, pR678, DOI 10.1016/j.cub.2009.06.068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; MacKenzie S, 2003, DEV COMP IMMUNOL, V27, P393, DOI 10.1016/S0145-305X(02)00135-0; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Milla P, 2012, CURR DRUG METAB, V13, P105, DOI 10.2174/138920012798356934; Moghimi SM, 2011, ACS NANO, V5, P8454, DOI 10.1021/nn2038252; Nakhla Anthony N., 1996, Journal of Liposome Research, V6, P141, DOI 10.3109/08982109609037209; Nordly P, 2009, EXPERT OPIN DRUG DEL, V6, P657, DOI 10.1517/17425240903018863; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Peterson RT, 2012, ANNU REV PHARMACOL, V52, P433, DOI 10.1146/annurev-pharmtox-010611-134751; PUYAL C, 1995, EUR J BIOCHEM, V228, P697, DOI 10.1111/j.1432-1033.1995.0697m.x; Rodrigues AP, 2006, PROCESS BIOCHEM, V41, P638, DOI 10.1016/j.procbio.2005.08.010; Roher N, 2011, INNATE IMMUN-LONDON, V17, P16, DOI 10.1177/1753425909348232; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Takano S, 2003, PHARMACEUT RES, V20, P962, DOI 10.1023/A:1024441702398; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thim HL, 2012, VACCINE, V30, P4828, DOI 10.1016/j.vaccine.2012.05.010; Tian JY, 2008, VET IMMUNOL IMMUNOP, V126, P220, DOI 10.1016/j.vetimm.2008.07.002; Wang KY, 2011, AFR J BIOTECHNOL, V10, P2751; Wang WL, 2011, FISH SHELLFISH IMMUN, V31, P10, DOI 10.1016/j.fsi.2011.01.015; Watson DS, 2012, VACCINE, V30, P2256, DOI 10.1016/j.vaccine.2012.01.070; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wieber A, 2011, INT J PHARMACEUT, V421, P151, DOI 10.1016/j.ijpharm.2011.09.011; Zhu LY, 2013, DEV COMP IMMUNOL, V39, P39, DOI 10.1016/j.dci.2012.04.001	49	32	33	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76338	10.1371/journal.pone.0076338	http://dx.doi.org/10.1371/journal.pone.0076338			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204616	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300023
J	Griebeler, EM				Griebeler, Eva Maria			Body Temperatures in Dinosaurs: What Can Growth Curves Tell Us?	PLOS ONE			English	Article							METABOLIC-RATE; LIFE-HISTORY; BONE-GROWTH; SEASONAL ACCLIMATIZATION; EVOLUTIONARY ADAPTATION; PATTERNS; SIZE; THERMOREGULATION; DEHYDROGENASES; PHYSIOLOGY	To estimate the body temperature (BT) of seven dinosaurs Gillooly, Alleen, and Charnov (2006) used an equation that predicts BT from the body mass and maximum growth rate (MGR) with the latter preserved in ontogenetic growth trajectories (BT-equation). The results of these authors evidence inertial homeothermy in Dinosauria and suggest that, due to overheating, the maximum body size in Dinosauria was ultimately limited by BT. In this paper, I revisit this hypothesis of Gillooly, Alleen, and Charnov (2006). I first studied whether BTs derived from the BT-equation of today's crocodiles, birds and mammals are consistent with core temperatures of animals. Second, I applied the BT-equation to a larger number of dinosaurs than Gillooly, Alleen, and Charnov (2006) did. In particular, I estimated BT of Archaeopteryx (from two MGRs), ornithischians (two), theropods (three), prosauropods (three), and sauropods (nine). For extant species, the BT value estimated from the BT-equation was a poor estimate of an animal's core temperature. For birds, BT was always strongly overestimated and for crocodiles underestimated; for mammals the accuracy of BT was moderate. I argue that taxon-specific differences in the scaling of MGR (intercept and exponent of the regression line, log-log-transformed) and in the parameterization of the Arrhenius model both used in the BT-equation as well as ecological and evolutionary adaptations of species cause these inaccuracies. Irrespective of the found inaccuracy of BTs estimated from the BT-equation and contrary to the results of Gillooly, Alleen, and Charnov (2006) I found no increase in BT with increasing body mass across all dinosaurs (Sauropodomorpha, Sauropoda) studied. This observation questions that, due to overheating, the maximum size in Dinosauria was ultimately limited by BT. However, the general high inaccuracy of dinosaurian BTs derived from the BT-equation makes a reliable test of whether body size in dinosaurs was ultimately limited by overheating impossible.	Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Griebeler, EM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-55122 Mainz, Germany.	em.griebeler@uni-mainz.de			Deutsche Forschungsgemeinschaft [GR2625/2-1, GR2625/2-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The author's research was generously funded by the Deutsche Forschungsgemeinschaft (GR2625/2-1, GR2625/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; Andrews R.M., 1982, Biology of Reptilia, V13, P273; AVERY RA, 1994, GERONTOLOGY, V40, P193, DOI 10.1159/000213587; BRATTSTROM BH, 1965, AM MIDL NAT, V73, P376, DOI 10.2307/2423461; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; Clarke A, 2010, BIOL REV, V85, P703, DOI 10.1111/j.1469-185X.2010.00122.x; COLBERT EH, 1947, COPEIA, P141; Cooper Ross G., 2004, Animal Science Journal, V75, P491, DOI 10.1111/j.1740-0929.2004.00218.x; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; CRAWFORD DL, 1989, P NATL ACAD SCI USA, V86, P9365, DOI 10.1073/pnas.86.23.9365; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; de Buffrenil V, 2002, J HERPETOL, V36, P419, DOI 10.2307/1566186; Dial KP, 2003, AUK, V120, P941, DOI 10.1642/0004-8038(2003)120[0941:EOALCO]2.0.CO;2; Downs CJ, 2008, FUNCT ECOL, V22, P239, DOI 10.1111/j.1365-2435.2007.01371.x; Eagle RA, 2011, SCIENCE, V333, P443, DOI 10.1126/science.1206196; Eaton MJ, 2011, ECOL APPL, V21, P2487, DOI 10.1890/10-0626.1; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Fields PA, 1997, J EXP BIOL, V200, P1839; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; FRAZER NB, 1985, COPEIA, P73; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2002, NATURE, V417, P70, DOI 10.1038/417070a; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Guderley H.E., 1996, Society for Experimental Biology Seminar Series, V59, P127; Hailey A, 1999, CAN J ZOOL, V77, P181, DOI 10.1139/cjz-77-2-181; James CD, 1996, AUST J ZOOL, V44, P177, DOI 10.1071/ZO9960177; KERKHOFF AJ, METABOLIC ECOLOGY SC, P48; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Lance VA, 2003, EXP GERONTOL, V38, P801, DOI 10.1016/S0531-5565(03)00112-8; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; LIN JJ, 1995, J EXP BIOL, V198, P551; LOWELL BB, 2000, NATURE, V353, P748; MAGNUSSON WE, 1995, COPEIA, P498; MCNAB BK, 1966, CONDOR, V68, P47, DOI 10.2307/1365174; McNab BK, 2009, P NATL ACAD SCI USA, V106, P12184, DOI 10.1073/pnas.0904000106; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Pough F.H., 2003, HERPETOLOGY, V3rd; RICKLEFS RE, 1984, ECOLOGY, V65, P1602, DOI 10.2307/1939139; RICKLEFS RE, 1979, BIOL REV, V54, P269, DOI 10.1111/j.1469-185X.1979.tb01013.x; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ritz J, 2010, HERPETOL J, V20, P213; RODBARD S, 1950, SCIENCE, V111, P465, DOI 10.1126/science.111.2887.465; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sander P. Martin, 2011, P276; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; SCHMIDTNIELSON K, 1997, ANIMAL PHYSL; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2005, J COMP PHYSIOL B, V175, P533, DOI 10.1007/s00360-005-0007-1; Seebacher F, 2003, J EXP BIOL, V206, P1193, DOI 10.1242/jeb.00223; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Seebacher F, 1997, COPEIA, P549; Seebacher F, 2001, J COMP PHYSIOL B, V171, P395; Seebacher F, 2004, J COMP PHYSIOL B, V174, P205, DOI 10.1007/s00360-003-0331-2; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; SPOTILA JR, 1973, AM NAT, V107, P391, DOI 10.1086/282842; St-Pierre J, 1998, J EXP BIOL, V201, P2961; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WERNER J, PLOS ONE UNPUB; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; WESTERN D, 1982, OECOLOGIA, V54, P281, DOI 10.1007/BF00379994; White CR, 2003, P NATL ACAD SCI USA, V100, P4046, DOI 10.1073/pnas.0436428100; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; WILKINSON DM, 2003, FUNC ECOL, V27, P131; Willmer P, 2005, ENV PHYSL ANIMALS; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844	76	11	11	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e74317	10.1371/journal.pone.0074317	http://dx.doi.org/10.1371/journal.pone.0074317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204568	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500004
J	He, WM; Chen, F				He, Wenming; Chen, Fang			Evaluating Status Change of Soil Potassium from Path Model	PLOS ONE			English	Article							WEATHERING DESERT PLANTS; MICROBIAL-POPULATIONS; EXCHANGE EQUILIBRIA; PHOSPHORUS; ADSORPTION; ROCK; ENVIRONMENT; RHIZOPLANE; ANDISOLS; NITROGEN	The purpose of this study is to determine critical environmental parameters of soil K availability and to quantify those contributors by using a proposed path model. In this study, plot experiments were designed into different treatments, and soil samples were collected and further analyzed in laboratory to investigate soil properties influence on soil potassium forms (water soluble K, exchangeable K, non-exchangeable K). Furthermore, path analysis based on proposed path model was carried out to evaluate the relationship between potassium forms and soil properties. Research findings were achieved as followings. Firstly, key direct factors were soil S, ratio of sodium-potassium (Na/K), the chemical index of alteration (CIA), Soil Organic Matter in soil solution (SOM), Na and total nitrogen in soil solution (TN), and key indirect factors were Carbonate (CO3), Mg, pH, Na, S, and SOM. Secondly, path model can effectively determine direction and quantities of potassium status changes between Exchangeable potassium (eK), Non-exchangeable potassium (neK) and water-soluble potassium (wsK) under influences of specific environmental parameters. In reversible equilibrium state of wsK reversible arrow(alpha)(beta) neK reversible arrow(gamma)(chi) eK, K balance state was inclined to be moved into beta and chi directions in treatments of potassium shortage. However in reversible equilibrium of wsK reversible arrow(epsilon)(theta) eK reversible arrow(lambda)(omega) neK, K balance state was inclined to be moved into theta and lambda directions in treatments of water shortage. Results showed that the proposed path model was able to quantitatively disclose moving direction of K status and quantify its equilibrium threshold. It provided a theoretical and practical basis for scientific and effective fertilization in agricultural plants growth.	[He, Wenming; Chen, Fang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei Province, Peoples R China; [He, Wenming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Chen, Fang] Int Plant Nutr Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, F (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Hubei Province, Peoples R China.	fchen@ipni.ac.cn			National Natural Science Foundation of China [41171243]; National Key Technology RD Program [2012BAD15B01]; International Plant Nutrition Institute [IPNI-HB-33]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); International Plant Nutrition Institute	The study was supported by the National Natural Science Foundation of China (41171243), the National Key Technology R&D Program (2012BAD15B01) and the Cooperated Program with the International Plant Nutrition Institute (IPNI-HB-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; BROUDER SM, 1994, SOIL SCI SOC AM J, V58, P1174, DOI 10.2136/sssaj1994.03615995005800040024x; EICK MJ, 1990, SOIL SCI SOC AM J, V54, P1278, DOI 10.2136/sssaj1990.03615995005400050013x; Han MY, 2011, SOIL SCI PLANT NUTR, V57, P549, DOI 10.1080/00380768.2011.593481; Hashimoto Y, 2012, SOIL SCI SOC AM J, V76, P441, DOI 10.2136/sssaj2011.0196; He CY, 2012, ECOL EVOL, V2, P1996, DOI 10.1002/ece3.299; He HM, 2008, ENVIRON FORENSICS, V9, P215, DOI 10.1080/15275920802122759; He HM, 2012, ENERG POLICY, V43, P235, DOI 10.1016/j.enpol.2011.12.060; He HM, 2010, ECOL MODEL, V221, P2949, DOI 10.1016/j.ecolmodel.2010.09.002; Hinsinger P, 2001, GEOCHIM COSMOCHIM AC, V65, P137, DOI 10.1016/S0016-7037(00)00524-X; Kamewada K, 1996, SOIL SCI PLANT NUTR, V42, P801, DOI 10.1080/00380768.1996.10416627; Kang J, 2009, SOIL SCI SOC AM J, V73, P360, DOI 10.2136/sssaj2008.0113; Kobayashi H, 2007, SOIL SCI PLANT NUTR, V53, P764, DOI 10.1111/j.1747-0765.2007.00192.x; Kocev D, 2010, ECOL MODEL, V221, P330, DOI 10.1016/j.ecolmodel.2009.09.002; Kulahci F, 2011, J HAZARD MATER, V191, P349, DOI 10.1016/j.jhazmat.2011.04.083; Lambers H, 2009, PLANT SOIL, V321, P83, DOI 10.1007/s11104-009-0042-x; Mahmood-Ul-Hassan M, 2011, SOIL SCI PLANT NUTR, V57, P331, DOI 10.1080/00380768.2011.559576; McCune B, 2009, ECOLOGY, V90, P567, DOI 10.1890/08-0344.1; NAKAHARA O, 1995, SOIL SCI PLANT NUTR, V41, P671, DOI 10.1080/00380768.1995.10417017; Osaki M, 1996, SOIL SCI PLANT NUTR, V42, P289; Puente ME, 2004, PLANT BIOLOGY, V6, P629, DOI 10.1055/s-2004-821100; Puente ME, 2004, PLANT BIOLOGY, V6, P643, DOI 10.1055/s-2004-821101; Schneider AK, 2012, APPL SOIL ECOL, V58, P29, DOI 10.1016/j.apsoil.2012.02.020; Uroz S, 2009, TRENDS MICROBIOL, V17, P378, DOI 10.1016/j.tim.2009.05.004; WADA SI, 1994, SOIL SCI PLANT NUTR, V40, P629, DOI 10.1080/00380768.1994.10414302; WADA SI, 1995, SOIL SCI PLANT NUTR, V41, P377, DOI 10.1080/00380768.1995.10419597; Wright S, 1921, GENETICS, V6, P124; Wright S, 1921, GENETICS, V6, P111; Wright S, 1920, P NATL ACAD SCI USA, V6, P320, DOI 10.1073/pnas.6.6.320; Wright SS, 1921, J AGR RES, V20, P557	30	7	7	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76712	10.1371/journal.pone.0076712	http://dx.doi.org/10.1371/journal.pone.0076712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204659	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500009
J	Shahriyari, L; Komarova, NL				Shahriyari, Leili; Komarova, Natalia L.			Symmetric vs. Asymmetric Stem Cell Divisions: An Adaptation against Cancer?	PLOS ONE			English	Article							IMMORTAL STRAND HYPOTHESIS; MATHEMATICAL-MODEL; SELF-RENEWAL; TUMOR-GROWTH; COLONIC CRYPT; DIFFERENTIATION; MUTATION; NEUROGENESIS; MECHANISMS; INITIATION	Traditionally, it has been held that a central characteristic of stem cells is their ability to divide asymmetrically. Recent advances in inducible genetic labeling provided ample evidence that symmetric stem cell divisions play an important role in adult mammalian homeostasis. It is well understood that the two types of cell divisions differ in terms of the stem cells' flexibility to expand when needed. On the contrary, the implications of symmetric and asymmetric divisions for mutation accumulation are still poorly understood. In this paper we study a stochastic model of a renewing tissue, and address the optimization problem of tissue architecture in the context of mutant production. Specifically, we study the process of tumor suppressor gene inactivation which usually takes place as a consequence of two "hits'', and which is one of the most common patterns in carcinogenesis. We compare and contrast symmetric and asymmetric (and mixed) stem cell divisions, and focus on the rate at which double-hit mutants are generated. It turns out that symmetrically-dividing cells generate such mutants at a rate which is significantly lower than that of asymmetrically-dividing cells. This result holds whether single-hit (intermediate) mutants are disadvantageous, neutral, or advantageous. It is also independent on whether the carcinogenic double-hit mutants are produced only among the stem cells or also among more specialized cells. We argue that symmetric stem cell divisions in mammals could be an adaptation which helps delay the onset of cancers. We further investigate the question of the optimal fraction of stem cells in the tissue, and quantify the contribution of non-stem cells in mutant production. Our work provides a hypothesis to explain the observation that in mammalian cells, symmetric patterns of stem cell division seem to be very common.	[Shahriyari, Leili; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health (NIH) [1R01CA129286]; NATIONAL CANCER INSTITUTE [R01CA129286] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) grant 1R01CA129286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2008, GENE THER, V15, P96, DOI 10.1038/sj.gt.3303063; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Aparicio S, 2009, CELL, V138, P1060, DOI 10.1016/j.cell.2009.09.004; Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Boman BM, 2008, CANCER RES, V68, P3304, DOI 10.1158/0008-5472.CAN-07-2061; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; Cairns J, 2006, SCI AGING KNOWLEDGE, V2006, pcp1; Campbell F, 1996, GUT, V39, P569, DOI 10.1136/gut.39.4.569; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Clarke RB, 2003, CELL PROLIFERAT, V36, P45, DOI 10.1046/j.1365-2184.36.s.1.5.x; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; de Graaf CA, 2010, P NATL ACAD SCI USA, V107, P21689, DOI 10.1073/pnas.1016166108; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dingli D, 2007, PLOS COMPUT BIOL, V3, P482, DOI 10.1371/journal.pcbi.0030053; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640; Egger B, 2010, DEVELOPMENT, V137, P2981, DOI 10.1242/dev.051250; Enderling H, 2009, MATH MODEL NAT PHENO, V4, P117, DOI 10.1051/mmnp/20094305; Enderling H, 2009, BRIT J CANCER, V100, P1917, DOI 10.1038/sj.bjc.6605071; Enderling H, 2011, PROGR BIOPHYSICS MOL; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Enderling H, 2009, CANCER RES, V69, P8814, DOI 10.1158/0008-5472.CAN-09-2115; Frank S. A., 2007, DYNAMICS CANC INCIDE; Frank SA, 2003, NATURE, V422, P494, DOI 10.1038/422494a; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ganguly R, 2007, CELL PROLIFERAT, V40, P338, DOI 10.1111/j.1365-2184.2007.00434.x; Ganguly R, 2006, CELL PROLIFERAT, V39, P3, DOI 10.1111/j.1365-2184.2006.00369.x; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hardy K, 2002, APOPTOSIS, V7, P373, DOI 10.1023/A:1016183731694; Ho AD, 2005, EXP HEMATOL, V33, P1, DOI 10.1016/j.exphem.2004.09.004; Hormoz S, 2013, J THEOR BIOL, V331, P19, DOI 10.1016/j.jtbi.2013.04.018; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komarova NL, 2007, MATH MOD METH APPL S, V17, P1647, DOI 10.1142/S021820250700242X; Komarova NL, 2006, B MATH BIOL, V68, P1573, DOI 10.1007/s11538-005-9046-8; Komarova NL, 2004, CELL CYCLE, V3, P1558, DOI 10.4161/cc.3.12.1186; Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Michor F, 2003, P ROY SOC B-BIOL SCI, V270, P2017, DOI 10.1098/rspb.2003.2483; Michor F, 2008, J CLIN ONCOL, V26, P2854, DOI 10.1200/JCO.2007.15.2421; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ordonez-Moran P, 2012, EMBO J; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Piotrowska M, 2008, COMPLEX SYSTEMS BIOM; Rando TA, 2007, CELL, V129, P1239, DOI 10.1016/j.cell.2007.06.019; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vogelstein B, 2002, GENETIC BASIS HUMAN, V821; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006; Wodarz D, 2005, COMPUTATIONAL BIOLOGY OF CANCER: LECTURE NOTES AND MATHEMATICAL MODELING, P1, DOI 10.1142/9789812701367; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	95	78	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76195	10.1371/journal.pone.0076195	http://dx.doi.org/10.1371/journal.pone.0076195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204602	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700004
J	Choi, HF; Blemker, SS				Choi, Hon Fai; Blemker, Silvia S.			Skeletal Muscle Fascicle Arrangements Can Be Reconstructed Using a Laplacian Vector Field Simulation	PLOS ONE			English	Article							HUMAN LOWER-LIMB; FIBER TRACKING; IN-VIVO; ARCHITECTURE; REPRESENTATION; ORIENTATION; GEOMETRIES; MODELS	Skeletal muscles are characterized by a large diversity in anatomical architecture and function. Muscle force and contraction are generated by contractile fiber cells grouped in fascicle bundles, which transmit the mechanical action between origin and insertion attachments of the muscle. Therefore, an adequate representation of fascicle arrangements in computational models of skeletal muscles is important, especially when investigating three-dimensional muscle deformations in finite element models. However, obtaining high resolution in vivo measurements of fascicle arrangements in skeletal muscles is currently still challenging. This motivated the development of methods in previous studies to generate numerical representations of fascicle trajectories using interpolation templates. Here, we present an alternative approach based on the hypothesis of a rotation and divergence free (Laplacian) vector field behavior which reflects observed physical characteristics of fascicle trajectories. To obtain this representation, the Laplace equation was solved in anatomical reconstructions of skeletal muscle shapes based on medical images using a uniform flux boundary condition on the attachment areas. Fascicle tracts were generated through a robust flux based tracing algorithm. The concept of this approach was demonstrated in two-dimensional synthetic examples of typical skeletal muscle architectures. A detailed evaluation was performed in an example of the anatomical human tibialis anterior muscle which showed an overall agreement with measurements from the literature. The utility and capability of the proposed method was further demonstrated in other anatomical examples of human skeletal muscles with a wide range of muscle shapes and attachment morphologies.	[Choi, Hon Fai; Blemker, Silvia S.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22903 USA; [Blemker, Silvia S.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA	University of Virginia; University of Virginia	Blemker, SS (corresponding author), Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA 22903 USA.	ssblemker@virginia.edu	Blemker, Silvia/A-1661-2009		Belgian American Educational Foundation; National Institutes of Health [R01-AR056201]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056201] Funding Source: NIH RePORTER	Belgian American Educational Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Hon Fai Choi is a postdoctoral research fellow supported by the Belgian American Educational Foundation (www.BAEF.be). This work was also partially supported by the National Institutes of Health Grant R01-AR056201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur AM, 2003, CLIN ANAT, V16, P285, DOI 10.1002/ca.10112; Arnold EM, 2011, PHILOS T R SOC B, V366, P1530, DOI 10.1098/rstb.2010.0345; Benard MR, 2009, MUSCLE NERVE, V39, P652, DOI 10.1002/mus.21287; Blemker SS, 2006, J BIOMECH, V39, P1383, DOI 10.1016/j.jbiomech.2005.04.012; Blemker SS, 2005, ANN BIOMED ENG, V33, P661, DOI 10.1007/s10439-005-1433-7; Dobrzynski C, 2008, PROCEEDINGS OF THE 17TH INTERNATIONAL MESHING ROUNDTABLE, P177, DOI 10.1007/978-3-540-87921-3_11; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Froeling M, 2012, J MAGN RESON IMAGING, V36, P237, DOI 10.1002/jmri.23608; Garabedian PR, 1966, PARTIAL DIFFERENTIAL; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Heemskerk AM, 2010, NMR BIOMED, V23, P294, DOI 10.1002/nbm.1463; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Holzapfel G., 2000, NONLINEAR SOLID MECH; Kermarrec E, 2010, AM J ROENTGENOL, V195, pW352, DOI 10.2214/AJR.09.3368; Kim SY, 2007, CLIN ANAT, V20, P648, DOI 10.1002/ca.20469; Klausen RA, 2012, COMPUTAT GEOSCI, V16, P261, DOI 10.1007/s10596-011-9256-0; Klimstra M, 2007, J ELECTROMYOGR KINES, V17, P504, DOI 10.1016/j.jelekin.2006.04.011; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Leon LM, 2006, COMPUT METHOD BIOMEC, V20, P648; Levin DIW, 2011, MED IMAGE ANAL, V15, P340, DOI 10.1016/j.media.2011.01.005; Lu YT, 2011, COMPUT METHOD BIOMEC, V14, P1079, DOI 10.1080/10255842.2010.509100; Maganaris CN, 2006, J BIOMECH, V39, P1663, DOI 10.1016/j.jbiomech.2005.04.025; Marchandise E, 2011, INT J NUMER METH ENG, V86, P1303, DOI 10.1002/nme.3099; Marchandise E, 2010, INT J NUMER METH BIO, V26, P876, DOI 10.1002/cnm.1388; Muramatsu T, 2002, J APPL PHYSIOL, V92, P129, DOI 10.1152/jappl.2002.92.1.129; Netter FH, 2006, ATLAS HUMAN ANATOMY; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Remacle JF, 2010, INT J NUMER METH ENG, V83, P403, DOI 10.1002/nme.2824; Standring S, 2008, GRAYS ANATOMY; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Weller HG, 1998, COMPUT PHYS, V12, P620, DOI 10.1063/1.168744; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275, DOI 10.1097/00003086-198310000-00042; Wu FTH, 2007, COMPUT METH PROG BIO, V88, P112, DOI 10.1016/j.cmpb.2007.07.012; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	34	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77576	10.1371/journal.pone.0077576	http://dx.doi.org/10.1371/journal.pone.0077576			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204878	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400044
J	Saint-Beat, B; Dupuy, C; Bocher, P; Chalumeau, J; De Crignis, M; Fontaine, C; Guizien, K; Lavaud, J; Lefebvre, S; Montanie, H; Mouget, JL; Orvain, F; Pascal, PY; Quaintenne, G; Radenac, G; Richard, P; Robin, F; Vezina, AF; Niquil, N				Saint-Beat, Blanche; Dupuy, Christine; Bocher, Pierrick; Chalumeau, Julien; De Crignis, Margot; Fontaine, Camille; Guizien, Katell; Lavaud, Johann; Lefebvre, Sebastien; Montanie, Helene; Mouget, Jean-Luc; Orvain, Francis; Pascal, Pierre-Yves; Quaintenne, Gwenael; Radenac, Gilles; Richard, Pierre; Robin, Frederic; Vezina, Alain F.; Niquil, Nathalie			Key Features of Intertidal Food Webs That Support Migratory Shorebirds	PLOS ONE			English	Article							MARENNES-OLERON BAY; GASTROPOD HYDROBIA-ULVAE; FRESH-WATER INFLOW; NETWORK ANALYSIS; CONTINENTAL-SHELF; BROUAGE MUDFLAT; AIGUILLON COVE; WADDEN SEA; ECOSYSTEM; CONSUMPTION	The migratory shorebirds of the East Atlantic flyway land in huge numbers during a migratory stopover or wintering on the French Atlantic coast. The Brouage bare mudflat (Marennes-Oleron Bay, NE Atlantic) is one of the major stopover sites in France. The particular structure and function of a food web affects the efficiency of carbon transfer. The structure and functioning of the Brouage food web is crucial for the conservation of species landing within this area because it provides sufficient food, which allows shorebirds to reach the north of Europe where they nest. The aim of this study was to describe and understand which food web characteristics support nutritional needs of birds. Two food-web models were constructed, based on in situ measurements that were made in February 2008 (the presence of birds) and July 2008 (absence of birds). To complete the models, allometric relationships and additional data from the literature were used. The missing flow values of the food web models were estimated by Monte Carlo Markov Chain - Linear Inverse Modelling. The flow solutions obtained were used to calculate the ecological network analysis indices, which estimate the emergent properties of the functioning of a food-web. The total activities of the Brouage ecosystem in February and July are significantly different. The specialisation of the trophic links within the ecosystem does not appear to differ between the two models. In spite of a large export of carbon from the primary producer and detritus in winter, the higher recycling leads to a similar retention of carbon for the two seasons. It can be concluded that in February, the higher activity of the ecosystem coupled with a higher cycling and a mean internal organization, ensure the sufficient feeding of the migratory shorebirds.	[Saint-Beat, Blanche; Dupuy, Christine; Bocher, Pierrick; Chalumeau, Julien; De Crignis, Margot; Fontaine, Camille; Lavaud, Johann; Montanie, Helene; Quaintenne, Gwenael; Radenac, Gilles; Richard, Pierre; Robin, Frederic; Niquil, Nathalie] Univ La Rochelle, CNRS, UMR 7266, Littoral Environm & Soc LIENSs, La Rochelle, France; [Guizien, Katell] Lab Oceanog Biol Banyuls, Banyuls Sur Mer, France; [Lefebvre, Sebastien] Univ Lille 1, Lab Oceanog & Geosci, Wimereux, France; [Mouget, Jean-Luc] Univ Maine, F-72017 Le Mans, France; [Pascal, Pierre-Yves] UFR Sci Exactes & Nat SEN, Dept Biol, Pointe a Pitre, France; [Vezina, Alain F.] Bedford Inst Oceanog, Dartmouth, NS, Canada; [Orvain, Francis; Niquil, Nathalie] CNRS, UMR Biol Organismes & Ecosyst Aquat BOREA 7208, Lab Biol Mollusques Marins & Ecosyst Associes Bio, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Le Mans Universite; Bedford Institute of Oceanography; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Saint-Beat, B (corresponding author), Univ La Rochelle, CNRS, UMR 7266, Littoral Environm & Soc LIENSs, La Rochelle, France.	blanche.saint-beat@univ-lr.fr	Niquil, Nathalie/N-2561-2013; Lefebvre, Sébastien/G-8562-2011; Guizien, Katell/D-1534-2013; RADENAC, Gilles/O-9760-2014; Richard, Pierre J/N-6482-2014; Niquil, Nathalie/C-8233-2009; Lavaud, Johann/N-6185-2014; Montanié, Hélène/N-9832-2014; Guizien, Katell/I-7061-2016	Lefebvre, Sébastien/0000-0002-7152-5897; Guizien, Katell/0000-0001-9884-7506; RADENAC, Gilles/0000-0002-7906-6453; Richard, Pierre J/0000-0002-0393-9967; Lavaud, Johann/0000-0002-4704-2502; Montanié, Hélène/0000-0001-7574-7828; Guizien, Katell/0000-0001-9884-7506; Saint-Beat, Blanche/0000-0002-2401-2052; Dupuy, Christine/0000-0002-5634-1336; Robin, Frederic/0000-0003-0232-1142; Niquil, Nathalie/0000-0002-0772-754X	French ANR (Agence Nationale de la Recherche); CNRS; Region Poitou-Charentes; French ANR (Agence Nationale de la Recherche); CNRS; Region Poitou-Charentes	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine); French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This work was supported by a grant from the French ANR (Agence Nationale de la Recherche) programme blanc "Vasiremi: Trophic significance of microbial biofilms in tidal flats," coordinated by CD. BSB was supported by a PhD fellowship from the CNRS and Region Poitou-Charentes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2005, ECOL MODEL, V189, P221, DOI 10.1016/j.ecolmodel.2005.04.002; BAIRD D, 1993, MAR ECOL PROG SER, V99, P221, DOI 10.3354/meps099221; Baird D, 2004, MAR ECOL PROG SER, V279, P45, DOI 10.3354/meps279045; Baird D, 1996, WATER SA, V22, P307; BAIRD D, 1991, PHILOS T R SOC B, V333, P15, DOI 10.1098/rstb.1991.0058; Baird D, 2007, MAR ECOL PROG SER, V351, P25, DOI 10.3354/meps07137; Blanchard GF, 1997, J PHYCOL, V33, P723, DOI 10.1111/j.0022-3646.1997.00723.x; Bocher P, 2007, MAR BIOL, V151, P577, DOI 10.1007/s00227-006-0500-4; Bocher P, 2012, J ORNITHOL, V153, P103, DOI 10.1007/s10336-011-0702-5; Boileau N, 2011, ALAUDA, V80, P13; Brey T., 2001, VIRTUAL HDB POPULATI; Brey T, 2010, METHODS ECOL EVOL, V1, P92, DOI 10.1111/j.2041-210X.2009.00008.x; CARIOULEGALL V, 1995, MAR ECOL-PROG SER, V121, P171, DOI DOI 10.3354/MEPS121171; CHRISTENSEN V, 1995, ECOL MODEL, V77, P3, DOI 10.1016/0304-3800(93)E0073-C; Christensen V, 2009, ECOL MODEL, V220, P1984, DOI 10.1016/j.ecolmodel.2009.04.041; Corinaldesi C, 2010, FEMS MICROBIOL ECOL, V72, P208, DOI 10.1111/j.1574-6941.2010.00840.x; Crisp D. J., 1971, P197; Degre D, 2006, ESTUAR COAST SHELF S, V69, P107, DOI 10.1016/j.ecss.2006.04.001; DEJONGE VN, 1980, MAR ECOL PROG SER, V2, P345, DOI 10.3354/meps002345; DEKINGA A, 1993, BIRD STUDY, V40, P144, DOI 10.1080/00063659309477140; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Delany S, 2009, ATLAS WADERS POPULAT; Dwyer RG, 2010, ECOLOGICAL ANTHROPOG; FINN JT, 1976, J THEOR BIOL, V56, P363, DOI 10.1016/S0022-5193(76)80080-X; Folmer EO, 2010, J ANIM ECOL, V79, P747, DOI 10.1111/j.1365-2656.2010.01680.x; FUHRMAN JA, 1981, MAR ECOL PROG SER, V5, P103, DOI 10.3354/meps005103; Gouleau D, 2000, CONT SHELF RES, V20, P1513, DOI 10.1016/S0278-4343(00)00035-2; Guarini JM, 2000, CONT SHELF RES, V20, P1771, DOI 10.1016/S0278-4343(00)00047-9; Haubois AG, 2005, ESTUAR COAST SHELF S, V64, P385, DOI 10.1016/j.ecss.2005.03.004; Haubois AG, 2004, J SEA RES, V51, P63, DOI 10.1016/j.seares.2003.02.001; Herlory O, 2004, MAR ECOL PROG SER, V282, P33, DOI 10.3354/meps282033; HIRATA H, 1984, INT J SYST SCI, V15, P261, DOI 10.1080/00207728408926559; Johnson GA, 2009, ECOL MODEL, V220, P3448, DOI 10.1016/j.ecolmodel.2009.08.003; Kay JJ, 1989, COAST ESTUARINE STUD, V32; KERSTEN M, 1987, ARDEA, V75, P175; Kones JK, 2009, ECOL MODEL, V220, P370, DOI 10.1016/j.ecolmodel.2008.10.012; Kuwae T, 2008, ECOLOGY, V89, P599, DOI 10.1890/07-1442.1; Kuwae T, 2012, ECOL LETT, V15, P347, DOI 10.1111/j.1461-0248.2012.01744.x; Lassalle G, 2011, PROG OCEANOGR, V91, P561, DOI 10.1016/j.pocean.2011.09.002; Lassalle G, 2012, ICES J MAR SCI, V69, P925, DOI 10.1093/icesjms/fss049; Leguerrier D, 2004, MAR ECOL PROG SER, V273, P147, DOI 10.3354/meps273147; Leguerrier D, 2003, MAR ECOL PROG SER, V246, P17, DOI 10.3354/meps246017; Leguerrier D, 2007, ESTUAR COAST SHELF S, V74, P403, DOI 10.1016/j.ecss.2007.04.014; Leloup FA, 2008, ESTUAR COAST SHELF S, V76, P111, DOI 10.1016/j.ecss.2007.06.011; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lourenco PM, 2008, ACTA OECOL, V34, P122, DOI 10.1016/j.actao.2008.04.005; Luis A., 2001, Wader Study Group Bulletin, V96, P71; Maheo R, 2008, LIMICOLES SEJOURNANT; Mouget JL, 2008, AQUAT MICROB ECOL, V52, P223, DOI 10.3354/ame01218; Niquil N, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 9: ESTUARINE AND COASTAL ECOSYSTEM MODELLING, P115; Niquil N, 2012, ESTUAR COAST SHELF S, V108, P132, DOI 10.1016/j.ecss.2011.12.031; Nolet BA, 2006, J ANIM ECOL, V75, P1285, DOI 10.1111/j.1365-2656.2006.01150.x; Orvain F, 2007, CONT SHELF RES, V27, P1153, DOI 10.1016/j.csr.2006.05.013; Pascal PY, 2008, J SEA RES, V60, P151, DOI 10.1016/j.seares.2008.05.003; Pascal PY, 2008, MAR BIOL, V154, P671, DOI 10.1007/s00227-008-0960-9; Pascal PY, 2008, J EXP MAR BIOL ECOL, V359, P55, DOI 10.1016/j.jembe.2008.02.018; Pascal PY, 2008, J EXP MAR BIOL ECOL, V355, P18, DOI 10.1016/j.jembe.2007.11.012; Pascal PY, 2009, LIMNOL OCEANOGR, V54, P1048, DOI 10.4319/lo.2009.54.4.1048; Ponsero A, 2011, REV ECOL-TERRE VIE, V66, P383; Quaintenne G, 2010, J ANIM ECOL, V79, P53, DOI 10.1111/j.1365-2656.2009.01608.x; Robin F, CONDOR IN PRESS; Romanova ND, 2010, OCEANOLOGY+, V50, P522, DOI 10.1134/S0001437010040089; Rzeznik-Orignac J, 2012, J EXP MAR BIOL ECOL, V432, P179, DOI 10.1016/j.jembe.2012.06.019; Saint-Beat B, 2013, ECOL MODEL, V258, P53, DOI 10.1016/j.ecolmodel.2013.01.023; Scharler UM, 2005, J MARINE SYST, V56, P283, DOI 10.1016/j.jmarsys.2004.12.003; Scheiffarth G, 2001, ARDEA, V89, P481; Scheiffarth G, 1997, HELGOLANDER MEERESUN, V51, P373, DOI 10.1007/BF02908721; Schiemer F, 1987, ANIMAL ENERGETICS, P185; Serodio J, 2009, AQUAT MICROB ECOL; Serodio J, 2008, CONT SHELF RES, V28, P1363, DOI 10.1016/j.csr.2008.03.019; Stillman RA, 2007, IBIS, V149, P73, DOI 10.1111/j.1474-919X.2007.00649.x; Sueur Francois, 2003, Alauda, V71, P49; SUTHERLAND WJ, 1983, J ANIM ECOL, V52, P821, DOI 10.2307/4456; Tortajada S, 2012, ACTA OECOL, V40, P40, DOI 10.1016/j.actao.2012.02.002; TURPIE JK, 1993, IBIS, V135, P156, DOI 10.1111/j.1474-919X.1993.tb02827.x; Ulanowicz R. E., 1991, Environmental Software, V6, P131, DOI 10.1016/0266-9838(91)90024-K; Ulanowicz R.E., 1997, ECOLOGY ASCENDENT PE; Ulanowicz R. E., 1986, GROWTH DEV ECOSYSTEM; Van den Meersche K., 2009, J STAT SOFTW, V30, P1, DOI [DOI 10.18637/JSS.V030.C01, 10.1002/wics.10., DOI 10.18637/jss.v030.c01]; van Gils JA, 2005, P ROY SOC B-BIOL SCI, V272, P2609, DOI 10.1098/rspb.2005.3245; van Oevelen D, 2006, J MAR RES, V64, P453, DOI 10.1357/002224006778189581; Verger F, 2005, MARAIS ESTUAIRES LIT; Vezina A.F., 1989, Coastal and Estuarine Studies, P62; VEZINA AF, 1988, MAR ECOL PROG SER, V42, P269, DOI 10.3354/meps042269; Viain Anouck, 2011, Wildfowl, V61, P121; Vieira S, 2010, BIOL J LINN SOC, V100, P439, DOI 10.1111/j.1095-8312.2010.01428.x; WARWICK RM, 1979, ESTUAR COAST MAR SCI, V9, P257, DOI 10.1016/0302-3524(79)90039-2; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2	88	23	23	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76739	10.1371/journal.pone.0076739	http://dx.doi.org/10.1371/journal.pone.0076739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204666	gold, Green Published			2022-12-25	WOS:000326155400018
J	Huang, JG; Stadt, KJ; Dawson, A; Comeau, PG				Huang, Jian-Guo; Stadt, Kenneth J.; Dawson, Andria; Comeau, Philip G.			Modelling Growth-Competition Relationships in Trembling Aspen and White Spruce Mixed Boreal Forests of Western Canada	PLOS ONE			English	Article							LODGEPOLE PINE; BRITISH-COLUMBIA; INCREMENT MODEL; HEIGHT-GROWTH; LIGHT; UNDERSTORY; INDEXES; DIAMETER; AGE; MIXTURES	We examined the effect of competition on stem growth of Picea glauca and Populus tremuloides in boreal mixedwood stands during the stem exclusion stage. We combined traditional approaches of collecting competition data with dendrochronology to provide retrospective measurements of stem diameter growth. Several competition indices including stand basal area (BA), the sum of stem diameter at breast height (SDBH), and density (N) for the broadleaf and coniferous species, as well as similar indices considering only trees with diameters greater than each subject (BAGR, SDBHGR, and NGR), were evaluated. We used a nonlinear mixed model to characterize the basal area increment over the past 5, 10, 15, 20, 25, 30, and 35 years as a function of growth of nearby dominant trees, the size of the subject trees, deciduous and coniferous competition indices, and ecoregions. SDBHGR and BAGR were better predictors for spruce, and SDBHGR and NGR were better for aspen, respectively, than other indices. Results showed strongest correlations with long-term stem growth, as the best models integrated growth for 10-25 years for aspen and >= 25 for spruce. Our model demonstrated a remarkable capability (adjusted R-2>0.67) to represent this complex variation in growth as a function of site, size and competition.	[Huang, Jian-Guo; Dawson, Andria; Comeau, Philip G.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Stadt, Kenneth J.] Sustainable Resource Dev, Forest Management Branch, Edmonton, AB, Canada	University of Alberta	Huang, JG (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	jianguo.huang@ualberta.ca	Comeau, Phil/AAB-6481-2020	Comeau, Phil/0000-0003-2578-4289	Natural Science and Engineering Research Council of Canada; Mixedwood Management Association; Forest Resource Improvement Association of Alberta	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Mixedwood Management Association; Forest Resource Improvement Association of Alberta	This project was funded by the Natural Science and Engineering Research Council of Canada, the Mixedwood Management Association, and the Forest Resource Improvement Association of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AESRD, 2012, PHAS 3 FOR INV; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberta Sustainable Resource Development, 2006, ALB FOR MAN PLANN ST, P114; [Anonymous], 2006, SAS MIXED MODELS; Beckingham J. D., 1996, 9 CAN FOR SERV N FOR; Beckingham JD, 1996, 5 CAN FOR SERV N FOR; BIGING GS, 1995, FOREST SCI, V41, P360; Biondi F, 1999, ECOL APPL, V9, P216, DOI 10.1890/1051-0761(1999)009[0216:CTRCAR]2.0.CO;2; Bokalo M, 2007, FOREST ECOL MANAG, V242, P175, DOI 10.1016/j.foreco.2007.01.038; Bokalo M, 2013, FORESTS, V4, P1, DOI 10.3390/f4010001; BURTON P, 1993, CAN J FOREST RES, V23, P2141, DOI 10.1139/x93-267; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chen Han Y. H., 2002, Environmental Reviews, V10, P137, DOI 10.1139/a02-007; Comeau PG, 1998, CAN J FOREST RES, V28, P1843, DOI 10.1139/cjfr-28-12-1843; Comeau PG, 2003, CAN J FOREST RES, V33, P1962, DOI 10.1139/X03-117; Comeau PG, 2009, FOREST CHRON, V85, P583, DOI 10.5558/tfc85583-4; Cortini F, 2012, FOREST ECOL MANAG, V277, P67, DOI 10.1016/j.foreco.2012.04.022; Cumming SG, 2000, ECOL APPL, V10, P744; Environment Canada, 2012, CAN CLIM NORM AV 197; Feng ZL, 2006, CAN J FOREST RES, V36, P3173, DOI 10.1139/X06-192; Filipescu CN, 2007, CAN J FOREST RES, V37, P1701, DOI 10.1139/X07-011; Filipescu CN, 2007, FOREST ECOL MANAG, V247, P175, DOI 10.1016/j.foreco.2007.04.038; Friend AD, 1993, VEGETATION DYNAMICS; Fritts H. C., 1976, TREE RINGS CLIMATE; Gutsell SL, 2002, J ECOL, V90, P153, DOI 10.1046/j.0022-0477.2001.00646.x; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang S, 1994, 1 ALB ENV PROT; HUANG SM, 1995, CAN J FOREST RES, V25, P1455, DOI 10.1139/x95-158; LANNER RM, 1985, FOREST ECOL MANAG, V13, P143, DOI 10.1016/0378-1127(85)90030-1; LIEFFERS VJ, 1994, CAN J FOREST RES, V24, P1193, DOI 10.1139/x94-157; Lieffers VJ, 1996, CAN J FOREST RES, V26, P1002, DOI 10.1139/x26-110; Lieffers VJ, 2002, FOREST CHRON, V78, P137, DOI 10.5558/tfc78137-1; LORIMER CG, 1983, FOREST ECOL MANAG, V6, P343, DOI 10.1016/0378-1127(83)90042-7; MacDonald GB, 1995, FOREST CHRON, V71, P725, DOI 10.5558/tfc71725-6; MacFarlane DW, 2006, CAN J FOREST RES, V36, P1695, DOI 10.1139/X06-054; MacPherson DM, 2001, FOREST CHRON, V77, P351, DOI 10.5558/tfc77351-2; Man R, 1999, FOREST CHRON, V75, P505; Metsaranta JM, 2009, FORESTRY, V82, P163, DOI 10.1093/forestry/cpn051; MORRIS DM, 1991, FOREST CHRON, V67, P403, DOI 10.5558/tfc67403-4; Newsome TA, 2006, 029 BC MIN FOR RES B; Newsome TA, 2010, FOREST ECOL MANAG, V259, P1170, DOI 10.1016/j.foreco.2010.01.003; Nunifu TK, 2009, CAN J FOREST RES, V39, P180, DOI 10.1139/X08-168; Osika DE, 2013, CAN J FOREST RES, V43, P139, DOI 10.1139/cjfr-2012-0169; Peters VS, 2005, ECOLOGY, V86, P1744, DOI 10.1890/03-0656; Peterson EB, 1992, 1 FOR CAN N FOR CENT, V1; Pritchard JM, 2004, FOREST ECOL MANAG, V200, P119, DOI 10.1016/j.foreco.2004.06.002; Pukkala T., 1989, Silva Fennica, V23, P101; Reid DEB, 2003, TREE PHYSIOL, V23, P833, DOI 10.1093/treephys/23.12.833; Stadt KJ, 2007, ANN FOREST SCI, V64, P477, DOI 10.1051/forest:2007025; Vanclay J. K., 1994, Modelling forest growth and yield: applications to mixed tropical forests.; WARING RH, 1982, CAN J FOREST RES, V12, P556, DOI 10.1139/x82-086; Wimberly MC, 1996, FOREST ECOL MANAG, V89, P1, DOI 10.1016/S0378-1127(96)03870-4; Wright EF, 1998, CAN J FOREST RES, V28, P871, DOI 10.1139/cjfr-28-6-871; Yang YQ, 2009, CAN J FOREST RES, V39, P2203, DOI 10.1139/X09-123	54	29	33	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77607	10.1371/journal.pone.0077607	http://dx.doi.org/10.1371/journal.pone.0077607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204891	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300026
J	Beguin, J; McIntire, EJB; Fortin, D; Cumming, SG; Raulier, F; Racine, P; Dussault, C				Beguin, Julien; McIntire, Eliot J. B.; Fortin, Daniel; Cumming, Steven G.; Raulier, Frederic; Racine, Pierre; Dussault, Claude			Explaining Geographic Gradients in Winter Selection of Landscapes by Boreal Caribou with Implications under Global Changes in Eastern Canada	PLOS ONE			English	Article							WOODLAND CARIBOU; BEHAVIORAL-RESPONSE; RANGIFER-TARANDUS; CLIMATE-CHANGE; FIRE REGIMES; FOREST; MODELS; BIODIVERSITY; AVOIDANCE; PREDATION	Many animal species exhibit broad-scale latitudinal or longitudinal gradients in their response to biotic and abiotic components of their habitat. Although knowing the underlying mechanism of these patterns can be critical to the development of sound measures for the preservation or recovery of endangered species, few studies have yet identified which processes drive the existence of geographical gradients in habitat selection. Using extensive spatial data of broad latitudinal and longitudinal extent, we tested three hypotheses that could explain the presence of geographical gradients in landscape selection of the endangered boreal woodland caribou (Rangifer tarandus caribou) during winter in Eastern Canadian boreal forests: 1) climate-driven selection, which postulates that geographic gradients are surrogates for climatic gradients; 2) road-driven selection, which proposes that boreal caribou adjust their selection for certain habitat classes as a function of proximity to roads; and 3) an additive effect of both roads and climate. Our data strongly supported road-driven selection over climate influences. Thus, direct human alteration of landscapes drives boreal caribou distribution and should likely remain so until the climate changes sufficiently from present conditions. Boreal caribou avoided logged areas two-fold more strongly than burnt areas. Limiting the spread of road networks and accounting for the uneven impact of logging compared to wildfire should therefore be integral parts of any habitat management plan and conservation measures within the range of the endangered boreal caribou. The use of hierarchical spatial models allowed us to explore the distribution of spatially-structured errors in our models, which in turn provided valuable insights for generating alternative hypotheses about processes responsible for boreal caribou distribution.	[Beguin, Julien; McIntire, Eliot J. B.; Cumming, Steven G.; Raulier, Frederic; Racine, Pierre] Univ Laval, Dept Sci Bois & Foret, Quebec City, PQ, Canada; [Beguin, Julien; McIntire, Eliot J. B.; Fortin, Daniel; Cumming, Steven G.; Raulier, Frederic; Racine, Pierre] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada; [McIntire, Eliot J. B.] Nat Resources Canada, Pacific Forestry Ctr, Canadian Forest Serv, Victoria, BC, Canada; [Fortin, Daniel] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Dussault, Claude] Minist Ressources Nat & Faune, Direct Expertise Energie Faune Forets Mines Terr, Joncquiere, PQ, Canada	Laval University; Laval University; Natural Resources Canada; Canadian Forest Service; Laval University	Beguin, J (corresponding author), Univ Laval, Dept Sci Bois & Foret, Quebec City, PQ, Canada.	julien.beguin.1@ulaval.ca	Racine, Pierre/K-7399-2012; Fortin, Daniel/ABG-3554-2020; McIntire, Eliot/F-7995-2011	Racine, Pierre/0000-0003-0658-1945; Beguin, Julien/0000-0002-1168-4407; McIntire, Eliot/0000-0002-6914-8316	NSERC (Natural Sciences and Engineering Research Council of Canada)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this research was provided by an NSERC (Natural Sciences and Engineering Research Council of Canada) scholarship to J.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton KG, 2000, AM NAT, V156, P390, DOI 10.1086/303400; Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P578, DOI 10.1111/j.1365-2486.2008.01679.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bastille-Rousseau G., 2012, SELECTION HABITAT CA; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bouchard M, 2008, CAN J FOREST RES, V38, P1621, DOI 10.1139/X07-201; Boulet M, 2007, MOL ECOL, V16, P4223, DOI 10.1111/j.1365-294X.2007.03476.x; COSEWIC, 2002, COSEWIC ASS UPD STAT; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Courtois R, 2004, FOREST CHRON, V80, P598, DOI 10.5558/tfc80598-5; Courtois R, 2003, CAN FIELD NAT, V117, P546, DOI 10.22621/cfn.v117i4.823; Courtois R, 2008, CAN J FOREST RES, V38, P2837, DOI 10.1139/X08-119; Couturier S, 2010, J WILDLIFE MANAGE, V74, P395, DOI 10.2193/2008-384; Cyr D, 2009, FRONT ECOL ENVIRON, V7, P519, DOI 10.1890/080088; DeCesare NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4626, DOI 10.1098/rspb.2012.1698; Dussault C, 2012, P ROY SOC B-BIOL SCI, V279, P4481, DOI 10.1098/rspb.2012.1700; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Environment Canada, 2012, REC STAT WOODL CAR B; Environment Canada, 2008, SCI REV IDENTIFICATI; Environment Canada, 2011, NAT CLIM DAT INF ARC; Equipe de retablissement du caribou forestier du Quebec, 2008, PLAN RETABLISSEMENT; Faille G, 2010, BIOL CONSERV, V143, P2840, DOI 10.1016/j.biocon.2010.08.001; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Fortin D, 2008, J APPL ECOL, V45, P1392, DOI 10.1111/j.1365-2664.2008.01542.x; Fortin D, 2013, AM NAT, V181, P827, DOI 10.1086/670243; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gauthier S., 2009, ECOSYSTEM MANAGEMENT; Government of Quebec, 2010, LOI AMENAGEMENT DURA; Herfindal I, 2006, OECOLOGIA, V150, P213, DOI 10.1007/s00442-006-0519-8; Houle M, 2010, LANDSCAPE ECOL, V25, P419, DOI 10.1007/s10980-009-9420-2; HUNTER ML, 1993, BIOL CONSERV, V65, P115, DOI 10.1016/0006-3207(93)90440-C; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MacArthur R.H., 1972, pvii; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; Ministere des ressources naturelles et; de la Faune du Quebec, 2003, NORM CART EC TROIS I, P109; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Oliver T, 2009, ECOL LETT, V12, P1091, DOI 10.1111/j.1461-0248.2009.01367.x; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; Panel Intergovernmentalon Climate Change - IPCC, 2007, CLIM CHANG SYNTHE RE; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; SCHAEFER JA, 1991, WILDLIFE MONOGR, P1; Sharma S, 2009, GLOBAL CHANGE BIOL, V15, P2549, DOI 10.1111/j.1365-2486.2009.01945.x; Thomas DC, 2011, RANGIFER, V16, P337; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Zuur Alain F., 2009, P1	55	4	4	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78510	10.1371/journal.pone.0078510	http://dx.doi.org/10.1371/journal.pone.0078510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194942	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000121
J	Hadass, O; Tomlinson, BN; Gooyit, M; Chen, SY; Purdy, JJ; Walker, JM; Zhang, CY; Giritharan, AB; Purnell, W; Robinson, CR; Shin, D; Schroeder, VA; Suckow, MA; Simonyi, A; Sun, GY; Mobashery, S; Cui, JK; Chang, M; Gu, ZZ				Hadass, Orr; Tomlinson, Brittany N.; Gooyit, Major; Chen, Shanyan; Purdy, Justin J.; Walker, Jennifer M.; Zhang, Chunyang; Giritharan, Andrew B.; Purnell, Whitley; Robinson, Christopher R., II; Shin, Dmitriy; Schroeder, Valerie A.; Suckow, Mark A.; Simonyi, Agnes; Sun, Grace Y.; Mobashery, Shahriar; Cui, Jiankun; Chang, Mayland; Gu, Zezong			Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; GELATINASE INHIBITOR; KNOCK-OUT; BLOOD; DEGRADATION; EXPRESSION; NEURODEGENERATION; ACTIVATION; MICROGLIA; MECHANISM	Traumatic brain injury (TBI) is a leading cause of death and long-term disability. Following the initial insult, severe TBI progresses to a secondary injury phase associated with biochemical and cellular changes. The secondary injury is thought to be responsible for the development of many of the neurological deficits observed after TBI and also provides a window of opportunity for therapeutic intervention. Matrix metalloproteinase-9 (MMP-9 or gelatinase B) expression is elevated in neurological diseases and its activation is an important factor in detrimental outcomes including excitotoxicity, mitochondrial dysfunction and apoptosis, and increases in inflammatory responses and astrogliosis. In this study, we used an experimental mouse model of TBI to examine the role of MMP-9 and the therapeutic potential of SB-3CT, a mechanism-based gelatinase selective inhibitor, in ameliorating the secondary injury. We observed that activation of MMP-9 occurred within one day following TBI, and remained elevated for 7 days after the initial insult. SB-3CT effectively attenuated MMP-9 activity, reduced brain lesion volumes and prevented neuronal loss and dendritic degeneration. Pharmacokinetic studies revealed that SB-3CT and its active metabolite, p-OH SB-3CT, were rapidly absorbed and distributed to the brain. Moreover, SB-3CT treatment mitigated microglial activation and astrogliosis after TBI. Importantly, SB-3CT treatment improved long-term neurobehavioral outcomes, including sensorimotor function, and hippocampus-associated spatial learning and memory. These results demonstrate that MMP-9 is a key target for therapy to attenuate secondary injury cascades and that this class of mechanism-based gelatinase inhibitor-with such desirable pharmacokinetic properties-holds considerable promise as a potential pharmacological treatment of TBI.	[Hadass, Orr; Tomlinson, Brittany N.; Chen, Shanyan; Purdy, Justin J.; Zhang, Chunyang; Giritharan, Andrew B.; Purnell, Whitley; Robinson, Christopher R., II; Shin, Dmitriy; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA; [Simonyi, Agnes; Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Hadass, Orr; Tomlinson, Brittany N.; Chen, Shanyan; Purdy, Justin J.; Zhang, Chunyang; Giritharan, Andrew B.; Purnell, Whitley; Robinson, Christopher R., II; Simonyi, Agnes; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Hadass, Orr; Tomlinson, Brittany N.] Univ Missouri, MS Pathol Program, Grad Sch, Columbia, MO USA; [Chen, Shanyan] Univ Missouri, Interdisciplinary Neurosci Program, Grad Sch, Columbia, MO USA; [Walker, Jennifer M.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Gooyit, Major; Mobashery, Shahriar; Chang, Mayland] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA; [Schroeder, Valerie A.; Suckow, Mark A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Notre Dame; University of Notre Dame; University of Notre Dame	Chang, M (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	mchang@nd.edu; guze@health.missouri.edu	Suckow, Mark/C-2696-2014	Suckow, Mark/0000-0001-7317-697X; Shin, Dmitriy/0000-0002-5571-9384	Mizzou Advantage; Department of Pathology and Anatomical Sciences; ICATS; NFL Charities Foundation; Indiana Department of Health Spinal Cord and Brain Fund; National Institutes of Health [GM075762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	Mizzou Advantage; Department of Pathology and Anatomical Sciences; ICATS; NFL Charities Foundation; Indiana Department of Health Spinal Cord and Brain Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from Mizzou Advantage, the Department of Pathology and Anatomical Sciences (to ZG) and ICATS Fellowship (to JP) at the University of Missouri; the NFL Charities Foundation and the Indiana Department of Health Spinal Cord and Brain Fund (to MC and ZG) and National Institutes of Health Training Grant GM075762 (to MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown S, 2000, J AM CHEM SOC, V122, P6799, DOI 10.1021/ja001461n; Buss A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-17; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; del Zoppo GJ, 2007, STROKE, V38, P646, DOI 10.1161/01.STR.0000254477.34231.cb; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Forbes C, 2009, CHEM BIOL DRUG DES, V74, P527, DOI 10.1111/j.1747-0285.2009.00881.x; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gooyit M, 2012, ACS CHEM NEUROSCI, V3, P730, DOI 10.1021/cn300062w; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo ZD, 2010, NEUROL RES, V32, P715, DOI 10.1179/016164109X12478302362491; Helton R, 2005, J NEUROSCI, V25, P4099, DOI 10.1523/JNEUROSCI.4555-04.2005; Horstmann S, 2003, STROKE, V34, P2165, DOI 10.1161/01.STR.0000088062.86084.F2; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kim GW, 2003, J NEUROSCI, V23, P8733; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; Lee M, 2007, CHEM BIOL DRUG DES, V70, P371, DOI 10.1111/j.1747-0285.2007.00577.x; Lee M, 2009, CHEM BIOL DRUG DES, V73, P189, DOI 10.1111/j.1747-0285.2008.00750.x; Liu HQ, 2011, EXP NEUROL, V231, P236, DOI 10.1016/j.expneurol.2011.06.015; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Montaner J, 2001, STROKE, V32, P2762, DOI 10.1161/hs1201.99512; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Noble LJ, 2002, J NEUROSCI, V22, P7526; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge William M, 2005, NeuroRx, V2, P3; Qiu LB, 2011, TOXICOLOGY, V285, P31, DOI 10.1016/j.tox.2011.03.019; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Switzer JA, 2011, STROKE, V42, P2633, DOI 10.1161/STROKEAHA.111.618215; Toth M, 2000, J BIOL CHEM, V275, P41415, DOI 10.1074/jbc.M006871200; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yagi Y, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S12; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yu F, 2008, J NEUROTRAUM, V25, P184, DOI 10.1089/neu.2007.0438; Zhang HQ, 2010, NEUROSCIENTIST, V16, P156, DOI 10.1177/1073858409355830; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	48	81	88	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76904	10.1371/journal.pone.0076904	http://dx.doi.org/10.1371/journal.pone.0076904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194849	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000028
J	Nyegaard, S; Novakovic, VA; Rasmussen, JT; Gilbert, GE				Nyegaard, Steffen; Novakovic, Valerie A.; Rasmussen, Jan T.; Gilbert, Gary E.			Lactadherin Inhibits Secretory Phospholipase A(2) Activity on Pre-Apoptotic Leukemia Cells	PLOS ONE			English	Article							INTERFACIAL BINDING SURFACE; GROUP-V; GROUP-II; PHOSPHATIDYLSERINE EXPOSURE; INFLAMMATORY DISEASES; EMERGING ROLES; GROWTH-FACTOR; IN-VIVO; MEMBRANE; EXPRESSION	Secretory phospholipase A(2) (sPLA(2)) is a critical component of insect and snake venoms and is secreted by mammalian leukocytes during inflammation. Elevated secretory PLA(2) concentrations are associated with autoimmune diseases and septic shock. Many sPLA(2)'s do not bind to plasma membranes of quiescent cells but bind and digest phospholipids on the membranes of stimulated or apoptotic cells. The capacity of these phospholipases to digest membranes of stimulated or apoptotic cells correlates to the exposure of phosphatidylserine. In the present study, the ability of the phosphatidyl-L-serine-binding protein, lactadherin to inhibit phospholipase enzyme activity has been assessed. Inhibition of human secretory phospholipase A(2)-V on phospholipid vesicles exceeded 90%, whereas inhibition of Naja mossambica sPLA(2) plateaued at 50-60%. Lactadherin inhibited 45% of activity of Naja mossambica sPLA(2) and >70% of human secretory phospholipase A(2)-V on the membranes of human NB4 leukemia cells treated with calcium ionophore A23187. The data indicate that lactadherin may decrease inflammation by inhibiting sPLA(2).	[Nyegaard, Steffen; Rasmussen, Jan T.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Nyegaard, Steffen; Novakovic, Valerie A.; Gilbert, Gary E.] Brigham & Womens Hosp, Dept Med, Vet Adm Boston Healthcare Syst, Boston, MA 02115 USA; [Nyegaard, Steffen; Novakovic, Valerie A.; Gilbert, Gary E.] Harvard Univ, Sch Med, Boston, MA USA	Aarhus University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rasmussen, JT (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark.	jatr@mb.au.dk		Novakovic, Valerie/0000-0002-9846-0907; Rasmussen, Jan Trige/0000-0002-2809-7225	Arla Foods (amba); Aarhus University; Danish Council for Independent Research | Natural Sciences; Veterans Administration Merit Award	Arla Foods (amba); Aarhus University; Danish Council for Independent Research | Natural Sciences(Det Frie Forskningsrad (DFF)); Veterans Administration Merit Award	This study was funded by Arla Foods (amba) (http://www.arla.dk/), Aarhus University (http://www.au.dk/en/) and The Danish Council for Independent Research | Natural Sciences (FNU) (http://fivu.dk/en) and a Veterans Administration Merit Award (http://www.research.va.gov/services/csrd/#.UYp_kcozooE) to GEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsman AJ, 2000, BBA-MOL BASIS DIS, V1502, P257, DOI 10.1016/S0925-4439(00)00050-8; Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; AXELSSON G, 1976, THROMB HAEMOSTASIS, V36, P517, DOI 10.1055/s-0038-1648071; Bailey RW, 2007, BIOPHYS J, V93, P2350, DOI 10.1529/biophysj.107.104679; Balboa MA, 1996, J BIOL CHEM, V271, P32381, DOI 10.1074/jbc.271.50.32381; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; BAYBURT T, 1993, BIOCHEMISTRY-US, V32, P573, DOI 10.1021/bi00053a024; BERG OG, 1991, BIOCHEMISTRY-US, V30, P7283, DOI 10.1021/bi00243a034; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; Boccellino M, 2002, LIPIDS, V37, P1047, DOI 10.1007/s11745-002-0999-7; Boilard E, 2010, EMBO MOL MED, V2, P172, DOI 10.1002/emmm.201000072; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11, DOI 10.1038/newbio236011a0; Burke JR, 1999, ARCH BIOCHEM BIOPHYS, V365, P239, DOI 10.1006/abbi.1999.1151; CHEN J, 1994, J BIOL CHEM, V269, P2365; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng M, 2012, DIABETES RES CLIN PR, V95, P125, DOI 10.1016/j.diabres.2011.09.030; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Dennis EA, 2000, AM J RESP CRIT CARE, V161, pS32, DOI 10.1164/ajrccm.161.supplement_1.ltta-7; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; FADOK VA, 1992, J IMMUNOL, V148, P2207; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GREEN JA, 1991, INFLAMMATION, V15, P355, DOI 10.1007/BF00917352; Haapamaki MM, 1999, AM J GASTROENTEROL, V94, P713, DOI 10.1111/j.1572-0241.1999.00941.x; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; HARA S, 1989, J BIOCHEM-TOKYO, V105, P395, DOI 10.1093/oxfordjournals.jbchem.a122675; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; Jain MK, 2006, CURR OPIN CHEM BIOL, V10, P473, DOI 10.1016/j.cbpa.2006.08.015; JAIN MK, 1986, BIOCHIM BIOPHYS ACTA, V860, P435, DOI 10.1016/0005-2736(86)90541-9; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; KAUFMANN SH, 1989, CANCER RES, V49, P5870; KUIPERS OP, 1990, ADV EXP MED BIOL, V279, P65; LANOTTE M, 1991, BLOOD, V77, P1080; Lapointe S, 2010, J CELL PHYSIOL, V224, P127, DOI 10.1002/jcp.22106; Lecoeur H, 2002, EXP CELL RES, V277, P1, DOI 10.1006/excr.2002.5537; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Masuda S, 2005, FEBS J, V272, P655, DOI 10.1111/j.1742-4658.2004.04489.x; MINAMI T, 1994, GUT, V35, P1593, DOI 10.1136/gut.35.11.1593; Munoz NM, 2007, J IMMUNOL, V179, P4800, DOI 10.4049/jimmunol.179.7.4800; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2013, BIOCHIMIE, V95, P43, DOI 10.1016/j.biochi.2012.09.007; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nelson J, 2012, BBA-BIOMEMBRANES, V1818, P1196, DOI 10.1016/j.bbamem.2012.01.005; Nelson J, 2011, BBA-BIOMEMBRANES, V1808, P1913, DOI 10.1016/j.bbamem.2011.04.003; Nevalainen TJ, 2000, BBA-MOL CELL BIOL L, V1488, P83, DOI 10.1016/S1388-1981(00)00112-8; Nielson KH, 2000, BBA-MOL CELL BIOL L, V1484, P163, DOI 10.1016/S1388-1981(00)00004-4; Olson ED, 2010, J BIOL CHEM, V285, P10993, DOI 10.1074/jbc.M109.070797; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Schlegel RA, 2001, CELL DEATH DIFFER, V8, P551, DOI 10.1038/sj.cdd.4400817; SCHROIT AJ, 1985, J BIOL CHEM, V260, P5131; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shi J, 2008, J THROMB HAEMOST, V6, P1167, DOI 10.1111/j.1538-7836.2008.03010.x; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; TAIT JF, 1988, BIOCHEMISTRY-US, V27, P6268, DOI 10.1021/bi00417a011; Tannert A, 2003, J BIOL CHEM, V278, P40631, DOI 10.1074/jbc.M302131200; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Waehrens LN, 2009, J HISTOCHEM CYTOCHEM, V57, P907, DOI 10.1369/jhc.2009.953729; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002; Wolfs JLN, 2005, CELL MOL LIFE SCI, V62, P1514, DOI 10.1007/s00018-005-5099-y; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yamaguchi H, 2008, J LEUKOCYTE BIOL, V83, P1300, DOI 10.1189/jlb.1107730; ZWAAL RFA, 1975, BIOCHIM BIOPHYS ACTA, V406, P83, DOI 10.1016/0005-2736(75)90044-9	80	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77143	10.1371/journal.pone.0077143	http://dx.doi.org/10.1371/journal.pone.0077143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194865	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000044
J	O'Shea, RP; Chandler, NP; Roy, R				O'Shea, Robert P.; Chandler, Nicholas P.; Roy, Rajneesh			Dentists Make Larger Holes in Teeth Than They Need to If the Teeth Present a Visual Illusion of Size	PLOS ONE			English	Article							MEDICAL DECISION-MAKING; NONMEDICAL INFLUENCES; EBBINGHAUS ILLUSION; OPTICAL ILLUSIONS; DECREMENT; CONTRAST; ASSIMILATION; SIMILARITY	Background: Health care depends, in part, on the ability of a practitioner to see signs of disease and to see how to treat it. Visual illusions, therefore, could affect health care. Yet there is very little prospective evidence that illusions can influence treatment. We sought such evidence. Methods and Results: We simulated treatment using dentistry as a model system. We supplied eight, practicing, specialist dentists, endodontists, with at least 21 isolated teeth each, randomly sampled from a much larger sample of teeth they were likely to encounter. Teeth contained holes and we asked the endodontists to cut cavities in preparation for filling. Each tooth presented a more or less potent version of a visual illusion of size, the Delboeuf illusion, that made the holes appear smaller than they were. Endodontists and the persons measuring the cavities were blind to the parameters of the illusion. We found that the size of cavity endodontists made was linearly related to the potency of the Delboeuf illusion (p<.01) with an effect size (Cohen's d) of 1.41. When the illusion made the holes appear smaller, the endodontists made cavities larger than needed. Conclusions: The visual context in which treatment takes place can influence the treatment. Undesirable effects of visual illusions could be counteracted by a health practitioner's being aware of them and by using measurement.	[O'Shea, Robert P.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Cognit Neurosci Res Cluster, Coffs Harbour, Australia; [Chandler, Nicholas P.; Roy, Rajneesh] Univ Otago, Fac Dent, Sir John Walsh Res Inst, Dunedin, New Zealand	University of Otago; Southern Cross University; Southern Cross University; University of Otago	O'Shea, RP (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	robert.oshea@scu.edu.au	O'Shea, Robert P./C-5723-2008	O'Shea, Robert P./0000-0003-3132-7199	University of Otago; Southern Cross University	University of Otago; Southern Cross University	This study was funded from general sources from University of Otago and from Southern Cross University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKESON BM, 1978, EXP AGING RES, V4, P55, DOI 10.1080/03610737808257126; Bach M, 2013, 106 OPTICAL ILLUSION; Blake  R., 2006, PERCEPTION; Chandler NP, 2002, J ROY COLL SURG EDIN, V47, P660; Choplin JM, 1999, PERCEPT PSYCHOPHYS, V61, P3, DOI 10.3758/BF03211944; COREN S, 1972, PERCEPT PSYCHOPHYS, V12, P224, DOI 10.3758/BF03212877; COREN S, 1974, PERCEPT PSYCHOPHYS, V16, P355, DOI 10.3758/BF03203955; Coren S., 1978, SEEING IS DECEIVING; Daffner R H, 1989, Curr Probl Diagn Radiol, V18, P62, DOI 10.1016/0363-0188(89)90030-3; DELBOEUF J, 1865, B ACADEMIE ROYALE SC, V19, P195; Delboeuf J., 1892, B ACAD ROYALE BELGIQ, V24, P545; Dental Council of New Zealand (DCNZ), 2006, REG; Epstein SA, 2008, MED CARE RES REV, V65, P674, DOI 10.1177/1077558708320987; Feldman HA, 1997, HEALTH SERV RES, V32, P343; Fialkow MF, 2009, J MINIM INVAS GYN, V16, P136, DOI 10.1016/j.jmig.2008.11.013; Goto T, 2007, JPN PSYCHOL RES, V49, P33, DOI 10.1111/j.1468-5884.2007.00330.x; Gutmann JL, 1993, INT ENDOD J, V262, P73; Harris KM, 1996, PERCEPT MOTOR SKILL, V82, P79, DOI 10.2466/pms.1996.82.1.79; Imhotep, E SMITH SURG PAPYRUS; Jaffe C C, 1984, Med Radiogr Photogr, V60, P1; Kahol K, 2009, J AM COLL SURGEONS, V208, P255, DOI 10.1016/j.jamcollsurg.2008.09.029; Kramer G A, 1989, J Dent Educ, V53, P119; McKinlay JB, 1996, SOC SCI MED, V42, P769, DOI 10.1016/0277-9536(95)00342-8; McKinney P, 2000, PLAST RECONSTR SURG, V106, P906, DOI 10.1097/00006534-200009040-00029; McPhee E R, 1978, J Mich Dent Assoc, V60, P565; MORINAGA S, 1966, PSYCHOL FORSCH, V29, P161, DOI 10.1007/BF00510815; MOUNTJOY PT, 1965, PSYCHOL REC, V15, P7; Murdoch-Kinch CA, 2003, J AM DENT ASSOC, V134, P87, DOI 10.14219/jada.archive.2003.0021; Nielsen CJ, 2001, J ENDODONT, V27, P687, DOI 10.1097/00004770-200111000-00009; Ridolfi Marcello, 2005, Rays, V30, P279; Robinson J. O, 1972, PSYCHOL VISUAL ILLUS; Rose D, 2002, SPATIAL VISION, V15, P191, DOI 10.1163/15685680252875165; ROSE SC, 1990, AM J EMERG MED, V8, P109, DOI 10.1016/0735-6757(90)90195-6; Rosen JM, 2009, PLAST RECONSTR SURG, V123, P729, DOI 10.1097/PRS.0b013e3181958ec4; Ross HE, 2002, MYSTERY MOON ILLUSIO; Roy R, 2008, ORAL SURG ORAL MED O, V105, P263, DOI 10.1016/j.tripleo.2007.08.010; Roy R, 2007, ENDO-ENDOD PRACT TOD, V1, P91; Seckel A, 2000, ART OPTICAL ILLUSION; Seymour NE, 2002, ANN SURG, V236, P458, DOI 10.1097/00000658-200210000-00008; Singer B A, 1994, Curr Opin Cosmet Dent, P6; Slavkin HC, 1999, J AM DENT ASSOC, V130, P1115, DOI 10.14219/jada.archive.1999.0346; Spodick David H, 2003, Am Heart Hosp J, V1, P192, DOI 10.1111/j.1541-9215.2003.02484.x; von Arx T, 2011, INT ENDOD J, V44, P290, DOI 10.1111/j.1365-2591.2010.01811.x; WAGNER RF, 1992, DERMATOLOGY, V184, P245; Way LW, 2003, ANN SURG, V237, P460, DOI 10.1097/00000658-200304000-00004; World Medical Association, 2004, DECL HELS ETH PRINC; Youn G, 1978, EXPT AGING RES, V13, P53	47	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77343	10.1371/journal.pone.0077343	http://dx.doi.org/10.1371/journal.pone.0077343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194880	gold, Green Published			2022-12-25	WOS:000326037000059
J	Fregni, G; Messaoudene, M; Fourmentraux-Neves, E; Mazouz-Dorval, S; Chanal, J; Maubec, E; Marinho, E; Scheer-Senyarich, I; Cremer, I; Avril, MF; Caignard, A				Fregni, Giulia; Messaoudene, Meriem; Fourmentraux-Neves, Emmanuelle; Mazouz-Dorval, Sarra; Chanal, Johan; Maubec, Eve; Marinho, Eduardo; Scheer-Senyarich, Isabelle; Cremer, Isabelle; Avril, Marie-Francoise; Caignard, Anne			Phenotypic and Functional Characteristics of Blood Natural Killer Cells from Melanoma Patients at Different Clinical Stages	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; DENDRITIC CELLS; METASTATIC MELANOMA; RECEPTOR NKP46/NCR1; NK RECEPTORS; EXPRESSION; CARCINOMA; RECOGNITION; ENVIRONMENT; LIGANDS	Melanomas are aggressive skin tumors characterized by high metastatic potential. Immunotherapy is a valuable alternative for metastatic melanoma patients resistant to chemotherapy. Natural Killer (NK) cells are efficient anti-tumor cytotoxic effectors. We previously showed that blood NK cells from stage IV metastatic melanoma patients display decreased NK receptors and that chemotherapy modifies the functional status of blood NK cells. To investigate the role of NK cells along melanoma progression, we have here studied NK cells from patients at different stages of the disease. First, we showed that ex vivo NK cells from certain stage III-IV patients displayed low degranulation potential. Using a dynamic label-free assay, we found that immunoselected IL-2 activated blood NK cells from patients efficiently lysed melanoma cells through NKp46 and NKG2D receptors, independently to the clinical stage. Moreover, the ex vivo phenotype of circulating NK cells from 33 patients (stage I to IV) was extensively analyzed. NK cells from patients displayed higher variability in the percentages of Natural Cytotoxicity Receptors (NCR) and Natural Killer Group 2D (NKG2D) receptor expression compared to donor NK cells. The main defect was the decreased expression of NCR1 (NKp46) by NK cells from metastatic patients. Interestingly, we found a positive correlation between the NK cell percentages of NKp46 and the duration of stage IV in melanoma patients. Finally, we showed that NK cells infiltrated primary melanomas and displayed a predominant peritumoral distribution. These results are new arguments for the development of NK-based therapies in melanoma patients.	[Fregni, Giulia; Messaoudene, Meriem; Fourmentraux-Neves, Emmanuelle; Mazouz-Dorval, Sarra; Chanal, Johan; Avril, Marie-Francoise; Caignard, Anne] Univ Paris 05, CNRS, INSERM, U1016,UMR 8104,Cochin Inst, Paris, France; [Chanal, Johan; Avril, Marie-Francoise] Univ Paris 05, Cochin Hosp, AP HP, Dept Dermatol, Paris, France; [Maubec, Eve; Marinho, Eduardo; Scheer-Senyarich, Isabelle] Univ Paris 05, AP HP, Dept Dermatol, Paris, France; [Maubec, Eve; Marinho, Eduardo; Scheer-Senyarich, Isabelle] Hop Xavier Bichat, Dept Pathol, Paris, France; [Cremer, Isabelle] Inst Rech Cordeliers, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Caignard, A (corresponding author), Univ Paris 05, CNRS, INSERM, U1016,UMR 8104,Cochin Inst, Paris, France.	anne.caignard@inserm.fr	Cremer, Isabelle/D-4278-2017; Maubec, Eve/V-4296-2017; Caignard, Anne/F-8159-2013	Cremer, Isabelle/0000-0002-0963-1031; Maubec, Eve/0000-0003-1658-6686; Caignard, Anne/0000-0001-9923-6045	INSERM; l'Association pour la Recherche contre le Cancer (ARC) [3964]; la Societe Francaise de Dermatologie (SFD); la Ligue Nationale contre le Cancer; l'Institut National du Cancer (Canceropole Ile de France); la Fondation de France [20363]; Canceropole IdF; Ligue Nationale contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); l'Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); la Societe Francaise de Dermatologie (SFD); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); l'Institut National du Cancer (Canceropole Ile de France); la Fondation de France(Fondation de France); Canceropole IdF(Region Ile-de-France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	Grant Support: This work was supported by grants from INSERM, l'Association pour la Recherche contre le Cancer (ARC, 3964), la Societe Francaise de Dermatologie (SFD, grant for Dr JC), la Ligue Nationale contre le Cancer (grant to AC, Comite Ile de France), l'Institut National du Cancer (Canceropole Ile de France), la Fondation de France (Grant 20363 to AC). GF had a grant from Canceropole IdF and Ligue Nationale contre le Cancer. MM is recipient of a PhD grant from Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021118; Cagnano E, 2008, J INVEST DERMATOL, V128, P972, DOI 10.1038/sj.jid.5701111; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Coupel S, 2007, BLOOD, V109, P2806, DOI 10.1182/blood-2006-06-030213; Della Chiesa M, 2006, BLOOD, V108, P4118, DOI 10.1182/blood-2006-06-006700; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; Erdag G, 2012, CANC RES; FERRADINI L, 1993, J CLIN INVEST, V91, P1183, DOI 10.1172/JCI116278; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fregni G, 2012, ONCOIMMUNOLOGY, V1, P38, DOI 10.4161/onci.1.1.18312; Fregni G, 2011, CLIN CANCER RES, V17, P2628, DOI 10.1158/1078-0432.CCR-10-2084; Glasner A, 2012, J IMMUNOL, V188, P2509, DOI 10.4049/jimmunol.1102461; Godefroy E, 2011, CANCER CELL, V19, P333, DOI 10.1016/j.ccr.2011.01.037; Halfteck GG, 2009, J IMMUNOL, V182, P2221, DOI 10.4049/jimmunol.0801878; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Konjevic G, 2010, BIOMED PHARMACOTHER, V64, P663, DOI 10.1016/j.biopha.2010.06.013; Konjevic G, 2007, CLIN EXP METASTAS, V24, P1, DOI 10.1007/s10585-006-9043-9; KORNSTEIN MJ, 1987, CANCER RES, V47, P1411; Lakshmikanth T, 2009, J CLIN INVEST; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Lopez-Botet M, 1998, CURR TOP MICROBIOL, V230, P41; Mamessier E, 2011, CANCER RES, V71, P6621, DOI 10.1158/0008-5472.CAN-11-0792; Martinovic KM, 2011, J SURG RES, V171, P637, DOI 10.1016/j.jss.2010.05.012; McCarter M, 2005, SURGERY, V138, P321, DOI 10.1016/j.surg.2005.06.011; McKay K, 2011, HUM PATHOL, V42, P1960, DOI 10.1016/j.humpath.2011.02.019; Miller G, 2003, FASEB J, V17, P728, DOI 10.1096/fj.02-0900fje; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Movassagh M, 2004, CANCER RES, V64, P2192, DOI 10.1158/0008-5472.CAN-03-2969; Perier A, 2011, ONCOGENE, V30, P2622, DOI 10.1038/onc.2010.638; Pietra G, 2012, CANC RES; Pittari G, 2010, BONE MARROW TRANSPL, V45, P862, DOI 10.1038/bmt.2009.265; Platonova S, 2011, CANCER RES, V71, P5412, DOI 10.1158/0008-5472.CAN-10-4179; Remark R, 2013, CLIN CANC RES; Rusakiewicz S, 2013, CANCER RES, V73, P3499, DOI 10.1158/0008-5472.CAN-13-0371; Schleypen JS, 2006, CLIN CANCER RES, V12, P718, DOI 10.1158/1078-0432.CCR-05-0857; Sun JC, 2011, J EXP MED, V208, P357, DOI 10.1084/jem.20100479; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vetter CS, 2000, J INVEST DERMATOL, V114, P941, DOI 10.1046/j.1523-1747.2000.00958.x; Wang E, 2001, EXPERT OPIN BIOL TH, V1, P277, DOI 10.1517/14712598.1.2.277; Wong JL, 2011, J IMMUNOTHER, V34, P270, DOI 10.1097/CJI.0b013e31820b370b; Zhu J, 2006, J IMMUNOL METHODS, V309, P25, DOI 10.1016/j.jim.2005.10.018	43	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76928	10.1371/journal.pone.0076928	http://dx.doi.org/10.1371/journal.pone.0076928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204708	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300069
J	Grgic, H; Poljak, Z; Sharif, S; Nagy, E				Grgic, Helena; Poljak, Zvonimir; Sharif, Shayan; Nagy, Eva			Pathogenicity and Cytokine Gene Expression Pattern of a Serotype 4 Fowl Adenovirus Isolate	PLOS ONE			English	Article							INCLUSION-BODY HEPATITIS; TERMINAL HEAD DOMAIN; HYDROPERICARDIUM SYNDROME; MAREKS-DISEASE; IN-VITRO; VERTICAL TRANSMISSION; BROILER BREEDERS; INTERFERON-GAMMA; IFN-GAMMA; VIRUS	Hydropericardium-hepatitis syndrome (HHS), a recently emerged disease of chickens, is caused by some strains of fowl adenovirus serotype 4 (FAdV-4). In this study, a Canadian FAdV-4 isolate, designated as FAdV-4 ON1, was evaluated for pathogenicity after oral and intramuscular (im) infection of specific pathogen free (SPF) chickens. Pathogenicity was evaluated by observation of clinical signs and gross and histological lesions. The highest viral DNA copy numbers, irrespective of the inoculation route, were detected in the cecal tonsils. Virus titers in cloacal swabs collected over the entire study period were compared between the orally and im inoculated chickens, and the difference in titers between the two groups was significant (P<0.001), the oral group had a higher rank. The antibody response of infected chickens tested by an adenovirus-specific ELISA showed a statistically significant (P<0.001) difference between the orally and im inoculated chickens. The im inoculated chickens had higher values than birds inoculated orally (P<0.001). Serum samples from both groups collected at 14 days post-infection completely neutralized FAdV-4 ON1. In addition, the effects of FAdV-4 ON1 infection on transcription of a number of avian cytokines were studied in vivo. The expression of interferon (IFN)-gamma and interleukin (IL)-10 in the liver was induced at early times after infection. This FAdV-4 ON1 potentially could be used as a live vaccine against HHS and developed as vaccine vector. The GenBank/EMBL/DDBJ accession number for the FAdV-4 ON1 sequence is GU188428.	[Grgic, Helena; Sharif, Shayan; Nagy, Eva] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Poljak, Zvonimir] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Nagy, E (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	enagy@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Poultry Research Council (CPRC); Ontario Ministry of Agriculture and Food (OMAF)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Poultry Research Council (CPRC); Ontario Ministry of Agriculture and Food (OMAF)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Canadian Poultry Research Council (CPRC) and the Ontario Ministry of Agriculture and Food (OMAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Careem MF, 2006, VIRAL IMMUNOL, V19, P167, DOI 10.1089/vim.2006.19.167; Abdul-Careem MF, 2007, VACCINE, V25, P424, DOI 10.1016/j.vaccine.2006.08.006; Abe T, 1998, AVIAN DIS, V42, P606, DOI 10.2307/1592690; Alexander HS, 1998, J VIROL METHODS, V74, P9, DOI 10.1016/S0166-0934(98)00062-7; ANJUM AD, 1990, AVIAN PATHOL, V19, P655, DOI 10.1080/03079459008418721; Cheema A E, 1989, Rev Sci Tech, V8, P789, DOI 10.20506/rst.8.3.420; Corredor JC, 2010, NONESSENTIAL LEFT EN, P9; Corredor JC, 2010, J GEN VIROL, V91, P51, DOI 10.1099/vir.0.013839-0; COWEN BS, 1992, WORLD POULTRY SCI J, V48, P247, DOI 10.1079/WPS19920019; Deng L, 2013, CLIN VACCINE IMMUNOL, V20, P1189, DOI 10.1128/CVI.00187-13; El Bakkouri M, 2008, VIROLOGY, V378, P169, DOI 10.1016/j.virol.2008.05.011; ERNY K, 1995, ARCH VIROL, V140, P491, DOI 10.1007/BF01718426; Fitzgerald SD., 2008, DIS POULTRY, V12th, P251; Gerosa F, 1996, J EXP MED, V183, P2559, DOI 10.1084/jem.183.6.2559; Grgic H, 2006, CAN J VET RES, V70, P230; Grgic H, 2013, VIRAL IMMUNOL, V26, P143, DOI 10.1089/vim.2012.0078; Grgic H, 2011, VIRUS RES, V156, P91, DOI 10.1016/j.virusres.2011.01.002; Griffin BD, 2011, J GEN VIROL, V92, P1260, DOI 10.1099/vir.0.030064-0; Guardado-Calvo P, 2007, J GEN VIROL, V88, P2407, DOI 10.1099/vir.0.82845-0; Hess M, 1999, AVIAN PATHOL, V28, P433, DOI 10.1080/03079459994443; Johnsen CK, 2002, VIRAL IMMUNOL, V15, P549, DOI 10.1089/088282402320914494; Johnson MA, 2003, VACCINE, V21, P2730, DOI 10.1016/S0264-410X(03)00227-5; Khawaja D. A., 1988, Pakistan Journal of Veterinary Research, V1, P2; Lillehoj HS, 1998, AVIAN DIS, V42, P307, DOI 10.2307/1592481; Mansoor MK, 2011, TROP ANIM HEALTH PRO, V43, P331, DOI 10.1007/s11250-010-9694-z; Mazaheri A, 1998, AVIAN PATHOL, V27, P269, DOI 10.1080/03079459808419335; Nakamura K, 1999, AVIAN DIS, V43, P414, DOI 10.2307/1592638; Ojkic D, 2003, VACCINE, V22, P42, DOI 10.1016/S0264-410X(03)00544-9; Ojkic D, 2001, VIROLOGY, V283, P197, DOI 10.1006/viro.2000.0890; Parvizi P, 2009, VET IMMUNOL IMMUNOP, V132, P209, DOI 10.1016/j.vetimm.2009.06.009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philippe C, 2005, J APPL POULTRY RES, V14, P588, DOI 10.1093/japr/14.3.588; Philippe C, 2007, CAN J VET RES, V71, P98; Plachy J, 1999, VIROLOGY, V256, P85, DOI 10.1006/viro.1999.9602; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; SAIFUDDIN M, 1991, ARCH VIROL, V116, P33, DOI 10.1007/BF01319229; Schonewille E, 2010, AVIAN DIS, V54, P905, DOI 10.1637/8999-072309-Reg.1; Sheppard M, 1998, ARCH VIROL, V143, P915, DOI 10.1007/s007050050342; Sung RS, 2001, MOL THER, V3, P757, DOI 10.1006/mthe.2001.0318; Toro H, 1999, AVIAN DIS, V43, P262, DOI 10.2307/1592616; Xing Z, 2000, J VIROL, V74, P3605, DOI 10.1128/JVI.74.8.3605-3612.2000	41	40	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77601	10.1371/journal.pone.0077601	http://dx.doi.org/10.1371/journal.pone.0077601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204888	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300105
J	Kramer, JR; Matsumura, I				Kramer, Joseph R.; Matsumura, Ichiro			Directed Evolution of Aminoglycoside Phosphotransferase (3 ') Type IIIa Variants That Inactivate Amikacin but Impose Significant Fitness Costs	PLOS ONE			English	Article							IN-VITRO; ANTIBIOTIC-RESISTANCE; ENZYME; GENES; PURIFICATION; ENTEROCOCCUS; PROMISCUITY; ADAPTATION; EXPRESSION; MUTATIONS	The rules that govern adaptive protein evolution remain incompletely understood. Aminoglycoside aminotransferase (3') type IIIa (hereafter abbreviated APH(3')-IIIa) is a good model enzyme because it inactivates kanamycin efficiently; it recognizes other aminoglycoside antibiotics, including amikacin, but not nearly as well. Here we direct the evolution of APH(3')-IIIa variants with increased activity against amikacin. After four rounds of random mutation and selection in Escherichia coli, the minimum inhibitory concentration of amikacin rose from 18 micrograms/mL (wild-type enzyme) to over 1200 micrograms/mL (clone 4.1). The artificially evolved 4.1 APH(3')-IIIa variant exhibited 19-fold greater catalytic efficiency (k(cat)/K-M) than did the wild-type enzyme in reactions with amikacin. E. coli expressing the evolved 4.1 APH(3')-IIIa also exhibited a four-fold decrease in fitness (as measured by counting colony forming units in liquid cultures with the same optical density) compared with isogenic cells expressing the wild-type protein under non-selective conditions. We speculate that these fitness costs, in combination with the prevalence of other amikacin-modifying enzymes, hinder the evolution of APH(3')-IIIa in clinical settings.	[Kramer, Joseph R.; Matsumura, Ichiro] Emory Univ, Sch Med, Dept Biochem, Rollins Res Ctr, Atlanta, GA 30322 USA	Emory University	Matsumura, I (corresponding author), Emory Univ, Sch Med, Dept Biochem, Rollins Res Ctr, Atlanta, GA 30322 USA.	imatsum@emory.edu			National Instutite of Health [1 R01 GM086824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490, R01GM086824] Funding Source: NIH RePORTER	National Instutite of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were supported by a grant from the National Instutite of Health (1 R01 GM086824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Atwal KS, 2004, J MED CHEM, V47, P1081, DOI 10.1021/jm030291x; Barlow M, 2002, GENETICS, V160, P823; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P2075, DOI 10.1128/AAC.48.6.2075-2080.2004; EASTERBY JS, 1973, BIOCHIM BIOPHYS ACTA, V293, P552, DOI 10.1016/0005-2744(73)90362-8; Fasan R, 2008, J MOL BIOL, V383, P1069, DOI 10.1016/j.jmb.2008.06.060; Fasan R, 2007, ANGEW CHEM INT EDIT, V46, P8414, DOI 10.1002/anie.200702616; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Gerlt JA, 1998, CURR OPIN CHEM BIOL, V2, P607, DOI 10.1016/S1367-5931(98)80091-4; Goldsmith M, 2012, CURR OPIN STRUC BIOL, V22, P406, DOI 10.1016/j.sbi.2012.03.010; Gould S. J., 1989, WONDERFUL LIFE BURGE; GRIMM E, 1995, NUCLEIC ACIDS RES, V23, P4518, DOI 10.1093/nar/23.21.4518; JACOBY GA, 1990, ANTIMICROB AGENTS CH, V34, P2381, DOI 10.1128/AAC.34.12.2381; Kaul M, 2007, J MOL BIOL, V369, P142, DOI 10.1016/j.jmb.2007.02.103; KAWAGUCHI H, 1976, J INFECT DIS, V134, pS242, DOI 10.1093/infdis/135.Supplement_2.S242; Kobayashi N, 2001, EPIDEMIOL INFECT, V126, P197, DOI 10.1017/S0950268801005271; Levin BR, 2000, GENETICS, V154, P985; Lindsley JE, 2000, METH MOL B, V95, P57; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Matsumura Ichiro, 2002, Methods Mol Biol, V182, P259; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; McKay GA, 1996, BIOCHEMISTRY-US, V35, P8680, DOI 10.1021/bi9603884; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Loughlin TL, 2006, MOL BIOL EVOL, V23, P764, DOI 10.1093/molbev/msj098; Petrosino J, 1998, TRENDS MICROBIOL, V6, P323, DOI 10.1016/S0966-842X(98)01317-1; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; SARUBBI FA, 1978, ANN INTERN MED, V89, P612, DOI 10.7326/0003-4819-89-5-612; Schmitz FJ, 1999, J ANTIMICROB CHEMOTH, V43, P253, DOI 10.1093/jac/43.2.253; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Toth M, 2010, ANTIMICROB AGENTS CH, V54, P1590, DOI 10.1128/AAC.01444-09; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; VERHAMME IMA, 1988, EUR J BIOCHEM, V172, P615, DOI 10.1111/j.1432-1033.1988.tb13933.x; Vila J, 1999, J CLIN MICROBIOL, V37, P758, DOI 10.1128/JCM.37.3.758-761.1999; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Yano T, 1998, P NATL ACAD SCI USA, V95, P5511, DOI 10.1073/pnas.95.10.5511; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	49	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76687	10.1371/journal.pone.0076687	http://dx.doi.org/10.1371/journal.pone.0076687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204655	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300042
J	Eldai, H; Periyasamy, S; Al Qarni, S; Al Rodayyan, M; Mustafa, SM; Deeb, A; Al Sheikh, E; Khan, MA; Johani, M; Yousef, Z; Aziz, MA				Eldai, Hisham; Periyasamy, Sathish; Al Qarni, Saeed; Al Rodayyan, Maha; Mustafa, Sabeena Muhammed; Deeb, Ahmad; Al Sheikh, Ebthehal; Khan, Mohammed Afzal; Johani, Mishal; Yousef, Zeyad; Aziz, Mohammad Azhar			Novel Genes Associated with Colorectal Cancer Are Revealed by High Resolution Cytogenetic Analysis in a Patient Specific Manner	PLOS ONE			English	Article							HETEROZYGOSITY; PROFILES	Genomic abnormalities leading to colorectal cancer (CRC) include somatic events causing copy number aberrations (CNAs) as well as copy neutral manifestations such as loss of heterozygosity (LOH) and uniparental disomy (UPD). We studied the causal effect of these events by analyzing high resolution cytogenetic microarray data of 15 tumor-normal paired samples. We detected 144 genes affected by CNAs. A subset of 91 genes are known to be CRC related yet high GISTIC scores indicate 24 genes on chromosomes 7, 8, 18 and 20 to be strongly relevant. Combining GISTIC ranking with functional analyses and degree of loss/gain we identify three genes in regions of significant loss (ATP8B1, NARS, and ATP5A1) and eight in regions of gain (CTCFL, SPO11, ZNF217, PLEKHA8, HOXA3, GPNMB, IGF2BP3 and PCAT1) as novel in their association with CRC. Pathway and target prediction analysis of CNA affected genes and microRNAs, respectively indicates TGF-beta signaling pathway to be involved in causing CRC. Finally, LOH and UPD collectively affected nine cancer related genes. Transcription factor binding sites on regions of >35% copy number loss/gain influenced 16 CRC genes. Our analysis shows patient specific CRC manifestations at the genomic level and that these different events affect individual CRC patients differently.	[Eldai, Hisham; Periyasamy, Sathish; Al Qarni, Saeed; Al Rodayyan, Maha; Mustafa, Sabeena Muhammed; Al Sheikh, Ebthehal; Aziz, Mohammad Azhar] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Deeb, Ahmad] King Abdullah Int Med Res Ctr, Res Off, Riyadh, Saudi Arabia; [Khan, Mohammed Afzal; Johani, Mishal; Yousef, Zeyad] Natl Guard Hlth Affairs, Riyadh, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia	Aziz, MA (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.	azizmo@ngha.med.sa	Periyasamy, Sathish/AHD-9115-2022; Aziz, Mohammad Azhar/F-7486-2013	Periyasamy, Sathish/0000-0002-8132-5717; Aziz, Mohammad Azhar/0000-0002-0798-5063; Deeb, Ahmad/0000-0002-3680-7338	King Abdullah International Medical Research Center [RC10/083]	King Abdullah International Medical Research Center	This study was supported by a research grant # RC10/083 awarded to MAA by King Abdullah International Medical Research Center. All the authors are employed by King Abdullah International Medical Research Center or National Guard Health Affairs. Both the institutions are part of King Abdul Aziz Medical City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2011, CL00704 PN AFF INC; Affymetrix Inc, 2011, AFF CYTOSCAN ASS US; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Al-Eid HS, 2004, CANC INCIDENCE REPOR; Al-Mulla F, 2006, J CLIN PATHOL, V59, P624, DOI 10.1136/jcp.2005.033167; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Bavi PP, 2008, SAUDI MED J, V29, P75; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Brosens RPM, 2010, ANAL CELL PATHOL, V33, P95, DOI [10.1155/2010/161608, 10.3233/ACP-CLO-2010-0531]; Corvalan AH, 2012, PLOS ONE, V7; Fleming N, 2012, CANC RES; Ghadimi BM, 2006, CELL ONCOL, V28, P273; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Haya S, 2007, CANC INCIDENCE SURVI; Heinrichs S, 2010, BLOOD, V115, P4157, DOI 10.1182/blood-2009-11-203182; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Jasmine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031968; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lin C-H, 2011, J BIOMEDICAL SCI, V18, P1; Mao X, 2006, CANCER GENET CYTOGEN, V167, P1, DOI 10.1016/j.cancergencyto.2005.08.030; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ninomiya S, 2012, CYTOGENET GENOME RES, V136, P246, DOI 10.1159/000337297; Niv Y, 2008, WORLD J GASTROENTERO, V14, P2139, DOI 10.3748/wjg.14.2139; Oikonomou E, 2006, ANTICANCER RES, V26, P1077; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Postma C, 2009, ANN ONCOL, V20, P1048, DOI 10.1093/annonc/mdn738; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Prokunina-Olsson L., 2009, BIOMED CENTRAL, V8, P1; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053850; Siraj AK, 2012, GENETICS MED; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]	35	45	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76251	10.1371/journal.pone.0076251	http://dx.doi.org/10.1371/journal.pone.0076251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204606	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500006
J	Henderson, DM				Henderson, Donald M.			Sauropod Necks: Are They Really for Heat Loss?	PLOS ONE			English	Article							TEMPERATURE REGULATION; BODY-SIZE; DINOSAURS; MASS; PNEUMATICITY; STEGOSAURUS; PHYSIOLOGY; ANIMALS; CENTERS; MAMMALS	Three-dimensional digital models of 16 different sauropods were used to examine the scaling relationship between metabolism and surface areas of the whole body, the neck, and the tail in an attempt to see if the necks could have functioned as radiators for the elimination of excess body heat. The sauropod taxa sample ranged in body mass from a 639 kg juvenile Camarasaurus to a 25 t adult Brachiosaurus. Metabolism was assumed to be directly proportional to body mass raised to the 3/4 power, and estimates of body mass accounted for the presence of lungs and systems of air sacs in the trunk and neck. Surface areas were determined by decomposing the model surfaces into triangles and their areas being computed by vector methods. It was found that total body surface area was almost isometric with body mass, and that it showed negative allometry when plotted against metabolic rate. In contrast, neck area showed positive allometry when plotted against metabolic rate. Tail area show negative allometry with respect to metabolic rate. The many uncertainties about the biology of sauropods, and the variety of environmental conditions that different species experienced during the groups 150 million years of existence, make it difficult to be absolutely certain about the function of the neck as a radiator. However, the functional combination of the allometric increase of neck area, the systems of air sacs in the neck and trunk, the active control of blood flow between the core and surface of the body, changing skin color, and strategic orientation of the neck with respect to wind, make it plausible that the neck could have functioned as a radiator to avoid over-heating.	Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada		Henderson, DM (corresponding author), Royal Tyrrell Museum Palaeontol, Drumheller, AB, Canada.	don.henderson@gov.ab.ca						Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; BAKKER RT, 1971, EVOLUTION, V25, P636, DOI 10.1111/j.1558-5646.1971.tb01922.x; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; Benedict F. G., 1934, Ergebnisse der Physiologie, V86, P300, DOI 10.1007/BF02322526; Bennett SC, 1996, PALEOBIOLOGY, V22, P496, DOI 10.1017/S0094837300016481; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; BRAMWELL CD, 1973, NATURE, V242, P203, DOI 10.1038/242203a0; CZERKAS SA, 1992, GEOLOGY, V20, P1068, DOI 10.1130/0091-7613(1992)020<1068:DODSRA>2.3.CO;2; DANIELS CB, 1992, COMP BIOCHEM PHYS A, V101, P43, DOI 10.1016/0300-9629(92)90625-Z; DODSON P, 1980, PALEOBIOLOGY, V6, P6, DOI 10.1017/S0094837300012446; Farlow J.O., 1990, P43; Farlow JO, 2010, SWISS J GEOSCI, V103, P173, DOI 10.1007/s00015-010-0021-5; FARLOW JO, 1976, SCIENCE, V192, P1123, DOI 10.1126/science.192.4244.1123; Gee C.T., 2010, BIOL SAUROPOD DINOSA, P34; HAACK SC, 1986, PALEOBIOLOGY, V12, P450, DOI 10.1017/S009483730000316X; Harvey Pough F, 1999, VERTEBRATE LIFE; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; Henderson DM, 2010, J VERTEBR PALEONTOL, V30, P768, DOI 10.1080/02724631003758334; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Paul Gregory S., 1997, P129; Paul GS, 1987, DINOSAURS PAST PRESE, VII, P5; Perry S, 2009, J EXPT ZOOLOGY A, V14, P115; PHILLIPS PK, 1995, J THERM BIOL, V20, P281, DOI 10.1016/0306-4565(94)00061-M; Preuschoft Holger, 2011, P197; Proctor NS, 1993, MANUAL ORNITHOLOGY; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SCHMIDTN.K, 1969, CONDOR, V71, P341, DOI 10.2307/1365733; Senter P, 2007, J ZOOL, V271, P45, DOI 10.1111/j.1469-7998.2006.00197.x; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Taylor MP, 2011, J ZOOL, V285, P150, DOI 10.1111/j.1469-7998.2011.00824.x; Tomkins JL, 2010, AM NAT, V176, P1; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Weissenbock NM, 2010, J THERM BIOL, V35, P182, DOI 10.1016/j.jtherbio.2010.03.002; WHEELER PE, 1978, NATURE, V275, P441, DOI 10.1038/275441a0; White CR, 2007, ECOLOGY, V88, P315, DOI 10.1890/05-1883; WRIGHT PG, 1984, S AFR J ZOOL, V19, P266	44	8	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77108	10.1371/journal.pone.0077108	http://dx.doi.org/10.1371/journal.pone.0077108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204747	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500015
J	Fuentes, TI; Appleby, N; Tsay, E; Martinez, JJ; Bailey, L; Hasaniya, N; Kearns-Jonker, M				Fuentes, Tania I.; Appleby, Nancy; Tsay, Eric; Martinez, J. Julian; Bailey, Leonard; Hasaniya, Nahidh; Kearns-Jonker, Mary			Human Neonatal Cardiovascular Progenitors: Unlocking the Secret to Regenerative Ability	PLOS ONE			English	Article							CARDIAC STEM-CELLS; CARDIOSPHERE-DERIVED CELLS; RANDOMIZED PHASE-1 TRIAL; HEART-FAILURE; MYOCARDIAL-INFARCTION; CANCER-CELLS; INVASION; SENESCENCE; EXPRESSION; MICRORNAS	Although clinical benefit can be achieved after cardiac transplantation of adult c-kit+ or cardiosphere-derived cells for myocardial repair, these stem cells lack the regenerative capacity unique to neonatal cardiovascular stem cells. Unraveling the molecular basis for this age-related discrepancy in function could potentially transform cardiovascular stem cell transplantation. In this report, clonal populations of human neonatal and adult cardiovascular progenitor cells were isolated and characterized, revealing the existence of a novel subpopulation of endogenous cardiovascular stem cells that persist throughout life and co-express both c-kit and isl1. Epigenetic profiling identified 41 microRNAs whose expression was significantly altered with age in phenotypically-matched clones. These differences were correlated with reduced proliferation and a limited capacity to invade in response to growth factor stimulation, despite high levels of growth factor receptor on progenitors isolated from adults. Further understanding of these differences may provide novel therapeutic targets to enhance cardiovascular regenerative capacity.	[Fuentes, Tania I.; Appleby, Nancy; Tsay, Eric; Martinez, J. Julian; Kearns-Jonker, Mary] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA; [Bailey, Leonard; Hasaniya, Nahidh] Loma Linda Univ, Sch Med, Dept Cardiothorac Surg, Loma Linda, CA USA	Loma Linda University; Loma Linda University	Kearns-Jonker, M (corresponding author), Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA.	mkearnsjonker@llu.edu		Kearns-Jonker, Mary/0000-0002-8989-3698	Loma Linda University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006988] Funding Source: NIH RePORTER	Loma Linda University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported using Loma Linda University Medical Center start-up funds to MKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2011, J MOL MED, V89, P445, DOI 10.1007/s00109-010-0716-0; Amir G, 2008, ANN THORAC SURG, V86, P1311, DOI 10.1016/j.athoracsur.2008.06.058; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hidaka K, 2010, CIRC RES, V106, P111, DOI 10.1161/CIRCRESAHA.109.209478; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Hou X., 2012, J CLIN EXPT CARDIOLO, VS6; Itzhaki-Alfia A, 2009, CIRCULATION, V120, P2559, DOI 10.1161/CIRCULATIONAHA.109.849588; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Kearns-Jonker M, 2012, J STEM CELL RES TH S, VS1; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li SJ, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-24; Liu H, 2010, TUMORI J, V96, P751, DOI 10.1177/030089161009600518; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peng SB, 2005, MOL CANCER RES, V3, P227; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pietra BA, 2000, J CLIN INVEST, V106, P1003, DOI 10.1172/JCI10467; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Serradifalco C, 2011, EUR J HISTOCHEM, V55, P229, DOI 10.4081/ejh.2011.e41; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Sirish P, 2012, J MOL CELL CARDIOL, V52, P264, DOI 10.1016/j.yjmcc.2011.10.012; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Sussman MA, 2012, CIRC RES, V110, P1267, DOI 10.1161/CIRCRESAHA.112.268995; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tarnowski M, 2010, EUR J HAEMATOL, V85, P472, DOI 10.1111/j.1600-0609.2010.01531.x; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Van Slambrouck S, 2007, BIOCHEM J, V401, P689, DOI 10.1042/BJ20060944; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yu DQ, 2012, ONCOL LETT, V3, P1221, DOI 10.3892/ol.2012.638; Yu T, 2011, MOL CANCER RES, V9, P161, DOI 10.1158/1541-7786.MCR-10-0386	57	18	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77464	10.1371/journal.pone.0077464	http://dx.doi.org/10.1371/journal.pone.0077464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204836	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200029
J	Pappas, JL; Miller, DJ				Pappas, Janice L.; Miller, Daniel J.			A Generalized Approach to the Modeling and Analysis of 3D Surface Morphology in Organisms	PLOS ONE			English	Article							THEORETICAL MORPHOSPACE; MORPHOGENESIS; GEOMETRY; QUANTIFY; GROWTH	The surface geometry of an organism represents the boundary of its three-dimensional (3D) form and can be used as a proxy for the phenotype. A mathematical approach is presented that describes surface morphology using parametric 3D equations with variables expressed as x, y, z in terms of parameters u, v. Partial differentiation of variables with respect to parameters yields elements of the Jacobian representing tangent lines and planes of every point on the surface. Jacobian elements provide a compact size-free summary of the entire surface, and can be used as variables in principal components analysis to produce a morphospace. Mollusk and echinoid models are generated to demonstrate that whole organisms can be represented in a common morphospace, regardless of differences in size, geometry, and taxonomic affinity. Models can be used to simulate theoretical forms, novel morphologies, and patterns of phenotypic variation, and can also be empirically-based by designing them with reference to actual forms using reverse engineering principles. Although this study uses the Jacobian to summarize models, they can also be analyzed with 3D methods such as eigensurface, spherical harmonics, wavelet analysis, and geometric morphometrics. This general approach should prove useful for exploring broad questions regarding morphological evolution and variation.	[Pappas, Janice L.; Miller, Daniel J.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Pappas, JL (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	jlpappas@umich.edu	Pappas, Janice L./H-7020-2019	Pappas, Janice/0000-0002-1207-8388				Abbott R. T., 1986, COMPENDIUM SEASHELLS; Abou Chakra M, 2011, J THEOR BIOL, V285, P113, DOI 10.1016/j.jtbi.2011.06.019; ACKERLY SC, 1989, PALEOBIOLOGY, V15, P147, DOI 10.1017/S0094837300009337; [Anonymous], 1991, SEASHELLS NO HEMISPH; Baxandall PR, 1981, DIFFERENTIAL VECTOR; Bayer U., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P226; Boettiger A, 2009, P NATL ACAD SCI USA, V106, P6837, DOI 10.1073/pnas.0810311106; Boyer DM, 2011, P NATL ACAD SCI USA, V108, P18221, DOI 10.1073/pnas.1112822108; Bronstein AM, 2010, INT J COMPUT VISION, V89, P266, DOI 10.1007/s11263-009-0301-6; CHECA A, 1991, LETHAIA, V24, P97, DOI 10.1111/j.1502-3931.1991.tb01183.x; CORTIE MB, 1993, COMPUT GRAPH, V17, P79, DOI 10.1016/0097-8493(93)90054-D; Darboux G., 1896, LECONS THEORIE GEN S, V4; Darboux G, 1894, LECONS THEORIE GEN S, VIII; Darboux G., 1889, LECONS THEORIE GEN S, VII; Darboux G, 1887, LECONS THEORIE GEN S, VI; Davies A, 1996, INTRO COMPUTATIONAL; Dera G, 2008, PALEOBIOLOGY, V34, P301, DOI 10.1666/07070.1; Do Carmo P., 1976, DIFFERENTIAL GEOMETR; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Frenet F., 1852, J MATH PURES APPL, V17, P437; GOULD SJ, 1991, PALEOBIOLOGY, V17, P411, DOI 10.1017/S0094837300010745; GOULD SJ, 1969, B MAR SCI, V19, P432; Gray Alfred., 1998, MODERN DIFFERENTIAL; Hammer O, 2005, LETHAIA, V38, P111, DOI 10.1080/00241160510013222; Kaplan W, 1971, CALCULUS LINEAR ALGE, V2; Kaplan W., 2003, ADV CALCULUS, V5th; Laga H, 2006, P IEEE INT C SHAP MO, P15, DOI [10.1109/SMI.2006.39, DOI 10.1109/SMI.2006.39]; MacLeod N, 2008, SYST ASSOC SPEC VOL, V76, P143; McGhee GR, 1999, PERS PALEOB; Memoli F, 2005, FOUND COMPUT MATH, V5, P313, DOI 10.1007/s10208-004-0145-y; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moseley H., 1838, PHILOS T ROYAL SOC L, V128, P351; Moseley H, PHILOS MAG, V21, P300; Moulton DE, 2012, J THEOR BIOL, V311, P69, DOI 10.1016/j.jtbi.2012.07.009; OKAMOTO T, 1988, PALEOBIOLOGY, V14, P272, DOI 10.1017/S0094837300012008; OKAMOTO T, 1988, PALAEONTOLOGY, V31, P35; Pappas JL, 2008, J BIOL SYST, V16, P119, DOI 10.1142/S0218339008002460; Pappas JL, 2011, J BIOL SYST, V19, P47, DOI 10.1142/S0218339011003816; Pappas JL, 2005, J BIOL SYST, V13, P385, DOI 10.1142/S0218339005001586; Pappas JL, 2005, J NANOSCI NANOTECHNO, V5, P120, DOI 10.1166/jnn.2005.009; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Polly PD, 2008, PALAEONTOL ELECTRON, V11; Pressley Andrew, 2001, ELEMENTARY DIFFERENT; Prusinkiewicz P, 1995, ALGORITHMIC BEAUTY S, P163; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; RAUP DM, 1965, SCIENCE, V147, P1294, DOI 10.1126/science.147.3663.1294; RAUP DM, 1961, P NATL ACAD SCI USA, V47, P602, DOI 10.1073/pnas.47.4.602; RAUP DM, 1962, SCIENCE, V138, P150, DOI 10.1126/science.138.3537.150; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; SAVAZZI E, 1990, LETHAIA, V23, P195, DOI 10.1111/j.1502-3931.1990.tb01360.x; Serret J., 1851, J MATH PURES APPL, V16, P193; Shen L, 2009, EVOLUTION, V63, P1003, DOI 10.1111/j.1558-5646.2008.00557.x; Spivak M., 1979, COMPREHENSIVE INTRO, VIII; Spivak M., 1979, COMPREHENSIVE INTRO, VII; Struik Dirk Jan, 1961, LECT CLASSICAL DIFFE, P7; Thompson D. W., 1917, GROWTH FORM; Ubukata T, 2005, PALEOBIOLOGY, V31, P643, DOI 10.1666/04075.1; Varady T, 1997, COMPUT AIDED DESIGN, V29, P255, DOI 10.1016/S0010-4485(96)00054-1; Villarceau Y., 1848, NOUVELLES ANN MATH, V7, P345; Zachos LG, 2011, COMPUTATIONAL PALEONTOLOGY, P75, DOI 10.1007/978-3-642-16271-8_5	60	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77551	10.1371/journal.pone.0077551	http://dx.doi.org/10.1371/journal.pone.0077551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204866	gold, Green Published			2022-12-25	WOS:000326155400043
J	Calixto, MC; Lintomen, L; Andre, DM; Leiria, LO; Ferreira, D; Lellis-Santos, C; Anhe, GF; Bordin, S; Landgraf, RG; Antunes, E				Calixto, Marina Ciarallo; Lintomen, Leticia; Andre, Diana Majoli; Leiria, Luiz Osorio; Ferreira, Danilo; Lellis-Santos, Camilo; Anhe, Gabriel Forato; Bordin, Silvana; Landgraf, Richardt Gama; Antunes, Edson			Metformin Attenuates the Exacerbation of the Allergic Eosinophilic Inflammation in High Fat-Diet-Induced Obesity in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ADHESION MOLECULE EXPRESSION; AIRWAY EPITHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; TNF-ALPHA; LUNG INFLAMMATION; ENDOTHELIAL-CELLS	A positive relationship between obesity and asthma has been well documented. The AMP-activated protein kinase (AMPK) activator metformin reverses obesity-associated insulin resistance (IR) and inhibits different types of inflammatory responses. This study aimed to evaluate the effects of metformin on the exacerbation of allergic eosinophilic inflammation in obese mice. Male C57BL6/J mice were fed for 10 weeks with high-fat diet (HFD) to induce obesity. The cell infiltration and inflammatory markers in bronchoalveolar lavage (BAL) fluid and lung tissue were evaluated at 48 h after ovalbumin (OVA) challenge. HFD obese mice displayed peripheral IR that was fully reversed by metformin (300 mg/kg/day, two weeks). OVA-challenge resulted in higher influx of total cell and eosinophils in lung tissue of obese mice compared with lean group. As opposed, the cell number in BAL fluid of obese mice was reduced compared with lean group. Metformin significantly reduced the tissue eosinophil infiltration and prevented the reduction of cell counts in BAL fluid. In obese mice, greater levels of eotaxin, TNF-alpha and NOx, together with increased iNOS protein expression were observed, all of which were normalized by metformin. In addition, metformin nearly abrogated the binding of NF-kappa B subunit p65 to the iNOS promoter gene in lung tissue of obese mice. Lower levels of phosphorylated AMPK and its downstream target acetyl CoA carboxylase (ACC) were found in lung tissue of obese mice, which were restored by metformin. In separate experiments, the selective iNOS inhibitor aminoguanidine (20 mg/kg, 3 weeks) and the anti-TNF-alpha mAb (2 mg/kg) significantly attenuated the aggravation of eosinophilic inflammation in obese mice. In conclusion, metformin inhibits the TNF-alpha-induced inflammatory signaling and NF-kappa B-mediated iNOS expression in lung tissue of obese mice. Metformin may be a good pharmacological strategy to control the asthma exacerbation in obese individuals.	[Calixto, Marina Ciarallo; Lintomen, Leticia; Andre, Diana Majoli; Leiria, Luiz Osorio; Ferreira, Danilo; Anhe, Gabriel Forato; Antunes, Edson] State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Lellis-Santos, Camilo; Bordin, Silvana] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Landgraf, Richardt Gama] Univ Fed Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Antunes, E (corresponding author), State Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil.	antunes@fcm.unicamp.br	Bordin, Silvana/G-3147-2012; ANTUNES, EDSON/F-6731-2012; Anhe, Gabriel F/C-1980-2012; André, Diana/N-3160-2013; Lellis-Santos, Camilo/D-9195-2015; Landgraf, Richardt/F-7146-2012; Lintomen, Leticia/C-4643-2015	Bordin, Silvana/0000-0002-0192-8869; ANTUNES, EDSON/0000-0003-2201-8247; Lellis-Santos, Camilo/0000-0002-7882-7548; Landgraf, Richardt/0000-0001-7774-7880; Lintomen, Leticia/0000-0002-2110-367X; Anhe, Gabriel/0000-0002-7694-8397	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/14225-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant number 2012/14225-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Arshi M, 2010, RESPIROLOGY, V15, P779, DOI 10.1111/j.1440-1843.2010.01767.x; Babu SK, 2011, CLIN IMMUNOL, V140, P18, DOI 10.1016/j.clim.2011.03.005; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; BONORA E, 1987, DIABETES METAB, V13, P116; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Calixto MC, 2010, BRIT J PHARMACOL, V159, P617, DOI 10.1111/j.1476-5381.2009.00560.x; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Connelly L, 2001, J IMMUNOL, V166, P3873, DOI 10.4049/jimmunol.166.6.3873; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; delPozo V, 1997, J IMMUNOL, V158, P859; Deveci F, 2008, RESPIROLOGY, V13, P488, DOI 10.1111/j.1440-1843.2008.01278.x; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Feder LS, 1997, AM J RESP CELL MOL, V17, P436, DOI 10.1165/ajrcmb.17.4.2845; GALUSKA D, 1994, DIABETOLOGIA, V37, P826, DOI 10.1007/s001250050184; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hoogendijk AJ, 2013, J BIOL CHEM, V288, P7047, DOI 10.1074/jbc.M112.413138; Hostamisligil GS, 1999, EXP CLIN ENDOCR DIAB, V107, P119, DOI 10.1055/s-0029-1212086; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Kinote A, 2012, ENDOCRINOLOGY, V153, P3633, DOI 10.1210/en.2012-1341; LASSALLE P, 1993, CLIN EXP IMMUNOL, V94, P105; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lintomen L, 2012, OBESITY, V20, P1959, DOI 10.1038/oby.2012.93; Lintomen L, 2009, PULM PHARMACOL THER, V22, P1, DOI 10.1016/j.pupt.2008.10.003; Matsukura S, 1999, J IMMUNOL, V163, P6876; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Mosen DM, 2008, J ALLERGY CLIN IMMUN, V122, P507, DOI 10.1016/j.jaci.2008.06.024; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Nakamura H, 1999, AM J RESP CRIT CARE, V160, P1952, DOI 10.1164/ajrccm.160.6.9811089; Nakamura H, 1998, AM J PHYSIOL-LUNG C, V275, pL601, DOI 10.1152/ajplung.1998.275.3.L601; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Palframan RT, 1998, BLOOD, V91, P2240, DOI 10.1182/blood.V91.7.2240.2240_2240_2248; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Rosenberg HF, 2007, J ALLERGY CLIN IMMUN, V119, P1303, DOI 10.1016/j.jaci.2007.03.048; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salt IP, 2012, EXPERT OPIN INV DRUG, V21, P1155, DOI 10.1517/13543784.2012.696609; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shore SA, 2003, J APPL PHYSIOL, V95, P938, DOI 10.1152/japplphysiol.00336.2003; Shore SA, 2008, J APPL PHYSIOL, V105, P1127, DOI 10.1152/japplphysiol.00117.2008; Shore SA, 2007, J APPL PHYSIOL, V102, P516, DOI 10.1152/japplphysiol.00847.2006; Sousa LP, 2009, BIOCHEM PHARMACOL, V78, P396, DOI 10.1016/j.bcp.2009.04.030; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; Sutherland ER, 2008, AM J RESP CRIT CARE, V178, P682, DOI 10.1164/rccm.200801-076OC; Thuesen BH, 2009, CLIN EXP ALLERGY, V39, P700, DOI 10.1111/j.1365-2222.2008.03197.x; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; Weiss ST, 2005, NAT IMMUNOL, V6, P537, DOI 10.1038/ni0605-537; Xiong YL, 1999, J IMMUNOL, V162, P445; Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	57	91	94	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76786	10.1371/journal.pone.0076786	http://dx.doi.org/10.1371/journal.pone.0076786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204674	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300010
J	Lau, SM; Cha, KM; Karunatillake, A; Stokes, RA; Cheng, K; McLean, M; Cheung, NW; Gonzalez, FJ; Gunton, JE				Lau, Sue Mei; Cha, Kuan Minn; Karunatillake, Ayesha; Stokes, Rebecca A.; Cheng, Kim; McLean, Mark; Cheung, N. W.; Gonzalez, Frank J.; Gunton, Jenny E.			Beta-Cell ARNT Is Required for Normal Glucose Tolerance in Murine Pregnancy	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; PLACENTAL-LACTOGEN; ENDOCRINE PANCREAS; INSULIN-SECRETION; GENE-EXPRESSION; ISLET MASS; PROLIFERATION; PROLACTIN; ADAPTATION; RECEPTORS	Aims: Insulin secretion increases in normal pregnancy to meet increasing demands. Inability to increase beta-cell function results in gestational diabetes mellitus (GDM). We have previously shown that the expression of the transcription factor ARNT (Aryl-hydrocarbon Receptor Nuclear Translocator) is reduced in the islets of humans with type 2 diabetes. Mice with a beta-cell specific deletion of ARNT (beta-ARNT mice) have impaired glucose tolerance secondary to defective insulin secretion. We hypothesised that ARNT is required to increase beta-cell function during pregnancy, and that beta-ARNT mice would be unable to compensate for the beta-cell stress of pregnancy. The aims of this study were to investigate the mechanisms of ARNT regulation of beta-cell function and glucose tolerance in pregnancy. Methods: beta-ARNT females were mated with floxed control (FC) males and FC females with beta-ARNT males. Results: During pregnancy, beta-ARNT mice had a marked deterioration in glucose tolerance secondary to defective insulin secretion. There was impaired beta-cell proliferation in late pregnancy, associated with decreased protein and mRNA levels of the islet cell-cycle regulator cyclinD2. There was also reduced expression of Irs2 and G6PI. In contrast, in control mice, pregnancy was associated with a 2.1-fold increase in ARNT protein and a 1.6-fold increase in cyclinD2 protein, and with increased beta-cell proliferation. Conclusions: Islet ARNT increases in normal murine pregnancy and beta-cell ARNT is required for cyclinD2 induction and increased beta-cell proliferation in pregnancy.	[Lau, Sue Mei; Cha, Kuan Minn; Karunatillake, Ayesha; Stokes, Rebecca A.; Cheng, Kim; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Lau, Sue Mei] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia; [McLean, Mark; Cheung, N. W.; Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia; [McLean, Mark] Univ Western Sydney, Fac Med, Sydney, NSW, Australia; [Cheung, N. W.; Gunton, Jenny E.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Gonzalez, Frank J.] NCI, Lab Metab, Bethesda, MD 20892 USA; [Gunton, Jenny E.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; Western Sydney University; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of New South Wales Sydney	Gunton, JE (corresponding author), Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.	j.gunton@garvan.org.au	Gunton, Jenny E/AAH-7719-2021	Cheung, Ngai Wah/0000-0001-6323-8006	National Health and Medical Research Council; Diabetes Australia Research Trust; Australasian Diabetes in Pregnancy Society; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust; Australasian Diabetes in Pregnancy Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders were peer-reviewed granting bodies: National Health and Medical Research Council, Diabetes Australia Research Trust, and Australasian Diabetes in Pregnancy Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; Avril I, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740215; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P1667, DOI 10.1016/0002-9378(91)90012-G; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; DAHRI S, 1995, P NUTR SOC, V54, P345, DOI 10.1079/PNS19950003; Galsgaard ED, 1999, J BIOL CHEM, V274, P18686, DOI 10.1074/jbc.274.26.18686; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Homko C, 2001, J CLIN ENDOCR METAB, V86, P568, DOI 10.1210/jc.86.2.568; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; OSULLIVAN JB, 1964, DIABETES, V13, P278; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; READING AJ, 1966, J MAMMAL, V47, P111, DOI 10.2307/1378075; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Sacks DA, 2012, DIABETES CARE, V35, P526, DOI 10.2337/dc11-1641; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; VANASSCHE FA, 1980, DIABETOLOGIA, V18, P487, DOI 10.1007/BF00261705; VANASSCHE FA, 1978, BRIT J OBSTET GYNAEC, V85, P818; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Weinhaus AJ, 1996, ENDOCRINOLOGY, V137, P1640, DOI 10.1210/en.137.5.1640; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	25	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77419	10.1371/journal.pone.0077419	http://dx.doi.org/10.1371/journal.pone.0077419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204824	Green Published, Green Submitted, gold			2022-12-25	WOS:000326152300024
J	Wikenros, C; Sand, H; Ahlqvist, P; Liberg, O				Wikenros, Camilla; Sand, Hakan; Ahlqvist, Per; Liberg, Olof			Biomass Flow and Scavengers Use of Carcasses after Re-Colonization of an Apex Predator	PLOS ONE			English	Article							MOOSE ALCES-ALCES; SNOW DEPTH; POPULATION-DYNAMICS; NATIONAL-PARK; CANIS-LUPUS; KILL RATES; WOLVES; YELLOWSTONE; WINTER; AGE	Background: Reestablishment of apex predators influences the availability and distribution of biomass for scavengers and can therefore be an important agent for structuring species communities. We studied how the re-colonization of the Scandinavian Peninsula by wolves (Canis lupus) affected the amount and temporal variation in use of moose (Alces alces) carcasses. Methodology/Principal Findings: We compared the availability of biomass from remains at wolf kills with those killed by hunters, vehicle collisions and natural death. Movement-triggered cameras monitored patterns of use on wolf kills and remains from hunter harvest by scavengers (n = 15 276) in relation to time of year, available carcass biomass, time since the death of the moose and presence of wolves. Remains from hunter harvest were the largest food source for scavengers both within wolf territories (57%) and in areas without wolves (81%). The total annual biomass available were similar in areas with (25 648 kg) and without (24 289 kg) wolves. Presence of wolves lowered the peak biomass available from hunter harvest in October (20%) and increased biomass available during December to August (38-324% per month). The probability of scavengers being present decreased faster with time at remains from hunter harvest compared to wolf kills and both the probability of being present and the number of visits by scavengers to wolf kills increased as the amount of biomass available on the carcass increased. Conclusions/Significance: Wolves reduced the seasonal variation of biomass from moose carcasses and most important increased it during spring. Scavengers also visited wolf kills most frequently during spring when most scavenging species have young, which may lead to an increase in survival and/or reproductive success of scavengers within wolf territories. This applies both for abundant scavenging species that were the most frequent visitors at wolf kills and threatened scavengers with lower visit frequency.	[Wikenros, Camilla; Sand, Hakan; Ahlqvist, Per; Liberg, Olof] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden	Swedish University of Agricultural Sciences	Wikenros, C (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	camilla.wikenros@slu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; World Wildlife Fund for Nature (Sweden); Swedish University for Agricultural Sciences; Olle and Signhild Engkvists Stiftelser; Carl Tryggers Stiftelse; Swedish Carnivore Association	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; World Wildlife Fund for Nature (Sweden); Swedish University for Agricultural Sciences; Olle and Signhild Engkvists Stiftelser; Carl Tryggers Stiftelse; Swedish Carnivore Association	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Swedish Environmental Protection Agency, Swedish Association for Hunting and Wildlife Management, World Wildlife Fund for Nature (Sweden), Swedish University for Agricultural Sciences, Olle and Signhild Engkvists Stiftelser, Carl Tryggers Stiftelse, and Swedish Carnivore Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almkvist B, 1980, SLUTRAPPORT VILTOLYC; Berger J, 2001, ECOL APPL, V11, P947, DOI 10.2307/3061004; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Broman E, 2002, WILDLIFE BIOL, V8, P219, DOI 10.2981/wlb.2002.036; CEDERLUND GN, 1991, J WILDLIFE MANAGE, V55, P675, DOI 10.2307/3809517; Dahlstrom B., 1995, KLIMAT SJOAR VATTEND, P91; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Ericsson G, 2001, ECOSCIENCE, V8, P157, DOI 10.1080/11956860.2001.11682641; Gardenfors U., 2010, RED LIST SWEDISH SPE; Gavashelishvili A, 2006, J ZOOL, V269, P365, DOI 10.1111/j.1469-7998.2006.00062.x; Haglund B., 1968, VILTREVY, V5, P213; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HUGGARD DJ, 1993, J WILDLIFE MANAGE, V57, P382, DOI 10.2307/3809437; JEDRZEJEWSKI W, 1992, ECOGRAPHY, V15, P212, DOI 10.1111/j.1600-0587.1992.tb00027.x; Karlsson J, 2007, J ZOOL, V272, P276, DOI 10.1111/j.1469-7998.2006.00267.x; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lavsund Sten, 2003, Alces, V39, P109; LINDSTROM ER, 1994, OIKOS, V70, P156, DOI 10.2307/3545711; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; MARKGREN G, 1969, Viltrevy (Stockholm), V6, P127; Mattisson J, 2011, J MAMMAL, V92, P1321, DOI 10.1644/11-MAMM-A-099.1; Metz MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017332; Nilsen EB, 2005, J APPL ECOL, V42, P389, DOI 10.1111/j.1365-2664.2005.01018.x; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Persson J, 2005, CAN J ZOOL, V83, P1453, DOI 10.1139/Z05-143; Peterson Rolf O., 2003, P104; Promberger C, 1992, THESIS MAXIMILIAMS U; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2012, CAN J ZOOL, V90, P403, DOI 10.1139/Z2012-007; Sand H, 2007, VARGEN ARTFAKTA SAMM; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; Seiler A, 2004, WILDLIFE BIOL, V10, P301, DOI 10.2981/wlb.2004.036; Seiler A, 2011, UNGULATE TRAIN COLLI, P21; Selva N, 2005, CAN J ZOOL, V83, P1590, DOI 10.1139/Z05-158; Selva N, 2003, ECOSCIENCE, V10, P303, DOI 10.1080/11956860.2003.11682778; Smith DW, 2003, BIOSCIENCE, V53, P330, DOI 10.1641/0006-3568(2003)053[0330:YAW]2.0.CO;2; Stahler D, 2002, ANIM BEHAV, V64, P283, DOI 10.1006/anbe.2002.3047; van Dijk J, 2008, J ANIM ECOL, V77, P1183, DOI 10.1111/j.1365-2656.2008.01445.x; Vedin H., 1995, KLIMAT SJOAR VATTEND, P44; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P., 2010, WOLF SCANDINAVIA STA; WIDEN P, 1987, HOLARCTIC ECOL, V10, P104; Wikenros C., 2011, THESIS SWEDISH U AGR; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x; Wilmers CC, 2003, ECOL LETT, V6, P996, DOI 10.1046/j.1461-0248.2003.00522.x; Zalewski A, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P77	54	42	42	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77373	10.1371/journal.pone.0077373	http://dx.doi.org/10.1371/journal.pone.0077373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194881	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000326037000060
J	Meleg, IN; Zaksek, V; Fiser, C; Kelemen, BS; Moldovan, OT				Meleg, Ioana Nicoleta; Zaksek, Valerija; Fiser, Cene; Kelemen, Beatrice Simona; Moldovan, Oana Teodora			Can Environment Predict Cryptic Diversity? The Case of Niphargus Inhabiting Western Carpathian Groundwater	PLOS ONE			English	Article							SUBTERRANEAN DIVING BEETLES; CAVE SHRIMP TROGLOCARIS; MOLECULAR PHYLOGENY; CRUSTACEA; WATER; PHYLOGEOGRAPHY; TAXONOMY; GENUS; DNA; SPECIATION	In the last decade, several studies have shown that subterranean aquatic habitats harbor cryptic species with restricted geographic ranges, frequently occurring as isolated populations. Previous studies on aquatic subterranean species have implied that habitat heterogeneity can promote speciation and that speciation events can be predicted from species' distributions. We tested the prediction that species distributed across different drainage systems and karst sectors comprise sets of distinct species. Amphipods from the genus Niphargus from 11 caves distributed along the Western Carpathians (Romania) were investigated using three independent molecular markers (COI, H3 and 28S). The results showed that: 1) the studied populations belong to eight different species that derive from two phylogenetically unrelated Niphargus clades; 2) narrow endemic species in fact comprise complexes of morphologically similar species that are indistinguishable without using a molecular approach. The concept of monophyly, concordance between mitochondrial and nuclear DNA, and the value of patristic distances were used as species delimitation criteria. The concept of cryptic species is discussed within the framework of the present work and the contribution of these species to regional biodiversity is also addressed.	[Meleg, Ioana Nicoleta; Moldovan, Oana Teodora] Romanian Acad, Emil Racovita Inst Speleol, Cluj Napoca, Romania; [Zaksek, Valerija; Fiser, Cene] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Kelemen, Beatrice Simona] Univ Babes Bolyai, Interdisciplinary Res Inst Bionanosci, Ctr Mol Biol, R-3400 Cluj Napoca, Romania	Emil Racovita Institute of Speleology; Romanian Academy of Sciences; University of Ljubljana; Babes Bolyai University from Cluj	Meleg, IN (corresponding author), Romanian Acad, Emil Racovita Inst Speleol, Cluj Napoca, Romania.	ioana.meleg@hasdeu.ubbcluj.ro	Moldovan, Oana/A-6646-2011; Meleg, Ioana Nicoleta/O-7397-2019; Kelemen, Beatrice/AAK-3413-2021; Kelemen, Beatrice Simona/C-5385-2012	Moldovan, Oana/0000-0002-1262-0675; Kelemen, Beatrice/0000-0002-2989-2941; Kelemen, Beatrice Simona/0000-0002-2989-2941; Meleg, Ioana Nicoleta/0000-0002-0836-4971	KARSTHIVES Project [PCCE_ID_31/2010]; CNCS-UEFISCDI; Slovenian Research Agency [P1-0184, 1000-11-214275]	KARSTHIVES Project; CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported through the KARSTHIVES Project PCCE_ID_31/2010 funded by CNCS-UEFISCDI for INM, BSK and OTM and by the Slovenian Research Agency through the program P1-0184 for VZ and CF. During the preparation of this paper VZ was financed by the Slovenian Research Agency (contract 1000-11-214275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Brad T, 1999, STUDII SI CERCETARI, V5, P157; Bradford T, 2010, MOL ECOL RESOUR, V10, P41, DOI 10.1111/j.1755-0998.2009.02706.x; Bucur Ruxandra, 2003, Atti del Museo Civico di Storia Naturale di Trieste, V50, P231; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P121, DOI 10.1651/08-3089.1; Camacho AI, 2012, J CRUSTACEAN BIOL, V32, P816, DOI 10.1163/193724012X638473; Colgan DJ, 2000, ZOOL SCR, V29, P29, DOI 10.1046/j.1463-6409.2000.00021.x; Cook BD, 2008, BIOL CONSERV, V141, P2821, DOI 10.1016/j.biocon.2008.08.018; de Queiroz K, 2005, BIOESSAYS, V27, P1263, DOI 10.1002/bies.20325; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Dudich E., 1943, Annales Historico-Naturales Musei Hungarici Zool, V36, P47; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fiser C, 2007, LIMNOLOGY, V8, P297, DOI 10.1007/s10201-007-0221-5; Fiser C, 2006, J NAT HIST, V40, P2265, DOI 10.1080/00222930601086572; Fiser C, 2013, OIKOS, V122, P770, DOI 10.1111/j.1600-0706.2012.20644.x; Fiser C, 2010, ORG DIVERS EVOL, V10, P5, DOI 10.1007/s13127-010-0006-2; Fiser C, 2009, ZOOTAXA, P1; Fiser C, 2009, CRUSTACEANA, V82, P593, DOI 10.1163/156854009X407704; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Garcia-Machado E, 2011, MOL PHYLOGENET EVOL, V61, P470, DOI 10.1016/j.ympev.2011.06.015; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Gomez A, 2002, EVOLUTION, V56, P1431; Goricki S, 2006, GENE, V378, P31, DOI 10.1016/j.gene.2006.04.016; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Hartke TR, 2011, J CRUSTACEAN BIOL, V31, P701, DOI 10.1651/10-3434.1; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Knox MA, 2012, MOL ECOL, V21, P4885, DOI 10.1111/j.1365-294X.2012.05729.x; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Mardulyn P, 2012, MOL ECOL, V21, P3385, DOI 10.1111/j.1365-294X.2012.05622.x; Moldovan OT, 2007, ACTA CARSOLOGICA, V36, P77; Murphy NP, 2009, MOL ECOL, V18, P109, DOI 10.1111/j.1365-294X.2008.04007.x; Oliver P, 2011, AUSTR SCI, V32, P20; Oraseanu I, 2010, KARST HYDROGEOLOGY A; Page TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001618; Pfenninger M, 2003, MOL ECOL, V12, P2731, DOI 10.1046/j.1365-294X.2003.01943.x; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Plesa C., 1969, BIOGEOGRAFIA ROMANIE, P354; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schellenberg A., 1940, Zoologische Jahrbuecher Jena Systematik, V74, P243; Schlick-Steiner BC, 2007, TRENDS ECOL EVOL, V22, P391, DOI 10.1016/j.tree.2007.05.004; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zaksek V, 2007, MOL PHYLOGENET EVOL, V42, P223, DOI 10.1016/j.ympev.2006.07.009; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x; Zou SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047276	66	45	46	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76760	10.1371/journal.pone.0076760	http://dx.doi.org/10.1371/journal.pone.0076760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204671	gold, Green Submitted, Green Published			2022-12-25	WOS:000326032600009
J	Vittal, R; Mickler, EA; Fisher, AJ; Zhang, C; Rothhaar, K; Gu, HM; Brown, KM; Emtiazdjoo, A; Lott, JM; Frye, SB; Smith, GN; Sandusky, GE; Cummings, OW; Wilkes, DS				Vittal, Ragini; Mickler, Elizabeth A.; Fisher, Amanda J.; Zhang, Chen; Rothhaar, Katia; Gu, Hongmei; Brown, Krista M.; Emtiazdjoo, Amir; Lott, Jeremy M.; Frye, Sarah B.; Smith, Gerald N.; Sandusky, George E.; Cummings, Oscar W.; Wilkes, David S.			Type V Collagen Induced Tolerance Suppresses Collagen Deposition, TGF-beta and Associated Transcripts in Pulmonary Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA; IN-VIVO; LUNG; MYOFIBROBLAST; AUTOREACTIVITY; IDENTIFICATION; INFLAMMATION; FIBROBLASTS; INHIBITION	Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease characterized by progressive scarring and matrix deposition. Recent reports highlight an autoimmune component in IPF pathogenesis. We have reported anti-col(V) immunity in IPF patients. The objective of our study was to determine the specificity of col(V) expression profile and anti-col(V) immunity relative to col(I) in clinical IPF and the efficacy of nebulized col(V) in pre-clinical IPF models. Methods: Col(V) and col(I) expression profile was analyzed in normal human and IPF tissues. C57-BL6 mice were intratracheally instilled with bleomycin (0.025 U) followed by col(V) nebulization at pre-/post-fibrotic stage and analyzed for systemic and local responses. Results: Compared to normal lungs, IPF lungs had higher protein and transcript expression of the alpha 1 chain of col(V) and col(I). Systemic anti-col(V) antibody concentrations, but not of anti-col(I), were higher in IPF patients. Nebulized col(V), but not col(I), prevented bleomycin-induced fibrosis, collagen deposition, and myofibroblast differentiation. Col(V) treatment suppressed systemic levels of anti-col(V) antibodies, IL-6 and TNF-alpha; and local Il-17a transcripts. Compared to controls, nebulized col(V)-induced tolerance abrogated antigen-specific proliferation in mediastinal lymphocytes and production of IL-17A, IL-6, TNF-alpha and IFN-gamma. In a clinically relevant established fibrosis model, nebulized col(V) decreased collagen deposition. mRNA array revealed downregulation of genes specific to fibrosis (Tgf-beta, Il-1 beta, Pdgfb), matrix (Acta2, Col1a2, Col3a1, Lox, Itgb1/6, Itga2/3) and members of the TGF-beta superfamily (Tgfbr1/2, Smad2/3, Ltbp1, Serpine1, Nfkb/Sp1/Cebpb). Conclusions: Anti-col(V) immunity is pathogenic in IPF, and col(V)-induced tolerance abrogates bleomycin-induced fibrogenesis and down regulates TGF- beta-related signaling pathways.	[Vittal, Ragini; Mickler, Elizabeth A.; Fisher, Amanda J.; Gu, Hongmei; Brown, Krista M.; Emtiazdjoo, Amir; Lott, Jeremy M.; Smith, Gerald N.; Wilkes, David S.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA; [Rothhaar, Katia; Frye, Sarah B.] ImmuneWorks Inc, Indianapolis, IN USA; [Zhang, Chen; Sandusky, George E.; Cummings, Oscar W.] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wilkes, DS (corresponding author), Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA.	dwilkes@iupui.edu	VITTAL, RAGINI/AAE-9052-2020		NIH-NHLBI-Lung Tissue Research Consortium; NIAID [P01AI084853];  [NIH-NHLBI-HL109288];  [NIH-NCAATS-KL2 TR000163];  [NIH-NHLBI-HL067177]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, KL2TR000163, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067177, R01HL109288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI084853] Funding Source: NIH RePORTER	NIH-NHLBI-Lung Tissue Research Consortium; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NHLBI-Lung Tissue Research Consortium and NIH-NHLBI-HL109288 to RV; NIH-NCAATS-KL2 TR000163 (A. Shekhar, PI; Co-investigator: RV); and by the NIH-NHLBI-HL067177 and NIAID P01AI084853 to DSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobadilla JL, 2008, AM J RESP CRIT CARE, V177, P660, DOI 10.1164/rccm.200612-1901OC; Braun RK, 2010, J HEART LUNG TRANSPL; Braun RK, 2009, TRANSPLANTATION, V88, P1341, DOI 10.1097/TP.0b013e3181bcde7b; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Chapman HA, 1999, J CLIN INVEST, V104, P1, DOI 10.1172/JCI7576; CRYSTAL RG, 1984, NEW ENGL J MED, V310, P154, DOI 10.1056/NEJM198401193100304; Delacoux F, 1998, J BIOL CHEM, V273, P15069, DOI 10.1074/jbc.273.24.15069; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fujimoto H, 2006, AM J PATHOL, V168, P1086, DOI 10.2353/ajpath.2006.050610; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hu BA, 2012, AM J PATHOL, V180, P2257, DOI 10.1016/j.ajpath.2012.02.010; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iwata T, 2008, J IMMUNOL, V181, P5738, DOI 10.4049/jimmunol.181.8.5738; Katsumoto TR, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/208219; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Labiris NR, 2003, BRIT J CLIN PHARMACO, V56, P588, DOI 10.1046/j.1365-2125.2003.01892.x; Lin X, 2011, AM J RESP CRIT CARE, V183, P1689, DOI 10.1164/rccm.201002-0232OC; Liu TJ, 2011, J IMMUNOL, V187, P450, DOI 10.4049/jimmunol.1000964; Lo Re S, 2011, AM J RESP CRIT CARE, V184, P1270, DOI 10.1164/rccm.201103-0516OC; Moodley YP, 2003, AM J RESP CELL MOL, V29, P490, DOI 10.1165/rcmb.2002-0262OC; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; NAGAYA H, 1973, AM REV RESPIR DIS, V107, P826; Parra ER, 2006, J HISTOCHEM CYTOCHEM, V54, P1315, DOI 10.1369/jhc.6A6969.2006; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Shum AK, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000284; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; SMITH GN, 1991, MATRIX, V11, P36, DOI 10.1016/S0934-8832(11)80225-8; STAATZ WD, 1991, J BIOL CHEM, V266, P7363; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Sueblinvong V, 2012, AM J MED SCI, V344, P41, DOI 10.1097/MAJ.0b013e318234c132; Sysa P, 2009, DNA CELL BIOL, V28, P425, DOI 10.1089/dna.2009.0884; Taille C, 2011, AM J RESP CRIT CARE, V183, P759, DOI 10.1164/rccm.201001-0076OC; Ulsamer A, 2012, J BIOL CHEM, V287, P5164, DOI 10.1074/jbc.M111.322123; Vancheri C, 2000, AM J RESP CELL MOL, V22, P628, DOI 10.1165/ajrcmb.22.5.3948; Velosa APP, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-1; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Yamada Y, 2009, J IMMUNOL, V183, P237, DOI 10.4049/jimmunol.0804028; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421	48	57	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76451	10.1371/journal.pone.0076451	http://dx.doi.org/10.1371/journal.pone.0076451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204629	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600006
J	Jostins, L; Levine, AP; Barrett, JC				Jostins, Luke; Levine, Adam P.; Barrett, Jeffrey C.			Using Genetic Prediction from Known Complex Disease Loci to Guide the Design of Next-Generation Sequencing Experiments	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; RISK PREDICTION; TRAITS	A central focus of complex disease genetics after genome-wide association studies (GWAS) is to identify low frequency and rare risk variants, which may account for an important fraction of disease heritability unexplained by GWAS. A profusion of studies using next-generation sequencing are seeking such risk alleles. We describe how already-known complex trait loci (largely from GWAS) can be used to guide the design of these new studies by selecting cases, controls, or families who are most likely to harbor undiscovered risk alleles. We show that genetic risk prediction can select unrelated cases from large cohorts who are enriched for unknown risk factors, or multiply-affected families that are more likely to harbor high-penetrance risk alleles. We derive the frequency of an undiscovered risk allele in selected cases and controls, and show how this relates to the variance explained by the risk score, the disease prevalence and the population frequency of the risk allele. We also describe a new method for informing the design of sequencing studies using genetic risk prediction in large partially-genotyped families using an extension of the Inside-Outside algorithm for inference on trees. We explore several study design scenarios using both simulated and real data, and show that in many cases genetic risk prediction can provide significant increases in power to detect low-frequency and rare risk alleles. The same approach can also be used to aid discovery of non-genetic risk factors, suggesting possible future utility of genetic risk prediction in conventional epidemiology. Software implementing the methods in this paper is available in the R package Mangrove.	[Jostins, Luke; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Cambridge, England; [Jostins, Luke] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Levine, Adam P.] UCL, Div Med, London, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London	Jostins, L (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	lj4@well.ox.ac.uk		Barrett, Jeffrey/0000-0002-1152-370X; Levine, Adam/0000-0003-1333-9938	Wellcome Trust [WT089120/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust (WT089120/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Brady Kristina, 2011, BMC Proc, V5 Suppl 9, pS77, DOI 10.1186/1753-6561-5-S9-S77; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BAKER JK, 1979, J ACOUST SOC AM, V65, pS132, DOI 10.1121/1.2017061; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Durbin R., 1998, BIOL SEQUENCE ANAL P; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Guey LT, 2011, GENET EPIDEMIOL; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hosmer D.W., 2000, APPL LOGISTIC REGRES, V354; Janssens ACJW, 2011, EUR J CLIN INVEST, V41, P1004, DOI 10.1111/j.1365-2362.2011.02494.x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kwan JSH, 2011, BEHAV GENET, V41, P776, DOI 10.1007/s10519-011-9475-0; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mehers KL, 2008, BRIT MED BULL, V88, P115, DOI 10.1093/bmb/ldn045; Molven A, 2011, EXPERT REV MOL DIAGN, V11, P313, DOI [10.1586/ERM.10.123, 10.1586/erm.10.123]; Morris JA, 2012, BIOINFORMATICS; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Peto R, 2011, BRIT J CANCER, V105, pI, DOI 10.1038/bjc.2011.473; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Shi G, 2011, GENET EPIDEMIOL, V35, P572, DOI 10.1002/gepi.20597; Spencer C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001337; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Talmud PJ, 2013, LANCET; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wei Z, 2013, AM J HUM GENET; Xing Chao, 2009, BMC Proc, V3 Suppl 7, pS23; Zhu XF, 2010, GENET EPIDEMIOL, V34, P171, DOI 10.1002/gepi.20449	36	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76328	10.1371/journal.pone.0076328	http://dx.doi.org/10.1371/journal.pone.0076328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204614	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300022
J	Lee, WI; Lin, JJ; Hsieh, MY; Lin, SJ; Jaing, TH; Chen, SH; Hung, IJ; Yang, CP; Chen, CJ; Huang, YC; Li, SP; Huang, JL				Lee, Wen-I; Lin, Jainn-Jim; Hsieh, Meng-Ying; Lin, Syh-Jae; Jaing, Tang-Her; Chen, Shih-Hsiang; Hung, Iou-Jih; Yang, Chao-Ping; Chen, Chin-Jung; Huang, Yhu-Chering; Li, Shin-Pai; Huang, Jing-Long			Immunologic Difference between Hypersensitivity to Mosquito Bite and Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus Infection	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE SYNDROME; NATURAL-KILLER-CELLS; VIROLOGICAL CHARACTERISTICS; EBV INFECTION; VIRAL-DNA; NK-CELLS; T-CELLS; LYMPHOCYTES; DEFICIENCY; CHILDREN	Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening, virus-triggered immune disease. Hypersensitivity to mosquito bite (HMB), a presentation of Chronic Active Epstein-Barr Virus infection (CAEBV), may progress to HLH. This study aimed to investigate the immunologic difference between the HMB episodes and the HLH episodes associated with EBV infection. Immunologic changes of immunoglobulins, lymphocyte subsets, cytotoxicity, intracellular perforin and granzyme expressions, EBV virus load and known candidate genes for hereditary HLH were evaluated and compared. In 12 HLH episodes (12 patients) and 14 HMB episodes (4 patients), there were both decreased percentages of CD4+ and CD8+ and increased memory CD4+ and activated (CD2+HLADR+) lymphocytes. In contrast to HMB episodes that had higher IgE levels and EBV virus load predominantly in NK cells, those HLH episodes with virus load predominantly in CD3+ lymphocyte had decreased perforin expression and cytotoxicity that were recovered in the convalescence period. However, there was neither significant difference of total virus load in these episodes nor candidate genetic mutations responsible for hereditary HLH. In conclusion, decreased perforin expression in the HLH episodes with predominant-CD3+ EBV virus load is distinct from those HMB episodes with predominant-NK EBV virus load. Whether the presence of non-elevated memory CD4+ cells or activated lymphocytes (CD2+HLADR+) increases the mortality rate in the HLH episodes remains to be further warranted through larger-scale studies.	[Lee, Wen-I; Jaing, Tang-Her; Huang, Jing-Long] Chang Gung Childrens Hosp, PICAR Inst, Tao Yuan, Taiwan; [Lee, Wen-I; Lin, Syh-Jae; Huang, Jing-Long] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Dept Pediat,Div Allergy Asthma & Rheumatol, Tao Yuan, Taiwan; [Lin, Jainn-Jim; Hsieh, Meng-Ying] Chang Gung Univ, Coll Med, Grad Inst Med Clin, Tao Yuan, Taiwan; [Hsieh, Meng-Ying] Chang Gung Childrens Hosp, Dept Pediat, Div Neurol, Tao Yuan, Taiwan; [Jaing, Tang-Her; Chen, Shih-Hsiang; Hung, Iou-Jih; Yang, Chao-Ping] Chang Gung Childrens Hosp, Dept Pediat, Div Hematol Oncol, Tao Yuan, Taiwan; [Lin, Jainn-Jim] Chang Gung Childrens Hosp, Dept Pediat, Div Crit Care & Emergency Med, Tao Yuan, Taiwan; [Chen, Chin-Jung; Huang, Yhu-Chering] Chang Gung Childrens Hosp, Dept Pediat, Div Infect, Tao Yuan, Taiwan; [Li, Shin-Pai] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, WI (corresponding author), Chang Gung Childrens Hosp, PICAR Inst, Tao Yuan, Taiwan.	wen2707@hotmail.com; long@adm.cgmh.org.tw	Jaing, Tang-Her/AAB-1430-2021; Li, Hsin-Pai/C-7305-2014; Chen, Shih-Hsiang/AAG-4976-2020	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	Chang-Gung Medical Research Progress Grant [CMRPG 450022, 490012, 4B0051]; National Science Council [NSC99-2314-B-182-003-MY3, 102-2314-B-182A-039-MY3]	Chang-Gung Medical Research Progress Grant; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by a Chang-Gung Medical Research Progress Grant (CMRPG 450022, 490012, and 4B0051) and a National Science Council Grant (NSC99-2314-B-182-003-MY3 and 102-2314-B-182A-039-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2003, CELLULAR MOL IMMUNOL, P105; Abbas AK, 2003, CELLULAR MOL IMMUNOL, P163; Asada H, 2003, ARCH DERMATOL, V139, P1601, DOI 10.1001/archderm.139.12.1601; Asada H, 2007, J DERMATOL SCI, V45, P153, DOI 10.1016/j.jdermsci.2006.11.002; CHANG YS, 1990, J CLIN MICROBIOL, V28, P2398, DOI 10.1128/JCM.28.11.2398-2402.1990; Chuang HC, 2005, BLOOD, V106, P3090, DOI 10.1182/blood-2005-04-1406; Cohen JI, 2009, ANN ONCOL, V20, P1472, DOI 10.1093/annonc/mdp064; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; Gotoh K, 2008, CLIN INFECT DIS, V46, P1525, DOI 10.1086/587671; Huang ZZ, 2012, PEDIATR BLOOD CANCER, V58, P410, DOI 10.1002/pbc.23216; Huck K, 2009, J CLIN INVEST, V119, P1350, DOI 10.1172/JCI37901; Imadome KI, 2005, J INFECT DIS, V192, P1340, DOI 10.1086/466530; ISHIHARA S, 1995, ACTA PAEDIATR, V84, P1271, DOI 10.1111/j.1651-2227.1995.tb13547.x; Janka GE, 2004, BRIT J HAEMATOL, V124, P4, DOI 10.1046/j.1365-2141.2003.04726.x; Jones J F, 1989, Adv Pediatr, V36, P307; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KAWAHA K, 1989, J CLIN INVEST, V84, P51, DOI 10.1172/JCI114168; KIKUTA H, 1988, NATURE, V333, P455, DOI 10.1038/333455a0; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 2005, J INFECT DIS, V191, P531, DOI 10.1086/427239; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Lee WI, 2005, J CLIN IMMUNOL, V25, P162, DOI 10.1007/s10875-005-2822-2; Lee WI, 2005, BLOOD, V105, P1881, DOI 10.1182/blood-2003-12-4420; Lin SJ, 2004, PEDIAT ALLERG IMM-UK, V15, P79, DOI 10.1046/j.0905-6157.2003.00103.x; Nichols KE, 2007, BLOOD, V110, P1705, DOI 10.1182/blood-2007-06-093773; OKANO M, 1991, CLIN MICROBIOL REV, V4, P129, DOI 10.1128/CMR.4.1.129-135.1991; Pacheco SE, 2005, J ALLERGY CLIN IMMUN, V116, P470, DOI 10.1016/j.jaci.2005.04.044; Park S, 2010, J CLIN ONCOL, V28, pE148, DOI 10.1200/JCO.2009.25.0357; Quintanilla-Martinez L, 2000, BLOOD, V96, P443; RICKINSON A, 1996, FIELDS VIROLOGY, V2, P2397; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; RICKINSON AB, 1986, IMMUNOL TODAY, V7, P13, DOI 10.1016/0167-5699(86)90183-0; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Schmid JP, 2011, BLOOD, V117, P1522, DOI 10.1182/blood-2010-07-298372; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; STRAUS SE, 1988, J INFECT DIS, V157, P405, DOI 10.1093/infdis/157.3.405; Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751; Tsai W C, 1989, Taiwan Yi Xue Hui Za Zhi, V88, P639; Voskoboinik I, 2005, BLOOD, V105, P4700, DOI 10.1182/blood-2004-12-4935; Voskoboinik I, 2007, BLOOD, V110, P1184, DOI 10.1182/blood-2007-02-072850; Wilson AD, 1998, INT IMMUNOL, V10, P1149, DOI 10.1093/intimm/10.8.1149; Zhang ZX, 2009, J PEDIAT HEMATOL ONC, V31, P855, DOI 10.1097/MPH.0b013e31819c1fdb	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76711	10.1371/journal.pone.0076711	http://dx.doi.org/10.1371/journal.pone.0076711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204658	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300045
J	Mori, T; Hayashi, T; Hayashi, E; Su, TP				Mori, Tomohisa; Hayashi, Teruo; Hayashi, Eri; Su, Tsung-Ping			Sigma-1 Receptor Chaperone at the ER-Mitochondrion Interface Mediates the Mitochondrion-ER-Nucleus Signaling for Cellular Survival	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; DYNAMIC INTERACTION; IRE1; ACTIVATION; APOPTOSIS; CAPACITY; DOMAIN	The membrane of the endoplasmic reticulum (ER) of a cell forms contacts directly with mitochondria whereby the contact is referred to as the mitochondrion-associated ER membrane or the MAM. Here we found that the MAM regulates cellular survival via an MAM-residing ER chaperone the sigma-1 receptor (Sig-1R) in that the Sig-1R chaperones the ER stress sensor IRE1 to facilitate inter-organelle signaling for survival. IRE1 is found in this study to be enriched at the MAM in CHO cells. We found that IRE1 is stabilized at the MAM by Sig-1Rs when cells are under ER stress. Sig-1Rs stabilize IRE1 and thus allow for conformationally correct IRE1 to dimerize into the long-lasting, activated endonuclease. The IRE1 at the MAM also responds to reactive oxygen species derived from mitochondria. Therefore, the ER-mitochondrion interface serves as an important subcellular entity in the regulation of cellular survival by enhancing the stress-responding signaling between mitochondria, ER, and nucleus.	[Mori, Tomohisa; Hayashi, Teruo; Hayashi, Eri; Su, Tsung-Ping] NIDA, Cellular Pathobiol Sect, Intramural Res Program, NIH,DHHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Su, TP (corresponding author), NIDA, Cellular Pathobiol Sect, Intramural Res Program, NIH,DHHS, Baltimore, MD USA.	TSU@intra.nida.nih.gov			Intramural Research Program, NIDA, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000206] Funding Source: NIH RePORTER	Intramural Research Program, NIDA, NIH, DHHS; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Intramural Research Program, NIDA, NIH, DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Csordas G, 2006, J CELL BIOL, V281, P17347; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Hajnoczky G, 2007, SCIENCE, V315, P607, DOI 10.1126/science.1138825; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Heldens L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023512; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Ji YL, 2011, TOXICOL SCI, V124, P446, DOI 10.1093/toxsci/kfr232; Kakiuchi C, 2006, J NEUROCHEM, V97, P545, DOI 10.1111/j.1471-4159.2006.03772.x; Katayama T, 2004, J CHEM NEUROANAT, V28, P67, DOI 10.1016/j.jchemneu.2003.12.004; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Liu CY, 2002, J BIOL CHEM, V277, P18346, DOI 10.1074/jbc.M112454200; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Ruscher K, 2011, BRAIN, V134, P732, DOI 10.1093/brain/awq367; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Slodzinski H, 2009, CLIN NEUROPATHOL, V28, P333, DOI 10.2379/NPX08162; Sorensen S, 2006, J BIOL CHEM, V281, P468, DOI 10.1074/jbc.M507071200; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Urano F, 2000, J CELL SCI, V113, P3697; Yasuda Y, 2002, BIOCHEM BIOPH RES CO, V296, P313, DOI 10.1016/S0006-291X(02)00859-8; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	47	192	201	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76941	10.1371/journal.pone.0076941	http://dx.doi.org/10.1371/journal.pone.0076941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204710	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300070
J	Xue, SX; Liu, YC; Zhang, YC; Sun, Y; Geng, XY; Sun, JS				Xue, Shuxia; Liu, Yichen; Zhang, Yichen; Sun, Yan; Geng, Xuyun; Sun, Jinsheng			Sequencing and De Novo Analysis of the Hemocytes Transcriptome in Litopenaeus vannamei Response to White Spot Syndrome Virus Infection	PLOS ONE			English	Article							SHRIMP PENAEUS-JAPONICUS; IMMEDIATE-EARLY GENES; RNA-SEQ; FUNCTIONAL GENOMICS; PROFILING ANALYSIS; KURUMA PRAWN; EXPRESSION; IDENTIFICATION; MONODON; TOOL	Background: White spot syndrome virus (WSSV) is a causative pathogen found in most shrimp farming areas of the world and causes large economic losses to the shrimp aquaculture. The mechanism underlying the molecular pathogenesis of the highly virulent WSSV remains unknown. To better understand the virus-host interactions at the molecular level, the transcriptome profiles in hemocytes of unchallenged and WSSV-challenged shrimp (Litopenaeus vannamei) were compared using a short-read deep sequencing method (Illumina). Results: RNA-seq analysis generated more than 25.81 million clean pair end (PE) reads, which were assembled into 52,073 unigenes (mean size = 520 bp). Based on sequence similarity searches, 23,568 (45.3%) genes were identified, among which 6,562 and 7,822 unigenes were assigned to gene ontology (GO) categories and clusters of orthologous groups (COG), respectively. Searches in the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG) mapped 14,941 (63.4%) unigenes to 240 KEGG pathways. Among all the annotated unigenes, 1,179 were associated with immune-related genes. Digital gene expression (DGE) analysis revealed that the host transcriptome profile was slightly changed in the early infection (5 hours post injection) of the virus, while large transcriptional differences were identified in the late infection (48 hpi) of WSSV. The differentially expressed genes mainly involved in pattern recognition genes and some immune response factors. The results indicated that antiviral immune mechanisms were probably involved in the recognition of pathogen-associated molecular patterns. Conclusions: This study provided a global survey of host gene activities against virus infection in a non-model organism, pacific white shrimp. Results can contribute to the in-depth study of candidate genes in white shrimp, and help to improve the current understanding of host-pathogen interactions.	[Liu, Yichen; Zhang, Yichen; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Xue, Shuxia; Sun, Yan; Geng, Xuyun; Sun, Jinsheng] Tianjin Ctr Control & Prevent Aquat Anim Infect D, Tianjin, Peoples R China	Tianjin Normal University; Tianjin Center for Disease Control & Prevention	Sun, JS (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	jinshsun@163.com	liu, yichen/GVT-6262-2022; liu, yang/HHY-8583-2022		Grants of the Major State Basic Research Development Program of China (973 programs) [2012CB114405]; National High-Tech Research and Development Program of China (863 programs) [2012AA10A401, 2012AA092205]; National Key Technology RD Program [2011BAD13B07, 2011BAD13B04]	Grants of the Major State Basic Research Development Program of China (973 programs)(National Basic Research Program of China); National High-Tech Research and Development Program of China (863 programs)(National High Technology Research and Development Program of China); National Key Technology RD Program(National Key Technology R&D Program)	This work was financially supported by Grants of the Major State Basic Research Development Program of China (973 programs, 2012CB114405), National High-Tech Research and Development Program of China (863 programs, 2012AA10A401 and 2012AA092205) and National Key Technology R&D Program (2011BAD13B07 and 2011BAD13B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chang LK, 2012, DEV COMP IMMUNOL, V36, P121, DOI 10.1016/j.dci.2011.06.008; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Griffitt RJ, 2007, ENVIRON TOXICOL CHEM, V26, P2413, DOI 10.1897/07-158R.1; Han F, 2007, VIRUS GENES, V34, P193, DOI 10.1007/s11262-006-0053-0; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; Lei KY, 2008, DEV COMP IMMUNOL, V32, P808, DOI 10.1016/j.dci.2007.11.010; Leu JH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-120; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li F, 2009, VIROLOGY, V385, P267, DOI 10.1016/j.virol.2008.12.007; Li Q, 2004, J GEN VIROL, V85, P2035, DOI 10.1099/vir.0.80048-0; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li TD, 2013, COMP BIOCHEM PHYS D, V8, P1, DOI 10.1016/j.cbd.2012.10.003; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Lightner D.V, 1996, HDB SHRIMP PATHOLOGY; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; Lo CF, 1996, DIS AQUAT ORGAN, V25, P133, DOI 10.3354/dao025133; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Rojtinnakorn J, 2002, FISH SHELLFISH IMMUN, V13, P69, DOI 10.1006/fsim.2001.0382; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Takahashi Y, 1998, FISH PATHOL, V33, P357, DOI 10.3147/jsfp.33.357; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tsai MF, 2000, VIROLOGY, V277, P92, DOI 10.1006/viro.2000.0596; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Xue SX, 2013, FISH SHELLFISH IMMUN, V34, P403, DOI 10.1016/j.fsi.2012.10.017; Yamano K, 2006, COMP BIOCHEM PHYS A, V143, P155, DOI 10.1016/j.cbpa.2005.11.005; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhu YB, 2007, VIRUS RES, V125, P145, DOI 10.1016/j.virusres.2006.12.013	47	53	59	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76718	10.1371/journal.pone.0076718	http://dx.doi.org/10.1371/journal.pone.0076718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204661	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300046
J	Koyama, A; Wallenstein, MD; Simpson, RT; Moore, JC				Koyama, Akihiro; Wallenstein, Matthew D.; Simpson, Rodney T.; Moore, John C.			Carbon-Degrading Enzyme Activities Stimulated by Increased Nutrient Availability in Arctic Tundra Soils	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; LEAF-LITTER DECOMPOSITION; MICROBIAL ACTIVITY; NITROGEN ADDITION; ORGANIC-MATTER; ECOENZYMATIC STOICHIOMETRY; PERMAFROST THAW; CLIMATE-CHANGE; N DEPOSITION; TEMPERATURE	Climate-induced warming of the Arctic tundra is expected to increase nutrient availability to soil microbes, which in turn may accelerate soil organic matter (SOM) decomposition. We increased nutrient availability via fertilization to investigate the microbial response via soil enzyme activities. Specifically, we measured potential activities of seven enzymes at four temperatures in three soil profiles (organic, organic/mineral interface, and mineral) from untreated native soils and from soils which had been fertilized with nitrogen (N) and phosphorus (P) since 1989 (23 years) and 2006 (six years). Fertilized plots within the 1989 site received annual additions of 10 g N.m(-2).year(-1) and 5 g P.m(-2).year(-1). Within the 2006 site, two fertilizer regimes were established - one in which plots received 5 g N.m(-2).year(-1) and 2.5 g P.m(-2).year(-1) and one in which plots received 10 g N.m(-2).year(-1) and 5 g P.m(-2).year(-1). The fertilization treatments increased activities of enzymes hydrolyzing carbon (C)-rich compounds but decreased phosphatase activities, especially in the organic soils. Activities of two enzymes that degrade N-rich compounds were not affected by the fertilization treatments. The fertilization treatments increased ratios of enzyme activities degrading C-rich compounds to those for N-rich compounds or phosphate, which could lead to changes in SOM chemistry over the long term and to losses of soil C. Accelerated SOM decomposition caused by increased nutrient availability could significantly offset predicted increased C fixation via stimulated net primary productivity in Arctic tundra ecosystems.	[Koyama, Akihiro; Wallenstein, Matthew D.; Simpson, Rodney T.; Moore, John C.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Koyama, Akihiro] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Wallenstein, Matthew D.; Moore, John C.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Koyama, A (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	akihiro.koyama@colostate.edu	Moore, John/E-9802-2011; Wallenstein, Matthew/C-6441-2008; Wallenstein, Matthew D/S-3512-2016; Koyama, Akihiro/E-4868-2019	Wallenstein, Matthew/0000-0002-6219-1442; Wallenstein, Matthew D/0000-0002-6219-1442; Koyama, Akihiro/0000-0002-3854-1035	National Science Foundation [OPP-0909507];  [DEB-0423385]; Division Of Environmental Biology [1026843] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this research was provided by the National Science Foundation (OPP-0909507 to J.C.M), and grants to the Marine Biological Laboratory at Woods Hole, MA in support of the Arctic LTER (DEB-0423385). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwa HA, 1999, SOIL BIOL BIOCHEM, V31, P769, DOI 10.1016/S0038-0717(98)00177-1; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2011, SOIL BIOL, V22, P229, DOI 10.1007/978-3-642-14225-3_12; Allison SD, 2010, SOIL BIOL BIOCHEM, V42, P1157, DOI 10.1016/j.soilbio.2010.03.026; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; BALDRIAN P, 2009, ADVANCES IN FUNGAL B, P109; Blok D, 2010, GLOBAL CHANGE BIOL, V16, P1296, DOI 10.1111/j.1365-2486.2009.02110.x; Boyd S. A., 1990, Soil biochemistry. Volume 6., P1; BURNS RG, 1982, SOIL BIOL BIOCHEM, V14, P423, DOI 10.1016/0038-0717(82)90099-2; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; CHAPIN FS, 1988, ECOLOGY, V69, P693; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; CLARHOLM M, 1993, BIOL FERT SOILS, V16, P287, DOI 10.1007/BF00369306; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; Development Core Team R, 2011, R LANG ENV STAT COMP; Di Nardo C, 2004, SOIL BIOL BIOCHEM, V36, P1539, DOI 10.1016/j.soilbio.2004.07.013; Enwall K, 2007, SOIL BIOL BIOCHEM, V39, P106, DOI 10.1016/j.soilbio.2006.06.015; GIANFREDA L, 1995, SOIL SCI SOC AM J, V59, P811, DOI 10.2136/sssaj1995.03615995005900030025x; GIANFREDA L, 1995, SOIL SCI SOC AM J, V59, P805, DOI 10.2136/sssaj1995.03615995005900030024x; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; Glazer AN., 2007, MICROBIOTECHNOL FUND, DOI [10.1017/CBO9780511811227, DOI 10.1017/CBO9780511811227]; Gough L, 2007, OIKOS, V116, P407, DOI 10.1111/j.0030-1299.2007.15449.x; Grogan P, 1999, ECOSYSTEMS, V2, P451, DOI 10.1007/s100219900093; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Henry HAL, 2005, GLOBAL CHANGE BIOL, V11, P1808, DOI 10.1111/j.1365-2486.2005.001007.x; Henry HAL, 2012, SOIL BIOL BIOCHEM, V47, P53, DOI 10.1016/j.soilbio.2011.12.026; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Joanisse GD, 2007, NEW PHYTOL, V175, P535, DOI 10.1111/j.1469-8137.2007.02113.x; Jonasson S, 1999, APPL SOIL ECOL, V11, P135, DOI 10.1016/S0929-1393(98)00145-0; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lang E, 2000, J BASIC MICROB, V40, P33, DOI 10.1002/(SICI)1521-4028(200002)40:1&lt;33::AID-JOBM33&gt;3.0.CO;2-Q; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; MAYER LM, 1989, LIMNOL OCEANOGR, V34, P973, DOI 10.4319/lo.1989.34.6.0973; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Naidja A, 2000, J ENVIRON QUAL, V29, P677, DOI 10.2134/jeq2000.00472425002900030002x; NANNIPIERI P, 1988, SOIL BIOL BIOCHEM, V20, P683, DOI 10.1016/0038-0717(88)90153-8; Nannipieri P., 1996, HUMIC SUBSTANCES TER, P293, DOI DOI 10.1016/B978-044481516-3/50008-6; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nicolaus B, 2010, ENVIRON TECHNOL, V31, P1145, DOI 10.1080/09593330903552094; Nowinski NS, 2008, ECOSYSTEMS, V11, P16, DOI 10.1007/s10021-007-9104-1; Oechel W. C, 1992, ARCTIC ECOSYSTEMS CH, P139; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Parham JA, 2000, SOIL BIOL BIOCHEM, V32, P1183, DOI 10.1016/S0038-0717(00)00034-1; Ping CL, 1998, J GEOPHYS RES-ATMOS, V103, P28917, DOI 10.1029/98JD02024; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; REJ R, 1981, CLIN CHEM, V27, P213; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Schmidt IK, 1999, APPL SOIL ECOL, V11, P147, DOI 10.1016/S0929-1393(98)00147-4; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SINSABAUGH RL, 1994, BIOL FERT SOILS, V17, P69, DOI 10.1007/BF00418675; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Sistla SA, 2013, NATURE, V497, P615, DOI 10.1038/nature12129; Steinweg JM, 2012, SOIL BIOL BIOCHEM, V55, P85, DOI 10.1016/j.soilbio.2012.06.015; Stone MM, 2012, GLOBAL CHANGE BIOL, V18, P1173, DOI 10.1111/j.1365-2486.2011.02545.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2; Stursova M, 2006, MICROB ECOL, V51, P90, DOI 10.1007/s00248-005-5156-y; TAN KH, 2011, PRINCIPLES OF SOIL C; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tiquia SM, 2002, APPL SOIL ECOL, V21, P31, DOI 10.1016/S0929-1393(02)00040-9; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wallenstein M, 2011, SOIL BIOL, V22, P245, DOI 10.1007/978-3-642-14225-3_13; Wallenstein MD, 2008, SOIL BIOL BIOCHEM, V40, P2098, DOI 10.1016/j.soilbio.2008.01.024; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; WALLENSTEIN MD, 2011, ECOLOGY OF EXTRACELL, P35; WEBER CF, 2013, FRONT MICROBIOL, P4; Zeglin LH, 2007, OECOLOGIA, V154, P349, DOI 10.1007/s00442-007-0836-6; Zimmerman AR, 2011, SOIL BIOL, V22, P271, DOI 10.1007/978-3-642-14225-3_15	92	36	40	4	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2013	8	10							e77212	10.1371/journal.pone.0077212	http://dx.doi.org/10.1371/journal.pone.0077212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237TP	24204773	Green Published, gold			2022-12-25	WOS:000325894100048
J	Kevany, BM; Tsybovsky, Y; Campuzano, IDG; Schnier, PD; Engel, A; Palczewski, K				Kevany, Brian M.; Tsybovsky, Yaroslav; Campuzano, Iain D. G.; Schnier, Paul D.; Engel, Andreas; Palczewski, Krzysztof			Structural and Functional Analysis of the Native Peripherin-ROM1 Complex Isolated from Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Retina; Retinal Degeneration; Retinal Metabolism; Vision; Vitamin A	OUTER SEGMENT MORPHOGENESIS; RETINAL DEGENERATION; ELECTRON-MICROSCOPY; 3-DIMENSIONAL ARCHITECTURE; TETRASPANIN FUNCTIONS; EXTRACELLULAR DOMAIN; RETINITIS-PIGMENTOSA; 2D CRYSTALLIZATION; MEMBRANE-PROTEINS; MASS-SPECTROMETRY	Background: The tetraspanins peripherin and ROM1 interact and localize to the rim structures of vertebrate photoreceptor disc membranes. Results: Native peripherin-ROM1 complex displays a tetrameric structure with a 2-fold symmetry and induces membrane curvature. Conclusion: Biochemical and structural analyses confirm the tetrameric state of the complex. Significance: Analyses provide evidence for the role of the peripherin-ROM1 complex in the rim structure. Peripherin and its homologue ROM1 are retina-specific members of the tetraspanin family of integral membrane proteins required for morphogenesis and maintenance of photoreceptor outer segments, regions that collect light stimuli. Over 100 pathogenic mutations in peripherin cause inherited rod- and cone-related dystrophies in humans. Peripherin and ROM1 interact in vivo and are predicted to form a core heterotetrameric complex capable of creating higher order oligomers. However, structural analysis of tetraspanin proteins has been hampered by their resistance to crystallization. Here we present a simplified methodology for high yield purification of peripherin-ROM1 from bovine retinas that permitted its biochemical and biophysical characterization. Using size exclusion chromatography and blue native gel electrophoresis, we confirmed that the core native peripherin-ROM1 complex exists as a tetramer. Peripherin, but not ROM1, is glycosylated and we examined the glycosylation site and glycan composition of ROM1 by liquid chromatographic tandem mass spectrometry. Mass spectrometry was used to analyze the native complex in detergent micelles, demonstrating its tetrameric state. Our electron microscopy-generated structure solved to 18 displayed the tetramer as an elongated structure with an apparent 2-fold symmetry. Finally, we demonstrated that peripherin-ROM1 tetramers induce membrane curvature when reconstituted in lipid vesicles. These results provide critical insights into this key retinal component with a poorly defined function.	[Kevany, Brian M.; Tsybovsky, Yaroslav; Engel, Andreas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Campuzano, Iain D. G.; Schnier, Paul D.] Amgen Inc, Dept Mol Struct, Thousand Oaks, CA 91320 USA	Case Western Reserve University; Amgen	Palczewski, K (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY008061, EY019478]; Transcontinental EM Initiative for Membrane Protein Structure; National Institutes of Health Protein Structure Initiative [U54GM094598]; NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061, R01EY019478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transcontinental EM Initiative for Membrane Protein Structure; National Institutes of Health Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and EY019478. This work was also supported by the Transcontinental EM Initiative for Membrane Protein Structure, which is a center for membrane protein structure determination funded by the National Institutes of Health Protein Structure Initiative under Grant U54GM094598.	Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; BoeszeBattaglia K, 1997, BIOCHEMISTRY-US, V36, P6835, DOI 10.1021/bi9627370; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cvetkov TL, 2011, J BIOL CHEM, V286, P38168, DOI 10.1074/jbc.M111.288993; DONOHO DL, 1992, J ROY STAT SOC B MET, V54, P41; Dryja TP, 1997, INVEST OPHTH VIS SCI, V38, P1972; Eskandari S, 1998, P NATL ACAD SCI USA, V95, P11235, DOI 10.1073/pnas.95.19.11235; Farjo R, 2006, OPHTHALMIC GENET, V27, P117, DOI 10.1080/13816810600976806; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Kedzierski W, 1999, J NEUROCHEM, V72, P430, DOI 10.1046/j.1471-4159.1999.0720430.x; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Muller-Weeks S, 2002, EXP EYE RES, V75, P143, DOI 10.1006/exer.2002.2013; Mustafi D, 2011, FASEB J, V25, P3157, DOI 10.1096/fj.11-186767; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; VAHEDIFARIDI A, 2013, J ELECTRON MICROSC, V62, P95, DOI DOI 10.1093/JMICRO/DFS091; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199; WU XR, 1990, J BIOL CHEM, V265, P19170; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	47	34	34	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36272	36284		10.1074/jbc.M113.520700	http://dx.doi.org/10.1074/jbc.M113.520700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196967	hybrid, Green Published			2022-12-25	WOS:000328883400011
J	Chakravartty, V; Cronan, JE				Chakravartty, Vandana; Cronan, John E.			The Wing of a Winged Helix-Turn-Helix Transcription Factor Organizes the Active Site of BirA, a Bifunctional Repressor/Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP; Bacterial Genetics; Bacterial Metabolism; Enzyme Catalysis; Enzyme Mutation; Microbiology; Promoters; Transcription Factors; Transcription Regulation; Transcription Target Genes	BIOTIN HOLOENZYME SYNTHETASE; ESCHERICHIA-COLI REPRESSOR; DNA-BINDING; PROTEIN; BIOSYNTHESIS; OPERON; GENE; LIGASE; MUTANT; DOMAIN	Background:E. coli BirA is a both transcriptional repressor of the biotin operon and the biotin protein ligase. Results: Structural and sequence integrity of the wing domain is important in both biotinylation and regulatory activities of BirA. Conclusion: DNA-binding domain wing coordinates the two functions of BirA. Significance: This is the first example of a wing domain that has a role in an enzymatic activity. The BirA biotin protein ligase of Escherichia coli belongs to the winged helix-turn-helix (wHTH) family of transcriptional regulators. The N-terminal BirA domain is required for both transcriptional regulation of biotin synthesis and biotin protein ligase activity. We addressed the structural and functional role of the wing of the wHTH motif in both BirA functions. A panel of N-terminal deletion mutant proteins including a discrete deletion of the wing motif were unable to bind DNA. However, all the N-terminal deletion mutants weakly complemented growth of a birA strain at low biotin concentrations, indicating compromised ligase activity. A wing domain chimera was constructed by replacing the BirA wing with the nearly isosteric wing of the E. coli OmpR transcription factor. Although this chimera BirA was defective in operator binding, it was much more efficient in complementation of a birA strain than was the wing-less protein. The enzymatic activities of the wing deletion and chimera proteins in the in vitro synthesis of biotinoyl-5-AMP differed greatly. The wing deletion BirA accumulated an off pathway compound, ADP, whereas the chimera protein did not. Finally, we report that a single residue alteration in the wing bypasses the deleterious effects caused by mutations in the biotin-binding loop of the ligase active site. We believe that the role of the wing in the BirA enzymatic reaction is to orient the active site and thereby protect biotinoyl-5-AMP from attack by solvent. This is the first evidence that the wing domain of a wHTH protein can play an important role in enzymatic activity.	[Chakravartty, Vandana; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI15650.	BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; BARKER DF, 1981, J MOL BIOL, V146, P469, DOI 10.1016/0022-2836(81)90043-7; Beckett D, 2007, ANNU REV GENET, V41, P443, DOI 10.1146/annurev.genet.41.042007.170450; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BUONCRISTIANI MR, 1986, GENE, V44, P255, DOI 10.1016/0378-1119(86)90189-7; CAMPBELL A, 1972, P NATL ACAD SCI USA, V69, P676, DOI 10.1073/pnas.69.3.676; Chakravartty V, 2012, J BACTERIOL, V194, P1113, DOI 10.1128/JB.06549-11; CHAPMANSMITH A, 1994, BIOCHEM J, V302, P881, DOI 10.1042/bj3020881; CRONAN JE, 1995, FEMS MICROBIOL LETT, V130, P221, DOI 10.1016/0378-1097(95)00210-V; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; KATO N, 1995, MOL GEN GENET, V248, P399, DOI 10.1007/BF02191639; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Maeda Y, 2010, APPL ENVIRON MICROB, V76, P5785, DOI 10.1128/AEM.00916-10; Miller JH., 1972, EXPT MOL GENETICS; Mukhopadhyay B, 2001, J BACTERIOL, V183, P3804, DOI 10.1128/JB.183.12.3804-3810.2001; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRAKASH O, 1979, P NATL ACAD SCI USA, V76, P5592, DOI 10.1073/pnas.76.11.5592; Solbiati J, 2010, CHEM BIOL, V17, P11, DOI 10.1016/j.chembiol.2009.12.007; Streaker ED, 1998, J MOL BIOL, V278, P787, DOI 10.1006/jmbi.1998.1733; Streaker ED, 1999, J MOL BIOL, V292, P619, DOI 10.1006/jmbi.1999.3086; Streaker ED, 2002, BIOCHEMISTRY-US, V41, P14263, DOI 10.1021/bi0203839; Teichmann M, 2012, TRANSCR-AUSTIN, V3, P2, DOI 10.4161/trns.3.1.18917; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200	30	17	18	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36029	36039		10.1074/jbc.M113.525618	http://dx.doi.org/10.1074/jbc.M113.525618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189073	hybrid, Green Published			2022-12-25	WOS:000329814700038
J	Ramaswamy, SS; MacLean, DM; Gorfe, AA; Jayaraman, V				Ramaswamy, Swarna S.; MacLean, David M.; Gorfe, Alemayehu A.; Jayaraman, Vasanthi			Proton-mediated Conformational Changes in an Acid-sensing Ion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channels (ASICs); Fluorescence Resonance Energy Transfer (FRET); Ligand-binding Protein; Receptor Desensitization; Receptor Structure-Function; Ligand-gated Ion Channels; Receptor Activation	BINDING DOMAIN; ASIC1; DESENSITIZATION; SELECTIVITY; ACTIVATION; DECREASES; LINKER	Background: Protons activate acid-sensing ion channels (ASICs). Results: Proton binding leads to a movement involving the thumb and finger subdomains. Mutation of carboxylates lining the finger leads to loss of activation and loss of this movement. Conclusion: The carboxylates lining the finger domain are essential for the movement of the thumb and finger domains and in activation. Significance: This study provides insight into proton-induced conformational changes in ASICs. Acid-sensing ion channels are cation channels activated by external protons and play roles in nociception, synaptic transmission, and the physiopathology of ischemic stroke. Using luminescence resonance energy transfer (LRET), we show that upon proton binding, there is a conformational change that increases LRET efficiency between the probes at the thumb and finger subdomains in the extracellular domain of acid-sensing ion channels. Additionally, we show that this conformational change is lost upon mutating Asp-238, Glu-239, and Asp-260, which line the finger domains, to alanines. Electrophysiological studies showed that the single mutant D260A shifted the EC50 by 0.2 pH units, the double mutant D238A/E239A shifted the EC50 by 2.5 pH units, and the triple mutant D238A/E239A/D260A exhibited no response to protons despite surface expression. The LRET experiments on D238A/E239A/D260A showed no changes in LRET efficiency upon reduction in pH from 8 to 6. The LRET and electrophysiological studies thus suggest that the three carboxylates, two of which are involved in carboxyl/carboxylate interactions, are essential for proton-induced conformational changes in the extracellular domain, which in turn are necessary for receptor activation.	[Ramaswamy, Swarna S.; MacLean, David M.; Jayaraman, Vasanthi] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; [Gorfe, Alemayehu A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Jayaraman, V (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, MSB 6-174,6431 Fannin St, Houston, TX 77030 USA.	vasanthi.jayaraman@uth.tmc.edu		MacLean, David/0000-0001-8294-6075	National Science Foundation [MCB-1110501]; Harry S. and Isabel C. Cameron Foundation fellowship; American Heart Association postdoctoral fellowship	National Science Foundation(National Science Foundation (NSF)); Harry S. and Isabel C. Cameron Foundation fellowship; American Heart Association postdoctoral fellowship(American Heart Association)	This work was supported in part by National Science Foundation Grant MCB-1110501 (to V. J), a Harry S. and Isabel C. Cameron Foundation fellowship (to S. S. R.), and an American Heart Association postdoctoral fellowship (to D. M. M.)	Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; DOSREMEDIOS CG, 1995, J STRUCT BIOL, V115, P175, DOI 10.1006/jsbi.1995.1042; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Gonzalez J, 2008, BIOCHEMISTRY-US, V47, P10027, DOI 10.1021/bi800690b; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1980, NEUROSCIENCE, V5, P2325, DOI 10.1016/0306-4522(80)90149-9; Li T, 2011, THEOR APPL MECH LETT, V1, DOI 10.1063/2.1104102; Li TB, 2011, J GEN PHYSIOL, V137, P289, DOI 10.1085/jgp.201010576; Li TB, 2010, J BIOL CHEM, V285, P31285, DOI 10.1074/jbc.M110.160382; Li TB, 2010, J BIOL CHEM, V285, P22706, DOI 10.1074/jbc.M110.134114; Li TB, 2010, AM J PHYSIOL-CELL PH, V299, pC66, DOI 10.1152/ajpcell.00100.2010; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Selvin S, 1996, PAEDIATR PERINAT EP, V10, P220, DOI 10.1111/j.1365-3016.1996.tb00045.x; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106	24	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35896	35903		10.1074/jbc.M113.478982	http://dx.doi.org/10.1074/jbc.M113.478982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24196950	hybrid, Green Published			2022-12-25	WOS:000329814700026
J	Abdolvahabi, A; Taylor, BW; Holden, RL; Shaw, EV; Kentsis, A; Rodriguez-Galindo, C; Mukai, S; Shaw, BF				Abdolvahabi, Alireza; Taylor, Brandon W.; Holden, Rebecca L.; Shaw, Elizabeth V.; Kentsis, Alex; Rodriguez-Galindo, Carlos; Mukai, Shizuo; Shaw, Bryan F.			Colorimetric and Longitudinal Analysis of Leukocoria in Recreational Photographs of Children with Retinoblastoma	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; DIAGNOSIS; CHEMOREDUCTION; SURVIVAL; THERAPY; IMPACT; CANCER; CELLS; BIRTH	Retinoblastoma is the most common primary intraocular tumor in children. The first sign that is often reported by parents is the appearance of recurrent leukocoria (i.e., "white eye'') in recreational photographs. A quantitative definition or scale of leukocoria - as it appears during recreational photography - has not been established, and the amount of clinical information contained in a leukocoric image (collected by a parent) remains unknown. Moreover, the hypothesis that photographic leukocoria can be a sign of early stage retinoblastoma has not been tested for even a single patient. This study used commercially available software (Adobe Photoshop (R)) and standard color space conversion algorithms (operable in Microsoft Excel (R)) to quantify leukocoria in actual "baby pictures'' of 9 children with retinoblastoma (that were collected by parents during recreational activities i.e., in nonclinical settings). One particular patient with bilateral retinoblastoma ("Patient Zero'') was photographed >7, 000 times by his parents (who are authors of this study) over three years: from birth, through diagnosis, treatment, and remission. This large set of photographs allowed us to determine the longitudinal and lateral frequency of leukocoria throughout the patient's life. This study establishes: (i) that leukocoria can emerge at a low frequency in early-stage retinoblastoma and increase in frequency during disease progression, but decrease upon disease regression, (ii) that Hue, Saturation and Value (i. e., HSV color space) are suitable metrics for quantifying the intensity of retinoblastoma-linked leukocoria; (iii) that different sets of intraocular retinoblastoma tumors can produce distinct leukocoric reflections; and (iv) the Saturation-Value plane of HSV color space represents a convenient scale for quantifying and classifying pupillary reflections as they appear during recreational photography.	[Abdolvahabi, Alireza; Taylor, Brandon W.; Holden, Rebecca L.; Shaw, Elizabeth V.; Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Kentsis, Alex] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Rodriguez-Galindo, Carlos] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Mukai, Shizuo] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Mukai, Shizuo] Massachusetts Eye & Ear Infirm, Retina Serv, Boston, MA 02114 USA	Baylor University; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary	Shaw, BF (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA.	Bryan_Shaw@baylor.edu	Shaw, Bryan/A-7001-2008; Rodriguez-Galindo, Carlos/N-8071-2018	Kentsis, Alex/0000-0002-8063-9191	College of Arts and Sciences at Baylor University; Mukai Fund, at Massachusetts Eye and Ear Infirmary	College of Arts and Sciences at Baylor University; Mukai Fund, at Massachusetts Eye and Ear Infirmary	This work was supported by a laboratory start-up fund provided to Bryan F. Shaw from the College of Arts and Sciences at Baylor University. This work was also supported by the Mukai Fund, at Massachusetts Eye and Ear Infirmary. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abramson DH, 2003, PEDIATRICS, V112, P1248, DOI 10.1542/peds.112.6.1248; [Anonymous], 2006, MICROWAVES RF, V45, P22; Bowman RJC, 2008, PEDIATR BLOOD CANCER, V50, P160, DOI 10.1002/pbc.21080; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P24, DOI 10.1136/bjo.2008.143842; Broaddus E, 2009, BRIT J OPHTHALMOL, V93, P21, DOI 10.1136/bjo.2008.138750; Canturk S, 2010, BRIT J OPHTHALMOL, V94, P1432, DOI 10.1136/bjo.2009.168062; Cha S B, 1993, J Ophthalmic Nurs Technol, V12, P189; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; Epelman S, 2012, CURR ONCOL REP, V14, P213, DOI 10.1007/s11912-012-0226-z; Gombos DS, 2000, ARCH OPHTHALMOL-CHIC, V118, P440, DOI 10.1001/archopht.118.3.440; Goustard-Langelier B, 2000, J NEUROSCI RES, V60, P678, DOI 10.1002/(SICI)1097-4547(20000601)60:5<678::AID-JNR13>3.0.CO;2-T; Haider S, 2008, J PEDIAT OPHTH STRAB, V45, P179, DOI 10.3928/01913913-20080501-13; HAIK BG, 1985, OPHTHALMOLOGY, V92, P1143; Houston Samuel K, 2011, Int Ophthalmol Clin, V51, P77, DOI 10.1097/IIO.0b013e3182010f29; HYMAN BT, 1982, J NEUROCHEM, V38, P650, DOI 10.1111/j.1471-4159.1982.tb08680.x; HYMAN BT, 1981, J NEUROCHEM, V37, P60, DOI 10.1111/j.1471-4159.1981.tb05291.x; Kiss Szilard, 2008, Int Ophthalmol Clin, V48, P135, DOI 10.1097/IIO.0b013e3181693670; Kivela T, 2009, BRIT J OPHTHALMOL, V93, P1129, DOI 10.1136/bjo.2008.150292; Kumar A, 2010, J AAPOS, V14, P345, DOI 10.1016/j.jaapos.2010.05.007; Leander C, 2007, PEDIATR BLOOD CANCER, V49, P817, DOI 10.1002/pbc.21052; Li J, 2010, PEDIATRICS, V126, pE202, DOI 10.1542/peds.2009-0882; Lim Z, 2010, AM J OPHTHALMOL, V149, P887, DOI 10.1016/j.ajo.2010.01.012; Luna-Fineman S, 2012, PEDIATR BLOOD CANCER, V58, P545, DOI 10.1002/pbc.23307; Maki JL, 2009, OPHTHALMIC GENET, V30, P199, DOI 10.3109/13816810903258837; Makky A, 2010, LANGMUIR, V26, P11145, DOI 10.1021/la101040q; Marshall J, 2003, AM J OPHTHALMOL, V135, P709, DOI 10.1016/S0002-9394(02)02079-2; Molineux A, 2012, SPEECH, IMAGE, AND LANGUAGE PROCESSING FOR HUMAN COMPUTER INTERACTION: MULTI-MODAL ADVANCEMENTS, P292, DOI 10.4018/978-1-4666-0954-9.ch014; Murphy D, 2012, LANCET, V379, P2465, DOI 10.1016/S0140-6736(11)61644-9; Narang S, 2012, CLIN EXP OPHTHALMOL, V40, P736, DOI 10.1111/j.1442-9071.2012.02757.x; Ollivier FJ, 2004, VET OPHTHALMOL, V7, P11, DOI 10.1111/j.1463-5224.2004.00318.x; Phan IT, 2010, J PEDIATR-US, V157, P858, DOI 10.1016/j.jpeds.2010.08.010; Poulaki Vasiliki, 2009, Int Ophthalmol Clin, V49, P155, DOI 10.1097/IIO.0b013e3181924bc2; Rodriguez-Galindo C, 2010, RETINOBLASTOMA; Rodriguez-Galindo C, 2008, PEDIATRICS, V122, pE763, DOI 10.1542/peds.2008-0518; Rodriguez-Galindo C, 2011, PEDIATR BLOOD CANCER, V57, P1093, DOI 10.1002/pbc.23305; Rubin Michael P, 2008, Int Ophthalmol Clin, V48, P149, DOI 10.1097/IIO.0b013e3181693467; Russell HC, 2010, J PEDIATR OPHTHALMOL, V1, P1; Seregard S, 2004, OPHTHALMOLOGY, V111, P1228, DOI 10.1016/j.ophtha.2003.10.023; Shoji K, 2010, J PEDIATR-US, V157, P331, DOI 10.1016/j.jpeds.2010.02.020; Shrestha A, 2010, Kathmandu Univ Med J (KUMJ), V8, P247; SMIRNIOTOPOULOS JG, 1994, RADIOGRAPHICS, V14, P1059, DOI 10.1148/radiographics.14.5.7991814; Smith A., 1978, COMPUT GRAPH-UK, V12, P12; Smith A., 2013, SMARTPHONE OWNERSHIP; Sussman DA, 2003, ARCH OPHTHALMOL-CHIC, V121, P979, DOI 10.1001/archopht.121.7.979; Swaminathan I, 2008, INT J CANCER, V122, P2607, DOI 10.1002/ijc.23428; Tillmann K, 2012, DIGITAL CAMERA MARKE; Ventura G, 2012, LANCET, V380, P803, DOI 10.1016/S0140-6736(12)61445-7; Wang SQ, 2011, LAB CHIP, V11, P3411, DOI 10.1039/c1lc20479c; Wessels G, 1996, MED PEDIATR ONCOL, V27, P160, DOI 10.1002/(SICI)1096-911X(199609)27:3<160::AID-MPO5>3.0.CO;2-C; Wilson MW, 2011, BRIT J OPHTHALMOL, V95, P553, DOI 10.1136/bjo.2009.177444; YOREK MA, 1985, INVEST OPHTH VIS SCI, V26, P1148; YOREK MA, 1984, BIOCHIM BIOPHYS ACTA, V795, P277, DOI 10.1016/0005-2760(84)90076-6; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhu HY, 2011, LAB CHIP, V11, P315, DOI [10.1039/c0lc00358a, 10.1039/c01c00358a]	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76677	10.1371/journal.pone.0076677	http://dx.doi.org/10.1371/journal.pone.0076677			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204654	gold, Green Submitted, Green Published			2022-12-25	WOS:000326334500008
J	Codron, D; Carbone, C; Clauss, M				Codron, Daryl; Carbone, Chris; Clauss, Marcus			Ecological Interactions in Dinosaur Communities: Influences of Small Offspring and Complex Ontogenetic Life Histories	PLOS ONE			English	Article							BODY-SIZE; REPRODUCTIVE EFFORT; NICHE SHIFTS; AVIAN EGG; DEMOGRAPHY; LIZARD; PATTERNS; EVOLUTION; FOOD; MASS	Because egg-laying meant that even the largest dinosaurs gave birth to very small offspring, they had to pass through multiple ontogenetic life stages to adulthood. Dinosaurs' successors as the dominant terrestrial vertebrate life form, the mammals, give birth to live young, and have much larger offspring and less complex ontogenetic histories. The larger number of juveniles in dinosaur as compared to mammal ecosystems represents both a greater diversity of food available to predators, and competitors for similar-sized individuals of sympatric species. Models of population abundances across different-sized species of dinosaurs and mammals, based on simulated ecological life tables, are employed to investigate how differences in predation and competition pressure influenced dinosaur communities. Higher small-to medium-sized prey availability leads to a normal body mass-species richness (M-S) distribution of carnivorous dinosaurs (as found in the theropod fossil record), in contrast to the right-skewed M-S distribution of carnivorous mammals (as found living members of the order Carnivora). Higher levels of interspecific competition leads to a left-skewed M-S distribution in herbivorous dinosaurs (as found in sauropods and ornithopods), in contrast to the normal M-S distribution of large herbivorous mammals. Thus, our models suggest that differences in reproductive strategy, and consequently ontogeny, explain observed differences in community structure between dinosaur and mammal faunas. Models also show that the largest dinosaurian predators could have subsisted on similar-sized prey by including younger life stages of the largest herbivore species, but that large predators likely avoided prey much smaller than themselves because, despite predicted higher abundances of smaller than larger-bodied prey, contributions of small prey to biomass intake would be insufficient to satisfy meat requirements. A lack of large carnivores feeding on small prey exists in mammals larger than 21.5 kg, and it seems a similar minimum prey-size threshold could have affected dinosaurs as well.	[Codron, Daryl; Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Codron, Daryl] Florisbad Quaternary Res, Natl Museum, Bloemfontein, South Africa; [Codron, Daryl] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Pietermaritzburg, South Africa; [Codron, Daryl] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Carbone, Chris] Zool Soc London, Inst Zool, London NW1 4RY, England	University of Zurich; University of Kwazulu Natal; University of Colorado System; University of Colorado Boulder; Zoological Society of London	Codron, D (corresponding author), Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland.	d.codron@nasmus.co.za	Codron, Daryl/B-8867-2008; Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019; Clauss, Marcus/A-4710-2008	Codron, Daryl/0000-0001-5223-9513; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207				Abts ML, 1985, LIFE HIST STRATEGY S; Akû║akaya H.R., 1999, APPL POPULATION ECOL; AR A, 1979, CONDOR, V81, P331, DOI 10.2307/1366955; Archibald J.D., 1996, DINOSAUR EXTINCTION; ARMITAGE KB, 1974, ECOLOGY, V55, P1233, DOI 10.2307/1935452; BARKALOW FS, 1970, J WILDLIFE MANAGE, V34, P489, DOI 10.2307/3798852; BARLOW J, 1991, MAR MAMMAL SCI, V7, P50, DOI 10.1111/j.1748-7692.1991.tb00550.x; Begon M., 2009, ECOLOGY INDIVIDUALS; Benton MJ, 2006, VERTEBRATE PALAEONTO; Berglind Sven-Ake, 2000, Ecological Bulletins, V48, P123; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; BLACKBURN TM, 1994, PHILOS T ROY SOC B, V343, P135, DOI 10.1098/rstb.1994.0016; BLACKBURN TM, 1994, OIKOS, V70, P127, DOI 10.2307/3545707; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Brett-Surman MK, 1997, COMPLETE DINOSAUR, P350; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; CABANA G, 1982, AM NAT, V120, P17, DOI 10.1086/283966; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; Carbone C, 2011, P ROY SOC B-BIOL SCI, V278, P2682, DOI 10.1098/rspb.2010.2497; Carrano Matthew T., 2006, P225; Chiappe LM, 2001, SCIENCE, V293, P2444, DOI 10.1126/science.1063723; Clarke A, 2013, AM NAT, V182, P283, DOI 10.1086/671259; Codron D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0922; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Codron J, 2013, CAN J ZOOL, V91, P124, DOI 10.1139/cjz-2012-0155; CONGDON JD, 1994, AM ZOOL, V34, P397; DAMUTH J, 1981, BIOL J LINN SOC, V15, P185, DOI 10.1111/j.1095-8312.1981.tb00758.x; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Damuth J, 2007, AM NAT, V169, P621, DOI 10.1086/513495; Dunning JB, 2013, UPDATES 2 EDITION CR; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Ericsson G, 2001, ECOLOGY, V82, P1613, DOI 10.1890/0012-9658(2001)082[1613:ARREAS]2.0.CO;2; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; Foster J., 2007, JURASSIC W DINOSAURS; Gadsden H, 2008, WEST N AM NATURALIST, V68, P46, DOI 10.3398/1527-0904(2008)68[46:DOTYSL]2.0.CO;2; Galan P, 1999, J ZOOL, V249, P203; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Hummel J, 2008, EVOL ECOL RES, V10, P925; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Lang E, 2013, PALAEOGEOGR PALAEOCL, V381, P26, DOI 10.1016/j.palaeo.2013.04.011; LEVINS RICHARD, 1968; Lockley Martin G., 1994, P347; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Ortega-Rubio A, 2000, HERPETOL J, V10, P33; Parker WS, 1974, COPEIA, V1994, P136; Paul GS, 1999, DINOSAUR EGGS BABIES, P244; Punzo F, 2007, AMPHIBIA-REPTILIA, V28, P65, DOI 10.1163/156853807779798974; Radloff FGT, 2012, ISOT ENVIRON HEALT S, V48, P439, DOI 10.1080/10256016.2012.667808; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Smith FA, 2004, AM NAT, V163, P672, DOI 10.1086/382898; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Sookias RB, 2012, BIOL LETTERS, V8, P674, DOI 10.1098/rsbl.2012.0060; Statsoft_Inc, 2007, STAT VERS 8 0 COMP P; Steinsaltz D, 2011, PALEOBIOLOGY, V37, P113, DOI 10.1666/08056.1; TINKLE DW, 1983, COPEIA, P585; Troost TA, 2008, EVOL ECOL, V22, P771, DOI 10.1007/s10682-007-9209-1; VANDEVENDER RW, 1982, HERPETOLOGICA, V38, P189; VINEGAR MB, 1975, ECOLOGY, V56, P172, DOI 10.2307/1935309; Weishampel DB., 2004, DINOSAURIA; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner J, 2010, REPROD DINOSAURIERN; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; WISSINGER SA, 1992, ECOLOGY, V73, P1431, DOI 10.2307/1940688; Woolley LA, 2011, BIOTROPICA, V43, P489, DOI 10.1111/j.1744-7429.2010.00733.x; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; [No title captured]	85	22	22	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77110	10.1371/journal.pone.0077110	http://dx.doi.org/10.1371/journal.pone.0077110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204749	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326334500017
J	Lyngdoh, T; Bochud, M; Glaus, J; Castelao, E; Waeber, G; Vollenweider, P; Preisig, M				Lyngdoh, Tanica; Bochud, Murielle; Glaus, Jennifer; Castelao, Enrique; Waeber, Gerard; Vollenweider, Peter; Preisig, Martin			Associations of Serum Uric Acid and SLC2A9 Variant with Depressive and Anxiety Disorders: A Population-Based Study	PLOS ONE			English	Article							OXIDATIVE STRESS; DIAGNOSTIC INTERVIEW; PSYCHIATRIC-DISORDERS; SHORT-TERM; CHOLESTEROL; RISK; DISEASE; VARIABILITY; COMORBIDITY; RELIABILITY	Background: Limited information exists regarding the association between serum uric acid (SUA) and psychiatric disorders. We explored the relationship between SUA and subtypes of major depressive disorder (MDD) and specific anxiety disorders. Additionally, we examined the association of SLC2A9 rs6855911 variant with anxiety disorders. Methods: We conducted a cross-sectional analysis on 3,716 individuals aged 35-66 years previously selected for the population-based CoLaus survey and who agreed to undergo further psychiatric evaluation. SUA was measured using uricase-PAP method. The French translation of the semi-structured Diagnostic Interview for Genetic Studies was used to establish lifetime and current diagnoses of depression and anxiety disorders according to the DSM-IV criteria. Results: Men reported significantly higher levels of SUA compared to women (357674 mmol/L vs. 263664 mmol/L). The prevalence of lifetime and current MDD was 44% and 18% respectively while the corresponding estimates for any anxiety disorders were 18% and 10% respectively. A quadratic hockey-stick shaped curve explained the relationship between SUA and social phobia better than a linear trend. However, with regards to the other specific anxiety disorders and other subtypes of MDD, there was no consistent pattern of association. Further analyses using SLC2A9 rs6855911 variant, known to be strongly associated with SUA, supported the quadratic relationship observed between SUA phenotype and social phobia. Conclusions: A quadratic relationship between SUA and social phobia was observed consistent with a protective effect of moderately elevated SUA on social phobia, which disappears at higher concentrations. Further studies are needed to confirm our observations.	[Lyngdoh, Tanica; Bochud, Murielle] Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Glaus, Jennifer; Castelao, Enrique; Preisig, Martin] CHU Vaudois, Dept Psychiat, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bochud, M (corresponding author), Lausanne Univ Hosp CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Murielle.Bochud@chuv.ch	Bochud, Murielle/A-3981-2010; Colaus, PsyColaus/K-6607-2013; Glaus, Jennifer/C-7887-2017	Bochud, Murielle/0000-0002-5727-0218; Glaus, Jennifer/0000-0001-8883-9473; Castelao, Enrique/0000-0003-1966-3683; Preisig, Martin/0000-0001-5689-4259; Waeber, Gerard/0000-0003-4193-788X	Swiss National Science Foundation [3200B0-105993]; GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, RD); GlaxoSmithKline	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, RD)(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	The PsyCoLaus study was supported by grants from the Swiss National Science Foundation (#3200B0-105993) and from GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, R&D). Profs PV and GW received an unrestricted grant from GlaxoSmithKline to build the CoLaus study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Angst J, 2006, EUR ARCH PSY CLIN N, V256, P44, DOI 10.1007/s00406-005-0600-z; Bettschart W, 1996, EVALUATION CLIN STAN, VI; Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944; Bove M, 2010, AGING MENT HEALTH, V14, P801, DOI 10.1080/13607861003713299; Brandstatter A, 2008, DIABETES CARE, V31, P1662, DOI 10.2337/dc08-0349; Chaudhari K, 2010, INDIAN J CLIN BIOCHE, V25, P77, DOI 10.1007/s12291-010-0016-z; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Cumurcu BE, 2009, PSYCHIAT CLIN NEUROS, V63, P639, DOI 10.1111/j.1440-1819.2009.02004.x; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fendri C, 2006, ENCEPHALE, V32, P244; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FRANCIS KT, 1979, PSYCHOSOM MED, V41, P617, DOI 10.1097/00006842-197912000-00003; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hettema JM, 2008, AM J MED GENET C, V148C, P140, DOI 10.1002/ajmg.c.30171; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2010, NEUROSCI RES, V68, P261, DOI 10.1016/j.neures.2010.08.007; Irie M, 2003, BIOCHEM BIOPH RES CO, V311, P1014, DOI 10.1016/j.bbrc.2003.10.105; Kessler RC, 1996, BRIT J PSYCHIAT, V168, P17, DOI 10.1192/S0007125000298371; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim TS, 2006, INT J GERIATR PSYCH, V21, P344, DOI 10.1002/gps.1469; Klandorf H, 2001, COMP BIOCHEM PHYS C, V129, P93, DOI 10.1016/S1532-0456(01)00186-7; LEBOYER M, 1991, EUR ARCH PSY CLIN N, V241, P165, DOI 10.1007/BF02219716; Leboyer M., 1995, INTERVIEW DIAGNOSTIQ; Lei MT, 2008, NEPHROL DIAL TRANSPL, V23, P2746, DOI 10.1093/ndt/gfn349; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Matsushita M, 2010, PSYCHIAT CLIN NEUROS, V64, P435, DOI 10.1111/j.1440-1819.2010.02109.x; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; RAHE RH, 1967, J AMER MED ASSOC, V202, P1052, DOI 10.1001/jama.202.11.1052; RAHE RH, 1968, J AMER MED ASSOC, V206, P2875, DOI 10.1001/jama.206.13.2875; RAHE RH, 1974, PSYCHOSOM MED, V36, P258, DOI 10.1097/00006842-197405000-00009; Rougemont-Buecking A, 2008, PSYCHIAT RES, V157, P211, DOI 10.1016/j.psychres.2006.04.022; Salim S, 2011, BRAIN RES, V1404, P63, DOI 10.1016/j.brainres.2011.06.024; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Spitsin SV, 2002, FREE RADICAL BIO MED, V33, P1363, DOI 10.1016/S0891-5849(02)01048-1; SPYCKERELLE Y, 1992, ARCH FR PEDIATR, V49, P875; Tochigi M, 2002, NEUROSCI RES, V44, P267, DOI 10.1016/S0168-0102(02)00146-3; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; Trevisan M, 1997, PSYCHOSOM MED, V59, P109, DOI 10.1097/00006842-199703000-00001; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wen SL, 2012, CLIN BIOCHEM, V45, P49, DOI 10.1016/j.clinbiochem.2011.10.010; Yanik M, 2004, ACTA NEUROPSYCHIATR, V16, P200, DOI 10.1111/j.0924-2708.2004.00090.x; ZIR LM, 1973, ARCH INTERN MED, V132, P808, DOI 10.1001/archinte.132.6.808	55	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76336	10.1371/journal.pone.0076336	http://dx.doi.org/10.1371/journal.pone.0076336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204615	Green Submitted, gold, Green Published			2022-12-25	WOS:000326270700005
J	Posokhova, E; Ng, D; Opel, A; Masuho, I; Tinker, A; Biesecker, LG; Wickman, K; Martemyanov, KA				Posokhova, Ekaterina; Ng, David; Opel, Aaisha; Masuho, Ikuo; Tinker, Andrew; Biesecker, Leslie G.; Wickman, Kevin; Martemyanov, Kirill A.			Essential Role of the m(2)R-RGS6-I-KACh Pathway in Controlling Intrinsic Heart Rate Variability	PLOS ONE			English	Article							ENDOGENOUS RGS PROTEINS; I-KACH; PARASYMPATHETIC REGULATION; GATING KINETICS; POINCARE PLOT; K+-CHANNEL; ACTIVATION; SUBTYPES; ABSENCE; COMPLEX	Normal heart function requires generation of a regular rhythm by sinoatrial pacemaker cells and the alteration of this spontaneous heart rate by the autonomic input to match physiological demand. However, the molecular mechanisms that ensure consistent periodicity of cardiac contractions and fine tuning of this process by autonomic system are not completely understood. Here we examined the contribution of the m(2)R-I-KACh intracellular signaling pathway, which mediates the negative chronotropic effect of parasympathetic stimulation, to the regulation of the cardiac pacemaking rhythm. Using isolated heart preparations and single-cell recordings we show that the m(2)R-I-KACh signaling pathway controls the excitability and firing pattern of the sinoatrial cardiomyocytes and determines variability of cardiac rhythm in a manner independent from the autonomic input. Ablation of the major regulator of this pathway, Rgs6, in mice results in irregular cardiac rhythmicity and increases susceptibility to atrial fibrillation. We further identify several human subjects with variants in the RGS6 gene and show that the loss of function in RGS6 correlates with increased heart rate variability. These findings identify the essential role of the m(2)R-I-KACh signaling pathway in the regulation of cardiac sinus rhythm and implicate RGS6 in arrhythmia pathogenesis.	[Posokhova, Ekaterina; Masuho, Ikuo; Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Ng, David; Biesecker, Leslie G.] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Opel, Aaisha] UCL, Dept Med, London, England; [Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, Ctr Heart, William Harvey Res Inst, London, England; [Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of London; University College London; University of London; Queen Mary University London; University of Minnesota System; University of Minnesota Twin Cities	Martemyanov, KA (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL USA.	kirill@scripps.edu	Masuho, Ikuo/J-6115-2014	Wickman, Kevin/0000-0002-5179-9540	NIH [HL105550]; British Heart Foundation [FS/09/042/27860]; Welcome Trust [081475/Z/06/Z]; NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Welcome Trust(Wellcome Trust); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH grant HL105550 (KW and KAM), the British Heart Foundation, FS/09/042/27860 (AT) and Welcome Trust, 081475/Z/06/Z (AT). DN and LB are supported by the Intramural Research Program of the NHGRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Buccelletti F, 2009, EUR REV MED PHARMACO, V13, P299; Camm AJ, 1996, CIRCULATION, V93, P1043; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Dobrev D, 2005, CIRCULATION, V112, P3697, DOI 10.1161/circulationaha.105.575332; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Frey B, 1996, PACE, V19, P1882, DOI 10.1111/j.1540-8159.1996.tb03245.x; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2007, AM J PHYSIOL-HEART C, V292, pH2532, DOI 10.1152/ajpheart.01391.2006; Gehrmann J, 2000, AM J PHYSIOL-HEART C, V279, pH733, DOI 10.1152/ajpheart.2000.279.2.H733; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hashimoto N, 2008, J CARDIOVASC PHARM, V51, P162, DOI 10.1097/FJC.0b013e31815e854c; Herrmann S, 2007, EMBO J, V26, P4423, DOI 10.1038/sj.emboj.7601868; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Jakubik J, 1995, FEBS LETT, V377, P275, DOI 10.1016/0014-5793(95)01360-1; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Kamen PW, 1996, CLIN SCI, V91, P201, DOI 10.1042/cs0910201; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lombardi F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00095; Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032; Machida N, 2001, J VET MED SCI, V63, P873, DOI 10.1292/jvms.63.873; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Mighiu AS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00204; Podrid PJ., 2001, CARDIAC ARRHYTHMIA M, V2; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Schumacher AM, 2006, BIOL RES NURS, V8, P55, DOI 10.1177/1099800406289775; Singh JP, 2002, AM J CARDIOL, V90, P1290, DOI 10.1016/S0002-9149(02)02865-5; Stein PK, 1999, ANNU REV MED, V50, P249, DOI 10.1146/annurev.med.50.1.249; Stewart A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00095; Stieber J, 2004, TRENDS CARDIOVAS MED, V14, P23, DOI 10.1016/j.tcm.2003.09.006; van de Borne P, 1999, CIRCULATION, V99, P1606, DOI 10.1161/01.CIR.99.12.1606; Voigt N, 2008, CARDIOVASC RES, V77, P35, DOI 10.1093/cvr/cvm051; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; Wickman K, 1999, ANN NY ACAD SCI, V868, P386, DOI 10.1111/j.1749-6632.1999.tb11300.x; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Yang Yanzong, 2010, Am J Hum Genet, V86, P872; Zuberi Z, 2010, CIRC-ARRHYTHMIA ELEC, V3, P391, DOI 10.1161/CIRCEP.109.894329	46	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76973	10.1371/journal.pone.0076973	http://dx.doi.org/10.1371/journal.pone.0076973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204714	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700014
J	Baker, JHE; Kyle, AH; Bartels, KL; Methot, SP; Flanagan, EJ; Balbirnie, A; Cran, JD; Minchinton, AI				Baker, Jennifer H. E.; Kyle, Alastair H.; Bartels, Kirsten L.; Methot, Stephen P.; Flanagan, Erin J.; Balbirnie, Andrew; Cran, Jordan D.; Minchinton, Andrew I.			Targeting the Tumour Vasculature: Exploitation of Low Oxygenation and Sensitivity to NOS Inhibition by Treatment with a Hypoxic Cytotoxin	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PHASE-III TRIAL; OXYHEMOGLOBIN SATURATIONS; DISRUPTING AGENTS; BLOOD-VESSELS; MURINE TUMORS; L-ARGININE; IN-VIVO; TIRAPAZAMINE; CANCER	Many cancer research efforts focus on exploiting genetic-level features that may be targeted for therapy. Tissue-level features of the tumour microenvironment also represent useful therapeutic targets. Here we investigate the presence of low oxygen tension and sensitivity to NOS inhibition of tumour vasculature as potential tumour-specific features that may be targeted by hypoxic cytotoxins, a class of therapeutics currently under investigation. We have previously demonstrated that tirapazamine (TPZ) mediates central vascular dysfunction in tumours. TPZ is a hypoxic cytotoxin that is also a competitive inhibitor of NOS. Here we further investigated the vascular-targeting activity of TPZ by combining it with NOS inhibitor L-NNA, or with low oxygen content gas breathing. Tumours were analyzed via multiplex immunohistochemical staining that revealed irreversible loss of perfusion and enhanced tumour cell death when TPZ was combined with either low oxygen or a NOS inhibitor. Tumour growth rate was reduced by TPZ + NOS inhibition, and tumours previously resistant to TPZ-mediated vascular dysfunction were sensitized by low oxygen breathing. Additional mapping analysis suggests that tumours with reduced vascular-associated stroma may have greater sensitivity to these effects. These results indicate that poorly oxygenated tumour vessels, also being abnormally organized and with inadequate smooth muscle, may be successfully targeted for significant anti-cancer effects by inhibition of NOS and hypoxia-activated prodrug toxicity. This strategy illustrates a novel use of hypoxia-activated cytotoxic prodrugs as vascular targeting agents, and also represents a novel mechanism for targeting tumour vessels.	[Baker, Jennifer H. E.; Kyle, Alastair H.; Bartels, Kirsten L.; Methot, Stephen P.; Flanagan, Erin J.; Balbirnie, Andrew; Cran, Jordan D.; Minchinton, Andrew I.] BC Canc Res Ctr, Integrat Oncol Radiat Biol Unit, Vancouver, BC, Canada	British Columbia Cancer Agency	Minchinton, AI (corresponding author), BC Canc Res Ctr, Integrat Oncol Radiat Biol Unit, Vancouver, BC, Canada.	aim@bccrc.ca		Methot, Stephen/0000-0003-2854-2226	Michael Smith Foundation for Health Research; Canadian Institutes for Health Research	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	JB and AK are supported by Michael Smith Foundation for Health Research Senior Graduate Studentships (http://www.msfhr.org/funding). Funding for this research was provided by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Anderson RF, 2005, ORG BIOMOL CHEM, V3, P2167, DOI 10.1039/b502586a; Bains LJ, 2009, INT J RADIAT ONCOL, V74, P957, DOI 10.1016/j.ijrobp.2008.11.068; Baker JHE, 2008, CLIN CANCER RES, V14, P2171, DOI 10.1158/1078-0432.CCR-07-4465; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOUCHER Y, 1990, CANCER RES, V50, P4478; BROWN JM, 1990, CANCER RES, V50, P7745; Butler SA, 1997, BRIT J CANCER, V76, P438, DOI 10.1038/bjc.1997.407; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Dewhirst MW, 1999, BRIT J CANCER, V79, P1717, DOI 10.1038/sj.bjc.6690273; Dewhirst MW, 2003, ADV EXP MED BIOL, V510, P51; DORIE MJ, 1993, CANCER RES, V53, P4633; Elwell JH, 1997, BIOCHEM PHARMACOL, V54, P249, DOI 10.1016/S0006-2952(97)00171-8; Evans JW, 1998, CANCER RES, V58, P2098; FENTON BM, 1988, J NATL CANCER I, V80, P1612, DOI 10.1093/jnci/80.20.1612; Fukumura D, 1997, AM J PATHOL, V150, P713; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; GABOURY JP, 1994, AM J PHYSIOL, V266, pH637, DOI 10.1152/ajpheart.1994.266.2.H637; Garner AP, 1999, CANCER RES, V59, P1929; Graham MA, 1997, CANCER CHEMOTH PHARM, V40, P1, DOI 10.1007/s002800050617; Horsman MR, 1996, BRIT J CANCER, V74, pS168; Huxham LA, 2006, RADIOTHER ONCOL, V78, P138, DOI 10.1016/j.radonc.2006.01.002; Huxham LA, 2008, MICROVASC RES, V75, P247, DOI 10.1016/j.mvr.2007.09.006; Kyle AH, 2007, CLIN CANCER RES, V13, P2804, DOI 10.1158/1078-0432.CCR-06-1941; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Marcu L, 2006, CURR CLIN PHARMACOL, V1, P71, DOI 10.2174/157488406775268192; Maseide K, 2001, CANCER LETT, V162, P245, DOI 10.1016/S0304-3835(00)00670-4; MINCHINTON AI, 1992, BRIT J CANCER, V66, P1053, DOI 10.1038/bjc.1992.409; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Patterson LH, 2000, BRIT J CANCER, V83, P1589, DOI 10.1054/bjoc.2000.1564; Peters KB, 2002, CANCER RES, V62, P5248; Le QT, 2012, CLIN CANCER RES, V18, P1798, DOI 10.1158/1078-0432.CCR-11-2094; Rischin D, 2010, J CLIN ONCOL, V28, P2989, DOI 10.1200/JCO.2009.27.4449; Seshadri M, 2007, NEOPLASIA, V9, P128, DOI 10.1593/neo.06748; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siim BG, 2004, CANCER RES, V64, P736, DOI 10.1158/0008-5472.CAN-03-2488; Siim BG, 1997, CANCER RES, V57, P2922; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Tozer GM, 2008, BRIT J RADIOL, V81, pS12, DOI 10.1259/bjr/36205483; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; Tozer GM, 1997, CANCER RES, V57, P948; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; WOOD PJ, 1994, CANCER RES, V54, P6458; Wouters BG, 2001, CANCER RES, V61, P145; ZEMAN EM, 1986, INT J RADIAT ONCOL, V12, P1239, DOI 10.1016/0360-3016(86)90267-1	50	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76832	10.1371/journal.pone.0076832	http://dx.doi.org/10.1371/journal.pone.0076832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204680	Green Published, gold, Green Submitted			2022-12-25	WOS:000326241200015
J	Fergus, P; Cheung, P; Hussain, A; Al-Jumeily, D; Dobbins, C; Iram, S				Fergus, Paul; Cheung, Pauline; Hussain, Abir; Al-Jumeily, Dhiya; Dobbins, Chelsea; Iram, Shamaila			Prediction of Preterm Deliveries from EHG Signals Using Machine Learning	PLOS ONE			English	Article							UTERINE EMG; ELECTRICAL-ACTIVITY; APPROXIMATE ENTROPY; ABDOMINAL SURFACE; EARLY-DIAGNOSIS; TERM; CLASSIFICATION; PREGNANCY; LABOR; BIRTH	There has been some improvement in the treatment of preterm infants, which has helped to increase their chance of survival. However, the rate of premature births is still globally increasing. As a result, this group of infants are most at risk of developing severe medical conditions that can affect the respiratory, gastrointestinal, immune, central nervous, auditory and visual systems. In extreme cases, this can also lead to long-term conditions, such as cerebral palsy, mental retardation, learning difficulties, including poor health and growth. In the US alone, the societal and economic cost of preterm births, in 2005, was estimated to be $26.2 billion, per annum. In the UK, this value was close to (sic)2.95 billion, in 2009. Many believe that a better understanding of why preterm births occur, and a strategic focus on prevention, will help to improve the health of children and reduce healthcare costs. At present, most methods of preterm birth prediction are subjective. However, a strong body of evidence suggests the analysis of uterine electrical signals (Electrohysterography), could provide a viable way of diagnosing true labour and predict preterm deliveries. Most Electrohysterography studies focus on true labour detection during the final seven days, before labour. The challenge is to utilise Electrohysterography techniques to predict preterm delivery earlier in the pregnancy. This paper explores this idea further and presents a supervised machine learning approach that classifies term and preterm records, using an open source dataset containing 300 records (38 preterm and 262 term). The synthetic minority oversampling technique is used to oversample the minority preterm class, and cross validation techniques, are used to evaluate the dataset against other similar studies. Our approach shows an improvement on existing studies with 96% sensitivity, 90% specificity, and a 95% area under the curve value with 8% global error using the polynomial classifier.	[Fergus, Paul; Cheung, Pauline; Hussain, Abir; Al-Jumeily, Dhiya; Dobbins, Chelsea; Iram, Shamaila] Liverpool John Moores Univ, Appl Comp Res Grp, Liverpool L3 5UX, Merseyside, England	Liverpool John Moores University	Fergus, P (corresponding author), Liverpool John Moores Univ, Appl Comp Res Grp, Liverpool L3 5UX, Merseyside, England.	P.Fergus@ljmu.ac.uk	Dobbins, Chelsea/Q-9789-2019; Al-Jumeily, Dhiya/AAE-8272-2020; Dobbins, Chelsea/AAF-8786-2021	Dobbins, Chelsea/0000-0001-9420-2452; Al-Jumeily, Dhiya/0000-0002-9170-0568; Iram, Shamaila/0000-0003-0217-500X; Fergus, Paul/0000-0002-7070-4447				[Anonymous], P IEEE 8 INT S MECH, DOI [10.1109/ISMA.2012.6215191, DOI 10.1109/ISMA.2012.6215191]; Baghamoradi S, 2011, 18 IR C BIOM ENG, P1; Buhimschi C, 1997, OBSTET GYNECOL, V90, P102, DOI 10.1016/S0029-7844(97)83837-9; Buhimschi C, 1996, AM J OBSTET GYNECOL, V174, P744, DOI 10.1016/S0002-9378(96)70459-3; Buhimschi C, 1998, AM J OBSTET GYNECOL, V178, P811, DOI 10.1016/S0002-9378(98)70498-3; Carre P, 1998, IEEE T BIO-MED ENG, V45, P1104, DOI 10.1109/10.709554; CHARNIAK E, 1991, AI MAG, V12, P50; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Diab A, 2012, IEEE ENG MED BIO, P1045, DOI 10.1109/EMBC.2012.6346113; Diab Mohamad O., 2010, Journal of Biomedical Science & Engineering, V3, P837, DOI 10.4236/jbise.2010.39113; Diab M.O., 2007, INT J COMPUT COGNIT, V5, P8; Diab MO, 2012, IEEE MEDITERR ELECT, P335, DOI 10.1109/MELCON.2012.6196443; Doret M, 2005, OBSTET GYNECOL, V105, P822, DOI 10.1097/01.AOG.0000157110.62926.d7; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fele-Zorz G, 2008, MED BIOL ENG COMPUT, V46, P911, DOI 10.1007/s11517-008-0350-y; Frey B., 2020, STAT PEOPLE WHO THIN; Garfield RE, 2005, BJOG-INT J OBSTET GY, V112, P103, DOI 10.1111/j.1471-0528.2005.00596.x; Garfield RE, 2007, SEMIN CELL DEV BIOL, V18, P289, DOI 10.1016/j.semcdb.2007.05.004; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gondry Jean, 1993, Biomedical Instrumentation and Technology, V27, P318; Greenough A, 2012, SEMIN FETAL NEONAT M, V17, P73, DOI 10.1016/j.siny.2012.01.009; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; Kenny LC., 2011, OBSTET 10 TEACHERS, V19, P225; Lammers WJEP, 2013, REPROD SCI, V20, P182, DOI 10.1177/1933719112446082; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Leman H, 1999, IEEE T BIO-MED ENG, V46, P1222, DOI 10.1109/10.790499; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Lusa, 2013, BMC BIOINFORMATICS, V14, P1; Maner WL, 2007, ANN BIOMED ENG, V35, P465, DOI 10.1007/s10439-006-9248-8; Maner WL, 2006, MED BIOL ENG COMPUT, V44, P117, DOI 10.1007/s11517-005-0011-3; Maner WL, 2003, OBSTET GYNECOL, V101, P1254, DOI 10.1016/S0029-7844(03)00341-7; Mangham LJ, 2009, PEDIATRICS, V123, pE312, DOI 10.1542/peds.2008-1827; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Marque Catherine K, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS5, DOI 10.1186/1471-2393-7-S1-S5; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Moslem B., 2011, 2011 18th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2011), P631, DOI 10.1109/ICECS.2011.6122354; Moslem B., 2011, 2011 18th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2011), P93, DOI 10.1109/ICECS.2011.6122222; Moslem B, 2011, IEEE ENG MED BIO, P2602, DOI 10.1109/IEMBS.2011.6090718; Moslem B, 2011, IEEE ENG MED BIO, P3371, DOI 10.1109/IEMBS.2011.6090913; Moslem B, 2012, IEEE MEDITERR ELECT, P331, DOI 10.1109/MELCON.2012.6196442; Moslem B, 2011, IEEE WRK SIG PRO SYS, P267, DOI 10.1109/SiPS.2011.6088987; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Nahar J, 2012, EXPERT SYST APPL, V39, P12371, DOI 10.1016/j.eswa.2012.04.045; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Rattihalli R, 2012, FETAL NEONATAL, V97, P160; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Russell SP, 2010, ARTIFICIAL INTELLIGE; Sun T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063559; Taft LM, J BIOMEDICAL INFORM, V42, P356; Tong LI, 2011, EXPERT SYST APPL, V38, P4222, DOI 10.1016/j.eswa.2010.09.087; van der Heijde F, 2005, CLASSIFICATION PARAM; Verdenik I, 2001, EUR J OBSTET GYN R B, V95, P149, DOI 10.1016/S0301-2115(00)00418-8; Vinken MPGC, 2009, OBSTET GYNECOL SURV, V64, P529, DOI 10.1097/OGX.0b013e3181a8c6b1; Wang YJ, 2012, IEEE T INF TECHNOL B, V16, P383, DOI 10.1109/TITB.2012.2187458	56	90	90	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77154	10.1371/journal.pone.0077154	http://dx.doi.org/10.1371/journal.pone.0077154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204760	Green Published, Green Accepted, gold			2022-12-25	WOS:000326241200018
J	Lee, EY; Schultz, KLW; Griffin, DE				Lee, Eun-Young; Schultz, Kimberly L. W.; Griffin, Diane E.			Mice Deficient in Interferon-Gamma or Interferon-Gamma Receptor 1 Have Distinct Inflammatory Responses to Acute Viral Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROADAPTED SINDBIS-VIRUS; WEST-NILE-VIRUS; T-CELL HOMEOSTASIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IFN-GAMMA; IMMUNE-RESPONSE; AUTOIMMUNE ENCEPHALOMYELITIS; DEMYELINATING DISEASE; TRANSGENIC MICE	Interferon (IFN)-gamma is an important component of the immune response to viral infections that can have a role both in controlling virus replication and inducing inflammatory damage. To determine the role of IFN-gamma in fatal alphavirus encephalitis, we have compared the responses of wild type C57BL/6 (WTB6) mice with mice deficient in either IFN-gamma (GKO) or the alpha-chain of the IFN-gamma receptor (GRKO) after intranasal infection with a neuroadapted strain of sindbis virus. Mortalities of GKO and GRKO mice were similar to WTB6 mice. Both GKO and GRKO mice had delayed virus clearance from the brain and spinal cord, more infiltrating perforin(+) cells and lower levels of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 mRNAs than WTB6 mice. However, inflammation was more intense in GRKO mice than WTB6 or GKO mice with more infiltrating CD3(+) T cells, greater expression of major histocompatibility complex-II and higher levels of interleukin-17A mRNA. Fibroblasts from GRKO embryos did not develop an antiviral response after treatment with IFN-gamma, but showed increases in TNF-alpha, IL-6, CXCL9 and CXCL10 mRNAs although these increases developed more slowly and were less intense than those of WTB6 fibroblasts. These data indicate that both GKO and GRKO mice fail to develop an IFN-gamma-mediated antiviral response, but differ in regulation of the inflammatory response to infection. Therefore, GKO and GRKO cannot be considered equivalent when assessing the role of IFN-gamma in CNS viral infections.	[Lee, Eun-Young; Schultz, Kimberly L. W.; Griffin, Diane E.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Griffin, DE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	dgriffin@jhsph.edu		, Kimberly/0000-0002-5826-6886	National Institutes of Health [R01 NS038932, T32 AI007247]; Chungbuk National University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chungbuk National University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by research grant R01 NS038932 (DEG) and training grant T32 AI007247 (KLWS) from the National Institutes of Health and a sabbatical fellowship from Chungbuk National University (E-YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson F, 2003, VIRAL IMMUNOL, V16, P415, DOI 10.1089/088282403322396208; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Badovinac VP, 2000, SCIENCE, V290, P1354, DOI 10.1126/science.290.5495.1354; Bartholdy C, 2000, J VIROL, V74, P10304, DOI 10.1128/JVI.74.22.10304-10311.2000; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bergmann CC, 2003, J IMMUNOL, V170, P3204, DOI 10.4049/jimmunol.170.6.3204; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; Briscoe J, 1996, EMBO J, V15, P799, DOI 10.1002/j.1460-2075.1996.tb00415.x; Burdeinick-Kerr R, 2007, J VIROL, V81, P5628, DOI 10.1128/JVI.01152-06; Byrnes AP, 2000, J VIROL, V74, P3905, DOI 10.1128/JVI.74.8.3905-3908.2000; Cantin E, 1999, J VIROL, V73, P5196, DOI 10.1128/JVI.73.6.5196-5200.1999; Chesler DA, 2002, CYTOKINE GROWTH F R, V13, P441, DOI 10.1016/S1359-6101(02)00044-8; Christensen JP, 2001, J IMMUNOL, V166, P3384, DOI 10.4049/jimmunol.166.5.3384; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Corbin JG, 1996, MOL CELL NEUROSCI, V7, P354, DOI 10.1006/mcne.1996.0026; Costa-Pereira AP, 2005, J IMMUNOL, V175, P5958, DOI 10.4049/jimmunol.175.9.5958; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Ferber IA, 1996, J IMMUNOL, V156, P5; FIETTE L, 1995, J EXP MED, V181, P2069, DOI 10.1084/jem.181.6.2069; Garcia CS, 2006, J IMMUNOL, V177, P2707, DOI 10.4049/jimmunol.177.4.2707; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; GRAHAM MB, 1993, J EXP MED, V178, P1725, DOI 10.1084/jem.178.5.1725; Greene IP, 2008, P NATL ACAD SCI USA, V105, P3575, DOI 10.1073/pnas.0712390105; GRIFFIN DE, 1977, J IMMUNOL, V118, P1070; GRIFFIN DE, 1976, J INFECT DIS, V133, P456, DOI 10.1093/infdis/133.4.456; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hausmann A, 2005, J GEN VIROL, V86, P399, DOI 10.1099/vir.0.80566-0; Hausmann J, 2005, J VIROL, V79, P13509, DOI 10.1128/JVI.79.21.13509-13518.2005; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; JACKSON AC, 1987, LAB INVEST, V56, P418; JACKSON AC, 1988, LAB INVEST, V58, P503; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kim BS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-217; Kim IJ, 2002, J NEUROSCI, V22, P4530, DOI 10.1523/JNEUROSCI.22-11-04530.2002; Kimura T, 2003, VIROLOGY, V311, P28, DOI 10.1016/S0042-6822(03)00110-7; Kimura T, 2000, J VIROL, V74, P6117, DOI 10.1128/JVI.74.13.6117-6125.2000; KOTENKO SV, 1995, J BIOL CHEM, V270, P20915, DOI 10.1074/jbc.270.36.20915; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45; Leon C, 2006, J IMMUNOL, V176, P5934, DOI 10.4049/jimmunol.176.10.5934; LEVINE B, 1991, SCIENCE, V254, P856, DOI 10.1126/science.1658936; Licinio J, 1997, J CLIN INVEST, V100, P2941, DOI 10.1172/JCI119846; Lin MT, 1997, J VIROL, V71, P383, DOI 10.1128/JVI.71.1.383-391.1997; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Liu ZQ, 2005, NEUROSCIENCE, V131, P283, DOI 10.1016/j.neuroscience.2004.10.043; Lobigs M, 2003, J GEN VIROL, V84, P567, DOI 10.1099/vir.0.18654-0; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Metcalf TU, 2011, J VIROL, V85, P11490, DOI 10.1128/JVI.05379-11; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nansen A, 1999, J IMMUNOL, V163, P6114; Nargi-Aizenman JL, 2004, ANN NEUROL, V55, P541, DOI 10.1002/ana.20033; Paessler S, 2007, VIROLOGY, V367, P307, DOI 10.1016/j.virol.2007.05.041; Park E, 2009, VIROLOGY, V388, P305, DOI 10.1016/j.virol.2009.03.031; Qing YL, 2004, J BIOL CHEM, V279, P41679, DOI 10.1074/jbc.M406413200; RAMSAY AJ, 1993, IMMUNOL TODAY, V14, P155, DOI 10.1016/0167-5699(93)90277-R; Rodriguez M, 2003, J VIROL, V77, P12252, DOI 10.1128/JVI.77.22.12252-12265.2003; Rossi CP, 1998, J VIROL, V72, P4515; Rottenberg M, 2002, VIRAL IMMUNOL, V15, P247, DOI 10.1089/08828240260066206; Rowell JF, 2002, J NEUROIMMUNOL, V127, P106, DOI 10.1016/S0165-5728(02)00108-X; Savarin C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-104; Schijns VECJ, 1996, J IMMUNOL, V157, P815; SCHIJNS VECJ, 1994, J IMMUNOL, V153, P2029; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2006, J VIROL, V80, P5338, DOI 10.1128/JVI.00274-06; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Takei Y, 2000, J AM SOC NEPHROL, V11, P250, DOI 10.1681/ASN.V112250; Tewari K, 2007, J IMMUNOL, V179, P2115, DOI 10.4049/jimmunol.179.4.2115; Thach DC, 2001, J VIROL, V75, P8674, DOI 10.1128/JVI.75.18.8674-8680.2001; Thach DC, 2000, J VIROL, V74, P6156, DOI 10.1128/JVI.74.13.6156-6161.2000; Topham DJ, 1997, J IMMUNOL, V159, P5197; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; TUCKER PC, 1993, J VIROL, V67, P4605, DOI 10.1128/JVI.67.8.4605-4610.1993; Tucker PC, 1996, J VIROL, V70, P3972, DOI 10.1128/JVI.70.6.3972-3977.1996; Turner SJ, 2007, J IMMUNOL, V178, P7616, DOI 10.4049/jimmunol.178.12.7616; UBOL S, 1994, P NATL ACAD SCI USA, V91, P5202, DOI 10.1073/pnas.91.11.5202; Wang HP, 2004, MOL CELL NEUROSCI, V27, P489, DOI 10.1016/j.mcn.2004.08.004; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007	86	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76412	10.1371/journal.pone.0076412	http://dx.doi.org/10.1371/journal.pone.0076412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204622	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300005
J	Chai, ZT; Kong, J; Zhu, XD; Zhang, YY; Lu, L; Zhou, JM; Wang, LR; Zhang, KZ; Zhang, QB; Ao, JY; Wang, M; Wu, WZ; Wang, L; Tang, ZY; Sun, HC				Chai, Zong-Tao; Kong, Jian; Zhu, Xiao-Dong; Zhang, Yuan-Yuan; Lu, Lu; Zhou, Jia-Min; Wang, Long-Rong; Zhang, Ke-Zhi; Zhang, Qiang-Bo; Ao, Jian-Yang; Wang, Miao; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan			MicroRNA-26a Inhibits Angiogenesis by Down-Regulating VEGFA through the PIK3C2 alpha/Akt/HIF-1 alpha Pathway in Hepatocellular Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; PERITUMORAL LIVER-TISSUE; TUMOR ANGIOGENESIS; HIGH EXPRESSION; METASTASIS; CANCER; HYPOXIA; MIR-26A; GENES	Background & Aims: microRNAs (miRNAs) have been reported to regulate angiogenesis by down-regulating the expression of pro-angiogenic or anti-angiogenic factors. The aims of this study were to investigate whether miR-26a inhibited angiogenesis by down-regulating vascular endothelial growth factor A (VEGFA) and its clinical relevance in hepatocellular carcinoma (HCC). Methods: The expression of miR-26a was modified in HepG2 and HCCLM3 cell lines respectively, and a panel of angiogenic factors was measured by real-time PCR in the cells. A luciferase reporter assay was used to validate the target gene of miR-26a. Specific inhibitors of signal transduction pathway and siRNA approaches were used to explore the regulatory mechanism of miR-26a. Migration and tube forming assays were conducted to show the changes of angiogenesis induced by miR-26a and its target genes. Finally animal studies were used to further validate those findings. Results: Ectopic expression of miR-26a exhibited decreased levels of VEGFA in HepG2 cells. Migration and tube forming of human umbilical vein endothelial cells (HUVECs) were decreased in the conditioned medium from ectopic expression of miR-26a in HepG2 cells compared to control HepG2 cells. The pro-angiogenic effects of the conditioned medium of HepG2 cells on HUVECs were specifically decreased by LY294002, YC-1, and bevacizumab. Integrated analysis disclosed PIK3C2 alpha as a downstream target gene of miR-26a. Ectopic expression of miR-26a suppressed ectopic and orthotopic tumor growth and vascularity in nude mice. The results in HCCLM3 were consistent with those in HepG2. miR-26a expression was inversely correlated with VEGFA expression in HCC patients. Conclusions: miR-26a modulated angiogenesis of HCC through the PIK3C2 alpha/Akt/HIF-1 alpha/VEGFA pathway. The expression of VEGFA was inversely correlated with miR-26a expression in HCC tumors.	[Chai, Zong-Tao; Zhu, Xiao-Dong; Zhang, Yuan-Yuan; Lu, Lu; Zhou, Jia-Min; Wang, Long-Rong; Zhang, Ke-Zhi; Zhang, Qiang-Bo; Wang, Miao; Wu, Wei-Zhong; Wang, Lu; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China; [Kong, Jian; Ao, Jian-Yang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China	Fudan University; Capital Medical University	Sun, HC (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Key Lab Carcinogenesis & Canc Invas,Minist Educ, Shanghai 200032, Peoples R China.	sun.huichuan@zs-hospital.sh.cn	zhang, yuanyuan/GYA-4428-2022; Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81101564, 81020108025]; Shanghai Natural Science Fund for Youth Scholars [12ZR1442300]; National Key Project for Infectious Diseases [2012ZX10002012-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Fund for Youth Scholars; National Key Project for Infectious Diseases	This project was supported by the National Natural Science Foundation of China (grant number: 81101564, 81020108025), Shanghai Natural Science Fund for Youth Scholars (12ZR1442300), the National Key Project for Infectious Diseases (2012ZX10002012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-2; Biswas K, 2013, J BIOL CHEM, V288, P2325, DOI 10.1074/jbc.M112.409656; Chen LZ, 2011, MOL THER, V19, P1521, DOI 10.1038/mt.2011.64; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jia JB, 2010, ONCOLOGIST, V15, P732, DOI 10.1634/theoncologist.2009-0170; Jiang BH, 1997, CANCER RES, V57, P5328; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma Y, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-11; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Shih TC, 2012, J HEPATOL, V57, P584, DOI 10.1016/j.jhep.2012.04.031; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Stahlhut C, 2012, DEVELOPMENT, V139, P4356, DOI 10.1242/dev.083774; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; Sun FX, 1996, INT J CANCER, V66, P239, DOI 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.3.CO;2-G; Tang ZY, 2005, J SURG ONCOL, V91, P95, DOI 10.1002/jso.20291; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WANG Y, 2012, FEBS J; Weiss L, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-38; Wu J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-30; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; YANG X, 2013, HEPATOLOGY; Yu L, 2013, ONCOL LETT, V5, P1223, DOI 10.3892/ol.2013.1173; Yu T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-64; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521; Zhu XL, 2012, ACTA BIOCH BIOPH SIN, V44, P519, DOI 10.1093/abbs/gms026; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	52	96	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77957	10.1371/journal.pone.0077957	http://dx.doi.org/10.1371/journal.pone.0077957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194905	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000084
J	Cordoba-Aguilar, A; Munguia-Steyer, R				Cordoba-Aguilar, Alex; Munguia-Steyer, Roberto			The Sicker Sex: Understanding Male Biases in Parasitic Infection, Resource Allocation and Fitness	PLOS ONE			English	Article							LIFE-HISTORY; EUGREGARINE PARASITISM; ECOLOGICAL IMMUNOLOGY; EVOLUTIONARY ECOLOGY; NATURAL-POPULATIONS; SIZE DIMORPHISM; IMMUNE DEFENSE; MATING SYSTEM; TRADE-OFFS; BODY-SIZE	The "sicker sex" idea summarizes our knowledge of sex biases in parasite burden and immune ability whereby males fare worse than females. The theoretical basis of this is that because males invest more on mating effort than females, the former pay the costs by having a weaker immune system and thus being more susceptible to parasites. Females, conversely, have a greater parental investment. Here we tested the following: a) whether both sexes differ in their ability to defend against parasites using a natural host-parasite system; b) the differences in resource allocation conflict between mating effort and parental investment traits between sexes; and, c) effect of parasitism on survival for both sexes. We used a number of insect damselfly species as study subjects. For (a), we quantified gregarine and mite parasites, and experimentally manipulated gregarine levels in both sexes during adult ontogeny. For (b), first, we manipulated food during adult ontogeny and recorded thoracic fat gain (a proxy of mating effort) and abdominal weight (a proxy of parental investment) in both sexes. Secondly for (b), we manipulated food and gregarine levels in both sexes when adults were about to become sexually mature, and recorded gregarine number. For (c), we infected male and female adults of different ages and measured their survival. Males consistently showed more parasites than females apparently due to an increased resource allocation to fat production in males. Conversely, females invested more on abdominal weight. These differences were independent of how much food/infecting parasites were provided. The cost of this was that males had more parasites and reduced survival than females. Our results provide a resource allocation mechanism for understanding sexual differences in parasite defense as well as survival consequences for each sex.	[Cordoba-Aguilar, Alex; Munguia-Steyer, Roberto] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Cordoba-Aguilar, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	acordoba@ecologia.unam.mx	Munguía-Steyer, Roberto/U-3935-2019	Munguía-Steyer, Roberto/0000-0002-2951-4684	PAPIIT UNAM [222312]; Direccion General de Asuntos del Personal Academico (PASPA-UNAM); Consejo Nacional de Ciencia y Tecnologia (Mexico)	PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Direccion General de Asuntos del Personal Academico (PASPA-UNAM); Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partly financed by a PAPIIT UNAM (Project No. 222312) grant. During analysis and manuscript preparation, AC-A had a sabbatical grant from Direccion General de Asuntos del Personal Academico (PASPA-UNAM) and Consejo Nacional de Ciencia y Tecnologia (Mexico). These funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ABRO A, 1990, Odonatologica, V19, P223; Adamo SA, 2001, ANIM BEHAV, V62, P417, DOI 10.1006/anbe.2001.1786; Andres JA, 1998, ECOL ENTOMOL, V23, P103, DOI 10.1046/j.1365-2311.1998.00125.x; ANHOLT BR, 1991, CAN J ZOOL, V69, P1156, DOI 10.1139/z91-164; Bacelar FS, 2011, J THEOR BIOL, V269, P131, DOI 10.1016/j.jtbi.2010.10.004; Benavides JA, 2012, AM J PHYS ANTHROPOL, V147, P52, DOI 10.1002/ajpa.21627; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Callander S, 2013, BEHAV ECOL, V24, P1251, DOI 10.1093/beheco/art059; Canales-Lazcano J, 2005, ODONATOLOGICA, V34, P123; Contreras-Garduno J, 2011, EVOL ECOL, V25, P845, DOI 10.1007/s10682-010-9438-6; Corallini Carla, 2002, Nova Supplementa Entomologica, V15, P9; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Cordoba-Aguilar A, 2006, J INSECT PHYSIOL, V52, P861, DOI 10.1016/j.jinsphys.2006.05.008; Cordoba-Aguilar A, 2009, BEHAVIOUR, V146, P189, DOI 10.1163/156853909X410739; Dmitriew C, 2007, CAN J ZOOL, V85, P310, DOI 10.1139/Z07-004; FORBES M R L, 1991, Oecologia (Berlin), V86, P335, DOI 10.1007/BF00317598; Forbes Mark R., 2008, P175; Forbes MR, 1999, INT J PARASITOL, V29, P991, DOI 10.1016/S0020-7519(99)00061-2; Gonzalez-Soriano E, 2001, ODONATOLOGICA, V30, P335; Gonzalez-Tokman DM, 2012, EVOLUTION, V66, P3294, DOI 10.1111/j.1558-5646.2012.01678.x; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; Hecker KR, 2002, CAN J ZOOL, V80, P162, DOI 10.1139/Z01-213; Houston AI, 2007, P ROY SOC B-BIOL SCI, V274, P2835, DOI 10.1098/rspb.2007.0934; Iserbyt A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-139; Iserbyt A, 2011, P ROY SOC B-BIOL SCI, V278, P3116, DOI 10.1098/rspb.2011.0126; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Krasnov BR, 2005, OECOLOGIA, V146, P209, DOI 10.1007/s00442-005-0189-y; Lachish S, 2011, J ANIM ECOL, V80, P1207, DOI 10.1111/j.1365-2656.2011.01893.x; Lajeunesse MJ, 2004, OIKOS, V106, P501, DOI 10.1111/j.0030-1299.2004.13076.x; Locklin JL, 2010, ODONATOLOGICA, V39, P319; Manjerovic MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038524; Marden JH, 2004, ANIM BEHAV, V68, P857, DOI 10.1016/j.anbehav.2003.09.019; MARDEN JH, 1989, PHYSIOL ZOOL, V62, P505, DOI 10.1086/physzool.62.2.30156182; McCurdy DG, 1998, OIKOS, V82, P303, DOI 10.2307/3546970; Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196; Nagel Laura, 2010, BMC Ecology, V10, P5, DOI 10.1186/1472-6785-10-5; Niemela PT, 2012, FUNCT ECOL, V26, P450, DOI 10.1111/j.1365-2435.2011.01939.x; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Pekar S, 2010, ANIM BEHAV, V79, P1301, DOI 10.1016/j.anbehav.2010.03.002; Pitala N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010814; Plaistow SJ, 2000, P ROY SOC B-BIOL SCI, V267, P969, DOI 10.1098/rspb.2000.1098; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; Poulin R, 2012, EVOL ECOL, V26, P1169, DOI 10.1007/s10682-011-9544-0; Richardson JML, 1997, OIKOS, V79, P477, DOI 10.2307/3546890; Robb Tonia, 2006, BMC Ecology, V6, P15, DOI 10.1186/1472-6785-6-15; ROBINSON J V, 1986, Odonatologica, V15, P211; Rolff J, 2002, P ROY SOC B-BIOL SCI, V269, P867, DOI 10.1098/rspb.2002.1959; Sanchez MI, 2013, PARASITOL RES, V112, P1913, DOI 10.1007/s00436-013-3347-x; Sanchez-Guillen RA, 2013, OECOLOGIA, V171, P105, DOI 10.1007/s00442-012-2388-7; Scantlebury M, 2010, J ZOOL, V282, P246, DOI 10.1111/j.1469-7998.2010.00734.x; Schilder RJ, 2006, P NATL ACAD SCI USA, V103, P18805, DOI 10.1073/pnas.0603156103; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Serrano-Meneses MA, 2008, J EVOLUTION BIOL, V21, P1259, DOI 10.1111/j.1420-9101.2008.01567.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Siva-Jothy MT, 2000, P ROY SOC B-BIOL SCI, V267, P2523, DOI 10.1098/rspb.2000.1315; Siva-Jothy MT, 1999, ECOL ENTOMOL, V24, P465, DOI 10.1046/j.1365-2311.1999.00222.x; Stoehr AM, 2006, BEHAV ECOL, V17, P751, DOI 10.1093/beheco/ark018; Stoks R, 2012, ANNU REV ENTOMOL, V57, P249, DOI 10.1146/annurev-ento-120710-100557; Taylor PD, 1996, LANDSCAPE ECOL, V11, P181, DOI 10.1007/BF02447516; Uller T, 2006, EVOL ECOL, V20, P1, DOI 10.1007/s10682-005-2006-9; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131; Zuk M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000267	64	33	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76246	10.1371/journal.pone.0076246	http://dx.doi.org/10.1371/journal.pone.0076246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194830	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000009
J	Chao, DL; Longini, IM; Halloran, ME				Chao, Dennis L.; Longini, Ira M., Jr.; Halloran, M. Elizabeth			The Effects of Vector Movement and Distribution in a Mathematical Model of Dengue Transmission	PLOS ONE			English	Article							SPACE-TIME ANALYSIS; AEDES-AEGYPTI; VIRUS TRANSMISSION; PUERTO-RICO; VACCINES; PATTERN; DISPERSAL; EFFICACY; IMMUNITY	Background: Mathematical models have been used to study the dynamics of infectious disease outbreaks and predict the effectiveness of potential mass vaccination campaigns. However, models depend on simplifying assumptions to be tractable, and the consequences of making such assumptions need to be studied. Two assumptions usually incorporated by mathematical models of vector-borne disease transmission is homogeneous mixing among the hosts and vectors and homogeneous distribution of the vectors. Methodology/Principal Findings: We explored the effects of mosquito movement and distribution in an individual-based model of dengue transmission in which humans and mosquitoes are explicitly represented in a spatial environment. We found that the limited flight range of the vector in the model greatly reduced its ability to transmit dengue among humans. A model that does not assume a limited flight range could yield similar attack rates when transmissibility of dengue was reduced by 39%. A model in which mosquitoes are distributed uniformly across locations behaves similarly to one in which the number of mosquitoes per location is drawn from an exponential distribution with a slightly higher mean number of mosquitoes per location. When the models with different assumptions were calibrated to have similar human infection attack rates, mass vaccination had nearly identical effects. Conclusions/Significance: Small changes in assumptions in a mathematical model of dengue transmission can greatly change its behavior, but estimates of the effectiveness of mass dengue vaccination are robust to some simplifying assumptions typically made in mathematical models of vector-borne disease.	[Chao, Dennis L.; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Longini, Ira M., Jr.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Longini, Ira M., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Halloran, M. Elizabeth] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle	Chao, DL (corresponding author), Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	dchao@fhcrc.org		Chao, Dennis/0000-0002-8253-6321	National Institute of General Medical Sciences [U01-GM070749]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences grant U01-GM070749. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study	Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103; Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Beatty M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001450; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; CIESIN, 2004, GLOB RUR URB MAPP PR; Coudeville L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051244; Douglas DL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002127; Durbin AP, 2011, VIRUSES-BASEL, V3, P1800, DOI 10.3390/v3101800; Dussart P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001482; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; HALLORAN ME, 1992, AM J EPIDEMIOL, V136, P328, DOI 10.1093/oxfordjournals.aje.a116498; Halloran ME., 2010, DESIGN ANAL VACCINE; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042; Konishi Eiji, 2011, Trop Med Health, V39, P63, DOI 10.2149/tmh.2011-S01; Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x; LIKOSKY WH, 1973, AM J EPIDEMIOL, V97, P264, DOI 10.1093/oxfordjournals.aje.a121508; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Minnesota Population Center, 2011, INT PUBL US MICR SER; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Teurlai M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001957; Tsuda Y, 2001, J MED ENTOMOL, V38, P93, DOI 10.1603/0022-2585-38.1.93; Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	37	20	20	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76044	10.1371/journal.pone.0076044	http://dx.doi.org/10.1371/journal.pone.0076044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204590	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600005
J	Janovsky, Z; Mikat, M; Hadrava, J; Horcickova, E; Kmecova, K; Pozarova, D; Smycka, J; Herben, T				Janovsky, Zdenek; Mikat, Michael; Hadrava, Jiri; Horcickova, Eva; Kmecova, Katerina; Pozarova, Doubravka; Smycka, Jan; Herben, Tomas			Conspecific and Heterospecific Plant Densities at Small-Scale Can Drive Plant-Pollinator Interactions	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; LOCAL-DENSITY; SIZE; LANDSCAPE; COMMUNITY; BUMBLEBEES; DIVERSITY; REPRODUCTION; VISITATION; CONSTANCY	Generalist pollinators are important in many habitats, but little research has been done on small-scale spatial variation in interactions between them and the plants that they visit. Here, using a spatially explicit approach, we examined whether multiple species of flowering plants occurring within a single meadow showed spatial structure in their generalist pollinator assemblages. We report the results for eight plant species for which at least 200 individual visits were recorded. We found that for all of these species, the proportions of their general pollinator assemblages accounted for by particular functional groups showed spatial heterogeneity at the scale of tens of metres. This heterogeneity was connected either with no or only subtle changes of vegetation and flowering species composition. In five of these species, differences in conspecific plant density influenced the pollinator communities (with greater dominance of main pollinators at low-conspecific plant densities). The density of heterospecific plant individuals influenced the pollinator spectrum in one case. Our results indicate that the picture of plant-pollinator interactions provided by averaging data within large plots may be misleading and that within-site spatial heterogeneity should be accounted for in terms of sampling effort allocation and analysis. Moreover, spatially structured plant-pollinator interactions may have important ecological and evolutionary consequences, especially for plant population biology.	[Janovsky, Zdenek; Mikat, Michael; Hadrava, Jiri; Horcickova, Eva; Smycka, Jan; Herben, Tomas] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Kmecova, Katerina] Secondary Grammar Sch Znojmo, Znojmo, Czech Republic; [Pozarova, Doubravka] Secondary Grammar Sch Rakovnik, Rakovnik, Czech Republic; [Herben, Tomas] Acad Sci Czech Republic, Inst Bot, Pruhonice By Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Janovsky, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	zdenekjanovsky@seznam.cz	Hadrava, Jiří/R-9347-2017; Herben, Tomas/G-1804-2014; Mikát, Michael/S-3418-2017; Janovský, Zdeněk/M-9818-2014; Horcickova, Eva/W-4247-2017	Hadrava, Jiří/0000-0003-3247-6399; Herben, Tomas/0000-0002-6636-0012; Mikát, Michael/0000-0001-5364-7180; Janovský, Zdeněk/0000-0002-0438-6778; Horcickova, Eva/0000-0003-2915-548X	Grant Agency of the Czech Republic [GACR P505/11/1589]; British Ecological Society [3298/4077]; Roman-Catholic Parish in Uhlirske Janovice, Czech Republic	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); British Ecological Society; Roman-Catholic Parish in Uhlirske Janovice, Czech Republic	The research was supported by Grant Agency of the Czech Republic (project no. GACR P505/11/1589; www.gacr.cz), British Ecological Society (Field Experience Grant 3298/4077; www.britishecologicalsociety.org) and Roman-Catholic Parish in Uhlirske Janovice, Czech Republic (www.farnostjanovice.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bosch M, 2001, OECOLOGIA, V126, P76, DOI 10.1007/s004420000488; Bosch M, 1999, AM J BOT, V86, P871, DOI 10.2307/2656707; Brunet J, 2006, EVOLUTION, V60, P234, DOI 10.1111/j.0014-3820.2006.tb01102.x; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chytry M, 2007, VEGETACE CESKE REPUB; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Forup ML, 2008, J APPL ECOL, V45, P742, DOI 10.1111/j.1365-2664.2007.01390.x; Forup ML, 2005, ECOL ENTOMOL, V30, P47, DOI 10.1111/j.0307-6946.2005.00660.x; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Goulson D, 2009, BUMBLEBEES BEHAV ECO; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greig-Smith P., 1983, QUANTITATIVE PLANT E; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hegland SJ, 2009, ECOL RES, V24, P929, DOI 10.1007/s11284-008-0572-3; Herrera CM, 2005, AM J BOT, V92, P13, DOI 10.3732/ajb.92.1.13; Jakobsson A, 2009, OECOLOGIA, V160, P707, DOI 10.1007/s00442-009-1346-5; Kirchner F, 2005, OIKOS, V111, P130, DOI 10.1111/j.0030-1299.2005.14022.x; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; Larsson M, 2005, OECOLOGIA, V146, P394, DOI 10.1007/s00442-005-0217-y; Lazaro A, 2008, OECOLOGIA, V157, P249, DOI 10.1007/s00442-008-1066-2; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Leps J, 2003, MULTIVARIATE ANAL EC; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Rader R, 2009, J APPL ECOL, V46, P1080, DOI 10.1111/j.1365-2664.2009.01700.x; Schuett EM, 2010, EVOL BIOL, V37, P19, DOI 10.1007/s11692-010-9082-7; SOWIG P, 1989, OECOLOGIA, V78, P550, DOI 10.1007/BF00378747; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tolasz R., 2007, ATLAS PODNEBI CESKA; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Westphal C, 2006, ECOL ENTOMOL, V31, P389, DOI 10.1111/j.1365-2311.2006.00801.x; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269	47	11	11	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77361	10.1371/journal.pone.0077361	http://dx.doi.org/10.1371/journal.pone.0077361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204818	Green Submitted, gold, Green Published			2022-12-25	WOS:000326032600032
J	Berry, JA; Hood, WM; Pietravalle, S; Delaplane, KS				Berry, Jennifer A.; Hood, W. Michael; Pietravalle, Stephane; Delaplane, Keith S.			Field-Level Sublethal Effects of Approved Bee Hive Chemicals on Honey Bees (Apis mellifera L)	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; VARROA-DESTRUCTOR; HYMENOPTERA; MITICIDES; COUMAPHOS; APIDAE; INFESTATION; FLUVALINATE; PESTICIDES; JACOBSONI	In a study replicated across two states and two years, we tested the sublethal effects on honey bees of the miticides Apistan (tau fluvalinate) and Check Mite+ (coumaphos) and the wood preservative copper naphthenate applied at label rates in field conditions. A continuous covariate, a colony Varroa mite index, helped us disambiguate the effects of the chemicals on bees while adjusting for a presumed benefit of controlling mites. Mite levels in colonies treated with Apistan or Check Mite+ were not different from levels in non-treated controls. Experimental chemicals significantly decreased 3-day brood survivorship and increased construction of queen supercedure cells compared to non-treated controls. Bees exposed to Check Mite+ as immatures had higher legacy mortality as adults relative to non-treated controls, whereas bees exposed to Apistan had improved legacy mortality relative to non-treated controls. Relative to non-treated controls, Check Mite+ increased adult emergence weight. Although there was a treatment effect on a test of associative learning, it was not possible to statistically separate the treatment means, but bees treated with Apistan performed comparatively well. And finally, there were no detected effects of bee hive chemical on colony bee population, amount of brood, amount of honey, foraging rate, time required for marked released bees to return to their nest, percentage of released bees that return to the nest, and colony Nosema spore loads. To our knowledge, this is the first study to examine sublethal effects of bee hive chemicals applied at label rates under field conditions while disambiguating the results from mite control benefits realized from the chemicals. Given the poor performance of the miticides at reducing mites and their inconsistent effects on the host, these results defend the use of bee health management practices that minimize use of exotic hive chemicals.	[Berry, Jennifer A.; Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Hood, W. Michael] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC USA; [Pietravalle, Stephane] Food & Environm Res Agcy, Sand Hutton, N Yorkshire, England	University System of Georgia; University of Georgia; Clemson University; Food & Environment Research Agency	Delaplane, KS (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	ksd@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	United States Department of Agriculture, Cooperative States Research and Education Service, Critical Issues Initiative [2008-37610-18834]	United States Department of Agriculture, Cooperative States Research and Education Service, Critical Issues Initiative	This research was funded by a primary contract (no. 2008-37610-18834) awarded to Clemson University by the United States Department of Agriculture, Cooperative States Research and Education Service, Critical Issues Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Charles I., 2011, P25; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; Burley LM, 2008, J ECON ENTOMOL, V101, P1081, DOI 10.1603/0022-0493(2008)101[1081:SOHBHA]2.0.CO;2; BUTLER C. G., 1957, INSECTES SOCIAUX, V4, P211, DOI 10.1007/BF02222154; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Collins AM, 2004, J APICULT RES, V43, P128, DOI 10.1080/00218839.2004.11101123; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; COX DR, 1972, J R STAT SOC B, V34, P187; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; DEJONG D, 1982, J APICULT RES, V21, P165, DOI 10.1080/00218839.1982.11100535; DOULL KM, 1965, J INVERTEBR PATHOL, V7, P1, DOI 10.1016/0022-2011(65)90143-6; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Hardin J., 2003, GEN ESTIMATING EQUAT; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Locke B, 2012, APPL ENVIRON MICROB, V78, P227, DOI 10.1128/AEM.06094-11; Mariani Fernando, 2012, Zootecnia Trop., V30, P081; McCullagh P, 1989, GEN LINEAR MODELS; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Murilhas AM, 2002, APIDOLOGIE, V33, P271, DOI 10.1051/apido:2002013; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pettis JS, 2004, APIDOLOGIE, V35, P91, DOI 10.1051/apido:2003060; Picard-Nizou AL, 1997, J ECON ENTOMOL, V90, P1710, DOI 10.1093/jee/90.6.1710; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rinderer TE, 1999, AM BEE J, V139, P134; Shimanuki H, 2000, USDA HDB, VAH-690, P61; Skinner JA, 2001, J APICULT RES, V40, P81, DOI 10.1080/00218839.2001.11101055; SMITH BH, 1991, J EXP BIOL, V161, P367; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; VSN International, 2012, GENSTAT WINDOWS; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	39	47	49	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76536	10.1371/journal.pone.0076536	http://dx.doi.org/10.1371/journal.pone.0076536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204638	Green Published, gold			2022-12-25	WOS:000326029300035
J	Clausen, FB; Jakobsen, TR; Rieneck, K; Krog, GR; Nielsen, LK; Tabor, A; Dziegiel, MH				Clausen, Frederik Banch; Jakobsen, Tanja Roien; Rieneck, Klaus; Krog, Grethe Risum; Nielsen, Leif Kofoed; Tabor, Ann; Dziegiel, Morten Hanefeld			Pre-Analytical Conditions in Non-Invasive Prenatal Testing of Cell-Free Fetal RHD	PLOS ONE			English	Article							MATERNAL PLASMA; PREGNANT-WOMEN; DNA DETECTION; RHESUS D; BLOOD; METHODOLOGY; REQUIREMENT; EXTRACTION; PREDICTION; DIAGNOSIS	Background: Non-invasive prenatal testing of cell-free fetal DNA (cffDNA) in maternal plasma can predict the fetal RhD type in D negative pregnant women. In Denmark, routine antenatal screening for the fetal RhD gene (RHD) directs the administration of antenatal anti-D prophylaxis only to women who carry an RhD positive fetus. Prophylaxis reduces the risk of immunization that may lead to hemolytic disease of the fetus and the newborn. The reliability of predicting the fetal RhD type depends on pre-analytical factors and assay sensitivity. We evaluated the testing setup in the Capital Region of Denmark, based on data from routine antenatal RHD screening. Methods: Blood samples were drawn at gestational age 25 weeks. DNA extracted from 1 mL of plasma was analyzed for fetal RHD using a duplex method for exon 7/10. We investigated the effect of blood sample transportation time (n = 110) and ambient outdoor temperatures (n = 1539) on the levels of cffDNA and total DNA. We compared two different quantification methods, the delta Ct method and a universal standard curve. PCR pipetting was compared on two systems (n = 104). Results: The cffDNA level was unaffected by blood sample transportation for up to 9 days and by ambient outdoor temperatures ranging from -10 degrees C to 28 degrees C during transport. The universal standard curve was applicable for cffDNA quantification. Identical levels of cffDNA were observed using the two automated PCR pipetting systems. We detected a mean of 100 fetal DNA copies/mL at a median gestational age of 25 weeks (range 10-39, n = 1317). Conclusion: The setup for real-time PCR-based, non-invasive prenatal testing of cffDNA in the Capital Region of Denmark is very robust. Our findings regarding the transportation of blood samples demonstrate the high stability of cffDNA. The applicability of a universal standard curve facilitates easy cffDNA quantification.	[Clausen, Frederik Banch; Rieneck, Klaus; Krog, Grethe Risum; Nielsen, Leif Kofoed; Dziegiel, Morten Hanefeld] Rigshosp, Copenhagen Univ Hosp, Sect 2034, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; [Jakobsen, Tanja Roien; Tabor, Ann] Rigshosp, Copenhagen Univ Hosp, Ctr Fetal Med, Dept Obstet, DK-2100 Copenhagen, Denmark; [Tabor, Ann; Dziegiel, Morten Hanefeld] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Clausen, FB (corresponding author), Rigshosp, Copenhagen Univ Hosp, Sect 2034, Dept Clin Immunol, DK-2100 Copenhagen, Denmark.	frederik.banch.clausen@rh.regionh.dk		Tabor, Ann/0000-0001-7450-1543; Nielsen, Leif Kofoed/0000-0002-6956-1821; Clausen, Frederik Banch/0000-0003-2487-5373; Dziegiel, Morten Hanefeld/0000-0001-8034-1523	Lundbeck Foundation; Blood Donors' Research Foundation; Aase and Ejnar Danielsen Foundation; Arvid Nilsson Foundation; Copenhagen University Hosiptal, Rigshospitalet; Lundbeck Foundation [R54-2010-5526] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Blood Donors' Research Foundation; Aase and Ejnar Danielsen Foundation; Arvid Nilsson Foundation; Copenhagen University Hosiptal, Rigshospitalet; Lundbeck Foundation(Lundbeckfonden)	This study was supported by The Lundbeck Foundation, The Blood Donors' Research Foundation, The Aase and Ejnar Danielsen Foundation, and The Arvid Nilsson Foundation, and Copenhagen University Hosiptal, Rigshospitalet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolekar R, 2011, FETAL DIAGN THER, V29, P301, DOI 10.1159/000322959; Angert RM, 2003, CLIN CHEM, V49, P195, DOI 10.1373/49.1.195; Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Chitty LS, 2011, ARCH DIS CHILD FE S1, V96, pFa1; Clausen FB, 2005, PRENATAL DIAG, V25, P1040, DOI 10.1002/pd.1248; Clausen FB, 2007, PRENATAL DIAG, V27, P6, DOI 10.1002/pd.1605; Clausen FB, 2012, TRANSFUSION, V52, P752, DOI 10.1111/j.1537-2995.2011.03362.x; Clausen FB, 2011, FETAL DIAGN THER, V29, P155, DOI 10.1159/000321347; Damkjaer MB, 2012, VOX SANG, V103, P145, DOI 10.1111/j.1423-0410.2012.01602.x; Daniels G, 2013, BRIT J HAEMATOL, V161, P461, DOI 10.1111/bjh.12275; Daniels G, 2010, CLIN LAB MED, V30, P431, DOI 10.1016/j.cll.2010.02.006; de, 2012, ISBT SCI SERIES, V7, P164; Faas BHW, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60534-X; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Finning K, 2004, ANN NY ACAD SCI, V1022, P119, DOI 10.1196/annals.1318.019; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2002, TRANSFUSION, V42, P1079, DOI 10.1046/j.1537-2995.2002.00165.x; Galbiati S, 2005, HUM GENET, V117, P243, DOI 10.1007/s00439-005-1330-z; Hill M, 2011, CLIN GENET, V80, P68, DOI 10.1111/j.1399-0004.2010.01533.x; Hill M, 2012, BEST PRACT RES CL OB, V26, P639, DOI 10.1016/j.bpobgyn.2012.03.004; Horinek A, 2008, FETAL DIAGN THER, V24, P15, DOI 10.1159/000132400; Hui LS, 2013, TRENDS GENET, V29, P84, DOI 10.1016/j.tig.2012.10.013; Jakobsen TR, 2012, PRENATAL DIAG, V32, P840, DOI 10.1002/pd.3917; Jakobsen TR, 2013, TRANSFUSION, V53, P1956, DOI 10.1111/trf.12073; Johnson KL, 2004, CLIN CHEM, V50, P516, DOI 10.1373/clinchem.2003.024380; Jorgez CJ, 2006, GENET MED, V8, P615, DOI 10.1097/01.gim.0000241904.32039.6f; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Metcalfe P, 2012, VOX SANG, V102, P243, DOI 10.1111/j.1423-0410.2011.01543.x; Muller SP, 2008, TRANSFUSION, V48, P2292, DOI 10.1111/j.1537-2995.2008.01843.x; Muller SP, 2011, PRENATAL DIAG, V31, P1300, DOI 10.1002/pd.2889; Randen I, 2003, VOX SANG, V85, P300, DOI 10.1111/j.0042-9007.2003.00371.x; Repiska G, 2012, CLIN CHEM LAB MED, V8, P1; Rieneck K, 2013, TRANSFUSION, V53, P2892, DOI 10.1111/trf.12172; Rijnders RJP, 2003, PRENATAL DIAG, V23, P1042, DOI 10.1002/pd.750; Scheffer PG, 2011, BJOG-INT J OBSTET GY, V118, P1340, DOI 10.1111/j.1471-0528.2011.03028.x; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Simpson JL, 2013, FERTIL STERIL, V99, P1124, DOI 10.1016/j.fertnstert.2013.02.012; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123; Van der Schoot CE, 2006, TRANSFUS CLIN BIOL, V13, P53, DOI 10.1016/j.tracli.2006.02.021; Wikman AT, 2012, OBSTET GYNECOL, V120, P227, DOI 10.1097/AOG.0b013e31825d33d9; Zhang J, 2000, ANN NY ACAD SCI, V906, P153; Zhang Y, 2008, CLIN CHIM ACTA, V397, P60, DOI 10.1016/j.cca.2008.07.017	47	34	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76990	10.1371/journal.pone.0076990	http://dx.doi.org/10.1371/journal.pone.0076990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204719	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300073
J	Downing, AS; Galic, N; Goudswaard, KPC; van Nes, EH; Scheffer, M; Witte, F; Mooij, WM				Downing, Andrea S.; Galic, Nika; Goudswaard, Kees P. C.; van Nes, Egbert H.; Scheffer, Marten; Witte, Frans; Mooij, Wolf M.			Was Lates Late? A Null Model for the Nile Perch Boom in Lake Victoria	PLOS ONE			English	Article							EAST-AFRICA; NILOTICUS L; FISHERIES; IMPACT; ECOSYSTEMS; RESURGENCE; LESSONS; TILAPIA; KYOGA; L.	Nile perch (Lates niloticus) suddenly invaded Lake Victoria between 1979 and 1987, 25 years after its introduction in the Ugandan side of the lake. Nile perch then replaced the native fish diversity and irreversibly altered the ecosystem and its role to lakeshore societies: it is now a prised export product that supports millions of livelihoods. The delay in the Nile perch boom led to a hunt for triggers of the sudden boom and generated several hypotheses regarding its growth at low abundances - all hypotheses having important implications for the management of Nile perch stocks. We use logistic growth as a parsimonious null model to predict when the Nile perch invasion should have been expected, given its growth rate, initial stock size and introduction year. We find the first exponential growth phase can explain the timing of the perch boom at the scale of Lake Victoria, suggesting that complex mechanisms are not necessary to explain the Nile perch invasion or its timing. However, the boom started in Kenya before Uganda, indicating perhaps that Allee effects act at smaller scales than that of the whole Lake. The Nile perch invasion of other lakes indicates that habitat differences may also have an effect on invasion success. Our results suggest there is probably no single management strategy applicable to the whole lake that would lead to both efficient and sustainable exploitation of its resources.	[Downing, Andrea S.; Galic, Nika; van Nes, Egbert H.; Scheffer, Marten; Mooij, Wolf M.] Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands; [Downing, Andrea S.] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Goudswaard, Kees P. C.] Wageningen UR, Inst Marine Resource & Ecosyst Studies IMARES, Yerseke, Netherlands; [Witte, Frans] Leiden Univ, Inst Biol, Leiden, Netherlands; [Mooij, Wolf M.] Netherlands Inst Ecol NIOO, Dept Aquat Ecol, Wageningen, Netherlands	Wageningen University & Research; Stockholm University; Wageningen University & Research; Leiden University; Leiden University - Excl LUMC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Downing, AS (corresponding author), Wageningen Univ, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands.	aeadowning@gmail.com	Mooij, Wolf M/C-2677-2008; van Nes, Egbert H/F-2681-2011; downing, andrea s./H-4465-2012; KNAW, NIOO-KNAW/A-4320-2012	Mooij, Wolf M/0000-0001-5586-8200; downing, andrea s./0000-0002-5206-9355; KNAW, NIOO-KNAW/0000-0002-3835-159X; Galic, Nika/0000-0002-4344-3464; van Nes, Egbert/0000-0002-6345-104X	Netherlands Organization for Scientific Research (NWO/WOTRO) [W01.65.304.00]	Netherlands Organization for Scientific Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the integrated project 'Exploitation or eutrophication as threats for fisheries? Disentangling social and ecological drivers of ecosystem changes in Lake Victoria (SEDEC)', supported by the Netherlands Organization for Scientific Research (NWO/WOTRO) grant number W01.65.304.00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIENG AP, 1990, J FISH BIOL, V37, P17, DOI 10.1111/j.1095-8649.1990.tb05016.x; Balirwa JS, 2007, AFR J ECOL, V45, P120, DOI 10.1111/j.1365-2028.2007.00753.x; Chapman LJ, 2008, INT VER THEOR ANGEW, V30, P16; Chapman LJ, 2003, CONSERV BIOL, V17, P500, DOI 10.1046/j.1523-1739.2003.01519.x; Chapman LJ, 1996, BIOL CONSERV, V78, P263, DOI 10.1016/S0006-3207(96)00030-4; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Downing AS, 2013, FRESHWATER BIOL, V58, P828, DOI 10.1111/fwb.12089; Downing AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046135; Gee J. M., 1969, Revue de Zoologie et de Botanique Africaines, V80, P244; Gee J.M, 1964, E AFRICAN FRESHWATER, P14; Goudswaard KPC, 2008, ENVIRON BIOL FISH, V81, P127, DOI 10.1007/s10641-006-9180-7; KAUFMAN L, 1992, BIOSCIENCE, V42, P846, DOI 10.2307/1312084; Kayanda R., 2009, AFR J TROP HYDROB F, V21, P15, DOI [10.4314/ajthf.v12i1.57366, DOI 10.4314/AJTHF.V12I1.57366]; Kishe-Machumu MA, 2012, HYDROBIOLOGIA, V682, P111, DOI 10.1007/s10750-011-0822-1; Kitchell JF, 1997, ECOL APPL, V7, P653; KUDHONGANIA A W, 1974, African Journal of Tropical Hydrobiology and Fisheries, V3, P15; Ligtvoet W, 1990, 1 SESS SUBC DEV MAN; Mkumbo OC, 2007, AQUAT ECOSYST HEALTH, V10, P449, DOI 10.1080/14634980701708057; Njiru M, 2007, AFR J ECOL, V45, P315, DOI 10.1111/j.1365-2028.2006.00712.x; Ogutu-Ohwayo R, 1995, IMPACT SPECIES CHANG, P59, DOI DOI 10.1007/978-94-011-0563-7_5; OGUTUOHWAYO R, 1990, ENVIRON BIOL FISH, V27, P81, DOI 10.1007/BF00001938; OGUTUOHWAYO R, 1988, HYDROBIOLOGIA, V162, P193, DOI 10.1007/BF00016667; Pitcher T.J., 1995, IMPACT SPECIES CHANG; Pringle RM, 2005, AFRICA, V75, P510, DOI 10.3366/afr.2005.75.4.510; Pringle RM, 2005, BIOSCIENCE, V55, P780, DOI 10.1641/0006-3568(2005)055[0780:TOOTNP]2.0.CO;2; Taylor CM, 2005, ECOL LETT, V8, P895, DOI 10.1111/j.1461-0248.2005.00787.x; Van Zwieten P. A. M., 2011, REV TROPICAL RESERVO; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters C, 1997, REV FISH BIOL FISHER, V7, P139, DOI 10.1023/A:1018479526149; Witte F, 2007, T AM FISH SOC, V136, P1146, DOI 10.1577/T05-179.1; Witte F, 2000, REV FISH BIOL FISHER, V10, P233, DOI 10.1023/A:1016677515930; WITTE F, 1995, IMPACT SPECIES CHANG, P83; Witte F., 1995, HDB FIELD OBSERVATIO	34	15	16	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76847	10.1371/journal.pone.0076847	http://dx.doi.org/10.1371/journal.pone.0076847			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204684	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300053
J	Laugier, GJM; Le Moguedec, G; Tayeh, A; Loiseau, A; Osawa, N; Estoup, A; Facon, B				Laugier, Guillaume J. M.; Le Moguedec, Gilles; Tayeh, Ashraf; Loiseau, Anne; Osawa, Naoya; Estoup, Arnaud; Facon, Benoit			Increase in Male Reproductive Success and Female Reproductive Investment in Invasive Populations of the Harlequin Ladybird Harmonia axyridis	PLOS ONE			English	Article							GENETIC-VARIATION; BIOLOGICAL INVASION; SPERM COMPETITION; SEXUAL SELECTION; DROSOPHILA-MELANOGASTER; INBREEDING DEPRESSION; ADAPTIVE EVOLUTION; PALLAS COLEOPTERA; PLANT; COCCINELLIDAE	Reproductive strategy affects population dynamics and genetic parameters that can, in turn, affect evolutionary processes during the course of biological invasion. Life-history traits associated with reproductive strategy are therefore potentially good candidates for rapid evolutionary shifts during invasions. In a series of mating trials, we examined mixed groups of four males from invasive and native populations of the harlequin ladybird Harmonia axyridis mating freely during 48 hours with one female of either type. We recorded the identity of the first male to copulate and after the 48 h-period, we examined female fecundity and share of paternity, using molecular markers. We found that invasive populations have a different profile of male and female reproductive output. Males from invasive populations are more likely to mate first and gain a higher proportion of offspring with both invasive and native females. Females from invasive populations reproduce sooner, lay more eggs, and have offspring sired by a larger number of fathers than females from native populations. We found no evidence of direct inbreeding avoidance behaviour in both invasive and native females. This study highlights the importance of investigating evolutionary changes in reproductive strategy and associated traits during biological invasions.	[Laugier, Guillaume J. M.; Tayeh, Ashraf; Loiseau, Anne; Estoup, Arnaud; Facon, Benoit] INRA, Ctr Biol Gest Populat, F-34060 Montpellier, France; [Le Moguedec, Gilles] INRA, Bot & Bioinformat Architecture Plantes, F-34060 Montpellier, France; [Osawa, Naoya] Kyoto Univ, Grad Sch Agr, Lab Forest Ecol, Kyoto, Japan	INRAE; Institut de Recherche pour le Developpement (IRD); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Kyoto University	Laugier, GJM (corresponding author), INRA, Ctr Biol Gest Populat, F-34060 Montpellier, France.	guillaume.laugier@supagro.inra.fr	Osawa, Naoya/ABG-1684-2020	Osawa, Naoya/0000-0002-6355-1948	Agropolis Fondation ["BIOFIS" 1001-001]	Agropolis Fondation	This work was supported by Agropolis Fondation under the reference ID "BIOFIS" 1001-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Barrett SCH, 2008, MOL ECOL, V17, P373, DOI 10.1111/j.1365-294X.2007.03503.x; Barry KL, 2011, EVOL ECOL, V25, P107, DOI 10.1007/s10682-010-9384-3; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BIRKHEAD TR, 1990, TRENDS ECOL EVOL, V5, P48, DOI 10.1016/0169-5347(90)90047-H; Blair AC, 2004, ECOLOGY, V85, P3035, DOI 10.1890/04-0341; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Brown JS, 2005, AM J BOT, V92, P495, DOI 10.3732/ajb.92.3.495; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; Bufford JL, 2011, ENCY BIOL INVASIONS; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Carroll SP, 1995, ANIM BEHAV, V50, P1463, DOI 10.1016/0003-3472(95)80003-4; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; CRAWLEY MJ, 1987, WHAT MAKES COMMUNITY, P00429; Daehler CC, 1998, EVOL ECOL, V12, P553, DOI 10.1023/A:1006556709662; DALY M, 1978, AM NAT, V112, P771, DOI 10.1086/283319; Danzmann RG, 1997, J HERED, V88, P333, DOI 10.1093/oxfordjournals.jhered.a023112; Davis HG, 2005, EVOL ECOL, V19, P255, DOI 10.1007/s10682-005-0912-5; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Elam DR, 2007, P NATL ACAD SCI USA, V104, P549, DOI 10.1073/pnas.0607306104; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Facon B, 2011, EVOL APPL, V4, P71, DOI 10.1111/j.1752-4571.2010.00134.x; Fedina TY, 2008, BIOL REV, V83, P151, DOI 10.1111/j.1469-185X.2008.00037.x; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Head ML, 2005, PLOS BIOL, V3, P289, DOI 10.1371/journal.pbio.0030033; HOGLUND J, 1998, COST REPROD SEXUAL S, V83, P478; Horvitz CC, 2011, ENCY BIOL INVASIONS, P147; House CM, 2006, BEHAV ECOL SOCIOBIOL, V60, P131, DOI 10.1007/s00265-005-0149-x; Jullien B, 2000, J POLIT ECON, V108, P503, DOI 10.1086/262127; Kanarek AR, 2010, EVOL APPL, V3, P122, DOI 10.1111/j.1752-4571.2009.00112.x; Kirkpatrick M, 2000, AM NAT, V155, P154, DOI 10.1086/303312; Kolbe JJ, 2007, CONSERV BIOL, V21, P1612, DOI 10.1111/j.1523-1739.2007.00826.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lee CE, 2011, ENCY BIOL INVASIONS; Loiseau A, 2009, MOL ECOL RESOUR, V9, P934, DOI 10.1111/j.1755-0998.2009.02517.x; Lombaert E, 2011, SYSTEMES INTEGRES BI; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MAC ARTHUR ROBERT H., 1967; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; OBATA S, 1987, APPL ENTOMOL ZOOL, V22, P434, DOI 10.1303/aez.22.434; Osawa N, 2000, POPUL ECOL, V42, P115, DOI 10.1007/PL00011990; OSAWA N, 1994, J ETHOL, V12, P63, DOI 10.1007/BF02350081; Pardoe I, 2008, J R STAT SOC A STAT, V171, P375, DOI 10.1111/j.1467-985X.2007.00518.x; PARKER GA, 1978, ANNU REV ENTOMOL, V23, P173, DOI 10.1146/annurev.en.23.010178.001133; Parker MA, 2002, J EVOLUTIONARY BIOL, V7, P567; Pattarini JA, 2006, EVOLUTION, V60, P2064, DOI 10.1111/j.0014-3820.2006.tb01844.x; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Pischedda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031683; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2012, R LANG ENV STAT COMP; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Reznik SY, 2011, EUR J ENTOMOL, V108, P385, DOI 10.14411/eje.2011.048; Shen Z, 2011, J MOUNTAIN AGR BIOL, V1; Simmons LW, 2007, MOL ECOL, V16, P4613, DOI 10.1111/j.1365-294X.2007.03528.x; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Stathas GJ, 2001, EUR J ENTOMOL, V98, P547, DOI 10.14411/eje.2001.069; Tayeh A, 2013, ECOLOGY EVOLUTION; Tobin PC, 2007, ECOL LETT, V10, P36, DOI 10.1111/j.1461-0248.2006.00991.x; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Ueno H, 1998, FUNCT ECOL, V12, P757, DOI 10.1046/j.1365-2435.1998.00245.x; UENO H, 1994, J ETHOL, V12, P169, DOI 10.1007/BF02350061; Ueno H, 1996, APPL ENTOMOL ZOOL, V31, P621, DOI 10.1303/aez.31.621; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Wang S, 2009, ECOL ENTOMOL, V34, P483, DOI 10.1111/j.1365-2311.2008.01075.x; Whitlock MC, 2009, LIKELIHOOD, P567	74	22	24	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77083	10.1371/journal.pone.0077083	http://dx.doi.org/10.1371/journal.pone.0077083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204741	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300081
J	Liu, JY; Chen, YC; Lin, CH; Kao, SH				Liu, Jer-Yuh; Chen, Yi-Ching; Lin, Chun-Hsiang; Kao, Shao-Hsuan			Perilla frutescens Leaf Extract Inhibits Mite Major Allergen Der p 2-induced Gene Expression of Pro-Allergic and Pro-Inflammatory Cytokines in Human Bronchial Epithelial Cell BEAS-2B	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; P38 MAPK; ACTIVATION; ASTHMA; IL-6; INTERLEUKIN-8; RELEASE; HYPERRESPONSIVENESS; PATHOGENESIS	Perilla frutescens has been used in traditional medicine for respiratory diseases due to its anti-bacterial and anti-inflammatory activity. This study aimed to investigate effects of Perilla frutescens leaf extract (PFE) on expression of pro-allergic and pro-inflammatory cytokines in airway epithelial cells exposed to mite major allergen Der p 2 (DP2) and the underlying mechanisms. Our results showed that PFE up to 100 mg/mL had no cytotoxic effect on human bronchial epithelial cell BEAS-2B. Further investigations revealed that PFE dose-dependently diminished mRNA expression of pro-allergic cytokine IL-4, IL-5, IL-13 and GM-CSF, as well as pro-inflammatory cytokine IL-6, IL-8 and MCP-1 in BEAS-2B cells treated with DP2. In parallel to mRNA, the DP-2-elevated levels of the tested cytokines were decreased. Further investigation showed that DP2-indued phosphorylation of p38 MAPK (P38) and JNK, but not Erk1/2, was also suppressed by PFE. In addition, PFE elevated cytosolic I kappa B alpha level and decreased nuclear NF-kappa B level in DP2-stimulated BEAS-2B cells. Taken together, these findings revealed that PFE significantly diminished both mRNA expression and protein levels of pro-allergic and pro-inflammatory cytokines in response to DP2 through inhibition of P38/JNK and NK-kappa B activation. These findings suggest that PFE should be beneficial to alleviate both allergic and inflammatory responses on airway epithelium in response to aeroallergens.	[Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Chen, Yi-Ching; Lin, Chun-Hsiang; Kao, Shao-Hsuan] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Kao, Shao-Hsuan] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Kao, SH (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	kaosh@csmu.edu.tw	Kao, Shao-Hsuan/I-3875-2019		National Science Council [NSC99-2320-B040-003-MY3, NSC99-2632-B040-001-MY3]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC99-2320-B040-003-MY3, NSC99-2632-B040-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BARNES PJ, 1989, J ALLERGY CLIN IMMUN, V83, P1013, DOI 10.1016/0091-6749(89)90441-7; Benson M, 1999, PEDIATR ALLERGY IMMU, V10, P178; Bhat RK, 2003, CLIN EXP ALLERGY, V33, P35, DOI 10.1046/j.1365-2222.2002.01481.x; Blau H, 2007, AM J PHYSIOL-LUNG C, V292, pL343, DOI 10.1152/ajplung.00030.2006; Chow AWM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012091; Douillet CD, 2006, AM J PHYSIOL-LUNG C, V291, pL734, DOI 10.1152/ajplung.00389.2005; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Graness A, 2002, J BIOL CHEM, V277, P18440, DOI 10.1074/jbc.M200468200; Heo JC, 2011, INT J MOL MED, V28, P733, DOI 10.3892/ijmm.2011.763; Hill AT, 1999, AM J RESP CRIT CARE, V160, P893, DOI 10.1164/ajrccm.160.3.9901091; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; Ingram JL, 2012, J ALLERGY CLIN IMMUN, V130, P829, DOI 10.1016/j.jaci.2012.06.034; Jeffery Peter K, 2004, Proc Am Thorac Soc, V1, P176, DOI 10.1513/pats.200402-009MS; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Liu YH, 2005, INT ARCH ALLERGY IMM, V138, P161, DOI 10.1159/000088438; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Makino T, 1999, NEPHRON, V83, P40, DOI 10.1159/000045471; Martin Thomas R, 2005, Proc Am Thorac Soc, V2, P403, DOI 10.1513/pats.200508-090JS; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Natarajan R, 2002, FREE RADICAL BIO MED, V32, P1033, DOI 10.1016/S0891-5849(02)00813-4; Oh HA, 2011, EXP BIOL MED, V236, P99, DOI 10.1258/ebm.2010.010252; Osterlund C, 2009, CLIN EXP ALLERGY, V39, P1199, DOI 10.1111/j.1365-2222.2009.03284.x; Park SY, 2009, J BIOL CHEM, V284, P20099, DOI 10.1074/jbc.M109.010017; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; Profita M, 2008, EUR J PHARMACOL, V582, P145, DOI 10.1016/j.ejphar.2007.12.029; Rahman I, 2004, BIOCHEM PHARMACOL, V68, P1255, DOI 10.1016/j.bcp.2004.05.042; Roschmann KIL, 2011, CLIN EXP ALLERGY, V41, P830, DOI 10.1111/j.1365-2222.2011.03713.x; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Schneider D, 2013, AM J PHYSIOL-LUNG C, V304, pL162, DOI 10.1152/ajplung.00182.2012; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; Shin TY, 2000, IMMUNOPHARM IMMUNOT, V22, P489, DOI 10.3109/08923970009026007; SOLOPERTO M, 1991, AM J PHYSIOL, V260, pL530, DOI 10.1152/ajplung.1991.260.6.L530; Strieter RM, 2002, J CLIN INVEST, V109, P699, DOI 10.1172/JCI200215277; Thomas WR, 1998, ALLERGY, V53, P821, DOI 10.1111/j.1398-9995.1998.tb03987.x; Ueda H, 2001, BIOSCI BIOTECH BIOCH, V65, P1673, DOI 10.1271/bbb.65.1673; Ueda H, 1997, BIOSCI BIOTECH BIOCH, V61, P1292, DOI 10.1271/bbb.61.1292; Wang CB, 2005, ALLERGY, V60, P1378, DOI 10.1111/j.1398-9995.2005.00884.x; Wang WC, 2011, J CELL BIOCHEM, V112, P1544, DOI 10.1002/jcb.23067; Zhu Z, 2002, J IMMUNOL, V168, P2953, DOI 10.4049/jimmunol.168.6.2953	45	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77458	10.1371/journal.pone.0077458	http://dx.doi.org/10.1371/journal.pone.0077458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204835	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300098
J	Ryan, SJ; Jones, JH; Dobson, AP				Ryan, Sadie J.; Jones, James H.; Dobson, Andrew P.			Interactions between Social Structure, Demography, and Transmission Determine Disease Persistence in Primates	PLOS ONE			English	Article							INFECTIOUS-DISEASES; MODELS; SPREAD; EXTINCTION; PATHOGENS; DYNAMICS; PATTERNS; INVASION; DECLINE	Catastrophic declines in African great ape populations due to disease outbreaks have been reported in recent years, yet we rarely hear of similar disease impacts for the more solitary Asian great apes, or for smaller primates. We used an age-structured model of different primate social systems to illustrate that interactions between social structure and demography create 'dynamic constraints' on the pathogens that can establish and persist in primate host species with different social systems. We showed that this varies by disease transmission mode. Sexually transmitted infections (STIs) require high rates of transmissibility to persist within a primate population. In particular, for a unimale social system, STIs require extremely high rates of transmissibility for persistence, and remain at extremely low prevalence in small primates, but this is less constrained in longer-lived, larger-bodied primates. In contrast, aerosol transmitted infections (ATIs) spread and persist at high prevalence in medium and large primates with moderate transmissibility;, establishment and persistence in small-bodied primates require higher relative rates of transmissibility. Intragroup contact structure - the social network - creates different constraints for different transmission modes, and our model underscores the importance of intragroup contacts on infection prior to intergroup movement in a structured population. When alpha males dominate sexual encounters, the resulting disease transmission dynamics differ from when social interactions are dominated by mother-infant grooming events, for example. This has important repercussions for pathogen spread across populations. Our framework reveals essential social and demographic characteristics of primates that predispose them to different disease risks that will be important for disease management and conservation planning for protected primate populations.	[Ryan, Sadie J.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Ryan, Sadie J.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Dept Immunol & Microbiol, Syracuse, NY 13210 USA; [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Dept Agr Engn & Sci, Pietermaritzburg, South Africa; [Jones, James H.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dobson, Andrew P.] Santa Fe Inst, Santa Fe, NM 87501 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Kwazulu Natal; Stanford University; Princeton University; The Santa Fe Institute	Ryan, SJ (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.	sjryan@esf.edu	Ryan, Sadie Jane/H-7488-2019	Ryan, Sadie Jane/0000-0002-4308-6321; Jones, James/0000-0003-1680-6757	NSF Bioinformatics Fellowship [0630709]; James S. McDonnell Foundation; NSF [EF-0553768]; University of California, Santa Barbara; State of California	NSF Bioinformatics Fellowship; James S. McDonnell Foundation; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California	This work was supported by an NSF Bioinformatics Fellowship #0630709 to SJR. APD was supported by the James S. McDonnell Foundation. This work was also conducted while SJR was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS SC, 1995, AM NAT, V145, P279, DOI 10.1086/285740; ANDERSON R M, 1991; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Cable JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001130; Charnov Eric L., 1993, Evolutionary Anthropology, V1, P191, DOI 10.1002/evan.1360010604; Corner LAL, 2003, PREV VET MED, V59, P147, DOI 10.1016/S0167-5877(03)00075-8; Craft ME, 2008, J ANIM ECOL, V77, P1257, DOI 10.1111/j.1365-2656.2008.01410.x; Cross PC, 2007, J R SOC INTERFACE, V4, P315, DOI 10.1098/rsif.2006.0185; Cross PC, 2005, ECOL LETT, V8, P587, DOI 10.1111/j.1461-0248.2005.00760.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DOBSON AP, 1992, J ANIM ECOL, V61, P487, DOI 10.2307/5339; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eames KTD, 2002, P NATL ACAD SCI USA, V99, P13330, DOI 10.1073/pnas.202244299; Eames KTD, 2008, THEORETICAL POPULATI, V73, P111; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2000, SEX TRANSM DIS, V27, P600, DOI 10.1097/00007435-200011000-00008; Gerber LR, 2005, ECOL APPL, V15, P1402, DOI 10.1890/04-0880; GETZ WM, 1983, AM NAT, V121, P892, DOI 10.1086/284112; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; GRENFELL BT, 1992, J ROY STAT SOC B MET, V54, P383; Harvey P.H., 1987, P181; Heesterbeek J. A. P., 1995, P90, DOI 10.1017/CBO9780511629396.004; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; HESS GR, 1994, CONSERV BIOL, V8, P256, DOI 10.1046/j.1523-1739.1994.08010256.x; Hess GR, 1996, AM NAT, V148, P226, DOI 10.1086/285922; Holt RD, 2003, ECOL LETT, V6, P837, DOI 10.1046/j.1461-0248.2003.00501.x; Jones J.H., 2008, EXPLAINING CULTURE S; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Marshall AR, 2005, INT J PRIMATOL, V26, P127, DOI 10.1007/s10764-005-0011-z; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; McCallum H, 2006, CONNECTIVITY CONSERV; MORRIS M, 1991, MATH BIOSCI, V107, P349, DOI 10.1016/0025-5564(91)90014-A; Morris M., 1995, EPIDEMIC MODELS THEI; Morris M, 1996, MODELS INFECT HUMAN; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pusey A.E., 1992, P243; Richard AF, 1985, PRIMATES NATURE; Roberts M, 1993, Trends Microbiol, V1, P343, DOI 10.1016/0966-842X(93)90075-3; Ryan SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029030; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wolfe N., 2005, EMERGING INFECT DIS, V11; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447; WRANGHAM RW, 1979, SOC SCI INFORM, V18, P335; [No title captured]	54	10	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76863	10.1371/journal.pone.0076863	http://dx.doi.org/10.1371/journal.pone.0076863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204688	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300057
J	Weegman, BP; Nash, P; Carlson, AL; Voltzke, KJ; Geng, ZH; Jahani, M; Becker, BB; Papas, KK; Firpo, MT				Weegman, Bradley P.; Nash, Peter; Carlson, Alexandra L.; Voltzke, Kristin J.; Geng, Zhaohui; Jahani, Marjan; Becker, Benjamin B.; Papas, Klearchos K.; Firpo, Meri T.			Nutrient Regulation by Continuous Feeding Removes Limitations on Cell Yield in the Large-Scale Expansion of Mammalian Cell Spheroids	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BIOARTIFICIAL PANCREAS; CULTURE; OXYGEN; OPTIMIZATION; BIOREACTORS; SECRETION; LINES	Cellular therapies are emerging as a standard approach for the treatment of several diseases. However, realizing the promise of cellular therapies across the full range of treatable disorders will require large-scale, controlled, reproducible culture methods. Bioreactor systems offer the scale-up and monitoring needed, but standard stirred bioreactor cultures do not allow for the real-time regulation of key nutrients in the medium. In this study, beta-TC6 insulinoma cells were aggregated and cultured for 3 weeks as a model of manufacturing a mammalian cell product. Cell expansion rates and medium nutrient levels were compared in static, stirred suspension bioreactors (SSB), and continuously fed (CF) SSB. While SSB cultures facilitated increased culture volumes, no increase in cell yields were observed, partly due to limitations in key nutrients, which were consumed by the cultures between feedings, such as glucose. Even when glucose levels were increased to prevent depletion between feedings, dramatic fluctuations in glucose levels were observed. Continuous feeding eliminated fluctuations and improved cell expansion when compared with both static and SSB culture methods. Further improvements in growth rates were observed after adjusting the feed rate based on calculated nutrient depletion, which maintained physiological glucose levels for the duration of the expansion. Adjusting the feed rate in a continuous medium replacement system can maintain the consistent nutrient levels required for the large-scale application of many cell products. Continuously fed bioreactor systems combined with nutrient regulation can be used to improve the yield and reproducibility of mammalian cells for biological products and cellular therapies and will facilitate the translation of cell culture from the research lab to clinical applications.	[Weegman, Bradley P.; Nash, Peter; Carlson, Alexandra L.; Voltzke, Kristin J.; Geng, Zhaohui; Jahani, Marjan; Becker, Benjamin B.; Firpo, Meri T.] Univ Minnesota, Dept Med, Div Endocrinol, Stem Cell Inst, Minneapolis, MN 55455 USA; [Weegman, Bradley P.; Nash, Peter; Carlson, Alexandra L.; Voltzke, Kristin J.; Geng, Zhaohui; Jahani, Marjan; Becker, Benjamin B.; Papas, Klearchos K.; Firpo, Meri T.] Univ Minnesota, Dept Surg, Schulze Diabet Inst, Minneapolis, MN 55455 USA; [Papas, Klearchos K.] Univ Arizona, Dept Surg, Inst Cellular Transplantat, Tucson, AZ USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Arizona	Firpo, MT (corresponding author), Univ Minnesota, Dept Med, Div Endocrinol, Stem Cell Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	firpo001@umn.edu			Richard M. Schulze Family Foundation	Richard M. Schulze Family Foundation	This research was funded by the Richard M. Schulze Family Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptista RP, 2013, BIOTECHNOL BIOENG, V110, P648, DOI 10.1002/bit.24717; Campos C, 2012, POSTGRAD MED, V124, P90, DOI 10.3810/pgm.2012.11.2615; Dazey B, 2005, STEM CELLS DEV, V14, P6, DOI 10.1089/scd.2005.14.6; De Coppi P, 2013, J PEDIATR SURG, V48, P273, DOI 10.1016/j.jpedsurg.2012.11.005; Eve DJ, 2010, MED SCI MONITOR, V16, pRA197; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Galvez J, 2012, J BIOTECHNOL, V157, P214, DOI 10.1016/j.jbiotec.2011.11.007; Gastens MH, 2007, CELL TRANSPLANT, V16, P685, DOI 10.3727/000000007783465172; HAY RJ, 1991, DEV BIOLOGICALS, V75, P193; Hsiao LC, 2013, CELL TRANSP IN PRESS; HU WS, 1994, CYTOTECHNOLOGY, V14, P155, DOI 10.1007/BF00749611; Kehoe DE, 2010, TISSUE ENG PT A, V16, P405, DOI [10.1089/ten.tea.2009.0454, 10.1089/ten.TEA.2009.0454]; Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402; KNAACK D, 1994, DIABETES, V43, P1413, DOI 10.2337/diabetes.43.12.1413; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Liu H, 2009, J BIOSCI BIOENG, V107, P524, DOI 10.1016/j.jbiosc.2009.01.004; Lock LT, 2011, J BIOTECHNOL, V151, P278, DOI 10.1016/j.jbiotec.2010.12.015; Marchenko S, 2007, J VIS EXP, V262; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Moos Malcolm Jr, 2008, Trends Pharmacol Sci, V29, P591, DOI 10.1016/j.tips.2008.09.003; Murdoch TB, 2004, CELL TRANSPLANT, V13, P605, DOI 10.3727/000000004783983602; Naing MW, 2011, CYTOTHERAPY, V13, P391, DOI 10.3109/14653249.2011.556352; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x; Olmer R, 2012, TISSUE ENG PART C-ME, V18, P772, DOI 10.1089/ten.tec.2011.0717; Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219; Papas KK, 1999, BIOTECHNOL BIOENG, V66, P231, DOI 10.1002/(SICI)1097-0290(1999)66:4<231::AID-BIT4>3.0.CO;2-U; Papas KK, 1997, BIOCHEM J, V326, P807, DOI 10.1042/bj3260807; PAPAS KK, 1993, CYTOTECHNOLOGY, V13, P1, DOI 10.1007/BF00749970; PAPAS KK, 1992, THESIS GEORGIA I TEC; Poitout V, 1996, DIABETES METAB, V22, P7; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; REUVENY S, 1986, J IMMUNOL METHODS, V86, P53, DOI 10.1016/0022-1759(86)90264-4; SAMBANIS A, 1994, CYTOTECHNOLOGY, V15, P351, DOI 10.1007/BF00762410; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Shafa M, 2011, J TISSUE ENG REGEN M, V6, P4; Sharma S, 2011, BIOTECHNOL J, V6, P1317, DOI 10.1002/biot.201000435; Sidoli FR, 2004, CYTOTECHNOLOGY, V44, P27, DOI 10.1023/B:CYTO.0000043397.94527.84; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Stacey GN, 2011, METHODS MOL BIOL, V731, P79, DOI 10.1007/978-1-61779-080-5_7; Suzuki R, 2002, LIFE SCI, V71, P1717, DOI 10.1016/S0024-3205(02)01724-1; TARLETON RL, 1991, BIOTECHNIQUES, V11, P590; Trabelsi K, 2012, APPL MICROBIOL BIOT, V93, P1031, DOI 10.1007/s00253-011-3574-y; TZIAMPAZIS E, 1994, CYTOTECHNOLOGY, V14, P191, DOI 10.1007/BF00749616; Woodside SM, 1998, CYTOTECHNOLOGY, V28, P163, DOI 10.1023/A:1008050202561; Yim R, 2005, TRANSFUSION, V45, pS144, DOI 10.1111/j.1537-2995.2005.00616.x; Zhi ZL, 2010, BIOMACROMOLECULES, V11, P610, DOI 10.1021/bm901152k; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	48	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76611	10.1371/journal.pone.0076611	http://dx.doi.org/10.1371/journal.pone.0076611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204645	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300040
J	Whyte, JL; Smith, AA; Liu, B; Manzano, WR; Evans, ND; Dhamdhere, GR; Fang, MY; Chang, HY; Oro, AE; Helms, JA				Whyte, Jemima L.; Smith, Andrew A.; Liu, Bo; Manzano, Wilfred R.; Evans, Nick D.; Dhamdhere, Girija R.; Fang, Mark Y.; Chang, Howard Y.; Oro, Anthony E.; Helms, Jill A.			Augmenting Endogenous Wnt Signaling Improves Skin Wound Healing	PLOS ONE			English	Article							HAIR FOLLICLE; BETA-CATENIN; STEM-CELLS; PROLIFERATION; TRANSCRIPTION; REGENERATION; ACTIVATION; GROWTH; ROLES; AXIN2	Wnt signaling is required for both the development and homeostasis of the skin, yet its contribution to skin wound repair remains controversial. By employing Axin2(LacZ/+) reporter mice we evaluated the spatial and temporal distribution patterns of Wnt responsive cells, and found that the pattern of Wnt responsiveness varies with the hair cycle, and correlates with wound healing potential. Using Axin2(LacZ/LacZ) mice and an ear wound model, we demonstrate that amplified Wnt signaling leads to improved healing. Utilizing a biochemical approach that mimics the amplified Wnt response of Axin2(LacZ/LacZ) mice, we show that topical application of liposomal Wnt3a to a non-healing wound enhances endogenous Wnt signaling, and results in better skin wound healing. Given the importance of Wnt signaling in the maintenance and repair of skin, liposomal Wnt3a may have widespread application in clinical practice.	[Whyte, Jemima L.; Smith, Andrew A.; Liu, Bo; Manzano, Wilfred R.; Evans, Nick D.; Dhamdhere, Girija R.; Fang, Mark Y.; Helms, Jill A.] Stanford Univ, Div Plast & Reconstruct Surg, Dept Surg, Stanford Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.; Oro, Anthony E.] Stanford Univ, Dept Dermatol, Stanford Sch Med, Stanford, CA 94305 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Helms, JA (corresponding author), Stanford Univ, Div Plast & Reconstruct Surg, Dept Surg, Stanford Sch Med, Stanford, CA 94305 USA.	aasmith@stanford.edu		Helms, Jill/0000-0002-0463-396X; Evans, Nicholas/0000-0002-3255-4388; Oro, Anthony/0000-0002-6261-138X; Smith, Andrew/0000-0003-1307-4677	California Institute for Regenerative Medicine (CIRM); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054780] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Scleroderma Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by grants from the California Institute for Regenerative Medicine (CIRM) to JAH, AO, and HYC. AAS is a CIRM Bridges Scholar. HYC is also supported by Scleroderma Research Foundation, and is an Early Career Scientist of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber C, 2011, J INVEST DERMATOL, V131, P278, DOI 10.1038/jid.2010.409; Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; CHANG J, 1995, AESTHET PLAST SURG, V19, P237, DOI 10.1007/BF00451096; Chen DM, 2012, DEVELOPMENT, V139, P1522, DOI 10.1242/dev.076463; Chua AWC, 2011, J INVEST DERMATOL, V131, P644, DOI 10.1038/jid.2010.371; Clark RAF, 1988, MOL CELLULAR BIOL WO, Vxxii; Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8; DasGupta R, 1999, DEVELOPMENT, V126, P4557; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Helms JA, 1996, DEVELOPMENT, V122, P1385; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kabashima K, 2010, AM J PATHOL, V176, P721, DOI 10.2353/ajpath.2010.090454; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kishimoto J, 2000, GENE DEV, V14, P1181; KSANDER GA, 1977, PLAST RECONSTR SURG, V59, P398, DOI 10.1097/00006534-197703000-00015; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Oro AE, 2003, DEV BIOL, V255, P238, DOI 10.1016/S0012-1606(02)00042-8; Osorio KM, 2011, J CELL BIOL, V193, P235, DOI 10.1083/jcb.201006068; Ouhtit A, 2000, AM J PATHOL, V156, P201, DOI 10.1016/S0002-9440(10)64720-7; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Seifert AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032875; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sumiyoshi K, 2004, J INVEST DERMATOL, V123, P229, DOI 10.1111/j.0022-202X.2004.22730.x; Tanaka EM, 2012, NATURE, V489, P508, DOI 10.1038/489508a; Telgenhoff D, 2005, CELL DEATH DIFFER, V12, P695, DOI 10.1038/sj.cdd.4401632; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Zhao L, 2009, METHOD ENZYMOL, V465, P331, DOI 10.1016/S0076-6879(09)65017-5	48	48	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76883	10.1371/journal.pone.0076883	http://dx.doi.org/10.1371/journal.pone.0076883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204695	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000326029300061
J	Gasche, L; Mahevas, S; Marchal, P				Gasche, Loic; Mahevas, Stephanie; Marchal, Paul			Supporting Fisheries Management by Means of Complex Models: Can We Point out Isles of Robustness in a Sea of Uncertainty?	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; ISIS-FISH; CONSERVATION BIOLOGY; DECISION-MAKING; INFERENCE; IMPACT; RECRUITMENT; DEFINITION; STRATEGIES; FRAMEWORK	Ecosystems are usually complex, nonlinear and strongly influenced by poorly known environmental variables. Among these systems, marine ecosystems have high uncertainties: marine populations in general are known to exhibit large levels of natural variability and the intensity of fishing efforts can change rapidly. These uncertainties are a source of risks that threaten the sustainability of both fish populations and fishing fleets targeting them. Appropriate management measures have to be found in order to reduce these risks and decrease sensitivity to uncertainties. Methods have been developed within decision theory that aim at allowing decision making under severe uncertainty. One of these methods is the information-gap decision theory. The info-gap method has started to permeate ecological modelling, with recent applications to conservation. However, these practical applications have so far been restricted to simple models with analytical solutions. Here we implement a deterministic approach based on decision theory in a complex model of the Eastern English Channel. Using the ISIS-Fish modelling platform, we model populations of sole and plaice in this area. We test a wide range of values for ecosystem, fleet and management parameters. From these simulations, we identify management rules controlling fish harvesting that allow reaching management goals recommended by ICES (International Council for the Exploration of the Sea) working groups while providing the highest robustness to uncertainties on ecosystem parameters.	[Gasche, Loic; Mahevas, Stephanie] IFREMER, Ctr Atlantique, Unite Ecol & Modeles Halieut, F-44311 Nantes 03, France; [Marchal, Paul] IFREMER, Ctr Manche Mer Nord, Lab Ressources Halieut, F-62321 Boulogne Sur Mer, France	Ifremer; Ifremer	Gasche, L (corresponding author), IFREMER, Ctr Atlantique, Unite Ecol & Modeles Halieut, F-44311 Nantes 03, France.	loic.gasche@ifremer.fr		Marchal, Paul/0000-0003-2047-4599; MAHEVAS, Stephanie/0000-0001-7707-2502	European Community [266445]; Region des Pays de la Loire	European Community(European Commission); Region des Pays de la Loire(Region Pays de la Loire)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) within the Ocean of Tomorrow call under Grant Agreement No. 266445 for the project Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors (VECTORS) and the Region des Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Haim Y., 2006, INFO GAP DECISION TH, V33, P368; BenHaim Y, 2006, INFO GAP DECISION TH, DOI DOI 10.1016/B978-0-12-373552-2.X5000-0; Biseau A, 1998, AQUAT LIVING RESOUR, V11, P119, DOI 10.1016/S0990-7440(98)80109-5; BREIMAN L., 1984, CRC PRESS; Caddy JF, 1995, TECHNICAL REPORT; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Carpentier A., 2009, CHANNEL HABITAT ATLA, P626; Charles AT, 1998, FISH RES, V37, P37, DOI 10.1016/S0165-7836(98)00125-8; CLARK CW, 1986, J ENVIRON ECON MANAG, V13, P235, DOI 10.1016/0095-0696(86)90024-0; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Deporte N, 2012, ICES J MAR SCI, V69, P331, DOI 10.1093/icesjms/fsr197; Dorazio RM, 2003, ECOL APPL, V13, P556, DOI 10.1890/1051-0761(2003)013[0556:BIADTA]2.0.CO;2; Drouineau H, 2006, AQUAT LIVING RESOUR, V19, P15, DOI 10.1051/alr:2006002; FranceAgriMer, 2010, TECHNICAL REPORT; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P982, DOI 10.1139/cjfas-54-4-982; Francis RICC, 1997, CAN J FISH AQUAT SCI, V54, P1699, DOI 10.1139/cjfas-54-8-1699; Harwood J, 2003, TRENDS ECOL EVOL, V18, P617, DOI 10.1016/j.tree.2003.08.001; Hayes KR, 2013, METHODS ECOL EVOL, V4, P601, DOI 10.1111/2041-210X.12046; Helton JC, 2003, RELIAB ENG SYST SAFE, V81, P23, DOI 10.1016/S0951-8320(03)00058-9; Hilborn R, 1997, FISHERIES, V22, P19; HILBORN R, 1987, North American Journal of Fisheries Management, V7, P1, DOI 10.1577/1548-8659(1987)7<1:LWUIRM>2.0.CO;2; Holland D.S, 2010, OECD FOOD AGR FISHER, V25; Homma T, 1996, RELIAB ENG SYST SAFE, V52, P1, DOI 10.1016/0951-8320(96)00002-6; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; ICES, 2012, TECHNICAL REPORT; Leblond E, 2011, TECHNICAL REPORT; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; Mahevas S, 2004, ECOL MODEL, V171, P65, DOI 10.1016/j.ecolmodel.2003.04.001; Mangel M, 1996, ECOL APPL, V6, P338, DOI 10.2307/2269369; Marchal P, 2011, ICES J MAR SCI, V68, P1580, DOI 10.1093/icesjms/fsr096; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Moilanen A, 2006, ECOL MODEL, V199, P115, DOI 10.1016/j.ecolmodel.2006.07.004; Pelletier D, 2005, FISH FISH, V6, P307, DOI 10.1111/j.1467-2979.2005.00199.x; Pelletier D, 2001, SPATIAL PROCESSES MA; Pelletier D, 2009, ECOL MODEL, V220, P1013, DOI 10.1016/j.ecolmodel.2009.01.007; Post van der Burg M, 2011, ECOL APPL, V21, P303, DOI 10.1890/09-0973.1; Pujol G, 2008, SENSITIVITY SENSITIV; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; R Development Core Team, 2012, R LANG ENV STAT COMP; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; RIJNSDORP AD, 1992, NETH J SEA RES, V29, P173, DOI 10.1016/0077-7579(92)90018-A; Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737; Saltelli A, 2000, STAT SCI, V15, P377, DOI 10.1214/ss/1009213004; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; Saltelli A, 2006, RELIAB ENG SYST SAFE, V91, P1109, DOI 10.1016/j.ress.2005.11.014; Sethi SA, 2010, FISH FISH, V11, P341, DOI 10.1111/j.1467-2979.2010.00363.x; Sniedovich M., 2007, DECISION MAKING MANU, V1, P111, DOI [https://doi.org/10.7494/dmms.2007.1.2.111, DOI 10.7494/DMMS.2007.1.2.111]; Sniedovich M, 2010, J RISK FINANC, V11, P268, DOI 10.1108/15265941011043648; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; von Neumann J, 1955, THEORY GAMES EC BEHA; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; WALD A, 1949, ANN MATH STAT, V20, P165, DOI 10.1214/aoms/1177730030; Walters C, 1986, ADAPTATIVE MANAGEMEN; WGNSSK, 2008, TECHNICAL REPORT; WGNSSK, 2009, TECHNICAL REPORT; WGNSSK, 2010, TECHNICAL REPORT; WGNSSK, 2012, REP WORK GROUP ASS D; WGNSSK, 2011, TECHNICAL REPORT	62	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77566	10.1371/journal.pone.0077566	http://dx.doi.org/10.1371/journal.pone.0077566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204873	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500035
J	Li, ZH; Xu, HY; Zheng, WL; Lam, SH; Gong, ZY				Li, Zhi-Hua; Xu, Hongyan; Zheng, Weiling; Lam, Siew Hong; Gong, Zhiyuan			RNA-Sequencing Analysis of TCDD-Induced Responses in Zebrafish Liver Reveals High Relatedness to In Vivo Mammalian Models and Conserved Biological Pathways	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION PROFILES; APOPTOTIC CELL-DEATH; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; DIOXIN; PROTEIN; AHR; REPRODUCIBILITY; IDENTIFICATION; ACTIVATION	TCDD is one of the most persistent environmental toxicants in biological systems and its effect through aryl hydrocarbon receptor (AhR) has been well characterized. However, the information on TCDD-induced toxicity in other molecular pathways is rather limited. To fully understand molecular toxicity of TCDD in an in vivo animal model, adult zebrafish were exposed to TCDD at 10 nM for 96 h and the livers were sampled for RNA-sequencing based transcriptomic profiling. A total of 1,058 differently expressed genes were identified based on fold-change >2 and TPM (transcripts per million) >10. Among the top 20 up-regulated genes, 10 novel responsive genes were identified and verified by RT-qPCR analysis on independent samples. Transcriptomic analysis indicated several deregulated pathways associated with cell cycle, endocrine disruptors, signal transduction and immune systems. Comparative analyses of TCDD-induced transcriptomic changes between fish and mammalian models revealed that proteomic pathway is consistently up-regulated while calcium signaling pathway and several immune-related pathways are generally down-regulated. Finally, our study also suggested that zebrafish model showed greater similarity to in vivo mammalian models than in vitro models. Our study indicated that the zebrafish is a valuable in vivo model in toxicogenomic analyses for understanding molecular toxicity of environmental toxicants relevant to human health. The expression profiles associated with TCDD could be useful for monitoring environmental dioxin and dioxin-like contamination.	[Li, Zhi-Hua; Xu, Hongyan; Zheng, Weiling; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Li, Zhi-Hua] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan, Peoples R China	National University of Singapore; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS	Gong, ZY (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsgzy@nus.edu.sg	Li, ZhiHua/GYU-9914-2022; Gong, Zhiyuan/H-8794-2012; LI, ZHIHUA/G-2896-2015; Lam, Siew Hong/H-8483-2012	Gong, Zhiyuan/0000-0002-9660-5260; LI, ZHIHUA/0000-0002-6484-657X; 	Singapore National Research Foundation; Environment & Water Industry Programme Office (EWI) of the PUB [R-154-000-328-272]	Singapore National Research Foundation(National Research Foundation, Singapore); Environment & Water Industry Programme Office (EWI) of the PUB	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB (grant number R-154-000-328-272). The funders had no role in study design, data collection and analysis, decision to publish, or reparation of the manuscript.	Black MB, 2012, TOXICOL SCI, V127, P199, DOI 10.1093/toxsci/kfs069; Boverhof DR, 2005, TOXICOL SCI, V85, P1048, DOI 10.1093/toxsci/kfi162; Cantrell SM, 1996, TOXICOL APPL PHARM, V141, P23; Cao ZJ, 2003, AQUAT TOXICOL, V63, P271, DOI 10.1016/S0166-445X(02)00184-4; Chen YH, 1996, J BIOL CHEM, V271, P26261, DOI 10.1074/jbc.271.42.26261; Consonni D, 2012, ENVIRON INT, V44, P151, DOI 10.1016/j.envint.2012.01.004; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dearstyne EA, 2002, TOXICOLOGY, V170, P139, DOI 10.1016/S0300-483X(01)00542-X; Dere E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-80; Dong W, 2002, TOXICOL SCI, V69, P191, DOI 10.1093/toxsci/69.1.191; Falahatpisheh H, 2007, CELL STRESS CHAPERON, V12, P209, DOI 10.1379/CSC-259.1; Forgacs AL, 2012, TOXICOL SCI, V125, P41, DOI 10.1093/toxsci/kfr262; Gentile CL, 2011, ANTIOXID REDOX SIGN, V15, P505, DOI 10.1089/ars.2010.3790; Guo L, 2006, NAT BIOTECHNOL, V24, P1162, DOI 10.1038/nbt1238; Handley-Goldstone HM, 2005, TOXICOL SCI, V85, P683, DOI 10.1093/toxsci/kfi116; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kim S, 2009, TOXICOL SCI, V112, P229, DOI 10.1093/toxsci/kfp189; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Mandal PK, 2005, J COMP PHYSIOL B, V175, P221, DOI 10.1007/s00360-005-0483-3; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marlowe JL, 2004, J BIOL CHEM, V279, P29013, DOI 10.1074/jbc.M404315200; MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2; MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ovando BJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-583; Pichler FB, 2003, NAT BIOTECHNOL, V21, P879, DOI 10.1038/nbt852; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251; Ryu YM, 2005, MOL CELL TOXICOL, V1, P164; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Teraoka H, 2008, INTERDISCIPLINARY ST, P61; Toomey BH, 2001, AQUAT TOXICOL, V53, P127, DOI 10.1016/S0166-445X(00)00161-2; Venkatesh B, 2003, CURR OPIN GENET DEV, V13, P588, DOI 10.1016/j.gde.2003.09.001; Volz DC, 2005, TOXICOL SCI, V85, P572, DOI 10.1093/toxsci/kfi109; Xu SH, 2010, AM J PHYSIOL-GASTR L, V299, pG126, DOI 10.1152/ajpgi.00522.2010; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019; Zodrow JM, 2004, AQUAT TOXICOL, V66, P25, DOI 10.1016/j.aquatox.2003.07.002	43	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77292	10.1371/journal.pone.0077292	http://dx.doi.org/10.1371/journal.pone.0077292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204792	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500023
J	Chapleur, O; Wu, TD; Guerquin-Kern, JL; Mazeas, L; Bouchez, T				Chapleur, Olivier; Wu, Ting-Di; Guerquin-Kern, Jean-Luc; Mazeas, Laurent; Bouchez, Theodore			SIMSISH Technique Does Not Alter the Apparent Isotopic Composition of Bacterial Cells	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CATALYZED REPORTER DEPOSITION; MICROBIAL ECOLOGY; NANOSIMS; IDENTIFICATION; IDENTITY; FISH; TOOL	In order to identify the function of uncultured microorganisms in their environment, the SIMSISH method, combining in situ hybridization (ISH) and nanoscale secondary ion mass spectrometry (nanoSIMS) imaging, has been proposed to determine the quantitative uptake of specific labelled substrates by uncultured microbes at the single cell level. This technique requires the hybridization of rRNA targeted halogenated DNA probes on fixed and permeabilized microorganisms. Exogenous atoms are introduced into cells and endogenous atoms removed during the experimental procedures. Consequently differences between the original and the apparent isotopic composition of cells may occur. In the present study, the influence of the experimental procedures of SIMSISH on the isotopic composition of carbon in E. coli cells was evaluated with nanoSIMS and compared to elemental analyser-isotopic ratio mass spectrometer (EA-IRMS) measurements. Our results show that fixation and hybridization have a very limited, reproducible and homogeneous influence on the isotopic composition of cells. Thereby, the SIMSISH procedure minimizes the contamination of the sample by exogenous atoms, thus providing a means to detect the phylogenetic identity and to measure precisely the carbon isotopic composition at the single cell level. This technique was successfully applied to a complex sample with double bromine iodine labelling targeting a large group of bacteria and a specific archaea to evaluate their specific C-13 uptake during labelled methanol anaerobic degradation.	[Chapleur, Olivier; Mazeas, Laurent; Bouchez, Theodore] Irstea, UR HBAN, Antony, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Univ Paris 11, INSERM, U759, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Chapleur, O (corresponding author), Irstea, UR HBAN, Antony, France.	olivier.chapleur@irstea.fr	BOUCHEZ, Théodore/AAC-4652-2021; Bouchez, Theodore/B-5383-2016; Guerquin-Kern, Jean-Luc/M-5000-2018	BOUCHEZ, Théodore/0000-0002-2236-8282; Bouchez, Theodore/0000-0002-2236-8282; Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; WU, Ting-Di/0000-0002-6398-0363; Chapleur, Olivier/0000-0001-9460-921X				Amann R, 1996, J BACTERIOL, V178, P3496, DOI 10.1128/jb.178.12.3496-3500.1996; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Behrens S, 2008, APPL ENVIRON MICROB, V74, P3143, DOI 10.1128/AEM.00191-08; Davission ML, 2008, DEV STANDARDS NANOSI; Halm H, 2009, ENVIRON MICROBIOL, V11, P1945, DOI 10.1111/j.1462-2920.2009.01917.x; Huang WE, 2007, ENVIRON MICROBIOL, V9, P1878, DOI 10.1111/j.1462-2920.2007.01352.x; Lee N, 1999, APPL ENVIRON MICROB, V65, P1289; Li T., 2007, THESIS; Li T, 2008, ENVIRON MICROBIOL, V10, P580, DOI 10.1111/j.1462-2920.2007.01478.x; Musat N, 2012, FEMS MICROBIOL REV, V36, P486, DOI 10.1111/j.1574-6976.2011.00303.x; Musat N, 2008, P NATL ACAD SCI USA, V105, P17861, DOI 10.1073/pnas.0809329105; Ouverney CC, 1999, APPL ENVIRON MICROB, V65, P1746; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054	14	5	5	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77522	10.1371/journal.pone.0077522	http://dx.doi.org/10.1371/journal.pone.0077522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204855	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700033
J	Delgado, MD; Caferri, E; Mendez, M; Godoy, JA; Campioni, L; Penteriani, V				del Mar Delgado, Maria; Caferri, Eleonora; Mendez, Maria; Godoy, Jose A.; Campioni, Letizia; Penteriani, Vincenzo			Population Characteristics May Reduce the Levels of Individual Call Identity	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PHENOTYPIC PLASTICITY; MICROSATELLITE MARKERS; REPRODUCTIVE SUCCESS; BREEDING PERFORMANCE; BOTAURUS-STELLARIS; VOCAL DISPLAYS; REACTION NORMS; STRIX-ALUCO; EAGLE	Individual variability influences the demographic and evolutionary dynamics of spatially structured populations, and conversely ecological and evolutionary dynamics provide the context under which variations at the individual level occur. Therefore, it is essential to identify and characterize the importance of the different factors that may promote or hinder individual variability. Animal signaling is a prime example of a type of behavior that is largely dependent on both the features of individuals and the characteristics of the population to which they belong. After 10 years studying the dynamics of a population of a long-lived species, the eagle owl (Bubo bubo), we investigated the emergence and maintenance of traits that reveal individual identity by focusing on vocal features. We found that individuals inhabiting a high density population characterized by a relative lack of heterogeneity (in terms of prey availability and breeding success) among breeding sites might be selected for reducing the levels of identity. Two non-mutually exclusive hypotheses may explain the structural call patterns we detected: (1) similarity in calls may be principally a consequence of the particular characteristics of the population; and (2) high density may encourage individuals to mimic each other's vocalizations in a cascade effect, leading to a widespread and unique communication network.	[del Mar Delgado, Maria] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [del Mar Delgado, Maria; Caferri, Eleonora; Mendez, Maria; Campioni, Letizia; Penteriani, Vincenzo] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Godoy, Jose A.] CSIC, Integrat Ecol Grp, Estn Biol Donana, E-41080 Seville, Spain; [Penteriani, Vincenzo] Univ Helsinki, Finnish Museum Nat Hist, Zool Museum, Helsinki, Finland	University of Helsinki; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Helsinki	Delgado, MD (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland.	maria.delgado@helsinki.fi	Godoy, José Antonio/B-9288-2008; campioni, letizia/AAZ-2888-2020	Godoy, José Antonio/0000-0001-7502-9471; campioni, letizia/0000-0002-6319-6931	Spanish Ministry of Economy and Competitiveness [CGL2012-33240]; FEDER; Spanish Ministry of Science and Innovation [CGL2004-02780/BOS, CGL2008-02871/BOS]; Junta of Andalucia [RNM-5090]; Academy of Finland [140367]; Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program)	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta of Andalucia(Junta de Andalucia); Academy of Finland(Academy of Finland); Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program)	The work was funded by one research project of the Spanish Ministry of Economy and Competitiveness (CGL2012-33240; with FEDER co-financing), two research projects of the Spanish Ministry of Science and Innovation (CGL2004-02780/BOS and CGL2008-02871/BOS; with FEDER co-financing) and the Junta of Andalucia (Excellence Project, RNM-5090). M. D. received a postdoctoral fellowship from the Spanish Ministry of Science and Innovation and a postdoctoral grant (no. 140367) from the Academy of Finland. V. P. was the recipient of a grant from the Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; Appleby BM, 1997, IBIS, V139, P152, DOI 10.1111/j.1474-919X.1997.tb04515.x; BELETSKY LD, 1992, BEHAVIOUR, V123, P290, DOI 10.1163/156853992X00066; Bradbury Jack W., 1998, pi; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Campioni L, 2013, OECOLOGIA, V172, P371, DOI 10.1007/s00442-012-2493-7; Campioni L, 2010, IBIS, V152, P569, DOI 10.1111/j.1474-919X.2010.01030.x; Catchpole C., 1995, BIRD SONG BIOL THEME; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Delgado MD, 2010, J ANIM ECOL, V79, P620, DOI 10.1111/j.1365-2656.2009.01655.x; Delgado MD, 2009, ARDEA, V97, P7, DOI 10.5253/078.097.0102; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Donovan TM, 1995, CONSERV BIOL, V9, P1380, DOI 10.1046/j.1523-1739.1995.09061380.x; Elkie P, 1999, PATCH ANAL USERS MAN; Ellis JMS, 2008, CONDOR, V110, P648, DOI 10.1525/cond.2008.8592; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Fisher J., 1954, P71; GALEOTTI P, 1991, ETHOL ECOL EVOL, V3, P113, DOI 10.1080/08927014.1991.9525378; Galeotti P, 2001, J AVIAN BIOL, V32, P256, DOI 10.1111/j.0908-8857.2001.320308.x; Gilbert G, 2002, IBIS, V144, P51, DOI 10.1046/j.0019-1019.2001.00012.x; Grava T, 2008, IBIS, V150, P279, DOI 10.1111/j.1474-919X.2007.00776.x; HOUSTON AI, 1992, EVOL ECOL, V6, P243, DOI 10.1007/BF02214164; Hsu YC, 2003, MOL ECOL NOTES, V3, P595, DOI 10.1046/j.1471-8286.2003.00523.x; Huber H, 2004, AM NAT, V163, P548, DOI 10.1086/382549; Husby A, 2010, EVOLUTION, V64, P2221, DOI 10.1111/j.1558-5646.2010.00991.x; Isaksson M, 2002, MOL ECOL NOTES, V2, P91, DOI 10.1046/j.1471-8286.2002.00156.x; KAWECKI TJ, 1993, EVOL ECOL, V7, P155, DOI 10.1007/BF01239386; Kie JG, 2002, ECOLOGY, V83, P530, DOI 10.1890/0012-9658(2002)083[0530:LHADSE]2.0.CO;2; King EG, 2010, AM NAT, V175, P702, DOI 10.1086/652434; Koehl M.A.R., 1989, P39; Kuparinen A, 2011, OECOLOGIA, V167, P435, DOI 10.1007/s00442-011-1989-x; Laiolo P, 2005, J APPL ECOL, V42, P1183, DOI 10.1111/j.1365-2664.2005.01093.x; Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P68, DOI 10.1890/1540-9295(2007)5[68:EOACIF]2.0.CO;2; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; Lyytinen A, 2004, P ROY SOC B-BIOL SCI, V271, P279, DOI 10.1098/rspb.2003.2571; McGregor Peter K., 1996, P409; Mennill DJ, 2011, IBIS, V153, P235, DOI 10.1111/j.1474-919X.2011.01119.x; Morita K, 2002, J FISH BIOL, V61, P1230, DOI [10.1006/jfbi.2002.2138, 10.1111/j.1095-8649.2002.tb02467.x]; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; Penteriani V, 2002, ETHOL ECOL EVOL, V14, P275; Penteriani V, 2005, IBIS, V147, P155, DOI 10.1111/j.1474-919x.2004.00381.x; Penteriani V, 2004, POPUL ECOL, V46, P185, DOI 10.1007/s10144-004-0178-8; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Penteriani V, 2011, ANIM BEHAV, V82, P413, DOI 10.1016/j.anbehav.2011.05.027; Penteriani V, 2011, ECOGRAPHY, V34, P729, DOI 10.1111/j.1600-0587.2010.06773.x; Perez-Garcia JM, 2012, BIRD STUDY, V59, P22, DOI 10.1080/00063657.2011.613111; Puglisi L, 2004, AUK, V121, P541, DOI 10.1642/0004-8038(2004)121[0541:DOIVIM]2.0.CO;2; R Development Core Team, 2009, R LANG ENV STAT COMP; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Specht R, 2003, AVISOFT SASLABPRO SO; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Thode AB, 2002, MOL ECOL NOTES, V2, P446, DOI 10.1046/j.1471-8286.2002.00267.x; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; WIENS JA, 1990, REV CHIL HIST NAT, V63, P309	67	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77557	10.1371/journal.pone.0077557	http://dx.doi.org/10.1371/journal.pone.0077557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204869	Green Published, gold			2022-12-25	WOS:000326270700037
J	Brooks, ME; McCoy, MW; Bolker, BM				Brooks, Mollie E.; McCoy, Michael W.; Bolker, Benjamin M.			A Method for Detecting Positive Growth Autocorrelation without Marking Individuals	PLOS ONE			English	Article							MEAN EFFECT SIZE; DEMOGRAPHIC STOCHASTICITY; ECOLOGICAL PROCESSES; POPULATION-MODELS; CONSEQUENCES; VARIANCE; VARIABILITY; DYNAMICS; METAMORPHOSIS; MORTALITY	In most ecological studies, within-group variation is a nuisance that obscures patterns of interest and reduces statistical power. However, patterns of within-group variability often contain information about ecological processes. In particular, such patterns can be used to detect positive growth autocorrelation (consistent variation in growth rates among individuals in a cohort across time), even in samples of unmarked individuals. Previous methods for detecting autocorrelated growth required data from marked individuals. We propose a method that requires only estimates of within-cohort variance through time, using maximum likelihood methods to obtain point estimates and confidence intervals of the correlation parameter. We test our method on simulated data sets and determine the loss in statistical power due to the inability to identify individuals. We show how to accommodate nonlinear growth trajectories and test the effects of size-dependent mortality on our method's accuracy. The method can detect significant growth autocorrelation at moderate levels of autocorrelation with moderate-sized cohorts (for example, statistical power of 80% to detect growth autocorrelation rho(2) = 0.5 in a cohort of 100 individuals measured on 16 occasions). We present a case study of growth in the red-eyed tree frog. Better quantification of the processes driving size variation will help ecologists improve predictions of population dynamics. This work will help researchers to detect growth autocorrelation in cases where marking is logistically infeasible or causes unacceptable decreases in the fitness of marked individuals.	[Brooks, Mollie E.; McCoy, Michael W.; Bolker, Benjamin M.] Univ Florida, Dept Biol, Gainesville, FL USA	State University System of Florida; University of Florida	Brooks, ME (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	mollieebrooks@gmail.com	Brooks, Mollie Elizabeth/AAM-5509-2021	Brooks, Mollie Elizabeth/0000-0001-6963-8326; McCoy, Michael/0000-0002-7993-6236; Bolker, Benjamin/0000-0002-2127-0443	NSF IGERT [0801544]; NSERC	NSF IGERT(National Science Foundation (NSF)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors acknowledge the University of Florida High-Performance Computing Center (http://hpc.ufl.edu) for providing computational resources. MEB was supported by NSF IGERT #0801544, Quantitative spatial ecology, evolution and environment. BMB was supported by an NSERC Discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, EVOLUTION, V50, P1052, DOI 10.1111/j.1558-5646.1996.tb02346.x; Bates D, 2012, LME4 LINEAR MIXED EF; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bolker B., 2012, R2ADMB ADMB R INTERF; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Brienen RJW, 2006, FOREST ECOL MANAG, V237, P179, DOI 10.1016/j.foreco.2006.09.042; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Day T, 2002, AM NAT, V159, P338, DOI 10.1086/338989; de Valpine P, 2009, ECOLOGY, V90, P2889, DOI 10.1890/08-0703.1; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fox GA, 2002, ECOLOGY, V83, P1928, DOI 10.2307/3071775; Gonzalez-Suarez M, 2011, AM NAT, V178, P525, DOI 10.1086/661906; Inouye BD, 2005, ECOLOGY, V86, P262, DOI 10.1890/03-3180; Kendall BE, 2011, ECOLOGY, V92, P1985, DOI 10.1890/11-0079.1; LAIRD AK, 1965, GROWTH, V29, P233; Lavine M, 2002, J AGR BIOL ENVIR ST, V7, P21, DOI 10.1198/108571102317475044; Mangel M, 2001, EVOL ECOL RES, V3, P583; Marshall DJ, 2005, AUSTRAL ECOL, V30, P275, DOI 10.1111/j.1442-9993.2005.01463.x; May RM, 2004, NATURE, V431, P403, DOI 10.1038/431403a; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; Morris W. F., 2002, QUANTITATIVE CONSERV; Peacor SD, 2007, ECOLOGY, V88, P1536, DOI 10.1890/06-1066; Peacor SD, 2006, J ANIM ECOL, V75, P990, DOI 10.1111/j.1365-2656.2006.01119.x; Persson L, 1998, THEOR POPUL BIOL, V54, P270, DOI 10.1006/tpbi.1998.1380; Pfister CA, 2005, ECOLOGY, V86, P2673, DOI 10.1890/04-1952; Pfister CA, 2002, ECOLOGY, V83, P59; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RICKLEFS RE, 1973, COPEIA, P296; RICKLEFS RE, 1967, ECOLOGY, V48, P978, DOI 10.2307/1934545; Roff Derek A., 1992; ROWE L, 1991, ECOLOGY, V72, P413, DOI 10.2307/2937184; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Scheipl F, 2008, COMPUT STAT DATA AN, V52, P3283, DOI 10.1016/j.csda.2007.10.022; Shelton AO, 2013, AM NAT, V181, P799, DOI 10.1086/670198; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Wearing HJ, 2004, AM NAT, V164, P543, DOI 10.1086/424040; WEINER J, 1985, ECOLOGY, V66, P743, DOI 10.2307/1940535; Weitz JS, 2006, ECOL LETT, V9, P548, DOI 10.1111/j.1461-0248.2006.00900.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zuidema PA, 2001, J ECOL, V89, P995, DOI 10.1111/j.1365-2745.2001.00621.x; Zuidema PA, 2009, AM NAT, V174, P709, DOI 10.1086/605981	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76389	10.1371/journal.pone.0076389	http://dx.doi.org/10.1371/journal.pone.0076389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204620	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000326241200012
J	Oliveira, LJ; Mansourri-Attia, N; Fahey, AG; Browne, J; Forde, N; Roche, JF; Lonergan, P; Fair, T				Oliveira, Lilian J.; Mansourri-Attia, Nadera; Fahey, Alan G.; Browne, John; Forde, Niamh; Roche, James F.; Lonergan, Patrick; Fair, Trudee			Characterization of the Th Profile of the Bovine Endometrium during the Oestrous Cycle and Early Pregnancy	PLOS ONE			English	Article							INDUCED TRANSCRIPTOME CHANGES; GENE-EXPRESSION PROFILES; NATURAL-KILLER-CELLS; NK CELLS; FETOMATERNAL INTERFACE; TROPHOBLAST CELLS; FETAL INTERFACE; DENDRITIC CELLS; MESSENGER-RNA; IMMUNE-SYSTEM	Despite extensive research in the area of cow fertility, the extent to which the maternal immune system is modulated during pregnancy in cattle remains unclear. Therefore, the objective of the current study was to characterize the presence and response profile of B, T-helper (LTh), T-cytotoxic (LTc), gamma delta-T (gamma delta T) and natural killer (NK) lymphocytes in terms of cell number, distribution and cytokine expression in bovine endometrial tissue to pregnancy. Endometrial tissue samples were collected from beef heifers on Days 5, 7, 13 and 16 of the estrous cycle or pregnancy. Samples were analysed by immunofluorescence to identify the presence and abundance of B-B7 (B-cells), CD4 (LTh), CD8 (LTc), gamma delta T cell receptor (TCR) and CD335/NKp46 (NK cells) -positive immune cells. Quantitative real time PCR (QPCR) was carried out to analyse mRNA relative abundance of FOXP3 (a marker of regulatory T (Treg) cells) and a panel of immune factors, including MHC-I, LIF, Interleukins 1, 2, 6, 8, 10, 11,12A, IFNa and IFNG. Results indicate that B-B7+ cells are quite populous in bovine endometrial tissue, CD4+ and CD8+-cells are present in moderate numbers and gamma delta TCR+ and CD335+ cells are present in low numbers. Pregnancy affected the total number and distribution pattern of the NK cell population, with the most significant variation observed on Day 16 of pregnancy. Neither B lymphocytes nor T lymphocyte subsets were regulated temporally during the oestrous cycle or by pregnancy prior to implantation. mRNA transcript abundance of the immune factors LIF, IL1b, IL8 and IL12A, IFNa and IFNG, expression was regulated temporally during the estrous cycle and LIF, IL1b, IL-10, IL11, IL12A were also temporally regulated during pregnancy. In conclusion, the endometrial immune profile of the oestrous cycle favours a Th2 environment in anticipation of pregnancy and the presence of an embryo acts to fine tune this environment.	[Oliveira, Lilian J.] Univ Sao Paulo, Fac Food Engn & Anim Sci, Sao Paulo, Brazil; [Mansourri-Attia, Nadera; Fahey, Alan G.; Browne, John; Forde, Niamh; Roche, James F.; Lonergan, Patrick; Fair, Trudee] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland	Universidade de Sao Paulo; University College Dublin	Fair, T (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland.	trudee.fair@ucd.ie	Fahey, Alan/AAY-6113-2020; J., Oliveira L./V-9028-2017; Fahey, Alan G/B-5566-2009	Fahey, Alan/0000-0002-4594-5767; J., Oliveira L./0000-0003-1402-8373; Forde, Niamh/0000-0002-3539-9643; Fair, Trudee/0000-0002-5079-8589	Science Foundation Ireland [05/PICA/B813]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland grant 05/PICA/B813 (www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain R, 2004, DEV DYNAM, V231, P700, DOI 10.1002/dvdy.20183; Al Naib A, 2011, J REPROD IMMUNOL, V91, P31, DOI 10.1016/j.jri.2011.05.005; ARICI A, 1995, J CLIN ENDOCR METAB, V80, P1908, DOI 10.1210/jc.80.6.1908; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Bainbridge DRJ, 2001, REPRODUCTION, V122, P907, DOI 10.1530/rep.0.1220907; Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Bosschaerts T, 2011, EUR J IMMUNOL, V41, P3270, DOI 10.1002/eji.201041307; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Chaouat G, 1999, AM J REPROD IMMUNOL, V42, P1; Chaouat G, 2007, SEMIN IMMUNOPATHOL, V29, P95, DOI 10.1007/s00281-007-0069-0; CHARNOCKJONES DS, 1994, J REPROD FERTIL, V101, P421; COBB SP, 1995, RES VET SCI, V59, P238, DOI 10.1016/0034-5288(95)90010-1; Connelley T, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-37; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Davies CJ, 2006, AM J REPROD IMMUNOL, V55, P188, DOI 10.1111/j.1600-0897.2005.00364.x; Davies CJ, 2000, PLACENTA, V21, P194, DOI 10.1053/plac.1999.0475; De Mestre A, 2010, INT J DEV BIOL, V54, P445, DOI 10.1387/ijdb.082795ad; Dietl J, 2006, PLACENTA, V27, P341, DOI 10.1016/j.placenta.2005.05.001; Dimitriadis E, 2010, INT J DEV BIOL, V54, P313, DOI 10.1387/ijdb.082772ed; Doyle J, 2009, J REPROD IMMUNOL, V82, P48, DOI 10.1016/j.jri.2009.06.125; Fahey AG, 2007, POULTRY SCI, V86, P1312, DOI 10.1093/ps/86.7.1312; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Fouladi-Nashta AA, 2005, DEV BIOL, V281, P1, DOI 10.1016/j.ydbio.2005.01.033; Fox A, 2010, J REPROD IMMUNOL, V84, P52, DOI 10.1016/j.jri.2009.10.003; Groebner AE, 2011, REPROD FERT DEVELOP, V23, P619, DOI 10.1071/RD10230; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Ishiwata H, 2003, MOL REPROD DEV, V65, P9, DOI 10.1002/mrd.10292; Kallikourdis M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000382; Kimber SJ, 2008, REPRODUCTION, V135, P635, DOI 10.1530/REP-07-0359; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Leung ST, 2000, J REPROD FERTIL, V119, P25, DOI 10.1530/jrf.0.1190025; Majewski AC, 2001, IMMUNOLOGY, V102, P317, DOI 10.1046/j.1365-2567.2001.01182.x; Mansouri-Attia N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101121; Mansouri-Attia N, 2009, PHYSIOL GENOMICS, V39, P14, DOI 10.1152/physiolgenomics.90404.2008; MEEUSEN E, 1993, EUR J IMMUNOL, V23, P1112, DOI 10.1002/eji.1830230520; Miyoshi M, 2004, REPROD DOMEST ANIM, V39, P125, DOI 10.1111/j.1439-0531.2004.00484.x; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x; Ntrivalas EI, 2005, AM J REPROD IMMUNOL, V53, P215, DOI 10.1111/j.1600-0897.2005.00268.x; O'Driscoll KKM, 2009, J DAIRY SCI, V92, P4249, DOI 10.3168/jds.2008-1906; O'Gorman GM, 2010, BIOL REPROD, V83, P296, DOI 10.1095/biolreprod.109.082560; Oliveira LJ, 2008, REPRODUCTION, V136, P481, DOI 10.1530/REP-08-0218; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143; Rossi M, 2005, REPRODUCTION, V130, P721, DOI 10.1530/rep.1.00688; Salamonsen LA, 1996, HUM REPROD, V11, P124, DOI 10.1093/humrep/11.suppl_2.124; Oliveira LHS, 2010, REV SOC BRAS MED TRO, V43, P4, DOI 10.1590/S0037-86822010000100002; Shuya LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025288; SKOPETS B, 1992, VET IMMUNOL IMMUNOP, V34, P81, DOI 10.1016/0165-2427(92)90153-H; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Vasudevan SKM, 2013, AM J REPROD IMMUNOL, V69, P157; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Yang ZY, 2011, INT IMMUNOPHARMACOL, V11, P1442, DOI 10.1016/j.intimp.2011.04.024	60	50	51	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e75571	10.1371/journal.pone.0075571	http://dx.doi.org/10.1371/journal.pone.0075571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204576	gold, Green Submitted, Green Published			2022-12-25	WOS:000326155400008
J	Tang, CW; Colagiuri, B				Tang, Chi Wang; Colagiuri, Ben			Can an Educational Handout Enhance Placebo Analgesia for Experimentally-Induced Pain?	PLOS ONE			English	Article							VERBAL EXPECTANCY; MAJOR DEPRESSION; CONTROLLED-TRIAL; EXPERIENCE	The placebo effect is an interesting phenomenon whereby a dummy treatment can produce therapeutic benefit, such as, pain relief. While evidence for the placebo effect is growing, relatively few studies have explored ways of enhancing placebo effects. To address this, the current study tested whether placebo-induced analgesia could be enhanced by providing an educational handout about the efficacy of analgesics. Fifty university students were allocated to receive placebo treatment under the guise of a new analgesic formula, either with or without an educational handout, or to a no treatment control group before undergoing electrical and cold pressor pain tests. There was a placebo effect for electrically-induced pain with those receiving placebo treatment reporting significantly less pain compared with those who received no treatment. There was also some evidence of enhancement of this placebo-induced analgesia for electrically-induced pain as a result of the educational handout. No differences were found on cold pressor-induced pain. These findings suggest that providing educational information about a treatment could enhance its efficacy via the placebo effect. Future studies should test different methods of providing educational information in order to determine which elicit the strongest effects.	[Tang, Chi Wang; Colagiuri, Ben] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia; [Colagiuri, Ben] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Colagiuri, B (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	ben.colagiuri@sydney.edu.au		Colagiuri, Ben/0000-0003-2157-2641	University of New South Wales	University of New South Wales	Dr. Ben Colagiuri was a recipient of a University of New South Wales Vice-Chancellor's Postdoctoral Research Fellowship from January 2011 to June 2012, during which time some of the current data were collected. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austan F, 1997, AM J CLIN HYPN, V39, P182, DOI 10.1080/00029157.1997.10403383; Bae EH, 2011, EPILEPSY BEHAV, V20, P355, DOI 10.1016/j.yebeh.2010.12.005; Benedetti F, 2003, J NEUROSCI, V23, P4315; Benedetti F, 2003, PREVENT TREAT, V6, P1; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Brunoni AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004824; BUCKALEW LW, 1981, PSYCHOL REP, V49, P955, DOI 10.2466/pr0.1981.49.3.955; CLARK WC, 1969, J ABNORM PSYCHOL, V74, P363, DOI 10.1037/h0027509; Colagiuri B, 2012, J PSYCHOPHARMACOL, V26, P1540, DOI 10.1177/0269881112458730; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Colagiuri B, 2010, CLIN TRIALS, V7, P246, DOI 10.1177/1740774510367916; Colagiuri B, 2010, PSYCHOPHARMACOLOGY, V208, P433, DOI 10.1007/s00213-009-1743-9; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; de Craen AJM, 1999, BRIT J CLIN PHARMACO, V48, P853, DOI 10.1046/j.1365-2125.1999.00094.x; DeSantana Josimari M, 2008, Curr Rheumatol Rep, V10, P492; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; DOWNING RW, 1979, ACTA PSYCHIAT SCAND, V60, P438, DOI 10.1111/j.1600-0447.1979.tb00554.x; GOTTLIEB AM, 1987, J CONSULT CLIN PSYCH, V55, P606, DOI 10.1037/0022-006X.55.4.606; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; KIRSCH I, 1985, AM PSYCHOL, V40, P1189, DOI 10.1037/0003-066X.40.11.1189; KNOX VJ, 1979, PSYCHOSOM MED, V41, P477; Koban L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049784; Lee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026016; Lewis T, 1930, HEART-J STUD CIRC, V15, P177; Louhiala P, 2008, Med Humanit, V34, P107, DOI 10.1136/jmh.2008.000307; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Pollo A, 2002, NEUROREPORT, V13, P1383, DOI 10.1097/00001756-200208070-00006; Rose JP, 2012, J BEHAV MED, V35, P462, DOI 10.1007/s10865-011-9374-0; Shelke AR, 2008, J PAIN SYMPTOM MANAG, V35, P381, DOI 10.1016/j.jpainsymman.2007.05.008; Siegel S, 2002, SCI PLACEBO EFFECT I, P108; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Suetsugi M, 2007, PROG NEURO-PSYCHOPH, V31, P839, DOI 10.1016/j.pnpbp.2007.01.019; ter Riet G, 1998, PAIN, V76, P273, DOI 10.1016/S0304-3959(98)00057-8; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; Walsh BT, 2002, JAMA-J AM MED ASSOC, V287, P1840, DOI 10.1001/jama.287.14.1840; Wolf S, 1941, J CLIN INVEST, V20, P521, DOI 10.1172/JCI101245	40	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77544	10.1371/journal.pone.0077544	http://dx.doi.org/10.1371/journal.pone.0077544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	241GW	24204865	Green Submitted, Green Published, gold			2022-12-25	WOS:000326155400042
J	Miyata, R; Ota, K; Aonishi, T				Miyata, Ryota; Ota, Keisuke; Aonishi, Toru			Optimal Design for Hetero-Associative Memory: Hippocampal CA1 Phase Response Curve and Spike-Timing-Dependent Plasticity	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; THETA-RHYTHM; REPLAY; SEQUENCES; SLEEP; EXPERIENCE; STORAGE; COMPRESSION; RETRIEVAL; NETWORKS	Recently reported experimental findings suggest that the hippocampal CA1 network stores spatio-temporal spike patterns and retrieves temporally reversed and spread-out patterns. In this paper, we explore the idea that the properties of the neural interactions and the synaptic plasticity rule in the CA1 network enable it to function as a hetero-associative memory recalling such reversed and spread-out spike patterns. In line with Lengyel's speculation (Lengyel et al., 2005), we firstly derive optimally designed spike-timing-dependent plasticity (STDP) rules that are matched to neural interactions formalized in terms of phase response curves (PRCs) for performing the hetero-associative memory function. By maximizing object functions formulated in terms of mutual information for evaluating memory retrieval performance, we search for STDP window functions that are optimal for retrieval of normal and doubly spread-out patterns under the constraint that the PRCs are those of CA1 pyramidal neurons. The system, which can retrieve normal and doubly spread-out patterns, can also retrieve reversed patterns with the same quality. Finally, we demonstrate that purposely designed STDP window functions qualitatively conform to typical ones found in CA1 pyramidal neurons.	[Miyata, Ryota; Aonishi, Toru] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Tokyo, Kanagawa, Japan; [Miyata, Ryota] Japan Soc Promot Sci, Tokyo, Japan; [Ota, Keisuke] RIKEN, Brain Sci Inst, Saitama, Japan	Tokyo Institute of Technology; Japan Society for the Promotion of Science; RIKEN	Aonishi, T (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Tokyo, Kanagawa, Japan.	aonishi@dis.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [12J09230, 23500375]; Grants-in-Aid for Scientific Research [12J09230] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by a Grant-in-Aid for Japan Society for the Promotion of Science Fellows [No. 12J09230 (RM)] and a Grant-in-Aid for Scientific Research (C) [No. 23500375 (TA)] from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aihara T, 2007, NEUROSCIENCE, V145, P80, DOI 10.1016/j.neuroscience.2006.11.025; Andersen P., 2007, HIPPOCAMPUS BOOK; Aonishi T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.114802; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brandalise F, 2012, NEUROSCIENCE2012 ANN; Buchanan Katherine A, 2010, Front Synaptic Neurosci, V2, P11, DOI 10.3389/fnsyn.2010.00011; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cutsuridis V, 2010, SPR SER COMPUT NEURO, V5, P1, DOI 10.1007/978-1-4419-0996-1; Cutsuridis V, 2011, NEURAL NETWORKS, V24, P29, DOI 10.1016/j.neunet.2010.08.005; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Marr D., 1982, VISION COMPUTATIONAL; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Ota K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050232; Ota K, 2012, SPR SER COMPUT NEURO, V6, P179, DOI 10.1007/978-1-4614-0739-3_8; Ota K, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041902; Ota K, 2009, J PHYS CONF SER, V197, DOI 10.1088/1742-6596/197/1/012016; Ota K, 2009, J COMPUT NEUROSCI, V26, P185, DOI 10.1007/s10827-008-0104-8; Shouval HZ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00019; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Teramae JN, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248105; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tsukada M, 2005, HIPPOCAMPUS, V15, P104, DOI 10.1002/hipo.20035; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77395	10.1371/journal.pone.0077395	http://dx.doi.org/10.1371/journal.pone.0077395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204822	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300023
J	Griffiths, KL; Stylianou, E; Poyntz, HC; Betts, GJ; Fletcher, HA; McShane, H				Griffiths, Kristin L.; Stylianou, Elena; Poyntz, Hazel C.; Betts, Gareth J.; Fletcher, Helen A.; McShane, Helen			Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice	PLOS ONE			English	Article							BOVIS BCG VACCINATION; T-CELLS; VIRUS ANKARA; IFN-GAMMA; IL-17; TH17; EXPRESSION; INDUCTION; RESPONSES; EFFICACY	Interleukin (IL)-17 is emerging as an important cytokine in vaccine-induced protection against tuberculosis disease in animal models. Here we show that compared to parenteral delivery, BCG delivered mucosally enhances cytokine production, including interferon gamma and IL-17, in the lungs. Furthermore, we find that cholera toxin, delivered mucosally along with BCG, further enhances IL-17 production by CD4(+) T cells over mucosal BCG alone both in the lungs and systemically. This boosting effect of CT is also observed using a vaccine regimen of BCG followed by the candidate vaccine MVA85A. Using a murine Mycobacterium tuberculosis (M.tb) aerosol challenge model, we demonstrate the ability of cholera toxin delivered at the time of a priming BCG vaccination to improve protection against tuberculosis disease in a manner at least partially dependent on the observed increase in IL-17. This observed increase in IL-17 in the lungs has no adverse effect on lung pathology following M.tb challenge, indicating that IL-17 can safely be boosted in murine lungs in a vaccine/M.tb challenge setting.	[Griffiths, Kristin L.; Stylianou, Elena; Poyntz, Hazel C.; Betts, Gareth J.; Fletcher, Helen A.; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England	University of Oxford; Jenner Institute	McShane, H (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	helen.mcshane@ndm.ox.ac.uk		Fletcher, Helen/0000-0002-0435-1006; /0000-0002-6008-2955; McShane, Helen/0000-0002-2126-5142	KLG's Wellcome Trust [WT086338RP]; HM's Wellcome Trust Senior Fellowship [WT076943MA]	KLG's Wellcome Trust; HM's Wellcome Trust Senior Fellowship	Funding was provided by KLG's Wellcome Trust studentship (www.wellcome.ac.uk; WT086338RP) and HM's Wellcome Trust Senior Fellowship (www.wellcome.ac.uk; WT076943MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LH, 2004, INFECT IMMUN, V72, P238, DOI 10.1128/IAI.72.1.238-246.2004; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cowan J, 2012, CLIN EXP IMMUNOL, V167, P317, DOI 10.1111/j.1365-2249.2011.04520.x; Cubillos S, 2010, TOXINS, V2, P428, DOI 10.3390/toxins2040428; Datta SK, 2010, P NATL ACAD SCI US; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; la Sala A, 2009, J EXP MED, V206, P1227, DOI 10.1084/jem.20080912; Lee JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005190; LEFFORD MJ, 1977, INFECT IMMUN, V18, P646, DOI 10.1128/IAI.18.3.646-653.1977; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Lyadova IV, 2001, CLIN EXP IMMUNOL, V126, P274, DOI 10.1046/j.1365-2249.2001.01667.x; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Minassian AM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000223; Parra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028164; Qiao D, 2011, SCAND J IMMUNOL; Santos A.J., 2013, IMMUNOBIOLOGY; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Streicher EM, 2012, INFECT GENET EVOL, V12, P686, DOI 10.1016/j.meegid.2011.07.019; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; WHO, 2012, TUBERCULOSIS; Yu J, 2009, AM J PHYSIOL-GASTR L, V296, pG563, DOI 10.1152/ajpgi.90502.2008	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78312	10.1371/journal.pone.0078312	http://dx.doi.org/10.1371/journal.pone.0078312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194918	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000326037000097
J	Lu, P; Struijs, MC; Mei, JP; Witte-Bouma, J; Korteland-van Male, AM; de Bruijn, ACJM; van Goudoever, JB; Renes, IB				Lu, Peng; Struijs, Marie-Chantal; Mei, Jiaping; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; van Goudoever, Johannes B.; Renes, Ingrid B.			Endoplasmic Reticulum Stress, Unfolded Protein Response and Altered T Cell Differentiation in Necrotizing Enterocolitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CRITICALLY-ILL INFANTS; ER STRESS; INTESTINAL INFLAMMATION; PLASMA INTERLEUKIN-6; PANETH CELLS; DEFENSINS; EXPRESSION; SEVERITY; COLITIS	Background: Endoplasmic reticulum (ER) stress and activation of the unfolded protein response (UPR) play important roles in chronic intestinal inflammation. Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in preterm infants and is characterized by acute intestinal inflammation and necrosis. The objective of the study is to investigate the role of ER stress and the UPR in NEC patients. Methods: Ileal tissues from NEC and control patients were obtained during surgical resection and/or at stoma closure. Splicing of XBP1 was detected using PCR, and gene expression was quantified using qPCR and Western blot. Results: Splicing of XBP1 was only detected in a subset of acute NEC (A-NEC) patients, and not in NEC patients who had undergone reanastomosis (R-NEC). The other ER stress and the UPR pathways, PERK and ATF6, were not activated in NEC patients. A-NEC patients showing XBP1 splicing (A-NEC-XBP1s) had increased mucosal expression of GRP78, CHOP, IL6 and IL8. Similar results were obtained by inducing ER stress and the UPR in vitro. A-NEC-XBP1s patients showed altered T cell differentiation indicated by decreased mucosal expression of RORC, IL17A and FOXP3. A-NEC-XBP1s patients additionally showed more severe morphological damage and a worse surgical outcome. Compared with A-NEC patients, R-NEC patients showed lower mucosal IL6 and IL8 expression and higher mucosal FOXP3 expression. Conclusions: XBP1 splicing, ER stress and the UPR in NEC are associated with increased IL6 and IL8 expression levels, altered T cell differentiation and severe epithelial injury.	[Lu, Peng; Witte-Bouma, Janneke; Korteland-van Male, Anita M.; de Bruijn, Adrianus C. J. M.; Renes, Ingrid B.] Erasmus MC Sophia, Div Neonatol, Dept Pediat, Rotterdam, Netherlands; [Lu, Peng; van Goudoever, Johannes B.; Renes, Ingrid B.] Emma Childrens Hosp AMC, Dept Pediat, Amsterdam, Netherlands; [Struijs, Marie-Chantal] Erasmus MC Sophia, Dept Pediat Surg, Rotterdam, Netherlands; [Mei, Jiaping] Southern Med Univ, Neonatal Intens Care Unit, Shenzhen Maternal & Child Healthcare Hosp, Affiliated Hosp, Shenzhen, Guangdong, Peoples R China; [van Goudoever, Johannes B.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Southern Medical University - China; Vrije Universiteit Amsterdam	Renes, IB (corresponding author), Erasmus MC Sophia, Div Neonatol, Dept Pediat, Rotterdam, Netherlands.	i.b.renes@amc.uva.nl	Renes, Ingrid/C-4801-2013; van Goudoever, Johannes Bernard/Y-4520-2018	van Goudoever, Johannes (Hans)/0000-0003-3960-1703				Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berman L, 2011, SEMIN FETAL NEONAT M, V16, P145, DOI 10.1016/j.siny.2011.02.002; Black A, 2012, EUR J IMMUNOL, V42, P311, DOI 10.1002/eji.201141847; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Chang SH, 2010, J BIOL CHEM, V285, P38751, DOI 10.1074/jbc.C110.185777; Coutinho HB, 1998, J CLIN PATHOL, V51, P512, DOI 10.1136/jcp.51.7.512; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; Goepfert AR, 2004, AM J OBSTET GYNECOL, V191, P1375, DOI 10.1016/j.ajog.2004.06.086; Gregory Katherine E, 2011, Adv Neonatal Care, V11, P155, DOI 10.1097/ANC.0b013e31821baaf4; Guner YS, 2011, LAB INVEST, V91, P1668, DOI 10.1038/labinvest.2011.113; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Harris MC, 2005, J PEDIATR-US, V147, P462, DOI 10.1016/j.jpeds.2005.04.037; HARRIS MC, 1994, J PEDIATR-US, V124, P105, DOI 10.1016/S0022-3476(94)70264-0; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lu P, 2011, INFLAMM BOWEL DIS, V17, P2047, DOI 10.1002/ibd.21592; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Mallow EB, 1996, J BIOL CHEM, V271, P4038; Markel TA, 2006, SHOCK, V25, P329, DOI 10.1097/01.shk.0000192126.33823.87; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; MORECROFT J, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13235.x; MORECROFT JA, 1994, J PEDIATR SURG, V29, P798, DOI 10.1016/0022-3468(94)90374-3; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; OUELLETTE AJ, 2010, NEOREV, V11, pE551, DOI DOI 10.1542/NE0.11-10-E551; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Putman PJ, 2011, PEDIATR RES, V69, P217, DOI 10.1203/PDR.0b013e3182092a9a; Ribeiro Carla M P, 2010, Proc Am Thorac Soc, V7, P387, DOI 10.1513/pats.201001-017AW; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; Schaart MW, 2009, J PEDIATR GASTR NUTR, V49, P31, DOI 10.1097/MPG.0b013e318186d341; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	45	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78491	10.1371/journal.pone.0078491	http://dx.doi.org/10.1371/journal.pone.0078491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194940	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000119
J	Pereira, M; Verma, CS; Fuentes, G				Pereira, Mariana; Verma, Chandra S.; Fuentes, Gloria			Differences in the Binding Affinities of ErbB Family: Heterogeneity in the Prediction of Resistance Mutants	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; MOLECULAR-DYNAMICS; GENERALIZED BORN; LAPATINIB; MODEL; AMBER; EGFR; SIMULATIONS	The pressure exerted by drugs targeted to a protein in any therapy inevitably leads to the emergence of drug resistance. One major mechanism of resistance involves the mutation of key residues in the target protein. Drugs that competitively replace a natural substrate are often made ineffective by mutations that reduce the drug's affinity relative to that of the natural substrate. Hence atomic level understanding of the mechanisms that underlie this behavior is of utmost importance in efforts to design new drugs that can target such mutant proteins. Methods that can predict these mutations before they appear in clinic would be a major advance in the selection of the appropriate treatment strategy in patients. The present computational approach aims to model this emergence in EGFR and ErbB2 after treatment with the drug lapatinib, by investigating the structural, dynamic and energetic effects on these kinases when bound to the natural substrate ATP and to lapatinib. The study reveals binding modes and subpopulations that are presumably normally cryptic and these have been analyzed extensively here with respect to sites that are predicted to be hotspots for resisting mutations. These positions are compared in the context of currently available data from laboratory-based experiments and mechanistic details, at the atomistic level, of the origin of resistance are developed. The prediction of novel mutations, if validated by their emergence in the clinic, will make these methods as a powerful predictive tool which can be used in the design of new kinase inhibitors.	[Pereira, Mariana; Verma, Chandra S.; Fuentes, Gloria] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Verma, CS (corresponding author), Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg; gfuentes@bii.a-star.edu.sg			Biomedical Sciences Institutes, Singapore	Biomedical Sciences Institutes, Singapore	Funding provided by The Biomedical Sciences Institutes, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 2008, BIOCHEM J, V415, P197, DOI 10.1042/BJ20080728; Balius TE, 2009, BIOCHEMISTRY-US, V48, P8435, DOI 10.1021/bi900729a; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Boyce SE, 2009, J MOL BIOL, V394, P747, DOI 10.1016/j.jmb.2009.09.049; Case DA, 2012, AMBER 12; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eck MJ, 2010, BBA-PROTEINS PROTEOM, V1804, P559, DOI 10.1016/j.bbapap.2009.12.010; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hayes JM, 2011, PROTEINS, V79, P703, DOI 10.1002/prot.22890; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YL, 2012, BIOCHEMISTRY-US, V51, P2390, DOI 10.1021/bi2016553; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Muzzioli E, 2011, CHEM BIOL DRUG DES, V78, P252, DOI 10.1111/j.1747-0285.2011.01140.x; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Rusnak DW, 2001, MOL CANCER THER, V1, P85; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schrodinger LCC, 2010, PYMOL MOL GRAPHICS S; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Spector N, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1652; Strausberg RL, 2004, NATURE, V429, P469, DOI 10.1038/nature02627; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Xia W, 2006, P NATL ACAD SCI USA, V103, P7795, DOI 10.1073/pnas.0602468103; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou WZ, 2012, J CHEM INF MODEL, V52, P2319, DOI 10.1021/ci300341v	37	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77054	10.1371/journal.pone.0077054	http://dx.doi.org/10.1371/journal.pone.0077054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194858	Green Published, gold			2022-12-25	WOS:000326037000037
J	Vivek, PJ; Tuteja, N; Soniya, EV				Vivek, Padmanabhan Jayanthi; Tuteja, Narendra; Soniya, Eppurathu Vasudevan			CDPK1 from Ginger Promotes Salinity and Drought Stress Tolerance without Yield Penalty by Improving Growth and Photosynthesis in Nicotiana tabacum	PLOS ONE			English	Article							DEPENDENT-PROTEIN-KINASE; CALMODULIN-LIKE DOMAIN; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; LOW-TEMPERATURE; OVER-EXPRESSION; GENE-EXPRESSION; CROSS-TALK; PLANT; COLD	In plants, transient changes in calcium concentrations of cytosol have been observed during stress conditions like high salt, drought, extreme temperature and mechanical disturbances. Calcium-dependent protein kinases (CDPKs) play important roles in relaying these calcium signatures into downstream effects. In this study, a stress-responsive CDPK gene, ZoCDPK1 was isolated from a stress cDNA generated from ginger using rapid amplification of cDNA ends (RLM-RACE) - PCR technique and characterized its role in stress tolerance. An important aspect seen during the analysis of the deduced protein is a rare coupling between the presence of a nuclear localization sequence in the junction domain and consensus sequence in the EF-hand loops of calmodulin-like domain. ZoCDPK1 is abundantly expressed in rhizome and is rapidly induced by high-salt stress, drought, and jasmonic acid treatment but not by low temperature stress or abscissic acid treatment. The sub-cellular localization of ZoCDPK1-GFP fusion protein was studied in transgenic tobacco epidermal cells using confocal laser scanning microscopy. Over-expression of ginger CDPK1 gene in tobacco conferred tolerance to salinity and drought stress as reflected by the high percentage of seed germination, higher relative water content, expression of stress responsive genes, higher leaf chlorophyll content, increased photosynthetic efficiency and other photosynthetic parameters. In addition, transgenic tobacco subjected to salinity/drought stress exhibited 50% more growth during stress conditions as compared to wild type plant during normal conditions. T3 transgenic plants are able to grow to maturity, flowers early and set viable seeds under continuous salinity or drought stress without yield penalty. The ZoCDPK1 up-regulated the expression levels of stress-related genes RD21A and ERD1 in tobacco plants. These results suggest that ZoCDPK1 functions in the positive regulation of the signaling pathways that are involved in the response to salinity and drought stress in ginger and it is likely operating in a DRE/CRT independent manner.	[Vivek, Padmanabhan Jayanthi; Soniya, Eppurathu Vasudevan] Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thiruvananthapuram, Kerala, India; [Tuteja, Narendra] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Soniya, EV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Plant Mol Biol Div, Thiruvananthapuram, Kerala, India.	evsoniya@rgcb.res.in			Kerala State Council for Science, Technology and Environment [1418/C3/06/KSCSTE]; University Grant Commission (UGC), New Delhi, India [10-2(5)/2005(ii)-E.U.II]	Kerala State Council for Science, Technology and Environment; University Grant Commission (UGC), New Delhi, India(University Grants Commission, India)	The current work was supported by Kerala State Council for Science, Technology and Environment [grant number: 1418/C3/06/KSCSTE]. P. J. Vivek received fellowship from University Grant Commission (UGC), New Delhi, India [F.No. 10-2(5)/2005(ii)-E.U.II]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Anil VS, 2000, PLANT PHYSIOL, V122, P1035, DOI 10.1104/pp.122.4.1035; Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Asano T, 2012, PLANT SIGNAL BEHAV, V7, P817, DOI 10.4161/psb.20351; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; Chung E, 2007, PLANT PATHOLOGY J, V23, P76, DOI 10.5423/PPJ.2007.23.2.076; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Dang HQ, 2011, PLANT MOL BIOL, V76, P19, DOI 10.1007/s11103-011-9758-0; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; GANG DR, 2008, GENOMICS TROPICAL CR; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Goel D, 2010, PROTOPLASMA, V245, P133, DOI 10.1007/s00709-010-0158-0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harmon AC, 2000, TRENDS PLANT SCI, V5, P154, DOI 10.1016/S1360-1385(00)01577-6; Harmon Alice C, 2003, Gravit Space Biol Bull, V16, P83; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hubbard KE, 2012, ANN BOT-LONDON, V109, P5, DOI 10.1093/aob/mcr252; Jaworski K, 2012, J PLANT PHYSIOL, V169, P1578, DOI 10.1016/j.jplph.2012.05.025; Kasuga M, 2004, PLANT CELL PHYSIOL, V45, P346, DOI 10.1093/pcp/pch037; KIYOSUE T, 1993, BIOCHEM BIOPH RES CO, V196, P1214, DOI 10.1006/bbrc.1993.2381; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Komatsu S, 2007, MOL GENET GENOMICS, V277, P713, DOI 10.1007/s00438-007-0220-6; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu GS, 2006, PLANT CELL ENVIRON, V29, P2091, DOI 10.1111/j.1365-3040.2006.01582.x; Lu SX, 2002, PLANT PHYSIOL, V128, P1008, DOI 10.1104/pp.010770; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Mechin Valerie, 2007, V355, P1; MEHLMER N, 2010, PLANT J, P97378; Milla MAR, 2006, FEBS LETT, V580, P904, DOI 10.1016/j.febslet.2006.01.013; Garcia MNM, 2012, PLANTA, V235, P761, DOI 10.1007/s00425-011-1540-7; Nakashima K, 1997, PLANT J, V12, P851, DOI 10.1046/j.1365-313X.1997.12040851.x; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Patharkar OR, 2006, PLANTA, V225, P57, DOI 10.1007/s00425-006-0330-0; PICAL C, 1993, FEBS LETT, V336, P347, DOI 10.1016/0014-5793(93)80835-I; Prakash SRS, 2006, J PLANT PHYSIOL, V163, P1135, DOI 10.1016/j.jplph.2006.04.002; Raices M, 2003, PLANT MOL BIOL, V52, P1011, DOI 10.1023/A:1025478315648; Raichaudhuri A, 2006, J BIOL CHEM, V281, P10399, DOI 10.1074/jbc.M511001200; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rutschmann F, 2002, PLANT PHYSIOL, V129, P156, DOI 10.1104/pp.000869; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Silva EN, 2010, J PLANT PHYSIOL, V167, P1157, DOI 10.1016/j.jplph.2010.03.005; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Tuteja N, 2010, METHODS MOL BIOL, V587, P377, DOI 10.1007/978-1-60327-355-8_26; Ulloa RM, 2002, PHYSIOL PLANTARUM, V115, P417, DOI 10.1034/j.1399-3054.2002.1150312.x; URAO T, 1994, MOL GEN GENET, V244, P331, DOI 10.1007/BF00286684; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Wurzinger B, 2011, PLANT SIGNAL BEHAV, V6, P8, DOI 10.4161/psb.6.1.14012; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Xu J, 2010, PLANTA, V231, P1251, DOI 10.1007/s00425-010-1122-0; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yoon GM, 1999, PLANT MOL BIOL, V39, P991, DOI 10.1023/A:1006170512542; Yu XC, 2006, PLANT PHYSIOL, V140, P558, DOI 10.1104/pp.105.074971; Zhao R, 2011, NEW PHYTOL, V192, P61, DOI 10.1111/j.1469-8137.2011.03793.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	82	42	45	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76392	10.1371/journal.pone.0076392	http://dx.doi.org/10.1371/journal.pone.0076392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194837	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000016
J	Dirks-Hofmeister, ME; Kolkenbrock, S; Moerschbacher, BM				Dirks-Hofmeister, Mareike E.; Kolkenbrock, Stephan; Moerschbacher, Bruno M.			Parameters That Enhance the Bacterial Expression of Active Plant Polyphenol Oxidases	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVATION; CLONING; PURIFICATION; ISOFORM; PROTEIN	Polyphenol oxidases (PPOs, EC 1.10.3.1) are type-3 copper proteins that enzymatically convert diphenolic compounds into their corresponding quinones. Although there is significant interest in these enzymes because of their role in food deterioration, the lack of a suitable expression system for the production of soluble and active plant PPOs has prevented detailed investigations of their structure and activity. Recently we developed a bacterial expression system that was sufficient for the production of PPO isoenzymes from dandelion (Taraxacum officinale). The system comprised the Escherichia coli Rosetta 2 (DE3) [pLysSRARE2] strain combined with the pET-22b(+)-vector cultivated in auto-induction medium at a constant low temperature (26 degrees C). Here we describe important parameters that enhance the production of active PPOs using dandelion PPO-2 for proof of concept. Low-temperature cultivation was essential for optimal yields, and the provision of CuCl2 in the growth medium was necessary to produce an active enzyme. By increasing the copper concentration in the production medium to 0.2 mM, the yield in terms of PPO activity per mol purified protein was improved 2.7-fold achieving a v(max) of 0.48 +/- 0.1 mu kat per mg purified PPO-2 for 4-methylcatechol used as a substrate. This is likely to reflect the replacement of an inactive apo-form of the enzyme with a correctly-folded, copper-containing counterpart. We demonstrated the transferability of the method by successfully expressing a PPO from tomato (Solanum lycopersicum) showing that our optimized system is suitable for the analysis of further plant PPOs. Our new system therefore provides greater opportunities for the future of research into this economically-important class of enzymes.	[Dirks-Hofmeister, Mareike E.; Kolkenbrock, Stephan; Moerschbacher, Bruno M.] Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany	University of Munster	Dirks-Hofmeister, ME (corresponding author), Univ Munster, Dept Plant Biol & Biotechnol, D-48149 Munster, Germany.	m.dirks-hofmeister@uni-muenster.de	Moerschbacher, Bruno M/C-2012-2017	Dirks-Hofmeister, Mareike E./0000-0002-9634-6932				BACHEM CWB, 1994, BIO-TECHNOL, V12, P1101, DOI 10.1038/nbt1194-1101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Decker H, 2000, J EXP BIOL, V203, P1777; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Dirks-Hofmeister ME, 2012, PLANT MOL BIOL, V80, P203, DOI 10.1007/s11103-012-9943-9; Espin JC, 1999, J AGR FOOD CHEM, V47, P3518, DOI 10.1021/jf981275p; Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Francis D, 2010, CURRENT PROTOCOLS PR, V61; Harrison MD, 2000, TRENDS BIOCHEM SCI, V25, P29, DOI 10.1016/S0968-0004(99)01492-9; Haruta M, 1998, BIOSCI BIOTECH BIOCH, V62, P358, DOI 10.1271/bbb.62.358; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Koussevitzky S, 2008, PHYSIOL PLANTARUM, V133, P266, DOI 10.1111/j.1399-3054.2008.01074.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu JW, 2010, J SCI FOOD AGR, V90, P2490, DOI 10.1002/jsfa.4111; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Marusek CM, 2006, J INORG BIOCHEM, V100, P108, DOI 10.1016/j.jinorgbio.2005.10.008; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; MOORE BM, 1990, J BIOL CHEM, V265, P4982; Rasband W., 2006, IMAGEJ; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Richter C, 2012, MOL PLANT MICROBE IN, V25, P200, DOI 10.1094/MPMI-04-11-0082; Shin CS, 1998, APPL MICROBIOL BIOT, V49, P364, DOI 10.1007/s002530051183; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sullivan ML, 2004, PLANT PHYSIOL, V136, P3234, DOI 10.1104/pp.104.047449; Telgmann L, 2011, METALLOMICS, V3, P1035, DOI 10.1039/c1mt00054c; Tran LT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-395; Virador VM, 2010, J AGR FOOD CHEM, V58, P1189, DOI 10.1021/jf902939q; Voulgaridou GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056582; Wu YL, 2010, J BIOTECHNOL, V145, P66, DOI 10.1016/j.jbiotec.2009.10.008; Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001	32	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77291	10.1371/journal.pone.0077291	http://dx.doi.org/10.1371/journal.pone.0077291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204791	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600027
J	Nakajima, T; Mezzarane, RA; Klarner, T; Barss, TS; Hundza, SR; Komiyama, T; Zehr, EP				Nakajima, Tsuyoshi; Mezzarane, Rinaldo A.; Klarner, Taryn; Barss, Trevor S.; Hundza, Sandra R.; Komiyama, Tomoyoshi; Zehr, E. Paul			Neural Mechanisms Influencing Interlimb Coordination during Locomotion in Humans: Presynaptic Modulation of Forearm H-Reflexes during Leg Cycling	PLOS ONE			English	Article							CUTANEOUS REFLEXES; MUSCLE AFFERENTS; INHIBITION; ARM; AMPLITUDE; MOVEMENT; SUPPRESSION; FEEDBACK; GAIN	Presynaptic inhibition of transmission between Ia afferent terminals and alpha motoneurons (Ia PSI) is a major control mechanism associated with soleus H-reflex modulation during human locomotion. Rhythmic arm cycling suppresses soleus H-reflex amplitude by increasing segmental Ia PSI. There is a reciprocal organization in the human nervous system such that arm cycling modulates H-reflexes in leg muscles and leg cycling modulates H-reflexes in forearm muscles. However, comparatively little is known about mechanisms subserving the effects from leg to arm. Using a conditioning-test (C-T) stimulation paradigm, the purpose of this study was to test the hypothesis that changes in Ia PSI underlie the modulation of H-reflexes in forearm flexor muscles during leg cycling. Subjects performed leg cycling and static activation while H-reflexes were evoked in forearm flexor muscles. H-reflexes were conditioned with either electrical stimuli to the radial nerve (to increase Ia PSI; C-T interval = 20 ms) or to the superficial radial (SR) nerve (to reduce Ia PSI; C-T interval = 37-47 ms). While stationary, H-reflex amplitudes were significantly suppressed by radial nerve conditioning and facilitated by SR nerve conditioning. Leg cycling suppressed H-reflex amplitudes and the amount of this suppression was increased with radial nerve conditioning. SR conditioning stimulation removed the suppression of H-reflex amplitude resulting from leg cycling. Interestingly, these effects and interactions on H-reflex amplitudes were observed with subthreshold conditioning stimulus intensities (radial n. similar to 0.6xMT; SR n., similar to perceptual threshold) that did not have clear post synaptic effects. That is, did not evoke reflexes in the surface EMG of forearm flexor muscles. We conclude that the interaction between leg cycling and somatosensory conditioning of forearm H-reex amplitudes is mediated by modulation of Ia PSI pathways. Overall our results support a conservation of neural control mechanisms between the arms and legs during locomotor behaviors in humans.	[Nakajima, Tsuyoshi] Kyorin Univ, Sch Med, Dept Integrat Physiol, Mitaka, Tokyo 181, Japan; [Nakajima, Tsuyoshi; Mezzarane, Rinaldo A.; Klarner, Taryn; Barss, Trevor S.; Zehr, E. Paul] Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada; [Nakajima, Tsuyoshi] Univ Brasilia, Coll Phys Educ, Lab Signal Proc & Motor Control, Brasilia, DF, Brazil; [Klarner, Taryn; Barss, Trevor S.; Hundza, Sandra R.; Zehr, E. Paul] Int Collaborat Repair Discoveries ICORD, Human Discovery Sci, Vancouver, BC, Canada; [Klarner, Taryn; Barss, Trevor S.; Hundza, Sandra R.; Zehr, E. Paul] Univ Victoria, Ctr Biomed Res, Victoria, BC, Canada; [Hundza, Sandra R.] Univ Victoria, Mot & Mobil Lab, Victoria, BC, Canada; [Komiyama, Tomoyoshi] Chiba Univ, Div Sports & Hlth Sci, Chiba, Japan; [Zehr, E. Paul] Univ Victoria, Div Med Sci, Victoria, BC, Canada	Kyorin University; University of Victoria; Universidade de Brasilia; University of Victoria; University of Victoria; Chiba University; University of Victoria	Zehr, EP (corresponding author), Univ Victoria, Rehabil Neurosci Lab, Victoria, BC, Canada.	pzehr@uvic.ca	MEZZARANE, Rinaldo A/I-2862-2013; Barss, Trevor/L-7045-2019	Barss, Trevor/0000-0003-3466-2750; Mezzarane, Rinaldo/0000-0001-9659-4015	Japan Society for the Promotion of Science (JSPS) for young Scientists; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada (BC Yukon)	Japan Society for the Promotion of Science (JSPS) for young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada (BC Yukon)(Heart & Stroke Foundation of Canada)	Japan Society for the Promotion of Science (JSPS) for young Scientists; the Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada (BC & Yukon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERARDELLI A, 1987, J PHYSIOL-LONDON, V391, P71, DOI 10.1113/jphysiol.1987.sp016726; Brooke JD, 2006, EXERC SPORT SCI REV, V34, P22, DOI 10.1097/00003677-200601000-00006; Brooke JD, 1997, PROG NEUROBIOL, V51, P393, DOI 10.1016/S0301-0082(96)00061-5; CALANCIE B, 1994, BRAIN, V117, P1143, DOI 10.1093/brain/117.5.1143; CAPADAY C, 1995, CAN J PHYSIOL PHARM, V73, P436, DOI 10.1139/y95-056; Cote MP, 2003, J NEUROSCI, V23, P2789; de Ruiter GC, 2010, NEUROSCI LETT, V475, P7, DOI 10.1016/j.neulet.2010.03.025; Dietz V, 2002, TRENDS NEUROSCI, V25, P462, DOI 10.1016/S0166-2236(02)02229-4; ECCLES JC, 1962, J PHYSIOL-LONDON, V161, P258, DOI 10.1113/jphysiol.1962.sp006885; Frigon A, 2004, J NEUROPHYSIOL, V91, P1516, DOI 10.1152/jn.00695.2003; FUKUSHIMA Y, 1982, J NEUROPHYSIOL, V48, P1079, DOI 10.1152/jn.1982.48.5.1079; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757, DOI 10.1113/jphysiol.1987.sp016681; Hundza SR, 2012, J NEUROPHYSIOL, V108, P3049, DOI 10.1152/jn.00485.2011; Hundza SR, 2009, EXP BRAIN RES, V193, P297, DOI 10.1007/s00221-008-1625-0; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Klarner T, 2011, SOC NEUR M; Loadman PM, 2007, EXP BRAIN RES, V179, P199, DOI 10.1007/s00221-006-0782-2; MATTHEWS PBC, 1986, J PHYSIOL-LONDON, V374, P73, DOI 10.1113/jphysiol.1986.sp016066; Mezzarane RA, 2011, EXP BRAIN RES, V208, P157, DOI 10.1007/s00221-010-2467-0; Mezzarane RA, 2007, EXP BRAIN RES, V180, P377, DOI 10.1007/s00221-007-0865-8; Mezzarane RA, 2012, J NEUROPHYSIOL, V108, P1176, DOI 10.1152/jn.00831.2011; MIZUNO Y, 1971, J NEUROPHYSIOL, V34, P1010, DOI 10.1152/jn.1971.34.6.1010; Nakajima T, 2011, J NEUROPHYSIOL, V106, P1679, DOI 10.1152/jn.01049.2010; NAKASHIMA K, 1990, J PHYSIOL-LONDON, V426, P369, DOI 10.1113/jphysiol.1990.sp018143; Palomino AF, 2011, EXP BRAIN RES, V214, P529, DOI 10.1007/s00221-011-2851-4; Pang MYC, 2001, J PHYSIOL-LONDON, V533, P617, DOI 10.1111/j.1469-7793.2001.0617a.x; Pierrot-Deseilligny E, 2012, CIRCUITRY OF THE HUMAN SPINAL CORD: SPINAL AND CORTICOSPINAL MECHANISMS OF MOVEMENT, P334; RUDOMIN P, 1990, TRENDS NEUROSCI, V13, P499, DOI 10.1016/0166-2236(90)90084-N; Sakamoto M, 2007, EXP BRAIN RES, V176, P188, DOI 10.1007/s00221-006-0742-x; Sasada S, 2010, J NEUROPHYSIOL, V104, P210, DOI 10.1152/jn.00774.2009; Stein RB, 1995, PROG NEUROBIOL, V47, P533, DOI 10.1016/0301-0082(95)00036-4; STUART GJ, 1992, J PHYSIOL-LONDON, V447, P675, DOI 10.1113/jphysiol.1992.sp019023; Tazoe T, 2013, EUR J NEUROSCI, V37, P96, DOI 10.1111/ejn.12026; Tsushima E, 2007, ANAL MED DATA SPSS, P159; Zehr EP, 2007, NEUROSCI LETT, V419, P10, DOI 10.1016/j.neulet.2007.03.045; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6; Zehr EP, 1997, J NEUROPHYSIOL, V77, P3311, DOI 10.1152/jn.1997.77.6.3311; Zehr EP, 2004, NEUROSCIENTIST, V10, P347, DOI 10.1177/1073858404264680; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	39	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76313	10.1371/journal.pone.0076313	http://dx.doi.org/10.1371/journal.pone.0076313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204611	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300019
J	Onyango, LA; Dunstan, RH; Roberts, TK; Macdonald, MM; Gottfries, J				Onyango, Laura A.; Dunstan, R. Hugh; Roberts, Timothy K.; Macdonald, Margaret M.; Gottfries, Johan			Phenotypic Variants of Staphylococci and Their Underlying Population Distributions Following Exposure to Stress	PLOS ONE			English	Article							SMALL-COLONY VARIANTS; VANCOMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CELL-SIZE; AUREUS; INFECTIONS; EPIDERMIDIS; BACTERIA; MODEL; WALL	This study investigated whether alterations in environmental conditions would induce the formation of small colony variant phenotypes (SCV) with associated changes in cell morphology and ultra-structure in S. aureus, s. epidermidis, and S. lugdunensis. Wild-type clinical isolates were exposed to low temperature (4 degrees C), antibiotic stress (penicillin G and vancomycin; 0-10,000 mu g mL(-1)), pH stress (pH 3-9) and osmotic challenge (NaCl concentrations of 0-20%). Changes in cell diameter, cell-wall thickness, and population distribution changes (n >= 300) were assessed via scanning and transmission electron microscopy (SEM and TEM), and compared to control populations. Our analyses found that prolonged exposure to all treatments resulted in the subsequent formation of SCV phenotypes. Observed SCVs manifested as minute colonies with reduced haemolysis and pigmentation (NaCl, pH and 4 degrees C treatments), or complete lack thereof (antibiotic treatments). SEM comparison analyses revealed significantly smaller cell sizes for SCV populations except in S. aureus and S. epidermidis 10% NaCl, and S. epidermidis 4 degrees C (p<0.05). Shifts in population distribution patterns were also observed with distinct sub-populations of smaller cells appearing for S. epidermidis, and S. lugdunensis. TEM analyses revealed significantly thicker cell-walls in all treatments and species except S. lugdunensis exposed to 4 degrees C. These findings suggest that staphylococci adapted to environmental stresses by altering their cell size and wall thickness which could represent the formation of altered phenotypes which facilitate survival under harsh conditions. The phenotypic response was governed by the type of prevailing environmental stress regime leading to appropriate alterations in ultra-structure and size, suggesting downstream changes in gene expression, the proteome, and metabolome.	[Onyango, Laura A.; Dunstan, R. Hugh; Roberts, Timothy K.; Macdonald, Margaret M.] Univ Newcastle, Environm & Pathogen Microbiol Lab, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia; [Gottfries, Johan] Gothenburg Univ, Dept Chem, Gothenburg, Sweden	University of Newcastle; University of Gothenburg	Onyango, LA (corresponding author), Univ Newcastle, Environm & Pathogen Microbiol Lab, Sch Environm & Life Sci, Newcastle, NSW 2300, Australia.	lauraonyango@yahoo.ca	Onyango, Laura A./H-4675-2019; Gottfries, Johan/M-3445-2016; Roberts, Tim K/A-4286-2009	Gottfries, Johan/0000-0001-7135-4664; Onyango, Laura/0000-0002-5240-2023	University of Newcastle International Scholarship; Gideon Lang Scholarship; Harold Stannet Williams and Judith Mason Research Foundation	University of Newcastle International Scholarship; Gideon Lang Scholarship; Harold Stannet Williams and Judith Mason Research Foundation	This work was partially supported via a University of Newcastle International Scholarship and Gideon Lang Scholarship, and additional funding from the Harold Stannet Williams and Judith Mason Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist E, 1922, J INFECT DIS, V31, P483, DOI 10.1093/infdis/31.5.483; Baatout S, 2007, ACTA ASTRONAUT, V60, P451, DOI 10.1016/j.actaastro.2006.09.012; BADDOUR LM, 1987, REV INFECT DIS, V9, P1168; BADDOUR LM, 1988, J INFECT DIS, V157, P757, DOI 10.1093/infdis/157.4.757; Bergamini TM, 1996, J SURG RES, V60, P3, DOI 10.1006/jsre.1996.0002; Brown GK, 2001, AUST VET J, V79, P554, DOI 10.1111/j.1751-0813.2001.tb10747.x; Butt HL, 1998, J MED MICROBIOL, V47, P577, DOI 10.1099/00222615-47-7-577; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Fabian FW, 1933, J BACTERIOL, V26, P543, DOI 10.1128/JB.26.6.543-558.1933; FAX CA, 2003, EXPERT REV ANTI-INFE, V4, P667; GOUDIE JG, 1955, J CLIN PATHOL, V8, P284, DOI 10.1136/jcp.8.4.284; HADLEY P, 1926, J INFECT DIS, V40, P4465; HALE JH, 1951, BRIT J EXP PATHOL, V32, P307; Hoffstadt RE, 1932, J INFECT DIS, V51, P216, DOI 10.1093/infdis/51.2.216; HOGT AH, 1983, FEMS MICROBIOL LETT, V18, P211; Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003; Kipp F, 2004, J CLIN MICROBIOL, V42, P1277, DOI 10.1128/JCM.42.3.1277-1279.2004; Leung MJ, 1998, J CLIN MICROBIOL, V36, P3096, DOI 10.1128/JCM.36.10.3096-3098.1998; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; Morita RY, 1997, BACTERIA OLIGOTROPHI, P193; Neut D, 2007, ACTA ORTHOP, V78, P299, DOI 10.1080/17453670710013843; Onyango LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029031; Onyango Laura A, 2010, BMC Res Notes, V3, P152, DOI 10.1186/1756-0500-3-152; Onyango Laura A., 2008, Journal of Nutritional & Environmental Medicine (Abingdon), V17, P56, DOI 10.1080/13590840801887272; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Prescott L. M., 2002, MICROBIOLOGY, P5; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Proctor RA, 1998, CLIN INFECT DIS, V27, P419, DOI 10.1086/514706; Schaaff F, 2003, INT J MED MICROBIOL, V293, P427, DOI 10.1078/1438-4221-00282; Seaman PF, 2007, J ANTIMICROB CHEMOTH, V59, P43, DOI 10.1093/jac/dkl450; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; Vesga O, 1996, J INFECT DIS, V173, P739, DOI 10.1093/infdis/173.3.739; VIJARANAKUL U, 1995, J BACTERIOL, V177, P5116, DOI 10.1128/jb.177.17.5116-5121.1995; von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006; von Eiff Christof, 2003, P253; vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; WISE RI, 1956, ANN NY ACAD SCI, V65, P169, DOI 10.1111/j.1749-6632.1956.tb36636.x; WISE RI, 1954, J CLIN INVEST, V33, P1611, DOI 10.1172/JCI103041	42	45	45	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77614	10.1371/journal.pone.0077614	http://dx.doi.org/10.1371/journal.pone.0077614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204894	gold, Green Published			2022-12-25	WOS:000326029300106
J	Borgeling, Y; Schmolke, M; Viemann, D; Nordhoff, C; Roth, J; Ludwig, S				Boergeling, Yvonne; Schmolke, Mirco; Viemann, Dorothee; Nordhoff, Carolin; Roth, Johannes; Ludwig, Stephan			Inhibition of p38 Mitogen-activated Protein Kinase Impairs Influenza Virus-induced Primary and Secondary Host Gene Responses and Protects Mice from Lethal H5N1 Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelium; Influenza Virus; Interferon; p38 MAPK; STAT Transcription Factor; JAK; STAT Signaling; Highly Pathogenic Avian Influenza Virus (HPAIV); Hypercytokinemia	NF-KAPPA-B; MAP KINASE; A VIRUS; TRANSCRIPTIONAL ACTIVATION; INDUCED PHOSPHORYLATION; SERINE PHOSPHORYLATION; ANTIVIRAL RESPONSES; REGULATORY FACTOR-3; EXPRESSION; INTERFERON	Highly pathogenic avian influenza viruses (HPAIV) induce severe inflammation in poultry and men. One characteristic of HPAIV infections is the induction of a cytokine burst that strongly contributes to viral pathogenicity. This cell-intrinsic hypercytokinemia seems to involve hyperinduction of p38 mitogen-activated protein kinase. Here we investigate the role of p38 MAPK signaling in the antiviral response against HPAIV in mice as well as in human endothelial cells, the latter being a primary source of cytokines during systemic infections. Global gene expression profiling of HPAIV-infected endothelial cells in the presence of the p38-specific inhibitor SB 202190 revealed that inhibition of p38 MAPK leads to reduced expression of IFN and other cytokines after H5N1 and H7N7 infection. More than 90% of all virus-induced genes were either partially or fully dependent on p38 signaling. Moreover, promoter analysis confirmed a direct impact of p38 on the IFN promoter activity. Furthermore, upon treatment with IFN or conditioned media from HPAIV-infected cells, p38 controls interferon-stimulated gene expression by coregulating STAT1 by phosphorylation at serine 727. In vivo inhibition of p38 MAPK greatly diminishes virus-induced cytokine expression concomitant with reduced viral titers, thereby protecting mice from lethal infection. These observations show that p38 MAPK acts on two levels of the antiviral IFN response. Initially the kinase regulates IFN induction and, at a later stage, p38 controls IFN signaling and thereby expression of IFN-stimulated genes. Thus, inhibition of MAP kinase p38 may be an antiviral strategy that protects mice from lethal influenza by suppressing excessive cytokine expression.	[Boergeling, Yvonne; Schmolke, Mirco; Nordhoff, Carolin; Ludwig, Stephan] Univ Munster, Ctr Mol Biol Inflammat, Inst Mol Virol, D-48149 Munster, Germany; [Boergeling, Yvonne; Ludwig, Stephan] Univ Munster, Interdisciplinary Ctr Clin Res, D-48149 Munster, Germany; [Roth, Johannes; Ludwig, Stephan] Univ Munster, Cells Mot Cluster Excellence, D-48149 Munster, Germany; [Viemann, Dorothee; Roth, Johannes] Univ Munster, Inst Immunol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Ludwig, S (corresponding author), Ctr Mol Biol Inflammat, Inst Mol Virol, Von Esmarch Str 56, D-48149 Munster, Germany.	ludwigs@uni-muenster.de	Schmolke, Mirco/AAI-9081-2020	Schmolke, Mirco/0000-0002-2491-3029; Ludwig, Stephan/0000-0003-4490-3052; Viemann, Dorothee/0000-0002-9009-3559	Interdisciplinary Center for Clinical Research (IZKF) of the University of Muenster [Lud2/010/11]; Deutsche Forschungsgemeinschaft [Lu477/12-1, SFB 1009 TP B02]	Interdisciplinary Center for Clinical Research (IZKF) of the University of Muenster; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Interdisciplinary Center for Clinical Research (IZKF) of the University of Muenster (Lud2/010/11) and Deutsche Forschungsgemeinschaft Grants Lu477/12-1 and SFB 1009 TP B02.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Carr SM, 2006, VIROLOGY, V344, P492, DOI 10.1016/j.virol.2005.08.041; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dinarello CA, 2011, J INTERN MED, V269, P16, DOI 10.1111/j.1365-2796.2010.02313.x; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Flati V, 1996, EMBO J, V15, P1566, DOI 10.1002/j.1460-2075.1996.tb00501.x; Geiler J, 2011, MED MICROBIOL IMMUN, V200, P53, DOI 10.1007/s00430-010-0173-y; Goh KC, 1999, EMBO J, V18, P5601, DOI 10.1093/emboj/18.20.5601; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Horvath CM, 1996, J VIROL, V70, P647, DOI 10.1128/JVI.70.1.647-650.1996; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kang YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000934; KATZE MG, 1984, MOL CELL BIOL, V4, P2198, DOI 10.1128/MCB.4.10.2198; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Klenk HD, 2005, THROMB HAEMOSTASIS, V94, P262, DOI 10.1160/TH05-04-0264; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee N, 2007, CLIN INFECT DIS, V45, P723, DOI 10.1086/520981; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Mazur I, 2008, CELL MICROBIOL, V10, P1140, DOI 10.1111/j.1462-5822.2008.01116.x; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Nencioni L, 2009, J BIOL CHEM, V284, P16004, DOI 10.1074/jbc.M900146200; Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pilz A, 2003, EMBO REP, V4, P368, DOI 10.1038/sj.embor.embor802; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reimer T, 2007, J INTERF CYTOK RES, V27, P751, DOI 10.1089/jir.2007.0024; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Seyer R, 2012, J INFECT DIS, V205, P262, DOI 10.1093/infdis/jir716; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Uddin S, 2000, J BIOL CHEM, V275, P27634; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2011, J IMMUNOL, V186, P164, DOI 10.4049/jimmunol.0904170; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9	50	75	81	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					13	27		10.1074/jbc.M113.469239	http://dx.doi.org/10.1074/jbc.M113.469239			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24189062	Green Published, hybrid			2022-12-25	WOS:000329370900002
J	Kistler, AD; Singh, G; Altintas, MM; Yu, H; Fernandez, IC; Gu, CK; Wilson, C; Srivastava, SK; Dietrich, A; Walz, K; Kerjaschki, D; Ruiz, P; Dryer, S; Sever, S; Dinda, AK; Faul, C; Reiser, J				Kistler, Andreas D.; Singh, Geetika; Altintas, Mehmet M.; Yu, Hao; Fernandez, Isabel C.; Gu, Changkyu; Wilson, Cory; Srivastava, Sandeep Kumar; Dietrich, Alexander; Walz, Katherina; Kerjaschki, Dontscho; Ruiz, Phillip; Dryer, Stuart; Sever, Sanja; Dinda, Amit K.; Faul, Christian; Reiser, Jochen			Transient Receptor Potential Channel 6 (TRPC6) Protects Podocytes during Complement-mediated Glomerular Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; CaMKII; Complement; Kidney; Podocytes; TRP Channels; TRPC6; Membranous Nephropathy; Nephrotoxic Serum Nephritis	DECAY-ACCELERATING FACTOR; MEMBRANOUS NEPHROPATHY; SLIT DIAPHRAGM; ACTIN; INJURY; SYNAPTOPODIN; CONTRIBUTES; ACTIVATION; PODOCIN; CYTOSKELETON	Background: Activating mutations of the calcium channel TRPC6 lead to adult onset genetic kidney disease. Results: In acquired kidney diseases, increased TRPC6 expression protects kidney podocytes against complement-mediated injury. Conclusion: The effect, protective or nocuous, of TRPC6 in podocytes is context dependent. Significance: Pharmacologic inhibition of TRPC6 in acquired kidney disease may be detrimental. Gain-of-function mutations in the calcium channel TRPC6 lead to autosomal dominant focal segmental glomerulosclerosis and podocyte expression of TRPC6 is increased in some acquired human glomerular diseases, particularly in membranous nephropathy. These observations led to the hypothesis that TRPC6 overactivation is deleterious to podocytes through pathological calcium signaling, both in genetic and acquired diseases. Here, we show that the effects of TRPC6 on podocyte function are context-dependent. Overexpression of TRPC6 alone did not directly affect podocyte morphology and cytoskeletal structure. Unexpectedly, however, overexpression of TRPC6 protected podocytes from complement-mediated injury, whereas genetic or pharmacological TRPC6 inactivation increased podocyte susceptibility to complement. Mechanistically, this effect was mediated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation. Podocyte-specific TRPC6 transgenic mice showed stronger CaMKII activation, reduced podocyte foot process effacement and reduced levels of proteinuria during nephrotoxic serum nephritis, whereas TRPC6 null mice exhibited reduced CaMKII activation and higher levels of proteinuria compared with wild type littermates. Human membranous nephropathy biopsy samples showed podocyte staining for active CaMKII, which correlated with the degree of TRPC6 expression. Together, these data suggest a dual and context dependent role of TRPC6 in podocytes where acute activation protects from complement-mediated damage, but chronic overactivation leads to focal segmental glomerulosclerosis.	[Kistler, Andreas D.; Yu, Hao; Faul, Christian] Univ Miami, Dept Med, Div Nephrol & Hypertens, Miller Sch Med, Miami, FL 33136 USA; [Kistler, Andreas D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Singh, Geetika; Srivastava, Sandeep Kumar; Dinda, Amit K.] All India Inst Med Sci, Dept Pathol, New Delhi 110029, DL, India; [Altintas, Mehmet M.; Fernandez, Isabel C.; Reiser, Jochen] Rush Univ, Dept Med, Ctr Med, Chicago, IL 60612 USA; [Gu, Changkyu; Sever, Sanja] Harvard Univ, Sch Med, Dept Med, Nephrol Div, Charlestown, MA 02129 USA; [Gu, Changkyu; Sever, Sanja] Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Wilson, Cory; Dryer, Stuart] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Dietrich, Alexander] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany; [Walz, Katherina] Univ Miami, John P Hussman Inst Human Genom, Miller Sch Med, Miami, FL 33136 USA; [Kerjaschki, Dontscho] Med Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria; [Ruiz, Phillip] Univ Miami, Dept Surg, Miami, FL 33136 USA	University of Miami; University of Zurich; University Zurich Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Rush University; Harvard University; Harvard University; Massachusetts General Hospital; University of Houston System; University of Houston; University of Munich; University of Miami; Medical University of Vienna; University of Miami	Kistler, AD (corresponding author), Rush Univ, Dept Med, Ctr Med, 1735 W Harrison St,Cohn Res Bldg,Ste 724, Chicago, IL 60612 USA.	jochen_reiser@rush.edu	Dietrich, Alexander/G-8619-2013; srivastava, sandeep/ABH-3565-2022; Faul, Christian/AAG-7800-2022; Faul, Christian/AFL-7858-2022; Altintas, Mehmet Mete/ABI-5904-2020; Altintas, Mehmet Mete/T-5333-2018	Dietrich, Alexander/0000-0002-1168-8707; srivastava, sandeep/0000-0002-9965-2257; Faul, Christian/0000-0002-7512-0977; Faul, Christian/0000-0002-7512-0977; Altintas, Mehmet Mete/0000-0002-1871-6985; Kistler, Andreas/0000-0002-4114-9560; Wilson, Cory/0000-0003-3948-3831; SRIVASTAVA, SANDEEP/0000-0003-4484-0223	National Institutes of Health [DK073495, DK089394, DK101350]; Swiss National Science Foundation; Swiss Society for Medical and Biological Scholarships; Amgen-FROMO scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101350, R01DK089394, R01DK073495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society for Medical and Biological Scholarships; Amgen-FROMO scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Grants DK073495, DK089394, and DK101350 from the National Institutes of Health (to J. R.).; Supported by a grant from the Swiss National Science Foundation, a grant from the Swiss Society for Medical and Biological Scholarships, and an Amgen-FROMO scholarship. To whom correspondence may be addressed: University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland. Tel.: 41-44-255-13-89; Fax: 41-44-255-45-93.	Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Chiluiza D, 2013, J BIOL CHEM, V288, P18407, DOI 10.1074/jbc.M113.463059; Cybulsky AV, 2011, CONTRIB NEPHROL, V169, P107, DOI 10.1159/000313948; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; CYBULSKY AV, 1989, AM J PHYSIOL, V257, pF826, DOI 10.1152/ajprenal.1989.257.5.F826; CYBULSKY AV, 1990, KIDNEY INT, V38, P803, DOI 10.1038/ki.1990.274; Debiec H, 2011, NEW ENGL J MED, V364, P2101, DOI 10.1056/NEJMoa1013792; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Glassock RJ, 2012, CURR OPIN NEPHROL HY, V21, P235, DOI 10.1097/MNH.0b013e3283522ea8; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Hebert MJ, 1998, NEPHROL DIAL TRANSPL, V13, P2799, DOI 10.1093/ndt/13.11.2799; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jefferson J Ashley, 2010, Drug Discov Today Dis Models, V7, P27, DOI 10.1016/j.ddmod.2010.11.001; Kerjaschki D, 1997, J CLIN INVEST, V100, P2303, DOI 10.1172/JCI119768; Kim EY, 2013, AM J PHYSIOL-CELL PH, V305, pC960, DOI 10.1152/ajpcell.00191.2013; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Laude AJ, 2009, FEBS J, V276, P1800, DOI 10.1111/j.1742-4658.2009.06927.x; Lavin PJ, 2008, CURR OPIN NEPHROL HY, V17, P386, DOI 10.1097/MNH.0b013e32830464f4; Lin F, 2004, J IMMUNOL, V172, P2636, DOI 10.4049/jimmunol.172.4.2636; Lin F, 2002, LAB INVEST, V82, P563, DOI 10.1038/labinvest.3780451; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Moller CC, 2009, J AM SOC NEPHROL, V20, P950, DOI 10.1681/ASN.2008030329; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Ophascharoensuk V, 1998, KIDNEY INT, V54, P416, DOI 10.1046/j.1523-1755.1998.00003.x; Quigg RJ, 1998, J EXP MED, V188, P1321, DOI 10.1084/jem.188.7.1321; Quigg RJ, 1998, J IMMUNOL, V160, P4553; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Skelding KA, 2009, NEUROCHEM RES, V34, P1792, DOI 10.1007/s11064-009-9985-9; Takano T, 2000, AM J PATHOL, V156, P2091, DOI 10.1016/S0002-9440(10)65080-8; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Turnberg D, 2003, J AM SOC NEPHROL, V14, P2271, DOI 10.1097/01.ASN.0000083901.47783.2E; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215	51	32	34	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36598	36609		10.1074/jbc.M113.488122	http://dx.doi.org/10.1074/jbc.M113.488122			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24194522	Green Published, hybrid			2022-12-25	WOS:000328883400040
J	Kichine, E; Di Falco, M; Hales, BF; Robaire, B; Chan, P				Kichine, Elsa; Di Falco, Marcos; Hales, Barbara F.; Robaire, Bernard; Chan, Peter			Analysis of the Sperm Head Protein Profiles in Fertile Men: Consistency across Time in the Levels of Expression of Heat Shock Proteins and Peroxiredoxins	PLOS ONE			English	Article							UBIQUITIN LIGASE COMPLEX; NUCLEAR-MATRIX; HUMAN SPERMATOZOA; STATISTICAL-MODEL; MASS-SPECTROMETRY; DNA-REPLICATION; SEMEN COAGULUM; PATERNAL DNA; BINDING; GENE	We investigated the identity and quantitative variations of proteins extracted from human sperm heads using a label-free Gel-MS approach. Sperm samples were obtained from three men with high sperm counts at three different time points. This design allowed us to analyse intra-individual and inter-individual variations of the human sperm head proteome. Each time point was analyzed in triplicate to minimize any background artifactual effects of the methodology on the variation analyses. Intra-individual analysis using the spectral counting method revealed that the expression levels of 90% of the common proteins identified in three samples collected at various time-points, separated by several months, had a coefficient of variation of less than 0.5 for each man. Across individuals, the expression level of more than 80% of the proteins had a CV under 0.7. Interestingly, 83 common proteins were found within the core proteome as defined by the intra-and inter-variation analyses set criteria (CV<0.7). Some of these uniformly expressed proteins were chaperones, peroxiredoxins, isomerases, and cytoskeletal proteins. Although there is a significant level of inter-individual variation in the protein profiles of human sperm heads even in a well-defined group of men with high sperm counts, the consistent expression levels of a wide range of proteins points to their essential role during spermatogenesis.	[Kichine, Elsa; Hales, Barbara F.; Robaire, Bernard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Di Falco, Marcos] Concordia Univ, Struct & Funct Genom Ctr, Montreal, PQ, Canada; [Robaire, Bernard] McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3A 2T5, Canada; [Chan, Peter] McGill Univ, Ctr Hlth, Dept Urol, Montreal, PQ, Canada	McGill University; Concordia University - Canada; McGill University; McGill University	Chan, P (corresponding author), McGill Univ, Ctr Hlth, Dept Urol, Montreal, PQ, Canada.	MUHC35490@yahoo.ca			Canadian Institutes to Health Research [MOP86636]	Canadian Institutes to Health Research	The work is supported by an operating grant from the Canadian Institutes to Health Research awarded to Peter Chan (MOP86636). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN J, 1994, BIOESSAYS, V16, P259, DOI 10.1002/bies.950160409; Baker MA, 2007, PROTEOM CLIN APPL, V1, P524, DOI 10.1002/prca.200601013; Baker MA, 2011, ASIAN J ANDROL, V13, P6, DOI 10.1038/aja.2010.62; BOURDI M, 1995, ARCH BIOCHEM BIOPHYS, V323, P397, DOI 10.1006/abbi.1995.0060; Brewer L, 2002, J BIOL CHEM, V277, P38895, DOI 10.1074/jbc.M204755200; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Campagno C, 2001, YEAST, V18, P663, DOI 10.1002/yea.715; Chelius D, 2002, J PROTEOME RES, V1, P317, DOI 10.1021/pr025517j; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; de Lamirande E, 2010, HUM REPROD, V25, P1619, DOI 10.1093/humrep/deq110; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Gong S, 2012, J ANDROL; Hawley SB, 2001, J BIOL CHEM, V276, P179, DOI 10.1074/jbc.M004919200; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kodama H, 1997, FERTIL STERIL, V68, P519, DOI 10.1016/S0015-0282(97)00236-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Martins RP, 2004, J BIOL CHEM, V279, P51862, DOI 10.1074/jbc.M409415200; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Neilson KA, 2011, PROTEOMICS, V11, P535, DOI 10.1002/pmic.201000553; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; O'Flaherty C, 2011, BIOL REPROD, V84, P238, DOI 10.1095/biolreprod.110.085712; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ocampo J, 2005, TISSUE CELL, V37, P293, DOI 10.1016/j.tice.2005.03.003; Organization WH, 2010, WHO LAB MAN EX HUM S; OTTERSON GA, 1994, EMBO J, V13, P1216, DOI 10.1002/j.1460-2075.1994.tb06371.x; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Puglisi R, 2011, J CELL PHYSL; REBBE NF, 1989, J BIOL CHEM, V264, P15006; Redgrove KA, 2011, DEV BIOL, V356, P460, DOI 10.1016/j.ydbio.2011.05.674; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROBERT M, 1995, HUM REPROD, V10, P2192, DOI 10.1093/oxfordjournals.humrep.a136267; SCHNEIDER H, 1994, BIOCHEMISTRY-US, V33, P8218, DOI 10.1021/bi00193a007; Shaman JA, 2007, J CELL BIOCHEM, V102, P680, DOI 10.1002/jcb.21321; Shaman JA, 2006, BIOL REPROD, V75, P741, DOI 10.1095/biolreprod.106.055178; Shen HM, 1999, J ANDROL, V20, P718; Sotolongo B, 2003, BIOL REPROD, V69, P2029, DOI 10.1095/biolreprod.103.020594; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Yahata T, 2000, J BIOL CHEM, V275, P8825, DOI 10.1074/jbc.275.12.8825; Yamauchi Y, 2007, BIOL REPROD, V77, P407, DOI 10.1095/biolreprod.107.061473; Yamauchi Y, 2007, BIOL REPROD, V76, P666, DOI 10.1095/biolreprod.106.057067	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77471	10.1371/journal.pone.0077471	http://dx.doi.org/10.1371/journal.pone.0077471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204839	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500029
J	Marathe, NP; Regina, VR; Walujkar, SA; Charan, SS; Moore, ERB; Larsson, DGJ; Shouche, YS				Marathe, Nachiket P.; Regina, Viduthalai R.; Walujkar, Sandeep A.; Charan, Shakti Singh; Moore, Edward R. B.; Larsson, D. G. Joakim; Shouche, Yogesh S.			A Treatment Plant Receiving Waste Water from Multiple Bulk Drug Manufacturers Is a Reservoir for Highly Multi-Drug Resistant Integron-Bearing Bacteria	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; OCHROBACTRUM-INTERMEDIUM; GENE CASSETTE; EFFLUENT; IDENTIFICATION; CONTAMINATION; PREVALENCE; EXPOSURE; PATIENT; AGENTS	The arenas and detailed mechanisms for transfer of antibiotic resistance genes between environmental bacteria and pathogens are largely unclear. Selection pressures from antibiotics in situations where environmental bacteria and human pathogens meet are expected to increase the risks for such gene transfer events. We hypothesize that waste-water treatment plants (WWTPs) serving antibiotic manufacturing industries may provide such spawning grounds, given the high bacterial densities present there together with exceptionally strong and persistent selection pressures from the antibiotic-contaminated waste. Previous analyses of effluent from an Indian industrial WWTP that processes waste from bulk drug production revealed the presence of a range of drugs, including broad spectrum antibiotics at extremely high concentrations (mg/L range). In this study, we have characterized the antibiotic resistance profiles of 93 bacterial strains sampled at different stages of the treatment process from the WWTP against 39 antibiotics belonging to 12 different classes. A large majority (86%) of the strains were resistant to 20 or more antibiotics. Although there were no classically-recognized human pathogens among the 93 isolated strains, opportunistic pathogens such as Ochrobactrum intermedium, Providencia rettgeri, vancomycin resistant Enterococci (VRE), Aerococcus sp. and Citrobacter freundii were found to be highly resistant. One of the O. intermedium strains (ER1) was resistant to 36 antibiotics, while P. rettgeri (OSR3) was resistant to 35 antibiotics. Class 1 and 2 integrons were detected in 74/93 (80%) strains each, and 88/93 (95%) strains harbored at least one type of integron. The qPCR analysis of community DNA also showed an unprecedented high prevalence of integrons, suggesting that the bacteria living under such high selective pressure have an appreciable potential for genetic exchange of resistance genes via mobile gene cassettes. The present study provides insight into the mechanisms behind and the extent of multidrug resistance among bacteria living under an extreme antibiotic selection pressure.	[Marathe, Nachiket P.; Regina, Viduthalai R.; Walujkar, Sandeep A.; Charan, Shakti Singh; Shouche, Yogesh S.] Natl Ctr Cell Sci, Microbial Culture Collect MCC, Pune, Maharashtra, India; [Moore, Edward R. B.] Culture Collect Univ Gothenburg, Gothenburg, Sweden; [Moore, Edward R. B.; Larsson, D. G. Joakim] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); University of Gothenburg	Shouche, YS (corresponding author), Natl Ctr Cell Sci, Microbial Culture Collect MCC, Pune, Maharashtra, India.	yogesh@nccs.res.in	Larsson, D.G. Joakim/E-5243-2011; Marathe, Nachiket/AAJ-3565-2021	Larsson, D.G. Joakim/0000-0002-5496-0328; Marathe, Nachiket/0000-0003-2955-3402; Moore, Edward/0000-0001-7693-924X	Swedish International Development Agency (SIDA) [348-2008-6146]; Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); The Swedish Foundation for Strategic Environmental Research (MISTRA); Council of Scientific and Industrial Research (CSIR), New Delhi	Swedish International Development Agency (SIDA); Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); The Swedish Foundation for Strategic Environmental Research (MISTRA); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was funded by the Swedish International Development Agency (SIDA) project nr. 348-2008-6146; this funding enabled the exchange of NPM between India and Sweden. The work was also funded by the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and The Swedish Foundation for Strategic Environmental Research (MISTRA). Nachiket Marathe held a fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi, during the completion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2005, J ANTIMICROB CHEMOTH, V55, P371, DOI 10.1093/jac/dkh534; Al-Jubouri MA, 2001, J CLIN PATHOL, V54, P412, DOI 10.1136/jcp.54.5.412-a; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; [Anonymous], 2006, M2A9 CLSI; Apisarnthanarak A, 2005, DIAGN MICR INFEC DIS, V53, P153, DOI 10.1016/j.diagmicrobio.2005.05.014; Babic S, 2007, CHROMATOGRAPHIA, V65, P105, DOI 10.1365/s10337-006-0109-2; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beijer K, 2013, CHEMOSPHERE, V90, P1149, DOI 10.1016/j.chemosphere.2012.09.023; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Biskri L, 2003, ANTIMICROB AGENTS CH, V47, P3326, DOI 10.1128/AAC.47.10.3326-3331.2003; Carlsson G, 2009, ENVIRON TOXICOL CHEM, V28, P2656, DOI 10.1897/08-524.1; Chinedum IE, 2005, AFR J BIOTECHNOL, V4, P1606; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dharne MS, 2008, J MICROBIOL IMMUNOL, V41, P183; Drago L, 2001, J ANTIMICROB CHEMOTH, V48, P37, DOI 10.1093/jac/48.1.37; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Gassama-Sow A, 2010, J INFECT DEV COUNTR, V4, P207, DOI 10.3855/jidc.583; Gaze W.H., 2013, EMERG INFECT DIS, V19, DOI [10.3201/eid1907.120871, DOI 10.3201/EID1907.120871]; Gaze WH, 2011, ISME J, V5, P1253, DOI 10.1038/ismej.2011.15; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Gunnarsson L, 2009, ENVIRON TOXICOL CHEM, V28, P2639, DOI 10.1897/09-120.1; Hansson K, 2002, J BACTERIOL, V184, P1712, DOI 10.1128/JB.184.6.1712-1721.2002; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Johnning A, 2013, APPL ENVIRON MICROB, V79, P7256, DOI 10.1128/AEM.02141-13; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Koreishi AF, 2006, OPHTHALMOLOGY, V113, P1463, DOI 10.1016/j.ophtha.2006.03.047; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Larsson DGJ, 2009, REGUL TOXICOL PHARM, V53, P161, DOI 10.1016/j.yrtph.2009.01.008; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Marathe N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-222; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Moller LVM, 1999, J CLIN MICROBIOL, V37, P241; Moura A, 2007, J ANTIMICROB CHEMOTH, V60, P1243, DOI 10.1093/jac/dkm340; OBI CL, 1995, E AFR MED J, V72, P370; Praharaj I, 2012, Indian J Med Microbiol, V30, P242, DOI 10.4103/0255-0857.96713; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Ramirez MS, 2005, ANTIMICROB AGENTS CH, V49, P5179, DOI 10.1128/AAC.49.12.5179-5181.2005; Reid KC, 2001, CLIN INFECT DIS, V32, P1540, DOI 10.1086/320542; Rutgersson C, 2013, ENVIRON TOXICOL CHEM, V32, P577, DOI 10.1002/etc.2105; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Sambhav K, 2011, J MED MICROBIOL, V60, P670, DOI 10.1099/jmm.0.016675-0; SAMBROOK J, 2000, MOL CLONING LAB MANU; Segura PA, 2009, ENVIRON HEALTH PERSP, V117, P675, DOI 10.1289/ehp.11776; Sim WJ, 2011, CHEMOSPHERE, V82, P179, DOI 10.1016/j.chemosphere.2010.10.026; Skurnik D, 2005, ANTIMICROB AGENTS CH, V49, P3062, DOI 10.1128/AAC.49.7.3062-3065.2005; Ramirez MS, 2010, ANTIMICROB AGENTS CH, V54, P699, DOI 10.1128/AAC.01392-08; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Thoma B, 2009, INT J MED MICROBIOL, V299, P209, DOI 10.1016/j.ijmm.2008.06.009; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wright MS, 2008, ISME J, V2, P417, DOI 10.1038/ismej.2008.8; Yoh M, 2005, J MED MICROBIOL, V54, P1077, DOI 10.1099/jmm.0.45846-0	64	72	76	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77310	10.1371/journal.pone.0077310	http://dx.doi.org/10.1371/journal.pone.0077310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204801	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700025
J	Stessman, HAF; Mansoor, A; Zhan, FH; Linden, MA; Van Ness, B; Baughn, LB				Stessman, Holly A. F.; Mansoor, Aatif; Zhan, Fenghuang; Linden, Michael A.; Van Ness, Brian; Baughn, Linda B.			Bortezomib Resistance Can Be Reversed by Induced Expression of Plasma Cell Maturation Markers in a Mouse In Vitro Model of Multiple Myeloma	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PROTEASOME INHIBITOR BORTEZOMIB; TRANSCRIPTION FACTOR XBP-1; B-CELL; DIFFERENTIATION; GENE; BLIMP-1; LIPOPOLYSACCHARIDE; LYMPHOCYTES; CANCER	Multiple myeloma (MM), the second most common hematopoietic malignancy, remains an incurable plasma cell (PC) neoplasm. While the proteasome inhibitor, bortezomib (Bz) has increased patient survival, resistance represents a major treatment obstacle as most patients ultimately relapse becoming refractory to additional Bz therapy. Current tests fail to detect emerging resistance; by the time patients acquire resistance, their prognosis is often poor. To establish immunophenotypic signatures that predict Bz sensitivity, we utilized Bz-sensitive and -resistant cell lines derived from tumors of the Bcl-X-L/Myc mouse model of PC malignancy. We identified significantly reduced expression of two markers (CD93, CD69) in "acquired" (Bz-selected) resistant cells. Using this phenotypic signature, we isolated a subpopulation of cells from a drug-naive, Bz-sensitive culture that displayed "innate" resistance to Bz. Although these genes were identified as biomarkers, they may indicate a mechanism for Bz-resistance through the loss of PC maturation which may be induced and/or selected by Bz. Significantly, induction of PC maturation in both "acquired" and "innate" resistant cells restored Bz sensitivity suggesting a novel therapeutic approach for reversing Bz resistance in refractory MM.	[Stessman, Holly A. F.; Mansoor, Aatif; Van Ness, Brian; Baughn, Linda B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Zhan, Fenghuang] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Linden, Michael A.; Baughn, Linda B.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Van Ness, B (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA.	vanne001@umn.edu; lbaughn@umn.edu		Stessman, Holly/0000-0002-0764-3493; Linden, Michael/0000-0002-7433-1676	Millennium Pharmaceuticals, Inc.; University of Minnesota; Masonic Cancer Center [P30CA077598-09];  [P30CA77598]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER	Millennium Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd); University of Minnesota(University of Minnesota System); Masonic Cancer Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	B.V.N. received research funding for this work from Millennium Pharmaceuticals, Inc. B.V.N. and L. B. B. received research funding for this work from the University of Minnesota Grant-In-Aid (http://www.research.umn.edu/advance/gia.html#.UYkNm6KNqsQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Array comparative genomic hybridization experiments were performed at the University of Minnesota Cytogenetics Core Laboratory with support from the Masonic Cancer Center Grant P30CA077598-09. Flow cytometry was performed at the Flow Cytometry Core Facility of the Masonic Cancer Center at the University of Minnesota supported by P30CA77598.	Adams J, 1999, CANCER RES, V59, P2615; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Bao L, 2013, LEUK RES; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Boylan KLM, 2007, CANCER RES, V67, P4069, DOI 10.1158/0008-5472.CAN-06-3699; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Cheung WC, 2004, J CLIN INVEST, V113, P1763, DOI 10.1172/JCI200420369; Chevrier S, 2009, P NATL ACAD SCI USA, V106, P3895, DOI 10.1073/pnas.0809736106; Greenlee-Wacker MC, 2012, CURR DRUG TARGETS, V13, P411; Gu JL, 2012, BIOCHEM BIOPH RES CO, V420, P644, DOI 10.1016/j.bbrc.2012.03.056; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; KEARNEY JF, 1978, J IMMUNOL, V120, P158; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Ling SCW, 2012, HAEMATOL-HEMATOL J, V97, P64, DOI 10.3324/haematol.2011.043331; Lonial S, 2010, HEMATOL-AM SOC HEMAT, P303, DOI 10.1182/asheducation-2010.1.303; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; PLATICA M, 1985, J NATL CANCER I, V74, P197; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajkumar SV, 2005, J CLIN ONCOL, V23, P630, DOI 10.1200/JCO.2005.11.030; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Shaughnessy Jr JD, 2011, BLOOD; Stessman HA, 2013, LEUKEMIA; Stessman HA, 2013, MOL CANC THER; Tagoug I, 2013, EUR J PHARMACOL, V706, P11, DOI 10.1016/j.ejphar.2013.02.002	35	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77608	10.1371/journal.pone.0077608	http://dx.doi.org/10.1371/journal.pone.0077608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204892	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700043
J	Lienau, EK; Blazar, JM; Wang, C; Brown, EW; Stones, R; Musser, S; Allard, MW				Lienau, E. Kurt; Blazar, Jeffrey M.; Wang, Charles; Brown, Eric W.; Stones, Robert; Musser, Steven; Allard, Marc W.			Phylogenomic Analysis Identifies Gene Gains That Define Salmonella enterica Subspecies I	PLOS ONE			English	Article							TREE; EVOLUTION; CLASSIFICATION; PATHOGENS; LIFE	Comparative methods for analyzing whole genome sequence (WGS) data enable us to assess the genetic information available for reconstructing the evolutionary history of pathogens. We used the comparative approach to determine diagnostic genes for Salmonella enterica subspecies I. S. enterica subsp. I strains are known to infect warm-blooded organisms regularly while its close relatives tend to infect only cold-blooded organisms. We found 71 genes gained by the common ancestor of Salmonella enterica subspecies I and not subsequently lost by any member of this subspecies sequenced to date. These genes included many putative functional phenotypes. Twenty-seven of these genes are found only in Salmonella enterica subspecies I; we designed primers to test these genes for use as diagnostic sequence targets and data mined the NCBI Sequence Read Archive (SRA) database for draft genomes which carried these genes. We found that the sequence specificity and variability of these amplicons can be used to detect and discriminate among 317 different serovars and strains of Salmonella enterica subspecies I.	[Lienau, E. Kurt; Blazar, Jeffrey M.; Wang, Charles; Brown, Eric W.; Musser, Steven; Allard, Marc W.] US FDA, Off Ctr Director, Ctr Food Safety & Appl Nutr, College Pk, MD USA; [Lienau, E. Kurt] Evolut Ind LLC, Frederick, MD USA; [Blazar, Jeffrey M.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Stones, Robert] Food & Environm Res Agcy, York, N Yorkshire, England	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland College Park; Food & Environment Research Agency	Lienau, EK (corresponding author), US FDA, Off Ctr Director, Ctr Food Safety & Appl Nutr, College Pk, MD USA.	kurt.lienau@evolutionindustriesllc.com; marc.allard@fda.hhs.gov			Center for Food Safety and Applied Nutrition (CFSAN) of the United States Internal Food and Drug Administration (FDA); Oak Ridge Institute for Science Education; Evolution Industries LLC	Center for Food Safety and Applied Nutrition (CFSAN) of the United States Internal Food and Drug Administration (FDA); Oak Ridge Institute for Science Education(United States Department of Energy (DOE)); Evolution Industries LLC	All funds for this research came from The Center for Food Safety and Applied Nutrition (CFSAN) of the United States Internal Food and Drug Administration (FDA) research funds. E. Kurt Lienau was partially supported by a grant from the Oak Ridge Institute for Science Education and by Evolution Industries LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Bapteste Eric, 2009, V532, P55, DOI 10.1007/978-1-60327-853-9_4; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Baumler AJ, 1997, TRENDS MICROBIOL, V5, P318, DOI 10.1016/S0966-842X(97)01082-2; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Creevey CJ, 2004, P ROY SOC B-BIOL SCI, V271, P2551, DOI 10.1098/rspb.2004.2864; Desai PT, 2013, MBIO, V4; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fookes M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002191; Fricke WF, 2011, J BACTERIOL, V193, P3556, DOI 10.1128/JB.00297-11; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Kurland CG, 2005, BIOESSAYS, V27, P741, DOI 10.1002/bies.20258; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; LEMINOR L, 1987, INT J SYST BACTERIOL, V37, P465, DOI 10.1099/00207713-37-4-465; Lienau EK, 2010, CLADISTICS, V26, P195, DOI 10.1111/j.1096-0031.2009.00288.x; Lienau EK, 2006, SYST BIOL, V55, P441, DOI 10.1080/10635150600697416; Lienau EK, 2011, CLADISTICS, V27, P417, DOI 10.1111/j.1096-0031.2010.00337.x; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Lienau EK, 2012, APPLICATION; Lienau EK, 2011, CLADISTICS IN PRESS; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593	28	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e76821	10.1371/journal.pone.0076821	http://dx.doi.org/10.1371/journal.pone.0076821			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204679	Green Published, Green Submitted, gold			2022-12-25	WOS:000326241200014
J	Molina-Montenegro, MA; Salgado-Luarte, C; Oses, R; Torres-Diaz, C				Molina-Montenegro, Marco A.; Salgado-Luarte, Cristian; Oses, Romulo; Torres-Diaz, Cristian			Is Physiological Performance a Good Predictor for Fitness? Insights from an Invasive Plant Species	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; MESOPHYLL CONDUCTANCE; TARAXACUM-OFFICINALE; PHOTOSYSTEM-II; WATER-STRESS; OAK TREES; PHOTOSYNTHESIS; DROUGHT; PLASTICITY; LIMITATIONS	Is physiological performance a suitable proxy of fitness in plants? Although, several studies have been conducted to measure some fitness-related traits and physiological performance, direct assessments are seldom found in the literature. Here, we assessed the physiology-fitness relationship using second-generation individuals of the invasive plant species Taraxacum officinale from 17 localities distributed in five continents. Specifically, we tested if i) the maximum quantum yield is a good predictor for seed-output ii) whether this physiology-fitness relationship can be modified by environmental heterogeneity, and iii) if this relationship has an adaptive consequence for T. officinale individuals from different localities. Overall, we found a significant positive relationship between the maximum quantum yield and fitness for all localities evaluated, but this relationship decreased in T. officinale individuals from localities with greater environmental heterogeneity. Finally, we found that those individuals from localities where environmental conditions are highly seasonal performed better under heterogeneous environmental conditions. Contrarily, under homogeneous controlled conditions, those individuals from localities with low environmental seasonality performed much better. In conclusion, our results suggest that the maximum quantum yield seem to be good predictors for plant fitness. We suggest that rapid measurements, such as those obtained from the maximum quantum yield, could provide a straightforward proxy of individual's fitness in changing environments.	[Molina-Montenegro, Marco A.; Oses, Romulo] Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile; [Salgado-Luarte, Cristian] Univ La Serena, Dept Biol, La Serena, Chile; [Torres-Diaz, Cristian] Univ Bio Bio, Dept Ciencias Nat, LGB, Chillan, Chile	Universidad Catolica del Norte; Universidad de La Serena; Universidad del Bio-Bio	Molina-Montenegro, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, CEAZA, Coquimbo, Chile.	marco.molina@ceaza.cl		Oses-Pedraza, Romulo/0000-0003-2310-3339; Molina-Montenegro, Marco/0000-0001-6801-8942				Angelopoulos K, 1996, J EXP BOT, V47, P1093, DOI 10.1093/jxb/47.8.1093; Arntz AM, 2000, ECOLOGY, V81, P2567, DOI 10.1890/0012-9658(2000)081[2567:FFTFVI]2.0.CO;2; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Bolhar-Nordenkampf H. R., 1993, P193; Case Andrea L., 2005, P126; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; CORNIC G, 1992, PHOTOSYNTHETICA, V27, P295; DIJKSTRA P, 1989, FUNCT ECOL, V3, P577, DOI 10.2307/2389572; EPRON D, 1992, PLANT CELL ENVIRON, V15, P809, DOI 10.1111/j.1365-3040.1992.tb02148.x; FARRIS MA, 1990, ECOLOGY, V71, P548, DOI 10.2307/1940308; Figueroa ME, 1997, J VEG SCI, V8, P881, DOI 10.2307/3237033; Flexas J, 2004, PLANT BIOLOGY, V6, P269, DOI 10.1055/s-2004-820867; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Franks SJ, 2011, NEW PHYTOL, V190, P249, DOI 10.1111/j.1469-8137.2010.03603.x; Fryer MJ, 1998, PLANT PHYSIOL, V117, P335; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Goltsev V, 2009, PHOTOSYNTH RES, V101, P217, DOI 10.1007/s11120-009-9451-1; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Grzesiak MT, 2007, PHOTOSYNTHETICA, V45, P606, DOI 10.1007/s11099-007-0104-3; HE JX, 1995, PHYSIOL PLANTARUM, V93, P771, DOI 10.1111/j.1399-3054.1995.tb05130.x; Holm L, 1997, WORLD WEEDS N HISTOR; HORMANN H, 1994, PHOTOSYNTH RES, V40, P93, DOI 10.1007/BF00019048; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Molina-Montenegro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047620; Molina-Montenegro MA, 2012, CONSERV BIOL, V26, P717, DOI 10.1111/j.1523-1739.2012.01865.x; Molina-Montenegro MA, 2011, PLANT ECOL DIVERS, V4, P37, DOI 10.1080/17550874.2011.577459; Molina-Montenegro MA, 2008, OIKOS, V117, P1833, DOI 10.1111/j.0030-1299.2008.16896.x; Osmond CB, 1994, PHOTOINHIBITION PHOT, P1; Pastenes C, 1996, PLANT PHYSIOL, V112, P1245, DOI 10.1104/pp.112.3.1245; Pedersen JF, 2005, CROP SCI, V45, P812, DOI 10.2135/cropsci2004.0155; PIGLIUCCI M, 1995, J EVOLUTION BIOL, V8, P421, DOI 10.1046/j.1420-9101.1995.8040421.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rohacek K, 1999, PHOTOSYNTHETICA, V37, P339, DOI 10.1023/A:1007172424619; Samson DA, 1986, AM NAT, V127, P670; Valladares F, 2005, J EXP BOT, V56, P483, DOI 10.1093/jxb/eri037; Valladares F, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P121; van Dijk PJ, 2004, GENETICS, V166, P483, DOI 10.1534/genetics.166.1.483	40	19	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76432	10.1371/journal.pone.0076432	http://dx.doi.org/10.1371/journal.pone.0076432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204626	Green Submitted, gold, Green Published			2022-12-25	WOS:000326155400014
J	You, S; Piali, L; Kuhn, C; Steiner, B; Sauvaget, V; Valette, F; Clozel, M; Bach, JF; Chatenoud, L				You, Sylvaine; Piali, Luca; Kuhn, Chantal; Steiner, Beat; Sauvaget, Virginia; Valette, Fabrice; Clozel, Martine; Bach, Jean-Francois; Chatenoud, Lucienne			Therapeutic Use of a Selective S1P(1) Receptor Modulator Ponesimod in Autoimmune Diabetes	PLOS ONE			English	Article							REGULATORY T-CELLS; RELAPSING MULTIPLE-SCLEROSIS; GLUTAMIC-ACID DECARBOXYLASE; SPHINGOSINE 1-PHOSPHATE; NOD MICE; ORAL FINGOLIMOD; LYMPHOID ORGANS; B-CELLS; FTY720; TOLERANCE	In the present study, we investigated the therapeutic potential of a selective S1P(1) receptor modulator, ponesimod, to protect and reverse autoimmune diabetes in non-obese diabetic (NOD) mice. Ponesimod was administered orally to NOD mice starting at 6, 10, 13 and 16 weeks of age up to 35 weeks of age or to NOD mice showing recent onset diabetes. Peripheral blood and spleen B and T cell counts were significantly reduced after ponesimod administration. In pancreatic lymph nodes, B lymphocytes were increased and expressed a transitional 1-like phenotype. Chronic oral ponesimod treatment efficiently prevented autoimmune diabetes in 6, 10 and 16 week-old pre-diabetic NOD mice. Treatment withdrawal led to synchronized disease relapse. Ponesimod did not inhibit the differentiation of autoreactive T cells as assessed by adoptive transfer of lymphocytes from treated disease-free NOD mice. In addition, it did not affect the migration, proliferation and activation of transgenic BDC2.5 cells into the target tissue. However, ponesimod inhibited spreading of the T cell responses to islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Treatment of diabetic NOD mice with ponesimod induced disease remission. However, here again, upon treatment cessation, the disease rapidly recurred. This recurrence was effectively prevented by combination treatment with a CD3 antibody leading to the restoration of self-tolerance. In conclusion, treatment with a selective S1P(1) modulator in combination with CD3 antibody represents a promising therapeutic approach for the treatment of autoimmune diabetes.	[You, Sylvaine; Kuhn, Chantal; Sauvaget, Virginia; Valette, Fabrice; Bach, Jean-Francois; Chatenoud, Lucienne] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [You, Sylvaine; Kuhn, Chantal; Sauvaget, Virginia; Valette, Fabrice; Bach, Jean-Francois; Chatenoud, Lucienne] INSERM, U1013, Paris, France; [Piali, Luca; Steiner, Beat; Clozel, Martine] Actel Pharmaceut Ltd, Allschwil, Switzerland	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Actelion Pharmaceuticals Ltd	Chatenoud, L (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	lucienne.chatenoud@inserm.fr	You, Sylvaine/AAF-5600-2021	You, Sylvaine/0000-0002-1578-5205	INSERM; Fondation Day Solvay; Juvenile Diabetes Research Foundation (JDRF); Actelion Pharmaceuticals Ltd.	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation Day Solvay(Solvay SA); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Actelion Pharmaceuticals Ltd.	This work was supported by grants from INSERM, Fondation Day Solvay, the Juvenile Diabetes Research Foundation (JDRF) and funding from Actelion Pharmaceuticals Ltd. The authors' laboratory is a member of the Centaure network. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Brinkmann V, 2000, TRENDS PHARMACOL SCI, V21, P49, DOI 10.1016/S0165-6147(99)01419-4; Brossard P, 2013, BR J CLIN PHARM, DOI 10.1111/bcp.12129; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Chatenoud L, 2010, NAT REV ENDOCRINOL, V6, P149, DOI 10.1038/nrendo.2009.275; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Enee E, 2008, J IMMUNOL, V180, P5430, DOI 10.4049/jimmunol.180.8.5430; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Keymeulen B, 2010, DIABETOLOGIA, V53, P614, DOI 10.1007/s00125-009-1644-9; Kovarik JM, 2004, J CLIN PHARMACOL, V44, P532, DOI 10.1177/0091270004264165; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Lampropoulou V, 2010, IMMUNOL REV, V233, P146, DOI 10.1111/j.0105-2896.2009.00855.x; Ledgerwood LG, 2008, NAT IMMUNOL, V9, P42, DOI 10.1038/ni1534; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Lepault F, 1998, LAB INVEST, V78, P551; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Maki T, 2002, TRANSPLANTATION, V74, P1684, DOI 10.1097/01.TP.0000038969.72218.0F; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matsuura M, 2000, INT J IMMUNOPHARMACO, V22, P323, DOI 10.1016/S0192-0561(99)00088-0; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Miller SD, 1997, NAT MED, V3, P1133, DOI 10.1038/nm1097-1133; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Nikolova Z, 2001, TRANSPL IMMUNOL, V8, P267, DOI 10.1016/S0966-3274(01)00031-4; Okazaki H, 2002, J RHEUMATOL, V29, P707; Penaranda C, 2011, J IMMUNOL, V187, P2015, DOI 10.4049/jimmunol.1100713; Penaranda C, 2010, DIABETES, V59, P1461, DOI 10.2337/db09-1129; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Salvadori M, 2006, AM J TRANSPLANT, V6, P2912, DOI 10.1111/j.1600-6143.2006.01552.x; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sherry N., 2011, LANCET; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Webb M, 2004, J NEUROIMMUNOL, V153, P108, DOI 10.1016/j.jneuroim.2004.04.015; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; You S, 2012, AM J TRANSPLANT, V12, P2909, DOI 10.1111/j.1600-6143.2012.04213.x; You S, 2003, J IMMUNOL, V170, P4011, DOI 10.4049/jimmunol.170.8.4011; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; You S, 2006, IMMUNOL REV, V212, P185, DOI 10.1111/j.0105-2896.2006.00410.x	50	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77296	10.1371/journal.pone.0077296	http://dx.doi.org/10.1371/journal.pone.0077296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204793	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300018
J	Armenta-Medina, A; Huanca-Mamani, W; Sanchez-Leon, N; Rodriguez-Arevalo, I; Vielle-Calzada, JP				Armenta-Medina, Alma; Huanca-Mamani, Wilson; Sanchez-Leon, Nidia; Rodriguez-Arevalo, Isaac; Vielle-Calzada, Jean-Philippe			Functional Analysis of Sporophytic Transcripts Repressed by the Female Gametophyte in the Ovule of Arabidopsis thaliana	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENE-EXPRESSION; FLORAL-DIP; SPOROGENESIS; PROTEINS; REVEALS; GENOME; CELLS; GAMETOGENESIS; INTEGUMENT	To investigate the genetic and molecular regulation that the female gametophyte could exert over neighboring sporophytic regions of the ovule, we performed a quantitative comparison of global expression in wild-type and nozzle/sporocyteless (spl) ovules of Arabidopsis thaliana (Arabidopsis), using Massively Parallel Signature Sequencing (MPSS). This comparison resulted in 1517 genes showing at least 3-fold increased expression in ovules lacking a female gametophyte, including those encoding 89 transcription factors, 50 kinases, 25 proteins containing a RNA-recognition motif (RRM), and 20 WD40 repeat proteins. We confirmed that eleven of these genes are either preferentially expressed or exclusive of spl ovules lacking a female gametophyte as compared to wild-type, and showed that six are also upregulated in determinant infertile1 (dif1), a meiotic mutant affected in a REC8-like cohesin that is also devoided of female gametophytes. The sporophytic misexpression of IOREMPTE, a WD40/transducin repeat gene that is preferentially expressed in the L1 layer of spl ovules, caused the arrest of female gametogenesis after differentiation of a functional megaspore. Our results show that in Arabidopsis, the sporophytic-gametophytic cross talk includes a negative regulation of the female gametophyte over specific genes that are detrimental for its growth and development, demonstrating its potential to exert a repressive control over neighboring regions in the ovule.	[Armenta-Medina, Alma; Sanchez-Leon, Nidia; Rodriguez-Arevalo, Isaac; Vielle-Calzada, Jean-Philippe] CINVESTAV, Grp Desarrollo Reprod & Apomixis, Lab Nacl Genom & Biodiversidad, Irapuato, Mexico; [Huanca-Mamani, Wilson] Univ Tarapaca, Fac Ciencias Agronom, Lab Biotechnol Vegetal, Arica, Chile; [Armenta-Medina, Alma; Sanchez-Leon, Nidia; Rodriguez-Arevalo, Isaac] CINVESTAV, Dept Ingn Genet Plantas, Irapuato, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad de Tarapaca; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Vielle-Calzada, JP (corresponding author), CINVESTAV, Grp Desarrollo Reprod & Apomixis, Lab Nacl Genom & Biodiversidad, Irapuato, Mexico.	vielle@ira.cinvestav.mx	Vielle-Calzada, Jean-Philippe/AAG-4036-2019	Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490	Consejo Nacional de Ciencia y Tecnologia; Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute; UC-MEXUS initiative	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute(Howard Hughes Medical Institute); UC-MEXUS initiative	This work was financially supported by grants from Consejo Nacional de Ciencia y Tecnologia, Consejo Estatal de Ciencia y Tecnologia de Guanajuato, the Howard Hughes Medical Institute, and the UC-MEXUS initiative. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GH, 2004, PLANT MOL BIOL, V54, P653, DOI 10.1023/B:PLAN.0000040819.33383.b6; Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Bai XF, 1999, PLANT CELL, V11, P417, DOI 10.1105/tpc.11.3.417; Baker SC, 1997, GENETICS, V145, P1109; Bechtold N, 2000, GENETICS, V155, P1875; Bellaoui M, 2001, PLANT CELL, V13, P2455, DOI 10.1105/tpc.13.11.2455; Bencivenga S, 2011, SEX PLANT REPROD, V24, P113, DOI 10.1007/s00497-011-0162-3; Bhatt AM, 1999, PLANT J, V19, P463, DOI 10.1046/j.1365-313X.1999.00548.x; Bjerkan KN, 2012, PLANT CELL, V24, P1013, DOI 10.1105/tpc.111.089425; Bou-Torrent J, 2008, PLANT SIGNAL BEHAV, V3, P453, DOI 10.4161/psb.3.7.5599; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Desfeux C, 2000, PLANT PHYSIOL, V123, P895, DOI 10.1104/pp.123.3.895; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Estrada-Luna AA, 2002, IN VITRO CELL DEV-PL, V38, P146, DOI 10.1079/IVP2001278; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; GAISER JC, 1995, PLANT CELL, V7, P333, DOI 10.1105/tpc.7.3.333; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Guitton AE, 2005, CURR BIOL, V15, P750, DOI 10.1016/j.cub.2005.02.066; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; HERR JM, 1995, AM J BOT, V82, P547, DOI 10.2307/2445703; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Jones-Rhoades MW, 2007, PLOS GENET, V3, P1848, DOI 10.1371/journal.pgen.0030171; Kaur J, 2006, PLANT CELL, V18, P545, DOI 10.1105/tpc.105.039156; Lee JH, 2011, PLANT SCI, V180, P352, DOI 10.1016/j.plantsci.2010.10.008; Lee JH, 2008, CELL, V133, P829, DOI 10.1016/j.cell.2008.04.028; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; LEONKLOOSTERZIEL KM, 1994, PLANT CELL, V6, P385, DOI 10.1105/tpc.6.3.385; Li HJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-169; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Nonomura KI, 2003, PLANT CELL, V15, P1728, DOI 10.1105/tpc.012401; Ohnishi T, 2011, PLANT PHYSIOL, V155, P881, DOI 10.1104/pp.110.167502; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Pillitteri LJ, 2007, DEVELOPMENT, V134, P3099, DOI 10.1242/dev.004788; REISER L, 1993, PLANT CELL, V5, P1291, DOI 10.1105/tpc.5.10.1291; ROBINSONBEERS K, 1992, PLANT CELL, V4, P1237, DOI 10.1105/tpc.4.10.1237; Sanchez-Leon N, 2012, J EXP BOT, V63, P3829, DOI 10.1093/jxb/ers075; Schiefthaler U, 1999, P NATL ACAD SCI USA, V96, P11664, DOI 10.1073/pnas.96.20.11664; Schmidt A, 2012, PLANT J, V70, P18, DOI 10.1111/j.1365-313X.2012.04897.x; Schneitz K, 1997, DEVELOPMENT, V124, P1367; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Steffen JG, 2007, PLANT J, V51, P281, DOI 10.1111/j.1365-313X.2007.03137.x; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang YB, 2012, PLANT J, V69, P227, DOI 10.1111/j.1365-313X.2011.04785.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yadegari R, 2004, PLANT CELL, V16, pS133, DOI 10.1105/tpc.018192; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; Yu HJ, 2005, PLANT PHYSIOL, V139, P1853, DOI 10.1104/pp.105.067314; Zhao XA, 2008, PLANT J, V54, P375, DOI 10.1111/j.1365-313X.2008.03426.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	62	6	6	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76977	10.1371/journal.pone.0076977	http://dx.doi.org/10.1371/journal.pone.0076977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194852	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000031
J	Ogawa, A; Bordier, C; Macaluso, E				Ogawa, Akitoshi; Bordier, Cecile; Macaluso, Emiliano			Audio-Visual Perception of 3D Cinematography: An fMRI Study Using Condition-Based and Computation-Based Analyses	PLOS ONE			English	Article							INFERIOR TEMPORAL NEURONS; SURFACE-ORIENTATION; HUMAN BRAIN; DEPTH-PERCEPTION; DISPARITY CUES; SOUND LOCATION; SHAPE; MOTION; CORTEX; RECOGNITION	The use of naturalistic stimuli to probe sensory functions in the human brain is gaining increasing interest. Previous imaging studies examined brain activity associated with the processing of cinematographic material using both standard "condition-based" designs, as well as "computational" methods based on the extraction of time-varying features of the stimuli (e.g. motion). Here, we exploited both approaches to investigate the neural correlates of complex visual and auditory spatial signals in cinematography. In the first experiment, the participants watched a piece of a commercial movie presented in four blocked conditions: 3D vision with surround sounds (3D-Surround), 3D with monaural sound (3D-Mono), 2D-Surround, and 2D-Mono. In the second experiment, they watched two different segments of the movie both presented continuously in 3D-Surround. The blocked presentation served for standard condition-based analyses, while all datasets were submitted to computation-based analyses. The latter assessed where activity co-varied with visual disparity signals and the complexity of auditory multi-sources signals. The blocked analyses associated 3D viewing with the activation of the dorsal and lateral occipital cortex and superior parietal lobule, while the surround sounds activated the superior and middle temporal gyri (S/MTG). The computation-based analyses revealed the effects of absolute disparity in dorsal occipital and posterior parietal cortices and of disparity gradients in the posterior middle temporal gyrus plus the inferior frontal gyrus. The complexity of the surround sounds was associated with activity in specific sub-regions of S/MTG, even after accounting for changes of sound intensity. These results demonstrate that the processing of naturalistic audio-visual signals entails an extensive set of visual and auditory areas, and that computation-based analyses can track the contribution of complex spatial aspects characterizing such life-like stimuli.	[Ogawa, Akitoshi; Bordier, Cecile; Macaluso, Emiliano] Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Neuroimaging Lab, Rome, Italy	IRCCS Santa Lucia	Ogawa, A (corresponding author), Santa Lucia Fdn, Ist Ricovero & Cura Carattere Sci, Neuroimaging Lab, Rome, Italy.	a.ogawa@hsantalucia.it	Macaluso, Emiliano/AAE-9185-2019; Ogawa, Akitoshi/AAB-6930-2020; Macaluso, Emiliano/H-3139-2017; Ogawa, Akitoshi/D-6287-2011	Macaluso, Emiliano/0000-0002-1919-5288; Ogawa, Akitoshi/0000-0003-1247-445X; Macaluso, Emiliano/0000-0002-1919-5288; Bordier, Cecile/0000-0003-2376-5922	Italian Ministry of Health; European Research Council under the European Union [242809]	Italian Ministry of Health(Ministry of Health, Italy); European Research Council under the European Union(European Research Council (ERC))	The Neuroimaging Laboratory, Santa Lucia Foundation, is supported by The Italian Ministry of Health. The research project including this study has received funding from the European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement 242809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi RO, CEREB CORTE IN PRESS; Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Alink A, 2012, HUM BRAIN MAPP, V33, P969, DOI 10.1002/hbm.21263; Altmann CF, 2008, NEUROIMAGE, V41, P69, DOI 10.1016/j.neuroimage.2008.02.013; Amit S., 2001, IEEE DATA ENG B, V24, P35; Anzai A, 2011, J NEUROSCI, V31, P10270, DOI 10.1523/JNEUROSCI.5956-10.2011; Anzai A, 2010, CURR OPIN NEUROBIOL, V20, P367, DOI 10.1016/j.conb.2010.04.006; Arnott SR, 2004, NEUROIMAGE, V22, P401, DOI 10.1016/j.neuroimage.2004.01.014; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, HUM BRAIN MAPP, V21, P75, DOI 10.1002/hbm.10153; Beer AL, 2009, EUR J NEUROSCI, V30, P703, DOI 10.1111/j.1460-9568.2009.06857.x; Bordier C, 2013, NEUROIMAGE, V67, P213, DOI 10.1016/j.neuroimage.2012.11.031; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M, 2002, REG INT AN US SPM TO; Callan A, 2013, NEUROIMAGE, V66, P22, DOI 10.1016/j.neuroimage.2012.10.057; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; Cumming B, 2002, CURR BIOL, V12, pR93, DOI 10.1016/S0960-9822(02)00669-3; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; Durand JB, 2009, NEUROIMAGE, V46, P1114, DOI 10.1016/j.neuroimage.2009.03.023; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Georgieva SS, 2008, CEREB CORTEX, V18, P2416, DOI 10.1093/cercor/bhn002; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Getzmann S, 2010, HEARING RES, V259, P44, DOI 10.1016/j.heares.2009.09.021; Gilaie-Dotan S, 2002, HUM BRAIN MAPP, V15, P67, DOI 10.1002/hbm.10008; GREENSPAN H, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P222, DOI 10.1109/CVPR.1994.323833; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Hasson U, 2008, NEURON, V57, P452, DOI 10.1016/j.neuron.2007.12.009; Janssen P, 2000, NEURON, V27, P385, DOI 10.1016/S0896-6273(00)00045-3; Janssen P, 2001, J NEUROSCI, V21, P9419, DOI 10.1523/JNEUROSCI.21-23-09419.2001; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; Joly O, 2009, NEUROIMAGE, V47, P262, DOI 10.1016/j.neuroimage.2009.04.043; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Kopco N, 2012, P NATL ACAD SCI USA, V109, P11019, DOI 10.1073/pnas.1119496109; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krug K, 2004, J NEUROPHYSIOL, V92, P1586, DOI 10.1152/jn.00851.2003; Krumbholz K, 2005, EUR J NEUROSCI, V21, P230, DOI 10.1111/j.1460-9568.2004.03836.x; Lahnakoski JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035215; Lewald J, 2008, EUR J NEUROSCI, V27, P1261, DOI 10.1111/j.1460-9568.2008.06094.x; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Minini L, 2010, J NEUROPHYSIOL, V104, P169, DOI 10.1152/jn.00790.2009; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; POGGIO GF, 1988, J NEUROSCI, V8, P4531; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Press C, 2012, NEUROIMAGE, V60, P1671, DOI 10.1016/j.neuroimage.2012.01.118; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Preston TJ, 2009, J NEUROSCI, V29, P1688, DOI 10.1523/JNEUROSCI.5021-08.2009; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Read J, 2005, PROG BIOPHYS MOL BIO, V87, P77, DOI 10.1016/j.pbiomolbio.2004.06.005; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; Sakata H, 2005, NEUROPSYCHOLOGIA, V43, P151, DOI 10.1016/j.neuropsychologia.2004.11.003; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Scheperjans F, 2008, CEREB CORTEX, V18, P846, DOI 10.1093/cercor/bhm116; Shamma S, 2001, TRENDS COGN SCI, V5, P340, DOI 10.1016/S1364-6613(00)01704-6; Swisher JD, 2007, J NEUROSCI, V27, P5326, DOI 10.1523/JNEUROSCI.0991-07.2007; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Tsutsui KI, 2001, J NEUROPHYSIOL, V86, P2856, DOI 10.1152/jn.2001.86.6.2856; Uka T, 2006, J NEUROSCI, V26, P6791, DOI 10.1523/JNEUROSCI.5435-05.2006; Warren JD, 2003, J NEUROSCI, V23, P5799; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Warren JD, 2002, NEURON, V34, P139, DOI 10.1016/S0896-6273(02)00637-2; Welchman AE, 2005, NAT NEUROSCI, V8, P820, DOI 10.1038/nn1461; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904; Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004; Zimmer U, 2005, NEURON, V47, P893, DOI 10.1016/j.neuron.2005.07.019; Zundorf IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064259	82	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76003	10.1371/journal.pone.0076003	http://dx.doi.org/10.1371/journal.pone.0076003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194828	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000007
J	Jamsai, D; Clark, BJ; Smith, SJ; Whittle, B; Goodnow, CC; Ormandy, CJ; O'Bryan, MK				Jamsai, Duangporn; Clark, Brett J.; Smith, Stephanie J.; Whittle, Belinda; Goodnow, Christopher C.; Ormandy, Christopher J.; O'Bryan, Moira K.			A Missense Mutation in the Transcription Factor ETV5 Leads to Sterility, Increased Embryonic and Perinatal Death, Postnatal Growth Restriction, Renal Asymmetry and Polydactyly in the Mouse	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; SELF-RENEWAL; FAMILY; GENES; MICE; ERM; MAINTENANCE; INFERTILITY; DOWNSTREAM; FERTILITY	ETV5 (Ets variant gene 5) is a transcription factor that is required for fertility. In this study, we demonstrate that ETV5 plays additional roles in embryonic and postnatal developmental processes in the mouse. Through a genome-wide mouse mutagenesis approach, we generated a sterile mouse line that carried a nonsense mutation in exon 12 of the Etv5 gene. The mutation led to the conversion of lysine at position 412 into a premature termination codon (PTC) within the ETS DNA binding domain of the protein. We showed that the PTC-containing allele produced a highly unstable mRNA, which in turn resulted in an undetectable level of ETV5 protein. The Etv5 mutation resulted in male and female sterility as determined by breeding experiments. Mutant males were sterile due to a progressive loss of spermatogonia, which ultimately resulted in a Sertoli cell only phenotype by 8 week-of-age. Further, the ETV5 target genes Cxcr4 and Ccl9 were significantly down-regulated in mutant neonate testes. CXCR4 and CCL9 have been implicated in the maintenance and migration of spermatogonia, respectively. Moreover, the Etv5 mutation resulted in several developmental abnormalities including an increased incidence of embryonic and perinatal lethality, postnatal growth restriction, polydactyly and renal asymmetry. Thus, our data define a physiological role for ETV5 in many aspects of development including embryonic and perinatal survival, postnatal growth, limb patterning, kidney development and fertility.	[Jamsai, Duangporn; Clark, Brett J.; Smith, Stephanie J.; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia; [Whittle, Belinda; Goodnow, Christopher C.] Australian Natl Univ, Australian Phen Facil, Canberra, ACT, Australia; [Ormandy, Christopher J.] Garvan Inst Med Res, Sydney, NSW, Australia	Monash University; Australian National University; Garvan Institute of Medical Research	Jamsai, D (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3004, Australia.	duangporn.jamsai@monash.edu	Ormandy, Chris/G-4165-2014; Goodnow, Christopher C/V-8108-2018; O'Bryan, Moira K/F-8256-2012	Goodnow, Christopher C/0000-0001-5296-6155; O'Bryan, Moira K/0000-0001-7298-4940; Ormandy, Christopher/0000-0002-2504-7919	Australian Research Council (ARC); New South Wales Cancer Council; Cancer Institute New South Wales; Banque Nationale de Paris-Paribas Australia; RT Hall Trust; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC) of Australia [384297]; NHMRC [545805, 481310]; NHMRC Australia Fellowship	Australian Research Council (ARC)(Australian Research Council); New South Wales Cancer Council(Cancer Council New South Wales); Cancer Institute New South Wales; Banque Nationale de Paris-Paribas Australia; RT Hall Trust; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants the Australian Research Council (ARC) to MKO'B and CJO; the New South Wales Cancer Council, Cancer Institute New South Wales, Banque Nationale de Paris-Paribas Australia and New Zealand, RT Hall Trust, and the National Breast Cancer Foundation to CJO. DJ was a National Health and Medical Research Council (NHMRC) of Australia Peter Doherty Postdoctoral Fellow (#384297). MKO'B and CJO are NHMRC Senior Research Fellows (#545805, #481310). CCG is an NHMRC Australia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borg CL, 2010, HUM REPROD UPDATE, V16, P205, DOI 10.1093/humupd/dmp032; Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894; Eo J, 2008, J ENDOCRINOL, V198, P281, DOI 10.1677/JOE-08-0142; Eo J, 2011, MOL HUM REPROD, V17, P568, DOI 10.1093/molehr/gar021; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Jamsai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056955; Jamsai D, 2010, SYST BIOL REPROD MED, V56, P246, DOI 10.3109/19396361003706424; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Latchman DS, 1996, NEW ENGL J MED, V334, P28, DOI 10.1056/NEJM199601043340108; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Lo JCY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002969; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; McLachlan RI, 2007, HUM REPROD, V22, P2, DOI 10.1093/humrep/del279; MONTE D, 1994, ONCOGENE, V9, P1397; O'Bryan MK, 2012, FERTIL STERIL, V98, P827, DOI 10.1016/j.fertnstert.2012.06.013; O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Paratore C, 2002, DEV BIOL, V250, P168, DOI 10.1006/dbio.2002.0795; Schlesser HN, 2008, BIOL REPROD, V78, P483, DOI 10.1095/biolreprod.107.062935; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Simon L, 2010, STEM CELLS, V28, P1882, DOI 10.1002/stem.508; Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wu X, 2011, BIOL REPROD, V85, P1114, DOI 10.1095/biolreprod.111.091793; Yang QE, 2013, J CELL SCI, V126, P1009, DOI 10.1242/jcs.119826; Zhang Z, 2010, DEVELOPMENT, V137, P3417, DOI 10.1242/dev.051789; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008	28	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77311	10.1371/journal.pone.0077311	http://dx.doi.org/10.1371/journal.pone.0077311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204802	gold, Green Submitted, Green Published			2022-12-25	WOS:000326032600031
J	Totaro, F; Cimmino, F; Pignataro, P; Acierno, G; De Mariano, M; Longo, L; Tonini, GP; Iolascon, A; Capasso, M				Totaro, Francesca; Cimmino, Flora; Pignataro, Piero; Acierno, Giovanni; De Mariano, Marilena; Longo, Luca; Tonini, Gian Paolo; Iolascon, Achille; Capasso, Mario			Impact of Interleukin-6-174 G > C Gene Promoter Polymorphism on Neuroblastoma	PLOS ONE			English	Article							CELL-LINES; COLORECTAL-CANCER; COMMON VARIATION; EXPRESSION; ASSOCIATION; IL-6; SUSCEPTIBILITY; RISK; PROGNOSIS; RECEPTOR	Background: Common variants in DNA may predispose to onset and progression of neuroblastoma (NB). The genotype GG of single nucleotide polymorphism (SNP) rs1800795 (-174 G>C) in interleukin (IL)-6 promoter has been associated with lower survival of high-risk NB. Result: To evaluate the impact of IL-6 SNP rs1800795 on disease risk and phenotype, we analyzed 326 Italian NB patients and 511 controls. Moreover, we performed in silico and quantitative Real Time (qRT)-PCR analyses to evaluate the influence of the SNP on gene expression in 198 lymphoblastoid cell lines (LCLs) and in 31 NB tumors, respectively. Kaplan-Meier analysis was used to verify the association between IL-6 gene expression and patient survival. We found that IL-6 SNP is not involved in susceptibility to NB development. However, our results show that a low frequency of genotype CC is significantly associated with a low overall survival, advanced stage, and high-risk phenotype. The in silico (p = 2.61x10(-5)) and qRT-PCR (p = 0.03) analyses showed similar trend indicating that the CC genotype is correlated with increased level of IL-6 expression. In report gene assay, we showed that the -174 C variant had a significantly increased transcriptional activity compared with G allele (p = 0.0006). Moreover, Kaplan-Meier analysis demonstrated that high levels of IL-6 are associated with poor outcome in children with NB in two independent gene expression array datasets. Conclusions: The biological effect of SNP IL-6-174 G>C in relation to promotion of cancer progression is consistent with the observed decreased survival time. The present study suggests that SNP IL-6-174 G>C may be a useful marker for NB prognosis.	[Totaro, Francesca; Cimmino, Flora; Acierno, Giovanni; Iolascon, Achille; Capasso, Mario] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Totaro, Francesca; Cimmino, Flora; Pignataro, Piero; Acierno, Giovanni; Iolascon, Achille; Capasso, Mario] CEINGE Biotecnol Avanzate, Naples, Italy; [De Mariano, Marilena; Longo, Luca] IRCCS AOU San Martino IST Ist Nazl Ric Canc, Genoa, Italy; [De Mariano, Marilena; Longo, Luca] Natl Inst Canc Res, IRCCS AOU San Martino IST, Genoa, Italy; [Tonini, Gian Paolo] Univ Padua, Pediat Res Inst, Oncohematol Dept SDB, Lab Neuroblastoma, Padua, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Padua	Capasso, M (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.	capasso@ceinge.unina.it	Cimmino, FLORA/K-6205-2016; Capasso, Mario/D-1617-2014; Iolascon, Achille/A-4461-2014; Longo, Luca/K-6156-2018; Cimmino, Flora/AAA-2378-2020	Cimmino, FLORA/0000-0003-1538-9285; Longo, Luca/0000-0002-5153-4243; Cimmino, Flora/0000-0003-1538-9285; Capasso, Mario/0000-0003-3306-1259; iolascon, achille/0000-0002-9558-0356	Associazione Italiana per la Ricerca sul Cancro [10537]; MIUR- FIRB Ricerca in Futuro [RBFR08DWQ3]; Fondazione Italiana per la Lotta al Neuroblastoma; Associazione Oncologia Pediatrica e Neuroblastoma; Italian Ministry of Health [GR-2010-2311890]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MIUR- FIRB Ricerca in Futuro; Fondazione Italiana per la Lotta al Neuroblastoma; Associazione Oncologia Pediatrica e Neuroblastoma; Italian Ministry of Health(Ministry of Health, Italy)	Associazione Italiana per la Ricerca sul Cancro (10537), MIUR- FIRB Ricerca in Futuro (RBFR08DWQ3), Fondazione Italiana per la Lotta al Neuroblastoma, Associazione Oncologia Pediatrica e Neuroblastoma and Italian Ministry of Health (GR-2010-2311890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Belluco C, 2003, CLIN CANCER RES, V9, P2173; Boiardi L, 2006, J RHEUMATOL, V33, P703; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; Bruunsgaard H, 2004, EXP GERONTOL, V39, P255, DOI 10.1016/j.exger.2003.10.012; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Capasso M, 2007, PEDIATR RES, V61, P313, DOI 10.1203/pdr.0b013e318030d108; Capasso M, 2013, CARCINOGENESIS, V34, P605, DOI 10.1093/carcin/bgs380; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chen MF, 2013, MOL CANC IN PRESS; Deans C, 2007, ANN SURG ONCOL, V14, P329, DOI 10.1245/s10434-006-9122-9; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Diskin SJ, 2012, NAT GENET, V44, P1126, DOI 10.1038/ng.2387; Egler RA, 2008, CLIN CANCER RES, V14, P7028, DOI 10.1158/1078-0432.CCR-07-5017; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hirano T, 1997, CYTOKINE HDB, P197; Holm K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-600; HUTCHINS D, 1994, INT J CANCER, V58, P80, DOI 10.1002/ijc.2910580114; Jones KG, 2001, CIRCULATION, V103, P2260; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; Landi S, 2003, CANCER RES, V63, P3560; Maris JM, 2008, NEW ENGL J MED, V358, P2585, DOI 10.1056/NEJMoa0708698; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; SIDELL N, 1991, J IMMUNOL, V146, P3809; Sohara Y, 2005, CANCER RES, V65, P1129, DOI 10.1158/0008-5472.CAN-04-2853; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Upadhyay R, 2008, CLIN IMMUNOL, V128, P199, DOI 10.1016/j.clim.2008.03.519; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609	33	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76810	10.1371/journal.pone.0076810	http://dx.doi.org/10.1371/journal.pone.0076810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204677	Green Submitted, Green Published, gold			2022-12-25	WOS:000326032600012
J	Si, XX; Chen, W; Guo, XD; Chen, L; Wang, GY; Xu, YX; Kang, JH				Si, Xiaoxing; Chen, Wen; Guo, Xudong; Chen, Long; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong			Activation of GSK3b by Sirt2 Is Required for Early Lineage Commitment of Mouse Embryonic Stem Cell	PLOS ONE			English	Article							DIFFERENTIATION; PLURIPOTENCY; INHIBITION; DEACETYLASE; EXPRESSION; GENERATION; SURVIVAL; GENES; WNT	Sirt2, a member of the NAD(+)-dependent protein deacetylase family, is increasingly recognized as a critical regulator of the cell cycle, cellular necrosis and cytoskeleton organization. However, its role in embryonic stem cells (ESCs) remains unclear. Here we demonstrate that Sirt2 is up-regulated during RA (retinoic acid)-induced and embryoid body (EB) differentiation of mouse ESCs. Using lentivirus-mediated shRNA methods, we found that knockdown of Sirt2 compromises the differentiation of mouse ESCs into ectoderm while promoting mesoderm and endoderm differentiation. Knockdown of Sirt2 expression also leads to the activation of GSK3 beta through decreased phosphorylation of the serine at position 9 (Ser9) but not tyrosine at position 216 (Tyr216). Moreover, the constitutive activation of GSK3 beta during EB differentiation mimics the effect of Sirt2 knockdown, while down-regulation of GSK3 beta rescues the effect of Sirt2 knockdown on differentiation. In contrast to the effect on lineage differentiation, Sirt2 knockdown and GSK3 beta up-regulation do not change the self-renewal state of mouse ESCs. Overall, our report reveals a new function for Sirt2 in regulating the proper lineage commitment of mouse ESCs.	[Si, Xiaoxing; Chen, Wen; Guo, Xudong; Chen, Long; Wang, Guiying; Xu, Yanxin; Kang, Jiuhong] Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University	Kang, JH (corresponding author), Tongji Univ, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res, Clin & Translat Res Ctr,Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	jhkang@tongji.edu.cn		Xu, Yanxin/0000-0003-3651-6909	Ministry of Science and Technology [2011CB965100, 2011CBA01100, 2010CB944900, 2010CB945000, 2012CB966603]; National Natural Science Foundation of China [91219305, 31210103905, 31101061, 31201107, 31171432, 81170499]; Science and Technology Commission of Shanghai Municipality [11ZR1438500, 12ZR1450900]; Ministry of Education [IRT1168, 20110072110039]; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [12CG19]; Fundamental Research Funds for the Central Universities [2000219067, 2000219066]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Education; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Ministry of Science and Technology (2011CB965100, 2011CBA01100, 2010CB944900, 2010CB945000, and 2012CB966603), National Natural Science Foundation of China (91219305, 31210103905, 31101061, 31201107, 31171432, and 81170499), Science and Technology Commission of Shanghai Municipality (11ZR1438500, 12ZR1450900), IRT1168 and 20110072110039 from Ministry of Education, and also supported by "Chen Guang" project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (12CG19) and the Fundamental Research Funds for the Central Universities (2000219067 and 2000219066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Chen HP, 2011, J CELL BIOCHEM, V112, P3246, DOI 10.1002/jcb.23251; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hezroni H, 2011, NUCLEUS-PHILA, V2, P300, DOI 10.4161/nucl.2.4.16767; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Nakanishi M, 2009, FASEB J, V23, P114, DOI 10.1096/fj.08-111203; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang H, 2010, BIOCHEM PHARMACOL, V80, P1386, DOI 10.1016/j.bcp.2010.07.034; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167	25	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76699	10.1371/journal.pone.0076699	http://dx.doi.org/10.1371/journal.pone.0076699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204656	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300043
J	Porphyre, T; Auty, HK; Tildesley, MJ; Gunn, GJ; Woolhouse, MEJ				Porphyre, Thibaud; Auty, Harriet K.; Tildesley, Michael J.; Gunn, George J.; Woolhouse, Mark E. J.			Vaccination against Foot-And-Mouth Disease: Do Initial Conditions Affect Its Benefit?	PLOS ONE			English	Article							NATURAL AEROSOLS; EPIDEMIC; VIRUS; FMD; TRANSMISSION; STRATEGIES; SPREAD; PIGS	When facing incursion of a major livestock infectious disease, the decision to implement a vaccination programme is made at the national level. To make this decision, governments must consider whether the benefits of vaccination are sufficient to outweigh potential additional costs, including further trade restrictions that may be imposed due to the implementation of vaccination. However, little consensus exists on the factors triggering its implementation on the field. This work explores the effect of several triggers in the implementation of a reactive vaccination-to-live policy when facing epidemics of foot-and-mouth disease. In particular, we tested whether changes in the location of the incursion and the delay of implementation would affect the epidemiological benefit of such a policy in the context of Scotland. To reach this goal, we used a spatial, premises-based model that has been extensively used to investigate the effectiveness of mitigation procedures in Great Britain. The results show that the decision to vaccinate, or not, is not straightforward and strongly depends on the underlying local structure of the population-at-risk. With regards to disease incursion preparedness, simply identifying areas of highest population density may not capture all complexities that may influence the spread of disease as well as the benefit of implementing vaccination. However, if a decision to vaccinate is made, we show that delaying its implementation in the field may markedly reduce its benefit. This work provides guidelines to support policy makers in their decision to implement, or not, a vaccination-to-live policy when facing epidemics of infectious livestock disease.	[Porphyre, Thibaud; Woolhouse, Mark E. J.] Univ Edinburgh, Ashworth Labs, Epidemiol Grp, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Auty, Harriet K.; Gunn, George J.] Scotlands Rural Coll, Epidemiol Res Unit, Inverness, Scotland; [Tildesley, Michael J.] Univ Warwick, Ctr Complex Sci, Coventry CV4 7AL, W Midlands, England	University of Edinburgh; Scotland's Rural College; University of Warwick	Porphyre, T (corresponding author), Univ Edinburgh, Ashworth Labs, Epidemiol Grp, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.	t.porphyre@ed.ac.uk	Porphyre, Thibaud/N-7581-2018	Porphyre, Thibaud/0000-0002-8552-9899; Auty, Harriet/0000-0002-6181-3780; Tildesley, Michael/0000-0002-6875-7232; Woolhouse, Mark/0000-0003-3765-8167	Centre of Expertise on Animal Disease Outbreaks (EPIC); Scottish Government [UEH/851/11]	Centre of Expertise on Animal Disease Outbreaks (EPIC); Scottish Government	This work was supported by the Centre of Expertise on Animal Disease Outbreaks (EPIC) funded by the Scottish Government (Programmes of Research 2011-2016 no. UEH/851/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2002, EPIDEMIOL INFECT, V128, P313, DOI 10.1017/S0950268801006501; Arnold ME, 2008, P ROY SOC B-BIOL SCI, V275, P107, DOI 10.1098/rspb.2007.1154; Backer JA, 2012, PREV VET MED, V107, P27, DOI 10.1016/j.prevetmed.2012.05.012; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; Bates TW, 2003, AM J VET RES, V64, P805, DOI 10.2460/ajvr.2003.64.805; Bessell PR, 2010, EPIDEMICS-NETH, V2, P109, DOI 10.1016/j.epidem.2010.06.002; Bessell PR, 2010, INT J INFECT DIS, V14, pE210, DOI 10.1016/j.ijid.2009.05.003; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bouma A, 2003, PREV VET MED, V57, P155, DOI 10.1016/S0167-5877(02)00217-9; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Cottam EM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000050; DEFRA, 2005, D5100R3D5100R3 DEFRA; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Donaldson AI, 2001, VET REC, V148, P600, DOI 10.1136/vr.148.19.600; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Jewell CP, 2009, J R SOC INTERFACE, V6, P1145, DOI 10.1098/rsif.2008.0433; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Kobayashi M, 2007, PREV VET MED, V79, P257, DOI 10.1016/j.prevetmed.2007.01.002; Morelli MJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002768; Orsel K, 2007, VACCINE, V25, P6381, DOI 10.1016/j.vaccine.2007.06.010; Parent KB, 2011, REV SCI TECH OIE, V30, P789; Quan M, 2009, J COMP PATHOL, V140, P225, DOI 10.1016/j.jcpa.2008.12.002; Savill Nicholas J, 2006, BMC Vet Res, V2, P3, DOI 10.1186/1746-6148-2-3; Schley D, 2009, EPIDEMIOL INFECT, V137, P1494, DOI 10.1017/S0950268809002349; Scottish Government, 2010, SCOTT GOV EX AN DIS; Tildesley MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1459, DOI 10.1098/rspb.2008.0006; Tildesley MJ, 2012, PREV VET MED, V104, P224, DOI 10.1016/j.prevetmed.2011.11.007; Tildesley MJ, 2010, P NATL ACAD SCI USA, V107, P1041, DOI 10.1073/pnas.0909047107; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tildesley MJ, 2009, J THEOR BIOL, V258, P623, DOI 10.1016/j.jtbi.2009.02.019; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Tomassen FHM, 2002, PREV VET MED, V54, P301, DOI 10.1016/S0167-5877(02)00053-3; Traulsen I, 2011, RES VET SCI, V91, P219, DOI 10.1016/j.rvsc.2010.12.016	35	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e77616	10.1371/journal.pone.0077616	http://dx.doi.org/10.1371/journal.pone.0077616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	24204895	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000325489100176
J	Geng, J; Sivaramakrishnan, S; Raghavan, M				Geng, Jie; Sivaramakrishnan, Sivaraj; Raghavan, Malini			Analyses of Conformational States of the Transporter Associated with Antigen Processing (TAP) Protein in a Native Cellular Membrane Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Antigen Presentation; ATPases; Major Histocompatibility Complex (MHC); Peptide Transport; Transporters; Transporter Associated with Antigen Processing (TAP)	NUCLEOTIDE-BINDING DOMAINS; RESONANCE ENERGY-TRANSFER; P-GLYCOPROTEIN; ABC TRANSPORTER; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; PEPTIDE-BINDING; MALTOSE TRANSPORTER; MECHANISM; INTERMEDIATE	The transporter associated with antigen processing (TAP) plays a critical role in the MHC class I antigen presentation pathway. TAP translocates cellular peptides across the endoplasmic reticulum membrane in an ATP hydrolysis-dependent manner. We used FRET spectroscopy in permeabilized cells to delineate different conformational states of TAP in a native subcellular membrane environment. For these studies, we tagged the TAP1 and TAP2 subunits with enhanced cyan fluorescent protein and enhanced yellow fluorescent protein, respectively, C-terminally to their nucleotide binding domains (NBDs), and measured FRET efficiencies under different conditions. Our data indicate that both ATP and ADP enhance the FRET efficiencies but that neither induces a maximally closed NBD conformation. Additionally, peptide binding induces a large and significant increase in NBD proximity with a concentration dependence that is reflective of individual peptide affinities for TAP, revealing the underlying mechanism of peptide-stimulated ATPase activity of TAP. Maximal NBD closure is induced by the combination of peptide and non-hydrolysable ATP analogs. Thus, TAP1-TAP2 NBD dimers are not fully stabilized by nucleotides alone, and substrate binding plays a key role in inducing the transition state conformations of the NBD. Taken together, these findings show that at least three steps are involved in the transport of peptides across the endoplasmic reticulum membrane for antigen presentation, corresponding to three dynamically and structurally distinct conformational states of TAP. Our studies elucidate structural changes in the TAP NBD in response to nucleotides and substrate, providing new insights into the mechanism of ATP-binding cassette transporter function.	[Geng, Jie; Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Sch Med, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu	Geng, Jie/E-8552-2019	Geng, Jie/0000-0001-8722-2228	National Institutes of Health [AI044115]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health [DK020572]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044115, R56AI044115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant AI044115 (to M. R.) and utilized the DNA sequencing cores of the Michigan Diabetes Research and Training Center funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health Grant DK020572.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Corradi V, 2012, J BIOL CHEM, V287, P28099, DOI 10.1074/jbc.M112.381251; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doshi R, 2013, J BIOL CHEM, V288, P21638, DOI 10.1074/jbc.M113.485714; Gaudet R, 2001, TECHNOL REV, V104, P20; George AM, 2012, PROG BIOPHYS MOL BIO, V109, P95, DOI 10.1016/j.pbiomolbio.2012.06.003; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Hellmich UA, 2012, J AM CHEM SOC, V134, P5857, DOI 10.1021/ja211007t; Herget M, 2007, J BIOL CHEM, V282, P3871, DOI 10.1074/jbc.M608480200; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Lapinski PE, 2001, J BIOL CHEM, V276, P7526, DOI 10.1074/jbc.M009448200; Lapinski PE, 2003, J BIOL CHEM, V278, P8229, DOI 10.1074/jbc.M208930200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; Neumann L, 1999, J MOL BIOL, V294, P1203, DOI 10.1006/jmbi.1999.3329; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Perria CL, 2006, J BIOL CHEM, V281, P39839, DOI 10.1074/jbc.M605492200; Procko E, 2005, IMMUNOL CELL BIOL, V83, P475, DOI 10.1111/j.1440-1711.2005.01354.x; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Raghavan M, 2008, TRENDS IMMUNOL, V29, P436, DOI 10.1016/j.it.2008.06.004; Raghuraman G, 2002, J BIOL CHEM, V277, P41786, DOI 10.1074/jbc.M207128200; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Schmitt L, 2000, CHEMBIOCHEM, V1, P17; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; SINICROPE FA, 1992, J BIOL CHEM, V267, P24995; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Willemse M, 2007, NAT BIOTECHNOL, V25, P170, DOI 10.1038/nbt0207-170; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208	48	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37039	37047		10.1074/jbc.M113.504696	http://dx.doi.org/10.1074/jbc.M113.504696			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24196954	hybrid, Green Published			2022-12-25	WOS:000329189700024
J	Lager, I; Yilmaz, JL; Zhou, XR; Jasieniecka, K; Kazachkov, M; Wang, P; Zou, JT; Weselake, R; Smith, MA; Bayon, S; Dyer, JM; Shockey, JM; Heinz, E; Green, A; Banas, A; Stymne, S				Lager, Ida; Yilmaz, Jenny Lindberg; Zhou, Xue-Rong; Jasieniecka, Katarzyna; Kazachkov, Michael; Wang, Peng; Zou, Jitao; Weselake, Randall; Smith, Mark A.; Bayon, Shen; Dyer, John M.; Shockey, Jay M.; Heinz, Ernst; Green, Allan; Banas, Antoni; Stymne, Sten			Plant Acyl-CoA: Lysophosphatidylcholine Acyltransferases (LPCATs) Have Different Specificities in Their Forward and Reverse Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Enzymes; Lipid Metabolism; Phosphatidylcholine; Plant Biochemistry; Lysophosphatidylcholine Acyltransferases; Phosphatidylcholine Metabolism; Plant Lipid Biochemistry; Enzyme	FATTY-ACIDS; DIACYLGLYCEROL ACYLTRANSFERASE; MICROSOMAL PREPARATIONS; BINDING-PROTEIN; MOLECULAR CHARACTERIZATION; TRIACYLGLYCEROL SYNTHESIS; DEVELOPING SEEDS; OLEOYL-COA; PHOSPHATIDYLCHOLINE; COTYLEDONS	Acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) enzymes have central roles in acyl editing of phosphatidylcholine (PC). Plant LPCAT genes were expressed in yeast and characterized biochemically in microsomal preparations of the cells. Specificities for different acyl-CoAs were similar for seven LPCATs from five different species, including species accumulating hydroxylated acyl groups in their seed oil, with a preference for C-18-unsaturated acyl-CoA and low activity with palmitoyl-CoA and ricinoleoyl (12-hydroxyoctadec-9-enoyl)-CoA. We showed that Arabidopsis LPCAT1 and LPCAT2 enzymes catalyzed the acylation and de-acylation of both sn positions of PC, with a preference for the sn-2 position. When acyl specificities of the Arabidopsis LPCATs were measured in the reverse reaction, sn-2-bound oleoyl, linoleoyl, and linolenoyl groups from PC were transferred to acyl-CoA to a similar extent. However, a ricinoleoyl group at the sn-2-position of PC was removed 4-6-fold faster than an oleoyl group in the reverse reaction, despite poor utilization in the forward reaction. The data presented, taken together with earlier published reports on in vivo lipid metabolism, support the hypothesis that plant LPCAT enzymes play an important role in regulating the acyl-CoA composition in plant cells by transferring polyunsaturated and hydroxy fatty acids produced on PC directly to the acyl-CoA pool for further metabolism or catabolism.	[Lager, Ida; Stymne, Sten] Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden; [Yilmaz, Jenny Lindberg] Scandinavian Biotechnol Res AB, S-23053 Alnarp, Sweden; [Zhou, Xue-Rong; Green, Allan] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT 2601, Australia; [Jasieniecka, Katarzyna; Banas, Antoni] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Jasieniecka, Katarzyna; Banas, Antoni] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Kazachkov, Michael; Zou, Jitao; Smith, Mark A.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada; [Wang, Peng] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Wang, Peng] Univ Nebraska, Ctr Plant Sci Innovat, Lincoln, NE 68588 USA; [Weselake, Randall] Univ Alberta, Dept Agr Food & Nutr Sci, Agr Lipid Biotechnol Program, Edmonton, AB T6G 2P5, Canada; [Bayon, Shen] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Dyer, John M.] ARS, US Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85138 USA; [Shockey, Jay M.] ARS, Commod Utilizat Res Unit, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Heinz, Ernst] Univ Hamburg, Bioctr Klein Flottbek & Bot Garden, D-22609 Hamburg, Germany	Swedish University of Agricultural Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; National Research Council Canada; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Alberta; Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Hamburg	Lager, I (corresponding author), Swedish Univ Agr Sci, Dept Plant Breeding, S-23053 Alnarp, Sweden.	Ida.Lager@slu.se	Zhou, Xue-Rong/D-4706-2009; Green, Allan/AAM-6856-2021; Green, Allan G/C-6572-2008	Zhou, Xue-Rong/0000-0003-3717-2984; Jasieniecka-Gazarkiewicz, Katarzyna/0000-0002-7682-188X; Wang, Peng/0000-0001-5960-6339; Banas, Antoni/0000-0001-9397-7627; Shockey, Jay/0000-0002-5057-5457	United States National Science Foundation Plant Genome Program [IOS 0701919]	United States National Science Foundation Plant Genome Program	The Momordica LPCAT was identified in the Edgar Cahoon laboratory from funding provided by the United States National Science Foundation Plant Genome Program IOS 0701919.	Arroyo-Caro J. M., 2013, LIPIDS IN PRESS, V48; BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; BAFOR M, 1993, ARCH BIOCHEM BIOPHYS, V303, P145, DOI 10.1006/abbi.1993.1265; Banas A, 2005, J BIOL CHEM, V280, P34626, DOI 10.1074/jbc.M504459200; Banas A, 1997, PHYSIOLOGY, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF PLANT LIPIDS, P57; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Bates PD, 2011, PLANT J, V68, P387, DOI 10.1111/j.1365-313X.2011.04693.x; Bates PD, 2009, PLANT PHYSIOL, V150, P55, DOI 10.1104/pp.109.137737; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broun P, 1997, PLANT PHYSIOL, V113, P933, DOI 10.1104/pp.113.3.933; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Cahoon EB, 2006, PHYTOCHEMISTRY, V67, P1166, DOI 10.1016/j.phytochem.2006.04.013; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Engeseth N, 1996, PLANTA, V198, P238, DOI 10.1007/BF00206249; Engeseth NJ, 1996, ARCH BIOCHEM BIOPHYS, V331, P55, DOI 10.1006/abbi.1996.0282; KANDA P, 1981, J LIPID RES, V22, P877; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Arroyo-Caro JM, 2013, LIPIDS, V48, P663, DOI 10.1007/s11745-013-3797-z; Mavraganis I, 2010, APPL ENVIRON MICROB, V76, P1135, DOI 10.1128/AEM.02297-09; Milcamps A, 2005, J BIOL CHEM, V280, P5370, DOI 10.1074/jbc.M410276200; Pollard M, 1999, PLANT PHYSIOL, V121, P1217, DOI 10.1104/pp.121.4.1217; SANCHEZ M, 1973, BIOCHEM J, V132, P697, DOI 10.1042/bj1320697; SLACK CR, 1983, BIOCHIM BIOPHYS ACTA, V754, P10, DOI 10.1016/0005-2760(83)90076-0; SLACK CR, 1985, BIOCHIM BIOPHYS ACTA, V833, P438, DOI 10.1016/0005-2760(85)90101-8; Smith MA, 2003, PLANTA, V217, P507, DOI 10.1007/s00425-003-1015-6; Soboll S., 1976, USE ISOLATED LIVER C, P29; SPERLING P, 1993, EUR J BIOCHEM, V213, P965, DOI 10.1111/j.1432-1033.1993.tb17841.x; STAHL U, 1995, PLANT PHYSIOL, V107, P953, DOI 10.1104/pp.107.3.953; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Stahl U, 2008, FEBS LETT, V582, P305, DOI 10.1016/j.febslet.2007.12.020; STOBART AK, 1985, BIOCHEM J, V232, P217, DOI 10.1042/bj2320217; STYMNE S, 1981, LIPIDS, V16, P298, DOI 10.1007/BF02534953; STYMNE S, 1978, EUR J BIOCHEM, V90, P223, DOI 10.1111/j.1432-1033.1978.tb12594.x; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Thomaeus S, 2001, PLANT SCI, V161, P997, DOI 10.1016/S0168-9452(01)00500-3; Tilton GB, 2004, J BIOL CHEM, V279, P7487, DOI 10.1074/jbc.M309532200; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; WITT W, 1984, BIOCHIM BIOPHYS ACTA, V795, P108, DOI 10.1016/0005-2760(84)90110-3; Yurchenko OP, 2009, PLANT BIOTECHNOL J, V7, P602, DOI 10.1111/j.1467-7652.2009.00427.x	45	94	99	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					36902	36914		10.1074/jbc.M113.521815	http://dx.doi.org/10.1074/jbc.M113.521815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24189065	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000329189700013
J	Vercammen, A; Skilleter, AJ; Lenroot, R; Catts, SV; Weickert, CS; Weickert, TW				Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Catts, Stanley V.; Weickert, Cynthia Shannon; Weickert, Thomas W.			Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia	PLOS ONE			English	Article							NEGATIVE SYMPTOMS; COGNITIVE-CONTROL; SELECTIVE ATTENTION; RESPONSE-INHIBITION; SERUM TESTOSTERONE; NEURAL MECHANISMS; HORMONES; SEVERITY; HEALTHY; TASK	Sex steroids affect cognitive function as well as emotion processing and regulation. They may also play a role in the pathophysiology of schizophrenia. However, the effects of sex steroids on cognition and emotion-related brain activation in schizophrenia are poorly understood. Our aim was to determine the extent to which circulating testosterone relates to brain activation in men with schizophrenia compared to healthy men during cognitive-emotional processing. We assessed brain activation in 18 men with schizophrenia and 22 age-matched healthy men during an emotional go/no-go task using fMRI and measured total serum testosterone levels on the same morning. We performed an ROI analysis to assess the relationship between serum testosterone and brain activation, focusing on cortical regions involved the emotional go/nogo task. Slower RT and reduced accuracy was observed when participants responded to neutral stimuli, while inhibiting responses to negative stimuli. Healthy men showed a robust increase in activation of the middle frontal gyrus when inhibiting responses to negative stimuli, but there was no significant association between activation and serum testosterone level in healthy men. Men with schizophrenia showed a less pronounced increase in activation when inhibiting responses to negative stimuli; however, they did show a strong inverse association between serum testosterone level and activation of the bilateral middle frontal gyrus and left insula. Additionally, increased accuracy during inhibition of response to negative words was associated with both higher serum testosterone levels and decreased activation of the middle frontal gyrus in men with schizophrenia only. We conclude that endogenous hormone levels, even within the normal range, may play an enhanced modulatory role in determining the neural and behavioural response during cognitive-emotional processing in schizophrenia.	[Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Catts, Stanley V.; Weickert, Cynthia Shannon; Weickert, Thomas W.] Neurosci Res Australia, Randwick, NSW, Australia; [Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Catts, Stanley V.; Weickert, Cynthia Shannon; Weickert, Thomas W.] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Vercammen, Ans; Skilleter, Ashley J.; Lenroot, Rhoshel; Weickert, Cynthia Shannon; Weickert, Thomas W.] Univ New S Wales, Sch Psychiat, Randwick, NSW, Australia; [Catts, Stanley V.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Queensland	Weickert, TW (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.	t.weickert@neura.edu.au	Weickert, Thomas W/D-3827-2011; Weickert, Thomas/AAI-6324-2021; Catts, Stanley V/G-6917-2013; Weickert, Thomas/AFS-7669-2022	Weickert, Thomas W/0000-0002-6408-718X; Weickert, Thomas/0000-0002-6408-718X; Shannon Weickert, Cynthia/0000-0002-4560-0259; Vercammen, Ans/0000-0003-1229-9401	University of New South Wales School of Psychiatry; National Health and Medical Research Council [568807]; Neuroscience Research Australia; Australian Schizophrenia Research Bank; National Health and Medical Research Council of Australia; Pratt Foundation; Ramsay Health Care; Viertal Charitable Foundation; Schizophrenia Research Institute; New South Wales Ministry of Health; Macquarie Group; National Health and Medical Research Council (Australia) Senior Research Fellowship [1021970]	University of New South Wales School of Psychiatry; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Neuroscience Research Australia; Australian Schizophrenia Research Bank; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Ramsay Health Care; Viertal Charitable Foundation; Schizophrenia Research Institute; New South Wales Ministry of Health; Macquarie Group; National Health and Medical Research Council (Australia) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the University of New South Wales School of Psychiatry; National Health and Medical Research Council Project grant number 568807; Neuroscience Research Australia; and the Australian Schizophrenia Research Bank, which is supported by the National Health and Medical Research Council of Australia; the Pratt Foundation; Ramsay Health Care; and the Viertal Charitable Foundation. This work was also supported by the Schizophrenia Research Institute (utilising funding from the New South Wales Ministry of Health and the Macquarie Group). CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (1021970). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; Akhondzadeh S, 2006, SCHIZOPHR RES, V84, P405, DOI 10.1016/j.schres.2006.02.008; Amin Z, 2006, NEUROIMAGE, V32, P457, DOI 10.1016/j.neuroimage.2006.03.013; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Aydogan U, 2012, ENDOCR J, V59, P1099, DOI 10.1507/endocrj.EJ12-0134; BENTALL RP, 1989, BRIT J MED PSYCHOL, V62, P355, DOI 10.1111/j.2044-8341.1989.tb02845.x; Bradley MM, 1999, NORMS ENGLISH WORDS; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; CALEV A, 1993, PSYCHOPATHOLOGY, V26, P229, DOI 10.1159/000284827; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cherrier MM, 2007, PSYCHONEUROENDOCRINO, V32, P72, DOI 10.1016/j.psyneuen.2006.10.008; Chiu PH, 2008, NEUROIMAGE, V42, P988, DOI 10.1016/j.neuroimage.2008.04.248; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Fernandez-Egea E, 2011, PSYCHOSOM MED, V73, P643, DOI 10.1097/PSY.0b013e318230343f; First M. B., 2007, STRUCTURED CLIN INTE; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Gopin CB, 2011, BIPOLAR DISORD, V13, P164, DOI 10.1111/j.1399-5618.2011.00906.x; Goyal RO, 2004, ANN NY ACAD SCI, V1032, P291, DOI 10.1196/annals.1314.042; Gray JR, 2001, J EXP PSYCHOL GEN, V130, P436, DOI 10.1037//0096-3445.130.3.436; Grimm S, 2012, NEUROIMAGE, V61, P1188, DOI 10.1016/j.neuroimage.2012.04.004; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Hermans EJ, 2006, BIOL PSYCHIAT, V59, P872, DOI 10.1016/j.biopsych.2005.11.015; Howes OD, 2007, J CLIN PSYCHIAT, V68, P361, DOI 10.4088/JCP.v68n0302; Huber TJ, 2005, PSYCHONEUROENDOCRINO, V30, P111, DOI 10.1016/j.psyneuen.2004.05.010; Jasinska AJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00345; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Ko YH, 2008, J CLIN PSYCHOPHARM, V28, P375, DOI 10.1097/JCP.0b013e31817d5912; Ko YH, 2007, PSYCHONEUROENDOCRINO, V32, P385, DOI 10.1016/j.psyneuen.2007.02.002; Kohler Christian G, 2006, Cogn Neuropsychiatry, V11, P250, DOI 10.1080/13546800500188575; Kulkarni J, 2012, CURR OPIN PSYCHIATR, V25, P89, DOI 10.1097/YCO.0b013e328350360e; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Mehta PH, 2010, J COGNITIVE NEUROSCI, V22, P2357, DOI 10.1162/jocn.2009.21389; Mendrek A, 2011, PSYCHONEUROENDOCRINO, V36, P1422, DOI 10.1016/j.psyneuen.2011.03.016; Montgomery J, 2004, J CLIN PSYCHIAT, V65, P1491, DOI 10.4088/JCP.v65n1108; Moore L, 2013, PSYCHONEUROENDOCRINO; Sankar JS, 2012, GENDER MED, V9, P232, DOI 10.1016/j.genm.2012.05.001; Shirayama Y, 2002, SCHIZOPHR RES, V58, P69, DOI 10.1016/S0920-9964(01)00367-X; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Honk J, 1999, HORM BEHAV, V36, P17, DOI 10.1006/hbeh.1999.1521; van Rijn S, 2011, PSYCHOL MED, V41, P1815, DOI 10.1017/S0033291710002576; van Wingen GA, 2009, NEUROPSYCHOPHARMACOL, V34, P539, DOI [10.1038/npp.2008.2, 10.1038/sj.npp.2008.2]; Vercammen A, 2012, J PSYCHIATR NEUROSCI, V37, P379, DOI 10.1503/jpn.110088; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Volman I, 2011, CEREB CORTEX, V21, P2282, DOI 10.1093/cercor/bhr001; Wechsler D., 1997, WECHSLER ADULT INTEL; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907	52	12	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77496	10.1371/journal.pone.0077496	http://dx.doi.org/10.1371/journal.pone.0077496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	244FY	24204845	Green Published, gold, Green Submitted			2022-12-25	WOS:000326373800003
J	Borozan, I; Watt, SN; Ferretti, V				Borozan, Ivan; Watt, Stuart N.; Ferretti, Vincent			Evaluation of Alignment Algorithms for Discovery and Identification of Pathogens Using RNA-Seq	PLOS ONE			English	Article							READ ALIGNMENT; SEQUENCES; ULTRAFAST; IDENTIFY; SOFTWARE; VIRUSES; SEARCH	Next-generation sequencing technologies provide an unparallelled opportunity for the characterization and discovery of known and novel viruses. Because viruses are known to have the highest mutation rates when compared to eukaryotic and bacterial organisms, we assess the extent to which eleven well-known alignment algorithms (BLAST, BLAT, BWA, BWA-SW, BWA-MEM, BFAST, Bowtie2, Novoalign, GSNAP, SHRiMP2 and STAR) can be used for characterizing mutated and non-mutated viral sequences - including those that exhibit RNA splicing - in transcriptome samples. To evaluate aligners objectively we developed a realistic RNA-Seq simulation and evaluation framework (RiSER) and propose a new combined score to rank aligners for viral characterization in terms of their precision, sensitivity and alignment accuracy. We used RiSER to simulate both human and viral read sequences and suggest the best set of aligners for viral sequence characterization in human transcriptome samples. Our results show that significant and substantial differences exist between aligners and that a digital-subtraction-based viral identification framework can and should use different aligners for different parts of the process. We determine the extent to which mutated viral sequences can be effectively characterized and show that more sensitive aligners such as BLAST, BFAST, SHRiMP2, BWA-SW and GSNAP can accurately characterize substantially divergent viral sequences with up to 15% overall sequence mutation rate. We believe that the results presented here will be useful to researchers choosing aligners for viral sequence characterization using next-generation sequencing data.	[Borozan, Ivan; Watt, Stuart N.; Ferretti, Vincent] Ontario Inst Canc Res, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Borozan, I (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.	Ivan.Borozan@oicr.on.ca		Borozan, Ivan/0000-0002-3145-3550	Ontario Institute for Cancer Research (OICR) through government of Ontario	Ontario Institute for Cancer Research (OICR) through government of Ontario	The authors received support for their work from the Ontario Institute for Cancer Research (OICR) through funding provided by the government of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bhaduri A, 2012, BIOINFORMATICS, V28, P1174, DOI 10.1093/bioinformatics/bts100; Borozan I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-206; Chen YX, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/bts665; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drake JW, 1998, GENETICS, V148, P1667; Feng HC, 2007, J VIROL, V81, P11332, DOI 10.1128/JVI.00875-07; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Ma MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024758; McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nachman MW, 2000, GENETICS, V156, P297; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Rijsbergen CJV, 1976, INFORM RETRIEVAL; Ruffalo M, 2011, BIOINFORMATICS, V27, P2790, DOI 10.1093/bioinformatics/btr477; Studholme DJ, 2011, ANNU REV PHYTOPATHOL, V49, P87, DOI 10.1146/annurev-phyto-072910-095408; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; zur Hausen H., 2006, INFECT CAUSING HUMAN	36	27	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e76935	10.1371/journal.pone.0076935	http://dx.doi.org/10.1371/journal.pone.0076935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204709	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500012
J	Yoshikawa, T; Wada, K; Lee, JJ; Mitsuda, T; Kidouchi, K; Kurosu, H; Morisawa, Y; Aminaka, M; Okubo, T; Kimura, S; Moriya, K				Yoshikawa, Toru; Wada, Koji; Lee, Jong Ja; Mitsuda, Toshihiro; Kidouchi, Kiyoshi; Kurosu, Hitomi; Morisawa, Yuji; Aminaka, Mayumi; Okubo, Takashi; Kimura, Satoshi; Moriya, Kyoji			Incidence Rate of Needlestick and Sharps Injuries in 67 Japanese Hospitals: A National Surveillance Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; PERCUTANEOUS INJURIES; BODY-FLUID; LONG-TERM; PREVENTION; BLOOD; SAFETY; EXPOSURES; SURGEONS; NURSES	Background: Determining incidence rates of needlestick and sharps injuries (NSIs) using data from multiple hospitals may help hospitals to compare their in-house data with national averages and thereby institute relevant measures to minimize NSIs. We aimed to determine the incidence rate of NSIs using the nationwide EPINet surveillance system. Methodology/Principal Findings: Data were analyzed from 5,463 cases collected between April 2009 and March 2011 from 67 Japanese HIV/AIDS referral hospitals that participated in EPINet-Japan. The NSI incidence rate was calculated as the annual number of cases with NSIs per 100 occupied beds, according to the demographic characteristics of the injured person, place, timing, device, and the patients' infectious status. The NSI incidence rates according to hospital size were analyzed by a non-parametric test of trend. The mean number of cases with NSIs per 100 occupied beds per year was 4.8 (95% confidence interval, 4.1-5.6) for 25 hospitals with 399 or fewer beds, 6.7 (5.9-7.4) for 24 hospitals with 400-799 beds, and 7.6 (6.7-8.5) for 18 hospitals with 800 or more beds (p-trend<0.01). NSIs frequently occurred in health care workers in their 20 s; the NSI incidence rate for this age group was 2.1 (1.6-2.5) for hospitals having 399 or fewer beds, 3.5 (3.0-4.1) for hospitals with 400-799 beds, and 4.5 (3.9-5.0) for hospitals with 800 or more beds (p-trend<0.01). Conclusions/Significance: The incidence rate of NSIs tended to be higher for larger hospitals and in workers aged less than 40 years; injury occurrence was more likely to occur in places such as patient rooms and operating rooms. Application of the NSI incidence rates by hospital size, as a benchmark, could allow individual hospitals to compare their NSI incidence rates with those of other institutions, which could facilitate the development of adequate control strategies.	[Yoshikawa, Toru] Inst Sci Labour, Dept Res, Kawasaki, Kanagawa, Japan; [Wada, Koji] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan; [Lee, Jong Ja] Kobe Univ Hosp, Dept Infect Control & Prevent, Kobe, Hyogo, Japan; [Mitsuda, Toshihiro] Yokohama City Univ Med, Dept Infect Prevent & Control, Yokohama, Kanagawa, Japan; [Kidouchi, Kiyoshi] Tono Publ Hlth Ctr, Gifu, Japan; [Kurosu, Hitomi] Tokyo Metropolitan Hlth & Med Treatment Corp Ebar, Dept Nursing, Tokyo, Japan; [Morisawa, Yuji] Jichi Med Univ Hosp, Dept Infect Prevent & Control, Shimotsuke, Tochigi, Japan; [Aminaka, Mayumi] Natl Coll Nursing, Tokyo, Japan; [Okubo, Takashi] Tokyo Healthcare Univ Postgrad Sch, Dept Infect Prevent & Control, Tokyo, Japan; [Kimura, Satoshi] Tokyo Healthcare Univ, Tokyo, Japan; [Moriya, Kyoji] Univ Tokyo, Dept Infect Control & Prevent, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Kobe University; Yokohama City University; Jichi Medical University; University of Tokyo	Wada, K (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan.	kwada-sgy@umin.ac.jp	Yoshikawa, Toru/K-9984-2019	Yoshikawa, Toru/0000-0003-0383-1814	Ministry of Education, Science, Sports and Culture, Japan [22390108, H22]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Science, Sports and Culture, Japan (H22 Grant-in-Aid for Scientific Research (B) (No. 22390108, Representative Researcher: Toru Yoshikawa). The funders played no role in study design, data collection, analysis, the decision to publish, or preparation of this manuscript.	Alamgir H, 2008, AM J INFECT CONTROL, V36, P12, DOI 10.1016/j.ajic.2007.03.005; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Fitzsimons D, 2008, OCCUP ENVIRON MED, V65, P446, DOI 10.1136/oem.2006.032334; HAIDUVEN DJ, 1992, INFECT CONT HOSP EP, V13, P265, DOI 10.2307/30145501; Jagger J, 1997, J Intraven Nurs, V20, pS33; Jagger J, 1999, HDB MODERN HOSP SAFE, V5, P352; Jagger J DCG, 2003, OCCUPATIONAL EXPOSUR, P430; Jagger Janine, 2002, J Infus Nurs, V25, pS15, DOI 10.1097/00129804-200211001-00004; Jagger Janine, 2008, J Infect Public Health, V1, P62, DOI 10.1016/j.jiph.2008.10.002; Kidouchi K, 1997, Kansenshogaku Zasshi, V71, P108; Kidouchi Kiyoshi, 2002, Nihon Rinsho, V60, P2137; Lamontagne F, 2007, INFECT CONT HOSP EP, V28, P18, DOI 10.1086/510814; Lee J, 2007, AM J INFECT CONTROL, V35, pe162; Makary MA, 2007, NEW ENGL J MED, V356, P2693, DOI 10.1056/NEJMoa070378; Ministry of Health Labour and Welfare Japan, 2005, GUID INF CONTR HOSP; Ministry of Health Labour and Welfare Japan, 2010, HOSP REP; Nagao M, 2009, AM J INFECT CONTROL, V37, P541, DOI 10.1016/j.ajic.2009.01.009; Nagao Y, 2007, AM J INFECT CONTROL, V35, P407, DOI 10.1016/j.ajic.2006.03.015; National center of global health and medicine, HIV AIDS REF HOSP; Organisation for Economic Co-operation and Development, 2011, AV LENGTH STAY HOSP; Perry JC, 2012, AM J PSYCHIAT, V169, P916, DOI 10.1176/appi.ajp.2012.11091403; Perry J, 2012, AM J INFECT CONTROL, V40, P354, DOI 10.1016/j.ajic.2011.04.328; Phillips EK, 2012, NEW ENGL J MED, V366, P670, DOI 10.1056/NEJMc1110979; Shiao JSC, 2008, RES NURS HEALTH, V31, P172, DOI 10.1002/nur.20240; Shiao JSC, 2009, J OCCUP HEALTH, V51, P132, DOI 10.1539/joh.L8111; Smith DR, 2006, J HOSP INFECT, V64, P44, DOI 10.1016/j.jhin.2006.03.021; Smith DR, 2009, AM J INFECT CONTROL, V37, P545, DOI 10.1016/j.ajic.2008.11.004; Suzuki Rie, 2006, Kansenshogaku Zasshi, V80, P39; Thomas WJC, 2009, ANN ROY COLL SURG, V91, P12, DOI 10.1308/003588409X359213; Tuma S, 2006, CLIN INFECT DIS, V42, P1159, DOI 10.1086/501456; Wada K, 2007, INFECT CONT HOSP EP, V28, P507, DOI 10.1086/513448; Wicker S, 2008, INT ARCH OCC ENV HEA, V81, P347, DOI 10.1007/s00420-007-0219-7; Yang B, 2012, NURSE ED TO IN PRESS; Yoshikawa T, 2007, INFECT CONT HOSP EP, V28, P215, DOI 10.1086/510802; 윤용훈, 2011, Annals of Occupational and Environmental Medicine, V23, P371	35	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77524	10.1371/journal.pone.0077524	http://dx.doi.org/10.1371/journal.pone.0077524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204856	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500032
J	Zhao, Y; Gentekaki, E; Yi, ZZ; Lin, XF				Zhao, Yan; Gentekaki, Eleni; Yi, Zhenzhen; Lin, Xiaofeng			Genetic Differentiation of the Mitochondrial Cytochrome Oxidase c Subunit I Gene in Genus Paramecium (Protista, Ciliophora)	PLOS ONE			English	Article							DNA-SEQUENCE; HETEROPLASMY; GENOME; NUCLEAR; DIVERSITY; PROTOZOA; NUMTS; OLIGOHYMENOPHOREA; AMPLIFICATION; LIKELIHOOD	Background: The mitochondrial cytochrome c oxidase subunit I (COI) gene is being used increasingly for evaluating inter- and intra-specific genetic diversity of ciliated protists. However, very few studies focus on assessing genetic divergence of the COI gene within individuals and how its presence might affect species identification and population structure analyses. Methodology/Principal findings: We evaluated the genetic variation of the COI gene in five Paramecium species for a total of 147 clones derived from 21 individuals and 7 populations. We identified a total of 90 haplotypes with several individuals carrying more than one haplotype. Parsimony network and phylogenetic tree analyses revealed that intra-individual diversity had no effect in species identification and only a minor effect on population structure. Conclusions: Our results suggest that the COI gene is a suitable marker for resolving inter-and intra-specific relationships of Paramecium spp.	[Zhao, Yan] Ocean Univ China, Inst Evolut & Marine Biodivers, Lab Protozool, Qingdao, Peoples R China; [Zhao, Yan; Yi, Zhenzhen; Lin, Xiaofeng] S China Normal Univ, Lab Protozool, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Gentekaki, Eleni] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Ocean University of China; South China Normal University; Dalhousie University	Gentekaki, E (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	eleni@dal.ca; zyi@scnu.edu.cn	Zhao, Yan/G-4714-2015		Natural Science Foundation of China [31030059, 31222050, 41110104011]; Research Fund for the Doctoral Program of Higher Education [20104407120006]; China Postdoctoral Science Foundation [20110491623]; Royal Society; Direct For Biological Sciences [1136580] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Royal Society(Royal Society of London); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Natural Science Foundation of China (Project No. 31030059, 31222050, 41110104011), the Research Fund for the Doctoral Program of Higher Education Project No. 20104407120006), China Postdoctoral Science Foundation (Project No. 20110491623), and the Royal Society Joint Projects scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2005, MOL ECOL, V14, P3605, DOI 10.1111/j.1365-294X.2005.02672.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barth D, 2006, J EUKARYOT MICROBIOL, V53, P20, DOI 10.1111/j.1550-7408.2005.00068.x; Barth D, 2008, ENVIRON MICROBIOL, V10, P626, DOI 10.1111/j.1462-2920.2007.01486.x; Barth D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-272; Berthier K, 2011, SYST ENTOMOL, V36, P285, DOI 10.1111/j.1365-3113.2010.00561.x; Boscaro V, 2012, MOL PHYLOGENET EVOL, V65, P1004, DOI 10.1016/j.ympev.2012.09.001; Burger G, 2000, J MOL BIOL, V297, P365, DOI 10.1006/jmbi.2000.3529; Catania F, 2009, MOL BIOL EVOL, V26, P421, DOI 10.1093/molbev/msn266; Chantangsi C, 2007, INT J SYST EVOL MICR, V57, P2412, DOI 10.1099/ijs.0.64865-0; Chen XR, 2012, EUR J PROTISTOL, V48, P63, DOI 10.1016/j.ejop.2011.07.005; CORLISS J O, 1979, P455; Coyer JA, 2004, MOL ECOL, V13, P1323, DOI 10.1111/j.1365-294X.2004.02128.x; de Graaf RM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-514; Drake JW, 1998, GENETICS, V148, P1667; Drummond A, 2010, GENEIOUS V5 1; EHRENBERG CG, 1838, INFUSIONSTHIERCHEN V; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan XP, 2013, EUR J PROTISTOL, V49, P312, DOI 10.1016/j.ejop.2012.06.003; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Finlay BJ, 2006, PROTIST, V157, P377, DOI 10.1016/j.protis.2006.05.012; Foissner W, 2008, BIODIVERS CONSERV, V17, P345, DOI 10.1007/s10531-007-9254-7; Fokin SI, 2004, EUR J PROTISTOL, V40, P225, DOI 10.1016/j.ejop.2004.02.001; Frey JE, 2004, HEREDITAS, V140, P92, DOI 10.1111/j.1601-5223.2004.01748.x; Gao F, 2012, MOL PHYLOGENET EVOL, V64, P308, DOI 10.1016/j.ympev.2012.04.008; Gao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033198; Gentekaki E, 2009, APPL ENVIRON MICROB, V75, P3187, DOI 10.1128/AEM.00178-09; Gentekaki E, 2012, EUR J PROTISTOL, V48, P305, DOI 10.1016/j.ejop.2012.04.001; Gjerde B, 2013, PARASITOL RES, V112, P1493, DOI 10.1007/s00436-013-3296-4; Greczek-Stachura M, 2012, PROTIST, V163, P671, DOI 10.1016/j.protis.2011.10.009; Grun P, 1976, CYTOPLASMIC GENETICS; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Kher CP, 2011, PROTIST, V162, P2, DOI 10.1016/j.protis.2010.03.004; Kudo RR, 1966, PROTOZOOLOGY; Lee JS, 2001, GENE, V280, P1, DOI 10.1016/S0378-1119(01)00765-X; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Lynn D.H., 2008, CIL PROT CHAR CLASS; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Messenger LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001584; Miraldo A, 2012, MOL ECOL, V21, P1005, DOI 10.1111/j.1365-294X.2011.05422.x; Nardi F, 2001, MOL BIOL EVOL, V18, P1293, DOI 10.1093/oxfordjournals.molbev.a003914; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Petri B, 1996, BIOL CHEM, V377, P661, DOI 10.1515/bchm3.1996.377.10.661; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Przybos E, 2012, PROTIST, V163, P263, DOI 10.1016/j.protis.2011.06.006; Reiner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014359; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Snoke MS, 2006, MOL BIOL EVOL, V23, P2474, DOI 10.1093/molbev/msl128; SOLIGNAC M, 1983, P NATL ACAD SCI-BIOL, V80, P6942, DOI 10.1073/pnas.80.22.6942; Song W.B., 2009, FREE LIVING CILIATES; Struder-Kypke MC, 2000, MOL PHYLOGENET EVOL, V14, P122, DOI 10.1006/mpev.1999.0686; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; Swart EC, 2012, GENOME BIOL EVOL, V4, P136, DOI 10.1093/gbe/evr136; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarcz S, 2013, EUR J PROTISTOL, V49, P50, DOI 10.1016/j.ejop.2012.05.004; Tarcz S, 2012, MOL PHYLOGENET EVOL, V63, P500, DOI 10.1016/j.ympev.2012.01.024; Vollmer NL, 2011, CURR GENET, V57, P115, DOI 10.1007/s00294-010-0331-1; Xu Y, 2012, SYST BIODIVERS, V10, P207, DOI 10.1080/14772000.2012.681713; Zhang QQ, 2011, ZOOL SCR, V40, P317, DOI 10.1111/j.1463-6409.2011.00473.x; Zufall RA, 2013, MOL ECOL, V22, P1081, DOI 10.1111/mec.12066	67	34	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77044	10.1371/journal.pone.0077044	http://dx.doi.org/10.1371/journal.pone.0077044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204730	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700016
J	Zhuang, LL; Huang, BX; Feng, J; Zhu, LH; Jin, R; Qiu, LZ; Zhou, GP				Zhuang, Li-Li; Huang, Bo-Xian; Feng, Jie; Zhu, Liang-Hua; Jin, Rui; Qiu, Ling-Zhi; Zhou, Guo-Ping			All-Trans Retinoic Acid Modulates ORMDL3 Expression via Transcriptional Regulation	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; VITAMIN-A; RECEPTOR-ALPHA; T-CELLS; ASTHMA; RISK; GENE; DIFFERENTIATION; SUPPLEMENTATION; ASSOCIATION	All-trans retinoic acid (ATRA) is an active metabolite of Vitamin A, it shows protective effects on asthma, including maintains airway epithelial integrity, inhibits asthma effector cells differentiation, modulates immune response, et al. However, the promoting effect of ATRA on Th2 response has restricted the clinical application of ATRA in asthma treatment. ORMDL3 is a candidate gene of childhood onset asthma, and high-transcript of ORMDL3 is associated with the development of asthma. Here we show that ATRA increases ORMDL3 production in vitro via inducing PKA-dependent CREB phosphorylation which in turn binds to the CRE element in promoter region of ORMDL3 and initiates ORMDL3 transcription. This finding is in consistent with the previous reports that ATRA could regulate target genes without the presence of retinoic acid response element (RARE) in promoter region but through other signals such as PKA/CREB. Nevertheless, in the present study, the traditional signal pathway of ATRA, retinoic acid receptor (RAR) signal transduction pathway, indirectly modulated ORMDL3 expression. RAR-alpha agonist (Am-80) increased ORMDL3 production even though there was no RARE in ORMDL3 promoter, introns or 3'-downstream region. Besides, the signal of RAR might differ from that of ATRA since Am-80 failed to induce CREB activation. In conclusion, our data indicate that ATRA facilitates ORMDL3 production probable through PKA/CREB, and this may be a starting point for more detailed mechanism researches on ATRA and asthma.	[Zhuang, Li-Li; Feng, Jie; Zhu, Liang-Hua; Jin, Rui; Qiu, Ling-Zhi; Zhou, Guo-Ping] Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Huang, Bo-Xian] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Huang, Bo-Xian] Nanjing Med Univ, Affiliated Hosp 1, Clin Ctr Reprod Med, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; China Pharmaceutical University; Nanjing Medical University	Zhou, GP (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Pediat, Nanjing, Jiangsu, Peoples R China.	gpzhou2003@gmail.com			National Natural Science Foundation of China [30872804, 81170661, 81300023]; Specialized Research Fund for the Doctoral Program of Higher Education [20113234110010]; Jiangsu Province Innovation Project for Graduate Student of China [CXZZ11_0714]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jiangsu Province Innovation Project for Graduate Student of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (30872804 and 81170661 to GPZ, 81300023 to RJ), Specialized Research Fund for the Doctoral Program of Higher Education (20113234110010 to GPZ), the Jiangsu Province Innovation Project for Graduate Student of China (CXZZ11_0714 to LLZ) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2006, MOL BIOL CELL, V17, P566, DOI 10.1091/mbc.E05-06-0519; Allen S, 2009, THORAX, V64, P610, DOI 10.1136/thx.2008.101469; Barnes NC, 2004, AM J RESP CRIT CARE, V170, P830, DOI 10.1164/rccm.2408006; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Checkley W, 2011, EUR RESPIR J, V38, P1310, DOI 10.1183/09031936.00006911; Checkley W, 2010, NEW ENGL J MED, V362, P1784, DOI 10.1056/NEJMoa0907441; Dawson HD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-16; Day RM, 2006, AM J RESP CELL MOL, V34, P695, DOI 10.1165/rcmb.2005-0306OC; Denburg JA, 2001, INT ARCH ALLERGY IMM, V124, P246, DOI 10.1159/000053724; Devereux G, 2005, J ALLERGY CLIN IMMUN, V115, P1109, DOI 10.1016/j.jaci.2004.12.1139; Druilhe A, 2008, AM J RESP CELL MOL, V38, P276, DOI 10.1165/rcmb.2006-0453OC; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Gamble MV, 1999, J LIPID RES, V40, P2279; Grenningloh R, 2006, J IMMUNOL, V176, P5161, DOI 10.4049/jimmunol.176.9.5161; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjertson M, 2003, J INVEST DERMATOL, V120, P239, DOI 10.1046/j.1523-1747.2003.12030.x; Jin R, 2012, INT J BIOCH CELL BIO; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kinoshita T, 2000, BLOOD, V95, P2821, DOI 10.1182/blood.V95.9.2821.009k11_2821_2828; Ko J, 2006, LIFE SCI, V79, P1293, DOI 10.1016/j.lfs.2006.03.046; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Litonjua AA, 2012, P NUTR SOC, V71, P67, DOI 10.1017/S002966511100334X; Lu TC, 2008, MOL CELL BIOL, V28, P5785, DOI 10.1128/MCB.00245-08; Mai XM, 2013, THORAX, V68, P25, DOI 10.1136/thoraxjnl-2012-202061; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Maret M, 2007, J NUTR, V137, P2730, DOI 10.1093/jn/137.12.2730; McGowan SE, 2007, RESP PHYSIOL NEUROBI, V157, P281, DOI 10.1016/j.resp.2007.01.011; McGowan SE, 2004, AM J PHYSIOL-LUNG C, V286, pL437, DOI 10.1152/ajplung.00158.2003; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Milner JD, 2004, PEDIATRICS, V114, P27, DOI 10.1542/peds.114.1.27; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; Schuster GU, 2008, J IMMUNOL, V180, P1834, DOI 10.4049/jimmunol.180.3.1834; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Snyder R, 2013, J MOL ENDOCRINOL, V50, P361, DOI 10.1530/JME-12-0154; Spiegl N, 2008, BLOOD, V112, P3762, DOI 10.1182/blood-2008-01-135251; URBACH J, 1994, BIOCHEM J, V299, P459, DOI 10.1042/bj2990459; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu K, 2005, CANCER RES, V65, P7856, DOI 10.1158/0008-5472.CAN-05-1056; Zhao Q, 2004, LEUKEMIA, V18, P285, DOI 10.1038/sj.leu.2403226; Zhuang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060630	47	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77304	10.1371/journal.pone.0077304	http://dx.doi.org/10.1371/journal.pone.0077304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204796	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700024
J	Cuk, K; Zucknick, M; Madhavan, D; Schott, S; Golatta, M; Heil, J; Marme, F; Turchinovich, A; Sinn, P; Sohn, C; Junkermann, H; Schneeweiss, A; Burwinkel, B				Cuk, Katarina; Zucknick, Manuela; Madhavan, Dharanija; Schott, Sarah; Golatta, Michael; Heil, Joerg; Marme, Frederik; Turchinovich, Andrey; Sinn, Peter; Sohn, Christof; Junkermann, Hans; Schneeweiss, Andreas; Burwinkel, Barbara			Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer	PLOS ONE			English	Article							BLOOD-BASED MARKERS; CIRCULATING MICRORNAS; MAMMOGRAPHIC DENSITY; EXPRESSION; SERUM; PROLIFERATION; MIR-376A; ORIGIN; MIRNAS; CELLS	Over the last few years, circulating microRNAs (miRNAs) have emerged as promising novel and minimally invasive markers for various diseases, including cancer. We already showed that certain miRNAs are deregulated in the plasma of breast cancer patients when compared to healthy women. Herein we have further explored their potential to serve as breast cancer early detection markers in blood plasma. Circulating miR-127-3p, miR-376a and miR-652, selected as candidates from a miRNA array-based screening, were found to be associated with breast cancer for the first time (n = 417). Further we validated our previously reported circulating miRNAs (miR-148b, miR-376c, miR-409-3p and miR-801) in an independent cohort (n = 210) as elevated in the plasma of breast cancer patients compared to healthy women. We described, for the first time in breast cancer, an over-representation of deregulated miRNAs (miR-127-3p, miR-376a, miR-376c and miR-409-3p) originating from the chromosome 14q32 region. The inclusion of patients with benign breast tumors enabled the observation that miR-148b, miR-652 and miR-801 levels are even elevated in the plasma of women with benign tumors when compared to healthy controls. Furthermore, an analysis of samples stratified by cancer stage demonstrated that miR-127-3p, miR-148b, miR-409-3p, miR-652 and miR-801 can detect also stage I or stage II breast cancer thus making them attractive candidates for early detection. Finally, ROC curve analysis showed that a panel of these seven circulating miRNAs has substantial diagnostic potential with an AUC of 0.81 for the detection of benign and malignant breast tumors, which further increased to 0.86 in younger women (up to 50 years of age).	[Cuk, Katarina; Madhavan, Dharanija; Turchinovich, Andrey; Burwinkel, Barbara] German Canc Res Ctr, Heidelberg, Germany; [Cuk, Katarina; Madhavan, Dharanija; Turchinovich, Andrey; Burwinkel, Barbara] Univ Womens Clin, Heidelberg, Germany; [Zucknick, Manuela] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Schott, Sarah; Golatta, Michael; Heil, Joerg; Marme, Frederik; Sohn, Christof; Junkermann, Hans; Schneeweiss, Andreas] Univ Womens Clin, Dept Gynecol & Obstet, Heidelberg, Germany; [Marme, Frederik; Schneeweiss, Andreas; Burwinkel, Barbara] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Sinn, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Cuk, K (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	katarina_cuk2@yahoo.de	Heil, Joerg/M-4998-2017; Turchinovich, Andrey/C-8213-2018; Sinn, Hans-Peter/C-5661-2008; Schott, Sarah/D-5242-2018; Schneeweiss, Andreas/HHS-4098-2022; Golatta, Michael/AAH-8735-2021; Junkermann, Hans/AAJ-3865-2021; turchinovich, andrey/B-2700-2014	Heil, Joerg/0000-0002-4684-9099; Sinn, Hans-Peter/0000-0003-2836-6699; Schott, Sarah/0000-0002-1714-1147; Golatta, Michael/0000-0002-2605-0060; Turchinovich, Andrey/0000-0003-4153-0895; Zucknick, Manuela/0000-0003-1317-7422	Dietmar-Hopp Foundation; Helmholtz Society; German Cancer Research Center (DKFZ)	Dietmar-Hopp Foundation; Helmholtz Society(Helmholtz Association); German Cancer Research Center (DKFZ)(Helmholtz Association)	This study was supported by the Dietmar-Hopp Foundation, Helmholtz Society and German Cancer Research Center (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agueli C, 2010, AM J HEMATOL, V85, P575, DOI 10.1002/ajh.21758; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devor EJ, 2012, EXP THER MED, V3, P677, DOI 10.3892/etm.2012.458; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; FLETCHER SW, 1993, J NATL CANCER I, V85, P1644, DOI 10.1093/jnci/85.20.1644; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Guo LJ, 2012, INT J MOL MED, V30, P680, DOI 10.3892/ijmm.2012.1021; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Howlader N, 2011, SEER CANC STAT REV 1; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lajer CB, 2011, BRIT J CANCER, V104, P830, DOI 10.1038/bjc.2011.29; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leucci E, 2010, INT J CANCER, V126, P1316, DOI 10.1002/ijc.24655; Lin S, 2012, MOL CELLS, V33, P277, DOI 10.1007/s10059-012-2252-y; MacGrogan G, 2003, VIRCHOWS ARCH, V443, P609, DOI 10.1007/s00428-003-0888-x; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Song WJ, 2012, J BREAST CANCER, V15, P218, DOI 10.4048/jbc.2012.15.2.218; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Tsai KW, 2011, INT J CANCER, V129, P2600, DOI 10.1002/ijc.25919; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valdes EK, 2005, AM SURGEON, V71, P348; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zehavi L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-44; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zheng YX, 2012, FEBS LETT, V586, P2396, DOI 10.1016/j.febslet.2012.05.054	48	94	103	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76729	10.1371/journal.pone.0076729	http://dx.doi.org/10.1371/journal.pone.0076729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194846	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000025
J	Tio, D; Leter, E; Boerrigter, B; Boonstra, A; Vonk-Noordegraaf, A; Bogaard, HJ				Tio, Darryl; Leter, Edward; Boerrigter, Bart; Boonstra, Anco; Vonk-Noordegraaf, Anton; Bogaard, Harm Jan			Risk Factors for Hemoptysis in Idiopathic and Hereditary Pulmonary Arterial Hypertension	PLOS ONE			English	Article							EMBOLIZATION; DILATATION	Introduction: When hemoptysis complicates pulmonary arterial hypertension (PAH), it is assumed to result from bronchial artery hypertrophy. In heritable PAH, the most common mutation is in the BMPR2 gene, which regulates growth, differentiation and apoptosis of mesenchymal cells. The aim of this study is to determine the relationship in PAH between the occurrence of hemoptysis, and disease progression, bronchial artery hypertrophy, pulmonary artery dilation and BMPR2 mutations. Methods: 129 IPAH patients underwent baseline pulmonary imaging (CT angio or MRI) and repeated right-sided heart catheterization. Gene mutations were assessed in a subset of patients. Results: Hemoptysis was associated with a greater presence of hypertrophic bronchial arteries and more rapid hemodynamic deterioration. The presence of a BMPR2 mutation did not predispose to the development of hemoptysis, but was associated with a greater number of hypertrophic bronchial arteries and a worse baseline hemodynamic profile. Conclusion: Hemoptysis in PAH is associated with bronchial artery hypertrophy and faster disease progression. Although the presence of a BMPR2 mutation did not correlate with a greater incidence of hemoptysis in our patient cohort, its association with worse hemodynamics and a trend of greater bronchial arterial hypertrophy may increase the risk of hemoptysis.	[Tio, Darryl; Boerrigter, Bart; Boonstra, Anco; Vonk-Noordegraaf, Anton; Bogaard, Harm Jan] Vrije Univ Amsterdam Med Ctr, Dept Pulmonol, Amsterdam, Netherlands; [Leter, Edward] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bogaard, HJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pulmonol, Amsterdam, Netherlands.	HJ.bogaard@vumc.nl	boonstra, anco/J-5446-2014	Tio, Darryl/0000-0002-9819-1612; Bogaard, Harm Jan/0000-0001-5371-0346				Boerrigter B, 2010, CHEST, V138, P1395, DOI 10.1378/chest.10-0363; Devaraj A, 2010, RADIOLOGY, V254, P609, DOI 10.1148/radiol.09090548; Edwards PD, 1998, BRIT J RADIOL, V71, P1018, DOI 10.1259/bjr.71.850.10211060; Endrys J, 1997, AM J ROENTGENOL, V182, P67; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Grosse C, 2010, RADIOGRAPHICS, V30, P1753, DOI 10.1148/rg.307105710; Hiraki T, 2004, CARDIOVASC INTER RAD, V27, P186, DOI 10.1007/s00270-003-2722-x; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Khalil A, 2008, CHEST, V133, P212, DOI 10.1378/chest.07-1159; Khalil A, 2012, AM J ROENTGENOL, V198, P207, DOI 10.2214/AJR.10.5370; Li Wei, 2010, Proc Am Thorac Soc, V7, P395, DOI 10.1513/pats.201002-024AW; Majka S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-84; Reesink HJ, 2007, CARDIOVASC INTER RAD, V30, P136, DOI 10.1007/s00270-005-0382-8; Remy-Jardin M, 2005, RADIOLOGY, V235, P274, DOI 10.1148/radiol.2351040335; Reynolds AM, 2012, EUR RESPIR J, V39, P329, DOI 10.1183/09031936.00187310; Senbaklavaci O, 2001, J THORAC CARDIOV SUR, V121, P1006, DOI 10.1067/mtc.2001.112634; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; WALLEY VM, 1990, PATHOLOGY, V22, P1; Zylkowska J, 2012, CHEST, V142, P1406, DOI 10.1378/chest.11-2794; Zylkowska J, 2011, CHEST, V139, P690, DOI 10.1378/chest.10-1134	22	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78132	10.1371/journal.pone.0078132	http://dx.doi.org/10.1371/journal.pone.0078132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194909	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000088
J	Bianchi, M; Clavenna, A; Sequi, M; Bortolotti, A; Fortino, I; Merlino, L; Bonati, M				Bianchi, Marina; Clavenna, Antonio; Sequi, Marco; Bortolotti, Angela; Fortino, Ida; Merlino, Luca; Bonati, Maurizio			Childhood Asthma Management Pre- and Post-Incident Asthma Hospitalization	PLOS ONE			English	Article							CHILDREN; EXACERBATIONS; POPULATION; SPIROMETRY; PREDICTORS; SYMPTOMS; OUTCOMES	Many hospitalizations for asthma could potentially be avoided with appropriate management. The aim of this study was to analyze data on disease management of a paediatric population with a hospitalization for asthma. The study population comprised 6-17 year old subjects belonging to three local health units of the Lombardy Region, northern Italy. Regional administrative databases were used to collect data on: the number of children with an incident hospitalization for asthma during the 2004-2006 period, anti-asthma therapy, specialist visit referrals, and claims for spirometry, released in the 12 months before and after hospitalization. Each patient's asthma management profile was compared with GINA guideline recommendations. Among the 183 hospitalized subjects, 101 (55%) received therapy before hospitalization and 82 (45%) did not. 10% did not receive any therapy either before or after hospital admission and in 13% the therapy was discontinued afterward. Based on GINA guidelines, asthma management adhered to recommendations only for 55% of subjects. Results may suggest that for half of hospitalized subjects, inaccurate diagnosis, under-treatment/scarce compliance with asthma guidelines by physicians, and/or scarce compliance to therapy by patients/their parents occurred. In all these cases, hospitalization would be a proxy indicator of preventable poor control of disease, rather than a proxy indicator of severity.	[Bianchi, Marina; Clavenna, Antonio; Sequi, Marco; Bortolotti, Angela; Fortino, Ida; Merlino, Luca; Bonati, Maurizio] IRCCS, Ist Ric Farmacol Mario Negri, Dept Publ Hlth, Lab Mother & Child Hlth, Milan, Italy; [Bortolotti, Angela; Fortino, Ida; Merlino, Luca] Reg Hlth Minist, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Bianchi, M (corresponding author), IRCCS, Ist Ric Farmacol Mario Negri, Dept Publ Hlth, Lab Mother & Child Hlth, Milan, Italy.	marina.bianchi@marionegri.it	Bonati, Maurizio/K-8980-2016; Clavenna, Antonio/J-6830-2018	Bonati, Maurizio/0000-0003-3997-3726; Clavenna, Antonio/0000-0001-5536-4192; MERLINO, Luca Giuseppe/0000-0001-9232-9994	Regione Lombardia (Progetto Epidemiologia dei farmaci - EPIFARM)	Regione Lombardia (Progetto Epidemiologia dei farmaci - EPIFARM)(Regione Lombardia)	This study has been funded in part by Regione Lombardia (Progetto Epidemiologia dei farmaci - EPIFARM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2012, GLOB STRAT ASTHM MAN; Bianchi M, 2012, RESP MED, V106, P1383, DOI 10.1016/j.rmed.2012.06.005; Bianchi M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-48; Bianchi M, 2011, EUR J CLIN PHARMACOL, V67, P967, DOI 10.1007/s00228-011-1033-4; Bianchi M, 2009, PEDIAT ALLERG IMM-UK, V20, P585, DOI 10.1111/j.1399-3038.2008.00797.x; Cabana M, 2006, PEDIATRICS, V118, pE151, DOI 10.1542/peds.2005-2352; Cates CJ, 2013, COCHRANE DB SYST REV, V6; Chipps BE, 2012, J ALLERGY CLIN IMMUN, V130, P332, DOI 10.1016/j.jaci.2012.04.014; Chroinin M Ni, 2009, COCHRANE DB SYST REV, V4; Covar RA, 2008, J ALLERGY CLIN IMMUN, V122, P741, DOI 10.1016/j.jaci.2008.08.021; Delmas M-C, 2011, Rev Mal Respir, V28, pe115, DOI 10.1016/j.rmr.2011.09.023; Ducharme FM, 2010, COCHRANE DB SYST REV, V5; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; Friedman HS, 2009, CLIN THER, V31, P1056, DOI 10.1016/j.clinthera.2009.05.008; Galant SP, 2006, PEDIATRICS, V117, P1038, DOI 10.1542/peds.2005-1076; Gershon AS, 2012, CHEST, V141, P1190, DOI 10.1378/chest.11-0831; Lu S, 2012, ACAD PEDIATR, V12, P436, DOI 10.1016/j.acap.2012.06.006; Tierney WM, 2004, J GEN INTERN MED, V19, P237, DOI 10.1111/j.1525-1497.2004.30311.x; Wu AC, 2011, CHEST, V140, P100, DOI 10.1378/chest.10-2794	19	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76439	10.1371/journal.pone.0076439	http://dx.doi.org/10.1371/journal.pone.0076439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204628	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300029
J	Masoodi, M; Pearl, DS; Eiden, M; Shute, JK; Brown, JF; Calder, PC; Trebble, TM				Masoodi, Mojgan; Pearl, Daniel S.; Eiden, Michael; Shute, Janis K.; Brown, James F.; Calder, Philip C.; Trebble, Timothy M.			Altered Colonic Mucosal Polyunsaturated Fatty Acid (PUFA) Derived Lipid Mediators in Ulcerative Colitis: New Insight into Relationship with Disease Activity and Pathophysiology	PLOS ONE			English	Article							LEUKOTRIENE B-4 PRODUCTION; FISH-OIL SUPPLEMENTATION; PROSTAGLANDIN D-2; ARACHIDONIC-ACID; POLYMORPHONUCLEAR LEUKOCYTES; ACUTE-INFLAMMATION; ACTIVITY INDEXES; RELEASE; LIPOXYGENASE; METABOLISM	Objectives: Ulcerative colitis (UC) is a relapsing inflammatory disorder of unconfirmed aetiology, variable severity and clinical course, characterised by progressive histological inflammation and with elevation of eicosanoids which have a known pathophysiological role in inflammation. Therapeutic interventions targetting eicosanoids (5-aminosalicylates (ASA)) are effective first line and adjunctive treatments in mild-moderate UC for achieving and sustaining clinical remission. However, the variable clinical response to 5-ASA and frequent deterioration in response to cyclo-oxygenase (COX) inhibitors, has prompted an in depth simultaneous evaluation of multiple lipid mediators (including eicosanoids) within the inflammatory milieu in UC. We hypothesised that severity of inflammation is associated with alteration of lipid mediators, in relapsing UC. Design: Study was case-control design. Mucosal lipid mediators were determined by LC-MS/MS lipidomics analysis on mucosal biopsies taken from patients attending outpatients with relapsing UC. Univariate and multivariate statistical analyses were used to investigate the association of mucosal lipid mediators, with the disease state and severity graded histologically. Results: Levels of PGE(2), PGD(2), TXB2, 5-HETE, 11-HETE, 12-HETE and 15-HETE are significantly elevated in inflamed mucosa and correlate with severity of inflammation, determined using validated histological scoring systems. Conclusions: Our approach of capturing inflammatory mediator signature at different stages of UC by combining comprehensive lipidomics analysis and computational modelling could be used to classify and predict mild-moderate inflammation; however, predictive index is diminished in severe inflammation. This new technical approach could be developed to tailor drug treatments to patients with active UC, based on the mucosal lipid mediator profile.	[Masoodi, Mojgan] Nestle Inst Hlth Sci, Lausanne, Switzerland; [Masoodi, Mojgan; Eiden, Michael] MRC, Cambridge, England; [Masoodi, Mojgan] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 1A1, Canada; [Pearl, Daniel S.; Trebble, Timothy M.] Portsmouth Hosp NHS Trust, Dept Gastroenterol, Portsmouth, Hants, England; [Pearl, Daniel S.; Shute, Janis K.; Brown, James F.] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England; [Pearl, Daniel S.] Taunton & Somerset NHS Fdn Trust, Dept Gastroenterol, Taunton, Somerset, England; [Calder, Philip C.] Univ Southampton, Human Dev & Hlth Acad Unit, Southampton, Hants, England; [Calder, Philip C.] Univ Hosp Southampton NHS Fdn Trust, NIHR Biomed Res Ctr Nutr, Southampton, Hants, England; [Calder, Philip C.] Univ Southampton, Southampton, Hants, England	Nestle SA; University of Toronto; Portsmouth Hospitals NHS Trust; University of Portsmouth; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Masoodi, M (corresponding author), Nestle Inst Hlth Sci, Lausanne, Switzerland.	mojgan.masoodi@rd.nestle.com; daniel.pearl@porthosp.nhs.uk	MASOODI, MOJGAN/P-1499-2019; Calder, Philip C/E-9739-2013	MASOODI, MOJGAN/0000-0001-9840-1731; Calder, Philip C/0000-0002-6038-710X; Brown, James/0000-0002-3901-6814	Portsmouth Hospitals National Health Service (NHS) Trust; University of Portsmouth, Portsmouth, United Kingdom; Medical Research Council; MRC [MC_PC_13030, MC_UP_A090_1006] Funding Source: UKRI; Medical Research Council [MC_UP_A090_1006, MC_PC_13030] Funding Source: researchfish	Portsmouth Hospitals National Health Service (NHS) Trust; University of Portsmouth, Portsmouth, United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Salary and research bursary provided by Portsmouth Hospitals National Health Service (NHS) Trust and University of Portsmouth, Portsmouth, United Kingdom and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2000, AM J PHYSIOL-GASTR L, V279, pG238; Ananthakrishnan AN, 2012, ANN INTERN MED, V156, P350, DOI 10.7326/0003-4819-156-5-201203060-00007; Azad S, 2011, SAUDI J GASTROENTERO, V17, P194, DOI 10.4103/1319-3767.80383; BORGEAT P, 1979, P NATL ACAD SCI USA, V76, P3213, DOI 10.1073/pnas.76.7.3213; BORGEAT P, 1979, J BIOL CHEM, V254, P7865; BOUGHTONSMITH NK, 1983, GUT, V24, P1176, DOI 10.1136/gut.24.12.1176; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Carty E, 2000, GUT, V46, P487, DOI 10.1136/gut.46.4.487; CASELLAS F, 1995, EUR J GASTROEN HEPAT, V7, P221; Cole AT, 1996, GUT, V39, P248, DOI 10.1136/gut.39.2.248; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; ELIAKIM R, 1992, SCAND J GASTROENTERO, V27, P968, DOI 10.3109/00365529209000172; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Geboes K., 2003, INFLAMM BOWEL DIS, V18, P255; GERTNER DJ, 1994, GUT, V35, P1429, DOI 10.1136/gut.35.10.1429; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GOMES P, 1986, GUT, V27, P92, DOI 10.1136/gut.27.1.92; GOULD SR, 1976, PROSTAGLANDINS, V11, P489, DOI 10.1016/0090-6980(76)90095-2; Harizi H, 2003, J IMMUNOL, V170, P139, DOI 10.4049/jimmunol.170.1.139; HAWTHORNE AB, 1992, GUT, V33, P922, DOI 10.1136/gut.33.7.922; IKEHATA A, 1995, SCAND J GASTROENTERO, V30, P44, DOI 10.3109/00365529509093234; Jakobovits SL, 2005, BRIT MED BULL, V75-76, P131, DOI 10.1093/bmb/ldl001; Jansen JJ, 2005, J CHEMOMETR, V19, P469, DOI 10.1002/cem.952; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; LANGHOLZ E, 1994, GASTROENTEROLOGY, V107, P3, DOI 10.1016/0016-5085(94)90054-X; Langholz Ebbe, 2010, Therap Adv Gastroenterol, V3, P77, DOI 10.1177/1756283X10361304; Lawson MM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005112.pub2; LEE TH, 1988, CLIN SCI, V74, P467, DOI 10.1042/cs0740467; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; LOBOS EA, 1987, DIGEST DIS SCI, V32, P1380, DOI 10.1007/BF01296664; Marteau P, 2005, GUT, V54, P960, DOI 10.1136/gut.2004.060103; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; NEEDLEMAN P, 1979, P NATL ACAD SCI USA, V76, P944, DOI 10.1073/pnas.76.2.944; NIELSEN OH, 1987, SCAND J CLIN LAB INV, V47, P605; Palmblad J, 1984, SCAND J RHEUMATOL; PALMER RMJ, 1980, PROSTAGLANDINS, V20, P411, DOI 10.1016/S0090-6980(80)80058-X; Pearl DS, 2014, J CROHNS COLITIS, V8, P70, DOI 10.1016/j.crohns.2013.03.013; Pearl DS, 2012, J CROHNS COLITIS S, DOI [10.1016/j.crohns.2012.07.022, DOI 10.1016/J.CR0HNS.2012.07.022]; Peyrin-Biroulet L, 2011, ALIMENT PHARM THER, V33, P870, DOI 10.1111/j.1365-2036.2011.04599.x; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; RAMPTON DS, 1980, GASTROENTEROLOGY, V78, P192; RAMPTON DS, 1980, GUT, V21, P591, DOI 10.1136/gut.21.7.591; RASK-MADSEN J, 1992, Agents and Actions, pC37; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Shimizu T, 2003, J PEDIATR GASTR NUTR, V37, P581, DOI 10.1097/00005176-200311000-00015; STONNINGTON CM, 1987, GUT, V28, P402, DOI 10.1136/gut.28.4.402; Sutherland L, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000543, DOI 10.1002/14651858.CD000543]; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Trebble TM, 2004, AM J CLIN NUTR, V80, P1137, DOI 10.1093/ajcn/80.5.1137; Trebble TM, 2003, AM J CLIN NUTR, V78, P376, DOI 10.1093/ajcn/78.3.376; Turner D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006443; TURNER SR, 1975, NATURE, V257, P680, DOI 10.1038/257680a0; Vachier I, 2002, BIOCHEM BIOPH RES CO, V290, P219, DOI 10.1006/bbrc.2001.6155; van Velzen EJJ, 2008, J PROTEOME RES, V7, P4483, DOI 10.1021/pr800145j; Vong L, 2010, P NATL ACAD SCI USA, V107, P12023, DOI 10.1073/pnas.1004982107; Zamuner SR, 2003, GUT, V52, P1714, DOI 10.1136/gut.52.12.1714	59	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76532	10.1371/journal.pone.0076532	http://dx.doi.org/10.1371/journal.pone.0076532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204637	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000326029300034
J	Ou, F; Rao, NN; Jiang, XD; Qian, MY; Feng, W; Yin, LX; Chen, X				Ou, Feng; Rao, Nini; Jiang, Xudong; Qian, Mengyao; Feng, Wei; Yin, Lixue; Chen, Xu			Analysis on Differential Gene Expression Data for Prediction of New Biological Features in Permanent Atrial Fibrillation	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; MECHANISMS; FIBROSIS	Permanent Atrial fibrillation (pmAF) has largely remained incurable since the existing information for explaining precise mechanisms underlying pmAF is not sufficient. Microarray analysis offers a broader and unbiased approach to identify and predict new biological features of pmAF. By considering the unbalanced sample numbers in most microarray data of case control, we designed an asymmetric principal component analysis algorithm and applied it to re-analyze differential gene expression data of pmAF patients and control samples for predicting new biological features. Finally, we identified 51 differentially expressed genes using the proposed method, in which 42 differentially expressed genes are new findings compared with two related works on the same data and the existing studies. The enrichment analysis illustrated the reliability of identified differentially expressed genes. Moreover, we predicted three new pmAF-related signaling pathways using the identified differentially expressed genes via the KO-Based Annotation System. Our analysis and the existing studies supported that the predicted signaling pathways may promote the pmAF progression. The results above are worthy to do further experimental studies. This work provides some new insights into molecular features of pmAF. It has also the potentially important implications for improved understanding of the molecular mechanisms of pmAF.	[Ou, Feng; Rao, Nini; Qian, Mengyao; Feng, Wei] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Jiang, Xudong] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Yin, Lixue; Chen, Xu] Sichuan Acad Med Sci, Cardiovasc Dept, Chengdu, Peoples R China; [Yin, Lixue; Chen, Xu] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Rao, NN (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	raonn@uestc.edu.cn	Jiang, Xudong/B-1555-2008	Jiang, Xudong/0000-0002-9104-2315	National Natural Science Foundation [81171411]; Key Technology Research and Development Program of Sichuan Province [2011FZ0034]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Technology Research and Development Program of Sichuan Province	This work was supported by grants from National Natural Science Foundation (Grant No. 81171411) and Key Technology Research and Development Program of Sichuan Province (Grant No. 2011FZ0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE M, 1991, CIRCULATION, V84, P1689, DOI 10.1161/01.CIR.84.4.1689; Ausma J, 1997, AM J PATHOL, V151, P985; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Censi F, 2011, IEEE T BIOMEDICAL EN, V58; Censi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013668; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Fraley SI, 2010, NATURE CELL BIOL, V12; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Goudis CA, 2012, EUROPACE, V14, P623, DOI 10.1093/europace/eur398; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Jiang XD, 2011, IEEE SIGNAL PROC MAG, V28, P16, DOI 10.1109/MSP.2010.939041; Jiang XD, 2009, IEEE T PATTERN ANAL, V31, P931, DOI 10.1109/TPAMI.2008.258; Kim YH, 2003, EXP MOL MED, V35, P336, DOI 10.1038/emm.2003.45; Kneller J, 2002, CIRC RES, V90, pE73, DOI 10.1161/01.RES.0000019783.88094.BA; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Ohki-Kaneda R, 2004, BIOCHEM BIOPH RES CO, V320, P1328, DOI 10.1016/j.bbrc.2004.06.090; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sata N, 2004, JPN HEART J, V45, P441, DOI 10.1536/jhj.45.441; Schotten U, 2001, CIRCULATION, V103, P691; Shimano M, 2008, HEART RHYTHM, V5, P451, DOI 10.1016/j.hrthm.2007.12.010; Wall ME, 2003, PRACTICAL APPROACH M, P91, DOI DOI 10.1007/0-306-47815-3_5; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	28	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76166	10.1371/journal.pone.0076166	http://dx.doi.org/10.1371/journal.pone.0076166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204599	Green Published, gold			2022-12-25	WOS:000326029300012
J	Sastalla, I; Fattah, R; Coppage, N; Nandy, P; Crown, D; Pomerantsev, AP; Leppla, SH				Sastalla, Inka; Fattah, Rasem; Coppage, Nicole; Nandy, Poulomi; Crown, Devorah; Pomerantsev, Andrei P.; Leppla, Stephen H.			The Bacillus cereus Hbl and Nhe Tripartite Enterotoxin Components Assemble Sequentially on the Surface of Target Cells and Are Not Interchangeable	PLOS ONE			English	Article							3 EXOPROTEIN COMPONENTS; PLCR VIRULENCE REGULON; RAY CRYSTAL-STRUCTURE; HEMOLYSIN E HLYE; PHOSPHOLIPASE-C; ESCHERICHIA-COLI; TOXINS; BL; ANTHRACIS; ENDOPHTHALMITIS	Bacillus cereus is a spore-forming, Gram-positive bacterium commonly associated with outbreaks of food poisoning. It is also known as an opportunistic pathogen causing clinical infections such as bacteremia, meningitis, pneumonia, and gas gangrene-like cutaneous infections, mostly in immunocompromised patients. B. cereus secretes a plethora of toxins of which four are associated with the symptoms of food poisoning. Two of these, the non-hemolytic enterotoxin Nhe and the hemolysin BL (Hbl) toxin, are predicted to be structurally similar and are unique in that they require the combined action of three toxin proteins to induce cell lysis. Despite their dominant role in disease, the molecular mechanism of their toxic function is still poorly understood. We report here that B. cereus strain ATCC 10876 harbors not only genes encoding Nhe, but also two copies of the hbl genes. We identified Hbl as the major secreted toxin responsible for inducing rapid cell lysis both in cultured cells and in an intraperitoneal mouse toxicity model. Antibody neutralization and deletion of Hbl-encoding genes resulted in significant reductions of cytotoxic activity. Microscopy studies with Chinese Hamster Ovary cells furthermore showed that pore formation by both Hbl and Nhe occurs through a stepwise, sequential binding of toxin components to the cell surface and to each other. This begins with binding of Hbl-B or NheC to the eukaryotic membrane, and is followed by the recruitment of Hbl-L-1 or NheB, respectively, followed by the corresponding third protein. Lastly, toxin component complementation studies indicate that although Hbl and Nhe can be expressed simultaneously and are predicted to be structurally similar, they are incompatible and cannot complement each other.	[Sastalla, Inka; Fattah, Rasem; Coppage, Nicole; Nandy, Poulomi; Crown, Devorah; Pomerantsev, Andrei P.; Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Sastalla, I (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sastallai@niaid.nih.gov		Sastalla, Inka/0000-0003-4128-0742	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; BEECHER DJ, 1995, INFECT IMMUN, V63, P632, DOI 10.1128/IAI.63.2.632-639.1995; Beecher DJ, 1997, J BIOL CHEM, V272, P233; BEECHER DJ, 1991, INFECT IMMUN, V59, P1778, DOI 10.1128/IAI.59.5.1778-1784.1991; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Phung D, 2012, FEMS MICROBIOL LETT, V330, P98, DOI 10.1111/j.1574-6968.2012.02538.x; Didier A, 2012, INFECT IMMUN, V80, P832, DOI 10.1128/IAI.05681-11; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; ESSER AF, 1994, TOXICOLOGY, V87, P229, DOI 10.1016/0300-483X(94)90253-4; Fagerlund A, 2008, MICROBIOL-SGM, V154, P693, DOI 10.1099/mic.0.2007/014134-0; GHOSH AC, 1978, J HYG-CAMBRIDGE, V80, P233; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; HANDELSMAN J, 1990, APPL ENVIRON MICROB, V56, P713, DOI 10.1128/AEM.56.3.713-718.1990; Heilkenbrinker U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063104; Henkel JS, 2010, EXPERIENTIA SUPPL, V100, P1; Hunt S, 2010, ADV EXP MED BIOL, V677, P116; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Kolsto AB, 2002, CURR TOP MICROBIOL, V264, P95; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Lereclus D, 2000, INT J MED MICROBIOL, V290, P295, DOI 10.1016/S1438-4221(00)80024-7; Lindback T, 1999, MICROBIOL-SGM, V145, P3139, DOI 10.1099/00221287-145-11-3139; Lindback T, 2004, MICROBIOL-SGM, V150, P3959, DOI 10.1099/mic.0.27359-0; Lindback T, 2010, INFECT IMMUN, V78, P3813, DOI 10.1128/IAI.00247-10; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Ludwig A, 2010, J BACTERIOL, V192, P4001, DOI 10.1128/JB.01283-09; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; Lund T, 1996, FEMS MICROBIOL LETT, V141, P151, DOI 10.1016/0378-1097(96)00208-X; Madegowda M, 2008, PROTEINS, V71, P534, DOI 10.1002/prot.21888; Moravek M, 2006, FEMS MICROBIOL LETT, V257, P293, DOI 10.1111/j.1574-6968.2006.00185.x; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Okstad OA, 1999, MICROBIOL-UK, V145, P3129, DOI 10.1099/00221287-145-11-3129; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Pomerantsev AP, 2009, J BACTERIOL, V191, P5134, DOI 10.1128/JB.00422-09; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Pomerantsev AP, 2003, INFECT IMMUN, V71, P6591, DOI 10.1128/IAI.71.11.6591-6606.2003; REDDY A, 1987, J BACTERIOL, V169, P5263, DOI 10.1128/jb.169.11.5263-5270.1987; Sastalla I, 2010, MICROBIOL-SGM, V156, P2982, DOI 10.1099/mic.0.041418-0; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; THOMPSON NE, 1984, INFECT IMMUN, V43, P887, DOI 10.1128/IAI.43.3.887-894.1984; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Williams LD, 2009, REGUL TOXICOL PHARM, V55, P236, DOI 10.1016/j.yrtph.2009.07.009; Yoong P, 2013, CURR OPIN MICROBIOL, V16, P63, DOI 10.1016/j.mib.2013.01.012	51	64	64	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76955	10.1371/journal.pone.0076955	http://dx.doi.org/10.1371/journal.pone.0076955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204713	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300071
J	Goto, T; Sato, A; Adachi, S; Iemura, S; Natsume, T; Shibuya, H				Goto, Toshiyasu; Sato, Atsushi; Adachi, Shungo; Iemura, Shun-ichiro; Natsume, Tohru; Shibuya, Hiroshi			IQGAP1 Protein Regulates Nuclear Localization of beta-Catenin via Importin-beta 5 Protein in Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-Catenin; Nuclear Translocation; Nuclear Transport; Signal Transduction; Wnt Pathway; Wnt Signaling; Dvl; IQGAP; Ran; Importin	SMALL GTPASES; BINDING; TRANSPORT; IMPORT; TARGET; AXIS; CALMODULIN; INDUCTION; RECEPTOR; PATHWAY	Background: The molecular mechanisms underlying the -catenin nuclear localization remain unclear. Results: IQGAP1 is a regulator of -catenin nuclear localization. Conclusion: Importin-5 and Ran contribute to the nuclear localization of -catenin. Significance: Novel molecular mechanisms were found in Wnt signaling. In the canonical Wnt signaling pathway, the translocation of -catenin is important for the activation of target genes in the nucleus. However, the molecular mechanisms underlying its nuclear localization remain unclear. In the present study, we found IQGAP1 to be a regulator of -catenin function via importin-5. In Xenopus embryos, depletion of IQGAP1 reduced Wnt-induced nuclear accumulation of -catenin and expression of Wnt target genes during early embryogenesis. Depletion of endogenous importin-5 associated with IQGAP1 also reduced expression of Wnt target genes and the nuclear localization of IQGAP1 and -catenin. Moreover, a small GTPase, Ran1, contributes to the nuclear translocation of -catenin and the activation of Wnt target genes. These results suggest that IQGAP1 functions as a regulator of translocation of -catenin in the canonical Wnt signaling pathway.	[Goto, Toshiyasu; Sato, Atsushi; Shibuya, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Adachi, Shungo; Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 1350064, Japan	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST)	Shibuya, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan.	shibuya.mcb@mri.tmd.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Carnac G, 1996, DEVELOPMENT, V122, P3055; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Glinka A, 1996, MECH DEVELOP, V60, P221, DOI 10.1016/S0925-4773(96)00624-7; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Goto T., 2013, PLOS ONE, V8; Gumbiner BM, 1997, CURR BIOL, V7, pR443, DOI 10.1016/S0960-9822(06)00214-4; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Laurent MN, 1997, DEVELOPMENT, V124, P4905; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mateer SC, 2002, J BIOL CHEM, V277, P12324, DOI 10.1074/jbc.M109535200; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	40	30	33	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36351	36360		10.1074/jbc.M113.520528	http://dx.doi.org/10.1074/jbc.M113.520528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196961	hybrid, Green Published			2022-12-25	WOS:000328883400017
J	Leslie, KL; Song, GJ; Barrick, S; Wehbi, VL; Vilardaga, JP; Bauer, PM; Bisello, A				Leslie, Kristen L.; Song, Gyun Jee; Barrick, Stacey; Wehbi, Vanessa L.; Vilardaga, Jean-Pierre; Bauer, Philip M.; Bisello, Alessandro			Ezrin-Radixin-Moesin-binding Phosphoprotein 50 (EBP50) and Nuclear Factor-kappa B (NF-kappa B) A FEED-FORWARD LOOP FOR SYSTEMIC AND VASCULAR INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Macrophages; NF-Kappa B (NF-KB); Scaffold Proteins; Vascular Biology; Vascular Smooth Muscle Cells; EBP50; NHERF1; PDZ Domain; PKC Zeta	SMOOTH-MUSCLE-CELLS; KINASE-C-ZETA; TUMOR-NECROSIS-FACTOR; CARDIOVASCULAR-DISEASE; MACROPHAGE ACTIVATION; REGULATORY FACTOR; HUMAN MONOCYTES; PKC-ZETA; PROTEIN; RECEPTOR	Background: EBP50 is a scaffolding protein that is critical during vascular remodeling. Results: EBP50 expression is induced by inflammatory stimuli and potentiates NF-B activation and inflammation. Conclusion: EBP50 and NF-B participate in a feed-forward loop leading to increased macrophage activation and enhanced response of vascular cells to inflammation. Significance: This work reveals a novel mechanism regulating systemic and vascular inflammation. The interaction between vascular cells and macrophages is critical during vascular remodeling. Here we report that the scaffolding protein, ezrin-binding phosphoprotein 50 (EBP50), is a central regulator of macrophage and vascular smooth muscle cells (VSMC) function. EBP50 is up-regulated in intimal VSMC following endoluminal injury and promotes neointima formation. However, the mechanisms underlying these effects are not fully understood. Because of the fundamental role that inflammation plays in vascular diseases, we hypothesized that EBP50 mediates macrophage activation and the response of vessels to inflammation. Indeed, EBP50 expression increased in primary macrophages and VSMC, and in the aorta of mice, upon treatment with LPS or TNF. This increase was nuclear factor-B (NF-B)-dependent. Conversely, activation of NF-B was impaired in EBP50-null VSMC and macrophages. We found that inflammatory stimuli promote the formation of an EBP50-PKC complex at the cell membrane that induces NF-B signaling. Macrophage activation and vascular inflammation after acute LPS treatment were reduced in EBP50-null cells and mice as compared with WT. Furthermore, macrophage recruitment to vascular lesions was significantly reduced in EBP50 knock-out mice. Thus, EBP50 and NF-B participate in a feed-forward loop leading to increased macrophage activation and enhanced response of vascular cells to inflammation.	[Bisello, Alessandro] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wehbi, Vanessa L.; Vilardaga, Jean-Pierre] Univ Pittsburgh, Sch Med, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Bauer, Philip M.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; [Bauer, Philip M.; Bisello, Alessandro] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bisello, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1358 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	alb138@pitt.edu	Barrick, Stacey/J-1595-2015	Barrick, Stacey/0000-0002-4837-3741	Vascular Medicine Institute, University of Pittsburgh; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; National Institutes of Health [UL1 RR024153, UL1TR000005, T32GM08424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072501] Funding Source: NIH RePORTER	Vascular Medicine Institute, University of Pittsburgh; Institute for Transfusion Medicine; Hemophilia Society of Western Pennsylvania; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by a Pilot Project Program in Hemostasis and Vascular Biology, Vascular Medicine Institute, University of Pittsburgh, supported by grants from the Institute for Transfusion Medicine and the Hemophilia Society of Western Pennsylvania and by National Institutes of Health Grants UL1 RR024153 and UL1TR000005 (to A. B.).; Supported by the National Institutes of Health Predoctoral Training Grant T32GM08424.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Breuss JM, 2002, CIRCULATION, V105, P633, DOI 10.1161/hc0502.102966; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Csanyi G, 2009, FREE RADICAL BIO MED, V47, P1254, DOI 10.1016/j.freeradbiomed.2009.07.022; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; Dagvadorj J, 2009, INNATE IMMUN, V15, P217, DOI 10.1177/1753425909103738; Davis AS, 2007, PLOS PATHOG, V3, P1887, DOI 10.1371/journal.ppat.0030186; Ediger TR, 2002, MOL ENDOCRINOL, V16, P1828, DOI 10.1210/me.2001-0290; Ediger TR, 1999, ENDOCRINOLOGY, V140, P2976, DOI 10.1210/en.140.7.2976; Estell K, 2003, MOL CELL BIOL, V23, P594, DOI 10.1128/MCB.23.2.594-606.2003; Fouassier L, 2009, AM J PATHOL, V174, P869, DOI 10.2353/ajpath.2009.080079; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; Landry DB, 1997, AM J PATHOL, V151, P1085; LaVallie ER, 2006, J BIOL CHEM, V281, P24124, DOI 10.1074/jbc.M601905200; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lingnau M, 2007, HUM IMMUNOL, V68, P730, DOI 10.1016/j.humimm.2007.06.004; Luscinskas FW, 1996, ANNU REV MED, V47, P413, DOI 10.1146/annurev.med.47.1.413; Manes S, 2010, FASEB J, V24, P3381, DOI 10.1096/fj.09-153106; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Monaco C, 2004, CARDIOVASC RES, V61, P671, DOI 10.1016/j.cardiores.2003.11.038; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salyer S, 2011, AM J PHYSIOL-CELL PH, V300, pC425, DOI 10.1152/ajpcell.00357.2010; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Shibata T, 2003, HEPATOLOGY, V38, P178, DOI 10.1053/jhep.2003.50270; Song GJ, 2012, J MOL CELL CARDIOL, V53, P809, DOI 10.1016/j.yjmcc.2012.08.022; Song GJ, 2012, ARTERIOSCL THROM VAS, V32, P33, DOI 10.1161/ATVBAHA.111.235200; Song GJ, 2010, J MOL CELL CARDIOL, V49, P1012, DOI 10.1016/j.yjmcc.2010.08.025; Song J, 2007, HISTOPATHOLOGY, V51, P40, DOI 10.1111/j.1365-2559.2007.02730.x; Stemmer-Rachamimov AO, 2001, AM J PATHOL, V158, P57, DOI 10.1016/S0002-9440(10)63944-2; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; Yin G, 2011, BRIT J DERMATOL, V164, P1043, DOI 10.1111/j.1365-2133.2010.10192.x	49	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36426	36436		10.1074/jbc.M113.483339	http://dx.doi.org/10.1074/jbc.M113.483339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196963	hybrid, Green Published			2022-12-25	WOS:000328883400024
J	Yao, JW; Maxwell, JB; Rock, CO				Yao, Jiangwei; Maxwell, John B.; Rock, Charles O.			Resistance to AFN-1252 Arises from Missense Mutations in Staphylococcus aureus Enoyl-acyl Carrier Protein Reductase (FabI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acyl Carrier Protein; Antibiotic Resistance; Antibiotics Action; Drug Resistance; Fatty Acid Synthase; Staphylococcus aureus; FabI; Enoyl-ACP Reductase	FATTY-ACID SYNTHESIS; IN-VITRO ACTIVITY; ESCHERICHIA-COLI; TRICLOSAN RESISTANCE; INHIBITOR AFN-1252; RESIDENCE TIME; ACP REDUCTASE; MECHANISM; COMPLEX; ENZYME	Background: AFN-1252 is a FabI inhibitor developed to treat Staphylococcus aureus. Results: AFN-1252 resistance arises from a single missense mutation that produces a FabI(M99T) protein. Conclusion: The interaction between Met-99 and AFN-1252 accounts for the staphylococcal selectivity of the drug. Significance: The AFN-1252-resistant strains remain susceptible to drug concentrations typically achieved in antibiotic therapy. AFN-1252 is a potent antibiotic against Staphylococcus aureus that targets the enoyl-acyl carrier protein reductase (FabI). A thorough screen for AFN-1252-resistant strains was undertaken to identify the spectrum of mechanisms for acquired resistance. A missense mutation in fabI predicted to encode FabI(M99T) was isolated 49 times, and a single isolate was predicted to encode FabI(Y147H). AFN-1252 only bound to the NADPH form of FabI, and the close interactions between the drug and Met-99 and Tyr-147 explained how the mutations would result in resistant enzymes. The clone expressing FabI(Y147H) had a pronounced growth defect that was rescued by exogenous fatty acid supplementation, and the purified protein had less than 5% of the enzymatic activity of FabI. FabI(Y147F) was also catalytically defective but retained its sensitivity to AFN-1252, illustrating the importance of the conserved Tyr-147 hydroxyl group in FabI function. The strains expressing FabI(M99T) exhibited normal growth, and the biochemical properties of the purified protein were indistinguishable from those of FabI. The AFN-1252 K<sub arrange="stack">i<sup arrange="stack">app increased from 4 nm in FabI to 69 nm in FabI(M99T), accounting for the increased resistance of the corresponding mutant strain. The low activity of FabI(Y147H) precluded an accurate K-i measurement. The strain expressing FabI(Y147H) was also resistant to triclosan; however, the strain expressing FabI(M99T) was more susceptible. Strains with higher levels of AFN-1252 resistance were not obtained. The AFN-1252-resistant strains remained sensitive to submicromolar concentrations of AFN-1252, which blocked growth through inhibition of fatty acid biosynthesis at the FabI step.	[Yao, Jiangwei; Maxwell, John B.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org		Yao, Jiangwei/0000-0001-7088-3468	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R25CA023944, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM034496 (to C. O. R.) and CA21765 (Cancer Center Support Grant). This work was also supported by the American Lebanese Syrian Associated Charities.	Banevicius MA, 2013, J CHEMOTHERAPY, V25, P26, DOI 10.1179/1973947812Y.0000000061; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brenwald NP, 2003, J HOSP INFECT, V55, P141, DOI 10.1016/S0195-6701(03)00222-6; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Ciusa ML, 2012, INT J ANTIMICROB AG, V40, P210, DOI 10.1016/j.ijantimicag.2012.04.021; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Escaich S, 2011, ANTIMICROB AGENTS CH, V55, P4692, DOI 10.1128/AAC.01248-10; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Karlowsky JA, 2007, ANTIMICROB AGENTS CH, V51, P1580, DOI 10.1128/AAC.01254-06; Karlowsky JA, 2009, ANTIMICROB AGENTS CH, V53, P3544, DOI 10.1128/AAC.00400-09; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lee HH, 2007, PROTEINS, V69, P691, DOI 10.1002/prot.21586; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Levy SB, 2001, EMERG INFECT DIS, V7, P512, DOI 10.3201/eid0707.017705; Lu H, 2010, CURR OPIN CHEM BIOL, V14, P467, DOI 10.1016/j.cbpa.2010.06.176; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Massengo-Tiasse RP, 2009, CELL MOL LIFE SCI, V66, P1507, DOI 10.1007/s00018-009-8704-7; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McAllister KA, 2006, J BACTERIOL, V188, P4737, DOI 10.1128/JB.01917-05; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Park HS, 2007, INT J ANTIMICROB AG, V30, P446, DOI 10.1016/j.ijantimicag.2007.07.006; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Parsons JB, 2013, ANTIMICROB AGENTS CH, V57, P2182, DOI 10.1128/AAC.02307-12; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2008, MOL MICROBIOL, V68, P987, DOI 10.1111/j.1365-2958.2008.06202.x; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a	47	35	35	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36261	36271		10.1074/jbc.M113.512905	http://dx.doi.org/10.1074/jbc.M113.512905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24189061	Green Published, hybrid			2022-12-25	WOS:000328883400010
J	Antunes, LCM; Han, J; Pan, JX; Moreira, CJC; Azambuja, P; Borchers, CH; Carels, N				Antunes, Luis Caetano M.; Han, Jun; Pan, Jingxi; Moreira, Carlos J. C.; Azambuja, Patricia; Borchers, Christoph H.; Carels, Nicolas			Metabolic Signatures of Triatomine Vectors of Trypanosoma cruzi Unveiled by Metabolomics	PLOS ONE			English	Article							PROLIXUS STAL HEMIPTERA; RHODNIUS-PROLIXUS; CHAGAS-DISEASE; GUT MICROBIOTA; MIDGUT; DIFFERENTIATION; INOSITOL; PHOSPHOLIPIDS; EICOSANOIDS; CULTIVATION	Chagas disease is a trypanosomiasis whose causative agent is the protozoan parasite Trypanosoma cruzi, which is transmitted to humans by hematophagous insects known as triatomines and affects a large proportion of South America. The digestive tract of the insect vectors in which T. cruzi develops constitutes a dynamic environment that affects the development of the parasite. Thus, we set out to investigate the chemical composition of the triatomine intestinal tract through a metabolomics approach. We performed Direct Infusion Fourier Transform Ion Cyclotron Resonance Mass Spectrometry on fecal samples of three triatomine species (Rhodnius prolixus, Triatoma infestans, Panstrongylus megistus) fed with rabbit blood. We then identified groups of metabolites whose frequencies were either uniform in all species or enriched in each of them. By querying the Human Metabolome Database, we obtained putative identities of the metabolites of interest. We found that a core group of metabolites with uniform frequencies in all species represented approximately 80% of the molecules detected, whereas the other 20% varied among triatomine species. The uniform core was composed of metabolites of various categories, including fatty acids, steroids, glycerolipids, nucleotides, sugars, and others. Nevertheless, the metabolic fingerprint of triatomine feces differs depending on the species considered. The variable core was mainly composed of prenol lipids, amino acids, glycerolipids, steroids, phenols, fatty acids and derivatives, benzoic acid and derivatives, flavonoids, glycerophospholipids, benzopyrans, and quinolines. Triatomine feces constitute a rich and varied chemical medium whose constituents are likely to affect T. cruzi development and infectivity. The complexity of the fecal metabolome of triatomines suggests that it may affect triatomine vector competence for specific T. cruzi strains. Knowledge of the chemical environment of T. cruzi in its invertebrate host is likely to generate new ways to understand the factors influencing parasite proliferation as well as methods to control Chagas disease.	[Antunes, Luis Caetano M.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Antunes, Luis Caetano M.; Carels, Nicolas] Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Natl Inst Sci & Technol Innovat Neglected Dis INC, CNPq, Rio De Janeiro, Brazil; [Antunes, Luis Caetano M.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Rio De Janeiro, Brazil; [Han, Jun; Pan, Jingxi; Borchers, Christoph H.] Univ Victoria, Genome BC Prote Ctr, Victoria, BC, Canada; [Moreira, Carlos J. C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Doencas Parasitarias, Rio De Janeiro, Brazil; [Azambuja, Patricia; Carels, Nicolas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, Natl Inst Mol Entomol INCT ME,CNPq, Rio De Janeiro, Brazil; [Carels, Nicolas] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, Rio De Janeiro, Brazil	University of British Columbia; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; University of Victoria; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Carels, N (corresponding author), Fundacao Oswaldo Cruz, Ctr Desenvolvimento Tecnol Saude, Natl Inst Sci & Technol Innovat Neglected Dis INC, CNPq, Rio De Janeiro, Brazil.	nicolas.carels@cdts.fiocruz.br	de Azambuja Penna, Patricia/AAA-3763-2019; Carels, Nicolas/L-4687-2016; Antunes, Luis Caetano Martha/P-4988-2019; BORCHERS, Christoph/U-5964-2019	Carels, Nicolas/0000-0003-4547-7155; Martha Antunes, Luis Caetano/0000-0003-1686-0788; Azambuja, Patricia/0000-0002-1405-8743	Canadian Institutes of Health Research; Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq) [374487/2012-0]; CNPq; Fundacao Oswaldo Cruz (FIOCRUZ) [40.3638/2008-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Centro de Desenvolvimento Tecnologico em Saude (CDTS); Genome Canada; Genome British Columbia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Centro de Desenvolvimento Tecnologico em Saude (CDTS); Genome Canada(Genome Canada); Genome British Columbia	This work was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research and a Young Talent Fellowship (no. 374487/2012-0) from Conselho de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/) to L. C. M. A.; by grants from CNPq to P. A. and N.C.; Fundacao Oswaldo Cruz (FIOCRUZ, http://www.fiocruz.br/)/PAPESV project to N.C. (no. 40.3638/2008-9); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/); Centro de Desenvolvimento Tecnologico em Saude (CDTS), Genome Canada and Genome British Columbia to L. C. M. A. P. A. is a Senior Scientist from CNPq; N.C. was a Visiting Scientist from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) and FIOCRUZ/CDTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, MOL BIOCHEM PARASIT, V114, P143, DOI 10.1016/S0166-6851(01)00245-6; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; Alves-Ferreira M, 2009, MEM I OSWALDO CRUZ, V104, P1100, DOI 10.1590/S0074-02762009000800006; Antunes LCM, 2011, J BACTERIOL, V193, P4719, DOI 10.1128/JB.05132-11; Antunes LCM, 2011, INFECT IMMUN, V79, P1759, DOI 10.1128/IAI.01373-10; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Arena ET, 2011, INFECT IMMUN, V79, P4392, DOI 10.1128/IAI.05478-11; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; AVILA JL, 1983, J GEN MICROBIOL, V129, P285; Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; BILLINGSLEY PF, 1988, INT J INSECT MORPHOL, V17, P295, DOI 10.1016/0020-7322(88)90010-4; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Borges EC, 2006, EXP PARASITOL, V112, P130, DOI 10.1016/j.exppara.2005.09.008; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Cavazzuti A, 2008, P NATL ACAD SCI USA, V105, P1448, DOI 10.1073/pnas.0704384105; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Croft SL, 2003, MOL BIOCHEM PARASIT, V126, P165, DOI 10.1016/S0166-6851(02)00283-9; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631; DOCAMPO R, 1991, BIOCHEM J, V275, P407, DOI 10.1042/bj2750407; Eichinger D, 2002, J BIOSCIENCES, V27, P589, DOI 10.1007/BF02704852; Einicker-Lamas M, 2007, EXP PARASITOL, V117, P171, DOI 10.1016/j.exppara.2007.04.011; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Garcia ES, 2010, MEM I OSWALDO CRUZ, V105, P605, DOI 10.1590/S0074-02762010000500001; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; GARCIA ES, 1991, PARASITOL TODAY, V7, P240, DOI 10.1016/0169-4758(91)90237-I; Garcia ES, 1999, MEM I OSWALDO CRUZ, V94, P213, DOI 10.1590/S0074-02761999000700033; Garcia ES, 1997, MOL BIOL INSECT DIS; Garcia ES, 1984, GENES ANTIGENS PARAS; Ginger ML, 2006, PHILOS T R SOC B, V361, P101, DOI 10.1098/rstb.2005.1756; Ginger ML, 2007, TRYPANOSOMES GENOME; Guerenstein PG, 2009, ACTA TROP, V110, P148, DOI 10.1016/j.actatropica.2008.09.019; Han J, 2008, METABOLOMICS, V4, P128, DOI 10.1007/s11306-008-0104-8; Han J, 2010, FUTURE MICROBIOL, V5, P153, DOI 10.2217/FMB.09.132; HILL P, 1976, PROC R SOC SER B-BIO, V194, P501, DOI 10.1098/rspb.1976.0091; HOUSEMAN JG, 1983, J INSECT PHYSIOL, V29, P141, DOI 10.1016/0022-1910(83)90137-3; Hyde JE, 2007, FEBS J, V274, P4688, DOI 10.1111/j.1742-4658.2007.05999.x; Kollien AH, 2004, INSECT MOL BIOL, V13, P569, DOI 10.1111/j.0962-1075.2004.00504.x; Kollien Astrid H., 1998, Tokai Journal of Experimental and Clinical Medicine, V23, P335; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; LEHANE MJ, 1994, INT J PARASITOL, V24, P27, DOI 10.1016/0020-7519(94)90056-6; Lopez-Ordonez T, 2001, INSECT MOL BIOL, V10, P505, DOI 10.1046/j.0962-1075.2001.00290.x; Machado FS, 2011, ADV PARASIT, V76, P1, DOI 10.1016/B978-0-12-385895-5.00001-3; Martin FPJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00113; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Moncayo A, 2006, ANN TROP MED PARASIT, V100, P663, DOI 10.1179/136485906X112248; Mukherjee S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016959; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; PERLOWAGORASZUMLEWICZ A, 1994, MEM I OSWALDO CRUZ, V89, P603, DOI 10.1590/S0074-02761994000400018; Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Rassi A, 1997, Rev Soc Bras Med Trop, V30, P93, DOI 10.1590/S0037-86821997000200002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reynolds TB, 2009, MICROBIOL-SGM, V155, P1386, DOI 10.1099/mic.0.025718-0; SCHAUB GA, 1987, PARASITOL RES, V73, P417, DOI 10.1007/BF00538198; Silva-Neto Mario A C, 2012, J Parasitol Res, V2012, P625838, DOI 10.1155/2012/625838; Snyder F, 2002, BIOCH LIPIDS LIPOPRO; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Stanley David, 2012, Insects, V3, P492, DOI 10.3390/insects3020492; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; Stanley DW, 1998, AM ZOOL, V38, P369; Torres C, 1999, BBA-GENE STRUCT EXPR, V1489, P428, DOI 10.1016/S0167-4781(99)00195-5; Vacchina P, 2008, J STEROID BIOCHEM, V111, P282, DOI 10.1016/j.jsbmb.2008.06.016; Vallejo GA, 2009, ACTA TROP, V110, P137, DOI 10.1016/j.actatropica.2008.10.001; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; Villalta F, 2009, PARASITOL RES, V104, P1251, DOI 10.1007/s00436-009-1383-3; Wainszelbaum MJ, 2003, BIOCHEM J, V375, P705, DOI 10.1042/BJ20021907	70	22	22	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77283	10.1371/journal.pone.0077283	http://dx.doi.org/10.1371/journal.pone.0077283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204787	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500021
J	Christian, A; Peng, GZ; Sekiya, T; Ye, Y; Wulf, MG; Steuer, T				Christian, Andreas; Peng, Guangzhao; Sekiya, Toru; Ye, Yong; Wulf, Marco G.; Steuer, Thorsten			Biomechanical Reconstructions and Selective Advantages of Neck Poses and Feeding Strategies of Sauropods with the Example of Mamenchisaurus youngi	PLOS ONE			English	Article							LONG NECKS; DINOSAURIA SAUROPODA; POSTURE; KEPT	A very long neck is a characteristic feature of most sauropod dinosaurs. In the genus Mamenchisaurus, neck length is extreme, greater than 40 percent of total body length. However, the posture, utilization, and selective advantage of very long necks in sauropods are still controversial. An excellently preserved skeleton of Mamenchisaurus youngi, including a complete neck, provides an opportunity for a comprehensive biomechanical analysis of neck posture and mobility. The biomechanical evidence indicates that Mamenchisaurus youngi had a nearly straight, near horizontal neck posture and browsed at low or medium heights. The results differ from the findings for some other sauropod species, like Euhelopus, Diplodocus, and Giraffatitan (Brachiosaurus) that had been analyzed in previous studies with similar methods. The selective advantage of extreme neck length in sauropods is likely advantageous for different feeding strategies.	[Christian, Andreas; Wulf, Marco G.; Steuer, Thorsten] Univ Flensburg, Abt Biol & Ihre Didakt, Flensburg, Germany; [Peng, Guangzhao; Sekiya, Toru; Ye, Yong] Zigong Dinosaur Museum, Zigong City, Sichuan Provinc, Peoples R China		Christian, A (corresponding author), Univ Flensburg, Abt Biol & Ihre Didakt, Flensburg, Germany.	christian@uni-flensburg.de			DFG (Deutsche Forschungsgemeinschaft) [FOR 533]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study has been funded by DFG (Deutsche Forschungsgemeinschaft) FOR 533 "Biology of the Sauropod Dinosaurs: The Evolution of Gigantism''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; Bakker RT., 1986, DINOSAUR HERESIES; Berman DS, 2005, LIFE O PAST, P233; Christian A, 1996, PALAEONTOLOGY, V39, P801; Christian A, 2002, MITTEILUNGEN MUSEUMS, V5, P269; Christian A., 2007, FOSS REC, V10, P37; Christian Andreas, 2011, P251; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; Dodson P., 1990, P402; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Gee Carole T., 2011, P34; Henderson DM, 2004, P ROY SOC B-BIOL SCI, V271, pS180, DOI 10.1098/rsbl.2003.0136; Klein N, 2012, BIOL LETTERS, V8, P1032, DOI 10.1098/rsbl.2012.0778; Mallison Heinrich, 2011, P237; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Martin J, 1987, 4 S MES TERR EC, P154; Ouyang H., 2002, 1 MAMENCHISAURID SKE, P111; Parrish J. Michael, 2006, P201; Paul G.S., 1988, HUNTERIA, V2, P1; Pi L.-Z., 1996, DEP SPATIAL PLANNING, P87; Preuschoft H, 1976, AUFSATZE REDEN SENCK, V28, P98; Preuschoft Holger, 2011, P197; Rauhut OWM, 2005, NATURE, V435, P670, DOI 10.1038/nature03623; Ruxton GD, 2011, BIOL LETTERS, V7, P779, DOI 10.1098/rsbl.2011.0116; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2009, SCIENCE, V323, P1671; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sekiya Toru, 2011, Memoir of the Fukui Prefectural Dinosaur Museum, V10, P1; Sereno PC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P157; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Seymour RS, 2009, BIOL LETTERS, V5, P317, DOI 10.1098/rsbl.2009.0096; Seymour RS, 2009, SCIENCE, V323, P1671, DOI 10.1126/science.323.5922.1671; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; Stevens KA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P178; Sverdlova NS, 2010, J BIOMECH, V43, P387, DOI 10.1016/j.jbiomech.2009.09.049; Taylor MP, 2011, J ZOOL, V285, P150, DOI 10.1111/j.1469-7998.2011.00824.x; Taylor MP, 2013, PEERJ, V1, DOI 10.7717/peerj.36; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Taylor MP, 2009, ACTA PALAEONTOL POL, V54, P213, DOI 10.4202/app.2009.0007; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilkinson DM, 2012, BIOL REV, V87, P616, DOI 10.1111/j.1469-185X.2011.00212.x; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Wiman C., 1929, Palaeontologia Sinica C vi, V1, P1; Wolff J, 1892, GESETZ TRANSFORMATIO; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1	51	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e71172	10.1371/journal.pone.0071172	http://dx.doi.org/10.1371/journal.pone.0071172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204557	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500002
J	Ha, S; Baver, S; Huo, LH; Gata, A; Hairston, J; Huntoon, N; Li, WJ; Zhang, T; Benecchi, EJ; Ericsson, M; Hentges, ST; Bjorbaek, C				Ha, Sangdeuk; Baver, Scott; Huo, Lihong; Gata, Adriana; Hairston, Joyce; Huntoon, Nicholas; Li, Wenjing; Zhang, Thompson; Benecchi, Elizabeth J.; Ericsson, Maria; Hentges, Shane T.; Bjorbaek, Christian			Somato-Dendritic Localization and Signaling by Leptin Receptors in Hypothalamic POMC and AgRP Neurons	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; PROOPIOMELANOCORTIN NEURONS; MESSENGER-RNA; INTERACTING PROTEIN; GENE-EXPRESSION; DYNAMIC CHANGES; NEUROPEPTIDE-Y; SOLITARY TRACT; NUCLEUS; RAT	Leptin acts via neuronal leptin receptors to control energy balance. Hypothalamic pro-opiomelanocortin (POMC) and agouti-related peptide (AgRP)/Neuropeptide Y (NPY)/GABA neurons produce anorexigenic and orexigenic neuropeptides and neurotransmitters, and express the long signaling form of the leptin receptor (LepRb). Despite progress in the understanding of LepRb signaling and function, the sub-cellular localization of LepRb in target neurons has not been determined, primarily due to lack of sensitive anti-LepRb antibodies. Here we applied light microscopy (LM), confocal-laser scanning microscopy (CLSM), and electron microscopy (EM) to investigate LepRb localization and signaling in mice expressing a HA-tagged LepRb selectively in POMC or AgRP/NPY/GABA neurons. We report that LepRb receptors exhibit a somato-dendritic expression pattern. We further show that LepRb activates STAT3 phosphorylation in neuronal fibers within several hypothalamic and hindbrain nuclei of wild-type mice and rats, and specifically in dendrites of arcuate POMC and AgRP/NPY/GABA neurons of Leprb(+/+) mice and in Leprb(db/db) mice expressing HA-LepRb in a neuron specific manner. We did not find evidence of LepRb localization or STAT3-signaling in axon-fibers or nerve-terminals of POMC and AgRP/NPY/GABA neurons. Three-dimensional serial EM-reconstruction of dendritic segments from POMC and AgRP/NPY/GABA neurons indicates a high density of shaft synapses. In addition, we found that the leptin activates STAT3 signaling in proximity to synapses on POMC and AgRP/NPY/GABA dendritic shafts. Taken together, these data suggest that the signaling-form of the leptin receptor exhibits a somato-dendritic expression pattern in POMC and AgRP/NPY/GABA neurons. Dendritic LepRb signaling may therefore play an important role in leptin's central effects on energy balance, possibly through modulation of synaptic activity via post-synaptic mechanisms.	[Ha, Sangdeuk; Baver, Scott; Huo, Lihong; Gata, Adriana; Hairston, Joyce; Huntoon, Nicholas; Li, Wenjing; Zhang, Thompson; Bjorbaek, Christian] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; [Ha, Sangdeuk; Baver, Scott; Huo, Lihong; Gata, Adriana; Hairston, Joyce; Huntoon, Nicholas; Li, Wenjing; Zhang, Thompson; Bjorbaek, Christian] Harvard Univ, Sch Med, Boston, MA USA; [Benecchi, Elizabeth J.; Ericsson, Maria] Harvard Univ, Sch Med, Electron Microscopy Facil, Boston, MA USA; [Hentges, Shane T.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Colorado State University	Bjorbaek, C (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA.	cbjorbae@bidmc.harvard.edu	Bjorbaek, Christian/S-4727-2019; Hentges, Shane T/B-9747-2012		American Diabetes Association [7-09-BS-17, 7-12-BS-010]; Boston Obesity Nutrition Research Center [DK46200]; National Institutes of Health [DK094040, DK060673]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094040, R01DK060673, R01DK078749, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086262] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Boston Obesity Nutrition Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by American Diabetes Association (grant numbers 7-09-BS-17 and 7-12-BS-010), Boston Obesity Nutrition Research Center (grant number DK46200), and National Institutes of Health (grant numbers DK094040 and DK060673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; BJORBAEK C, 1995, DIABETES, V44, P90, DOI 10.2337/diabetes.44.1.90; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Bjorbaek C, 2009, J INVEST MED, V57, P789, DOI 10.2310/JIM.0b013e3181bb0d49; Bouret SG, 2012, J NEUROSCI, V32, P1244, DOI 10.1523/JNEUROSCI.2277-11.2012; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Flynn Kevin C, 2013, Bioarchitecture, V3, P86; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Gamber KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030485; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GRAFSTEIN B, 1980, PHYSIOL REV, V60, P1167, DOI 10.1152/physrev.1980.60.4.1167; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Haan C, 2006, BIOCHEM PHARMACOL, V72, P1538, DOI 10.1016/j.bcp.2006.04.013; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hentges ST, 2007, J NEUROPHYSIOL, V97, P3298, DOI 10.1152/jn.00051.2007; Hill JW, 2010, CELL METAB, V11, P286, DOI 10.1016/j.cmet.2010.03.002; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Huo LH, 2006, DIABETES, V55, P567, DOI 10.2337/diabetes.55.03.06.db05-1143; Huo LH, 2004, ENDOCRINOLOGY, V145, P2516, DOI 10.1210/en.2003-1242; Huo LH, 2007, ENDOCRINOLOGY, V148, P2189, DOI 10.1210/en.2006-1572; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Irving AJ, 2006, NEUROSCIENCE, V138, P1137, DOI 10.1016/j.neuroscience.2005.11.042; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; KISS JZ, 1984, BRAIN RES, V324, P91, DOI 10.1016/0006-8993(84)90625-5; Klemann CJHM, 2011, SYNAPSE, V65, P1222, DOI 10.1002/syn.20962; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Leinninger GM, 2008, ACTA PHYSIOL, V192, P49, DOI 10.1111/j.1748-1716.2007.01784.x; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; MacLennan AJ, 2000, NEUROSCIENCE, V99, P761, DOI 10.1016/S0306-4522(00)90236-7; McKinney RA, 2010, J PHYSIOL-LONDON, V588, P107, DOI 10.1113/jphysiol.2009.178905; Mercer AJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00019; Mihaly E, 2000, J CLIN ENDOCR METAB, V85, P2596, DOI 10.1210/jc.85.7.2596; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; O'Malley D, 2007, MOL CELL NEUROSCI, V35, P559, DOI 10.1016/j.mcn.2007.05.001; Peters A., 1991, FINE STRUCTURE NERVO; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Piper ML, 2008, MOL ENDOCRINOL, V22, P751, DOI 10.1210/me.2007-0389; Qiu J, 2003, J NEUROSCI, V23, P9529; Reyes ARS, 2010, BRAIN RES, V1358, P71, DOI 10.1016/j.brainres.2010.08.080; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Robertson SA, 2008, PHYSIOL BEHAV, V94, P637, DOI 10.1016/j.physbeh.2008.04.005; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Sickles DW, 2002, NEUROTOXICOLOGY, V23, P223, DOI 10.1016/S0161-813X(02)00025-6; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Stroh T, 2006, NEUROCHEM RES, V31, P247, DOI 10.1007/s11064-005-9013-7; Stuart G, 2008, DENDRITES; Taga T, 1996, J NEUROCHEM, V67, P1; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thompson JL, 2013, BIOL PSYCHIAT, V73, P860, DOI 10.1016/j.biopsych.2012.10.026; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Treweek JB, 2009, J COMP NEUROL, V512, P323, DOI 10.1002/cne.21884; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Verma NK, 2009, J BIOL CHEM, V284, P12349, DOI 10.1074/jbc.M807761200; Wang YJ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/570413; White David W., 1996, Cytokine and Growth Factor Reviews, V7, P303, DOI 10.1016/S1359-6101(96)00040-8; White UA, 2011, CURR PHARM DESIGN, V17, P340; Wilson BD, 1999, ENDOCRINOLOGY, V140, P2387, DOI 10.1210/en.140.5.2387; Xu XH, 2006, J CELL SCI, V119, P452, DOI 10.1242/jcs.02750; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039	85	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77622	10.1371/journal.pone.0077622	http://dx.doi.org/10.1371/journal.pone.0077622			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204898	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700045
J	Liu, Y; Lu, XR; Xiang, FL; Lu, M; Feng, QP				Liu, Yin; Lu, Xiangru; Xiang, Fu-Li; Lu, Man; Feng, Qingping			Nitric Oxide Synthase-3 Promotes Embryonic Development of Atrioventricular Valves	PLOS ONE			English	Article							BICUSPID AORTIC-VALVE; MITRAL-VALVE; MESENCHYMAL TRANSITION; HEART DEVELOPMENT; CARDIAC VALVES; MICE; EXPRESSION; DISEASE; MOUSE; REGURGITATION	Nitric oxide synthase-3 (NOS3) has recently been shown to promote endothelial-to-mesenchymal transition (EndMT) in the developing atrioventricular (AV) canal. The present study was aimed to investigate the role of NOS3 in embryonic development of AV valves. We hypothesized that NOS3 promotes embryonic development of AV valves via EndMT. To test this hypothesis, morphological and functional analysis of AV valves were performed in wild-type (WT) and NOS3(-/-) mice at postnatal day 0. Our data show that the overall size and length of mitral and tricuspid valves were decreased in NOS3(-/-) compared with WT mice. Echocardiographic assessment showed significant regurgitation of mitral and tricuspid valves during systole in NOS3(-/-) mice. These phenotypes were all rescued by cardiac specific NOS3 overexpression. To assess EndMT, immunostaining of Snail1 was performed in the embryonic heart. Both total mesenchymal and Snail1(+) cells in the AV cushion were decreased in NOS3(-/-) compared with WT mice at E10.5 and E12.5, which was completely restored by cardiac specific NOS3 overexpression. In cultured embryonic hearts, NOS3 promoted transforming growth factor (TGF beta), bone morphogenetic protein (BMP2) and Snail1expression through cGMP. Furthermore, mesenchymal cell formation and migration from cultured AV cushion explants were decreased in the NOS3(-/-) compared with WT mice. We conclude that NOS3 promotes AV valve formation during embryonic heart development and deficiency in NOS3 results in AV valve insufficiency.	[Liu, Yin; Xiang, Fu-Li; Feng, Qingping] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Feng, Qingping] Univ Western Ontario, Dept Med, London, ON, Canada; [Lu, Xiangru; Feng, Qingping] Lawson Hlth Res Inst, London, ON, Canada; [Lu, Man] Sichuan Prov Peoples Hosp, Sichuan Acad Med Sci, Dept Ultrasound, Chengdu, Sichuan, Peoples R China	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Sichuan Provincial People's Hospital	Feng, QP (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada.	qfeng@uwo.ca		Feng, Qingping/0000-0001-9739-2765	Heart and Stroke Foundation of Ontario (HSFO) [NA-6774]; Canadian Institutes of Health Research	Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by grants from Heart and Stroke Foundation of Ontario (HSFO, NA-6774) and the Canadian Institutes of Health Research (to Dr. Feng). Dr. Feng is a HSFO Career investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768; Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Anyanwu AC, 2010, SEMIN THORAC CARDIOV, V22, P69, DOI 10.1053/j.semtcvs.2010.05.006; Bartram U, 2001, CIRCULATION, V103, P2745; Bloch W, 1999, CARDIOVASC RES, V43, P675, DOI 10.1016/S0008-6363(99)00160-1; Butcher JT, 2007, PHILOS T R SOC B, V362, P1489, DOI 10.1098/rstb.2007.2130; Camenisch TD, 2002, DEV BIOL, V248, P170, DOI 10.1006/dbio.2002.0731; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chang ACY, 2011, DEV CELL, V21, P288, DOI 10.1016/j.devcel.2011.06.022; Chauvaud S, 1998, J THORAC CARDIOV SUR, V115, P84, DOI 10.1016/S0022-5223(98)99001-8; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Galley HF, 2001, BRIT J ANAESTH, V86, P388, DOI 10.1093/bja/86.3.388; GLICK BN, 1994, AM J CARDIOL, V73, P400, DOI 10.1016/0002-9149(94)90018-3; Gupta A, 2011, CARDIOL YOUNG, V21, P121, DOI 10.1017/S104795111000168X; Hammoud L, 2007, CARDIOVASC RES, V75, P359, DOI 10.1016/j.cardiores.2007.05.006; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Horne BD, 2004, CIRCULATION, V110, P3143, DOI 10.1161/01.CIR.0000147189.85636.C3; Kokubo H, 2004, CIRC RES, V95, P540, DOI 10.1161/01.RES.0000141136.85194.f0; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345; Liu Y., 2012, EUR HEART J; Liu Y, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.004; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Metukuri MR, 2009, WOUND REPAIR REGEN, V17, P578, DOI 10.1111/j.1524-475X.2009.00509.x; Mokadam NA, 2011, TEX HEART I J, V38, P9; MONCADA S, 1991, PHARMACOL REV, V43, P109; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; RINDT H, 1993, J BIOL CHEM, V268, P5332; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schwappacher R, 2011, BMC PHARM, V11, P65; Seguela PE, 2011, ARCH CARDIOVASC DIS, V104, P465, DOI 10.1016/j.acvd.2011.06.004; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Stout KK, 2009, CIRCULATION, V119, P3232, DOI 10.1161/CIRCULATIONAHA.108.782292; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Xiang FL, 2009, CIRCULATION, V120, P1065, DOI 10.1161/CIRCULATIONAHA.108.839068; Yamagishi T, 2009, ANAT SCI INT, V84, P77, DOI 10.1007/s12565-009-0027-0	43	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77611	10.1371/journal.pone.0077611	http://dx.doi.org/10.1371/journal.pone.0077611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204893	Green Submitted, Green Published, gold			2022-12-25	WOS:000326270700044
J	Rockey, DC; Weymouth, N; Shi, ZD				Rockey, Don C.; Weymouth, Nate; Shi, Zengdun			Smooth Muscle alpha Actin (Acta2) and Myofibroblast Function during Hepatic Wound Healing	PLOS ONE			English	Article							FOCAL ADHESION KINASE; AMINO-ACID SEQUENCE; FAT-STORING CELLS; SKELETAL-MUSCLE; STELLATE CELLS; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; LIVER-INJURY; GAMMA-ACTIN; IN-VIVO	Smooth muscle alpha actin (Acta2) expression is largely restricted to smooth muscle cells, pericytes and specialized fibroblasts, known as myofibroblasts. Liver injury, associated with cirrhosis, induces transformation of resident hepatic stellate cells into liver specific myofibroblasts, also known as activated cells. Here, we have used in vitro and in vivo wound healing models to explore the functional role of Acta2 in this transformation. Acta2 was abundant in activated cells isolated from injured livers but was undetectable in quiescent cells isolated from normal livers. Both cellular motility and contraction were dramatically increased in injured liver cells, paralleled by an increase in Acta2 expression, when compared with quiescent cells. Inhibition of Acta2 using several different techniques had no effect on cytoplasmic actin isoform expression, but led to reduced cellular motility and contraction. Additionally, Acta2 knockdown was associated with a significant reduction in Erk1/2 phosphorylation compared to control cells. The data indicate that Acta2 is important specifically in myofibroblast cell motility and contraction and raise the possibility that the Acta2 cytoskeleton, beyond its structural importance in the cell, could be important in regulating signaling processes during wound healing in vivo.	[Rockey, Don C.; Shi, Zengdun] Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA; [Weymouth, Nate] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA	Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rockey, DC (corresponding author), Med Univ S Carolina, Dept Internal Med, Charleston, SC 29425 USA.	rockey@musc.edu			National Institutes of Health [DK 02124, DK 50574, DK 57830]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002124, R01DK050574, R01DK057830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grants DK 02124, DK 50574, and DK 57830 to DCR). We thank Shmuel Tuvia for assistance with immunohistochemical studies and confocal imaging and John Chung for development of antisense oligonucleotides. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin E, 2013, BIOL CHEM IN PRESS; ARORA PD, 1994, J CELL PHYSIOL, V159, P161, DOI 10.1002/jcp.1041590120; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; DARBY I, 1990, LAB INVEST, V63, P21; Davis BH, 1996, CLIN LAB MED, V16, P361, DOI 10.1016/S0272-2712(18)30274-9; DELEEUW AM, 1984, HEPATOLOGY, V4, P392; DESMOULIERE A, 1995, EXP NEPHROL, V3, P134; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gabbiani G, 1981, Prog Clin Biol Res, V54, P183; GABBIANI G, 1972, J EXP MED, V135, P719, DOI 10.1084/jem.135.4.719; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; GARRELS JI, 1976, CELL, V9, P793, DOI 10.1016/0092-8674(76)90142-2; GATES RE, 1994, CELL GROWTH DIFFER, V5, P891; GRESSNER AM, 1995, J HEPATOL, V22, P28; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; Kapanci Y, 1997, MODERN PATHOL, V10, P1134; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649; Khimji AK, 2008, AM J PATHOL, V173, P716, DOI 10.2353/ajpath.2008.071121; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; KUHN C, 1991, AM J PATHOL, V138, P1257; Kumar A, 1997, P NATL ACAD SCI USA, V94, P4406, DOI 10.1073/pnas.94.9.4406; Liu ZA, 2010, BRIT J PHARMACOL, V159, P304, DOI 10.1111/j.1476-5381.2009.00477.x; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477; McClain SA, 1996, AM J PATHOL, V149, P1257; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; MITCHELL J, 1989, LAB INVEST, V60, P643; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIWA T, 1991, MOL CELL BIOL, V11, P3296, DOI 10.1128/MCB.11.6.3296; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; Okayama T, 2008, BBA-MOL BASIS DIS, V1782, P542, DOI 10.1016/j.bbadis.2008.06.006; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Paradis V, 2010, AM J PATHOL, V177, P1791, DOI 10.2353/ajpath.2010.100166; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; PROCTOR E, 1982, GASTROENTEROLOGY, V83, P1183; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; ROCHE WR, 1990, J PATHOL, V161, P281, DOI 10.1002/path.1711610402; ROCKEY DC, 1992, J SUBMICR CYTOL PATH, V24, P193; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Santos MF, 1997, J CLIN INVEST, V100, P216, DOI 10.1172/JCI119515; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shafiei MS, 2012, LAB INVEST, V92, P305, DOI 10.1038/labinvest.2011.155; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Svegliati-Baroni G, 2003, J HEPATOL, V39, P528, DOI 10.1016/S0168-8278(03)00291-5; TANAKA Y, 1991, J PATHOL, V164, P273, DOI 10.1002/path.1711640314; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VANDEKERCKHOVE J, 1979, DIFFERENTIATION, V14, P123, DOI 10.1111/j.1432-0436.1979.tb01021.x; Weymouth N, 2012, DEV BIOL, V363, P1, DOI 10.1016/j.ydbio.2011.11.002; Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673	67	97	97	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77166	10.1371/journal.pone.0077166	http://dx.doi.org/10.1371/journal.pone.0077166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204762	gold, Green Published, Green Submitted			2022-12-25	WOS:000326270700020
J	Molnar, F; Caragine, C; Caraco, T; Korniss, G				Molnar, Ferenc, Jr.; Caragine, Christina; Caraco, Thomas; Korniss, Gyorgy			Restoration Ecology: Two-Sex Dynamics and Cost Minimization	PLOS ONE			English	Article							HOST SPATIAL HETEROGENEITY; PHASE-TRANSITIONS; INVASION; DIFFUSION; EXTINCTION; MODELS; CONSEQUENCES; REPRODUCTION; COMPETITION; NUCLEATION	We model a spatially detailed, two-sex population dynamics, to study the cost of ecological restoration. We assume that cost is proportional to the number of individuals introduced into a large habitat. We treat dispersal as homogeneous diffusion in a one-dimensional reaction-diffusion system. The local population dynamics depends on sex ratio at birth, and allows mortality rates to differ between sexes. Furthermore, local density dependence induces a strong Allee effect, implying that the initial population must be sufficiently large to avert rapid extinction. We address three different initial spatial distributions for the introduced individuals; for each we minimize the associated cost, constrained by the requirement that the species must be restored throughout the habitat. First, we consider spatially inhomogeneous, unstable stationary solutions of the model's equations as plausible candidates for small restoration cost. Second, we use numerical simulations to find the smallest rectangular cluster, enclosing a spatially homogeneous population density, that minimizes the cost of assured restoration. Finally, by employing simulated annealing, we minimize restoration cost among all possible initial spatial distributions of females and males. For biased sex ratios, or for a significant between-sex difference in mortality, we find that sex-specific spatial distributions minimize the cost. But as long as the sex ratio maximizes the local equilibrium density for given mortality rates, a common homogeneous distribution for both sexes that spans a critical distance yields a similarly low cost.	[Molnar, Ferenc, Jr.; Caragine, Christina; Korniss, Gyorgy] Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA; [Caraco, Thomas] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	Rensselaer Polytechnic Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Molnar, F (corresponding author), Rensselaer Polytech Inst, Dept Phys Appl Phys & Astron, Troy, NY 12180 USA.	molnaf@rpi.edu	Korniss, Gyorgy/A-7360-2011	Caraco, Thomas/0000-0002-8538-6007; Molnar, Ferenc/0000-0002-5614-3989; Caragine, Christina/0000-0002-5958-7200	National Science Foundation [DEB-0918413, DEB-0918392]; Direct For Biological Sciences [0918413] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Science Foundation supported this research under Grant Nos. DEB-0918413 and DEB-0918392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allstadt A, 2007, EVOL ECOL RES, V9, P375; Allstadt A, 2009, J THEOR BIOL, V258, P537, DOI 10.1016/j.jtbi.2009.02.012; Aviles L, 2002, AM NAT, V159, P115, DOI 10.1086/324792; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Buckley M, 2006, ENVIRON MANAGE, V38, P48, DOI 10.1007/s00267-005-0165-7; CARACO T, 1995, ECOLOGY, V76, P196, DOI 10.2307/1940641; Caraco T, 2001, THEOR POPUL BIOL, V59, P185, DOI 10.1006/tpbi.2000.1517; Caraco T, 1998, J THEOR BIOL, V192, P351, DOI 10.1006/jtbi.1998.0663; CASWELL H, 1986, AM NAT, V128, P707, DOI 10.1086/284598; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dennis B., 1989, Natural Resource Modeling, V3, P481; DOI M, 1976, J PHYS A-MATH GEN, V9, P1479, DOI 10.1088/0305-4470/9/9/009; Ellner SP, 1998, J MATH BIOL, V36, P469, DOI 10.1007/s002850050109; Escudero C, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021908; Fisher R.A., 1930, GENETICAL THEORY NAT; Gandhi A, 1999, J THEOR BIOL, V200, P121, DOI 10.1006/jtbi.1999.0978; Gardiner C. W., 1985, HDB STOCHASTIC METHO; Hall RJ, 2012, ENCY THEORETICAL ECO, P629; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Holl KD, 2000, RESTOR ECOL, V8, P260, DOI 10.1046/j.1526-100x.2000.80037.x; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Keitt TH, 2001, AM NAT, V157, P203, DOI 10.1086/318633; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Korniss G, 2005, J THEOR BIOL, V233, P137, DOI 10.1016/j.jtbi.2004.09.018; Korniss G, 1997, PHYS REV E, V56, P4072, DOI 10.1103/PhysRevE.56.4072; KORNISS G, 1995, EUROPHYS LETT, V32, P49, DOI 10.1209/0295-5075/32/1/009; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; Machado E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031603; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; Miller TEX, 2011, AM NAT, V177, P549, DOI 10.1086/659628; Molnar F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043364; Molnar F, 2011, CHEMOMETR INTELL LAB, V108, P76, DOI 10.1016/j.chemolab.2011.03.009; Moro E, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.025102; New York State Department of Environmental Conservation, 2012, CAN LYNX; NVIDIA, 2013, CUDA C PROGR GUID; O'Malley L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041116; O'Malley L, 2006, THEOR POPUL BIOL, V70, P464, DOI 10.1016/j.tpb.2006.06.006; O'Malley L, 2009, B MATH BIOL, V71, P1160, DOI 10.1007/s11538-009-9398-6; Pigolotti S, 2013, THEOR POPUL BIOL, V84, P72, DOI 10.1016/j.tpb.2012.12.002; Ramos RA, 1999, PHYS REV B, V59, P9053, DOI 10.1103/PhysRevB.59.9053; RIKVOLD PA, 1994, PHYS REV E, V49, P5080, DOI 10.1103/PhysRevE.49.5080; Robinson GR, 2000, ECOL APPL, V10, P174, DOI 10.1890/1051-0761(2000)010[0174:DSPORD]2.0.CO;2; Schiesser W. E., 1991, NUMERICAL METHOD LIN; Schmickl T, 2010, ECOL MODEL, V221, P1089, DOI 10.1016/j.ecolmodel.2009.12.028; Schmittmann B, 1995, STAT MECH DRIVEN DIF, V17; Shea K, 2000, J APPL ECOL, V37, P77, DOI 10.1046/j.1365-2664.2000.00467.x; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Tauber UC, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/40/405002; Tainaka K, 2006, EUROPHYS LETT, V74, P554, DOI 10.1209/epl/i2005-10558-3; Tauber UC, 2005, J PHYS A-MATH GEN, V38, pR79, DOI 10.1088/0305-4470/38/17/R01; van Kampen N. G., 1981, STOCHASTIC PROCESSES	56	0	0	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77332	10.1371/journal.pone.0077332	http://dx.doi.org/10.1371/journal.pone.0077332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204810	gold, Green Submitted, Green Published			2022-12-25	WOS:000326241200025
J	Polverino, G; Phamduy, P; Porfiri, M				Polverino, Giovanni; Phamduy, Paul; Porfiri, Maurizio			Fish and Robots Swimming Together in a Water Tunnel: Robot Color and Tail-Beat Frequency Influence Fish Behavior	PLOS ONE			English	Article							GOLDEN SHINERS; VISUAL CUES; BODY-SIZE; ZEBRAFISH; RESPONSES; WILD; PREFERENCE; RISK; MOSQUITOFISH; PREDATION	The possibility of integrating bioinspired robots in groups of live social animals may constitute a valuable tool to study the basis of social behavior and uncover the fundamental determinants of animal functions and dysfunctions. In this study, we investigate the interactions between individual golden shiners (Notemigonus crysoleucas) and robotic fish swimming together in a water tunnel at constant flow velocity. The robotic fish is designed to mimic its live counterpart in the aspect ratio, body shape, dimension, and locomotory pattern. Fish positional preference with respect to the robot is experimentally analyzed as the robot's color pattern and tail-beat frequency are varied. Behavioral observations are corroborated by particle image velocimetry studies aimed at investigating the flow structure behind the robotic fish. Experimental results show that the time spent by golden shiners in the vicinity of the bioinspired robotic fish is the highest when the robot mimics their natural color pattern and beats its tail at the same frequency. In these conditions, fish tend to swim at the same depth of the robotic fish, where the wake from the robotic fish is stronger and hydrodynamic return is most likely to be effective.	[Polverino, Giovanni; Phamduy, Paul; Porfiri, Maurizio] NYU, Dept Mech & Aerosp Engn, Polytech Inst, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Dept Mech & Aerosp Engn, Polytech Inst, Brooklyn, NY USA.	mporfiri@nyu.edu	Polverino, Giovanni/AAC-2556-2020	Polverino, Giovanni/0000-0001-9737-7995; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [CMMI-0745753, CMMI-0926791, DGE-0741714]; Honors Center of Italian Universities (H2CU); Div Of Civil, Mechanical, & Manufact Inn [0745753] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Honors Center of Italian Universities (H2CU); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation under Grant # CMMI-0745753. Additional support has been provided in part by the Honors Center of Italian Universities (H2CU) through a scholarship to G. Polverino and National Science Foundation under Grant # CMMI-0926791 and DGE-0741714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2013, BEHAV PROCESS, V100, P9, DOI 10.1016/j.beproc.2013.07.010; Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Altringham JD, 1999, J EXP BIOL, V202, P3397; BAKKER TCM, 1994, BEHAV ECOL, V5, P74, DOI 10.1093/beheco/5.1.74; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Cianca V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069661; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; de Margerie E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/034001; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Ellerby David J., 2013, P345; Engeszer RE, 2008, P NATL ACAD SCI USA, V105, P929, DOI 10.1073/pnas.0708778105; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; Epps BP, 2009, EXP FLUIDS, V47, P927, DOI 10.1007/s00348-009-0684-8; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Fernandez-Juricic E, 2011, BEHAV ECOL, V22, P1304, DOI 10.1093/beheco/arr132; Fish Frank E., 2010, P90, DOI 10.1201/b10190-5; Frasca M, 2004, WORLD SCI SERIES NON; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Goth A, 2004, J EXP BIOL, V207, P2199, DOI 10.1242/jeb.01008; HALL DJ, 1979, J FISH RES BOARD CAN, V36, P1029, DOI 10.1139/f79-145; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Hanson KC, 2010, CAN J ZOOL, V88, P324, DOI 10.1139/Z10-006; Hemelrijk CK, 2012, INTERFACE FOCUS, V2, P726, DOI 10.1098/rsfs.2012.0025; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; KOPMAN V, 2013, DESIGN MODELING CHAR, V18, P471, DOI DOI 10.1109/TMECH.2012.2222431; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; Krause J, 2002, LIVING GROUPS; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Kubinyi E, 2004, BEHAV PROCESS, V65, P231, DOI 10.1016/j.beproc.2003.10.003; Kunzler R, 2001, BEHAV ECOL, V12, P681, DOI 10.1093/beheco/12.6.681; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luca RM, 2012, BEHAV BRAIN RES, V226, P66, DOI 10.1016/j.bbr.2011.09.001; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Mazzi D, 2003, BEHAV ECOL SOCIOBIOL, V54, P156, DOI 10.1007/s00265-003-0609-0; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; Partan SR, 2011, CURR ZOOL, V57, P140, DOI 10.1093/czoolo/57.2.140; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Pather S, 2009, BEHAV BRAIN RES, V196, P323, DOI 10.1016/j.bbr.2008.09.013; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; PITCHER TJ, 1986, J FISH BIOL, V29, P83, DOI 10.1111/j.1095-8649.1986.tb05001.x; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Polverino G, BIOINSPIR B IN PRESS; Polverino G, 2013, BEHAV BRAIN RES, V250, P133, DOI 10.1016/j.bbr.2013.05.008; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054315; Reebs SG, 2001, BEHAVIOUR, V138, P797, DOI 10.1163/156853901753172656; Rosenthal GG, 2005, ANIM BEHAV, V70, P1063, DOI 10.1016/j.anbehav.2005.02.005; Rosier RL, 2011, NAT ED KNOWL, V2, P8; Rossi C, 2012, SWIMMING PHYSL FISH; Rowland WJ, 1999, ENVIRON BIOL FISH, V56, P285, DOI 10.1023/A:1007517720723; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Seehausen O, 1999, J EVOLUTION BIOL, V12, P514, DOI 10.1046/j.1420-9101.1999.00055.x; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Snekser JL., 2010, INT J COMP PSYCHOL, V23, P70; Spinello C, 2013, ALCOHOL, V47, P391, DOI 10.1016/j.alcohol.2013.04.003; STAMHUIS EJ, 1995, J EXP BIOL, V198, P283; Su Z, 2012, INT J HUM RESOUR MAN, P1; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swain DT, 2012, P IEEE, V100, P150, DOI 10.1109/JPROC.2011.2165449; Takanishi A, 1998, INTERACTION CREATURE; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Ward AJW, 2010, BEHAV ECOL, V21, P1315, DOI 10.1093/beheco/arq152; Wen L, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036012; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023	74	45	45	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77589	10.1371/journal.pone.0077589	http://dx.doi.org/10.1371/journal.pone.0077589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204882	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400046
J	Zhou, TB; Qin, YH; Lei, FY; Huang, WF; Drummen, GPC				Zhou, Tian-Biao; Qin, Yuan-Han; Lei, Feng-Ying; Huang, Wei-Fang; Drummen, Gregor P. C.			Prohibitin Attenuates Oxidative Stress and Extracellular Matrix Accumulation in Renal Interstitial Fibrosis Disease	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; RETINOIC ACID TREATMENT; MITOCHONDRIAL-FUNCTION; REPERFUSION INJURY; NEONATAL MICE; RAT-KIDNEY; EXPRESSION; PROTECTS; GENES; CELLS	Prohibitin is an evolutionary conserved and pleiotropic protein that has been implicated in various cellular functions, including proliferation, tumour suppression, apoptosis, transcription, and mitochondrial protein folding. Both prohibitin over- and under-expression have been implicated in various diseases and cell types. We recently demonstrated that prohibitin down-regulation results in increased renal interstitial fibrosis (RIF). Here we investigated the role of oxidative stress and prohibitin expression in RIF in unilateral ureteral obstructed rats. Lentivirus-based delivery vectors were used to knockdown or over- express prohibitin. Our results show that increased prohibitin expression was negatively correlated with the RIF index, reactive oxygen species, malon dialdehyde, transforming growth factor beta 1, collagen IV, fibronectin, and cell apoptosis index. In conclusion, we postulate that prohibitin acts as a positive regulator of mechanisms that counteract oxidative stress and extracellular matrix accumulation and therefore has an antioxidative effect.	[Zhou, Tian-Biao; Qin, Yuan-Han; Lei, Feng-Ying; Huang, Wei-Fang] GuangXi Med Univ, Dept Pediat Nephrol, Affiliated Hosp 1, Nanning, Peoples R China; [Zhou, Tian-Biao] Sun Yat Sen Univ, Dept Nephrol, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Drummen, Gregor P. C.] Bio&Nano Solut, Cellular Stress & Ageing Program, Bionanosci & Bioimaging Program, Dusseldorf, Germany	Guangxi Medical University; Sun Yat Sen University	Qin, YH (corresponding author), GuangXi Med Univ, Dept Pediat Nephrol, Affiliated Hosp 1, Nanning, Peoples R China.	yuanhanqin@yahoo.cn		Li, Weijia/0000-0002-7546-6388; Drummen, Gregor/0000-0002-8746-7062	Nature Science Foundation of China [81060061, 81150017]; Natural Science Foundation of the Guangxi Zhuang Autonomous Region [0832121]; Health Department of Guangxi Zhuang Autonomous Region [200917]; Grant for External Collaborative Research AGE	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Guangxi Zhuang Autonomous Region(National Natural Science Foundation of Guangxi Province); Health Department of Guangxi Zhuang Autonomous Region; Grant for External Collaborative Research AGE	This study was supported by the Nature Science Foundation of China (no. 81060061 and no. 81150017), the Natural Science Foundation of the Guangxi Zhuang Autonomous Region (no. 0832121) and the Health Department of Guangxi Zhuang Autonomous Region (no. 200917), and a Grant for External Collaborative Research AGE-2009 (G.P.C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTUS MS, 1995, GENE, V158, P291, DOI 10.1016/0378-1119(95)00164-2; An JZ, 2010, INT J MOL EPIDEMIOL, V1, P1; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Botto N, 2011, J PEDIATR UROL, V7, P310, DOI 10.1016/j.jpurol.2011.02.022; Cai GY, 2008, NEPHROL DIAL TRANSPL, V23, P1861, DOI 10.1093/ndt/gfm666; Chowdhury Indrajit, 2012, Front Biosci (Elite Ed), V4, P690; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; Eis V, 2004, J AM SOC NEPHROL, V15, P337, DOI 10.1097/01.ASN.0000111246.87175.32; Funk AJ, 2012, NEUROPSYCHOPHARMACOL, V37, P896, DOI 10.1038/npp.2011.267; Guo W, 2007, MOL CELL BIOCHEM, V295, P167, DOI 10.1007/s11010-006-9286-4; Ha T, 2008, CARDIOVASC RES, V78, P546, DOI 10.1093/cvr/cvn037; He DY, 2011, BIOL PHARM BULL, V34, P1219, DOI 10.1248/bpb.34.1219; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Higgins DF, 2003, KIDNEY INT, V64, P2079, DOI 10.1046/j.1523-1755.2003.00306.x; Hu XR, 2010, EUR J PHARMACOL, V638, P84, DOI 10.1016/j.ejphar.2010.03.059; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Kim SY, 2007, BIOCHEM BIOPH RES CO, V360, P653, DOI 10.1016/j.bbrc.2007.06.118; Kobayashi H, 2012, J IMMUNOL, V188, P5106, DOI 10.4049/jimmunol.1103377; Li ZG, 2011, J BIOL CHEM, V286, P41323, DOI 10.1074/jbc.M111.259184; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsell DG, 2002, PEDIATR NEPHROL, V17, P470, DOI 10.1007/s00467-002-0910-6; Meng LQ, 2007, VASC PHARMACOL, V47, P174, DOI 10.1016/j.vph.2007.06.002; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Morisada N, 2010, J PHARMACOL SCI, V114, P379, DOI 10.1254/jphs.10143FP; Nadimpalli R, 2000, J BIOL CHEM, V275, P29579, DOI 10.1074/jbc.M002339200; Neusser MA, 2010, AM J PATHOL, V176, P594, DOI 10.2353/ajpath.2010.090268; Nowak G, 2012, AM J PHYSIOL-RENAL, V303, pF515, DOI 10.1152/ajprenal.00072.2012; Qiao X, 2013, AM J PHYSIOL-RENAL, V304, pF112, DOI 10.1152/ajprenal.00054.2012; Qu X, 2012, J PATHOL; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Salhan D, 2012, AM J PHYSIOL-RENAL, V303, pF503, DOI 10.1152/ajprenal.00170.2012; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Sun DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033491; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Takahashi S, 2011, BIOCHEM BIOPH RES CO, V405, P462, DOI 10.1016/j.bbrc.2011.01.054; Terashima H, 2010, AM J PHYSIOL-RENAL, V299, pF792, DOI 10.1152/ajprenal.00141.2009; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Thompson WE, 2001, ENDOCRINOLOGY, V142, P4076, DOI 10.1210/en.142.9.4076; Thornhill BA, 2007, KIDNEY INT, V72, P1103, DOI 10.1038/sj.ki.5002512; Wu HZ, 2011, ANAL BIOANAL CHEM, V399, P3431, DOI 10.1007/s00216-010-4463-4; Wu KJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/163106; Xia Z, 2008, AM J NEPHROL, V28, P34, DOI 10.1159/000108759; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhou TB, 2012, INT J MOL SCI, V13, P2769, DOI 10.3390/ijms13032769; Zhou TB, 2012, NEPHROLOGY, V17, P189, DOI 10.1111/j.1440-1797.2011.01522.x	48	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77187	10.1371/journal.pone.0077187	http://dx.doi.org/10.1371/journal.pone.0077187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204768	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400029
J	Heron-Milhavet, L; Franckhauser, C; Fernandez, A; Lamb, NJ				Heron-Milhavet, Lisa; Franckhauser, Celine; Fernandez, Anne; Lamb, Ned J.			Characterization of the Akt2 Domain Essential for Binding Nuclear p21cip1 to Promote Cell Cycle Arrest during Myogenic Differentiation	PLOS ONE			English	Article							PROTEIN-KINASE; FIBROBLASTS; MECHANISM	The binding of the cdk inhibitor p21cip1 to Akt2 in the nucleus is an essential component in determining the specific role of Akt2 in the cell cycle arrest that precedes myogenic differentiation. Here, through a combination of biochemical and cell biology approaches, we have addressed the molecular basis of this binding. Using amino-terminal truncation of Akt2, we show that p21cip1 binds at the carboxy terminal of Akt2 since deletion of the first 400 amino acids did not affect the interaction between Akt2 and p21cip1. Pull down using carboxy terminal-truncated Akt2 protein revealed the importance of the region between amino acids 400 and 445 for the binding to p21cip1. Since Akt2_400-445 and Akt2_ 420-445 peptides could both bind p21cip1, this refines the binding domain on Akt2 between amino acids 420 and 445. In order to confirm these data in living cells, we developed a protocol to synchronize myoblasts at the cell cycle exit point when p21cip1 expression is induced by MyoD before myogenic differentiation. When a synthetic Akt2 peptide spanning the region (410-437) was microinjected in p21-expressing myoblasts, p21cip1 no longer localized exclusively in the nucleus, instead being redistributed throughout the cell, thus showing that injected peptide 410-437 acts to compete with the binding of endogenous Akt2 to p21cip1. Taken together, our data suggest that this 27 amino acid sequence on Akt2 is necessary and sufficient to bind p21cip1 both in vitro and in living cells.	[Heron-Milhavet, Lisa; Franckhauser, Celine; Fernandez, Anne; Lamb, Ned J.] CNRS, Inst Human Genet, UPR1142, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Lamb, NJ (corresponding author), CNRS, Inst Human Genet, UPR1142, Montpellier, France.	ned.lamb@acrux.igh.cnrs.fr	Heron-Milhavet, Lisa/O-4339-2017	Heron-Milhavet, Lisa/0000-0002-7099-0850	ARC [3976]; LNCC	ARC(Australian Research Council); LNCC	This work was supported by ARC grant #3976 (http://www.arc-cancer.net/) and LNCC Grant (Herault et Aude) (http://www.ligue-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; FERNANDEZ A, 1991, EXP CELL RES, V195, P468, DOI 10.1016/0014-4827(91)90398-E; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	12	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76987	10.1371/journal.pone.0076987	http://dx.doi.org/10.1371/journal.pone.0076987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194853	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000032
J	Yan, J; Gan, L; Chen, D; Sun, C				Yan, Jun; Gan, Lu; Chen, Di; Sun, Chao			Adiponectin Impairs Chicken Preadipocytes Differentiation through p38 MAPK/ATF-2 and TOR/p70 S6 Kinase Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE TRIGLYCERIDE LIPASE; PIMA INDIAN POPULATION; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; VISCERAL ADIPOSITY; TISSUE; RECEPTORS; RAPAMYCIN; ATF-2	Adiponectin is a protein hormone secreted exclusively by adipocytes that plays an important role in the modulation of glucose and lipid metabolism. In the present study, we investigated the ability of adiponectin to stimulate chicken preadipocyte differentiation and its effect on cellular signaling pathways associated with adipocyte differentiation. Data showed that over-expression of adiponectin inhibited adipocyte differentiation and the expression of adipogenic marker gene, while activated the expression of lipolytic marker gene. Meanwhile, adiponectin led to activation of p38 mitogen-activated protein kinase (p38 MAPK)/activating transcription factor 2 (ATF-2) signaling pathway and down-regulation of target of rapamycin (TOR)/p70 S6 Kinase signaling pathway. Furthermore, the activation of p38 MAPK/ATF-2 signaling pathway was blocked by the p38 MAPK inhibitor SB253580, whereas adiponectin had a synergistic effect on the suppression of TOR/p70 S6 Kinase signaling pathway with the TOR inhibitor rapamycin. In conclusion, the results demonstrate the ability of adiponectin to inhibit chicken preadipocyte differentiation, which depends on the p38 MAPK/ATF-2 and TOR/p70 S6 Kinase pathways.	[Yan, Jun; Gan, Lu; Chen, Di; Sun, Chao] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Sun, C (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	sunchao2775@163.com	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680	National Nature Science Foundation of China [31172185]; Agriculture Technology Innovation in Shaanxi Province of China [2012NKC01-13]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agriculture Technology Innovation in Shaanxi Province of China	This work was supported by National Nature Science Foundation of China (31172185) and Agriculture Technology Innovation in Shaanxi Province of China (2012NKC01-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Chabrolle C, 2007, DOMEST ANIM ENDOCRIN, V33, P480, DOI 10.1016/j.domaniend.2006.08.002; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hendricks GL, 2009, ENDOCRINOLOGY, V150, P3092, DOI 10.1210/en.2008-1558; Lindsay RS, 2003, DIABETES, V52, P2419, DOI 10.2337/diabetes.52.9.2419; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Luo XH, 2005, EXP CELL RES, V309, P99, DOI 10.1016/j.yexcr.2005.05.021; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maekawa T, 2008, ONCOGENE, V27, P1045, DOI 10.1038/sj.onc.1210727; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Nogalska A, 2005, METABOLISM, V54, P1041, DOI 10.1016/j.metabol.2005.03.007; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shuman JD, 1997, J BIOL CHEM, V272, P12793, DOI 10.1074/jbc.272.19.12793; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Tahmoorespur M, 2010, POULTRY SCI, V89, P2092, DOI 10.3382/ps.2010-00772; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Wanninger J, 2009, AM J PHYSIOL-GASTR L, V297, P16; Xin X, 2011, AM J PHYSIOL-ENDOC M, V300, pE103, DOI 10.1152/ajpendo.00427.2010; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	20	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77716	10.1371/journal.pone.0077716	http://dx.doi.org/10.1371/journal.pone.0077716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194895	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000074
J	Pridmore, RW				Pridmore, Ralph W.			Cone Photoreceptor Sensitivities and Unique Hue Chromatic Responses: Correlation and Causation Imply the Physiological Basis of Unique Hues	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; OPPONENT-COLORS THEORY; VISUAL PIGMENTS; SPECTRAL SENSITIVITIES; COMPLEMENTARY COLORS; QUANTITATIVE ASPECTS; RED-GREEN; MECHANISMS; REPRESENTATION; INFORMATION	This paper relates major functions at the start and end of the color vision process. The process starts with three cone photoreceptors transducing light into electrical responses. Cone sensitivities were once expected to be Red Green Blue color matching functions (to mix colors) but microspectrometry proved otherwise: they instead peak in yellowish, greenish, and blueish hues. These physiological functions are an enigma, unmatched with any set of psychophysical (behavioral) functions. The end-result of the visual process is color sensation, whose essential percepts are unique (or pure) hues red, yellow, green, blue. Unique hues cannot be described by other hues, but can describe all other hues, e. g., that hue is reddish-blue. They are carried by four opponent chromatic response curves but the literature does not specify whether each curve represents a range of hues or only one hue (a unique) over its wavelength range. Here the latter is demonstrated, confirming that opponent chromatic responses define, and may be termed, unique hue chromatic responses. These psychophysical functions also are an enigma, unmatched with any physiological functions or basis. Here both enigmas are solved by demonstrating the three cone sensitivity curves and the three spectral chromatic response curves are almost identical sets (Pearson correlation coefficients r from 0.95-1.0) in peak wavelengths, curve shapes, math functions, and curve crossover wavelengths, though previously unrecognized due to presentation of curves in different formats, e. g., log, linear. (Red chromatic response curve is largely nonspectral and thus derives from two cones.) Close correlation combined with deterministic causation implies cones are the physiological basis of unique hues. This match of three physiological and three psychophysical functions is unique in color vision.	Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia	Macquarie University	Pridmore, RW (corresponding author), Macquarie Univ, Dept Cognit Sci, Sydney, NSW 2109, Australia.	rpridmo@bigpond.net.au		pridmore, ralph/0000-0001-7166-7249				[Anonymous], 2004, CIE PUBL, V15, P2004; AYAMA M, 1982, SCIENCE, V215, P1538, DOI 10.1126/science.7063866; BENZSCHAWEL T, 1986, J OPT SOC AM A, V3, P1713, DOI 10.1364/JOSAA.3.001713; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; BOYNTON RM, 1965, J OPT SOC AM, V55, P78, DOI 10.1364/JOSA.55.000078; Broackes J, 2011, REV PHILOS PSYCHOL, V2, P601, DOI 10.1007/s13164-011-0050-7; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; Crick F, 1988, WHAT MAD PURSUIT PER; DARTNALL HJA, 1983, PROC R SOC SER B-BIO, V220, P115, DOI 10.1098/rspb.1983.0091; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Dowling J. E., 1987, RETINA APPROACHABLE; Estevez O, 1979, THESIS U AMSTERDAM; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FULD K, 1991, VISION RES, V31, P237, DOI 10.1016/0042-6989(91)90114-K; Gegenfurtner K. R., 1999, COLOR VISION GENES P; Geller E, 2003, MCGRAW HILL DICT MAT; GOURAS P, 1982, COLOR RES APPL, V7, P205, DOI 10.1002/col.5080070232; GUTH SL, 1980, J OPT SOC AM, V70, P197, DOI 10.1364/JOSA.70.000197; Guth SL, 2002, P AIC COL 01; Helmholtz H, 1856, H HDB PHYSL OPTIK; Hering H, 1878, LEHRE LICHTSINN; HURVICH LM, 1955, J OPT SOC AM, V45, P602, DOI 10.1364/JOSA.45.000602; Hurvich LM., 1981, COLOR VISION; Illari P., 2011, CAUSALITY SCI, DOI [DOI 10.1093/ACPROF:OSO/9780199574131.003.0002, 10.1093/acprof:oso/9780199574131.003.0002]; INGLING CR, 1978, SCIENCE, V201, P1221, DOI 10.1126/science.201.4362.1221; INGLING CR, 1977, VISION RES, V17, P1075, DOI 10.1016/0042-6989(77)90013-X; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; Jameson D., 1972, HDB SENSORY PHYSL, VVII; Jameson K., 1997, COLOR CATEGORIES THO; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; Judd D. B., 1975, COLOR BUSINESS SCI I; JUDD DB, 1949, J RES NAT BUR STAND, V42, P1, DOI 10.6028/jres.042.001; KULP TD, 1995, VISION RES, V35, P2967, DOI 10.1016/0042-6989(95)00049-6; Lankheet MJM, 1998, VISUAL NEUROSCI, V15, P37, DOI 10.1017/S0952523898151027; Lee TW, 2002, VISION RES, V42, P2095, DOI 10.1016/S0042-6989(02)00122-0; MARKS WB, 1964, SCIENCE, V143, P1181, DOI 10.1126/science.143.3611.1181; Mollon J., 1997, J DALTONS COLOUR VIS, V54, P391; Mollon JD, 2008, PERCEPTION, V37, P127; Mollon JD, 2009, CURR BIOL, V19, pR441, DOI 10.1016/j.cub.2009.05.008; Mollon J. D., 1995, COLOUR ART SCI; Mollon J.D., 1983, COLOUR VISION PHYSL; Morita T, 2004, NEUROIMAGE, V21, P1665, DOI 10.1016/j.neuroimage.2003.12.019; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Pridmore RW, 2006, COLOR RES APPL, V31, P364, DOI 10.1002/col.20229; Pridmore RW, 2013, J OPT-INDIA, V42, P8, DOI 10.1007/s12596-012-0090-0; Pridmore RW, 2011, COLOR RES APPL, V36, P394, DOI 10.1002/col.20611; Pridmore RW, 2010, COLOR RES APPL, V35, P122, DOI 10.1002/col.20534; PRIDMORE RW, 1978, J OPT SOC AM, V68, P1490, DOI 10.1364/JOSA.68.001490; PRIDMORE RW, 1980, J OPT SOC AM, V70, P248, DOI 10.1364/JOSA.70.000248; Pridmore RW, 1999, VISION RES, V39, P3892, DOI 10.1016/S0042-6989(99)00086-3; Romeskie MI, 1976, THESIS BROWN U U MIC; SCHNAPF JL, 1987, NATURE, V325, P439, DOI 10.1038/325439a0; Schnapf JL, 1999, COLOR VISION GENES P; Sharpe LT., 1999, COLOR VISION GENES P, P89; Simpson John, 2000, OXFORD ENGLISH DICT; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; Stiles WS, 1982, COLOR SCI CONCEPTS M, P591; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stoughton CM, 2008, CURR BIOL, V18, pR698, DOI 10.1016/j.cub.2008.06.018; SVAETICHIN G, 1958, ANN NY ACAD SCI, V74, P385, DOI 10.1111/j.1749-6632.1958.tb39560.x; TAKAHASHI S, 1985, J OPT SOC AM A, V2, P705, DOI 10.1364/JOSAA.2.000705; Valberg A, 2001, VISION RES, V41, P1645, DOI 10.1016/S0042-6989(01)00041-4; VOS JJ, 1990, VISION RES, V30, P937, DOI 10.1016/0042-6989(90)90059-T; Wachtler T, 2003, NEURON, V37, P681, DOI 10.1016/S0896-6273(03)00035-7; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WERNER JS, 1979, J OPT SOC AM, V69, P422, DOI 10.1364/JOSA.69.000422; WERNER JS, 1979, PERCEPT PSYCHOPHYS, V25, P371, DOI 10.3758/BF03199845; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G, 1982, COLOR SCI CONCEPTS M, P586; Wyszecki G, 1982, COLOR SCI, Vsecond; Young T., 1802, PHILOS T ROY SOC LON, V92, P12, DOI DOI 10.1098/RSTL.1802.0004	74	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77134	10.1371/journal.pone.0077134	http://dx.doi.org/10.1371/journal.pone.0077134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204755	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600022
J	Rougeot, J; Renard, M; Randsholt, NB; Peronnet, F; Mouchel-Vielh, E				Rougeot, Julien; Renard, Myrtille; Randsholt, Neel B.; Peronnet, Frederique; Mouchel-Vielh, Emmanuele			The Elongin Complex Antagonizes the Chromatin Factor Corto for Vein versus Intervein Cell Identity in Drosophila Wings	PLOS ONE			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR; REMODELING COMPLEX; UBIQUITIN LIGASE; GENE-EXPRESSION; BC COMPLEX; SCAFFOLD PROTEIN; POLYCOMB-GROUP; FACTOR-SIII; HOX GENE	Drosophila wings mainly consist of two cell types, vein and intervein cells. Acquisition of either fate depends on specific expression of genes that are controlled by several signaling pathways. The nuclear mechanisms that translate signaling into regulation of gene expression are not completely understood, but they involve chromatin factors from the Trithorax (TrxG) and Enhancers of Trithorax and Polycomb (ETP) families. One of these is the ETP Corto that participates in intervein fate through interaction with the Drosophila EGF Receptor - MAP kinase ERK pathway. Precise mechanisms and molecular targets of Corto in this process are not known. We show here that Corto interacts with the Elongin transcription elongation complex. This complex, that consists of three subunits (Elongin A, B, C), increases RNA polymerase II elongation rate in vitro by suppressing transient pausing. Analysis of phenotypes induced by EloA, B, or C deregulation as well as genetic interactions suggest that the Elongin complex might participate in vein vs intervein specification, and antagonizes corto as well as several TrxG genes in this process. Chromatin immunoprecipitation experiments indicate that Elongin C and Corto bind the vein-promoting gene rhomboid in wing imaginal discs. We propose that Corto and the Elongin complex participate together in vein vs intervein fate, possibly through tissue-specific transcriptional regulation of rhomboid.	[Rougeot, Julien; Renard, Myrtille; Randsholt, Neel B.; Peronnet, Frederique; Mouchel-Vielh, Emmanuele] Univ Paris 06, UMR7622, Paris, France; [Rougeot, Julien; Renard, Myrtille; Randsholt, Neel B.; Peronnet, Frederique; Mouchel-Vielh, Emmanuele] CNRS, Dev Biol Lab, UMR7622, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Mouchel-Vielh, E (corresponding author), Univ Paris 06, UMR7622, Paris, France.	emmanuele.mouchel@upmc.fr	Rougeot, Julien/GQI-4130-2022; Peronnet, Frederique/J-7101-2015; Rougeot, Julien/AAF-1269-2019	Peronnet, Frederique/0000-0003-1354-240X; Rougeot, Julien/0000-0001-6899-9306	UPMC; CNRS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	UPMC; CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Fundings from UPMC and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Aso T, 1997, BIOCHEM BIOPH RES CO, V241, P334, DOI 10.1006/bbrc.1997.7819; Aso T, 2000, J BIOL CHEM, V275, P6546, DOI 10.1074/jbc.275.9.6546; Beck S, 2010, ADV EXP MED BIOL, V689, P41; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Biehs B, 1998, DEVELOPMENT, V125, P4245; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Coisy M, 2004, MOL CELL, V15, P43, DOI 10.1016/j.molcel.2004.06.022; Coleno-Costes A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003006; Conaway JW, 1998, BBA-REV CANCER, V1377, pM49, DOI 10.1016/S0304-419X(97)00035-8; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Crozatier M, 2003, MECH DEVELOP, V120, P529, DOI 10.1016/S0925-4773(03)00041-8; Curtis BJ, 2011, DEV BIOL, V350, P534, DOI 10.1016/j.ydbio.2010.12.001; Daubresse G, 1999, DEVELOPMENT, V126, P1175; de Celis JF, 2003, BIOESSAYS, V25, P443, DOI 10.1002/bies.10258; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; FRISTROM D, 1994, DEVELOPMENT, V120, P2661; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gerber M, 2004, MOL CELL BIOL, V24, P9911, DOI 10.1128/MCB.24.22.9911-9919.2004; GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Guichard A, 1999, DEVELOPMENT, V126, P2663; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Montagne J, 1996, DEVELOPMENT, V122, P2589; Mouchel-Vielh E, 2008, GENES CELLS, V13, P1099, DOI 10.1111/j.1365-2443.2008.01231.x; Mouchel-Vielh E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-17; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; NG M, 1995, DEVELOPMENT, V121, P589; Ni JQ, 2008, NAT METHODS, V5, P49, DOI 10.1038/NMETH1146; Oh SW, 2003, GENETICS, V163, P195; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Rendina R, 2010, GENETICS, V186, P167, DOI 10.1534/genetics.110.118695; Roch F, 1998, DEVELOPMENT, V125, P1823; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Rozenblatt-Rosen O, 1998, P NATL ACAD SCI USA, V95, P4152, DOI 10.1073/pnas.95.8.4152; Salvaing J, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-9; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Salvaing J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001658; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; TAKAGI Y, 1995, J BIOL CHEM, V270, P24300, DOI 10.1074/jbc.270.41.24300; Takagi Y, 1996, J BIOL CHEM, V271, P25562, DOI 10.1074/jbc.271.41.25562; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Terriente-Felix A, 2011, DEV BIOL, V350, P382, DOI 10.1016/j.ydbio.2010.12.003; Terriente-Felix A, 2009, DEV BIOL, V329, P350, DOI 10.1016/j.ydbio.2009.03.010; Therrien M, 2000, GENETICS, V156, P1231; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Yamazaki K, 2002, J BIOL CHEM, V277, P26444, DOI 10.1074/jbc.M202859200; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	67	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77592	10.1371/journal.pone.0077592	http://dx.doi.org/10.1371/journal.pone.0077592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204884	Green Published, gold, Green Submitted			2022-12-25	WOS:000326032600037
J	Figlerowicz, M; Urbanowicz, A; Lewandowski, D; Jodynis-Liebert, J; Sadowski, C				Figlerowicz, Marek; Urbanowicz, Anna; Lewandowski, Dominik; Jodynis-Liebert, Jadwiga; Sadowski, Czeslaw			Functional Insights into Recombinant TROSPA Protein from Ixodes ricinus	PLOS ONE			English	Article							TICK-BORNE PATHOGENS; BORRELIA-BURGDORFERI; LYME BORRELIOSIS; OSPA-TYPES; SCAPULARIS; VECTOR; IDENTIFICATION; POLAND	Lyme disease (also called borreliosis) is a prevalent chronic disease transmitted by ticks and caused by Borrelia burgdorferi s. l. spirochete. At least one tick protein, namely TROSPA from I. scapularis, commonly occurring in the USA, was shown to be required for colonization of the vector by bacteria. Located in the tick gut, TROSPA interacts with the spirochete outer surface protein A (OspA) and initiates the tick colonization. Ixodes ricinus is a primary vector involved in B. burgdorferi s. l. transmission in most European countries. In this study, we characterized the capacities of recombinant TROSPA protein from I. ricinus to interact with OspA from different Borrelia species and to induce an immune response in animals. We also showed that the N-terminal part of TROSPA (a putative transmembrane domain) is not involved in the interaction with OspA and that reduction of the total negative charge on the TROSPA protein impaired TROSPA-OspA binding. In general, the data presented in this paper indicate that recombinant TROSPA protein retains the capacity to form a complex with OspA and induces a significant level of IgG in orally immunized rats. Thus, I. ricinus TROSPA may be considered a good candidate component for an animal vaccine against Borrelia.	[Figlerowicz, Marek; Urbanowicz, Anna; Lewandowski, Dominik] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Jodynis-Liebert, Jadwiga; Sadowski, Czeslaw] Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland; [Figlerowicz, Marek] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Medical Sciences; Poznan University of Technology	Figlerowicz, M (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.	Marek.Figlerowicz@ibch.poznan.pl	Urbanowicz, Anna/C-9550-2016; Figlerowicz, Marek/B-9550-2015	Urbanowicz, Anna/0000-0002-6854-7737; Figlerowicz, Marek/0000-0002-6392-0192; Jodynis-Liebert, Jadwiga/0000-0002-5008-4877; Lewandowski, Dominik/0000-0002-2233-5501	European Union; Polish Government [N N302 041536]; European Regional Development Fund under the Operational Programme Innovative Economy - Grants for innovation	European Union(European Commission); Polish Government; European Regional Development Fund under the Operational Programme Innovative Economy - Grants for innovation	The research described in this work was co-funded by European Union within European Regional Development Fund through MPD programme and by the Polish Government through grant N N302 041536. The publication costs were covered by the European Regional Development Fund under the Operational Programme Innovative Economy - Grants for innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2006, NATURE, V439, P524, DOI 10.1038/439524a; Capelli G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-61; Chmielewska-Badora J, 2012, ANN AGR ENV MED, V19, P271; Devriendt B, 2012, J CONTROL RELEASE, V160, P431, DOI 10.1016/j.jconrel.2012.02.006; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; Egelkrout E, 2012, PLANT SCI, V184, P83, DOI 10.1016/j.plantsci.2011.12.005; Eisen L, 2002, VECTORS BORRELIA BUR, P91; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Hamer SA, 2007, EMERG INFECT DIS, V13, P1131, DOI 10.3201/eid1307.070046; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; Konnai S, 2012, TICKS TICK-BORNE DIS, V3, P75, DOI 10.1016/j.ttbdis.2012.02.001; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Lencakova D, 2006, INT J MED MICROBIOL, V296, P108, DOI 10.1016/j.ijmm.2005.12.012; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; Paduraru OA, 2012, EMERG INFECT DIS, V18, P2089, DOI 10.3201/eid1812.120711; Pal U, 2000, J CLIN INVEST, V106, P561, DOI 10.1172/JCI9427; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Rar VA, 2005, EMERG INFECT DIS, V11, P1708, DOI 10.3201/eid1111.041195; Saluja V, 2010, EUR J PHARM BIOPHARM, V76, P470, DOI 10.1016/j.ejpb.2010.08.003; Sambrook J, 2001, PROT 3; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Scott JD, 2012, J PARASITOL, V98, P49, DOI 10.1645/GE-2874.1; Welc-Faleciak R, 2010, ANN AGR ENV MED, V17, P309	25	12	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76848	10.1371/journal.pone.0076848	http://dx.doi.org/10.1371/journal.pone.0076848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204685	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300054
J	Kuramoto, L; Cragg, J; Nandhagopal, R; Mak, E; Sossi, V; de la Fuente-Fernandez, R; Stoessl, AJ; Schulzer, M				Kuramoto, Lisa; Cragg, Jacquelyn; Nandhagopal, Ramachandiran; Mak, Edwin; Sossi, Vesna; de la Fuente-Fernandez, Raul; Stoessl, A. Jon; Schulzer, Michael			The Nature of Progression in Parkinson's Disease: An Application of Non-Linear, Multivariate, Longitudinal Random Effects Modelling	PLOS ONE			English	Article							COMPENSATORY CHANGES; IMPACT	Background: To date, statistical methods that take into account fully the non-linear, longitudinal and multivariate aspects of clinical data have not been applied to the study of progression in Parkinson's disease (PD). In this paper, we demonstrate the usefulness of such methodology for studying the temporal and spatial aspects of the progression of PD. Extending this methodology further, we also explore the presymptomatic course of this disease. Methods: Longitudinal Positron Emission Tomography (PET) measurements were collected on 78 PD patients, from 4 subregions on each side of the brain, using 3 different radiotracers. Non-linear, multivariate, longitudinal random effects modelling was applied to analyze and interpret these data. Results: The data showed a non-linear decline in PET measurements, which we modelled successfully by an exponential function depending on two patient-related covariates duration since symptom onset and age at symptom onset. We found that the degree of damage was significantly greater in the posterior putamen than in the anterior putamen throughout the disease. We also found that over the course of the illness, the difference between the less affected and more affected sides of the brain decreased in the anterior putamen. Younger patients had significantly poorer measurements than older patients at the time of symptom onset suggesting more effective compensatory mechanisms delaying the onset of symptoms. Cautious extrapolation showed that disease onset had occurred some 8 to 17 years prior to symptom onset. Conclusions: Our model provides important biological insights into the pathogenesis of PD, as well as its preclinical aspects. Our methodology can be applied widely to study many other chronic progressive diseases.	[Kuramoto, Lisa; Schulzer, Michael] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada; [Cragg, Jacquelyn; Nandhagopal, Ramachandiran; Mak, Edwin; de la Fuente-Fernandez, Raul; Stoessl, A. Jon; Schulzer, Michael] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Sossi, Vesna] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia	Kuramoto, L (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada.	lisa.kuramoto@ubc.ca	Stoessl, A Jon/J-9661-2015	Stoessl, A Jon/0000-0002-9778-7246; Ramachandiran, Nandhagopal/0000-0002-2379-0055	Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Canada Research Chairs; James A. Moore Chair in Parkinson's Research; Pacific Parkinson's Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canada Research Chairs(Canada Research ChairsCGIAR); James A. Moore Chair in Parkinson's Research; Pacific Parkinson's Research Institute	The authors gratefully acknowledge financial support from the Canadian Institutes of Health Research for funding operating costs of studies and infrastructure (PET, statistics), the Michael Smith Foundation for Health Research for infrastructure support (imaging, statistics) and salary support (VS), Canada Research Chairs for salary support (AJS), James A. Moore Chair in Parkinson's Research for salary support (RFF), and the Pacific Parkinson's Research Institute for infrastructure support for research operations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Jr, 2005, BRAIN, V128, P2777, DOI 10.1093/brain/awh607; Armitage P, 1998, ENCY BIOSTATISTICS C, P1125; Au WL, 2005, MOL BRAIN RES, V134, P24, DOI 10.1016/j.molbrainres.2004.09.028; Brent R. P., 1973, ALGORITHMS MINIMIZAT; Brooks DJ, 2003, EXP NEUROL, V184, pS68, DOI 10.1016/j.expneurol.2003.08.008; Bruck A, 2006, MOVEMENT DISORD, V21, P958, DOI 10.1002/mds.20855; Davidian M., 1995, NONLINEAR MODELS REP; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fleiss JL, 2013, STAT METHODS RATES P; Hilker R, 2005, ARCH NEUROL-CHICAGO, V62, P378, DOI 10.1001/archneur.62.3.378; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lee CS, 2004, ARCH NEUROL-CHICAGO, V61, P1920, DOI 10.1001/archneur.61.12.1920; Lee CS, 2000, ANN NEUROL, V47, P493, DOI 10.1002/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Marshall G, 2006, STAT MED, V25, P2817, DOI 10.1002/sim.2361; Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Nandhagopal R, 2008, NEUROLOGY, V70, P1478, DOI 10.1212/01.wnl.0000310432.92489.90; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Nandhagopal R, 2011, BRAIN, V134, P3290, DOI 10.1093/brain/awr233; R Development Core Team, 2006, R LANG ENV STAT COMP; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; Rubenstein LM, 1997, PHARMACOECONOMICS, V12, P486, DOI 10.2165/00019053-199712040-00006; Scheife RT, 2000, AM J HEALTH-SYST PH, V57, P953, DOI 10.1093/ajhp/57.10.953; Schwarz J, 2004, J NUCL MED, V45, P1694; SPINKS TJ, 1992, PHYS MED BIOL, V37, P1637, DOI 10.1088/0031-9155/37/8/002	30	27	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76595	10.1371/journal.pone.0076595	http://dx.doi.org/10.1371/journal.pone.0076595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204641	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300038
J	Lin, C; Katanaev, VL				Lin, Chen; Katanaev, Vladimir L.			Kermit Interacts with G alpha o, Vang, and Motor Proteins in Drosophila Planar Cell Polarity	PLOS ONE			English	Article							TRIMERIC G-PROTEIN; ASYMMETRIC LOCALIZATION; TISSUE POLARITY; RAT FRIZZLED-1; MORPHOGENESIS; PRICKLE; GENES; IDENTIFICATION; REGULATORS; MUTATIONS	In addition to the ubiquitous apical-basal polarity, epithelial cells are often polarized within the plane of the tissue - the phenomenon known as planar cell polarity (PCP). In Drosophila, manifestations of PCP are visible in the eye, wing, and cuticle. Several components of the PCP signaling have been characterized in flies and vertebrates, including the heterotrimeric Go protein. However, Go signaling partners in PCP remain largely unknown. Using a genetic screen we uncover Kermit, previously implicated in G protein and PCP signaling, as a novel binding partner of Go. Through pull-down and genetic interaction studies, we find that Kermit interacts with Go and another PCP component Vang, known to undergo intracellular relocalization during PCP establishment. We further demonstrate that the activity of Kermit in PCP differentially relies on the motor proteins: the microtubule-based dynein and kinesin motors and the actin-based myosin VI. Our results place Kermit as a potential transducer of Go, linking Vang with motor proteins for its delivery to dedicated cellular compartments during PCP establishment.	[Lin, Chen; Katanaev, Vladimir L.] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland; [Katanaev, Vladimir L.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia	University of Lausanne; Russian Academy of Sciences	Katanaev, VL (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, Lausanne, Switzerland.	vladimir.katanaev@unil.ch	Chuu, Chih-Pin/B-1086-2010; Tseng, Jen-Chih/AAK-3386-2020; Chen, Ya-Wen/AAG-7549-2019; Katanaev, Vladimir/F-9480-2014; Chuu, Chih-Pin/N-6697-2019; Fukui, Yasuhisa/E-8806-2010; Chen, Linyi/AAV-2632-2020; Lin, Ching Yu/AAN-9581-2020; Chen, Ya-Wen/B-1100-2010; Chang, Jang-Yang/D-2099-2010; Tsai, Kun-Chih/C-1371-2010	Chen, Ya-Wen/0000-0002-6080-8859; Katanaev, Vladimir/0000-0002-7909-5617; Chen, Linyi/0000-0001-7258-8817; Lin, Ching Yu/0000-0001-9041-5653; 	Deutsche Forschungsgemeinschaft [KA 2721/2-1]; Swiss National Science Foundation [31003A_138350]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The work was funded by the grants from Deutsche Forschungsgemeinschaft (grant #KA 2721/2-1) and Swiss National Science Foundation (grant # 31003A_138350) to VLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Courbard JR, 2009, DEV BIOL, V333, P67, DOI 10.1016/j.ydbio.2009.06.024; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; Djiane A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011228; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Giese AP, 2012, DEVELOPMENT, V139, P3775, DOI 10.1242/dev.074229; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jernigan KK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000647; Jones KH, 1996, GENETICS, V142, P205; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Katanaev VL, 2006, P NATL ACAD SCI USA, V103, P6524, DOI 10.1073/pnas.0601853103; Katanaev VL, 2009, FRIZZLED PROTEINS AR; Katanaev VL, 2006, CELL CYCLE, V5, P2464, DOI 10.4161/cc.5.21.3410; Katanayeva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012331; Kilander MBC, 2011, CELL SIGNAL, V23, P550, DOI 10.1016/j.cellsig.2010.11.004; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Koval A, 2011, BIOCHEM PHARMACOL, V82, P1311, DOI 10.1016/j.bcp.2011.06.005; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nunn C, 2006, SEMIN CELL DEV BIOL, V17, P390, DOI 10.1016/j.semcdb.2006.04.001; Oh SW, 2003, GENETICS, V163, P195; Purvanov V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000877; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schertel C, 2013, DEV CELL, V25, P207, DOI 10.1016/j.devcel.2013.02.019; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Singh J, 2012, WIRES DEV BIOL, V1, P479, DOI 10.1002/wdev.32; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 2009, SEMIN CELL DEV BIOL, V20, P957, DOI 10.1016/j.semcdb.2009.03.006; Tan C, 2001, DEVELOPMENT, V128, P3665; Toba G, 1999, GENETICS, V151, P725; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0	48	4	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2013	8	10							e76885	10.1371/journal.pone.0076885	http://dx.doi.org/10.1371/journal.pone.0076885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232HM	24204696	Green Published, Green Submitted, gold			2022-12-25	WOS:000325483600080
J	Tang, WK; Xia, D				Tang, Wai Kwan; Xia, Di			Altered Intersubunit Communication Is the Molecular Basis for Functional Defects of Pathogenic p97 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Crystal Structure; Genetic Diseases; Molecular Chaperone; Mutant; ATPase Activity; IBMPFD; Communication; p97; VCP; Prebound ADP	ATPASE ACTIVITY; AAA ATPASE; PAGET-DISEASE; CONFORMATIONAL-CHANGES; NUCLEOTIDE-BINDING; PROTEIN VCP; MUTATIONS; MECHANISM; P97/VCP; BONE	Background: Single-point mutations in AAA chaperone p97 cause multiple disorders, but the molecular basis remains unknown. Results: Significant differences in structural and biochemical properties between wild type and pathogenic p97 were revealed. Conclusion: Mutations altered the communication among subunits within a hexameric p97, resulting in p97 molecules with defective function. Significance: Mechanistic insights into the function of p97 are provided. The human AAA ATPase p97 is a molecular chaperone essential in cellular proteostasis. Single amino acid substitutions in p97 have been linked to a clinical multiple-disorder condition known as inclusion body myopathy associated with Paget's disease of the bone and frontotemporal dementia. How the mutations affect the molecular mechanism that governs the function of p97 remains unclear. Here, we show that within the hexameric ring of a mutant p97, D1 domains fail to regulate their respective nucleotide-binding states, as evidenced by the lower amount of prebound ADP, weaker ADP binding affinity, full occupancy of adenosine-5-O-(3-thiotriphosphate) binding, and elevated overall ATPase activity, indicating a loss of communication among subunits. Defective communication between subunits is further illustrated by altered conformation in the side chain of residue Phe-360 that probes into the nucleotide-binding pocket from a neighboring subunit. Consequently, conformations of N domains in a hexameric ring of a mutant p97 become uncoordinated, thus impacting its ability to process substrate.	[Tang, Wai Kwan; Xia, Di] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Xia, D (corresponding author), NCI, Cell Biol Lab, NIH, 37 Convent Dr,Bldg 37,Rm 2122C, Bethesda, MD 20892 USA.	xiad@mail.nih.gov	Tang, Wai Kwan/A-6158-2012		National Institutes of Health Intramural Research Program (NCI, Center for Cancer Research); NATIONAL CANCER INSTITUTE [ZIABC010600] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program (NCI, Center for Cancer Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program (NCI, Center for Cancer Research).	Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biter AB, 2012, P NATL ACAD SCI USA, V109, P12515, DOI 10.1073/pnas.1207040109; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Davies JM, 2005, STRUCTURE, V13, P183, DOI 10.1016/j.str.2004.11.014; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Gu JM, 2013, BONE, V52, P9, DOI 10.1016/j.bone.2012.09.012; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Nishikori S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201400; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tang W. K., 2012, NEUROMUSCULAR DISORD, P155; Tang WK, 2012, J STRUCT BIOL, V179, P83, DOI 10.1016/j.jsb.2012.04.024; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tang WK, 2009, ACTA CRYSTALLOGR F, V65, P1166, DOI 10.1107/S174430910904055X; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	45	54	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36624	36635		10.1074/jbc.M113.488924	http://dx.doi.org/10.1074/jbc.M113.488924			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196964	Green Published, hybrid			2022-12-25	WOS:000328883400042
J	Yacoub, D; Benslimane, N; Al-Zoobi, L; Hassan, G; Nadiri, A; Mourad, W				Yacoub, Daniel; Benslimane, Nadir; Al-Zoobi, Loubna; Hassan, Ghada; Nadiri, Amal; Mourad, Walid			CD154 Is Released from T-cells by a Disintegrin and Metalloproteinase Domain-containing Protein 10 (ADAM10) and ADAM17 in a CD40 Protein-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Inflammation; Integrins; Molecular Biology; Receptors; CD154; CD40; T-cells	MATRIX METALLOPROTEINASE-2; ALPHA-5-BETA-1 INTEGRIN; LIPID RAFTS; LIGAND; RECEPTOR; PKC; CLEAVAGE; BINDING	Background: CD154 is released from T-cells in a manner that remains elusive. Results: CD154 is released from Jurkat E6.1 T-cells by ADAM10 and ADAM17 upon its interaction with CD40 exclusively. Conclusion: The cleavage of CD154 is mediated through specific signaling events that bypass many other CD154 signaling events. Significance: These data may lead to the generation of novel targets for the treatment of CD154-associated disorders. CD154 (CD40 ligand) is a type II transmembrane protein that belongs to the tumor necrosis factor superfamily. The soluble form of CD154 (sCD154), which results from the shedding of membrane-bound CD154, plays a key role in the production of proinflammatory cytokines and has been linked to various autoimmune and vascular disorders. Therefore, elucidating the mechanisms by which CD154 is released from the cell surface following its interaction with its various receptors is of primordial importance. Using co-culture experiments, we show that CD154 is shed predominantly upon its engagement with CD40. Indeed, only CD40 (both membrane-bound and soluble) and not 51 or M2 is involved in the cleavage and release of CD154 from Jurkat E6.1 T-cells. Interestingly, CD154 is cleaved independently of the formation of cell surface CD40 homodimers and independently of its association into lipid rafts. In contrast, we found that the protein kinase C (PKC) signaling family and the matrix metalloproteinases ADAM10 and ADAM17 are intimately involved in this process. In conclusion, our data indicate that CD154 is released from T-cells by ADAM10 and ADAM17 upon CD40 ligation. These findings add significant insights into the mechanisms by which CD154 is down-regulated and may lead to the generation of novel therapeutic targets for the treatment of CD154-associated disorders.	[Yacoub, Daniel; Benslimane, Nadir; Al-Zoobi, Loubna; Hassan, Ghada; Nadiri, Amal; Mourad, Walid] Hop St Luc, Ctr Hosp Univ Montreal, Lab Immunol Cellulaire & Mol, Montreal, PQ H2X 1P1, Canada	Universite de Montreal	Mourad, W (corresponding author), Hop St Luc, Ctr Hosp Univ Montreal, Pavillon Edward Asselin 415,264 Rene Levesque Est, Montreal, PQ H2X 1P1, Canada.	mw.mourad@umontreal.ca		Hassan, Ghada S./0000-0002-1391-5248; Mourad, Walid/0000-0002-1859-9387	Canadian Institutes of Health Research (IRSC); Canadian Arthritis Network (CAN)	Canadian Institutes of Health Research (IRSC)(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network (CAN)	This work was supported by the Canadian Institutes of Health Research (IRSC) and the Canadian Arthritis Network (CAN).	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Benslimane N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043070; Choi WS, 2010, J THROMB HAEMOST, V8, P1364, DOI 10.1111/j.1538-7836.2010.03837.x; Cisse M, 2011, MOL CELL NEUROSCI, V47, P223, DOI 10.1016/j.mcn.2011.04.008; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Gil C, 2007, FEBS LETT, V581, P1851, DOI 10.1016/j.febslet.2007.03.080; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Henn V, 2001, BLOOD, V98, P1047, DOI 10.1182/blood.V98.4.1047; Jin Yinzhu, 2001, Journal of Medical and Dental Sciences, V48, P23; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Killock DJ, 2010, BIOCHEM J, V428, P293, DOI 10.1042/BJ20091611; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ludewig B, 1996, EUR J IMMUNOL, V26, P3137, DOI 10.1002/eji.1830261246; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Matthies KMG, 2006, CELL IMMUNOL, V241, P47, DOI 10.1016/j.cellimm.2006.08.001; Menchen L, 2009, GUT, V58, P920, DOI 10.1136/gut.2008.150318; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Pietravalle F, 1996, J BIOL CHEM, V271, P5965, DOI 10.1074/jbc.271.11.5965; Reinboldt S, 2009, PLATELETS, V20, P441, DOI 10.1080/09537100903096684; Reyes-Moreno C, 2007, J BIOL CHEM, V282, P19473, DOI 10.1074/jbc.M701076200; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Santos-Martinez MJ, 2008, THROMB RES, V121, P535, DOI 10.1016/j.thromres.2007.06.002; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Wang Y, 2011, J BIOL CHEM, V286, P38980, DOI 10.1074/jbc.M111.277087; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; YELLIN MJ, 1994, J IMMUNOL, V153, P666; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	34	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36083	36093		10.1074/jbc.M113.506220	http://dx.doi.org/10.1074/jbc.M113.506220			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189063	Green Published, hybrid			2022-12-25	WOS:000329814700043
J	Greiner, AM; Chen, H; Spatz, JP; Kemkemer, R				Greiner, Alexandra M.; Chen, Hao; Spatz, Joachim P.; Kemkemer, Ralf			Cyclic Tensile Strain Controls Cell Shape and Directs Actin Stress Fiber Formation and Focal Adhesion Alignment in Spreading Cells	PLOS ONE			English	Article							DYNAMIC REORIENTATION; TENSIONAL HOMEOSTASIS; MATRIX-RIGIDITY; FORCE; POLARIZATION; FIBROBLASTS; GEOMETRY; COMPLEX; MICROTUBULES; ORIENTATION	The actin cytoskeleton plays a crucial role for the spreading of cells, but is also a key element for the structural integrity and internal tension in cells. In fact, adhesive cells and their actin stress fiber-adhesion system show a remarkable reorganization and adaptation when subjected to external mechanical forces. Less is known about how mechanical forces alter the spreading of cells and the development of the actin-cell-matrix adhesion apparatus. We investigated these processes in fibroblasts, exposed to uniaxial cyclic tensile strain (CTS) and demonstrate that initial cell spreading is stretch-independent while it is directed by the mechanical signals in a later phase. The total temporal spreading characteristic was not changed and cell protrusions are initially formed uniformly around the cells. Analyzing the actin network, we observed that during the first phase the cells developed a circumferential arc-like actin network, not affected by the CTS. In the following orientation phase the cells elongated perpendicular to the stretch direction. This occurred simultaneously with the de novo formation of perpendicular mainly ventral actin stress fibers and concurrent realignment of cell-matrix adhesions during their maturation. The stretch-induced perpendicular cell elongation is microtubule-independent but myosin II-dependent. In summary, a CTS-induced cell orientation of spreading cells correlates temporary with the development of the actomyosin system as well as contact to the underlying substrate by cell-matrix adhesions.	[Greiner, Alexandra M.; Chen, Hao] Karlsruhe Inst Technol, Dept Cell & Neurobiol, D-76021 Karlsruhe, Germany; [Spatz, Joachim P.; Kemkemer, Ralf] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany; [Spatz, Joachim P.] Heidelberg Univ, Dept Biophys Chem, Heidelberg, Germany; [Kemkemer, Ralf] Reutlingen Univ, Dept Appl Chem, Reutlingen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Ruprecht Karls University Heidelberg	Kemkemer, R (corresponding author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Stuttgart, Germany.	ralf.kemkemer@is.mpg.de	Spatz, Joachim P/A-1107-2017; Greiner, Alexandra/G-1404-2013	Spatz, Joachim P/0000-0003-3419-9807; 	FHG-MPG (Fraunhofer-Gesellschaft and Max-Planck-Gesellschaft) project "Biomimetic matrices"; Baden-Wurttemberg-Stiftung, Kompetenznetz "Funktionelle Nanostrukturen"; Max Planck Society	FHG-MPG (Fraunhofer-Gesellschaft and Max-Planck-Gesellschaft) project "Biomimetic matrices"; Baden-Wurttemberg-Stiftung, Kompetenznetz "Funktionelle Nanostrukturen"; Max Planck Society(Max Planck Society)	Parts of the study were funded by the FHG-MPG (Fraunhofer-Gesellschaft and Max-Planck-Gesellschaft) project "Biomimetic matrices" and the Baden-Wurttemberg-Stiftung, Kompetenznetz "Funktionelle Nanostrukturen". The support of the Max Planck Society is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Aratyn-Schaus Y, 2010, CURR BIOL, V20, P1145, DOI 10.1016/j.cub.2010.05.049; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Betapudi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008560; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; BUCK RC, 1980, EXP CELL RES, V127, P470, DOI 10.1016/0014-4827(80)90456-5; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Cai YF, 2009, CURR OPIN CELL BIOL, V21, P47, DOI 10.1016/j.ceb.2009.01.020; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048346; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; DARTSCH PC, 1986, ACTA ANAT, V125, P108; De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Dobereiner HG, 2005, J APPL PHYSIOL, V98, P1542, DOI 10.1152/japplphysiol.01181.2004; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2011, CELL HEALTH CYTOSKEL, V3, P13, DOI 10.2147/CHC.S14984; Kaverina I, 2002, J CELL SCI, V115, P2283; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Lee CF, 2010, BIOCHEM BIOPH RES CO, V401, P344, DOI 10.1016/j.bbrc.2010.09.046; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; McCaig CD, 1997, BIOESSAYS, V19, P819, DOI 10.1002/bies.950190912; Mizutani T, 2004, CELL MOTIL CYTOSKEL, V59, P242, DOI 10.1002/cm.20037; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Pierres A, 2008, BIOPHYS J, V94, P4114, DOI 10.1529/biophysj.107.125278; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Rehfeldt F, 2007, NAT PHYS, V3, P592, DOI 10.1038/nphys712; Schmoranzer J, 2003, J CELL SCI, V116, P4513, DOI 10.1242/jcs.00748; Suter DM, 1998, J CELL BIOL, V141, P227, DOI 10.1083/jcb.141.1.227; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	56	67	67	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77328	10.1371/journal.pone.0077328	http://dx.doi.org/10.1371/journal.pone.0077328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204809	gold, Green Published, Green Submitted			2022-12-25	WOS:000326241200024
J	Ibragimova, I; Slifker, MJ; Maradeo, ME; Banumathy, G; Dulaimi, E; Uzzo, RG; Cairns, P				Ibragimova, Ilsiya; Slifker, Michael J.; Maradeo, Marie E.; Banumathy, Gowrishankar; Dulaimi, Essel; Uzzo, Robert G.; Cairns, Paul			Genome-Wide Promoter Methylome of Small Renal Masses	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; KIDNEY CANCER; HYPERMETHYLATION PROFILE; PARTIAL NEPHRECTOMY; CELL SIGNATURE; X-INACTIVATION; CPG-ISLANDS; EPIGENETICS	The majority of renal cell carcinoma (RCC) is now incidentally detected and presents as small renal masses (SRMs) defined as <= 4 cm in size. SRMs are heterogeneous comprising several histological types of RCC each with different biology and behavior, and benign tumors mainly oncocytoma. The varied prognosis of the different types of renal tumor has implications for management options. A key epigenetic alteration involved in the initiation and progression of cancer is aberrant methylation in the promoter region of a gene. The hypermethylation is associated with transcriptional repression and is an important mechanism of inactivation of tumor suppressor genes in neoplastic cells. We have determined the genome-wide promoter methylation profiles of 47 pT1a and 2 pT1b clear cell, papillary or chromophobe RCC, 25 benign renal oncocytoma <= 4 cm and 4 normal renal parenchyma specimens by Infinium HumanMethylation27 beadchip technology. We identify gene promoter hypermethylation signatures that distinguish clear cell and papillary from each other, from chromophobe and oncocytoma, and from normal renal cells. Pairwise comparisons revealed genes aberrantly hypermethylated in a tumor type but unmethylated in normal, and often unmethylated in the other renal tumor types. About 0.4% to 1.7% of genes comprised the promoter methylome in SRMs. The Infinium methylation score for representative genes was verified by gold standard technologies. The genes identified as differentially methylated implicate pathways involved in metabolism, tissue response to injury, epithelial to mesenchymal transition (EMT), signal transduction and G-protein coupled receptors (GPCRs), cancer, and stem cell regulation in the biology of RCC. Our findings contribute towards an improved understanding of the development of RCC, the different biology and behavior of histological types, and discovery of molecular subtypes. The differential methylation signatures may have utility in early detection and particularly differential diagnosis for prognostic stratification as well as identify novel gene and pathway targets for therapeutic intervention.	[Ibragimova, Ilsiya; Maradeo, Marie E.; Banumathy, Gowrishankar; Cairns, Paul] Fox Chase Canc Ctr, Canc Epigenet Program, Philadelphia, PA 19111 USA; [Ibragimova, Ilsiya; Maradeo, Marie E.; Banumathy, Gowrishankar; Dulaimi, Essel; Uzzo, Robert G.; Cairns, Paul] Fox Chase Canc Ctr, Kidney Keystone Program, Philadelphia, PA 19111 USA; [Slifker, Michael J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Dulaimi, Essel] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Uzzo, Robert G.] Fox Chase Canc Ctr, Dept Surg, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Cairns, P (corresponding author), Fox Chase Canc Ctr, Canc Epigenet Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Paul.Cairns@fccc.edu	Uzzo, Robert G./U-5238-2019		EDRN [3U01CA111242-05]; National Cancer Institute [P30 CA006927]; Action to Cure Kidney Cancer; NATIONAL CANCER INSTITUTE [P30CA006927, U01CA111242] Funding Source: NIH RePORTER	EDRN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Action to Cure Kidney Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This publication was supported in part by the EDRN through grant number 3U01CA111242-05 and by P30 CA006927 from the National Cancer Institute, by Action to Cure Kidney Cancer, and by an individual's donation to study papillary RCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saleem T, 2004, CANCER GENET CYTOGEN, V152, P23, DOI 10.1016/j.cancergencyto.2003.10.001; [Anonymous], 2011, ILLUMINA BODY MAP DA; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Battagli C, 2003, CANCER RES, V63, P8695; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Cairns P, 2011, CANCER BIOMARK, V9, P461, DOI 10.3233/CBM-2011-0176; Corcoran AT, 2013, UROLOGY, V81, P707, DOI 10.1016/j.urology.2013.01.009; Costa VL, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-133; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Delahunt B, 1997, MODERN PATHOL, V10, P537; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Easwaran H, 2012, GENOME RES, V22, P837, DOI 10.1101/gr.131169.111; Edge SB, 2009, AJCC CANC STAGING MA, P479; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feldmann G, 2010, CANCER RES, V70, P4460, DOI 10.1158/0008-5472.CAN-09-1107; Frank I, 2003, J UROLOGY, V170, P2217, DOI 10.1097/01.ju.0000095475.12515.5e; Gill IS, 2003, J UROLOGY, V170, P64, DOI 10.1097/01.ju.0000072272.02322.ff; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; He H, 2012, MOL CANCER RES, V10, P273, DOI 10.1158/1541-7786.MCR-11-0419; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hoffman AM, 2011, EPIGENOMICS-UK, V3, P19, DOI 10.2217/EPI.10.64; Hoque MO, 2004, CANCER RES, V64, P5511, DOI 10.1158/0008-5472.CAN-04-0799; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ilhan A, 2011, HUM PATHOL, V42, P641, DOI 10.1016/j.humpath.2010.10.004; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagara I, 2008, J UROLOGY, V180, P343, DOI 10.1016/j.juro.2008.02.044; Kalari S, 2010, ADV GENET, V70, P277, DOI [10.1016/B978-0-12-380866-0.60010-1, 10.1016/S0065-2660(10)70010-9]; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; McKiernan J, 2002, UROLOGY, V60, P1003, DOI 10.1016/S0090-4295(02)01967-2; McRonald FE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-31; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Pavlovich CP, 2002, AM J SURG PATHOL, V26, P1542, DOI 10.1097/00000478-200212000-00002; Polascik TJ, 2002, UROLOGY, V60, P941, DOI 10.1016/S0090-4295(02)01825-3; Ricketts CJ, 2012, EPIGENETICS-US, V7, P278, DOI 10.4161/epi.7.3.19103; Riss J, 2006, CANCER RES, V66, P7216, DOI 10.1158/0008-5472.CAN-06-0040; Sambrook J, 2001, MOL CLONING LAB MANU; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Slater AA, 2013, EPIGENETICS, V8; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smits KM, 2008, CLIN CANCER RES, V14, P782, DOI 10.1158/1078-0432.CCR-07-1753; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; ten Klooster JP, 2007, BIOL CELL, V99, P1, DOI 10.1042/BC20060071; The CCDS Database, 2013, CCDS DATABASE CURREN; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tsuchiya KD, 2004, GENOME RES, V14, P1275, DOI 10.1101/gr.2575904; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Yusenko MV, 2010, INT J UROL, V17, P602, DOI 10.1111/j.1442-2042.2010.02574.x; Zeller C, 2013, AM J PATHOL, V182, P668, DOI 10.1016/j.ajpath.2012.11.040	75	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77309	10.1371/journal.pone.0077309	http://dx.doi.org/10.1371/journal.pone.0077309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204800	gold, Green Published, Green Submitted			2022-12-25	WOS:000326152300019
J	Anunciacao, O; Vinga, S; Oliveira, AL				Anunciacao, Orlando; Vinga, Susana; Oliveira, Arlindo L.			Using Information Interaction to Discover Epistatic Effects in Complex Diseases	PLOS ONE			English	Article							LOGISTIC-REGRESSION; SELECTION	It is widely agreed that complex diseases are typically caused by the joint effects of multiple instead of a single genetic variation. These genetic variations may show stronger effects when considered together than when considered individually, a phenomenon known as epistasis or multilocus interaction. In this work, we explore the applicability of information interaction to discover pairwise epistatic effects related with complex diseases. We start by showing that traditional approaches such as classification methods or greedy feature selection methods (such as the Fleuret method) do not perform well on this problem. We then compare our information interaction method with BEAM and SNPHarvester in artificial datasets simulating epistatic interactions and show that our method is more powerful to detect pairwise epistatic interactions than its competitors. We show results of the application of information interaction method to the WTCCC breast cancer dataset. Our results are validated using permutation tests. We were able to find 89 statistically significant pairwise interactions with a p-value lower than 10(-3). Even though many recent algorithms have been designed to find epistasis with low marginals, we observed that all (except one) of the SNPs involved in statistically significant interactions have moderate or high marginals. We also report that the interactions found in this work were not present in gene-gene interaction network STRING.	[Anunciacao, Orlando; Vinga, Susana; Oliveira, Arlindo L.] Univ Lisbon, INESC ID Inst Super Tecn, P-1699 Lisbon, Portugal	INESC-ID; Universidade de Lisboa	Anunciacao, O (corresponding author), Univ Lisbon, INESC ID Inst Super Tecn, P-1699 Lisbon, Portugal.	orlando@kdbio.inesc-id.pt	Vinga, Susana/B-8450-2008; Oliveira, Arlindo L/C-1700-2008	Vinga, Susana/0000-0002-1954-5487; Oliveira, Arlindo L/0000-0001-8638-5594; Anunciacao, Orlando/0000-0002-5929-5523	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/41984/2007, PTDC/EIA-EIA/111239/2009, PEst-OE/EEI/LA0021/2011]; Susana Vinga's Program Investigador FCT from FCT [IF/00653/2012]; European Social Fund through the Operational Program Human Potential	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Susana Vinga's Program Investigador FCT from FCT; European Social Fund through the Operational Program Human Potential	Funding was provided by Fundacao para a Ciencia e Tecnologia (FCT) - http://www.fct.pt, particularly by Orlando Anunciacao's grant SFRH/BD/41984/2007, Projects Neuroclinomics PTDC/EIA-EIA/111239/2009, INESC-ID PEst-OE/EEI/LA0021/2011 and Susana Vinga's Program Investigador FCT (IF/00653/2012) from FCT, co-funded by the European Social Fund through the Operational Program Human Potential. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anunciacao O, 2010, ADV INTEL SOFT COMPU, V74, P43, DOI 10.1007/978-3-642-13214-8_6; Davis NA, 2013, GENETIC EPIDEMIOLOGY; Fleuret F, 2004, J MACH LEARN RES, V5, P1531; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Freund Y, 1999, MACH LEARN, V37, P277, DOI 10.1023/A:1007662407062; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Holmes G, 2002, LECT NOTES ARTIF INT, V2430, P161; Knijnenburg TA, 2009, BIOINFORMATICS, V25, pI161, DOI 10.1093/bioinformatics/btp211; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Li MY, 2009, BIOINFORMATICS, V25, P497, DOI 10.1093/bioinformatics/btn641; Listgarten J, 2004, CLIN CANCER RES, V10, P2725, DOI 10.1158/1078-0432.CCR-1115-03; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McKinney BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000432; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Nagelkerke N, 2005, STAT MED, V24, P121, DOI 10.1002/sim.1997; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Platt J., 1999, FAST TRAINING SUPPOR; Vapnik V., 1998, STAT LEARNING THEORY; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Wan X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-13; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	25	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76300	10.1371/journal.pone.0076300	http://dx.doi.org/10.1371/journal.pone.0076300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194833	Green Submitted, gold, Green Published			2022-12-25	WOS:000326037000012
J	Kurtenbach, S; Prochnow, N; Kurtenbach, S; Klooster, J; Zoidl, C; Dermietzel, R; Kamermans, M; Zoidl, G				Kurtenbach, Sarah; Prochnow, Nora; Kurtenbach, Stefan; Klooster, Jan; Zoidl, Christiane; Dermietzel, Rolf; Kamermans, Maarten; Zoidl, Georg			Pannexin1 Channel Proteins in the Zebrafish Retina Have Shared and Unique Properties	PLOS ONE			English	Article							GAP-JUNCTION HEMICHANNELS; HORIZONTAL CELLS; OUTER RETINA; DANIO-RERIO; PH; ATP; EXPRESSION; COMMUNICATION; ACTIVATION; MEMBRANE	In mammals, a single pannexin1 gene (Panx1) is widely expressed in the CNS including the inner and outer retinae, forming large-pore voltage-gated membrane channels, which are involved in calcium and ATP signaling. Previously, we discovered that zebrafish lack Panx1 expression in the inner retina, with drPanx1a exclusively expressed in horizontal cells of the outer retina. Here, we characterize a second drPanx1 protein, drPanx1b, generated by whole-genome duplications during teleost evolution. Homology searches strongly support the presence of pannexin sequences in cartilaginous fish and provide evidence that pannexins evolved when urochordata and chordata evolution split. Further, we confirm Panx1 ohnologs being solely present in teleosts. A hallmark of differential expression of drPanx1a and drPanx1b in various zebrafish brain areas is the non-overlapping protein localization of drPanx1a in the outer and drPanx1b in the inner fish retina. A functional comparison of the evolutionary distant fish and mouse Panx1s revealed both, preserved and unique properties. Preserved functions are the capability to form channels opening at resting potential, which are sensitive to known gap junction and hemichannel blockers, intracellular calcium, extracellular ATP and pH changes. However, drPanx1b is unique due to its highly complex glycosylation pattern and distinct electrophysiological gating kinetics. The existence of two Panx1 proteins in zebrafish displaying distinct tissue distribution, protein modification and electrophysiological properties, suggests that both proteins fulfill different functions in vivo.	[Kurtenbach, Sarah; Prochnow, Nora; Zoidl, Christiane; Dermietzel, Rolf; Zoidl, Georg] Ruhr Univ Bochum, Fac Med, Bochum, Germany; [Klooster, Jan; Kamermans, Maarten] Netherlands Inst Neurosci, Res Unit Retinal Signal Proc, Amsterdam, Netherlands; [Kamermans, Maarten] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kurtenbach, Sarah; Kurtenbach, Stefan; Zoidl, Christiane; Zoidl, Georg] York Univ, Fac Hlth, Toronto, ON M3J 2R7, Canada	Ruhr University Bochum; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; York University - Canada	Zoidl, G (corresponding author), Ruhr Univ Bochum, Fac Med, Univ Str 150, Bochum, Germany.	gzoidl@yorku.ca	Kurtenbach, Stefan/H-3786-2019	Kurtenbach, Stefan/0000-0002-7445-596X	CIHR/CRC; NSERC (Georg Zoidl); International Graduate School of Neuroscience (IGSN), Research School; "Heinrich und Alma Vogelsang Stiftung" of the Ruhr University Bochum, Germany	CIHR/CRC; NSERC (Georg Zoidl); International Graduate School of Neuroscience (IGSN), Research School; "Heinrich und Alma Vogelsang Stiftung" of the Ruhr University Bochum, Germany	This study was funded by CIHR/CRC, NSERC (Georg Zoidl), International Graduate School of Neuroscience (IGSN), Research School and the "Heinrich und Alma Vogelsang Stiftung" of the Ruhr University Bochum, Germany (Sarah Kurtenbach). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alberto AVP, 2013, N-S ARCH PHARMACOL, V386, P775, DOI 10.1007/s00210-013-0868-x; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bargiotas P, 2012, CHANNELS, V6, P453, DOI 10.4161/chan.22315; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bond SR, 2012, J MEMBRANE BIOL, V245, P483, DOI 10.1007/s00232-012-9497-4; Bonnet U, 2000, EUR NEUROPSYCHOPHARM, V10, P97, DOI 10.1016/S0924-977X(99)00063-2; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Dvoriantchikova G, 2006, FEBS LETT, V580, P2178, DOI 10.1016/j.febslet.2006.03.026; Fahrenfort I, 2004, VISUAL NEUROSCI, V21, P501, DOI 10.1017/S095252380421402X; Fahrenfort I, 2009, PLOS ONE, V4, pe6090, DOI [10.1371/journal.pone.0006090, DOI 10.1371/J0URNAL.P0NE.0006090.PUBMED:19564917]; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Grundken C, 2011, J NEUROSCI METH, V199, P15, DOI 10.1016/j.jneumeth.2011.04.016; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hirasawa H, 2003, J GEN PHYSIOL, V122, P657, DOI 10.1085/jgp.200308863; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; INAMURA K, 1989, J CEREBR BLOOD F MET, V9, P821, DOI 10.1038/jcbfm.1989.116; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kienitz MC, 2011, J BIOL CHEM, V286, P290, DOI 10.1074/jbc.M110.163477; Klaassen LJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001107; Kraaij DA, 2000, J GEN PHYSIOL, V115, P3, DOI 10.1085/jgp.115.1.3; Kranz K, 2013, J COMP NEUROL, V521, P1119, DOI 10.1002/cne.23223; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma M. L., 2010, 2010 GAT COMP ENV WO, P1, DOI [DOI 10.1109/GCE.2010.5676129, 10.1109/GCE.2010.5676129]; Martin PEM, 2001, J CELL SCI, V114, P3845; Nottingham S, 2001, AM J PHYSIOL-REG I, V281, pR1940, DOI 10.1152/ajpregu.2001.281.6.R1940; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Prochnow N, 2009, EXP BRAIN RES, V199, P255, DOI 10.1007/s00221-009-1957-4; Qiu F, 2012, PURINERG SIGNAL, V8, P81, DOI 10.1007/s11302-011-9263-6; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Shields CR, 2007, J COMP NEUROL, V501, P765, DOI 10.1002/cne.21282; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trexler EB, 1999, J GEN PHYSIOL, V113, P721; Vanden Abeele F, 2006, J CELL BIOL, V174, P535, DOI 10.1083/jcb.200601115; Vroman R, 2013, EXTRACELLUL IN PRESS; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Xiong ZQ, 2000, J NEUROPHYSIOL, V83, P3519, DOI 10.1152/jn.2000.83.6.3519; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061; Zoidl G, 2008, CELL COMMUN ADHES, V15, P169, DOI 10.1080/15419060802014081	53	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77722	10.1371/journal.pone.0077722	http://dx.doi.org/10.1371/journal.pone.0077722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194896	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000075
J	Tovar-Lopez, FJ; Rosengarten, G; Nasabi, M; Sivan, V; Khoshmanesh, K; Jackson, SP; Mitchell, A; Nesbitt, WS				Tovar-Lopez, Francisco Javier; Rosengarten, Gary; Nasabi, Mahyar; Sivan, Vijay; Khoshmanesh, Khashayar; Jackson, Shaun P.; Mitchell, Arnan; Nesbitt, Warwick S.			An Investigation on Platelet Transport during Thrombus Formation at Micro-Scale Stenosis	PLOS ONE			English	Article							LATERAL MIGRATION; WALL; BLOOD	This paper reports on an investigation of mass transport of blood cells at micro-scale stenosis where local strain-rate micro-gradients trigger platelet aggregation. Using a microfluidic flow focusing platform we investigate the blood flow streams that principally contribute to platelet aggregation under shear micro-gradient conditions. We demonstrate that relatively thin surface streams located at the channel wall are the primary contributor of platelets to the developing aggregate under shear gradient conditions. Furthermore we delineate a role for red blood cell hydrodynamic lift forces in driving enhanced advection of platelets to the stenosis wall and surface of developing aggregates. We show that this novel microfluidic platform can be effectively used to study the role of mass transport phenomena driving platelet recruitment and aggregate formation and believe that this approach will lead to a greater understanding of the mechanisms underlying shear-gradient dependent discoid platelet aggregation in the context of cardiovascular diseases such as acute coronary syndromes and ischemic stroke.	[Tovar-Lopez, Francisco Javier; Nasabi, Mahyar; Sivan, Vijay; Khoshmanesh, Khashayar; Mitchell, Arnan] RMIT Univ, Sch Elect & Comp Engn, Microplatforms Res Grp, Melbourne, Vic 3001, Australia; [Rosengarten, Gary] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic 3001, Australia; [Khoshmanesh, Khashayar] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Jackson, Shaun P.; Nesbitt, Warwick S.] Monash Univ, Alfred Med Res & Educ Precinct, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Nesbitt, Warwick S.] Bion Inst, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Stanford University; Monash University; Bionics Institute	Tovar-Lopez, FJ (corresponding author), RMIT Univ, Sch Elect & Comp Engn, Microplatforms Res Grp, Melbourne, Vic 3001, Australia.	tovar.lopez.fj@gmail.com	Tovar, Francisco/AGG-3400-2022; Mitchell, Arnan/C-5017-2008	Mitchell, Arnan/0000-0002-2463-2956; Tovar-Lopez, Francisco J/0000-0001-8578-7786; Jackson, Shaun/0000-0002-4750-1991; Nesbitt, Warwick/0000-0001-5644-7053; Khoshmanesh, Khashayar/0000-0001-6036-7371	Australian Research Council [DE120101302, DE120101402]	Australian Research Council(Australian Research Council)	FJTL and KK acknowledge Australian Research Council for funding under Discovery Early Career Researcher Award scheme under DE120101302 and DE120101402 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819; Asakura T, 1990, CIRC RES, V66; Asmolov ES, 1999, J FLUID MECH, V381, P63, DOI 10.1017/S0022112098003474; Balasubramanian V, 2002, JOURNAL OF BIOMATERI, V13; Bluestein D, 1997, ANN BIOMED ENG, V25, P344, DOI 10.1007/BF02648048; Bluestein D, 1999, ANNALSBIOMEDICAL ENG, V27; Cox R, 1968, CHEM ENG SCI, V23; Crowl L, 2010, INT J NUMERICAL METH, V26; Dhinakaran S, 2013, J NONNEWTONIAN FLUID; Di Carlo D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.094503; ECKSTEIN EC, 1991, BIOPHYS J, V60, P53, DOI 10.1016/S0006-3495(91)82030-6; Flachskampf FA, 2012, J AM COLL CARDIOL, V59; Goldsmith H, 1975, ANN REV UID MECH, V7; Goldsmith H, 1977, ASAIO J, V23; GOLDSMITH HL, 1989, AM J PHYSIOL, V257, pH1005, DOI 10.1152/ajpheart.1989.257.3.H1005; Goldsmith HL, 1986, THROMB HAEMOSTASIS, V55; Hathcock JJ, 2006, ARTERIOSCLER THROMB, V26; Holz M, 2000, PHYS CHEM CHEM PHYS, V2; Kang DH, 2010, CIRCULATION, V121, P1502, DOI 10.1161/CIRCULATIONAHA.109.909903; KARINO T, 1984, BIORHEOLOGY, V21, P587; Kilimnik A, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3664402; Lancellotti P, 2012, J AM COLL CARDIOL, V59; Mach A, 2011, LAB CHIP, V11; Magnaudet J, 2003, J FLUID MECH, V476, P115, DOI 10.1017/S0022112002002902; Matas JP, 2004, OIL GAS SCI TECHNOL, V59, P59, DOI 10.2516/ogst:2004006; Merten M, 2000, CIRCULATION, V102; Michelson A.D, 2006, PLATELETS, VSecond; Mody N, 2008, BIOPHYS J, V95; MOFFATT HK, 1964, J FLUID MECH, V18, P1, DOI 10.1017/S0022112064000015; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Packham MA, 1994, CANADIAN J PHYSL PHA, V72; Saffman P, 1965, J FLUID MECH, V22; SCHOEPHOERSTER RT, 1993, ARTERIOSCLER THROMB, V13, P1806, DOI 10.1161/01.ATV.13.12.1806; SEGRE G, 1961, NATURE, V189, P209, DOI 10.1038/189209a0; Shin SJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046321; Sorensen EN, 1999, ANN BIOMED ENG, V27; Tovar-Lopez F, 2011, J BIOMECH, V44; Tovar-Lopez F, 2011, 15 INT C MIN SYST CH; Tovar-Lopez FJ, 2010, LAB CHIP, V10; UIJTTEWAAL WSJ, 1993, AM J PHYSIOL, V264, pH1239, DOI 10.1152/ajpheart.1993.264.4.H1239; Unger M, 2000, SCIENCE, V288; Wu Z, 2009, LAB CHIP, V9; Zeng LY, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3082232; Zhao H, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.3677935; Zhao R, 2007, BIORHEOLOGY, V44, P161	45	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e74123	10.1371/journal.pone.0074123	http://dx.doi.org/10.1371/journal.pone.0074123			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194822	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000001
J	Zhao, GJ; Zhao, B; Tong, ZX; Mu, RQ; Guan, YF				Zhao, Guojie; Zhao, Bin; Tong, Zhaoxue; Mu, Runqing; Guan, Yifu			Effects of 2 '-O-Methyl Nucleotide Substitution on EcoRI Endonuclease Cleavage Activities	PLOS ONE			English	Article							RESTRICTION-ENDONUCLEASE; CHIRAL PHOSPHOROTHIOATES; RECOGNITION SEQUENCE; PROTEIN INTERACTIONS; RNA TARGETS; DNA-BINDING; OLIGONUCLEOTIDES; COMPLEX; SPECIFICITY; MECHANISM	To investigate the effect of sugar pucker conformation on DNA-protein interactions, we used 2'-O-methyl nucleotide (2'-OMeN) to modify the EcoRI recognition sequence -TGAATTCT-, and monitored the enzymatic cleavage process using FRET method. The 2'-O-methyl nucleotide has a C3'-endo sugar pucker conformation different from the C2'-endo sugar pucker conformation of native DNA nucleotides. The initial reaction velocities were measured and the kinetic parameters, Km and V-max were derived using Michaelis-Menten equation. Experimental results showed that 2'-OMeN substitutions for the EcoRI recognition sequence decreased the cleavage efficiency for A2, A3 and T4 substitutions significantly, and 2'-OMeN substitution for T5 residue inhibited the enzymatic activity completely. In contrast, substitutions for G1 and C6 could maintain the original activity. 2'-fluoro nucleic acid (2'-FNA) and locked nucleic acid (LNA) having similar C3'-endo sugar pucker conformation also demonstrated similar enzymatic results. This position-dependent enzymatic cleavage property might be attributed to the phosphate backbone distortion caused by the switch from C2'-endo to C3'-endo sugar pucker conformation, and was interpreted on the basis of the DNA-EcoRI structure. These 2'-modified nucleotides could behave as a regulatory element to modulate the enzymatic activity in vitro, and this property will have potential applications in genetic engineering and biomedicine.	[Zhao, Guojie; Tong, Zhaoxue; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Zhao, Bin] Shenyang Sport Univ, Dept Movement Sci, Shenyang, Peoples R China; [Mu, Runqing] China Med Univ, Affiliated Hosp 1, Dept Lab Med, Shenyang, Peoples R China	China Medical University; Shenyang Sport University; China Medical University	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China.	yfguan@mail.cmu.edu.cn	zhao, guojie/I-4238-2012		National Natural Science Foundation of China [31070705]; Doctoral Startup Found of Liaoning Province [20131139]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Startup Found of Liaoning Province	This work was supported by a grant from the National Natural Science Foundation of China (No. 31070705) and Doctoral Startup Found of Liaoning Province (No. 20131139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL AK, 1995, CURR OPIN STRUC BIOL, V5, P11, DOI 10.1016/0959-440X(95)80004-K; ALVES J, 1984, EUR J BIOCHEM, V140, P83, DOI 10.1111/j.1432-1033.1984.tb08069.x; BRENNAN CA, 1986, J BIOL CHEM, V261, P7270; CAMPBELL JM, 1990, J BIOCHEM BIOPH METH, V20, P259, DOI 10.1016/0165-022X(90)90084-P; CONNOLLY BA, 1984, J BIOL CHEM, V259, P760; CONNOLLY BA, 1984, BIOCHEMISTRY-US, V23, P3443, DOI 10.1021/bi00310a010; Dominick PK, 2004, J AM CHEM SOC, V126, P5050, DOI 10.1021/ja039192z; Eisenschmidt K, 2002, J BIOTECHNOL, V96, P185, DOI 10.1016/S0168-1656(02)00029-9; FRATINI AV, 1982, J BIOL CHEM, V257, P4686; FREDERICK CA, 1984, NATURE, V309, P327, DOI 10.1038/309327a0; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Geahigan KB, 2000, BIOCHEMISTRY-US, V39, P4939, DOI 10.1021/bi9917636; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Gohda K, 1997, J BIOCHEM, V121, P219; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Huang Y, 2011, ANAL CHEM, V83, P8913, DOI 10.1021/ac2013114; JELTSCH A, 1993, J MOL BIOL, V229, P221, DOI 10.1006/jmbi.1993.1019; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; KIM YC, 1990, SCIENCE, V249, P1307, DOI 10.1126/science.2399465; KOZIOLKIEWICZ M, 1992, BIOCHEMISTRY-US, V31, P9460, DOI 10.1021/bi00154a019; Kurpiewski MR, 1996, BIOCHEMISTRY-US, V35, P8846, DOI 10.1021/bi960261e; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; LESSER DR, 1993, P NATL ACAD SCI USA, V90, P7548, DOI 10.1073/pnas.90.16.7548; LESSER DR, 1992, J BIOL CHEM, V267, P24810; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; Li XM, 2008, ANAL BIOCHEM, V381, P1, DOI 10.1016/j.ab.2008.06.027; Macickova-Cahova H, 2009, NUCLEIC ACIDS RES, V37, P7612, DOI 10.1093/nar/gkp845; Majlessi M, 1998, NUCLEIC ACIDS RES, V26, P2224, DOI 10.1093/nar/26.9.2224; MCCLARIN JA, 1986, SCIENCE, V234, P1526, DOI 10.1126/science.3024321; MILLIGAN JF, 1989, BIOCHEMISTRY-US, V28, P2849, DOI 10.1021/bi00433a016; Nathan D, 2002, J MOL BIOL, V316, P7, DOI 10.1006/jmbi.2001.5247; Pallan PS, 2011, NUCLEIC ACIDS RES, V39, P3482, DOI 10.1093/nar/gkq1270; Phillips MI, 2000, METHOD ENZYMOL, V313, P46; Piao XY, 2008, ACTA BIOCHIM POL, V55, P713; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Prakash TP, 2007, CURR TOP MED CHEM, V7, P641, DOI 10.2174/156802607780487713; Robinson CR, 1998, P NATL ACAD SCI USA, V95, P2186, DOI 10.1073/pnas.95.5.2186; Rosati O, 2002, BIOCHEM BIOPH RES CO, V295, P198, DOI 10.1016/S0006-291X(02)00645-9; RUBIN RA, 1978, NUCLEIC ACIDS RES, V5, P2991, DOI 10.1093/nar/5.8.2991; SEELA F, 1986, NUCLEIC ACIDS RES, V14, P2319, DOI 10.1093/nar/14.5.2319; Sen S, 1999, BIOPHYS J, V77, P1782, DOI 10.1016/S0006-3495(99)77024-4; Urata H, 2009, BIOCHEM BIOPH RES CO, V390, P192, DOI 10.1016/j.bbrc.2009.08.164; Watrob H, 2001, BIOCHEMISTRY-US, V40, P683, DOI 10.1021/bi002055j; WILLIAMS DM, 1991, BIOCHEMISTRY-US, V30, P4001, DOI 10.1021/bi00230a027; Wilson C, 2006, CURR OPIN CHEM BIOL, V10, P607, DOI 10.1016/j.cbpa.2006.10.001; Wright DJ, 1999, J BIOL CHEM, V274, P31896, DOI 10.1074/jbc.274.45.31896	46	7	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77111	10.1371/journal.pone.0077111	http://dx.doi.org/10.1371/journal.pone.0077111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194862	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000041
J	Koome, ME; Davidson, JO; Drury, PP; Mathai, S; Booth, LC; Gunn, AJ; Bennet, L				Koome, Miriam E.; Davidson, Joanne O.; Drury, Paul P.; Mathai, Sam; Booth, Lindsea C.; Gunn, Alistair Jan; Bennet, Laura			Antenatal Dexamethasone after Asphyxia Increases Neural Injury in Preterm Fetal Sheep	PLOS ONE			English	Article							BRAIN-INJURY; SYNTHETIC GLUCOCORTICOIDS; MATERNAL DEXAMETHASONE; SINGLE COURSE; NEUROPROTECTION; MATURATION; ISCHEMIA; CORTICOSTEROIDS; MYELINATION; HYPOTHERMIA	Background and Purpose: Maternal glucocorticoid treatment for threatened premature delivery dramatically improves neonatal survival and short-term morbidity; however, its effects on neurodevelopmental outcome are variable. We investigated the effect of maternal glucocorticoid exposure after acute asphyxia on injury in the preterm brain. Methods: Chronically instrumented singleton fetal sheep at 0.7 of gestation received asphyxia induced by complete umbilical cord occlusion for 25 minutes. 15 minutes after release of occlusion, ewes received a 3 ml i.m. injection of either dexamethasone (12 mg, n = 10) or saline (n = 10). Sheep were killed after 7 days recovery; survival of neurons in the hippocampus and basal ganglia, and oligodendrocytes in periventricular white matter were assessed using an unbiased stereological approach. Results: Maternal dexamethasone after asphyxia was associated with more severe loss of neurons in the hippocampus (CA3 regions, 290 +/- 76 vs 484 +/- 98 neurons/mm(2), mean +/- SEM, P<0.05) and basal ganglia (putamen, 538 +/- 112 vs 814 +/- 34 neurons/mm(2), P<0.05) compared to asphyxia-saline, and with greater loss of both total (913 +/- 77 vs 1201 +/- 75/mm(2), P<0.05) and immature/mature myelinating oligodendrocytes in periventricular white matter (66 +/- 8 vs 114 +/- 12/mm(2), P<0.05, vs sham controls 165 +/- 10/mm(2), P<0.001). This was associated with transient hyperglycemia (peak 3.5 +/- 0.2 vs. 1.4 +/- 0.2 mmol/L at 6 h, P<0.05) and reduced suppression of EEG power in the first 24 h after occlusion (maximum -1.5 +/- 1.2 dB vs. -5.0 +/- 1.4 dB in saline controls, P<0.01), but later onset and fewer overt seizures. Conclusions: In preterm fetal sheep, exposure to maternal dexamethasone during recovery from asphyxia exacerbated brain damage.	[Koome, Miriam E.; Davidson, Joanne O.; Drury, Paul P.; Mathai, Sam; Booth, Lindsea C.; Gunn, Alistair Jan; Bennet, Laura] Univ Auckland, Dept Physiol, Auckland, New Zealand	University of Auckland	Bennet, L (corresponding author), Univ Auckland, Dept Physiol, Auckland, New Zealand.	l.bennet@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Booth, Lindsea/0000-0003-3093-5766; Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Bennet, Laura/0000-0002-4336-7596	Health Research Council of New Zealand; Auckland Medical Research Foundation; Lottery Health New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Lottery Health New Zealand	This study was supported by public good grants from the Health Research Council of New Zealand, the Auckland Medical Research Foundation, and Lottery Health New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham I, 1996, BRAIN RES, V733, P56; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Barrett RD, 2012, BRAIN RES, V1469, P35, DOI 10.1016/j.brainres.2012.06.018; Baud O, 1999, NEW ENGL J MED, V341, P1190, DOI 10.1056/NEJM199910143411604; Bennet L, 2010, SEMIN FETAL NEONAT M, V15, P253, DOI 10.1016/j.siny.2010.05.007; Bennet L, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/751694; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Charles MS, 2012, NEUROBIOL DIS, V47, P29, DOI 10.1016/j.nbd.2012.03.021; Davidson JO, 2012, ANN NEUROL, V71, P121, DOI 10.1002/ana.22654; Davidson JO, 2011, J PHYSIOL-LONDON, V589, P3823, DOI 10.1113/jphysiol.2011.212043; Dean JM, 2006, NEUROSCIENCE, V142, P615, DOI 10.1016/j.neuroscience.2006.06.066; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Elitt CM, 2003, EARLY HUM DEV, V73, P1, DOI 10.1016/S0378-3782(03)00030-6; Filan P, 2005, BJOG-INT J OBSTET GY, V112, P504, DOI 10.1111/j.1471-0528.2004.00476.x; George SA, 2012, STROKE, V43, P3114, DOI 10.1161/STROKEAHA.112.671982; Glass HC, 2011, J PEDIATR-US, V159, P731, DOI 10.1016/j.jpeds.2011.07.015; Gunn A J, 2006, NeuroRx, V3, P154, DOI 10.1007/BF03207046; HAY WW, 1983, P SOC EXP BIOL MED, V173, P553, DOI 10.3181/00379727-173-41686; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; Khan AA, 2011, PAEDIATR PERINAT EP, V25, P20, DOI 10.1111/j.1365-3016.2010.01147.x; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P395, DOI 10.1038/jcbfm.1986.72; LEBLANC MH, 1994, STROKE, V25, P1443, DOI 10.1161/01.STR.25.7.1443; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Mehta S, 2003, J Postgrad Med, V49, P299; Ogilvy-Stuart AL, 2010, ARCH DIS CHILD-FETAL, V95, pF126, DOI 10.1136/adc.2008.154716; Quaedackers JS, 2005, BJOG-INT J OBSTET GY, V112, P182, DOI 10.1111/j.1471-0528.2004.00344.x; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Scheepens A, 2003, DEV BRAIN RES, V142, P67, DOI 10.1016/S0165-3806(03)00032-4; Scheepens A, 2003, J PHYSIOL-LONDON, V552, P163, DOI 10.1113/jphysiol.2003.043414; SCHER MS, 1993, PEDIATRICS, V91, P128; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shinwell ES, 2009, SEMIN FETAL NEONAT M, V14, P164, DOI 10.1016/j.siny.2008.12.001; Singh RR, 2012, CLIN EXP PHARMACOL P, V39, P979, DOI 10.1111/1440-1681.12009; Tijsseling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033369; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Whitelaw A, 2000, ARCH DIS CHILD-FETAL, V83, pF154, DOI 10.1136/fn.83.2.F154; WILLIAMS CE, 1992, ANN NEUROL, V31, P14, DOI 10.1002/ana.410310104	39	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77480	10.1371/journal.pone.0077480	http://dx.doi.org/10.1371/journal.pone.0077480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204840	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300099
J	Lonardo, E; Cioffi, M; Sancho, P; Sanchez-Ripoll, Y; Trabulo, SM; Dorado, J; Balic, A; Hidalgo, M; Heeschen, C				Lonardo, Enza; Cioffi, Michele; Sancho, Patricia; Sanchez-Ripoll, Yolanda; Maria Trabulo, Sara; Dorado, Jorge; Balic, Anamaria; Hidalgo, Manuel; Heeschen, Christopher			Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells	PLOS ONE			English	Article							STELLATE CELLS; SELF-RENEWAL; EPIDEMIOLOGY; INHIBITION; RISK	Pancreatic ductal adenocarcinomas contain a subset of exclusively tumorigenic cancer stem cells (CSCs), which are capable of repopulating the entire heterogeneous cancer cell populations and are highly resistant to standard chemotherapy. Here we demonstrate that metformin selectively ablated pancreatic CSCs as evidenced by diminished expression of pluripotency-associated genes and CSC-associated surface markers. Subsequently, the ability of metformin-treated CSCs to clonally expand in vitro was irreversibly abrogated by inducing apoptosis. In contrast, non-CSCs preferentially responded by cell cycle arrest, but were not eliminated by metformin treatment. Mechanistically, metformin increased reactive oxygen species production in CSC and reduced their mitochondrial transmembrane potential. The subsequent induction of lethal energy crisis in CSCs was independent of AMPK/mTOR. Finally, in primary cancer tissue xenograft models metformin effectively reduced tumor burden and prevented disease progression; if combined with a stroma-targeting smoothened inhibitor for enhanced tissue penetration, while gemcitabine actually appeared dispensable.	[Lonardo, Enza; Cioffi, Michele; Sancho, Patricia; Sanchez-Ripoll, Yolanda; Maria Trabulo, Sara; Dorado, Jorge; Balic, Anamaria; Heeschen, Christopher] Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Mol Pathol Programme, Madrid, Spain; [Hidalgo, Manuel] Spanish Natl Canc Res Ctr, Clin Res Programme CNIO, Gastrointestinal Canc Clin Res Unit, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Heeschen, C (corresponding author), Spanish Natl Canc Res Ctr CNIO, Stem Cells & Canc Grp, Mol Pathol Programme, Madrid, Spain.	cheeschen@cnio.es	Guba, Markus/M-4309-2019; lonardo, enza/AAI-5726-2020; HIDALGO, MANUEL/I-4995-2015; Sancho, Patricia/ABH-5258-2020	HIDALGO, MANUEL/0000-0002-3765-3318; Sancho, Patricia/0000-0002-1092-5395; Lonardo, Enza/0000-0001-6654-1043; Heeschen, Christopher/0000-0002-1158-8554; Balic, Anamaria/0000-0001-6796-1197; Cioffi, Michele/0000-0003-4180-5369	ERC [Pa-CSC 233460]; European Community [256974]; Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria [PS09/02129]; Ministerio de Ciencia e Innovacion, Spain [PLE2009-0105]; Roche; La Caixa	ERC(European Research Council (ERC)European Commission); European Community(European Commission); Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Roche(Roche Holding); La Caixa(La Caixa Foundation)	The research was supported by the ERC Advanced Investigator Grant (Pa-CSC 233460), European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no256974, the Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PS09/02129), and the Programa Nacional de Internacionalizacion de la I+D, Subprogramma: FCCI 2009 (PLE2009-0105; both Ministerio de Ciencia e Innovacion, Spain). E.L. is supported by the Roche Postdoctoral Fellowship Program. M.C. is supported by the La Caixa Predoctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gallmeier E, 2011, STEM CELLS, V29, P418, DOI 10.1002/stem.595; Garrido-Laguna I, 2010, BRIT J CANCER, V103, P649, DOI 10.1038/sj.bjc.6605819; Hamada S, 2012, BIOCHEM BIOPH RES CO, V421, P349, DOI 10.1016/j.bbrc.2012.04.014; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hess G, 2009, J CLIN ONCOL, V27, P3822, DOI 10.1200/JCO.2008.20.7977; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; Lonardo E, 2012, CELL CYCLE, V11, P1282, DOI 10.4161/cc.19679; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Martin-Castillo B, 2010, CELL CYCLE, V9, P1057, DOI 10.4161/cc.9.6.10994; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Michaud D S, 2004, Minerva Chir, V59, P99; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ouslimani N, 2005, METABOLISM, V54, P829, DOI 10.1016/j.metabol.2005.01.029; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sadeghi N, 2012, CLIN CANC RES; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Von Hoff DD, 2011, CELL STEM CELL; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262	32	116	120	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76518	10.1371/journal.pone.0076518	http://dx.doi.org/10.1371/journal.pone.0076518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204632	Green Submitted, gold, Green Published			2022-12-25	WOS:000326029300031
J	Wilson, MB; Spivak, M; Hegeman, AD; Rendahl, A; Cohen, JD				Wilson, Michael B.; Spivak, Marla; Hegeman, Adrian D.; Rendahl, Aaron; Cohen, Jerry D.			Metabolomics Reveals the Origins of Antimicrobial Plant Resins Collected by Honey Bees	PLOS ONE			English	Article							APIS-MELLIFERA; PROPOLIS; HYMENAEA; DISEASE; RESISTANCE; PHENOLICS; COLONIES	The deposition of antimicrobial plant resins in honey bee, Apis mellifera, nests has important physiological benefits. Resin foraging is difficult to approach experimentally because resin composition is highly variable among and between plant families, the environmental and plant-genotypic effects on resins are unknown, and resin foragers are relatively rare and often forage in unobservable tree canopies. Subsequently, little is known about the botanical origins of resins in many regions or the benefits of specific resins to bees. We used metabolomic methods as a type of environmental forensics to track individual resin forager behavior through comparisons of global resin metabolite patterns. The resin from the corbiculae of a single bee was sufficient to identify that resin's botanical source without prior knowledge of resin composition. Bees from our apiary discriminately foraged for resin from eastern cottonwood (Populus deltoides), and balsam poplar (P. balsamifera) among many available, even closely related, resinous plants. Cottonwood and balsam poplar resin composition did not show significant seasonal or regional changes in composition. Metabolomic analysis of resin from 6 North American Populus spp. and 5 hybrids revealed peaks characteristic to taxonomic nodes within Populus, while antimicrobial analysis revealed that resin from different species varied in inhibition of the bee bacterial pathogen, Paenibacillus larvae. We conclude that honey bees make discrete choices among many resinous plant species, even among closely related species. Bees also maintained fidelity to a single source during a foraging trip. Furthermore, the differential inhibition of P. larvae by Populus spp., thought to be preferential for resin collection in temperate regions, suggests that resins from closely related plant species many have different benefits to bees.	[Wilson, Michael B.; Hegeman, Adrian D.; Cohen, Jerry D.] Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA; [Wilson, Michael B.; Hegeman, Adrian D.; Cohen, Jerry D.] Univ Minnesota, Microbial & Plant Genom Inst, St Paul, MN 55108 USA; [Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN USA; [Hegeman, Adrian D.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Rendahl, Aaron] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wilson, MB (corresponding author), Univ Minnesota, Dept Hort Sci, St Paul, MN 55108 USA.	wils0888@umn.edu	Cohen, Jerry/AAF-3737-2020; Spivak, Marla/AAI-5088-2020; Hegeman, Adrian/D-5984-2013	Cohen, Jerry/0000-0003-2816-8676; Rendahl, Aaron/0000-0001-5434-3592; Hegeman, Adrian/0000-0003-1008-6066	NSF Plant Genome Research Program [IOS-0923960, IOS-1238812]; NSF [IOS-0717530]; University of Minnesota College of Food, Agriculture, and Natural Resource Sciences; National Honey Board; Gordon and Margaret Bailey Endowment for Environmental Horticulture; University of Minnesota Graduate School; Direct For Biological Sciences [0923960, 1256992] Funding Source: National Science Foundation	NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); University of Minnesota College of Food, Agriculture, and Natural Resource Sciences; National Honey Board; Gordon and Margaret Bailey Endowment for Environmental Horticulture; University of Minnesota Graduate School(University of Minnesota System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was through the NSF Plant Genome Research Program grants IOS-0923960 and IOS-1238812 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 5338&org = BIO), NSF grant IOS-0717530, the University of Minnesota College of Food, Agriculture, and Natural Resource Sciences (www.cfans.umn.edu/), the National Honey Board (http://www.honey.com/honey-industry/honey-and-bee-research), the Gordon and Margaret Bailey Endowment for Environmental Horticulture, and the University of Minnesota Graduate School (http://www.grad.umn.edu/fellowships/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; ALFONSUS ERWIN C., 1933, GLEANINGS IN BEE CULT, V61, P92; ARRHENIUS SP, 1983, BIOCHEM SYST ECOL, V11, P361, DOI 10.1016/0305-1978(83)90037-6; Bankova V, 1998, APIDOLOGIE, V29, P361, DOI 10.1051/apido:19980406; Bankova V, 2006, NAT PROD COMMUN, V1, P1023; Bankova VS, 2000, APIDOLOGIE, V31, P3, DOI 10.1051/apido:2000102; Bastos EMAF, 2008, J INVERTEBR PATHOL, V97, P273, DOI 10.1016/j.jip.2007.10.007; Chapuisat M, 2007, P ROY SOC B-BIOL SCI, V274, P2013, DOI 10.1098/rspb.2007.0531; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crane E, 1990, BEES BEEKEEPING SCI, P367; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; ENGLISH S, 1991, PHYTOCHEMISTRY, V30, P531, DOI 10.1016/0031-9422(91)83721-V; ENGLISH S, 1992, PHYTOCHEMISTRY, V31, P1255, DOI 10.1016/0031-9422(92)80272-G; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; Greenway W, 1987, SILVAE GENET, V38, P28; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Johnson R, 2010, HONEY BEE COLONY COL; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Langenheim J.H., 2003, PLANT RESINS CHEM EV; LANGENHEIM JH, 1983, BIOCHEM SYST ECOL, V11, P29, DOI 10.1016/0305-1978(83)90026-1; LANGENHEIM JH, 1981, BIOCHEM SYST ECOL, V9, P27, DOI 10.1016/0305-1978(81)90056-9; Leonhardt SD, 2010, CHEM SENSES, V35, P603, DOI 10.1093/chemse/bjq058; Leonhardt SD, 2009, BIOTROPICA, V41, P730, DOI 10.1111/j.1744-7429.2009.00535.x; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Mennerat A, 2009, ANIM BEHAV, V77, P569, DOI 10.1016/j.anbehav.2008.11.008; Schmid-Hempel P., 1998, Parasites in social insects.; SEELEY TD, 1976, INSECT SOC, V23, P495, DOI 10.1007/BF02223477; Simone M, 2009, EVOLUTION, V63, P3016, DOI 10.1111/j.1558-5646.2009.00772.x; Simone-Finstrom M, 2010, BEHAV ECOL SOCIOBIOL, V64, P1609, DOI 10.1007/s00265-010-0974-4; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Teixeira EW, 2005, EVID-BASED COMPL ALT, V2, P85, DOI 10.1093/ecam/neh055; USDA NRCS National Plant Data Team, 2013, USDA PLANTS DAT; van Dooremalen C, 2012, PLOS ONE, V7, DOI [DOI 10.1371/J0URNAL.P0NE.0036285, 10.1371/journal.pone.0036285]; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Witham TG, 1983, VARIABLE PLANTS HERB, P15	45	53	55	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77512	10.1371/journal.pone.0077512	http://dx.doi.org/10.1371/journal.pone.0077512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204850	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300100
J	Suzuki, Y; Yamamura, H; Ohya, S; Imaizumi, Y				Suzuki, Yoshiaki; Yamamura, Hisao; Ohya, Susumu; Imaizumi, Yuji			Caveolin-1 Facilitates the Direct Coupling between Large Conductance Ca2+-activated K+ (BKCa) and Cav1.2 Ca2+ Channels and Their Clustering to Regulate Membrane Excitability in Vascular Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Caveolin; Fluorescence Resonance Energy Transfer (FRET); Imaging; Single Molecule Biophysics; Vascular Smooth Muscle Cells; L-type Voltage-dependent Calcium Channel; Large Conductance Calcium-activated Potassium Channel; Total Internal Reflection Fluorescent Microscopy	SMOOTH-MUSCLE-CELLS; PIG VAS-DEFERENS; ARTERIAL; PROTEIN; RELEASE; ACTIVATION; RELAXATION; EXPRESSION; SINGLE; DEPOLARIZATION	Background: The contribution of caveolae to physiological interaction between two major ion channels, large conductance Ca2+-activated K+ (BKCa) and Ca2+ (Cav1.2) channels, is unknown in vascular myocytes. Results: The loss of caveola by caveolin-1 deficiency reduced BKCa-Cav1.2 coupling, Cav1.2 clustering, and membrane excitability regulation. Conclusion: Caveolin-1 provides platform for BKCa-Cav1.2 molecular complex. Significance: Caveolin-1-BKCa-Cav1.2 in caveola forms a novel Ca2+ signal domain for arterial tonus regulation. L-type voltage-dependent Ca2+ channels (LVDCC) and large conductance Ca2+-activated K+ channels (BKCa) are the major factors defining membrane excitability in vascular smooth muscle cells (VSMCs). The Ca2+ release from sarcoplasmic reticulum through ryanodine receptor significantly contributes to BKCa activation in VSMCs. In this study direct coupling between LVDCC (Cav1.2) and BKCa and the role of caveoline-1 on their interaction in mouse mesenteric artery SMCs were examined. The direct activation of BKCa by Ca2+ influx through coupling LVDCC was demonstrated by patch clamp recordings in freshly isolated VSMCs. Using total internal reflection fluorescence microscopy, it was found that a large part of yellow fluorescent protein-tagged BKCa co-localized with the cyan fluorescent protein-tagged Cav1.2 expressed in the plasma membrane of primary cultured mouse VSMCs and that the two molecules often exhibited FRET. It is notable that each BK subunit of a tetramer in BKCa can directly interact with Cav1.2 and promotes Cav1.2 cluster in the molecular complex. Furthermore, caveolin-1 deficiency in knock-out (KO) mice significantly reduced not only the direct coupling between BKCa and Cav1.2 but also the functional coupling between BKCa and ryanodine receptor in VSMCs. The measurement of single cell shortening by 40 mm K+ revealed enhanced contractility in VSMCs from KO mice than wild type. Taken together, caveolin-1 facilitates the accumulation/clustering of BKCa-LVDCC complex in caveolae, which effectively regulates spatiotemporal Ca2+ dynamics including the negative feedback, to control the arterial excitability and contractility.	[Suzuki, Yoshiaki; Yamamura, Hisao; Ohya, Susumu; Imaizumi, Yuji] Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Ohya, Susumu] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol, Kyoto 6078414, Japan	Nagoya City University; Kyoto Pharmaceutical University	Imaizumi, Y (corresponding author), Nagoya City Univ, Dept Mol & Cellular Pharmacol, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Imaizumi, Yuji/AAF-6585-2020; Suzuki, Yoshiaki/ABH-5320-2020; Ohya, Susumu/AAB-3618-2020	Suzuki, Yoshiaki/0000-0002-7879-6059; Ohya, Susumu/0000-0002-5765-0667	Ministry of Education, Culture, Sports, Science, and Technology [20056027, 23136512]; Japan Society for the Promotion of Science [23390020, 226641]; Grants-in-Aid for Scientific Research [23390020, 25460111] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 20056027 and 23136512 (to Y. I.) from the Ministry of Education, Culture, Sports, Science, and Technology, Grant-in-aid for Scientific Research (B) 23390020 (to Y. I.), and Grant-in-aid for Japan Society for the Promotion of Science Fellows 226641 (to Y. S.) from the Japan Society for the Promotion of Science.	Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Daniel EE, 2006, J CELL MOL MED, V10, P529, DOI 10.1111/j.1582-4934.2006.tb00418.x; Dinardo MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040235; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Guia A, 1999, CIRC RES, V84, P1032, DOI 10.1161/01.RES.84.9.1032; Hnasko Robert, 2003, Mol Interv, V3, P445, DOI 10.1124/mi.3.8.445; Hotta S, 2007, J PHARMACOL SCI, V103, P121, DOI 10.1254/jphs.SC0060213; Imaizumi Y, 1998, J PHYSIOL-LONDON, V510, P705, DOI 10.1111/j.1469-7793.1998.705bj.x; IMAIZUMI Y, 1989, J PHYSIOL-LONDON, V411, P131, DOI 10.1113/jphysiol.1989.sp017565; ITOH T, 1983, J PHYSIOL-LONDON, V337, P609, DOI 10.1113/jphysiol.1983.sp014645; Kim H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000780; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Liao P, 2007, J BIOL CHEM, V282, P35133, DOI 10.1074/jbc.M705478200; Loane DJ, 2007, J CELL SCI, V120, P985, DOI 10.1242/jcs.03399; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Morimura K, 2006, AM J PHYSIOL-CELL PH, V290, pC388, DOI 10.1152/ajpcell.00409.2005; Nakajo K, 2010, P NATL ACAD SCI USA, V107, P18862, DOI 10.1073/pnas.1010354107; Naraghi M, 1997, J NEUROSCI, V17, P6961; Navedo MF, 2007, AM J PHYSIOL-HEART C, V293, pH1359, DOI 10.1152/ajpheart.00450.2007; Navedo MF, 2006, J GEN PHYSIOL, V127, P611, DOI 10.1085/jgp.200609519; Navedo MF, 2010, CIRC RES, V106, P748, DOI 10.1161/CIRCRESAHA.109.213363; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nuno DW, 2012, AM J PHYSIOL-REG I, V303, pR959, DOI 10.1152/ajpregu.00667.2011; Ohba T, 2013, J PHARMACOL EXP THER, V347, P145, DOI 10.1124/jpet.113.205138; Ohi Y, 2001, J PHYSIOL-LONDON, V534, P313, DOI 10.1111/j.1469-7793.2001.t01-3-00313.x; Ohya S, 2001, PFLUG ARCH EUR J PHY, V441, P611, DOI 10.1007/s004240000463; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Rodrigues GJ, 2010, EUR J PHARMACOL, V627, P251, DOI 10.1016/j.ejphar.2009.11.010; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Santana LF, 2009, J MOL CELL CARDIOL, V47, P436, DOI 10.1016/j.yjmcc.2009.07.008; Shakirova Y, 2006, AM J PHYSIOL-CELL PH, V291, pC1326, DOI 10.1152/ajpcell.00046.2006; Suzuki Y, 2013, BIOCHEM BIOPH RES CO, V430, P1169, DOI 10.1016/j.bbrc.2012.12.015; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Weston AH, 2010, BRIT J PHARMACOL, V160, P836, DOI 10.1111/j.1476-5381.2010.00657.x; Yamamura H, 2012, BIOCHEM BIOPH RES CO, V427, P54, DOI 10.1016/j.bbrc.2012.08.145; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011	53	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36750	36761		10.1074/jbc.M113.511485	http://dx.doi.org/10.1074/jbc.M113.511485			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24202214	Green Published, hybrid			2022-12-25	WOS:000328883400052
J	Chung, JH; Karkhanis, V; Tae, S; Yan, FT; Smith, P; Ayers, LW; Agostinelli, C; Pileri, S; Denis, GV; Baiocchi, RA; Sif, S				Chung, Jihyun; Karkhanis, Vrajesh; Tae, Sookil; Yan, Fengting; Smith, Porsha; Ayers, Leona W.; Agostinelli, Claudio; Pileri, Stefano; Denis, Gerald V.; Baiocchi, Robert A.; Sif, Said			Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Cyclin D1; Leukemia; Lymphoma; Retinoblastoma (Rb); PRC2; PRMT5; RB1; RBL2	TARGET GENES; P53 ACTIVITY; CYCLIN D1; EXPRESSION; EZH2; PROLIFERATION; METHYLATION; APOPTOSIS; TRANSCRIPTION; INTERACTS	Background: PRMT5, PRC2, and cyclin D1 are overexpressed in non-Hodgkin lymphoma (NHL). Results: PRMT5 expression inversely correlates with levels of hypophospho-RB1 and RBL2. Conclusion: PRMT5 inhibition reactivates RB1 and RBL2 and silences PRC2 and cyclin D1. Significance: PRMT5 inhibition results in NHL growth arrest and cell death. Epigenetic regulation mediated by lysine- and arginine-specific enzymes plays an essential role in tumorigenesis, and enhanced expression of the type II protein arginine methyltransferase PRMT5 as well as the polycomb repressor complex PRC2 has been associated with increased cell proliferation and survival. Here, we show that PRMT5 is overexpressed in three different types of non-Hodgkin lymphoma cell lines and clinical samples as well as in mouse primary lymphoma cells and that it up-regulates PRC2 expression through inactivation of the retinoblastoma proteins RB1 and RBL2. Although PRMT5 epigenetically controls RBL2 expression, it indirectly promotes RB1 phosphorylation through enhanced cyclin D1 expression. Furthermore, we demonstrate that PRMT5 knockdown in non-Hodgkin lymphoma cell lines and mouse primary lymphoma cells leads to RBL2 derepression and RB1 reactivation, which in turn inhibit PRC2 expression and trigger derepression of its CASP10, DAP1, HOXA5, and HRK pro-apoptotic target genes. We also show that reduced PRMT5 expression leads to cyclin D1 transcriptional repression via loss of TP53K372 methylation, which results in decreased BCL3 expression and enhanced recruitment of NF-B p52-HDAC1 repressor complexes to the cyclin D1 promoter. These findings indicate that PRMT5 is a master epigenetic regulator that governs expression of its own target genes and those regulated by PRC2 and that its inhibition could offer a promising therapeutic strategy for lymphoma patients.	[Chung, Jihyun; Karkhanis, Vrajesh; Tae, Sookil; Sif, Said] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Ayers, Leona W.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Yan, Fengting; Smith, Porsha; Baiocchi, Robert A.] Ohio State Univ, Coll Med, Div Hematol, Columbus, OH 43210 USA; [Agostinelli, Claudio; Pileri, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Hematopathol Unit, I-40126 Bologna, Italy; [Denis, Gerald V.] Boston Univ, Sch Med, Canc Res Ctr, Boston, MA 02118 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Bologna; Boston University	Sif, S (corresponding author), Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	sif.1@osu.edu	Sif, Said/AAE-5554-2019	Sif, Said/0000-0001-6268-1145; Denis, Gerald/0000-0001-9886-0401; Agostinelli, Claudio/0000-0002-4945-1422	National Institutes of Health from NCI [R01 CA116093]; Leukemia Research Foundation MCL Initiative; Associazione Italiana per la Ricerca sul Cancro (AIRC) [10007]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA116093, R29CA075107, R03CA102889] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000091] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation MCL Initiative; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA116093 from NCI (to S. S.). This work was also supported by the Leukemia Research Foundation MCL Initiative and Associazione Italiana per la Ricerca sul Cancro (AIRC) 5X100 Grant 10007 (to S. P.).	Agostinelli C, 2012, HISTOPATHOLOGY, V61, P33, DOI 10.1111/j.1365-2559.2012.04198.x; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HX, 2004, MOL CELL BIOL, V24, P924, DOI 10.1128/MCB.24.2.924-935.2004; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; DEISS LP, 1995, GENE DEV, V9, P15, DOI 10.1101/gad.9.1.15; FISHER RI, 1995, BLOOD, V85, P1075, DOI 10.1182/blood.V85.4.1075.bloodjournal8541075; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lenburg ME, 2007, J BIOL CHEM, V282, P4803, DOI 10.1074/jbc.M605870200; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schug J., 2008, CURR PROTOC BIOINFOR, V21, DOI DOI 10.1002/0471250953.BI0206S21; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stevenson FK, 2001, ADV CANCER RES, V83, P81, DOI 10.1016/S0065-230X(01)83004-9; Swerdlow SH, 2008, WHO CLASSIFICATION T, P229; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; TEODOROVIC I, 1995, J CLIN ONCOL, V13, P2819, DOI 10.1200/JCO.1995.13.11.2819; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Wang L, 2008, MOL CELL BIOL, V28, P6262, DOI 10.1128/MCB.00923-08; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	50	68	78	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 6	2013	288	49					35534	35547		10.1074/jbc.M113.510669	http://dx.doi.org/10.1074/jbc.M113.510669			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291YA	24189068	Green Published, hybrid			2022-12-25	WOS:000329867600048
J	Schanz, T; Lins, Y; Viefhaus, H; Barciaga, T; Labe, S; Preuschoft, H; Witzel, U; Sander, PM				Schanz, Tom; Lins, Yvonne; Viefhaus, Hanna; Barciaga, Thomas; Laebe, Sashima; Preuschoft, Holger; Witzel, Ulrich; Sander, P. Martin			Quantitative Interpretation of Tracks for Determination of Body Mass	PLOS ONE			English	Article							CONSTITUTIVE PARAMETERS; SAUROPOD; CONSISTENCY; CENTERS	To better understand the biology of extinct animals, experimentation with extant animals and innovative numerical approaches have grown in recent years. This research project uses principles of soil mechanics and a neoichnological field experiment with an African elephant to derive a novel concept for calculating the mass (i.e., the weight) of an animal from its footprints. We used the elephant's footprint geometry (i.e., vertical displacements, diameter) in combination with soil mechanical analyses (i.e., soil classification, soil parameter determination in the laboratory, Finite Element Analysis (FEA) and gait analysis) for the back analysis of the elephant's weight from a single footprint. In doing so we validated the first component of a methodology for calculating the weight of extinct dinosaurs. The field experiment was conducted under known boundary conditions at the Zoological Gardens Wuppertal with a female African elephant. The weight of the elephant was measured and the walking area was prepared with sediment in advance. Then the elephant was walked across the test area, leaving a trackway behind. Footprint geometry was obtained by laser scanning. To estimate the dynamic component involved in footprint formation, the velocity the foot reaches when touching the subsoil was determined by the Digital Image Correlation (DIC) technique. Soil parameters were identified by performing experiments on the soil in the laboratory. FEA was then used for the backcalculation of the elephant's weight. With this study, we demonstrate the adaptability of using footprint geometry in combination with theoretical considerations of loading of the subsoil during a walk and soil mechanical methods for prediction of trackmakers weight.	[Schanz, Tom; Lins, Yvonne; Viefhaus, Hanna; Barciaga, Thomas] Ruhr Univ Bochum, Lehrstuhl Grundbau Boden & Felsmech, Bochum, Germany; [Laebe, Sashima; Sander, P. Martin] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Preuschoft, Holger] Ruhr Univ Bochum, Inst Anat, Abt Funkt Morphol, Bochum, Germany; [Witzel, Ulrich] Ruhr Univ Bochum, Lehrstuhl Maschinenelemente & Konstrukt Lehre, Forsch Grp Biomech, Bochum, Germany	Ruhr University Bochum; University of Bonn; Ruhr University Bochum; Ruhr University Bochum	Schanz, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Grundbau Boden & Felsmech, Univ Str 150, Bochum, Germany.	tom.schanz@rub.de						Alexander RM, 2006, P ROY SOC B-BIOL SCI, V273, P1849, DOI 10.1098/rspb.2006.3532; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; [Anonymous], 1979, 40191 DIN; Barnes Fran A., 1994, Gaia, V10, P37; Bates KT, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0009; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Christian Andreas, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P81; COLBERT EDWIN H., 1962, AMER MUS NOVITATES, V2076, P1; Diedrich Cajus, 2011, Palaeobiodiversity Palaeoenvironments, V91, P129, DOI 10.1007/s12549-010-0044-y; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; Falkingham PL, 2011, BIOL LETTERS, V7, P142, DOI 10.1098/rsbl.2010.0403; Falkingham PL, 2010, PALAIOS, V25, P356, DOI 10.2110/palo.2009.p09-164r; Falkingham PL, 2009, PALAEOGEOGR PALAEOCL, V271, P69, DOI 10.1016/j.palaeo.2008.09.011; Farlow J.O., 1989, P371; Fischer R, 1998, MITTEILUNGEN I GEOLO, V37; Gatesy S, 2003, ICHNOS, V10; Genin JJ, 2010, J EXP BIOL, V213, P694, DOI 10.1242/jeb.035436; Gunga HC, 2008, FOSS REC, V11, P33, DOI 10.1002/mmng.200700011; Gunga HC, 2007, NATURWISSENSCHAFTEN, V94, P623, DOI 10.1007/s00114-007-0234-2; HAZEN A., 1892, MASSACHUSETTS STATE, V24, P539; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; Henderson Donald M., 2003, Ichnos, V10, P99, DOI 10.1080/10420940390257914; Hutchinson JR, 2003, NATURE, V422, P493, DOI 10.1038/422493a; Ishigaki Shinobu, 2009, Memoir of the Fukui Prefectural Dinosaur Museum, V8, P1; Jackson SJ, 2010, ICHNOS, V17, P197, DOI 10.1080/10420940.2010.510026; Kaever M., 1974, B SOC GEOL FR, V16, P516, DOI DOI 10.2113/GSSGFBULL.S7-XVI.5.516; Klein N., 2011, BIOL SAUROPOD DINOSA; Knabe T, 2013, COMPUT GEOTECH, V49, P143, DOI 10.1016/j.compgeo.2012.10.002; Knabe T, 2012, CAN GEOTECH J, V49, P170, DOI [10.1139/t11-091, 10.1139/T11-091]; Lambe T.W., 1969, SOIL MECH; Lockley M. G., 2004, GERMANY ICHNOS, V11, P261; LOCKLEY MG, 1986, GEOL SOC AM BULL, V97, P1163, DOI 10.1130/0016-7606(1986)97<1163:NALDTS>2.0.CO;2; Lockley MG, 2001, GUIDEBOOK NEW MEXICO, V52; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; Mannion PD, 2010, PALEOBIOLOGY, V36, P253, DOI 10.1666/08085.1; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Ohde J, 1939, BAUINGENIEUR, V20, P93; Platt BF, 2012, PALAIOS, V27, P726, DOI 10.2110/palo.2012.p12-006r; Preuschoft Holger, 2011, P197; Prince N.K., 1989, P155; Rochter L., 2011, THESIS RUHR U BOCHUM; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schanz T, 1996, GEOTECHNIQUE, V46, P145, DOI 10.1680/geot.1996.46.1.145; Schanz T., 1998, PREFAILURE DEFORMATI, V383-387; Schanz T., 1999, HARDENING SOIL MODEL; SHANZ T., 1998, MITT I GEOTECHNIK, V45; Thulborn T., 1990, DINOSAUR TRACKS; Wright JL, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P252	50	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77606	10.1371/journal.pone.0077606	http://dx.doi.org/10.1371/journal.pone.0077606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204890	gold, Green Published, Green Submitted			2022-12-25	WOS:000326334500036
J	Leung, KH; Lu, LH; Wang, MD; Mak, TY; Chan, DSH; Tang, FK; Leung, CH; Kwan, HY; Yu, ZL; Ma, DL				Leung, Ka-Ho; Lu, Lihua; Wang, Modi; Mak, Tsun-Yin; Chan, Daniel Shiu-Hin; Tang, Fung-Kit; Leung, Chung-Hang; Kwan, Hiu-Yee; Yu, Zhiling; Ma, Dik-Lung			A Label-Free Luminescent Switch-On Assay for ATP Using a G-Quadruplex-Selective Iridium(III) Complex	PLOS ONE			English	Article							MOLECULAR LIGHT SWITCH; APTAMER; PROBE; IONS	We report herein the G-quadruplex-selective property of a luminescent cyclometallated iridium(III) complex for the detection of adenosine-5'-triphosphate (ATP) in aqueous solution. The ATP-binding aptamer was employed as the ATP recognition unit, while the iridium(III) complex was used to monitor the formation of the G-quadruplex structure induced by ATP. The sensitivity and fold enhancement of the assay were higher than those of the previously reported assay using the organic dye crystal violet as a fluorescent probe. This label-free luminescent switch-on assay exhibits high sensitivity and selectivity towards ATP with a limit of detection of 2.5 mu M.	[Leung, Ka-Ho; Lu, Lihua; Wang, Modi; Mak, Tsun-Yin; Chan, Daniel Shiu-Hin; Tang, Fung-Kit; Ma, Dik-Lung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Kwan, Hiu-Yee; Yu, Zhiling] Hong Kong Baptist Univ, Sch Chinese Med, Ctr Canc & Inflammat Res, Hong Kong, Hong Kong, Peoples R China	Hong Kong Baptist University; University of Macau; Hong Kong Baptist University	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wang, Modi/ABG-9659-2021; Leung, KaHo/AAB-9337-2019	Leung, KaHo/0000-0002-2998-669X; Yu, Zhiling/0000-0002-2979-9608; Ma, Dik-Lung/0000-0002-9515-340X; KWAN, Hiu Yee/0000-0002-6088-7323	Hong Kong Baptist University [FRG2/11-12/009, FRG2/12-13/021]; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/11101212]; Research Grants Council [HKBU/201811, HKBU/204612]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]; Science and Technology Development Fund, Macao SAR [001/2012/A]; University of Macau [MYRG091(Y2-L2)-ICMS12-LCH, MYRG121(Y2-L2)-ICMS12-LCH]	Hong Kong Baptist University; Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Science and Technology Development Fund, Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/11-12/009, FRG2/12-13/021), Centre for Cancer and Inflammation Research, School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/11101212), the Research Grants Council (HKBU/201811 and HKBU/204612), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the Science and Technology Development Fund, Macao SAR (001/2012/A) and the University of Macau (MYRG091(Y2-L2)-ICMS12-LCH and MYRG121(Y2-L2)-ICMS12-LCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callan JF, 2008, J FLUORESC, V18, P1157, DOI 10.1007/s10895-008-0367-5; Chan DSH, 2009, CHEM COMMUN, P7479, DOI 10.1039/b913995h; Chen Z, 2008, ANAL BIOANAL CHEM, V392, P1185, DOI 10.1007/s00216-008-2342-z; Famulok M, 2011, ACCOUNTS CHEM RES, V44, P1349, DOI 10.1021/ar2000293; Guan XA, 2010, BIOMED MICRODEVICES, V12, P683, DOI 10.1007/s10544-010-9421-6; He HZ, 2013, NUCLEIC ACIDS RES, V41, P4345, DOI 10.1093/nar/gkt108; He HZ, 2013, BIOSENS BIOELECTRON, V41, P871, DOI 10.1016/j.bios.2012.08.060; He HZ, 2012, CHEM COMMUN, V48, P9462, DOI 10.1039/c2cc32253f; He HZ, 2012, ANALYST, V137, P1538, DOI 10.1039/c2an15999f; Leung CH, 2013, CHEM SCI, V4, P3781, DOI 10.1039/c3sc51228b; Leung CH, 2012, NUCLEIC ACIDS RES, V40, P941, DOI 10.1093/nar/gkr763; Leung KH, 2013, CHEM COMMUN, V49, P5630, DOI 10.1039/c3cc41129j; Leung KH, 2013, CHEM COMMUN, V49, P771, DOI 10.1039/c2cc37710a; Leung KH, 2012, RSC ADV, V2, P8273, DOI 10.1039/c2ra21119j; Liu F, 2011, CHEM BIODIVERS, V8, P311, DOI 10.1002/cbdv.201000130; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Ma DL, 2013, CHEM SCI, V4, P3366, DOI 10.1039/c3sc50924a; Ma DL, 2013, ANGEW CHEM INT EDIT, V52, P7666, DOI 10.1002/anie.201208414; Ma DL, 2013, CHEM SOC REV, V42, P3427, DOI 10.1039/c2cs35472a; Ma DL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr106; Man BYW, 2010, CHEM COMMUN, V46, P8534, DOI 10.1039/c0cc01201g; Manikandan M, 2012, ANALYST, V137, P5128, DOI 10.1039/c2an35754b; Nakano S, 2013, J AM CHEM SOC, V135, P3465, DOI 10.1021/ja3097652; Perez-Ruiz T, 2003, ANAL BIOANAL CHEM, V377, P189, DOI 10.1007/s00216-003-2071-2; Shi S, 2012, DALTON T, V41, P5789, DOI 10.1039/c2dt30076a; Shi S, 2010, DALTON T, V39, P2490, DOI 10.1039/b916094a; Sitaula S, 2012, CHEM COMMUN, V48, P9284, DOI 10.1039/c2cc34279k; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang J, 2005, ANAL CHEM, V77, P3542, DOI 10.1021/ac050165w; Wang J, 2007, ADV MATER, V19, P3943, DOI 10.1002/adma.200602256; Wang YY, 2008, ANALYST, V133, P1593, DOI 10.1039/b806908e; Wang Y, 2013, ANAL CHEM, V85, P6775, DOI 10.1021/ac400858g; Wilner OI, 2012, CHEM REV, V112, P2528, DOI 10.1021/cr200104q; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; Yao JL, 2013, DALTON T, V42, P5661, DOI 10.1039/c3dt32640c; Zhang HF, 2012, J MATER CHEM, V22, P23900, DOI 10.1039/c2jm35379b; Zhang HQ, 2013, CHEM REV, V113, P2812, DOI 10.1021/cr300340p; Zhang ZX, 2012, ANAL CHEM, V84, P4789, DOI 10.1021/ac300348v; Zhao Q, 2006, INORG CHEM, V45, P6152, DOI 10.1021/ic052034j; Zhao Q, 2011, CHEM SOC REV, V40, P2508, DOI 10.1039/c0cs00114g; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zhou ZX, 2011, ANAL CHEM, V83, P5122, DOI 10.1021/ac200120g; Zinellu A, 2010, ELECTROPHORESIS, V31, P2854, DOI 10.1002/elps.201000138; Zuo XL, 2007, J AM CHEM SOC, V129, P1042, DOI 10.1021/ja067024b; Zuo XL, 2009, J AM CHEM SOC, V131, P6944, DOI 10.1021/ja901315w	45	23	23	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77021	10.1371/journal.pone.0077021	http://dx.doi.org/10.1371/journal.pone.0077021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204723	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400023
J	Derogis, PBMC; Freitas, FP; Marques, ASF; Cunha, D; Appolinario, PP; de Paula, F; Lourenco, TC; Murgu, M; Di Mascio, P; Medeiros, MHG; Miyamoto, S				Derogis, Priscilla B. M. C.; Freitas, Florencio P.; Marques, Anna S. F.; Cunha, Daniela; Appolinario, Patricia P.; de Paula, Fernando; Lourenco, Tiago C.; Murgu, Michael; Di Mascio, Paolo; Medeiros, Marisa H. G.; Miyamoto, Sayuri			The Development of a Specific and Sensitive LC-MS-Based Method for the Detection and Quantification of Hydroperoxy- and Hydroxydocosahexaenoic Acids as a Tool for Lipidomic Analysis	PLOS ONE			English	Article							SINGLET MOLECULAR-OXYGEN; PERFORMANCE LIQUID-CHROMATOGRAPHY; ELECTROSPRAY MASS-SPECTROMETRY; HYDROXY FATTY-ACIDS; DOCOSAHEXAENOIC ACID; NEURODEGENERATIVE DISEASES; HUMAN-PLATELETS; PEROXIDATION; MECHANISMS; BRAIN	Docosahexaenoic acid (DHA) is an n-3 polyunsaturated fatty acid that is highly enriched in the brain, and the oxidation products of DHA are present or increased during neurodegenerative disease progression. The characterization of the oxidation products of DHA is critical to understanding the roles that these products play in the development of such diseases. In this study, we developed a sensitive and specific analytical tool for the detection and quantification of twelve major DHA hydroperoxide (HpDoHE) and hydroxide (HDoHE) isomers (isomers at positions 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 19 and 20) in biological systems. In this study, HpDoHE were synthesized by photooxidation, and the corresponding hydroxides were obtained by reduction with NaBH4. The isolated isomers were characterized by LC-MS/MS, and unique and specific fragment ions were chosen to construct a selected reaction monitoring (SRM) method for the targeted quantitative analysis of each HpDoHE and HDoHE isomer. The detection limits for the LC-MS/MS-SRM assay were 1-670 pg for HpDoHE and 0.5-8.5 pg for HDoHE injected onto a column. Using this method, it was possible to detect the basal levels of HDoHE isomers in both rat plasma and brain samples. Therefore, the developed LC-MS/MS-SRM can be used as an important tool to identify and quantify the hydro(pero)xy derivatives of DHA in biological system and may be helpful for the oxidative lipidomic studies.	[Derogis, Priscilla B. M. C.; Freitas, Florencio P.; Cunha, Daniela; Appolinario, Patricia P.; Di Mascio, Paolo; Medeiros, Marisa H. G.; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Marques, Anna S. F.; de Paula, Fernando; Lourenco, Tiago C.; Murgu, Michael] Waters Technol Brazil, Luiz Barssotti Applicat Lab, Sao Paulo, Brazil	Universidade de Sao Paulo	Miyamoto, S (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	miyamoto@iq.usp.br	Miyamoto, Sayuri/A-2144-2008; Di Mascio, Paolo/D-1264-2014; Freitas, Florêncio P/K-4656-2014; Medeiros, Marisa H. G./A-5212-2008; de Medeiros, Marisa Helena Gennari/AAA-8015-2019	Miyamoto, Sayuri/0000-0002-5714-8984; Di Mascio, Paolo/0000-0003-4125-8350; Medeiros, Marisa H. G./0000-0002-5438-1174; de Medeiros, Marisa Helena Gennari/0000-0002-5438-1174; Bento Matos Cruz Derogis, Priscilla/0000-0003-2345-3996	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico); Instituto do Milenio: Redoxoma; INCT de Processos Redox em Biomedicina - Redoxoma; NAP-Redoxoma; CEPID-Redoxoma; Pro-Reitoria de Pesquisa-USP	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto do Milenio: Redoxoma; INCT de Processos Redox em Biomedicina - Redoxoma; NAP-Redoxoma; CEPID-Redoxoma; Pro-Reitoria de Pesquisa-USP	This work was supported by the Brazilian research funding institutions: FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), CNPq (Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico), Instituto do Milenio: Redoxoma, INCT de Processos Redox em Biomedicina - Redoxoma, NAP-Redoxoma, CEPID-Redoxoma and Pro-Reitoria de Pesquisa-USP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appolinario PP, 2011, QUIM NOVA, V34, P1409, DOI 10.1590/S0100-40422011000800021; AVELDANO MI, 1983, J BIOL CHEM, V258, P9339; BAZAN NG, 1984, BIOCHEM BIOPH RES CO, V125, P741, DOI 10.1016/0006-291X(84)90601-6; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; BENDANI MK, 1995, NEUROSCI LETT, V189, P159, DOI 10.1016/0304-3940(95)11482-C; Bernoud-Hubac N, 2001, J BIOL CHEM, V276, P30964, DOI 10.1074/jbc.M103768200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buege J A, 1978, Methods Enzymol, V52, P302; Cheng ZY, 2007, CHEM REV, V107, P748, DOI 10.1021/cr040077w; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Gomolka B, 2011, PROSTAG OTH LIPID M, V94, P81, DOI 10.1016/j.prostaglandins.2010.12.006; HAMBRECHT GS, 1987, NEUROCHEM RES, V12, P1029, DOI 10.1007/BF00970932; Hong S, 2005, PROSTAG OTH LIPID M, V78, P107, DOI 10.1016/j.prostaglandins.2005.04.004; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; Horrocks LA, 1999, PHARMACOL RES, V40, P211, DOI 10.1006/phrs.1999.0495; Iuliano L, 2011, CHEM PHYS LIPIDS, V164, P457, DOI 10.1016/j.chemphyslip.2011.06.006; Jira W, 1996, CHEM PHYS LIPIDS, V84, P165, DOI 10.1016/S0009-3084(96)02635-7; Kawai Y, 2007, CHEM RES TOXICOL, V20, P99, DOI 10.1021/tx060199e; Kerwin JL, 1996, ANAL BIOCHEM, V237, P56, DOI 10.1006/abio.1996.0200; KIM HY, 1990, PROSTAG OTH LIPID M, V40, P473, DOI 10.1016/0090-6980(90)90110-H; Lu Y, 2005, J LIPID RES, V46, P790, DOI 10.1194/jlr.D400020-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; Lyberg AM, 2006, LIPIDS, V41, P67, DOI 10.1007/s11745-006-5072-z; MacMillan DK, 1995, J AM SOC MASS SPECTR, V6, P1190, DOI 10.1016/1044-0305(95)00505-6; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Miyamoto S, 2003, J AM CHEM SOC, V125, P6172, DOI 10.1021/ja029115o; Miyamoto S, 2003, J AM CHEM SOC, V125, P4510, DOI 10.1021/ja029262m; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Pratico D, 2004, AM J PATHOL, V164, P1655, DOI 10.1016/S0002-9440(10)63724-8; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Schneider C, 2009, MOL NUTR FOOD RES, V53, P315, DOI 10.1002/mnfr.200800131; Seal JR, 2004, ANAL BIOANAL CHEM, V378, P1007, DOI 10.1007/s00216-003-2274-6; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Song WL, 2008, J BIOL CHEM, V283, P6, DOI 10.1074/jbc.M706124200; Sun YY, 2007, WAVE RANDOM COMPLEX, V17, P1, DOI 10.1080/17455030600791694; TERAO J, 1988, ANAL BIOCHEM, V169, P415, DOI 10.1016/0003-2697(88)90306-5; Uemi M, 2011, CHEM RES TOXICOL, V24, P887, DOI 10.1021/tx200079d; Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z	49	31	32	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77561	10.1371/journal.pone.0077561	http://dx.doi.org/10.1371/journal.pone.0077561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204871	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300025
J	Antanasijevic, A; Cheng, H; Wardrop, DJ; Rong, LJ; Caffrey, M				Antanasijevic, Aleksandar; Cheng, Han; Wardrop, Duncan J.; Rong, Lijun; Caffrey, Michael			Inhibition of Influenza H7 Hemagglutinin-Mediated Entry	PLOS ONE			English	Article							VIRUS HEMAGGLUTININ; TERT-BUTYLHYDROQUINONE; CONFORMATIONAL-CHANGE; RECEPTOR-BINDING; MEMBRANE-FUSION; IDENTIFICATION; EMERGENCE; COMPLEX; ORIGIN; REGION	The recent outbreak of H7N9 influenza in China is of high concern to public health. H7 hemagglutinin (HA) plays a critical role in influenza entry and thus HA presents an attractive target for antivirals. Previous studies have suggested that the small molecule tert-butyl hydroquinone (TBHQ) inhibits the entry of influenza H3 HA by binding to the stem loop of HA and stabilizing the neutral pH conformation of HA, thereby disrupting the membrane fusion step. Based on amino acid sequence, structure and immunogenicity, H7 is a related Group 2 HA. In this work we show, using a pseudovirus entry assay, that TBHQ inhibits H7 HA-mediated entry, as well as H3 HA-mediated entry, with an IC50 similar to 6 mu M. Using NMR, we show that TBHQ binds to the H7 stem loop region. STD NMR experiments indicate that the aromatic ring of TBHQ makes extensive contact with the H7 HA surface. Limited proteolysis experiments indicate that TBHQ inhibits influenza entry by stabilizing the H7 HA neutral pH conformation. Together, this work suggests that the stem loop region of H7 HA is an attractive target for therapeutic intervention and that TBHQ, which is a widely used food preservative, is a promising lead compound.	[Antanasijevic, Aleksandar; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Cheng, Han; Rong, Lijun] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA; [Wardrop, Duncan J.] Univ Illinois, Dept Chem, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	caffrey@uic.edu		Cheng, Han/0000-0002-9464-8611; Wardrop, Duncan/0000-0002-1234-5626				BODIAN DL, 1993, BIOCHEMISTRY-US, V32, P2967, DOI 10.1021/bi00063a007; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cianci C, 1999, J VIROL, V73, P1785, DOI 10.1128/JVI.73.3.1785-1794.1999; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshpande MS, 2001, BIOORG MED CHEM LETT, V11, P2393, DOI 10.1016/S0960-894X(01)00459-0; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gharavi N, 2007, CURR DRUG METAB, V8, P1, DOI 10.2174/138920007779315035; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Han T, 2011, ANN NY ACAD SCI, V1217, P178, DOI 10.1111/j.1749-6632.2010.05829.x; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Ilyushina NA, 2007, J GEN VIROL, V88, P1266, DOI 10.1099/vir.0.82256-0; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lagoja IM, 2008, MED RES REV, V28, P1, DOI 10.1002/med.20096; Lamb RA, 2013, AM J RESP CRIT CARE, V188, P1, DOI 10.1164/rccm.201305-0914ED; Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Oka M, 2001, CHEM PHARM BULL, V49, P379, DOI 10.1248/cpb.49.379; Ramirez B, 2013, METH MOL BI IN PRESS; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Staschke KA, 1998, VIROLOGY, V248, P264, DOI 10.1006/viro.1998.9273; Ueda M, 1998, J CLIN MICROBIOL, V36, P340, DOI 10.1128/JCM.36.2.340-344.1998; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; VANESCH GJ, 1986, FOOD CHEM TOXICOL, V24, P1063, DOI 10.1016/0278-6915(86)90289-9; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Wang MX, 2012, J VIROL, V86, P4455, DOI 10.1128/JVI.07187-11; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yermolina MV, 2011, J MED CHEM, V54, P765, DOI 10.1021/jm1008715; Yu KL, 2002, BIOORG MED CHEM LETT, V12, P3379, DOI 10.1016/S0960-894X(02)00761-8; Zhu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029120	42	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76363	10.1371/journal.pone.0076363	http://dx.doi.org/10.1371/journal.pone.0076363			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194835	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000014
J	Li, MH; Tian, LL; Wang, L; Yao, HC; Zhang, JR; Lu, JG; Sun, YN; Gao, X; Xiao, H; Liu, M				Li, MingHua; Tian, LinLi; Wang, Lin; Yao, HongChao; Zhang, JiaRui; Lu, JianGuang; Sun, YaNan; Gao, Xu; Xiao, Hui; Liu, Ming			Down-Regulation of miR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; BETA-CATENIN; MICRORNA EXPRESSION; CANCER; PROLIFERATION; TUMORIGENESIS; INVASION; MIRNAS; ROLES; LEADS	miRNAs regulate gene expression and are key mediators of tumourigenesis. miR-129 has diverse effects in tumours, but its role in laryngeal squamous cell carcinoma (LSCC) remains unknown. This article focuses on the role of miR-129-5p in LSCC. We show miR-129-5p is upregulated in primary LSCC tumours and correlated with advanced disease. Down-regulating miR-129-5p suppressed cell proliferation and migration, and caused cell cycle arrest in Hep-2 cell lines. Downregulation of miR-129-5p alone is sufficient to induce apoptosis both in vivo and in vitro. Moreover, the growth of LSCC xenograft exposed to miR-129-5p antisense oligonucleotides (ASO) in BALB/c mice was markedly inhibited. In addition, we found that miR-129-5p targeted adenomatous polyposis coli (APC) to release inhibition of Wnt signalling causing cell growth and tumourigenesis. Our results suggest miR-129-5p functions as an oncogene in LSCC by repressing APC and is a potential therapeutic target for LSCC.	[Li, MingHua; Wang, Lin; Yao, HongChao; Sun, YaNan; Liu, Ming] Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Serv Head & Neck Surg, Harbin, Peoples R China; [Tian, LinLi; Zhang, JiaRui; Lu, JianGuang; Xiao, Hui] Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Serv Laryngol, Harbin, Peoples R China; [Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Xiao, H (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Otolaryngol Head & Neck Surg, Serv Laryngol, Harbin, Peoples R China.	ybbxuz2001@163.com; liumingorl@qq.com	gao, xu/U-4765-2019		National Science Foundation of China [81241085]; Key Project of Natural Science Foundation of Heilongjiang Province [ZD201215/H1302]; Research Fund for the Doctoral Program of Higher Education of China [20102307110007]; Science and Technology Innovation Talent Research Funds of Harbin [2012RFXXS072]; Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z11087]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Innovation Talent Research Funds of Harbin; Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation)	This work was supported by grants from the National Science Foundation of China (81241085); the Key Project of Natural Science Foundation of Heilongjiang Province (ZD201215/H1302); the Research Fund for the Doctoral Program of Higher Education of China (20102307110007); the Science and Technology Innovation Talent Research Funds of Harbin (2012RFXXS072); and the Postdoctoral Science Foundation of Heilongjiang Province (LBH-Z11087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birks DK, 2011, PEDIATR BLOOD CANCER, V56, P211, DOI 10.1002/pbc.22723; Chen XD, 2012, INT J CANCER, V130, P1607, DOI 10.1002/ijc.26171; Chiang YP, 2011, J GASTROINTEST SURG, V15, P63, DOI 10.1007/s11605-010-1367-8; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dreher A, 2011, BIOCHEM BIOPH RES CO, V412, P20, DOI 10.1016/j.bbrc.2011.07.011; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ebert MPA, 2003, J CLIN ONCOL, V21, P1708, DOI 10.1200/JCO.2003.10.017; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guillen-Ahlers H, 2008, CURR DRUG TARGETS, V9, P591, DOI 10.2174/138945008784911813; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035800; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Mirisola V, 2011, CANCER LETT, V307, P37, DOI 10.1016/j.canlet.2011.03.013; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ogawa R, 2009, MED MOL MORPHOL, V42, P102, DOI 10.1007/s00795-009-0443-1; Ren JY, 2010, EUR J CANCER, V46, P3409, DOI 10.1016/j.ejca.2010.07.047; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Tsuchiya R, 2004, ORAL ONCOL, V40, P932, DOI 10.1016/j.oraloncology.2004.04.011; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wu JJ, 2010, CELL CYCLE, V9, P1809, DOI 10.4161/cc.9.9.11535; Zhang TH, 2011, ANTICANCER RES, V31, P3859; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	36	60	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77829	10.1371/journal.pone.0077829	http://dx.doi.org/10.1371/journal.pone.0077829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194897	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000076
J	Macey, PM; Kumar, R; Woo, MA; Yan-Go, FL; Harper, RM				Macey, Paul M.; Kumar, Rajesh; Woo, Mary A.; Yan-Go, Frisca L.; Harper, Ronald M.			Heart Rate Responses to Autonomic Challenges in Obstructive Sleep Apnea	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; MAGNETIC-RESONANCE-SPECTROSCOPY; MEDIAL PREFRONTAL CORTEX; GENDER-DIFFERENCES; BRAIN MORPHOLOGY; BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; CLINICAL PRESENTATION; INTERMITTENT HYPOXIA; NEURAL ALTERATIONS	Obstructive sleep apnea (OSA) is accompanied by structural alterations and dysfunction in central autonomic regulatory regions, which may impair dynamic and static cardiovascular regulation, and contribute to other syndrome pathologies. Characterizing cardiovascular responses to autonomic challenges may provide insights into central nervous system impairments, including contributions by sex, since structural alterations are enhanced in OSA females over males. The objective was to assess heart rate responses in OSA versus healthy control subjects to autonomic challenges, and, separately, characterize female and male patterns. We studied 94 subjects, including 37 newly-diagnosed, untreated OSA patients (6 female, age mean +/- std: 52.1 +/- 8.1 years; 31 male aged 54.3 +/- 8.4 years), and 57 healthy control subjects (20 female, 50.5 +/- 8.1 years; 37 male, 45.6 +/- 9.2 years). We measured instantaneous heart rate with pulse oximetry during cold pressor, hand grip, and Valsalva maneuver challenges. All challenges elicited significant heart rate differences between OSA and control groups during and after challenges (repeated measures ANOVA, p < 0.05). In post-hoc analyses, OSA females showed greater impairments than OSA males, which included: for cold pressor, lower initial increase (OSA vs. control: 9.5 vs. 7.3 bpm in females, 7.6 vs. 3.7 bpm in males), OSA delay to initial peak (2.5 s females/0.9 s males), slower mid-challenge rate-of-increase (OSA vs. control: -0.11 vs. 0.09 bpm/s in females, 0.03 vs. 0.06 bpm/s in males); for hand grip, lower initial peak (OSA vs. control: 2.6 vs. 4.6 bpm in females, 5.3 vs. 6.0 bpm in males); for Valsalva maneuver, lower Valsalva ratio (OSA vs. control: 1.14 vs. 1.30 in females, 1.29 vs. 1.34 in males), and OSA delay during phase II (0.68 s females/1.31 s males). Heart rate responses showed lower amplitude, delayed onset, and slower rate changes in OSA patients over healthy controls, and impairments may be more pronounced in females. The dysfunctions may reflect central injury in the syndrome, and suggest autonomic deficiencies that may contribute to further tissue and functional pathologies.	[Macey, Paul M.; Woo, Mary A.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Macey, Paul M.; Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90024 USA; [Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90024 USA; [Yan-Go, Frisca L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Macey, PM (corresponding author), Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA.	pmacey@ucla.edu	Macey, Paul M./B-5037-2008	Macey, Paul M./0000-0003-4093-7458	National Institutes of Health [NR013693]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Supported by the National Institutes of Health NR013693 (http://www.ninr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, CLIN AUTON RES, V6, P125; Arsenos P, 2012, INT J CARDIOL, V154, P358, DOI 10.1016/j.ijcard.2011.11.007; Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENARROCH EE, 1993, MAYO CLIN PROC, V68, P988, DOI 10.1016/S0025-6196(12)62272-1; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; Cortelli P, 1994, Clin Auton Res, V4, P57, DOI 10.1007/BF01828839; Cross RL, 2008, SLEEP, V31, P1103; [Diagnostic Classification Steering Committee American Sleep Disorders Association], 1990, INT CLASS SLEEP DIS, Vxii; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; Greenberg-Dotan S, 2007, SLEEP, V30, P1173, DOI 10.1093/sleep/30.9.1173; Grimaldi D, 2013, CHRONOBIOL INT, V30, P31, DOI 10.3109/07420528.2012.701139; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Harper RM, 2003, J APPL PHYSIOL, V94, P1583, DOI 10.1152/japplphysiol.00881.2002; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; Henderson LA, 2003, J APPL PHYSIOL, V94, P1063, DOI 10.1152/japplphysiol.00702.2002; HIRANO T, 1993, NEUROSURGERY, V32, P675, DOI 10.1227/00006123-199304000-00029; Imadojemu VA, 2007, CHEST, V131, P1406, DOI 10.1378/chest.06-2580; Ito R, 2005, CLIN EXP HYPERTENS, V27, P259, DOI 10.1081/CEH-200048874; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Joo E, 2012, SLEEP, V35, pA184; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Jordan AS, 2005, J APPL PHYSIOL, V99, P2020, DOI 10.1152/japplphysiol.00410.2004; Jordan AS, 2003, SLEEP MED REV, V7, P377, DOI 10.1053/smrv.2002.0260; Kalaria RN, 2004, RESP PHYSIOL NEUROBI, V140, P53, DOI 10.1016/j.resp.2004.01.003; Kasiakogias A, 2013, J HYPERTENS, V31, P352, DOI 10.1097/HJH.0b013e32835bdcda; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Kim HA, 2013, J NEUROL SCI, V325, P61, DOI 10.1016/j.jns.2012.11.019; Kimmerly DS, 2005, J PHYSIOL-LONDON, V569, P331, DOI 10.1113/jphysiol.2005.091637; King AB, 1999, J COMP NEUROL, V413, P572; Kufoy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033769; Kumar R, 2008, NEUROSCI LETT, V438, P330, DOI 10.1016/j.neulet.2008.04.071; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Kumar R, 2009, DEPRESS ANXIETY, V26, P480, DOI 10.1002/da.20531; Lafleche AB, 1998, AM J PHYSIOL-HEART C, V275, pH409, DOI 10.1152/ajpheart.1998.275.2.H409; Lehericy S, 1998, ANN NEUROL, V44, P398, DOI 10.1002/ana.410440319; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Low PA, 2013, J CLIN NEUROL, V9, P1, DOI 10.3988/jcn.2013.9.1.1; LUTHERER LO, 1989, J AUTONOM NERV SYST, V27, P101, DOI 10.1016/0165-1838(89)90092-1; LUTHERER LO, 1983, BRAIN RES, V269, P251, DOI 10.1016/0006-8993(83)90134-8; Macey KE, 2006, RESP PHYSIOL NEUROBI, V151, P44, DOI 10.1016/j.resp.2005.05.024; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2012, SLEEP, V35, P1603, DOI 10.5665/sleep.2228; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Macey PM, 2012, SLEEP, V35, P9, DOI 10.5665/sleep.1572; Macey PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010211; Macey PM, 2003, RESP PHYSIOL NEUROBI, V138, P275, DOI 10.1016/j.resp.2003.09.002; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; MARKS JD, 1987, EXP NEUROL, V95, P730, DOI 10.1016/0014-4886(87)90312-8; Mohsenin V, 2003, SLEEP MED, V4, P523, DOI 10.1016/S1389-9457(03)00168-0; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Murakami E, 1996, Hypertens Res, V19, P133, DOI 10.1291/hypres.19.133; O'Donoghue FJ, 2012, SLEEP, V35, P41, DOI 10.5665/sleep.1582; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pae EK, 2005, NEUROSCI LETT, V375, P123, DOI 10.1016/j.neulet.2004.10.091; Pillar G, 1998, CHEST, V114, P697, DOI 10.1378/chest.114.3.697; Pinto S, 2012, MUSCLE NERVE, V46, P341, DOI 10.1002/mus.23313; PORTH CJM, 1984, HEART LUNG, V13, P507; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; Resstel LBM, 2005, EUR J NEUROSCI, V21, P2513, DOI 10.1111/j.1460-9568.2005.04078.x; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Santarnecchi E, 2013, J SLEEP RES, V22, P337, DOI 10.1111/jsr.12006; Shepertycky MR, 2005, SLEEP, V28, P309; Smith R, 2002, CHEST, V121, P164, DOI 10.1378/chest.121.1.164; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Tonon C, 2007, SLEEP, V30, P305, DOI 10.1093/sleep/30.3.305; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Waravdekar NV, 1996, AM J RESP CRIT CARE, V153, P1333, DOI 10.1164/ajrccm.153.4.8616563; WILLIAMS JL, 1994, NEUROSURGERY, V34, P379, DOI 10.1227/00006123-199402000-00035; Wong SW, 2007, J APPL PHYSIOL, V103, P1402, DOI 10.1152/japplphysiol.00171.2007; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Woodson BT, 2004, OTOLARYNG HEAD NECK, V130, P643, DOI 10.1016/S0194-5998(03)01318-4; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 1996, ARCH INTERN MED, V156, P2445, DOI 10.1001/archinte.156.21.2445; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Zhang ZH, 1998, BRAIN RES, V813, P73, DOI 10.1016/S0006-8993(98)00996-2; Zhou D, 2008, PHYSIOL GENOMICS, V32, P370, DOI 10.1152/physiolgenomics.00147.2007	84	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76631	10.1371/journal.pone.0076631	http://dx.doi.org/10.1371/journal.pone.0076631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194842	Green Published, gold, Green Submitted			2022-12-25	WOS:000326037000021
J	Kaspar, P; Ilencikova, K; Zikova, M; Horvath, O; Cermak, V; Bartunek, P; Strnad, H				Kaspar, Petr; Ilencikova, Kristina; Zikova, Martina; Horvath, Ondrej; Cermak, Vladimir; Bartunek, Petr; Strnad, Hynek			c-Myb Inhibits Myoblast Fusion	PLOS ONE			English	Article							CELL PROLIFERATION; DIFFERENTIATION; EXPRESSION; MYOGENESIS; P300; BETA	Satellite cells represent a heterogeneous population of stem and progenitor cells responsible for muscle growth, repair and regeneration. We investigated whether c-Myb could play a role in satellite cell biology because our previous results using satellite cell-derived mouse myoblast cell line C2C12 showed that c-Myb was expressed in growing cells and downregulated during differentiation. We detected c-Myb expression in activated satellite cells of regenerating muscle. c-Myb was also discovered in activated satellite cells associated with isolated viable myofiber and in descendants of activated satellite cells, proliferating myoblasts. However, no c-Myb expression was detected in multinucleated myotubes originated from fusing myoblasts. The constitutive expression of c-Myb lacking the 3' untranslated region (3' UTR) strongly inhibited the ability of myoblasts to fuse. The inhibition was dependent on intact c-Myb transactivation domain as myoblasts expressing mutated c-Myb in transactivation domain were able to fuse. The absence of 3' UTR of c-Myb was also important because the expression of c-Myb coding region with its 3' UTR did not inhibit myoblast fusion. The same results were repeated in C2C12 cells as well. Moreover, it was documented that 3' UTR of c-Myb was responsible for downregulation of c-Myb protein levels in differentiating C2C12 cells. DNA microarray analysis of C2C12 cells revealed that the expression of several muscle-specific genes was downregulated during differentiation of c-Myb-expressing cells, namely: ACTN2, MYH8, TNNC2, MYOG, CKM and LRRN1. A detailed qRT-PCR analysis of MYOG, TNNC2 and LRRN1 is presented. Our findings thus indicate that c-Myb is involved in regulating the differentiation program of myogenic progenitor cells as its expression blocks myoblast fusion.	[Kaspar, Petr; Ilencikova, Kristina; Zikova, Martina; Horvath, Ondrej; Cermak, Vladimir; Bartunek, Petr; Strnad, Hynek] Acad Sci Czech Republic, Inst Mol Genet, Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kaspar, P (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague 4, Czech Republic.	kaspar@img.cas.cz	Strnad, Hynek/B-7361-2008; Cermak, Vladimir/C-2991-2013; Zikova, Martina/A-3276-2012; Bartunek, Petr/J-3897-2014; Kaspar, Petr/J-1705-2014	Strnad, Hynek/0000-0002-0141-8340; Cermak, Vladimir/0000-0002-2754-3000; Bartunek, Petr/0000-0002-6202-7650; 	Grant Agency of the Czech Republic [P305/10/2133]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by grant P305/10/2133 from the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Basu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029376; Cesi V, 2011, CELL CYCLE, V10, P4149, DOI 10.4161/cc.10.23.18346; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Grabher C, 2011, LEUKEMIA, V25, P506, DOI 10.1038/leu.2010.280; Kaspar P, 2008, DIFFERENTIATION, V76, P245, DOI 10.1111/j.1432-0436.2007.00222.x; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Pattabiraman DR, 2009, MOL CANCER RES, V7, P1477, DOI 10.1158/1541-7786.MCR-09-0070; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Zhang YY, 2011, BLOOD, V118, P4093, DOI 10.1182/blood-2011-03-342501; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	25	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76742	10.1371/journal.pone.0076742	http://dx.doi.org/10.1371/journal.pone.0076742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204667	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600008
J	Liu, R; Yang, M; Meng, YL; Liao, J; Sheng, JY; Pu, YP; Yin, LH; Kim, SJ				Liu, Ran; Yang, Miao; Meng, Yanli; Liao, Juan; Sheng, Jingyi; Pu, Yuepu; Yin, Lihong; Kim, Sun Jung			Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							MICRORNAS; CANCER; LRH-1; EXPRESSION; ONCOMIRS; HLRH-1; GROWTH; CYCLE	Recent studies have demonstrated the possible function of miR-139-5p in tumorigenesis. However, the exact mechanism of miR-139-5p in cancer remains unclear. In this study, the association of miR-139-5p expression with esophageal squamous cell carcinoma (ESCC) was evaluated in 106 pairs of esophageal cancer and adjacent non-cancerous tissue from ESCC patients. The tumor suppressive features of miR-139-5p were measured by evaluating cell proliferation and cell cycle state, migratory activity and invasion capability, as well as apoptosis. Luciferase reporter assay and Western blot analysis were performed to determine the target gene regulated by miR-139-5p. The mRNA level of NR5A2, the target gene of miR-139-5p, was determined in ESCC patients. Results showed that reduced miR-139-5p level was associated with lymph node metastases of ESCC. MiR-139-5p was investigated to induce cell cycle arrest in the G0/G1 phase and to suppress the invasive capability of esophageal carcinoma cells by targeting the 3'UTR of oncogenic NR5A2. Cyclin E1 and MMP9 were confirmed to participate in cell cycle arrest and invasive suppression induced by NR5A2, respectively. Pearson correlation analysis further confirmed the significantly negative correlation between miR-139-5p and NR5A2 expression. The results suggest that miR-139-5p exerts a growth-and invasiveness-suppressing function in human ESCCs, which demonstrates that miR-139-5p is a potential biomarker for early diagnosis and prognosis and is a therapeutic target for ESCC.	[Liu, Ran; Yang, Miao; Liao, Juan; Sheng, Jingyi; Pu, Yuepu; Yin, Lihong] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Meng, Yanli] Gen Hosp, North China Petr Bur, Renqiu, Peoples R China; [Kim, Sun Jung] Dongguk Univ, Dept Life Sci, Seoul, South Korea	Southeast University - China; Dongguk University	Liu, R (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.	ranliu@seu.edu.cn; sunjungk@dongguk.edu	Meng, Yan/HGC-0394-2022; kim, sun jung/T-1013-2019; ravegnini, gloria/K-1330-2016	ravegnini, gloria/0000-0002-7774-402X	National Natural Science Foundation of China [81172747, 81072259, 30800891, 81111140396]; National Research Foundation of Korea (NRF) [NRF-2011-C00056]; Natural Science Foundation of Jiangsu province, China [BK2010407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Natural Science Foundation of Jiangsu province, China(Natural Science Foundation of Jiangsu Province)	This study is supported by the National Natural Science Foundation of China (No. 81172747, 81072259, 30800891, 81111140396; http://www.nsfc.gov.cn), the National Research Foundation of Korea (NRF) Grant (NRF-2011-C00056; http://www.nrf.re.kr), and Natural Science Foundation of Jiangsu province, China (No. BK2010407; http://www.jstd.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Baquie M, 2011, HUM MOL GENET, V20, P2823, DOI 10.1093/hmg/ddr193; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benod C, 2011, P NATL ACAD SCI USA, V108, P16927, DOI 10.1073/pnas.1112047108; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Chand AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031593; Dalmay T, 2008, J INTERN MED, V263, P366, DOI 10.1111/j.1365-2796.2008.01926.x; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo HY, 2012, INT J BIOCHEM CELL B, V44, P1465, DOI 10.1016/j.biocel.2012.05.015; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Kano M, 2010, INT J CANCER, V127, P2804, DOI 10.1002/ijc.25284; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Liu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033987; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Matsushima K, 2010, DIGESTION, V82, P138, DOI 10.1159/000310918; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Wang SL, 2005, BIOCHEM BIOPH RES CO, V333, P917, DOI 10.1016/j.bbrc.2005.05.186; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23	30	56	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77068	10.1371/journal.pone.0077068	http://dx.doi.org/10.1371/journal.pone.0077068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204738	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300079
J	Schwank, G; Andersson-Rolf, A; Koo, BK; Sasaki, N; Clevers, H				Schwank, Gerald; Andersson-Rolf, Amanda; Koo, Bon-Kyoung; Sasaki, Nobuo; Clevers, Hans			Generation of BAC Transgenic Epithelial Organoids	PLOS ONE			English	Article							FLUORESCENT PROTEIN; STEM-CELLS; IN-VITRO; EXPANSION; LIFETIME	Under previously developed culture conditions, mouse and human intestinal epithelia can be cultured and expanded over long periods. These so-called organoids recapitulate the three-dimensional architecture of the gut epithelium, and consist of all major intestinal cell types. One key advantage of these ex vivo cultures is their accessibility to live imaging. So far the establishment of transgenic fluorescent reporter organoids has required the generation of transgenic mice, a laborious and time-consuming process, which cannot be extended to human cultures. Here we present a transfection protocol that enables the generation of recombinant mouse and human reporter organoids using BAC (bacterial artificial chromosome) technology.	[Schwank, Gerald; Andersson-Rolf, Amanda; Koo, Bon-Kyoung; Sasaki, Nobuo; Clevers, Hans] KNAW, Hubrecht Inst, Utrecht, Netherlands; [Schwank, Gerald; Andersson-Rolf, Amanda; Koo, Bon-Kyoung; Sasaki, Nobuo; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Andersson-Rolf, Amanda; Koo, Bon-Kyoung] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Cambridge	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Utrecht, Netherlands.	h.clevers@hubrecht.eu	Schwank, Gerald/AAE-6640-2020; Schwank, Gerald/A-8586-2018; Koo, Bon-Kyoung/V-5219-2017; Sasaki, Nobuo/HDO-8251-2022	Schwank, Gerald/0000-0003-0767-2953; Schwank, Gerald/0000-0003-0767-2953; Koo, Bon-Kyoung/0000-0002-4134-8033; Sasaki, Nobuo/0000-0002-8798-7244	European Research Council [EU/232814-StemCeLLMark]; KNAW/3V-fund; SNF [PA00P3 139732]; Human Frontiers in Science Program long-term fellowship [LT000422/2012]; National Research Foundation of Korea [NRF-2011-357-C00093]	European Research Council(European Research Council (ERC)European Commission); KNAW/3V-fund; SNF; Human Frontiers in Science Program long-term fellowship; National Research Foundation of Korea(National Research Foundation of Korea)	This work was funded by grants from the European Research Council (EU/232814-StemCeLLMark), the KNAW/3V-fund, the SNF fellowship for advanced researchers PA00P3 139732 (G. S.), the Human Frontiers in Science Program long-term fellowship LT000422/2012 (G. S.), and the National Research Foundation of Korea NRF-2011-357-C00093 (B.-K.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciotta G, METHODS, V53, P113; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Kaartinen V, 2001, GENESIS, V31, P126, DOI 10.1002/gene.10015; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Koo BK, NAT METHODS, V9, P81; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935	17	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76871	10.1371/journal.pone.0076871	http://dx.doi.org/10.1371/journal.pone.0076871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204693	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300059
J	Mowrey, DD; Liu, Q; Bondarenko, V; Chen, Q; Seyoum, E; Xu, Y; Wu, J; Tang, P				Mowrey, David D.; Liu, Qiang; Bondarenko, Vasyl; Chen, Qiang; Seyoum, Edom; Xu, Yan; Wu, Jie; Tang, Pei			Insights into Distinct Modulation of alpha 7 and alpha 7 beta 2 Nicotinic Acetylcholine Receptors by the Volatile Anesthetic Isoflurane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anesthetics; Cys-loop Receptors; Electrophysiology; Nicotinic Acetylcholine Receptors; NMR; Protein Dynamics; 7; 72; Isoflurane	GATED ION-CHANNEL; X-RAY-STRUCTURE; ALPHA-4-BETA-2 NACHR; GENERAL-ANESTHETICS; MICE LACKING; CONFORMATIONAL TRANSITIONS; TRANSMEMBRANE DOMAINS; MOLECULAR-DYNAMICS; GABA(A) RECEPTOR; AMINO-ACIDS	Background: What determines hypersensitivity or insensitivity of 2-containing or 7 nAChRs to volatile anesthetics remains unclear. Results: Isoflurane binds to the EC end of the TM domain, modulates channel dynamics, and inhibits channel current in 2 not 7. Conclusion: The dynamic and structural differences between 2 and 7 affect isoflurane binding and inhibition. Significance: Both structure and dynamics are critical for drug action. Nicotinic acetylcholine receptors (nAChRs) are targets of general anesthetics, but functional sensitivity to anesthetic inhibition varies dramatically among different subtypes of nAChRs. Potential causes underlying different functional responses to anesthetics remain elusive. Here we show that in contrast to the 7 nAChR, the 72 nAChR is highly susceptible to inhibition by the volatile anesthetic isoflurane in electrophysiology measurements. Isoflurane-binding sites in 2 and 7 were found at the extracellular and intracellular end of their respective transmembrane domains using NMR. Functional relevance of the identified 2 site was validated via point mutations and subsequent functional measurements. Consistent with their functional responses to isoflurane, 2 but not 7 showed pronounced dynamics changes, particularly for the channel gate residue Leu-249(9). These results suggest that anesthetic binding alone is not sufficient to generate functional impact; only those sites that can modulate channel dynamics upon anesthetic binding will produce functional effects.	[Mowrey, David D.; Bondarenko, Vasyl; Chen, Qiang; Seyoum, Edom; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Mowrey, David D.; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Liu, Qiang; Wu, Jie] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Tang, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, 2049 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	tangp@upmc.edu	Liu, Qiang/HHZ-3181-2022	Tang, Pei/0000-0002-2869-2737; Seyoum, Edom/0000-0003-1357-1235	National Institutes of Health Grants [R01GM56257, R01GM66358, R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056257, R01GM066358, R37GM049202] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM56257 and R01GM66358 (to P. T.) and R37GM049202 (to Y. X.).	Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2013, BBA-BIOMEMBRANES, V1828, P398, DOI 10.1016/j.bbamem.2012.09.014; Bondarenko V, 2012, BBA-BIOMEMBRANES, V1818, P1261, DOI 10.1016/j.bbamem.2012.02.008; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Dascal N., 2001, CURR PROTOC NEUROSCI; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Downie DL, 2002, J BIOL CHEM, V277, P10367, DOI 10.1074/jbc.M107847200; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Flood P, 1997, ANESTHESIOLOGY, V86, P859, DOI 10.1097/00000542-199704000-00016; Flood P, 2002, ANESTH ANALG, V95, P83, DOI 10.1097/00000539-200207000-00015; Goddard T. D., 2001, SPARKY 3; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Khiroug SS, 2002, J PHYSIOL-LONDON, V540, P425, DOI 10.1113/jphysiol.2001.013847; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Liu LT, 2010, J PHYS CHEM B, V114, P626, DOI 10.1021/jp908944e; Liu LT, 2009, J PHYS CHEM B, V113, P12581, DOI 10.1021/jp9039513; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; LYU PC, 1991, P NATL ACAD SCI USA, V88, P5317, DOI 10.1073/pnas.88.12.5317; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; Mittermaier AK, 2009, TRENDS BIOCHEM SCI, V34, P601, DOI 10.1016/j.tibs.2009.07.004; Mori T, 2001, MOL PHARMACOL, V59, P732, DOI 10.1124/mol.59.4.732; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Mowrey D, 2010, J PHYS CHEM B, V114, P7649, DOI 10.1021/jp1009675; Mowrey DD, 2013, STRUCTURE, V21, P1897, DOI 10.1016/j.str.2013.07.014; Nickalls RWD, 2003, BRIT J ANAESTH, V91, P170, DOI 10.1093/bja/aeg132; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Palma E, 1999, J BIOL CHEM, V274, P18335, DOI 10.1074/jbc.274.26.18335; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Varga Z, 2005, INT J QUANTUM CHEM, V105, P302, DOI 10.1002/qua.20706; Velisetty P, 2012, J BIOL CHEM, V287, P36864, DOI 10.1074/jbc.M112.401067; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu J, 2004, J PHARMACOL EXP THER, V311, P80, DOI 10.1124/jpet.104.070417; Xu W, 1999, J NEUROSCI, V19, P9298; Xu Y, 2000, BIOPHYS J, V78, P746, DOI 10.1016/S0006-3495(00)76632-X; Yamashita M, 2005, ANESTHESIOLOGY, V102, P76, DOI 10.1097/00000542-200501000-00015; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p; Zhao LK, 2003, J PHARMACOL EXP THER, V305, P1132, DOI 10.1124/jpet.103.048777	55	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35793	35800		10.1074/jbc.M113.508333	http://dx.doi.org/10.1074/jbc.M113.508333			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24194515	hybrid, Green Published			2022-12-25	WOS:000329814700017
J	Chen, DB; Gao, H; Lu, LY; Zhou, T				Chen, Duan-Bing; Gao, Hui; Lu, Linyuan; Zhou, Tao			Identifying Influential Nodes in Large-Scale Directed Networks: The Role of Clustering	PLOS ONE			English	Article							COMPLEX NETWORKS; LINK PREDICTION; CENTRALITY; DYNAMICS	Identifying influential nodes in very large-scale directed networks is a big challenge relevant to disparate applications, such as accelerating information propagation, controlling rumors and diseases, designing search engines, and understanding hierarchical organization of social and biological networks. Known methods range from node centralities, such as degree, closeness and betweenness, to diffusion-based processes, like PageRank and LeaderRank. Some of these methods already take into account the influences of a node's neighbors but do not directly make use of the interactions among it's neighbors. Local clustering is known to have negative impacts on the information spreading. We further show empirically that it also plays a negative role in generating local connections. Inspired by these facts, we propose a local ranking algorithm named ClusterRank, which takes into account not only the number of neighbors and the neighbors' influences, but also the clustering coefficient. Subject to the susceptible-infected-recovered (SIR) spreading model with constant infectivity, experimental results on two directed networks, a social network extracted from delicious.com and a large-scale short-message communication network, demonstrate that the ClusterRank outperforms some benchmark algorithms such as PageRank and LeaderRank. Furthermore, ClusterRank can also be applied to undirected networks where the superiority of ClusterRank is significant compared with degree centrality and k-core decomposition. In addition, ClusterRank, only making use of local information, is much more efficient than global methods: It takes only 191 seconds for a network with about 107 nodes, more than 15 times faster than PageRank.	[Chen, Duan-Bing; Gao, Hui; Zhou, Tao] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Web Sci Ctr, Chengdu 610054, Peoples R China; [Lu, Linyuan] Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China; [Chen, Duan-Bing] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland	University of Electronic Science & Technology of China; Hangzhou Normal University; University of Fribourg	Lu, LY (corresponding author), Hangzhou Normal Univ, Alibaba Business Coll, Inst Informat Econ, Hangzhou, Zhejiang, Peoples R China.	linyuan.lue@unifr.ch	zhou, tao/GQA-3572-2022	Zhou, Tao/0000-0003-0561-2316	National Natural Science Foundation of China [11222543, 90924011, 60903073, 11205042]; International Scientific Cooperation and Communication Project of Sichuan Province in China [2010HH0002]; Huawei university-enterprise cooperation [YBCB2011057]; Hangzhou Normal University [2011QDL29, 2011QDL31]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Scientific Cooperation and Communication Project of Sichuan Province in China; Huawei university-enterprise cooperation(Huawei Technologies); Hangzhou Normal University	This work was partially supported by the National Natural Science Foundation of China under Grant Nos. 11222543, 90924011, 60903073 and 11205042, and the International Scientific Cooperation and Communication Project of Sichuan Province in China under Grant No. 2010HH0002. D. B. C. acknowledges the Huawei university-enterprise cooperation project YBCB2011057. L. L. acknowledges the research start-up fund of Hangzhou Normal University under Grant Nos. 2011QDL29 and 2011QDL31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chen DB, 2013, ARXIV13057480; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Ding LJ, 2011, KYBERNETES, V40, P814, DOI 10.1108/03684921111142359; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Feng X, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20207-x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Galan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020474; Jiang LL, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/40001; Kim H, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026107; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Li Q, 2013, ARXIV13065042; Liu Z, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/48007; Lu LY, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/12/123005; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Masuda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025190; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Petermann T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066116; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Saito K, 2012, KNOWL INF SYST, V30, P613, DOI 10.1007/s10115-011-0396-2; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Vespignani A, 2012, NAT PHYS, V8, P32, DOI 10.1038/nphys2160; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei DJ, 2013, PHYSICA A, V392, P2564, DOI 10.1016/j.physa.2013.01.054; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Wu XA, 2006, CHINESE PHYS LETT, V23, P1046, DOI 10.1088/0256-307X/23/4/079; Wu XJ, 2011, PHYS LETT A, V375, P1559, DOI 10.1016/j.physleta.2011.02.052; Yang HX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.045101; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; Zhang XH, 2013, KNOWL-BASED SYST, V42, P74, DOI 10.1016/j.knosys.2013.01.017; Zhang YL, 2011, IEEE INT CONF TRUST, P1512, DOI [10.1109/TrastCom.2011.209, 10.1109/TrustCom.2011.209]; Zhou T, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046141; Zhou T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.056109; Zhou T, 2006, PROG NAT SCI-MATER, V16, P452; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033	50	227	250	19	172	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2013	8	10							e77455	10.1371/journal.pone.0077455	http://dx.doi.org/10.1371/journal.pone.0077455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	244FY	24204833	Green Published, gold			2022-12-25	WOS:000326373800001
J	Danovi, D; Folarin, A; Gogolok, S; Ender, C; Elbatsh, AMO; Engstrom, PG; Stricker, SH; Gagrica, S; Georgian, A; Yu, D; U, KP; Harvey, KJ; Ferretti, P; Paddison, PJ; Preston, JE; Abbott, NJ; Bertone, P; Smith, A; Pollard, SM				Danovi, Davide; Folarin, Amos; Gogolok, Sabine; Ender, Christine; Elbatsh, Ahmed M. O.; Engstroem, Paer G.; Stricker, Stefan H.; Gagrica, Sladjana; Georgian, Ana; Yu, Ding; U, Kin Pong; Harvey, Kevin J.; Ferretti, Patrizia; Paddison, Patrick J.; Preston, Jane E.; Abbott, N. Joan; Bertone, Paul; Smith, Austin; Pollard, Steven M.			A High-Content Small Molecule Screen Identifies Sensitivity of Glioblastoma Stem Cells to Inhibition of Polo-Like Kinase 1	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; INTEGRATED GENOMIC ANALYSIS; CENTRAL-NERVOUS-SYSTEM; BRAIN-BARRIER MODEL; IMAGE-BASED SCREENS; CANCER-CELLS; ADHERENT CULTURE; HUMAN GLIOMAS; SOLID TUMORS; PHASE-I	Glioblastoma multiforme (GBM) is the most common primary brain cancer in adults and there are few effective treatments. GBMs contain cells with molecular and cellular characteristics of neural stem cells that drive tumour growth. Here we compare responses of human glioblastoma-derived neural stem (GNS) cells and genetically normal neural stem (NS) cells to a panel of 160 small molecule kinase inhibitors. We used live-cell imaging and high content image analysis tools and identified JNJ-10198409 (J101) as an agent that induces mitotic arrest at prometaphase in GNS cells but not NS cells. Antibody microarrays and kinase profiling suggested that J101 responses are triggered by suppression of the active phosphorylated form of polo-like kinase 1 (Plk1) (phospho T210), with resultant spindle defects and arrest at prometaphase. We found that potent and specific Plk1 inhibitors already in clinical development (BI 2536, BI 6727 and GSK 461364) phenocopied J101 and were selective against GNS cells. Using a porcine brain endothelial cell blood-brain barrier model we also observed that these compounds exhibited greater blood-brain barrier permeability in vitro than J101. Our analysis of mouse mutant NS cells (INK4a/ARF(-/-), or p53(-/-)), as well as the acute genetic deletion of p53 from a conditional p53 floxed NS cell line, suggests that the sensitivity of GNS cells to BI 2536 or J101 may be explained by the lack of a p53-mediated compensatory pathway. Together these data indicate that GBM stem cells are acutely susceptible to proliferative disruption by Plk1 inhibitors and that such agents may have immediate therapeutic value.	[Danovi, Davide; Folarin, Amos; Gogolok, Sabine; Ender, Christine; Elbatsh, Ahmed M. O.; Stricker, Stefan H.; Gagrica, Sladjana; Pollard, Steven M.] UCL, UCL Canc Inst, Samantha Dickson Brain Canc Unit, London, England; [Danovi, Davide; Folarin, Amos; Gogolok, Sabine; Ender, Christine; Elbatsh, Ahmed M. O.; Stricker, Stefan H.; Gagrica, Sladjana; Pollard, Steven M.] UCL, UCL Canc Inst, Dept Canc Biol, London, England; [Engstroem, Paer G.; Bertone, Paul] European Mol Biol Lab, European Bioinformat Inst, Cambridge, England; [Georgian, Ana; Preston, Jane E.; Abbott, N. Joan] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England; [Yu, Ding; Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98104 USA; [Harvey, Kevin J.] EMD Millipore Corp, San Diego, CA USA; [U, Kin Pong; Ferretti, Patrizia] UCL, Inst Child Hlth, London, England; [Bertone, Paul] European Mol Biol Lab, Genome Biol Unit, D-69012 Heidelberg, Germany; [Bertone, Paul] European Mol Biol Lab, Dev Biol Unit, D-69012 Heidelberg, Germany; [Bertone, Paul; Smith, Austin] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, England	University of London; University College London; University of London; University College London; European Molecular Biology Laboratory (EMBL); University of London; King's College London; Fred Hutchinson Cancer Center; Merck KGaA; MilliporeSigma; University of London; University College London; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Cambridge	Pollard, SM (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	steven.pollard@ed.ac.uk	Stricker, Stefan H/A-4930-2015; Ferretti, Patrizia/E-9375-2010; Folarin, Amos/AAD-5525-2020; Bertone, Paul/A-6600-2013; Bertone, Paul/Z-3734-2019; Ding, Yu/A-2949-2013; Danovi, Davide/P-2874-2019; Pollard, Steven/B-7966-2010	Stricker, Stefan H/0000-0002-5488-8530; Ferretti, Patrizia/0000-0002-3590-6772; Folarin, Amos/0000-0002-0333-1927; Bertone, Paul/0000-0001-5059-4829; Bertone, Paul/0000-0001-5059-4829; Danovi, Davide/0000-0003-4119-5337; Preston, Jane/0000-0002-8018-9637; Smith, Austin/0000-0002-3029-4682; Pollard, Steven/0000-0001-6428-0492; Harvey, Kevin/0000-0002-4479-1575; Engstrom, Par/0000-0001-5265-2121	EC; EMBL; Cancer Research UK; Children with Cancer; Brain Tumour Charity; FP7 Marie Curie Intra-European Fellowship; Alex Bolt Research Fellowship; Medical Research Council [MC_PC_12009, G1001028, G1100526] Funding Source: researchfish; The Brain Tumour Charity [8/105] Funding Source: researchfish; MRC [G1001028] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); EMBL; Cancer Research UK(Cancer Research UK); Children with Cancer; Brain Tumour Charity; FP7 Marie Curie Intra-European Fellowship; Alex Bolt Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Brain Tumour Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the EC-funded STREP project 'Neuroscreen,' EMBL, and grants from Cancer Research UK, Children with Cancer, and The Brain Tumour Charity. CE was supported by a FP7 Marie Curie Intra-European Fellowship. AS is an MRC Professor. SP was supported by an Alex Bolt Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Danovi D, 2012, METHOD ENZYMOL, V506, P311, DOI 10.1016/B978-0-12-391856-7.00040-8; Degenhardt Y, 2010, MOL CANCER THER, V9, P2079, DOI 10.1158/1535-7163.MCT-10-0095; Dietzmann K, 2001, J NEURO-ONCOL, V53, P1, DOI 10.1023/A:1011808200978; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Grinshtein N, 2011, CANCER RES, V71, P1385, DOI 10.1158/0008-5472.CAN-10-2484; He J, 2001, J NEUROPATH EXP NEUR, V60, P863, DOI 10.1093/jnen/60.9.863; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Masica DL, 2011, CANCER RES, V71, P4550, DOI 10.1158/0008-5472.CAN-11-0180; Moralli D, 2011, STEM CELL REV REP, V7, P471, DOI 10.1007/s12015-010-9224-4; Olmos D, 2011, CLIN CANCER RES, V17, P3420, DOI 10.1158/1078-0432.CCR-10-2946; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Patabendige A, 2013, BRAIN RES, V1521, P16, DOI 10.1016/j.brainres.2013.04.006; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Schoffski P, 2010, EUR J CANCER, V46, P2206, DOI 10.1016/j.ejca.2010.03.039; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Stricker SH, 2013, GENE DEV, V27, P654, DOI 10.1101/gad.212662.112; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Szczurek E, 2013, INT J CANCER, V133, P2123, DOI 10.1002/ijc.28235; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yan T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-524; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	54	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77053	10.1371/journal.pone.0077053	http://dx.doi.org/10.1371/journal.pone.0077053			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204733	Green Published, gold, Green Submitted			2022-12-25	WOS:000326334500014
J	Fischer, J; Bohm, S; Muller, T; Witt, H; Sarrazin, C; Susser, S; Migaud, P; Schott, E; Stewart, G; Brodzinski, A; Fulop, B; van Bommel, F; George, J; Berg, T				Fischer, Janett; Boehm, Stephan; Mueller, Tobias; Witt, Heiko; Sarrazin, Christoph; Susser, Simone; Migaud, Pascal; Schott, Eckart; Stewart, Graeme; Brodzinski, Annika; Fueloep, Balazs; van Boemmel, Florian; George, Jacob; Berg, Thomas			Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; GENETIC-VARIATION; INTERLEUKIN 28B; IL28B GENOTYPE; SPONTANEOUS CLEARANCE; SERUM-CHOLESTEROL; TREATMENT FAILURE; EXPRESSION; RIBAVIRIN	Background & Aims: Genetic variations near the interferon lambda 3 gene (IFNL3, IL28B) are the most powerful predictors for sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) infection, compared to other biochemical or histological baseline parameters. We evaluated whether the interplay of both IFNL3 polymorphisms rs12979860 and rs8099917 together with non-genetic clinical factors contributes to the predictive role of these genetic variants. Methods: The cohort comprised 1,402 patients of European descent with chronic HCV type 1 infection. 1,298 patients received interferon-based antiviral therapy, and 719 (55%) achieved SVR. The IFNL3 polymorphisms were genotyped by polymerase chain reaction and melting curve analysis. Results: A significant correlation was found between the IFNL3 polymorphisms and biochemical as well as virologic predictors of treatment outcome such as ALT, GGT, cholesterol, and HCV RNA levels. In multivariate regression analysis, IFLN3 SNPs, HCV RNA levels, and the GGT/ALT ratio were independent predictors of SVR. Dependent on the GGT/ALT ratio and on the HCV RNA concentration, significant variations in the likelihood for achieving SVR were observed in both, carriers of the responder as well as non-responder alleles. Conclusions: Our data support a clear association between IFNL3 genotypes and baseline parameters known to impact interferon responsiveness. Improved treatment outcome prediction was achieved when these predictors were considered in combination with the IFNL3 genotype.	[Fischer, Janett; Boehm, Stephan; Mueller, Tobias; Brodzinski, Annika; Fueloep, Balazs; van Boemmel, Florian; Berg, Thomas] Univ Klinikum Leipzig, Sekt Hepatol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany; [Witt, Heiko] Tech Univ Munich, Kinderklin Schwabing, D-80290 Munich, Germany; [Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum EKFZ Munich, D-80290 Munich, Germany; [Sarrazin, Christoph; Susser, Simone] JW Goethe Univ Hosp, Med Klin 1, Frankfurt, Germany; [Migaud, Pascal; Schott, Eckart] Univ Hosp Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, Berlin, Germany; [Stewart, Graeme] Westmead Hosp, Inst Immunol & Allergy Res, Westmead, NSW, Australia; [Stewart, Graeme; George, Jacob] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia; [George, Jacob] Westmead Hosp, Storr Liver Unit, Westmead, NSW, Australia	Leipzig University; Technical University of Munich; Technical University of Munich; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Fischer, J (corresponding author), Univ Klinikum Leipzig, Sekt Hepatol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany.	janett.fischer@medizin.uni-leipzig.de	George, jacob/P-1496-2014	Berg, Thomas/0000-0003-0003-6241; Mueller, Tobias/0000-0003-3426-5421; Migaud, Pascal/0000-0002-5659-9345	German Competence Network for Viral Hepatitis (Hep-Net); German Ministry of Education and Research (BMBF) [01 KI 0437, 10.1.3, 10.1, 01KI0787]; EU-Vigilance network of excellence combating viral resistance (VIRGIL) [LSHM-CT-2004-503359]; Australian Research Council Linkage Project Grant [LPO0990067]; National Health and Medical Research Council Grant [1006759]; Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney	German Competence Network for Viral Hepatitis (Hep-Net); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); EU-Vigilance network of excellence combating viral resistance (VIRGIL); Australian Research Council Linkage Project Grant(Australian Research Council); National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney	This work was supported by the German Competence Network for Viral Hepatitis (Hep-Net), funded by the German Ministry of Education and Research (BMBF, grant number 01 KI 0437, project number 10.1.3 and Core Project number 10.1, grant number 01KI0787), by the EU-Vigilance network of excellence combating viral resistance (VIRGIL, project number LSHM-CT-2004-503359). Parts of the work were supported by an Australian Research Council Linkage Project Grant (LPO0990067), a National Health and Medical Research Council Grant (1006759) and the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MED VIROL, V83, P1597, DOI 10.1002/jmv.22158; Akuta N, 2012, INTERVIROLOGY, V55, P417, DOI 10.1159/000323526; Amanzada A, 2012, DIGESTION, V86, P218, DOI 10.1159/000339879; Asahina Y, 2012, HEPATOLOGY, V55, P20, DOI 10.1002/hep.24623; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berg T, 2003, HEPATOLOGY, V37, P600, DOI 10.1053/jhep.2003.50106; Berg T, 2011, HEPATOLOGY, V54, p375A; Berg T, 2009, HEPATOLOGY, V50, P369, DOI 10.1002/hep.22991; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Booth D, 2013, NAT GENET, V45, P119, DOI 10.1038/ng.2537; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cho O, 2010, CYTOKINE, V51, P93, DOI 10.1016/j.cyto.2010.03.004; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Everhart JE, 2013, HEPATOLOGY, V57, P1725, DOI 10.1002/hep.26203; Fabris C, 2012, J MED VIROL, V84, P747, DOI 10.1002/jmv.23259; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Heim MH, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13586; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jacobson IM, 2012, J VIRAL HEPATITIS, V19, P1, DOI 10.1111/j.1365-2893.2012.01590.x; Ladero JM, 2012, J GASTROEN HEPATOL, V27, P279, DOI 10.1111/j.1440-1746.2011.06834.x; LARNER AC, 1986, J BIOL CHEM, V261, P453; Lupberger J, 2013, HEPATOLOGY, V58, P1225, DOI [10.1002/hep.26443, 10.1002/hep.26404]; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mirza S, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-71; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petta S, 2012, ANTIVIR THER, V17, P823, DOI 10.3851/IMP2100; Petta S, 2012, J HEPATOL, V56, P1356, DOI 10.1016/j.jhep.2012.01.007; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; SCHECTMAN G, 1992, ARTERIOSCLER THROMB, V12, P1053, DOI 10.1161/01.ATV.12.9.1053; Sheridan DA, 2013, CLIN RES HEPATOL GAS, V37, P10, DOI 10.1016/j.clinre.2012.07.002; Shiffman ML, 2012, LIVER INT, V32, P54, DOI 10.1111/j.1478-3231.2011.02718.x; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Sulkowski MS, 2011, HEPATOLOGY, V54, p473A; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2012, HEPATOLOGY, V56, P373, DOI 10.1002/hep.25792; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Weich V, 2011, J GASTROENTEROL, V46, P1427, DOI 10.1007/s00535-011-0458-y; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	52	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77530	10.1371/journal.pone.0077530	http://dx.doi.org/10.1371/journal.pone.0077530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204859	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700035
J	Silal, SP; Barnes, KI; Kok, G; Mabuza, A; Little, F				Silal, Sheetal Prakash; Barnes, Karen I.; Kok, Gerdalize; Mabuza, Aaron; Little, Francesca			Exploring the Seasonality of Reported Treated Malaria Cases in Mpumalanga, South Africa	PLOS ONE			English	Article							CLIMATE-CHANGE; PROVINCE; TRANSMISSION	South Africa, having met the World Health Organisation's pre-elimination criteria, has set a goal to achieve malaria elimination by 2018. Mpumalanga, one of three provinces where malaria transmission still occurs, has a malaria season subject to unstable transmission that is prone to sporadic outbreaks. As South Africa prepares to intensify efforts towards malaria elimination, there is a need to understand patterns in malaria transmission so that efforts may be targeted appropriately. This paper describes the seasonality of transmission by exploring the relationship between malaria cases and three potential drivers: rainfall, geography (physical location) and the source of infection (local/imported). Seasonal decomposition of the time series by Locally estimated scatterplot smoothing is applied to the case data for the geographical and source of infection sub-groups. The relationship between cases and rainfall is assessed using a cross-correlation analysis. The malaria season was found to have a short period of no/low level of reported cases and a triple peak in reported cases between September and May; the three peaks occurring in October, January and May. The seasonal pattern of locally-sourced infection mimics the triple-peak characteristic of the total series while imported infections contribute mostly to the second and third peak of the season (Christmas and Easter respectively). Geographically, Bushbuckridge municipality, which exhibits a different pattern of cases, contributed mostly to the first and second peaks in cases while Maputo province (Mozambique) experienced a similar pattern in transmission to the imported cases. Though rainfall lagged at 4 weeks was significantly correlated with malaria cases, this effect was dampened due to the growing proportion of imported cases since 2006. These findings may be useful as they enhance the understanding of the current incidence pattern and may inform mathematical models that enable one to predict the impact changes in these drivers will have on malaria transmission.	[Silal, Sheetal Prakash; Little, Francesca] Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa; [Barnes, Karen I.] Univ Cape Town, Div Clin Pharmacol, Dept Med, ZA-7925 Cape Town, South Africa; [Kok, Gerdalize; Mabuza, Aaron] Mpumalanga Dept Hlth, Malaria Eliminat Programme, Nelspruit, South Africa	University of Cape Town; University of Cape Town	Silal, SP (corresponding author), Univ Cape Town, Dept Stat Sci, ZA-7925 Cape Town, South Africa.	Sheetal.Silal@uct.ac.za	Silal, Sheetal/O-5991-2015; Silal, Sheetal/AAB-1873-2020	Silal, Sheetal/0000-0002-3007-5383; Silal, Sheetal/0000-0002-3007-5383; Little, Francesca/0000-0002-5917-9928	National Research Foundation (NRF) in South Africa	National Research Foundation (NRF) in South Africa(National Research Foundation - South Africa)	This material is based upon work supported financially by the Thuthuka Grant from the National Research Foundation (NRF) in South Africa. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the NRF does not accept any liability in regard thereto (www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R PROJECT STAT COMPU; [Anonymous], 2013, STATA DATA ANAL STAT; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Blumberg L, 2007, MALARIA CONTROL S AF; Brockwell P.J., 2009, TIME SERIES THEORY M; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Govere J, 2000, AFR ENTOMOL, V8, P91; Govere JM, 2001, S AFR J SCI, V97, P55; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Mabuza A, 2005, S AFRICAN MED J, V95; Maharaj R, 2012, MALARIA J, V11, DOI [10.1186/1475-2875-11-320, 10.1186/1475-2875-11-423]; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Pankratz A., 1991, FORECASTING DYNAMIC; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sharp B, 2001, TECHNICAL REPORT; Sharp BL, 1996, S AFR MED J, V86, P83; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; South Africa National Department of Health, 2011, TECHNICAL REPORT; South Africa National Department of Health, 2010, TECHNICAL REPORT; Statistics South Africa, 2011, TECHNICAL REPORT; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Tumwiine J, 2010, J MATH ANAL APPL, V361, P139, DOI 10.1016/j.jmaa.2009.09.005; WHO, 2012, WHO FACTSH WORLD MAL; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	28	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76640	10.1371/journal.pone.0076640	http://dx.doi.org/10.1371/journal.pone.0076640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204650	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700009
J	Esposito, A; Popleteeva, M; Venkitaraman, AR				Esposito, Alessandro; Popleteeva, Marina; Venkitaraman, Ashok R.			Maximizing the Biochemical Resolving Power of Fluorescence Microscopy	PLOS ONE			English	Article							PHOTON ECONOMY; SEPARATION; SPEED	Most recent advances in fluorescence microscopy have focused on achieving spatial resolutions below the diffraction limit. However, the inherent capability of fluorescence microscopy to non-invasively resolve different biochemical or physical environments in biological samples has not yet been formally described, because an adequate and general theoretical framework is lacking. Here, we develop a mathematical characterization of the biochemical resolution in fluorescence detection with Fisher information analysis. To improve the precision and the resolution of quantitative imaging methods, we demonstrate strategies for the optimization of fluorescence lifetime, fluorescence anisotropy and hyperspectral detection, as well as different multi-dimensional techniques. We describe optimized imaging protocols, provide optimization algorithms and describe precision and resolving power in biochemical imaging thanks to the analysis of the general properties of Fisher information in fluorescence detection. These strategies enable the optimal use of the information content available within the limited photon-budget typically available in fluorescence microscopy. This theoretical foundation leads to a generalized strategy for the optimization of multi-dimensional optical detection, and demonstrates how the parallel detection of all properties of fluorescence can maximize the biochemical resolving power of fluorescence microscopy, an approach we term Hyper Dimensional Imaging Microscopy (HDIM). Our work provides a theoretical framework for the description of the biochemical resolution in fluorescence microscopy, irrespective of spatial resolution, and for the development of a new class of microscopes that exploit multi-parametric detection systems.	[Esposito, Alessandro; Popleteeva, Marina; Venkitaraman, Ashok R.] Univ Cambridge, MRC, Canc Unit, Cambridge, England	University of Cambridge	Esposito, A (corresponding author), Univ Cambridge, MRC, Canc Unit, Cambridge, England.	ae275@hutchison-mrc.cam.ac.uk	Esposito, Alessandro/A-8536-2008	Esposito, Alessandro/0000-0002-5051-091X	United Kingdom Medical Research Council; MRC [G1001522, MC_UU_12022/8, MC_UU_12022/1, MC_U105359877, G1001521] Funding Source: UKRI; Medical Research Council [MC_UU_12022/8, MC_U105359877, MC_UU_12022/1, G1001521, G1001522] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in ARV's laboratory by the United Kingdom Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; BALLEW RM, 1991, ANAL CHIM ACTA, V245, P121, DOI 10.1016/S0003-2670(00)80210-X; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Becker W, 2003, PROC SPIE, V4963, P175, DOI 10.1117/12.472866; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Becker W., 2004, P SOC PHOTO-OPT INS, V5223, P1; Chan SP, 2001, ANAL CHEM, V73, P4486, DOI 10.1021/ac0102361; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Draaijer A., 1995, P491; Esposito A, 2005, OPT EXPRESS, V13; Esposito A., 2007, STANDARDIZATION FLUO; Esposito A., 2004, CURRENT PROTOCOLS CE; Esposito A, 2007, J OPT SOC AM A, V24, P3261, DOI 10.1364/JOSAA.24.003261; Esposito A, 2011, OPT EXPRESS, V19, P2546, DOI 10.1364/OE.19.002546; Fereidouni F, 2012, OPT EXPRESS, V20, P12729, DOI 10.1364/OE.20.012729; Gerritsen H. C., 2009, FRET FLIM IMAGING TE; Gerritsen HC, 2002, J MICROSC-OXFORD, V206, P218, DOI 10.1046/j.1365-2818.2002.01031.x; GOOD HP, 1984, J PHYS CHEM-US, V88, P5435, DOI 10.1021/j150666a066; Gratton E, 2003, J BIOMEDICAL OPTICS, V8; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; KOLLNER M, 1992, CHEM PHYS LETT, V200, P199, DOI 10.1016/0009-2614(92)87068-Z; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Li DDU, 2012, SENSORS-BASEL, V12, P5650, DOI 10.3390/s120505650; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Mukamel EA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168102; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Neher RA, 2009, BIOPHYS J, V96, P3791, DOI 10.1016/j.bpj.2008.10.068; O'Connor D. V., 1984, TIME CORRELATED SING; Palero JA, 2006, OPT EXPRESS, V14, P4395, DOI 10.1364/OE.14.004395; Pancheri L, 2009, PROC EUR SOLID-STATE, P429; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Watkins LP, 2004, BIOPHYS J, V86, P4015, DOI 10.1529/biophysj.103.037739	33	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2013	8	10							e77392	10.1371/journal.pone.0077392	http://dx.doi.org/10.1371/journal.pone.0077392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KW	24204821	Green Submitted, Green Published, gold			2022-12-25	WOS:000326241200027
J	Alvarez, ML; Khosroheidari, M; Eddy, E; Kiefer, J				Alvarez, M. Lucrecia; Khosroheidari, Mahdieh; Eddy, Elena; Kiefer, Jeff			Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA Pvt1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SMAD PROTEINS; PHYSICAL INTERACTION; INTRONIC MICRORNAS; MESSENGER-RNAS; HUMAN-CELLS; HB-EGF; BETA; KINASE; EXPRESSION	Diabetic nephropathy is the most common cause of chronic kidney failure and end-stage renal disease in the Western World. One of the major characteristics of this disease is the excessive accumulation of extracellular matrix (ECM) in the kidney glomeruli. While both environmental and genetic determinants are recognized for their role in the development of diabetic nephropathy, epigenetic factors, such as DNA methylation, long non-coding RNAs, and microRNAs, have also recently been found to underlie some of the biological mechanisms, including ECM accumulation, leading to the disease. We previously found that a long non-coding RNA, the plasmacytoma variant translocation 1 (PVT1), increases plasminogen activator inhibitor 1 (PAI-1) and transforming growth factor beta 1 (TGF-beta 1) in mesangial cells, the two main contributors to ECM accumulation in the glomeruli under hyperglycemic conditions, as well as fibronectin 1 (FN1), a major ECM component. Here, we report that miR-1207-5p, a PVT1-derived microRNA, is abundantly expressed in kidney cells, and is upregulated by glucose and TGF-beta 1. We also found that like PVT1, miR-1207-5p increases expression of TGF-beta 1, PAI-1, and FN1 but in a manner that is independent of its host gene. In addition, regulation of miR-1207-5p expression by glucose and TGF beta 1 is independent of PVT1. These results provide evidence supporting important roles for miR-1207-5p and its host gene in the complex pathogenesis of diabetic nephropathy.	[Alvarez, M. Lucrecia; Khosroheidari, Mahdieh; Eddy, Elena; Kiefer, Jeff] Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ USA	Translational Genomics Research Institute	Alvarez, ML (corresponding author), Translat Genom Res Inst, Diabet Cardiovasc & Metab Dis Ctr, Phoenix, AZ USA.	lucrecia.alvarez@asu.edu	Jeff/ABB-2636-2021	Jeff/0000-0002-1238-3120	American Diabetes Association	American Diabetes Association(American Diabetes Association)	This work was funded by the American Diabetes Association (http://www.diabetes.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ML, 2013, DIABETOLOGIA, V56, P444, DOI 10.1007/s00125-012-2768-x; Alvarez ML, 2013, DIABETES RES CLIN PR, V99, P1, DOI 10.1016/j.diabres.2012.10.010; Alvarez ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018671; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Deshpande SD, 2013, DIABETES; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao X, 2012, IUBMB LIFE, V64, P835, DOI 10.1002/iub.1079; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Ha H, 2003, J AM SOC NEPHROL, V14, pS246, DOI 10.1097/01.ASN.0000077411.98742.54; Hanson RL, 2007, DIABETES, V56, P975, DOI 10.2337/db06-1072; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Huang CM, 2002, DIABETES, V51, P3577, DOI 10.2337/diabetes.51.12.3577; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Kato M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003389; Kato M, 2012, EXP CELL RES, V318, P993, DOI 10.1016/j.yexcr.2012.02.034; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Langlois MA, 2005, J BIOL CHEM, V280, P16949, DOI 10.1074/jbc.M501591200; Lee HB, 2005, NEPHROLOGY, V10, pS11, DOI 10.1111/j.1440-1797.2005.00449.x; Lee HB, 2003, J AM SOC NEPHROL, V14, pS241, DOI 10.1097/01.ASN.0000077410.66390.0F; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Millis MP, 2007, DIABETES, V56, P3027, DOI 10.2337/db07-0675; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; NELSON RG, 1995, DIABETES CARE, V18, P182, DOI 10.2337/diacare.18.2.182; Ng DPK, 2005, CURR MOL MED, V5, P509, DOI 10.2174/1566524054553504; Ng YY, 2005, KIDNEY INT, V67, pS83, DOI 10.1111/j.1523-1755.2005.09421.x; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Ravid M, 1998, ARCH INTERN MED, V158, P998, DOI 10.1001/archinte.158.9.998; Reddy MA, 2011, J AM SOC NEPHROL, V22, P2182, DOI 10.1681/ASN.2011060629; Reeves WB, 2000, P NATL ACAD SCI USA, V97, P7667, DOI 10.1073/pnas.97.14.7667; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Thomas MC, 2012, CURR OPIN NEPHROL HY, V21, P195, DOI 10.1097/MNH.0b013e328350313e; Treiber T, 2010, MOL CELL, V39, P315, DOI 10.1016/j.molcel.2010.07.020; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Yan B, 2012, DNA CELL BIOL, V31, pS34, DOI 10.1089/dna.2011.1544; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou L, 2010, J AM SOC NEPHROL, V21, P31, DOI 10.1681/ASN.2008111133	57	118	138	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77468	10.1371/journal.pone.0077468	http://dx.doi.org/10.1371/journal.pone.0077468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204837	Green Published, Green Submitted, gold			2022-12-25	WOS:000326155400038
J	Dhooghe, B; Noel, S; Bouzin, C; Behets-Wydemans, G; Leal, T				Dhooghe, Barbara; Noel, Sabrina; Bouzin, Caroline; Behets-Wydemans, Gaetane; Leal, Teresinha			Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RECEPTOR-MEDIATED ENDOCYTOSIS; NASAL POTENTIAL DIFFERENCE; PHOSPHODIESTERASE-5 INHIBITORS; LUNG INFLAMMATION; WILD-TYPE; MOUSE; DELTA-F508-CFTR; GENE; F508DEL-CFTR	Although lung disease is the major cause of mortality in cystic fibrosis (CF), gastrointestinal (GI) manifestations are the first hallmarks in 15-20% of affected newborns presenting with meconium ileus, and remain major causes of morbidity throughout life. We have previously shown that cGMP-dependent phosphodiesterase type 5 (PDE5) inhibitors rescue defective CF Transmembrane conductance Regulator (CFTR)-dependent chloride transport across the mouse CF nasal mucosa. Using F508del-CF mice, we examined the transrectal potential difference 1 hour after intraperitoneal injection of the PDE5 inhibitor vardenafil or saline to assess the amiloride-sensitive sodium transport and the chloride gradient and forskolin-dependent chloride transport across the GI tract. In the same conditions, we performed immunohistostaining studies in distal colon to investigate CFTR expression and localization. F508del-CF mice displayed increased sodium transport and reduced chloride transport compared to their wild-type littermates. Vardenafil, applied at a human therapeutic dose (0.14 mg/kg) used to treat erectile dysfunction, increased chloride transport in F508del-CF mice. No effect on sodium transport was detected. In crypt colonocytes of wild-type mice, the immunofluorescence CFTR signal was mostly detected in the apical cell compartment. In F508del-CF mice, a 25% reduced signal was observed, located mostly in the subapical region. Vardenafil increased the peak of intensity of the fluorescence CFTR signal in F508del-CF mice and displaced it towards the apical cell compartment. Our findings point out the intestinal mucosa as a valuable tissue to study CFTR transport function and localization and to evaluate efficacy of therapeutic strategies in CF. From our data we conclude that vardenafil mediates potentiation of the CFTR chloride channel and corrects mislocalization of the mutant protein. The study provides compelling support for targeting the cGMP signaling pathway in CF pharmacotherapy.	[Dhooghe, Barbara; Noel, Sabrina; Leal, Teresinha] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Inst Expt & Clin Res IREC, B-1200 Brussels, Belgium; [Bouzin, Caroline; Behets-Wydemans, Gaetane] Catholic Univ Louvain, IREC Imaging Platform Pole Pharmacol & Therapeut, Inst Expt & Clin Res IREC, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Leal, T (corresponding author), Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol LTAP, Inst Expt & Clin Res IREC, B-1200 Brussels, Belgium.	teresinha.leal@uclouvain.be	Noel, Sabrina/H-5567-2011	Noel, Sabrina/0000-0003-1803-6434	European Economic Community European Coordination Action for Research in Cystic Fibrosis EU [FP6 LHHM-CT-2005-018932]	European Economic Community European Coordination Action for Research in Cystic Fibrosis EU	Breeding pairs of Cftrtm1EUR (F508del (FVB/129)) mice obtained from the MC Rotterdam, Rotterdam, The Netherlands, with the support of European Economic Community European Coordination Action for Research in Cystic Fibrosis EU FP6 LHHM-CT-2005-018932. The authors thank Vaincre la Mucoviscidose for providing Cftr knockout mice. Vardenafil was a gift from Bayer Pharma (Berlin, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Ameen N, 2000, HISTOCHEM CELL BIOL, V114, P69; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Birault V, 2013, CURR OPIN CHEM BIOL, V17, P353, DOI 10.1016/j.cbpa.2013.04.020; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Chen EYJ, 2000, BIOCHEMISTRY-US, V39, P3797, DOI 10.1021/bi992620m; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cobb BR, 2003, AM J RESP CELL MOL, V29, P410, DOI 10.1165/rcmb.2002-0247OC; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dormer RL, 2005, THORAX, V60, P55, DOI 10.1136/thx.2003.019778; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Grubb BR, 1997, AM J PHYSIOL-GASTR L, V273, pG258, DOI 10.1152/ajpgi.1997.273.2.G258; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Hug MJ, 2011, METHODS MOL BIOL, V741, P87, DOI 10.1007/978-1-61779-117-8_7; Ismailov II, 1996, J BIOL CHEM, V271, P4725; Jouret F, 2007, J AM SOC NEPHROL, V18, P707, DOI 10.1681/ASN.2006030269; Kelley TJ, 1998, AM J PHYSIOL-LUNG C, V274, pL990, DOI 10.1152/ajplung.1998.274.6.L990; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES MR, 1995, HUM GENE THER, V6, P445, DOI 10.1089/hum.1995.6.4-445; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Leier G, 2012, CELL PHYSIOL BIOCHEM, V29, P775, DOI 10.1159/000265129; Leonard A., 2012, OJRD, V02, P43, DOI [10.4236/ojrd.2012.22007, DOI 10.4236/OJRD.2012.22007]; Leonard A, 2012, J CYST FIBROS, V11, P231, DOI 10.1016/j.jcf.2011.12.004; Lubamba B, 2011, EUR RESPIR J, V37, P72, DOI 10.1183/09031936.00013510; Lubamba B, 2008, AM J RESP CRIT CARE, V177, P506, DOI 10.1164/rccm.200703-344OC; Lubamba B, 2012, J CYST FIBROS, V11, P266, DOI 10.1016/j.jcf.2012.03.003; Lubamba B, 2009, AM J RESP CRIT CARE, V179, P1022, DOI 10.1164/rccm.200901-0049OC; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Mendes Filipa, 2004, J Cyst Fibros, V3 Suppl 2, P37, DOI 10.1016/j.jcf.2004.05.008; Mendes Filipa, 2004, J Cyst Fibros, V3 Suppl 2, P69, DOI 10.1016/j.jcf.2004.05.016; Merk D, 2013, EXPERT OPIN DRUG DIS, V8, P691, DOI 10.1517/17460441.2013.788495; MIDDLETON PG, 1994, EUR RESPIR J, V7, P2050; Moniz S, 2013, ACS CHEM BIOL, V8, P432, DOI 10.1021/cb300484r; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pier GB, 2012, J EXP MED, V209, P1235, DOI 10.1084/jem.20121248; Poschet JF, 2007, AM J PHYSIOL-LUNG C, V293, pL712, DOI 10.1152/ajplung.00314.2006; Raggi C, 2011, PFLUG ARCH EUR J PHY, V462, P851, DOI 10.1007/s00424-011-1026-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rowe SM, 2013, COLD SPRING HARB PER, V3; Rowe SM, 2012, THORAX, V67, P882, DOI 10.1136/thoraxjnl-2012-202550; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Stutts MJ, 1997, J BIOL CHEM, V272, P14037, DOI 10.1074/jbc.272.22.14037; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Weiner SA, 2008, PEDIATR RES, V63, P73, DOI 10.1203/PDR.0b013e31815b4bc6; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; Wilschanski M, 2007, GUT, V56, P1153, DOI 10.1136/gut.2004.062786	55	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77314	10.1371/journal.pone.0077314	http://dx.doi.org/10.1371/journal.pone.0077314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204804	Green Published, gold, Green Submitted			2022-12-25	WOS:000326152300020
J	Wine, JJ; Char, JE; Chen, J; Cho, HJ; Dunn, C; Frisbee, E; Joo, NS; Milla, C; Modlin, SE; Park, IH; Thomas, EAC; Tran, KV; Verma, R; Wolfe, MH				Wine, Jeffrey J.; Char, Jessica E.; Chen, Jonathan; Cho, Hyung-ju; Dunn, Colleen; Frisbee, Eric; Joo, Nam Soo; Milla, Carlos; Modlin, Sara E.; Park, Il-Ho; Thomas, Ewart A. C.; Tran, Kim V.; Verma, Rohan; Wolfe, Marlene H.			In Vivo Readout of CFTR Function: Ratiometric Measurement of CFTR-Dependent Secretion by Individual, Identifiable Human Sweat Glands	PLOS ONE			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; CYSTIC-FIBROSIS HETEROZYGOTES; MESSENGER-RNA TRANSCRIPTS; POTENTIAL DIFFERENCE; CHRONIC-PANCREATITIS; SUBMUCOSAL GLANDS; CODING SEQUENCES; FLUID SECRETION; MUCUS SECRETION; GENE-MUTATIONS	To assess CFTR function in vivo, we developed a bioassay that monitors and compares CFTR-dependent and CFTR-independent sweat secretion in parallel for multiple (similar to 50) individual, identified glands in each subject. Sweating was stimulated by intradermally injected agonists and quantified by optically measuring spherical sweat bubbles in an oil-layer that contained dispersed, water soluble dye particles that partitioned into the sweat bubbles, making them highly visible. CFTR-independent secretion (M-sweat) was stimulated with methacholine, which binds to muscarinic receptors and elevates cytosolic calcium. CFTR-dependent secretion (C-sweat) was stimulated with a beta-adrenergic cocktail that elevates cytosolic cAMP while blocking muscarinic receptors. A C-sweat/M-sweat ratio was determined on a gland-by-gland basis to compensate for differences unrelated to CFTR function, such as gland size. The average ratio provides an approximately linear readout of CFTR function: the heterozygote ratio is similar to 0.5 the control ratio and for CF subjects the ratio is zero. During assay development, we measured C/M ratios in 6 healthy controls, 4 CF heterozygotes, 18 CF subjects and 4 subjects with 'CFTR-related' conditions. The assay discriminated all groups clearly. It also revealed consistent differences in the C/M ratio among subjects within groups. We hypothesize that these differences reflect, at least in part, levels of CFTR expression, which are known to vary widely. When C-sweat rates become very low the C/M ratio also tended to decrease; we hypothesize that this nonlinearity reflects ductal fluid absorption. We also discovered that M-sweating potentiates the subsequent C-sweat response. We then used potentiation as a surrogate for drugs that can increase CFTR-dependent secretion. This bioassay provides an additional method for assessing CFTR function in vivo, and is well suited for within-subject tests of systemic, CFTR-directed therapeutics.	[Wine, Jeffrey J.; Char, Jessica E.; Chen, Jonathan; Cho, Hyung-ju; Frisbee, Eric; Joo, Nam Soo; Modlin, Sara E.; Park, Il-Ho; Tran, Kim V.; Verma, Rohan; Wolfe, Marlene H.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Wine, Jeffrey J.; Dunn, Colleen; Milla, Carlos] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Wine, Jeffrey J.; Thomas, Ewart A. C.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wine, JJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.	wine@stanford.edu	Park, Il-Ho/AAI-1394-2019	Park, Il-Ho/0000-0002-7011-6071; Milla, Carlos/0000-0001-5515-3053	Cystic Fibrosis Foundation Therapeutic [WINE08A0]	Cystic Fibrosis Foundation Therapeutic	Supported by Cystic Fibrosis Foundation Therapeutics, Grant WINE08A0 to J.J.W. http://www.cff.org/research/cfft/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1997, BRIT MED J, V314, P1874, DOI 10.1136/bmj.314.7098.1874; Andersen B, 1990, METHODOLOGICAL ERROR; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barlow D., 1984, SINGLE CASE EXPT DES; Bates D. M., 2007, LME4 LINEAR MIXED EF; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; Bishop MD, 2005, HUM GENET, P1; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; Clancy JP, 2011, THORAX; Cohn JA, 2005, HUM MUTAT, V26, P303, DOI 10.1002/humu.20232; Cohn JA, 2004, GASTROENTEROL CLIN N, V33, P817, DOI 10.1016/j.gtc.2004.07.008; DISANTAGNESE PA, 1953, PEDIATRICS, V12, P549; Dohle GR, 1999, HUM REPROD, V14, P371, DOI 10.1093/humrep/14.2.371; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; GIBSON LE, 1959, PEDIATRICS, V23, P545; GOCHBERG SH, 1956, PEDIATRICS, V18, P701; Guo XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025452; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Kazdin AE., 2011, SINGLE CASE RES DESI, V2; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Kuno Y., 1956, HUMAN PERSPIRATION; Lee RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412817; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lillie EO, 2011, PERS MED, V8, P161, DOI 10.2217/PME.11.7; Luisetti M, 2003, SEMIN RESP CRIT CARE, V24, P179, DOI 10.1055/s-2003-39028; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; National Research Council (US) Committee on a Framework for Developing a New Taxonomy of Disease, 2011, PREC MED BUILD KNOWL; Quinton P, 2012, BETA ADRENERGIC SWEA; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raman V, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e13; Ramsey Bonnie W, 2007, Proc Am Thorac Soc, V4, P367, DOI 10.1513/pats.200703-038BR; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; ROCHON J, 1990, J CLIN EPIDEMIOL, V43, P499, DOI 10.1016/0895-4356(90)90139-G; Sanders DB, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e79; SATO K, 1983, AM J PHYSIOL, V245, pC189, DOI 10.1152/ajpcell.1983.245.3.C189; SATO K, 1981, AM J PHYSIOL, V240, pR44, DOI 10.1152/ajpregu.1981.240.1.R44; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SATO K, 1981, AM J PHYSIOL, V241, pC113, DOI 10.1152/ajpcell.1981.241.3.C113; SATO K, 1988, J LAB CLIN MED, V111, P511; SCHWARZ V, 1967, BIBL PAEDIATR, P89; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; SPIEGELHALTER DJ, 1988, SCAND J GASTROENTERO, V23, P40, DOI 10.3109/00365528809099158; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Suen YF, 2006, BIOORG MED CHEM LETT, V16, P537, DOI 10.1016/j.bmcl.2005.10.050; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; VEEZE HJ, 1994, J CLIN INVEST, V93, P461, DOI 10.1172/JCI116993; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WILSCHANSKI M, 1995, J PEDIATR-US, V127, P705, DOI 10.1016/S0022-3476(95)70157-5; Wine JJ, 2011, METHODS MOL BIOL, V742, P93, DOI 10.1007/978-1-61779-120-8_6	60	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e77114	10.1371/journal.pone.0077114	http://dx.doi.org/10.1371/journal.pone.0077114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204751	gold, Green Submitted, Green Published			2022-12-25	WOS:000326152300015
J	Baranyi, M; Cervenak, J; Bender, B; Kacskovics, I				Baranyi, Maria; Cervenak, Judit; Bender, Balazs; Kacskovics, Imre			Transgenic Rabbits That Overexpress the Neonatal Fc Receptor (FcRn) Generate Higher Quantities and Improved Qualities of Anti-Thymocyte Globulin (ATG)	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ANTITHYMOCYTE GLOBULIN; POLYCLONAL ANTILYMPHOCYTE; MONOCLONAL-ANTIBODIES; MEDIATED PRESENTATION; DENDRITIC CELLS; FLOW-CYTOMETRY; MYELOMA CELLS; B-CELL; APOPTOSIS	Immune suppression with rabbit anti-thymocyte globulin (rATG) is a well-established therapeutic concept for preventing host rejection of transplanted organs and graft versus host disease. Increasing the efficiency of rATG production by reducing the number of animals would be highly beneficial to lower cost and to improve quality standards. We have developed transgenic (Tg) mice and rabbits that overexpress the neonatal Fc receptor (FcRn) and have shown an augmented humoral immune response in these animals. To test whether our FcRn Tg rabbits produced rATG more efficiently, we immunized them and their New Zealand White controls with live Jurkat cells. By day 21 after immunization, Tg animals produced significantly, 1.5 times higher amount of total IgG compared to their wt littermates. Also, the binding efficiency of Tg sera to Jurkat cells and their complement-mediated cytotoxicity was significantly higher. The purified Tg IgG preparation contained 2.6 the amount of Jurkat specific IgG as the wt preparation analyzed by complement-mediated lysis, suggesting greater antigen-specific B cell activation in the Tg rabbits. To test this hypothesis, immunization with ovalbumin and human alpha(1)-antitrypsin was performed, resulting in significantly greater numbers of antigen-specific B-cells in the FcRn Tg rabbits as compared with wt controls. The shift towards significantly larger populations of antigen-specific B cells relative to the nonspecific B cell pool is further corroborated by our previous findings in FcRn Tg mice. Consequently, our FcRn Tg rabbits have the potential to offer substantial qualitative and quantitative improvements for the production of rATG and other polyclonal or monoclonal antibodies.	[Baranyi, Maria; Cervenak, Judit; Bender, Balazs; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary		Kacskovics, I (corresponding author), ImmunoGenes Kft, Budakeszi, Hungary.	kacskovics@immunogenes.com	Kacskovics, Imre/J-8449-2013	Kacskovics, Imre/0000-0002-0402-3862	Hungarian Economic Development Centre [KMOP-1.1.4-11/B-2011-0226]	Hungarian Economic Development Centre	This work was supported by the grant KMOP-1.1.4-11/B-2011-0226 from the Hungarian Economic Development Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; Ayuk FA, 2005, EXP HEMATOL, V33, P1531, DOI 10.1016/j.exphem.2005.08.004; Ayuk F, 2009, ANN HEMATOL, V88, P401, DOI 10.1007/s00277-009-0696-8; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Beiras-Fernandez A, 2003, Exp Clin Transplant, V1, P79; Bender B, 2007, TRANSGENIC RES, V16, P613, DOI 10.1007/s11248-007-9108-9; BonnefoyBerard N, 1996, J HEART LUNG TRANSPL, V15, P435; BONNEFOYBERARD N, 1991, TRANSPLANTATION, V51, P669, DOI 10.1097/00007890-199103000-00024; BONNEFOYBERARD N, 1994, BLOOD, V83, P1051; BOURDAGE JS, 1995, TRANSPLANTATION, V59, P1194, DOI 10.1097/00007890-199504270-00020; Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; Brennan DC, 2003, TRANSPLANTATION, V75, P577, DOI 10.1097/01.TP.0000053199.45370.4C; Cervenak J, 2011, J IMMUNOL, V186, P959, DOI 10.4049/jimmunol.1000353; Cosimi AB, 1988, ANTILYMPHOCYTE GLOBU; DEEG HJ, 1985, TRANSPLANTATION, V40, P162, DOI 10.1097/00007890-198508000-00011; Flisikowska T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021045; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; JOOSTE SV, 1968, IMMUNOLOGY, V15, P697; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; LEVEY RH, 1966, P NATL ACAD SCI USA, V56, P1130, DOI 10.1073/pnas.56.4.1130; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Marsh J, 1999, BLOOD, V93, P2191, DOI 10.1182/blood.V93.7.2191.407a03_2191_2195; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Preville X, 2000, J IMMUNOL METHODS, V245, P45, DOI 10.1016/S0022-1759(00)00271-4; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Ringden O, 1998, TRANSPLANTATION, V66, P620, DOI 10.1097/00007890-199809150-00013; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Schneider Z, 2011, IMMUNOL LETT, V137, P62, DOI 10.1016/j.imlet.2011.02.018; SPIEGELB.HL, 1965, J EXP MED, V121, P323, DOI 10.1084/jem.121.3.323; STORB R, 1974, BLOOD, V44, P57, DOI 10.1182/blood.V44.1.57.57; Theurich S, 2010, BIOL BLOOD MARROW TR, V16, pS220, DOI 10.1016/j.bbmt.2009.12.204; Timm MM, 2006, LEUKEMIA, V20, P1863, DOI 10.1038/sj.leu.2404359; Vegh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036286; Vegh A, 2011, MABS-AUSTIN, V3, P173, DOI 10.4161/mabs.3.2.14462; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Zand MS, 2006, BLOOD, V107, P2895, DOI 10.1182/blood-2005-06-2269; Zand MS, 2005, TRANSPLANTATION, V79, P1507, DOI 10.1097/01.TP.0000164159.20075.16	46	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76839	10.1371/journal.pone.0076839	http://dx.doi.org/10.1371/journal.pone.0076839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194847	Green Submitted, Green Published, gold			2022-12-25	WOS:000326037000026
J	Chen, WW; Liu, PX; Wang, YD; Nie, WM; Li, ZW; Xu, W; Li, FY; Zhou, ZP; Zhao, M; Liu, HG				Chen, Weiwei; Liu, Peixin; Wang, Yedong; Nie, Weimin; Li, Zhiwei; Xu, Wen; Li, Fengyi; Zhou, Zhiping; Zhao, Min; Liu, Henggui			Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							B7 FAMILY; PROSTATE-CANCER; T-CELLS; TUMOR VASCULATURE; LIGAND EXPRESSION; BREAST-CANCER; MEMBER; PROLIFERATION; ACTIVATION; MOLECULE	B7-H3 is a recently discovered member of the B7 superfamily molecules and has been found to play a negative role in T cell responses. In this study, we identified a new B7-H3 isoform that is produced by alternative splicing from the forth intron of B7-H3 and encodes the sB7-H3 protein. Protein sequence analysis showed that sB7-H3 contains an additional four amino acids, encoded by the intron sequence, at the C-terminus compared to the ectodomain of 2Ig-B7-H3. We further found that this spliced sB7-H3 plays a negative regulatory role in T cell responses and serum sB7-H3 is higher in patients with hepatocellular carcinoma (HCC) than in healthy donors. Furthermore, we found that the expression of the spliced sb7-h3 gene is higher in carcinoma and peritumor tissues than in PBMCs of both healthy controls and patients, indicating that the high level of serum sB7-H3 in patients with HCC is caused by the increased expression of this newly discovered spliced sB7-H3 isoform in carcinoma and peritumor tissues.	[Chen, Weiwei; Liu, Peixin; Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Chen, Weiwei; Wang, Yedong; Nie, Weimin; Li, Zhiwei; Xu, Wen; Li, Fengyi; Zhou, Zhiping; Zhao, Min] 302 Hosp PLA, Treatment & Res Ctr Infect Dis, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fifth Medical Center of Chinese PLA General Hospital	Liu, HG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	drzhaomin@sina.com; lhg@hvri.ac.cn			State Key Laboratory of Veterinary Biotechnology Research Fund [SKLVBP201217]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]; National Nature Science Foundation of China [81072423]; National Grand Program on Key Infectious Disease [2012ZX10005-006]	State Key Laboratory of Veterinary Biotechnology Research Fund; Chinese Special Fund for Agro-scientific Research in the Public Interest; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This work was supported by the grants from State Key Laboratory of Veterinary Biotechnology Research Fund (SKLVBP201217), Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033), the National Nature Science Foundation of China (81072423), and National Grand Program on Key Infectious Disease (2012ZX10005-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arigami T, 2011, CANCER SCI, V102, P1019, DOI 10.1111/j.1349-7006.2011.01877.x; Arigami T, 2010, ANN SURG, V252, P1044, DOI 10.1097/SLA.0b013e3181f1939d; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chavin G, 2009, CLIN CANCER RES, V15, P2174, DOI 10.1158/1078-0432.CCR-08-2262; Chen WW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021341; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Dong HD, 1999, NAT MED, V5, P1365; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kakoulidou M, 2007, J NEUROIMMUNOL, V185, P150, DOI 10.1016/j.jneuroim.2007.01.007; Katayama A, 2011, INT J ONCOL; Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leitner J, 2009, EUR J IMMUNOL; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; Liu HG, 2007, CLIN IMMUNOL, V125, P337, DOI 10.1016/j.clim.2007.06.010; Luan Y, 2012, J VIRAL HEPATITIS, V19, P23, DOI 10.1111/j.1365-2893.2010.01421.x; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Peng JM, 2010, VET IMMUNOL IMMUNOP, V136, P157, DOI 10.1016/j.vetimm.2010.03.001; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; Sadanandam A, 2012, BREAST CANCER RES TR, V136, P693, DOI 10.1007/s10549-012-2290-3; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun J, 2010, CANCER IMMUNOL IMMUN, V59, P1163, DOI 10.1007/s00262-010-0841-1; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012; Wang LH, 2010, CHINESE MED J-PEKING, V123, P3545, DOI 10.3760/cma.j.issn.0366-6999.2010.24.008; Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518; Wang SD, 2003, J EXP MED, V197, P1083, DOI 10.1084/jem.20021752; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zhang GB, 2004, ACTA BIOCH BIOPH SIN, V36, P430, DOI 10.1093/abbs/36.6.430; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhang GB, 2009, LUNG CANCER, V66, P245, DOI 10.1016/j.lungcan.2009.01.017; Zhou YH, 2007, TISSUE ANTIGENS, V70, P96, DOI 10.1111/j.1399-0039.2007.00853.x	44	22	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76965	10.1371/journal.pone.0076965	http://dx.doi.org/10.1371/journal.pone.0076965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194851	Green Submitted, gold, Green Published			2022-12-25	WOS:000326037000030
J	Eady, TN; Khoutorova, L; Anzola, DV; Hong, SH; Obenaus, A; Mohd-Yusof, A; Bazan, NG; Belayev, L				Eady, Tiffany N.; Khoutorova, Larissa; Anzola, Daniela V.; Hong, Sung-Ha; Obenaus, Andre; Mohd-Yusof, Alena; Bazan, Nicolas G.; Belayev, Ludmila			Acute Treatment with Docosahexaenoic Acid Complexed to Albumin Reduces Injury after a Permanent Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							MARKED NEUROPROTECTIVE EFFICACY; ARTERY OCCLUSION; FATTY-ACIDS; TRANSIENT; THERAPY; BRAIN; RESPONSES; BENEFITS; STROKE; MODEL	Docosahexaenoic acid complexed to albumin (DHA-Alb) is highly neuroprotective after temporary middle cerebral artery occlusion (MCAo), but whether a similar effect occurs in permanent MCAo is unknown. Male Sprague-Dawley rats (270-330 g) underwent permanent MCAo. Neurological function was evaluated on days 1, 2 and 3 after MCAo. We studied six groups: DHA (5 mg/kg), Alb (0.63 or 1.25 g/kg), DHA-Alb (5 mg/kg + 0.63 g/kg or 5 mg/kg + 1.25 g/kg) or saline. Treatment was administered i.v. at 3 h after onset of stroke (n = 7-10 per group). Ex vivo imaging of brains and histopathology were conducted on day 3. Saline-and Alb-treated rats developed severe neurological deficits but were not significantly different from one another. In contrast, rats treated with low and moderate doses of DHA-Alb showed improved neurological score compared to corresponding Alb groups on days 2 and 3. Total, cortical and subcortical lesion volumes computed from T2 weighted images were reduced following a moderate dose of DHA-Alb (1.25 g/kg) by 25%, 22%, 34%, respectively, compared to the Alb group. The total corrected, cortical and subcortical infarct volumes were reduced by low (by 36-40%) and moderate doses (by 34-42%) of DHA-Alb treatment compared to the Alb groups. In conclusion, DHA-Alb therapy is highly neuroprotective in permanent MCAo in rats. This treatment can provide the basis for future therapeutics for patients suffering from ischemic stroke.	[Eady, Tiffany N.; Khoutorova, Larissa; Anzola, Daniela V.; Hong, Sung-Ha; Bazan, Nicolas G.; Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA; [Belayev, Ludmila] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Neurosurg, New Orleans, LA USA; [Obenaus, Andre; Mohd-Yusof, Alena] Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Loma Linda University	Belayev, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Neurosci Ctr Excellence, New Orleans, LA 70112 USA.	lbelay@lsuhsc.edu	Bazan, Nicolas/AAN-4121-2020	Bazan, Nicolas/0000-0002-9243-5444	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS065786]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065786] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grant R01 NS065786 (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2002, PEDIATR NEUROL, V26, P210, DOI 10.1016/S0887-8994(01)00383-6; Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 2005, STROKE, V36, P118, DOI 10.1161/01.STR.0000149620.74770.2e; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bogaert YE, 2000, EXP NEUROL, V161, P115, DOI 10.1006/exnr.1999.7250; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; de Turco EBR, 2002, J NEUROCHEM, V83, P515, DOI 10.1046/j.1471-4159.2002.01121.x; Eady Tiffany N, 2012, Exp Transl Stroke Med, V4, P19, DOI 10.1186/2040-7378-4-19; Eady TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046151; Fernandes JS, 2008, NUTR RES, V28, P798, DOI 10.1016/j.nutres.2008.09.004; Liu YT, 2001, EUR J PHARMACOL, V428, P193, DOI 10.1016/S0014-2999(01)01255-9; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Siegel G, 2012, ATHEROSCLEROSIS, V225, P291, DOI 10.1016/j.atherosclerosis.2012.09.006; Virtanen JK, 2008, AM J CLIN NUTR, V88, P1618, DOI 10.3945/ajcn.2007.25816; Yurko-Mauro K, 2010, CURR ALZHEIMER RES, V7, P190, DOI 10.2174/156720510791050911; ZHANG JP, 1995, J NEUROCHEM, V64, P1688	27	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e77237	10.1371/journal.pone.0077237	http://dx.doi.org/10.1371/journal.pone.0077237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194876	gold, Green Published, Green Submitted			2022-12-25	WOS:000326037000055
J	Liu, LL; Zhang, ZJ; Mei, Q; Chen, M				Liu, Lili; Zhang, Zijun; Mei, Qian; Chen, Ming			PSI: A Comprehensive and Integrative Approach for Accurate Plant Subcellular Localization Prediction	PLOS ONE			English	Article							WEB SERVER; PROTEINS; LOCATION; DATABASE; SUITE; TOOL	Predicting the subcellular localization of proteins conquers the major drawbacks of high-throughput localization experiments that are costly and time-consuming. However, current subcellular localization predictors are limited in scope and accuracy. In particular, most predictors perform well on certain locations or with certain data sets while poorly on others. Here, we present PSI, a novel high accuracy web server for plant subcellular localization prediction. PSI derives the wisdom of multiple specialized predictors via a joint-approach of group decision making strategy and machine learning methods to give an integrated best result. The overall accuracy obtained (up to 93.4%) was higher than best individual (CELLO) by similar to 10.7%. The precision of each predicable subcellular location (more than 80%) far exceeds that of the individual predictors. It can also deal with multi-localization proteins. PSI is expected to be a powerful tool in protein location engineering as well as in plant sciences, while the strategy employed could be applied to other integrative problems. A user-friendly web server, PSI, has been developed for free access at http://bis.zju.edu.cn/psi/.	[Liu, Lili; Zhang, Zijun; Mei, Qian; Chen, Ming] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Chen, M (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mchen@zju.edu.cn	Chen, Ming/AAV-3682-2020; Liu, Lili/I-7619-2019	Chen, Ming/0000-0002-9677-1699; Liu, Lili/0000-0002-2622-9669; Mei, Qian/0000-0003-4648-7232	National Natural Sciences Foundation of China [30771326, 30971743]; Program for New Century Excellent Talents in University of China [NCET-07-0740]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Sciences Foundation of China [30771326, 30971743], the Program for New Century Excellent Talents in University of China [NCET-07-0740]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bau D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-402; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Boden M, 2005, BIOINFORMATICS, V21, P2279, DOI 10.1093/bioinformatics/bti372; Brady Scott, 2008, Pac Symp Biocomput, P604; Carugo O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-380; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Doennes Pierre, 2004, Genomics Proteomics & Bioinformatics, V2, P209; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fyshe A, 2008, BIOINFORMATICS, V24, P2512, DOI 10.1093/bioinformatics/btn463; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Guda C, 2006, NUCLEIC ACIDS RES, V34, pW210, DOI 10.1093/nar/gkl093; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lin HN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S8; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Niu B, 2008, MOL DIVERS, V12, P41, DOI 10.1007/s11030-008-9073-0; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Shen YQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-420; Shen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-563; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Szafron D, 2004, NUCLEIC ACIDS RES, V32, pW365, DOI 10.1093/nar/gkh485; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	33	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e75826	10.1371/journal.pone.0075826	http://dx.doi.org/10.1371/journal.pone.0075826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194827	Green Submitted, gold, Green Published			2022-12-25	WOS:000326037000006
J	Buric, M; Kouba, A; Kozak, P				Buric, Milos; Kouba, Antonin; Kozak, Pavel			Reproductive Plasticity in Freshwater Invader: From Long-Term Sperm Storage to Parthenogenesis	PLOS ONE			English	Article							CRAYFISH ORCONECTES-LIMOSUS; MARMORKREBS MARBLED CRAYFISH; LIFE-HISTORY PARAMETERS; INVASIVE CRAYFISH; GENETIC DIVERSITY; MATE CHOICE; EGG; TEMPERATURE; PREVALENCE; FECUNDITY	Orconectes limosus, a North American crayfish species, is one of the most important aquatic invaders in European inland waters. Despite more than 120 years occurrence in Europe and intense research, there are still gaps in knowledge of its life history and ecology. Investigation into O. limosus invasive success requires identifying the mechanisms that enabled them to establish dense and widespread populations from small initial numbers without observable limitation by an introduction bottleneck. In part, O. limosus success may lie in its ability to reproduce by facultative parthenogenesis. Moreover, there are possible other mating scenarios, because of two mating seasons (autumn and spring) in O. limosus. This work investigated the effect of four reproductive scenarios (autumn mating only, spring mating only, autumn and spring mating, and without mating) on the reproductive success of O. limosus. Females successfully reproduced in all tested mating regimes using parthenogenesis as well as log term sperm storage. This reproductive plasticity likely facilitates the overwhelming success of O. limosus spread and establishment in new localities. It can explain the spread of O. limosus from the initial introduction of 90 specimens to most of continental Europe and Great Britain. These conclusions imply a serious threat, not only for autochthonous European astacofauna, but for other aquatic organisms as well as entire ecosystems.	[Buric, Milos] Univ South Bohemia, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Ceske Budejovice, Vodnany, Czech Republic; Univ South Bohemia, Res Inst Fish Culture & Hydrobiol, Ceske Budejovice, Vodnany, Czech Republic	University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice	Buric, M (corresponding author), Univ South Bohemia, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Ceske Budejovice, Vodnany, Czech Republic.	buric@frov.jcu.cz	Kozák, Pavel/G-5025-2015; Kouba, Antonín/C-9338-2015; Buric, Milos/F-8114-2015	Kozák, Pavel/0000-0002-6985-1538; Kouba, Antonín/0000-0001-8118-8612; Buric, Milos/0000-0003-2220-5579	project CENAKVA [cZ.1.05/2.1.00/01.0024]; Czech Science Foundation [P505/12/0545]	project CENAKVA; Czech Science Foundation(Grant Agency of the Czech Republic)	The study was supported by the by the project CENAKVA No. cZ.1.05/2.1.00/01.0024, and by Czech Science Foundation project No. P505/12/0545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAUGH D W, 1973, Southwestern Naturalist, V18, P97, DOI 10.2307/3669916; Andrews EA, 1910, J EXP ZOOL, V9, P235, DOI 10.1002/jez.1400090202; Andrews EA, 1907, THE YOUNG OF THE CRA, VXXXV; Aquiloni L, 2009, FRESHWATER BIOL, V54, P1510, DOI 10.1111/j.1365-2427.2009.02169.x; Belanger RM, 2006, BEHAVIOUR, V143, P713, DOI 10.1163/156853906777791342; BERRILL M, 1984, ANIM BEHAV, V32, P333, DOI 10.1016/S0003-3472(84)80265-1; Berry FC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-25; Buric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020281; Buric M, 2010, ZOOLOGY, V113, P301, DOI 10.1016/j.zool.2010.06.001; Buric M, 2010, ZOOL STUD, V49, P28; Buric M, 2009, AQUAT SCI, V71, P473, DOI 10.1007/s00027-009-0102-6; BUTLER MJ, 1985, OECOLOGIA, V66, P168, DOI 10.1007/BF00379851; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; DUBE P, 1992, AQUACULTURE, V102, P161, DOI 10.1016/0044-8486(92)90298-Y; Filipova L, 2011, J N AM BENTHOL SOC, V30, P871, DOI 10.1899/10-130.1; Galeotti P, 2006, P ROY SOC B-BIOL SCI, V273, P1105, DOI 10.1098/rspb.2005.3345; Galeotti P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043771; Gherardi F, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P258; Gherardi F, 2010, REV SCI TECH OIE, V29, P241, DOI 10.20506/rst.29.2.1973; Gherardi F, 2011, NEW FRONTIERS IN CRU, P20; Gherardi F, 2006, ARCH HYDROBIOL, V165, P557, DOI 10.1127/0003-9136/2006/0165-0557; Gherardi F, 2011, AQUAT SCI, V73, P185, DOI 10.1007/s00027-011-0181-z; Hamr P, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P585; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich David, 2007, Aquatic Invasions, V2, P1, DOI 10.3391/ai.2007.2.1.1; Holdich DM, 1999, CRUSTACEAN ISS, V11, P281; Hulak M, 2010, J APPL GENET, V51, P73, DOI 10.1007/BF03195713; Klocker CA, 2004, NORTHEAST NAT, V11, P167, DOI 10.1656/1092-6194(2004)011[0167:IAAICO]2.0.CO;2; Kossakowski J, 1966, RAKI WARSZAWA PANSTW; Kozak P, 2006, B FR PECHE PISCIC, P1171, DOI 10.1051/kmae:2006019; Kozubikova E, 2009, CONSERV BIOL, V23, P1204, DOI 10.1111/j.1523-1739.2009.01240.x; Lindqvist OV, 1999, CRUSTACEAN ISS, V11, P23; Lozan Jose Luis, 2000, Limnologica, V30, P156, DOI 10.1016/S0075-9511(00)80010-9; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; McDonald M, 1893, REPORT OF THE UNITED; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Musil M., 2010, Freshwater Crayfish, V17, P189; Nystrom P, 1996, FRESHWATER BIOL, V36, P631, DOI 10.1046/j.1365-2427.1996.d01-528.x; Perdikaris C, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011077; Pieplow U, 1938, Z FISCHEREI, V36, P349; Puky M, 2006, B FR PECHE PISCIC, P919, DOI 10.1051/kmae:2006031; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; REYNOLDS JD, 1992, INVERTEBR REPROD DEV, V22, P253, DOI 10.1080/07924259.1992.9672278; Reynolds JD, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P152; Rubolini D, 2007, FRESHWATER BIOL, V52, P1898, DOI 10.1111/j.1365-2427.2007.01814.x; Schulz H.K., 2006, Freshwater Crayfish, V15, P212; SMITH DG, 1981, OHIO J SCI, V81, P169; Souty-Grosset C, 2006, ATLAS OF CRAYFISH IN, V64; Stebbing PD, 2003, J CHEM ECOL, V29, P465, DOI 10.1023/A:1022646414938; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; Stucki Thomas P., 2002, Freshwater Crayfish, V13, P463; TAUGBOL T, 1990, Aquaculture and Fisheries Management, V21, P17, DOI 10.1111/j.1365-2109.1990.tb00378.x; VANDENBRINK FWB, 1988, ARCH HYDROBIOL, V114, P275; Villanelli F, 1998, FRESHWATER BIOL, V40, P305, DOI 10.1046/j.1365-2427.1998.00355.x; Vitousek PM, 1996, AM SCI, V84, P468; Vogt G, 1999, CRUSTACEAN ISS, V11, P87; Walker D, 2002, MOL ECOL, V11, P2115, DOI 10.1046/j.1365-294X.2002.01609.x; Wickins JF, 2002, CRUSTACEAN FARMING R; Yue GH, 2008, INT J BIOL SCI, V4, P279; Yue GH, 2010, BIOL INVASIONS, V12, P2697, DOI 10.1007/s10530-009-9675-1; Yue GH, 2010, INT J BIOL SCI, V6, P107; [No title captured]	65	30	31	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77597	10.1371/journal.pone.0077597	http://dx.doi.org/10.1371/journal.pone.0077597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204886	Green Published, Green Submitted, gold			2022-12-25	WOS:000326032600038
J	Chandwani, S; Keilani, S; Ortiz-Virumbrales, M; Morant, A; Bezdecny, S; Ehrlich, ME				Chandwani, Samira; Keilani, Serene; Ortiz-Virumbrales, Maitane; Morant, Andrika; Bezdecny, Steve; Ehrlich, Michelle E.			Induction of DARPP-32 by Brain-Derived Neurotrophic Factor in Striatal Neurons In Vitro Is Modified by Histone Deacetylase Inhibitors and Nab2	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; HUNTINGTONS-DISEASE; EXPRESSION; DIFFERENTIATION; ACID; TRANSCRIPTION; BDNF; ACTIVATION; PHENOTYPE; REQUIREMENT	Neurotrophins and modifiers of chromatin acetylation and deacetylation participate in regulation of transcription during neuronal maturation and maintenance. The striatal medium spiny neuron is supported by cortically-derived brain derived neurotrophic factor and is the most vulnerable neuron in Huntington's disease, in which growth factor and histone deacetylase activity are both disrupted. We examined the ability of three histone deacetylase inhibitors, trichostatin A, valproic acid and Compound 4 b, alone and combined with brain derived neurotrophic factor (BDNF), to promote phenotypic maturation of striatal medium spiny neurons in vitro. Exposure of these neurons to each of the three compounds led to an increase in overall histone H3 and H4 acetylation, dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa (DARPP-32) mRNA and protein, and mRNA levels of other markers of medium spiny neuron maturation. We were, however, unable to prove that HDAC inhibitors directly lead to remodeling of Ppp1r1b chromatin. In addition, induction of DARPP-32 by brain-derived neurotrophic factor was inhibited by histone deacetylase inhibitors. Although BDNF-induced increases in pTrkB, pAkt, pERK and Egr-1 were unchanged by combined application with VPA, the increase in DARPP-32 was relatively diminished. Strikingly, the NGF1A-binding protein, Nab2, was induced by BDNF, but not in the presence of VPA or TSA. Gel shift analysis showed that alpha-Nab2 super-shifted a band that is more prominent with extract derived from BDNF-treated neurons than with extracts from cultures treated with VPA alone or VPA plus BDNF. In addition, overexpression of Nab2 induced DARPP-32. We conclude that histone deacetylase inhibitors inhibit the induction of Nab2 by BDNF, and thereby the relative induction of DARPP-32.	[Ehrlich, Michelle E.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ehrlich, ME (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	michelle.ehrlich@mssm.edu			National Institutes of Health [NS-059936, NS-045942]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059936, R01NS045942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants NS-059936 and NS-045942 (M. E. E.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDELT AA, 1994, BRAIN RES, V647, P340, DOI 10.1016/0006-8993(94)91333-1; Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004; Bogush AI, 2005, GENESIS, V42, P37, DOI 10.1002/gene.20118; Bogush A, 2007, J BIOL CHEM, V282, P7352, DOI 10.1074/jbc.M606508200; Brown TB, 2008, HUM MOL GENET, V17, P3095, DOI 10.1093/hmg/ddn206; Carri AD, 2013, DEVELOPMENT, V140, P301, DOI 10.1242/dev.084608; Chen B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-78; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; EHRLICH ME, 1990, DEV BRAIN RES, V54, P257, DOI 10.1016/0165-3806(90)90148-R; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Gavalda N, 2004, MOL CELL NEUROSCI, V25, P460, DOI 10.1016/j.mcn.2003.11.012; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Ivkovic S, 1997, NEUROSCIENCE, V79, P509, DOI 10.1016/S0306-4522(96)00684-7; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Keilani S, 2012, J NEUROSCI, V32, P6808, DOI 10.1523/JNEUROSCI.5448-11.2012; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Leng Y, 2008, J NEUROSCI, V28, P2576, DOI 10.1523/JNEUROSCI.5467-07.2008; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Mahan AL, 2012, J NEUROSCI, V32, P4651, DOI 10.1523/JNEUROSCI.3308-11.2012; McFarland KN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041423; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; OUIMET CC, 1989, J NEUROSCI, V9, P865; Pedrini S, 2008, J NEUROCHEM, V106, P917, DOI 10.1111/j.1471-4159.2008.05475.x; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Stroppolo A, 2001, J NEUROCHEM, V79, P1027, DOI 10.1046/j.1471-4159.2001.00651.x; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; VENTIMIGLIA R, 1995, EUR J NEUROSCI, V7, P213, DOI 10.1111/j.1460-9568.1995.tb01057.x; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Xie YX, 2010, J NEUROSCI, V30, P14708, DOI 10.1523/JNEUROSCI.1637-10.2010; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	44	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e76842	10.1371/journal.pone.0076842	http://dx.doi.org/10.1371/journal.pone.0076842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204683	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600013
J	Avasarala, S; Bikkavilli, RK; Van Scoyk, M; Zhang, W; Lapite, A; Hostetter, L; Byers, JT; Heasley, LE; Sohn, JW; Winn, RA				Avasarala, Sreedevi; Bikkavilli, Rama Kamesh; Van Scoyk, Michelle; Zhang, Wei; Lapite, Ajibike; Hostetter, Logan; Byers, Joshua T.; Heasley, Lynn E.; Sohn, Jang Won; Winn, Robert A.			Heterotrimeric G-Protein, G(alpha 16), Is a Critical Downstream Effector of Non-Canonical Wnt Signaling and a Potent Inhibitor of Transformed Cell Growth in Non Small Cell Lung Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; EPITHELIAL-MESENCHYMAL TRANSITIONS; COUPLED RECEPTORS; TERATOCARCINOMA CELLS; RAT FRIZZLED-1; TCF PATHWAY; CYCLIC-GMP; KINASE; EXPRESSION; TRANSDUCTION	G-protein-coupled receptors (GPCR) are the largest family of cell surface molecules that play important role/s in a number of biological and pathological processes including cancers. Earlier studies have highlighted the importance of Wnt7a signaling via its cognate receptor Frizzled9, a GPCR, in inhibition of cell proliferation, anchorage-independent growth, and reversal of transformed phenotype in non small cell lung cancer primarily through activation of the tumor suppressor, PPAR gamma. However, the G-protein effectors that couple to this important tumor suppressor pathway have not been identified, and are of potential therapeutic interest. In this study, by using two independent Wnt7a/Frizzled9-specific read-outs, we identify G(alpha 16) as a novel downstream effector of Wnt7a/Frizzled9 signaling. Interestingly, G(alpha 16) expression is severely down-regulated, both at the messenger RNA levels and protein levels, in many non small cell lung cancer cell lines. Additionally, through gene-specific knock-downs and expression of GTPase-deficient forms (Q212L) of G(alpha 16), we also establish G(alpha 16) as a novel regulator of non small cell lung cancer cell proliferation and anchorage-independent cell growth. Taken together, our data not only establish the importance of G(alpha 16) as a critical downstream effector of the non-canonical Wnt signaling pathway but also as a potential therapeutic target for the treatment of non small cell lung cancer.	[Avasarala, Sreedevi; Bikkavilli, Rama Kamesh; Van Scoyk, Michelle; Lapite, Ajibike; Hostetter, Logan; Byers, Joshua T.; Winn, Robert A.] Univ Illinois, Coll Med, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Zhang, Wei] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA; [Heasley, Lynn E.] Univ Colorado, Dept Craniofacial Biol, Denver, CO 80202 USA; [Sohn, Jang Won] Hanyang Univ, Sch Med, Dept Internal Med, Seoul 133791, South Korea; [Winn, Robert A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Colorado System; University of Colorado Denver; Hanyang University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Winn, RA (corresponding author), Univ Illinois, Coll Med, Dept Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	rwinn@uic.edu	Byers, Joshua/R-7690-2019		U.S. Department of Veterans Affairs, National Institutes of Health (NIH) [R01CA1385282522717, 5R21CA153268-02]; NATIONAL CANCER INSTITUTE [R21CA153268, R01CA138528] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL103286] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs, National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Merit Award from the U.S. Department of Veterans Affairs, National Institutes of Health (NIH) grants R01CA1385282522717 and 5R21CA153268-02 to RAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bikkavilli RK, 2008, J CELL SCI, V121, P3598, DOI 10.1242/jcs.032854; Bikkavilli RK, 2008, J CELL SCI, V121, P234, DOI 10.1242/jcs.021964; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli Rama Kamesh, 2009, Commun Integr Biol, V2, P46; Blanquicett Carmelo, 2008, Cancer Ther, V6, P25; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; CUTTITTA F, 1985, CANCER SURV, V4, P707; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Gudermann T, 2006, ENDOCR-RELAT CANCER, V13, P1069, DOI 10.1677/erc.1.01302; Heasley LE, 1996, J BIOL CHEM, V271, P349, DOI 10.1074/jbc.271.1.349; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Li MY, 2010, AM J RESP CELL MOL, V43, P674, DOI 10.1165/rcmb.2009-0349OC; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu T, 2002, J BIOL CHEM, V277, P30887, DOI 10.1074/jbc.M203852200; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Malbon CC, 2005, NAT REV MOL CELL BIO, V6, P689, DOI 10.1038/nrm1716; Malbon CC, 2004, FRONT BIOSCI-LANDMRK, V9, P1048, DOI 10.2741/1308; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tennis MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032921; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang H, 2004, BIOCHEM SOC T, V32, P792, DOI 10.1042/BST0320792; Wick M, 2002, MOL PHARMACOL, V62, P1207, DOI 10.1124/mol.62.5.1207; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Zhang Wanguang, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P36	46	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76895	10.1371/journal.pone.0076895	http://dx.doi.org/10.1371/journal.pone.0076895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204697	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300062
J	Darvishi, E; Omidi, M; Bushehri, AAS; Golshani, A; Smith, ML				Darvishi, Emad; Omidi, Mansoor; Bushehri, Ali Akbar Shahnejat; Golshani, Ashkan; Smith, Myron L.			The Antifungal Eugenol Perturbs Dual Aromatic and Branched-Chain Amino Acid Permeases in the Cytoplasmic Membrane of Yeast	PLOS ONE			English	Article							GENETIC PROFILE ANALYSIS; CLOVE ESSENTIAL OIL; SACCHAROMYCES-CEREVISIAE; CHEMICAL-COMPOSITION; TYROSINE; PHENYLALANINE; MECHANISM; TRANSPORT; CANDIDA	Eugenol is an aromatic component of clove oil that has therapeutic potential as an antifungal drug, although its mode of action and precise cellular target(s) remain ambiguous. To address this knowledge gap, a chemical-genetic profile analysis of eugenol was done using similar to 4700 haploid Saccharomyces cerevisiae gene deletion mutants to reveal 21 deletion mutants with the greatest degree of susceptibility. Cellular roles of deleted genes in the most susceptible mutants indicate that the main targets for eugenol include pathways involved in biosynthesis and transport of aromatic and branched-chain amino acids. Follow-up analyses showed inhibitory effects of eugenol on amino acid permeases in the yeast cytoplasmic membrane. Furthermore, phenotypic suppression analysis revealed that eugenol interferes with two permeases, Tat1p and Gap1p, which are both involved in dual transport of aromatic and branched-chain amino acids through the yeast cytoplasmic membrane. Perturbation of cytoplasmic permeases represents a novel antifungal target and may explain previous observations that exposure to eugenol results in leakage of cell contents. Eugenol exposure may also contribute to amino acid starvation and thus holds promise as an anticancer therapeutic drug. Finally, this study provides further evidence of the usefulness of the yeast Gene Deletion Array approach in uncovering the mode of action of natural health products.	[Darvishi, Emad; Omidi, Mansoor; Bushehri, Ali Akbar Shahnejat] Univ Tehran, Dept Agron & Plant Breeding, Karaj, Iran; [Darvishi, Emad; Golshani, Ashkan; Smith, Myron L.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	University of Tehran; Carleton University	Golshani, A (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	ashkan_golshani@carleton.ca; myron_smith@carleton.ca	Darvishi, Emad/AAQ-2436-2020	Smith, Myron/0000-0001-6274-0053	Natural Sciences and Engineering Research Council of Canada; Ministry of Science, Research and Technology, Iran	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Science, Research and Technology, Iran	Funding was from Natural Sciences and Engineering Research Council of Canada to AG and MLS; Ministry of Science, Research and Technology, Iran to ED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir Md, 2010, BMC Chemical Biology, V10, P6, DOI 10.1186/1472-6769-10-6; Alamgir M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-583; [Anonymous], 1983, MED PLANTS N AFRICA; Carrasco H, 2012, MOLECULES, V17, P1002, DOI 10.3390/molecules17011002; Chaieb K, 2007, PHYTOTHER RES, V21, P501, DOI 10.1002/ptr.2124; CLSI, 2008, M27A3 CLSI; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Eloff JN, 1998, J ETHNOPHARMACOL, V60, P1, DOI 10.1016/S0378-8741(97)00123-2; Espinel-Ingroff A, 2008, REV IBEROAM MICOL, V25, P101, DOI 10.1016/S1130-1406(08)70027-5; Fu YM, 1999, CANCER RES, V59, P758; Galvan IJ, 2008, PHYTOCHEMISTRY, V69, P738, DOI 10.1016/j.phytochem.2007.09.007; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gayoso CW, 2005, FITOTERAPIA, V76, P247, DOI 10.1016/j.fitote.2004.12.005; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GRAUSLUND M, 1995, BBA-MOL CELL RES, V1269, P275, DOI 10.1016/0167-4889(95)00138-8; Hagan P, 2002, TRENDS MICROBIOL, V10, pS1, DOI 10.1016/S0966-842X(02)02450-2; Hughes Timothy R, 2002, Funct Integr Genomics, V2, P199, DOI 10.1007/s10142-002-0059-1; Jirovetz L, 2006, J AGR FOOD CHEM, V54, P6303, DOI 10.1021/jf060608c; Kispal G, 1996, J BIOL CHEM, V271, P24458, DOI 10.1074/jbc.271.40.24458; Knijnenburg TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-53; Lauwers E, 2007, MOL BIOL CELL, V18, P3068, DOI 10.1091/mbc.E07-03-0196; Loeffler J, 2003, CLIN INFECT DIS, V36, pS31, DOI 10.1086/344658; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; Louie GV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000993; Memarian N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-117; Miller JH., 1972, EXPT MOL GENETICS; Mir-Rashed N, 2010, MED MYCOL, V48, P949, DOI 10.3109/13693781003767584; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Pinto E, 2009, J MED MICROBIOL, V58, P1454, DOI 10.1099/jmm.0.010538-0; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Roberts SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043989; SCHMID R, 1972, AM J BOT, V59, P423, DOI 10.2307/2441553; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Sherman F., 1986, METHODS YEAST GENETI; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; Tsukahara K, 2001, MOL PHARMACOL, V60, P1254, DOI 10.1124/mol.60.6.1254; Urrestarazu A, 1998, MOL GEN GENET, V257, P230, DOI 10.1007/s004380050643; Zore GB, 2011, PHYTOMEDICINE, V18, P1181, DOI 10.1016/j.phymed.2011.03.008; [No title captured]	44	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76028	10.1371/journal.pone.0076028	http://dx.doi.org/10.1371/journal.pone.0076028			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204588	Green Submitted, Green Published, gold			2022-12-25	WOS:000326029300008
J	Munoz-Pareja, M; Guallar-Castillon, P; Mesas, AE; Lopez-Garcia, E; Rodriguez-Artalejo, F				Munoz-Pareja, Maritza; Guallar-Castillon, Pilar; Mesas, Arthur E.; Lopez-Garcia, Esther; Rodriguez-Artalejo, Fernando			Obesity-Related Eating Behaviors Are Associated with Higher Food Energy Density and Higher Consumption of Sugary and Alcoholic Beverages: A Cross-Sectional Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ADULT-POPULATION; BODY-WEIGHT; ABDOMINAL OBESITY; DIET QUALITY; US ADULTS; PATTERNS; SPAIN; YOUNG; RISK	Objectives: Obesity-related eating behaviors (OREB) are associated with higher energy intake. Total energy intake can be decomposed into the following constituents: food portion size, food energy density, the number of eating occasions, and the energy intake from energy-rich beverages. To our knowledge this is the first study to examine the association between the OREB and these energy components. Methods: Data were taken from a cross-sectional study conducted in 2008-2010 among 11,546 individuals representative of the Spanish population aged >= 18 years. Information was obtained on the following 8 self-reported OREB: not planning how much to eat before sitting down, eating precooked/canned food or snacks bought at vending machines or at fast-food restaurants, not choosing low-energy foods, not removing visible fat from meat or skin from chicken, and eating while watching TV. Usual diet was assessed with a validated diet history. Analyses were performed with linear regression with adjustment for main confounders. Results: Compared to individuals with <= 1 OREB, those with >= 5 OREB had a higher food energy density (beta 0.10; 95% CI 0.08, 0.12 kcal/g/day; p-trend <0.001) and a higher consumption of sugary drinks (beta 7; 95% CI -7, 20 ml/day; p-trend <0.05) and of alcoholic beverages (beta 24; 95% CI 10, 38 ml/day; p-trend <0.001). Specifically, a higher number of OREB was associated with higher intake of dairy products and red meat, and with lower consumption of fresh fruit, oily fish and white meat. No association was found between the number of OREB and food portion size or the number of eating occasions. Conclusions: OREB were associated with higher food energy density and higher consumption of sugary and alcoholic beverages. Avoiding OREB may prove difficult because they are firmly socially rooted, but these results may nevertheless serve to palliate the undesirable effects of OREB by reducing the associated energy intake.	[Munoz-Pareja, Maritza; Guallar-Castillon, Pilar; Lopez-Garcia, Esther; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid IdiPaz, Dept Prevent Med & Publ Hlth, CIBERESP, Madrid, Spain; [Mesas, Arthur E.] Univ Estadual Londrina, Dept Saude Colet, Londrina, Brazil	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade Estadual de Londrina	Rodriguez-Artalejo, F (corresponding author), Univ Autonoma Madrid IdiPaz, Dept Prevent Med & Publ Hlth, CIBERESP, Madrid, Spain.	fernando.artalejo@uam.es	Lopez-Garcia, Esther/A-8894-2019; Guallar-Castillon, Pilar/F-1533-2016; Mesas, Arthur/AAK-3361-2021; Mesas, Arthur Eumann/AAG-9545-2020; Mesas, Arthur Eumann/P-5879-2018	Guallar-Castillon, Pilar/0000-0003-4759-6713; Mesas, Arthur/0000-0002-0088-8607; Mesas, Arthur Eumann/0000-0002-0088-8607; Mesas, Arthur Eumann/0000-0002-0088-8607	Sanofi-Aventis; FIS [PI09/1626, PI12/1166]; Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; Plan Nacional sobre Drogas (Ministry of Health of Spain) [06/2010]	Sanofi-Aventis(Sanofi-Aventis); FIS(Instituto de Salud Carlos III); Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; Plan Nacional sobre Drogas (Ministry of Health of Spain)	The ENRICA study was funded by Sanofi-Aventis. Additional funding for data collection was obtained from FIS grant PI09/1626 and from the 'Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular'. Specific funding for this analysis was obtained from FIS grant PI12/1166 and from grant 06/2010 from the Plan Nacional sobre Drogas (Ministry of Health of Spain). The ENRICA study is being run by an independent academic steering committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS91; [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS100; [Anonymous], 2009, STAT SURV DAT REF MA; Bell EA, 1998, AM J CLIN NUTR, V67, P412; Bell EA, 2001, AM J CLIN NUTR, V73, P1010; Bellisle F, 1997, BRIT J NUTR, V77, pS57, DOI 10.1079/BJN19970104; Bes-Rastrollo M, 2008, AM J CLIN NUTR, V88, P769, DOI 10.1093/ajcn/88.3.769; Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883; Breslow RA, 2010, J AM DIET ASSOC, V110, P551, DOI 10.1016/j.jada.2009.12.026; Brown CM, 2008, INT J OBESITY, V32, pS28, DOI 10.1038/ijo.2008.204; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Dapcich V, 2004, GUIA ALIMENTACION SA; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Mesas AE, 2012, J NUTR, V142, P1321, DOI 10.3945/jn.112.158154; Feldman S, 2007, J NUTR EDUC BEHAV, V39, P257, DOI 10.1016/j.jneb.2007.04.181; Gidding SS, 2009, CIRCULATION, V119, P1161, DOI 10.1161/CIRCULATIONAHA.109.191856; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Katzen M, 2006, EAT DRINK WEIGHT LES; Leon-Munoz LM, 2012, J NUTR; Mesas AE, 2012, OBES REV, V13, P858, DOI 10.1111/j.1467-789X.2012.01005.x; Mesas AE, 2012, OBES REV, V13, P106, DOI 10.1111/j.1467-789X.2011.00936.x; Ministerio de Sanidad y Consumo, 2007, AL SAL GUIA FAM; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Rey-Lopez JP, 2011, PUBLIC HEALTH NUTR, V14, P1563, DOI 10.1017/S1368980011000383; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Pan A, 2011, CURR OPIN CLIN NUTR, V14, P385, DOI 10.1097/MCO.0b013e328346df36; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Popkin BM, 2010, AM J CLIN NUTR, V91, P1342, DOI 10.3945/ajcn.2009.28962; Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Rolls BJ, 2010, P NUTR SOC, V69, P70, DOI 10.1017/S0029665109991674; Rolls BJ, 2006, J AM DIET ASSOC, V106, P543, DOI 10.1016/j.jada.2006.01.014; Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; Thomson M, 2008, AM J HEALTH PROMOT, V22, P329, DOI 10.4278/ajhp.22.5.329; Valencia-Martin JL, 2011, ALCOHOL CLIN EXP RES, V35, P2075, DOI 10.1111/j.1530-0277.2011.01559.x; Wiecha JL, 2006, J AM DIET ASSOC, V106, P1624, DOI 10.1016/j.jada.2006.07.007; Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012	41	19	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77137	10.1371/journal.pone.0077137	http://dx.doi.org/10.1371/journal.pone.0077137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204756	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300084
J	Neymotin, SA; Hilscher, MM; Moulin, TC; Skolnick, Y; Lazarewicz, MT; Lytton, WW				Neymotin, Samuel A.; Hilscher, Markus M.; Moulin, Thiago C.; Skolnick, Yosef; Lazarewicz, Maciej T.; Lytton, William W.			I-h Tunes Theta/Gamma Oscillations and Cross-Frequency Coupling In an In Silico CA3 Model	PLOS ONE			English	Article							PYRAMIDAL NEURONS; GAMMA OSCILLATION; UP-REGULATION; HCN CHANNELS; THETA; INTERNEURONS; MODULATION; SYNCHRONIZATION; NETWORKS; CELLS	I-h channels are uniquely positioned to act as neuromodulatory control points for tuning hippocampal theta (4-12 Hz) and gamma (25 Hz) oscillations, oscillations which are thought to have importance for organization of information flow. contributes to neuronal membrane resonance and resting membrane potential, and is modulated by second messengers. We investigated oscillatory control using a multiscale computer model of hippocampal CA3, where each cell class (pyramidal, basket, and oriens-lacunosum moleculare cells), contained type-appropriate isoforms of. Our model demonstrated that modulation of pyramidal and basket allows tuning theta and gamma oscillation frequency and amplitude. Pyramidal also controlled cross-frequency coupling (CFC) and allowed shifting gamma generation towards particular phases of the theta cycle, effected via 's ability to set pyramidal excitability. Our model predicts that in vivo neuromodulatory control of allows flexibly controlling CFC and the timing of gamma discharges at particular theta phases.	[Neymotin, Samuel A.; Skolnick, Yosef; Lytton, William W.] State Univ New York Downstate, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Neymotin, Samuel A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Hilscher, Markus M.] Vienna Univ Technol, A-1040 Vienna, Austria; [Hilscher, Markus M.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Moulin, Thiago C.] Univ Fed Rio de Janeiro, Inst Med Biochem, Rio De Janeiro, Brazil; [Skolnick, Yosef] CUNY Brooklyn Coll, Comp Sci Program, Brooklyn, NY 11210 USA; [Lazarewicz, Maciej T.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Lytton, William W.] State Univ New York Downstate, Dept Neurol, Brooklyn, NY USA; [Lytton, William W.] Kings Cty Hosp, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; Technische Universitat Wien; Uppsala University; Universidade Federal do Rio de Janeiro; City University of New York (CUNY) System; Brooklyn College (CUNY); University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Neymotin, SA (corresponding author), State Univ New York Downstate, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	samn@neurosim.downstate.edu	Moulin, Thiago/I-4070-2013; Hilscher, Markus M./I-5941-2013	Moulin, Thiago/0000-0001-7811-5383; Hilscher, Markus M./0000-0001-7782-0830; Neymotin, Samuel/0000-0003-3646-5195; Lytton, William/0000-0002-3727-2849; Skolnick, Yosef/0000-0002-8617-0347	National Institutes of Health [R01MH086638]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research supported by National Institutes of Health grant R01MH086638 (http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili EA, 2002, NEWS PHYSIOL SCI, V17, P32, DOI 10.1152/physiologyonline.2002.17.1.32; Aponte Y, 2006, J PHYSIOL-LONDON, V574, P229, DOI 10.1113/jphysiol.2005.104042; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Borgers C, 2003, NEURAL COMPUT, V15, P509, DOI 10.1162/089976603321192059; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Caixeta FV, 2013, SCI REP-UK, V3, DOI 10.1038/srep02348; Canolty R, 2010, TRENDS COGN SCI, V14; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Carnevale NT, 2006, NEURON BOOK; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI-SWITZ, V3, P25, DOI 10.3389/neuro.01.005.2009; Dyhrfjeld-Johnsen J, 2008, FRONT CELL NEUROSCI, V2, DOI 10.3389/neuro.03.002.2008; El Khoury N, 2013, CIRCULATION, V127, P2009, DOI 10.1161/CIRCULATIONAHA.113.001689; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HAGIWARA N, 1989, J PHYSIOL-LONDON, V409, P121, DOI 10.1113/jphysiol.1989.sp017488; Heys JG, 2012, J NEUROSCI, V32, P9066, DOI 10.1523/JNEUROSCI.0868-12.2012; Hilscher MM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00120; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lee H, 2012, NEURON, V75, P714, DOI 10.1016/j.neuron.2012.06.016; Lisman J., 1995, SCIENCE, V267, P10; Lytton WW, 2006, NEUROINFORMATICS, V4, P163, DOI 10.1385/NI:4:2:163; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Migliore M, 2004, J COMPUT NEUROSCI, V16, P5, DOI 10.1023/B:JCNS.0000004837.81595.b0; Migliore M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036867; Newman E, 2012, SOC NEUR ABSTR, V42; Neymotin Samuel, 2008, V151, P119; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; Tsuno Y, 2013, J PHYSIOL-LONDON, V591, P2611, DOI 10.1113/jphysiol.2012.250431; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Wang XJ, 1996, J NEUROSCI, V16, P6402; White JA, 2000, P NATL ACAD SCI USA, V97, P8128, DOI 10.1073/pnas.100124097; Winograd M, 2008, P NATL ACAD SCI USA, V105, P7298, DOI 10.1073/pnas.0800360105; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	58	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76285	10.1371/journal.pone.0076285	http://dx.doi.org/10.1371/journal.pone.0076285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204609	Green Published, gold			2022-12-25	WOS:000326029300017
J	Okamoto-Terry, H; Umeki, K; Nakanishi-Matsui, M; Futai, M				Okamoto-Terry, Haruko; Umeki, Kaori; Nakanishi-Matsui, Mayumi; Futai, Masamitsu			Glu-44 in the Amino-terminal alpha-Helix of Yeast Vacuolar ATPase E Subunit (Vma4p) Has a Role for VoV1 Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Confocal Microscopy; Enzyme Catalysis; Protein Assembly; Yeast; V-ATPase	H+-ATPASE; V-ATPASE; MUTATIONAL ANALYSIS; PROTON PUMPS; G VMA10P; STATOR; ACIDIFICATION; DOMAIN; ISOFORM; GLUCOSE	Background: The V-ATPase is inactivated by reversible disassembly upon glucose starvation. Results: Glu-44 of the V-ATPase E subunit was identified by alanine scanning mutagenesis with reduced disassembly under glucose starvation. Conclusion: Mutations to Glu-44 of the E subunit disrupt normal disassembly of the V-ATPase and affect catalytic activity. Significance: Interactions with the E subunit in the V-ATPase are important for controlling disassembly and catalytic activity. The proton (H+) pumping vacuolar-type ATPase (V-ATPase) is a rotary enzyme that plays a pivotal role in forming intracellular acidic compartments in eukaryotic cells. In Saccharomyces cerevisiae, the membrane extrinsic catalytic V-1 and the transmembrane proton-pumping V-o complexes have been shown to reversibly dissociate upon removal of glucose from the medium. However, the basis of this disassembly is largely unknown. In the earlier study, we have found that the amino-terminal -helical domain between Lys-33 and Lys-83 of yeast E subunit (Vma4p) in the peripheral stalk of the V-1 complex has a role in glucose-dependent VoV1 assembly. Results of alanine-scanning mutagenesis within the domain revealed that the Vma4p Glu-44 is a key residue in VoV1 disassembly. Biochemical analysis on Vma4p Glu-44 to Ala, Asn, Asp, and Gln substitutions indicated that Glu-44 has a role in V-ATPase catalysis. These results suggest that Glu-44 is one of the key functional residues for subunit interaction in the V-ATPase stalk complex that allows both efficient rotation catalysis and assembly.	[Okamoto-Terry, Haruko; Umeki, Kaori; Nakanishi-Matsui, Mayumi; Futai, Masamitsu] Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Futai Special Lab, Yahaba, Iwate 0283694, Japan	Iwate Medical University	Okamoto-Terry, H (corresponding author), Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Futai Special Lab, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	hokamoto@iwate-med.ac.jp; futaim@iwate-med.ac.jp	Okamoto, Haruko/AAG-9512-2021	Okamoto, Haruko/0000-0001-5981-6571	Japanese Society for the Promotion of Science [23570171]; Japan Science and Technology Agency; Hayashi Memorial Foundation for Female Natural Scientists	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants-in-aid from Japanese Society for the Promotion of Science 23570171 (to H. O.-T.) and supported in part by a grant for Research Seeds Quest Program from Japan Science and Technology Agency (to M. F.) and by the Hayashi Memorial Foundation for Female Natural Scientists (to M. N.-M.).	Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BLABER M, 1993, SCIENCE, V260, P1637, DOI 10.1126/science.8503008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charsky CMH, 2000, J BIOL CHEM, V275, P37232, DOI 10.1074/jbc.M006640200; Compton MA, 2006, J BIOL CHEM, V281, P15312, DOI 10.1074/jbc.M600890200; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Flannery AR, 2008, J BIOL CHEM, V283, P29099, DOI 10.1074/jbc.M803280200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Hayashi K, 2008, BBA-BIOENERGETICS, V1777, P1370, DOI 10.1016/j.bbabio.2008.06.011; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2005, J BIOENERG BIOMEMBR, V37, P399, DOI 10.1007/s10863-005-9479-7; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kane PM, 2000, J EXP BIOL, V203, P81; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merzendorfer H, 2000, BBA-BIOMEMBRANES, V1467, P369, DOI 10.1016/S0005-2736(00)00233-9; Nakanishi-Matsui M., 2012, ROLES REGULATORY MEC, P53; Okamoto H., 2013, VACUOLAR TYPE ATPASE, P2719; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Owegi MA, 2005, J BIOL CHEM, V280, P18393, DOI 10.1074/jbc.M412567200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P447, DOI 10.1007/s10863-011-9379-y; Rishikesan S, 2011, J BIOENERG BIOMEMBR, V43, P187, DOI 10.1007/s10863-011-9342-y; Schnitzer D, 2011, PLANT CELL PHYSIOL, V52, P946, DOI 10.1093/pcp/pcr044; Stewart AG, 2012, STRUCTURE, V20, P1799, DOI 10.1016/j.str.2012.10.003; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	39	8	8	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 20	2013	288	51					36236	36243		10.1074/jbc.M113.506741	http://dx.doi.org/10.1074/jbc.M113.506741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278IQ	24196958	Green Published, hybrid			2022-12-25	WOS:000328883400006
J	Turegun, B; Kast, DJ; Dominguez, R				Turegun, Bengi; Kast, David J.; Dominguez, Roberto			Subunit Rtt102 Controls the Conformation of the Arp7/9 Heterodimer and Its Interactions with Nucleotide and the Catalytic Subunit of SWI/SNF Remodelers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ATP; Chromatin Remodeling; Isothermal Titration Calorimetry; Protein-Protein interactions; X-ray Scattering; Actin-related Proteins; Nucleotide Binding	ACTIN-RELATED PROTEINS; X-RAY-SCATTERING; NUCLEAR ACTIN; BIOLOGICAL MACROMOLECULES; SACCHAROMYCES-CEREVISIAE; CHROMATIN; NUCLEOSOME; COMPLEX; CORE; SWI2/SNF2	Background: The function of subunit Rtt102 of SWI/SNF remodelers is largely unknown. Results: Rtt102 induces a conformational change in the Arp7/9 heterodimer, promoting nucleotide binding and restricting binding of Arp7/9 to a shorter segment of the HSA domain. Conclusion: Rtt102 stabilizes the structure of Arp7/9-containing remodelers. Significance: This work establishes Rtt102 as a modulator of SWI/SNF remodeler structure through effects on the Arp7/9 heterodimer. Chromatin-remodeling complexes are assembled around a catalytic subunit that contains a central ATPase domain and flanking sequences that recruit auxiliary subunits. The catalytic subunits of SWI/SNF remodelers recruit Arp7/9 through a helicase/SANT-associated (HSA) domain N-terminal to the ATPase domain. Arp7/9-containing remodelers also carry the auxiliary subunit Rtt102, but the role of this subunit is poorly understood. Here, we show that Rtt102 binds with nanomolar affinity to the Arp7/9 heterodimer and modulates its conformation and interactions with the ATPase subunit and nucleotide. When bound to Rtt102, Arp7/9 interacts with a shorter segment of the HSA domain. Structural analysis by small-angle x-ray scattering further shows that when bound to Rtt102, the complex of Arp7/9 with the catalytic subunit assumes a more stable compact conformation. We also found that Arp7, Arp9, and Arp7/9 interact very weakly with ATP, but Rtt102 promotes high-affinity ATP binding to a single site in the heterodimer. Collectively, the results establish a function for subunit Rtt102 as a stabilizing factor for the Arp7/9 heterodimer, enhancing its interaction with nucleotide and controlling the conformation of SWI/SNF remodelers in an Arp7/9-dependent manner.	[Turegun, Bengi; Kast, David J.; Dominguez, Roberto] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Turegun, Bengi] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Dominguez, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Physiol, 728 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	droberto@mail.med.upenn.edu	Kast, David/O-2388-2016	Kast, David/0000-0002-1031-1211	National Science Foundation Grant [DMR-0936384]; National Institutes of Health Grant from NIGMS [GM103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM073791] Funding Source: NIH RePORTER	National Science Foundation Grant(National Science Foundation (NSF)); National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Gillilan (MacCHESS) for help with SAXS data collection and Adam Zwolak for assistance with SAXS data analysis. We thank Dr. Les Dutton for access to the CD spectrophotometer instrument. Data collection at CHESS beamline F2 was supported by National Science Foundation Grant DMR-0936384 (to CHESS) and National Institutes of Health Grant GM103485 from NIGMS (to MacCHESS).	Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Bingham JB, 1999, CURR BIOL, V9, P223, DOI 10.1016/S0960-9822(99)80095-5; Blanchet CE, 2013, ANNU REV PHYS CHEM, V64, P37, DOI 10.1146/annurev-physchem-040412-110132; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; He X, 2008, BIOCHEMISTRY-US, V47, P7025, DOI 10.1021/bi702304p; Kapoor P, 2013, NAT STRUCT MOL BIOL, V20, P426, DOI 10.1038/nsmb.2529; Kast DJ, 2011, EMBO J, V30, P2097, DOI 10.1038/emboj.2011.150; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Lee KK, 2004, BIOCHEM SOC T, V32, P899, DOI 10.1042/BST0320899; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Nishimoto N, 2012, J CELL SCI, V125, P3870, DOI 10.1242/jcs.104349; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Saravanan M, 2012, P NATL ACAD SCI USA, V109, P20883, DOI 10.1073/pnas.1214735109; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Sen P, 2011, NUCLEIC ACIDS RES, V39, P9155, DOI 10.1093/nar/gkr622; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Sunada R, 2005, YEAST, V22, P753, DOI 10.1002/yea.1239; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Toft KN, 2008, ANAL CHEM, V80, P3648, DOI 10.1021/ac800011y; Tolstorukov MY, 2013, P NATL ACAD SCI USA, V110, P10165, DOI 10.1073/pnas.1302209110; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	51	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					35758	35768		10.1074/jbc.M113.514083	http://dx.doi.org/10.1074/jbc.M113.514083			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189066	hybrid, Green Published			2022-12-25	WOS:000329814700014
J	Wu, XW; Qi, J; Bradner, JE; Xiao, GT; Chen, LF				Wu, Xuewei; Qi, Jun; Bradner, James E.; Xiao, Gutian; Chen, Lin-Feng			Bromodomain and Extraterminal (BET) Protein Inhibition Suppresses Human T Cell Leukemia Virus 1 (HTLV-1) Tax Protein-mediated Tumorigenesis by Inhibiting Nuclear Factor kappa B (NF-kappa B) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Leukemia; NF-B; Signaling; Transcription; Brd4; HTLV-1; JQ1; TAX; Acetylation	LYMPHOTROPIC VIRUS; GENE-EXPRESSION; RAT FIBROBLASTS; DOWN-REGULATION; TRANSFORMATION; BRD4; PHOSPHORYLATION; ACETYLATION; ACTIVATION; MECHANISMS	Background: The HTLV-1 oncoprotein Tax induces sustained NF-B activation for cell survival and proliferation gene expression. Results: Recruitment of Brd4 to acetylated RelA is essential for Tax-mediated NF-B target gene expression and cell proliferation. Conclusion: Blocking the binding of Brd4 to acetylated RelA by JQ1 suppresses Tax-mediated NF-B activation and tumorigenesis. Significance: Inhibiting Brd4 could be a potential therapeutic strategy for diseases associated with HTLV-1 infection. The etiology of human T cell leukemia virus 1 (HTLV-1)-mediated adult T cell leukemia is associated with the ability of viral oncoprotein Tax to induce sustained NF-B activation and the expression of many NF-B target genes. Acetylation of the RelA subunit of NF-B and the subsequent recruitment of bromodomain-containing factor Brd4 are important for the expression of NF-B target genes in response to various stimuli. However, their contributions to Tax-mediated NF-B target gene expression and tumorigenesis remain unclear. Here we report that Tax induced the acetylation of lysine 310 of RelA and the binding of Brd4 to acetylated RelA to facilitate Tax-mediated transcriptional activation of NF-B. Depletion of Brd4 down-regulated Tax-mediated NF-B target gene expression and cell proliferation. Inhibiting the interaction of Brd4 and acetylated RelA with the bromodomain extraterminal protein inhibitor JQ1 suppressed the proliferation of Tax-expressing rat fibroblasts and Tax-positive HTLV-1-infected cells and Tax-mediated cell transformation and tumorigenesis. Moreover, JQ1 attenuated the Tax-mediated transcriptional activation of NF-B, triggering the polyubiquitination and proteasome-mediated degradation of constitutively active nuclear RelA. Our results identify Brd4 as a key regulator for Tax-mediated NF-B gene expression and suggest that targeting epigenetic regulators such as Brd4 with the bromodomain extraterminal protein inhibitor might be a potential therapeutic strategy for cancers and other diseases associated with HTLV-1 infection.	[Wu, Xuewei; Chen, Lin-Feng] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Chen, Lin-Feng] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Qi, Jun; Bradner, James E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Xiao, Gutian] Univ Pittsburgh, Med Ctr, Inst Canc, Pittsburgh, PA 15213 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Dana-Farber Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chen, LF (corresponding author), Univ Illinois, Coll Med, Dept Biochem, MC 714, Urbana, IL 61801 USA.	lfchen@life.illinois.edu			National Institutes of Health [DK-085158, DK-093865, CA116616]; University of Illinois at Urbana-Champaign; NATIONAL CANCER INSTITUTE [R01CA116616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085158, R21DK093865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois at Urbana-Champaign; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported, in whole or in part, by National Institutes of Health Grants DK-085158, DK-093865 (to L. F. C.), and CA116616 (to G. T. X.). This work was also supported by funds provided by the University of Illinois at Urbana-Champaign (to L. F. C.).	Bex F, 1998, METHODS, V16, P83, DOI 10.1006/meth.1998.0646; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Chan JK, 2012, IMMUNOL REV, V246, P286, DOI 10.1111/j.1600-065X.2012.01094.x; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; Choi KC, 2009, MOL CANCER RES, V7, P2011, DOI 10.1158/1541-7786.MCR-09-0239; Chung CW, 2012, PROGR MED CHEM, V51, P1, DOI 10.1016/B978-0-12-396493-9.00001-7; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; DEPPER JM, 1984, J IMMUNOL, V133, P1691; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; GREENE WC, 1989, IMMUNOL TODAY, V10, P272, DOI 10.1016/0167-5699(89)90141-2; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kashanchi F, 2005, ONCOGENE, V24, P5938, DOI 10.1038/sj.onc.1208973; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Matsumoto K, 1997, J VIROL, V71, P4445, DOI 10.1128/JVI.71.6.4445-4451.1997; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; McBride AA, 2004, TRENDS MICROBIOL, V12, P527, DOI 10.1016/j.tim.2004.10.002; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Peloponese JM, 2006, IMMUNOL RES, V34, P1, DOI 10.1385/IR:34:1:1; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Qu ZX, 2011, VIRUSES-BASEL, V3, P714, DOI 10.3390/v3060714; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; SMITH MR, 1991, J CLIN INVEST, V87, P761, DOI 10.1172/JCI115078; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Taylor GP, 2005, ONCOGENE, V24, P6047, DOI 10.1038/sj.onc.1208979; Taylor JM, 2008, APOPTOSIS, V13, P733, DOI 10.1007/s10495-008-0208-7; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; Waldmann TA, 2007, ONCOGENE, V26, P3699, DOI 10.1038/sj.onc.1210368; Waldmann TA, 2002, J CLIN IMMUNOL, V22, P51, DOI 10.1023/A:1014416616687; WANO Y, 1988, P NATL ACAD SCI USA, V85, P9733, DOI 10.1073/pnas.85.24.9733; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhao LL, 2013, J MED CHEM, V56, P3833, DOI 10.1021/jm301793a; Zimmerman B, 2010, VET PATHOL, V47, P677, DOI 10.1177/0300985810370009; Zou Z., 2013, ONCOGENE; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	53	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 13	2013	288	50					36094	36105		10.1074/jbc.M113.485029	http://dx.doi.org/10.1074/jbc.M113.485029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	291FZ	24189064	Green Published, hybrid			2022-12-25	WOS:000329814700044
J	Donohue, SL; DeSantis, LRG; Schubert, BW; Ungar, PS				Donohue, Shelly L.; DeSantis, Larisa R. G.; Schubert, Blaine W.; Ungar, Peter S.			Was the Giant Short-Faced Bear a Hyper-Scavenger? A New Approach to the Dietary Study of Ursids Using Dental Microwear Textures	PLOS ONE			English	Article							URSUS-SPELAEUS; FEEDING-BEHAVIOR; LARGE CARNIVORES; GENOMES REVEAL; ARCTODUS-SIMUS; POLAR BEARS; BROWN BEARS; FOOD-HABITS; SUN BEARS; LA-BREA	Dramatic environmental changes associated with global cooling since the late Miocene, and the onset of glacial-interglacial cycles in the Pleistocene served as a backdrop to the evolutionary radiation of modern bears (family Ursidae). These environmental changes likely prompted changes in food availability, and triggered dietary adaptations that served as motive forces in ursid evolution. Here, we assess correspondence of dental microwear textures of first and second lower molars with diet in extant ursids. We use the resulting baseline data to evaluate the hypothesis that the Pleistocene giant short-faced bear, Arctodus simus, was a bone consumer and hyper-scavenger at Rancho La Brea, California, USA. Significant variation along the tooth row is consistent with functional differentiation, with the second molar serving as a better dietary recorder than the first. Results evince significant variation among species: carnivorous and omnivorous ursids (Ursus maritimus, U. americanus) have significantly higher and more variable complexity (Asfc) than more herbivorous ones (Ailuropoda melanoleuca, Tremarctos ornatus, U. malayanus), and A. melanoleuca is differentiated from U. maritimus and U. americanus by significantly higher and more variable anisotropy (epLsar) values. Arctodus simus from Rancho La Brea exhibits wear attributes most comparable to its closest living relative (T. ornatus), which is inconsistent with hard-object (e. g., bone) consumption, and the hypothesis that short-faced bears were bone consuming hyper-scavengers across their range.	[Donohue, Shelly L.; DeSantis, Larisa R. G.] Vanderbilt Univ, Dept Earth & Environm Sci, Nashville, TN 37235 USA; [Schubert, Blaine W.] Dept Geosci, Johnson City, TN USA; [Schubert, Blaine W.] Don Sundquist Ctr Excellence Paleontol, Johnson City, TN USA; [Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA	Vanderbilt University; University of Arkansas System; University of Arkansas Fayetteville	DeSantis, LRG (corresponding author), Vanderbilt Univ, Dept Earth & Environm Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	larisa.desantis@vanderbilt.edu		DeSantis, Larisa/0000-0003-1159-9154	Geologic Society of America; American Society of Mammalogists; Vanderbilt University; University of Arkansas; National Science Foundation [EAR1053839]	Geologic Society of America; American Society of Mammalogists; Vanderbilt University; University of Arkansas; National Science Foundation(National Science Foundation (NSF))	This research was funded by the Geologic Society of America, the American Society of Mammalogists, Vanderbilt University, the University of Arkansas, and the National Science Foundation (EAR1053839). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Bentzen TW, 2007, CAN J ZOOL, V85, P596, DOI 10.1139/Z07-036; BOCHERENS H, 1995, CR ACAD SCI II, V320, P779; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Christiansen P, 1999, ANN ZOOL FENN, V36, P93; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; DAEGLING DJ, 1994, S AFR J SCI, V90, P527; DEROCHER AE, 1993, ARCTIC, V46, P251; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; DIERENFELD ES, 1982, J NUTR, V112, P636, DOI 10.1093/jn/112.4.636; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Dyck MG, 2009, J MAMMAL, V90, P585, DOI 10.1644/08-MAMM-A-103R2.1; EMSLIE SD, 1985, CONTRIBUTIONS SCI NA, V0371, P00001; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Figueirido B, 2009, J ZOOL, V277, P70, DOI 10.1111/j.1469-7998.2008.00511.x; Figueirido B, 2010, J VERTEBR PALEONTOL, V30, P262, DOI 10.1080/02724630903416027; Fox-Dobbs K, 2008, PALAEOGEOGR PALAEOCL, V261, P30, DOI 10.1016/j.palaeo.2007.12.011; Fredriksson GM, 2006, BIOL J LINN SOC, V89, P489, DOI 10.1111/j.1095-8312.2006.00688.x; Goillot C, 2009, PALAEOGEOGR PALAEOCL, V271, P13, DOI 10.1016/j.palaeo.2008.09.004; Hansen RL, 2010, ZOO BIOL, V29, P470, DOI 10.1002/zoo.20280; Haupt RJ, 2013, J MAMMAL, V94, P856, DOI 10.1644/12-MAMM-A-204.1; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Kurten B., 1980, PLEISTOCENE MAMMALS; Kurten B., 1967, ACTA ZOOL FENN, V117, P1; Long Y, 2004, GIANT PANDAS BIOL CO, P103; Matheus, 2003, LOCOMOTOR ADAPTATION; Matheus PE, 1995, QUATERNARY RES, V44, P447, DOI 10.1006/qres.1995.1090; Meloro C, 2011, J VERTEBR PALEONTOL, V31, P428, DOI 10.1080/02724634.2011.550357; Merceron G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009542; Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; Peigne S, 2009, P NATL ACAD SCI USA, V106, P15390, DOI 10.1073/pnas.0907373106; PEYTON B, 1980, J MAMMAL, V61, P639, DOI 10.2307/1380309; Pinto-Llona AC, 2013, PALAEOGEOGR PALAEOCL, V370, P41, DOI 10.1016/j.palaeo.2012.11.017; Plavcan JM, 2001, EVOL ANTHROPOL, V10, P204, DOI 10.1002/evan.20001; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; RAINE RM, 1990, INT C BEAR, V8, P297; Roof Jayde C., 1997, Florida Field Naturalist, V25, P92; Sacco T, 2004, J ZOOL, V263, P41, DOI 10.1017/S0952836904004856; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schmitt E, 2011, THESIS E TENNESSEE S; Schubert BW, 2010, J ZOOL, V280, P257, DOI 10.1111/j.1469-7998.2009.00656.x; Schubert BW, 2009, BOREAS, V38, P482, DOI 10.1111/j.1502-3885.2009.00090.x; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Scott JR, 2012, MAMMALIA, V76, P157, DOI 10.1515/mammalia-2011-0083; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sorkin B, 2006, HIST BIOL, V18, P375, DOI 10.1080/08912960600618073; Stratman Marty R., 1999, Florida Field Naturalist, V27, P95; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Wong ST, 2002, URSUS, V13, P127; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	55	45	48	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77531	10.1371/journal.pone.0077531	http://dx.doi.org/10.1371/journal.pone.0077531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204860	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500033
J	Huang, R; Zhao, M; Yang, XF; Huang, JM; Yang, Y; Chen, BF; Tan, JB; Huang, JK; Li, Z; Lv, YJ; Ji, GY				Huang, Rui; Zhao, Min; Yang, Xingfen; Huang, Junming; Yang, Ying; Chen, Bifeng; Tan, Jianbin; Huang, Jiankang; Li, Zhi; Lv, Yingjian; Ji, Guiyuan			Effects of Prunella vulgaris on the Mice Immune Function	PLOS ONE			English	Article							EXTRACT; ACID	The present study was designed to evaluate the effects of Prunella Vulgaris (P. vulgaris) on the immune function in mice. The mice were randomly divided into one control group and three treatment groups of 10 mice each. The control group received pure water and the treatment groups received P. vulgaris extract at concentrations of 0.15, 0.30 and 0.90 g/kg BW orally for 30 days, respectively. Changes in cell immune function, non-specific immunity and humoral immunity function were evaluated. Active lymphocytes and T lymphocyte subsets were determined by fluorescence-activated cell sorting (FACS). Certain Serum concentrations of cytokines were measured by enzyme-linked immunosorbent assay (ELISA). The results showed that, for cell immune function, compared with the control group, foot pad thickness in high dose group increased significantly (p<0.01), whereas no significant difference in the proliferative ability of splenic lymphocytes was observed among all groups (p>0.05). For non-specific immunity, NK cell activity increased significantly in a dose-dependent manner in P. vulgaris treated mice (p<0.01), mononuclear-macrophage function in medium and high dose P. vulgaris treated mice were significantly higher than that of the control group (p<0.05). For humoral immunity, no significant differences were observed in terms of the half value of hemolysis (HC50), number of hemolytic plaques and serum IgG level (p>0.05). The percentage of active T and Th lymphocytes of mice peripheral blood in high dose group were significantly higher than that of the control group (p<0.01). There was no significant difference in serum levels of IL-1 beta, IL-4, IL-10 and IFN-gamma among all of the four groups (p>0.05). The data indicated that 0.90 g/kg BW P. vulgaris extract (equivalent to 7.5 g/kg BW crude drug) had some effect on cellular immune function and non-specific immune function in mice.	[Huang, Rui; Zhao, Min; Yang, Xingfen; Huang, Junming; Yang, Ying; Chen, Bifeng; Tan, Jianbin; Huang, Jiankang; Li, Zhi; Lv, Yingjian; Ji, Guiyuan] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Huang, Rui; Ji, Guiyuan] Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Huang, Rui] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Sun Yat Sen University	Yang, XF (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou, Guangdong, Peoples R China.	xingfenyang@hotmail.com			National High Technology Research and Development Program 863 [2010AA023001]; Guangdong Natural Science Foundation [S2013010013289]; Guangdong science and technology plan project [201300000161]; Guangdong provincial bureau of Chinese medicine project [20132108]	National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong science and technology plan project; Guangdong provincial bureau of Chinese medicine project	The authors thank the National High Technology Research and Development Program 863 (2010AA023001), Guangdong Natural Science Foundation project (S2013010013289), Guangdong science and technology plan project (201300000161), and the Guangdong provincial bureau of Chinese medicine project (20132108) for their financial contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen C.Y., 2009, CHIN GER J CLIN ONCO, V8, P426, DOI [10.1007/s10330-009-0067-x, DOI 10.1007/S10330-009-0067-X]; Fan YL, 2001, PHARM CLIN CHINESE M, V17, P10; Fuentes-Arderiu X, 2009, CYTOM PART B-CLIN CY, V76B, P291, DOI 10.1002/cyto.b.20479; Han EH, 2009, FOOD CHEM TOXICOL, V47, P62, DOI 10.1016/j.fct.2008.10.010; Harput US, 2006, PHYTOTHER RES, V20, P157, DOI 10.1002/ptr.1805; He R., 2009, WORLD SCI TECH, V11, P834; Huang N, 2009, J AGR FOOD CHEM, V57, P10579, DOI 10.1021/jf9023728; Ikeda Y, 2007, J IMMUNOL, V178, P4854, DOI 10.4049/jimmunol.178.8.4854; Jiang LH, 2007, LISHIZHEN MED MAT ME, V18, P2622; Liu GM, 2009, J CHIN MED MAT, V3, P1920; Ministry of Health of the people's Republic of China, 2003, INT SIST U ESP ESP E, P22; Pharmacopoeia Commission of People's Republic of China, 2010, PHARM PEOPL REP CH 1; Psotova J, 2005, FITOTERAPIA, V76, P556, DOI 10.1016/j.fitote.2005.04.019; Ryu SY, 2000, PLANTA MED, V66, P358, DOI 10.1055/s-2000-8531; Wang GX, 2009, CH J PUBLIC HLTH, V25, P1468; Warnatz K, 2008, CYTOM PART B-CLIN CY, V74B, P261, DOI 10.1002/cyto.b.20432; Yang Kun, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P37; Zdarilova A, 2009, TOXICOL IN VITRO, V23, P386, DOI 10.1016/j.tiv.2008.12.021; Zheng Y., 2004, CHINESE J INTEGRATED, V12, P10; 陆军, 2012, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V30, P49; 王文佳, 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P107	21	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77355	10.1371/journal.pone.0077355	http://dx.doi.org/10.1371/journal.pone.0077355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204816	Green Published, Green Submitted, gold			2022-12-25	WOS:000326334500025
J	Idema, T; Dubuis, JO; Kang, L; Manning, ML; Nelson, PC; Lubensky, TC; Liu, AJ				Idema, Timon; Dubuis, Julien O.; Kang, Louis; Manning, M. Lisa; Nelson, Philip C.; Lubensky, Tom C.; Liu, Andrea J.			The Syncytial Drosophila Embryo as a Mechanically Excitable Medium	PLOS ONE			English	Article							F-ACTIN; CELL-DIVISION; LIVING CELLS; CALCIUM; MICRORHEOLOGY; CYTOSKELETON; DYNAMICS; CLEAVAGE; GASTRULATION; MICRODOMAINS	Mitosis in the early syncytial Drosophila embryo is highly correlated in space and time, as manifested in mitotic wavefronts that propagate across the embryo. In this paper we investigate the idea that the embryo can be considered a mechanically-excitable medium, and that mitotic wavefronts can be understood as nonlinear wavefronts that propagate through this medium. We study the wavefronts via both image analysis of confocal microscopy videos and theoretical models. We find that the mitotic waves travel across the embryo at a well-defined speed that decreases with replication cycle. We find two markers of the wavefront in each cycle, corresponding to the onsets of metaphase and anaphase. Each of these onsets is followed by displacements of the nuclei that obey the same wavefront pattern. To understand the mitotic wavefronts theoretically we analyze wavefront propagation in excitable media. We study two classes of models, one with biochemical signaling and one with mechanical signaling. We find that the dependence of wavefront speed on cycle number is most naturally explained by mechanical signaling, and that the entire process suggests a scenario in which biochemical and mechanical signaling are coupled.	[Idema, Timon; Kang, Louis; Nelson, Philip C.; Lubensky, Tom C.; Liu, Andrea J.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Dubuis, Julien O.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Manning, M. Lisa] Syracuse Univ, Dept Phys, Syracuse, NY USA	University of Pennsylvania; Princeton University; Syracuse University	Liu, AJ (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	ajliu@sas.upenn.edu	Nelson, Philip C/I-6251-2015; Idema, Timon/I-6547-2012; Liu, Andrea/GYD-4759-2022; Manning, Lisa/B-1746-2012; Liu, Andrea J/K-3968-2017	Nelson, Philip C/0000-0002-1782-3076; Idema, Timon/0000-0002-8901-5342; Liu, Andrea/0000-0002-2295-2729; Manning, Lisa/0000-0001-7682-2324; Liu, Andrea J/0000-0002-2295-2729	Netherlands Organization for Scientific Research (NWO); National Science Foundation (NSF) [NSF-DMR-1104637]; NSF [NSF-DMR-1104707]; Division Of Materials Research [1104707] Funding Source: National Science Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The study was supported by a Rubicon grant from the Netherlands Organization for Scientific Research (NWO) to T. I., http://www.nwo.nl/rubicon; Grant NSF-DMR-1104637 from the National Science Foundation (NSF) to A.J.L., and grant NSF-DMR-1104707 from the NSF to L. K. and T. C. L., http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLADZE KI, 1982, NATURE, V296, P424, DOI 10.1038/296424a0; Alberts B, 2008, MOL BIOL CELL; ALLBRITTON NL, 1993, CELL CALCIUM, V14, P691, DOI 10.1016/0143-4160(93)90095-N; [Anonymous], 2007, PRINCIPLES CONDENSED; Bischofs IB, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021911; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; DEVREOTES P, 1989, SCIENCE, V245, P1054, DOI 10.1126/science.2672337; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; Foe Victoria E., 1993, P149; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; Gardel ML, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158302; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Idema T, 2013, ARXIV13043657; Idema T, 2013, EUR BIOPHYS J BIOPHY, V42, P647, DOI 10.1007/s00249-013-0912-2; Jaffe LF, 2008, PHILOS T R SOC B, V363, P1311, DOI 10.1098/rstb.2007.2249; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; KAGEYAMA T, 1986, ZOOL SCI, V3, P1046; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; KANE DA, 1993, DEVELOPMENT, V119, P447; Kanesaki T, 2011, INTEGR BIOL-UK, V3, P1112, DOI 10.1039/c1ib00059d; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; KEATING TJ, 1994, J CELL SCI, V107, P2229; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; LANG I, 1986, J CELL BIOL, V102, P1183, DOI 10.1083/jcb.102.4.1183; Lee KJ, 1996, PHYS REV LETT, V76, P1174, DOI 10.1103/PhysRevLett.76.1174; LEVINE H, 1991, PHYS REV LETT, V66, P2400, DOI 10.1103/PhysRevLett.66.2400; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; MULLER O, 1991, MACROMOLECULES, V24, P3111; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Palmer A, 1999, BIOPHYS J, V76, P1063, DOI 10.1016/S0006-3495(99)77271-1; Parry H, 2006, BIOCHEM SOC T, V34, P385, DOI 10.1042/BST0340385; Parry H, 2005, J CELL BIOL, V171, P47, DOI 10.1083/jcb.200503139; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Saka Y, 2001, DEV BIOL, V229, P307, DOI 10.1006/dbio.2000.0101; SATOH N, 1977, DEV GROWTH DIFFER, V19, P111; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; SCHMIDT CF, 1989, MACROMOLECULES, V22, P3638, DOI 10.1021/ma00199a023; Schotz EM, 2004, THESIS U KONSTANZ KO; SILVER RB, 1989, DEV BIOL, V131, P11; SILVER RB, 1990, ANN NY ACAD SCI, V582, P207; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; TRINKAUS JP, 1992, DEVELOPMENT, P75; Tyson JJ, 2011, CURR BIOL, V21, pR185, DOI 10.1016/j.cub.2011.01.042; WARN RM, 1984, J CELL BIOL, V98, P156, DOI 10.1083/jcb.98.1.156; Whitaker M, 2008, PHILOS T R SOC B, V363, P1401, DOI 10.1098/rstb.2008.2259; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; WINFREE AT, 1972, SCIENCE, V175, P634, DOI 10.1126/science.175.4022.634; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7	56	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e77216	10.1371/journal.pone.0077216	http://dx.doi.org/10.1371/journal.pone.0077216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24204774	Green Submitted, Green Published, gold			2022-12-25	WOS:000326334500020
J	Wu, GS; Song, YL; Yin, ZQ; Guo, JJ; Wang, SP; Zhao, WW; Chen, XP; Zhang, QW; Lu, JJ; Wang, YT				Wu, Guo-Sheng; Song, Yue-Lin; Yin, Zhi-Qi; Guo, Jia-Jie; Wang, Sheng-Peng; Zhao, Wen-Wen; Chen, Xiu-Ping; Zhang, Qing-Wen; Lu, Jin-Jian; Wang, Yi-Tao			Ganoderiol A-Enriched Extract Suppresses Migration and Adhesion of MDA-MB-231 Cells by Inhibiting FAK-SRC-Paxillin Cascade Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; RHO-GTPASES; TYROSINE PHOSPHORYLATION; MOLECULAR-MECHANISMS; ADENOCARCINOMA CELLS; POTENTIAL TARGET; TUMOR INVASION; CYCLE ARREST; IN-VITRO; N-WASP	Cell adhesion, migration and invasion are critical steps for carcinogenesis and cancer metastasis. Ganoderma lucidum, also called Lingzhi in China, is a traditional Chinese medicine, which exhibits anti-proliferation, anti-inflammation and anti-metastasis properties. Herein, GAEE, G. lucidum extract mainly contains ganoderiol A (GA), dihydrogenated GA and GA isomer, was shown to inhibit the abilities of adhesion and migration, while have a slight influence on that of invasion in highly metastatic breast cancer MDA-MB-231 cells at non-toxic doses. Further investigation revealed that GAEE decreased the active forms of focal adhesion kinase (FAK) and disrupted the interaction between FAK and SRC, which lead to deactivating of paxillin. Moreover, GAEE treatment downregulated the expressions of RhoA, Rac1, and Cdc42, and decreased the interaction between neural Wiskott-Aldrich Syndrome protein (N-WASP) and Cdc42, which impair cell migration and actin assembly. To our knowledge, this is the first report to show that G. lucidum triterpenoids could suppress cell migration and adhesion through FAK-SRC-paxillin signaling pathway. Our study also suggests that GAEE may be a potential agent for treatment of breast cancer.	[Wu, Guo-Sheng; Song, Yue-Lin; Guo, Jia-Jie; Wang, Sheng-Peng; Zhao, Wen-Wen; Chen, Xiu-Ping; Zhang, Qing-Wen; Lu, Jin-Jian; Wang, Yi-Tao] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Yin, Zhi-Qi] China Pharmaceut Univ, Dept Nat Med Chem, Nanjing, Jiangsu, Peoples R China	University of Macau; China Pharmaceutical University	Lu, JJ (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China.	jinjianlu@umac.mo; ytwang@umac.mo	Wang, Yitao/O-5184-2016; Chen, Xiuping/O-8927-2017; Lu, Jinjian/R-6207-2019; Song, Yuelin/J-6508-2014; Zhang, Qingwen/F-9419-2011; Chen, Xiuping/AAG-3086-2020; Lu, Jinjian/X-2083-2019	Chen, Xiuping/0000-0003-2675-7645; Song, Yuelin/0000-0001-9431-6257; Lu, Jinjian/0000-0001-6703-3120	Macao Science and Technology Development Fund [074/2012/A3, 077/2011/A3]; University of Macau [UL016/09Y4/CMS/WYT01/ICMS, MYRG208(Y3-L4)-ICMS11-WYT, SRG026-ICMS13-LJ, MRG012/WYT/2013/ICMS, MRG013/WYT/2013/ICMS]	Macao Science and Technology Development Fund; University of Macau	This work was supported by Macao Science and Technology Development Fund (074/2012/A3 and 077/2011/A3) and Research Fund of University of Macau (UL016/09Y4/CMS/WYT01/ICMS, MYRG208(Y3-L4)-ICMS11-WYT, SRG026-ICMS13-LJ, MRG012/WYT/2013/ICMS and MRG013/WYT/2013/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZNAVOORIAN S, 1993, CANCER-AM CANCER SOC, V71, P1368, DOI 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Calvo F, 2011, CURR OPIN CELL BIOL, V23, P621, DOI 10.1016/j.ceb.2011.04.010; Chen NH, 2008, J PHARMACOL SCI, V108, P212, DOI 10.1254/jphs.SC0080019; Chen NH, 2010, PHARMACOL REP, V62, P150, DOI 10.1016/S1734-1140(10)70252-8; Chen TC, 2012, INVEST OPHTH VIS SCI, V53, P1539, DOI 10.1167/iovs.11-9203; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Galvao ERCGN, 2011, J CANCER RES CLIN, V137, P915, DOI 10.1007/s00432-011-0978-0; Geiger TR, 2009, BBA-REV CANCER, V1796, P293, DOI 10.1016/j.bbcan.2009.07.006; Han EKH, 2007, ANTI-CANCER AGENT ME, V7, P681, DOI 10.2174/187152007784111296; Hsu YL, 2012, J AGR FOOD CHEM, V60, P852, DOI 10.1021/jf2052515; Hsu YL, 2011, MOL NUTR FOOD RES, V55, P318, DOI 10.1002/mnfr.201000148; Huang Z, 2008, CELL SIGNAL, V20, P2002, DOI 10.1016/j.cellsig.2008.07.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang JH, 2008, INT J MOL MED, V21, P577; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lin KL, 2011, CHEM-BIOL INTERACT, V194, P148, DOI 10.1016/j.cbi.2011.10.002; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nizamutdinova IT, 2008, CARCINOGENESIS, V29, P1885, DOI 10.1093/carcin/bgn151; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; SATO H, 1986, AGR BIOL CHEM TOKYO, V50, P2887, DOI 10.1080/00021369.1986.10867818; Schultze A, 2010, INVEST NEW DRUG, V28, P825, DOI 10.1007/s10637-009-9326-5; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Sliva D, 2003, J ALTERN COMPLEM MED, V9, P491, DOI 10.1089/107555303322284776; Stopeck AT, 2012, CLIN EXP METASTAS, V29, P807, DOI 10.1007/s10585-012-9496-y; Tan W, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-27; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Turner CE, 2000, J CELL SCI, V113, P4139; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Vindis C, 2004, J BIOL CHEM, V279, P27965, DOI 10.1074/jbc.M401295200; Wang L, 2010, CANCER LETT, V297, P42, DOI 10.1016/j.canlet.2010.04.022; Weng CJ, 2007, MOL NUTR FOOD RES, V51, P1472, DOI 10.1002/mnfr.200700155; Weng CJ, 2010, CLIN EXP METASTAS, V27, P361, DOI 10.1007/s10585-010-9334-z; Wu GS, 2012, FITOTERAPIA, V83, P408, DOI 10.1016/j.fitote.2011.12.004; Wu GS, 2012, AM J CHINESE MED, V40, P631, DOI 10.1142/S0192415X12500474; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yu XZ, 2012, J CELL BIOL, V199, P527, DOI 10.1083/jcb.201203025; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	53	37	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e76620	10.1371/journal.pone.0076620	http://dx.doi.org/10.1371/journal.pone.0076620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204647	Green Published, gold			2022-12-25	WOS:000326270700008
J	Zhang, SQ; Mu, YG; Zhang, JZH; Xu, WX				Zhang, Saiqun; Mu, Yuguang; Zhang, John Z. H.; Xu, Weixin			Effect of Self-Assembly of Fullerene Nano-Particles on Lipid Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; STABLE COLLOIDAL DISPERSIONS; C-60 FULLERENES; COMPUTER-SIMULATION; WATER; TRANSLOCATION; CLUSTERS; NANOMATERIALS; CYTOTOXICITY; ANTIOXIDANTS	Carbon nanoparticles can penetrate the cell membrane and cause cytotoxicity. The diffusion feature and translocation free energy of fullerene through lipid membranes is well reported. However, the knowledge on self-assembly of fullerenes and resulting effects on lipid membrane is poorly addressed. In this work, the self-assembly of fullerene nanoparticles and the resulting influence on the dioleoylphosphtidylcholine (DOPC) model membrane were studied by using all-atom molecular dynamics simulations with explicit solvents. Our simulation results confirm that gathered small fullerene cluster can invade lipid membrane. Simulations show two pathways: 1) assembly process is completely finished before penetration; 2) assembly process coincides with penetration. Simulation results also demonstrate that in the membrane interior, fullerene clusters tend to stay at the position which is 1.0 nm away from the membrane center. In addition, the diverse microscopic stacking mode (i.e., equilateral triangle, tetrahedral pentahedral, trigonal bipyramid and octahedron) of these small fullerene clusters are well characterized. Thus our simulations provide a detailed high-resolution characterization of the microscopic structures of the small fullerene clusters. Further, we found the gathered small fullerene clusters have significant adverse disturbances to the local structure of the membrane, but no great influence on the global integrity of the lipid membrane, which suggests the prerequisite of high-content fullerene for cytotoxicity.	[Zhang, Saiqun; Xu, Weixin] E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China; [Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Zhang, John Z. H.; Xu, Weixin] E China Normal Univ, State Key Lab Precis Spect, Shanghai 200062, Peoples R China; [Zhang, John Z. H.] NYU, Dept Chem, New York, NY 10003 USA	East China Normal University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; East China Normal University; New York University	Xu, WX (corresponding author), E China Normal Univ, Inst Adv Interdisciplinary Res, Shanghai 200062, Peoples R China.	wxxu@sat.ecnu.edu.cn			National Natural Science Foundation of China [21003048, 10974054, 20933002, 11204083]; Research Fund for the Doctoral Program of Higher Education of China [20120076120033]; Shanghai PuJiang program [12PJ1403000]; State Key Laboratory of Precision spectroscopy, East China Normal University; IDA Cloud Computing Call, NTU Tier 1 [RG 23/11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai PuJiang program(Shanghai Pujiang Program); State Key Laboratory of Precision spectroscopy, East China Normal University; IDA Cloud Computing Call, NTU Tier 1	The authors thank the National Natural Science Foundation of China (Grants No. 21003048, 10974054, 20933002 and 11204083). WXX is grateful to Research Fund for the Doctoral Program of Higher Education of China(20120076120033), Shanghai PuJiang program (12PJ1403000) and Open Research Fund of the State Key Laboratory of Precision spectroscopy, East China Normal University, for financial support. YGM gratefully thanks the support of the IDA Cloud Computing Call, NTU Tier 1 grant RG 23/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alargova RG, 2001, J AM CHEM SOC, V123, P10460, DOI 10.1021/ja010202a; Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Andrievsky G, 2005, FULLER NANOTUB CAR N, V13, P363, DOI 10.1080/15363830500237267; ANDRIEVSKY GV, 1995, J CHEM SOC CHEM COMM, P1281, DOI 10.1039/c39950001281; Andrievsky GV, 1999, CHEM PHYS LETT, V300, P392, DOI 10.1016/S0009-2614(98)01393-1; Baker GL, 2008, TOXICOL SCI, V101, P122, DOI 10.1093/toxsci/kfm243; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bortolus M, 2011, LANGMUIR, V27, P12560, DOI 10.1021/la202524r; Branz W, 2000, CHEM PHYS LETT, V328, P245, DOI 10.1016/S0009-2614(00)00929-5; Bulavin L, 2000, PHYS CHEM CHEM PHYS, V2, P1627, DOI 10.1039/a907786c; Calvaresi M, 2009, SMALL, V5, P2191, DOI 10.1002/smll.200900528; Chang R, 2010, B KOREAN CHEM SOC, V31, P3195, DOI 10.5012/bkcs.2010.31.11.3195; Chen CY, 2005, NANO LETT, V5, P2050, DOI 10.1021/nl051624b; Choudhury N, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2217442; Cirifalco LA, 1991, J PHYS CHEM-US, V95, P5370; Cruts B, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-4; Deguchi S, 2001, LANGMUIR, V17, P6013, DOI 10.1021/la010651o; Dhawan A, 2006, ENVIRON SCI TECHNOL, V40, P7394, DOI 10.1021/es0609708; Ding HM, 2012, ACS NANO, V6, P1230, DOI 10.1021/nn2038862; Doye JPK, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235409; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434; Fiedler SL, 2010, BIOPHYS J, V99, P144, DOI 10.1016/j.bpj.2010.03.039; Fortner JD, 2005, ENVIRON SCI TECHNOL, V39, P4307, DOI 10.1021/es048099n; Hansen K, 1997, Z PHYS D ATOM MOL CL, V40, P361, DOI 10.1007/s004600050228; Hansen K, 1996, J CHEM PHYS, V105, P6088, DOI 10.1063/1.472448; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hofinger S, 2011, BIOMATERIALS, V32, P7079, DOI 10.1016/j.biomaterials.2011.06.011; Hou WC, 2011, LANGMUIR, V27, P11899, DOI 10.1021/la2017837; HWANG KC, 1993, NATURE, V361, P138, DOI 10.1038/361138a0; Ikeda A, 2012, CHEM-ASIAN J, V7, P605, DOI 10.1002/asia.201100792; Innocenzi P, 2001, CHEM MATER, V13, P3126, DOI 10.1021/cm0110223; Isobe H, 2006, CHEM-ASIAN J, V1, P167, DOI 10.1002/asia.200600051; Kim H, 2008, J CHEM THEORY COMPUT, V4, P335, DOI 10.1021/ct700211y; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Lai K, 2013, PHYS CHEM CHEM PHYS, V15, P270, DOI 10.1039/c2cp42027a; Li LW, 2007, J PHYS CHEM B, V111, P4067, DOI 10.1021/jp064982r; Li LW, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121647; Li LW, 2006, J PHYS CHEM B, V110, P10509, DOI 10.1021/jp060718m; Li WF, 2012, P NATL ACAD SCI USA, V109, P17789, DOI 10.1073/pnas.1201807109; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Oberdrster E, 2004, 227 ACS NAT M AN CA; Osawa E., 2002, PERSPECTIVES FULLERE; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pogodin S, 2012, ACS NANO, V6, P10555, DOI 10.1021/nn3028858; Qiao R, 2007, NANO LETT, V7, P614, DOI 10.1021/nl062515f; Revell P. A., 2006, Nanotechnology Perceptions, V2, P283; Roslyakov A, 1999, ZH AKAD MED NAUK UKR, V5, P338; Rossi G, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/05/058503; RUOFF RS, 1991, NATURE, V350, P663, DOI 10.1038/350663b0; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586; SIJBESMA R, 1993, J AM CHEM SOC, V115, P6510, DOI 10.1021/ja00068a006; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Tremblay JF, 2002, CHEM ENG NEWS, V80, P16; Ungurenasu C, 2000, J MED CHEM, V43, P3186, DOI 10.1021/jm991175q; Utsunomiya S, 2002, ENVIRON SCI TECHNOL, V36, P4943, DOI 10.1021/es025872a; Wang IC, 1999, J MED CHEM, V42, P4614, DOI 10.1021/jm990144s; Wang W, 2009, P NATL ACAD SCI USA, V106, P5517, DOI 10.1073/pnas.0809649106; Wang ZN, 2009, CHEMPHYSCHEM, V10, P2284, DOI 10.1002/cphc.200900328; Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130; Xu WX, 2008, BIOPHYS CHEM, V137, P116, DOI 10.1016/j.bpc.2008.08.002; Xu WX, 2009, J PHYS CHEM B, V113, P7308, DOI 10.1021/jp8106827; Zhang WH, 2000, PHYS REV B, V62, P8276, DOI 10.1103/PhysRevB.62.8276; Zhang YJ, 2011, J AM CHEM SOC, V133, P6882, DOI 10.1021/ja1109425	67	18	19	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2013	8	10							e77436	10.1371/journal.pone.0077436	http://dx.doi.org/10.1371/journal.pone.0077436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242VF	24204827	Green Published, Green Submitted, gold			2022-12-25	WOS:000326270700029
J	Di Russo, F; Berchicci, M; Perri, RL; Ripani, FR; Ripani, M				Di Russo, Francesco; Berchicci, Marika; Perri, Rinaldo Livio; Ripani, Francesca Romana; Ripani, Maurizio			A Passive Exoskeleton Can Push Your Life Up: Application on Multiple Sclerosis Patients	PLOS ONE			English	Article							LOCALIZATION; LATENCY; MEG	In the present study, we report the benefits of a passive and fully articulated exoskeleton on multiple sclerosis patients by means of behavioral and electrophysiological measures, paying particular attention to the prefrontal cortex activity. Multiple sclerosis is a neurological condition characterized by lesions of the myelin sheaths that encapsulate the neurons of the brain, spine and optic nerve, and it causes transient or progressive symptoms and impairments in gait and posture. Up to 50% of multiple sclerosis patients require walking aids and 10% are wheelchair-bound 15 years following the initial diagnosis. We tested the ability of a new orthosis, the "Human Body Posturizer", designed to improve the structural and functional symmetry of the body through proprioception, in multiple sclerosis patients. We observed that a single Human Body Posturizer application improved mobility, ambulation and response accuracy, in all of the tested patients. Most importantly, we associated these clinical observations and behavioral effects to changes in brain activity, particularly in the prefrontal cortex.	[Di Russo, Francesco; Berchicci, Marika; Perri, Rinaldo Livio; Ripani, Maurizio] Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy; [Di Russo, Francesco] IRCCS Santa Lucia Fdn, Neuropsychol Unit, Rome, Italy; [Ripani, Francesca Romana] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Locomotor Sci, I-00185 Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia; Sapienza University Rome	Di Russo, F (corresponding author), Univ Rome Foro Italico, Dept Human Movement Social & Hlth Sci, Rome, Italy.	francesco.dirusso@uniroma4.it	Di Russo, Francesco/N-6686-2015; Perri, Rinaldo/U-2480-2017	Di Russo, Francesco/0000-0002-3127-9433; Perri, Rinaldo/0000-0002-7343-9669; , Marika/0000-0001-8470-191X; RIPANI, Maurizio/0000-0003-4450-8511	University of Rome "Foro Italico" [RIC-109/2012]	University of Rome "Foro Italico"	The work was funded by the University of Rome "Foro Italico" (www.uniroma4.it), research grant number RIC-109/2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omaishi J, 1999, J LEUKOCYTE BIOL, V65, P444, DOI 10.1002/jlb.65.4.444; Albert J, 2013, NEUROIMAGE, V76, P272, DOI 10.1016/j.neuroimage.2013.03.011; Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; Aminoff JC, 2001, J CLIN NEUROPHYSIOL, V18, P372, DOI 10.1097/00004691-200107000-00009; Berchicci M, 2013, J GERONTOL A-BIOL, V68, P1337, DOI 10.1093/gerona/glt094; Berchicci M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00135; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Bozzacchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047783; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Ciccarelli A., 2012, ITAL J ANAT EMBRYOL, V117, P41; Colaiacomo B., 2011, ITAL J ANAT EMBRYOL, V116, P46; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Ferris Daniel P, 2005, Top Spinal Cord Inj Rehabil, V11, P34; Fuster J.M., 2013, PRINCIPLES FRONTAL L, P11; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Ilmoniemi R J, 1993, Brain Topogr, V5, P331, DOI 10.1007/BF01128686; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Larson EB, 2002, CORTEX, V38, P201, DOI 10.1016/S0010-9452(08)70650-6; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lucci G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056566; Oldfield R.C., 1971, NEUROPSYCHOLOGIA, V104, P199; Rahman T, 2007, IEEE T NEUR SYS REH, V15, P244, DOI 10.1109/TNSRE.2007.897026; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Whelan R, 2010, CLIN NEUROPHYSIOL, V121, P1420, DOI 10.1016/j.clinph.2010.03.019; Zimmermann P., 1995, TEST ATTENTIONAL PER	29	28	29	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e77348	10.1371/journal.pone.0077348	http://dx.doi.org/10.1371/journal.pone.0077348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204814	Green Published, gold, Green Submitted			2022-12-25	WOS:000326155400036
J	Wang, H; Jessup, JA; Zhao, Z; Da Silva, J; Lin, M; MacNamara, LM; Ahmad, S; Chappell, MC; Ferrario, CM; Groban, L				Wang, Hao; Jessup, Jewell A.; Zhao, Zhuo; Da Silva, Jaqueline; Lin, Marina; MacNamara, Lindsay M.; Ahmad, Sarfaraz; Chappell, Mark C.; Ferrario, Carlos M.; Groban, Leanne			Characterization of the Cardiac Renin Angiotensin System in Oophorectomized and Estrogen-Replete mRen2.Lewis Rats	PLOS ONE			English	Article							CONVERTING-ENZYME-INHIBITORS; ATTENUATES DIASTOLIC DYSFUNCTION; LEFT-VENTRICULAR HYPERTROPHY; REN-2 HYPERTENSIVE-RATS; POSTMENOPAUSAL WOMEN; HEART-FAILURE; OVARIECTOMIZED RATS; REPLACEMENT THERAPY; HORMONE REPLACEMENT; PRESSURE-OVERLOAD	The cardioprotective effects of estrogen are well recognized, but the mechanisms remain poorly understood. Accumulating evidence suggests that the local cardiac renin-angiotensin system (RAS) is involved in the development and progression of cardiac hypertrophy, remodeling, and heart failure. Estrogen attenuates the effects of an activated circulating RAS; however, its role in regulating the cardiac RAS is unclear. Bilateral oophorectomy (OVX; n = 17) or sham-operation (Sham; n = 13) was performed in 4-week-old, female mRen2.Lewis rats. At 11 weeks of age, the rats were randomized and received either 17 beta-estradiol (E2, 36 mu g/pellet, 60-day release, n = 8) or vehicle (OVX-V, n = 9) for 4 weeks. The rats were sacrificed, and blood and hearts were used to determine protein and/or gene expression of circulating and tissue RAS components. E2 treatment minimized the rise in circulating angiotensin (Ang) II and aldosterone produced by loss of ovarian estrogens. Chronic E2 also attenuated OVX-associated increases in cardiac Ang II, Ang-(1-7) content, chymase gene expression, and mast cell number. Neither OVX nor OVX+E2 altered cardiac expression or activity of renin, angiotensinogen, angiotensin-converting enzyme (ACE), and Ang II type 1 receptor (AT1R). E2 treatment in OVX rats significantly decreased gene expression of MMP-9, ACE2, and Ang-(1-7) mas receptor, in comparison to sham-operated and OVX littermates. E2 treatment appears to inhibit upsurges in cardiac Ang II expression in the OVX-mRen2 rat, possibly by reducing chymase-dependent Ang II formation. Further studies are warranted to determine whether an E2-mediated reduction in cardiac chymase directly contributes to this response in OVX rats.	[Wang, Hao; Jessup, Jewell A.; Zhao, Zhuo; Da Silva, Jaqueline; Lin, Marina; MacNamara, Lindsay M.; Groban, Leanne] Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27106 USA; [Ahmad, Sarfaraz; Chappell, Mark C.; Groban, Leanne] Wake Forest Sch Med, Dept Hypertens, Winston Salem, NC USA; [Ahmad, Sarfaraz; Chappell, Mark C.; Groban, Leanne] Wake Forest Sch Med, Vasc Res Ctr, Winston Salem, NC USA; [Ferrario, Carlos M.] Wake Forest Sch Med, Dept Internal Med Nephrol, Winston Salem, NC USA; [Ferrario, Carlos M.] Wake Forest Sch Med, Dept Surg, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Groban, L (corresponding author), Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27106 USA.	lgroban@wakehealth.edu	Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020; DA SILVA, JAQUELINE/Z-3311-2019; Chappell, Mark/AAX-9087-2021	Ferrario, Carlos/0000-0003-0792-6239; Wang, Hao/0000-0003-1537-661X; DA SILVA, JAQUELINE/0000-0003-3946-4753; Groban, Leanne/0000-0001-8934-7358	National Institutes of Health [R01-AG033727, 2P01 HL-051952]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work described here was supported in part by grants from the National Institutes of Health R01-AG033727 (Groban) and 2P01 HL-051952 (Ferrario). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Taha M, 2009, J IMMUNOL, V183, P1393, DOI 10.4049/jimmunol.0803157; Agabiti-Rosei E, 2002, J HYPERTENS, V20, pS34; Ahmad S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028501; AlJaroudi W, 2012, CIRCULATION, V125, P782, DOI 10.1161/CIRCULATIONAHA.111.066423; Brosnihan KB, 2008, EXP PHYSIOL, V93, P658, DOI 10.1113/expphysiol.2007.041806; Brosnihan KB, 2008, AM J PHYSIOL-HEART C, V294, pH1995, DOI 10.1152/ajpheart.01193.2007; Brosnihan KB, 1997, AM J PHYSIOL-REG I, V273, pR1908, DOI 10.1152/ajpregu.1997.273.6.R1908; Brosnihan KB, 1997, J HYPERTENS, V15, P719, DOI 10.1097/00004872-199715070-00003; Brosnihan KB, 1999, BRAZ J MED BIOL RES, V32, P373, DOI 10.1590/S0100-879X1999000400001; Catena C, 2012, HORM METAB RES, V44, P181, DOI 10.1055/s-0031-1291318; Catena C, 2012, AM J CARDIOVASC DIS, V2, P50; Chancey AL, 2005, AM J PHYSIOL-HEART C, V289, pH316, DOI 10.1152/ajpheart.00765.2004; Chappell MC, 2006, AM J PHYSIOL-REG I, V291, pR1557, DOI 10.1152/ajpregu.00051.2006; Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; Chrysant SG, 2010, AM J CARDIOL, V105, P849, DOI 10.1016/j.amjcard.2009.11.044; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; de Sa DDC, 2010, HEART, V96, P528, DOI 10.1136/hrt.2009.177980; DellItalia LJ, 1995, AM J PHYSIOL-HEART C, V269, pH2065, DOI 10.1152/ajpheart.1995.269.6.H2065; Fak AS, 2000, FERTIL STERIL, V73, P66, DOI 10.1016/S0015-0282(99)00451-3; Ferrario CM, 2009, AM J PHYSIOL-HEART C, V296, pH1184, DOI 10.1152/ajpheart.01114.2008; Ferrario CM, 2005, AM J PHYSIOL-HEART C, V289, pH2281, DOI 10.1152/ajpheart.00618.2005; Gallagher PE, 1999, HYPERTENSION, V33, P323, DOI 10.1161/01.HYP.33.1.323; Garabelli PJ, 2008, EXP PHYSIOL, V93, P613, DOI 10.1113/expphysiol.2007.040246; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Ghali Jalal K, 2008, Expert Rev Cardiovasc Ther, V6, P555, DOI 10.1586/14779072.6.4.555; Gonzalez A, 2004, MED CLIN N AM, V88, P83, DOI 10.1016/S0025-7125(03)00125-1; GORAYA TY, 1994, NUCLEIC ACIDS RES, V22, P1194, DOI 10.1093/nar/22.7.1194; Groban L, 2006, J GERONTOL A-BIOL, V61, P28, DOI 10.1093/gerona/61.1.28; Groban L, 2008, J GERONTOL A-BIOL, V63, P3, DOI 10.1093/gerona/63.1.3; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; Huentelman MJ, 2005, EXP PHYSIOL, V90, P783, DOI 10.1113/expphysiol.2005.031096; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Jessup JA, 2013, MENOPAUSE, V20, P860, DOI [10.1097/gme.0b013e318280589a, 10.1097/GME.0b013e318280589a]; Jessup JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015433; Jessup JA, 2011, ENDOCRINOLOGY, V152, P2428, DOI 10.1210/en.2011-0061; Jessup JA, 2011, MENOPAUSE, V18, P698, DOI 10.1097/gme.0b013e31820390a2; Ji H, 2008, EXP PHYSIOL, V93, P648, DOI 10.1113/expphysiol.2007.041392; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Krishnamurthi K, 1999, ENDOCRINOLOGY, V140, P5435, DOI 10.1210/en.140.11.5435; Lam KK, 2006, MENOPAUSE, V13, P294, DOI 10.1097/01.gme.0000182806.99137.5e; Levick SP, 2011, CARDIOVASC RES, V89, P12, DOI 10.1093/cvr/cvq272; Li P, 2002, HYPERTENS RES, V25, P757; Lu H, 2012, AM J PHYSIOL-HEART C, V302, pH811, DOI 10.1152/ajpheart.00980.2011; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Modena MG, 1999, HYPERTENSION, V34, P1041, DOI 10.1161/01.HYP.34.5.1041; Nappi JM, 2011, VASC HEALTH RISK MAN, V7, P353, DOI 10.2147/VHRM.S13779; Nickenig G, 1998, CIRCULATION, V97, P2197, DOI 10.1161/01.CIR.97.22.2197; Oberman A, 2006, AM J CARDIOL, V97, P512, DOI 10.1016/j.amjcard.2005.08.071; Okura H, 2009, CIRC-CARDIOVASC IMAG, V2, P41, DOI 10.1161/CIRCIMAGING.108.809087; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Oyamada S, 2011, J PHARMACOL EXP THER, V339, P143, DOI 10.1124/jpet.111.179697; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; PROUDLER AJ, 1995, LANCET, V346, P89, DOI 10.1016/S0140-6736(95)92114-1; Proudler AJ, 2003, CLIN ENDOCRINOL, V58, P30, DOI 10.1046/j.1365-2265.2003.01600.x; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Ricchiuti V, 2009, J ENDOCRINOL, V200, P75, DOI 10.1677/JOE-08-0199; Roesch DM, 2000, ENDOCRINOLOGY, V141, P4629, DOI 10.1210/en.141.12.4629; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; Schunkert H, 1997, CIRCULATION, V95, P39, DOI 10.1161/01.CIR.95.1.39; Seely EW, 2004, CLIN ENDOCRINOL, V60, P315, DOI 10.1046/j.1365-2265.2004.01980.x; SHAI SY, 1990, BIOCHEM BIOPH RES CO, V167, P1128, DOI 10.1016/0006-291X(90)90640-9; Sharkey LC, 1999, J MOL CELL CARDIOL, V31, P1527, DOI 10.1006/jmcc.1999.0985; Shekelle PG, 2003, J AM COLL CARDIOL, V41, P1529, DOI 10.1016/S0735-1097(03)00262-6; SHEN V, 1993, J CLIN INVEST, V91, P2479, DOI 10.1172/JCI116483; Shenoy V, 2009, PEPTIDES, V30, P2309, DOI 10.1016/j.peptides.2009.09.005; Takai S, 2010, CURR MED CHEM, V17, P3223, DOI 10.2174/092986710792232003; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Trask AJ, 2007, AM J PHYSIOL-HEART C, V292, pH3019, DOI 10.1152/ajpheart.01198.2006; Trask AJ, 2010, AM J HYPERTENS, V23, P687, DOI 10.1038/ajh.2010.51; URATA H, 1993, EUR HEART J, V14, P177; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; Wang H, 2012, CARDIOVASC RES, V94, P96, DOI 10.1093/cvr/cvs090; Wassmann S, 2001, CIRCULATION, V103, P435; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wu Z, 2003, ENDOCRINOLOGY, V144, P3251, DOI 10.1210/en.2003-0015; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P12262, DOI 10.1073/pnas.93.22.12262; Zierau O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00169	82	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2013	8	10							e76992	10.1371/journal.pone.0076992	http://dx.doi.org/10.1371/journal.pone.0076992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241GW	24204720	gold, Green Published, Green Submitted			2022-12-25	WOS:000326155400022
J	Araujo, VC; Demasi, APD; Soares, AB; Passador-Santos, F; Napimoga, MH; Martinez, EF; Freitas, NS; Araujo, NS				Araujo, Vera Cavalcanti; Dias Demasi, Ana Paula; Soares, Andresa Borges; Passador-Santos, Fabricio; Napimoga, Marcelo Henrique; Martinez, Elizabeth Ferreira; Freitas, Nadir Severina; Araujo, Ney Soares			Neutrophils in Oral Paracoccidioidomycosis and the Involvement of Nrf2	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; NF-KAPPA-B; ENHANCES SUSCEPTIBILITY; IMMUNE-RESPONSE; INNATE; MICE; ACTIVATION; PATHWAY; CELLS; RECRUITMENT	Neutrophils have been implicated in granuloma formation in several infectious diseases, in addition to their main phagocytic and pathogen destruction role. It has been demonstrated that Nrf2 regulates antioxidant protection in neutrophils, attenuating inflammation without compromising the hosts bacterial defense. In this study, we analyzed the presence of neutrophils in Paracoccidioides brasiliensis mycosis (PCM), as well as the immunoexpression of Nrf2. Thirty-nine cases of oral PCM were classified according to quantity of fungi and to the presence of loose or well-organized granulomas and microabscesses. An Nrf2 antibody was used for immunohistochemical analysis. The results showed that neutrophils are present in microabscesses and loose granulomas, but were absent in structured granulomas. A greater quantity of fungi was shown in cases with only loose granulomas when compared to loose and well organized granulomas. Nrf2 was observed in the nuclei of neutrophils of loose granulomas and abscesses, with its expression in loose granulomas maintained despite the additional presence of well organized granulomas in the same specimen. This study suggests that neutrophils participate in P. brasiliensis granuloma formation and that Nrf2 has a possible role in neutrophil survival, via modulation of the inflammatory response.	[Araujo, Vera Cavalcanti; Dias Demasi, Ana Paula; Soares, Andresa Borges; Passador-Santos, Fabricio; Napimoga, Marcelo Henrique; Martinez, Elizabeth Ferreira; Freitas, Nadir Severina; Araujo, Ney Soares] Sao Leopoldo Mand Inst & Res Ctr, Dept Pathol, Campinas, SP, Brazil	Faculdade Sao Leopoldo Mandic	Araujo, VC (corresponding author), Sao Leopoldo Mand Inst & Res Ctr, Dept Pathol, Campinas, SP, Brazil.	vcaraujo@usp.br	Napimoga, Marcelo/S-2434-2019; Passador-Santos, Fabricio/AAR-5899-2020; Martinez, Elizabeth Ferreira/F-8067-2012; Demasi, Ana/AAR-7854-2020; Passador-Santos, Fabricio/GRN-8160-2022; Araujo, Vera C/G-3586-2014; Soares, Ângela Maria/K-1765-2014	Napimoga, Marcelo/0000-0003-4472-365X; Passador-Santos, Fabricio/0000-0003-2777-8640; Demasi, Ana/0000-0003-4736-6694; Soares, Ângela Maria/0000-0003-1962-9901; Araujo, Vera/0000-0002-5860-3715	Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [473939/2011-8]	Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Brazilian Agencies Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for the financial support (473939/2011-8). URL: www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach C, 2006, J IMMUNOL, V176, P6656, DOI 10.4049/jimmunol.176.11.6656; Ameen M, 2010, CLIN EXP DERMATOL, V35, P576, DOI 10.1111/j.1365-2230.2009.03647.x; APPELBERG R, 1994, IMMUNOLOGY, V83, P302; Appelberg R, 2007, TRENDS MICROBIOL, V15, P87, DOI 10.1016/j.tim.2006.11.009; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Bliss SK, 1999, J IMMUNOL, V162, P7369; Charmoy M, 2007, J LEUKOCYTE BIOL, V82, P288, DOI 10.1189/jlb.0706440; Chen L, 2001, EUR J IMMUNOL, V31, P265, DOI 10.1002/1521-4141(200101)31:1<265::AID-IMMU265>3.3.CO;2-C; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Franco M, 1993, Curr Top Med Mycol, V5, P115; Goven D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010886; Kaminagakura E, 2007, ORAL DIS, V13, P434, DOI 10.1111/j.1601-0825.2006.01319.x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaul N, 1996, FREE RADICAL BIO MED, V21, P401, DOI 10.1016/0891-5849(96)00178-5; Kennedy MA, 2010, VET CLIN N AM-SMALL, V40, P369, DOI 10.1016/j.cvsm.2010.01.003; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kinnula VL, 2002, ANTIOXID REDOX SIGN, V4, P27, DOI 10.1089/152308602753625825; Kong XN, 2011, AM J RESP CRIT CARE, V184, P928, DOI 10.1164/rccm.201102-0271OC; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marshall AJ, 1998, INFECT IMMUN, V66, P1325, DOI 10.1128/IAI.66.4.1325-1333.1998; McFarlane E, 2008, INFECT IMMUN, V76, P532, DOI 10.1128/IAI.01388-07; Pagliari C, 2011, MICROB PATHOGENESIS, V50, P263, DOI 10.1016/j.micpath.2010.12.008; Fortes MRP, 2011, AN BRAS DERMATOL, V86, P516, DOI 10.1590/S0365-05962011000300014; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ribeiro-Gomes FL, 2004, J IMMUNOL, V172, P4454, DOI 10.4049/jimmunol.172.7.4454; Romani L, 1997, J IMMUNOL, V158, P2356; Seiler P, 2003, EUR J IMMUNOL, V33, P2676, DOI 10.1002/eji.200323956; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006	34	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e76976	10.1371/journal.pone.0076976	http://dx.doi.org/10.1371/journal.pone.0076976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	24204715	Green Submitted, gold, Green Published			2022-12-25	WOS:000326152300011
J	Herbst, SK; Javadi, AH; van der Meer, E; Busch, NA				Herbst, Sophie K.; Javadi, Amir Homayoun; van der Meer, Elke; Busch, Niko A.			How Long Depends on How Fast-Perceived Flicker Dilates Subjective Duration	PLOS ONE			English	Article							TIME PERCEPTION; NEURAL MECHANISMS; VISUAL RESPONSES; INTERNAL CLOCK; SPEEDING-UP; ADAPTATION; MODELS; CORTEX; BRAIN	How do humans perceive the passage of time and the duration of events without a dedicated sensory system for timing? Previous studies have demonstrated that when a stimulus changes over time, its duration is subjectively dilated, indicating that duration judgments are based on the number of changes within an interval. In this study, we tested predictions derived from three different accounts describing the relation between a changing stimulus and its subjective duration as either based on (1) the objective rate of changes of the stimulus, (2) the perceived saliency of the changes, or (3) the neural energy expended in processing the stimulus. We used visual stimuli flickering at different frequencies (4-166 Hz) to study how the number of changes affects subjective duration. To this end, we assessed the subjective duration of these stimuli and measured participants' behavioral flicker fusion threshold (the highest frequency perceived as flicker), as well as their threshold for a frequency-specific neural response to the flicker using EEG. We found that only consciously perceived flicker dilated perceived duration, such that a 2 s long stimulus flickering at 4 Hz was perceived as lasting as long as a 2.7 s steady stimulus. This effect was most pronounced at the slowest flicker frequencies, at which participants reported the most consistent flicker perception. Flicker frequencies higher than the flicker fusion threshold did not affect perceived duration at all, even if they evoked a significant frequency-specific neural response. In sum, our findings indicate that time perception in the peri-second range is driven by the subjective saliency of the stimulus' temporal features rather than the objective rate of stimulus changes or the neural response to the changes.	[Herbst, Sophie K.; van der Meer, Elke; Busch, Niko A.] Berlin Sch Mind & Brain, Berlin, Germany; [Herbst, Sophie K.; van der Meer, Elke] Humboldt Univ, D-10099 Berlin, Germany; [Javadi, Amir Homayoun] UCL, Dept Cognit Perceptual & Brain Sci, Inst Behav Neurosci, London, England; [Busch, Niko A.] Charite, Inst Med Psychol, D-13353 Berlin, Germany	Humboldt University of Berlin; University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Herbst, SK (corresponding author), Berlin Sch Mind & Brain, Berlin, Germany.	sophie.herbst@hu-berlin.de	Javadi, Amir-Homayoun/G-8547-2013	Javadi, Amir-Homayoun/0000-0003-0569-6441; Herbst, Sophie/0000-0001-6161-3167; Busch, Niko/0000-0003-4837-0345	German Research Foundation [BU2400/1-1]; Studienstiftung des deutschen Volkes	German Research Foundation(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes	This work was supported by the German Research Foundation (Grant \# BU2400/1-1). Sophie Herbst is funded by the Studienstiftung des deutschen Volkes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayhan I, 2009, J VISION, V9, DOI 10.1167/9.11.2; Bach M, 1999, DOC OPHTHALMOL, V99, P69, DOI 10.1023/A:1002648202420; Binetti N, 2012, J VISION, V12, DOI 10.1167/12.7.8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown JF, 1931, PSYCHOL FORSCH, V14, P233, DOI 10.1007/BF00403874; Brown SA, 1996, AM J VET RES, V57, P105; Bruno A, 2012, FRONTIERS PSYCHOL, V3; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Burr DC, 2011, J VISION, V11, DOI 10.1167/11.2.21; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Droit-Volet S, 2002, Q J EXP PSYCHOL-B, V55, P193, DOI 10.1080/02724990143000252; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Eagleman DM, 2009, PHILOS T R SOC B, V364, P1841, DOI 10.1098/rstb.2009.0026; Fraisse P, 1963, PSYCHOL TIME; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; GRONDIN S, 1993, PERCEPT PSYCHOPHYS, V54, P383, DOI 10.3758/BF03205274; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Guyau J-M, 1890, GENESE IDEE TEMPS; Herbst SK, 2012, PERCEPTION, V41, P883, DOI 10.1068/p7300; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; HOLM S, 1979, SCAND J STAT, V6, P65; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Jeffries H., 1961, THEORY PROBABILITY; Jiang Y, 2007, NAT NEUROSCI, V10, P657, DOI 10.1038/nn1879; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Johnston A, 2008, VISION RES, V48, P1852, DOI 10.1016/j.visres.2008.04.029; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; Kelly S, 2005, COGNITION BRAIN PHIL, P218; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; Matthews WJ, 2011, J EXP PSYCHOL HUMAN, V37, P303, DOI 10.1037/a0019961; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Pastor MA, 2003, J NEUROSCI, V23, P11621; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Plomp G, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00564; Poynter D., 1989, ADV PSYCHOL, VVol. 59, P305, DOI [10.1016/S0166-4115(08)61045-6, DOI 10.1016/S0166-4115(08)61045-6, 10.1016/s0166-4115(08)61045-6]; Ramos S, 2011, BIOS BIOR C BRC 2011, P1; REGAN D, 1968, ELECTROEN CLIN NEURO, V25, P231, DOI 10.1016/0013-4694(68)90020-5; Roeckelein J., 2000, CONCEPT TIME PSYCHOL; ROEHRIG WC, 1959, J PSYCHOL, V47, P317, DOI 10.1080/00223980.1959.9916333; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Shady S, 2004, P NATL ACAD SCI USA, V101, P5170, DOI 10.1073/pnas.0303452101; TREISMAN M, 1992, Q J EXP PSYCHOL-A, V45, P235, DOI 10.1080/14640749208401326; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; VANDERTWEEL LH, 1965, ELECTROEN CLIN NEURO, V18, P587, DOI 10.1016/0013-4694(65)90076-3; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wells EF, 2001, EXP BRAIN RES, V139, P106, DOI 10.1007/s002210100721	55	35	35	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76074	10.1371/journal.pone.0076074	http://dx.doi.org/10.1371/journal.pone.0076074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194829	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000008
J	Wagnild, J; Wall-Scheffler, CM				Wagnild, Janelle; Wall-Scheffler, Cara M.			Energetic Consequences of Human Sociality: Walking Speed Choices among Friendly Dyads	PLOS ONE			English	Article							PREFERRED SPEED; COSTS; FOOTPRINTS; OPTIMIZATION; LOCOMOTION; EVOLUTION; ILERET; TIME; SEX	Research has shown that individuals have an optimal walking speed-a speed which minimizes energy expenditure for a given distance. Because the optimal walking speed varies with mass and lower limb length, it also varies with sex, with males in any given population tending to have faster optimal walking speeds. This potentially creates an energetic dilemma for mixed-sex walking groups. Here we examine speed choices made by individuals of varying stature, mass, and sex walking together. Individuals (N = 22) walked around a track alone, with a significant other (with and without holding hands), and with friends of the same and opposite sex while their speeds were recorded every 100 m. Our findings show that males walk at a significantly slower pace to match the females' paces (p = 0.009), when the female is their romantic partner. The paces of friends of either same or mixed sex walking together did not significantly change (p > 0.05). Thus significant pace adjustment appears to be limited to romantic partners. These findings have implications for both mobility and reproductive strategies of groups. Because the male carries the energetic burden by adjusting his pace (slowing down 7%), the female is spared the potentially increased caloric cost required to walk together. In energetically demanding environments, we will expect to find gender segregation in group composition, particularly when travelling longer distances.	[Wagnild, Janelle; Wall-Scheffler, Cara M.] Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA; [Wall-Scheffler, Cara M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wall-Scheffler, CM (corresponding author), Seattle Pacific Univ, Dept Biol, Seattle, WA 98119 USA.	cwallsch@spu.edu		Wagnild, Janelle/0000-0003-3933-6380				Aiello LC, 2002, AM J HUM BIOL, V14, P551, DOI 10.1002/ajhb.10069; Alexander RM, 2002, AM J HUM BIOL, V14, P641, DOI 10.1002/ajhb.10067; [Anonymous], 1981, MAN ENV SYSTEMS; BELL RR, 1981, PSYCHOL WOMEN QUART, V5, P402, DOI 10.1111/j.1471-6402.1981.tb00582.x; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; BENTLEY GR, 1985, HUM ECOL, V13, P79, DOI 10.1007/BF01531090; Blurton Jones N. G., 1989, COMP SOCIOECOLOGY BE, P367; Brightman R, 1996, COMP STUD SOC HIST, V38, P687, DOI 10.1017/S0010417500020508; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Browning RC, 2005, OBES RES, V13, P891, DOI 10.1038/oby.2005.103; Cashdan E, 2012, EVOL HUM BEHAV, V33, P274, DOI 10.1016/j.evolhumbehav.2011.10.005; Costa M, 2010, J NONVERBAL BEHAV, V34, P15, DOI 10.1007/s10919-009-0077-y; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Dufour DL, 2002, AM J HUM BIOL, V14, P584, DOI 10.1002/ajhb.10071; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; ELKINS LE, 1993, SEX ROLES, V29, P497, DOI 10.1007/BF00289323; Ellison P.T., 2008, PALEOANTHROPOLOGY, V2008, P172; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; FRAYER DW, 1985, ANNU REV ANTHROPOL, V14, P429, DOI 10.1146/annurev.an.14.100185.002241; Gibbons A, 2011, SCIENCE, V332, P534, DOI 10.1126/science.332.6029.534-b; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Hill RA, 2003, BEHAV ECOL SOCIOBIOL, V53, P278, DOI 10.1007/s00265-003-0590-7; JONES NB, 1986, ETHOL SOCIOBIOL, V7, P91, DOI 10.1016/0162-3095(86)90002-6; JONES NB, 1987, ETHOL SOCIOBIOL, V8, P183; Kramer PA, 1998, AM J PHYS ANTHROPOL, V107, P71; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; O'Connor SM, 2012, J NEUROPHYSIOL, V107, P2549, DOI 10.1152/jn.00866.2011; Peyrot N, 2012, MED SCI SPORT EXER, V44, P659, DOI 10.1249/MSS.0b013e318236edd8; Pollard KA, 2008, ANIM BEHAV, V76, P1683, DOI 10.1016/j.anbehav.2008.08.006; PRENTICE AM, 1988, ANNU REV NUTR, V8, P63, DOI 10.1146/annurev.nu.08.070188.000431; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Richmond BG, 2011, PALEOANTHROPOLOGY AB, V2011, P29; Steudel-Numbers KL, 2009, J HUM EVOL, V56, P355, DOI 10.1016/j.jhevol.2008.11.002; Torrence Robin., 1983, HUNTER GATHERER EC P, P11, DOI DOI 10.1073/PNAS.0913047107; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Wall-Scheffler CM, 2013, J HUM EVOL, V64, P448, DOI 10.1016/j.jhevol.2013.01.014; Wall-Scheffler CM, 2012, ANNU REV ANTHROPOL, V41, P71, DOI 10.1146/annurev-anthro-092611-145739; Wall-Scheffler CM., 2012, J ANTHR, V2012, P1, DOI DOI 10.1155/2012/340493; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Watson JC, 2011, PRIMATE LOCOMOTION L; WELLENS AR, 1978, J PSYCHOL, V99, P39, DOI 10.1080/00223980.1978.9921437; Wickler SJ, 2000, J EXP BIOL, V203, P2195; Ziomkiewicz A, 2008, HUM REPROD, V23, P2555, DOI 10.1093/humrep/den213	43	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e76576	10.1371/journal.pone.0076576	http://dx.doi.org/10.1371/journal.pone.0076576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239PE	24194840	Green Published, Green Submitted, gold			2022-12-25	WOS:000326037000019
J	Yashunsky, V; Kharilker, L; Zlotkin-Rivkin, E; Rund, D; Melamed-Book, N; Zahavi, EE; Perlson, E; Mercone, S; Golosovsky, M; Davidov, D; Aroeti, B				Yashunsky, Victor; Kharilker, Leorah; Zlotkin-Rivkin, Efrat; Rund, David; Melamed-Book, Naomi; Zahavi, Eitan Erez; Perlson, Eran; Mercone, Silvana; Golosovsky, Michael; Davidov, Dan; Aroeti, Benjamin			Real-Time Sensing of Enteropathogenic E. coli-Induced Effects on Epithelial Host Cell Height, Cell-Substrate Interactions, and Endocytic Processes by Infrared Surface Plasmon Spectroscopy	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; BARRIER FUNCTION; BACTERIAL PATHOGENS; LIVING CELLS; IN-VIVO; ESPF; DISRUPTION; INFECTION; RESONANCE; TRANSLOCATION	Enteropathogenic Escherichia coli (EPEC) is an important, generally non-invasive, bacterial pathogen that causes diarrhea in humans. The microbe infects mainly the enterocytes of the small intestine. Here we have applied our newly developed infrared surface plasmon resonance (IR-SPR) spectroscopy approach to study how EPEC infection affects epithelial host cells. The IR-SPR experiments showed that EPEC infection results in a robust reduction in the refractive index of the infected cells. Assisted by confocal and total internal reflection microscopy, we discovered that the microbe dilates the intercellular gaps and induces the appearance of fluid-phase-filled pinocytic vesicles in the lower basolateral regions of the host epithelial cells. Partial cell detachment from the underlying substratum was also observed. Finally, the waveguide mode observed by our IR-SPR analyses showed that EPEC infection decreases the host cell's height to some extent. Together, these observations reveal novel impacts of the pathogen on the host cell architecture and endocytic functions. We suggest that these changes may induce the infiltration of a watery environment into the host cell, and potentially lead to failure of the epithelium barrier functions. Our findings also indicate the great potential of the label-free IR-SPR approach to study the dynamics of host-pathogen interactions with high spatiotemporal sensitivity.	[Yashunsky, Victor; Golosovsky, Michael; Davidov, Dan] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kharilker, Leorah; Zlotkin-Rivkin, Efrat; Rund, David; Aroeti, Benjamin] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Alexander Silberman Inst Life Sci, Jerusalem, Israel; [Kharilker, Leorah; Zlotkin-Rivkin, Efrat; Rund, David; Aroeti, Benjamin] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Bioimaging Unit, Jerusalem, Israel; [Yashunsky, Victor] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Zahavi, Eitan Erez; Perlson, Eran] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Mercone, Silvana] Univ Paris 13, Sorbonne Paris Cite, LSPM UPR CNRS 3407, F-93430 Villetaneuse, France; [Melamed-Book, Naomi] Hebrew Univ Jerusalem, Confocal Unit, Alexander Silberman Inst Life Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Universite Paris 13; Hebrew University of Jerusalem	Yashunsky, V (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	victor.yashunsky@mail.huji.ac.il	Yashunsky, Victor/M-9523-2017; Yashunsky, Victor/P-1456-2019; Golosovsky, Michael/L-8303-2013; Mercone, Silvana/F-9799-2019	Yashunsky, Victor/0000-0003-3175-3390; Yashunsky, Victor/0000-0003-3175-3390; Mercone, Silvana/0000-0002-5790-1032; Perlson, Eran/0000-0001-6047-9613	NOFAR grant from the Israel Ministry of Industry and Trade; Start-Up grant Tack A from Yissum; Israel Science Foundation (ISF); Israel Academy of Sciences [1167/08]; Israel Cancer Association	NOFAR grant from the Israel Ministry of Industry and Trade; Start-Up grant Tack A from Yissum; Israel Science Foundation (ISF)(Israel Science Foundation); Israel Academy of Sciences; Israel Cancer Association	This work was supported by a NOFAR grant from the Israel Ministry of Industry and Trade. BA acknowledges support from the Start-Up grant Tack A from Yissum, the Israel Science Foundation (ISF), funded by the Israel Academy of Sciences (Grant 1167/08), and a grant from the Israel Cancer Association. The funders had no role in the study design, the data collection, and analysis, the decision to publish, or preparation of the manuscript.	Aroeti B, 2012, GUT MICROBES, V3, P267, DOI 10.4161/gmic.19814; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chabot V, 2009, BIOSENS BIOELECTRON, V24, P1667, DOI 10.1016/j.bios.2008.08.025; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; Elliott SJ, 2002, INFECT IMMUN, V70, P2271, DOI 10.1128/IAI.70.5.2271-2277.2002; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971; Golosovsky M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116143; Goosney DL, 2000, ANNU REV CELL DEV BI, V16, P173, DOI 10.1146/annurev.cellbio.16.1.173; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Guttman JA, 2006, CELL MICROBIOL, V8, P634, DOI 10.1111/j.1462-5822.2005.00656.x; Guttman JA, 2008, TRENDS MICROBIOL, V16, P535, DOI 10.1016/j.tim.2008.08.004; Guttman JA, 2007, ANAT REC, V290, P199, DOI 10.1002/ar.20414; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Howie HL, 2008, INFECT IMMUN, V76, P2715, DOI 10.1128/IAI.00153-08; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Ivanov AI, 2010, AM J PATHOL, V177, P512, DOI 10.2353/ajpath.2010.100168; Johansen K, 2000, REV SCI INSTRUM, V71, P3530, DOI 10.1063/1.1287631; Kreitzer G, 2003, NAT CELL BIOL, V5, P126, DOI 10.1038/ncb917; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Law RJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009977; Levayer R, 2012, TRENDS CELL BIOL, V22, P61, DOI 10.1016/j.tcb.2011.10.001; Lukyanenko V, 2011, AM J PHYSIOL-CELL PH, V301, pC1140, DOI 10.1152/ajpcell.00036.2011; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Moriez R, 2005, AM J PATHOL, V167, P1071, DOI 10.1016/S0002-9440(10)61196-0; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Opitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017088; PALIK ED, 1984, J OPT SOC AM A, V1, P1297; Preston AM, 2006, J MORPHOL, V267, P103, DOI 10.1002/jmor.10390; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sason H, 2009, MOL BIOL CELL, V20, P544, DOI 10.1091/mbc.E08-05-0516; Schmitt M, 2004, PANCREAS, V28, P181, DOI 10.1097/00006676-200403000-00010; Shalabney A, 2011, LASER PHOTONICS REV, V5, P571, DOI 10.1002/lpor.201000009; Shames SR, 2010, CELL MICROBIOL, V12, P1322, DOI 10.1111/j.1462-5822.2010.01470.x; Shifflett DE, 2005, LAB INVEST, V85, P1308, DOI 10.1038/labinvest.3700330; Shifrin Y, 2002, CELL MICROBIOL, V4, P235, DOI 10.1046/j.1462-5822.2002.00188.x; TIEN PK, 1971, APPL OPTICS, V10, P2395, DOI 10.1364/AO.10.002395; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799; VERTUTDOI A, 1994, ANTIMICROB AGENTS CH, V38, P2373, DOI 10.1128/AAC.38.10.2373; Vidal JE, 2006, INFECT IMMUN, V74, P2293, DOI 10.1128/IAI.74.4.2293-2303.2006; Viswanathan VK, 2004, CELL MICROBIOL, V6, P987, DOI 10.1111/j.1462-5822.2004.00416.x; Viswanathan VK, 2004, INFECT IMMUN, V72, P3218, DOI 10.1128/IAI.72.6.3218-3227.2004; Weflen AW, 2009, ANN NY ACAD SCI, V1165, P169, DOI 10.1111/j.1749-6632.2009.04060.x; Windt DL, 1998, COMPUT PHYS, V12, P360, DOI 10.1063/1.168689; Yashunsky V, 2010, AIP CONF PROC, V1281, P1617, DOI 10.1063/1.3498133; Yashunsky V, 2012, P SOC PHOTO-OPT INS, V8234, P823419; Yashunsky V, 2012, J BIOMED OPT, V17, DOI [10.1117/1.JBO.17.8.081409, DOI 10.1117/1.JB0.17.8.081409.PUBMED:23224170]; Yashunsky V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048454; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017; Yashunsky V, 2009, BIOPHYS J, V97, P1003, DOI 10.1016/j.bpj.2009.05.052; Zahavi EE, 2011, MOL BIOL CELL, V22, P2436, DOI 10.1091/mbc.E11-01-0001; Zilbershtein A, 2012, VIB SPECTROSC, V61, P43, DOI 10.1016/j.vibspec.2012.01.019	57	6	6	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2013	8	10							e78431	10.1371/journal.pone.0078431	http://dx.doi.org/10.1371/journal.pone.0078431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239PE	24194932	gold, Green Submitted, Green Published			2022-12-25	WOS:000326037000111
J	Guan, NY; Wei, L; Luo, ZG; Tao, DC				Guan, Naiyang; Wei, Lei; Luo, Zhigang; Tao, Dacheng			Limited-Memory Fast Gradient Descent Method for Graph Regularized Nonnegative Matrix Factorization	PLOS ONE			English	Article							INFORMATION	Graph regularized nonnegative matrix factorization (GNMF) decomposes a nonnegative data matrix X is an element of R-mxn to the product of two lower-rank nonnegative factor matrices, i.e., W is an element of R-mxr and H is an element of R-rxn (r<min{m,n}) and aims to preserve the local geometric structure of the dataset by minimizing squared Euclidean distance or Kullback-Leibler (KL) divergence between X and WH. The multiplicative update rule (MUR) is usually applied to optimize GNMF, but it suffers from the drawback of slow-convergence because it intrinsically advances one step along the rescaled negative gradient direction with a non-optimal step size. Recently, a multiple step-sizes fast gradient descent (MFGD) method has been proposed for optimizing NMF which accelerates MUR by searching the optimal step-size along the rescaled negative gradient direction with Newton's method. However, the computational cost of MFGD is high because 1) the high-dimensional Hessian matrix is dense and costs too much memory; and 2) the Hessian inverse operator and its multiplication with gradient cost too much time. To overcome these deficiencies of MFGD, we propose an efficient limited-memory FGD (L-FGD) method for optimizing GNMF. In particular, we apply the limited-memory BFGS (L-BFGS) method to directly approximate the multiplication of the inverse Hessian and the gradient for searching the optimal step size in MFGD. The preliminary results on real-world datasets show that L-FGD is more efficient than both MFGD and MUR. To evaluate the effectiveness of L-FGD, we validate its clustering performance for optimizing KL-divergence based GNMF on two popular face image datasets including ORL and PIE and two text corpora including Reuters and TDT2. The experimental results confirm the effectiveness of L-FGD by comparing it with the representative GNMF solvers.	[Guan, Naiyang; Wei, Lei; Luo, Zhigang] Natl Univ Def Technol, Sch Comp Sci, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Tao, Dacheng] Univ Technol Sydney, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia	National University of Defense Technology - China; University of Technology Sydney; University of Technology Sydney	Luo, ZG (corresponding author), Natl Univ Def Technol, Sch Comp Sci, Natl Key Lab Parallel & Distributed Proc, Changsha, Hunan, Peoples R China.	zgluo@nudt.edu.cn; Dacheng.Tao@uts.edu.au			Scientific Research Plan Project of National University of Defense Technology [JC13-06-01]; Australian Research Council [120103730]	Scientific Research Plan Project of National University of Defense Technology; Australian Research Council(Australian Research Council)	This work was partially supported by Scientific Research Plan Project of National University of Defense Technology (No. JC13-06-01) and Australian Research Council Discovery Project (120103730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkin M, 2006, J MACH LEARN RES, V7, P2399; Cai D, 2011, IEEE T PATTERN ANAL, V33, P1548, DOI 10.1109/TPAMI.2010.231; Cieri Chris, 1999, P DARPA BROADC NEWS, P57; Tao DC, 2007, KNOWL INF SYST, V13, P1, DOI 10.1007/s10115-006-0050-6; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Donoho D, 2004, ADV NEUR IN, V16, P1141; Graham D., 1998, FACE RECOGNITION, V163, P446, DOI DOI 10.1007/978-3-642-72201-1_25; Guan N., 2012, ARXIV12073438V1; Guan NY, 2012, IEEE T NEUR NET LEAR, V23, P1087, DOI 10.1109/TNNLS.2012.2197827; Guan NY, 2012, IEEE T SIGNAL PROCES, V60, P2882, DOI 10.1109/TSP.2012.2190406; Guan NY, 2011, IEEE T NEURAL NETWOR, V22, P1218, DOI 10.1109/TNN.2011.2157359; Guan NY, 2011, IEEE T IMAGE PROCESS, V20, P2030, DOI 10.1109/TIP.2011.2105496; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lewis DD, 2004, J MACH LEARN RES, V5, P361; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Samaria F. S., 1994, Proceedings of the Second IEEE Workshop on Applications of Computer Vision (Cat. No.94TH06742), P138, DOI 10.1109/ACV.1994.341300; Sandler R, 2011, IEEE T PATTERN ANAL, V33, P1590, DOI 10.1109/TPAMI.2011.18; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Tao DC, 2009, IEEE T PATTERN ANAL, V31, P260, DOI 10.1109/TPAMI.2008.70; Tao DP, 2012, NEUROCOMPUTING, V91, P11, DOI 10.1016/j.neucom.2012.02.024; Vavasis SA, 2009, SIAM J OPTIMIZ, V20, P1364, DOI 10.1137/070709967; Zafeiriou S, 2006, IEEE T NEURAL NETWOR, V17, P683, DOI 10.1109/TNN.2006.873291	24	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2013	8	10							e77162	10.1371/journal.pone.0077162	http://dx.doi.org/10.1371/journal.pone.0077162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239NN	24204761	gold, Green Published, Green Submitted			2022-12-25	WOS:000326032600023
J	Foucreau, N; Piscart, C; Puijalon, S; Hervant, F				Foucreau, Natacha; Piscart, Christophe; Puijalon, Sara; Hervant, Frederic			Effect of Climate-Related Change in Vegetation on Leaf Litter Consumption and Energy Storage by Gammarus pulex from Continental or Mediterranean Populations	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; STREAM ECOSYSTEMS; TROPICAL STREAMS; SUMMER DROUGHT; CHANGE IMPACTS; GAS-EXCHANGE; DECOMPOSITION; GROWTH; RIVER; PHYSIOLOGY	As a consequence of global warming, it is important to characterise the potential changes occurring for some functional processes through the intra-specific study of key species. Changes in species distribution, particularly when key or engineer species are affected, should contribute to global changes in ecosystem functioning. In this study, we examined the potential consequences induced by global warming on ecosystem functioning in term of organic matter recycling. We compared consumption of leaf litter by some shredder populations (Gammarus pulex) between five tree species inhabiting continental (i.e., the northern region of the Rhone River Valley) and/or Mediterranean (i.e., the southern region of the Rhone River Valley) conditions. To consider any potential adaptation of the gammarid population to vegetation in the same climate conditions, three populations of the key shredder Gammarus pulex from the northern region and three from the southern region of the Rhone River Valley were used. We experimentally compared the effects of the geographical origin of both the gammarid populations and the leaf litter species on the shredding activity and the physiological state of animals (through body triglyceride content). This study demonstrated that leaf toughness is more important than geographical origin for determining shredder leaf litter consumption. The overall consumption rate of the gammarid populations from the southern region of Rhone Valley was much higher than that of the populations from the northern region, but no clear differences between the origins of the leaf litter (i.e., continental vs. Mediterranean) were observed. The northwards shift of G. pulex populations adapted to warmer conditions might significantly modify organic matter recycling in continental streams. As gammarid populations can demonstrate local adaptations to certain leaf species as a trophic resource, changes in riparian vegetation associated with climate change might locally affect the leaf litter degradation process by this shredder.	[Foucreau, Natacha; Piscart, Christophe; Puijalon, Sara; Hervant, Frederic] Univ Lyon 1, CNRS, ENTPE, UMR Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Foucreau, N (corresponding author), Univ Lyon 1, CNRS, ENTPE, UMR Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France.	natacha.foucreau@univ-lyon1.fr	Piscart, christophe/AAD-8973-2019; Puijalon, Sara/ABA-6520-2020	Piscart, christophe/0000-0002-4054-4542; Puijalon, Sara/0000-0002-1942-7958	National Research Agency - Agence Nationale de la Recherche - ANR [ANR-09-CEP-006-01]	National Research Agency - Agence Nationale de la Recherche - ANR(French National Research Agency (ANR))	The national research agency for funds (program Wetchange ANR-09-CEP-006-01 of the National Research Agency - Agence Nationale de la Recherche - ANR) http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelho M, 2008, INT REV HYDROBIOL, V93, P358, DOI 10.1002/iroh.200711019; BARLOCHE.F, 1973, OIKOS, V24, P295, DOI 10.2307/3543888; Becker J, 2013, FRESHWATER BIOL, V58, P372, DOI 10.1111/fwb.12065; Boyero L, 2011, ECOL LETT, V14, P289, DOI 10.1111/j.1461-0248.2010.01578.x; Canhoto C, 1996, HYDROBIOLOGIA, V333, P79, DOI 10.1007/BF00017570; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Clarke A, 2004, FUNCT ECOL, V18, P252, DOI 10.1111/j.0269-8463.2004.00842.x; CLARKE A, 1985, MAR BIOL, V88, P247, DOI 10.1007/BF00392587; Clemens HP, 1950, SAY CONTR STONE LAB, V12; Costa FO, 1999, ACTA OECOL, V20, P305, DOI 10.1016/S1146-609X(99)00136-8; Costa GC, 2008, J BIOGEOGR, V35, P637, DOI 10.1111/j.1365-2699.2007.01809.x; Cottin D, 2012, NATURWISSENSCHAFTEN, V99, P259, DOI 10.1007/s00114-012-0894-4; CUMMINS KW, 1974, BIOSCIENCE, V24, P631, DOI 10.2307/1296676; Daufresne M, 2004, GLOBAL CHANGE BIOL, V10, P124, DOI 10.1046/j.1529-8817.2003.00720.x; De Micco V, 2008, TREES-STRUCT FUNCT, V22, P643, DOI 10.1007/s00468-008-0222-y; Dehedin A, 2013, GLOBAL CHANGE BIOL, V19, P763, DOI 10.1111/gcb.12084; DELONG MD, 1993, CAN J FISH AQUAT SCI, V50, P1891, DOI 10.1139/f93-211; di Lascio A, 2011, FUND APPL LIMNOL, V179, P193, DOI 10.1127/1863-9135/2011/0179-0193; GALLARDO A, 1993, ECOLOGY, V74, P152, DOI 10.2307/1939510; GESSNER MO, 1994, ECOLOGY, V75, P1807, DOI 10.2307/1939639; Graca MAS, 2001, FRESHWATER BIOL, V46, P947, DOI 10.1046/j.1365-2427.2001.00729.x; Gulis V, 2006, FRESHWATER BIOL, V51, P1655, DOI 10.1111/j.1365-2427.2006.01615.x; Hervant F, 2002, J EXP BIOL, V205, P2079; Hervant F, 1999, J EXP BIOL, V202, P3587; IPCC, 2007, CONTRIBUTION WORKING; Koop JHE, 2008, LIMNOLOGICA, V38, P378, DOI 10.1016/j.limno.2008.05.004; Kramer K, 2008, FOREST ECOL MANAG, V255, P3893, DOI 10.1016/j.foreco.2008.03.044; Lecerf A, 2005, OECOLOGIA, V146, P432, DOI 10.1007/s00442-005-0212-3; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Logan CA, 2012, MAR ECOL PROG SER, V450, P93, DOI 10.3354/meps09491; Maazouzi C, 2009, FUND APPL LIMNOL, V175, P327, DOI 10.1127/1863-9135/2009/0175-0327; Menendez M, 2012, HYDROBIOLOGIA, V691, P135, DOI 10.1007/s10750-012-1064-6; Moretti M, 2007, LIMNOLOGICA, V37, P250, DOI 10.1016/j.limno.2007.01.003; Moser B, 2011, J ECOL, V99, P1229, DOI 10.1111/j.1365-2745.2011.01841.x; Onoda Y, 2011, ECOL LETT, V14, P301, DOI 10.1111/j.1461-0248.2010.01582.x; Ostrofsky ML, 1997, J N AM BENTHOL SOC, V16, P750, DOI 10.2307/1468168; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pinkster S., 1972, BIJDR DIERK, V42, P165; Pinna M, 2004, INT REV HYDROBIOL, V89, P484, DOI 10.1002/iroh.200410765; Piscart C, 2011, BIOL INVASIONS, V13, P2861, DOI 10.1007/s10530-011-9969-y; Piscart C, 2011, FRESHWATER BIOL, V56, P325, DOI 10.1111/j.1365-2427.2010.02500.x; Piscart C, 2009, ENVIRON POLLUT, V157, P1011, DOI 10.1016/j.envpol.2008.10.010; Portner HO, 2005, SCI MAR, V69, P271; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Rosset V, 2011, BIOL CONSERV, V144, P2311, DOI 10.1016/j.biocon.2011.06.009; Roth-Nebelsick A, 2013, PLANT CELL ENVIRON, V36, P579, DOI 10.1111/j.1365-3040.2012.02597.x; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Seibel BA, 2007, J EXP BIOL, V210, P1, DOI 10.1242/jeb.02588; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Somero GN, 2012, ANNU REV MAR SCI, V4, P39, DOI 10.1146/annurev-marine-120710-100935; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Sutcliffe D.W., 1993, Freshwater Forum, V3, P26; Torres-Ruiz M, 2010, HYDROBIOLOGIA, V651, P265, DOI 10.1007/s10750-010-0305-9; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Van der Putten WH, 2012, ANNU REV ECOL EVOL S, V43, P365, DOI 10.1146/annurev-ecolsys-110411-160423; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Warren CR, 2007, OECOLOGIA, V154, P1, DOI 10.1007/s00442-007-0803-2; Wesolowski T, 2006, FOREST ECOL MANAG, V237, P387, DOI 10.1016/j.foreco.2006.09.061; Whiteley NM, 2011, J EXP MAR BIOL ECOL, V400, P70, DOI 10.1016/j.jembe.2011.02.027; WILLOUGHBY LG, 1976, FRESHWATER BIOL, V6, P577, DOI 10.1111/j.1365-2427.1976.tb01647.x; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	63	14	14	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77242	10.1371/journal.pone.0077242	http://dx.doi.org/10.1371/journal.pone.0077242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204778	Green Published, gold, Green Submitted			2022-12-25	WOS:000326029300092
J	Kaneko, M; Shintani, Y; Narita, T; Ikebe, C; Tano, N; Yamahara, K; Fukushima, S; Coppen, SR; Suzuki, K				Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Ikebe, Chiho; Tano, Nobuko; Yamahara, Kenichi; Fukushima, Satsuki; Coppen, Steven R.; Suzuki, Ken			Extracellular High Mobility Group Box 1 Plays a Role in the Effect of Bone Marrow Mononuclear Cell Transplantation for Heart Failure	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; STEM-CELLS; INJECTION; RAT; INFLAMMATION; HMGB1; REGENERATION	Transplantation of unfractionated bone marrow mononuclear cells (BMCs) repairs and/or regenerates the damaged myocardium allegedly due to secretion from surviving BMCs (paracrine effect). However, donor cell survival after transplantation is known to be markedly poor. This discrepancy led us to hypothesize that dead donor BMCs might also contribute to the therapeutic benefits from BMC transplantation. High mobility group box 1 (HMGB1) is a nuclear protein that stabilizes nucleosomes, and also acts as a multi-functional cytokine when released from damaged cells. We thus studied the role of extracellular HMGB1 in the effect of BMC transplantation for heart failure. Four weeks after coronary artery ligation in female rats, syngeneic male BMCs (or PBS only as control) were intramyocardially injected with/without anti-HMGB1 antibody or control IgG. One hour after injection, ELISA showed that circulating extracellular HMGB1 levels were elevated after BMC transplantation compared to the PBS injection. Quantitative donor cell survival assessed by PCR for male-specific sry gene at days 3 and 28 was similarly poor. Echocardiography and catheterization showed enhanced cardiac function after BMC transplantation compared to PBS injection at day 28, while this effect was abolished by antibody-neutralization of HMGB1. BMC transplantation reduced post-infarction fibrosis, improved neovascularization, and increased proliferation, while all these effects in repairing the failing myocardium were eliminated by HMGB1-inhibition. Furthermore, BMC transplantation drove the macrophage polarization towards alternatively-activated, anti-inflammatory M2 macrophages in the heart at day 3, while this was abolished by HMGB1-inhibition. Quantitative RT-PCR showed that BMC transplantation upregulated expression of an anti-inflammatory cytokine IL-10 in the heart at day 3 compared to PBS injection. In contrast, neutralizing HMGB1 by antibody-treatment suppressed this anti-inflammatory expression. These data suggest that extracellular HMGB1 contributes to the effect of BMC transplantation to recover the damaged myocardium by favorably modulating innate immunity in heart failure.	[Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Ikebe, Chiho; Tano, Nobuko; Coppen, Steven R.; Suzuki, Ken] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Yamahara, Kenichi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan; [Fukushima, Satsuki] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan	University of London; Queen Mary University London; National Cerebral & Cardiovascular Center - Japan; Osaka University	Suzuki, K (corresponding author), Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	ken.suzuki@qmul.ac.uk	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; Shintani, Yasunori/0000-0001-9579-0727	Barts and The London Charity [422/433]; NIHR; Medical Research Council, UK [G116/158]; Medical Research Council [G116/158] Funding Source: researchfish; MRC [G116/158] Funding Source: UKRI	Barts and The London Charity; NIHR(National Institute for Health Research (NIHR)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Barts and The London Charity Large Project Grant (422/433) and supported by NIHR-funded Barts Cardiovascular Biomedical Research Unit. This study was also funded by the Medical Research Council, UK (Senior Fellowship G116/158 to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Donndorf P, 2011, J THORAC CARDIOV SUR, V142, P911, DOI 10.1016/j.jtcvs.2010.12.013; Francis J, 2001, AM J PHYSIOL-REG I, V281, pR1734, DOI 10.1152/ajpregu.2001.281.5.R1734; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; George JC, 2008, J INTERV CARDIOL, V21, P424, DOI 10.1111/j.1540-8183.2008.00390.x; Hu YL, 2011, BASIC RES CARDIOL, V106, P1311, DOI 10.1007/s00395-011-0204-x; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Limana F, 2005, CIRC RES, V97, pE73, DOI 10.1161/01.RES.0000186276.06104.04; Limana F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019845; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; Ohnishi S, 2007, STEM CELLS, V25, P1166, DOI 10.1634/stemcells.2006-0347; Omura T, 2000, BASIC RES CARDIOL, V95, P316, DOI 10.1007/s003950070051; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Popovic PJ, 2006, J IMMUNOL, V177, P8701, DOI 10.4049/jimmunol.177.12.8701; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Takahashi K, 2008, CIRCULATION, V118, pS106, DOI 10.1161/CIRCULATIONAHA.107.757443; Tang DL, 2005, SHOCK, V23, P434, DOI 10.1097/01.shk.0000159556.95285.df; van Ramshorst J, 2011, J CARDIOVASC TRANSL, V4, P182, DOI 10.1007/s12265-010-9249-8; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yeghiazarians Y, 2009, MOL THER, V17, P1250, DOI 10.1038/mt.2009.85; Zhou XY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/743879; Ziebart T, 2008, CIRC RES, V103, P1327, DOI 10.1161/CIRCRESAHA.108.180463	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e76908	10.1371/journal.pone.0076908	http://dx.doi.org/10.1371/journal.pone.0076908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204700	gold, Green Submitted, Green Published			2022-12-25	WOS:000326029300064
J	Kus, R; Duszyk, A; Milanowski, P; Labecki, M; Bierzynska, M; Radzikowska, Z; Michalska, M; Zygierewicz, J; Suffczynski, P; Durka, PJ				Kus, Rafal; Duszyk, Anna; Milanowski, Piotr; Labecki, Maciej; Bierzynska, Maria; Radzikowska, Zofia; Michalska, Magdalena; Zygierewicz, Jaroslaw; Suffczynski, Piotr; Durka, Piotr Jerzy			On the Quantification of SSVEP Frequency Responses in Human EEG in Realistic BCI Conditions	PLOS ONE			English	Article								This article concerns one of the most important problems of brain-computer interfaces (BCI) based on Steady State Visual Evoked Potentials (SSVEP), that is the selection of the a-priori most suitable frequencies for stimulation. Previous works related to this problem were done either with measuring systems that have little in common with actual BCI systems (e. g., single flashing LED) or were presented on a small number of subjects, or the tested frequency range did not cover a broad spectrum. Their results indicate a strong SSVEP response around 10 Hz, in the range 13-25 Hz, and at high frequencies in the band of 40-60 Hz. In the case of BCI interfaces, stimulation with frequencies from various ranges are used. The frequencies are often adapted for each user separately. The selection of these frequencies, however, was not yet justified in quantitative group-level study with proper statistical account for inter-subject variability. The aim of this study is to determine the SSVEP response curve, that is, the magnitude of the evoked signal as a function of frequency. The SSVEP response was induced in conditions as close as possible to the actual BCI system, using a wide range of frequencies (5-30 Hz, in step of 1 Hz). The data were obtained for 10 subjects. SSVEP curves for individual subjects and the population curve was determined. Statistical analysis were conducted both on the level of individual subjects and for the group. The main result of the study is the identification of the optimal range of frequencies, which is 12-18 Hz, for the registration of SSVEP phenomena. The applied criterion of optimality was: to find the largest contiguous range of frequencies yielding the strong and constant-level SSVEP response.	[Kus, Rafal; Milanowski, Piotr; Labecki, Maciej; Michalska, Magdalena; Zygierewicz, Jaroslaw; Suffczynski, Piotr; Durka, Piotr Jerzy] Univ Warsaw, Fac Phys, Warsaw, Poland; [Duszyk, Anna; Radzikowska, Zofia] Univ Social Sci & Humanities, Dept Psychol, Warsaw, Poland; [Bierzynska, Maria] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland	University of Warsaw; SWPS University of Social Sciences & Humanities; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Kus, R (corresponding author), Univ Warsaw, Fac Phys, Warsaw, Poland.	rkus@fuw.edu.pl	Suffczynski, Piotr/ABG-5183-2020	Duszyk, Anna/0000-0002-5984-2339; Zygierewicz, Jaroslaw/0000-0002-7536-0735; Durka, Piotr/0000-0001-5816-8082; Suffczynski, Piotr/0000-0002-2300-1415	Ventures Programme of Foundation for Polish Science operated within the Innovative Economy Operational Programme (IE OP) within European Regional Development Fund; Polish funds for science	Ventures Programme of Foundation for Polish Science operated within the Innovative Economy Operational Programme (IE OP) within European Regional Development Fund; Polish funds for science	The work was partially supported by the Ventures Programme of Foundation for Polish Science operated within the Innovative Economy Operational Programme (IE OP) 2007-2013 within European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The additional part of the funding was from Polish funds for science.	Bakardjian H, 2010, NEUROSCI LETT, V469, P34, DOI 10.1016/j.neulet.2009.11.039; Benjamini Y, 2001, ANN STAT, V29, P1165; Brunner C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025010; Cecotti H, 2010, IEEE T NEUR SYS REH, V18, P127, DOI 10.1109/TNSRE.2009.2039594; Durka PJ, 2012, B POL ACAD SCI-TECH, V60, P427, DOI 10.2478/v10175-012-0054-1; Fuchs S, 2008, NEUROIMAGE, V41, P1086, DOI 10.1016/j.neuroimage.2008.02.040; Fukunaga K, 1990, INTRO STAT PATTERN R; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Kaashoek I, 2008, TECHNICAL REPORT; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; KOLES ZJ, 1991, ELECTROEN CLIN NEURO, V79, P440, DOI 10.1016/0013-4694(91)90163-X; KOLES ZJ, 1994, ELECTROEN CLIN NEURO, V91, P319, DOI 10.1016/0013-4694(94)90119-8; KOLES ZJ, 1995, ELECTROEN CLIN NEURO, V95, P219, DOI 10.1016/0013-4694(95)00083-B; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez-Gordo MA, 2011, CLIN NEUROPHYSIOL, V122, P128, DOI 10.1016/j.clinph.2010.05.021; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Molina GM, 2010, 18 EUR SIGN P C EUSI; Muller-Putz GR, 2005, J NEURAL ENG, V2, P123, DOI 10.1088/1741-2560/2/4/008; Ng K, 2011, ENG MED BIOL SOC EMB; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Pastor MA, 2003, J NEUROSCI, V23, P11621; REGAN D, 1968, ELECTROEN CLIN NEURO, V25, P231, DOI 10.1016/0013-4694(68)90020-5; REGAN D, 1975, NATURE, V253, P401, DOI 10.1038/253401a0; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wang Y, 2005, 1 INT C NEUR INT CON; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576	28	68	68	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77536	10.1371/journal.pone.0077536	http://dx.doi.org/10.1371/journal.pone.0077536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204862	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300102
J	Unger, SD; Rhodes, OE; Sutton, TM; Williams, RN				Unger, Shem D.; Rhodes, Olin E., Jr.; Sutton, Trent M.; Williams, Rod N.			Population Genetics of the Eastern Hellbender (Cryptobranchus alleganiensis alleganiensis) across Multiple Spatial Scales	PLOS ONE			English	Article							CONSERVATION GENETICS; LANDSCAPE GENETICS; AMPHIBIAN DECLINES; ATLANTIC SALMON; BROOK CHARR; DIVERSITY; SALAMANDER; SOFTWARE; BARRIERS; RANGE	Conservation genetics is a powerful tool to assess the population structure of species and provides a framework for informing management of freshwater ecosystems. As lotic habitats become fragmented, the need to assess gene flow for species of conservation management becomes a priority. The eastern hellbender (Cryptobranchus alleganiensis alleganiensis) is a large, fully aquatic paedamorphic salamander. Many populations are experiencing declines throughout their geographic range, yet the genetic ramifications of these declines are currently unknown. To this end, we examined levels of genetic variation and genetic structure at both range-wide and drainage (hierarchical) scales. We collected 1,203 individuals from 77 rivers throughout nine states from June 2007 to August 2011. Levels of genetic diversity were relatively high among all sampling locations. We detected significant genetic structure across populations (Fst values ranged from 0.001 between rivers within a single watershed to 0.218 between states). We identified two genetically differentiated groups at the range-wide scale: 1) the Ohio River drainage and 2) the Tennessee River drainage. An analysis of molecular variance (AMOVA) based on landscape-scale sampling of basins within the Tennessee River drainage revealed the majority of genetic variation (similar to 94-98%) occurs within rivers. Eastern hellbenders show a strong pattern of isolation by stream distance (IBSD) at the drainage level. Understanding levels of genetic variation and differentiation at multiple spatial and biological scales will enable natural resource managers to make more informed decisions and plan effective conservation strategies for cryptic, lotic species.	[Unger, Shem D.; Rhodes, Olin E., Jr.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Sutton, Trent M.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK USA; [Williams, Rod N.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia; University of Alaska System; University of Alaska Fairbanks; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Unger, SD (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA.	cryptobranchus11@gmail.com			Indiana Department of Natural Resources [E2-07-WD0007]; Department of Forestry and Natural Resources at Purdue University; Cryptobranchid Interest Group Ron Goellner Fund	Indiana Department of Natural Resources; Department of Forestry and Natural Resources at Purdue University; Cryptobranchid Interest Group Ron Goellner Fund	Funding was provided by the Indiana Department of Natural Resources (E2-07-WD0007; http://www.in.gov/dnr/), Department of Forestry and Natural Resources at Purdue University (https://ag.purdue.edu/fnr/Pages/default.aspx), and Cryptobranchid Interest Group Ron Goellner Fund (2010; http://www.caudata.org/cig/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrino J, 2000, MOL ECOL, V9, P771, DOI 10.1046/j.1365-294x.2000.00931.x; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Allee W.C, 1931, ANIMAL AGGREGATION S; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; Avise J.C., 2004, MOL MARKERS NATURAL; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Burgmeier NG, 2011, J HERPETOL, V45, P195, DOI 10.1670/10-094.1; Burgmeier NG, 2011, HERPETOLOGICA, V67, P135, DOI 10.1655/HERPETOLOGICA-D-10-00027.1; Busch JD, 2007, MOL ECOL, V16, P2450, DOI 10.1111/j.1365-294X.2007.03283.x; Castric V, 2001, EVOLUTION, V55, P1016, DOI 10.1554/0014-3820(2001)055[1016:LSAHGD]2.0.CO;2; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Costello AB, 2003, EVOLUTION, V57, P328, DOI 10.1111/j.0014-3820.2003.tb00267.x; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crowhurst RS, 2011, CONSERV GENET, V12, P637, DOI 10.1007/s10592-010-0170-0; Curtis JMR, 2004, BIOL CONSERV, V115, P45, DOI 10.1016/S0006-3207(03)00092-2; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Dionne M, 2008, MOL ECOL, V17, P2382, DOI 10.1111/j.1365-294X.2008.03771.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Echelle AA, 2010, CONSERV GENET, V11, P1375, DOI 10.1007/s10592-009-9966-1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finn DS, 2007, FRESHWATER BIOL, V52, P1881, DOI 10.1111/j.1365-2427.2007.01813.x; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gall BG, 2010, ETHOLOGY, V116, P47, DOI 10.1111/j.1439-0310.2009.01718.x; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Grant EHC, 2007, ECOL LETT, V10, P165, DOI 10.1111/j.1461-0248.2006.01007.x; Grant EHC, 2010, P NATL ACAD SCI USA, V107, P6936, DOI 10.1073/pnas.1000266107; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Humphries WJ, 2005, J HERPETOL, V34, P604; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2008, CAN J FISH AQUAT SCI, V65, P2752, DOI 10.1139/F08-171; Kanno Y, 2011, MOL ECOL, V20, P3711, DOI 10.1111/j.1365-294X.2011.05210.x; Kelly MW, 2005, CONSERV GENET, V6, P789, DOI 10.1007/s10592-005-9037-1; King TL, 2001, MOL ECOL, V10, P807, DOI 10.1046/j.1365-294X.2001.01231.x; Krosch MN, 2011, FRESHWATER BIOL, V56, P1328, DOI 10.1111/j.1365-2427.2010.02571.x; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Latch EK, 2008, J HERED, V99, P265, DOI 10.1093/jhered/esn009; Leberg PL, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P212; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2005, BIOTROPICA, V37, P222, DOI 10.1111/j.1744-7429.2005.00029.x; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; McCune B., 2011, PC ORD MULTIVARIATE; MEFFE G K, 1988, Conservation Biology, V2, P157, DOI 10.1111/j.1523-1739.1988.tb00167.x; Mullen LB, 2010, MOL ECOL, V19, P898, DOI 10.1111/j.1365-294X.2010.04541.x; Nickerson M.A., 1973, Publications Biol Geol Milwaukee publ Mus, VNo. 1,1973, P1; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petranka, 1998, SALAMANDERS US CANAD; Pittman SE, 2011, CONSERV GENET, V12, P1589, DOI 10.1007/s10592-011-0257-2; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Pritchard J, 2003, DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Quattro JM, 2002, CONSERV GENET, V3, P155, DOI 10.1023/A:1015275602748; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Rhodes OE, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P296; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sabatino SJ, 2009, CONSERV GENET, V10, P1235, DOI 10.1007/s10592-008-9655-5; Sambrook J., 2001, MOL CLONING LAB MANU; Samuiloviene A, 2009, FISH PHYSIOL BIOCHEM, V35, P649, DOI 10.1007/s10695-009-9310-1; Seymour AM, 2001, ANIM CONSERV, V4, P211, DOI 10.1017/S1367943001001251; Sterling KA, 2012, CONSERV GENET, V13, P859, DOI 10.1007/s10592-012-0335-0; STONEBURNER DL, 1978, FRESHWATER BIOL, V8, P291, DOI 10.1111/j.1365-2427.1978.tb01450.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tonione M, 2011, GENETICA, V139, P209, DOI 10.1007/s10709-010-9538-9; Unger SD, 2012, AMPHIBIA-REPTILIA, V33, P313, DOI 10.1163/156853812X641712; Unger SD, 2010, CONSERV GENET RESOUR, V2, P89, DOI 10.1007/s12686-009-9170-0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wheeler BA, 2003, BIOL CONSERV, V109, P151, DOI 10.1016/S0006-3207(02)00136-2; Wooten JA, 2011, ACTA HERPETOL, V6, P175; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x	82	17	17	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e74180	10.1371/journal.pone.0074180	http://dx.doi.org/10.1371/journal.pone.0074180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204565	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300002
J	Wei, SQ; Moon, HG; Zheng, YJ; Liang, XL; An, CH; Jin, Y				Wei, Shuquan; Moon, Hyung-Geun; Zheng, Yijie; Liang, Xiaoliang; An, Chang Hyeok; Jin, Yang			Flotillin-2 Modulates Fas Signaling Mediated Apoptosis after Hyperoxia in Lung Epithelial Cells	PLOS ONE			English	Article							DEATH DOMAIN; LIPID RAFTS; CAVEOLIN-1; PROTEIN; ACTIVATION; EXPRESSION; INTERACTS; RECEPTOR; PATHWAY; STRESS	Lipid rafts are subdomains of the cell membrane with distinct protein composition and high concentrations of cholesterol and glycosphingolipids. Raft proteins are thought to mediate diverse cellular processes including signal transduction. However, its cellular mechanisms remain unclear. Caveolin-1 (cav-1, marker protein of caveolae) has been thought as a switchboard between extracellular matrix (ECM) stimuli and intracellular signals. Flotillin-2/reggie-1(Flot-2) is another ubiquitously expressed raft protein which defines non-caveolar raft microdomains (planar raft). Its cellular function is largely uncharacterized. Our novel studies demonstrated that Flot-2, in conjunction with cav-1, played important functions on controlling cell death via regulating Fas pathways. Using Beas2B epithelial cells, we found that in contrast to cav-1, Flot-2 conferred cytoprotection via preventing Fas mediated death-inducing signaling complex (DISC) formation, subsequently suppressed caspase-8 mediated extrinsic apoptosis. Moreover, Flot-2 reduced the mitochondria mediated intrinsic apoptosis by regulating the Bcl-2 family and suppressing cytochrome C release from mitochondria to cytosol. Flot-2 further modulated the common apoptosis pathway and inhibited caspase-3 activation via up-regulating the members in the inhibitor of apoptosis (IAP) family. Last, Flot-2 interacted with cav-1 and limited its expression. Taken together, we found that Flot-2 protected cells from Fas induced apoptosis and counterbalanced the pro-apoptotic effects of cav-1. Thus, Flot-2 played crucial functions in cellular homeostasis and cell survival, suggesting a differential role of individual raft proteins.	[Wei, Shuquan; Moon, Hyung-Geun; Zheng, Yijie; Liang, Xiaoliang; An, Chang Hyeok; Jin, Yang] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care, Dept Med,Med Sch, Boston, MA 02115 USA; [Wei, Shuquan] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Guangzhou Medical University	Jin, Y (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care, Dept Med,Med Sch, Boston, MA 02115 USA.	yjin@rics.bwh.harvard.edu		An, Chang Hyeok/0000-0001-9145-1322	National Institutes of Health (NIH) [R01 HL102076]; Flight Attendant Medical Research Institute (FAMRI) CIA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102076] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI) CIA grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) R01 HL102076 (Y.J.) and Flight Attendant Medical Research Institute (FAMRI) CIA grant (http://www.famri.org/researchers/current_and_upcoming_awards.html) (Y.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Budinger GRS, 2011, AM J RESP CRIT CARE, V183, P1043, DOI 10.1164/rccm.201002-0181OC; Camhi S L, 1995, New Horiz, V3, P170; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Denecker G, 2001, CELL MOL LIFE SCI, V58, P356, DOI 10.1007/PL00000863; Ding Y, 2005, PROTEIN EXPRES PURIF, V42, P137, DOI 10.1016/j.pep.2005.03.001; Eguchi Y, 1997, CANCER RES, V57, P1835; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Eramo A, 2004, EUR J IMMUNOL, V34, P1930, DOI 10.1002/eji.200324786; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gajate C, 2001, BLOOD, V98, P3860, DOI 10.1182/blood.V98.13.3860; Gajate C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005044; Guo YH, 2009, BLOOD, V113, P4431, DOI 10.1182/blood-2008-07-169433; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X; Li WP, 2001, J CELL SCI, V114, P1397; Li-Weber M, 2003, SEMIN IMMUNOL, V15, P145, DOI 10.1016/S1044-5323(03)00030-7; Matsumura H, 2000, J CELL BIOL, V151, P1247, DOI 10.1083/jcb.151.6.1247; Mollinedo F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.41; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Newman GR, 1999, CELL TISSUE RES, V295, P111, DOI 10.1007/s004410051217; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rajalingam K, 2007, APOPTOSIS, V12, P1503, DOI 10.1007/s10495-007-0067-7; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Volonte D, 2008, AM J PHYSIOL-HEART C, V294, pH392, DOI 10.1152/ajpheart.01039.2007; Wang X, 2003, J BIOL CHEM, V278, P29184, DOI 10.1074/jbc.M301624200; Wang XQ, 2006, J INVEST DERMATOL, V126, P951, DOI 10.1038/sj.jid.5700282; WYLLIE AH, 1986, HISTOPATHOLOGY, V10, P995; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yang YL, 2000, CELL RES, V10, P169, DOI 10.1038/sj.cr.7290046; Yerbes R, 2011, BBA-MOL CELL RES, V1813, P168, DOI 10.1016/j.bbamcr.2010.10.003; Zhang M, 2011, FREE RADICAL BIO MED, V50, P1252, DOI 10.1016/j.freeradbiomed.2011.02.031; Zhang M, 2009, AM J PHYSIOL-LUNG C, V297, pL945, DOI 10.1152/ajplung.00081.2009; Zhao F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-479; Zhao XX, 2009, BIOCHEM BIOPH RES CO, V378, P21, DOI 10.1016/j.bbrc.2008.10.123; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	50	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77519	10.1371/journal.pone.0077519	http://dx.doi.org/10.1371/journal.pone.0077519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204853	Green Published, Green Submitted, gold			2022-12-25	WOS:000326029300101
J	Zhao, HY; Casillas, E; Shroff, H; Patterson, GH; Schuck, P				Zhao, Huaying; Casillas, Ernesto, Jr.; Shroff, Hari; Patterson, George H.; Schuck, Peter			Tools for the Quantitative Analysis of Sedimentation Boundaries Detected by Fluorescence Optical Analytical Ultracentrifugation	PLOS ONE			English	Article							PROTEIN	Fluorescence optical detection in sedimentation velocity analytical ultracentrifugation allows the study of macromolecules at nanomolar concentrations and below. This has significant promise, for example, for the study of systems of high-affinity protein interactions. Here we describe adaptations of the direct boundary modeling analysis approach implemented in the software SEDFIT that were developed to accommodate unique characteristics of the confocal fluorescence detection system. These include spatial gradients of signal intensity due to scanner movements out of the plane of rotation, temporal intensity drifts due to instability of the laser and fluorophores, and masking of the finite excitation and detection cone by the sample holder. In an extensive series of experiments with enhanced green fluorescent protein ranging from low nanomolar to low micromolar concentrations, we show that the experimental data provide sufficient information to determine the parameters required for first-order approximation of the impact of these effects on the recorded data. Systematic deviations of fluorescence optical sedimentation velocity data analyzed using conventional sedimentation models developed for absorbance and interference optics are largely removed after these adaptations, resulting in excellent fits that highlight the high precision of fluorescence sedimentation velocity data, thus allowing a more detailed quantitative interpretation of the signal boundaries that is otherwise not possible for this system.	[Zhao, Huaying; Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA; [Casillas, Ernesto, Jr.; Patterson, George H.] Natl Inst Biomed Imaging & Bioengn, Sect Biophoton, NIH, Bethesda, MD USA; [Shroff, Hari] Natl Inst Biomed Imaging & Bioengn, Sect High Resolut Opt Imaging, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Schuck, P (corresponding author), Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA.	schuckp@mail.nih.gov	Patterson, George/ABI-4751-2020; Schuck, Peter/AAA-6888-2020; Shroff, Hari/E-7247-2016	Schuck, Peter/0000-0002-8859-6966; Shroff, Hari/0000-0003-3613-8215; Casillas, Ernesto/0000-0002-9202-0206	National Institute of Biomedical Imaging and Bioengineering; National Institute of Child Health and Human Development, National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051, ZIAEB000074, ZIAEB000071] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering and the National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, AN ULTR FLUOR DET SY, DOI Lakewood, NJ; Bailey MF, 2009, ANAL BIOCHEM, V390, P218, DOI 10.1016/j.ab.2009.03.045; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Harding SE, 2010, BIOCHEM SOC T, V38, P901, DOI 10.1042/BST0380901; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Kingsbury JS, 2011, METHOD ENZYMOL, V492, P283, DOI 10.1016/B978-0-12-381268-1.00021-5; Kroe RR, 2009, ANAL BIOCHEM, V390, P1, DOI 10.1016/j.ab.2008.11.033; Lyons DF, 2013, ANAL BIOCHEM, V437, P133, DOI 10.1016/j.ab.2013.02.019; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Mok YF, 2011, METHODS, V54, P67, DOI 10.1016/j.ymeth.2010.10.004; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Schuck Peter, 2013, Biophys Rev, V5, P159, DOI 10.1007/s12551-013-0106-2; Schuck P, 2011, METHODS, V54, P1, DOI 10.1016/j.ymeth.2011.04.003; Schuck P, 2010, ANAL BIOCHEM, V401, P280, DOI 10.1016/j.ab.2010.02.037; Svedberg T, 1940, THE ULTRACENTRIFUGE; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	21	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2013	8	10							e77245	10.1371/journal.pone.0077245	http://dx.doi.org/10.1371/journal.pone.0077245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239MM	24204779	gold, Green Published, Green Submitted			2022-12-25	WOS:000326029300093
J	Yang, GK; Maahs, DM; Perkins, BA; Cherney, DZI				Yang, Gary K.; Maahs, David M.; Perkins, Bruce A.; Cherney, David Z. I.			Renal Hyperfiltration and Systemic Blood Pressure in Patients with Uncomplicated Type 1 Diabetes Mellitus	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HEMODYNAMIC FUNCTION; ENDOTHELIAL FUNCTION; GLOMERULAR HYPERFILTRATION; ARTERIAL STIFFNESS; HYPERGLYCEMIA; INHIBITION; HUMANS; RESPONSES; HYPERTENSION	Background: Patients with type 1 diabetes mellitus (DM) and renal hyperfiltration also exhibit systemic microvascular abnormalities, including endothelial dysfunction. The effect of renal hyperfiltration on systemic blood pressure (BP) is less clear. We therefore measured BP, renal hemodynamic function and circulating renin angiotensin aldosterone system (RAAS) mediators in type 1 DM patients with hyperfiltration (n = 36, DM-H, GFR >= 135 ml/min/1.73 m(2)) or normofiltration (n = 40, DM-N), and 56 healthy controls (HC). Since renal hyperfiltration represents a state of intrarenal RAAS activation, we hypothesized that hyperfiltration would be associated with higher BP and elevated levels of circulating RAAS mediators. Methods: BP, glomerular filtration rate (GFR -inulin), effective renal plasma flow (paraaminohippurate) and circulating RAAS components were measured in DM-H, DM-N and HC during clamped euglycemia (4-6 mmol/L). Studies were repeated in DM-H and DM-N during clamped hyperglycemia (9-11 mmol/L). Results: Baseline GFR was elevated in DM-H vs. DM-N and HC (167 +/- 6 vs. 11562 and 115 +/- 2 ml/min/1.73 m(2), p<0.0001). Baseline systolic BP (SBP, 117 +/- 2 vs. 111 +/- 2 vs. 109 +/- 1, p = 0.004) and heart rate (76 +/- 1 vs. 67 +/- 1 vs. 61 +/- 1, p<0.0001) were higher in DM-H vs. DM-N and HC. Despite higher SBP in DM-H, plasma aldosterone was lower in DM-H vs. DM-N and HC (42 +/- 5 vs. 86 +/- 14 vs. 276 +/- 41 ng/dl, p = 0.01). GFR (p<0.0001) and SBP (p<0.0001) increased during hyperglycemia in DM-N but not in DM-H. Conclusions: DM-H was associated with higher heart rate and SBP values and an exaggerated suppression of systemic aldosterone. Future work should focus on the mechanisms that explain this paradox in diabetes of renal hyperfiltration coupled with systemic RAAS suppression.	[Yang, Gary K.] Univ Toronto, Fac Med, Toronto, ON M5G 1L7, Canada; [Maahs, David M.] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO USA; [Perkins, Bruce A.] Univ Toronto, Toronto Gen Hosp, Div Endocrinol, Dept Med, Toronto, ON M5G 1L7, Canada; [Cherney, David Z. I.] Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5G 1L7, Canada	University of Toronto; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Cherney, DZI (corresponding author), Univ Toronto, Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON M5G 1L7, Canada.	david.cherney@uhn.on.ca	Perkins, Bruce A/L-3726-2017	Yang, Gary/0000-0002-3039-4392; Maahs, David/0000-0002-4602-7909	Kidney Foundation of Canada; Canadian Diabetes Association-KRESCENT Program; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research	Kidney Foundation of Canada; Canadian Diabetes Association-KRESCENT Program; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DC was also supported by a Kidney Foundation of Canada Scholarship and a Canadian Diabetes Association-KRESCENT Program Joint New Investigator Award. Operating funds were provided by the Heart and Stroke Foundation of Canada and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherney DZI, 2010, DIABETIC MED, V27, P1358, DOI 10.1111/j.1464-5491.2010.03121.x; Cherney DZI, 2008, DIABETES, V57, P688, DOI 10.2337/db07-1230; Cherney DZI, 2012, DIABETES CARE, V35, P2324, DOI 10.2337/dc12-0773; Cherney DZI, 2012, AM J PHYSIOL-REG I, V303, pR710, DOI 10.1152/ajpregu.00286.2012; Cherney DZI, 2010, NEPHROL DIAL TRANSPL, V25, P4093, DOI 10.1093/ndt/gfq564; Cherney DZI, 2010, DIABETES CARE, V33, P2068, DOI 10.2337/dc10-0767; Cherney DZI, 2010, AM J PHYSIOL-REG I, V299, pR206, DOI 10.1152/ajpregu.00027.2010; Cherney DZI, 2010, DIABETES CARE, V33, P1344, DOI 10.2337/dc09-2340; Cherney DZI, 2010, DIABETES CARE, V33, P361, DOI 10.2337/dc09-1303; Cherney DZI, 2005, KIDNEY INT, V68, P1722, DOI 10.1111/j.1523-1755.2005.00588.x; Chillaron JJ, 2011, J DIABETES COMPLICAT, V25, P232, DOI 10.1016/j.jdiacomp.2011.03.006; Christiansen EH, 1998, EUR HEART J, V19, P1735, DOI 10.1053/euhj.1998.1090; DAVIDSON WD, 1963, J LAB CLIN MED, V62, P351; Ficociello LH, 2009, DIABETES CARE; FLORAS JS, 1993, J HYPERTENS, V11, P647, DOI 10.1097/00004872-199306000-00009; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Hopkins PN, 1996, J HYPERTENS, V14, P199, DOI 10.1097/00004872-199602000-00008; Imano E, 2001, DIABETES RES CLIN PR, V52, P185, DOI 10.1016/S0168-8227(01)00219-4; Jacobsen P, 2003, J INTERN MED, V254, P464, DOI 10.1046/j.1365-2796.2003.01216.x; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; JUNG K, 1990, NEPHRON, V54, P360, DOI 10.1159/000185900; KALINYAK JE, 1993, J AM SOC NEPHROL, V4, P1337; KIKKAWA R, 1986, RENAL PHYSIOL BIOCH, V9, P187; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Marcovecchio ML, 2009, DIABETOLOGIA, V52, P1173, DOI 10.1007/s00125-009-1327-6; Miller JA, 1999, J AM SOC NEPHROL, V10, P1778; Miller JA, 1996, CLIN SCI, V90, P189, DOI 10.1042/cs0900189; Miller JA, 2003, DIABETES, V52, P1806, DOI 10.2337/diabetes.52.7.1806; Pecis M, 1997, DIABETES CARE, V20, P1329, DOI 10.2337/diacare.20.8.1329; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; Ritz E, 2007, CURR HYPERTENS REP, V9, P409, DOI 10.1007/s11906-007-0075-6; Rodrigues TD, 2006, DIABETES RES CLIN PR, V74, P135, DOI 10.1016/j.diabres.2006.03.016; ROSENBERG ME, 1994, KIDNEY INT, V45, P403, DOI 10.1038/ki.1994.52; Rosolowsky ET, 2008, DIABETES RES CLIN PR, V82, pS46, DOI 10.1016/j.diabres.2008.09.018; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sasson AN, 2012, WORLD J DIABETES, V3, P1, DOI 10.4239/wjd.v3.i1.1; Sochett EB, 2006, J AM SOC NEPHROL, V17, P1703, DOI 10.1681/ASN.2005080872; SOWERS JR, 1995, HYPERTENSION, V26, P869, DOI 10.1161/01.HYP.26.6.869; Thulesen J, 1999, NEPHRON, V81, P172, DOI 10.1159/000045274; Torbjornsdotter TB, 2004, DIABETES CARE, V27, P510, DOI 10.2337/diacare.27.2.510; Vervoort G, 2005, EUR J CLIN INVEST, V35, P330, DOI 10.1111/j.1365-2362.2005.01497.x; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521	43	54	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 4	2013	8	7							e68908	10.1371/journal.pone.0068908	http://dx.doi.org/10.1371/journal.pone.0068908			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204FO	23861950	Green Published, Green Submitted, gold			2022-12-25	WOS:000323350700107
J	Wang, RC; Kniazeva, M; Han, M				Wang, Rencheng; Kniazeva, Marina; Han, Min			Peroxisome Protein Transportation Affects Metabolism of Branched-Chain Fatty Acids That Critically Impact Growth and Development of C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; BIOSYNTHESIS; ROLES; DISORDERS; PATHWAY; GENES	The impact of specific lipid molecules, including fatty acid variants, on cellular and developmental regulation is an important research subject that remains under studied. Monomethyl branched-chain fatty acids (mmBCFAs) are commonly present in multiple organisms including mammals, however our understanding of mmBCFA functions is very limited. C. elegans has been the premier model system to study the functions of mmBCFAs and their derived lipids, as mmBCFAs have been shown to play essential roles in post-embryonic development in this organism. To understand more about the metabolism of mmBCFAs in C. elegans, we performed a genetic screen for suppressors of the L1 developmental arrest phenotype caused by mmBCFA depletion. Extensive characterization of one suppressor mutation identified prx-5, which encodes an ortholog of the human receptor for the type-1 peroxisomal targeting signal protein. Our study showed that inactivating prx-5 function compromised the peroxisome protein import, resulting in an increased level of branched-chain fatty acid C17ISO in animals lacking normal mmBCFA synthesis, thereby restoring wild-type growth and development. This work reveals a novel connection between peroxisomal functions and mmBCFA metabolism.	[Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu		You, Hai-Lu/0000-0003-2203-6461	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Howard Hughes Medical Institute Investigator fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HRADEC J, 1994, J CHROMATOGR B, V660, P386, DOI 10.1016/0378-4347(94)00292-4; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kniazeva M, 2012, GENE DEV, V26, P554, DOI 10.1101/gad.187054.112; Moser HW, 1999, MOL GENET METAB, V68, P316, DOI 10.1006/mgme.1999.2926; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Seamen E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000589; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Thieringer H, 2003, J CELL SCI, V116, P1797, DOI 10.1242/jcs.00380; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Vrablik TL, 2012, GENE DEV, V26, P631, DOI 10.1101/gad.190777.112; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Webster CM, 2013, DEV BIOL, V373, P14, DOI 10.1016/j.ydbio.2012.10.002; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; Zhang SBO, 2010, P NATL ACAD SCI USA, V107, P4640, DOI 10.1073/pnas.0912308107; Zhang YR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-164; Zhu H, 2013, ELIFE IN PRESS; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	35	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2013	8	9							e76270	10.1371/journal.pone.0076270	http://dx.doi.org/10.1371/journal.pone.0076270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	228WY	24204734	Green Published, Green Submitted, gold			2022-12-25	WOS:000325223900092
J	Huang, HZ; Ding, Y; Sun, XZS; Nguyen, TA				Huang, Hongzhou; Ding, Ying; Sun, Xiuzhi S.; Nguyen, Thu A.			Peptide Hydrogelation and Cell Encapsulation for 3D Culture of MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							IN-VITRO; SCAFFOLDS; DESIGN; BETA; DIFFERENTIATION; NANOFIBERS; MEDICINE; BIOLOGY; TISSUES; GROWTH	Three-dimensional (3D) cell culture plays an invaluable role in tumor biology by providing in vivo like microenviroment and responses to therapeutic agents. Among many established 3D scaffolds, hydrogels demonstrate a distinct property as matrics for 3D cell culture. Most of the existing pre-gel solutions are limited under physiological conditions such as undesirable pH or temperature. Here, we report a peptide hydrogel that shows superior physiological properties as an in vitro matrix for 3D cell culture. The 3D matrix can be accomplished by mixing a self-assembling peptide directly with a cell culture medium without any pH or temperature adjustment. Results of dynamic rheological studies showed that this hydrogel can be delivered multiple times via pipetting without permanently destroying the hydrogel architecture, indicating the deformability and remodeling ability of the hydrogel. Human epithelial cancer cells, MCF-7, are encapsulated homogeneously in the hydrogel matrix during hydrogelation. Compared with two-dimensional (2D) monolayer culture, cells residing in the hydrogel matrix grow as tumor-like clusters in 3D formation. Relevant parameters related to cell morphology, survival, proliferation, and apoptosis were analyzed using MCF-7 cells in 3D hydrogels. Interestingly, treatment of cisplatin, an anti-cancer drug, can cause a significant decrease of cell viability of MCF-7 clusters in hydrogels. The responses to cisplatin were dose- and time-dependent, indicating the potential usage of hydrogels for drug testing. Results of confocal microscopy and Western blotting showed that cells isolated from hydrogels are suitable for downstream proteomic analysis. The results provided evidence that this peptide hydrogel is a promising 3D cell culture material for drug testing.	[Huang, Hongzhou; Sun, Xiuzhi S.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Ding, Ying] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Nguyen, Thu A.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Sun, XZS (corresponding author), Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA.	xss@k-state.edu; tnguyen@vet.k-state.edu	Ding, Ying/M-8060-2017	Ding, Ying/0000-0001-8600-9740	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station [12-181-J]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; Directorate For Engineering [1321261] Funding Source: National Science Foundation	KSU Targeted Excellence Program; KSU Research Foundation Scholarship Program; Kansas Agricultural Experiment Station; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This project was partially funded by KSU Targeted Excellence Program and KSU Research Foundation Scholarship Program as well as the contribution (no. 12-181-J) from the Kansas Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab AK, 2006, J CONTROL RELEASE, V111, P281, DOI 10.1016/j.jconrel.2005.12.014; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047; Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Cavalli S, 2010, CHEM SOC REV, V39, P241, DOI 10.1039/b906701a; Chawla K, 2011, BIOMACROMOLECULES, V12, P560, DOI 10.1021/bm100980w; Chignola R, 2000, CELL PROLIFERAT, V33, P219, DOI 10.1046/j.1365-2184.2000.00174.x; CHIRILA TV, 1993, BIOMATERIALS, V14, P26, DOI 10.1016/0142-9612(93)90072-A; Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027; Feder-Mengus C, 2008, TRENDS MOL MED, V14, P333, DOI 10.1016/j.molmed.2008.06.001; GORLACH A, 1994, INT J CANCER, V56, P249, DOI 10.1002/ijc.2910560218; Gurski LA, 2010, BIOMATERIALS, V31, P4248, DOI 10.1016/j.biomaterials.2010.01.141; Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h; Huang HZ, 2011, SOFT MATTER, V7, P8905, DOI 10.1039/c1sm05157a; Kelter G, 2005, ANTI-CANCER DRUG, V16, P1091, DOI 10.1097/00001813-200511000-00008; Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Liu SQ, 2010, SOFT MATTER, V6, P67, DOI 10.1039/b916705f; Mather ML, 2010, REGEN MED, V5, P809, DOI 10.2217/RME.10.32; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Perez-Castillejos R, 2010, MATER TODAY, V13, P32, DOI 10.1016/S1369-7021(10)70015-8; Rapaport H, 2008, ADV FUNCT MATER, V18, P2889, DOI 10.1002/adfm.200800117; Salick DA, 2009, ADV MATER, V21, P4120, DOI 10.1002/adma.200900189; SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005; Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; Zhang S, 2008, ADV CANCER RES, V99, P335, DOI 10.1016/S0065-230X(07)99005-3	40	158	163	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 20	2013	8	3							e59482	10.1371/journal.pone.0059482	http://dx.doi.org/10.1371/journal.pone.0059482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	125SW	23527204	Green Published, Green Submitted, gold			2022-12-25	WOS:000317562600075
